PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mitra, A; Skrzypczak, M; Ginalski, K; Rowicka, M				Mitra, Abhishek; Skrzypczak, Magdalena; Ginalski, Krzysztof; Rowicka, Maga			Strategies for Achieving High Sequencing Accuracy for Low Diversity Samples and Avoiding Sample Bleeding Using Illumina Platform	PLOS ONE			English	Article								Sequencing microRNA, reduced representation sequencing, Hi-C technology and any method requiring the use of in-house barcodes result in sequencing libraries with low initial sequence diversity. Sequencing such data on the Illumina platform typically produces low quality data due to the limitations of the Illumina cluster calling algorithm. Moreover, even in the case of diverse samples, these limitations are causing substantial inaccuracies in multi-plexed sample assignment (sample bleeding). Such inaccuracies are unacceptable in clinical applications, and in some other fields (e.g. detection of rare variants). Here, we discuss how both problems with quality of low-diversity samples and sample bleeding are caused by incorrect detection of clusters on the flowcell during initial sequencing cycles. We propose simple software modifications (Long Template Protocol) that overcome this problem. We present experimental results showing that our Long Template Protocol remarkably increases data quality for low diversity samples, as compared with the standard analysis protocol; it also substantially reduces sample bleeding for all samples. For comprehensiveness, we also discuss and compare experimental results from alternative approaches to sequencing low diversity samples. First, we discuss how the low diversity problem, if caused by barcodes, can be avoided altogether at the barcode design stage. Second and third, we present modified guidelines, which are more stringent than the manufacturer's, for mixing low diversity samples with diverse samples and lowering cluster density, which in our experience consistently produces high quality data from low diversity samples. Fourth and fifth, we present rescue strategies that can be applied when sequencing results in low quality data and when there is no more biological material available. In such cases, we propose that the flowcell be re-hybridized and sequenced again using our Long Template Protocol. Alternatively, we discuss how analysis can be repeated from saved sequencing images using the Long Template Protocol to increase accuracy.	[Mitra, Abhishek; Rowicka, Maga] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Mitra, Abhishek; Rowicka, Maga] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Skrzypczak, Magdalena; Ginalski, Krzysztof] Univ Warsaw, Ctr New Technol, Lab Bioinformat & Syst Biol, PL-02089 Warsaw, Poland; [Rowicka, Maga] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Warsaw; University of Texas System; University of Texas Medical Branch Galveston	Ginalski, K (corresponding author), Univ Warsaw, Ctr New Technol, Lab Bioinformat & Syst Biol, Zwirki & Wigury 93, PL-02089 Warsaw, Poland.	kginal@cent.uw.edu.pl; merowick@utmb.edu	Skrzypczak, Magdalena/F-2575-2016; Rowicka, Maga/E-2496-2012	Skrzypczak, Magdalena/0000-0002-3336-0403; Rowicka, Maga/0000-0002-4011-071X	national center for advancing translational science (NCATS), National Institutes of Health [UL1 TR000071]; Foundation for Polish Science (TEAM); National Science Centre [2011/02/A/NZ2/00014]; European Regional Development Fund under Innovative Economy Programme [POIG.02.02.00-14-024/08-00]; National Institutes of Health [R01GM112131]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112131] Funding Source: NIH RePORTER	national center for advancing translational science (NCATS), National Institutes of Health; Foundation for Polish Science (TEAM); National Science Centre(National Science Centre, Poland); European Regional Development Fund under Innovative Economy Programme; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grant UL1 TR000071 from the national center for advancing translational science (NCATS), National Institutes of Health (M. R. and A. M.) and by grants from the Foundation for Polish Science (TEAM), the National Science Centre (2011/02/A/NZ2/00014) and the European Regional Development Fund under Innovative Economy Programme (POIG.02.02.00-14-024/08-00) (K. G. and M. S.) and National Institutes of Health grant R01GM112131 (M. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Baker M, 2010, NAT METHODS, V7, P687, DOI 10.1038/nmeth0910-687; Crosetto N, 2013, NAT METHODS, V10, P361, DOI 10.1038/nmeth.2408; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krueger F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016607; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Meyer M, 2010, COLD SPRING HARBOR P; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109; vanBerkum N.L., 2010, J VISUALIZED EXPT JO; Whiteford N, 2009, BIOINFORMATICS, V25, P2194, DOI 10.1093/bioinformatics/btp383	13	67	69	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120520	10.1371/journal.pone.0120520	http://dx.doi.org/10.1371/journal.pone.0120520			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860802	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300013
J	Spiridonov, A; Brazauskas, A; Radzevicius, S				Spiridonov, Andrej; Brazauskas, Antanas; Radzevicius, Sigitas			The Role of Temporal Abundance Structure and Habitat Preferences in the Survival of Conodonts during the Mid-Early Silurian Ireviken Mass Extinction Event	PLOS ONE			English	Article							SPECIES SELECTION; RISK; GOTLAND; VARIABILITY; DIVERSITY; DYNAMICS; MODELS; RESOLUTION; PATTERNS; EPISODES	The Ireviken event was one of the most intense extinction episodes that occurred during the mid-Paleozoic era. It had a strong global effect on a range of clades, with conodonts, graptolites and chitinozoans affected most. Using geophysical proxies and conodont species parameters of their temporal abundance structure we investigate how they affected the selectivity of conodont species survival during this calamity. After performing bivariate logistic analyses on 34 species of conodonts, we find three variables that were statistically significantly associated with their odds of survival. These namely include spectral exponents that describe degrees of autocorrelation in a time series, the skewness of species abundance distribution, and average environmental preferences, which are mostly determined by ancient water depths at sampling sites. Model selection of multivariate logistic models found the best model includes species local abundance skewness and substrate preference. A similar pattern is revealed through the regression tree analysis. The apparent extinction selectivity points to a possible causes of environmental deterioration during the Ireviken event. The significant positive relationship between extinction risk and preferential existence in deeper environments suggests the open ocean causal mechanisms of biotic stress that occurred during the Ireviken event. Marine regressions, which were previously suggested as a causal factor in this extinction episode, on theoretical grounds should have had higher impact on species living in near-shore environments, through the processes of habitat loss which are associated with decreases of shelfal areas. In addition, the significant positive correlations found between skewness of abundance distributions and spectral exponent values and the probability of species survival suggest that community and ecosystem processes (which controlled species abundance fluctuation patterns) were significantly related to selectivity processes of this smaller mass extinction event.	[Spiridonov, Andrej; Brazauskas, Antanas; Radzevicius, Sigitas] Vilnius State Univ, Dept Geol & Mineral, LT-03101 Vilnius, Lithuania	Vilnius University	Spiridonov, A (corresponding author), Vilnius State Univ, Dept Geol & Mineral, MK Ciurlionio 21-27, LT-03101 Vilnius, Lithuania.	s.andrej@gmail.com		Spiridonov, Andrej/0000-0002-8773-5629; Radzevicius, Sigitas/0000-0001-8877-7428	Research Council of Lithuania [MIP-034/2012]; project IGCP 591: The Early to Middle Paleozoic Revolution	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); project IGCP 591: The Early to Middle Paleozoic Revolution	This research was supported by the Research Council of Lithuania MIP-034/2012 (URL http://www.lmt.lt/en/about.html), and it is a contribution to the project IGCP 591: The Early to Middle Paleozoic Revolution (URL http://igcp591.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EARTH LIFE GLOBAL BI; [Anonymous], 2008, MODEL SELECTION MODE; Arens NC, 2008, PALEOBIOLOGY, V34, P456, DOI 10.1666/07034.1; ARINO A, 1995, EVOL ECOL, V9, P429, DOI 10.1007/BF01237765; Bennett, 1997, EVOLUTION ECOLOGY PA; Benton Michael J., 1996, P185; Bokma F, 2014, SYST BIOL, V63, P251, DOI 10.1093/sysbio/syt067; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Boyle JT, 2014, GFF, V136, P38, DOI 10.1080/11035897.2013.861864; Brazauskas A, 1993, THESIS VILNIUS U; Brazauskas A., 2004, LITOSFERA LIETUVOS Z, P173; Brown J. H., 1995, MACROECOLOGY; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Calner Mikael, 2008, P21, DOI 10.1007/978-3-540-75916-4_4; Chesson P, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P279; Christensen RHB, 2012, R PACKAGE VERSION 3; Clapham ME, 2011, GEOLOGY, V39, P1059, DOI 10.1130/G32230.1; Cocks LRM, 2005, EARTH-SCI REV, V72, P39, DOI 10.1016/j.earscirev.2005.04.001; Cohen JE, 2014, THEOR POPUL BIOL, V93, P30, DOI 10.1016/j.tpb.2014.01.001; Cooper RA, 2014, GEOL MAG, V151, P349, DOI 10.1017/S0016756813000198; Cooper RA, 2010, PALEOBIOLOGY, V36, P167, DOI 10.1666/09043.1; Cuddington KM, 1999, P ROY SOC B-BIOL SCI, V266, P969, DOI 10.1098/rspb.1999.0731; Donoghue PCJ, 1999, GEOLOGY, V27, P251, DOI 10.1130/0091-7613(1999)027<0251:GFATCF>2.3.CO;2; Eldredge Niles, 1996, P42; Ellis DV, 2007, WELL LOGGING EARTH S; Eriksson ME, 2006, GFF, V128, P91, DOI 10.1080/11035890601282091; FOOTE M, 2007, PRINCIPLES PALEONTOL; Foote M, 2006, PALEOBIOLOGY, V32, P345, DOI 10.1666/05062.1; Frank SA, 2011, J EVOLUTION BIOL, V24, P2299, DOI 10.1111/j.1420-9101.2011.02378.x; Gelsthorpe DN, 2004, REV PALAEOBOT PALYNO, V130, P89, DOI 10.1016/j.revpalbo.2003.12.003; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Hallam A., 1972, MODELS PALAEOBIOLOGY, P62; Halley JM, 2004, FLUCT NOISE LETT, V4, pR1, DOI 10.1142/S0219477504001884; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harnik PG, 2012, P ROY SOC B-BIOL SCI, V279, P4969, DOI 10.1098/rspb.2012.1902; Harnik PG, 2011, P NATL ACAD SCI USA, V108, P13594, DOI 10.1073/pnas.1100572108; Heino M, 2000, ECOGRAPHY, V23, P177, DOI 10.1111/j.1600-0587.2000.tb00273.x; Hints Olle, 2006, Proceedings of the Estonian Academy of Sciences Geology, V55, P128; Holyoak M, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P1; Hull Pincelli M., 2013, Paleontological Society Papers, V19, P115; Inchausti P, 2003, J ANIM ECOL, V72, P899, DOI 10.1046/j.1365-2656.2003.00767.x; Izenman AJ, 2008, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-78189-1_1; Jablonski D, 2005, PALEOBIOLOGY, V31, P192, DOI 10.1666/0094-8373(2005)031[0192:MEAM]2.0.CO;2; Jablonski D., 1985, P335; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Jeppsson L., 1987, P129; JEPPSSON L, 1993, TERRA NOVA, V5, P348, DOI 10.1111/j.1365-3121.1993.tb00268.x; Jeppsson Lennart, 1993, Proceedings of the Estonian Academy of Sciences Geology, V42, P23; Jeppsson Lennart, 1997, P451; Jeppsson Lennart, 1998, New York State Museum Bulletin, V491, P239; Johnson ME, 2006, GFF, V128, P115, DOI 10.1080/11035890601282115; Kaitala V, 1997, ANN ZOOL FENN, V34, P217; Kaljo D, 2004, CARBON ISOTOPE DATIN, P51; Kendal WS, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066120; Kiessling W, 2013, P 3 IGCP 591 ANN M L, P21; Legendre S, 2008, AM NAT, V172, P282, DOI 10.1086/589454; Lehnert O, 2010, PALAEOGEOGR PALAEOCL, V296, P320, DOI 10.1016/j.palaeo.2010.01.009; Lieberman BS, 2007, EVOL BIOL, V34, P28, DOI 10.1007/s11692-007-9005-4; Lipps JH, 1986, DYNAMICS EXTINCTION, P89; LLOYD EA, 1993, P NATL ACAD SCI USA, V90, P595, DOI 10.1073/pnas.90.2.595; Lockwood R, 2003, P NATL ACAD SCI USA, V100, P2478, DOI 10.1073/pnas.0535132100; Loreau M., 2010, POPULATIONS ECOSYSTE; Loydell DK, 2007, GEOL J, V42, P531, DOI 10.1002/gj.1090; Luning S, 2000, EARTH-SCI REV, V49, P121, DOI 10.1016/S0012-8252(99)00060-4; Mannik P, 2013, GEOL MAG, V150, P639, DOI 10.1017/S001675681200088X; Mazerolle M, 2011, R PACKAGE VERSION 31; Melbourne BA, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P307; Melchin MJ, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P525, DOI 10.1016/B978-0-444-59425-9.00021-4; Melchin Michael J., 1998, New York State Museum Bulletin, V491, P165; Miller AI, 2009, SCIENCE, V326, P1106, DOI 10.1126/science.1180061; Molloy P., 2012, EARTH LIFE 3, P615; Munnecke A, 2003, PALAEOGEOGR PALAEOCL, V195, P99, DOI 10.1016/S0031-0182(03)00304-3; Okasha S, 2012, INTERFACE FOCUS, V2, P49, DOI 10.1098/rsfs.2011.0046; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Olszewski TD, 2012, BIOL LETTERS, V8, P131, DOI 10.1098/rsbl.2011.0337; Ovaskainen O, 2010, TRENDS ECOL EVOL, V25, P643, DOI 10.1016/j.tree.2010.07.009; Paluveer L, 2014, GFF, V136, P198, DOI 10.1080/11035897.2013.873987; Paskevicius J., 1997, GEOLOGY BALTIC REPUB; PASKEVICIUS J, 1979, BIOSTRATIGRAPHY GRAP; Payne JL, 2011, PALEOBIOLOGY, V37, P616, DOI 10.1666/10037.1; Pfaff, 2006, ANAL INTEGRATED COIN; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Purnell MA, 2005, SPEC PAP PALAEONTOL, P7; Radzevicius S, 2014, SPR GEOL, P437, DOI 10.1007/978-3-319-04364-7_84; Raup D.M., 1992, EXTINCTION BAD GENES; Ripa J, 1996, P ROY SOC B-BIOL SCI, V263, P1751, DOI 10.1098/rspb.1996.0256; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Simpson C, 2009, PALEOBIOLOGY, V35, P631, DOI 10.1666/0094-8373-35.4.631; Stanley S. M., 1979, MACROEVOLUTION PATTE; Talent J.A., 2012, EARTH LIFE INT YEAR, P631, DOI [DOI 10.1007/978-90-481-3428-1_12, DOI 10.1007/978-90-481-3428-1_20]; Therneau TM, 1997, 61 MAYO CLIN SECT BI; Tjur T, 2009, AM STAT, V63, P366, DOI 10.1198/tast.2009.08210; Tomasovych A, 2010, AM NAT, V175, P587, DOI 10.1086/651661; Tonarova P, 2014, GFF, V136, P270, DOI 10.1080/11035897.2013.862855; TRFfS Computing, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; VALENTINE JW, 1972, MODELS PALEOBIOLOGY, P192; VRBA ES, 1986, PALEOBIOLOGY, V12, P217, DOI 10.1017/S0094837300013671; VRBA ES, 1992, J MAMMAL, V73, P1, DOI 10.2307/1381862; Vucetich JA, 2000, CONSERV BIOL, V14, P1704, DOI 10.1111/j.1523-1739.2000.99359.x; Whiteside JH, 2011, GEOLOGY, V39, P99, DOI 10.1130/G31401.1; Yablokov AV, 1986, PHENETICS EVOLUTION; Zaffos A, 2012, PALEOBIOLOGY, V38, P278, DOI 10.1666/10026.1	103	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124146	10.1371/journal.pone.0124146	http://dx.doi.org/10.1371/journal.pone.0124146			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859854	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300131
J	Wang, NY; Hirao, A; Sieber, F				Wang, Nae-Yuh; Hirao, Ai; Sieber, Frederick			Association between Intraoperative Blood Pressure and Postoperative Delirium in Elderly Hip Fracture Patients	PLOS ONE			English	Article							SPINAL-ANESTHESIA; RANDOMIZED-TRIAL; OLDER-ADULTS; SURGERY; RISK; PERFORMANCE; NECK	Background One possible area of intervention to prevent postoperative delirium (PD) is intraoperative blood pressure management. However, the relationship between intraoperative blood pressure and PD is unclear. A secondary analysis of a RCT study examining the PD risk over the range of absolute intraoperative mean arterial blood pressure (MAP) readings and the corresponding relative changes from preoperative baseline level was performed to determine the role of MAP on PD. Methods Nonparametric locally weighted quadratic polynomial smoothing (LOESS) regression explored the pattern of PD risk at postoperative day 2 as a function of mean surgery MAP (msMAP) and percent change of msMAP from baseline in 103 elderly hip fracture patients. Segment-linear logistic regression models were then constructed to determine the odds ratios (OR) of PD over the observed range of these msMAP measures, adjusting for potential confounds. Results Twenty-three patients (22%) developed PD on day 2. LOESS regression revealed a j-shaped association between absolute levels of msMAP and PD risk. When msMAP was >= 80 mmHg, higher msMAP imparted greater PD risk (OR = 2.28 per 10 mmHg msMAP increase; 95% CI: 1.11-4.70), while higher msMAP was associated with lower PD risk (OR = 0.19 per 10 mmHg increase; CI: 0.05-0.76) if msMAP was <80 mmHg. There was no statistically significant relationship between PD risk and average percent change from baseline in these msMAP measures. Conclusion In elderly hip fracture patients, both very high and very low levels of msMAP were associated with significantly increased risk of PD.	[Wang, Nae-Yuh] Johns Hopkins Med Inst, Dept Med Biostat & Epidemiol, Baltimore, MD 21205 USA; [Hirao, Ai; Sieber, Frederick] Johns Hopkins Bayview Med Ctr, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Sieber, F (corresponding author), Johns Hopkins Bayview Med Ctr, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21224 USA.	fsieber1@jhmi.edu		Wang, Nae-Yuh/0000-0001-6513-9730	NIH [R01AG033615]; National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health [M01 RR02719, UL1 TR000424, UL1 TR001079]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033615] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NIH R01AG033615. Funding for statistical support is also received from the National Center for Research Resources (NCRR) and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health through Grant Numbers M01 RR02719, UL1 TR000424, and UL1 TR001079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2006, CARDIOL CLIN, V24, P135, DOI 10.1016/j.ccl.2005.09.002; Bijker JB, 2012, ANESTHESIOLOGY, V116, P658, DOI 10.1097/ALN.0b013e3182472320; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Edlund A, 2001, J AM GERIATR SOC, V49, P1335, DOI 10.1046/j.1532-5415.2001.49261.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gruber-Baldini AL, 2013, J AM GERIATR SOC, V61, P1286, DOI 10.1111/jgs.12396; Guenther U, 2011, CURR OPIN ANESTHESIO, V24, P670, DOI 10.1097/ACO.0b013e32834c7b44; Hoppenstein D, 2005, J CLIN ANESTH, V17, P431, DOI 10.1016/j.jclinane.2004.09.013; Hori D, 2014, BRIT J ANAESTH, V113, P1009, DOI 10.1093/bja/aeu319; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Knecht S, 2008, HYPERTENSION, V51, P663, DOI 10.1161/HYPERTENSIONAHA.107.105577; Leslie DL, 2011, J AM GERIATR SOC, V59, pS241, DOI 10.1111/j.1532-5415.2011.03671.x; Lien SF, 2012, CURR HYPERTENS REP, V14, P432, DOI 10.1007/s11906-012-0287-2; Minville V, 2009, ANESTH ANALG, V108, P1291, DOI 10.1213/ane.0b013e31819b073b; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Papadopoulos George, 2012, Open Orthop J, V6, P400, DOI 10.2174/1874325001206010400; Patti R, 2011, EUR J ONCOL NURS, V15, P519, DOI 10.1016/j.ejon.2011.01.004; Sieber FE, 2010, MAYO CLIN PROC, V85, P18, DOI 10.4065/mcp.2009.0469; Williams-Russo P, 1999, ANESTHESIOLOGY, V91, P926, DOI 10.1097/00000542-199910000-00011; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Yocum GT, 2009, ANESTHESIOLOGY, V110, P254, DOI 10.1097/ALN.0b013e3181942c7a	21	51	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123892	10.1371/journal.pone.0123892	http://dx.doi.org/10.1371/journal.pone.0123892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860338	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300121
J	Arras, SDM; Chitty, JL; Blake, KL; Schulz, BL; Fraser, JA				Arras, Samantha D. M.; Chitty, Jessica L.; Blake, Kirsten L.; Schulz, Benjamin L.; Fraser, James A.			A Genomic Safe Haven for Mutant Complementation in Cryptococcus neoformans	PLOS ONE			English	Article							CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; GENE DISRUPTION; VIRULENCE; YEAST; PATHOGENICITY; IDENTIFICATION; TRANSFORMATION; INFECTIONS; EXPRESSION	Just as Koch's postulates formed the foundation of early infectious disease study, Stanley Falkow's molecular Koch's postulates define best practice in determining whether a specific gene contributes to virulence of a pathogen. Fundamentally, these molecular postulates state that if a gene is involved in virulence, its removal will compromise virulence. Likewise, its reintroduction should restore virulence to the mutant. These approaches are widely employed in Cryptococcus neoformans, where gene deletion via biolistic transformation is a well-established technique. However, the complementation of these mutants is less straightforward. Currently, one of three approaches will be taken: the gene is reintroduced at the original locus, the gene is reintroduced into a random site in the genome, or the mutant is not complemented at all. Depending on which approach is utilized, the mutant may be complemented but other genes are potentially disrupted in the process. To counter the drawbacks of the current approaches to complementation we have created a new tool to assist in this key step in the study of a gene's role in virulence. We have identified and characterized a small gene-free region in the C. neoformans genome dubbed the "safe haven", and constructed a plasmid vector that targets DNA constructs to this preselected site. The plasmid vector integrates with high frequency, effectively complementing a mutant strain without disrupting adjacent genes. qRT-PCR of the flanking genes on either side of the safe haven site following integration of the targeting vector revealed no changes in their expression, and no secondary phenotypes were observed in a range of phenotypic assays including an intranasal murine infection model. Combined, these data confirm that we have successfully created a much-needed molecular resource for the Cryptococcus community, enabling the reliable fulfillment of the molecular Koch's postulates.	[Fraser, James A.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Fraser, JA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	jafraser@uq.edu.au	McMahon, Kirsten/M-8735-2017; Schulz, Benjamin L/B-3911-2009; Fraser, James A/B-4918-2012; Chitty, Jessica/U-6619-2019; Chitty, Jessica/C-8005-2017	McMahon, Kirsten/0000-0001-8254-0235; Schulz, Benjamin L/0000-0002-4823-7758; Fraser, James A/0000-0001-5724-5285; Chitty, Jessica/0000-0003-1776-1618; Chitty, Jessica/0000-0003-1776-1618	National Health and Medical Research Council [APP1049716]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the National Health and Medical Research Council, http://www.nhmrc.gov.au/, APP1049716 to JAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Chen SCA, 2002, J ANTIMICROB CHEMOTH, V49, P57, DOI 10.1093/jac/49.suppl_1.57; Chow EWL, 2012, MOL BIOL EVOL, V29, P1987, DOI 10.1093/molbev/mss066; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Donovan M, 2001, INFECT IMMUN, V69, P2542, DOI 10.1128/IAI.69.4.2542-2548.2001; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; GOSHORN AK, 1992, INFECT IMMUN, V60, P876, DOI 10.1128/IAI.60.3.876-884.1992; Groisman EA, 2001, PRINCIPLE BACTERICAL; Hegemann JH, 2011, METHODS MOL BIOL, V765, P189, DOI 10.1007/978-1-61779-197-0_12; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Idnurm A, 2009, EUKARYOT CELL, V8, P315, DOI 10.1128/EC.00375-08; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; KIRSCH DR, 1991, INFECT IMMUN, V59, P3297, DOI 10.1128/IAI.59.9.3297-3300.1991; Koch, 1884, 2 AETIOLOGIE TUBERKU; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; MURRAY JAH, 1987, MOL MICROBIOL, V1, P1, DOI 10.1111/j.1365-2958.1987.tb00519.x; Ormerod KL, 2013, G3-GENES GENOM GENET, V3, P675, DOI 10.1534/g3.113.005660; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Perfect JR, 2014, J CLIN INVEST, V124, P1893, DOI 10.1172/JCI75241; PERFECT JR, 1993, INFECT IMMUN, V61, P4446, DOI 10.1128/IAI.61.10.4446-4451.1993; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sudarshan S, 1999, FUNGAL GENET BIOL, V27, P36, DOI 10.1006/fgbi.1999.1126; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Wills EA, 2001, MOL MICROBIOL, V40, P610, DOI 10.1046/j.1365-2958.2001.02401.x	33	53	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122916	10.1371/journal.pone.0122916	http://dx.doi.org/10.1371/journal.pone.0122916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856300	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500065
J	Preza, GC; Yang, OO; Elliott, J; Anton, PA; Ochoa, MT				Preza, Gloria Cuevas; Yang, Otto O.; Elliott, Julie; Anton, Peter A.; Ochoa, Maria T.			T Lymphocyte Density and Distribution in Human Colorectal Mucosa, and Inefficiency of Current Cell Isolation Protocols	PLOS ONE			English	Article							IMAGE-ANALYSIS; TISSUE; EXPRESSION; INFECTION; CYTOMETRY; RESPONSES; BLOOD	Mucosal tissues are critical immune effector sites containing complex populations of leukocytes in a tissue microenvironment that remains incompletely understood. We identify and quantify in human distal colorectal tissue absolute mucosal CD3(+) lymphocytes, including CD4(+) and CD8(+) subsets, by direct visualization using immunohistochemistry (IHC), immunofluorescence (IF), and an automated counting protocol (r(2)=0.90). Sigmoid and rectal mucosal tissues are both densely packed with T lymphocytes in the mucosal compartment. Both compartments had similar densities of CD3(+) T lymphocytes with 37,400 +/- 2,801 cells/mm(3) and 33,700 +/- 4,324 cell/mm(3), respectively. Sigmoid mucosa contained 57% CD3(+)CD4(+) and 40% CD3(+)CD8(+) T lymphocytes which calculates to 21,300 +/- 1,476/mm(3) and 15,000 +/- 275/mm(3) T lymphocytes, respectively. Rectal mucosa had 57% CD3(+)CD4(+) and 42% CD3(+)CD8(+) or 21,577 +/- 332, and 17,090 +/- 1,206 cells/mm(3), respectively. By comparison, sigmoid mucosal biopsies subjected to conventional collagenase digestion, mononuclear cell (MMC) isolation and staining for flow cytometry yielded 4,549 +/- 381/mm(3) and 2,708 +/- 245/mm(3) CD4+ and CD8+ T lymphocytes. These data suggest only similar to 20.7% recovery compared to IHC results for these markers. Further studies will determine if this reflects a selective bias in only CD3(+), CD4(+) and CD8(+) T cells or can be generalized to all flow-analyzed cells from mucosal tissues for phenotyping and functional testing.	[Preza, Gloria Cuevas; Ochoa, Maria T.] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [Yang, Otto O.; Elliott, Julie; Anton, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Yang, Otto O.; Elliott, Julie; Anton, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA; [Yang, Otto O.] AIDS Healthcare Fdn, Los Angeles, CA USA	University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ochoa, MT (corresponding author), Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA.	maritoc@usc.edu		Ochoa, Maria T/0000-0001-6550-5008	UCLA Center for AIDS Research Mucosal Immunology Core Laboratory (MICL) [AI28697]; National Institutes of Health/National Institute of Allergy and Infectious Diseases (MDP) [IPCP U19, AI060614]; National Institutes of Health/NIA grant [R01 AG032422]; Mucosal Immunology Group [UMI AI068618]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068618, U01AI068618, U19AI060614, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032422] Funding Source: NIH RePORTER	UCLA Center for AIDS Research Mucosal Immunology Core Laboratory (MICL); National Institutes of Health/National Institute of Allergy and Infectious Diseases (MDP); National Institutes of Health/NIA grant; Mucosal Immunology Group; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by UCLA Center for AIDS Research Mucosal Immunology Core Laboratory (MICL) (AI28697), to PAA; National Institutes of Health/National Institute of Allergy and Infectious Diseases grants: IPCP U19 AI060614 (MDP), Mucosal Immunology Group (UMI AI068618), to PAA; and National Institutes of Health/NIA grant R01 AG032422, to OOY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzakouk M, 1996, J IMMUNOL METHODS, V194, P211, DOI 10.1016/0022-1759(96)00038-5; Anton PA, 2000, AIDS, V14, P1761, DOI 10.1097/00002030-200008180-00011; Anton PA, 2008, VACCINE, V26, P4617, DOI 10.1016/j.vaccine.2008.05.084; Anton PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023243; BULL DM, 1977, J CLIN INVEST, V59, P966, DOI 10.1172/JCI108719; CERFBENSUSSAN N, 1991, GASTROENTEROL CLIN N, V20, P549; Diederichsen ACP, 1998, APMIS, V106, P562, DOI 10.1111/j.1699-0463.1998.tb01385.x; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Falo C, 2003, AM J CLIN ONCOL-CANC, V26, P465, DOI 10.1097/01.coc.0000026834.38957.35; Ford AL, 1996, J IMMUNOL METHODS, V194, P71, DOI 10.1016/0022-1759(96)00067-1; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Geho DH, 2005, PHYSIOLOGY, V20, P194, DOI 10.1152/physiol.00009.2005; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Ibarrondo FJ, 2005, J VIROL, V79, P4289, DOI 10.1128/JVI.79.7.4289-4297.2005; KRAEHENBUHL JP, 1992, PHYSIOL REV, V72, P853, DOI 10.1152/physrev.1992.72.4.853; Leonhardt H, 1993, COLOR ATLAS TXB HUMA; MacDonald TT, 2013, PRINCIPLES MUCOSAL I; McDonald TT, 1994, GEN BACKGROUND GASTR; McGowan I, 2007, JAIDS-J ACQ IMM DEF, V46, P417, DOI 10.1097/QAI.0b013e318156ef16; Mcgowan I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060147; Mulrane L, 2008, EXPERT REV MOL DIAGN, V8, P707, DOI 10.1586/14737159.8.6.707; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; PRESS MF, 1993, CANCER RES, V53, P4960; Preza GC, 2014, AIDS RES HUM RETROV, V30, P241, DOI [10.1089/aid.2013.0145, 10.1089/AID.2013.0145]; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Staniszewski W, 2009, FOLIA HISTOCHEM CYTO, V47, P699, DOI 10.2478/v10042-009-0115-y; TREPEL F, 1974, KLIN WOCHENSCHR, V52, P511, DOI 10.1007/BF01468720; WESTERMANN J, 1992, CLIN INVESTIGATOR, V70, P539	29	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122723	10.1371/journal.pone.0122723	http://dx.doi.org/10.1371/journal.pone.0122723			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856343	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500052
J	Fayle, TM; Scholtz, O; Dumbrell, AJ; Russell, S; Segar, ST; Eggleton, P				Fayle, Tom M.; Scholtz, Olivia; Dumbrell, Alex J.; Russell, Stephen; Segar, Simon T.; Eggleton, Paul			Detection of Mitochondrial COII DNA Sequences in Ant Guts as a Method for Assessing Termite Predation by Ants	PLOS ONE			English	Article							FOETENS FAB HYMENOPTERA; BEHAVIORAL INTERACTIONS; FORMICIDAE; ISOPTERA; BIODIVERSITY; DIVERSITY; CLASSIFICATION; RECRUITMENT; DISTURBANCE; PHYLOGENY	Termites and ants contribute more to animal biomass in tropical rain forests than any other single group and perform vital ecosystem functions. Although ants prey on termites, at the community level the linkage between these groups is poorly understood. Thus, assessing the distribution and specificity of ant termitophagy is of considerable interest. We describe an approach for quantifying ant-termite food webs by sequencing termite DNA (cytochrome c oxidase subunit II, COII) from ant guts and apply this to a soil-dwelling ant community from tropical rain forest in Gabon. We extracted DNA from 215 ants from 15 species. Of these, 17.2 % of individuals had termite DNA in their guts, with BLAST analysis confirming the identity of 34.1 % of these termites to family level or better. Although ant species varied in detection of termite DNA, ranging from 63% (5/7; Camponotus sp. 1) to 0% (0/7; Ponera sp. 1), there was no evidence (with small sample sizes) for heterogeneity in termite consumption across ant taxa, and no evidence for species-specific ant-termite predation. In all three ant species with identifiable termite DNA in multiple individuals, multiple termite species were represented. Furthermore, the two termite species that were detected on multiple occasions in ant guts were in both cases found in multiple ant species, suggesting that anttermite food webs are not strongly compartmentalised. However, two ant species were found to consume only Anoplotermes-group termites, indicating possible predatory specialisation at a higher taxonomic level. Using a laboratory feeding test, we were able to detect termite COII sequences in ant guts up to 2 h after feeding, indicating that our method only detects recent feeding events. Our data provide tentative support for the hypothesis that unspecialised termite predation by ants is widespread and highlight the use of molecular approaches for future studies of ant-termite food webs.	[Fayle, Tom M.; Segar, Simon T.] Univ South Bohemia, Czech Acad Sci, Ctr Biol, Inst Entomol, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Fayle, Tom M.; Segar, Simon T.] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Fayle, Tom M.] Univ London Imperial Coll Sci Technol & Med, Forest Ecol & Conservat Grp, Ascot SL5 7PY, Berks, England; [Fayle, Tom M.] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu 88400, Sabah, Malaysia; [Scholtz, Olivia] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY 10460 USA; [Dumbrell, Alex J.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Russell, Stephen] Nat Hist Museum, Dept Facil Sci, London SW6 5BD, England; [Eggleton, Paul] Nat Hist Museum, Dept Life Sci, London SW6 5BD, England	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; Imperial College London; Universiti Malaysia Sabah; Wildlife Conservation Society; University of Essex; Natural History Museum London; Natural History Museum London	Fayle, TM (corresponding author), Univ South Bohemia, Czech Acad Sci, Ctr Biol, Inst Entomol, Branisovska 31, Ceske Budejovice 37005, Czech Republic.	tmfayle@gmail.com	Fayle, Tom Maurice/A-2721-2009; Segar, Simon/K-6783-2015; Eggleton, Paul/A-3155-2015	Fayle, Tom Maurice/0000-0002-1667-1189; Eggleton, Paul/0000-0002-1420-7518	UK Natural Environment Research Council [NE/H011307/1]; project "Biodiversity of Forest Ecosystems" [CZ.1.07/2.3.00/20.0064]; state budget of the Czech Republic; Czech Science Foundation [14-32302S]; Yayasan Sime Darby (TMF); University of South Bohemia Postdoc project [CZ.1.07/2.3.00/30.0006]; European Social Fund; Natural Environment Research Council [NE/H011307/1] Funding Source: researchfish; NERC [NE/H011307/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); project "Biodiversity of Forest Ecosystems"; state budget of the Czech Republic; Czech Science Foundation(Grant Agency of the Czech Republic); Yayasan Sime Darby (TMF); University of South Bohemia Postdoc project; European Social Fund(European Social Fund (ESF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding provided by a UK Natural Environment Research Council small grant (NE/H011307/1), the project "Biodiversity of Forest Ecosystems" CZ.1.07/2.3.00/20.0064 co-financed by the European Social Fund and the state budget of the Czech Republic, a Czech Science Foundation Standard Grant (14-32302S), Yayasan Sime Darby (TMF) and a University of South Bohemia Postdoc project CZ.1.07/2.3.00/30.0006 co-financed by the European Social Fund and the state budget of the Czech Republic (STS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bolton B, 2008, ZOOTAXA, P1; Buczkowski G, 2007, INSECT SOC, V54, P219, DOI 10.1007/s00040-007-0933-x; Buczkowski G, 2008, J INSECT BEHAV, V21, P296, DOI 10.1007/s10905-008-9127-2; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cerda X., 2011, PREDATION HYMENOPTER, P39; Crist TO, 2009, MYRMECOL NEWS, V12, P3; DEJEAN A, 1985, INSECT SOC, V32, P23, DOI 10.1007/BF02233224; Dejean A, 2007, J APPL ENTOMOL, V131, P625, DOI 10.1111/j.1439-0418.2007.01223.x; DEJEAN A, 1993, J ETHOL, V11, P43, DOI 10.1007/BF02350005; Dejean A, 1999, SOCIOBIOLOGY, V34, P555; Dejean A, 1996, INSECT SOC, V43, P87, DOI 10.1007/BF01253959; DeSouza O, 2009, B ENTOMOL RES, V99, P603, DOI 10.1017/S000748530900666X; Donovan SE, 2001, ECOL ENTOMOL, V26, P356, DOI 10.1046/j.1365-2311.2001.00342.x; Dormann C.F., 2008, R NEWS, V8, P8; Eggleton P, 2002, AGR ECOSYST ENVIRON, V90, P189, DOI 10.1016/S0167-8809(01)00206-7; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; Ellwood MDF, 2002, BIOTROPICA, V34, P575, DOI 10.1111/j.1744-7429.2002.tb00576.x; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Holldobler B., 1990, pi; Hrcek J, 2011, MOL ECOL RESOUR, V11, P786, DOI 10.1111/j.1755-0998.2011.03016.x; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; LaPolla JS, 2010, SYST ENTOMOL, V35, P118, DOI 10.1111/j.1365-3113.2009.00492.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawton JH, 1996, BIODIVERS CONSERV, V5, P261, DOI 10.1007/BF00055835; LEDOUX ANDRE, 1952, ANN SCI NAT ZOOL 11E SE R, V14, P231; Leponce M, 1999, INSECT SOC, V46, P126, DOI 10.1007/s000400050122; Pequeno PACL, 2012, SOCIOBIOLOGY, V59, P893; LONGHURST C, 1978, ANIM BEHAV, V26, P1213, DOI 10.1016/0003-3472(78)90111-2; LONGHURST C, 1978, OECOLOGIA, V32, P101, DOI 10.1007/BF00344694; LONGHURST C, 1979, OECOLOGIA, V38, P83, DOI 10.1007/BF00347826; LONGHURST C, 1979, J CHEM ECOL, V5, P703, DOI 10.1007/BF00986555; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; PRESTWICH GD, 1984, ANNU REV ENTOMOL, V29, P201, DOI 10.1146/annurev.en.29.010184.001221; Quinet Y, 2005, J INSECT BEHAV, V18, P1, DOI 10.1007/s10905-005-9343-y; Rougerie R, 2011, MOL ECOL, V20, P179, DOI 10.1111/j.1365-294X.2010.04918.x; Schatz B, 1999, SOCIOBIOLOGY, V34, P569; Scholtz O, 2010, THESIS; Scholtz OI, 2008, ZOOL J LINN SOC-LOND, V153, P631, DOI 10.1111/j.1096-3642.2008.00396.x; Schoning C, 2007, BIOTROPICA, V39, P663, DOI 10.1111/j.1744-7429.2007.00296.x; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; TRANIELLO JFA, 1981, P NATL ACAD SCI-BIOL, V78, P1976, DOI 10.1073/pnas.78.3.1976; WENT FW, 1972, BIOSCIENCE, V22, P82, DOI 10.2307/1296037	53	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122533	10.1371/journal.pone.0122533	http://dx.doi.org/10.1371/journal.pone.0122533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853549	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000352478400070
J	Kenty, JHR; Melton, DA				Kenty, Jennifer H. R.; Melton, Douglas A.			Testing Pancreatic Islet Function at the Single Cell Level by Calcium Influx with Associated Marker Expression	PLOS ONE			English	Article							BETA-CELL; INSULIN-SECRETION; CYTOPLASMIC CA2+; IDENTIFIED ALPHA; INTACT ISLETS; DELTA-CELLS; OSCILLATIONS; EXOCYTOSIS; LANGERHANS; PATTERNS	Studying the response of islet cells to glucose stimulation is important for understanding cell function in healthy and disease states. Most functional assays are performed on whole islets or cell populations, resulting in averaged observations and loss of information at the single cell level. We demonstrate methods to examine calcium fluxing in individual cells of intact islets in response to multiple glucose challenges. Wild-type mouse islets predominantly contained cells that responded to three (out of three) sequential high glucose challenges, whereas cells of diabetic islets (db/db or NOD) responded less frequently or not at all. Imaged islets were also immunostained for endocrine markers to associate the calcium flux profile of individual cells with gene expression. Wild-type mouse islet cells that robustly fluxed calcium expressed beta cell markers (INS/NKX6.1), whereas islet cells that inversely fluxed at low glucose expressed alpha cell markers (GCG). Diabetic mouse islets showed a higher proportion of dysfunctional beta cells that responded poorly to glucose challenges. Most of the failed calcium influx responses in beta cells were observed in the second and third high glucose challenges, emphasizing the importance of multiple sequential glucose challenges for assessing the full function of islet cells. Human islet cells were also assessed and showed functional alpha and beta cells. This approach to analyze islet responses to multiple glucose challenges in correlation with gene expression assays expands the understanding of beta cell function and the diseased state.	[Kenty, Jennifer H. R.; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Sánchez-Margalet, Victor/AAB-9986-2021; Young, Richard A/F-6495-2012	Sánchez-Margalet, Victor/0000-0001-8638-8680; Young, Richard A/0000-0001-8855-8647	Helmsley Charitable Trust [2015PG-T1044]; JPB Foundation [135]; National Institues of Health (NIH) [1RC4DK090781-01]; Vanderbilt-University/NIH [U01DK072473]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072473, RC4DK090781] Funding Source: NIH RePORTER	Helmsley Charitable Trust; JPB Foundation; National Institues of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-University/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by Helmsley Charitable Trust (2015PG-T1044), http://helmsleytrust.org/, to JHRK; JPB Foundation (135), http://jpbfoundation.org/, to JHRK; National Institues of Health (NIH) (1RC4DK090781-01), https://www.hhmi.org/, to JHRK; and Vanderbilt-University/NIH (U01DK072473), to JHRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada N, 1998, DIABETES, V47, P751, DOI 10.2337/diabetes.47.5.751; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GILON P, 1993, J BIOL CHEM, V268, P22265; Hamming KSC, 2010, DIABETES, V59, P1686, DOI 10.2337/db09-0630; Henquin J C, 1997, Jpn J Physiol, V47 Suppl 1, pS9; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Hodson DJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1612; Hrvatin S, 2014, PLOS ONE, V10, P1371; Kjems LL, 2002, DIABETES, V51, pS177, DOI 10.2337/diabetes.51.2007.S177; Le Marchand SJ, 2010, JBC, P1; Le Marchand SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047084; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Liang XD, 2011, WORLD J GASTROENTERO, V17, P2812, DOI 10.3748/wjg.v17.i23.2812; MARCHETTI P, 1994, DIABETES, V43, P827, DOI 10.2337/diabetes.43.6.827; Merrins MJ, 2010, BIOPHYS J, V99, P76, DOI 10.1016/j.bpj.2010.04.012; Mohammed JS, 2008, THE ROYAL SOCIETY OF, V9, P97; Moser T, 1997, J NEUROSCI, V17, P2314; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Nunemaker CS, 2005, DIABETES, V54, P3517, DOI 10.2337/diabetes.54.12.3517; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; Rupnik M, 2009, ACTA PHYSIOL, V195, P123, DOI 10.1111/j.1748-1716.2008.01927.x; Rutter GA, 2013, MOL ENDOCRINOL, V27, P1984, DOI 10.1210/me.2013-1278; Sanchez-Cardenas C, 2010, NEUROENDOCRINOLOGY, V91, P239, DOI 10.1159/000274493; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Sedej S, 2005, J PHYSIOL-LONDON, V567, P799, DOI 10.1113/jphysiol.2005.090381; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Stozer A, 2013, PLOS ONE, V9, P1, DOI [10.1371/journal.pcbi.1002923, DOI 10.1371/JOURNAL.PCBI.1002923]; Stozer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054638; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Westerlund J, 1997, J CLIN INVEST, V100, P2547, DOI 10.1172/JCI119797	36	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122044	10.1371/journal.pone.0122044	http://dx.doi.org/10.1371/journal.pone.0122044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853429	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400059
J	Shi, YY; He, XH; Zhu, GG; Tu, HL; Liu, ZC; Li, WH; Han, S; Yin, J; Peng, BW; Liu, WH				Shi, Yingying; He, Xiaohua; Zhu, Guoguo; Tu, Huilin; Liu, Zhongchun; Li, Wenhua; Han, Song; Yin, Jun; Peng, Biwen; Liu, Wanhong			Coxsackievirus A16 Elicits Incomplete Autophagy Involving the mTOR and ERK Pathways	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HERPES-SIMPLEX-VIRUS; CELL-DEATH; PROTEIN; ACTIVATION; REPLICATION; INHIBITION; INDUCTION; MECHANISM; APOPTOSIS	Autophagy is an important homeostatic process for the degradation of cytosolic proteins and organelles and has been reported to play an important role in cellular responses to pathogens and virus replication. However, the role of autophagy in Coxsackievirus A16 (CA16) infection and pathogenesis remains unknown. Here, we demonstrated that CA16 infection enhanced autophagosome formation, resulting in increased extracellular virus production. Moreover, expression of CA16 nonstructural proteins 2C and 3C was sufficient to trigger autophagosome accumulation by blocking the fusion of autophagosomes with lyso-somes. Interestingly, we found that Immunity-related GTPase family M (IRGM) was crucial for the activation of CA16 infection-induced autophagy; in turn, reducing IRGM expression suppressed autophagy. Expression of viral protein 2C enhanced IRGM promoter activation, thereby increasing IRGM expression and inducing autophagy. CA16 infection inhibited Akt/mTOR signaling and activated extracellular signal-regulated kinase (ERK) signaling, both of which are necessary for autophagy induction. In summary, CA16 can use autophagy to enhance its own replication. These results raise the possibility of targeting the autophagic pathway for the treatment of hand, foot, and mouth disease (HFMD).	[Shi, Yingying; He, Xiaohua; Zhu, Guoguo; Tu, Huilin; Han, Song; Yin, Jun; Peng, Biwen; Liu, Wanhong] Wuhan Univ, Sch Basic Med Sci, Pathogen Organism & Infect Dis Res Inst, Wuhan 430071, Peoples R China; [Shi, Yingying; Liu, Wanhong] Hubei Prov Key Lab Allergy & Immunol, Wuhan 430071, Peoples R China; [He, Xiaohua; Peng, Biwen] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Developmentally Originated Dis, Wuhan 430072, Peoples R China; [Zhu, Guoguo] Wuhan Gen Hosp Guangzhou Command, Emergency Dept, Intens Care Unit, Wuhan 430071, Peoples R China; [Liu, Zhongchun] Wuhan Univ, Renmin Hosp, Inst Neuropsychiat, Wuhan 430060, Peoples R China; [Li, Wenhua] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University	Liu, WH (corresponding author), Wuhan Univ, Sch Basic Med Sci, Pathogen Organism & Infect Dis Res Inst, Wuhan 430071, Peoples R China.	liuwanhong@whu.edu.cn		/0000-0002-5599-6779	National Natural Sciences Foundation of China [81171577, 81371790, 81371422, 81171127]; Major AIDS and Viral Hepatitis and Other Major Infectious Disease Prevention and Control project of China [2014ZX10001003]; Fundamental Research Funds for the Central Universities of China; Translational Medical Research Fund of the Wuhan University School of Medicine	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Major AIDS and Viral Hepatitis and Other Major Infectious Disease Prevention and Control project of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Translational Medical Research Fund of the Wuhan University School of Medicine	This work was supported by the National Natural Sciences Foundation of China (No. 81171577, 81371790, 81371422 and 81171127), Major AIDS and Viral Hepatitis and Other Major Infectious Disease Prevention and Control project of China (2014ZX10001003), the Fundamental Research Funds for the Central Universities of China, and the Translational Medical Research Fund of the Wuhan University School of Medicine.	Alexander DE, 2007, J VIROL, V81, P12128, DOI 10.1128/JVI.01356-07; Bekpen C, 2010, SEMIN IMMUNOPATHOL, V32, P437, DOI 10.1007/s00281-010-0224-x; BIENZ K, 1987, VIROLOGY, V160, P220, DOI 10.1016/0042-6822(87)90063-8; Brabec-Zaruba M, 2007, J VIROL, V81, P10815, DOI 10.1128/JVI.00143-07; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; CHEN XQ, 2013, PLOS NEGLECT TROP D, V7, P82861, DOI DOI 10.1371/JOURNAL.PONE.0082861; DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2; Datan E, 2014, VIROLOGY, V452, P175, DOI 10.1016/j.virol.2014.01.008; Deegan S, 2014, BIOCH BIOPHYS RES CO; Ding BB, 2014, CELL HOST MICROBE, V15, P564, DOI 10.1016/j.chom.2014.04.004; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Hou L, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-156; Huang J, 2014, MOL CELL BIOCH; Hung CH, 2014, J VIROL, V88, P12133, DOI 10.1128/JVI.02033-14; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Liang QM, 2013, J VIROL, V87, P12499, DOI 10.1128/JVI.01898-13; Liu YJ, 2014, VIRUS GENES, V48, P260, DOI 10.1007/s11262-014-1035-2; Lussignol M, 2013, J VIROL, V87, P859, DOI 10.1128/JVI.01158-12; Mao QY, 2014, HUM VACC IMMUNOTHER, V10, P360, DOI 10.4161/hv.27087; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Shives KD, 2014, J VIROL, V88, P9458, DOI 10.1128/JVI.01323-14; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Sun MX, 2012, AUTOPHAGY, V8, P1434, DOI 10.4161/auto.21159; Sun YJ, 2014, J VIROL, V88, P525, DOI 10.1128/JVI.01849-13; Surviladze Z, 2013, J VIROL, V87, P2508, DOI 10.1128/JVI.02319-12; Svensson L, 1999, J VIROL METHODS, V80, P17, DOI 10.1016/S0166-0934(99)00018-X; Tang SW, 2013, J VIROL, V87, P1699, DOI 10.1128/JVI.02147-12; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Teterina NL, 1997, J VIROL, V71, P8962, DOI 10.1128/JVI.71.12.8962-8972.1997; Wang CL, 2012, J VIROL, V86, P9964, DOI 10.1128/JVI.00914-12; Wang J, 2014, AUTOPHAGY, V10, P766, DOI 10.4161/auto.27954; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094746; Weidman MK, 2001, VIROLOGY, V291, P260, DOI 10.1006/viro.2001.1215; Yoon SY, 2008, J VIROL, V82, P11976, DOI 10.1128/JVI.01028-08; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406; Zhu BL, 2012, J VIROL, V86, P12003, DOI 10.1128/JVI.01434-12; Zhu GG, 2013, BIOCHEM BIOPH RES CO, V441, P856, DOI 10.1016/j.bbrc.2013.10.142	54	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122109	10.1371/journal.pone.0122109	http://dx.doi.org/10.1371/journal.pone.0122109			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853521	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400060
J	Sugimoto, C; Konno, T; Wakao, R; Fujita, H; Fujita, H; Wakao, H				Sugimoto, Chie; Konno, Takahiko; Wakao, Rika; Fujita, Hiroko; Fujita, Hiroyoshi; Wakao, Hiroshi			Mucosal-Associated Invariant T Cell Is a Potential Marker to Distinguish Fibromyalgia Syndrome from Arthritis	PLOS ONE			English	Article							ANKYLOSING-SPONDYLITIS; DIAGNOSIS; INFLAMMATION	Background Fibromyalgia (FM) is defined as a widely distributed pain. While many rheumatologists and pain physicians have considered it to be a pain disorder, psychiatry, psychology, and general medicine have deemed it to be a syndrome (FMS) or psychosomatic disorder. The lack of concrete structural and/or pathological evidence has made patients suffer prejudice that FMS is a medically unexplained symptom, implying inauthenticity. Furthermore, FMS often exhibits comorbidity with rheumatoid arthritis (RA) or spondyloarthritis (SpA), both of which show similar indications. In this study, disease specific biomarkers were sought in blood samples from patients to facilitate objective diagnoses of FMS, and distinguish it from RA and SpA. Methods Peripheral blood mononuclear cells (PBMCs) from patients and healthy donors (HD) were subjected to multicolor flow cytometric analysis. The percentage of mucosal-associated invariant T (MAIT) cells in PBMCs and the mean fluorescent intensity (MFI) of cell surface antigen expression in MAIT cells were analyzed. Results There was a decrease in the MAIT cell population in FMS, RA, and SpA compared with HD. Among the cell surface antigens in MAIT cells, three chemokine receptors, CCR4, CCR7, and CXCR1, a natural killer (NK) receptor, NKp80, a signaling lymphocyte associated molecule (SLAM) family, CD150, a degrunulation marker, CD107a, and a coreceptor, CD8 beta emerged as potential biomarkers for FMS to distinguish from HD. Additionally, a memory marker, CD44 and an inflammatory chemokine receptor, CXCR1 appeared possible markers for RA, while a homeostatic chemokine receptor, CXCR4 deserved for SpA to differentiate from FMS. Furthermore, the drug treatment interruption resulted in alternation of the expression of CCR4, CCR5, CXCR4, CD27, CD28, inducible costimulatory molecule (ICOS), CD127 (IL-7 receptor alpha), CD94, NKp80, an activation marker, CD69, an integrin family member, CD49d, and a dipeptidase, CD26, in FMS. Conclusions Combined with the currently available diagnostic procedures and criteria, analysis of MAIT cells offers a more objective standard for the diagnosis of FMS, RA, and SpA, which exhibit multifaceted and confusingly similar clinical manifestations.	[Sugimoto, Chie; Fujita, Hiroko; Fujita, Hiroyoshi; Wakao, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Hyg & Cellular Prevent Med, Sapporo, Hokkaido 0608638, Japan; [Konno, Takahiko] Tokeidai Mem Clin, Dept Rheumatol, Sapporo, Hokkaido 0600031, Japan; [Wakao, Rika] PMDA, Tokyo 1000013, Japan	Hokkaido University	Wakao, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Hyg & Cellular Prevent Med, Sapporo, Hokkaido 0608638, Japan.	hwakao@med.hokudai.ac.jp			Ministry of Science, Culture, and Sport (Japan)	Ministry of Science, Culture, and Sport (Japan)	Funding was provided by Ministry of Science, Culture, and Sport (Japan), Kakenhi B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7, DOI 10.1016/j.coi.2013.09.007; Brachtl G, 2014, ANN HEMATOL, V93, P361, DOI 10.1007/s00277-013-1967-y; Chiba A, 2012, ARTHRITIS RHEUM-US, V64, P153, DOI 10.1002/art.33314; Cho YN, 2014, J IMMUNOL, V193, P3891, DOI 10.4049/jimmunol.1302701; Dimsdale JE, 2013, J PSYCHOSOM RES, V75, P223, DOI 10.1016/j.jpsychores.2013.06.033; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; Bote ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074524; Garcia JJ, 2014, ANN CLIN BIOCHEM, V51, P576, DOI 10.1177/0004563213506413; Hauser W, 2012, REUMATISMO, V64, P194, DOI 10.4081/reumatismo.2012.194; Illes Z, 2004, INT IMMUNOL, V16, P223, DOI 10.1093/intimm/dxh018; Imamura M, 2014, CLIN INTERV AGING, V9, P939, DOI 10.2147/CIA.S60330; Kadetoff D, 2012, J NEUROIMMUNOL, V242, P33, DOI 10.1016/j.jneuroim.2011.10.013; Kroenke K, 2007, PSYCHIAT CLIN N AM, V30, P593, DOI 10.1016/j.psc.2007.08.002; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; LIPOWSKI ZJ, 1988, AM J PSYCHIAT, V145, P1358; Miyazaki Y, 2011, INT IMMUNOL, V23, P529, DOI 10.1093/intimm/dxr047; Ou X, 2013, BLOOD, V122, P161, DOI 10.1182/blood-2013-02-487470; Paladini F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2860; Pernambuco AP, 2013, CLIN EXP RHEUMATOL, V31, pS60; Rodriguez-Pinto I, 2014, IMMUNOL LETT, V161, P200, DOI 10.1016/j.imlet.2014.01.009; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Sturgill J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/938576; Tang XZ, 2013, J IMMUNOL, V190, P3142, DOI 10.4049/jimmunol.1203218; Wakao H, 2013, CELL STEM CELL, V12, P546, DOI 10.1016/j.stem.2013.03.001; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yunus MB, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/584573; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328	29	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121124	10.1371/journal.pone.0121124	http://dx.doi.org/10.1371/journal.pone.0121124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853812	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400028
J	Esapa, CT; Hannan, FM; Babinsky, VN; Potter, P; Thomas, GP; Croucher, PI; Brown, MA; Brown, SDM; Cox, RD; Thakker, RV				Esapa, Christopher T.; Hannan, Fadil M.; Babinsky, Valerie N.; Potter, Paul; Thomas, Gethin P.; Croucher, Peter I.; Brown, Matthew A.; Brown, Steve D. M.; Cox, Roger D.; Thakker, Rajesh V.			N-ethyl-N-Nitrosourea (ENU) Induced Mutations within the Klotho Gene Lead to Ectopic Calcification and Reduced Lifespan in Mouse Models	PLOS ONE			English	Article							FAMILIAL TUMORAL CALCINOSIS; MUTANT MICE; MISSENSE MUTATION; FGF23; GALNT3; PROTEIN; DRIVEN; DIFFERENTIATION; MUTAGENESIS; HOMEOSTASIS	Ectopic calcification (EC), which is the pathological deposition of calcium and phosphate in extra-skeletal tissues, may be associated with hypercalcaemic and hyperphosphataemic disorders, or it may occur in the absence of metabolic abnormalities. In addition, EC may be inherited as part of several monogenic disorders and studies of these have provided valuable insights into the metabolic pathways regulating mineral metabolism. For example, studies of tumoural calcinosis, a disorder characterised by hyperphosphataemia and progressive EC, have revealed mutations of fibroblast growth factor 23 (FGF23), polypeptide N-acetyl galactosaminyltransferase 3 (GALNT3) and klotho (KL), which are all part of a phosphate-regulating pathway. However, such studies in humans are limited by the lack of available large families with EC, and to facilitate such studies we assessed the progeny of mice treated with the chemical mutagen N-ethyl-N-nitrosourea (ENU) for EC. This identified two mutants with autosomal recessive forms of EC, and reduced lifespan, designated Ecalc1 and Ecalc2. Genetic mapping localized the Ecalc1 and Ecalc2 loci to a 11.0 Mb region on chromosome 5 that contained the klotho gene (Kl), and DNA sequence analysis identified nonsense (Gln203Stop) and missense (Ile604Asn) Kl mutations in Ecalc1 and Ecalc2 mice, respectively. The Gln203Stop mutation, located in KL1 domain, was severely hypomorphic and led to a 17-fold reduction of renal Kl expression. The Ile604Asn mutation, located in KL2 domain, was predicted to impair klotho protein stability and in vitro expression studies in COS-7 cells revealed endoplasmic reticulum retention of the Ile604Asn mutant. Further phenotype studies undertaken in Ecalc1 (kl(203X/203X)) mice demonstrated elevations in plasma concentrations of phosphate, FGF23 and 1,25-dihydroxyvitamin D. Thus, two allelic variants of Kl that develop EC and represent mouse models for tumoural calcinosis have been established.	[Esapa, Christopher T.; Hannan, Fadil M.; Babinsky, Valerie N.; Thakker, Rajesh V.] Univ Oxford, OCDEM, Radcliffe Dept Med, Acad Endocrine Unit, Oxford, England; [Esapa, Christopher T.; Potter, Paul; Brown, Steve D. M.; Cox, Roger D.] MRC Harwell, MRC, Mammalian Genet Unit, Harwell, Berks, England; [Esapa, Christopher T.; Potter, Paul; Brown, Steve D. M.; Cox, Roger D.] MRC Harwell, Mary Lyon Ctr, Harwell, Berks, England; [Hannan, Fadil M.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England; [Thomas, Gethin P.; Brown, Matthew A.] Univ Queensland, Princess Alexandra Hosp, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Croucher, Peter I.] Garvan Inst Med Res, Sydney, NSW, Australia	University of Oxford; MRC Harwell; MRC Harwell; University of Liverpool; University of Queensland; Garvan Institute of Medical Research	Thakker, RV (corresponding author), Univ Oxford, OCDEM, Radcliffe Dept Med, Acad Endocrine Unit, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Brown, Matthew A/E-5749-2010; Potter, Paul Keith/GWU-6398-2022	Brown, Matthew A/0000-0003-0538-8211; Potter, Paul Keith/0000-0003-2689-2361; Croucher, Peter/0000-0002-7102-2413; Cox, Roger/0000-0001-7170-5014; Hannan, Fadil/0000-0002-2975-5170; Thomas, Gethin/0000-0001-9081-3686; Thakker, Rajesh/0000-0002-1438-3220	Medical Research Council UK [G0600702/1, G9825289, G1000467]; MRC [G0600702, MR/K006312/1, MC_U142661184, G9825289, MC_U142684172, G1000467] Funding Source: UKRI; Medical Research Council [MC_U142661184, MR/K006312/1, G9825289, G0600702, MC_U142684172, G1000467] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council UK [grant numbers G0600702/1, G9825289 and G1000467]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Bentley L, 2014, ENDOCRINOLOGY, V155, P908, DOI 10.1210/en.2013-1247; Carpinelli MR, 2011, HEARING RES, V275, P105, DOI 10.1016/j.heares.2010.12.009; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Esapa CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043205; Farrow EG, 2011, BEST PRACT RES CL RH, V25, P735, DOI 10.1016/j.berh.2011.10.020; Ford-Hutchinson AF, 2003, J RHEUMATOL, V30, P2659; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Hannan FM, 2008, NAT CLIN PRACT ENDOC, V4, P53, DOI 10.1038/ncpendmet0718; Hardisty-Hughes RE, 2010, NAT PROTOC, V5, P177, DOI 10.1038/nprot.2009.204; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Ichikawa S, 2007, J CLIN INVEST, V117, P2684, DOI 10.1172/JCI31330; Ichikawa S, 2010, AM J MED GENET A, V152A, P896, DOI 10.1002/ajmg.a.33337; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Kawaguchi H, 1999, J CLIN INVEST, V104, P229, DOI 10.1172/JCI5705; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Kim HJ, 2010, BONE, V47, P657, DOI 10.1016/j.bone.2010.06.018; KROGER H, 1995, BONE, V17, P157, DOI 10.1016/S8756-3282(95)00162-X; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Li QL, 2013, DIS MODEL MECH, V6, P1227, DOI 10.1242/dmm.012765; Lindberg K, 2014, J AM SOC NEPHROL; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Lysaght AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107681; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mian IS, 1998, BLOOD CELL MOL DIS, V24, P83, DOI 10.1006/bcmd.1998.9998; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Nesbit MA, 2004, J BIOL CHEM, V279, P22624, DOI 10.1074/jbc.M401797200; Noguchi J, 2008, BIOCHEM BIOPH RES CO, V374, P549, DOI 10.1016/j.bbrc.2008.07.089; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Pendleton A, 2002, AM J HUM GENET, V71, P933, DOI 10.1086/343054; Piret SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045217; Quwailid MM, 2004, MAMM GENOME, V15, P585, DOI 10.1007/s00335-004-2379-z; Razzaque MS, 2012, NAT REV ENDOCRINOL, V8, P579, DOI 10.1038/nrendo.2012.75; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Stechman MJ, 2010, LAB ANIM-UK, V44, P218, DOI 10.1258/la.2010.009128; Suga T, 2000, AM J RESP CELL MOL, V22, P26, DOI 10.1165/ajrcmb.22.1.3554; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Utsugi T, 2000, METABOLISM, V49, P1118, DOI 10.1053/meta.2000.8606; Whyte MP, 2006, EXTRASKELETAL ECTOPI, P436; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; Wu MT, 2013, CALCIFIED TISSUE INT, V93, P365, DOI 10.1007/s00223-013-9712-z; Yamashita T, 2000, J ENDOCRINOL, V164, P239, DOI 10.1677/joe.0.1640239; Yoshida T, 2002, ENDOCRINOLOGY, V143, P683, DOI 10.1210/en.143.2.683; Yuan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002726; Zhou TBT, 2013, J BIOL CHEM, V288, P36302, DOI 10.1074/jbc.M113.490052	51	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122650	10.1371/journal.pone.0122650	http://dx.doi.org/10.1371/journal.pone.0122650			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860694	Green Published, gold			2022-12-27	WOS:000352590300054
J	Lund, K; Dembinski, JL; Solberg, N; Urbanucci, A; Mills, IG; Krauss, S				Lund, Kaja; Dembinski, Jennifer L.; Solberg, Nina; Urbanucci, Alfonso; Mills, Ian G.; Krauss, Stefan			Slug-Dependent Upregulation of L1CAM Is Responsible for the Increased Invasion Potential of Pancreatic Cancer Cells following Long-Term 5-FU Treatment	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ADHESION MOLECULE; PROTEIN EXPRESSION; E-CADHERIN; 5-FLUOROURACIL; GEMCITABINE; GROWTH; RESISTANCE; PROGNOSIS; L1	Background Pancreatic adenocarcinoma is a lethal disease with 5-year survival of less than 5%. 5-fluorouracil (5-FU) is a principal first-line therapy, but treatment only extends survival modestly and is seldom curative. Drug resistance and disease recurrence is typical and there is a pressing need to overcome this. To investigate acquired 5-FU resistance in pancreatic adenocarcinoma, we established chemoresistant monoclonal cell lines from the Panc 03.27 cell line by long-term exposure to increasing doses of 5-FU. Results 5-FU-resistant cell lines exhibited increased expression of markers associated with multidrug resistance explaining their reduced sensitivity to 5-FU. In addition, 5-FU-resistant cell lines showed alterations typical for an epithelial-to-mesenchymal transition (EMT), including upregulation of mesenchymal markers and increased invasiveness. Microarray analysis revealed the L1CAM pathway as one of the most upregulated pathways in the chemoresistant clones, and a significant upregulation of L1CAM was seen on the RNA and protein level. In pancreatic cancer, expression of L1CAM is associated with a chemoresistant and migratory phenotype. Using esiRNA targeting L1CAM, or by blocking the extracellular part of L1CAM with antibodies, we show that the increased invasiveness observed in the chemoresistant cells functionally depends on L1CAM. Using esiRNA targeting beta-catenin and/or Slug, we demonstrate that in the chemoresistant cell lines, L1CAM expression depends on Slug rather than beta-catenin. Conclusion Our findings establish Slug-induced L1CAM expression as a mediator of a chemoresistant and migratory phenotype in pancreatic adenocarcinoma cells.	[Lund, Kaja; Dembinski, Jennifer L.; Solberg, Nina; Krauss, Stefan] Univ Oslo, Rikshosp, Inst Microbiol, Canc Stem Cell Innovat Ctr CAST,Unit Cell Signali, N-0027 Oslo, Norway; [Urbanucci, Alfonso; Mills, Ian G.] Univ Oslo, Nord European Mol Biol Lab Partnership, Ctr Mol Med Norway, Oslo, Norway; [Urbanucci, Alfonso; Mills, Ian G.] Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, Oslo, Norway; [Mills, Ian G.] Oslo Univ Hosp, Dept Urol, Oslo, Norway; [Mills, Ian G.] Oslo Univ Hosp, Ctr Mol Med Urol, Oslo, Norway; [Dembinski, Jennifer L.] Norwegian Inst Publ Hlth, Dept Bacteriol & Immunol, Div Infect Dis Control, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH)	Lund, K (corresponding author), Univ Oslo, Rikshosp, Inst Microbiol, Canc Stem Cell Innovat Ctr CAST,Unit Cell Signali, N-0027 Oslo, Norway.	kaja.lund@rr-research.no	Mills, Ian/AAK-9292-2020; Urbanucci, Alfonso/S-4450-2019	Mills, Ian/0000-0001-5347-5083; Urbanucci, Alfonso/0000-0003-2931-3652; Dembinski, Jennifer/0000-0001-9259-9572; Krauss, Stefan/0000-0001-6992-8091	Research Council of Norway [205783]; Molecular Life Sciences (University of Oslo); Helse Sor-Ost; Norwegian Cancer Society; Research Council of Norway; Affitech Research AS	Research Council of Norway(Research Council of Norway); Molecular Life Sciences (University of Oslo); Helse Sor-Ost; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Affitech Research AS	KL is founded by the Research Council of Norway, grant nr. 205783, and Affitech Research AS. Affitech Research AS partly supported KL during an industrial PhD, together with the Research Council of Norway, grant nr. 205783. AU was funded by Molecular Life Sciences (University of Oslo) and Helse Sor-Ost. NS was funded by the Norwegian Cancer Society. JLD was funded by The Research Council of Norway. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt MJE, 2006, CANCER RES, V66, P936, DOI 10.1158/0008-5472.CAN-05-1818; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Ben QW, 2010, ANN SURG ONCOL, V17, P2213, DOI 10.1245/s10434-010-0955-x; Bergmann F, 2010, ONCOL REP, V24, P909, DOI 10.3892/or_00000936; Bichat F, 1997, ANTICANCER RES, V17, P3393; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Colas E, 2012, CLIN TRANSL ONCOL, V14, P715, DOI 10.1007/s12094-012-0866-3; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; COPUR S, 1995, BIOCHEM PHARMACOL, V49, P1419, DOI 10.1016/0006-2952(95)00067-A; De Iudicibus S, 2008, ANTICANCER RES, V28, P3921; Dembinski Jennifer L, 2010, Cancers (Basel), V2, P2011, DOI 10.3390/cancers2042011; Gast D, 2008, ONCOGENE, V27, P1281, DOI 10.1038/sj.onc.1210747; Gavert N, 2005, J CELL BIOL, V168, P633, DOI 10.1083/jcb.200408051; Gavert N, 2011, MOL CANCER RES, V9, P14, DOI 10.1158/1541-7786.MCR-10-0406; Geismann C, 2011, INT J ONCOL, V38, P257, DOI 10.3892/ijo_00000846; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; Ginnebaugh KR, 2014, EXPERT OPIN THER TAR; Grem JL, 2000, INVEST NEW DRUG, V18, P299, DOI 10.1023/A:1006416410198; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada K, 2014, INT J ONCOL, V44, P1302, DOI 10.3892/ijo.2014.2270; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoshino H, 2009, BIOCHEM BIOPH RES CO, V390, P1061, DOI 10.1016/j.bbrc.2009.10.117; Huszar M, 2010, J PATHOL, V220, P551, DOI 10.1002/path.2673; JOHNSTON PG, 1995, CANCER RES, V55, P1407; Kato J, 2001, INT J CANCER, V95, P92; Kiefel H, 2012, CARCINOGENESIS, V33, P1919, DOI 10.1093/carcin/bgs220; Kiefel H, 2012, CELL ADHES MIGR, V6, P374, DOI 10.4161/cam.20832; Kikuta K, 2010, BIOCHEM BIOPH RES CO, V403, P380, DOI 10.1016/j.bbrc.2010.11.040; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Min JK, 2010, CLIN CANCER RES, V16, P3571, DOI 10.1158/1078-0432.CCR-09-3075; Murkoster SS, 2007, ONCOGENE, V26, P2759, DOI 10.1038/sj.onc.1210076; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Novak-Hofer I, 2008, CANCER LETT, V261, P193, DOI 10.1016/j.canlet.2007.11.012; Olie RA, 2000, CANCER RES, V60, P2805; Pan JJ, 2011, J GASTROINTEST ONCOL, V2, P151, DOI 10.3978/j.issn.2078-6891.2011.022; Pfeifer M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-64; Popat S, 2004, J CLIN ONCOL, V22, P529, DOI 10.1200/JCO.2004.05.064; Pratt S, 2005, MOL CANCER THER, V4, P855, DOI 10.1158/1535-7163.MCT-04-0291; RATHJEN FG, 1984, EMBO J, V3, P1; Raveh S, 2009, CANCER LETT, V282, P137, DOI 10.1016/j.canlet.2008.12.021; Sebens S, 2012, PANCREATIC CANC MOL, P329; Seufferlein T, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds224; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Tentes IK, 2010, EXP CELL RES, V316, P3172, DOI 10.1016/j.yexcr.2010.09.003; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tischler V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-127; Tsutsumi S, 2011, J SURG ONCOL, V103, P669, DOI 10.1002/jso.21880; Uchibori K, 2012, INT J ONCOL, V40, P1005, DOI 10.3892/ijo.2011.1300; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Zeechini S, 2008, CANCER RES, V68, P1110, DOI 10.1158/0008-5472.CAN-07-2897; Zhang WJ, 2012, BIOCHEM BIOPH RES CO, V417, P679, DOI 10.1016/j.bbrc.2011.11.142	53	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123684	10.1371/journal.pone.0123684	http://dx.doi.org/10.1371/journal.pone.0123684			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860483	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300108
J	Shi, QH; Sun, XY; Wang, YL; Hao, JS; Yang, Q				Shi, Qing-Hui; Sun, Xiao-Yan; Wang, Yun-Liang; Hao, Jia-Sheng; Yang, Qun			Morphological Characters Are Compatible with Mitogenomic Data in Resolving the Phylogeny of Nymphalid Butterflies (Lepidoptera: Papilionoidea: Nymphalidae)	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; COMPLETE NUCLEOTIDE-SEQUENCE; SATYRINAE BUTTERFLIES; MAXIMUM-LIKELIHOOD; RIBOSOMAL-RNA; EVOLUTION; INSECTA; GENE; UTILITY; ORGANIZATION	Nymphalidae is the largest family of butterflies with their phylogenetic relationships not adequately approached to date. The mitochondrial genomes (mitogenomes) of 11 new nymphalid species were reported and a comparative mitogenomic analysis was conducted together with other 22 available nymphalid mitogenomes. A phylogenetic analysis of the 33 species from all 13 currently recognized nymphalid subfamilies was done based on the mitogenomic data set with three Lycaenidae species as the outgroups. The mitogenome comparison showed that the eleven new mitogenomes were similar with those of other butterflies in gene content and order. The reconstructed phylogenetic trees reveal that the nymphalids are made up of five major clades (the nymphaline, heliconiine, satyrine, danaine and libytheine clades), with sister relationship between subfamilies Cyrestinae and Biblidinae, and most likely between subfamilies Morphinae and Satyrinae. This whole mitogenome-based phylogeny is generally congruent with those of former studies based on nuclear-gene and mitogenomic analyses, but differs considerably from the result of morphological cladistic analysis, such as the basal position of Libytheinae in morpho-phylogeny is not confirmed in molecular studies. However, we found that the mitogenomic phylogeny established herein is compatible with selected morphological characters (including developmental and adult morpho-characters).	[Shi, Qing-Hui; Wang, Yun-Liang; Hao, Jia-Sheng] Anhui Normal Univ, Coll Iife Sci, Wuhu, Peoples R China; [Sun, Xiao-Yan; Hao, Jia-Sheng; Yang, Qun] Chinese Acad Sci, Nanjing Inst Palaeontol & Stratig, State Key Lab Palaeobiol & Stratig, Nanjing, Jiangsu, Peoples R China; [Shi, Qing-Hui] Sanming Coll, Sanming, Peoples R China	Anhui Normal University; Chinese Academy of Sciences; Sanming University	Hao, JS (corresponding author), Anhui Normal Univ, Coll Iife Sci, Wuhu, Peoples R China.	jshaonigpas@sina.com; qunyang@nigpas.ac.cn			National Science Foundation of China [41172004, 41472028]; State Key Laboratory of Palaeobiology and Stratigraphy, Nanjing Institute of Geology and Palaeontology, Chinese Academy of Sciences [104143]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Palaeobiology and Stratigraphy, Nanjing Institute of Geology and Palaeontology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Science Foundation of China (Grant No. 41172004, 41472028), and a grant from the State Key Laboratory of Palaeobiology and Stratigraphy, Nanjing Institute of Geology and Palaeontology, Chinese Academy of Sciences (Grant No. 104143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackery P.R., 1984, S ROYAL ENTOMOLOGICA, P9; Ackery Philip R., 1999, Handbuch der Zoologie (Berlin), V4, P263; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boggs C.L., 2003, BUTTERFLIES ECOLOGY; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Brower AVZ, 2000, P ROY SOC B-BIOL SCI, V267, P1201, DOI 10.1098/rspb.2000.1129; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Cao YQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-276; Caterino MS, 1999, MOL PHYLOGENET EVOL, V11, P122, DOI 10.1006/mpev.1998.0549; Chai HN, 2012, INT J BIOL SCI, V8, P561, DOI 10.7150/ijbs.3540; [陈国忠 Chen Guozhong], 2005, [微生物学杂志, Journal of Mirobiology], V25, P54; Chen Na, 2007, Acta Zoologica Sinica, V53, P106; Chou I, 1998, CLASSIICATION IDENTI; DeJong R, 1996, ENTOMOL SCAND, V27, P65, DOI 10.1163/187631296X00205; DeVries PJ, 1987, BUTTERFLIES COSTA RI; EHRLICH PAUL R., 1958, UNIV KANSAS SCI BULL, V39, P305; Feng X, 2010, MOL BIOL REP, V37, P3877, DOI 10.1007/s11033-010-0044-z; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Freitas AVL, 2004, SYST BIOL, V53, P363, DOI 10.1080/10635150490445670; Freitas AVL, 1999, NYMPHALIDAE LEPIDOPT; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hao J., 2013, ISRN GENOMICS, V2013, P1, DOI 10.1155/2013/491636; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; Hao JS, 2007, GENET MOL BIOL, V18, P111; Harvey D.J., 1991, DEV EVOLUTION BUTTER, P255; Heikkila M, 2012, P ROY SOC B-BIOL SCI, V279, P1093, DOI 10.1098/rspb.2011.1430; HEPPNER J B, 1991, Tropical Lepidoptera, V2, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Kim I, 2006, INSECT MOL BIOL, V15, P217, DOI 10.1111/j.1365-2583.2006.00630.x; Kim MI, 2009, MOL CELLS, V28, P347, DOI 10.1007/s10059-009-0129-5; Kim MJ, 2010, AFR J BIOTECHNOL, V9, P735; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KRISTENSEN N P, 1976, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V14, P25; Liao F, 2010, INT J BIOL SCI, V6, P172; Liu YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P693, DOI [10.1111/j.1745-7270.2008.00449.x, 10.1093/abbs/40.8.693]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072410; Marin MA, 2011, NEOTROP ENTOMOL, V40, P1, DOI 10.1590/S1519-566X2011000100001; Muller W., 1886, Zoologische Jahrbuecher, Vi, P417; Niehuis O, 2006, ORG DIVERS EVOL, V6, P17, DOI 10.1016/j.ode.2005.03.001; Niehuis O, 2006, MOL PHYLOGENET EVOL, V39, P812, DOI 10.1016/j.ympev.2006.01.007; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pagenstecher A, 1901, TIERREICH, V14, P1; Pagenstecher A, 1902, LEPIDOPTERA RHOPALOC, P1; Pagenstecher A, 1911, LEPIDOPTERORUM CATAL; Pan MH, 2008, SCI CHINA SER C, V51, P693, DOI 10.1007/s11427-008-0097-6; Pena C, 2008, BIOL LETTERS, V4, P274, DOI 10.1098/rsbl.2008.0062; Pena C, 2006, MOL PHYLOGENET EVOL, V40, P29, DOI 10.1016/j.ympev.2006.02.007; Penz CM, 2003, SYST ENTOMOL, V28, P451, DOI 10.1046/j.1365-3113.2003.00221.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; SHIELDS O, 1989, Journal of the Lepidopterists' Society, V43, P178; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Silva-Brandao KL, 2008, MOL PHYLOGENET EVOL, V46, P515, DOI 10.1016/j.ympev.2007.11.024; Simmons RB, 2001, MOL PHYLOGENET EVOL, V20, P196, DOI 10.1006/mpev.2001.0958; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Li-Li, 2012, Zoological Research, V33, P133, DOI 10.3724/SP.J.1141.2012.02133; Vandewoestijne S, 2004, MOL PHYLOGENET EVOL, V31, P630, DOI 10.1016/j.ympev.2003.09.007; Vane-Wright Richard I., 2003, P477; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Wahlberg N, 2003, MOL PHYLOGENET EVOL, V28, P473, DOI 10.1016/S1055-7903(03)00052-6; Wahlberg N, 2000, CLADISTICS, V16, P347, DOI 10.1111/j.1096-0031.2000.tb00355.x; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2009, P ROY SOC B-BIOL SCI, V276, P4295, DOI 10.1098/rspb.2009.1303; Wang Xiao-Can, 2011, Zoological Research, V32, P465, DOI 10.3724/SP.J.1141.2011.05465; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Wu LW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-468; Yang L, 2009, MOL BIOL REP, V36, P1441, DOI 10.1007/s11033-008-9334-0; Yang XS, 2013, GENE, V515, P349, DOI 10.1016/j.gene.2012.11.031; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zhang M, 2008, PROG NAT SCI-MATER, V18, P1357, DOI 10.1016/j.pnsc.2008.03.025	81	21	23	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124349	10.1371/journal.pone.0124349	http://dx.doi.org/10.1371/journal.pone.0124349			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860387	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300135
J	Hassan, S; Yellur, R; Subramani, P; Adiga, P; Gokhale, M; Iyer, MS; Mayya, SS				Hassan, Shabbeer; Yellur, Rajashree; Subramani, Pooventhan; Adiga, Poornima; Gokhale, Manoj; Iyer, Manasa S.; Mayya, Shreemathi S.			Research Design and Statistical Methods in Indian Medical Journals: A Retrospective Survey	PLOS ONE			English	Article							CLINICAL RESEARCH; ARTICLES; QUALITY; BIOSTATISTICS; GUIDELINES; STATEMENT	Good quality medical research generally requires not only an expertise in the chosen medical field of interest but also a sound knowledge of statistical methodology. The number of medical research articles which have been published in Indian medical journals has increased quite substantially in the past decade. The aim of this study was to collate all evidence on study design quality and statistical analyses used in selected leading Indian medical journals. Ten (10) leading Indian medical journals were selected based on impact factors and all original research articles published in 2003 (N = 588) and 2013 (N = 774) were categorized and reviewed. A validated checklist on study design, statistical analyses, results presentation, and interpretation was used for review and evaluation of the articles. Main outcomes considered in the present study were -study design types and their frequencies, error/defects proportion in study design, statistical analyses, and implementation of CONSORT checklist in RCT (randomized clinical trials). From 2003 to 2013: The proportion of erroneous statistical analyses did not decrease (chi(2) = 0.592, phi=0.027, p=0.4418), 25% (80/320) in 2003 compared to 22.6% (111/490) in 2013. Compared with 2003, significant improvement was seen in 2013; the proportion of papers using statistical tests increased significantly (chi(2)=26.96, phi=0.16, p< 0.0001) from 42.5% (250/588) to 56.7 %(439/774). The overall proportion of errors in study design decreased significantly (chi(2)=16.783, phi=0.12 p<0.0001), 41.3%(243/588) compared to 30.6%(237/774). In 2013, randomized clinical trials designs has remained very low (7.3%, 43/588) with majority showing some errors (41 papers, 95.3%). Majority of the published studies were retrospective in nature both in 2003 [79.1% (465/588)] and in 2013 [78.2%(605/774)]. Major decreases in error proportions were observed in both results presentation (chi(2)= 24.477, phi=0.17, p<0.0001), 82.2%(263/320) compared to 66.3%(325/490) and interpretation (chi(2)= 25.616, phi=0.173, p<0.0001), 32.5%(104/320) compared to 17.1%(84/490), though some serious ones were still present. Indian medical research seems to have made no major progress regarding using correct statistical analyses, but error/defects in study designs have decreased significantly. Randomized clinical trials are quite rarely published and have high proportion of methodological problems.	[Hassan, Shabbeer; Yellur, Rajashree; Subramani, Pooventhan; Adiga, Poornima; Gokhale, Manoj; Iyer, Manasa S.; Mayya, Shreemathi S.] Manipal Univ, Dept Stat, Manipal 576104, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Mayya, SS (corresponding author), Manipal Univ, Dept Stat, Level 6,Hlth Sci Lib Bldg, Manipal 576104, Karnataka, India.	shreemathi.mayya@manipal.edu	Mayya, Shreemathi/Q-1326-2015; Hassan, Shabbeer/G-7330-2016; Hassan, Shabbeer/O-6502-2019	Hassan, Shabbeer/0000-0003-3231-324X; Hassan, Shabbeer/0000-0003-3231-324X				Altman D G, 1982, Stat Med, V1, P59, DOI 10.1002/sim.4780010109; ALTMAN DG, 1983, BRIT MED J, V286, P1489, DOI 10.1136/bmj.286.6376.1489; ALTMAN DG, 1981, BRIT MED J, V282, P44, DOI 10.1136/bmj.282.6257.44; ALTMAN DG, 1991, STAT MED, V10, P1897, DOI 10.1002/sim.4780101206; Altman DG, 2000, STAT MED, V19, P3275, DOI 10.1002/1097-0258(20001215)19:23<3275::AID-SIM626>3.0.CO;2-M; [Anonymous], 2005, NAT MED, V11, P1, DOI 10.1038/nm0105-1; AVRAM MJ, 1985, ANESTH ANALG, V64, P607; BAILAR JC, 1988, ANN INTERN MED, V108, P266, DOI 10.7326/0003-4819-108-2-266; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; EMERSON JD, 1983, NEW ENGL J MED, V309, P709, DOI 10.1056/NEJM198309223091206; FEINSTEIN AR, 1974, CLIN PHARMACOL THER, V15, P97; FLETCHER RH, 1979, NEW ENGL J MED, V301, P180, DOI 10.1056/NEJM197907263010403; Garcia-Berthou E, 2004, BMC MED RES METHODOL, V28, P4; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Horton NJ, 2005, NEW ENGL J MED, V353, P1977, DOI 10.1056/NEJM200511033531823; Jaykaran, 2011, J PHARMACOL PHARMACO, V2, P85, DOI 10.4103/0976-500X.81897; Jaykaran, 2010, AFR HEALTH SCI, V10, P204; Jin ZC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010822; JUZYCH MS, 1992, ARCH OPHTHALMOL-CHIC, V110, P1225, DOI 10.1001/archopht.1992.01080210043020; KANTER MH, 1994, TRANSFUSION, V34, P697, DOI 10.1046/j.1537-2995.1994.34894353466.x; Lang TA., 2016, MED WRITING, V25, P31, DOI [10.1002/9781118715598.ch25, DOI 10.1002/9781118715598.CH25]; MCDERMOTT MM, 1995, J GEN INTERN MED, V10, P13, DOI 10.1007/BF02599570; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MORRIS RW, 1988, J BONE JOINT SURG BR, V70, P242, DOI 10.1302/0301-620X.70B2.3346297; Murari G, 2013, J CLIN RES BIOETH, V4, P146, DOI [10.4172/2155-9627.1000146, DOI 10.4172/2155-9627.1000146]; Rennie D, 2003, JAMA-J AM MED ASSOC, V289, P89, DOI 10.1001/jama.289.1.89; ROSENFELD RM, 1991, ARCH OTOLARYNGOL, V117, P1172; Satyanarayana K, 2010, INDIAN J MED RES, V132, P119; Schwartz SJ, 1996, ARCH PHYS MED REHAB, V77, P497, DOI 10.1016/S0003-9993(96)90040-4; Thomson Reuters, 2013, J CITATION REPORTS; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wainapel SF, 1985, ARCH PHYS MED REHAB, V66, P332; Wang Q, 1998, JAMA, V280	38	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121268	10.1371/journal.pone.0121268	http://dx.doi.org/10.1371/journal.pone.0121268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856194	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500015
J	Zhang, ZC; Ma, J; Luan, G; Kang, L; Su, YH; He, YN; Luan, F				Zhang, Zhanchi; Ma, Jun; Luan, Guang; Kang, Lin; Su, Yuhong; He, Yanan; Luan, Feng			MiR-506 Suppresses Tumor Proliferation and Invasion by Targeting FOXQ1 in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							STEM-LIKE CELLS; MESENCHYMAL TRANSITION; C-MYC; EXPRESSION; PROGRESSION; GROWTH; OVEREXPRESSION; INHIBITION; ACTIVATION; SENESCENCE	MiRNAs are small noncoding RNAs that play important roles in various biological processes including tumorigenesis. However, little is known about the expression and function of miR-506 in nasopharyngeal carcinoma (NPC). In this study, we showed that miR-506 was downregulated in nasopharyngeal carcinoma (NPC) cell lines and tissues. Ectopic expression of miR-506 dramatically suppressed cell proliferation, colony formation and invasion. Moreover, we identified the Forkhead box Q1 (FOXQ1) gene as a novel direct target of miR-506. MiR-506 exerts its tumor suppressor function through inhibition of the FOXQ1, which was involved in tumor metastasis and proliferation in various cancers. Furthermore, the expression of FOXQ1 is up-regulated in NPC cell lines and tissues. Taken together, our results indicate that miR-506 functions as a tumor suppressor miRNA in NPC and that its suppressive effects are mediated chiefly by repressing FOXQ1 expression.	[Zhang, Zhanchi; Ma, Jun; Kang, Lin; Su, Yuhong] Hebei Med Univ, Dept Human Anat, Shijiazhuang, Peoples R China; [Luan, Guang] Hebei Med Univ, Hosp 3, Shijiazhuang, Peoples R China; [He, Yanan; Luan, Feng] Hebei Med Univ, Hosp 3, Dept Otorhinolaryngol, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Luan, F (corresponding author), Hebei Med Univ, Hosp 3, Dept Otorhinolaryngol, Shijiazhuang, Peoples R China.	luanfengly@163.com			Hebei youth foundation of scientific and technological research in colleges and universities project [QN2014140]; Health and family planning commission medical scientific research projects in Hebei province [ZL20140017]; Hebei science and technology support program project [132777135]	Hebei youth foundation of scientific and technological research in colleges and universities project; Health and family planning commission medical scientific research projects in Hebei province; Hebei science and technology support program project	This work was supported by Hebei youth foundation of scientific and technological research in colleges and universities project (QN2014140), Health and family planning commission medical scientific research projects in Hebei province (ZL20140017), and Hebei science and technology support program project (132777135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao B, 2014, J BIOL CHEM, V289, P14520, DOI 10.1074/jbc.M113.532887; Chen LX, 2007, CELL PROLIFERAT, V40, P253, DOI 10.1111/j.1365-2184.2007.00432.x; Christensen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060051; Dylla L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063032; Fei BJ, 2012, ONCOL RES, V20, P557, DOI 10.3727/096504013X13775486749254; Feng J, 2014, ONCOTARGET, V5, P9689, DOI 10.18632/oncotarget.2103; Fu LL, 2012, CELL PROLIFERAT, V45, P477, DOI 10.1111/j.1365-2184.2012.00840.x; Han G, 2012, ONCOL RES, V20, P149, DOI 10.3727/096504012X13522227232237; He X., 2014, ONCOTARGET; Huang GF, 2013, J NANOMATER, V2013, DOI 10.1155/2013/371356; Huang GL, 2014, J HUM GENET, V59, P141, DOI 10.1038/jhg.2013.135; Katoh M, 2004, INT J ONCOL, V25, P1495; Li J, 2014, CELL PROLIFERAT, V47, P152, DOI 10.1111/cpr.12093; Li LJ, 2013, TUMOR BIOL, V34, P1919, DOI 10.1007/s13277-013-0736-9; Li Z, 2015, CELL PROLIFERAT, V48, P1, DOI 10.1111/cpr.12160; Li Z, 2015, GASTRIC CANCER, V18, P43, DOI 10.1007/s10120-014-0340-8; Li Z, 2013, J ORTHOP RES, V31, P847, DOI 10.1002/jor.22308; Li Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053176; Liang SH, 2013, TUMOR BIOL, V34, P2605, DOI 10.1007/s13277-013-0808-x; Liu G, 2014, J PATHOL, V233, P308, DOI 10.1002/path.4348; Lu J, 2014, ONCOTARGET, V5, P11319, DOI 10.18632/oncotarget.2435; Luo X, 2013, CELL PROLIFERAT, V46, P436, DOI 10.1111/cpr.12038; Luo ZH, 2013, CARCINOGENESIS, V34, P415, DOI 10.1093/carcin/bgs329; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Ohno M, 2014, ONCOTARGET, V5, P5581, DOI 10.18632/oncotarget.2143; Peng XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-186; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Schirmer U, 2014, ONCOTARGET, V5, P462, DOI 10.18632/oncotarget.1552; Sehrawat A, 2013, CARCINOGENESIS, V34, P864, DOI 10.1093/carcin/bgs397; Streicher KL, 2012, ONCOGENE, V31, P1558, DOI 10.1038/onc.2011.345; Sun HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055693; Sun Y, 2015, J PATHOL, V235, P25, DOI 10.1002/path.4443; Wang K, 2013, PATHOL ONCOL RES, V19, P405, DOI 10.1007/s12253-012-9593-x; Wang WW, 2013, PATHOL RES PRACT, V209, P353, DOI 10.1016/j.prp.2013.03.005; Wang Y, 2014, ACTA PHARMACOL SIN, V35, P1207, DOI 10.1038/aps.2014.59; Wang Z, 2014, ONCOTARGET; Wen S, 2014, ONCOGENE; Wu JJ, 2014, MOL CELL BIOCHEM, V394, P275, DOI 10.1007/s11010-014-2103-6; Wu WH, 2012, ONCOL RES, V20, P163, DOI 10.3727/096504012X13522227232354; Xiao XC, 2012, ONCOL RES, V20, P537, DOI 10.3727/096504013X13775486749335; Xu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099516; Ye YF, 2013, BIOCHEM BIOPH RES CO, V436, P19, DOI 10.1016/j.bbrc.2013.05.008; Yin M, 2014, ONCOGENE; Yu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083080; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Zhang T, 2014, TUMOR BIOL, V35, P12593, DOI 10.1007/s13277-014-2581-x; Zhen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.376	47	66	73	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122851	10.1371/journal.pone.0122851	http://dx.doi.org/10.1371/journal.pone.0122851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856555	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500061
J	Zhao, XJ; Gao, MM; He, JH; Zou, LQ; Lyu, Y; Zhang, L; Geng, B; Liu, G; Xu, GH				Zhao, Xiaojing; Gao, Mingming; He, Jinhan; Zou, Liangqiang; Lyu, Ying; Zhang, Ling; Geng, Bin; Liu, George; Xu, Guoheng			Perilipin1 Deficiency in Whole Body or Bone Marrow-Derived Cells Attenuates Lesions in Atherosclerosis-Prone Mice	PLOS ONE			English	Article							DIFFERENTIATION-RELATED PROTEIN; CHOLESTERYL ESTER HYDROLASE; HORMONE-SENSITIVE LIPASE; MACROPHAGE FOAM CELLS; LIPID DROPLETS; STORAGE; METABOLISM; LIPOLYSIS; APOLIPOPROTEIN; ADIPOPHILIN	Aims The objective of this study is to determine the role of perilipin 1 (Plin1) in whole body or bone marrow-derived cells on atherogenesis. Methods and Results Accumulated evidence have indicated the role of Plin1 in atherosclerosis, however, these findings are controversial. In this study, we showed that Plin1 was assembled and colocalized with CD68 in macrophages in atherosclerotic plaques of ApoE-/-mice. We further found 39% reduction of plaque size in the aortic roots of Plin1 and ApoE double knockout (Plin1-/-ApoE-/-) females compared with ApoE-/-female littermates. In order to verify whether this reduction was macrophage-specific, the bone marrow cells from wild-type or Plin1 deficient mice (Plin1-/-) were transplanted into LDL receptor deficient mice (LDLR-/-). Mice receiving Plin1-/-bone marrow cells showed also 49% reduction in aortic atherosclerotic lesions compared with LDLR-/-mice received wild-type bone marrow cells. In vitro experiments showed that Plin1-/-macrophages had decreased protein expression of CD36 translocase and an enhanced cholesterol ester hydrolysis upon aggregated-LDL loading, with unaltered expression of many other regulators of cholesterol metabolism, such as cellular lipases, and Plin2 and 3. Given the fundamental role of Plin1 in protecting LD lipids from lipase hydrolysis, it is reasonably speculated that the assembly of Plin1 in microphages might function to reduce lipolysis and hence increase lipid retention in ApoE-/-plaques, but this pro-atherosclerotic property would be abrogated on inactivation of Plin1. Conclusion Plin1 deficiency in bone marrow-derived cells may be responsible for reduced atherosclerotic lesions in the mice.	[Zhao, Xiaojing; Zou, Liangqiang; Lyu, Ying; Geng, Bin; Xu, Guoheng] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Gao, Mingming; Zhang, Ling; Liu, George] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [He, Jinhan] Sichuan Univ, West China Hosp, Dept Pharm, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China	Peking University; Sichuan University	Geng, B (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	bingeng@bjmu.edu.cn; georgeliu@bjmu.edu	Geng, Bin/ABB-6045-2020	Geng, Bin/0000-0001-7573-8710	Major National Basic Research Program of China [2012CB517806, 2012CB517505, 2011CB503900]; National Natural Science Foundation of China [91439119, 30821001, 30930037]	Major National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major National Basic Research Program of China (2012CB517806, 2012CB517505 and 2011CB503900) and the National Natural Science Foundation of China (91439119, 30821001 and 30930037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beylot M, 2012, METABOLISM, V61, P415, DOI 10.1016/j.metabol.2011.07.019; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Buchebner M, 2010, J LIPID RES, V51, P2896, DOI 10.1194/jlr.M004259; Buechler C, 2001, BBA-MOL CELL BIOL L, V1532, P97, DOI 10.1016/S1388-1981(01)00121-4; Buers I, 2009, ARTERIOSCL THROM VAS, V29, P767, DOI 10.1161/ATVBAHA.108.182675; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Faber BCG, 2001, CIRC RES, V89, P547, DOI 10.1161/hh1801.096340; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Forcheron F, 2005, ARTERIOSCL THROM VAS, V25, P1711, DOI 10.1161/01.ATV.0000174123.19103.52; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Griffin EE, 2005, J LIPID RES, V46, P2052, DOI 10.1194/jlr.M500059-JLR200; JIANG HP, 1992, P NATL ACAD SCI USA, V89, P7856, DOI 10.1073/pnas.89.17.7856; KHOO JC, 1993, J LIPID RES, V34, P1969; Lamant M, 2006, J BIOL CHEM, V281, P36289, DOI 10.1074/jbc.M510861200; Larigauderie G, 2006, ATHEROSCLEROSIS, V189, P142, DOI 10.1016/j.atherosclerosis.2005.12.016; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Maeda N, 2007, ATHEROSCLEROSIS, V195, P75, DOI 10.1016/j.atherosclerosis.2006.12.006; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Paul A, 2008, CIRC RES, V102, P1492, DOI 10.1161/CIRCRESAHA.107.168070; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; van Berkel TJC, 2005, CURR OPIN LIPIDOL, V16, P525, DOI 10.1097/01.mol.0000183943.20277.26; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Zhai W, 2010, HORM METAB RES, V42, P247, DOI 10.1055/s-0029-1243599; Zhao B, 2005, J LIPID RES, V46, P2114, DOI 10.1194/jlr.M500207-JLR200; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	33	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123738	10.1371/journal.pone.0123738	http://dx.doi.org/10.1371/journal.pone.0123738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855981	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500104
J	Ahronheim, SR; McGillivray, D; Barbic, S; Barbic, D; Klam, S; Brisebois, P; Lambrinakos-Raymond, K; Nemeth, J				Ahronheim, Sara R.; McGillivray, David; Barbic, Skye; Barbic, David; Klam, Stephanie; Brisebois, Paul; Lambrinakos-Raymond, Kristen; Nemeth, Joe			Expectant Parents' Understanding of the Implications and Management of Fever in the Neonate	PLOS ONE			English	Article							CHILDHOOD FEVER; EMERGENCY; PERCEPTIONS; PATTERNS; INFANTS	Objective We estimated the extent to which Canadian expectant parents would seek medical care in a febrile neonate (age 30 days or less). We also evaluated expectant parents' knowledge of signs and symptoms of fever in a neonate, and explored the actions Canadian expectant parents would take to optimize the health of their child. Methods We conducted a cross-sectional survey of a sample of expectant parents from a large urban center in Canada. We recruited participants from waiting rooms in an obstetrical ultrasound clinic located in an urban tertiary care hospital in Montreal, Canada. We asked participants nine questions about fever in neonates including if, and how, they would seek care for their neonate if they suspected he/she were febrile. Results Among the 355 respondents, (response rate 87%) we found that 75% of parents reported that they would take their febrile neonate for immediate medical assessment, with nearly one fifth of the sample reporting that they would not seek medical care. We found no significant associations between the choice to seek medical care and expectant parents socio-demographic characteristics. Conclusions Despite universal access to high quality health care in Canada, our study highlights concerning gaps in the knowledge of the care of the febrile infant in one fifth of expectant parents. Physicians and health providers should strive to provide early education to expectant parents about how to recognize signs of fever in the neonate and how best to seek medical care. This may improve neonatal health outcomes in Canada.	[Ahronheim, Sara R.] McGill Univ, Jewish Gen Hosp, Dept Emergency Med, Montreal, PQ H3T 1E2, Canada; [Ahronheim, Sara R.; McGillivray, David] McGill Univ, Ctr Hosp, Montreal Childrens Hosp, Div Pediat Emergency Med, Montreal, PQ, Canada; [Barbic, Skye] Univ British Columbia, St Pauls Hosp, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Barbic, David] Univ British Columbia, St Pauls Hosp, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Klam, Stephanie] McGill Univ, Jewish Gen Hosp, Dept Obstet & Gynecol, Montreal, PQ H3T 1E2, Canada; [Brisebois, Paul; Lambrinakos-Raymond, Kristen] McGill Univ, Montreal, PQ, Canada; [Nemeth, Joe] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Div Emergency Med, Montreal, PQ, Canada	McGill University; McGill University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; McGill University; McGill University; McGill University	Ahronheim, SR (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Emergency Med, Montreal, PQ H3T 1E2, Canada.	sara.ahronheim@mcgill.ca	Barbic, Skye/AAW-4044-2020	Barbic, Skye/0000-0002-7076-2452				Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Alpern ER, 2010, TXB PEDIAT EMERGENCY, P266; Bertille N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083469; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Cohee LMS, 2010, CLIN PEDIATR, V49, P221, DOI 10.1177/0009922809336209; Conference Board of Canada, 2014, INFANT MORTALITY; Crocetti M, 2009, CLIN PEDIATR, V48, P183, DOI 10.1177/0009922808324949; Dongre AR, 2009, INDIAN J PEDIATR, V76, P691, DOI 10.1007/s12098-009-0106-1; Goldman RD, 2009, PEDIATRICS, V124, P439, DOI 10.1542/peds.2007-3736; Institut National de la Statistique des Etudes Economique (INSEE), 2008, REPARTITION DES IMMI; Jain S, 2014, PEDIATRICS, V133, P187, DOI 10.1542/peds.2013-1820; Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Marx J, 2013, ROSENS EMERGENCY MED, P476, DOI [10.1111/j.1553-2712.2011.01011.x, DOI 10.1111/J.1553-2712.2011.01011.X]; Niehues T, 2013, DTSCH ARZTEBL INT, V110, P764, DOI 10.3238/arztebl.2013.0764; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Organisation for Economic Co-operation and Development, 2014, OECD FACTBOOK 2014 E; Perry AM, 2013, PEDIATR EMERG CARE, V29, P58, DOI 10.1097/PEC.0b013e31827b540e; Rupe A, 2010, CLIN PEDIATR, V49, P172, DOI 10.1177/0009922809336208; Sandberg J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097253; Schorr CA, 2014, TRENDS MOL MED, V20, P192, DOI 10.1016/j.molmed.2014.02.001; Schweich PJ, 1998, PEDIATR EMERG CARE, V14, P89, DOI 10.1097/00006565-199804000-00001; Seow VK, 2007, AM J EMERG MED, V25, P1004, DOI 10.1016/j.ajem.2007.03.001; Statistics Canada, 2009, CANADIAN VITAL STATI; Taveras EM, 2004, PEDIATR EMERG CARE, V20, P579, DOI 10.1097/01.pec.0000139739.46591.dd; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; Thompson-Robinson Melva, 2006, J Cult Divers, V13, P97; Walsh A, 2006, J ADV NURS, V54, P217, DOI 10.1111/j.1365-2648.2006.03802.x; Yarden-Bilavsky H, 2014, ACTA PAEDIATR, V103, P379, DOI 10.1111/apa.12560; Zupran J, 2005, PERINATAL MORTALITY; Zyoud SH, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-66	32	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120959	10.1371/journal.pone.0120959	http://dx.doi.org/10.1371/journal.pone.0120959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853510	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400024
J	DeFaveri, J; Merila, J				DeFaveri, Jacquelin; Merila, Juha			Temporal Stability of Genetic Variability and Differentiation in the Three-Spined Stickleback (Gasterosteus aculeatus)	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; CONTEMPORARY EFFECTIVE POPULATION; COD GADUS-MORHUA; FRESH-WATER; THREESPINE STICKLEBACK; LINKAGE DISEQUILIBRIUM; ALLELE FREQUENCIES; ADAPTIVE DIVERGENCE; NATURAL-POPULATIONS; BALTIC SEA	Temporal variation in allele frequencies, whether caused by deterministic or stochastic forces, can inform us about interesting demographic and evolutionary phenomena occurring in wild populations. In spite of the continued surge of interest in the genetics of three-spined stickleback (Gasterosteus aculeatus) populations, little attention has been paid towards the temporal stability of allele frequency distributions, and whether there are consistent differences in effective size (Ne) of local populations. We investigated temporal stability of genetic variability and differentiation in 15 microsatellite loci within and among eight collection sites of varying habitat type, surveyed twice over a six-year time period. In addition, Nes were estimated with the expectation that they would be lowest in isolated ponds, intermediate in larger lakes and largest in open marine sites. In spite of the marked differences in genetic variability and differentiation among the study sites, the temporal differences in allele frequencies, as well as measures of genetic diversity and differentiation, were negligible. Accordingly, the Ne estimates were temporally stable, but tended to be lower in ponds than in lake or marine habitats. Hence, we conclude that allele frequencies in putatively neutral markers in three-spined sticklebacks seem to be temporally stable -at least over periods of few generations - across a wide range of habitat types differing markedly in levels of genetic variability, effective population size and gene flow.	[DeFaveri, Jacquelin; Merila, Juha] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	University of Helsinki	Merila, J (corresponding author), Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland.	juha.merila@helsinki.fi	Merila, Juha/A-4061-2008	Merila, Juha/0000-0001-9614-0072	Academy of Finland [s 200940, 108601, 118673]; LUOVA graduate school; European Community [217246]; joint Baltic Sea research and development programme	Academy of Finland(Academy of Finland); LUOVA graduate school; European Community(European Commission); joint Baltic Sea research and development programme	This research was supported by the Academy of Finland (www.aka.fi; grant #:s 200940, 108601 and 118673 to JM) and LUOVA graduate school (JD). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP/2007-2013) under grant agreement no 217246 made with BONUS (http://www.bonusportal.org), the joint Baltic Sea research and development programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1981, CAN J FISH AQUAT SCI, V38, P1507, DOI 10.1139/f81-203; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Araguas RM, 2012, FRESHWATER BIOL, V57, P143, DOI 10.1111/j.1365-2427.2011.02705.x; Barker JSF, 2011, MOL ECOL, V20, P4452, DOI 10.1111/j.1365-294X.2011.05324.x; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bernal-Ramirez JH, 2003, MAR BIOL, V142, P567, DOI 10.1007/s00227-002-0972-9; Berthier P, 2002, GENETICS, V160, P741; Cano JM, 2008, MOL ECOL, V17, P3234, DOI 10.1111/j.1365-294X.2008.03837.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Consuegra S, 2005, CONSERV GENET, V6, P823, DOI 10.1007/s10592-005-9042-4; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cuveliers EL, 2011, MOL ECOL, V20, P3555, DOI 10.1111/j.1365-294X.2011.05196.x; DeFaveri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080866; DeFaveri J, 2013, EVOLUTION, V67, P2530, DOI 10.1111/evo.12097; DeFaveri J, 2012, MAR BIOL, V159, P1659, DOI 10.1007/s00227-012-1951-4; DeFaveri J, 2011, EVOLUTION, V65, P1800, DOI 10.1111/j.1558-5646.2011.01247.x; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Drevecky CJ, 2013, J FISH BIOL, V83, P111, DOI 10.1111/jfb.12154; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Fraser BA, 2010, EVOLUTION, V64, P2086, DOI 10.1111/j.1558-5646.2010.00965.x; Fraser DJ, 2007, MOL ECOL, V16, P3866, DOI 10.1111/j.1365-294X.2007.03453.x; Garant D, 2000, MOL ECOL, V9, P615, DOI 10.1046/j.1365-294x.2000.00909.x; Garland T., 2009, EXPT EVOLUTION CONCE; Gomez-Uchida D, 2013, ECOL EVOL, V3, P569, DOI 10.1002/ece3.485; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hare MP, 2011, CONSERV BIOL, V25, P438, DOI 10.1111/j.1523-1739.2010.01637.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hemmer-Hansen J, 2007, HEREDITY, V99, P592, DOI 10.1038/sj.hdy.6801055; HILL WG, 1979, GENETICS, V92, P317; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hoehn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048464; Hoffman EA, 2004, EVOLUTION, V58, P2536; Hohenlohe PA, 2012, PHILOS T R SOC B, V367, P395, DOI 10.1098/rstb.2011.0245; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jonsdottir ODB, 2001, ICES J MAR SCI, V58, P114, DOI 10.1006/jmsc.2000.0995; JORDE PE, 1995, GENETICS, V139, P1077; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Jorde PE, 2012, MOL ECOL RESOUR, V12, P476, DOI 10.1111/j.1755-0998.2011.03111.x; Jurvelius J, 1996, FISH RES, V27, P227, DOI 10.1016/0165-7836(95)00464-5; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Kennington WJ, 2013, CONSERV GENET, V14, P115, DOI 10.1007/s10592-012-0433-z; Kitano J, 2008, CURR BIOL, V18, P769, DOI 10.1016/j.cub.2008.04.027; Lande R., 1987, VIABLE POPULATIONS C, P87, DOI DOI 10.1017/CBO9780511623400.007; Langella O, 2002, POPULATIONS 1 2 POPU; Larsson LC, 2010, HEREDITY, V104, P40, DOI 10.1038/hdy.2009.98; Leinonen T, 2016, J EVOL BIOL, V19, P1803; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Makinen HS, 2008, MOL ECOL, V17, P3565, DOI 10.1111/j.1365-294X.2008.03714.x; Makinen HS, 2006, MOL ECOL, V15, P1519, DOI 10.1111/j.1365-294X.2006.02871.x; McCairns RJS, 2008, MOL ECOL, V17, P3901, DOI 10.1111/j.1365-294X.2008.03884.x; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; NEI M, 1981, GENETICS, V98, P625; Nielsen EE, 2004, MOL ECOL, V13, P585, DOI 10.1046/j.1365-294X.2004.02097.x; Nielsen EE, 2008, FISH FISH, V9, P450, DOI 10.1111/j.1467-2979.2008.00304.x; Palm S, 2003, CONSERV GENET, V4, P249, DOI 10.1023/A:1024064913094; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Peltonen H, 2004, ICES J MAR SCI, V61, P966, DOI 10.1016/j.icesjms.2004.06.008; Peuhkuri N, 1998, ANN ZOOL FENN, V35, P21; POLLAK E, 1983, GENETICS, V104, P531; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; Raeymaekers JAM, 2005, MOL ECOL, V14, P1001, DOI 10.1111/j.1365-294X.2005.02456.x; Raeymaekers JAM, 2014, MOL ECOL, V23, P162, DOI 10.1111/mec.12582; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reusch TBH, 2001, MOL ECOL, V10, P2435, DOI 10.1046/j.0962-1083.2001.01366.x; Richards C, 1996, CONSERV BIOL, V10, P832, DOI 10.1046/j.1523-1739.1996.10030832.x; Ruzzante DE, 2001, CONSERV GENET, V2, P257, DOI 10.1023/A:1012247213644; Saillant E, 2006, FISH B-NOAA, V104, P136; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Shimada Y, 2011, MOL BIOL EVOL, V28, P181, DOI 10.1093/molbev/msq181; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Tallmon DA, 2010, MOL ECOL RESOUR, V10, P684, DOI 10.1111/j.1755-0998.2010.02831.x; Tessier N, 1997, MOL ECOL, V6, P735, DOI 10.1046/j.1365-294X.1997.00244.x; Tessier N, 1999, MOL ECOL, V8, P169, DOI 10.1046/j.1365-294X.1999.00547.x; Therkildsen NO, 2010, CAN J FISH AQUAT SCI, V67, P1585, DOI 10.1139/F10-084; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walter RP, 2009, CAN J FISH AQUAT SCI, V66, P167, DOI 10.1139/F08-201; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; Waples RS, 2010, MOL ECOL RESOUR, V10, P785, DOI 10.1111/j.1755-0998.2010.02876.x; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; WAPLES RS, 1990, CONSERV BIOL, V4, P144, DOI 10.1111/j.1523-1739.1990.tb00103.x; WAPLES RS, 1989, EVOLUTION, V43, P1236, DOI 10.2307/2409359; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whither RE, 1984, CAN J ZOOL, V63, P528; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Wootton RJ, 2005, ENVIRON BIOL FISH, V74, P151, DOI 10.1007/s10641-005-7690-3	103	12	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123891	10.1371/journal.pone.0123891	http://dx.doi.org/10.1371/journal.pone.0123891			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853707	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400126
J	Inui, Y; Shimizu-kaya, U; Okubo, T; Yamsaki, E; Itioka, T				Inui, Yoko; Shimizu-kaya, Usun; Okubo, Tadahiro; Yamsaki, Eri; Itioka, Takao			Various Chemical Strategies to Deceive Ants in Three Arhopala Species (Lepidoptera: Lycaenidae) Exploiting Macaranga Myrmecophytes	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; PERCEPTUAL SIMILARITY; NESTMATE RECOGNITION; SOCIAL PARASITE; CREMATOGASTER; HYMENOPTERA; ASSOCIATION; BUTTERFLIES; DIVERSITY; SYMBIOSIS	Macaranga myrmecophytes (ant-plants) are generally well protected from herbivore attacks by their symbiotic ants (plant-ants). However, larvae of Arhopala (Lepidoptera: Lycaenidae) species survive and develop on specific Macaranga ant-plant species without being attacked by the plant-ants of their host species. We hypothesized that Arhopala larvae chemically mimic or camouflage themselves with the ants on their host plant so that the larvae are accepted by the plant-ant species of their host. Chemical analyses of cuticular hydrocarbons showed that chemical congruency varied among Arhopala species; A. dajagaka matched well the host plant-ants, A. amphimuta did not match, and unexpectedly, A. zylda lacked hydrocarbons. Behaviorally, the larvae and dummies coated with cuticular chemicals of A. dajagaka were well attended by the plant-ants, especially by those of the host. A. amphimuta was often attacked by all plant-ants except for the host plant-ants toward the larvae, and those of A. zylda were ignored by all plant-ants. Our results suggested that conspicuous variations exist in the chemical strategies used by the myrmecophilous butterflies that allow them to avoid ant attack and be accepted by the plant-ant colonies.	[Inui, Yoko] Osaka Kyoiku Univ, Dept Arts & Sci, Osaka 543, Japan; [Shimizu-kaya, Usun; Okubo, Tadahiro; Itioka, Takao] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan; [Yamsaki, Eri] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan	Osaka University of Education; Kyoto University; Kyoto University	Inui, Y (corresponding author), Osaka Kyoiku Univ, Dept Arts & Sci, Osaka 543, Japan.	inui@cc.osaka-kyoiku.ac.jp	Yamasaki, Eri/L-6541-2016	Yamasaki, Eri/0000-0002-8858-2839	Ministry of Education, Culture, Sports, Science and Technology, Japan [21255004, 23770022]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was financially supported by Grant-in-Aid to TI (no. 21255004) and to YI (no. 23770022, URL: http://kaken.nii.ac.jp/p?q5=23770022) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Akino T, 2006, APPL ENTOMOL ZOOL, V41, P667, DOI 10.1303/aez.2006.667; Axen AH, 1996, ANIM BEHAV, V52, P321, DOI 10.1006/anbe.1996.0178; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; BONAVITACOUGOURDAN A, 1987, J ENTOMOL SCI, V22, P1; Bos N, 2013, J EXP BIOL, V216, P3314, DOI 10.1242/jeb.087007; Bos N, 2012, J INSECT PHYSIOL, V58, P138, DOI 10.1016/j.jinsphys.2011.10.010; BUCKNER JS, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P227; Cvacka J, 2006, J CHEM ECOL, V32, P409, DOI 10.1007/s10886-005-9008-5; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Fiala B, 1999, BIOL J LINN SOC, V66, P305, DOI 10.1006/bijl.1998.0279; FIALA B, 1989, OECOLOGIA, V79, P463, DOI 10.1007/BF00378662; FIALA B, 1994, OECOLOGIA, V97, P186, DOI 10.1007/BF00323148; FIEDLER K, 1989, J NAT HIST, V23, P833, DOI 10.1080/00222938900770441; Fiedler K, 1996, EXPERIENTIA, V52, P14, DOI 10.1007/BF01922410; GRUNSHAW JP, 1990, J CHEM ECOL, V16, P2835, DOI 10.1007/BF00979477; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Heckroth HP, 1998, J TROP ECOL, V14, P427, DOI 10.1017/S0266467498000327; HENNING SF, 1983, J ENTOMOL SOC S AFR, V46, P341; Hojo MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086054; Hojo MK, 2009, P ROY SOC B-BIOL SCI, V276, P551, DOI 10.1098/rspb.2008.1064; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Inui Y, 2007, J CHEM ECOL, V33, P2054, DOI 10.1007/s10886-007-9369-z; Itino T, 2001, ECOL RES, V16, P787, DOI 10.1046/j.1440-1703.2001.00442.x; Itioka T, 2000, BIOTROPICA, V32, P318, DOI 10.1111/j.1744-7429.2000.tb00475.x; Jeral JM, 1997, PHYSIOL ENTOMOL, V22, P207, DOI 10.1111/j.1365-3032.1997.tb01160.x; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Leonhardt SD, 2009, INSECT SOC, V56, P157, DOI 10.1007/s00040-009-0007-3; Lorenzi MC, 2002, PARASITOLOGY, V125, P507, DOI 10.1017/S003118200200238X; MASCHWITZ U, 1984, OECOLOGIA, V64, P78, DOI 10.1007/BF00377547; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Nomura M, 2000, ECOL RES, V15, P1, DOI 10.1046/j.1440-1703.2000.00318.x; Nomura M, 2011, PLANT ECOL, V212, P143, DOI 10.1007/s11258-010-9810-1; Okubo Tadahiro, 2009, Transactions of the Lepidopterological Society of Japan, V60, P37; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Shimizu-kaya U, 2013, J NAT HIST, V47, P2707, DOI 10.1080/00222933.2013.791943; Shimizu-kaya U, 2013, ENTOMOL NEWS, V123, P63, DOI 10.3157/021.123.0115; Ueda S, 2008, P ROY SOC B-BIOL SCI, V275, P2319, DOI 10.1098/rspb.2008.0573; Ueda S, 2012, ECOL RES, V27, P437, DOI 10.1007/s11284-011-0915-3; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vander Meer Robert K., 1998, P79	42	7	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120652	10.1371/journal.pone.0120652	http://dx.doi.org/10.1371/journal.pone.0120652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853675	Green Submitted, gold, Green Published			2022-12-27	WOS:000352478400017
J	Smith, ADAC; Tilling, K; Lawlor, DA; Nelson, SM				Smith, Andrew D. A. C.; Tilling, Kate; Lawlor, Debbie A.; Nelson, Scott M.			External Validation and Calibration of IVFpredict: A National Prospective Cohort Study of 130,960 In Vitro Fertilisation Cycles	PLOS ONE			English	Article							CLINICAL-PREDICTION MODELS; IVF SUCCESS; TEMPLETON MODEL; TECHNOLOGY; BIRTHS	Background Accurately predicting the probability of a live birth after in vitro fertilisation (IVF) is important for patients, healthcare providers and policy makers. Two prediction models (Templeton and IVFpredict) have been previously developed from UK data and are widely used internationally. The more recent of these, IVFpredict, was shown to have greater predictive power in the development dataset. The aim of this study was external validation of the two models and comparison of their predictive ability. Methods and Findings 130,960 IVF cycles undertaken in the UK in 2008-2010 were used to validate and compare the Templeton and IVFpredict models. Discriminatory power was calculated using the area under the receiver-operator curve and calibration assessed using a calibration plot and Hosmer-Lemeshow statistic. The scaled modified Brier score, with measures of reliability and resolution, were calculated to assess overall accuracy. Both models were compared after updating for current live birth rates to ensure that the average observed and predicted live birth rates were equal. The discriminative power of both methods was comparable: the area under the receiver-operator curve was 0.628 (95% confidence interval (CI): 0.625-0.631) for IVFpredict and 0.616 (95% CI: 0.613-0.620) for the Templeton model. IVFpredict had markedly better calibration and higher diagnostic accuracy, with calibration plot intercept of 0.040 (95% CI: 0.017-0.063) and slope of 0.932 (95% CI: 0.839-1.025) compared with 0.080 (95% CI: 0.044-0.117) and 1.419 (95% CI: 1.149-1.690) for the Templeton model. Both models underestimated the live birth rate, but this was particularly marked in the Templeton model. Updating the models to reflect improvements in live birth rates since the models were developed enhanced their performance, but IVFpredict remained superior. Conclusion External validation in a large population cohort confirms IVFpredict has superior discrimination and calibration for informing patients, clinicians and healthcare policy makers of the probability of live birth following IVF.	[Smith, Andrew D. A. C.; Tilling, Kate; Lawlor, Debbie A.] Univ Bristol, Med Res Council, Integrat Epidemiol Unit, Bristol, Avon, England; [Smith, Andrew D. A. C.; Tilling, Kate; Lawlor, Debbie A.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Nelson, Scott M.] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol; University of Bristol; University of Glasgow	Lawlor, DA (corresponding author), Univ Bristol, Med Res Council, Integrat Epidemiol Unit, Bristol, Avon, England.	d.a.lawlor@bristol.ac.uk; scott.nelson@glasgow.ac.uk	Smith, Andrew DAC/F-9714-2011; Tilling, Kate/AAY-1578-2021	Lawlor, Debbie A/0000-0002-6793-2262; Tilling, Kate/0000-0002-1010-8926	UK Medical Research Council [MC_UU_12013/5, MC_UU_12013/9]; Wellcome Trust [WT094311MA]; National Institute for Health Research Senior Investigator awards [NF-SI-0611-10196]; MRC [MC_UU_12013/5, MC_UU_12013/9] Funding Source: UKRI; Medical Research Council [MC_UU_12013/5, MC_UU_12013/9] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10196] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Senior Investigator awards; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	ADACS, KT and DAL work in a Unit that receives funding from the UK Medical Research Council (www.mrc.ac.uk) and that funding supported their input to this study (MC_UU_12013/5 and MC_UU_12013/9). This work is also supported by a grant from the Wellcome Trust (www.wellcome.ac.uk) which pays the salary of ADACS (WT094311MA). DAL receives support from a National Institute for Health Research Senior Investigator awards (NF-SI-0611-10196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Arvis P, 2012, HUM REPROD, V27, P2971, DOI 10.1093/humrep/des283; Banerjee P, 2010, P NATL ACAD SCI USA, V107, P13570, DOI 10.1073/pnas.1002296107; BOUCKAERT A, 1994, HUM REPROD, V9, P448, DOI 10.1093/oxfordjournals.humrep.a138526; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Coppus SFPJ, 2009, HUM REPROD, V24, P1774, DOI 10.1093/humrep/dep109; Ferraretti AP, 2012, HUM REPROD, V27, P2571, DOI 10.1093/humrep/des255; Hemingway H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5595; HOSMER DW, 2000, WILEY PS TX, P1; Janssen KJM, 2009, CAN J ANAESTH, V56, P194, DOI 10.1007/s12630-009-9041-x; Jones Christopher A, 2011, J Exp Clin Assist Reprod, V8, P3; Leushuis E, 2009, HUM REPROD UPDATE, V15, P537, DOI 10.1093/humupd/dmp013; Li HWR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061095; Lintsen AME, 2010, HUM REPROD, V25, P110, DOI 10.1093/humrep/dep358; Macklon NS, 2006, ENDOCR REV, V27, P170, DOI 10.1210/er.2005-0015; Minaretzis D, 1998, J ASSIST REPROD GEN, V15, P365, DOI 10.1023/A:1022528915761; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Smeenk JMJ, 2000, HUM REPROD, V15, P1065, DOI 10.1093/humrep/15.5.1065; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Strandell A, 2000, HUM REPROD, V15, P2520, DOI 10.1093/humrep/15.12.2520; te Velde ER, 2014, HUM REPROD, V29, P57, DOI 10.1093/humrep/det393; Templeton A, 1996, LANCET, V348, P1402, DOI 10.1016/S0140-6736(96)05291-9; van der Steeg JW, 2006, BJOG-INT J OBSTET GY, V113, P825, DOI 10.1111/j.1471-0528.2006.00992.x; van Loendersloot LL, 2011, REPROD BIOMED ONLINE, V22, P597, DOI 10.1016/j.rbmo.2011.02.012; van Loendersloot L, 2014, J ADV RES, V5, P295, DOI 10.1016/j.jare.2013.05.002; Wang YA, 2008, HUM REPROD, V23, P1633, DOI 10.1093/humrep/den135; Wiegerinck MAHM, 1999, HUM REPROD, V14, P689, DOI 10.1093/humrep/14.3.689; Wilks D. S., 2006, STATISTICAL METHODS	32	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121357	10.1371/journal.pone.0121357	http://dx.doi.org/10.1371/journal.pone.0121357			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853703	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000352478400036
J	Bagley, JC; Alda, F; Breitman, MF; Bermingham, E; van den Berghe, EP; Johnson, JB				Bagley, Justin C.; Alda, Fernando; Florencia Breitman, M.; Bermingham, Eldredge; van den Berghe, Eric P.; Johnson, Jerald B.			Assessing Species Boundaries Using Multilocus Species Delimitation in a Morphologically Conserved Group of Neotropical Freshwater Fishes, the Poecilia sphenops Species Complex (Poeciliidae)	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; PISCES-POECILIIDAE; CRYPTIC DIVERSITY; COMPUTER-PROGRAM; COALESCENT; PHYLOGENY; DIVERSIFICATION; BIOGEOGRAPHY; SYSTEMATICS; TELEOSTEI	Accurately delimiting species is fundamentally important for understanding species diversity and distributions and devising effective strategies to conserve biodiversity. However, species delimitation is problematic in many taxa, including 'non-adaptive radiations' containing morphologically cryptic lineages. Fortunately, coalescent-based species delimitation methods hold promise for objectively estimating species limits in such radiations, using multilocus genetic data. Using coalescent-based approaches, we delimit species and infer evolutionary relationships in a morphologically conserved group of Central American freshwater fishes, the Poecilia sphenops species complex. Phylogenetic analyses of multiple genetic markers (sequences of two mitochondrial DNA genes and five nuclear loci) from 10/15 species and genetic lineages recognized in the group support the P. sphenops species complex as monophyletic with respect to outgroups, with eight mitochondrial 'major-lineages' diverged by >= 2% pairwise genetic distances. From general mixed Yule-coalescent models, we discovered (conservatively) 10 species within our concatenated mitochondrial DNA dataset, 9 of which were strongly supported by subsequent multilocus Bayesian species delimitation and species tree analyses. Results suggested species-level diversity is underestimated or overestimated by at least similar to 15% in different lineages in the complex. Nonparametric statistics and coalescent simulations indicate genealogical discordance among our gene tree results has mainly derived from interspecific hybridization in the nuclear genome. However, mitochondrial DNA show little evidence for introgression, and our species delimitation results appear robust to effects of this process. Overall, our findings support the utility of combining multiple lines of genetic evidence and broad phylogeographical sampling to discover and validate species using coalescent-based methods. Our study also highlights the importance of testing for hybridization versus incomplete lineage sorting, which aids inference of not only species limits but also evolutionary processes influencing genetic diversity.	[Bagley, Justin C.; Florencia Breitman, M.; Johnson, Jerald B.] Brigham Young Univ, Evolutionary Ecol Labs, Dept Biol, Provo, UT 84602 USA; [Alda, Fernando; Bermingham, Eldredge] Smithsonian Trop Res Inst, Balboa, Panama; [Florencia Breitman, M.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon CENPAT, Puerto Madryn, Chubut, Argentina; [van den Berghe, Eric P.] Zamorano Univ, Dept Ambiente & Desarrollo, Ctr Zamorano Biodiversidad, Tegucigalpa, Honduras; [Johnson, Jerald B.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA	Brigham Young University; Smithsonian Institution; Smithsonian Tropical Research Institute; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Brigham Young University	Bagley, JC (corresponding author), Brigham Young Univ, Evolutionary Ecol Labs, Dept Biol, Provo, UT 84602 USA.	justin.bagley@byu.edu	Johnson, Jerald/AAN-5574-2020; Bagley, Justin/D-3982-2011; Alda, Fernando/C-5646-2011; Bagley, Justin C./N-9654-2019; Breitman, Maria Florencia/AAP-5104-2020; Breitman, Maria/I-8004-2014	Bagley, Justin/0000-0001-6737-8380; Alda, Fernando/0000-0002-6858-9566; Bagley, Justin C./0000-0001-6737-8380; Breitman, Maria/0000-0001-6964-841X	Brigham Young University (BYU) Mentoring Environment Grant; U.S. National Science Foundation (NSF) Doctoral Dissertation Improvement Grant [DEB-1210883]; BYU Graduate Studies Graduate Research Fellowship; NSF PIRE Grant [OISE PIRE-0530267]	Brigham Young University (BYU) Mentoring Environment Grant; U.S. National Science Foundation (NSF) Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); BYU Graduate Studies Graduate Research Fellowship; NSF PIRE Grant(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by a Brigham Young University (BYU) Mentoring Environment Grant to JBJ and a U.S. National Science Foundation (NSF) Doctoral Dissertation Improvement Grant (DEB-1210883) to JBJ and JCB. JCB received stipend support from a BYU Graduate Studies Graduate Research Fellowship award, and an NSF PIRE Grant (OISE PIRE-0530267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Agapow PM, 2005, CONSERV BIOL SER, V8, P57; Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Alda F, 2013, MOL PHYLOGENET EVOL, V66, P1011, DOI 10.1016/j.ympev.2012.12.012; Alpirez Quesada O, 1971, ESTUDIO SISTEMITICO; Bacon CD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-23; Bagley JC, 2014, BIOL REV, V89, P767, DOI 10.1111/brv.12076; Barley AJ, 2013, EVOLUTION, V67, P3556, DOI 10.1111/evo.12219; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bouckaert R, 2014, PLOS COMPUTATIONAL B; Breden F, 1999, MOL PHYLOGENET EVOL, V12, P95, DOI 10.1006/mpev.1998.0600; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Bussing, 1998, FRESHWATER FISHES CO; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Camargo A, 2012, SYST BIOL, V61, P272, DOI 10.1093/sysbio/syr105; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Chan KMA, 2005, EVOLUTION, V59, P720; Chow S, 1998, FISHERIES SCI, V64, P397, DOI 10.2331/fishsci.64.397; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coyne J.A., 2004, SPECIATION; Cronquist A, 1978, BIOSYSTEMATICS AGR, P3; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Fowler H. W., 1943, Notulae Naturae Philadelphia, V117, P1; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; GITTENBERGER E, 1991, BIOL J LINN SOC, V43, P263, DOI 10.1111/j.1095-8312.1991.tb00598.x; GREENFIELD DW, 1990, COPEIA, P449; Hamilton A, 2001, MOL PHYLOGENET EVOL, V19, P277, DOI 10.1006/mpev.2000.0919; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; HUBBS CARL L., 1933, THE AQUARIUM, V1, P263; Hubbs CL, 1926, MISCELLANEOUS PUBLIC, V16, P1; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; Jockusch EL, 2002, BIOL J LINN SOC, V76, P361, DOI 10.1046/j.1095-8312.2002.d01-6.x; Joly S, 2012, MOL ECOL RESOUR, V12, P179, DOI 10.1111/j.1755-0998.2011.03065.x; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Lee JB, 2009, MOL ECOL, V18, P4088, DOI 10.1111/j.1365-294X.2009.04339.x; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lomolino M, 2012, BIOGEOGRAPHY; Lucinda Paulo Henrique Franco, 2005, Neotrop. ichthyol., V3, P1, DOI 10.1590/S1679-62252005000100001; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Matamoros WA, 2012, REV FISH BIOL FISHER, V22, P351, DOI 10.1007/s11160-011-9232-8; Mayden R. L., 1997, V54, P381; Mayr E., 1942, P1; MENZEL BW, 1973, COPEIA, P225; Miller R.R., 1975, Occasional Papers of the Museum of Zoology University of Michigan, VNo. 672, P1; Miller R. R, 2005, FRESHWATER FISHES ME; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; MISHLER BD, 1982, SYST ZOOL, V31, P491, DOI 10.2307/2413371; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Morando M, 2003, SYST BIOL, V52, P159, DOI 10.1080/10635150390192717; Myers EA, 2013, MOL ECOL, V22, P5418, DOI 10.1111/mec.12478; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Palacios M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071069; Pascual R, 1981, 8 C GEOL ARG ACT 3, P746; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Poeser FN, 1998, ITAL J ZOOL, V65, P145, DOI 10.1080/11250009809386806; Poeser FN, 2003, AMAZON RIVER AMAZON, V1801; Poeser FN, 2011, COPEIA, P418, DOI 10.1643/CI-09-111; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Ptacek MB, 1998, J FISH BIOL, V53, P64, DOI 10.1006/jfbi.1998.0807; Quattro JM, 1999, COPEIA, P191, DOI 10.2307/1447401; Rambaut A, 2013, TRACER V 1 5; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; RIVAS L R, 1978, Northeast Gulf Science, V2, P98; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; Ruane S, 2014, SYST BIOL, V63, P231, DOI 10.1093/sysbio/syt099; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; SCHULTZ RJ, 1971, COPEIA, P282; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Smith BT, 2013, MOL ECOL, V22, P483, DOI 10.1111/mec.12118; Smith SA, 2005, J BIOGEOGR, V32, P1835, DOI 10.1111/j.1365-2699.2005.01317.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tobler M, 2011, EVOLUTION, V65, P2213, DOI 10.1111/j.1558-5646.2011.01298.x; Unmack PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038433; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wakeley J., 2008, COALESCENT THEORY IN; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waters JM, 1999, MOL PHYLOGENET EVOL, V11, P1, DOI 10.1006/mpev.1998.0554; Welton LJ, 2013, MOL ECOL, V22, P3495, DOI 10.1111/mec.12324; Willis SC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-96; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zwickl D. J, 2006, GENETIC ALGORITHM AP	109	44	44	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121139	10.1371/journal.pone.0121139	http://dx.doi.org/10.1371/journal.pone.0121139			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849959	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800045
J	Biedron, R; Konopinski, MK; Marcinkiewicz, J; Jozefowski, S				Biedron, Rafal; Konopinski, Maciej K.; Marcinkiewicz, Janusz; Jozefowski, Szczepan			Oxidation by Neutrophils-Derived HOCl Increases Immunogenicity of Proteins by Converting Them into Ligands of Several Endocytic Receptors Involved in Antigen Uptake by Dendritic Cells and Macrophages	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; A SCAVENGER RECEPTORS; CYSTEINE-RICH DOMAIN; MANNOSE RECEPTOR; HYPOCHLOROUS ACID; IMMUNE-RESPONSE; SR-BI; MYELOPEROXIDASE; RECOGNITION; CD36	The initiation of adaptive immune responses to protein antigens has to be preceded by their uptake by antigen presenting cells and intracellular proteolytic processing. Paradoxically, endocytic receptors involved in antigen uptake do not bind the majority of proteins, which may be the main reason why purified proteins stimulate at most weak immune responses. A shared feature of different types of adjuvants, capable of boosting immunogenicity of protein vaccines, is their ability to induce acute inflammation, characterized by early influx of activated neutrophils. Neutrophils are also rapidly recruited to sites of tissue injury or infection. These cells are the source of potent oxidants, including hypochlorous acid (HOCl), causing oxidation of proteins present in inflammatory foci. We demonstrate that oxidation of proteins by endogenous, neutrophils-derived HOCl increases their immunogenicity. Upon oxidation, different, randomly chosen simple proteins (yeast alcohol dehydrogenase, human and bovine serum albumin) and glycoproteins (human apo-transferrin, ovalbumin) gain the ability to bind with high affinity to several endocytic receptors on antigen presenting cells, which seems to be the major mechanism of their increased immunogenicity. The mannose receptor (CD206), scavenger receptors A (CD204) and CD36 were responsible for the uptake and presentation of HOCl-modified proteins by murine dendritic cells and macrophages. Other scavenger receptors, SREC-I and LOX-1, as well as RAGE were also able to bind HOCl-modified proteins, but they did not contribute significantly to these ligands uptake by dendritic cells because they were either not expressed or exhibited preference for more heavily oxidised proteins. Our results indicate that oxidation by neutrophils-derived HOCl may be a physiological mechanism of conferring immunogenicity on proteins which in their native forms do not bind to endocytic receptors. This mechanism might enable the immune system to detect infections caused by pathogens not recognized by pattern recognition receptors.	[Biedron, Rafal; Marcinkiewicz, Janusz; Jozefowski, Szczepan] Jagiellonian Univ, Coll Med, Dept Immunol, Krakow, Poland; [Konopinski, Maciej K.] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences	Jozefowski, S (corresponding author), Jagiellonian Univ, Coll Med, Dept Immunol, Krakow, Poland.	szczepan.jozefowski@uj.edu.pl	Biedron, Rafal/AAN-9034-2020; Konopiński, Maciej/G-9982-2011	Konopiński, Maciej/0000-0003-0893-0846	National Science Centre, Poland [NN 401 042139]	National Science Centre, Poland(National Science Centre, Poland)	The study was financed by a grant from the National Science Centre, Poland (grant no. NN 401 042139). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/547179; Becker M, 2006, EUR J IMMUNOL, V36, P950, DOI 10.1002/eji.200535660; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Chiang CLL, 2006, CANCER IMMUNOL IMMUN, V55, P1384, DOI 10.1007/s00262-006-0127-9; Chiang CLL, 2013, CLIN CANCER RES, V19, P4801, DOI 10.1158/1078-0432.CCR-13-1185; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Cotena A, 2004, J IMMUNOL, V173, P6427, DOI 10.4049/jimmunol.173.10.6427; Dagenais TR, 2009, J IMMUNOL, V183, P3344, DOI 10.4049/jimmunol.0802005; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; DIMENT S, 1987, J LEUKOCYTE BIOL, V42, P485, DOI 10.1002/jlb.42.5.485; Emara M, 2011, J BIOL CHEM, V286, P13033, DOI 10.1074/jbc.M111.220657; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gerber CE, 1996, EUR J CLIN CHEM CLIN, V34, P901; Geurts N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027131; HABERLAND ME, 1984, J BIOL CHEM, V259, P1305; Harvey BP, 2014, MOL IMMUNOL, V58, P56, DOI 10.1016/j.molimm.2013.10.013; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; Hjelm F, 2006, SCAND J IMMUNOL, V64, P177, DOI 10.1111/j.1365-3083.2006.01818.x; Huang HB, 2013, CLIN VACCINE IMMUNOL, V20, P1585, DOI 10.1128/CVI.00463-13; Ilchmann A, 2010, J ALLERGY CLIN IMMUN, V125, P175, DOI 10.1016/j.jaci.2009.08.013; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Jacobson LS, 2013, J BIOL CHEM, V288, P7481, DOI 10.1074/jbc.M112.400655; JANSEN RW, 1991, J BIOL CHEM, V266, P3343; JOUVINMARCHE E, 1989, IMMUNOGENETICS, V29, P92, DOI 10.1007/BF00395856; Jozefowski S, 2005, IMMUNOLOGY, V116, P418, DOI 10.1111/j.1365-2567.2005.02241.x; Jozefowski S, 2005, J IMMUNOL, V175, P8032, DOI 10.4049/jimmunol.175.12.8032; Jozefowski S, 2004, J LEUKOCYTE BIOL, V76, P1066, DOI 10.1189/jlb.0504270; Jozefowski S, 2014, INNATE IMMUN-LONDON, V20, P826, DOI 10.1177/1753425913510960; Jozefowski S, 2012, POSTEP HIG MED DOSW, V66, P104, DOI 10.5604/17322693.984079; Jozefowski S, 2011, MICROB PATHOGENESIS, V50, P350, DOI 10.1016/j.micpath.2011.03.001; Jozefowski S, 2010, INFLAMM RES, V59, P277, DOI 10.1007/s00011-009-0096-5; Jutras I, 2008, MOL CELL PROTEOMICS, V7, P697, DOI 10.1074/mcp.M700267-MCP200; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Leung S, 2013, CELL IMMUNOL, V282, P79, DOI 10.1016/j.cellimm.2012.12.006; Lysko PG, 1999, J PHARMACOL EXP THER, V289, P1277; Mac-Daniel L, 2014, J IMMUNOL, V193, P1246, DOI 10.4049/jimmunol.1302669; MARCINKIEWICZ J, 1991, INT J BIOCHEM, V23, P1393, DOI 10.1016/0020-711X(91)90280-Z; Marsche G, 2001, FASEB J, V15, P1095, DOI 10.1096/fj.00-0532fje; Marsche G, 2003, J BIOL CHEM, V278, P47562, DOI 10.1074/jbc.M308428200; Marsche G, 2007, FASEB J, V21, P3075, DOI 10.1096/fj.07-8316com; Marsche G, 2007, FASEB J, V21, P1145, DOI 10.1096/fj.06-7439com; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Murshid A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00063; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Odobasic D, 2013, BLOOD, V121, P4195, DOI 10.1182/blood-2012-09-456483; Paveley RA, 2011, INT J PARASITOL, V41, P1335, DOI 10.1016/j.ijpara.2011.08.005; Peiser L, 2006, INFECT IMMUN, V74, P5191, DOI 10.1128/IAI.00124-06; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Poole JA, 2015, J IMMUNOTOXICOL, V12, P64, DOI 10.3109/1547691X.2014.882449; Prokopowicz Z, 2012, ARCH IMMUNOL THER EX, V60, P43, DOI 10.1007/s00005-011-0156-8; Prokopowicz ZM, 2010, J IMMUNOL, V184, P824, DOI 10.4049/jimmunol.0902606; Rzepecka J, 2009, MOL IMMUNOL, V46, P1109, DOI 10.1016/j.molimm.2008.10.032; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SNIDER DP, 1990, J EXP MED, V171, P1957, DOI 10.1084/jem.171.6.1957; Tagliani E, 2008, J IMMUNOL, V180, P3201, DOI 10.4049/jimmunol.180.5.3201; Tamura Y, 2004, J BIOL CHEM, V279, P30938, DOI 10.1074/jbc.M313088200; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; Terrazas CA, 2013, FASEB J, V27, P4547, DOI 10.1096/fj.13-228932; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Valencia JV, 2004, ANAL BIOCHEM, V324, P68, DOI 10.1016/j.ab.2003.09.013; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; Walsh KP, 2013, TRENDS IMMUNOL, V34, P521, DOI 10.1016/j.it.2013.07.006; Westman E, 2004, SCAND J IMMUNOL, V59, P458, DOI 10.1111/j.0300-9475.2004.01428.x; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Yi HF, 2012, J MOL MED, V90, P413, DOI 10.1007/s00109-011-0828-1; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345; Zhao Y, 2014, MUCOSAL IMMUNOL, V7, P440, DOI 10.1038/mi.2013.63	81	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123293	10.1371/journal.pone.0123293	http://dx.doi.org/10.1371/journal.pone.0123293			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849867	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800222
J	Weise, D; Adamidis, M; Pizzolato, F; Rumpf, JJ; Fricke, C; Classen, J				Weise, David; Adamidis, Melanie; Pizzolato, Fabio; Rumpf, Jost-Julian; Fricke, Christopher; Classen, Joseph			Assessment of Brainstem Function with Auricular Branch of Vagus Nerve Stimulation in Parkinson's Disease	PLOS ONE			English	Article							CARDIAC SYMPATHETIC DENERVATION; HEART-RATE-VARIABILITY; FAR-FIELD POTENTIALS; EVOKED-POTENTIALS; PATHOLOGY; PROJECTIONS; IMPAIRMENT; DIAGNOSIS; GANGLIA	Background The efferent dorsal motor nucleus of the vagal nuclei complex may degenerate early in the course of Parkinson's disease (PD), while efferent nucleus ambiguous, the principal source of parasympathetic vagal neurons innervating the heart, and afferent somatosensory nuclei remain intact. Objective To obtain neurophysiological evidence related to this pattern, we tested processing of afferent sensory information transmitted via the auricular branch of the vagus nerve (ABVN) which is known to be connected to autonomic regulation of cardiac rhythm. Methods In this cross-sectional observational study, we recorded (i) somatosensory evoked potentials (ABVN-SEP) and (ii) cutaneo-cardioautonomic response elicited by stimulation of the ABVN (modulation of heart-rate variability (HRV index; low frequency power, ln(LF), high frequency power, ln(HF); ln(LF/HF) ratio)) in 50 PD patients and 50 age and sex matched healthy controls. Additionally, auditory evoked potentials and trigeminal nerve SEP were assessed. Results Neither ABVN-SEP nor any of the other functional brainstem parameters differed between patients and controls. Although HRV index was decreased in PD patients, modulation of ln (LF/HF) by ABVN-stimulation, likely indicating cardiac parasympathetic activation, did not differ between both groups. Conclusions Findings do not point to prominent dysfunction of processing afferent information from ABVN and its connected parasympathetic cardiac pathway in PD. They are consistent with the known pattern of degeneration of the vagal nuclei complex of the brainstem.	[Weise, David; Adamidis, Melanie; Pizzolato, Fabio; Rumpf, Jost-Julian; Fricke, Christopher; Classen, Joseph] Univ Leipzig, Dept Neurol, D-04109 Leipzig, Germany; [Pizzolato, Fabio] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy	Leipzig University; University of Verona	Weise, D (corresponding author), Univ Leipzig, Dept Neurol, D-04109 Leipzig, Germany.	david.weise@medizin.uni-leipzig.de		Classen, Joseph/0000-0001-7182-6967	Medical Faculty, University of Leipzig	Medical Faculty, University of Leipzig	The study was supported by a junior research grant by the Medical Faculty, University of Leipzig (DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOUSTINE S, 1976, ANN OTO RHINOL LARYN, V85, P406, DOI 10.1177/000348947608500315; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2011, J NEURAL TRANSM, V118, P809, DOI 10.1007/s00702-010-0508-2; Camm AJ, 1996, CIRCULATION, V93, P1043; Cersosimo MG, 2012, J NEUROL SCI, V313, P57, DOI 10.1016/j.jns.2011.09.030; Cheng ZJ, 2004, AM J PHYSIOL-REG I, V286, pR625, DOI 10.1152/ajpregu.00143.2003; Cheng ZX, 1999, J COMP NEUROL, V410, P320; Clancy JA, 2014, BRAIN STIMUL, V7, P871, DOI 10.1016/j.brs.2014.07.031; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; Dietrich S, 2008, BIOMED TECH, V53, P104, DOI 10.1515/BMT.2008.022; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Fallgatter AJ, 2005, INT J PSYCHOPHYSIOL, V56, P37, DOI 10.1016/j.ijpsycho.2004.09.007; Fallgatter AJ, 2003, J NEURAL TRANSM, V110, P1437, DOI 10.1007/s00702-003-0087-6; GAWEL MJ, 1981, J NEUROL NEUROSUR PS, V44, P227, DOI 10.1136/jnnp.44.3.227; Goldstein DS, 2003, LANCET NEUROL, V2, P669, DOI 10.1016/S1474-4422(03)00555-6; GUPTA D, 1986, SURG RADIOL ANAT, V8, P217, DOI 10.1007/BF02425070; Haapaniemi TH, 2001, J NEUROL NEUROSUR PS, V70, P305, DOI 10.1136/jnnp.70.3.305; Haensch CA, 2009, PARKINSONISM RELAT D, V15, P134, DOI 10.1016/j.parkreldis.2008.04.031; Heimer L., 1995, HUMAN BRAIN SPINAL C; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jain S, 2011, PARKINSONISM RELAT D, V17, P119, DOI 10.1016/j.parkreldis.2010.11.005; Jellinger KA, 2008, ACTA NEUROPATHOL, V116, P1, DOI 10.1007/s00401-008-0406-y; Kalaitzakis ME, 2008, ACTA NEUROPATHOL, V116, P125, DOI 10.1007/s00401-008-0381-3; KALIA M, 1982, J COMP NEUROL, V211, P248, DOI 10.1002/cne.902110304; Kraus T, 2013, BRAIN STIMUL, V6, P798, DOI 10.1016/j.brs.2013.01.011; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; LEANDRI M, 1985, ELECTROEN CLIN NEURO, V62, P99, DOI 10.1016/0168-5597(85)90021-8; Leutzow B, 2013, BRAIN STIMUL, V6, P812, DOI 10.1016/j.brs.2013.03.005; Metzgera FG, 2012, DEMENT GERIATR COGN, V33, P289, DOI 10.1159/000339359; NOMURA S, 1984, BRAIN RES, V292, P199, DOI 10.1016/0006-8993(84)90756-X; Parvizi J, 2001, ANN NEUROL, V49, P53, DOI 10.1002/1531-8249(200101)49:1<53::AID-ANA30>3.0.CO;2-Q; Poewe W, 2008, EUR J NEUROL, V15, P14, DOI 10.1111/j.1468-1331.2008.02056.x; Polak T, 2007, J NEURAL TRANSM, V114, P613, DOI 10.1007/s00702-007-0625-8; Polak T, 2011, J NEUROL, V258, P2276, DOI 10.1007/s00415-011-6084-z; Polak T, 2009, J NEURAL TRANSM, V116, P473, DOI 10.1007/s00702-009-0202-4; Seidel K, 2014, BRAIN PATHOLOGY ZURI; Shibata M, 2009, J NEUROL SCI, V276, P79, DOI 10.1016/j.jns.2008.09.005; Takatsu H, 2000, J NUCL MED, V41, P71; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Vitale C, 2012, MOVEMENT DISORD, V27, P1530, DOI 10.1002/mds.25149; Yu LL, 2013, HEART RHYTHM, V10, P428, DOI 10.1016/j.hrthm.2012.11.019; Zamotrinsky AV, 2001, AUTON NEUROSCI-BASIC, V88, P109, DOI 10.1016/S1566-0702(01)00227-2; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968; Zhao M, 2012, CLIN EXP PHARMACOL P, V39, P701, DOI 10.1111/j.1440-1681.2011.05644.x	46	24	25	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120786	10.1371/journal.pone.0120786	http://dx.doi.org/10.1371/journal.pone.0120786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849807	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800032
J	Zhang, DJ; Zheng, XY; Xi, ZY; Bourtzis, K; Gilles, JRL				Zhang, Dongjing; Zheng, Xiaoying; Xi, Zhiyong; Bourtzis, Kostas; Gilles, Jeremie R. L.			Combining the Sterile Insect Technique with the Incompatible Insect Technique: I-Impact of Wolbachia Infection on the Fitness of Triple- and Double-Infected Strains of Aedes albopictus	PLOS ONE			English	Article							INDUCED CYTOPLASMIC INCOMPATIBILITY; DIPTERA-CULICIDAE; DROSOPHILA; POPULATIONS; MOSQUITOS; VECTOR; ERADICATION; SYMBIOSIS; DENSITY	The mosquito species Aedes albopictus is a major vector of the human diseases dengue and chikungunya. Due to the lack of efficient and sustainable methods to control this mosquito species, there is an increasing interest in developing and applying the sterile insect technique (SIT) and the incompatible insect technique (IIT), separately or in combination, as population suppression approaches. Ae. albopictus is naturally double-infected with two Wolbachia strains, wAlbA and wAlbB. A new triple Wolbachia-infected strain (i.e., a strain infected with wAlbA, wAlbB, and wPip), known as HC and expressing strong cytoplasmic incompatibility (CI) in appropriate matings, was recently developed. In the present study, we compared several fitness traits of three Ae. albopictus strains (triple-infected, double-infected and uninfected), all of which were of the same genetic background ("Guangzhou City, China") and were reared under the same conditions. Investigation of egg-hatching rate, survival of pupae and adults, sex ratio, duration of larval stages (development time from L-1 to pupation), time to emergence (development time from L1 to adult emergence), wing length, female fecundity and adult longevity indicated that the presence of Wolbachia had only a minimal effect on host fitness. Based on this evidence, the HC strain is currently under consideration for mass rearing and application in a combined SIT-IIT strategy to control natural populations of Ae. albopictus in mainland China.	[Zhang, Dongjing; Bourtzis, Kostas; Gilles, Jeremie R. L.] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Zhang, Dongjing; Zheng, Xiaoying; Xi, Zhiyong] Zhongshan Sch Med, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Guangzhou, Guangdong, Peoples R China; [Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Sun Yat Sen University; Michigan State University	Gilles, JRL (corresponding author), Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	J.Gilles@iaea.org	Xi, Zhiyong/AAD-7936-2022	Xi, Zhiyong/0000-0001-7786-012X; Zheng, Xiaoying/0000-0001-6264-8433	Key Project of Chinese Ministry of Education [311030]; Guangdong Innovative Research Team Program [2011S009]; Scientific and Technological Leading Talents of Guangzhou Development District [2013L-P116]; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation	Key Project of Chinese Ministry of Education(Ministry of Education, China); Guangdong Innovative Research Team Program; Scientific and Technological Leading Talents of Guangzhou Development District; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation	Research in Prof. Zhiyong Xi's laboratory was supported by the Key Project of Chinese Ministry of Education (No. 311030), Guangdong Innovative Research Team Program (No. 2011S009), Scientific and Technological Leading Talents of Guangzhou Development District (No. 2013L-P116) and a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation.	Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; ARUNACHALAM N, 1985, J MED ENTOMOL, V22, P648, DOI 10.1093/jmedent/22.6.648; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bourtzis K., 2007, P125, DOI 10.1007/978-1-4020-6059-5_11; Bourtzis K, 1996, GENETICS, V144, P1063; Bourtzis K, 2003, CONT T ENT, P217; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38; Calvitti M, 2009, MED VET ENTOMOL, V23, P132, DOI 10.1111/j.1365-2915.2008.00791.x; Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254; Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140; Chen L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002030; Dobson SL, 2004, EVOLUTION, V58, P2156, DOI 10.1111/j.0014-3820.2004.tb01594.x; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844; Dobson SL, 2001, J MED ENTOMOL, V38, P382, DOI 10.1603/0022-2585-38.3.382; EDWARDS C. A., 1970, Critical Revs environml Control, V1, P7; Fu YQ, 2010, APPL ENVIRON MICROB, V76, P5887, DOI 10.1128/AEM.00218-10; Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209; Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HOFFMANN AA, 1990, GENETICS, V126, P933; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Ioannidis Panagiotis, 2007, Entomological Research, V37, P125, DOI 10.1111/j.1748-5967.2007.00102.x; Islam MS, 2006, J MED ENTOMOL, V43, P689, DOI 10.1603/0022-2585(2006)43[689:WEOAAD]2.0.CO;2; Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79; KNIPLING EF, 1960, SCI AM, V203, P54, DOI 10.1038/scientificamerican1060-54; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; RITTER L, 1995, PERSISTANT ORGANIC P; Ritter L, 1995, INT PROGRAMME CHEM S, V65, P66; Sarakatsanou A, 2011, J APPL ENTOMOL, V135, P554, DOI 10.1111/j.1439-0418.2011.01610.x; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	51	95	101	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121126	10.1371/journal.pone.0121126	http://dx.doi.org/10.1371/journal.pone.0121126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849812	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800044
J	Blais, SP; Kornblatt, JA; Barbeau, X; Bonnaure, G; Lague, P; Chenevert, R; Lapointe, J				Blais, Sebastien P.; Kornblatt, Jack A.; Barbeau, Xavier; Bonnaure, Guillaume; Laguee, Patrick; Chenevert, Robert; Lapointe, Jacques			tRNA(Glu) Increases the Affinity of Glutamyl-tRNA Synthetase for Its Inhibitor Glutamyl-Sulfamoyl-Adenosine, an Analogue of the Aminoacylation Reaction Intermediate Glutamyl-AMP: Mechanistic and Evolutionary Implications	PLOS ONE			English	Article							RIBONUCLEIC-ACID SYNTHETASE; ESCHERICHIA-COLI; TITRATION CALORIMETRY; CATALYTIC MECHANISM; COMPLEX; BINDING; RECOGNITION; ACTIVATION; THERMODYNAMICS; PHENYLALANINE	For tRNA-dependent protein biosynthesis, amino acids are first activated by aminoacyl-tRNA synthetases (aaRSs) yielding the reaction intermediates aminoacyl-AMP (aa-AMP). Stable analogues of aa-AMP, such as aminoacyl-sulfamoyl-adenosines, inhibit their cognate aaRSs. Glutamyl-sulfamoyl-adenosine (Glu-AMS) is the best known inhibitor of Escherichia coli glutamyl-tRNA synthetase (GluRS). Thermodynamic parameters of the interactions between Glu-AMS and E. coli GluRS were measured in the presence and in the absence of tRNA by isothermal titration microcalorimetry. A significant entropic contribution for the interactions between Glu-AMS and GluRS in the absence of tRNA or in the presence of the cognate tRNA(Glu) or of the non-cognate tRNA(Phe) is indicated by the negative values of -T Delta S-b, and by the negative value of Delta C-p. On the other hand, the large negative enthalpy is the dominant contribution to Delta G(b) in the absence of tRNA. The affinity of GluRS for Glu-AMS is not altered in the presence of the non-cognate tRNA(Phe), but the dissociation constant K-d is decreased 50-fold in the presence of tRNA(Glu); this result is consistent with molecular dynamics results indicating the presence of an H-bond between Glu-AMS and the 3'-OH oxygen of the 3'-terminal ribose of tRNA(Glu) in the Glu-AMS_GluRS_tRNA(Glu) complex. Glu-AMS being a very close structural analogue of Glu-AMP, its weak binding to free GluRS suggests that the unstable Glu-AMP reaction intermediate binds weakly to GluRS; these results could explain why all the known GluRSs evolved to activate glutamate only in the presence of tRNA(Glu), the coupling of glutamate activation to its transfer to tRNA preventing unproductive cleavage of ATP.	[Blais, Sebastien P.; Barbeau, Xavier; Bonnaure, Guillaume; Laguee, Patrick; Lapointe, Jacques] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Blais, Sebastien P.; Barbeau, Xavier; Bonnaure, Guillaume; Laguee, Patrick; Lapointe, Jacques] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [Barbeau, Xavier; Chenevert, Robert] Univ Laval, Dept Chim, Quebec City, PQ G1K 7P4, Canada; [Blais, Sebastien P.; Barbeau, Xavier; Bonnaure, Guillaume; Laguee, Patrick; Chenevert, Robert; Lapointe, Jacques] Quebec Network Res Prot Funct Struct & Engn PROTE, Quebec City, PQ, Canada; [Kornblatt, Jack A.] Concordia Univ, Fac Arts & Sci, Ctr Struct & Funct Gen, Dept Biol, Montreal, PQ H3G 1M8, Canada	Laval University; Laval University; Laval University; Concordia University - Canada	Blais, SP (corresponding author), Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada.	sebastien.blais@bcm.ulaval.ca; jacques.lapointe@bcm.ulaval.ca		kornblatt, jack/0000-0002-9802-8321; Lague, Patrick/0000-0002-5236-4979	Natural Sciences and Engineering Research Council of Canada (NSERC) [CG051791, 9988]; Fonds de Recherche du Quebec - Nature et Technologies, (FRQNT) [PR-133605]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec - Nature et Technologies, (FRQNT)	This work was supported by grant #CG051791 to JL and grant #9988 to JAK from the Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca), and by the grant #PR-133605 to JL and RC from the Fonds de Recherche du Quebec - Nature et Technologies, (FRQNT) (http://www.frqnt.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende JE, 1971, METHOD ENZYMOL, V20, P210; BALTZINGER M, 1983, BIOCHEMISTRY-US, V22, P675, DOI 10.1021/bi00272a023; Baugh L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053851; Bernier S, 2005, J ENZYM INHIB MED CH, V20, P61, DOI 10.1080/14756360400002007; BLUME A, 1992, BIOCHEMISTRY-US, V31, P4636, DOI 10.1021/bi00134a014; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chenevert R, 2003, MOL B INT U, P416; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; Dubois DY, 2009, BIOCHEMISTRY-US, V48, P6012, DOI 10.1021/bi801690f; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Finn J, 2005, AMINOACYL TRNA SYNTH, P405; First E.A., 2005, AMINOACYL TRNA SYNTH, P328; Freist W, 1997, BIOL CHEM, V378, P1313; FULLER AT, 1971, NATURE, V234, P416, DOI 10.1038/234416a0; Gadakh B, 2012, EXPERT OPIN THER PAT, V22, P1453, DOI 10.1517/13543776.2012.732571; Giege R, 2012, CELLULAR MOL BIOL, DOI [10.1128/ecosalplus.ESP-0009-2013, DOI 10.1128/EC0SALPLUS.ESP-0009-2013]; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; HARAYOKOYAMA M, 1986, BIOCHEMISTRY-US, V25, P7031, DOI 10.1021/bi00370a041; Ibba M, 1999, P NATL ACAD SCI USA, V96, P418, DOI 10.1073/pnas.96.2.418; Karlsson M, 2008, J CHEM THEORY COMPUT, V4, P1021, DOI 10.1021/ct800033x; KERN D, 1980, J BIOL CHEM, V255, P1956; KERN D, 1980, EUR J BIOCHEM, V106, P137; KERN D, 1979, BIOCHEMISTRY-US, V18, P5809, DOI 10.1021/bi00593a010; LIN SX, 1983, BIOCHEMISTRY-US, V22, P681, DOI 10.1021/bi00272a024; Ling JQ, 2012, J BIOL CHEM, V287, P28518, DOI 10.1074/jbc.M112.372920; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Madore E, 1999, EUR J BIOCHEM, V266, P1128, DOI 10.1046/j.1432-1327.1999.00965.x; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; MEISTER A, 1963, METHOD ENZYMOL, V6, P751, DOI 10.1016/0076-6879(63)06242-X; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; NUREKI O, 1995, SCIENCE, V267, P1958, DOI 10.1126/science.7701318; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Brien R, 2005, BIOCALORIMETRY, V2, P3; RAVEL JM, 1965, J BIOL CHEM, V240, P432; Salcedo G, 2014, BBA-BIOENERGETICS, V1837, P44, DOI 10.1016/j.bbabio.2013.08.005; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Schulze JO, 2006, J MOL BIOL, V361, P888, DOI 10.1016/j.jmb.2006.06.054; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; Sekine SI, 2006, STRUCTURE, V14, P1791, DOI 10.1016/j.str.2006.10.005; Smith CK, 2007, BIOCHEMISTRY-US, V46, P1358, DOI 10.1021/bi061893w; Thomson J.A., 2004, BIOCALORIMETRY, P37; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vondenhoff GHM, 2011, EUR J MED CHEM, V46, P5227, DOI 10.1016/j.ejmech.2011.08.049; Yu HT, 2010, J PHYS CHEM B, V114, P11552, DOI 10.1021/jp104209w	47	3	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121043	10.1371/journal.pone.0121043	http://dx.doi.org/10.1371/journal.pone.0121043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860020	gold, Green Submitted, Green Published			2022-12-27	WOS:000352590300020
J	Darda, L; Hakami, F; Morgan, R; Murdoch, C; Lambert, DW; Hunter, KD				Darda, Lav; Hakami, Fahad; Morgan, Richard; Murdoch, Craig; Lambert, Daniel W.; Hunter, Keith D.			The Role of HOXB9 and miR-196a in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							ORAL DYSPLASIA; BREAST-CANCER; ABERRANT EXPRESSION; ESTROGEN-RECEPTOR; DOWN-REGULATION; LUNG-CANCER; GENES; MUTATIONS; MICRORNA-196A; PROGRESSION	Background Previous studies have demonstrated that a number of HOX genes, a family of transcription factors with key roles in early development, are up-regulated in head and neck squamous cell carcinoma (HNSCC) and other cancers. The loci of several Homeobox (HOX) genes also contain microRNAs (miRs), including miR-196a. Methods Global miR expression and expression of all 39 HOX genes in normal oral keratinocytes (NOKs), oral pre-malignant (OPM) and HNSCC cells was assessed by expression microarray and qPCR and in tissues by immunohistochemistry (IHC) and qPCR of laser microdissected (LCM) tissues. Expression of miR196a and HOXB9 was reduced using anti-miR-196a and siRNA, respectively. Expression microarray profiles of anti-miR196a and pre-miR196a transfected cells were compared to parental cells in order to identify novel targets of miR196a. Putative miR196a targets were validated by qPCR and were confirmed as binding to the 3'UTR of miR196a by a dual luciferase reporter assay combined with mutational analysis of the miR-196a binding site. Results miR-196a and HOXB9 are highly expressed in HNSCC compared to NOKs, a pattern also seen in HNSCC tissues by HOXB9 IHC and qPCR of miR-196a in LCM tissue. Knock-down of miR-196a expression decreased HNSCC cell migration, invasion and adhesion to fibronectin, but had no effect on proliferation. Furthermore, knock-down of HOXB9 expression decreased migration, invasion and proliferation but did not alter adhesion. We identified a novel primary mRNA transcript containing HOXB9 and miR196a-1 as predicted from in-silico analysis. Expression array analysis identified a number of miR196a targets, including MAMDC2 and HOXC8. We confirmed that MAMDC2 is a novel miR-196a target using a dual luciferase reporter assay with the effect abolished on mutation of the binding site. Conclusions These results show that miR-196a and HOXB9 are overexpressed, perhaps co-ordinately, as HNSCC develops and exert a pro-tumourigenic phenotype in HNSCC and OPM cells.	[Darda, Lav; Hakami, Fahad; Lambert, Daniel W.; Hunter, Keith D.] Univ Sheffield, Sch Clin Dent, Unit Oral & Maxillofacial Pathol, Sheffield, S Yorkshire, England; [Morgan, Richard] Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England; [Murdoch, Craig] Univ Sheffield, Sch Clin Dent, Unit Oral & Maxillofacial Med & Surg, Sheffield, S Yorkshire, England; [Hunter, Keith D.] Univ Pretoria, Dept Oral Pathol & Biol, ZA-0002 Pretoria, South Africa	University of Sheffield; University of Bradford; University of Sheffield; University of Pretoria	Hunter, KD (corresponding author), Univ Sheffield, Sch Clin Dent, Unit Oral & Maxillofacial Pathol, Sheffield, S Yorkshire, England.	k.hunter@sheffield.ac.uk	Hunter, Keith/M-9784-2019; Hunter, Keith D/B-5670-2009	Hunter, Keith/0000-0002-7873-0877; Morgan, Richard/0000-0002-8721-4479; Murdoch, Craig/0000-0001-9724-122X				Asli NS, 2010, DEV BIOL, V344, P857, DOI 10.1016/j.ydbio.2010.06.003; Barber BA, 2010, ANN ANAT, V192, P261, DOI 10.1016/j.aanat.2010.07.009; Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7; BURNS JE, 1994, ORAL ONCOL, V30B, P335, DOI 10.1016/0964-1955(94)90035-3; BURNS JE, 1993, BRIT J CANCER, V67, P1274, DOI 10.1038/bjc.1993.238; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Chen ZJ, 2012, ORAL ONCOL, V48, P686, DOI 10.1016/j.oraloncology.2012.02.020; Chiba N, 2012, P NATL ACAD SCI USA, V109, P2760, DOI 10.1073/pnas.1018867108; Cismasiu VB, 2004, J BIOL CHEM, V279, P26922, DOI 10.1074/jbc.M313115200; Colley HE, 2011, BRIT J CANCER, V105, P1582, DOI 10.1038/bjc.2011.403; Danen-van Oorschot AA, 2012, PEDIATR BLOOD CANCER, V58, P715, DOI 10.1002/pbc.23279; DETRE S, 1995, J CLIN PATHOL, V48, P876, DOI 10.1136/jcp.48.9.876; Diaz-Lopez A, 2011, CANCER MICROENVIRON, V4, P23, DOI 10.1007/s12307-010-0055-2; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Hassan NMM, 2006, ONCOL RES, V16, P217, DOI 10.3727/000000006783981080; Hayashida T, 2010, P NATL ACAD SCI USA, V107, P1100, DOI 10.1073/pnas.0912710107; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Hunter KD, 2006, CANCER RES, V66, P7405, DOI 10.1158/0008-5472.CAN-06-0186; Kanai M, 2010, ONCOL REP, V23, P843, DOI 10.3892/or_00000706; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Liu CJ, 2012, ANN SURG ONCOL; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Mao L, 2011, CANCER RES, V71, P4314, DOI 10.1158/0008-5472.CAN-11-0051; Markovic A, 2012, EXPERT REV ANTICANC, V12, P1149, DOI [10.1586/ERA.12.91, 10.1586/era.12.91]; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; McGlinn E, 2009, P NATL ACAD SCI USA, V106, P18610, DOI 10.1073/pnas.0910374106; McGregor F, 1997, CANCER RES, V57, P3886; McGregor F, 2002, CANCER RES, V62, P4757; Morgan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-89; Mueller DW, 2011, INT J CANCER, V129, P1064, DOI 10.1002/ijc.25768; Nagel S, 2007, BLOOD, V109, P3015, DOI 10.1182/blood-2006-08-044347; Neves JI, 2005, INT J SURG PATHOL, V13, P353, DOI 10.1177/106689690501300407; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Plowright L, 2009, BRIT J CANCER, V100, P470, DOI 10.1038/sj.bjc.6604857; PRIME SS, 1990, J PATHOL, V160, P259, DOI 10.1002/path.1711600313; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Raza-Egilmez SZ, 1998, CANCER RES, V58, P4269; Rodriguez BAT, 2008, CARCINOGENESIS, V29, P1459, DOI 10.1093/carcin/bgn115; Seki H, 2012, ANN SURG ONCOL, V19, P1831, DOI 10.1245/s10434-012-2295-5; Severino P, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-533; Sha L, 2014, CLIN EXP MED; Sha S, 2013, DIG LIVER DIS; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sun M, 2012, MOL CANCER THER, V11, P842, DOI 10.1158/1535-7163.MCT-11-1015; Taketani T, 2002, CANCER RES, V62, P4571; Tsai KW, 2012, GENE CHROMOSOME CANC, V51, P394, DOI 10.1002/gcc.21924; Tsai MM, 2014, CANCER LETT, V351, P222, DOI 10.1016/j.canlet.2014.06.004; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yu JS, 2008, MOL CANCER RES, V6, P1106, DOI 10.1158/1541-7786.MCR-07-2123; Zhang Huan, 2012, Cancer Biology Medicine, V9, P63, DOI 10.3969/j.issn.2095-3941.2012.01.012; Zhang P, 2009, CELL COMMUN ADHES, V16, P146, DOI 10.3109/15419061003653771	60	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122285	10.1371/journal.pone.0122285	http://dx.doi.org/10.1371/journal.pone.0122285			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860510	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000352590300038
J	Liu, H; Sultan, MARF; Liu, XL; Zhang, J; Yu, F; Zhao, HX				Liu, Hui; Sultan, Muhammad Abdul Rab Faisal; Liu, Xiang Li; Zhang, Jin; Yu, Fei; Zhao, Hui Xian			Physiological and Comparative Proteomic Analysis Reveals Different Drought Responses in Roots and Leaves of Drought-Tolerant Wild Wheat (Triticum boeoticum)	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEIN; WATER-STRESS; RUBISCO ACTIVASE; 2-DIMENSIONAL ELECTROPHORESIS; LIPID-PEROXIDATION; IDENTIFICATION; EXPRESSION; RESISTANCE; PROLINE; ACCUMULATION	To determine the proteomic-level responses of drought tolerant wild wheat (Triticum boeoticum), physiological and comparative proteomic analyses were conducted using the roots and the leaves of control and short term drought-stressed plants. Drought stress was imposed by transferring hydroponically grown seedlings at the 3-leaf stage into 1/2 Hoagland solution containing 20% PEG-6000 for 48 h. Root and leaf samples were separately collected at 0 (control), 24, and 48 h of drought treatment for analysis. Physiological analysis indicated that abscisic acid (ABA) level was greatly increased in the drought-treated plants, but the increase was greater and more rapid in the leaves than in the roots. The net photosynthetic rate of the wild wheat leaves was significantly decreased under short-term drought stress. The deleterious effects of drought on the studied traits mainly targeted photosynthesis. Comparative proteomic analysis identified 98 and 85 differently changed protein spots (DEPs) (corresponding to 87 and 80 unique proteins, respectively) in the leaves and the roots, respectively, with only 6 mutual unique proteins in the both organs. An impressive 86% of the DEPs were implicated in detoxification and defense, carbon metabolism, amino acid and nitrogen metabolism, proteins metabolism, chaperones, transcription and translation, photosynthesis, nucleotide metabolism, and signal transduction. Further analysis revealed some mutual and tissue-specific responses to short-term drought in the leaves and the roots. The differences of drought-response between the roots and the leaves mainly included that signal sensing and transduction-associated proteins were greatly up-regulated in the roots. Photosynthesis and carbon fixation ability were decreased in the leaves. Glycolysis was down-regulated but PPP pathway enhanced in the roots, resulting in occurrence of complex changes in energy metabolism and establishment of a new homeostasis. Protein metabolism was down-regulated in the roots, but enhanced in the leaves. These results will contribute to the existing knowledge on the complexity of root and leaf protein changes that occur in response to drought, and also provide a framework for further functional studies on the identified proteins.	[Liu, Hui; Sultan, Muhammad Abdul Rab Faisal; Liu, Xiang Li; Zhang, Jin; Yu, Fei; Zhao, Hui Xian] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Liu, Xiang Li; Zhang, Jin; Yu, Fei; Zhao, Hui Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Yu, F (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	flyfeiyu@gmail.com; hxzhao212@nwsuaf.edu.cn			Nature Science Foundation of China [30871578, 31471482]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by grants from the Nature Science Foundation of China (30871578 and 31471482).	Abedi T, 2010, CZECH J GENET PLANT, V46, P27, DOI 10.17221/67/2009-CJGPB; Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002; Al-Ghamdi AA, 2009, INT J AGRIC BIOL, V11, P7; Alam I, 2010, PLANT SOIL, V333, P491, DOI 10.1007/s11104-010-0365-7; Anand A, 2003, PLANT BIOTECHNOL J, V1, P241, DOI 10.1046/j.1467-7652.2003.00023.x; Ashoub A, 2013, PLANTA, V237, P771, DOI 10.1007/s00425-012-1798-4; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brechenmacher L, 2009, PLANT PHYSIOL, V149, P670, DOI 10.1104/pp.108.131649; Budak Hikmet, 2013, ScientificWorldJournal, V2013, P548246, DOI 10.1155/2013/548246; Budak H, 2013, PLANT MOL BIOL, V83, P89, DOI 10.1007/s11103-013-0024-5; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Caruso G, 2009, PLANT SCI, V177, P570, DOI 10.1016/j.plantsci.2009.08.007; Chen JG, 2006, J PLANT GROWTH REGUL, V25, P69, DOI 10.1007/s00344-005-0049-3; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Chhuneja P, 2012, THEOR APPL GENET, V124, P1051, DOI 10.1007/s00122-011-1768-4; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; Datta J. K., 2011, International Journal of Agricultural Technology, V7, P383; Demirevska K., 2008, General and Applied Plant Physiology, V34, P79; Demirevska K, 2009, ACTA PHYSIOL PLANT, V31, P1129, DOI 10.1007/s11738-009-0331-2; Dulai Sandor, 2006, Acta Biologica Szegediensis, V50, P11; EMMERICH WE, 1990, AGRON J, V82, P1103, DOI 10.2134/agronj1990.00021962008200060015x; Ergen NZ, 2009, FUNCT INTEGR GENOMIC, V9, P377, DOI 10.1007/s10142-009-0123-1; Farhad MS, 2011, AUST J CROP SCI, V5, P55; Finnie C, 1999, PLANT MOL BIOL, V40, P545, DOI 10.1023/A:1006211014713; Gao Y, 2009, J EXP BOT, V60, P1141, DOI 10.1093/jxb/ern356; Ghaffari M, 2013, FUNCT PLANT BIOL, V40, P609, DOI 10.1071/FP12251; Ghosh D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00006; Hames BD, 1997, INSTANT NOTES BIOCH, P304; HOAGLAND D. R., 1933, PROC AMER SOC HORT SCI, V30, P288; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; Hubbard MJ, 1996, FEBS LETT, V391, P323, DOI 10.1016/0014-5793(96)00767-3; Huseynova IM, 2007, BBA-BIOENERGETICS, V1767, P869, DOI 10.1016/j.bbabio.2007.01.014; Jimenez S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-25; JORDAN DB, 1983, J BIOL CHEM, V258, P3752; Jung YC, 2005, PLANT CELL REP, V24, P366, DOI 10.1007/s00299-005-0944-x; Khan R, 2014, MOL BIOTECHNOL, V56, P814, DOI 10.1007/s12033-014-9760-2; Khrouchtchova A, 2005, FEBS LETT, V579, P4808, DOI 10.1016/j.febslet.2005.07.061; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Kuwabara C, 2002, PHYSIOL PLANTARUM, V115, P101, DOI 10.1034/j.1399-3054.2002.1150112.x; Larcher W., 2003, PHYSL PLANT ECOLOGY, DOI 10.1007/978-3-662-05214-3; Lee K, 2010, J PLANT PHYSIOL, V167, P161, DOI 10.1016/j.jplph.2009.09.006; Liu WJ, 2006, BIOL PLANTARUM, V50, P597, DOI 10.1007/s10535-006-0094-1; Liu XJ, 2006, J PLANT PHYSIOL, V163, P546, DOI 10.1016/j.jplph.2005.04.031; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Malakshah SN, 2007, BIOSCI BIOTECH BIOCH, V71, P2144, DOI 10.1271/bbb.70027; Mirzaei M, 2012, J PROTEOME RES, V11, P348, DOI 10.1021/pr2008779; Mohammadi PP, 2012, J PROTEOMICS, V75, P1906, DOI 10.1016/j.jprot.2011.12.041; Mujeeb-Kazi A, 2007, PAK J BOT, V39, P1207; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Nan R, 2002, J PLANT PHYSIOL, V159, P307, DOI 10.1078/0176-1617-00703; Nehemia A, 1977, PLANT PHYSIOL, V59, P1169; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; O'Leary SJB, 2007, TREE PHYSIOL, V27, P1649, DOI 10.1093/treephys/27.12.1649; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ohmiya A, 1998, PLANT CELL PHYSIOL, V39, P492, DOI 10.1093/oxfordjournals.pcp.a029396; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Prinsi B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-113; Renault H, 2011, PLANT CELL PHYSIOL, V52, P894, DOI 10.1093/pcp/pcr041; Rokka A, 2001, PLANT J, V25, P463, DOI 10.1046/j.1365-313x.2001.00981.x; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5; Stylianou IM, 2008, GENETICS, V178, P1795, DOI 10.1534/genetics.107.081216; Sultan MARF, 2012, CZECH J GENET PLANT, V48, P178, DOI 10.17221/21/2012-CJGPB; Tatar Oezguer, 2008, Asian Journal of Plant Sciences, V7, P409; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Valkoun JJ, 2001, EUPHYTICA, V119, P17, DOI 10.1023/A:1017562909881; Vander Jagt D.L., 1989, GLUTATHIONE CHEM, P597; Wang D, 2010, PHYSIOL PLANTARUM, V139, P55, DOI 10.1111/j.1399-3054.2009.01344.x; Wang MC, 2008, PROTEOMICS, V8, P1470, DOI 10.1002/pmic.200700569; Yue QX, 2008, MOL CELL PROTEOMICS, V7, P949, DOI 10.1074/mcp.M700259-MCP200; Zhang N, 2002, P NATL ACAD SCI USA, V99, P3330, DOI 10.1073/pnas.042529999; Zhou SP, 2011, J AM SOC HORTIC SCI, V136, P288, DOI 10.21273/JASHS.136.4.288	78	103	105	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121852	10.1371/journal.pone.0121852	http://dx.doi.org/10.1371/journal.pone.0121852			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859656	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300032
J	Liu, ZY; Jin, YQ; Chen, LL; Wang, Y; Yang, XN; Cheng, J; Wu, W; Qi, ZL; Shen, ZL				Liu, Zhangyin; Jin, Yu-Qing; Chen, Lulu; Wang, Yang; Yang, Xiaonan; Cheng, Jia; Wu, Wei; Qi, Zuoliang; Shen, Zunli			Specific Marker Expression and Cell State of Schwann Cells during Culture In Vitro	PLOS ONE			English	Article							PERIPHERAL-NERVE; TRANSCRIPTION FACTOR; NEURAL CREST; RAT S100-ALPHA; SOX2; MYELINATION; PROTEIN; DIFFERENTIATION; REGENERATION; DEDIFFERENTIATION	Schwann cells (SCs) in animals exist in different developmental stages or wound repair phases, distinguished mainly by the expression of SC-specific markers. No study has yet determined SC state under in vitro culture conditions, and the specific markers expressed in SC are obscure as well. In this study, we harvested sciatic nerves from newborn mice and isolated SCs by an enzyme-digestion method, then we examined the expression profiles of ten markers (S100, p75(NTR), Sox10, Sox2, GAP43, NCAM, Krox20, Oct6, MBP, and MPZ) at both the RNA and protein levels in in vitro mouse SCs and speculated their relation with in vivo SC stages. We assayed RNA and protein levels of SC specific markers by immunofluorescence, Western Blot, and real-time quantitative RT-PCR. The results show that the expression of most markers (S100, p75(NTR), GAP43, NCAM, Krox20, Oct6, MBP and MPZ) was not detectable in all of early stage cultured SCs. The expression of transcription factors Sox10 and Sox2 was, however, detectable in all SCs. After 8 days, the positive expression rate of all markers except GAP43 and Oct6 was almost 100%. These results indicates Sox10 is a necessary marker for SC identification, while S100 is not reliable. SCs cultured in vitro express Sox2, p75(NTR), NCAM, GAP43, Oct6, and MPZ, suggesting that they are similar to in vivo undifferentiated iSCs or dedifferentiated iSCs after nerve injury.	[Liu, Zhangyin; Jin, Yu-Qing; Chen, Lulu; Wang, Yang; Shen, Zunli] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China; [Liu, Zhangyin; Jin, Yu-Qing; Chen, Lulu; Wang, Yang; Shen, Zunli] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Ctr Trauma, Shanghai 200030, Peoples R China; [Yang, Xiaonan; Qi, Zuoliang] Chinese Acad Med Sci, Plast Surg Hosp, Beijing 100730, Peoples R China; [Yang, Xiaonan; Qi, Zuoliang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Cheng, Jia; Wu, Wei] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University	Jin, YQ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Sch Med, Dept Plast & Reconstruct Surg, Shanghai 200030, Peoples R China.	yuqing.jin@gmail.com; zunlishen@163.com			National Natural Science Foundation of China [81000522, 31170932]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant sponsor: National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/), grant numbers 81000522 and 31170932. The authors declare no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bhatheja K, 2006, INT J BIOCHEM CELL B, V38, P1995, DOI 10.1016/j.biocel.2006.05.007; Blanchard AD, 1996, J NEUROSCI RES, V46, P630, DOI 10.1002/(SICI)1097-4547(19961201)46:5<630::AID-JNR11>3.0.CO;2-0; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Casella CTB, 1996, GLIA, V17, P327, DOI 10.1002/(SICI)1098-1136(199608)17:4<327::AID-GLIA7>3.0.CO;2-W; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Chi GF, 2010, EXP NEUROL, V222, P304, DOI 10.1016/j.expneurol.2010.01.008; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; FIELDS KL, 1982, J NEUROIMMUNOL, V2, P155, DOI 10.1016/0165-5728(82)90006-6; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Friedrich RP, 2005, MOL CELL BIOL, V25, P1821, DOI 10.1128/MCB.25.5.1821-1829.2005; Frob F, 2012, GLIA, V60, P806, DOI 10.1002/glia.22310; Garcia-Suarez O, 2009, J ANAT, V214, P888, DOI 10.1111/j.1469-7580.2009.01078.x; Ghislain J, 2002, DEVELOPMENT, V129, P155; GOULD VE, 1986, LAB INVEST, V55, P463; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hardy RJ, 1996, J NEUROSCI, V16, P7941; Heinen A, 2013, J CLIN IMMUNOL, V33, pS18, DOI 10.1007/s10875-012-9786-9; Hoke A, 2003, J NEUROSCI, V23, P561; Jagalur NB, 2011, J NEUROSCI, V31, P8585, DOI 10.1523/JNEUROSCI.0659-11.2011; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Jin YQ, 2008, J NEUROSCI METH, V170, P140, DOI 10.1016/j.jneumeth.2008.01.003; Jung J, 2011, ANAT CELL BIOL, V44, P41, DOI 10.5115/acb.2011.44.1.41; Kirsch M, 2009, CELL TISSUE RES, V338, P19, DOI 10.1007/s00441-009-0837-3; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lee MJ, 1997, MOL CELL NEUROSCI, V8, P336, DOI 10.1006/mcne.1996.0589; Liu HQ, 2010, J NEUROPATH EXP NEUR, V69, P386, DOI 10.1097/NEN.0b013e3181d68d12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MONUKI ES, 1993, MECH DEVELOP, V42, P15, DOI 10.1016/0925-4773(93)90095-F; Nobbio L, 2009, J BIOL CHEM, V284, P23146, DOI 10.1074/jbc.M109.027128; Pannunzio ME, 2005, J NEUROSCI METH, V149, P74, DOI 10.1016/j.jneumeth.2005.05.004; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Ryu EJ, 2007, J NEUROSCI, V27, P11552, DOI 10.1523/JNEUROSCI.5497-06.2007; Saito H, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-88; SHEARMAN JD, 1987, CELL TISSUE RES, V249, P459; Shin YH, 2013, BIOCHEM BIOPH RES CO, V430, P852, DOI 10.1016/j.bbrc.2012.11.057; Sommer L, 1998, CELL TISSUE RES, V292, P11, DOI 10.1007/s004410051029; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Turner BJ, 2010, HUM MOL GENET, V19, P815, DOI 10.1093/hmg/ddp550; Verrier JD, 2009, GLIA, V57, P1265, DOI 10.1002/glia.20846; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; Wakatsuki S, 2009, J BIOL CHEM, V284, P2957, DOI 10.1074/jbc.M803191200; Wang Y, 2012, NEUROSCI LETT, V514, P96, DOI 10.1016/j.neulet.2012.02.066; Wei YJ, 2009, CELL TISSUE RES, V337, P361, DOI 10.1007/s00441-009-0836-4; Wu W, 2009, BIOTECHNOL LETT, V31, P1703, DOI 10.1007/s10529-009-0064-8; Xu YF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-21; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Yu WM, 2009, GLIA, V57, P850, DOI 10.1002/glia.20811; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; ZIMMER DB, 1987, AM J PHYSIOL, V252, pC285, DOI 10.1152/ajpcell.1987.252.3.C285; ZIMMER DB, 1991, BRAIN RES BULL, V27, P157, DOI 10.1016/0361-9230(91)90061-N; Zorick TS, 1996, CURR OPIN CELL BIOL, V8, P870, DOI 10.1016/S0955-0674(96)80090-1	59	55	62	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123278	10.1371/journal.pone.0123278	http://dx.doi.org/10.1371/journal.pone.0123278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859851	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300089
J	Muddukrishna, A; Jonsson, PA; Brorsson, M				Muddukrishna, Ananya; Jonsson, Peter A.; Brorsson, Mats			Characterizing Task-Based OpenMP Programs	PLOS ONE			English	Article							PERFORMANCE ANALYSIS	Programmers struggle to understand performance of task-based OpenMP programs since profiling tools only report thread-based performance. Performance tuning also requires task-based performance in order to balance per-task memory hierarchy utilization against exposed task parallelism. We provide a cost-effective method to extract detailed task-based performance information from OpenMP programs. We demonstrate the utility of our method by quickly diagnosing performance problems and characterizing exposed task parallelism and per-task instruction profiles of benchmarks in the widely-used Barcelona OpenMP Tasks Suite. Programmers can tune performance faster and understand performance tradeoffs more effectively than existing tools by using our method to characterize task-based performance.	[Muddukrishna, Ananya; Brorsson, Mats] KTH Royal Inst Technol, Stockholm, Sweden; [Jonsson, Peter A.; Brorsson, Mats] SICS Swedish ICT, Stockholm, Sweden	Royal Institute of Technology; RISE Research Institutes of Sweden	Muddukrishna, A (corresponding author), KTH Royal Inst Technol, Stockholm, Sweden.	ananya@kth.se	Brorsson, Mats/G-2362-2010	Brorsson, Mats/0000-0002-9637-2065	Artemis PaPP Project [295440]	Artemis PaPP Project	The work was funded by Artemis PaPP Project number 295440. The funder's website is: http://www.artemis-ia.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Ayguade E, 2009, IEEE T PARALL DISTR, V20, P404, DOI 10.1109/TPDS.2008.105; Bienia Christian, 2008, 2008 IEEE International Symposium on Workload Characterization (IISWC), P47, DOI 10.1109/IISWC.2008.4636090; Brunst H, 2008, LECT NOTES COMPUT SC, V4315, P5; Csardi G., 2006, INTERJOURNAL COMPLEX, VCX 18; Ding Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077742; Drebes A., 2014, 7 WORKSH PROGR ISS H; Duran Alejandro, 2009, Proceedings of the 2009 International Conference on Parallel Processing (ICPP 2009), P124, DOI 10.1109/ICPP.2009.64; Duran A., 2008, SC 2008 ACMIEEE SUPE, P1; Duran A, 2008, LECT NOTES COMPUT SC, V5004, P100, DOI 10.1007/978-3-540-79561-2_9; Eeckhout Lieven, 2003, J INSTRUCTION LEVEL, V5, P1; Eichenberger A, 2013, OMPT OMPD OPENMP TOO; Eichenberger Alexandre E., 2013, OpenMP in the Era of Low Power Devices and Accelerators. 9th International Workshop on OpenMP, IWOMP 2013. Proceedings: LNCS 8122, P171, DOI 10.1007/978-3-642-40698-0_13; Furlinger K, 2009, LECT NOTES COMPUT SC, V5568, P132, DOI 10.1007/978-3-642-02303-3_11; Geimer M, 2010, CONCURR COMP-PRACT E, V22, P702, DOI 10.1002/cpe.1556; He Y, 2010, SPAA '10: PROCEEDINGS OF THE TWENTY-SECOND ANNUAL SYMPOSIUM ON PARALLELISM IN ALGORITHMS AND ARCHITECTURES, P145; Hoste K, 2007, IEEE MICRO, V27, P63, DOI 10.1109/MM.2007.56; Intel Corporation, 2010, INT SOFTW AUT TOOL; Intel Corporation, 2013, 326734012 INT CORP; Intel Corporation, 2013, 323267008US INT CORP; Intel Corporation, 2013, PROF OPENMP APPL INT; Itzkowitz M, 2010, TOOLS FOR HIGH PERFORMANCE COMPUTING 2009, P67, DOI 10.1007/978-3-642-11261-4_6; Joshi A, 2006, IEEE T COMPUT, V55, P769, DOI 10.1109/TC.2006.85; Lin Y, 2009, LECT NOTES COMPUT SC, V5568, P104, DOI 10.1007/978-3-642-02303-3_9; Liu X., 2013, P 27 INT ACM C INT C, P69, DOI DOI 10.1145/2464996.2465433; Lorenz D., 2012, 2012 41st International Conference on Parallel Processing Workshops (ICPPW 2012), P444, DOI 10.1109/ICPPW.2012.62; Lorenz D, 2010, LECT NOTES COMPUT SC, V6132, P109, DOI 10.1007/978-3-642-13217-9_9; Luk CK, 2005, ACM SIGPLAN NOTICES, V40, P190, DOI 10.1145/1064978.1065034; Mucci P. J., 1999, PROC DEP DEFENSE HPC, V710, P1; Olivier S., 2011, ROSS 2011, P49, DOI DOI 10.1145/1988796.1988804; Olivier S., 2012, SCI PROGRAMMING-NETH, V21, P1; Olivier S, 2007, LECT NOTES COMPUT SC, V4382, P235, DOI 10.1007/978-3-540-72521-3_18; Olivier SL, 2012, INT J HIGH PERFORM C, V26, P110, DOI 10.1177/1094342011434065; Podobas A, 2012, QUANTITATIVE EVALUAT, V12, P03; Podobas Artur, 2010, P 3 WORKSH PROGR ISS; Qawasmeh Ahmad, 2013, OpenMP in the Era of Low Power Devices and Accelerators. 9th International Workshop on OpenMP, IWOMP 2013. Proceedings: LNCS 8122, P186, DOI 10.1007/978-3-642-40698-0_14; Qian C, 2013, 2013 IEEE 15TH INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS & 2013 IEEE INTERNATIONAL CONFERENCE ON EMBEDDED AND UBIQUITOUS COMPUTING (HPCC_EUC), P735, DOI 10.1109/HPCC.and.EUC.2013.108; Schmidl D., 2012, IWOMP 2012, V7312, P196, DOI [10.1007/978-3- 642- 30961-8 15, DOI 10.1007/978-3-642-30961-815]; Schmidl D, 2014, TOOLS HIGH PERFORMAN, P25; Sinnen O., 2007, TASK SCHEDULING PARA, V60; Williams S, 2009, COMMUN ACM, V52, P65, DOI 10.1145/1498765.1498785	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123545	10.1371/journal.pone.0123545	http://dx.doi.org/10.1371/journal.pone.0123545			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860023	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300104
J	Patila, T; Miyagawa, S; Imanishi, Y; Fukushima, S; Siltanen, A; Mervaala, E; Kankuri, E; Harjula, A; Sawa, Y				Patila, Tommi; Miyagawa, Shigeru; Imanishi, Yukiko; Fukushima, Satsuki; Siltanen, Antti; Mervaala, Eero; Kankuri, Esko; Harjula, Ari; Sawa, Yoshiki			Comparison of Arrhythmogenicity and Proinflammatory Activity Induced by Intramyocardial or Epicardial Myoblast Sheet Delivery in a Rat Model of Ischemic Heart Failure	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CELL THERAPY; TRANSPLANTATION; INTERLEUKIN-1-BETA; PHASE; INFLAMMATION; EXPRESSION; INJURY; REPAIR	Although cell therapy of the failing heart by intramyocardial injections of myoblasts to results in regenerative benefit, it has also been associated with undesired and prospectively fatal arrhythmias. We hypothesized that intramyocardial injections of myoblasts could enhance inflammatory reactivity and facilitate electrical cardiac abnormalities that can be reduced by epicardial myoblast sheet delivery. In a rat model of ischemic heart failure, myoblast therapy either by intramyocardial injections or epicardial cell sheets was given 2 weeks after occlusion of the coronary artery. Ventricular premature contractions (VPCs) were assessed, using an implanted three-lead electrocardiograph at 1, 7, and 14 days after therapy, and 16-point epicardial electropotential mapping (EEPM) was used to evaluate ventricular arrhythmogenicity under isoproterenol stress. Cardiac functioning was assessed by echocardiography. Both transplantation groups showed therapeutic benefit over sham therapy. However, VPCs were more frequent in the Injection group on day 1 and day 14 after therapy than in animals receiving epicardial or sham therapy (p < 0.05 and p < 0.01, respectively). EEPM under isoproterenol stress showed macroreentry at the infarct border area, leading to ventricular tachycardias in the Injection group, but not in the myoblast sheet- or sham-treated groups (p = 0.045). Both transplantation types modified the myocardial cytokine expression profile. In animals receiving epicardial myoblast therapy, selective reductions in the expressions of interferon gamma, interleukin (IL)-1 beta and IL12 were observed, accompanied by reduced infiltration of inflammatory CD11b- and CD68-positive leukocytes, compared with animals receiving myoblasts as intramyocardial injections. Intramyocardial myoblast delivery was associated with enhanced inflammatory and immunomodulatory reactivity and increased frequency of VPCs. In comparison to intramyocardial injection, the epicardial route may serve as the preferred method of skeletal myoblast transplantation to treat heart failure.	[Patila, Tommi; Miyagawa, Shigeru; Imanishi, Yukiko; Fukushima, Satsuki; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiothorac Surg, Osaka, Japan; [Harjula, Ari] Univ Helsinki, Dept Cardiothorac Surg, Helsinki, Finland; [Harjula, Ari] Helsinki Univ Hosp, Helsinki, Finland; [Siltanen, Antti; Mervaala, Eero; Kankuri, Esko] Univ Helsinki, Pharmacol, Helsinki, Finland; [Patila, Tommi] Univ Helsinki, Dept Pediat Cardiac Surg, Hosp Children & Adolescents, Helsinki, Finland	Osaka University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Patila, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiothorac Surg, Osaka, Japan.	tommi.patila@hus.fi	Fukushima, Satsuki/ABE-6582-2020	Fukushima, Satsuki/0000-0002-9481-8860; harjula, ari/0000-0001-6691-3636; Miyagawa, Shigeru/0000-0003-0015-6569; Imanishi, Yukiko/0000-0001-6241-0644; Kankuri, Esko/0000-0002-2193-8773	Japan Society for the Promotion of Science; Japan Science and Technology Agency (eSEED project); Finnish Academy [130919, 275882]; Finnish Funding Agency for Technology and Innovation TEKES [2703/31/2010]; Finnish Government Subsidiary Funds (HUCH-EVO); Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (eSEED project); Finnish Academy(Academy of Finland); Finnish Funding Agency for Technology and Innovation TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Government Subsidiary Funds (HUCH-EVO); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research	This study has been supported by Japan Society for the Promotion of Science (http://www.jsps.go.jp); the Japan Science and Technology Agency (eSEED project to YS); Finnish Academy (http://www.aka.fi, Decision no: 130919 to AH and no: 275882 to EM); Finnish Funding Agency for Technology and Innovation TEKES (eSEED project: 2703/31/2010 to EK); Finnish Government Subsidiary Funds (HUCH-EVO to AH), Sigrid Juselius Foundation (EM and EK), and the Finnish Foundation for Cardiovascular Research(AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2013, EXP PHYSIOL, V98, P385, DOI 10.1113/expphysiol.2012.069021; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Combes A, 2002, PFLUG ARCH EUR J PHY, V445, P246, DOI 10.1007/s00424-002-0921-y; Coppen SR, 2008, CIRCULATION, V118, pS138, DOI 10.1161/CIRCULATIONAHA.107.779629; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Fernandes S, 2006, CARDIOVASC RES, V69, P348, DOI 10.1016/j.cardiores.2005.10.003; Fukushima S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003071; Hagege AA, 2006, CIRCULATION, V114, pI108, DOI 10.1161/CIRCULATIONAHA.105.000521; Hata H, 2006, J THORAC CARDIOV SUR, V132, P918, DOI 10.1016/j.jtcvs.2006.01.024; Henkel DM, 2006, AM HEART J, V151, P806, DOI 10.1016/j.ahj.2005.05.015; Kitabayashi K, 2010, CELL TRANSPLANT, V19, P573, DOI 10.3727/096368909X486048; Kondoh H, 2006, CARDIOVASC RES, V69, P466, DOI 10.1016/j.cardiores.2005.11.005; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Long C S, 2001, Heart Fail Rev, V6, P81; McTiernan CF, 1997, CIRC RES, V81, P493, DOI 10.1161/01.RES.81.4.493; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Menasche P, 2011, J MOL CELL CARDIOL, V50, P258, DOI 10.1016/j.yjmcc.2010.06.010; Menasche P, 2008, J AM COLL CARDIOL, V52, P1881, DOI 10.1016/j.jacc.2008.07.066; Menasche P, 2009, CIRCULATION, V119, P2735, DOI 10.1161/CIRCULATIONAHA.108.812693; Miyagawa S, 2011, ANN THORAC SURG, V91, P320, DOI 10.1016/j.athoracsur.2010.09.080; Morimoto H, 2008, CARDIOVASC RES, V78, P554, DOI 10.1093/cvr/cvn035; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Narita T, 2013, INT J CARDIOL, V168, P261, DOI 10.1016/j.ijcard.2012.09.081; Okura Y, 1998, CIRC RES, V82, P1035, DOI 10.1161/01.RES.82.10.1035; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8; Siltanen A, 2011, TISSUE ENG PT A, V17, P115, DOI 10.1089/ten.TEA.2010.0205; Siminiak T, 2004, AM HEART J, V148, P531, DOI 10.1016/j.ahj.2004.03.043; Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017; Suzuki K, 2004, FASEB J, V18, P1153, DOI 10.1096/fj.03-1308fje; Suzuki K, 2004, CIRCULATION, V110, pII219, DOI 10.1161/01.CIR.0000138388.55416.06; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Wang S, 2012, CLIN EXP IMMUNOL, V169, P320, DOI 10.1111/j.1365-2249.2012.04612.x; Zitta K, 2010, BIOCHEM BIOPH RES CO, V399, P542, DOI 10.1016/j.bbrc.2010.07.106	38	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123963	10.1371/journal.pone.0123963	http://dx.doi.org/10.1371/journal.pone.0123963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860790	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300125
J	Valdez, L; Giorello, F; Feijoo, M; Opazo, JC; Lessa, EP; Naya, DE; D'Elia, G				Valdez, Lourdes; Giorello, Facundo; Feijoo, Matias; Opazo, Juan C.; Lessa, Enrique P.; Naya, Daniel E.; D'Elia, Guillermo			Characterization of the Kidney Transcriptome of the Long-Haired Mouse Abrothrix hirta (Rodentia, Sigmodontinae) and Comparison with That of the Olive Mouse A. olivacea	PLOS ONE			English	Article							EVOLUTIONARY; CRICETIDAE; RECONSTRUCTION; SYSTEMATICS; ADAPTATION; POSITION	To understand how small mammals cope with the challenge of water homeostasis is a matter of interest for ecologists and evolutionary biologists. Here we take a step towards the understanding of the transcriptomic functional response of kidney using as a model the long-haired mouse (Abrothrix hirta) a species that distributes across Patagonian steppes and Austral temperate rainforests in Argentina and Chile. Specifically, we i) characterize the renal transcriptome of A. hirta, and ii) compare it with that-already available-of the co-generic and co-distributed A. olivacea. Renal mRNA transcripts from 16 specimens of A. hirta from natural populations were analyzed. Over 500 million Illumina paired-end reads were assembled de novo under two approaches, an individual assembly for each specimen, and a single in-silico normalized joint assembly including all reads from all specimens. The total number of annotated genes was similar with both strategies: an average of 14,956 in individual assemblies and 14,410 in the joint assembly. Overall, 15,463 distinct genes express in the kidney of A. hirta. Transcriptomes of A. hirta and A. olivacea were similar in terms of gene abundance and composition: 95.6% of the genes of A. hirta were also found in A. olivacea making their functional profiles also similar. However, differences in the transcriptome of these two species were observed in the set of highly expressed genes, in terms of private genes for each species and the functional profiles of highly expressed genes. As part of the novel transcriptome characterization, we provide distinct gene lists with their functional annotation that would constitute the basis for further research on these or any other species of the subfamily Sigmodontinae, which includes about 400 living species distributed from Tierra del Fuego to southern United States.	[Valdez, Lourdes; Opazo, Juan C.; D'Elia, Guillermo] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambient & Evolut, Valdivia, Chile; [Giorello, Facundo; Feijoo, Matias; Lessa, Enrique P.; Naya, Daniel E.] Univ Republica, Fac Ciencias, Dept Ecol & Evoluc, Montevideo, Uruguay	Universidad Austral de Chile; Universidad de la Republica, Uruguay	D'Elia, G (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambient & Evolut, Valdivia, Chile.	guille.delia@gmail.com	D'Elía, Guillermo/AAE-8873-2020; D'Elía, Guillermo/G-2253-2011; Lessa, Enrique/D-8894-2011	D'Elía, Guillermo/0000-0001-7173-2709; D'Elía, Guillermo/0000-0001-7173-2709; Lessa, Enrique/0000-0001-9750-4093; Opazo, Juan C./0000-0001-7938-4083	Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt (Chile) [1110737, 1141055]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (Chile) [AUS1203]; Programa de Desarrollo de las Ciencias Basicas (Uruguay); Agencia Nacional de Investigacion e Innovacion (Uruguay); Comision Sectorial de Investigacion Cientifica, Universidad de la Republica (Uruguay); Proyecto de Investigacion Cientifica y Tecnologica, Fondo para la Investigacion Cientifica y Tecnologica [2008-547]	Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt (Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (Chile); Programa de Desarrollo de las Ciencias Basicas (Uruguay); Agencia Nacional de Investigacion e Innovacion (Uruguay); Comision Sectorial de Investigacion Cientifica, Universidad de la Republica (Uruguay); Proyecto de Investigacion Cientifica y Tecnologica, Fondo para la Investigacion Cientifica y Tecnologica	This work was funded by grants 1110737 and 1141055 from Fondo Nacional de Desarrollo Cientifico y Tecnologico Fondecyt (Chile); grant AUS1203 from Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (Chile); Programa de Desarrollo de las Ciencias Basicas (Uruguay); Agencia Nacional de Investigacion e Innovacion (Uruguay); and Comision Sectorial de Investigacion Cientifica, Universidad de la Republica (Uruguay). Specimen collection in Argentina was partially funded by grant 2008-547 from Proyecto de Investigacion Cientifica y Tecnologica, Fondo para la Investigacion Cientifica y Tecnologica. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-kahtani MA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P346, DOI 10.1086/420941; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bozinovic F, 2006, COMP BIOCHEM PHYS C, V142, P163, DOI 10.1016/j.cbpc.2005.08.004; Canon C, 2014, ZOOL SCR, V43, P443, DOI 10.1111/zsc.12069; CHERIAN MG, 1980, TOXICOLOGY, V17, P225, DOI 10.1016/0300-483X(80)90098-0; Crambert G, 2003, SCI STKE, pRE1, DOI [10.1016/j.semnephrol.2005.03.005, DOI 10.1016/J.SEMNEPHR0L.2005.03.005]; D'Elia G, 2008, J MAMMAL, V89, P778, DOI 10.1644/07-MAMM-A-246R1.1; DARLING A, 2004, 4 INT C LIN CLUST HP; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Feijoo M, 2010, MAMM BIOL, V75, P122, DOI 10.1016/j.mambio.2008.10.004; Francis WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-167; Giorello FM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-446; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Helyar SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042089; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kumar S., 2012, INT J COMP APP IRAFI, V5, P1; Lessa EP, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00039; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liang M, 2004, J PHYSIOL-LONDON, V554, P22, DOI 10.1113/jphysiol.2003.049395; Losos JB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001466; MacManes MD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00013; Mann Fischer G., 1978, GAYANA ZOOLOGIA, V40, P1; Marra NJ, 2014, MOL ECOL, V23, P2699, DOI 10.1111/mec.12764; Marra NJ, 2012, COMP BIOCHEM PHYS D, V7, P328, DOI 10.1016/j.cbd.2012.07.001; Mbandi SK, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00017; Mitchell-Olds T, 2008, HEREDITY, V100, P101, DOI 10.1038/sj.hdy.6801015; Nadeau NJ, 2013, MOL ECOL, V22, P814, DOI 10.1111/j.1365-294X.2012.05730.x; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Naya DE, 2014, J MAMMAL, V95, P1222, DOI 10.1644/13-MAMM-A-261; Orsini L, 2013, MOL ECOL, V22, P527, DOI 10.1111/mec.12177; Osgood Wilfred H., 1943, FIELD MUS NAT HIST ZOOL SER, V30, P1; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Silva SI, 2005, REV CHIL HIST NAT, V78, P589; Teta Pablo, 2014, Mastozool. neotrop., V21, P291; VANLEEUWEN BH, 1986, J BIOL CHEM, V261, P5529; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wei CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064396; Zhao D, 2006, AM J PHYSIOL-RENAL, V291, pF429, DOI 10.1152/ajprenal.00011.2006	44	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121148	10.1371/journal.pone.0121148	http://dx.doi.org/10.1371/journal.pone.0121148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860131	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300021
J	Dodson, JJ; Bourret, A; Barrette, MF; Turgeon, J; Daigle, G; Legault, M; Lecomte, F				Dodson, Julian J.; Bourret, Audrey; Barrette, Marie France; Turgeon, Julie; Daigle, Gaetan; Legault, Michel; Lecomte, Frederic			Intraspecific Genetic Admixture and the Morphological Diversification of an Estuarine Fish Population Complex	PLOS ONE			English	Article							SMELT OSMERUS-MORDAX; ANADROMOUS RAINBOW SMELT; MULTILOCUS GENOTYPE DATA; LAWRENCE-RIVER ESTUARY; TRANSGRESSIVE SEGREGATION; CHARACTER DISPLACEMENT; SYMPATRIC POPULATIONS; INVASIVE POPULATIONS; ADAPTIVE RADIATION; HYBRID SPECIATION	The North-east American Rainbow smelt (Osmerus mordax) is composed of two glacial races first identified through the spatial distribution of two distinct mtDNA lineages. Contemporary breeding populations of smelt in the St. Lawrence estuary comprise contrasting mixtures of both lineages, suggesting that the two races came into secondary contact in this estuary. The overall objective of this study was to assess the role of intraspecific genetic admixture in the morphological diversification of the estuarine rainbow smelt population complex. The morphology of mixed-ancestry populations varied as a function of the relative contribution of the two races to estuarine populations, supporting the hypothesis of genetic admixture. Populations comprising both ancestral mtDNA races did not exhibit intermediate morphologies relative to pure populations but rather exhibited many traits that exceeded the parental trait values, consistent with the hypothesis of transgressive segregation. Evidence for genetic admixture at the level of the nuclear gene pool, however, provided only partial support for this hypothesis. Variation at nuclear AFLP markers revealed clear evidence of the two corresponding mtDNA glacial races. The admixture of the two races at the nuclear level is only pronounced in mixed-ancestry populations dominated by one of the mtDNA lineages, the same populations showing the greatest degree of morphological diversification and population structure. In contrast, mixed-ancestry populations dominated by the alternate mtDNA lineage showed little evidence of introgression of the nuclear genome, little morphological diversification and little contemporary population genetic structure. These results only partially support the hypothesis of transgressive segregation and may be the result of the differential effects of natural selection acting on admixed genomes from different sources.	[Dodson, Julian J.; Turgeon, Julie] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Bourret, Audrey; Barrette, Marie France] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Daigle, Gaetan] Univ Laval, Dept Math & Stat, Quebec City, PQ G1K 7P4, Canada; [Legault, Michel; Lecomte, Frederic] Minist Forets Faune & Parcs, Faune & Habitats Sect Faune, Direct Gen Expertise, Quebec City, PQ, Canada	Laval University; University of Sherbrooke; Laval University	Dodson, JJ (corresponding author), Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada.	julian.dodson@bio.ulaval.ca	Lecomte, Frederic/AAN-7766-2021	Lecomte, Frederic/0000-0002-8845-1249	Natural Sciences and Engineering Research Council (NSERC, Canada); Ministere des Forets, de la Faune et des Parcs, Quebec; Quebec government	Natural Sciences and Engineering Research Council (NSERC, Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministere des Forets, de la Faune et des Parcs, Quebec; Quebec government	This study was supported by 1. (a) Discovery research grant; Natural Sciences and Engineering Research Council (NSERC, Canada) (b) research contract; Direction de la faune aquatique, Ministere du Developpement Durable, de l'Environnement, de la Faune et des Parcs du Quebec (now the Ministere des Forets, de la Faune et des Parcs, Quebec) 2. Quebec government funders, represented by ML and FL, participated instudy design, data collection and preparation of the manuscript.	Abbott RJ, 2010, TAXON, V59, P1375, DOI 10.1002/tax.595005; April J, 2013, MOL ECOL, V22, P409, DOI 10.1111/mec.12116; Avise J, 2004, MOL MARKERS NATURAL; BABY MC, 1991, J FISH BIOL, V39, P61, DOI 10.1111/j.1095-8649.1991.tb05068.x; Bachiller E, 2013, ICES J MAR SCI, V70, P232, DOI 10.1093/icesjms/fss171; Barrette MF, 2009, BIOL J LINN SOC, V97, P140, DOI 10.1111/j.1095-8312.2008.01195.x; Bell MA, 2005, TRENDS ECOL EVOL, V20, P358, DOI 10.1016/j.tree.2005.04.021; Benvenuto C, 2012, EVOL APPL, V5, P498, DOI 10.1111/j.1752-4571.2012.00279.x; Bernatchez L, 1996, CAN J FISH AQUAT SCI, V53, P424, DOI 10.1139/cjfas-53-2-424; Bernatchez L, 1997, MOL ECOL, V6, P73, DOI 10.1046/j.1365-294X.1997.00156.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bradbury IR, 2006, J FISH BIOL, V69, P95, DOI 10.1111/j.1095-8649.2006.01263.x; Bradbury IR, 2011, MAR ECOL PROG SER, V438, P207, DOI 10.3354/meps09286; Buerkle CA, 2005, MOL ECOL NOTES, V5, P684, DOI 10.1111/j.1471-8286.2005.01011.x; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; DOUGLAS ME, 1992, OIKOS, V65, P213, DOI 10.2307/3545012; Efron B, 1998, INTRO BOOTSTRAP; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FRECHET A, 1983, CAN J FISH AQUAT SCI, V40, P718, DOI 10.1139/f83-094; Frechet A., 1983, ZOOLOGY, V61, P621; Gardner-Lubbe S, 2008, J APPL STAT, V35, P947, DOI 10.1080/02664760802185399; Gompert Z, 2010, MOL ECOL RESOUR, V10, P378, DOI 10.1111/j.1755-0998.2009.02733.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Karpouzi VS, 2003, J FISH BIOL, V62, P1353, DOI 10.1046/j.1095-8649.2003.00118.x; Kolbe JJ, 2008, BIOL LETTERS, V4, P434, DOI 10.1098/rsbl.2008.0205; Kolbe JJ, 2007, MOL ECOL, V16, P1579, DOI 10.1111/j.1365-294X.2006.03135.x; Kovach AI, 2013, FISH RES, V141, P95, DOI 10.1016/j.fishres.2012.07.008; Labropoulou M, 1997, J FISH BIOL, V50, P324, DOI 10.1006/jfbi.1996.0297; Lachenbruch PA, 1967, BIOMETRICS, V23, P65; Lecomte F, 2005, J FISH BIOL, V66, P1601, DOI 10.1111/j.0022-1112.2005.00702.x; Lecomte F, 2004, EVOL ECOL RES, V6, P631; Lecomte F, 2005, THESIS U LAVAL; M-F Barrette, 2004, THESIS U LAVAL; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Morris MRJ, 2014, MOL ECOL, V23, P3226, DOI 10.1111/mec.12820; MOTTA PJ, 1995, ENVIRON BIOL FISH, V44, P37, DOI 10.1007/BF00005906; Parsons KJ, 2011, EVOL BIOL, V38, P306, DOI 10.1007/s11692-011-9126-7; Pfennig DW, 2010, AM NAT, V176, pS26, DOI 10.1086/657056; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; Pigeon D, 1998, CAN J FISH AQUAT SCI, V55, P1739, DOI 10.1139/cjfas-55-7-1739; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Roberts RB, 2011, P NATL ACAD SCI USA, V108, P13194, DOI 10.1073/pnas.1018456108; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; Scott WB, 1973, BULLETIN OF THE FISH, V184; Searle SR., 1992, VARIANCE COMPONENTS; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Stelkens R, 2009, EVOLUTION, V63, P884, DOI 10.1111/j.1558-5646.2008.00599.x; Stelkens RB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-283; Therriault J.-C., 1991, CAN SPEC PUBL FISH A; Turgeon J, 2003, CONSERV GENET, V4, P67, DOI 10.1023/A:1021860910719	60	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123172	10.1371/journal.pone.0123172	http://dx.doi.org/10.1371/journal.pone.0123172			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856193	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500078
J	Jia, QY; Li, CL; Xia, Y; Zhang, Q; Wu, HM; Du, HM; Liu, L; Wang, CJ; Shi, HB; Guo, XY; Liu, X; Sun, SM; Wang, X; Zhou, M; Zhao, HL; Song, K; Wu, YT; Niu, KJ				Jia, Qiyu; Li, Chunlei; Xia, Yang; Zhang, Qing; Wu, Hongmei; Du, Huanmin; Liu, Li; Wang, Chongjin; Shi, Hongbin; Guo, Xiaoyan; Liu, Xing; Sun, Shaomei; Wang, Xing; Zhou, Ming; Zhao, Honglin; Song, Kun; Wu, Yuntang; Niu, Kaijun			Association between Complement C3 and Prevalence of Fatty Liver Disease in an Adult Population: A Cross-Sectional Study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; ASIA-PACIFIC; MICE; PATHOGENESIS; STEATOSIS; PROTEIN; CODAM; ATHEROSCLEROSIS; CONTRIBUTES; ACTIVATION	Activation of the innate immune system plays a key role in the development of fatty liver disease (FLD). The complement system is a major humoral component of the innate immune response and complement C3 plays a central role, implying that C3 may be a powerful predictor or therapeutic target for FLD. However, few studies have assessed the association between C3 and FLD in a large population. Here we use a cross-sectional study to investigate the link between serum C3 levels and FLD. Participants were recruited from Tianjin Medical University's General Hospital-Health Management Centre. Serum C3 was measured using immunoturbidimetry method and FLD was diagnosed by liver ultrasonography. Multiple logistic regression analysis was used to examine the association between quartiles of C3 and FLD prevalence. The overall prevalence of nonalcoholic fatty liver disease (NAFLD) and alcoholic fatty liver disease (AFLD) were 37.3% and 10.1%, respectively. After adjusting for covariates, the odds ratio of having NAFLD or AFLD (only in males) in the fourth quartile of C3 compared with the first quartile was 4.13 times greater (95% confidence interval, 2.97-5.77) (trend P values < 0.0001) and 2.09 times greater (95% confidence interval, 1.08-4.18) (trend P values = 0.02). This is the first study to demonstrate that serum C3 levels are independently associated with a higher prevalence of NAFLD and AFLD (only in males) in an adult population. Further studies are needed to establish a causal link and determine the precise role of C3 in FLD.	[Jia, Qiyu; Zhang, Qing; Liu, Li; Wang, Chongjin; Shi, Hongbin; Sun, Shaomei; Wang, Xing; Zhou, Ming; Zhao, Honglin; Song, Kun; Niu, Kaijun] Tianjin Med Univ, Gen Hosp, Hlth Management Ctr, Tianjin, Peoples R China; [Li, Chunlei; Xia, Yang; Wu, Hongmei; Du, Huanmin; Guo, Xiaoyan; Liu, Xing; Wu, Yuntang; Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Li, Chunlei; Xia, Yang; Wu, Hongmei; Du, Huanmin; Guo, Xiaoyan; Liu, Xing; Wu, Yuntang; Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wu, YT (corresponding author), Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China.	wuyuntang@tijmu.edu.cn; nkj0809@gmail.com	Xia, Yang/AAW-9116-2021	Xia, Yang/0000-0001-8783-1592; Niu, Kaijun/0000-0002-8772-2481	key technologies R&D program of Tianjin [11ZCGYSY05700, 12ZCZDSY20400, 13ZCZDSY20200]; Technologies development program of Beichen District of Tianjin [bcws2013-21, bc2014-05]; technologies project of Tianjin Binhai New Area [2013-02-04, 2013-02-06]; Science Foundation of Tianjin Medical University, China [2010KY28]	key technologies R&D program of Tianjin; Technologies development program of Beichen District of Tianjin; technologies project of Tianjin Binhai New Area; Science Foundation of Tianjin Medical University, China	This study was supported by grants from the key technologies R&D program of Tianjin (Key Project: No. 11ZCGYSY05700, 12ZCZDSY20400, and 13ZCZDSY20200), the Technologies development program of Beichen District of Tianjin (No. bcws2013-21 and bc2014-05), the technologies project of Tianjin Binhai New Area (No. 2013-02-04 and 2013-02-06), and the Science Foundation of Tianjin Medical University (No. 2010KY28), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286; Black J.T, 1992, MULTIVARIATE DATA AN; Bykov I, 2007, J HEPATOL, V46, P907, DOI 10.1016/j.jhep.2006.11.020; Bykov I, 2006, ANN MED, V38, P280, DOI 10.1080/07853890600664608; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; CIANFLONE K, 1995, EUR J CLIN INVEST, V25, P817, DOI 10.1111/j.1365-2362.1995.tb01690.x; Cianflone K, 2003, BBA-BIOMEMBRANES, V1609, P127, DOI 10.1016/S0005-2736(02)00686-7; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; Fan JG, 2007, J GASTROEN HEPATOL, V22, P794, DOI 10.1111/j.1440-1746.2007.04952.x; Fan JG, 2013, J GASTROEN HEPATOL, V28, P11, DOI 10.1111/jgh.12036; Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x; Gao X, 2013, J DIABETES, V5, P406, DOI 10.1111/1753-0407.12056; Hertle E, 2014, THROMB HAEMOSTASIS, V111, P1102, DOI 10.1160/TH13-10-0831; Jarvelainen HA, 2002, CLIN IMMUNOL, V105, P57, DOI 10.1006/clim.2002.5267; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; Kleiner DE, 2012, SEMIN LIVER DIS, V32, P3, DOI 10.1055/s-0032-1306421; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Muscari A, 2007, DIABETES CARE, V30, P2362, DOI 10.2337/dc07-0637; Naughton MA, 1996, J IMMUNOL, V156, P3051; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Phieler J, 2013, SEMIN IMMUNOL, V25, P47, DOI 10.1016/j.smim.2013.04.003; Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053; Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Song K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088701; Sun S, 2014, MEDIAT INFLAMM, V2014, P12, DOI DOI 10.1016/J.INFFUS.2014.12.003; van Greevenbroek MMJ, 2011, EUR J CLIN INVEST, V41, P372, DOI 10.1111/j.1365-2362.2010.02418.x; van Oostrom AJHHM, 2007, ATHEROSCLEROSIS, V190, P167, DOI 10.1016/j.atherosclerosis.2006.01.009; Verrijken A, 2013, OBESITY, V21, P2138, DOI 10.1002/oby.20366; Wlazlo N, 2013, EUR J CLIN INVEST, V43, P679, DOI 10.1111/eci.12093; Wu CL, 2014, BIOL REV CAMB PHILOS; Yesilova Z, 2005, AM J GASTROENTEROL, V100, P842, DOI 10.1111/j.1572-0241.2005.40838.x; Zampino R, 2013, J VIRAL HEPATITIS, V20, P517, DOI 10.1111/jvh.12053	36	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122026	10.1371/journal.pone.0122026	http://dx.doi.org/10.1371/journal.pone.0122026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856141	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500029
J	Massei, G; Koon, KK; Benton, S; Brown, R; Gomm, M; Orahood, DS; Pietravalle, S; Eckery, DC				Massei, Giovanna; Koon, Ka-Kei; Benton, Steven; Brown, Richard; Gomm, Matt; Orahood, Darcy S.; Pietravalle, Stephane; Eckery, Douglas C.			Immunocontraception for Managing Feral Cattle in Hong Kong	PLOS ONE			English	Article							WHITE-TAILED DEER; GNRH IMMUNOCONTRACEPTION; WILDLIFE; GONACON(TM); FERTILITY; VACCINE; TRANSLOCATIONS; CONTRACEPTION; CONFLICTS; EFFICACY	Conflicts between human interests and feral cattle in Hong Kong derive from growing numbers of free-roaming cattle. Public antipathy towards lethal population control led the local authorities to consider fertility control to reduce cattle numbers. This study assessed the potential side effects of the immunocontraceptive GonaCon on individual female cattle and established the effectiveness of GonaCon to induce infertility. We evaluated GonaCon in 34 captive cattle assigned to four groups: Control administered a sham solution; Webbed (surgically sterilized through removal of the oviducts), administered one dose of GonaCon; Webbed, administered one dose of GonaCon and a booster dose three months later, and Treated, administered one dose of GonaCon. The side effects of GonaCon were assessed by monitoring injection site, body weight, body condition, size of lymph nodes, body temperature, and feeding behaviour 1 week and 1, 3, 6, 9 and 12 months after vaccination and by haematological and biochemical variables at vaccination and three months post-vaccination. The effectiveness of GonaCon to cause infertility was monitored by quantifying antiGnRH antibody titres and by using kits to detect cycling and pregnancy. GonaCon-treated cattle showed no injection site reaction, limping, or abnormal behaviour. No differences were observed in all physiological and welfare indicators between control and vaccinated cattle. All control cattle and 4 of the 12 cattle in the Treated group became pregnant. Cattle administered a booster dose had higher anti-GnRH antibody titres than cattle that received one dose. We concluded that GonaCon does not compromise the animals' welfare and is effective in reducing fertility in cattle. A booster dose is likely to increase the duration of infertility. Further studies are required to assess the feasibility and costs of immunocontraception for controlling free-roaming cattle populations.	[Massei, Giovanna; Gomm, Matt] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England; [Koon, Ka-Kei; Benton, Steven] Fisheries & Conservat Dept, Anim Management Div, Agr, Hong Kong, Hong Kong, Peoples R China; [Brown, Richard] City Univ Hong Kong, Sch Vet Med, Hong Kong, Hong Kong, Peoples R China; [Orahood, Darcy S.; Eckery, Douglas C.] USDA, APHIS, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Pietravalle, Stephane] Food & Environm Res Agcy, York, N Yorkshire, England	Animal & Plant Health Agency UK; City University of Hong Kong; United States Department of Agriculture (USDA); Food & Environment Research Agency	Massei, G (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England.	giovanna.massei@apha.gsi.gov.uk	Massei, Giovanna/B-8781-2016	BROWN, Richard Arthur Llewellyn/0000-0002-4890-7328	Agriculture, Fisheries and Conservation Department in Hong Kong	Agriculture, Fisheries and Conservation Department in Hong Kong	This study was funded by the Agriculture, Fisheries and Conservation Department in Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFCD, 2013, STRAY CATTL BUFF MAN; [Anonymous], 2013, GENSTAT WINDOWS; Beringer J, 2002, WILDLIFE SOC B, V30, P767; D'Occhio MJ, 2013, GONACON TRIAL HEIFER; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Defra, 2001, COND SCOR DAIR COWS; Delsink A. K., 2012, FREE RANGING AFRICAN; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Druce HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027952; Duka Toni, 2005, Ecological Management & Restoration, V6, P172, DOI 10.1111/j.1442-8903.2005.00234.x; Fagerstone KA, 2010, INTEGR ZOOL, V5, P15, DOI 10.1111/j.1749-4877.2010.00185.x; Fernandez-de-Mera IG, 2003, VET PARASITOL, V115, P335, DOI 10.1016/S0304-4017(03)00211-5; Fernando P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050917; Fonturbel FE, 2011, WILDLIFE BIOL, V17, P217, DOI 10.2981/10-091; Friedrich M, 2010, REPROD DOMEST ANIM, V45, P142, DOI 10.1111/j.1439-0531.2008.01287.x; Gionfriddo JP, 2011, WILDLIFE SOC B, V35, P142, DOI 10.1002/wsb.32; Gionfriddo JP, 2011, WILDLIFE SOC B, V35, P149, DOI 10.1002/wsb.17; Gray ME, 2010, WILDLIFE RES, V37, P475, DOI 10.1071/WR09175; Heydon MJ, 2010, WILDLIFE RES, V37, P731, DOI 10.1071/WR10006; Killian G, 2006, AM J REPROD IMMUNOL, V55, P378, DOI 10.1111/j.1600-0897.2006.00379.x; Killian G, 2008, WILDLIFE RES, V35, P531, DOI 10.1071/WR07134; Killian G, 2009, J WILDLIFE DIS, V45, P184, DOI 10.7589/0090-3558-45.1.184; Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x; Levy JK, 2011, THERIOGENOLOGY, V76, P1517, DOI 10.1016/j.theriogenology.2011.06.022; Madon M. B., 2008, P 23 VERT PEST C U C; Massei G, 2008, WILDLIFE RES, V35, P540, DOI 10.1071/WR07132; Massei G, 2014, WILDLIFE RES, V41, P1, DOI 10.1071/WR13141; Massei G, 2012, WILDLIFE RES, V39, P378, DOI 10.1071/WR11196; Massei G, 2010, WILDLIFE RES, V37, P428, DOI 10.1071/WR08179; McCall TC, 2011, DESERT BIGHORN COUNC, V51, P11; McLeod SR, 2014, ECOL MODEL, V273, P1, DOI 10.1016/j.ecolmodel.2013.10.016; Miller LA, 2004, J WILDLIFE DIS, V40, P725, DOI 10.7589/0090-3558-40.4.725; Miller LA, 2000, AM J REPROD IMMUNOL, V44, P266, DOI 10.1111/j.8755-8920.2000.440503.x; Miller LA, 2008, AM J REPROD IMMUNOL, V60, P214, DOI 10.1111/j.1600-0897.2008.00616.x; Pei KJC, 2010, ZOOL STUD, V49, P253; Powers JG, 2011, BIOL REPROD, V85, P1152, DOI 10.1095/biolreprod.110.088237; Rutberg AT, 2008, WILDLIFE RES, V35, P494, DOI 10.1071/WR07128; Ryan D., 1989, NSW AGR AGFACT AO 2; Sharp T., 2011, MODEL ASSESSING RELA, VSecond; Snape MA, 2011, P 8 EUR VERT PEST MA, P432, DOI [10. 5073/ jka. 2011. 432. 061, DOI 10.5073/JKA.2011.432.061]; Yoder CA, 2010, VACCINE, V29, P233, DOI 10.1016/j.vaccine.2010.10.055	41	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121598	10.1371/journal.pone.0121598	http://dx.doi.org/10.1371/journal.pone.0121598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856283	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500023
J	Mathiasen, L; Bruckmann, C; Pasqualato, S; Blasi, F				Mathiasen, Lisa; Bruckmann, Chiara; Pasqualato, Sebastiano; Blasi, Francesco			Purification and Characterization of a DNA-Binding Recombinant PREP1: PBX1 Complex	PLOS ONE			English	Article							PROTEINS; HOMEODOMAIN; EXPRESSION; MECHANISM; E2A-PBX1; FUSION; SITES	Human PREP1 and PBX1 are homeodomain transcriptional factors, whose biochemical and structural characterization has not yet been fully described. Expression of full-length recombinant PREP1 (47.6 kDa) and PBX1 (46.6 kDa) in E. coli is difficult because of poor yield, high instability and insufficient purity, in particular for structural studies. We cloned the cDNA of both proteins into a dicistronic vector containing an N-terminal glutathione S-transferase (GST) tag and co-expressed and co-purified a stable PBX1:PREP1 complex. For structural studies, we produced two C-terminally truncated complexes that retain their ability to bind DNA and are more stable than the full-length proteins through various purification steps. Here we report the production of large amounts of soluble and pure recombinant human PBX1: PREP1 complex in an active form capable of binding DNA.	[Mathiasen, Lisa; Bruckmann, Chiara; Blasi, Francesco] Fdn Italian Canc Res, Inst Mol Oncol IFOM, I-20139 Milan, Italy; [Pasqualato, Sebastiano] European Inst Oncol, Dept Expt Oncol, Crystallog Unit, I-20139 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO)	Blasi, F (corresponding author), Fdn Italian Canc Res, Inst Mol Oncol IFOM, Via Adamello 16, I-20139 Milan, Italy.	francesco.blasi@ifom.eu		bruckmann, chiara/0000-0002-1026-7505; Blasi, Francesco/0000-0001-9406-1784; Pasqualato, Sebastiano/0000-0002-9038-7768	AIRC/Marie Curie International Fellowship in Cancer Research funded; European School of Molecular Medicine (SEMM) funded; AIRC (Italian Association for Cancer Research) [12829]	AIRC/Marie Curie International Fellowship in Cancer Research funded(Fondazione AIRC per la ricerca sul cancro); European School of Molecular Medicine (SEMM) funded; AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro)	AIRC/Marie Curie International Fellowship in Cancer Research funded C.B., and the European School of Molecular Medicine (SEMM) funded L.M. This work was supported by AIRC (Italian Association for Cancer Research) grant n. 12829 to F.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthelsen J, 1996, J BIOL CHEM, V271, P3822; Berthelsen J, 1998, EMBO J, V17, P1423, DOI 10.1093/emboj/17.5.1423; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Berthelsen J, 1999, GENE DEV, V13, P946, DOI 10.1101/gad.13.8.946; Chang CP, 1997, MOL CELL BIOL, V17, P5679, DOI 10.1128/MCB.17.10.5679; Cole C, 2008, NUCL ACIDS RES, V36; Farber PJ, 2011, J MOL BIOL, V405, P819, DOI 10.1016/j.jmb.2010.11.016; Ferretti E, 2000, DEVELOPMENT, V127, P155; Jabet C, 1999, J MOL BIOL, V291, P521, DOI 10.1006/jmbi.1999.2983; KAMPS MP, 1991, GENE DEV, V5, P358, DOI 10.1101/gad.5.3.358; Kilstrup-Nielsen C, 2003, EMBO J, V22, P89, DOI 10.1093/emboj/cdg010; Knoepfler PS, 1997, ONCOGENE, V14, P2521, DOI 10.1038/sj.onc.1201097; LEBRUN DP, 1994, ONCOGENE, V9, P1641; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Longobardi E, 2014, DEV DYNAMICS OFFICIA, V243; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Saleh M, 2000, EXP CELL RES, V260, P105, DOI 10.1006/excr.2000.5010; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Sprules T, 2000, BIOCHEMISTRY-US, V39, P9943, DOI 10.1021/bi0001067; Tumpel S, 2007, DEV BIOL, V302, P646, DOI 10.1016/j.ydbio.2006.10.029; Wen J, 1996, ANAL BIOCHEM, V240, P155, DOI 10.1006/abio.1996.0345; Wootton JC, 1996, METHOD ENZYMOL, V266, P554	23	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0125789	10.1371/journal.pone.0125789	http://dx.doi.org/10.1371/journal.pone.0125789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856340	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500128
J	Posthumus, AG; Scholmerich, VLN; Steegers, EAP; Kawachi, I; Denktas, S				Posthumus, Anke G.; Scholmerich, Vera L. N.; Steegers, Eric A. P.; Kawachi, Ichiro; Denktas, Semiha			The Association of Ethnic Minority Density with Late Entry into Antenatal Care in the Netherlands	PLOS ONE			English	Article							PRENATAL-CARE; HEALTH-CARE; PERINATAL-CARE; DEPRIVATION; WOMEN; POOR; IMMIGRANTS; PREGNANCY; COUNTRIES; PATTERNS	In the Netherlands, non-Western ethnic minority women make their first antenatal visit later than native Dutch women. Timely entry into antenatal care is important as it provides the opportunity for prenatal screening and the detection of risk factors for adverse pregnancy outcomes. In this study we explored whether women's timely entry is influenced by their neighborhood. Moreover, we assessed whether ethnic minority density (the proportion of ethnic minorities in a neighborhood) influences Western and non-Western ethnic minority women's chances of timely entry into care differently. We hypothesized that ethnic minority density has a protective effect against non-Western women's late entry into care. Data on time of entry into care and other individual-level characteristics were obtained from the Netherlands Perinatal Registry (2000-2008; 97% of all pregnancies). We derived neighborhood- level data from three other national databases. We included 1,137,741 pregnancies of women who started care under supervision of a community midwife in 3422 neighborhoods. Multi-level logistic regression was used to assess the associations of individual and neighborhood-level determinants with entry into antenatal care before and after 14 weeks of gestation. We found that neighborhood characteristics influence timely entry above and beyond individual characteristics. Ethnic minority density was associated with a higher risk of late entry into antenatal care. However, our analysis showed that for non-Western women, living in high ethnic minority density areas is less detrimental to their risk of late entry than for Western women. This means that a higher proportion of ethnic minority residents has a protective effect on non-Western women's chances of timely entry into care. Our results suggest that strategies to improve timely entry into care could seek to create change at the neighborhood level in order to target individuals likely of entering care too late.	[Posthumus, Anke G.; Scholmerich, Vera L. N.; Steegers, Eric A. P.; Denktas, Semiha] Erasmus Univ, Med Ctr, Dept Obstet & Gynecol, Div Obstet & Prenatal Med, Rotterdam, Netherlands; [Scholmerich, Vera L. N.] Vrije Univ Amsterdam, Dept Org Sci, Amsterdam, Netherlands; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Harvard University; Harvard T.H. Chan School of Public Health	Posthumus, AG (corresponding author), Erasmus Univ, Med Ctr, Dept Obstet & Gynecol, Div Obstet & Prenatal Med, Rotterdam, Netherlands.	a.posthumus@erasmusmc.nl	Denktas, Semiha/AAE-2349-2021	Denktas, Semiha/0000-0003-1617-2379				Alderliesten ML, 2007, BJOG-INT J OBSTET GY, V114, P1232, DOI 10.1111/j.1471-0528.2007.01438.x; Amelink-Verburg MP, 2008, BJOG-INT J OBSTET GY, V115, P570, DOI 10.1111/j.1471-0528.2007.01580.x; Amelink-Verburg MP, 2010, J MIDWIFERY WOM HEAL, V55, P216, DOI 10.1016/j.jmwh.2010.01.001; Arcia E, 2001, SOC SCI MED, V53, P41, DOI 10.1016/S0277-9536(00)00310-5; Bakker FdG H., 2009, SEKSUELE GEZONDHEID; Becares L, 2013, SOC SCI MED, V88, P76, DOI 10.1016/j.socscimed.2013.04.007; Berkman L., 2000, SOCIAL EPIDEMIOLOGY; Boerleider AW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-81; Bosqui TJ, 2014, SOC PSYCH PSYCH EPID, V49, P519, DOI 10.1007/s00127-013-0773-0; Brar S, 2009, J OBSTET GYNAECOL CA, V31, P708, DOI 10.1016/S1701-2163(16)34274-8; Chote AA, 2011, MIDWIFERY, V27, P36, DOI 10.1016/j.midw.2009.07.008; Crowder K, 2005, AM J SOCIOL, V110, P1715, DOI 10.1086/428686; Cubbin C, 2008, MATERN CHILD HLTH J, V12, P61, DOI 10.1007/s10995-007-0225-0; de Graaf JP, 2013, J MATERN-FETAL NEO M, V26, P473, DOI 10.3109/14767058.2012.735722; Debiec KE, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.001; Derose KP, 2007, HEALTH AFFAIR, V26, P1258, DOI 10.1377/hlthaff.26.5.1258; Derose KP, 2009, MED CARE RES REV, V66, P272, DOI 10.1177/1077558708330428; Feijen-de Jong EI, 2012, EUR J PUBLIC HEALTH, V22, P904, DOI 10.1093/eurpub/ckr164; Ferlander S, 2007, ACTA SOCIOL, V50, P115, DOI 10.1177/0001699307077654; Heaman Maureen I, 2008, BMC Pregnancy Childbirth, V8, P15, DOI 10.1186/1471-2393-8-15; Heaman MI, 2007, J OBSTET GYNAECOL CA, V29, P806, DOI 10.1016/S1701-2163(16)32637-8; Landrine H, 2004, J BEHAV MED, V27, P527, DOI 10.1007/s10865-004-0002-0; Larson EH, 1997, SOC SCI MED, V45, P171, DOI 10.1016/S0277-9536(96)00332-2; Lin N., 2002, SOCIAL CAPITAL A THE; McKenzie K, 2002, BRIT J PSYCHIAT, V181, P280, DOI 10.1192/bjp.181.4.280; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Mohnen SM, 2013, EUR J PUBLIC HEALTH, V23, P33, DOI 10.1093/eurpub/cks039; Partridge S, 2012, AM J PERINAT, V29, P787, DOI 10.1055/s-0032-1316439; Perloff JD, 1999, SOC WORK, V44, P116, DOI 10.1093/sw/44.2.116; Pickett KE, 2008, ETHNIC HEALTH, V13, P321, DOI 10.1080/13557850701882928; Poeran J, 2013, SOC SCI MED, V83, P42, DOI 10.1016/j.socscimed.2013.02.008; Poortinga W, 2006, SOC SCI MED, V63, P255, DOI 10.1016/j.socscimed.2005.11.039; Raatikainen K, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-268; Rowe RE, 2008, PUBLIC HEALTH, V122, P1363, DOI 10.1016/j.puhe.2008.05.011; Scholmerich VL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095873PONE-D-13-42172, DOI 10.1371/J0URNAL.P0NE.0095873]; Snijders T., 1999, MULTILEVEL MODELING; STCLAIR PA, 1989, MED CARE, V27, P823, DOI 10.1097/00005650-198908000-00006; Szreter S, 2004, INT J EPIDEMIOL, V33, P650, DOI 10.1093/ije/dyh013; Timmermans S, 2011, EUR J EPIDEMIOL, V26, P165, DOI 10.1007/s10654-010-9542-5; Trinh Lieu Thuy Thi, 2006, Reprod Health, V3, P8, DOI 10.1186/1742-4755-3-8; Uiters E, 2006, EUR J PUBLIC HEALTH, V16, P388, DOI 10.1093/eurpub/ckl040; van Eyck J, 2008, Ned Tijdschr Geneeskd, V152, P2121; Van Huijsduijnen JH, 2006, WOON 2006 ONDER ZOEK; Vassy C, 2014, SOC SCI MED, V106, P67, DOI 10.1016/j.socscimed.2014.01.046	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122720	10.1371/journal.pone.0122720	http://dx.doi.org/10.1371/journal.pone.0122720			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856150	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500050
J	Wille, T; Barlag, B; Jakovljevic, V; Hensel, M; Sourjik, V; Gerlach, RG				Wille, Thorsten; Barlag, Britta; Jakovljevic, Vladimir; Hensel, Michael; Sourjik, Victor; Gerlach, Roman G.			A Gateway-Based System for Fast Evaluation of Protein-Protein Interactions in Bacteria	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; GAUSSIA LUCIFERASE; GENE-EXPRESSION; 2-HYBRID SYSTEM; FUSION PROTEINS; LIVING CELLS; PCR PRODUCTS	Protein-protein interactions are important layers of regulation in all kingdoms of life. Identification and characterization of these interactions is one challenging task of the post-genomic era and crucial for understanding of molecular processes within a cell. Several methods have been successfully employed during the past decades to identify protein-protein interactions in bacteria, but most of them include tedious and time-consuming manipulations of DNA. In contrast, the MultiSite Gateway system is a fast tool for transfer of multiple DNA fragments between plasmids enabling simultaneous and site directed cloning of up to four fragments into one construct. Here we developed a new set of Gateway vectors including custom made entry vectors and modular Destination vectors for studying protein-protein interactions via Fluorescence Resonance Energy Transfer (FRET), Bacterial two Hybrid (B2H) and split Gaussia luciferase (Gluc), as well as for fusions with SNAP-tag and HaloTag for dual-color super-resolution microscopy. As proof of principle, we characterized the interaction between the Salmonella effector SipA and its chaperone InvB via split Gluc and B2H approach. The suitability for FRET analysis as well as functionality of fusions with SNAP- and HaloTag could be demonstrated by studying the transient interaction between chemotaxis response regulator CheY and its phosphatase CheZ.	[Wille, Thorsten; Gerlach, Roman G.] Robert Koch Inst, Jr Res Grp 3, Wernigerode Branch, Wernigerode, Germany; [Barlag, Britta; Hensel, Michael] Univ Osnabruck, Sch Biol Chem, Div Microbiol, Osnabruck, Germany; [Jakovljevic, Vladimir; Sourjik, Victor] Univ Heidelberg ZMBH, DKFZ German Canc Res Ctr, Ctr Mol Biol, ZMBH Alliance, Heidelberg, Germany; [Sourjik, Victor] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Sourjik, Victor] LOEWE State Offens Dev Sci & Econ Excellence, Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany	Robert Koch Institute; University Osnabruck; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Gerlach, RG (corresponding author), Robert Koch Inst, Jr Res Grp 3, Wernigerode Branch, Wernigerode, Germany.	gerlachr@rki.de		Hensel, Michael/0000-0001-6604-6253; Jakovljevic, Vladimir/0000-0002-6082-4867	DFG [GE2533/1-1, SFB 944]; ERC [294761]	DFG(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	This work was supported in part by the DFG through project P4 of the collaborative research centre SFB 944 'Physiology and dynamics of cellular microcompartments' at the University of Osnabruck (to M.H.) and GE2533/1-1 (to R.G.G.) and an ERC grant 294761 (to V.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BERG HC, 1984, J GEN MICROBIOL, V130, P2915; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daugherty PS, 1999, PROTEIN ENG, V12, P613, DOI 10.1093/protein/12.7.613; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; HARTLEY JL, 2000, GENOME RES, V10, P1788, DOI DOI 10.1101/GR.143000; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karimova G, 2000, METHOD ENZYMOL, V328, P59, DOI 10.1016/S0076-6879(00)28390-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Khanna R, 2006, NEUROSCIENCE, V140, P1201, DOI 10.1016/j.neuroscience.2006.04.053; Kim SB, 2009, ANAL CHEM, V81, P67, DOI 10.1021/ac801658y; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; LANDY A, 1989, ANNU REV BIOCHEM, V58, P913, DOI 10.1146/annurev.biochem.58.1.913; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lu J-P, 2008, NATURE PRECEDINGS; Medina E, 1999, INFECT IMMUN, V67, P1093, DOI 10.1128/IAI.67.3.1093-1099.1999; OROSZ A, 1991, EUR J BIOCHEM, V201, P653, DOI 10.1111/j.1432-1033.1991.tb16326.x; Pelletier DA, 2008, J PROTEOME RES, V7, P3319, DOI 10.1021/pr8001832; Perehinec TM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-80; Posfai G, 1999, NUCLEIC ACIDS RES, V27, P4409, DOI 10.1093/nar/27.22.4409; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; SHUMAN S, 1994, J BIOL CHEM, V269, P32678; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wille T, 2014, CELL MICROBIOL, V16, P161, DOI 10.1111/cmi.12222; Wille T, 2012, APPL ENVIRON MICROB, V78, P250, DOI 10.1128/AEM.06670-11; Wilmes S, 2012, ANGEW CHEM INT EDIT, V51, P4868, DOI 10.1002/anie.201200853; You CJ, 2013, ACS CHEM BIOL, V8, P320, DOI 10.1021/cb300543t	47	7	7	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123646	10.1371/journal.pone.0123646	http://dx.doi.org/10.1371/journal.pone.0123646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856398	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500102
J	Alis, CM; Lim, MT; Moat, HS; Barchiesi, D; Preis, T; Bishop, SR				Alis, Christian M.; Lim, May T.; Moat, Helen Susannah; Barchiesi, Daniele; Preis, Tobias; Bishop, Steven R.			Quantifying Regional Differences in the Length of Twitter Messages	PLOS ONE			English	Article							NORTH-SOUTH DIVIDE; PATTERNS; BEHAVIOR; REAL	The increasing usage of social media for conversations, together with the availability of its data to researchers, provides an opportunity to study human conversations on a large scale. Twitter, which allows its users to post messages of up to a limit of 140 characters, is one such social media. Previous studies of utterances in books, movies and Twitter have shown that most of these utterances, when transcribed, are much shorter than 140 characters. Furthermore, the median length of Twitter messages was found to vary across US states. Here, we investigate whether the length of Twitter messages varies across different regions in the UK. We find that the median message length, depending on grouping, can differ by up to 2 characters.	[Alis, Christian M.; Barchiesi, Daniele; Bishop, Steven R.] UCL, Dept Math, London, England; [Lim, May T.] Univ Philippines Diliman, Natl Inst Phys, Quezon City, Philippines; [Moat, Helen Susannah; Preis, Tobias] Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England	University of London; University College London; University of the Philippines System; University of the Philippines Diliman; University of Warwick	Alis, CM (corresponding author), UCL, Dept Math, London, England.	c.alis@ucl.ac.uk	Alis, Christian/GRJ-3506-2022; Preis, Tobias/A-2874-2009	Alis, Christian/0000-0001-7397-6803; Preis, Tobias/0000-0001-9185-0892; Moat, Helen Susannah/0000-0001-8974-9277	Research Councils United Kingdom via the Digital Economy theme [EP/KO 39830/1]; EPSRC [EP/J005207/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J005207/1] Funding Source: researchfish	Research Councils United Kingdom via the Digital Economy theme; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	C. M. A., H. S. M., D. B., T. P. and S. R. B. acknowledge funding from Research Councils United Kingdom via the Digital Economy theme (grant EP/KO 39830/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alis CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077793; Alis CM, 2012, EUROPEAN PHYS J B, V85, P1; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Baker A.R.H., 2004, GEOGRAPHIES ENGLAND; BLACKABY DH, 1995, OXFORD B ECON STAT, V57, P487, DOI 10.1111/j.1468-0084.1995.tb00036.x; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; Bryden J, 2013, EPJ DATA SCI, V2, DOI 10.1140/epjds15; Caldarelli G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095809; De Domenico M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02980; Earle P, 2010, SEISMOL RES LETT, V81, P246, DOI 10.1785/gssrl.81.2.246; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Gonzalez S, 2011, EUR URBAN REG STUD, V18, P62, DOI 10.1177/0969776410369044; Hacking JM, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d508; Helbing D, 2014, J STAT PHYS, P1; Hodas NO, 2014, SCI REP-UK, V4, DOI 10.1038/srep04343; Ipsos MediaCT, 2014, IPSOS MEDIACT TECH T; Kalucki J., 2010, STREAMING API DOCUME; Kloumann IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029484; Kuhn T, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041036; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lu X, 2014, SCI REPORTS, V4; Mathiesen J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00814; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Miller G, 2011, SCIENCE, V333, P1814, DOI 10.1126/science.333.6051.1814; Moat HS, 2014, BEHAV BRAIN SCI, V37, P92, DOI 10.1017/S0140525X13001817; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981; Noah A.Smith, 2010, EMNLP; Perc M., 2013, SCI REPORTS, V3; Preis T, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140095; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03141; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Sasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061823; Twitter, 2014, Q REP PURS SECT 13 1; Wales K., 2000, ENGL TODAY, V16, P4, DOI [10.1017/S0266078400011378, DOI 10.1017/S0266078400011378]; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335	44	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122278	10.1371/journal.pone.0122278	http://dx.doi.org/10.1371/journal.pone.0122278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853678	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400062
J	Guo, KF; Lu, JX; Huang, Y; Wu, M; Zhang, L; Yu, HY; Zhang, ML; Bao, YQ; He, JC; Chen, HB; Jia, WP				Guo, Kaifeng; Lu, Junxi; Huang, Yan; Wu, Mian; Zhang, Lei; Yu, Haoyong; Zhang, Mingliang; Bao, Yuqian; He, John Cijiang; Chen, Haibing; Jia, Weiping			Protective Role of PGC-1 alpha in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling	PLOS ONE			English	Article							GAMMA COACTIVATOR 1-ALPHA; MESANGIAL CELLS; TRANSCRIPTIONAL COACTIVATOR; OXIDATIVE STRESS; POTENTIAL ROLE; FISSION; PROTEIN; PGC-1; DYSFUNCTION; KIDNEY	The overproduction of mitochondrial reactive oxygen species (ROS) plays a key role in the pathogenesis of diabetic nephropathy (DN). However, the underlying molecular mechanism remains unclear. Our aim was to investigate the role of PGC-1 alpha in the pathogenesis of DN. Rat glomerular mesangial cells (RMCs) were incubated in normal or high glucose medium with or without the PGC-1 alpha-overexpressing plasmid (pcDNA3-PGC-1 alpha) for 48 h. In the diabetic rats, decreased PGC-1 alpha expression was associated with increased mitochondrial ROS generation in the renal cortex, increased proteinuria, glomerular hypertrophy, and higher glomerular 8-OHdG (a biomarker for oxidative stress). In vitro, hyperglycemia induced the downregulation of PGC-1 alpha, which led to increased DRP1 expression, increased mitochondrial fragmentation and damaged network structure. This was associated with an increase in ROS generation and mesangial cell hypertrophy. These pathological changes were reversed in vitro by the transfection of pcDNA3-PGC-1 alpha. These data suggest that PGC-1 alpha may protect DN via the inhibition of DRP1-mediated mitochondrial dynamic remodeling and ROS production. These findings may assist the development of novel therapeutic strategies for patients with DN.	[Guo, Kaifeng; Lu, Junxi; Huang, Yan; Wu, Mian; Zhang, Lei; Yu, Haoyong; Zhang, Mingliang; Bao, Yuqian; Chen, Haibing; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab,Shanghai Key Lab Diabet M, Shanghai Clin Ctr Diabet,Shanghai Diabet Inst, Shanghai 200233, Peoples R China; [He, John Cijiang] Icahn Sch Med Mt Sinai, Div Nephrol, Dept Med, New York, NY 10029 USA; [He, John Cijiang] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Shanghai Jiao Tong University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	He, JC (corresponding author), Icahn Sch Med Mt Sinai, Div Nephrol, Dept Med, New York, NY 10029 USA.	cijiang.he@mssm.edu; chenhb@sjtu.edu.cn; wpjia@sjtu.edu.cn			Major State Basic Research Development Program of China (973 program) [2012CB517700]; National Natural Science Foundation of China [81070649]; Plan for New hundred people of Shanghai Jiao Tong University; EFSD/CDS/Lilly Programme; Shanghai Pujiang Program [14PJD025]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan for New hundred people of Shanghai Jiao Tong University; EFSD/CDS/Lilly Programme; Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by the Major State Basic Research Development Program of China (973 program) #2012CB517700, grants from the National Natural Science Foundation of China #81070649, the Plan for New hundred people of Shanghai Jiao Tong University, the EFSD/CDS/Lilly Programme for Collaborative Research between China and Europe, and the Shanghai Pujiang Program #14PJD025 (to H Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYO SH, 1990, AM J PATHOL, V136, P1339; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; Ferrari LF, 2011, J NEUROSCI, V31, P11404, DOI 10.1523/JNEUROSCI.2223-11.2011; Ferree A, 2012, ADV EXP MED BIOL, V748, P13, DOI 10.1007/978-1-4614-3573-0_2; Floyd R A, 1986, Free Radic Res Commun, V1, P163, DOI 10.3109/10715768609083148; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Friederich M, 2008, BBA-BIOENERGETICS, V1777, P935, DOI 10.1016/j.bbabio.2008.03.030; Gemma C, 2009, OBESITY, V17, P1032, DOI 10.1038/oby.2008.605; Hwang I, 2012, DIABETES, V61, P728, DOI 10.2337/db11-0584; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nordquist L, 2007, CURR DIABETES REV, V3, P53, DOI 10.2174/157339907779802120; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Ribel-Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051302; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Ruggiero C, 2011, AM J PHYSIOL-ENDOC M, V300, pE1047, DOI 10.1152/ajpendo.00666.2010; Sarin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.201; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yano N, 2009, BIOCHEM J, V423, P129, DOI 10.1042/BJ20082277; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046; Zheng Z, 2010, DIABETES, V59, P2315, DOI 10.2337/db10-0638; Zhu LY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004182	43	68	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0125176	10.1371/journal.pone.0125176	http://dx.doi.org/10.1371/journal.pone.0125176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853493	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400150
J	Pefura-Yone, EW; Kengne, AP; Balkissou, AD; Boulleys-Nana, JR; Efe-De-Melingui, NR; Ndjeutcheu-Moualeu, PI; Mbele-Onana, CL; Kenmegne-Noumsi, EC; Kolontchang-Yomi, BL; Theubo-Kamgang, BJ; Ebouki, ER; Djuikam-Kamga, CK; Magne-Fotso, CG; Amougou, F; Mboumtou, L; Ngo-Yonga, M; Petchou-Talla, EL; Afane-Ze, E; Kuaban, C				Pefura-Yone, Eric Walter; Kengne, Andre Pascal; Balkissou, Adamou Dodo; Boulleys-Nana, Julie Raicha; Efe-de-Melingui, Nelly Rachel; Ndjeutcheu-Moualeu, Patricia Ingrid; Mbele-Onana, Charles Lebon; Kenmegne-Noumsi, Elvira Christelle; Kolontchang-Yomi, Barbara Linda; Theubo-Kamgang, Boris Judicael; Ebouki, Emilienne Regine; Djuikam-Kamga, Chrystelle Karen; Magne-Fotso, Christiane Gaelle; Amougou, Francine; Mboumtou, Liliane; Ngo-Yonga, Martine; Petchou-Talla, Elsie Linda; Afane-Ze, Emmanuel; Kuaban, Christopher		RGRDC	Prevalence of Asthma and Allergic Rhinitis among Adults in Yaounde, Cameroon	PLOS ONE			English	Article							QUALITY-OF-LIFE; RURAL AREA; POPULATION; DIAGNOSIS; SYMPTOMS; DISEASES; BURDEN; WHEEZE; IMPACT; URBAN	Background Population-based estimates of asthma and allergic rhinitis in sub-Saharan African adults are lacking. We assessed the prevalence and determinants of asthma and allergic rhinitis in urban adult Cameroonians. Methods A community-based survey was conducted from December 2013 to April 2014 among adults aged 19 years and above (N = 2,304, 57.3% women), selected through multilevel stratified random sampling across all districts of Yaounde (Capital city). Internationally validated questionnaires were used to investigate the presence of allergic diseases. Logistic regressions were employed to investigate the determinants of allergic conditions. Results Prevalence rates were 2.7% (95% CI: 2.1-3.4) for asthma-ever, 6.9% (5.9-7.9) for lifetime wheezing, 2.9% (92.2-3.6) for current wheezing and 11.4%(10.1-12.7) for self-reported lifetime allergic rhinitis; while 240 (10.4%) participants reported current symptoms of allergic rhinitis, and 125 (5.4%) had allergic rhino-conjunctivitis. The prevalence of current asthma medication use and self-reported asthma attack was 0.8 (0.4-1.2) and 1 (0.6-1.4) respectively. Multivariable adjusted determinants of current wheezing were signs of atopic eczema [2.91 (1.09-7.74)] and signs of allergic rhinitis [3.24 (1.83-5.71)]. Age group 31-40 years [0.27(0.09-0.78), p = 0.016] was an independent protective factor for wheezing. Determinants of current rhinitis symptoms were active smoking [2.20 (1.37-3.54), p<0.001], signs of atopic eczema [2.84 (1.48-5.46)] and current wheezing [3.02 (1.70-5.39)]. Conclusion Prevalence rates for asthma and allergic rhinitis among adults in this population were at the lower tails of those reported in other regions of the world. Beside the classical interrelation between allergic diseases found in this study, active smoking was an independent determinant of allergic rhinitis symptoms. Nationwide surveys are needed to investigate regional variations.	[Pefura-Yone, Eric Walter; Afane-Ze, Emmanuel; Kuaban, Christopher] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Subspecialties, Yaounde, Cameroon; [Pefura-Yone, Eric Walter; Afane-Ze, Emmanuel] Yaounde Jamot Hosp, Serv Pneumol, Yaounde, Cameroon; [Kengne, Andre Pascal] South African Med Res Council, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Balkissou, Adamou Dodo] Biyemassi Dist Hosp, Yaounde, Cameroon; [Boulleys-Nana, Julie Raicha; Efe-de-Melingui, Nelly Rachel; Ndjeutcheu-Moualeu, Patricia Ingrid; Mbele-Onana, Charles Lebon; Kenmegne-Noumsi, Elvira Christelle; Kolontchang-Yomi, Barbara Linda; Theubo-Kamgang, Boris Judicael; Ebouki, Emilienne Regine; Djuikam-Kamga, Chrystelle Karen; Magne-Fotso, Christiane Gaelle; Amougou, Francine; Mboumtou, Liliane; Ngo-Yonga, Martine; Petchou-Talla, Elsie Linda] Inst Super Technol Med, Yaounde, Cameroon; [Kuaban, Christopher] Univ Bamenda, Fac Heath Sci, Bamenda, Cameroon	University of Yaounde I; South African Medical Research Council; University of Cape Town	Pefura-Yone, EW (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Subspecialties, Yaounde, Cameroon.	pefura2002@yahoo.fr	Kengne, Andre Pascal/ABB-3696-2020	Kengne, Andre Pascal/0000-0002-5183-131X				Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013; Adeloye D, 2013, CROAT MED J, V54, P519, DOI 10.3325/cmj.2013.54.519; Amberbir A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022551; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Arif AA, 2003, EUR RESPIR J, V21, P827, DOI 10.1183/09031936.03.00054103a; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Braback L, 2005, EUR RESPIR J, V26, P1064, DOI 10.1183/09031936.05.00022105; Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610; Bureau Central des Recensements et des Etudes de Population, 2010, RAPP PRES RES DEF; Bureau Central des Recensements et des Etudes de Population, 2010, POP CHIFFR; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Cameroon's National Institute of Statistics, POP CAM STAT STRUCT; Canova C, 2013, EUR RESPIR J, V42, P935, DOI 10.1183/09031936.00097412; Chinn S, 2004, THORAX, V59, P646, DOI 10.1136/thx.2004.021642; Custovic A, 1998, ALLERGY, V53, P115, DOI 10.1111/j.1398-9995.1998.tb05011.x; de Marco R, 2012, EUR RESPIR J, V39, P883, DOI 10.1183/09031936.00061611; Desalu O O, 2009, Afr J Med Med Sci, V38, P149; Desalu OO, 2009, J INVEST ALLERG CLIN, V19, P474; Ehrlich RI, 2005, THORAX, V60, P895, DOI 10.1136/thx.2004.030932; El Felkih L, 2014, REV FR ALLERGOL, V54, P107, DOI 10.1016/j.reval.2014.01.033; Erhabor GE, 2006, J ASTHMA, V43, P161, DOI 10.1080/02770900500499046; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Leynaert B, 2000, AM J RESP CRIT CARE, V162, P1391, DOI 10.1164/ajrccm.162.4.9912033; Liu AH, 2007, PAEDIATR PERINAT EP, V21, P2, DOI 10.1111/j.1365-3016.2007.00878.x; Meltzer Eli O, 2012, Allergy Asthma Proc, V33 Suppl 1, pS113, DOI 10.2500/aap.2012.33.3603; Mugusi F, 2004, TROP DOCT, V34, P209, DOI 10.1177/004947550403400408; Musafiri S, 2011, RESP MED, V105, P1596, DOI 10.1016/j.rmed.2011.06.013; Nyembue TD, 2012, INT FORUM ALLERGY RH, V2, P285, DOI 10.1002/alr.21017; Organisation Mondiale de la Sante, 1986, JEUN SANT DEF SOC; Ozdoganoglu T, 2012, THER ADV RESPIR DIS, V6, P11, DOI 10.1177/1753465811431975; Pefura-Yone EW, 2015, J ASTHMA, V52, P571, DOI 10.3109/02770903.2014.995306; Pefura-Yone EW, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004062; Piau JP, 2010, INT J TUBERC LUNG D, V14, P506; Rutkowski K, 2014, POSTEP DERM ALERGOL, V31, P77, DOI 10.5114/pdia.2014.40936; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Schoenwetter WF, 2004, CURR MED RES OPIN, V20, P305, DOI 10.1185/030079903125003053; Song WJ, 2014, ASIA PAC ALLERGY, V4, P3, DOI [10.5415/apallergy.2014.4.1.3, 10.5415/apallergy.2014.4.2.75]; Sonomjamts M, 2014, ASIA PAC ALLERGY, V4, P25, DOI 10.5415/apallergy.2014.4.1.25; Woodward M., 2005, CHAPMEN HALL CRC TEX, V849; World Health Organization, 1997, OB PREV MAN GLOB EP, DOI [10.2147/IJNRD.S78310, DOI 10.2147/IJNRD.S78310]; Zhang Y, 2014, ALLERGY ASTHMA IMMUN, V6, P105, DOI 10.4168/aair.2014.6.2.105; Zhu Hong, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P494	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123099	10.1371/journal.pone.0123099	http://dx.doi.org/10.1371/journal.pone.0123099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853516	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400096
J	Shim, J; Son, HJ; Kim, Y; Kim, KH; Kim, JT; Moon, H; Kim, MJ; Misaka, T; Rhyu, MR				Shim, Jaewon; Son, Hee Jin; Kim, Yiseul; Kim, Ki Hwa; Kim, Jung Tae; Moon, Hana; Kim, Min Jung; Misaka, Takumi; Rhyu, Mee-Ra			Modulation of Sweet Taste by Umami Compounds via Sweet Taste Receptor Subunit hT1R2	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN; BITTER; MECHANISM	Although the five basic taste qualities-sweet, sour, bitter, salty and umami-can be recognized by the respective gustatory system, interactions between these taste qualities are often experienced when food is consumed. Specifically, the umami taste has been investigated in terms of whether it enhances or reduces the other taste modalities. These studies, however, are based on individual perception and not on a molecular level. In this study we investigated umami-sweet taste interactions using umami compounds including monosodium glutamate (MSG), 5'-mononucleotides and glutamyl-dipeptides, glutamate-glutamate (Glu-Glu) and glutamate-aspartic acid (Glu-Asp), in human sweet taste receptor hT1R2/hT1R3-expressing cells. The sensitivity of sucrose to hT1R2/hT1R3 was significantly attenuated by MSG and umami active peptides but not by umami active nucleotides. Inhibition of sweet receptor activation by MSG and glutamyl peptides is obvious when sweet receptors are activated by sweeteners that target the extracellular domain (ECD) of T1R2, such as sucrose and acesulfame K, but not by cyclamate, which interact with the T1R3 transmembrane domain (TMD). Application of umami compounds with lactisole, inhibitory drugs that target T1R3, exerted a more severe inhibitory effect. The inhibition was also observed with F778A sweet receptor mutant, which have the defect in function of T1R3 TMD. These results suggest that umami peptides affect sweet taste receptors and this interaction prevents sweet receptor agonists from binding to the T1R2 ECD in an allosteric manner, not to the T1R3. This is the first report to define the interaction between umami and sweet taste receptors.	[Shim, Jaewon; Son, Hee Jin; Kim, Yiseul; Kim, Ki Hwa; Kim, Jung Tae; Moon, Hana; Kim, Min Jung; Rhyu, Mee-Ra] Korea Food Res Inst, Div Creat Food Sci Hlth, Songnam, Gyeonggi Do, South Korea; [Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan	Korea Food Research Institute (KFRI); University of Tokyo	Rhyu, MR (corresponding author), Korea Food Res Inst, Div Creat Food Sci Hlth, Songnam, Gyeonggi Do, South Korea.	mrrhyu@kfri.re.kr		Misaka, Takumi/0000-0002-9547-5767; Shim, Jaewon/0000-0003-4818-7057	Korea Food Research Institute [E0131201, E0143043494]	Korea Food Research Institute	This study was supported by Korea Food Research Institute (E0131201, E0143043494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadi-Porter FM, 2010, J MOL BIOL, V398, P584, DOI 10.1016/j.jmb.2010.03.017; Breslin PAS, 1996, TRENDS FOOD SCI TECH, V7, P390, DOI 10.1016/S0924-2244(96)10039-X; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chu B, 2014, CURR BIOL, V24, P1978, DOI 10.1016/j.cub.2014.07.020; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Cygankiewicz AI, 2014, CRIT REV FOOD SCI, V54, P771, DOI 10.1080/10408398.2011.606929; Fujiwara S, 2012, FOOD CHEM, V130, P561, DOI 10.1016/j.foodchem.2011.07.073; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Imada T, 2010, BIOCHEM BIOPH RES CO, V397, P220, DOI 10.1016/j.bbrc.2010.05.088; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Keast SJR, 2003, FOOD QUAL PREFER, V14, P111, DOI 10.1016/S0950-3293(02)00110-6; KEMP SE, 1994, J FOOD SCI, V59, P682, DOI 10.1111/j.1365-2621.1994.tb05592.x; Kim MJ, 2015, BIOCHEM BIOPH RES CO, V456, P586, DOI 10.1016/j.bbrc.2014.11.114; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Li XD, 2009, AM J CLIN NUTR, V90, p733S, DOI 10.3945/ajcn.2009.27462G; Liman ER, 2014, NEURON, V81, P984, DOI 10.1016/j.neuron.2014.02.022; Liu B, 2011, J NEUROSCI, V31, P11070, DOI 10.1523/JNEUROSCI.0791-11.2011; Lyall V, 1999, AM J PHYSIOL-CELL PH, V277, pC800, DOI 10.1152/ajpcell.1999.277.4.C800; Masuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035380; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Sako N, 2003, CHEM SENSES, V28, P261, DOI 10.1093/chemse/28.3.261; Sakurai T, 2009, J AGR FOOD CHEM, V57, P2508, DOI 10.1021/jf8040148; Temussi PA, 2009, TRENDS BIOCHEM SCI, V34, P296, DOI 10.1016/j.tibs.2009.02.005; Tokita K, 2012, J NEUROPHYSIOL, V108, P2179, DOI 10.1152/jn.00465.2012; Winnig M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-22; Woskow M. H., 1969, FOOD TECHNOLOGY, V23, P32; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101	28	17	20	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124030	10.1371/journal.pone.0124030	http://dx.doi.org/10.1371/journal.pone.0124030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853419	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400131
J	Silva-Rocha, I; Salvi, D; Sillero, N; Mateo, JA; Carretero, MA				Silva-Rocha, Iolanda; Salvi, Daniele; Sillero, Neftali; Mateo, Jose A.; Carretero, Miguel A.			Snakes on the Balearic Islands: An Invasion Tale with Implications for Native Biodiversity Conservation	PLOS ONE			English	Article							PLANT INVASIONS; COLUBRIDAE; IMPACTS; NICHE; TEMPERATURE; POPULATIONS; EXTINCTION; PREDICTION; SERPENTES; PATTERNS	Biological invasions are a major conservation threat for biodiversity worldwide. Islands are particularly vulnerable to invasive species, especially Mediterranean islands which have suffered human pressure since ancient times. In the Balearic archipelago, reptiles represent an outstanding case with more alien than native species. Moreover, in the last decade a new wave of alien snakes landed in the main islands of the archipelago, some of which were originally snake-free. The identification of the origin and colonization pathways of alien species, as well as the prediction of their expansion, is crucial to develop effective conservation strategies. In this study, we used molecular markers to assess the allochthonous status and the putative origin of the four introduced snake species (Hemorrhois hippocrepis, Malpolon monspessulanus, Macroprotodon mauritanicus and Rhinechis scalaris) as well as ecological niche models to infer their patterns of invasion and expansion based on current and future habitat suitability. For most species, DNA sequence data suggested the Iberian Peninsula as the potential origin of the allochthonous populations, although the shallow phylogeographic structure of these species prevented the identification of a restricted source-area. For all of them, the ecological niche models showed a current low habitat suitability in the Balearic, which is however predicted to increase significantly in the next few decades under climate change scenarios. Evidence from direct observations and spatial distribution of the first-occurrence records of alien snakes (but also lizards and worm lizards) suggest the nursery trade, and in particular olive tree importation from Iberian Peninsula, as the main pathway of introduction of alien reptiles in the Balearic islands. This trend has been reported also for recent invasions in NE Spain, thus showing that olive trees transplantation may be an effective vector for bioinvasion across the Mediterranean. The combination of molecular and ecological tools used in this study reveals a promising approach for the understanding of the complex invasion process, hence guiding conservation management actions.	[Silva-Rocha, Iolanda; Salvi, Daniele; Carretero, Miguel A.] Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Vairao, Vila Do Conde, Portugal; [Sillero, Neftali] Univ Porto, Fac Ciencias, CICGE, Vila Nova De Gaia, Portugal; [Mateo, Jose A.] Govern Illes Balears, Serv Proteccio Especies, Palma de Mallorca, Spain	Universidade do Porto; Universidade do Porto	Salvi, D (corresponding author), Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Vairao, Vila Do Conde, Portugal.	danielesalvi.bio@gmail.com	Carretero, Miguel A/A-1472-2013; Sillero, Neftali/C-1803-2008; Salvi, Daniele/I-6360-2013; Silva-Rocha, Iolanda/I-1989-2014	Carretero, Miguel A/0000-0002-2335-7198; Sillero, Neftali/0000-0002-3490-3780; Salvi, Daniele/0000-0002-3804-2690; Silva-Rocha, Iolanda/0000-0001-8451-4460	FEDER; FCT [PTDC/BIA-BEC/101256/2008]; North Portugal Regional Operational Programme, through the European Regional Development Fund [ON.2]; FCT (Fundacao para a Ciencia e a Tecnologia, Portugal) [SFRH/BPD/66592/2009, SFRH/BD/95745/2013]; European Social Fund; Portuguese Ministerio da Educacao e Ciencia	FEDER(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); North Portugal Regional Operational Programme, through the European Regional Development Fund; FCT (Fundacao para a Ciencia e a Tecnologia, Portugal)(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); Portuguese Ministerio da Educacao e Ciencia(Portuguese Foundation for Science and Technology)	The molecular work of this study was funded by FEDER through the COMPETE program; by the FCT project PTDC/BIA-BEC/101256/2008; and by the project 'Genomics and Evolutionary Biology' cofinanced by North Portugal Regional Operational Programme (ON.2), through the European Regional Development Fund. DS is supported by the FCT (Fundacao para a Ciencia e a Tecnologia, Portugal) post-doctoral grant SFRH/BPD/66592/2009 and IS-R by the FCT PhD grant SFRH/BD/95745/2013 under the Programa Operacional Potencial Humano-Quadro de Referencia Estrategico Nacional funds from the European Social Fund and Portuguese Ministerio da Educacao e Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Carmen, 2010, Boletin de la Asociacion Herpetologica Espanola, V21, P126; Anderson RP, 2013, ANN NY ACAD SCI, V1297, P8, DOI 10.1111/nyas.12264; [Anonymous], 2005, EC HUN WELL BEING CU; Ayllon E, 2014, 13 IB C HERP AV PORT; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Blondel J., 2010, MEDITERRANEAN REGION; Bonnet X, 1999, BIOL CONSERV, V89, P39, DOI 10.1016/S0006-3207(98)00140-2; Bons J, 1996, ANFIBIOS REPTILES MA; Bover P, 2014, INTEGR ZOOL, V9, P183, DOI 10.1111/1749-4877.12049; Brown GP, 2007, P NATL ACAD SCI USA, V104, P17698, DOI 10.1073/pnas.0705057104; Bruekers Jaco, 2003, Lacerta, V61, P203; Bruno S, 1990, SERPENTI ITALIA EURO, DOI [10.3748/wjg.v20.i43, DOI 10.3748/WJG.V20.I43]; BUSACK S D, 1990, Annals of Carnegie Museum, V59, P261; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Carranza S, 2006, MOL PHYLOGENET EVOL, V40, P532, DOI 10.1016/j.ympev.2006.03.028; Carranza S, 2004, MOL PHYLOGENET EVOL, V33, P523, DOI 10.1016/j.ympev.2004.07.009; Cavazza W, 2003, EPISODES, V26, P160, DOI 10.18814/epiiugs/2003/v26i3/002; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Diamond J., 1989, P37; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Feriche M, 2008, COPEIA, P279, DOI 10.1643/CH-06-272; Ficetola GF, 2009, GLOBAL ECOL BIOGEOGR, V18, P214, DOI 10.1111/j.1466-8238.2008.00433.x; Ficetola GF, 2009, DIVERS DISTRIB, V15, P108, DOI 10.1111/j.1472-4642.2008.00516.x; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holt RD, 2003, EVOL ECOL RES, V5, P159; Kraus Fred, 2009, V4, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; MARCONI Marina de A., 2010, FUNDAMENTOS METODOLO, V7; MATEO JA, 2011, BOL ASOC HERPETOL ES, V22, P2; Mateo JA, 2012, AYLLON ENRIQUE RELAT; Mayol J, 1985, MANUALES INTRO NATUR, V6; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Moreno-Rueda G, 2007, HERPETOL J, V17, P204; Moreno-Rueda G, 2009, CLIMATIC CHANGE, V92, P235, DOI 10.1007/s10584-008-9469-y; Nulchis V, 2008, NORTH-WEST J ZOOL, V4, P119; Oliver JA, 2010, SEM SPEC INTR INV IL; Perez-Mellado V., 1998, FAUNA IBERICA, P272; PerezMellado V, 1997, J ZOOL, V243, P533, DOI 10.1111/j.1469-7998.1997.tb02799.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinya S, 2011, ACTA HERPETOL, V6, P59; Pitt WC, 2005, P 11 WILDF DAM MAN C; Pleguezuelos J.M., 2002, ATLAS LIBRO ROJO ANF; PLEGUEZUELOS JM, 1994, HERPETOL J, V4, P98; Pleguezuelos JM, 2004, ATLAS LIBRO ROJO ANF, P502; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Reaser JK, 2007, ENVIRON CONSERV, V34, P98, DOI 10.1017/S0376892907003815; Reynolds RG, 2010, IRCF REPT AMPH, V17, P117; Rivera X, 2011, BOTLLETI SOC CATALAN, V19, P79; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Silva-Rocha I, 2012, ITAL J ZOOL, V79, P502, DOI 10.1080/11250003.2012.680983; Silva-Rocha I, 2012, THESIS U PORTO; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Stell R, 2006, PUBLIC PRIVATE RELIG; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tome B, 2014, SYST PARASITOL, V87, P249, DOI 10.1007/s11230-014-9477-4; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Utiger U, 2004, REV SUISSE ZOOL, V111, P225, DOI 10.5962/bhl.part.80236; Valdeon Aitor, 2010, Boletin de la Asociacion Herpetologica Espanola, V21, P122; Vasconcelos Raquel, 2006, Herpetozoa, V19, P77; Vigne JD, 1985, ACT 110 C NAT SOC SA, V2, P79; Vitousek Peter M., 1996, SCOPE, V55, P245; Wade E., 2001, Bulletin of the Natural History Museum Zoology Series, V67, P85; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Zamora-Camacho FJ, 2010, ACTA HERPETOL, V5, P143	70	28	28	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121026	10.1371/journal.pone.0121026	http://dx.doi.org/10.1371/journal.pone.0121026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853711	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400027
J	Suzuki, M; Chiwaki, F; Sawada, Y; Ashikawa, M; Aoyagi, K; Fujita, T; Yanagihara, K; Komatsu, M; Narita, M; Suzuki, T; Nagase, H; Kushima, R; Sakamoto, H; Fukagawa, T; Katai, H; Nakagama, H; Yoshida, T; Uezono, Y; Sasaki, H				Suzuki, Masami; Chiwaki, Fumiko; Sawada, Yumi; Ashikawa, Maho; Aoyagi, Kazuhiko; Fujita, Takeshi; Yanagihara, Kazuyoshi; Komatsu, Masayuki; Narita, Minoru; Suzuki, Tsutomu; Nagase, Hiroshi; Kushima, Ryoji; Sakamoto, Hiromi; Fukagawa, Takeo; Katai, Hitoshi; Nakagama, Hitoshi; Yoshida, Teruhiko; Uezono, Yasuhito; Sasaki, Hiroki			Peripheral Opioid Antagonist Enhances the Effect of Anti-Tumor Drug by Blocking a Cell Growth-Suppressive Pathway In Vivo	PLOS ONE			English	Article							PERITONEAL MESOTHELIAL CELLS; FACTOR RECEPTOR OGFR; GASTRIC-CANCER; PANCREATIC-CANCER; STEM-CELLS; CARCINOMATOSIS; DISSEMINATION; PROGRESSION; METASTASIS; MECHANISMS	The dormancy of tumor cells is a major problem in chemotherapy, since it limits the therapeutic efficacy of anti-tumor drugs that only target dividing cells. One potential way to overcome chemo-resistance is to "wake up" these dormant cells. Here we show that the opioid antagonist methylnaltrexone (MNTX) enhances the effect of docetaxel (Doc) by blocking a cell growth-suppressive pathway. We found that PENK, which encodes opioid growth factor (OGF) and suppresses cell growth, is predominantly expressed in diffuse-type gastric cancers (GCs). The blockade of OGF signaling by MNTX releases cells from their arrest and boosts the effect of Doc. In comparison with the use of Doc alone, the combined use of Doc and MNTX significantly prolongs survival, alleviates abdominal pain, and diminishes Docresistant spheroids on the peritoneal membrane in model mice. These results suggest that blockade of the pathways that suppress cell growth may enhance the effects of antitumor drugs.	[Suzuki, Masami; Sawada, Yumi; Ashikawa, Maho; Uezono, Yasuhito] Natl Canc Ctr, Div Canc Pathophysiol, Tokyo, Japan; [Chiwaki, Fumiko; Aoyagi, Kazuhiko; Fujita, Takeshi; Komatsu, Masayuki; Sakamoto, Hiromi; Yoshida, Teruhiko; Sasaki, Hiroki] Natl Canc Ctr, Div Genet, Tokyo, Japan; [Nakagama, Hitoshi] Natl Canc Ctr, Div Canc Dev Syst, Tokyo, Japan; [Chiwaki, Fumiko; Aoyagi, Kazuhiko; Komatsu, Masayuki; Sasaki, Hiroki] Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr Hosp East, Exploratory Oncol Res & Clin Trial Ctr, Div Translat Res, Chiba, Japan; [Narita, Minoru] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Pharmacol, Tokyo 142, Japan; [Suzuki, Tsutomu] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Toxicol, Tokyo 142, Japan; [Sakamoto, Hiromi] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki, Japan; [Kushima, Ryoji] Natl Canc Ctr, Dept Pathol, Tokyo, Japan; [Fukagawa, Takeo; Katai, Hitoshi] Natl Canc Ctr, Gastr Surg Div, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Hoshi University; Hoshi University; University of Tsukuba; National Cancer Center - Japan; National Cancer Center - Japan	Sasaki, H (corresponding author), Natl Canc Ctr, Div Genet, Tokyo, Japan.	hksasaki@ncc.go.jp			National Institute of Biomedical Innovation (for the Advanced Research for Medical Products Mining Programme) [ID10-41, ID12-01]; National Cancer Center Research and Development Fund [23-A-7, 23-B-6, 23-B-18, 25-A-6]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25860432, 23501322]; Princess Takamatsu Cancer Research Fund; Foundation of Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research [15K21745] Funding Source: KAKEN	National Institute of Biomedical Innovation (for the Advanced Research for Medical Products Mining Programme); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Cancer Research Fund; Foundation of Promotion of Cancer Research in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Institute of Biomedical Innovation (for the Advanced Research for Medical Products Mining Programme ID10-41, ID12-01), National Cancer Center Research and Development Fund (23-A-7, 23-B-6, 23-B-18, 25-A-6), The Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25860432 and No. 23501322), and The Princess Takamatsu Cancer Research Fund. Drs. Suzuki and Fujita are the recipients of Research Resident Fellowships from the Foundation of Promotion of Cancer Research in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Aoyagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018196; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Castells M, 2012, INT J MOL SCI, V13, P9545, DOI 10.3390/ijms13089545; Cheng F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-5; Cheng F, 2007, CANCER RES, V67, P10511, DOI 10.1158/0008-5472.CAN-07-1922; Coccolini F, 2013, WORLD J GASTROENTERO, V19, P6979, DOI 10.3748/wjg.v19.i41.6979; Donahue RN, 2009, AM J PHYSIOL-REG I, V296, pR1716, DOI 10.1152/ajpregu.00075.2009; Fujita T, 2013, CANCER SCI, V104, P214, DOI 10.1111/cas.12054; Glockzin G, 2012, SURG ONCOL CLIN N AM, V21, P625, DOI 10.1016/j.soc.2012.07.002; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; IKEGUCHI M, 1994, ANTICANCER RES, V14, P2131; Ishii H, 2008, CANCER SCI, V99, P1871, DOI 10.1111/j.1349-7006.2008.00914.x; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Kuramoto M, 2009, ANN SURG, V250, P242, DOI 10.1097/SLA.0b013e3181b0c80e; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Mitsui H, 2012, GYNECOL ONCOL, V124, P303, DOI 10.1016/j.ygyno.2011.10.006; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Roviello F, 2013, EJSO-EUR J SURG ONC, V39, P1309, DOI 10.1016/j.ejso.2013.10.010; Sevcik MA, 2006, GASTROENTEROLOGY, V131, P900, DOI 10.1053/j.gastro.2006.06.021; Sodek KL, 2012, CANCER METAST REV, V31, P397, DOI 10.1007/s10555-012-9351-2; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Suzuki M, 2012, ANESTHESIOLOGY, V117, P847, DOI 10.1097/ALN.0b013e31826a4ac8; Tamburrino A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00056; Thibault B, 2014, CANCER METAST REV, V33, P17, DOI 10.1007/s10555-013-9456-2; Tsukada T, 2012, INT J ONCOL, V41, P476, DOI 10.3892/ijo.2012.1490; Yan TD, 2010, WORLD J GASTRO ONCOL, V2, P109, DOI 10.4251/wjgo.v2.i2.109; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yanagihara K, 2006, CANCER RES, V66, P7532, DOI 10.1158/0008-5472.CAN-05-3259; Zagon IS, 2000, BRAIN RES, V856, P75, DOI 10.1016/S0006-8993(99)02330-6; Zagon IS, 2002, BRAIN RES REV, V38, P351, DOI 10.1016/S0165-0173(01)00160-6	31	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123407	10.1371/journal.pone.0123407	http://dx.doi.org/10.1371/journal.pone.0123407			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853862	gold, Green Submitted, Green Published			2022-12-27	WOS:000352478400101
J	Xue, PP; Zheng, MM; Gong, P; Lin, CM; Zhou, JJ; Li, YJ; Shen, L; Diao, ZY; Yan, GJ; Sun, HX; Hu, YL				Xue, Pingping; Zheng, Mingming; Gong, Ping; Lin, Caimei; Zhou, Jianjun; Li, Yujing; Shen, Li; Diao, Zhenyu; Yan, Guijun; Sun, Haixiang; Hu, Yali			Single Administration of Ultra-Low-Dose Lipopolysaccharide in Rat Early Pregnancy Induces TLR4 Activation in the Placenta Contributing to Preeclampsia	PLOS ONE			English	Article							FETAL-GROWTH RESTRICTION; NITRIC-OXIDE SYNTHASE; TROPHOBLAST INVASION; HTR-8/SVNEO CELLS; DECIDUAL CELLS; ANIMAL-MODEL; EXPRESSION; PATHOPHYSIOLOGY; MICRORNA-155; CYTOKINES	Balanced immune responses are essential for the maintenance of successful pregnancy. Aberrant responses of immune system during pregnancy increase the risk of preeclampsia. Toll-like receptor 4 (TLR4) plays a crucial role in the activation of immune system at the maternal-fetal interface. This study aimed to generate a rat model of preeclampsia by lipopolysaccharide (LPS, a TLR4 agonist) administration on gestational day (GD) 5 as rats are subjected to placentation immediately after implantation between GDs 4 and 5, and to assess the contribution of TLR4 signaling to the development of preeclampsia. Single administration of 0.5 mu g/kg LPS significantly increased blood pressure of pregnant rats since GD 6 (systolic blood pressure, 124.89 +/- 1.79 mmHg versus 119.02 +/- 1.80 mmHg, P < 0.05) and urinary protein level since GD 9 (2.02 +/- 0.29 mg versus 1.11 +/- 0.18 mg, P < 0.01), but barely affected blood pressure or proteinuria of virgin rats compared with those of saline-treated pregnant rats. This was accompanied with adverse pregnancy outcomes including fetal growth restriction. The expression of TLR4 and NF-kappa B p65 were both increased in the placenta but not the kidney from LPS-treated pregnant rats, with deficient trophoblast invasion and spiral artery remodeling. Furthermore, the levels of inflammatory cytokines were elevated systemically and locally in the placenta from pregnant rats treated with LPS. TLR4 signaling in the placenta was activated, to which that in the placenta of humans with preeclampsia changed similarly. In conclusion, LPS administration to pregnant rats in early pregnancy could elicit TLR4-mediated immune response at the maternal-fetal interface contributing to poor early placentation that may culminate in the preeclampsia-like syndrome.	[Xue, Pingping; Lin, Caimei; Shen, Li; Hu, Yali] Nanjing Med Univ, Drum Tower Clin Med Coll, Nanjing, Jiangsu, Peoples R China; [Zheng, Mingming; Zhou, Jianjun; Diao, Zhenyu; Yan, Guijun; Sun, Haixiang] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol, Nanjing 210008, Jiangsu, Peoples R China; [Gong, Ping] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Nanjing, Jiangsu, Peoples R China; [Li, Yujing] Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Nanjing University; Nanjing University of Chinese Medicine; Southeast University - China	Sun, HX (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Obstet & Gynecol, Nanjing 210008, Jiangsu, Peoples R China.	stevensunz@163.com; dtylhu@126.com	li, yu/HGL-9518-2022; Li, yujing/GQA-4109-2022		Chinese National Natural Science Foundation [81370724, 81070508]; Maternal and Fetus Medicine Key Lab of Jiangsu Province, China [XK 201102]; Innovative Research Program for Postgraduate in Higher Education Institutions of Jiangsu Province [CXLX13_568]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Maternal and Fetus Medicine Key Lab of Jiangsu Province, China; Innovative Research Program for Postgraduate in Higher Education Institutions of Jiangsu Province	This study was supported by the following grants: Chinese National Natural Science Foundation (81370724, 81070508); Maternal and Fetus Medicine Key Lab of Jiangsu Province, China (XK 201102); Innovative Research Program for Postgraduate in Higher Education Institutions of Jiangsu Province for the year 2013 (CXLX13_568). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2004, J IMMUNOL, V173, P4286, DOI 10.4049/jimmunol.173.7.4286; Al-Ofi E, 2014, J REPROD IMMUNOL, V103, P23, DOI 10.1016/j.jri.2014.02.004; Anton L, 2012, HUM REPROD, V27, P61, DOI 10.1093/humrep/der362; BULMER JN, 1992, BAILLIERE CLIN OB GY, V6, P461, DOI 10.1016/S0950-3552(05)80006-9; Cotechini T, 2014, J EXP MED, V211, P165, DOI 10.1084/jem.20130295; Dai AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039950; Dai YM, 2011, HUM REPROD, V26, P1882, DOI 10.1093/humrep/der118; Equils O, 2006, J IMMUNOL, V177, P1257, DOI 10.4049/jimmunol.177.2.1257; Faas MM, 2004, AM J OBSTET GYNECOL, V191, P1192, DOI 10.1016/j.ajog.2004.03.041; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; Fonseca BM, 2012, REPROD BIOL, V12, P97, DOI 10.1016/S1642-431X(12)60080-1; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053; LaMarca BD, 2007, CURR HYPERTENS REP, V9, P480, DOI 10.1007/s11906-007-0088-1; Li M, 2009, THROMB RES, V124, P656, DOI 10.1016/j.thromres.2009.07.012; Liu SF, 1996, CRIT CARE MED, V24, P1219, DOI 10.1097/00003246-199607000-00026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood CJ, 2006, AM J PATHOL, V168, P445, DOI 10.2353/ajpath.2006.050082; Lyall F, 2013, HYPERTENSION, V62, P1046, DOI 10.1161/HYPERTENSIONAHA.113.01892; Ma YH, 2006, AM J REPROD IMMUNOL, V55, P12, DOI 10.1111/j.1600-0897.2005.00347.x; Moraloglu O, 2012, J MATERN-FETAL NEO M, V25, P845, DOI 10.3109/14767058.2011.599081; OLSON NC, 1995, BRIT VET J, V151, P489, DOI 10.1016/S0007-1935(05)80023-5; Raghupathy R, 2013, MED PRIN PRACT, V22, P8, DOI 10.1159/000354200; Riley JK, 2010, CLIN REV ALLERG IMMU, V39, P185, DOI 10.1007/s12016-009-8178-2; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Soares MJ, 2012, PLACENTA, V33, P233, DOI 10.1016/j.placenta.2011.11.026; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Sun HX, 2012, HYPERTENSION, V60, P1407, DOI 10.1161/HYPERTENSIONAHA.112.197301; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; van der Graaf AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079884; Verlohren S, 2010, HYPERTENSION, V56, P304, DOI 10.1161/HYPERTENSIONAHA.110.153163; Wang CCL, 2003, DIABETES, V52, P2562, DOI 10.2337/diabetes.52.10.2562; Xue P, 2013, PLACENTA, V34, P650, DOI 10.1016/j.placenta.2013.04.015; Yazji I, 2013, P NATL ACAD SCI USA, V110, P9451, DOI 10.1073/pnas.1219997110; Yeh CC, 2013, REPROD SCI, V20, P339, DOI 10.1177/1933719112450330; Zhang Y, 2009, PLACENTA, V30, P1065, DOI 10.1016/j.placenta.2009.09.004; Zhou JJ, 2013, HYPERTENSION, V62, P599, DOI 10.1161/HYPERTENSIONAHA.113.01449	37	61	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124001	10.1371/journal.pone.0124001	http://dx.doi.org/10.1371/journal.pone.0124001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853857	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400128
J	Huchko, MJ; Sneden, J; Zakaras, JM; Smith-McCune, K; Sawaya, G; Maloba, M; Bukusi, EA; Cohen, CR				Huchko, Megan J.; Sneden, Jennifer; Zakaras, Jennifer M.; Smith-McCune, Karen; Sawaya, George; Maloba, May; Bukusi, Elizabeth Ann; Cohen, Craig R.			A Randomized Trial Comparing the Diagnostic Accuracy of Visual Inspection with Acetic Acid to Visual Inspection with Lugol's Iodine for Cervical Cancer Screening in HIV-Infected Women	PLOS ONE			English	Article							LOW-RESOURCE SETTINGS; INTRAEPITHELIAL NEOPLASIA; ENDOCERVICAL CURETTAGE; INDIA; PREVENTION; AFRICA; BIOPSY	Visual inspection with Acetic Acid (VIA) and Visual Inspection with Lugol's Iodine (VILI) are increasingly recommended in various cervical cancer screening protocols in low-resource settings. Although VIA is more widely used, VILI has been advocated as an easier and more specific screening test. VILI has not been well-validated as a stand-alone screening test, compared to VIA or validated for use in HIV-infected women. We carried out a randomized clinical trial to compare the diagnostic accuracy of VIA and VILI among HIV-infected women. Women attending the Family AIDS Care and Education Services (FACES) clinic in western Kenya were enrolled and randomized to undergo either VIA or VILI with colposcopy. Lesions suspicious for cervical intraepithelial neoplasia 2 or greater (CIN2+) were biopsied. Between October 2011 and June 2012, 654 were randomized to undergo VIA or VILI. The test positivity rates were 26.2% for VIA and 30.6% for VILI (p = 0.22). The rate of detection of CIN2+ was 7.7% in the VIA arm and 11.5% in the VILI arm (p = 0.10). There was no significant difference in the diagnostic performance of VIA and VILI for the detection of CIN2+. Sensitivity and specificity were 84.0% and 78.6%, respectively, for VIA and 84.2% and 76.4% for VILI. The positive and negative predictive values were 24.7% and 98.3% for VIA, and 31.7% and 97.4% for VILI. Among women with CD4+ count < 350, VILI had a significantly decreased specificity (66.2%) compared to VIA in the same group (83.9%, p = 0.02) and compared to VILI performed among women with CD4+ count >= 350 (79.7%, p = 0.02). VIA and VILI had similar diagnostic accuracy and rates of CIN2+ detection among HIV-infected women.	[Huchko, Megan J.; Sneden, Jennifer; Zakaras, Jennifer M.; Smith-McCune, Karen; Sawaya, George; Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Sawaya, George] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Maloba, May; Bukusi, Elizabeth Ann] Kenya Govt Med Res Ctr, Family AIDS Care & Educ Serv, Kisumu, Kenya; [Bukusi, Elizabeth Ann] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Bukusi, Elizabeth Ann] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kenya Medical Research Institute; Kenya Medical Research Institute; University of Nairobi	Huchko, MJ (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA.	megan.huchko@ucsf.edu	Huchko, Megan/S-6063-2019		National Center for Advancing Translational Sciences, National Institutes of Health, through University of California San Francisco's Clinical and Translational Science Institute [KL2 TR000143]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences, National Institutes of Health, through University of California San Francisco's Clinical and Translational Science Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	MH's salary was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through University of California San Francisco's Clinical and Translational Science Institute, Grant Number KL2 TR000143. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adefuye PO, 2013, VACCINE, V31, pF53, DOI 10.1016/j.vaccine.2012.06.070; Belinson JL, 2001, OBSTET GYNECOL, V98, P441, DOI 10.1016/S0029-7844(01)01454-5; Bradford L, 2013, CLIN OBSTET GYNECOL, V56, P76, DOI 10.1097/GRF.0b013e31828237ac; Bruni L, 2019, ICO IARC INFORM CTR; Cervical Cancer Action, 2012, PROGR CERV CANC PREV; Chung MH, 2013, AIDS; De Vuyst H, 2005, INT J GYNECOL OBSTET, V89, P120, DOI 10.1016/j.ijgo.2005.01.035; Ezechi OC, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-5; Ferlay J, 2010, GLOBOCAN 2008 V2 0 C, V10; Firnhaber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053494; Franceschi S, 2007, CLIN INFECT DIS, V45, P510, DOI 10.1086/520022; Ghosh P, 2012, INDIAN J MED RES, V136, P265; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Huchko MJ, 2011, INT J GYNECOL OBSTET, V114, P106, DOI 10.1016/j.ijgo.2011.02.009; Joshi S, 2013, AIDS, V27, P607, DOI 10.1097/QAD.0b013e32835b1041; Kenya Ministry of Health and Sanitation and Ministry of Medical Services, 2011, NAT CERV CANC PREV P; Kurman R.J., 2014, WHO CLASSIFICATION T, V4th; Lewis KCL, 2011, AFR HEALTH SCI, V11, P362; Maiman M, 1998, GYNECOL ONCOL, V68, P233, DOI 10.1006/gyno.1998.4938; Muwonge R, 2010, INT J GYNECOL OBSTET, V111, P68, DOI 10.1016/j.ijgo.2010.04.024; Ngoma T, 2010, INT J GYNECOL OBSTET, V109, P100, DOI 10.1016/j.ijgo.2009.11.025; Pretorius RG, 2004, AM J OBSTET GYNECOL, V191, P430, DOI 10.1016/j.ajog.2004.02.065; Pretorius RG, 2012, J LOW GENIT TRACT DI, V16, P333, DOI 10.1097/LGT.0b013e3182480c18; Sahasrabuddhe VV, 2012, INT J CANCER, V130, P234, DOI 10.1002/ijc.25971; Sankaranarayanan R, 2003, INT J CANCER, V106, P404, DOI 10.1002/ijc.11245; Sankaranarayanan R, 2004, INT J CANCER, V110, P907, DOI 10.1002/ijc.20190; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Shastri SS, 2005, B WORLD HEALTH ORGAN, V83, P186; Sherris J, 2009, INT PERSPECT SEX R H, V35, P147, DOI [10.1363/3514709, 10.1363/ifpp.35.147.09]; WHO, 2013, WHO GUID SCREEN TREA; World Health Organization, 2007, MOD 2 INTR STI S TI, V2nd; World Health Organization and International Agency for Research on Cancer, 2012, PREV CERV CANC SCREE; Wright TC, 2002, OBSTET GYN CLIN N AM, V29, P701, DOI 10.1016/S0889-8545(02)00045-1	34	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0118568	10.1371/journal.pone.0118568	http://dx.doi.org/10.1371/journal.pone.0118568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849627	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800006
J	Liong, S; Lappas, M				Liong, Stella; Lappas, Martha			Endoplasmic Reticulum Stress Is Increased in Adipose Tissue of Women with Gestational Diabetes	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; POLYCYSTIC-OVARY-SYNDROME; ER STRESS; INFLAMMASOME ACTIVATION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; P2X(7) RECEPTOR; HUMAN PLACENTA; OBESITY; MELLITUS	Maternal obesity and gestational diabetes mellitus (GDM) are two increasingly common and important obstetric complications that are associated with severe long-term health risks to mothers and babies. IL-1 beta, which is increased in obese and GDM pregnancies, plays an important role in the pathophysiology of these two pregnancy complications. In non-pregnant tissues, endoplasmic (ER) stress is increased in diabetes and can induce IL-1 beta via inflammasome activation. The aim of this study was to determine whether ER stress is increased in omental adipose tissue of women with GDM, and if ER stress can also upregulate inflammasome-dependent secretion of IL-1 beta. ER stress markers IRE1 alpha, GRP78 and XBP-1s were significantly increased in adipose tissue of obese compared to lean pregnant women. ER stress was also increased in adipose tissue of women with GDM compared to BMI-matched normal glucose tolerant (NGT) women. Thapsigargin, an ER stress activator, induced upregulated secretion of mature IL-1 alpha and IL-1 beta in human omental adipose tissue explants primed with bacterial endotoxin LPS, the viral dsRNA analogue poly(I:C) or the pro-inflammatory cytokine TNF-alpha. Inhibition of capase-1 with Ac-YVAD-CHO resulted in decreased IL-1 alpha and IL-1 beta secretion, whereas inhibition of pannexin-1 with carbenoxolone suppressed IL-1 beta secretion only. Treatment with anti-diabetic drugs metformin and glibenclamide also reduced IL-1 alpha and IL-1 beta secretion in infection and cytokine-primed adipose tissue. In conclusion, this study has demonstrated ER stress to activate the inflammasome in pregnant adipose tissue. Therefore, increased ER stress may contribute towards the pathophysiology of obesity in pregnancy and GDM.	[Liong, Stella; Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Heidelberg, Vic, Australia; [Liong, Stella; Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia	University of Melbourne	Lappas, M (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Heidelberg, Vic, Australia.	mlappas@unimelb.edu.au	Liong, Stella/AAQ-5308-2021	Liong, Stella/0000-0001-6131-858X	Career Development Fellowship by the National Health and Medical Research Council (NHMRC) [1047025]; Medical Research Foundation for Women and Babies; Diabetes Australia Research Trust (DART)	Career Development Fellowship by the National Health and Medical Research Council (NHMRC); Medical Research Foundation for Women and Babies; Diabetes Australia Research Trust (DART)	Associate Professor Martha Lappas is supported by a Career Development Fellowship by the National Health and Medical Research Council (NHMRC; grant no. 1047025). This work was funded by grants from the Medical Research Foundation for Women and Babies and Diabetes Australia Research Trust (DART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalifah R, 2012, J CLIN NEONATOL, V1, P29, DOI 10.4103/2249-4847.92241; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BOYD AE, 1988, DIABETES, V37, P847, DOI 10.2337/diabetes.37.7.847; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Choi AMK, 2011, NAT IMMUNOL, V12, P379, DOI 10.1038/ni.2028; Colomiere M, 2010, J MOL ENDOCRINOL, V44, P213, DOI 10.1677/JME-09-0091; Dhurandhar NV, 1997, OBES RES, V5, P464, DOI 10.1002/j.1550-8528.1997.tb00672.x; ELLIOTT BD, 1991, AM J OBSTET GYNECOL, V165, P807, DOI 10.1016/0002-9378(91)90421-M; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072344; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Giannarelli R, 2003, DIABETES METAB, V29, pS28; Hata N, 2008, CLIN OPHTHALMOL, V2, P743; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kewcharoenwong C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03363; Kim S, 2013, INNATE IMMUNITY; Kim S, 2013, INNATE IMMUN; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lappas M, 2005, J ENDOCRINOL, V186, P457, DOI 10.1677/joe.1.06227; Lappas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115854; Lappas M, 2014, J ENDOCRINOL, V222, P99, DOI 10.1530/JOE-14-0179; Lappas M, 2014, METABOLISM, V63, P860, DOI 10.1016/j.metabol.2014.03.007; Lappas M, 2014, MOL CELL ENDOCRINOL, V382, P74, DOI 10.1016/j.mce.2013.09.011; Lautatzis ME, 2013, METABOLISM, V62, P1522, DOI 10.1016/j.metabol.2013.06.006; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499; Mitanchez D, 2010, DIABETES METAB, V36, P617, DOI 10.1016/j.diabet.2010.11.013; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Osborn O, 2008, SWISS MED WKLY, V138, P665, DOI /aop/smw-aop12276; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2008, DRUG NEWS PERSPECT, V21, P424, DOI 10.1358/dnp.2008.21.8.1265800; Perkins JM, 2007, CLIN DIABETES, V25, P57; Rosa JS, 2008, PEDIATR DIABETES, V9, P9, DOI 10.1111/j.1399-5448.2007.00243.x; Rosenn B, 2008, J MATERN-FETAL NEO M, V21, P159, DOI 10.1080/14767050801929455; Rowan JA, 2011, DIABETES CARE, V34, P2279, DOI 10.2337/dc11-0660; Sage AT, 2012, OBESITY, V20, P748, DOI 10.1038/oby.2011.144; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; SOBEL DO, 1992, DIABETES, V41, P515, DOI 10.2337/diabetes.41.4.515; Tertti K, 2014, ACTA DIABETOL; Um JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029524; Vanky E, 2005, FERTIL STERIL, V83, P1575, DOI 10.1016/j.fertnstert.2004.11.051; Vassiliadis S, 1999, MEDIAT INFLAMM, V8, P85, DOI 10.1080/09629359990577; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zeng YC, 2014, ADV MED SCI-POLAND, V59, P95, DOI 10.1016/j.advms.2014.03.001	52	37	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122633	10.1371/journal.pone.0122633	http://dx.doi.org/10.1371/journal.pone.0122633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849717	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800151
J	Mahapatra, T; Mahapatra, S; Banerjee, B; Mahapatra, U; Samanta, S; Pal, D; Chakraborty, ND; Manna, B; Sur, D; Kanungo, S				Mahapatra, Tanmay; Mahapatra, Sanchita; Banerjee, Barnali; Mahapatra, Umakanta; Samanta, Sandip; Pal, Debottam; Chakraborty, Nandini Datta; Manna, Byomkesh; Sur, Dipika; Kanungo, Suman			Predictors of Rational Management of Diarrhea in an Endemic Setting: Observation from India	PLOS ONE			English	Article							HEALTH-SEEKING BEHAVIOR; ANTIBIOTIC USE; PRESCRIBING PRACTICES; CHILDHOOD DIARRHEA; RURAL BANGLADESH; CARE PROVIDERS; URBAN SLUMS; KNOWLEDGE; RESISTANCE; CHILDREN	Background Decades after the establishment of clear guidelines for management, mostly due to irrational approach, diarrhea is still a major concern in the developing world, including India. The scenario is even worse in urban slums owing to poor health-seeking and socio-environmental vulnerability. Determining the distribution of rational diarrhea management by practitioners and identification of its important predictors seemed urgent to minimize the potential for antibiotic resistance, diarrhea-related mortality and morbidity in these areas. Methods Between May 2011 and January 2012, 264 consenting, randomly selected qualified and non-qualified practitioners (including pharmacists) were interviewed in the slums of Kolkata, a populous city in eastern India, regarding their characteristics, diarrhea-related knowledge (overall and in six separate domains: signs/symptoms, occurrence/spread, management, prevention/control, cholera and ORS), prescribed antibiotics, intravenous fluid (IVF) and laboratory investigations. Rationality was established based on standard textbooks. Results Among participants, 53.03% had no medical qualifications, 6.06% were attached to Governmental hospitals, 19.32% had best knowledge regarding diarrhea. While treating diarrhea, 7.20%, 17.80% and 20.08% respectively advised antibiotics, IVF and laboratory tests rationally. Logistic regression revealed that qualified and Governmental-sector practitioners managed diarrhea more rationally. Having best diarrhea-related knowledge regarding signs/symptoms (OR=5.49, p value=0.020), occurrence/spread (OR=3.26, p value=0.035) and overall (OR=6.82, p value=0.006) were associated with rational antibiotic prescription. Rational IVF administration was associated with best knowledge regarding diarrheal signs/symptoms (OR=3.00, p value=0.017), occurrence/spread (OR=3.57, p value=0.004), prevention/control (OR=4.89, p value=0.037), ORS (OR=2.55, p value=0.029) and overall (OR=4.57, p value<0.001). Best overall (OR=2.68, p value=0.020) and cholera-related knowledge (OR=2.34, p value=0.019) were associated with rational laboratory testing strategy. Conclusion Diarrheal management practices were unsatisfactory in urban slums where practitioners' knowledge was a strong predictor for rational management. Interventions targeting non-qualified, independent practitioners to improve their diarrhea-related knowledge seemed to be required urgently to ensure efficient management of diarrhea in these endemic settings.	[Mahapatra, Tanmay; Mahapatra, Sanchita; Pal, Debottam; Chakraborty, Nandini Datta; Sur, Dipika; Kanungo, Suman] Natl Inst Cholera & Enter Dis, Dept Epidemiol, Scheme XM, Kolkata 700010, W Bengal, India; [Banerjee, Barnali; Manna, Byomkesh] Natl Inst Cholera & Enter Dis, Dept Data Management, Scheme XM, Kolkata 700010, W Bengal, India; [Mahapatra, Umakanta] Midnapore Med Coll & Hosp, Dept Gen Med, Medinipur 721101, W Bengal, India; [Samanta, Sandip] Dr BC Roy Mem Hosp Children, Dept Pediat, Kolkata 700005, W Bengal, India; [Sur, Dipika] PATH India Off, New Delhi 110067, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Midnapore Medical College	Kanungo, S (corresponding author), Natl Inst Cholera & Enter Dis, Dept Epidemiol, Scheme XM, P-33,CIT Rd, Kolkata 700010, W Bengal, India.	sumankanungo@gmail.com	Kanungo, Sloka/HHM-7508-2022	Kanungo, Suman/0000-0003-4441-4443	Institutional Intramural Funding of National Institute of Cholera and Enteric Diseases, Kolkata, Government of India [IM/SK/09-10/40]	Institutional Intramural Funding of National Institute of Cholera and Enteric Diseases, Kolkata, Government of India	This work was supported by the Institutional Intramural Funding (IM/SK/09-10/40) of National Institute of Cholera and Enteric Diseases, Kolkata, Government of India (http://www.niced.org.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2007, HEALTH POLICY, V84, P332, DOI 10.1016/j.healthpol.2007.05.011; [Anonymous], 2004, MED RATIONAL USE MED; BAPNA JS, 1992, EUR J CLIN PHARMACOL, V43, P413, DOI 10.1007/BF02220618; Basu S, 2008, NIGER J CLIN PRACT, V11, P52; Behrman RE, 2004, NELSONS TXB PEDIAT; Bharathiraja R., 2005, Indian Journal of Pediatrics, V72, P877, DOI 10.1007/BF02731121; BOJALIL R, 1994, J CLIN EPIDEMIOL, V47, P147, DOI 10.1016/0895-4356(94)90019-1; Chakraborti S, 2011, INDIAN PEDIATR, V48, P811, DOI 10.1007/s13312-011-0125-7; Das B. P., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1562; Das SK, 2013, AM J TROP MED HYG, V89, P62, DOI 10.4269/ajtmh.13-0107; DEAN AG, 2000, DATABASE STAT PROGRA; Dekate P, 2013, INDIAN J PEDIATR, V80, P235, DOI 10.1007/s12098-012-0909-3; Ecker Lucie, 2013, Rev. perú. med. exp. salud publica, V30, P181; Gaash B., 2008, INDIAN J PRACTISING, V5; Ganguly NK, 2011, INDIAN J MED RES, V134, P281; GREENHALGH T, 1987, SOC SCI MED, V25, P307, DOI 10.1016/0277-9536(87)90233-4; GUTIERREZ G, 1994, MED CARE, V32, P436, DOI 10.1097/00005650-199405000-00003; Hardman J. G., 2001, GOODMAN GILMANS PHAR; Hennessy TW, 2004, CLIN INFECT DIS, V38, pS203, DOI 10.1086/381588; Hussain S, 2011, AFR J PHARM PHARMACO, V5, P1484, DOI 10.5897/AJPP11.242; Kanungo S, 2014, EPIDEMIOL INFECT, V142, P314, DOI 10.1017/S0950268813001076; Karras DJ, 2003, ANN EMERG MED, V42, P835, DOI 10.1016/S0196-0644(03)00602-4; Kiang KM, 2005, EMERG INFECT DIS, V11, P904, DOI 10.3201/eid1106.05144; Kristiansson C, 2008, TROP MED INT HEALTH, V13, P434, DOI 10.1111/j.1365-3156.2008.02019.x; Laxminarayan R, 2014, SCIENCE, V345, P1299, DOI 10.1126/science.1254163; Longo DL, 2012, HARRISONS PRINCIPLES; Mahajan V, 2012, INDIAN PEDIATR, V49, P963, DOI 10.1007/s13312-012-0251-x; Manna B, 2013, AM J TROP MED HYG, V89, P56, DOI 10.4269/ajtmh.12-0756; Mansourian A. R., 2007, Journal of Medical Sciences (Pakistan), V7, P427; McNulty CAM, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-77; Mebratie AD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004020; Mittal SK, 2001, J PEDIATR GASTR NUTR, V33, pS26, DOI 10.1097/00005176-200110002-00005; Mukherjee P, 2014, ANTIMICROB AGENTS CH, V58, P4248, DOI 10.1128/AAC.02931-14; Nair GB, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-4; Okeke TA, 1996, J DIARRHOEAL DIS RES, V14, P33; Ouyang-Latimer J, 2011, ANTIMICROB AGENTS CH, V55, P874, DOI 10.1128/AAC.00739-10; Paredes P, 1996, SOC SCI MED, V42, P1141, DOI 10.1016/0277-9536(95)00387-8; Patel V, 2005, J Postgrad Med, V51, P9; Raghunath D, 2008, J BIOSCIENCES, V33, P593, DOI 10.1007/s12038-008-0077-9; Reardon S, 2014, NATURE, V509, P141, DOI 10.1038/509141a; Riaz H, 2011, AFR J PHARM PHARMACO, V5, P596, DOI 10.5897/AJPP11.051; Riddle MS, 2005, MIL MED, V170, P492, DOI 10.7205/MILMED.170.6.492; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Salazar-Lindo E, 1991, J DIARRHOEAL DIS RES, P227; SCHORLING JB, 1991, INT J EPIDEMIOL, V20, P293, DOI 10.1093/ije/20.1.293; Seyal T, 2009, ANNALS, V1, P38; Siddiqi S, 2002, INT J HEALTH PLAN M, V17, P23, DOI 10.1002/hpm.650; Smorenberg A, 2013, PERIOPER MED, V2, DOI 10.1186/2047-0525-2-17; Sosa A, 2002, PHYS ANTIBIOTIC PRES; Supcharassaeng Surachai, 2011, Journal of the Medical Association of Thailand, V94, P545; Sur D, 2001, J Indian Med Assoc, V99, P587; Sur Dipika, 2006, J Indian Med Assoc, V104, P220; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Wattal Chand, 2010, J Assoc Physicians India, V58 Suppl, P32; Webair HH, 2013, PATIENT PREFER ADHER, V7, P1129, DOI 10.2147/PPA.S51124; WHO, 2004, WORLD MED SIT; World Health Organization, 2014, ANT RES GLOB REP SUR; Zaidi S Shujaat H, 2006, J Coll Physicians Surg Pak, V16, P245	58	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123479	10.1371/journal.pone.0123479	http://dx.doi.org/10.1371/journal.pone.0123479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849617	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800235
J	Wasserman, JK; Nicholas, G; Yaworski, R; Wasserman, AM; Woulfe, JM; Jansen, GH; Chakraborty, S; Nguyen, TB				Wasserman, Jason K.; Nicholas, Garth; Yaworski, Rebecca; Wasserman, Anne-Marie; Woulfe, John M.; Jansen, Gerard H.; Chakraborty, Santanu; Nguyen, Thanh B.			Radiological and Pathological Features Associated with IDH1-R132H Mutation Status and Early Mortality in Newly Diagnosed Anaplastic Astrocytic Tumours	PLOS ONE			English	Article							IDH2 MUTATIONS; 2-HYDROXYGLUTARATE; SURVIVAL; GLIOBLASTOMA; TEMOZOLOMIDE; METHYLATION; GLIOMAS; CELL	Background Glioblastoma can occur either de novo or by the transformation of a low grade tumour; the majority of which harbor a mutation in isocitrate dehydrogenase (IDH1). Anaplastic tumours are high-grade gliomas that may represent the final step in the evolution of a secondary glioblastoma or the initial presentation of an early primary glioblastoma. We sought to determine whether pathological and/or radiological variables exist that can reliably distinguish IDH1-R132H-positive from IDH1-R132H-negative tumours and to identify variables associated with early mortality. Methods Patients diagnosed with anaplastic astrocytic tumours were included. Magnetic resonance imaging was performed and immunohistochemistry was used to identify tumours with the IDH1-R132H mutation. Survival was assessed 12 months after diagnosis. Variables associated with IDH1-R132H status were identified by univariate and ROC analysis. Results 37 gliomas were studied; 18 were positive for the IDH1-R132H mutation. No tumours demonstrated a combined loss of chromosomes 1p/19q. Patients with IDH1-R132H-positive tumours were less likely to die within 12 months of diagnosis (17% vs. 47%; p = 0.046), more likely to have tumours located in the frontal lobe (55% vs. 16%; p = 0.015), and have a higher minimum apparent diffusion coefficient (1.115 x 10(-3) mm(2)/sec vs. 0.838 x 10(-3) mm(2)/sec; p = 0.016), however, these variables demonstrated only moderate strength for predicting the IDH1-R132H mutation status (AUC = 0.735 and 0.711, respectively). The Ki-67 index was significantly lower in IDH1-R132H-positive tumours (0.13 vs. 0.21; p = 0.034). An increased risk of death was associated with contrast-enhancement >= 5 cm(3) in patients with IDH1-R132H-positive tumours while edema >= 1 cm beyond the tumour margin and <5 mitoses/mm(2) were associated with an increased risk of death in patients with IDH1-R132H-negative tumours. Conclusions IDH1-R132H-positive and -negative anaplastic tumours demonstrate unique features. Factors associated with early mortality are also dependent on IDH1-R132H status and can be used to identify patients at high risk for death.	[Wasserman, Jason K.; Yaworski, Rebecca; Woulfe, John M.; Jansen, Gerard H.; Nguyen, Thanh B.] Dept Anat Pathol, Div Lab Med, Ottawa, ON, Canada; [Nicholas, Garth; Wasserman, Anne-Marie] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada; [Chakraborty, Santanu] Dept Med Imaging, Div Neuroimaging, Ottawa, ON, Canada; [Wasserman, Jason K.; Nicholas, Garth; Woulfe, John M.; Jansen, Gerard H.; Chakraborty, Santanu; Nguyen, Thanh B.] Univ Ottawa, Ottawa, ON, Canada; [Wasserman, Jason K.; Nicholas, Garth; Woulfe, John M.; Jansen, Gerard H.; Chakraborty, Santanu; Nguyen, Thanh B.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Nguyen, TB (corresponding author), Dept Anat Pathol, Div Lab Med, Ottawa, ON, Canada.	thnguyen@toh.on.ca		Chakraborty, Santanu/0000-0002-2975-2260				Beiko J, 2014, NEURO-ONCOLOGY, V16, P81, DOI 10.1093/neuonc/not159; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Carrillo JA, 2012, AM J NEURORADIOL, V33, P1349, DOI 10.3174/ajnr.A2950; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Faguer R, 2014, NEURO CHIRURGIE; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Jiang HH, 2013, NEURO-ONCOLOGY, V15, P775, DOI 10.1093/neuonc/not027; Jiang HH, 2013, J NEURO-ONCOL, V111, P367, DOI 10.1007/s11060-012-1026-x; Kitis O, 2005, EUR J RADIOL, V55, P393, DOI 10.1016/j.ejrad.2005.02.004; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2014, BRAIN PATHOL, V24, P429, DOI 10.1111/bpa.12171; Metellus P, 2010, ACTA NEUROPATHOL, V120, P719, DOI 10.1007/s00401-010-0777-8; Minniti G, 2014, J NEURO-ONCOL, V118, P377, DOI 10.1007/s11060-014-1443-0; Murakami R, 2009, RADIOLOGY, V251, P838, DOI 10.1148/radiol.2513080899; Norden AD, 2008, LANCET NEUROL, V7, P1152, DOI 10.1016/S1474-4422(08)70260-6; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Pope WB, 2012, J NEURO-ONCOL, V107, P197, DOI 10.1007/s11060-011-0737-8; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Shi JL, 2014, NEUROL SCI, V35, P839, DOI 10.1007/s10072-013-1607-2; Shibahara I, 2012, INT J CLIN ONCOL, V17, P551, DOI 10.1007/s10147-011-0323-2; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; van den Bent MJ, 2013, J NEURO-ONCOL, V112, P173, DOI 10.1007/s11060-013-1056-z; Wang JB, 2014, ONCOL LETT, V7, P651, DOI 10.3892/ol.2014.1806; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	31	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123890	10.1371/journal.pone.0123890	http://dx.doi.org/10.1371/journal.pone.0123890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849605	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800258
J	Ziegler, A; Schock-Kusch, D; Bopp, D; Dounia, S; Radle, M; Stahl, U				Ziegler, Andreas; Schock-Kusch, Daniel; Bopp, Dominik; Dounia, Sandra; Raedle, Matthias; Stahl, Ulf			Single Bacteria Movement Tracking by Online Microscopy - A Proof of Concept Study	PLOS ONE			English	Article							MULTIPARAMETER FLOW-CYTOMETRY; ESCHERICHIA-COLI W3110; PHYSIOLOGICAL-STATE; BACILLUS-SUBTILIS; CELL-DENSITY; FED-BATCH; MOTILITY; FERMENTATIONS; SURFACE	In this technical report we demonstrate a low-cost online unit allowing movement tracking of flagellated bacteria on a single-cell level during fermentation processes. The system's ability to distinguish different metabolic states (viability) of bacteria by movement velocity was investigated. A flow-through cuvette with automatically adjustable layer thickness was developed. The cuvette can be used with most commercially available laboratory microscopes equipped with 40x amplification and a digital camera. In addition, an automated sample preparation unit and a software module was developed measuring size, moved distance, and speed of bacteria. In a proof of principle study the movement velocities of Bacillus amyloliquefaciens FZB42 during three batch fermentation processes were investigated. In this process the bacteria went through different metabolic states, vegetative growth, diauxic shift, vegetative growth after diauxic shift, and sporulation. It was shown that the movement velocities during the different metabolic states significantly differ from each other. Therefore, the described setup has the potential to be used as a bacteria viability monitoring tool. In contrast to some other techniques, such as electro-optical techniques, this method can even be used in turbid production media.	[Ziegler, Andreas; Schock-Kusch, Daniel; Bopp, Dominik; Raedle, Matthias] Mannheim Univ Appl Sci, Inst Proc Control & Innovat Energy Convers, Mannheim, Germany; [Dounia, Sandra; Stahl, Ulf] Berlin Univ Technol, Dept Appl & Mol Microbiol, Berlin, Germany; [Dounia, Sandra; Stahl, Ulf] Res & Teaching Inst Brewing Berlin, Res Inst Special Microbiol, Berlin, Germany	Technical University of Berlin	Ziegler, A (corresponding author), Mannheim Univ Appl Sci, Inst Proc Control & Innovat Energy Convers, Mannheim, Germany.	a.ziegler@hs-mannheim.de			Federal Ministry for Economic Affairs and Energy [HS-Mannheim: KF 2035730UL1, TU Berlin: KF 2503705UL1]	Federal Ministry for Economic Affairs and Energy	The study was funded by the Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag (URL: http://www.aif.de/innovationsfoerderung/zim-kooperationen.html, Grant Numbers: HS-Mannheim: KF 2035730UL1 TU Berlin: KF 2503705UL1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Absi NR, 2003, CYTOM PART A, V51A, P87, DOI 10.1002/cyto.a.10016; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Broger T, 2011, J BIOTECHNOL, V154, P240, DOI 10.1016/j.jbiotec.2011.05.003; Brognaux A, 2013, J IND MICROBIOL BIOT, V40, P679, DOI 10.1007/s10295-013-1271-9; Davey HM, 2011, APPL ENVIRON MICROB, V77, P5571, DOI 10.1128/AEM.00744-11; Enfors SO, 2001, J BIOTECHNOL, V85, P175, DOI 10.1016/S0168-1656(00)00365-5; FRYMIER PD, 1995, P NATL ACAD SCI USA, V92, P6195, DOI 10.1073/pnas.92.13.6195; Grossart HP, 2001, AQUAT MICROB ECOL, V25, P247, DOI 10.3354/ame025247; Hammes F, 2012, CYTOM PART A, V81A, P508, DOI 10.1002/cyto.a.22048; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Herwig H, 2008, STROMUNGSMECHANIK EI, P163; Hewitt CJ, 1999, BIOTECHNOL BIOENG, V63, P705, DOI 10.1002/(SICI)1097-0290(19990620)63:6<705::AID-BIT8>3.0.CO;2-M; Hewitt CJ, 1999, J BIOTECHNOL, V75, P251, DOI 10.1016/S0168-1656(99)00168-6; Hewitt CJ, 2001, CYTOMETRY, V44, P179, DOI 10.1002/1097-0320(20010701)44:3<179::AID-CYTO1110>3.0.CO;2-D; Hopfner T, 2010, BIOPROC BIOSYST ENG, V33, P247, DOI 10.1007/s00449-009-0319-8; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; J. R. POSTGATE, 1969, Methods in microbiology. Vol. 1, P611, DOI 10.1016/S0580-9517(08)70149-1; Junne S, 2008, BIOTECHNOL BIOENG, V99, P862, DOI 10.1002/bit.21639; Junne S, 2010, J IND MICROBIOL BIOT, V37, P935, DOI 10.1007/s10295-010-0742-5; Karim QN, 1998, J CLIN PATHOL, V51, P623, DOI 10.1136/jcp.51.8.623; Krebs B, 1998, Z PFLANZENK PFLANZEN, V105, P181; Kudo S, 2005, FEMS MICROBIOL LETT, V242, P221, DOI 10.1016/j.femsle.2004.11.007; Lourenco ND, 2012, ANAL BIOANAL CHEM, V404, P1211, DOI 10.1007/s00216-012-6073-9; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; Mendelson NH, 1999, J BACTERIOL, V181, P600, DOI 10.1128/JB.181.2.600-609.1999; Muller S, 2010, FEMS MICROBIOL REV, V404, P1618; Ping LY, 2012, SCI CHINA LIFE SCI, V55, P202, DOI 10.1007/s11427-012-4298-7; PRIEST FG, 1987, INT J SYST BACTERIOL, V37, P69, DOI 10.1099/00207713-37-1-69; Rudolph G, 2009, ADV BIOCHEM ENG BIOT, V116, P125, DOI 10.1007/10_2009_12; Sonnleitner B, 2013, ADV BIOCHEM ENG BIOT, V132, P1, DOI 10.1007/10_2012_173; STOCKER BAD, 1959, J GEN MICROBIOL, V20, P670, DOI 10.1099/00221287-20-3-670; Stoylov SP, 2009, BIOELECTROCHEMISTRY, V75, P50, DOI 10.1016/j.bioelechem.2009.02.001; Surek D, 2007, ANGEWANDTE STROMUNGS, P71; Vater SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087765; Vigeant MAS, 1997, APPL ENVIRON MICROB, V63, P3474, DOI 10.1128/AEM.63.9.3474-3479.1997	35	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122531	10.1371/journal.pone.0122531	http://dx.doi.org/10.1371/journal.pone.0122531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849813	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800140
J	Hu, T; Li, X; Zhang, QH; Huang, KC; Jia, Y; Yang, R; Tang, FX; Tian, Q; Ma, D; Li, S				Hu, Ting; Li, Xiong; Zhang, Qinghua; Huang, Kecheng; Jia, Yao; Yang, Ru; Tang, Fangxu; Tian, Qiang; Ma, Ding; Li, Shuang			Could the Extent of Lymphadenectomy Be Modified by Neoadjuvant Chemotherapy in Cervical Cancer? A Large-Scale Retrospective Study	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; CELL CARCINOMA ANTIGEN; STAGE-IB; CYCLOOXYGENASE-2 EXPRESSION; PROGNOSTIC-SIGNIFICANCE; RADICAL HYSTERECTOMY; RANDOMIZED-TRIAL; FOLLOW-UP; IIA; CISPLATIN	Background The effect of neoadjuvant chemotherapy (NACT) on topographical distribution patterns of lymph node metastasis in cervical cancer was unknown. Methods Patients with FIGO stage IB1-IIB who underwent radical surgery with or without NACT were enrolled (3527 patients). A matched-case comparison design was used to compare the effects of NACT on lymph node metastasis. Results We analyzed groups of 167 and 140 patients who were diagnosed with lymph node metastasis in the matched primary surgery group and NACT group, respectively, and no significant difference was observed (p = 0.081). The incidence of lymph node metastasis was significantly decreased in the NACT-responsive group compared to the non-responsive group (18.4% vs. 38.6%, P < 0.001). The metastatic rates for every lymph node group also declined in the NACT-responsive group except for the deep inguinal and the para-aortic lymph node groups. Clinical response, deep stromal, parametrial and lymph vascular invasions were independent risk factors for lymph node metastasis in the NACT group. Furthermore, deep stromal invasion and lymph vascular invasion, but not the response to NACT, were independently associated with upper LNM. The number of lymph nodes involved, response to NACT, tumor histology and a positive vaginal margin were independent prognostic factors affecting DFS or OS rates in node-positive patients treated with NACT plus radical surgery. Conclusion The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless of the response to NACT.	[Hu, Ting; Li, Xiong; Zhang, Qinghua; Huang, Kecheng; Jia, Yao; Yang, Ru; Tang, Fangxu; Ma, Ding; Li, Shuang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China; [Zhang, Qinghua] Cent Hosp Wuhan, Dept Gynecol & Obstet, Wuhan, Peoples R China; [Tian, Qiang] Inst Syst Biol, Seattle, WA 98109 USA	Huazhong University of Science & Technology; Institute for Systems Biology (ISB)	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China.	lee5190008@126.com; dma@tjh.tjmu.edu.cn	li, xiong/ABG-2578-2020	li, xiong/0000-0003-0203-2973; Li, Shuang/0000-0002-9193-0320	Key Basic Research and Development Program Foundation of China (973 Program) [2009CB521808]; National Natural Science Foundation of China [81230038, 81230052, 30973472, 81001151, 81071663, 30973205, 30973184, 81172464, 81101964]; National Major Science and Technology Project [2009ZX09103-739]	Key Basic Research and Development Program Foundation of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Science and Technology Project	This study was endorsed by the Key Basic Research and Development Program Foundation of China (973 Program; No. 2009CB521808) and was supported by grants from the National Natural Science Foundation of China (Nos. 81230038; 81230052; 30973472; 81001151; 81071663; 30973205; 30973184; 81172464; 81101964) and National Major Science and Technology Project (No. 2009ZX09103-739).	Behtash N, 2006, EJSO-EUR J SURG ONC, V32, P1226, DOI 10.1016/j.ejso.2006.07.012; Benedetti-Panici P, 2003, EUR J CANCER, V39, P2470, DOI 10.1016/S0959-8049(03)00425-8; BenedettiPanici P, 1996, GYNECOL ONCOL, V62, P19, DOI 10.1006/gyno.1996.0184; Chen HJ, 2008, GYNECOL ONCOL, V110, P308, DOI 10.1016/j.ygyno.2008.05.026; Duk JM, 1996, J CLIN ONCOL, V14, P111, DOI 10.1200/JCO.1996.14.1.111; Eddy GL, 2007, GYNECOL ONCOL, V106, P362, DOI 10.1016/j.ygyno.2007.04.007; Ferrandina G, 2002, J CLIN ONCOL, V20, P973, DOI 10.1200/JCO.20.4.973; Gien LT, 2009, J SURG ONCOL, V99, P242, DOI 10.1002/jso.21199; Goff BA, 1999, GYNECOL ONCOL, V74, P436, DOI 10.1006/gyno.1999.5472; HENRIKSEN E, 1949, AM J OBSTET GYNECOL, V58, P924, DOI 10.1016/0002-9378(49)90200-8; Hu T, 2012, EUR J CANCER, V48, P2353, DOI 10.1016/j.ejca.2012.03.015; Huang H, 2011, EJSO-EUR J SURG ONC, V37, P978, DOI 10.1016/j.ejso.2011.08.128; INOUE T, 1990, CANCER, V65, P1923, DOI 10.1002/1097-0142(19900501)65:9<1923::AID-CNCR2820650909>3.0.CO;2-M; Kim HS, 2011, GYNECOL ONCOL, V121, P551, DOI 10.1016/j.ygyno.2011.01.024; Kim HS, 2010, GYNECOL ONCOL, V119, P217, DOI 10.1016/j.ygyno.2010.06.017; Kim K, 2009, MED HYPOTHESES, V73, P1005, DOI 10.1016/j.mehy.2009.05.026; Lee JM, 2007, J OBSTET GYNAECOL RE, V33, P288, DOI 10.1111/j.1447-0756.2007.00526.x; Lee JY, 2011, ARCH GYNECOL OBSTET, V284, P477, DOI 10.1007/s00404-010-1685-9; MONK BJ, 1994, GYNECOL ONCOL, V54, P4, DOI 10.1006/gyno.1994.1157; Mossa B, 2010, EUR J GYNAECOL ONCOL, V31, P497; NAMKOONG SE, 1995, GYNECOL ONCOL, V59, P136, DOI 10.1006/gyno.1995.1280; Organization WH, WHO HDB REP RES CANC; Park TK, 2001, INT J GYNECOL CANCER, V11, P475, DOI 10.1046/j.1525-1438.2001.01057.x; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; PILLERON JP, 1974, AM J OBSTET GYNECOL, V119, P458, DOI 10.1016/0002-9378(74)90201-4; Ryu HS, 2007, INT J GYNECOL CANCER, V17, P132, DOI 10.1111/j.1525-1438.2007.00803.x; Ryu HS, 2000, GYNECOL ONCOL, V76, P320, DOI 10.1006/gyno.1999.5690; Sakuragi N, 1999, CANCER, V85, P1547, DOI 10.1002/(SICI)1097-0142(19990401)85:7<1547::AID-CNCR16>3.0.CO;2-2; Sardi JE, 1997, GYNECOL ONCOL, V67, P61, DOI 10.1006/gyno.1997.4812; SCAMBIA G, 1994, J CLIN ONCOL, V12, P2309, DOI 10.1200/JCO.1994.12.11.2309; STEHMAN FB, 1991, CANCER, V67, P2776, DOI 10.1002/1097-0142(19910601)67:11<2776::AID-CNCR2820671111>3.0.CO;2-L; Xiong Y, 2011, GYNECOL ONCOL, V123, P99, DOI 10.1016/j.ygyno.2011.06.011	32	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123539	10.1371/journal.pone.0123539	http://dx.doi.org/10.1371/journal.pone.0123539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859857	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300103
J	Ji, WJ; Zhao, B				Ji, Wenjing; Zhao, Bin			Estimating Mortality Derived from Indoor Exposure to Particles of Outdoor Origin	PLOS ONE			English	Article							FINE PARTICULATE MATTER; LONG-TERM EXPOSURE; AIR-POLLUTION; PERSONAL EXPOSURE; GLOBAL BURDEN; CARDIOVASCULAR MORTALITY; AIRBORNE PARTICLES; AMBIENT PM2.5; LUNG-CANCER; TIME-SERIES	Following an extensive review of the literature, we further analyze the published data to examine the health effects of indoor exposure to particulate matter (PM) of outdoor origin. We obtained data on all-cause, cardiovascular, and respiratory mortality per 10 mu g/m(3) increase in outdoor PM10 or PM2.5; the infiltration factors for buildings; and estimated time spent outdoors by individuals in the United States, Europe, China, and globally. These data were combined log-linear exposure-response model to estimate the all-cause, cardiovascular, and respiratory mortality of exposure to indoor PM pollution of outdoor origin. Indoor PM pollution of outdoor origin is a cause of considerable mortality, accounting for 81% to 89% of the total increase in mortality associated with exposure to outdoor PM pollution for the studied regions. The findings suggest that enhancing the capacity of buildings to protect occupants against exposure to outdoor PM pollution has significant potential to improve public health outcomes.	[Ji, Wenjing; Zhao, Bin] Tsinghua Univ, Sch Architecture, Dept Bldg Sci, Beijing 100084, Peoples R China	Tsinghua University	Zhao, B (corresponding author), Tsinghua Univ, Sch Architecture, Dept Bldg Sci, Beijing 100084, Peoples R China.	binzhao@tsinghua.edu.cn	Zhao, Bin/B-5158-2012	Zhao, Bin/0000-0003-1325-6091; Ji, Wenjing/0000-0002-5296-5774	Key Laboratory of Eco Planning AMP; Green Building, Ministry of Education (Tsinghua University), China; Tsinghua National Laboratory for Information Science and Technology (TNList) Crossdiscipline Foundation	Key Laboratory of Eco Planning AMP; Green Building, Ministry of Education (Tsinghua University), China; Tsinghua National Laboratory for Information Science and Technology (TNList) Crossdiscipline Foundation	This study was funded by the special fund of the Key Laboratory of Eco Planning & Green Building, Ministry of Education (Tsinghua University), China and Tsinghua National Laboratory for Information Science and Technology (TNList) Crossdiscipline Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt E, 2000, ENVIRON SCI TECHNOL, V34, P3579, DOI 10.1021/es990348y; Allen R, 2003, ENVIRON SCI TECHNOL, V37, P3484, DOI 10.1021/es021007e; Allen RW, 2012, ENVIRON HEALTH PERSP, V120, P824, DOI 10.1289/ehp.1104447; Anderson HR, 2004, META ANAL TIME SERIE; Anenberg SC, 2010, ENVIRON HEALTH PERSP, V118, P1189, DOI 10.1289/ehp.0901220; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Brook RD, 2013, DIABETES CARE, V36, P3313, DOI 10.2337/dc12-2189; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Cao JJ, 2012, ENVIRON HEALTH PERSP, V120, P373, DOI 10.1289/ehp.1103671; Chen C, 2011, ATMOS ENVIRON, V45, P275, DOI 10.1016/j.atmosenv.2010.09.048; Chen H, 2013, ENVIRON HEALTH PERSP, V121, P804, DOI 10.1289/ehp.1205958; Chen RJ, 2012, AM J EPIDEMIOL, V175, P1173, DOI 10.1093/aje/kwr425; Daniels MJ, 2000, AM J EPIDEMIOL, V152, P397, DOI 10.1093/aje/152.5.397; Diapouli E, 2013, J AIR WASTE MANAGE, V63, P1113, DOI 10.1080/10962247.2013.791649; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DOCKERY DW, 1981, ATMOS ENVIRON, V15, P335, DOI 10.1016/0004-6981(81)90036-6; EVANS JS, 1984, ENVIRON INT, V10, P55, DOI 10.1016/0160-4120(84)90233-2; Hanninen OO, 2004, ATMOS ENVIRON, V38, P6411, DOI 10.1016/j.atmosenv.2004.07.015; Hoek G, 2008, ATMOS ENVIRON, V42, P156, DOI 10.1016/j.atmosenv.2007.09.026; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; Krewski D., 2000, REANALYSIS HARVARD 6; Lachenmyer C, 2000, AEROSOL SCI TECH, V32, P34, DOI 10.1080/027868200303911; Landis MS, 2001, ATMOS ENVIRON, V35, P6511, DOI 10.1016/S1352-2310(01)00407-1; LAVE LB, 1970, SCIENCE, V169, P723, DOI 10.1126/science.169.3947.723; Lazaridis M, 2006, INDOOR AIR, V16, P282, DOI 10.1111/j.1600-0668.2006.00425.x; Lee HS, 1997, ATMOS ENVIRON, V31, P1689, DOI 10.1016/S1352-2310(96)00275-0; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Long CM, 2001, ENVIRON SCI TECHNOL, V35, P2089, DOI 10.1021/es001477d; Meng QY, 2007, ENVIRON SCI TECHNOL, V41, P7315, DOI 10.1021/es070037k; Meng QY, 2009, ATMOS ENVIRON, V43, P5750, DOI 10.1016/j.atmosenv.2009.07.066; Meng QY, 2005, J EXPO ANAL ENV EPID, V15, P17, DOI 10.1038/sj.jea.7500378; Ott W, 2000, J AIR WASTE MANAGE, V50, P1390, DOI 10.1080/10473289.2000.10464169; Ozkaynak H, 1996, J EXPO ANAL ENV EPID, V6, P57; OZKAYNAK H, 1987, RISK ANAL, V7, P449, DOI 10.1111/j.1539-6924.1987.tb00482.x; Ozkaynak H, 1993, 68024544 US EPA RES, VIII; Polidori A, 2007, J AIR WASTE MANAGE, V57, P366, DOI 10.1080/10473289.2007.10465339; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Reff A, 2005, INDOOR AIR, V15, P53, DOI 10.1111/j.1600-0668.2004.00323.x; Sarnat JA, 2007, J EXPO SCI ENV EPID, V17, pS75, DOI 10.1038/sj.jes.7500621; Sarnat SE, 2006, J AIR WASTE MANAGE, V56, P186, DOI 10.1080/10473289.2006.10464449; Schneider T, 2003, INDOOR AIR, V13, P38, DOI 10.1034/j.1600-0668.2003.02025.x; Smith KR., 1987, BIOFUELS AIR POLLUTI; Stanek LW, 2011, ATMOS ENVIRON, V45, P5655, DOI 10.1016/j.atmosenv.2011.07.023; Stieb DM, 2002, J AIR WASTE MANAGE, V52, P470, DOI 10.1080/10473289.2002.10470794; van Donkelaar A, 2010, ENVIRON HEALTH PERSP, V118, P847, DOI 10.1289/ehp.0901623; Wallace L, 2005, ENVIRON SCI TECHNOL, V39, P1707, DOI 10.1021/es049547u; Wallace LA, 2003, ENVIRON HEALTH PERSP, V111, P1265, DOI 10.1289/ehp.6135; Weichenthal S, 2014, ENVIRON HEALTH PERSP, V122, P609, DOI 10.1289/ehp.1307277; Wichmann J, 2010, ATMOS ENVIRON, V44, P4536, DOI 10.1016/j.atmosenv.2010.08.023; Williams R, 2003, ATMOS ENVIRON, V37, P5365, DOI 10.1016/j.atmosenv.2003.09.010; Wilson WE, 2000, J AIR WASTE MANAGE, V50, P1167, DOI 10.1080/10473289.2000.10464164; Wu SW, 2014, ENVIRON SCI TECHNOL, V48, P3438, DOI 10.1021/es404778w; Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108; Zhou B, 2012, ATMOS ENVIRON, V62, P472, DOI 10.1016/j.atmosenv.2012.08.059	58	69	70	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124238	10.1371/journal.pone.0124238	http://dx.doi.org/10.1371/journal.pone.0124238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860147	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300133
J	Kim, KR; Kim, HJ; Lee, SK; Ma, GT; Park, KK; Chung, WY				Kim, Ki Rim; Kim, Hyun Jeong; Lee, Sun Kyoung; Ma, Gwang Taek; Park, Kwang Kyun; Chung, Won Yoon			15-Deoxy-Delta(12,14)-Prostaglandin J(2) Inhibits Osteolytic Breast Cancer Bone Metastasis and Estrogen Deficiency-Induced Bone Loss	PLOS ONE			English	Article							HORMONE-RELATED PROTEIN; MEDIATED OSTEOCLAST DIFFERENTIATION; PPAR-GAMMA LIGANDS; HEME OXYGENASE-1; ZOLEDRONIC ACID; PROSTATE-CANCER; CELLS; ACTIVATION; EXPRESSION; APOPTOSIS	Breast cancer is the major cause of cancer death in women worldwide. The most common site of metastasis is bone. Bone metastases obstruct the normal bone remodeling process and aberrantly enhance osteoclast-mediated bone resorption, which results in osteolytic lesions. 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) is an endogenous ligand of peroxisome proliferator-activated receptor gamma (PPAR.) that has anti-inflammatory and antitumor activity at micromolar concentrations through PPAR.-dependent and/or PPAR.-independent pathways. We investigated the inhibitory activity of 15d-PGJ(2) on the bone loss that is associated with breast cancer bone metastasis and estrogen deficiency caused by cancer treatment. 15d-PGJ2 dose-dependently inhibited viability, migration, invasion, and parathyroid hormone-related protein (PTHrP) production in MDA-MB-231 breast cancer cells. 15d-PGJ(2) suppressed receptor activator of nuclear factor kappa-B ligand (RANKL) mRNA levels and normalized osteoprotegerin (OPG) mRNA levels in hFOB1.19 osteoblastic cells treated with culture medium from MDA-MB-231 cells or PTHrP, which decreased the RANKL/OPG ratio. 15d-PGJ(2) blocked RANKL-induced osteoclastogenesis and inhibited the formation of resorption pits by decreasing the activities of cathepsin K and matrix metalloproteinases, which are secreted by mature osteoclasts. 15d-PGJ(2) exerted its effects on breast cancer and bone cells via PPAR.-independent pathways. In Balb/c nu/nu mice that received an intracardiac injection of MDA-MB-231 cells, subcutaneously injected 15d-PGJ(2) substantially decreased metastatic progression, cancer cell-mediated bone destruction in femora, tibiae, and mandibles, and serum PTHrP levels. 15d-PGJ(2) prevented the destruction of femoral trabecular structures in estrogen-deprived ICR mice as measured by bone morphometric parameters and serum biochemical data. Therefore, 15d-PGJ(2) may be beneficial for the prevention and treatment of breast cancer-associated bone diseases.	[Kim, Ki Rim] Kyungpook Natl Univ, Dept Dent Hyg, Sangju 742711, South Korea; [Kim, Ki Rim; Kim, Hyun Jeong; Lee, Sun Kyoung; Park, Kwang Kyun; Chung, Won Yoon] Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Biol,PLUS Project BK21, Seoul 120752, South Korea; [Kim, Hyun Jeong; Lee, Sun Kyoung; Ma, Gwang Taek; Park, Kwang Kyun; Chung, Won Yoon] Yonsei Univ, Grad Sch, Dept Appl Life Sci, Seoul 120749, South Korea	Kyungpook National University; Yonsei University; Yonsei University Health System; Yonsei University	Chung, WY (corresponding author), Yonsei Univ, Coll Dent, Oral Canc Res Inst, Dept Oral Biol,PLUS Project BK21, Seoul 120752, South Korea.	wychung@yuhs.ac		Kim, Hyun Jeong/0000-0003-4608-2120; Chung, Won-Yoon/0000-0001-8428-9005; Lee, Sun Kyoung/0000-0002-3707-8050	Yonsei University College of Dentistry [6-2009-0025]	Yonsei University College of Dentistry	This work was supported by a faculty research grant from Yonsei University College of Dentistry for 2009 (6-2009-0025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Azim HA, 2012, J EGYPT NATL CANCER, V24, P107, DOI 10.1016/j.jnci.2012.06.002; Brufsky AM, 2008, ONCOLOGIST, V13, P187, DOI 10.1634/theoncologist.2007-0152; Bundred N, 2012, CANCER TREAT REV, V38, P776, DOI 10.1016/j.ctrv.2012.02.002; Campbell JP, 2012, JOVE-J VIS EXP, DOI 10.3791/4260; Ciucci A, 2006, MOL PHARMACOL, V70, P1812, DOI 10.1124/mol.106.025759; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Costa AG, 2011, NAT REV RHEUMATOL, V7, P447, DOI 10.1038/nrrheum.2011.77; Daubine F, 2007, J NATL CANCER I, V99, P322, DOI 10.1093/jnci/djk054; Diez-Dacal B, 2010, THESCIENTIFICWORLDJO, V10, P655, DOI 10.1100/tsw.2010.69; Esposito M, 2014, PHARMACOL THERAPEUT, V141, P222, DOI 10.1016/j.pharmthera.2013.10.006; Guise TA, 2002, BONE, V30, P670, DOI 10.1016/S8756-3282(02)00685-3; Guise TA, 2010, CURR MED RES OPIN, V26, P6; Hounoki H, 2008, BONE, V42, P765, DOI 10.1016/j.bone.2007.11.016; Inada Masaki, 2011, Clin Calcium, V21, P164, DOI CliCa1102164170; Ishihara Shunji, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P379, DOI 10.2174/1568011043352902; Jeong J, 2011, J KOREAN MED SCI, V26, P1569, DOI 10.3346/jkms.2011.26.12.1569; Jun AY, 2012, FITOTERAPIA, V83, P1523, DOI 10.1016/j.fitote.2012.08.020; Kaikkonen S, 2013, MOL ENDOCRINOL, V27, P212, DOI 10.1210/me.2012-1313; Kakonen SM, 2002, J BIOL CHEM, V277, P24571, DOI 10.1074/jbc.M202561200; Karaplis A C, 2000, Rev Endocr Metab Disord, V1, P331, DOI 10.1023/A:1026526703898; Kim DH, 2009, CARCINOGENESIS, V30, P645, DOI 10.1093/carcin/bgp012; Kim EH, 2006, ANN NY ACAD SCI, V1090, P375, DOI 10.1196/annals.1378.041; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Lee SK, 2013, PHYTOTHER RES, V27, P1776, DOI 10.1002/ptr.4930; Lindemann RK, 2001, J BIOL CHEM, V276, P46661, DOI 10.1074/jbc.M105816200; Liu H, 2003, BREAST CANCER RES TR, V79, P63, DOI 10.1023/A:1023366117157; Luo KW, 2013, CANC LETT, V339, P1569; Mbalaviele G, 2000, J BIOL CHEM, V275, P14388, DOI 10.1074/jbc.275.19.14388; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Oiao L, 2008, MOL CANCER THER, V7, P2203, DOI 10.1158/1535-7163.MCT-08-0326; Okazaki R, 1999, ENDOCRINOLOGY, V140, P5060, DOI 10.1210/en.140.11.5060; Park SY, 2014, TOXICOL APPL PHARM, V275, P152, DOI 10.1016/j.taap.2014.01.009; Park Serk In, 2010, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1415s51; Pratap J, 2008, CANCER RES, V68, P7795, DOI 10.1158/0008-5472.CAN-08-1078; Ray DM, 2006, J IMMUNOL, V177, P5068, DOI 10.4049/jimmunol.177.8.5068; Safina A, 2011, MOL CANCER RES, V9, P1042, DOI 10.1158/1541-7786.MCR-10-0196; Shen ZN, 2005, BIOCHEM BIOPH RES CO, V328, P375, DOI 10.1016/j.bbrc.2004.12.186; Surh YJ, 2011, BIOCHEM PHARMACOL, V82, P1335, DOI 10.1016/j.bcp.2011.07.100; Suva LJ, 2011, NAT REV ENDOCRINOL, V7, P208, DOI 10.1038/nrendo.2010.227; Thudi NK, 2008, PROSTATE, V68, P1116, DOI 10.1002/pros.20776; Wang JJ, 2011, PROSTAG OTH LIPID M, V94, P104, DOI 10.1016/j.prostaglandins.2011.01.004; Wei W, 2011, PPAR RES, V2011, DOI 10.1155/2011/867180; Yang CR, 2010, SHOCK, V33, P662, DOI 10.1097/SHK.0b013e3181cc0738	45	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122764	10.1371/journal.pone.0122764	http://dx.doi.org/10.1371/journal.pone.0122764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859665	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300060
J	Pietschmann, S; von Bueren, AO; Kerber, MJ; Baumert, BG; Kortmann, RD; Muller, K				Pietschmann, Sophie; von Bueren, Andre O.; Kerber, Michael J.; Baumert, Brigitta G.; Kortmann, Rolf Dieter; Mueller, Klaus			An Individual Patient Data Meta-Analysis on Characteristics, Treatments and Outcomes of Glioblastoma/Gliosarcoma Patients with Metastases Outside of the Central Nervous System	PLOS ONE			English	Article							RECURSIVE PARTITIONING ANALYSIS; MULTIFORME; RADIOTHERAPY; SURVIVAL; TEMOZOLOMIDE	Purpose To determine the characteristics, treatments and outcomes of patients with glioblastoma multiforme (GBM) or gliosarcoma (GS) and metastases outside of the central nervous system (CNS). Methods PubMed and Web of Science searches for peer-reviewed articles pertaining to GBM/GS patients with metastatic dissemination were conducted using the keywords gliosarcoma, glioblastoma, GBM, metastasis, metastases and metastatic. Additionally, we performed hand search following the references from the selected papers. Cases with metastases to the CNS were excluded and evaluated in a separate study. Results 109 articles published between 1928 and 2013 were eligible. They reported on 150 patients. We observed a remarkable increase in the number of cases per decade over time. Median overall survival from diagnosis of metastasis (OSM+) was 6.0 +/- 0.8 months and median overall survival from initial diagnosis (OSID) 13 +/- 2.4 months. On univariate analyses, gender, age, the histological subtype, the time interval between initial diagnosis and diagnosis of metastasis and pulmonary involvement did not influence OSM+. We did not observe any substantial treatment progress. A comparison of the present cohort with 84 GBM/GS patients with exclusive CNS dissemination suggests that metastases outside the CNS are related to a slightly more favorable outcome. Conclusions The occurrence of extra-CNS metastasis from GBM/GS is associated with a dismal prognosis, however it seems to compare slightly favorable to CNS dissemination. Crucial treatment progress has not been achieved over recent decades. A central registry should be considered to consecutively gain more information about the ideal therapeutic approach.	[Pietschmann, Sophie; Kerber, Michael J.; Kortmann, Rolf Dieter; Mueller, Klaus] Univ Med Ctr Leipzig, Dept Radiat Oncol, Leipzig, Saxony, Germany; [von Bueren, Andre O.] Univ Med Ctr Goettingen, Div Pediat Hematol & Oncol, Dept Pediat & Adolescent Med, Gottingen, Lower Saxony, Germany; [Baumert, Brigitta G.] MediClin Robert Janker Clin, Dept Radiat Oncol, Bonn, North Rhine Wes, Germany; [Baumert, Brigitta G.] MediClin Robert Janker Clin, Clin Cooperat Unit Neurooncol, Bonn, North Rhine Wes, Germany; [Baumert, Brigitta G.] Univ Bonn, Med Ctr, Bonn, North Rhine Wes, Germany	Leipzig University; University of Gottingen; University of Bonn	Muller, K (corresponding author), Univ Med Ctr Leipzig, Dept Radiat Oncol, Leipzig, Saxony, Germany.	Klaus.Mueller@medizin.uni-leipzig.de	von Bueren, Andre/AAF-2065-2020; Baumert, Brigitta G./AAM-6549-2020	Baumert, Brigitta G./0000-0001-8871-4654; von Bueren, Andre/0000-0003-4197-6264	German Research Foundation (DFG); Universitat Leipzig	German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig	The authors acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolini F, 2012, TUMORI, V98, P756, DOI 10.1700/1217.13500; Bouillot-Eimer S, 2005, CLIN NEUROPATHOL, V24, P247; Fujii O, 2010, JPN J CLIN ONCOL, V40, P726, DOI 10.1093/jjco/hyq051; Galanis E, 1998, J NEUROSURG, V89, P425, DOI 10.3171/jns.1998.89.3.0425; GAMIS AS, 1990, CANCER, V66, P180, DOI 10.1002/1097-0142(19900701)66:1<180::AID-CNCR2820660132>3.0.CO;2-M; GARRET R, 1958, CANCER, V11, P888, DOI 10.1002/1097-0142(195809/10)11:5<888::AID-CNCR2820110504>3.0.CO;2-T; Kalokhe G, 2012, J NEURO-ONCOL, V107, P21, DOI 10.1007/s11060-011-0731-1; Lamborn KR, 2004, NEURO-ONCOLOGY, V6, P227, DOI 10.1215/S1152851703000620; Lun M, 2011, J NEURO-ONCOL, V105, P261, DOI 10.1007/s11060-011-0575-8; MacDonald TJ, 2011, NEURO-ONCOLOGY, V13, P1049, DOI 10.1093/neuonc/nor092; Mirimanoff RO, 2006, J CLIN ONCOL, V24, P2563, DOI 10.1200/JCO.2005.04.5963; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; PASQUIER B, 1980, CANCER, V45, P112, DOI 10.1002/1097-0142(19800101)45:1<112::AID-CNCR2820450121>3.0.CO;2-9; Piccirilli M, 2008, TUMORI J, V94, P40; Pietschmann S, 2014, J NEUROONCOLOGY; Shahideh M, 2012, J CLIN NEUROSCI, V19, P1080, DOI 10.1016/j.jocn.2011.09.024; SMITH DR, 1969, J NEUROSURG, V31, P50, DOI 10.3171/jns.1969.31.1.0050; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tendulkar RD, 2010, INT J RADIAT ONCOL, V78, P1451, DOI 10.1016/j.ijrobp.2009.09.071; YOKOYAMA H, 1985, SURG NEUROL, V24, P641, DOI 10.1016/0090-3019(85)90122-3; Zwiener I, 2011, DTSCH ARZTEBL INT, V108, P163, DOI [10.3238/arztebl.2011.0163, 10.3238/arztebl.2010.0163]	21	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121592	10.1371/journal.pone.0121592	http://dx.doi.org/10.1371/journal.pone.0121592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860797	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300027
J	Bianco, MS; Ceclio, AB; de Carvalho, LB				Bianco, Matheus Saraiva; Ceclio Filho, Arthur Bernardes; de Carvalho, Leonardo Bianco			Nutritional Status of the Cauliflower Cultivar 'Verona' Grown with Omission of out Added Macronutrients	PLOS ONE			English	Article							MINERAL-NUTRITION; PHOSPHORUS; NITROGEN; YIELD; ACCUMULATION; DEFICIENCY; NUTRIENTS; CALCIUM; STRESS	Knowledge of plant nutritional status allows an understanding of the physiological responses of plants to crop fertilization. A hydroponic experiment evaluated the symptoms of macronutrient deficiency in cauliflower 'Verona' and determined: a) the macronutrient contents of foliar tissues when visual symptoms were observed, b) macronutrients content of foliar and inflorescence tissues at harvest. The effect of nutrient deficiency on inflorescence mass was also evaluated. Nitrogen deficiency caused chlorosis followed by purple color in the old leaves, while P deficiency caused only chlorosis in old leaves. Chlorosis at the edge of old leaves progressing to the center of the leaves was observed with the omission of K, and after was observed necrosis in the chlorotic areas. Ca deficiency caused tip burn in new leaves, while Mg deficiency caused internerval chlorosis in old leaves. The omission of eachmacronutrient reduced inflorescence dry matter. This deleterious effect was larger for N, P, and K deficiencies, reducing inflorescence dry matter by 87, 49, and 42%, respectively. When the nutrient solutions without N, P, K, Ca, or Mg were supplied to cauliflower plants, the macronutrient contents at harvest were 8.8, 0.6, 3.5, 13.0, and 0.8 g kg(-1) in the foliar tissues and 27.3, 2.2, 21.6, 1.1, and 0.7 g kg(-1) in the inflorescence tissues, respectively.	[Bianco, Matheus Saraiva; Ceclio Filho, Arthur Bernardes] Univ Estadual Paulista, Fac Ciencias Agr & Vet, Plant Prod Dept, Sao Paulo, Brazil; [de Carvalho, Leonardo Bianco] Univ Estado Santa Catarina, Dept Agron, Ctr Ciencias Agrovet, Lages, Santa Catarina, Brazil	Universidade Estadual Paulista; Universidade do Estado de Santa Catarina	Bianco, MS (corresponding author), Univ Estadual Paulista, Fac Ciencias Agr & Vet, Plant Prod Dept, Sao Paulo, Brazil.	matbianco2004@yahoo.com.br	Cecílio Filho, Arthur/D-7237-2012	Cecílio Filho, Arthur/0000-0002-6706-5496; Bianco de Carvalho, Leonardo/0000-0001-8110-3471				Alves AU, 2011, CIENC AGROTEC, V35, P45, DOI 10.1590/S1413-70542011000100005; Avalhaes CC, 2009, NUCLEUS, V6, P250, DOI DOI 10.3738/1982.2278.162; Bergmann W., 1992, NUTR DISORDERS PLANT; Berry W., 2014, PLANT PHYSL ONLINE; Bianco S, 2010, PLANTA DANINHA, V28, P293, DOI 10.1590/S0100-83582010000200008; BOTTRILL DE, 1970, PLANT SOIL, V32, P424, DOI 10.1007/BF01372881; Carvalho LB, 2009, PLANTA DANINHA, V27, P283, DOI 10.1590/S0100-83582009000200010; Castoldi R, 2009, HORTIC BRAS, V27, P438, DOI 10.1590/S0102-05362009000400007; Cavalcante LF, 2012, J PLANT NUTR, V35, P176, DOI 10.1080/01904167.2012.636121; Chatterjee C, 2004, DIS MANAG FRUITS VEG, V1, P145; CONROY JP, 1986, PLANT PHYSIOL, V81, P423, DOI 10.1104/pp.81.2.423; CUTCLIFFE JA, 1976, CAN J PLANT SCI, V56, P127, DOI 10.4141/cjps76-019; Camargo Mônica Sartori de, 2008, Bragantia, V67, P371, DOI 10.1590/S0006-87052008000200012; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Faquin V., 2005, NUTR MINERAL PLANTAS; da Mota GMF, 2009, ACTA SCI-AGRON, V31, P321, DOI 10.4025/actasciagron.v31i2.844; Fontes P.C.R., 2011, NUTR MINERAL PLANTAS; Furlani A. M. C., 1978, Bragantia, V37, P33, DOI 10.1590/S0006-87051978000100005; Furlani PR, 1998, FUNDACAO IAC B TECNI; Kano C, 2010, HORTIC BRAS, V28, P453, DOI 10.1590/S0102-05362010000400013; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; LAUER MJ, 1989, PLANT PHYSIOL, V91, P848, DOI 10.1104/pp.91.3.848; LYNCH J, 1991, CROP SCI, V31, P380, DOI 10.2135/cropsci1991.0011183X003100020031x; Malavolta E., 2006, MANUAL NUTR MINERAL; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Mello Simone da Costa, 2009, Bragantia, V68, P761, DOI 10.1590/S0006-87052009000300024; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Sanchez LR, 2001, INVEST AGRAR-SIST R, V16, P119, DOI [10.4269/ajtmh. 14- 0145, DOI 10.4269/AJTMH.14-0145]; Stephens CT, 1983, DISORDERS COLE CROPS, pE; Sturmer SLK, 2002, REUN BRAS FERT SOL N; Taiz L., 2006, PLANT PHYSIOL; Takeishi J, 2009, BIOSCI J, V25, P1; TRANI PE, 1997, B TECNICO, V100, P157; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Zanão Júnior Luiz Antônio, 2005, Hortic. Bras., V23, P76, DOI 10.1590/S0102-05362005000100016	35	14	18	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123500	10.1371/journal.pone.0123500	http://dx.doi.org/10.1371/journal.pone.0123500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856380	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500093
J	Moreira, EF; Boscolo, D; Viana, BF				Moreira, Eduardo Freitas; Boscolo, Danilo; Viana, Blandina Felipe			Spatial Heterogeneity Regulates Plant-Pollinator Networks across Multiple Landscape Scales	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; ECOLOGICAL-SYSTEMS; HONEY-BEE; BIODIVERSITY; NESTEDNESS; DIVERSITY; SPECIALIZATION; STABILITY; SERVICES; PATTERN	Mutualistic plant-pollinator interactions play a key role in biodiversity conservation and ecosystem functioning. In a community, the combination of these interactions can generate emergent properties, e.g., robustness and resilience to disturbances such as fluctuations in populations and extinctions. Given that these systems are hierarchical and complex, environmental changes must have multiple levels of influence. In addition, changes in habitat quality and in the landscape structure are important threats to plants, pollinators and their interactions. However, despite the importance of these phenomena for the understanding of biological systems, as well as for conservation and management strategies, few studies have empirically evaluated these effects at the network level. Therefore, the objective of this study was to investigate the influence of local conditions and landscape structure at multiple scales on the characteristics of plant-pollinator networks. This study was conducted in agri-natural lands in Chapada Diamantina, Bahia, Brazil. Pollinators were collected in 27 sampling units distributed orthogonally along a gradient of proportion of agriculture and landscape diversity. The Akaike information criterion was used to select models that best fit the metrics for network characteristics, comparing four hypotheses represented by a set of a priori candidate models with specific combinations of the proportion of agriculture, the average shape of the landscape elements, the diversity of the landscape and the structure of local vegetation. The results indicate that a reduction of habitat quality and landscape heterogeneity can cause species loss and decrease of networks nestedness. These structural changes can reduce robustness and resilience of plant-pollinator networks what compromises the reproductive success of plants, the maintenance of biodiversity and the pollination service stability. We also discuss the possible explanations for these relationships and the implications for landscape planning in agricultural areas.	[Moreira, Eduardo Freitas; Viana, Blandina Felipe] Univ Fed Bahia, Dept Zool, Salvador, Bahia, Brazil; [Boscolo, Danilo] Univ Sao Paulo, FFCLRP, Fac Philosophy Sci & Literature Ribeirao Preto, Sao Paulo, Brazil	Universidade Federal da Bahia; Universidade de Sao Paulo	Moreira, EF (corresponding author), Univ Fed Bahia, Dept Zool, Salvador, Bahia, Brazil.	eduardofreitasmoreira@gmail.com	Viana, Blandina/M-6537-2013; Felipe Viana, Blandina Felipe/AAH-2606-2022; Moreira, Eduardo Freitas/J-5630-2016; Moreira, Eduardo/AAF-6779-2020; Felipe Viana, Blandina Felipe/AFM-0275-2022; Boscolo, Danilo/I-8655-2019	Viana, Blandina/0000-0002-4924-1257; Felipe Viana, Blandina Felipe/0000-0002-4924-1257; Moreira, Eduardo Freitas/0000-0001-7754-9585; Felipe Viana, Blandina Felipe/0000-0002-4924-1257; Boscolo, Danilo/0000-0002-0741-501X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq) [24/2009]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present work had funding support from the Brazilian governmental agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq - URL: http://www.cnpq.br/ - Edital MCT/CNPq/CT-AGRO - No 24/2009), who financed the purchase of equipment and field data collections campaigns; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - URL: http://www.capes.gov.br/index.php), who granted a scholarship during the master's degree course of Eduardo Freitas Moreira (first author). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bommarco R, 2010, P ROY SOC B-BIOL SCI, V277, P2075, DOI 10.1098/rspb.2009.2221; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chittka L, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P106, DOI 10.1017/CBO9780511542268.007; Diekotter T, 2014, GCB BIOENERGY, V6, P219, DOI 10.1111/gcbb.12080; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Ferreira PA, 2013, ECOL INDIC, V31, P35, DOI 10.1016/j.ecolind.2012.07.025; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; Fortuna MA, 2013, OIKOS, V122, P938, DOI 10.1111/j.1600-0706.2012.00042.x; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Hagen M, 2010, BIOL CONSERV, V143, P1654, DOI 10.1016/j.biocon.2010.03.036; Holzschuh A, 2010, J ANIM ECOL, V79, P491, DOI 10.1111/j.1365-2656.2009.01642.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; INMET, 2013, BANC DAD MET ENS PES; Jiang ZY, 2008, REMOTE SENS ENVIRON, V112, P3833, DOI 10.1016/j.rse.2008.06.006; Keitt TH, 2009, ECOL APPL, V19, P1561, DOI 10.1890/08-0117.1; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lihoreau M, 2011, FUNCT ECOL, V25, P1284, DOI 10.1111/j.1365-2435.2011.01881.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; PARRISH JAD, 1979, ECOLOGY, V60, P597, DOI 10.2307/1936080; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Sabatino M, 2010, ECOL APPL, V20, P1491, DOI 10.1890/09-1626.1; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Thomson D, 2004, ECOLOGY, V85, P458, DOI 10.1890/02-0626; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Veloso HP, 1991, CLASSIFICACAO VEGETA, DOI [10.5681/joddd.2014.003, DOI 10.5681/JODDD.2014.003]; Viana Blandina F., 2012, Journal of Pollination Ecology, V7, P31; Weng Q, 2011, T&F SER REMOTE SENS, P1, DOI 10.1201/b10599; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Wu JG, 2002, ECOL MODEL, V153, P7, DOI 10.1016/S0304-3800(01)00499-9; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003; Zurbuchen A, 2010, J ANIM ECOL, V79, P674, DOI 10.1111/j.1365-2656.2010.01675.x	56	75	79	4	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123628	10.1371/journal.pone.0123628	http://dx.doi.org/10.1371/journal.pone.0123628			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856293	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500100
J	Sun, Y; Zhang, TT; Wang, CP; Jin, XL; Jia, CW; Yu, SN; Chen, J				Sun, Yang; Zhang, Tingting; Wang, Cuiping; Jin, Xianglan; Jia, Congwei; Yu, Shuangni; Chen, Jie			MiRNA-615-5p Functions as a Tumor Suppressor in Pancreatic Ductal Adenocarcinoma by Targeting AKT2	PLOS ONE			English	Article							MICRORNA EXPRESSION; COLORECTAL-CANCER; K-RAS; GENES; OVEREXPRESSION; PROLIFERATION; AMPLIFICATION; DIAGNOSIS; CELLS; RISK	Background Aberrant microRNA (miRNA) expression is associated with tumor development. This study aimed to elucidate the role of miR-615-5p in the development of pancreatic ductal adenocarcinoma (PDAC). Methods Locked nucleic acid in situ hybridization (LNA-ISH) was performed to compare miR-615-5p expression in patients between PDAC and matched adjacent normal tissues. Effects of miR-615-5p overexpression on cell proliferation, apoptosis, colony formation, migration, and invasion were determined in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2. Effects of miR-615-5p on AKT2 were examined by dual-luciferase reporter assay. Lentivirus expressing miR-615 was used to create stable overexpression cell lines, which were subsequently used in mouse xenograft and metastasis models to assess tumor growth, apoptosis and metastasis. Results miR-615-5p expression was significantly lower in PDAC than in adjacent normal tissues. Low levels of miR-615-5p were independently associated with poor prognosis (HR:2.243, 95% CI: 1.190-4.227, P=0.013). AKT2 protein expression was inversely correlated with miR-615-5p expression (r=-0.3, P=0.003). miR-615-5p directly targeted the 3'-untranslated region of AKT2 mRNA and repressed its expression. miR-615-5p overexpression inhibited pancreatic cancer cell proliferation, migration, and invasion in vitro, and tumor growth and metastasis in vivo. Furthermore, miR-615-5p overexpression also induced pancreatic cancer cell apoptosis both in vitro and in vivo. Conclusions These results show that miR-615-5p inhibits pancreatic cancer cell proliferation, migration, and invasion by targeting AKT2. The data implicate miR-615-5p in the prognosis and treatment of PDAC.	[Chen, Jie] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China; Tsinghua Univ, Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University	Chen, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, 1 Shuai Fu Yuan Hu Tong, Beijing 100730, Peoples R China.	xhblk@163.com			National Nature Science Foundation of China [30973470, 81172334]; National Science and Technology Support Project (the 11th Five-Year Plan) of China [2006BAI02A14]; Scientific Research Special Projects of Health Industry of China [200802011]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Project (the 11th Five-Year Plan) of China(National Key Technology R&D Program); Scientific Research Special Projects of Health Industry of China	This study was supported by the National Nature Science Foundation of China (grant 30973470, 81172334), the National Science and Technology Support Project (the 11th Five-Year Plan) of China (grant 2006BAI02A14), and the Scientific Research Special Projects of Health Industry of China (grant 200802011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2003, J CELL BIOCHEM, V88, P470, DOI 10.1002/jcb.10287; Asano T, 2004, ONCOGENE, V23, P8571, DOI 10.1038/sj.onc.1207902; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bond-Smith G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2476; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; El Tayebi HM, 2012, FEBS LETT, V586, P3309, DOI 10.1016/j.febslet.2012.06.054; Farrow B, 2008, J SURG RES, V149, P319, DOI 10.1016/j.jss.2007.12.757; Fuchs CS, 1996, ARCH INTERN MED, V156, P2255, DOI 10.1001/archinte.156.19.2255; Gao W., 2014, ONCOGENE; Gapstur SM, 2000, JAMA-J AM MED ASSOC, V283, P2552, DOI 10.1001/jama.283.19.2552; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gray S, 2011, J PANCREAS, V12, P216; Hagan JP, 2007, CYTOGENET GENOME RES, V118, P252, DOI 10.1159/000108308; Han ZY, 2012, CARCINOGENESIS, V33, P131, DOI 10.1093/carcin/bgr226; Hulf T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-54; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Jung HM, 2013, MOL BIOL CELL, V24, P1638, DOI 10.1091/mbc.E12-12-0891; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Liao WT, 2013, CLIN CANCER RES, V19, P4662, DOI 10.1158/1078-0432.CCR-13-0244; Lindsay TH, 2005, PAIN, V119, P233, DOI 10.1016/j.pain.2005.10.019; Lohr M, 2000, INT J PANCREATOL, V27, P93, DOI 10.1385/IJGC:27:2:093; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Michaud DS, 2001, JAMA-J AM MED ASSOC, V286, P921, DOI 10.1001/jama.286.8.921; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Nelson PT, 2009, NEUROSCI LETT, V466, P69, DOI 10.1016/j.neulet.2009.04.044; Ruggeri BA, 1998, MOL CARCINOGEN, V21, P81, DOI 10.1002/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R; Sempere LF, 2010, CLIN CANCER RES, V16, P4246, DOI 10.1158/1078-0432.CCR-10-1152; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; VERHEIJEN R, 1989, J CELL SCI, V92, P123; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zhao G, 2013, MOL CANCER THER, V12, P83, DOI 10.1158/1535-7163.MCT-12-0534-T; Zhao LQ, 2011, ACTA BIOCH BIOPH SIN, V43, P831, DOI 10.1093/abbs/gmr080; Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	48	36	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119783	10.1371/journal.pone.0119783	http://dx.doi.org/10.1371/journal.pone.0119783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856297	gold, Green Published			2022-12-27	WOS:000352588500009
J	Virbickas, T; Stakenas, S; Steponenas, A				Virbickas, Tomas; Stakenas, Saulius; Steponenas, Andrius			Impact of Beaver Dams on Abundance and Distribution of Anadromous Salmonids in Two Lowland Streams in Lithuania	PLOS ONE			English	Article							ATLANTIC SALMON; BROOK TROUT; HABITAT USE; ECOLOGICAL STATUS; FISH ASSEMBLAGES; CUTTHROAT TROUT; CASTOR-FIBER; RIVERS; COMMUNITIES; MOVEMENTS	European beaver dams impeded movements of anadromous salmonids as it was established by fishing survey, fish tagging and redd counts in two lowland streams in Lithuania. Significant differences in abundancies of other litophilic fish species and evenness of representation by species in the community were detected upstream and downstream of the beaver dams. Sea trout parr marked with RFID tags passed through several successive beaver dams in upstream direction, but no tagged fish were detected above the uppermost dam. Increase in abundances of salmonid parr in the stream between the beaver dams and decrease below the dams were recorded in November, at the time of spawning of Atlantic salmon and sea trout, but no significant changes were detected in the sections upstream of the dams. After construction of several additional beaver dams in the downstream sections of the studied streams, abundance of Atlantic salmon parr downstream of the dams decreased considerably in comparison with that estimated before construction.	[Virbickas, Tomas; Stakenas, Saulius; Steponenas, Andrius] Nat Res Ctr, Dept Freshwater Biol, Vilnius, Lithuania	Nature Research Center - Lithuania	Stakenas, S (corresponding author), Nat Res Ctr, Dept Freshwater Biol, Vilnius, Lithuania.	saulius.stakenas@gmail.com	Stakėnas, Saulius/B-2361-2019	Stakėnas, Saulius/0000-0001-5424-9221	Research Council of Lithuania [MIP-120/2010]; Nature Research Centre and Lithuanian Society of Hydrobiologists	Research Council of Lithuania(Research Council of Lithuania (LMTLT)); Nature Research Centre and Lithuanian Society of Hydrobiologists(Research Council of Lithuania (LMTLT))	The study was funded by Research Council of Lithuania (project No. MIP-120/2010), Nature Research Centre and Lithuanian Society of Hydrobiologists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 2013ACOM082013 ICES, P3; BALON EK, 1979, ARCH HYDROBIOL, V85, P543; Bertolo A, 2008, FRESHWATER BIOL, V53, P304, DOI 10.1111/j.1365-2427.2007.01895.x; Birzaks Janis, 2012, Zoology and Ecology, V22, P9, DOI 10.1080/21658005.2012.680744; Bohlin T, 1975, 54 I FRESHW RES; Broberg MM, 2000, J FISH BIOL, V57, P1610, DOI 10.1111/j.1095-8649.2000.tb02237.x; Brower J.A., 1977, FIELD LAB METHODS GE; Bryant M.D., 1983, P OL WILD FISH C FIS, P183; CHISHOLM IM, 1987, T AM FISH SOC, V116, P176, DOI 10.1577/1548-8659(1987)116<176:WSCAUO>2.0.CO;2; Collen P, 2001, REV FISH BIOL FISHER, V10, P439; Cunjak R. A., 1998, Fisheries Management and Ecology, V5, P209, DOI 10.1046/j.1365-2400.1998.00094.x; Cunjak RA, 1996, CAN J FISH AQUAT SCI, V53, P267, DOI 10.1139/cjfas-53-S1-267; Elmeros Morten, 2003, Lutra, V46, P153; Fieseler C, 2006, LIMNOLOGICA, V36, P2, DOI 10.1016/j.limno.2005.10.001; France RL, 1997, CAN J ZOOL, V75, P1009, DOI 10.1139/z97-121; Gailiusis B., 2001, LIETUVOS UPES HIDROG; Guignion D, 2009, CONSERVATION STRATEG; Hagglund A, 1999, FOREST ECOL MANAG, V115, P259, DOI 10.1016/S0378-1127(98)00404-6; Halley Duncan J., 2003, Lutra, V46, P91; Halley Duncan J., 2001, P122; HANSON WILLIS D., 1963, AMER MIDLAND NAT, V69, P136, DOI 10.2307/2422849; Hay DW, 1989, P SALM MIGR DISTR S, P93; HELCOM, 2011, BALT SEA ENV; HUTCHINGS JA, 1987, CAN J ZOOL, V65, P766, DOI 10.1139/z87-120; Jakober MJ, 1998, T AM FISH SOC, V127, P223, DOI 10.1577/1548-8659(1998)127<0223:ROSIOF>2.0.CO;2; JOHNSON J, 2006, CATALOG WATERS IMPOR; Kemp PS, 2012, FISH FISH, V13, P158, DOI 10.1111/j.1467-2979.2011.00421.x; Kesminas V, 2000, BALTIJOS LASISA LIET; Kesminas V., 1999, HYDROBIOLOGICAL RE 1, P66; Lindstrom JW, 2004, N AM J FISH MANAGE, V24, P1341, DOI 10.1577/M03-223.1; Melcher A, 2007, FISHERIES MANAG ECOL, V14, P453, DOI 10.1111/j.1365-2400.2007.00583.x; Mitchell SC, 2007, J ANIM ECOL, V76, P1062, DOI 10.1111/j.1365-2656.2007.01286.x; MOORE A, 1990, J FISH BIOL, V37, P713, DOI 10.1111/j.1095-8649.1990.tb02535.x; NICKELSON TE, 1992, CAN J FISH AQUAT SCI, V49, P783, DOI 10.1139/f92-088; Nika N, 2011, THESIS KLAIPEDA U; Parker H, 2007, RIVER RES APPL, V23, P752, DOI 10.1002/rra.1008; Pedersen S., 2011, 2482012 DTU NAT I AQ; Rosell F, 2005, MAMMAL REV, V35, P248, DOI 10.1111/j.1365-2907.2005.00067.x; Sarauskiene D, 2008, ENV RES ENG MANAG, V46, P13; SCHLOSSER IJ, 1995, ECOLOGY, V76, P908, DOI 10.2307/1939356; Schlosser IJ, 2000, ECOLOGY, V81, P1371, DOI 10.2307/177214; Scruton DA, 1998, AQUAT CONSERV, V8, P145, DOI 10.1002/(SICI)1099-0755(199801/02)8:1<145::AID-AQC257>3.0.CO;2-7; Sigourney DB, 2006, T AM FISH SOC, V135, P1068, DOI 10.1577/T05-159.1; Skrupskelis Kestutis, 2012, Archives of Polish Fisheries, V20, P257; Snodgrass JW, 1998, ECOLOGY, V79, P928, DOI 10.2307/176590; Stakenas S, 2009, ECOL FRESHW FISH, V18, P167, DOI 10.1111/j.1600-0633.2008.00339.x; Steinmetz B, 1991, ATLAS FISH SCALES OT; SWANSTON DN, 1991, AM FISHERIES SOC SPE, V19, P139; Tambets M, 2005, J FISH BIOL, V67, P275, DOI 10.1111/j.0022-1112.2005.0955b.x; Taylor BR, 2010, RIVER RES APPL, V26, P183, DOI 10.1002/rra.1252; Taylor JE, 1999, ENVIRON HIST, V4, P54, DOI 10.2307/3985328; Ulevicius A, 2008, UPINI BEBR CASTOR FI; Virbickas T, 2007, FISHERIES MANAG ECOL, V14, P531, DOI 10.1111/j.1365-2400.2007.00572.x	53	8	8	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123107	10.1371/journal.pone.0123107	http://dx.doi.org/10.1371/journal.pone.0123107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856377	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500073
J	Almeida, CD; Andrade-Oliveira, V; Camara, NOS; Jacysyn, JF; Faquim-Mauro, EL				Almeida, Caroline de Souza; Andrade-Oliveira, Vinicius; Saraiva Camara, Niels Olsen; Jacysyn, Jacqueline F.; Faquim-Mauro, Eliana L.			Crotoxin from Crotalus durissus terrificus Is Able to Down-Modulate the Acute Intestinal Inflammation in Mice	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; GROWTH-FACTOR-BETA; ACID-INDUCED COLITIS; BOWEL-DISEASE; CROHNS-DISEASE; ULCERATIVE-COLITIS; LAMINA PROPRIA; T-CELLS; IL-12 PRODUCTION; LIPOXIN A(4)	Inflammatory bowel diseases (IBD) is the result of dysregulation of mucosal innate and adaptive immune responses. Factors such as genetic, microbial and environmental are involved in the development of these disorders. Accordingly, animal models that mimic human diseases are tools for the understanding the immunological processes of the IBD as well as to evaluate new therapeutic strategies. Crotoxin (CTX) is the main component of Crotalus durissus terrificus snake venom and has an immunomodulatory effect. Thus, we aimed to evaluate the modulatory effect of CTX in a murine model of colitis induced by 2,4,6-trinitrobenzene sulfonic acid (TNBS). The CTX was administered intraperitoneally 18 hours after the TNBS intrarectal instillation in BALB/c mice. The CTX administration resulted in decreased weight loss, disease activity index (DAI), macroscopic tissue damage, histopathological score and myeloperoxidase (MPO) activity analyzed after 4 days of acute TNBS colitis. Furthermore, the levels of TNF-alpha, IL-1 beta and IL-6 were lower in colon tissue homogenates of TNBS-mice that received the CTX when compared with untreated TNBS mice. The analysis of distinct cell populations obtained from the intestinal lamina propria showed that CTX reduced the number of group 3 innate lymphoid cells (ILC3) and Th17 population; CTX decreased IL-17 secretion but did not alter the frequency of CD4(+) Tbet(+) T cells induced by TNBS instillation in mice. In contrast, increased CD4(+) FoxP3(+) cell population as well as secretion of TGF-beta, prostaglandin E-2 (PGE(2)) and lipoxin A(4) (LXA(4)) was observed in TNBS-colitis mice treated with CTX compared with untreated TNBS-colitis mice. In conclusion, the CTX is able to modulate the intestinal acute inflammatory response induced by TNBS, resulting in the improvement of clinical status of the mice. This effect of CTX is complex and involves the suppression of the pro-inflammatory environment elicited by intrarectal instillation of TNBS due to the induction of a local anti-inflammatory profile in mice.	[Almeida, Caroline de Souza; Faquim-Mauro, Eliana L.] Butantan Inst, Immunopathol Lab, Sao Paulo, SP, Brazil; [Andrade-Oliveira, Vinicius; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Dept Immunol, Sao Paulo, Brazil; [Jacysyn, Jacqueline F.] Univ Sao Paulo, Fac Med, LIM62, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo	Faquim-Mauro, EL (corresponding author), Butantan Inst, Immunopathol Lab, Sao Paulo, SP, Brazil.	eliana.faquim@butantan.gov.br	Faquim-Mauro, Eliana L/C-9636-2012; camara, niels olsen saraiva/AAX-3269-2020; Faquim-Mauro, Eliana/M-2489-2017; Camara, Niels OS/G-8336-2011; de Andrade Oliveira, Vinicius/S-1176-2019	camara, niels olsen saraiva/0000-0001-5436-1248; Faquim-Mauro, Eliana/0000-0001-8083-4272; Camara, Niels OS/0000-0001-5436-1248; de Andrade Oliveira, Vinicius/0000-0002-0426-1828	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/23735-0, 2012/022070-2]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP [2010/05701-9]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, 2011/23735-0 and 2012/022070-2) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). Caroline de Souza Almeida was receipt of a fellowship from FAPESP (2010/05701-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Aliberti J, 2002, NAT IMMUNOL, V3, P76, DOI 10.1038/ni745; Aliberti J, 2002, J EXP MED, V196, P1253, DOI 10.1084/jem.20021183; Awane M, 1999, J IMMUNOL, V162, P5337; Azevedo-Marques M, 2003, ANIMAIS PECONHENTOS, P91, DOI DOI 10.1016/J.TTBDIS.2014.03.010; Bai AP, 2009, J LEUKOCYTE BIOL, V86, P959, DOI 10.1189/jlb.0109006; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Bolanos R, 1978, DEV BIOL STAND, V41, P907; Bon C, 1998, NEUROTOXINS IN NEURO, P52; BRADFORD HF, 1976, BRAIN RES, V105, P168, DOI 10.1016/0006-8993(76)90933-1; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brandtzaeg P, 2001, ACTA ODONTOL SCAND, V59, P235, DOI 10.1080/00016350152509265; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cardoso DF, 1997, TOXICON, V35, P607, DOI 10.1016/S0041-0101(96)00134-1; Cardoso DF, 2001, MEDIAT INFLAMM, V10, P125, DOI 10.1080/09629350120072699; Castro FR, 2007, TOXICON, V49, P299, DOI 10.1016/j.toxicon.2006.09.028; Chen HY, 2009, PROSTAG LEUKOTR ESS, V80, P195, DOI 10.1016/j.plefa.2009.01.006; Chen H, 2011, J ZHEJIANG UNIV-SC B, V12, P712, DOI 10.1631/jzus.B1000362; Chen Y, 2004, SCIENCE, V265, P1237; Costa LA, 2001, IMMUNOL LETT, V75, P137, DOI 10.1016/S0165-2478(00)00293-5; da Silva NG, 2013, TOXICON, V63, P98, DOI 10.1016/j.toxicon.2012.12.003; Dambacher J, 2009, GUT, V58, P1207, DOI 10.1136/gut.2007.130112; DAVIES MDJ, 1981, GUT, V22, P481, DOI 10.1136/gut.22.6.481; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; Doetze A, 2000, INT IMMUNOL, V12, P623, DOI 10.1093/intimm/12.5.623; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Ermann J, 2014, P NATL ACAD SCI USA, V111, pE2559, DOI 10.1073/pnas.1408540111; FAURE G, 1994, EUR J BIOCHEM, V223, P161, DOI 10.1111/j.1432-1033.1994.tb18978.x; Favoretto BC, 2011, TOXICON, V57, P600, DOI 10.1016/j.toxicon.2010.12.023; Fiorucci S, 2002, P NATL ACAD SCI USA, V99, P15770, DOI 10.1073/pnas.232583599; Ford AC, 2011, AM J GASTROENTEROL, V106, P644, DOI 10.1038/ajg.2011.73; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 2002, J IMMUNOL, V168, P900, DOI 10.4049/jimmunol.168.2.900; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Garcia F, 2003, TOXICON, V42, P433, DOI 10.1016/S0041-0101(03)00198-3; GEBOES K, 1994, ACTA GASTRO-ENT BELG, V57, P273; Grutz G, 2005, J LEUKOCYTE BIOL, V77, P3, DOI 10.1189/jlb.0904484; Guan QD, 2013, J LEUKOCYTE BIOL, V94, P803, DOI 10.1189/jlb.0113050; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; HAWGOOD BJ, 1977, BRIT J PHARMACOL, V61, P597, DOI 10.1111/j.1476-5381.1977.tb07553.x; Hedi H, 2004, CELL IMMUNOL, V228, P99, DOI 10.1016/j.cellimm.2004.04.003; Holtmann MH, 2004, LANGENBECK ARCH SURG, V389, P341, DOI 10.1007/s00423-003-0448-5; Holtmann MH, 2001, EXPERT OPIN BIOL TH, V1, P455, DOI 10.1517/14712598.1.3.455; Jin Y, 2012, J INTERF CYTOK RES, V32, P548, DOI 10.1089/jir.2012.0030; Jurjus Abdo R., 2004, Journal of Pharmacological and Toxicological Methods, V50, P81, DOI 10.1016/j.vascn.2003.12.002; Kh Slotta, 1938, ESTUDOS QUIMICOS VEN; Killig M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00142; Kolios G, 1998, HEPATO-GASTROENTEROL, V45, P1601; Kraus TA, 2005, CURR OPIN GASTROEN, V21, P692, DOI 10.1097/01.mog.0000182862.88798.28; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Lima TS, 2002, EXPBIOL MED, V23, P1219; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; McAlindon ME, 1998, GUT, V42, P214, DOI 10.1136/gut.42.2.214; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; Monteleone G, 1999, J IMMUNOL, V163, P143; Monteleone I, 2002, GUT, V50, P60; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Natsui M, 1997, J GASTROEN HEPATOL, V12, P801, DOI 10.1111/j.1440-1746.1997.tb00375.x; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Nunes FPB, 2010, TOXICON, V55, P1100, DOI 10.1016/j.toxicon.2009.12.011; Ogino H, 2011, DIGEST DIS SCI, V56, P376, DOI 10.1007/s10620-010-1286-2; Parkinson John F., 2006, Inflammation & Allergy Drug Targets, V5, P91, DOI 10.2174/187152806776383125; Parronchi P, 1997, AM J PATHOL, V150, P823; Pizarro TT, 2007, ANNU REV MED, V58, P433, DOI 10.1146/annurev.med.58.121205.100607; Pizarro TT, 1999, J IMMUNOL, V162, P6829; Powell N, 2012, IMMUNITY, V37, P674, DOI 10.1016/j.immuni.2012.09.008; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Rangel-Santos A, 2004, TOXICON, V44, P609, DOI 10.1016/j.toxicon.2004.07.004; Rolim-Rosa R., 1980, MEM INST BUTANTAN, V44, P259; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sampaio SC, 2006, TOXICON, V47, P313, DOI 10.1016/j.toxicon.2005.11.008; Sampaio SC, 2005, TOXICON, V45, P671, DOI 10.1016/j.toxicon.2005.01.009; Sampaio SC, 2003, TOXICON, V41, P899, DOI 10.1016/S0041-0101(03)00069-2; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; SCHAEFFER RC, 1988, TOXICON, V26, P67, DOI 10.1016/0041-0101(88)90138-9; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Silva MCCD, 1996, MEDIAT INFLAMM, V5, P18, DOI 10.1155/S0962935196000038; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Souza DG, 2007, J IMMUNOL, V179, P8533, DOI 10.4049/jimmunol.179.12.8533; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tsukada Y, 2002, AM J GASTROENTEROL, V97, P2820; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Walker JA, 2013, NAT REV IMMUNOL, V13, P75, DOI 10.1038/nri3349; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; YAMADA T, 1991, INFLAMMATION, V15, P399, DOI 10.1007/BF00917356; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Zambelli VO, 2008, TOXICON, V51, P1357, DOI 10.1016/j.toxicon.2008.03.004; Zhang Z, 2006, INFLAMM BOWEL DIS, V12, P382, DOI 10.1097/01.MIB.0000218764.06959.91	97	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121427	10.1371/journal.pone.0121427	http://dx.doi.org/10.1371/journal.pone.0121427			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853847	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400038
J	Ballester, R; Huertas, F; Yuste, FJ; Llorens, F; Sanabria, D				Ballester, Rafael; Huertas, Florentino; Javier Yuste, Francisco; Llorens, Francesc; Sanabria, Daniel			The Relationship between Regular Sports Participation and Vigilance in Male and Female Adolescents	PLOS ONE			English	Article							SHUTTLE RUN TEST; SOCCER PLAYERS; PHYSICAL-FITNESS; AEROBIC FITNESS; NEUROCOGNITIVE FUNCTION; TASK-PERFORMANCE; OLDER-ADULTS; CHILDREN; EXPERTISE; EXERCISE	The present study investigated the relationship between regular sport participation (soccer) and vigilance performance. Two groups of male and female adolescents differentiated in terms of their sport participation (athletes, n = 39, and non-athletes, n = 36) took part in the study. In one session, participants performed the Leger Multi-stage fitness test to estimate their aerobic fitness level. In the other session, participants completed the Psychomotor Vigilance Task (PVT) to evaluate their vigilance performance. Perceived arousal prior to the task and motivation toward the task were also measured in the PVT session. The results revealed that athletes had better cardiovascular fitness and showed better performance in the PVT. However, correlation analyses did not show any significant relationship between cardiovascular fitness and performance in the PVT. Athletes showed larger scores in motivation and perceived arousal measures with respect to non-athletes, although, once again, these variables were not correlated with PVT performance. Gender differences were observed only in the Leger test, with males showing greater fitness level than females. The major outcome of this research points to a positive relationship between regular sport participation and vigilance during adolescence. This relationship did not seem to be influenced by gender, perceived arousal, motivation toward the task or cardiovascular fitness. We discuss our results in terms of the different hypotheses put forward in the literature to explain the relationship between physical activity and cognitive functioning.	[Ballester, Rafael; Huertas, Florentino; Javier Yuste, Francisco; Llorens, Francesc] Univ Catolica Valencia San Vicente Martir, Dept Phys Act & Sport Sci, Valencia, Spain; [Sanabria, Daniel] Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain; [Sanabria, Daniel] Univ Granada, Dept Expt Psychol, Granada, Spain	Universidad Catolica de Valencia San Vicente Martir; University of Granada; University of Granada	Ballester, R (corresponding author), Univ Catolica Valencia San Vicente Martir, Dept Phys Act & Sport Sci, Valencia, Spain.	rafael.ballester@ucv.es	Olmedo, Florentino Huertas/I-8787-2013; Sanabria, Daniel/C-3409-2012; Llorens, Francesc/AAY-1464-2020; Ballester, Rafael/R-4245-2016	Olmedo, Florentino Huertas/0000-0002-1518-8582; Sanabria, Daniel/0000-0002-4164-7607; Ballester, Rafael/0000-0002-1602-6809; Llorens, Francesc/0000-0003-3313-709X	Spanish Ministerio de Educacion y Cultura [FPU13-05605]; Junta de Andalucia Proyecto de Excelencia [SEJ-6414]; Ministerio de Economia y Competitividad [PSI2013-46385]	Spanish Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Junta de Andalucia Proyecto de Excelencia(Junta de Andalucia); Ministerio de Economia y Competitividad(Spanish Government)	This research was supported by a Spanish Ministerio de Educacion y Cultura (https://sede.educacion.gob.es) predoctoral grant (FPU13-05605) to the first author, and project research grants: Junta de Andalucia Proyecto de Excelencia SEJ-6414 (http://www.juntadeandalucia.es) and Ministerio de Economia y Competitividad PSI2013-46385 (http://www.mineco.gob.es) to DS and FH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Beijamini F, 2008, BRAZ J MED BIOL RES, V41, P734, DOI 10.1590/S0100-879X2008000800016; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Bonnefond A, 2011, BRAIN COGNITION, V77, P464, DOI 10.1016/j.bandc.2011.08.010; Chaddock L, 2011, J INT NEUROPSYCH SOC, V17, P975, DOI 10.1017/S1355617711000567; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Davies DR, 1982, PSYCHOL VIGILANCE; Drummond SPA, 2005, SLEEP, V28, P1059; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; Gunzelmann G, 2010, COGNITIVE FATIGUE MU, P83; Hainsworth R., 1998, CLIN GUIDE CARDIAC A, P3, DOI [10.1007/978-94-017-1057-2_1, DOI 10.1007/978-94-017-1057-2_1]; Hammami MA, 2013, J SPORT SCI, V31, P589, DOI 10.1080/02640414.2012.746721; Haugen T, 2014, SCAND J PUBLIC HEALT, V42, P67, DOI 10.1177/1403494813504502; Huttermann S, 2015, COGNITION EMOTION, V29, P471, DOI 10.1080/02699931.2014.920767; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01108.x; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Loh S, 2004, BEHAV RES METH INS C, V36, P339, DOI 10.3758/BF03195580; Luque-Casado A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056935; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Matthews G, 1999, PERS INDIV DIFFER, V26, P583, DOI 10.1016/S0191-8869(98)00158-5; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; North T C, 1990, Exerc Sport Sci Rev, V18, P379; Pesce C, 2001, J PSYCHOPHYSIOL, V15, P256, DOI 10.1027//0269-8803.15.4.256; Pesce C, 2007, J SPORT SCI, V25, P1259, DOI 10.1080/02640410601040085; Pontifex MB, 2012, NEUROPSYCHOLOGY, V26, P407, DOI 10.1037/a0028795; Reilly T, 2005, J SPORT SCI, V23, P561, DOI 10.1080/02640410400021245; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Singh TP, 2008, MED SCI SPORT EXER, V40, P601, DOI 10.1249/MSS.0b013e3181621ec4; Smiley-Oyen AL, 2008, ANN BEHAV MED, V36, P280, DOI 10.1007/s12160-008-9064-5; Steinmayr R, 2010, LEARN INDIVID DIFFER, V20, P14, DOI 10.1016/j.lindif.2009.10.009; Tomkinson GR, 2003, SPORTS MED, V33, P285, DOI 10.2165/00007256-200333040-00003; Trautmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032279; Vanttinen T, 2010, PERCEPT MOTOR SKILL, V110, P675, DOI 10.2466/PMS.110.3.675-692; Vanttinen T, 2011, J STRENGTH COND RES, V25, P3342, DOI 10.1519/JSC.0b013e318236d0c2; Venker CC, 2007, SLEEP BREATH, V11, P217, DOI 10.1007/s11325-007-0103-4; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; WILKINSON RT, 1982, HUM FACTORS, V24, P487, DOI 10.1177/001872088202400409; Wilson A, 2010, BEHAV RES METHODS, V42, P754, DOI 10.3758/BRM.42.3.754	47	22	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123898	10.1371/journal.pone.0123898	http://dx.doi.org/10.1371/journal.pone.0123898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849873	Green Published, gold			2022-12-27	WOS:000352477800260
J	Hung, BT; Long, NP; Hung, LP; Luan, NT; Anh, NH; Nghi, TD; Van Hieu, M; Trang, NTH; Rafidinarivo, HF; Anh, NK; Hawkes, D; Huy, NT; Hirayama, K				Bui The Hung; Nguyen Phuoc Long; Le Phi Hung; Nguyen Thien Luan; Nguyen Hoang Anh; Tran Diem Nghi; Mai Van Hieu; Nguyen Thi Huyen Trang; Rafidinarivo, Herizo Fabien; Nguyen Ky Anh; Hawkes, David; Nguyen Tien Huy; Hirayama, Kenji			Research Trends in Evidence-Based Medicine: A Joinpoint Regression Analysis of More than 50 Years of Publication Data	PLOS ONE			English	Article							CANCER INCIDENCE TRENDS; PRACTICE GUIDELINES; SYSTEMATIC REVIEWS; INFORMATION NEEDS; RECOMMENDATIONS; METAANALYSIS; QUALITY; TRIALS; MORTALITY; CONSENSUS	Background Evidence-based medicine (EBM) has developed as the dominant paradigm of assessment of evidence that is used in clinical practice. Since its development, EBM has been applied to integrate the best available research into diagnosis and treatment with the purpose of improving patient care. In the EBM era, a hierarchy of evidence has been proposed, including various types of research methods, such as meta-analysis (MA), systematic review (SRV), randomized controlled trial (RCT), case report (CR), practice guideline (PGL), and so on. Although there are numerous studies examining the impact and importance of specific cases of EBM in clinical practice, there is a lack of research quantitatively measuring publication trends in the growth and development of EBM. Therefore, a bibliometric analysis was constructed to determine the scientific productivity of EBM research over decades. Methods NCBI PubMed database was used to search, retrieve and classify publications according to research method and year of publication. Joinpoint regression analysis was undertaken to analyze trends in research productivity and the prevalence of individual research methods. Findings Analysis indicates that MA and SRV, which are classified as the highest ranking of evidence in the EBM, accounted for a relatively small but auspicious number of publications. For most research methods, the annual percent change (APC) indicates a consistent increase in publication frequency. MA, SRV and RCT show the highest rate of publication growth in the past twenty years. Only controlled clinical trials (CCT) shows a non-significant reduction in publications over the past ten years. Conclusions Higher quality research methods, such as MA, SRV and RCT, are showing continuous publication growth, which suggests an acknowledgement of the value of these methods. This study provides the first quantitative assessment of research method publication trends in EBM.	[Bui The Hung; Nguyen Phuoc Long; Le Phi Hung; Nguyen Thien Luan; Nguyen Ky Anh] Univ Med & Pharm, Ho Chi Minh 70000, Vietnam; [Bui The Hung; Nguyen Phuoc Long; Le Phi Hung; Nguyen Thien Luan; Nguyen Hoang Anh; Tran Diem Nghi; Mai Van Hieu; Nguyen Thi Huyen Trang; Rafidinarivo, Herizo Fabien; Nguyen Ky Anh; Hawkes, David; Nguyen Tien Huy] Online Res Club, Ho Chi Minh City, Ho Chi Minh, Vietnam; [Nguyen Hoang Anh; Tran Diem Nghi; Mai Van Hieu] Vietnam Natl Univ, Sch Med, Ho Chi Minh 70000, Vietnam; [Nguyen Thi Huyen Trang] Univ Med & Pharm Hue City, Hue 53000, Vietnam; [Rafidinarivo, Herizo Fabien] Nagasaki Univ, Grad Sch Pharmaceut Sci, Nagasaki 8528523, Japan; [Hawkes, David] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Nguyen Tien Huy] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Clin Prod Dev, Nagasaki 8528523, Japan; [Hirayama, Kenji] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Immunogenet, Nagasaki 8528523, Japan	Hochiminh City University of Medicine & Pharmacy; Vietnam National University Hochiminh City; Hue University; Nagasaki University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Nagasaki University; Nagasaki University	Hawkes, D (corresponding author), Online Res Club, Ho Chi Minh City, Ho Chi Minh, Vietnam.	david.hawkes@florey.edu.au; tienhuy@nagasaki-u.ac.jp; hiraken@nagasaki-u.ac.jp	Huy, Nguyen Tien/B-2573-2010; Hirayama, Kenji/AAN-7065-2021; Long, Nguyen Phuoc/U-4162-2019; Anh, Nguyễn/HGU-8434-2022	Huy, Nguyen Tien/0000-0002-9543-9440; Long, Nguyen Phuoc/0000-0002-4678-0546; Hawkes, David/0000-0002-3882-801X; Nguyen Ky, Anh/0000-0001-9513-9563; Hirayama, Kenji/0000-0001-9467-1777; Anh Thu, Nguyen/0000-0002-1187-0795	Vietnam Student Development Fund (VNSDF)	Vietnam Student Development Fund (VNSDF)	NPL, NTHT, TDN, MVH, and NHA have been awarded scholarships from the Vietnam Student Development Fund (VNSDF; www.vnsdf.org). The funder had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	[Anonymous], JAMA, V268, P2420; Aronson JK, 2006, BMJ-BRIT MED J, V333, P1267, DOI 10.1136/bmj.39036.666389.94; Aronson JK, 2003, BRIT MED J, V326, P1346, DOI 10.1136/bmj.326.7403.1346; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Berthold DR, 2009, J CLIN ONCOL, V27, P1150, DOI 10.1200/JCO.2008.21.1938; Bryhn AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019241; Burns PB, 2011, PLAST RECONSTR SURG, V128, P305, DOI 10.1097/PRS.0b013e318219c171; Chambers LW, 1997, CMAJ, V157, P1598; Claridge JA, 2005, WORLD J SURG, V29, P547, DOI 10.1007/s00268-005-7910-1; COVELL DG, 1985, ANN INTERN MED, V103, P596, DOI 10.7326/0003-4819-103-4-596; Crowther M, 2010, BLOOD, V116, P3140, DOI 10.1182/blood-2010-05-280883; David H, 2014, TRENDS MOL MED; Dawes Martin, 2005, BMC Med Educ, V5, P1; Eddy DM, 2005, HEALTH AFFAIR, V24, P9, DOI 10.1377/hlthaff.24.1.9; El Dib RP, 2007, J EVAL CLIN PRACT, V13, P689, DOI 10.1111/j.1365-2753.2007.00886.x; Epling J, 2002, FAM MED, V34, P646; Gallin JI, 2012, PRINCIPLES PRACTICE; Gerber A, 2005, MED HYPOTHESES, V64, P1034, DOI 10.1016/j.mehy.2004.12.015; Goldman Joshua J, 2011, Virtual Mentor, V13, P26, DOI 10.1001/virtualmentor.2011.13.1.jdsc1-1101; Gomez SL, 2013, JNCI-J NATL CANCER I, V105, P1096, DOI 10.1093/jnci/djt157; Goovaerts P, 2013, INT J APPL EARTH OBS, V22, P75, DOI 10.1016/j.jag.2012.03.002; Goovaerts P, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-63; Graham AJ, 2004, CAN J SURG, V47, P461; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Helvie MA, 2014, CANCER; Heneghan Carl, 2009, Evid Based Med, V14, P67, DOI 10.1136/ebm.14.3.67; Hockenberry Marilyn, 2006, Pediatr Nurs, V32, P371; Holmes L, 2008, PUBLIC HEALTH, V122, P862, DOI 10.1016/j.puhe.2007.10.010; Holmes Laurens Jr, 2012, ISRN Oncol, V2012, P906197, DOI 10.5402/2012/906197; Ilic M, 2013, CROAT MED J, V54, P369, DOI 10.3325/cmj.2013.54.369; Io Medicine, 2011, CLIN PRACTICE GUIDEL; Julie A, 2004, US TODAY; KASSIRER JP, 1993, NEW ENGL J MED, V329, P1263, DOI 10.1056/NEJM199310213291710; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Leape L L, 1990, QRB Qual Rev Bull, V16, P42; Lewis Sonja J, 2004, J Manag Care Pharm, V10, pS3; Lohr K N, 1994, Int J Qual Health Care, V6, P17; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; Long NP, 2014, TROPICAL MED HLTH; Manchikanti Laxmaiah, 2007, Pain Physician, V10, P329; Manchikanti L, 2008, PAIN PHYSICIAN, V11, P161; Martins-Melo FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093770; Melnyk BM, 2005, BEGINNINGS; MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597; Namazi M, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.18371; NASH DB, 1990, ARCH PATHOL LAB MED, V114, P1122; Nichols M, 2013, EUR HEART J, V34, P3017, DOI 10.1093/eurheartj/eht159; OSHEROFF JA, 1991, ANN INTERN MED, V114, P576, DOI 10.7326/0003-4819-114-7-576; Park Hyeon Jin, 2012, Korean J Hematol, V47, P28, DOI 10.5045/kjh.2012.47.1.28; Rizzo JD, 2005, BEST PRACT RES CL HA, V18, P439, DOI 10.1016/j.beha.2005.01.021; Rodriguez-Ortiz Pablo Gabriel, 2009, Rev Alerg Mex, V56, P185; Sackett DL, 1997, LANCET, V349, P570, DOI 10.1016/S0140-6736(97)80122-5; SACKETT DL, 1989, CHEST, V95, pS2, DOI 10.1378/chest.95.2.2S; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Sastre EA, 2011, MED TEACH, V33, pE306, DOI 10.3109/0142159X.2011.565827; Sibbald B, 1998, BRIT MED J, V316, P201; Stanley K, 2007, CIRCULATION, V115, P1164, DOI 10.1161/CIRCULATIONAHA.105.594945; Tanjong-Ghogomu E, 2009, BULL HOSP JT DIS, V67, P198; Valier H, 2008, MED HIST, V52, P493, DOI 10.1017/S0025727300002994; Vikram T, 2012, J OBSTET GYN INDIA, V62, P146, DOI 10.1007/s13224-012-0173-5; Walker E, 2008, CLEV CLIN J MED, V75, P431, DOI 10.3949/ccjm.75.6.431; Wood J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2215; Woodruff RSY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065276; Woolf SH, 2000, HEMATOL ONCOL CLIN N, V14, P761, DOI 10.1016/S0889-8588(05)70310-5; WOOLF SH, 1993, ARCH INTERN MED, V153, P2646, DOI 10.1001/archinte.153.23.2646; Young T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086706	70	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121054	10.1371/journal.pone.0121054	http://dx.doi.org/10.1371/journal.pone.0121054			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849641	Green Published, gold			2022-12-27	WOS:000352477800043
J	Burke, JJ; Chen, JP				Burke, John J.; Chen, Junping			Enhancement of Reproductive Heat Tolerance in Plants	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; HIGH-TEMPERATURE STRESS; SHOCK-PROTEIN; IN-VITRO; CARBON-DIOXIDE; GENETIC-TRANSFORMATION; TISSUE-SPECIFICITY; COMBINING ABILITY; TOMATO GENOTYPES; TOBACCO POLLEN	Comparison of average crop yields with reported record yields has shown that major crops exhibit annual average yields three-to seven-fold lower than record yields because of unfavorable environments. The current study investigated the enhancement of pollen heat tolerance through expressing an Arabidopsis thaliana heat shock protein 101 (AtHSP101) that is not normally expressed in pollen but reported to play a crucial role in vegetative thermotolerance. The AtHSP101 construct under the control of the constitutive ocs/mas 'superpromoter' was transformed into cotton Coker 312 and tobacco SRI lines via Agrobacterium mediated transformation. Thermotolerance of pollen was evaluated by in vitro pollen germination studies. Comparing with those of wild type and transgenic null lines, pollen from AtHSP101 transgenic tobacco and cotton lines exhibited significantly higher germination rate and much greater pollen tube elongation under elevated temperatures or after a heat exposure. In addition, significant increases in boll set and seed numbers were also observed in transgenic cotton lines exposed to elevated day and night temperatures in both greenhouse and field studies. The results of this study suggest that enhancing heat tolerance of reproductive tissues in plant holds promise in the development of crops with improved yield production and yield sustainability in unfavorable environments.	[Burke, John J.; Chen, Junping] USDA ARS, Cropping Syst Res Lab, Lubbock, TX 79401 USA	United States Department of Agriculture (USDA)	Burke, JJ (corresponding author), USDA ARS, Cropping Syst Res Lab, 3810 4th St, Lubbock, TX 79401 USA.	john.burke@ars.usda.gov			United States Department of Agriculture, Agricultural Research Service, Base Funding	United States Department of Agriculture, Agricultural Research Service, Base Funding	This work was supported by United States Department of Agriculture, Agricultural Research Service, Base Funding.	ABDULBAKI AA, 1995, HORTSCIENCE, V30, P115, DOI 10.21273/HORTSCI.30.1.115; BANDYOPADHYAY RS, 1989, J BIOL CHEM, V264, P19399; BAYLEY C, 1992, THEOR APPL GENET, V83, P645, DOI 10.1007/BF00226910; Bokszczanin KL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00315; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; BOUCHEZ D, 1989, EMBO J, V8, P4197, DOI 10.1002/j.1460-2075.1989.tb08605.x; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Brown P.W., 1997, SERIES U ARIZONA, V108, P91; Burke JJ, 2004, AGRON J, V96, P359, DOI 10.2134/agronj2004.0359; Burke JJ, 2005, United States Department of Agriculture patents, Patent No. [US 6,939,676 B2, 6939676]; Chaturvedi P, 2013, J PROTEOME RES, V12, P4892, DOI 10.1021/pr400197p; COOPER P, 1984, PLANT PHYSIOL, V75, P431, DOI 10.1104/pp.75.2.431; DANE F, 1991, J AM SOC HORTIC SCI, V116, P906, DOI 10.21273/JASHS.116.5.906; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; DUPUIS I, 1990, PLANT PHYSIOL, V94, P665, DOI 10.1104/pp.94.2.665; Fisher W. D., 1975, P 27 COTT IMPR C, P85; FRALEY RT, 1986, CRC CR REV PLANT SCI, V4, P1, DOI 10.1080/07352688609382217; FROVA C, 1994, MOL GEN GENET, V245, P424, DOI 10.1007/BF00302254; Gagliardi D, 1995, PLANT MOL BIOL, V29, P841, DOI 10.1007/BF00041173; Goswami C. L., 1980, Cotton Development, V9, P15; Guinn G., 1984, Crop physiology. Advancing frontiers, P177; HALTERLEIN AJ, 1980, J AM SOC HORTIC SCI, V105, P12; Harsant J, 2013, J EXP BOT, V64, P2971, DOI 10.1093/jxb/ert142; HERRERO MP, 1980, CROP SCI, V20, P796, DOI 10.2135/cropsci1980.0011183X002000060030x; Hong SW, 2000, P NATL ACAD SCI USA, V97, P4392, DOI 10.1073/pnas.97.8.4392; HOPF N, 1992, PLANT MOL BIOL, V19, P623, DOI 10.1007/BF00026788; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Kakani VG, 2005, ANN BOT-LONDON, V96, P59, DOI 10.1093/aob/mci149; Kakani VG, 2002, PLANT CELL ENVIRON, V25, P1651, DOI 10.1046/j.1365-3040.2002.00943.x; KANDASAMY MK, 1989, PROTOPLASMA, V153, P104, DOI 10.1007/BF01322470; KONCZ C, 1983, EMBO J, V2, P1597, DOI 10.1002/j.1460-2075.1983.tb01630.x; Lee U, 2005, PLANT CELL, V17, P559, DOI 10.1105/tpc.104.027540; Magnard JL, 1996, PLANT PHYSIOL, V111, P1085, DOI 10.1104/pp.111.4.1085; Mandhu Bajaj, 1992, Angiosperm pollen and ovules., P349; MEYER VG, 1969, CROP SCI, V9, P237, DOI 10.2135/cropsci1969.0011183X000900020039x; MITCHELL JC, 1988, J PLANT PHYSIOL, V133, P625, DOI 10.1016/S0176-1617(88)80019-1; NI M, 1995, PLANT J, V7, P661, DOI 10.1046/j.1365-313X.1995.7040661.x; OTTEN LABM, 1978, BIOCHIM BIOPHYS ACTA, V527, P497, DOI 10.1016/0005-2744(78)90363-7; Pan SQ, 2000, PLANT CELL, V12, P125, DOI 10.1105/tpc.12.1.125; Percy RG, 2006, CROP SCI, V46, P1828, DOI 10.2135/cropsci2005.12-0483; Pettigrew WT, 2008, CROP SCI, V48, P278, DOI 10.2135/cropsci2007.05.0261; Prasad PVV, 2006, AGR FOREST METEOROL, V139, P237, DOI 10.1016/j.agrformet.2006.07.003; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; RAO GU, 1992, ANN BOT-LONDON, V69, P193, DOI 10.1093/oxfordjournals.aob.a088329; REDDY KR, 1992, AGRON J, V84, P237, DOI 10.2134/agronj1992.00021962008400020022x; Reddy KR, 1999, AGRON J, V91, P851, DOI 10.2134/agronj1999.915851x; REDDY KR, 1995, AGR ECOSYST ENVIRON, V54, P17, DOI 10.1016/0167-8809(95)00593-H; REDDY KR, 1992, AGRON J, V84, P26, DOI 10.2134/agronj1992.00021962008400010006x; RODRIGUEZGARAY B, 1988, CROP SCI, V28, P857, DOI 10.2135/cropsci1988.0011183X002800050030x; Sakata T, 2000, J PLANT RES, V113, P395, DOI 10.1007/PL00013947; SARVELLA P, 1966, CROP SCI, V6, P361, DOI 10.2135/cropsci1966.0011183X000600040020x; SCHOPER JB, 1987, CROP SCI, V27, P27, DOI 10.2135/cropsci1987.0011183X002700010007x; SHIVANNA KR, 1991, SEX PLANT REPROD, V4, P104; Snider JL, 2009, PHYSIOL PLANTARUM, V137, P125, DOI 10.1111/j.1399-3054.2009.01266.x; VELTEN J, 1984, EMBO J, V3, P2723, DOI 10.1002/j.1460-2075.1984.tb02202.x; VELTEN J, 1985, NUCLEIC ACIDS RES, V13, P6981, DOI 10.1093/nar/13.19.6981; Volkov RA, 2005, PLANT MOL BIOL, V57, P487, DOI 10.1007/s11103-005-0339-y; Walker-Peach C, 1984, AGROBACTERIUM MEDIAT; WEAVER ML, 1989, HORTSCIENCE, V24, P493; Xin ZG, 2003, BIOTECHNIQUES, V34, P820, DOI 10.2144/03344rr04; Young TE, 2001, PLANT PHYSIOL, V127, P777, DOI 10.1104/pp.010160	61	44	51	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122933	10.1371/journal.pone.0122933	http://dx.doi.org/10.1371/journal.pone.0122933			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849955	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800177
J	Zhang, YY; George, J; Li, Y; Olufade, R; Zhao, XY				Zhang, Yuanyuan; George, Jasmine; Li, Yun; Olufade, Rebecca; Zhao, Xueying			Matrix Metalloproteinase-9 Expression Is Enhanced in Renal Parietal Epithelial Cells of Zucker Diabetic Fatty Rats and Is Induced by Albumin in In Vitro Primary Parietal Cell Culture	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; KIDNEY INJURY; MURINE MODEL; NEPHROPATHY; MMP-9; PODOCYTOPENIA; SUPPRESSION; MODULATION; PODOCYTES; MIGRATION	As a subfamily of matrix metalloproteinases (MMPs), gelatinases including MMP-2 and MMP-9 play an important role in remodeling and homeostasis of the extracellular matrix. However, conflicting results have been reported regarding their expression level and activity in the diabetic kidney. This study investigated whether and how MMP-9 expression and activity were changed in glomerular epithelial cells upon albumin overload. In situ zymography, immunostaining and Western blot for renal MMP gelatinolytic activity and MMP-9 protein expression were performed in Zucker lean and Zucker diabetic rats. Confocal microscopy revealed a focal increase in gelatinase activity and MMP-9 protein in the glomeruli of diabetic rats. Increased glomerular MMP-9 staining was mainly observed in hyperplastic parietal epithelial cells (PECs) expressing claudin-1 in the diabetic kidneys. Interestingly, increased parietal MMP-9 was often accompanied by decreased staining for podocyte markers (nephrin and podocalyxin) in the sclerotic area of affected glomeruli in diabetic rats. Additionally, urinary excretion of podocyte marker proteins was significantly increased in association with the levels of MMP-9 and albumin in the urine of diabetic animals. To evaluate the direct effect of albumin on expression and activity of MMP-9, primary cultured rat glomerular PECs were incubated with rat serum albumin (0.25 - 1 mg/ml) for 24 - 48 hrs. MMP-9 mRNA levels were significantly increased following albumin treatment. Meanwhile, albumin administration resulted in a dose-dependent increase in MMP-9 protein and activity in culture supernatants of PECs. Moreover, albumin activated p44/42 mitogen-activated protein kinase (MAPK) in PECs. Inhibition of p44/42 MAPK suppressed albumin-induced MMP-9 secretion from glomerular PECs. Taken together, we have demonstrated that an up-regulation of MMP-9 in activated parietal epithelium is associated with a loss of adjacent podocytes in progressive diabetic nephropathy. Albumin overload may induce MMP-9 expression and secretion by PECs via the activation of p44/42 MAPK pathway.	[Zhang, Yuanyuan; George, Jasmine; Li, Yun; Olufade, Rebecca; Zhao, Xueying] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Zhao, XY (corresponding author), Morehouse Sch Med, Dept Physiol, 720 Westview Dr Sw, Atlanta, GA 30310 USA.	xzhao@msm.edu	zhang, yuanyuan/GYA-4428-2022	George, Jasmine/0000-0002-6999-5099	National Institutes of Health [SDK096441, NIH/NCRR G12-RR03034, NIH/NCRR U54RR026137]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026137, G12RR003034] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101, G12MD007602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health SDK096441, NIH/NCRR G12-RR03034 and U54RR026137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja TS, 2003, NEPHRON CLIN PRACT, V95, pC100, DOI 10.1159/000074323; Antonio RC, 2014, MOL CELL BIOCHEM, V386, P99, DOI 10.1007/s11010-013-1848-7; Bai YL, 2006, CELL PHYSIOL BIOCHEM, V17, P57, DOI 10.1159/000091464; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Caron A, 2005, CAN J PHYSIOL PHARM, V83, P287, DOI 10.1139/Y05-011; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Fang Z, 2009, J HUAZHONG U SCI-MED, V29, P710, DOI 10.1007/s11596-009-0607-1; Kawata N, 2006, UROLOGY, V68, P523, DOI 10.1016/j.urology.2006.03.063; Kothari P, 2014, J IMMUNOL, V192, P349, DOI 10.4049/jimmunol.1301906; Kuroda Tadahide, 2004, Clin Exp Nephrol, V8, P206; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Liu SY, 2006, MOL CELL BIOCHEM, V284, P9, DOI 10.1007/s11010-005-9005-6; McLennan SV, 2002, DIABETOLOGIA, V45, P268, DOI 10.1007/s00125-001-0730-4; Mikami S, 2015, INT J CANCER, V136, P1504, DOI 10.1002/ijc.29137; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Ohse T, 2009, AM J PHYSIOL-RENAL, V297, pF1566, DOI 10.1152/ajprenal.00214.2009; Ohse T, 2009, KIDNEY INT, V76, P1225, DOI 10.1038/ki.2009.386; Ohtomo S, 2008, KIDNEY INT, V74, P768, DOI 10.1038/ki.2008.302; Orgaz JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5255; Ralay R. H., 2011, J NEUROTRAUM, V28, P1757, DOI DOI 10.1089/NEU.2011.1799; Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68; Shankland SJ, 2013, CURR OPIN NEPHROL HY, V22, P302, DOI 10.1097/MNH.0b013e32835fefd4; Smeets B, 2011, J AM SOC NEPHROL, V22, P1262, DOI 10.1681/ASN.2010090970; Smeets B, 2009, J AM SOC NEPHROL, V20, P2604, DOI 10.1681/ASN.2009010122; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Suzuki T, 2009, AM J PATHOL, V174, P1675, DOI 10.2353/ajpath.2009.080789; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Venkatareddy M, 2014, J AM SOC NEPHROL, V25, P1118, DOI 10.1681/ASN.2013080859; WATANABE K, 1990, NEPHRON, V56, P405, DOI 10.1159/000186184; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Whitney JL, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-12; Wong CY, 2008, PATHOLOGY, V40, P52, DOI 10.1080/00313020701716367; Yang CQ, 2014, CELL PHYSIOL BIOCHEM, V34, P266, DOI 10.1159/000362997; Yang JW, 2002, J CLIN INVEST, V110, P1525, DOI 10.1172/JC1200216219; Yao XM, 2010, J ENDOCRINOL INVEST, V33, P292, DOI [10.1007/BF03346588, 10.3275/6558]; Yao XM, 2009, DIABETES OBES METAB, V11, P519, DOI 10.1111/j.1463-1326.2008.00990.x; Yaoita E, 2001, CELL TISSUE RES, V304, P339; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zhao Hong, 2013, World J Nephrol, V2, P84, DOI 10.5527/wjn.v2.i3.84; Zhao XY, 2011, AM J NEPHROL, V34, P268, DOI 10.1159/000330187	42	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123276	10.1371/journal.pone.0123276	http://dx.doi.org/10.1371/journal.pone.0123276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849723	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800221
J	Chen, SY; Meng, FJ; Chen, ZZ; Tomlinson, BN; Wesley, JM; Sun, GY; Whaley-Connell, AT; Sowers, JR; Cui, JK; Gu, ZZ				Chen, Shanyan; Meng, Fanjun; Chen, Zhenzhou; Tomlinson, Brittany N.; Wesley, Jennifer M.; Sun, Grace Y.; Whaley-Connell, Adam T.; Sowers, James R.; Cui, Jiankun; Gu, Zezong			Two-Dimensional Zymography Differentiates Gelatinase Isoforms in Stimulated Microglial Cells and in Brain Tissues of Acute Brain Injuries	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; POSTTRANSLATIONAL MODIFICATIONS; NADPH OXIDASE; MMP-9; PROTEIN; ROLES; ACTIVATION; INHIBITION; INDUCTION; RAT	Excessive activation of gelatinases (MMP-2/-9) is a key cause of detrimental outcomes in neurodegenerative diseases. A single-dimension zymography has been widely used to determine gelatinase expression and activity, but this method is inadequate in resolving complex enzyme isoforms, because gelatinase expression and activity could be modified at transcriptional and posttranslational levels. In this study, we investigated gelatinase isoforms under in vitro and in vivo conditions using two-dimensional (2D) gelatin zymography electrophoresis, a protocol allowing separation of proteins based on isoelectric points (pI) and molecular weights. We observed organomercuric chemical 4-aminophenylmercuric acetate-induced activation of MMP-2 isoforms with variant pI values in the conditioned medium of human fibrosarcoma HT1080 cells. Studies with murine BV-2 microglial cells indicated a series of proform MMP-9 spots separated by variant pI values due to stimulation with lipopolysaccharide (LPS). The MMP-9 pI values were shifted after treatment with alkaline phosphatase, suggesting presence of phosphorylated isoforms due to the proinflammatory stimulation. Similar MMP-9 isoforms with variant pI values in the same molecular weight were also found in mouse brains after ischemic and traumatic brain injuries. In contrast, there was no detectable pI differentiation of MMP-9 in the brains of chronic Zucker obese rats. These results demonstrated effective use of 2D zymography to separate modified MMP isoforms with variant pI values and to detect posttranslational modifications under different pathological conditions.	[Chen, Shanyan; Meng, Fanjun; Chen, Zhenzhou; Tomlinson, Brittany N.; Wesley, Jennifer M.; Sun, Grace Y.; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA; [Chen, Shanyan; Meng, Fanjun; Chen, Zhenzhou; Tomlinson, Brittany N.; Wesley, Jennifer M.; Sun, Grace Y.; Cui, Jiankun; Gu, Zezong] Univ Missouri, Sch Med, Ctr Translat Neurosci, Columbia, MO USA; [Chen, Shanyan] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA; [Tomlinson, Brittany N.] Univ Missouri, Grad Sch, Pathol Program, Columbia, MO USA; [Sun, Grace Y.] Univ Missouri, Sch Med, Dept Biochem, Columbia, MO USA; [Whaley-Connell, Adam T.; Sowers, James R.] Univ Missouri, Sch Med, Dept Internal Med, Diabet & Cardiovasc Ctr, Columbia, MO USA; [Sowers, James R.; Cui, Jiankun; Gu, Zezong] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital	Gu, ZZ (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65211 USA.	guze@health.missouri.edu	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Whaley-Connell, Adam/0000-0001-8955-5560	American Heart Association National Scientist Development award [09SDG2260983]; Dana Foundation; National Football Leagues (NFL) Charities Foundation; University of Missouri Mizzou Advantage One Health One Medicine Program; Department of Pathology Research funds	American Heart Association National Scientist Development award(American Heart Association); Dana Foundation; National Football Leagues (NFL) Charities Foundation; University of Missouri Mizzou Advantage One Health One Medicine Program; Department of Pathology Research funds	Funding was provided by American Heart Association National Scientist Development award (09SDG2260983) to ZG; The Dana Foundation to ZG, http://www.dana.org/grants/; The National Football Leagues (NFL) Charities Foundation to ZG, https://www.nflcharities.org/; The University of Missouri Mizzou Advantage One Health One Medicine Program, http://mizzouadvantage.missouri.edu/medicine/; and the Department of Pathology Research funds to ZG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroor AR, 2013, ENDOCRINOLOGY, V154, P2501, DOI 10.1210/en.2013-1096; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brussee V, 2008, DIABETES, V57, P1664, DOI 10.2337/db07-1737; Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Chander PN, 2004, J AM SOC NEPHROL, V15, P2391, DOI 10.1097/01.ASN.0000135971.88164.2C; Chen H, 2011, NEUROBIOL DIS, V42, P341, DOI 10.1016/j.nbd.2011.01.027; Chen JL, 2011, STROKE, V42, P445, DOI 10.1161/STROKEAHA.110.596486; Chen ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092133; Choi NS, 2004, J BIOCHEM MOL BIOL, V37, P298; Choi SH, 2012, J NEUROCHEM, V120, P292, DOI 10.1111/j.1471-4159.2011.07572.x; Chuang DY, 2014, ASN NEURO, V6, DOI 10.1177/1759091414554946; Cui JK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-21; Gibbs DF, 1999, AM J RESP CELL MOL, V20, P1145, DOI 10.1165/ajrcmb.20.6.3482; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayden MR, 2013, CARDIORENAL MED, V3, P265, DOI 10.1159/000357113; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jacob Archana M., 2008, V446, P21, DOI 10.1007/978-1-60327-084-7_2; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kusano K, 1998, ENDOCRINOLOGY, V139, P1338, DOI 10.1210/en.139.3.1338; Labrie M, 2013, CELL MOL LIFE SCI, V70, P3109, DOI 10.1007/s00018-012-1214-z; Larocca M, 2010, J SCI FOOD AGR, V90, P2411, DOI 10.1002/jsfa.4100; Launer LJ, 2009, STROKE, V40, pS53, DOI 10.1161/STROKEAHA.108.533075; Lee EJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-116; Leonard BL, 2005, ACTA DIABETOL, V42, P162, DOI 10.1007/s00592-005-0197-8; Lodemel JB, 2004, COMP BIOCHEM PHYS B, V139, P253, DOI 10.1016/j.cbpc.2004.08.004; Okamoto T, 2001, J BIOL CHEM, V276, P29596, DOI 10.1074/jbc.M102417200; Opdenakker G, 2003, LANCET NEUROL, V2, P747, DOI 10.1016/S1474-4422(03)00587-8; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Leme AFP, 2009, PROTEOMICS, V9, P733, DOI 10.1002/pmic.200800484; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Rossano R, 2014, J CELL MOL MED, V18, P242, DOI 10.1111/jcmm.12181; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931; Shen SM, 2005, NEUROCHEM INT, V47, P298, DOI 10.1016/j.neuint.2005.03.007; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Sun GY, 2007, J NEUROCHEM, V103, P1, DOI 10.1111/j.1471-4159.2007.04670.x; Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE; Tsioufis C, 2012, CURR TOP MED CHEM, V12, P1159, DOI 10.2174/1568026611208011159; Tyagi SC, 1996, J MOL CELL CARDIOL, V28, P1415, DOI 10.1006/jmcc.1996.0132; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Warner RL, 2004, EXP MOL PATHOL, V76, P189, DOI 10.1016/j.yexmp.2004.01.003; Wilkesman JG, 2007, ELECTROPHORESIS, V28, P429, DOI 10.1002/elps.200600332; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Yim HE, 2012, J NUTR BIOCHEM, V23, P937, DOI 10.1016/j.jnutbio.2011.04.020; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807	59	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123852	10.1371/journal.pone.0123852	http://dx.doi.org/10.1371/journal.pone.0123852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859655	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300116
J	Fernandez, A; Black, J; Jones, M; Wilson, L; Salvador-Carulla, L; Astell-Burt, T; Black, D				Fernandez, Ana; Black, John; Jones, Mairwen; Wilson, Leigh; Salvador-Carulla, Luis; Astell-Burt, Thomas; Black, Deborah			Flooding and Mental Health: A Systematic Mapping Review	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ADOLESCENTS 28 MONTHS; SOCIAL SUPPORT; DISASTER PREPAREDNESS; NATURAL DISASTER; RELATIONSHIP ADJUSTMENT; PSYCHOLOGICAL HEALTH; PSYCHOSOCIAL-ASPECTS; POSTDISASTER PTSD; CLIMATE-CHANGE	Background Floods are the most common type of global natural disaster. Floods have a negative impact on mental health. Comprehensive evaluation and review of the literature are lacking. Objective To systematically map and review available scientific evidence on mental health impacts of floods caused by extended periods of heavy rain in river catchments. Methods We performed a systematic mapping review of published scientific literature in five languages for mixed studies on floods and mental health. PUBMED and Web of Science were searched to identify all relevant articles from 1994 to May 2014 (no restrictions). Results The electronic search strategy identified 1331 potentially relevant papers. Finally, 83 papers met the inclusion criteria. Four broad areas are identified: i) the main mental health disorders- post-traumatic stress disorder, depression and anxiety; ii] the factors associated with mental health among those affected by floods; iii) the narratives associated with flooding, which focuses on the long-term impacts of flooding on mental health as a consequence of the secondary stressors; and iv) the management actions identified. The quantitative and qualitative studies have consistent findings. However, very few studies have used mixed methods to quantify the size of the mental health burden as well as exploration of in-depth narratives. Methodological limitations include control of potential confounders and short-term follow up. Limitations Floods following extreme events were excluded from our review. Conclusions Although the level of exposure to floods has been systematically associated with mental health problems, the paucity of longitudinal studies and lack of confounding controls precludes strong conclusions.	[Fernandez, Ana; Salvador-Carulla, Luis] Univ Sydney, Brain & Mind Res Inst, Ctr Disabil Res & Policy, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Black, John; Black, Deborah] Univ Sydney, Fac Hlth Sci, Ageing Work & Hlth Unit, Sydney, NSW 2006, Australia; [Jones, Mairwen] Univ Sydney, Fac Hlth Sci, Discipline Behav & Social Sci Hlth, Sydney, NSW 2006, Australia; [Wilson, Leigh; Astell-Burt, Thomas] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; Western Sydney University	Black, D (corresponding author), Univ Sydney, Fac Hlth Sci, Ageing Work & Hlth Unit, Sydney, NSW 2006, Australia.	deborah.black@sydney.edu.au	Astell-Burt, Thomas/B-9341-2018; PRISMA, Grupo/AAI-6753-2021; black, deborah/C-2829-2017; Salvador-Carulla, Luis/K-6512-2013; Fernandez, Ana/H-4545-2012	Astell-Burt, Thomas/0000-0002-1498-4851; black, deborah/0000-0001-9174-1565; Salvador-Carulla, Luis/0000-0002-5742-9866; Fernandez, Ana/0000-0002-0333-1345; Jones, Mairwen/0000-0002-3711-6731				Acharya L, 2006, INT REV PSYCHIATR, V18, P587, DOI 10.1080/09540260601038407; Ahern M, 2005, EPIDEMIOL REV, V27, P36, DOI 10.1093/epirev/mxi004; Alderman K, 2013, DISASTER MED PUBLIC, V7, P380, DOI 10.1017/dmp.2013.42; Alderman K, 2012, ENVIRON INT, V47, P37, DOI 10.1016/j.envint.2012.06.003; [Anonymous], 2013, PLOS CURRENTS; Apisarnthanarak A, 2013, INFECT CONT HOSP EP, V34, P655, DOI 10.1086/670643; Assanangkornchai S, 2007, STRESS HEALTH, V23, P43, DOI 10.1002/smi.1118; Assanarigkornchai S, 2004, STRESS HEALTH, V20, P81, DOI 10.1002/smi.999; Auger C, 2000, CAN FAM PHYSICIAN, V46, P2420; Azuma K, 2014, INT J ENVIRON HEAL R, V24, P158, DOI 10.1080/09603123.2013.800964; Bayntun C., 2012, PLOS CURR-TREE LIFE, P1, DOI [10.1371/5028b6037259a, DOI 10.1371/5028B6037259A]; Bei B, 2013, AGING MENT HEALTH, V17, P992, DOI 10.1080/13607863.2013.799119; Blaxter M., 1996, MED SOCIOLOGY NEWS, V22, P68; Bokszczanin A, 2008, ANXIETY STRESS COPIN, V21, P325, DOI 10.1080/10615800801950584; Bokszczanin A, 2007, J TRAUMA STRESS, V20, P347, DOI 10.1002/jts.20220; Boon HJ, 2014, NAT HAZARDS, V71, P683, DOI 10.1007/s11069-013-0935-0; Bouzid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062041; Carroll B, 2010, DISASTERS, V34, P1045, DOI 10.1111/j.1467-7717.2010.01182.x; Carroll B, 2009, HEALTH PLACE, V15, P540, DOI 10.1016/j.healthplace.2008.08.009; Cherniack E Paul, 2008, Am J Disaster Med, V3, P133; Choudhury WA, 2006, INT REV PSYCHIATR, V18, P529, DOI 10.1080/09540260601037896; Clapton J, 2009, SCIE SYSTEMATIC MAPP; Clemens SL, 2013, MED J AUSTRALIA, V199, P552, DOI 10.5694/mja13.10307; Collins TW, 2013, J IMMIGR MINOR HEALT, V15, P415, DOI 10.1007/s10903-012-9626-2; Convery I, 2010, J FLOOD RISK MANAG, V3, P99, DOI 10.1111/j.1753-318X.2010.01060.x; Convery I, 2008, J FLOOD RISK MANAG, V1, P100, DOI 10.1111/j.1753-318X.2008.00012.x; Crabtree A, 2013, SOC INDIC RES, V113, P711, DOI 10.1007/s11205-013-0297-8; Cretikos MA, 2007, MED J AUSTRALIA, V187, P670, DOI 10.5694/j.1326-5377.2007.tb01470.x; de Freitas CM, 2012, CIENC SAUDE COLETIVA, V17, P1601, DOI 10.1590/S1413-81232012000600023; De Leo D, 2013, J LOSS TRAUMA, V18, P170, DOI 10.1080/15325024.2012.684581; Deshmukh N, 2008, ASIA PAC J SOC WORK, V18, P36, DOI 10.1080/21650993.2008.9756041; Dorji C, 2006, INT REV PSYCHIATR, V18, P537, DOI 10.1080/09540260601037979; Du WW, 2010, PREHOSP DISASTER MED, V25, P265, DOI 10.1017/S1049023X00008141; Felton JW, 2013, J ABNORM PSYCHOL, V122, P64, DOI 10.1037/a0029303; Fewtrell L, 2008, PUBLIC HEALTH, V122, P446, DOI 10.1016/j.puhe.2007.09.010; Fistein E, 2012, JCPSP-J COLL PHYSICI, V22, P66, DOI 01.2012/JCPSP.6668; Fredman SJ, 2010, J TRAUMA STRESS, V23, P446, DOI 10.1002/jts.20555; Ginexi EM, 2000, AM J COMMUN PSYCHOL, V28, P495, DOI 10.1023/A:1005188515149; Gordon KH, 2011, CRISIS, V32, P52, DOI 10.1027/0227-5910/a000051; Group NFRA, 2008, FLOOD RISK MANAGEMEN; Gruebner O, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-177; Gruebner O, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-36; Hajat S, 2005, Extreme Weather Events and Public Health Responses, P185, DOI 10.1007/3-540-28862-7_18; HARVEY JH, 1995, J SOC BEHAV PERS, V10, P313; Heo JH, 2008, PSYCHIAT INVEST, V5, P186, DOI 10.4306/pi.2008.5.3.186; Ishikawa M, 2013, INT J SOC PSYCHIATR, V59, P468, DOI 10.1177/0020764012440677; Jones EC, 2011, HUM ORGAN, V70, P33, DOI 10.17730/humo.70.1.4h340201207274qj; Kaniasty K, 2008, J TRAUMA STRESS, V21, P274, DOI 10.1002/jts.20334; Keogh DU, 2011, NAT HAZARDS, V59, P699, DOI 10.1007/s11069-011-9791-y; Kolves K, 2013, J AFFECT DISORDERS, V146, P1, DOI 10.1016/j.jad.2012.07.037; Kovats R Sari, 2004, J Br Menopause Soc, V10, P139, DOI 10.1258/1362180042721085; Kreuger L, 2003, J SOC SERV RES, V30, P93, DOI 10.1300/J079v30n02_06; Krug EG, 1998, NEW ENGL J MED, V338, P373, DOI 10.1056/NEJM199802053380607; Lalande G, 2000, Sante Ment Que, V25, P95; Liu AZ, 2006, CAN J PSYCHIAT, V51, P350, DOI 10.1177/070674370605100603; Lowe D, 2013, INT J ENV RES PUB HE, V10, P7015, DOI [10.3390/ijerph10127015, 10.3390/ijerph110100030]; Maghrabi K, 2012, LIFE SCI J, V9, P95; Maltais D, 2000, Sante Ment Que, V25, P116; Maltais D, 2005, SCI SOC SANTE, V23, P5, DOI 10.3406/sosan.2005.1648; Maltais D, 2000, Sante Ment Que, V25, P74; Maltais D, 2001, CAN J AGING, V20, P407, DOI 10.1017/S071498080001285X; Mason V, 2010, PSYCHOL HEALTH MED, V15, P61, DOI 10.1080/13548500903483478; McMillen C, 2002, COMPR PSYCHIAT, V43, P478, DOI 10.1053/comp.2002.34632; Moher David, 2009, Open Med, V3, pe123; Monson CM, 2009, J TRAUMA STRESS, V22, P276, DOI 10.1002/jts.20432; Motreff Y, 2013, PREHOSP DISASTER MED, V28, P428, DOI 10.1017/S1049023X13008662; Norris FH, 2004, J TRAUMA STRESS, V17, P283, DOI 10.1023/B:JOTS.0000038476.87634.9b; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; North CS, 2013, JAMA-J AM MED ASSOC, V310, P507, DOI 10.1001/jama.2013.107799; North CS, 2000, AM J PUBLIC HEALTH, V90, P1057, DOI 10.2105/AJPH.90.7.1057; North CS, 2004, J NERV MENT DIS, V192, P823, DOI 10.1097/01.nmd.0000146911.52616.22; Otero JC, 2006, J CLIN PSYCHIAT, V67, P56; Otto K, 2006, PERS INDIV DIFFER, V40, P1075, DOI 10.1016/j.paid.2005.11.010; Oven KJ, 2012, APPL GEOGR, V33, P16, DOI 10.1016/j.apgeog.2011.05.012; Paranjothy S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-145; Parker D, 2007, NAT HAZARDS, V43, P397, DOI 10.1007/s11069-007-9137-y; Peek-Asa C, 2012, PREHOSP DISASTER MED, V27, P503, DOI 10.1017/S1049023X1200129X; Peng MN, 2011, MED PRIN PRACT, V20, P336, DOI 10.1159/000323757; Pluye P, 2014, ANNU REV PUBL HEALTH, V35, P29, DOI 10.1146/annurev-publhealth-032013-182440; Raguenaud ME, 2012, PREHOSP DISASTER MED, V27, P483, DOI 10.1017/S1049023X12001082; Reacher M, 2004, Commun Dis Public Health, V7, P39; Sheikh K, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-19; Smith BW, 1996, J SOC BEHAV PERS, V11, P225; Smith BW, 2000, J TRAUMA STRESS, V13, P349, DOI 10.1023/A:1007745920466; Smith BW, 2000, J COMMUNITY PSYCHOL, V28, P169, DOI 10.1002/(SICI)1520-6629(200003)28:2<169::AID-JCOP5>3.0.CO;2-I; Stanke C, 2012, PLOS CURR, V4; Stefan W, 2013, THE ANGRY SUMMER REP; Tapsell S, 2001, IAHS-AISH P, P319; Tapsell SM, 2008, HEALTH PLACE, V14, P133, DOI 10.1016/j.healthplace.2007.05.006; Telles Shirley, 2009, Indian J Med Sci, V63, P330, DOI 10.4103/0019-5359.55883; Tobin GA, 1996, ENVIRON BEHAV, V28, P340, DOI 10.1177/0013916596283004; Bich TH, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.6356; Tunstall Sylvia, 2006, Journal of Water and Health, V4, P365, DOI 10.2166/wh.2006.031; Turner LR, 2013, AUST NZ J PUBL HEAL, V37, P396, DOI 10.1111/1753-6405.12093; Tyler KA, 2000, RES AGING, V22, P143, DOI 10.1177/0164027500222003; Verger P, 2003, J EXPO ANAL ENV EPID, V13, P436, DOI 10.1038/sj.jea.7500290; Verger P, 1999, Sante, V9, P313; Verger P, 2000, REV EPIDEMIOL SANTE, V48, P44; Wind TR, 2013, PREHOSPITAL DISASTER, V28, P279, DOI 10.1017/S1049023X13000290; Wind TR, 2012, SOC SCI MED, V75, P1715, DOI 10.1016/j.socscimed.2012.06.032; Wind TR, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.6351	101	135	137	5	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0119929	10.1371/journal.pone.0119929	http://dx.doi.org/10.1371/journal.pone.0119929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25860572	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300011
J	Lanaspa, MA; Epperson, LE; Li, NX; Cicerchi, C; Garcia, GE; Roncal-Jimenez, CA; Trostel, J; Jain, S; Mant, CT; Rivard, CJ; Ishimoto, T; Shimada, M; Sanchez-Lozada, LG; Nakagawa, T; Jani, A; Stenvinkel, P; Martin, SL; Johnson, RJ				Lanaspa, Miguel A.; Epperson, L. Elaine; Li, Nanxing; Cicerchi, Christina; Garcia, Gabriela E.; Roncal-Jimenez, Carlos A.; Trostel, Jessica; Jain, Swati; Mant, Colin T.; Rivard, Christopher J.; Ishimoto, Takuji; Shimada, Michiko; Sanchez-Lozada, Laura Gabriela; Nakagawa, Takahiko; Jani, Alkesh; Stenvinkel, Peter; Martin, Sandra L.; Johnson, Richard J.			Opposing Activity Changes in AMP Deaminase and AMP-Activated Protein Kinase in the Hibernating Ground Squirrel	PLOS ONE			English	Article							MAMMALIAN HIBERNATION; MITOCHONDRIAL METABOLISM; LIQUID-CHROMATOGRAPHY; BODY-TEMPERATURE; ENERGY SENSOR; CELL-FUNCTION; DAILY TORPOR; AROUSAL; MUSCLE; ACCUMULATION	Hibernating animals develop fatty liver when active in summertime and undergo a switch to a fat oxidation state in the winter. We hypothesized that this switch might be determined by AMP and the dominance of opposing effects: metabolism through AMP deaminase (AMPD2) (summer) and activation of AMP-activated protein kinase (AMPK) (winter). Liver samples were obtained from 13-lined ground squirrels at different times during the year, including summer and multiples stages of winter hibernation, and fat synthesis and beta-fatty acid oxidation were evaluated. Changes in fat metabolism were correlated with changes in AMPD2 activity and intrahepatic uric acid (downstream product of AMPD2), as well as changes in AMPK and intrahepatic beta-hydroxybutyrate (a marker of fat oxidation). Hepatic fat accumulation occurred during the summer with relatively increased enzymes associated with fat synthesis (FAS, ACL and ACC) and decreased enoyl CoA hydratase (ECH1) and carnitine palmitoyltransferase 1A (CPT1A), rate limiting enzymes of fat oxidation. In summer, AMPD2 activity and intrahepatic uric acid levels were high and hepatic AMPK activity was low. In contrast, the active phosphorylated form of AMPK and beta-hydroxybutyrate both increased during winter hibernation. Therefore, changes in AMPD2 and AMPK activity were paralleled with changes in fat synthesis and fat oxidation rates during the summer-winter cycle. These data illuminate the opposing forces of metabolism of AMP by AMPD2 and its availability to activate AMPK as a switch that governs fat metabolism in the liver of hibernating ground squirrel.	[Lanaspa, Miguel A.; Li, Nanxing; Cicerchi, Christina; Garcia, Gabriela E.; Roncal-Jimenez, Carlos A.; Trostel, Jessica; Jain, Swati; Rivard, Christopher J.; Ishimoto, Takuji; Shimada, Michiko; Sanchez-Lozada, Laura Gabriela; Nakagawa, Takahiko; Jani, Alkesh; Johnson, Richard J.] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Epperson, L. Elaine; Martin, Sandra L.] Dept Cell & Dev Biol, Aurora, CO 80045 USA; [Mant, Colin T.] Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Sanchez-Lozada, Laura Gabriela] INC Ignacio Chavez, Lab Renal Physiopathol, Mexico City, DF, Mexico; [Sanchez-Lozada, Laura Gabriela] INC Ignacio Chavez, Dept Nephrol, Mexico City, DF, Mexico; [Stenvinkel, Peter] Karolinska Inst, Dept Clin Intervent & Technol, Div Renal Med, Stockholm, Sweden; [Johnson, Richard J.] Eastern Colorado Hlth Syst, Div Nephrol, Dept Vet Affairs, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Karolinska Institutet	Lanaspa, MA (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.	Miguel.Lanaspagarcia@ucdenver.edu	Lanaspa, Miguel/AAO-4971-2020; Ishimoto, Takuji/M-4873-2014; Sanchez-Lozada, Laura/AAS-2104-2021	Ishimoto, Takuji/0000-0002-9861-5331; Sanchez-Lozada, Laura-Gabriela/0000-0003-0348-9617; Stenvinkel, Peter/0000-0002-8785-4820	NIH [HL68607, RC4 DK90859]; University of Colorado [HL089049]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068607, R01HL089049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082509, RC4DK090859] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by NIH grants HL68607, RC4 DK90859 and startup funds from the University of Colorado to RJJ and grant HL089049 to SLM for support of the animal samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Badry KS, COMP BIOCH PHYSL A, V74, P435; ALBADRY KS, 1983, COMP BIOCHEM PHYS A, V74, P143, DOI 10.1016/0300-9629(83)90725-9; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; Bairlein F, 2002, NATURWISSENSCHAFTEN, V89, P1, DOI 10.1007/s00114-001-0279-6; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Brown JCL, 2010, BBA-BIOENERGETICS, V1797, P476, DOI 10.1016/j.bbabio.2010.01.009; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; CHANEY AL, 1962, CLIN CHEM, V8, P130; Cicerchi C, 2014, FASEB J, V28, P3339, DOI 10.1096/fj.13-243634; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Drew KL, 2002, COMP BIOCHEM PHYS C, V133, P483, DOI 10.1016/S1532-0456(02)00118-7; Epperson LE, 2011, PHYSIOL GENOMICS, V43, P799, DOI 10.1152/physiolgenomics.00028.2011; FLORANT GL, 1985, AM J PHYSIOL, V249, pR159, DOI 10.1152/ajpregu.1985.249.2.R159; Florant GL, 2012, J COMP PHYSIOL B, V182, P451, DOI 10.1007/s00360-011-0630-y; Hampton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085157; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Healy JE, 2011, COMP BIOCHEM PHYS A, V159, P322, DOI 10.1016/j.cbpa.2011.03.026; Hindle AG, 2015, J EXP BIOL, V218, P276, DOI 10.1242/jeb.109512; Hindle AG, 2014, PHYSIOL GENOMICS, V46, P348, DOI 10.1152/physiolgenomics.00190.2013; Horman S, 2005, COMP BIOCHEM PHYS B, V142, P374, DOI 10.1016/j.cbpb.2005.08.010; Horwitz BA, 2013, AM J PHYSIOL-REG I, V305, pR759, DOI 10.1152/ajpregu.00450.2012; Jani A, 2013, AM J PHYSIOL-RENAL, V305, pF1521, DOI 10.1152/ajprenal.00675.2012; Jani A, 2011, TRANSPLANTATION, V92, P1215, DOI 10.1097/TP.0b013e3182366401; Johnson RJ, 2013, OBESITY, V21, P659, DOI 10.1002/oby.20026; Keesey RE, 1997, J NUTR, V127, pS1875, DOI 10.1093/jn/127.9.1875S; Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048801; Lanaspa MA, 2009, J BIOL CHEM, V284, P19974, DOI 10.1074/jbc.M109.001792; Lee CC, 2008, ANNU REV MED, V59, P177, DOI 10.1146/annurev.med.59.061506.110403; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lushchak VI, 2008, COMP BIOCHEM PHYS B, V149, P362, DOI 10.1016/j.cbpb.2007.10.008; Martin SL, 2008, DIABETES VASC DIS RE, V5, P76, DOI 10.3132/dvdr.2008.013; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nelson CJ, 2009, PHYSIOL GENOMICS, V37, P43, DOI 10.1152/physiolgenomics.90323.2008; Okamoto I, 2006, COMP BIOCHEM PHYS C, V144, P47, DOI 10.1016/j.cbpc.2006.05.003; Ortmann S, 2000, AM J PHYSIOL-REG I, V278, pR698, DOI 10.1152/ajpregu.2000.278.3.R698; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Plaideau C, 2012, FASEB J, V26, P2685, DOI 10.1096/fj.11-198168; Robin JP, 1998, AM J PHYSIOL-REG I, V274, pR746, DOI 10.1152/ajpregu.1998.274.3.R746; Rouble AN, 2014, MOL CELL BIOCHEM, V393, P271, DOI 10.1007/s11010-014-2070-y; Shaw NM, 1979, BIOCHEM SOC T, V7, P1250, DOI 10.1042/bst0071250; Sheriff MJ, 2012, J COMP PHYSIOL B, V182, P841, DOI 10.1007/s00360-012-0661-z; SKURAT AV, 1995, J BIOL CHEM, V270, P12491, DOI 10.1074/jbc.270.21.12491; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Staples JF, 2008, J COMP PHYSIOL B, V178, P811, DOI 10.1007/s00360-008-0282-8; Staples JF, 2014, J EXP BIOL, V217, P2032, DOI 10.1242/jeb.092973; Toien O, 2001, AM J PHYSIOL-REG I, V281, pR572; Valente A, 2015, BIOL REV, V90, P77, DOI 10.1111/brv.12099; Van Breukelen F, 2001, AM J PHYSIOL-REG I, V281, pR1374, DOI 10.1152/ajpregu.2001.281.5.R1374	49	30	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123509	10.1371/journal.pone.0123509	http://dx.doi.org/10.1371/journal.pone.0123509			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856396	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500094
J	Pan, J; Li, H; Zhang, B; Xiong, R; Zhang, Y; Kang, WY; Chen, W; Zhao, ZB; Chen, SD				Pan, Jing; Li, Hui; Zhang, Bei; Xiong, Ran; Zhang, Yu; Kang, Wen-Yan; Chen, Wei; Zhao, Zong-Bo; Chen, Sheng-Di			Small Peptide Inhibitor of JNK3 Protects Dopaminergic Neurons from MPTP Induced Injury via Inhibiting the ASK1-JNK3 Signaling Pathway	PLOS ONE			English	Article							N-TERMINAL KINASE; PARKINSONS-DISEASE; MOUSE MODEL; APOPTOSIS; ACTIVATION; BRAIN; AP-1; NEURODEGENERATION; EXPRESSION; INDUCTION	Introduction and Aims The ASK1-JNK3 signaling pathway plays a pivotal role in the pathogenesis of Parkinson's disease (PD). The specific binding of beta-arrestin2 to JNK3 is essential for activation of the ASK1-JNK3 cascade, representing a potential therapeutic target for preventing dopaminergic neuronal death in PD. The aim of this study was to identify a novel strategy for the prevention of dopaminergic neuronal death in PD. Methods Based on the specific binding of beta-arrestin2 to JNK3, a 21-amino-acid fusion peptide, termed JNK3-N-Tat, was synthesized. We evaluated the ability of this peptide to inhibit the binding of beta-arrestin2 to its target domain in JNK3 in vitro and in vivo. Results The JNK3-N-Tat peptide inhibited activation of the ASK1-JNK3 cascade by disrupting the interaction between beta-arrestin2 and JNK3. JNK3-N-Tat exerted beneficial effects through pathways downstream of JNK3 and improved mitochondrial function, resulting in attenuated MPP+/MPTP-induced damage. JNK3-N-Tat protected mesencephalic dopaminergic neurons against MPTP-induced toxicity. Conclusions JNK3-N-Tat, a JNK3-inhibitory peptide, protects dopaminergic neurons against MPP+/MPTP-induced injury by inhibiting the ASK1-JNK3 signaling pathway.	[Pan, Jing; Li, Hui; Zhang, Bei; Xiong, Ran; Zhang, Yu; Kang, Wen-Yan; Chen, Wei; Zhao, Zong-Bo; Chen, Sheng-Di] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China; [Pan, Jing; Li, Hui; Zhang, Bei; Xiong, Ran; Zhang, Yu; Kang, Wen-Yan; Chen, Wei; Zhao, Zong-Bo; Chen, Sheng-Di] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Inst Neurol, Shanghai 200030, Peoples R China; [Chen, Sheng-Di] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200030, Peoples R China; [Chen, Sheng-Di] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Neurodegenerat Dis, Shanghai 200030, Peoples R China; [Chen, Sheng-Di] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Chen, SD (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Neurol, Shanghai 200030, Peoples R China.	chen_sd@medmail.com.cn			National Key Program of Basic Research of China [2011CB504104]; National Natural Science Foundation of China [81430022, 81371407, 81371409, 30900454]	National Key Program of Basic Research of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Key Program of Basic Research (2011CB504104) of China, the National Natural Science Foundation of China (81430022, 81371407, 81371409, 30900454). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; Antoniou X, 2011, J ALZHEIMERS DIS, V24, P633, DOI 10.3233/JAD-2011-091567; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Choi WS, 2010, J NEUROPATH EXP NEUR, V69, P511, DOI 10.1097/NEN.0b013e3181db8100; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; Furuya T, 2004, J NEUROSCI, V24, P1865, DOI 10.1523/JNEUROSCI.3309-03.2004; Guo C, 2008, J BIOL CHEM, V283, P15903, DOI 10.1074/jbc.M710006200; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Kuan CY, 2005, CNS NEUROL DISORD-DR, V4, P63, DOI 10.2174/1568007053005145; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Li X, 2009, FEBS LETT, V583, P3310, DOI 10.1016/j.febslet.2009.09.035; Liedhegner EAS, 2011, CHEM RES TOXICOL, V24, P1644, DOI 10.1021/tx200082h; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Martin JH, 1996, MOL BRAIN RES, V35, P47, DOI 10.1016/0169-328X(95)00181-Q; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Nagai H, 2007, J BIOCHEM MOL BIOL, V40, P1; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Pan J, 2009, NEUROCHEM INT, V54, P418, DOI 10.1016/j.neuint.2009.01.013; Resnick L, 2004, DRUG DISCOV TODAY, V9, P932, DOI 10.1016/S1359-6446(04)03251-9; Ries V, 2008, J NEUROCHEM, V107, P1578, DOI 10.1111/j.1471-4159.2008.05713.x; Saporito MS, 1999, J PHARMACOL EXP THER, V288, P421; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Wang LH, 2008, NEUROLOGY, V71, P462, DOI 10.1212/01.wnl.0000324506.93877.5e; Wang WY, 2004, NEUROSCI RES, V48, P195, DOI 10.1016/j.neures.2003.10.012; Wang ZQ, 2011, ANN NEUROL, V70, P591, DOI 10.1002/ana.22514; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Xie XL, 1998, STRUCTURE, V6, P983, DOI 10.1016/S0969-2126(98)00100-2; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	34	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119204	10.1371/journal.pone.0119204	http://dx.doi.org/10.1371/journal.pone.0119204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856433	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500005
J	Safi, S; Benner, A; Walloschek, J; Renner, M; op den Winkel, J; Muley, T; Storz, K; Dienemann, H; Hoffmann, H; Schneider, T				Safi, Seyer; Benner, Axel; Walloschek, Janos; Renner, Maria; op den Winkel, Jan; Muley, Thomas; Storz, Konstantina; Dienemann, Hendrik; Hoffmann, Hans; Schneider, Thomas			Development and Validation of a Risk Score for Predicting Death after Pneumonectomy	PLOS ONE			English	Article							CELL LUNG-CANCER; MAJOR PULMONARY RESECTION; OPERATIVE MORTALITY; THORACIC-SURGERY; POSTOPERATIVE MORTALITY; 30-DAY MORTALITY; MORBIDITY; COMPLICATIONS; THORACOSCORE; DATABASE	Pneumonectomy is associated with significant postoperative mortality. This study was undertaken to develop and validate a risk model of mortality following pneumonectomy. We reviewed our prospective database and identified 774 pneumonectomies from a total of 7792 consecutive anatomical lung resections in the years 2003 to 2010 (rate of pneumonectomy: 9.9%). Based on data from 542 pneumonectomies between 2003 and 2007 (i.e., the "discovery set"), a penalized multivariable logistic regression analysis was performed to identify preoperative risk factors. A risk model was developed and validated in an independent data set of 232 pneumonectomies that were performed between 2008 and 2010 (i.e., the "validation set"). Of the 542 patients in the discovery set (DS), 35 patients (6.5%) died after pneumonectomy during the same admission. We developed a risk prediction model for in-hospital mortality following pneumonectomy; that model included age, current alcohol use, coronary artery disease, preoperative leukocyte count and palliative indication as possible risk factors. The risk model was subsequently successfully validated in an independent data set (n = 232) in which 18 patients (7.8%) died following pneumonectomy. For the validation set, the sensitivity of the model was 53.3% (DS: 54.3%), the specificity was 88.0% (DS: 87.4%), the positive predictive value was 26.7%(DS: 22.9%) and the negative predictive value was 95.8% (DS: 96.5%). The Brier score was 0.062 (DS: 0.054). The prediction model is statistically valid and clinically relevant.	[Safi, Seyer; Walloschek, Janos; op den Winkel, Jan; Muley, Thomas; Storz, Konstantina; Dienemann, Hendrik; Hoffmann, Hans] Univ Heidelberg Hosp, Thorax Klin, Dept Thorac Surg, Heidelberg, Baden Wurttembe, Germany; [Benner, Axel; Renner, Maria] German Canc Res Ctr, Div Biostat, Heidelberg, Baden Wurttembe, Germany; [Schneider, Thomas] St Vincentius Kliniken Karlsruhe, Dept Thorac Surg, Karlsruhe, Baden Wurttembe, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Hoffmann, H (corresponding author), Univ Heidelberg Hosp, Thorax Klin, Dept Thorac Surg, Heidelberg, Baden Wurttembe, Germany.	hans.hoffmann@med.uni-heidelberg.de	Safi, Seyer/AAY-2772-2020; Muley, Thomas/AAY-9200-2020	Safi, Seyer/0000-0002-2335-4309; 				Albain KS, 2009, LANCET, V374, P379, DOI 10.1016/S0140-6736(09)60737-6; Alexiou C, 2001, EUR J CARDIO-THORAC, V20, P476, DOI 10.1016/S1010-7940(01)00823-5; Algar FJ, 2003, EUR J CARDIO-THORAC, V23, P201, DOI 10.1016/S1010-7940(02)00719-4; Bagan P, 2013, ANN THORAC SURG, V95, P392, DOI 10.1016/j.athoracsur.2012.06.023; Bernard A, 2001, J THORAC CARDIOV SUR, V121, P1076, DOI 10.1067/mtc.2001.114350; Bradley A, 2012, EUR RESPIR J, V40, P1496, DOI 10.1183/09031936.00218111; Brunelli A, 2009, EUR J CARDIO-THORAC, V35, P769, DOI 10.1016/j.ejcts.2009.01.037; DALES RE, 1993, CHEST, V104, P155, DOI 10.1378/chest.104.1.155; Damhuis RAM, 2012, BRIT J SURG, V99, P1149, DOI 10.1002/bjs.8813; Dancewicz Maciej, 2006, Interact Cardiovasc Thorac Surg, V5, P97, DOI 10.1510/icvts.2005.118125; Dienemann H, 1998, CHIRURG, V69, P412, DOI 10.1007/s001040050431; Falcoz PE, 2007, J THORAC CARDIOV SUR, V133, P325, DOI 10.1016/j.jtcvs.2006.09.020; Fernandez FG, 2011, ANN THORAC SURG, V92, P244, DOI 10.1016/j.athoracsur.2011.03.021; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gaissert HA, 2009, J THORAC CARDIOV SUR, V138, P289, DOI 10.1016/j.jtcvs.2008.11.069; GINSBERG RJ, 1983, J THORAC CARDIOV SUR, V86, P654; HARMON H, 1976, ANN SURG, V183, P719, DOI 10.1097/00000658-197606000-00016; Harpole DH, 1999, J THORAC CARDIOV SUR, V117, P969, DOI 10.1016/S0022-5223(99)70378-8; Joo JB, 2001, AM SURGEON, V67, P318; Klapper J, 2014, J AM COLL SURGEONS, V219, P518, DOI 10.1016/j.jamcollsurg.2014.01.062; Kozower BD, 2010, ANN THORAC SURG, V90, P875, DOI 10.1016/j.athoracsur.2010.03.115; Krasna MJ, 2009, J THORAC CARDIOV SUR, V138, P295, DOI 10.1016/j.jtcvs.2009.02.006; Leo F, 2007, EUR J CARDIO-THORAC, V31, P779, DOI 10.1016/j.ejcts.2007.01.036; Mansour Z, 2009, ANN THORAC SURG, V88, P1737, DOI 10.1016/j.athoracsur.2009.07.016; Marret E, 2010, INTERACT CARDIOV TH, V10, P936, DOI 10.1510/icvts.2009.231621; McMillan RR, 2014, ANN THORAC SURG, V98, P1769, DOI 10.1016/j.athoracsur.2014.06.024; PATEL RL, 1992, ANN THORAC SURG, V54, P84, DOI 10.1016/0003-4975(92)91145-Y; Powell ES, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-41; Puri V, 2013, ANN THORAC SURG, V95, P1885, DOI 10.1016/j.athoracsur.2013.04.014; Qadri SSA, 2014, EUR J CARDIO-THORAC, V45, P864, DOI 10.1093/ejcts/ezt517; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Senbaklavaci O, 2013, LANGENBECK ARCH SURG, V398, P903, DOI 10.1007/s00423-013-1081-6; Shapiro M, 2010, ANN THORAC SURG, V90, P927, DOI 10.1016/j.athoracsur.2010.05.041; WAHI R, 1989, ANN THORAC SURG, V48, P33, DOI 10.1016/0003-4975(89)90172-0; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121295	10.1371/journal.pone.0121295	http://dx.doi.org/10.1371/journal.pone.0121295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856315	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500016
J	Wang, MG; Liu, YJ; Zhang, CC; Liu, JP; Liu, X; Wang, LC; Wang, WY; Chen, H; Wei, CC; Ye, XF; Li, XY; Tu, JM				Wang, Mugui; Liu, Yujun; Zhang, Cuicui; Liu, Jianping; Liu, Xin; Wang, Liangchao; Wang, Wenyi; Chen, Hao; Wei, Chuchu; Ye, Xiufen; Li, Xinyuan; Tu, Jumin			Gene Editing by Co-Transformation of TALEN and Chimeric RNA/DNA Oligonucleotides on the Rice OsEPSPS Gene and the Inheritance of Mutations	PLOS ONE			English	Article							TARGETED MUTAGENESIS; DNA; ARABIDOPSIS; RNA; REPAIR; PLANTS; FREQUENCY	Although several site-specific nucleases (SSNs), such as zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas, have emerged as powerful tools for targeted gene editing in many organisms, to date, gene targeting (GT) in plants remains a formidable challenge. In the present study, we attempted to substitute a single base in situon the rice OsEPSPSgene by co-transformation of TALEN with chimeric RNA/DNA oligonucleotides (COs), including different strand composition such as RNA/DNA (C1) or DNA/RNA (C2) but contained the same target base to be substituted. In contrast to zero GT event obtained by the co-transformation of TALEN with homologous recombination plasmid (HRP), we obtained one mutant showing target base substitution although accompanied by undesired deletion of 12 bases downstream the target site from the co-transformation of TALEN and C1. In addition to this typical event, we also obtained 16 mutants with different length of base deletions around the target site among 105 calli lines derived from transformation of TALEN alone (4/19) as well as co-transformation of TELAN with either HRP (5/30) or C1 (2/25) or C2 (5/31). Further analysis demonstrated that the homozygous gene-edited mutants without foreign gene insertion could be obtained in one generation. The induced mutations in transgenic generation were also capable to pass to the next generation stably. However, the genotypes of mutants did not segregate normally in T1 population, probably due to lethal mutations. Phenotypic assessments in T1 generation showed that the heterozygous plants with either one or three bases deletion on target sequence, called d(1) and d(3), were more sensitive to glyphosate and the heterozygous d1 plants had significantly lower seed-setting rate than wild-type.	[Wang, Mugui; Liu, Yujun; Zhang, Cuicui; Liu, Jianping; Liu, Xin; Wang, Liangchao; Wang, Wenyi; Chen, Hao; Wei, Chuchu; Ye, Xiufen; Li, Xinyuan; Tu, Jumin] Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University	Tu, JM (corresponding author), Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	jtu@zju.edu.cn	Tu, Jumin/AAI-6310-2020		Genetically Modified Organism Breeding Major Project [2011ZX08001001-001-002]	Genetically Modified Organism Breeding Major Project	This work was financially supported by "Genetically Modified Organism Breeding Major Project (2011ZX08001001-001-002)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev V, 1998, NAT BIOTECHNOL, V16, P1343, DOI 10.1038/4322; Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Barampuram S, 2011, METHODS MOL BIOL, V701, P1, DOI 10.1007/978-1-61737-957-4_1; Beetham PR, 1999, P NATL ACAD SCI USA, V96, P8774, DOI 10.1073/pnas.96.15.8774; Christian M, 2013, G3-GENES GENOM GENET, V3, P1697, DOI 10.1534/g3.113.007104; CHU CC, 1975, SCI SINICA, V18, P659; ColeStrauss A, 1996, SCIENCE, V273, P1386, DOI 10.1126/science.273.5280.1386; Dong CM, 2006, PLANT CELL REP, V25, P457, DOI 10.1007/s00299-005-0098-x; Fauser F, 2012, P NATL ACAD SCI USA, V109, P7535, DOI 10.1073/pnas.1202191109; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Feng ZY, 2013, CELL RES, V23, P1229, DOI 10.1038/cr.2013.114; Gamper HB, 2000, BIOCHEMISTRY-US, V39, P5808, DOI 10.1021/bi9921891; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gurushidze M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092046; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; KMIEC EB, 1994, MOL CELL BIOL, V14, P7163, DOI 10.1128/MCB.14.11.7163; Kren BT, 1998, NAT MED, V4, P285, DOI 10.1038/nm0398-285; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Mach J, 2014, PLANT CELL, V26, P2, DOI 10.1105/tpc.114.122606; Okuzaki A, 2004, PLANT CELL REP, V22, P509, DOI 10.1007/s00299-003-0698-2; Puchta H, 1996, P NATL ACAD SCI USA, V93, P5055, DOI 10.1073/pnas.93.10.5055; Puchta H, 2012, PLANT CELL, V24, P4324, DOI 10.1105/tpc.112.101824; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shan QW, 2013, MOL PLANT, V6, P1365, DOI 10.1093/mp/sss162; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; WILSON JH, 1994, P NATL ACAD SCI USA, V91, P177, DOI 10.1073/pnas.91.1.177; Xu JW, 2002, SCI CHINA SER C, V45, P251, DOI 10.1360/02yc9028; Yoon K, 1996, P NATL ACAD SCI USA, V93, P2071, DOI 10.1073/pnas.93.5.2071; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61; Zhang F, 2010, P NATL ACAD SCI USA, V107, P12028, DOI 10.1073/pnas.0914991107; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Y, 2013, PLANT PHYSIOL, V161, P20, DOI 10.1104/pp.112.205179; Zhou M, 2006, PLANT PHYSIOL, V140, P184, DOI 10.1104/pp.105.068577; Zhu T, 1999, P NATL ACAD SCI USA, V96, P8768, DOI 10.1073/pnas.96.15.8768; Zhu T, 2000, NAT BIOTECHNOL, V18, P555, DOI 10.1038/75435	41	28	31	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122755	10.1371/journal.pone.0122755	http://dx.doi.org/10.1371/journal.pone.0122755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856577	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500054
J	Lee, C; Hong, S; Lee, MH; Koo, HS				Lee, Changrim; Hong, Seokbong; Lee, Min Hye; Koo, Hyeon-Sook			A PHF8 Homolog in C. elegans Promotes DNA Repair via Homologous Recombination	PLOS ONE			English	Article							CROSS-LINK REPAIR; FANCONI-ANEMIA; HISTONE DEMETHYLASES; FOCI; H3K4	PHF8 is a JmjC domain-containing histone demethylase, defects in which are associated with X-linked mental retardation. In this study, we examined the roles of two PHF8 homologs, JMJD-1.1 and JMJD-1.2, in the model organism C. elegans in response to DNA damage. A deletion mutation in either of the genes led to hypersensitivity to interstrand DNA crosslinks (ICLs), while only mutation of jmjd-1.1 resulted in hypersensitivity to double-strand DNA breaks (DSBs). In response to ICLs, JMJD-1.1 did not affect the focus formation of FCD-2, a homolog of FANCD2, a key protein in the Fanconi anemia pathway. However, the dynamic behavior of RPA-1 and RAD-51 was affected by the mutation: the accumulations of both proteins at ICLs appeared normal, but their subsequent disappearance was retarded, suggesting that later steps of homologous recombination were defective. Similar changes in the dynamic behavior of RPA-1 and RAD-51 were seen in response to DSBs, supporting a role of JMJD-1.1 in homologous recombination. Such a role was also supported by our finding that the hypersensitivity of jmjd-1.1 worms to ICLs was rescued by knockdown of lig-4, a homolog of Ligase 4 active in nonhomologous end-joining. The hypersensitivity of jmjd-1.1 worms to ICLs was increased by rad-54 knockdown, suggesting that JMJD-1.1 acts in parallel with RAD-54 in modulating chromatin structure. Indeed, the level of histone H3 Lys9 tri-methylation, a marker of heterochromatin, was higher in jmjd-1.1 cells than in wild-type cells. We conclude that the histone demethylase JMJD-1.1 influences homologous recombination either by relaxing heterochromatin structure or by indirectly regulating the expression of multiple genes affecting DNA repair.	[Lee, Changrim; Hong, Seokbong; Lee, Min Hye; Koo, Hyeon-Sook] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea	Yonsei University	Koo, HS (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.	kooh@yonsei.ac.kr		Hong, Seokbong/0000-0002-7428-8065; Koo, Hyeon-Sook/0000-0002-5712-3875	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [20110023645]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 20110023645) to HSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Agarwal S, 2011, J CELL BIOL, V192, P735, DOI 10.1083/jcb.201011025; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Godthelp BC, 2002, ONCOGENE, V21, P5002, DOI 10.1038/sj.onc.1205656; Gospodinov A, 2013, DNA REPAIR, V12, P800, DOI 10.1016/j.dnarep.2013.07.006; Hoffmann I, 2012, MOL ONCOL, V6, P683, DOI 10.1016/j.molonc.2012.07.004; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Lee KY, 2007, BIOCHEM BIOPH RES CO, V352, P479, DOI 10.1016/j.bbrc.2006.11.039; Lee KY, 2010, DNA REPAIR, V9, P374, DOI 10.1016/j.dnarep.2009.12.018; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Lin HQ, 2010, CELL RES, V20, P899, DOI 10.1038/cr.2010.84; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Nottke AC, 2011, P NATL ACAD SCI USA, V108, P12805, DOI 10.1073/pnas.1102298108; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Ryu JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064028; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Wakeman TP, 2012, EMBO J, V31, P2169, DOI 10.1038/emboj.2012.50; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028	32	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123865	10.1371/journal.pone.0123865	http://dx.doi.org/10.1371/journal.pone.0123865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853498	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400123
J	Peterson, SW; Jurjevic, Z; Frisvad, JC				Peterson, Stephen W.; Jurjevic, Zeljko; Frisvad, Jens C.			Expanding the Species and Chemical Diversity of Penicillium Section Cinnamopurpurea	PLOS ONE			English	Article							SEXUAL REPRODUCTION; EUPENICILLIUM-OCHROSALMONEUM; ASPERGILLUS-FLAVUS; CONIDIAL HEADS; SP NOV.; CITREOVIRIDIN; RECOGNITION; METABOLITES; FUNGUS; IDENTIFICATION	A set of isolates very similar to or potentially conspecific with an unidentified Penicillium isolate NRRL 735, was assembled using a BLAST search of ITS similarity among described (GenBank) and undescribed Penicillium isolates in our laboratories. DNA was amplified from six loci of the assembled isolates and sequenced. Two species in section Cinnamo-purpurea are self-compatible sexual species, but the asexual species had polymorphic loci suggestive of sexual reproduction and variation in conidium size suggestive of ploidy level differences typical of heterothallism. Accordingly we use genealogical concordance analysis, a technique valid only in heterothallic organisms, for putatively asexual species. Seven new species were revealed in the analysis and are described here. Extrolite analysis showed that two of the new species, P. colei and P. monsserratidens produce the mycotoxin citreoviridin that has demonstrated pharmacological activity against human lung tumors. These isolates could provide leads in pharmaceutical research.	[Peterson, Stephen W.] USDA ARS, Natl Ctr Agr Utilizat Res, Bacterial Foodborne Pathogens & Mycol Res Unit, Peoria, IL 61604 USA; [Jurjevic, Zeljko] EMSL Analytical Inc, Cinnaminson, NJ 08077 USA; [Frisvad, Jens C.] Tech Univ Denmark, DK-2800 Lyngby, Denmark	United States Department of Agriculture (USDA); Technical University of Denmark	Peterson, SW (corresponding author), USDA ARS, Natl Ctr Agr Utilizat Res, Bacterial Foodborne Pathogens & Mycol Res Unit, 1815 N Univ St, Peoria, IL 61604 USA.	Stephen.peterson@ars.usda.gov	Frisvad, Jens C/K-2818-2017	Frisvad, Jens C/0000-0002-0573-4340				Almeida MI, 2012, FOOD ADDIT CONTAM A, V29, P694, DOI 10.1080/19440049.2011.651750; Asai T, 2013, ORG LETT, V15, P1020, DOI 10.1021/ol303506t; BERNY JF, 1990, NATO ADV SCI I A-LIF, V185, P49; Bohm J, 2013, P NATL ACAD SCI USA, V110, P1476, DOI 10.1073/pnas.1217943110; Bugni TS, 2004, J NAT PROD, V67, P1396, DOI 10.1021/np049973t; COLE RJ, 1981, APPL ENVIRON MICROB, V42, P677, DOI 10.1128/AEM.42.4.677-681.1981; CONSTANTINESCU O, 1990, NATO ADV SCI I A-LIF, V185, P17; Dettman JR, 2006, MYCOLOGIA, V98, P436, DOI 10.3852/mycologia.98.3.436; Dettman JR, 2003, EVOLUTION, V57, P2721; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; FILTENBORG O, 1990, NATO ADV SCI I A-LIF, V185, P433; FRANCK B, 1980, ANGEW CHEM INT EDIT, V19, P461, DOI 10.1002/anie.198004611; Frisvad JC, 2007, STUD MYCOL, P31, DOI 10.3114/sim.2007.59.04; FRISVAD JC, 1990, NATO ADV SCI I A-LIF, V185, P159; Gebhardt K, 2004, J ANTIBIOT, V57, P707, DOI 10.7164/antibiotics.57.707; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Hind HG, 1940, BIOCHEM J, V34, P577, DOI 10.1042/bj0340577; Hirata Y., 1947, CHEM SOC JAPAN, V68, P104; Holtzel A, 2004, J ANTIBIOT, V57, P715; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063769; Horn BW, 2008, MYCOLOGIA, V100, P12, DOI 10.3852/mycologia.100.1.12; Horn BW, 2014, PHYTOPATHOLOGY, V104, P75, DOI 10.1094/PHYTO-05-13-0129-R; Horn BW, 2009, MYCOLOGIA, V101, P423, DOI 10.3852/09-011; Horn BW, 1999, APPL ENVIRON MICROB, V65, P1444; Houbraken J, 2011, STUD MYCOL, P53, DOI 10.3114/sim.2011.70.02; Houbraken J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.70.01; Houbraken J, 2011, INT J SYST EVOL MICR, V61, P1462, DOI 10.1099/ijs.0.025098-0; Ishikawa FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031175; Jadulco R, 2002, J NAT PROD, V65, P730, DOI 10.1021/np010390i; Janso JE, 2005, MYCOLOGIA, V97, P444, DOI 10.3852/mycologia.97.2.444; Jayasuriya H, 2005, CHEM BIODIVERS, V2, P112, DOI 10.1002/cbdv.200490162; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; LEISTNER L, 1979, FLEISCHWIRTSCHAFT, V59, P1892; LOCCI R, 1965, GIORN MICROBIOL, V13, P271; Lopez-Villavicencio M, 2010, FUNGAL GENET BIOL, V47, P693, DOI 10.1016/j.fgb.2010.05.002; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marin P, 2014, INT DAIRY J, V36, P89, DOI 10.1016/j.idairyj.2014.01.012; Mayr E., 1942, P1; McNeill J., 2012, 18 INT BOT C MELB AU; NAGEL DW, 1972, PHYTOCHEMISTRY, V11, P627, DOI 10.1016/0031-9422(72)80022-0; Nelson P., 1983, FUSARIUM SPECIES ILL; NISHIYAMA S, 1987, CHEM LETT, P515, DOI 10.1246/cl.1987.515; NISHIYAMA S, 1985, TETRAHEDRON LETT, V26, P6239, DOI 10.1016/S0040-4039(00)95062-7; NIWA M, 1981, CHEM LETT, P1285, DOI 10.1246/cl.1981.1285; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Ogawa K, 2000, BIOSCI BIOTECH BIOCH, V64, P833, DOI 10.1271/bbb.64.833; Okuda T, 2000, INTEGRATION MODERN T, P83; Osmundson TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062419; Peterson SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078084; Peterson SW, 2011, IMA FUNGUS, V2, P121, DOI 10.5598/imafungus.2011.02.02.02; Peterson SW, 2009, MYCOLOGIA, V101, P71, DOI 10.3852/08-036; Pitt J. I., 1979, The genus Penicillium and its teleomorphic states Eupenicillium and Talaromyces.; RAMIREZ C, 1978, MYCOPATHOLOGIA, V66, P77, DOI 10.1007/BF00429597; Raper KB, 1949, MANUAL PENICILLIA; REBUFFAT S, 1980, PHYTOCHEMISTRY, V19, P427, DOI 10.1016/0031-9422(80)83194-3; Ridgway R., 1912, COLOR STANDARDS COLO; Rosa CAR, 2010, FOOD ADDIT CONTAM A, V27, P241, DOI 10.1080/19440040903289712; SAKABE N, 1964, TETRAHEDRON LETT, P1825; SAKABE N, 1977, TETRAHEDRON, V33, P3077, DOI 10.1016/0040-4020(77)80452-3; Samson RA, 2011, STUD MYCOL, P159, DOI 10.3114/sim.2011.70.04; Samson RA, 2011, STUD MYCOL, P39, DOI 10.3114/sim.2011.69.04; SAMSON RA, 1989, STUD MYCOL, P133; SAMSON RA, 2004, STUD MYCOL, V49, P1; Samson RA, 2010, FOOD INDOOR FUNGI; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sugui JA, 2014, J CLIN MICROBIOL, V52, P3707, DOI 10.1128/JCM.01704-14; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Toyama H, 2004, APPL BIOCHEM BIOTECH, V113, P325; URAGUCHI K, 1969, J STORED PROD RES, V5, P227, DOI 10.1016/0022-474X(69)90037-X; van der Walt L, 2010, PLANT DIS, V94, P666, DOI 10.1094/PDIS-94-6-0666; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Visagie CM, 2014, STUD MYCOL, P343, DOI 10.1016/j.simyco.2014.09.001; Wang Long, 2000, Mycosystema, V19, P463; WICKLOW DT, 1988, APPL ENVIRON MICROB, V54, P1096, DOI 10.1128/AEM.54.5.1096-1098.1988; WICKLOW DT, 1984, MYCOLOGIA, V76, P959, DOI 10.2307/3793157; WICKLOW DT, 1984, MYCOLOGIA, V76, P943, DOI 10.2307/3793151; Wigmann EF, 2015, FOOD RES INT, V67, P219, DOI 10.1016/j.foodres.2014.11.025; Wu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070642; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]	81	22	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121987	10.1371/journal.pone.0121987	http://dx.doi.org/10.1371/journal.pone.0121987			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853891	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400057
J	Razzouk, D; Kayo, M; Sousa, A; Gregorio, G; Cogo-Moreira, H; Cardoso, AA; Mari, JD				Razzouk, Denise; Kayo, Monica; Sousa, Aglae; Gregorio, Guilherme; Cogo-Moreira, Hugo; Cardoso, Andrea Alves; Mari, Jair de Jesus			The Impact of Antipsychotic Polytherapy Costs in the Public Health Care in Sao Paulo, Brazil	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; SCHIZOPHRENIA; POLYPHARMACY; PRESCRIPTION; GUIDELINES; MANAGEMENT; EFFICACY; DRUGS	Introduction Guidelines for the treatment of psychoses recommend antipsychotic monotherapy. However, the rate of antipsychotic polytherapy has increased over the last decade, reaching up to 60% in some settings. Studies evaluating the costs and impact of antipsychotic polytherapy in the health system are scarce. Objective To estimate the costs of antipsychotic polytherapy and its impact on public health costs in a sample of subjects with psychotic disorders living in residential facilities in the city of Sao Paulo, Brazil. Method A cross-sectional study that used a bottom-up approach for collecting costs data in a public health provider's perspective. Subjects with psychosis living in 20 fully-staffed residential facilities in the city of Sao Paulo were assessed for clinical and psychosocial profile, severity of symptoms, quality of life, use of health services and pharmacological treatment. The impact of polytherapy on total direct costs was evaluated. Results 147 subjects were included, 134 used antipsychotics regularly and 38% were in use of antipsychotic polytherapy. There were no significant differences in clinical and psychosocial characteristics between polytherapy and monotherapy groups. Four variables explained 30% of direct costs: the number of antipsychotics, location of the residential facility, time living in the facility and use of olanzapine. The costs of antipsychotics corresponded to 94.4% of the total psychotropic costs and to 49.5% of all health services use when excluding accommodation costs. Olanzapine costs corresponded to 51% of all psychotropic costs. Conclusion Antipsychotic polytherapy is a huge economic burden to public health service, despite the lack of evidence supporting this practice. Great variations on antipsychotic costs explicit the need of establishing protocols for rational antipsychotic prescriptions and consequently optimising resource allocation. Cost-effectiveness studies are necessary to estimate the best value for money among antipsychotics, especially in low and middle income countries.	[Razzouk, Denise; Kayo, Monica; Sousa, Aglae; Gregorio, Guilherme; Cardoso, Andrea Alves] Univ Fed Sao Paulo, Dept Psychiat, CESM, Sao Paulo, SP, Brazil; [Cogo-Moreira, Hugo; Mari, Jair de Jesus] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Razzouk, D (corresponding author), Univ Fed Sao Paulo, Dept Psychiat, CESM, Sao Paulo, SP, Brazil.	drazzouk@gmail.com	de Jesus Mari, Jair/A-7309-2008; Cogo-Moreira, Hugo/E-4602-2011; Kayo, Monica/C-8224-2015; Cogo-Moreira, Hugo/GSD-6132-2022; Razzouk, Denise/A-2336-2011; Cogo-Moreira, Hugo/U-6442-2019	de Jesus Mari, Jair/0000-0002-5403-0112; Cogo-Moreira, Hugo/0000-0001-9411-9237; Kayo, Monica/0000-0003-4859-8593; Cogo-Moreira, Hugo/0000-0001-9411-9237; Razzouk, Denise/0000-0003-4228-8949; Cogo-Moreira, Hugo/0000-0001-9411-9237	FAPESP, Grant PPSUS [2009/53286-3]; Ministry of Health of Brazil; CNPQ, Secretary of Health of the State of Sao Paulo	FAPESP, Grant PPSUS(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministry of Health of Brazil; CNPQ, Secretary of Health of the State of Sao Paulo	The data collection of this study was funded by FAPESP (http://www.fapesp.br/, Grant PPSUS 2009 - number 2009/53286-3), Ministry of Health of Brazil, and by CNPQ(http://www.cnpq.br/), Secretary of Health of the State of Sao Paulo. No author was paid to write this article by a pharmaceutical company or any other agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi-Severini S, 2008, PSYCHIAT SERV, V59, P547, DOI 10.1176/ps.2008.59.5.547; Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; Aranha e Silva A, 2008, DESAFIOS DESINSTITUC; Baandrup L, 2012, EUR J HEALTH ECON, V13, P355, DOI 10.1007/s10198-011-0308-0; Bandeira Marina, 2003, Arch. Clin. Psychiatry (São Paulo), V30, P121; Barbui C, 2009, SCHIZOPHRENIA BULL, V35, P458, DOI 10.1093/schbul/sbn030; Barnes TRE, 2011, CNS DRUGS, V25, P383, DOI 10.2165/11587810-000000000-00000; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Cardoso CS, 2002, J BRASILEIRO PSIQUIA, V51, P31; Chisholm D, 2000, BRIT J PSYCHIAT, V177, pS28, DOI 10.1192/bjp.177.39.s28; Correll CU, 2012, PSYCHIAT CLIN N AM, V35, P661, DOI 10.1016/j.psc.2012.06.007; de Lima MS, 2007, REV BRAS PSIQUIATR, V29, P246, DOI 10.1590/S1516-44462007000300010; Elkis H, 2007, PSYCHIAT CLIN N AM, V30, P511, DOI 10.1016/j.psc.2007.04.001; Essock SM, 2011, AM J PSYCHIAT, V168, P702, DOI 10.1176/appi.ajp.2011.10060908; Fleischhacker WW, 2014, INT J NEUROPSYCHOPH, V17, P1083, DOI 10.1017/S1461145712000399; Goodwin G, 2009, EUR NEUROPSYCHOPHARM, V19, P520, DOI 10.1016/j.euroneuro.2009.04.003; Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x; Hasan A, 2013, WORLD J BIOL PSYCHIA, V14, P2, DOI 10.3109/15622975.2012.739708; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Huffman JC, 2011, GEN HOSP PSYCHIAT, V33, P501, DOI 10.1016/j.genhosppsych.2011.05.012; IPAP, 2006, SCHIZ ALG; Knapp M, 2009, SCHIZOPRENIA BIOPSYC, P347; Lam RW, 2009, J AFFECT DISORDERS, V117, pS26, DOI 10.1016/j.jad.2009.06.041; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Lima LA, 2006, INT J SOC PSYCHIATR, V52, P101, DOI 10.1177/0020764006062091; Lindner Leandro Mendonça, 2009, Rev. Saúde Pública, V43, P62; Loosbrock Danielle L, 2003, J Ment Health Policy Econ, V6, P67; Ministerio da Saude, 2011, BANC DE PREC; Ministerio da Saude [MS], 2005, C REG REF SERV SAUD; Moore TA, 2007, J CLIN PSYCHIAT, V68, P1751, DOI 10.4088/JCP.v68n1115; Razzouk D, 2013, VALUE HEALTH, V16, pA694, DOI 10.1016/j.jval.2013.08.2086; Roh D, 2014, AUST NZ J PSYCHIAT, V48, P52, DOI 10.1177/0004867413488221; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sousa A, 2013, ISPOR 4 LAT AM C; Souza JS, 2013, CNS SPECTRUMS, V18, P82, DOI 10.1017/S1092852912000806; Tomasi R, 2006, ACTA PSYCHIAT SCAND, V113, P212, DOI 10.1111/j.1600-0447.2005.00657.x; Wallace CJ, 2000, SCHIZOPHRENIA BULL, V26, P631, DOI 10.1093/oxfordjournals.schbul.a033483; WYKES T, 1986, BRIT J PSYCHIAT, V148, P1, DOI 10.1192/bjp.148.1.1; Yatham LN, 2013, BIPOLAR DISORD, V15, P1, DOI 10.1111/bdi.12025	39	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124791	10.1371/journal.pone.0124791	http://dx.doi.org/10.1371/journal.pone.0124791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853709	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400144
J	Thio, THG; Ibrahim, F; Al-Faqheri, W; Soin, N; Bador, MK; Madou, M				Thio, Tzer Hwai Gilbert; Ibrahim, Fatimah; Al-Faqheri, Wisam; Soin, Norhayati; Bador, Maria Kahar; Madou, Marc			Sequential Push-Pull Pumping Mechanism for Washing and Evacuation of an Immunoassay Reaction Chamber on a Microfluidic CD Platform	PLOS ONE			English	Article								introduced technique increases the flexibility of the microfluidic CD platform to perform multi-step biological and chemical processes.A centrifugal compact disc (CD) microfluidic platform with reservoirs, micro-channels, and valves can be employed for implementing a complete immunoassay. Detection or biosensor chambers are either coated for immuno-interaction or a biosensor chip is inserted in them. On microfluidic CDs featuring such multi-step chemical/biological processes, the biosensor chamber must be repeatedly filled with fluids such as enzymes solutions, buffers, and washing solutions. After each filling step, the biosensor chamber needs to be evacuated by a passive siphoning process to prepare it for the next step in the assay. However, rotational speed dependency and limited space on a CD are two big obstacles to performing such repetitive filling and siphoning steps. In this work, a unique thermo-pneumatic (TP) Push-Pull pumping method is employed to provide a superior alternative biosensor chamber filling and evacuation technique. The proposed technique is demonstrated on two CD designs. The first design features a simple two-step microfluidic process to demonstrate the evacuation technique, while the second design shows the filling and evacuation technique with an example sequence for an actual immunoassay. In addition, the performance of the filling and evacuation technique as a washing step is also evaluated quantitatively and compared to the conventional manual bench top washing method. The two designs and the performance evaluation demonstrate that the technique is simple to implement, reliable, easy to control, and allows for repeated push-pulls and thus filling and emptying of the biosensor chamber. Furthermore, by addressing the issue of rotational speed dependency and limited space concerns in implementing repetitive filling and evacuation steps, this newly	[Thio, Tzer Hwai Gilbert; Ibrahim, Fatimah; Al-Faqheri, Wisam] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia; [Thio, Tzer Hwai Gilbert; Ibrahim, Fatimah; Al-Faqheri, Wisam; Soin, Norhayati; Bador, Maria Kahar; Madou, Marc] Univ Malaya, Fac Engn, Dept Biomed Engn, Ctr Innovat Med Engn, Kuala Lumpur 50603, Malaysia; [Thio, Tzer Hwai Gilbert] INTI Int Univ, Fac Sci Technol Engn & Math, Persiaran Perdana BBN, Nilai 71800, Negeri Sembilan, Malaysia; [Soin, Norhayati] Univ Malaya, Fac Engn, Dept Elect Engn, Kuala Lumpur 50603, Malaysia; [Bador, Maria Kahar] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Madou, Marc] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Madou, Marc] Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA USA	Universiti Malaya; Universiti Malaya; INTI International University; Universiti Malaya; Universiti Malaya; University of California System; University of California Irvine; University of California System; University of California Irvine	Ibrahim, F (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.	fatimah@um.edu.my	Madou, Marc J./E-5869-2013; IBRAHIM, FATIMAH/B-8506-2010; Thio, Tzer Hwai Gilbert/AGG-4429-2022; ABDUL KAHAR, MARIA KAHAR BADOR/B-8939-2010; SOIN, NORHAYATI/B-9368-2010	Madou, Marc J./0000-0003-4847-3117; IBRAHIM, FATIMAH/0000-0003-1804-4362; ABDUL KAHAR, MARIA KAHAR BADOR/0000-0002-0881-133X; SOIN, NORHAYATI/0000-0002-8775-1346; Thio, Tzer Hwai Gilbert/0000-0002-4192-3720	University of Malaya High Impact Research Grant from Ministry of Higher Education Malaysia (MOHE) [UM-MOHE UM.C/625/1/HIR/MOHE05]; Fundamental Research Grant Scheme [FRGS: FP042-2013B]; University of Malaya Research Grant [UMRG: RG009A-13AET]; National Institutes of Health [1 R01 AI089541-01]; Department of Chemistry, Faculty of Science, University of Malaya; "Hits-to-Lead: Designing Dengue Virus Inhibitors, National Biotechnology Directorate (NBD) Initiative-Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm); Ministry of Science, Technology and Innovation [MOSTI IPHARM 53-02-03-1049]	University of Malaya High Impact Research Grant from Ministry of Higher Education Malaysia (MOHE); Fundamental Research Grant Scheme; University of Malaya Research Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Chemistry, Faculty of Science, University of Malaya; "Hits-to-Lead: Designing Dengue Virus Inhibitors, National Biotechnology Directorate (NBD) Initiative-Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm); Ministry of Science, Technology and Innovation(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This research is supported by University of Malaya High Impact Research Grant UM-MOHE UM. C/625/1/HIR/MOHE05 from Ministry of Higher Education Malaysia (MOHE), Fundamental Research Grant Scheme (FRGS: FP042-2013B) and University of Malaya Research Grant (UMRG: RG009A-13AET). The authors would like to acknowledge Prof. Dr. Noorsaadah Abd Rahman from Department of Chemistry, Faculty of Science, University of Malaya and her grant "Hits-to-Lead: Designing Dengue Virus Inhibitors, National Biotechnology Directorate (NBD) Initiative-Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), Ministry of Science, Technology and Innovation (MOSTI IPHARM 53-02-03-1049)" for partially sponsoring the initial setup of the CD Spin Test System. FI acknowledges Yayasan Sultan Iskandar Johor for funding the one-off special equipment grant in this research. MM acknowledges support of the National Institutes of Health (grant 1 R01 AI089541-01).	Amasia M, 2012, SENSOR ACTUAT B-CHEM, V161, P1191, DOI 10.1016/j.snb.2011.11.080; Burger J, 16 INT SOL STAT SENS, P2867; Ducree J, 2007, J MICROMECH MICROENG, V17, pS103, DOI 10.1088/0960-1317/17/7/S07; He HY, 2009, BIOMICROFLUIDICS, V3, DOI 10.1063/1.3116665; Ibrahim F, 2010, ANAL EXPT CENTRIFUGA, P466; Kido H, 2007, COLLOID SURFACE B, V58, P44, DOI 10.1016/j.colsurfb.2007.03.015; Lai S, 2004, ANAL CHEM, V76, P1832, DOI 10.1021/ac0348322; Lee BS, 2009, LAB CHIP, V9, P1548, DOI 10.1039/b820321k; Lide D.R., 2005, CRC HDB CHEM PHYS IN; Madou M, 2006, ANNU REV BIOMED ENG, V8, P601, DOI 10.1146/annurev.bioeng.8.061505.095758; Nwankire CE, 2014, BIOSENS BIOELECTRON, V56, P352, DOI 10.1016/j.bios.2014.01.031; Stanley J., 2002, ESSENTIALS IMMUNOLOG; Thio THG, 2013, LAB CHIP, V13, P3199, DOI 10.1039/c3lc00004d; Thio THG, 2013, MED BIOL ENG COMPUT, V51, P525, DOI 10.1007/s11517-012-1020-7; Yusoff NA, 2009, LAB ON A DISK POTENT, P946; Zoval JV, 2004, P IEEE, V92, P140, DOI 10.1109/JPROC.2003.820541	16	9	9	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121836	10.1371/journal.pone.0121836	http://dx.doi.org/10.1371/journal.pone.0121836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853411	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400050
J	White, SB; Chen, J; Gordon, AC; Harris, KR; Nicolai, JR; West, DL; Larson, AC				White, Sarah B.; Chen, Jeane; Gordon, Andrew C.; Harris, Kathleen R.; Nicolai, Jodi R.; West, Derek L.; Larson, Andrew C.			Percutaneous Ultrasound Guided Implantation of VX2 for Creation of a Rabbit Hepatic Tumor Model	PLOS ONE			English	Article							LIVER-TUMOR; ANIMAL-MODEL; CHEMOEMBOLIZATION; CANCER; CARCINOMA; ABLATION; TRANSPLANTATION; EMBOLIZATION; INOCULATION; HEPATECTOMY	Creation of a VX2 tumor model has traditionally required a laparotomy and surgical implantation of tumor fragments. Open surgical procedures are invasive and require long procedure times and recovery that can result in post-operative morbidity and mortality. The purpose of this study is to report the results of a percutaneous ultrasound guided method for creation of a VX2 model in rabbit livers. A total of 27 New Zealand white rabbits underwent a percutaneous ultrasound guided approach, where a VX2 tumor fragment was implanted in the liver. Magnetic resonance imaging was used to assess for tumor growth and necropsy was performed to determine rates of tract seeding and metastatic disease. Ultrasound guided tumor implantation was successful in all 27 rabbits. One rabbit died 2 days following the implantation procedure. Two rabbits had no tumors seen on follow-up imaging. Therefore, tumor development was seen in 24/26 (92%) rabbits. During the follow-up period, tract seeding was seen in 8% of rabbits and 38% had extra-hepatic metastatic disease. Therefore, percutaneous ultrasound guided tumor implantation safely provides reliable tumor growth for establishing hepatic VX2 tumors in a rabbit model with decreased rates of tract seeding, compared to previously reported methods.	[White, Sarah B.] Med Coll Wisconsin, Dept Radiol, Div Intervent Radiol, Milwaukee, WI 53226 USA; [White, Sarah B.; Chen, Jeane; Gordon, Andrew C.; Harris, Kathleen R.; Nicolai, Jodi R.; West, Derek L.; Larson, Andrew C.] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Chen, Jeane] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Gordon, Andrew C.; Larson, Andrew C.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [West, Derek L.] Univ Texas Houston, Sch Med, Dept Diagnost & Intervent Imaging, Houston, TX USA; [Larson, Andrew C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Medical College of Wisconsin; Northwestern University; Northwestern University; Northwestern University; University of Texas System; University of Texas Health Science Center Houston; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	White, SB (corresponding author), Med Coll Wisconsin, Dept Radiol, Div Intervent Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	sbwhite@mcw.edu			 [NIH 5 R25 CA 132822-03]; NATIONAL CANCER INSTITUTE [R01CA159178, R01CA196967, R01CA181658, R25CA132822, P30CA060553] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by SBW: NIH 5 R25 CA 132822-03, http://grants.nih.gov/grants/guide/pa-files/PAR-14-076.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKOWITZ DM, 1975, J NATL CANCER I, V54, P233, DOI 10.1093/jnci/54.1.233; BURGENER FA, 1979, INVEST RADIOL, V14, P410, DOI 10.1097/00004424-197909000-00005; Chen JH, 2004, LAB ANIM-UK, V38, P79, DOI 10.1258/00236770460734434; FRANK JA, 1987, J NEUROSURG, V67, P106, DOI 10.3171/jns.1987.67.1.0106; Geschwind JFH, 2000, J VASC INTERV RADIOL, V11, P1245, DOI 10.1016/S1051-0443(07)61299-8; Guo Y, 2012, INVEST RADIOL, V47, P116, DOI 10.1097/RLI.0b013e31822e57cc; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hurst EW, 1933, J EXP MED, V58, P607, DOI 10.1084/jem.58.5.607; Jiang Xiong-ying, 2013, Zhonghua Yi Xue Za Zhi, V93, P3139; Larson AC, 2006, J MAGN RESON IMAGING, V24, P242, DOI 10.1002/jmri.20623; Lee JM, 2003, EUR RADIOL, V13, P1324, DOI 10.1007/s00330-002-1658-x; Lee KH, 2009, J SURG RES, V155, P94, DOI 10.1016/j.jss.2008.08.036; Lin WY, 2002, J VET MED SCI, V64, P649, DOI 10.1292/jvms.64.649; Liu JY, 2013, ONCOL LETT, V6, P1550, DOI 10.3892/ol.2013.1618; Luo W, 2010, J ULTRAS MED, V29, P51, DOI 10.7863/jum.2010.29.1.51; Okuma T, 2006, J NUCL MED, V47, P1351; Oshiro H, 2014, MED MOL MORPHOL, V27, P27; Parvinian A, 2014, DIAGN INTERV RADIOL, V20, P335, DOI 10.5152/dir.2014.13415; Qian T, 2014, MAGN RESON IMAGING, V32, P1052, DOI 10.1016/j.mri.2014.05.011; Rashidi B, 2001, INT J CANCER, V91, P231, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1042>3.3.CO;2-O; Rhee TK, 2007, J VASC INTERV RADIOL, V18, P411, DOI 10.1016/j.jvir.2007.01.013; Tanaka T, 2014, J VASC INTERV RADIOL, V25, P1037, DOI 10.1016/j.jvir.2014.04.005; THORSTENSEN O, 1994, INVEST RADIOL, V29, P469; Virmani S, 2008, J VASC INTERV RADIOL, V19, P931, DOI 10.1016/j.jvir.2008.02.019; Vossen JA, 2008, CLIN EXP METASTAS, V25, P811, DOI 10.1007/s10585-008-9195-x; Weichert JP, 2000, RADIOLOGY, V216, P865, DOI 10.1148/radiology.216.3.r00se43865; Zhang YD, 2014, TECHNOLOGIES, V2, DOI 10.3390/technologies2040164	28	19	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123888	10.1371/journal.pone.0123888	http://dx.doi.org/10.1371/journal.pone.0123888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853660	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400125
J	Wikenros, C; Sand, H; Bergstrom, R; Liberg, O; Chapron, G				Wikenros, Camilla; Sand, Hakan; Bergstrom, Roger; Liberg, Olof; Chapron, Guillaume			Response of Moose Hunters to Predation following Wolf Return in Sweden	PLOS ONE			English	Article							CANIS-LUPUS PREDATION; ALCES-ALCES; POPULATION-DYNAMICS; KILL RATES; YELLOWSTONE ELK; NORTH-AMERICAN; BODY CONDITION; WOLVES; HARVEST; DEER	Background Predation and hunter harvest constitute the main mortality factors affecting the size and dynamics of many exploited populations. The re-colonization by wolves (Canis lupus) of the Scandinavian Peninsula may therefore substantially reduce hunter harvest of moose (Alces alces), the main prey of wolves. Methodology/Principal findings We examined possible effects of wolf presence on hunter harvest in areas where we had data before and after wolf establishment (n = 25), and in additional areas that had been continuously exposed to wolf predation during at least ten years (n = 43). There was a general reduction in the total number of moose harvested (n = 31,827) during the ten year study period in all areas irrespective of presence of wolves or not. However, the reduction in hunter harvest was stronger within wolf territories compared to control areas without wolves. The reduction in harvest was larger in small (500-800 km(2)) compared to large (1,200-1,800 km(2)) wolf territories. In areas with newly established wolf territories moose management appeared to be adaptive with regard to both managers (hunting quotas) and to hunters (actual harvest). In these areas an instant reduction in moose harvest over-compensated the estimated number of moose killed annually by wolves and the composition of the hunted animals changed towards a lower proportion of adult females. Conclusions/Significance We show that the re-colonization of wolves may result in an almost instant functional response by another large predator-humans-that reduced the potential for a direct numerical effect on the density of wolves' main prey, the moose. Because most of the worlds' habitat that will be available for future colonization by large predators are likely to be strongly influenced by humans, human behavioural responses may constitute a key trait that govern the impact of large predators on their prey.	[Wikenros, Camilla; Sand, Hakan; Liberg, Olof; Chapron, Guillaume] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Bergstrom, Roger] Forestry Res Inst Sweden, Uppsala, Sweden	Swedish University of Agricultural Sciences; Skogforsk	Wikenros, C (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden.	camilla.wikenros@slu.se			Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; WWF Sweden; Olle Foundation; Carl Tryggers Foundation; Swedish Carnivore Association; Signhild Engkvists Foundation	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; WWF Sweden; Olle Foundation; Carl Tryggers Foundation; Swedish Carnivore Association; Signhild Engkvists Foundation	The study was funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Swedish Environmental Protection Agency, Swedish Association for Hunting and Wildlife Management, WWF Sweden, Olle and Signhild Engkvists Foundations, Carl Tryggers Foundation, and the Swedish Carnivore Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2007, WILDLIFE BIOL, V13, P467, DOI 10.2981/0909-6396(2007)13[467:SOELLL]2.0.CO;2; [Anonymous], 2006, RES FRAN INV AV BJOM; Ballard WB, 2001, WILDLIFE SOC B, V29, P99; Boertje RD, 2010, J WILDLIFE MANAGE, V74, P917, DOI 10.2193/2009-261; Boman M, 2011, ENVIRON RESOUR ECON, V50, P515, DOI 10.1007/s10640-011-9480-z; Caswell, 2000, MATRIX POPULATION MO; Coulson T, 2005, J ANIM ECOL, V74, P789, DOI 10.1111/j.1365-2656.2005.00975.x; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; DelGiudice GD, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P155, DOI 10.1007/978-0-387-85952-1_10; Eberhardt LL, 2003, ECOL APPL, V13, P776, DOI 10.1890/1051-0761(2003)013[0776:ATIOWO]2.0.CO;2; Ericsson G, 1999, WILDLIFE BIOL, V5, P177, DOI 10.2981/wlb.1999.022; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Evans SB, 2006, J WILDLIFE MANAGE, V70, P1372, DOI 10.2193/0022-541X(2006)70[1372:SOAFEI]2.0.CO;2; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fryxell JM, 2010, SCIENCE, V328, P903, DOI 10.1126/science.1185802; Fuller Todd K., 2003, P161; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GASAWAY WC, 1992, WILDLIFE MONOGR, P1; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Gundersen H, 2008, EUR J WILDLIFE RES, V54, P335, DOI 10.1007/s10344-007-0155-6; Hayes RD, 2000, CAN J ZOOL, V78, P60, DOI 10.1139/cjz-78-1-60; Hayes RD, 2000, CAN J ZOOL, V78, P36, DOI 10.1139/cjz-78-1-36; Hebblewhite M, 2013, POPUL ECOL, V55, P511, DOI 10.1007/s10144-013-0384-3; Jonzen N, 2013, ECOL MODEL, V265, P140, DOI 10.1016/j.ecolmodel.2013.05.017; Lavsund Sten, 2003, Alces, V39, P109; Liberg Olof, 2010, P37; Mattisson J, 2013, OECOLOGIA, V173, P813, DOI 10.1007/s00442-013-2668-x; McCullough DR, 2001, J WILDLIFE MANAGE, V65, P46, DOI 10.2307/3803276; Mech LD, 2012, BIOL CONSERV, V150, P143, DOI 10.1016/j.biocon.2012.03.003; Mech LD, 2000, J WILDLIFE MANAGE, V64, P129, DOI 10.2307/3802982; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Nilsen EB, 2005, J APPL ECOL, V42, P389, DOI 10.1111/j.1365-2664.2005.01018.x; Nilsen EB, 2006, EUR J WILDLIFE RES, V52, P153, DOI 10.1007/s10344-005-0023-1; Olsson O, 1997, WILDLIFE BIOL, V3, P13, DOI 10.2981/wlb.1997.003; Pole A, 2003, P R SOC LOND B S, V270, P57; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ronnegard L, 2008, WILDLIFE BIOL, V14, P358, DOI 10.2981/0909-6396(2008)14[358:EOFMUT]2.0.CO;2; Saether BE, 2004, WILDLIFE BIOL, V10, P51, DOI 10.2981/wlb.2004.009; Saether BE, 2007, ECOGRAPHY, V30, P417, DOI 10.1111/j.2007.0906-7590.05006.x; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Sand H, 2012, CAN J ZOOL, V90, P403, DOI 10.1139/Z2012-007; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Sand H, 2012, OIKOS, V121, P1454, DOI 10.1111/j.1600-0706.2012.20082.x; Seiler A, 2004, WILDLIFE BIOL, V10, P225, DOI 10.2981/wlb.2004.028; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Solberg EJ, 2000, WILDLIFE BIOL, V6, P41, DOI 10.2981/wlb.2000.036; Solberg EJ, 1999, J ANIM ECOL, V68, P186, DOI 10.1046/j.1365-2656.1999.00275.x; Solberg EJ, 2006, MOOSE NORWAY ANAL MA, P125; Storaas T, 2001, ALCES-N AM MOOSE CON, V37, P97; Swenson JE, 2007, J WILDLIFE MANAGE, V71, P1993, DOI 10.2193/2006-308; Ueno M, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00083.1; Varley N, 2006, ECOL MODEL, V193, P315, DOI 10.1016/j.ecolmodel.2005.09.001; Vucetich JA, 2005, OIKOS, V111, P259, DOI 10.1111/j.0030-1299.2005.14180.x; Vucetich JA, 2002, ECOLOGY, V83, P3003; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wabakken P, 2008, WOLF SCANDINAVIA STA, V6; White PJ, 2005, WILDLIFE SOC B, V33, P942, DOI 10.2193/0091-7648(2005)33[942:NYEAWR]2.0.CO;2; White PJ, 2005, BIOL CONSERV, V125, P141, DOI 10.1016/j.biocon.2005.01.048; Wikenros C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077373; Zimmermann B., 2014, THESIS HEDMARK U COL	61	25	25	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0119957	10.1371/journal.pone.0119957	http://dx.doi.org/10.1371/journal.pone.0119957			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853570	Green Published, gold, Green Accepted			2022-12-27	WOS:000352478400007
J	Bang, C; Cheng, J				Bang, Chi; Cheng, Jun			Dynamic Interplay of Spectrosome and Centrosome Organelles in Asymmetric Stem Cell Divisions	PLOS ONE			English	Article							DROSOPHILA FUSOME; SELF-RENEWAL; ORIENTATION; ACTIVATION; MECHANISMS; PROTEINS	Stem cells have remarkable self-renewal ability and differentiation potency, which are critical for tissue repair and tissue homeostasis. Recently it has been found, in many systems (e.g. gut, neurons, and hematopoietic stem cells), that the self-renewal and differentiation balance is maintained when the stem cells divide asymmetrically. Drosophila male germline stem cells (GSCs), one of the best characterized model systems with well-defined stem cell niches, were reported to divide asymmetrically, where centrosome plays an important role. Utilizing time-lapse live cell imaging, customized tracking, and image processing programs, we found that most acentrosomal GSCs have the spectrosomes reposition from the basal end (wild type) to the apical end close to hub-GSC interface (acentrosomal GSCs). In addition, these apically positioned spectrosomes were mostly stationary while the basally positioned spectrosomes were mobile. For acentrosomal GSCs, their mitotic spindles were still highly oriented and divided asymmetrically with longer mitosis duration, resulting in asymmetric divisions. Moreover, when the spectrosome was knocked out, the centrosomes velocity decreased and centrosomes located closer to hub-GSC interface. We propose that in male GSCs, the spectrosome recruited to the apical end plays a complimentary role in ensuring proper spindle orientation when centrosome function is compromised.	[Bang, Chi; Cheng, Jun] Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cheng, J (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA.	juncheng@uic.edu			Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust	The work was partly funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Brunet A, 2007, NATURE, V449, P288, DOI 10.1038/449288a; Cheng J, 2009, CURRENT PROTOCOLS ST; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Dubielecka PM, 2003, CELL MOL BIOL LETT, V8, P221; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Januschke J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1245; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Lighthouse DV, 2008, DEV BIOL, V317, P59, DOI 10.1016/j.ydbio.2008.02.009; LIN HF, 1995, DEV GENET, V16, P6, DOI 10.1002/dvg.1020160104; LIN HF, 1994, DEVELOPMENT, V120, P947; Liu Wei, 2008, V450, P61, DOI 10.1007/978-1-60327-214-8_4; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pariser H, 2005, P NATL ACAD SCI USA, V102, P12407, DOI 10.1073/pnas.0505901102; Petrella LN, 2007, DEVELOPMENT, V134, P703, DOI 10.1242/dev.02766; Riparbelli MG, 2011, DEV BIOL, V349, P427, DOI 10.1016/j.ydbio.2010.10.021; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yuan HB, 2012, DEV BIOL, V361, P57, DOI 10.1016/j.ydbio.2011.10.010	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123294	10.1371/journal.pone.0123294	http://dx.doi.org/10.1371/journal.pone.0123294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849996	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800223
J	Haselhuhn, MP; Ormiston, ME; Wong, EM				Haselhuhn, Michael P.; Ormiston, Margaret E.; Wong, Elaine M.			Men's Facial Width-to-Height Ratio Predicts Aggression: A Meta-Analysis	PLOS ONE			English	Article							FACE; COOPERATION; CUES; BAD	Recent research has identified men's facial width-to-height ratio (fWHR) as a reliable predictor of aggressive tendencies and behavior. Other research, however, has failed to replicate the fWHR-aggression relationship and has questioned whether previous findings are robust. In the current paper, we synthesize existing work by conducting a meta-analysis to estimate whether and how fWHR predicts aggression. Our results indicate a small, but significant, positive relationship between men's fWHR and aggression.	[Haselhuhn, Michael P.; Wong, Elaine M.] Univ Calif Riverside, Sch Business Adm, Riverside, CA 92521 USA; [Ormiston, Margaret E.] London Business Sch, Org Behav Area, London NW1 4SA, England	University of California System; University of California Riverside; University of London; London Business School	Haselhuhn, MP (corresponding author), Univ Calif Riverside, Sch Business Adm, Riverside, CA 92521 USA.	michael.haselhuhn@ucr.edu						Carre JM, 2013, SOC COGN AFFECT NEUR, V8, P224, DOI 10.1093/scan/nsr096; Carre JM, 2010, PERCEPTION, V39, P356, DOI 10.1068/p6543; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; Geniole SN, 2014, PERS INDIV DIFFER, V57, P59, DOI 10.1016/j.paid.2013.09.023; Goetz SMM, 2013, PSYCHOL SCI, V24, P2329, DOI 10.1177/0956797613493294; Gomez-Valdes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052317; Haselhuhn MP, 2014, LEADERSHIP QUART, V25, P835, DOI 10.1016/j.leaqua.2013.12.003; Haselhuhn MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072259; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Hehman E, 2013, PSYCHOL SCI, V24, P289, DOI 10.1177/0956797612451467; Lefevre CE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0729; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Lipsey M.W., 2001, PRACTICAL META ANAL, V49; Mills J., 2015, JOURNAL OF ACCOUNTIN; Orwin RG, 1983, J ED STAT, V8, P157, DOI [DOI 10.2307/1164923, 10.3102/10769986008002157]; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Ronay R, 2011, J EXP SOC PSYCHOL, V47, P702, DOI 10.1016/j.jesp.2010.11.009; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Stirrat M, 2012, EVOL HUM BEHAV, V33, P551, DOI 10.1016/j.evolhumbehav.2012.02.002; Trebicky V, 2015, AGGRESSIVE BEHAV, V41, P331, DOI 10.1002/ab.21559; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2; Zebrowitz LA, 1998, J PERS SOC PSYCHOL, V75, P1300, DOI 10.1037/0022-3514.75.5.1300; Zebrowitz LA, 1996, PERS SOC PSYCHOL B, V22, P1258, DOI 10.1177/01461672962212006; Zilioli S, 2015, AGGRESSIVE BEHAV, V41, P322, DOI 10.1002/ab.21544	29	87	92	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122637	10.1371/journal.pone.0122637	http://dx.doi.org/10.1371/journal.pone.0122637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849992	Green Published, gold			2022-12-27	WOS:000352477800153
J	Malyshev, A; Goz, R; LoTurco, JJ; Volgushev, M				Malyshev, Aleksey; Goz, Roman; LoTurco, Joseph J.; Volgushev, Maxim			Advantages and Limitations of the Use of Optogenetic Approach in Studying Fast-Scale Spike Encoding	PLOS ONE			English	Article							DYNAMICAL RESPONSE PROPERTIES; NEURONS IN-VIVO; NEOCORTICAL NEURONS; CORTICAL-NEURONS; PYRAMIDAL NEURONS; SYNAPTIC PLASTICITY; NEURAL ACTIVITY; OPTICAL CONTROL; EXCITATION; ENSEMBLES	Understanding single-neuron computations and encoding performed by spike-generation mechanisms of cortical neurons is one of the central challenges for cell electrophysiology and computational neuroscience. An established paradigm to study spike encoding in controlled conditions in vitro uses intracellular injection of a mixture of signals with fluctuating currents that mimic in vivo-like background activity. However this technique has two serious limitations: it uses current injection, while synaptic activation leads to changes of conductance, and current injection is technically most feasible in the soma, while the vast majority of synaptic inputs are located on the dendrites. Recent progress in optogenetics provides an opportunity to circumvent these limitations. Transgenic expression of light-activated ionic channels, such as Channelrhodopsin2 (ChR2), allows induction of controlled conductance changes even in thin distant dendrites. Here we show that photostimulation provides a useful extension of the tools to study neuronal encoding, but it has its own limitations. Optically induced fluctuating currents have a low cutoff (similar to 70Hz), thus limiting the dynamic range of frequency response of cortical neurons. This leads to severe underestimation of the ability of neurons to phase-lock their firing to high frequency components of the input. This limitation could be worked around by using short (2 ms) light stimuli which produce membrane potential responses resembling EPSPs by their fast onset and prolonged decay kinetics. We show that combining application of short light stimuli to different parts of dendritic tree for mimicking distant EPSCs with somatic injection of fluctuating current that mimics fluctuations of membrane potential in vivo, allowed us to study fast encoding of artificial EPSPs photoinduced at different distances from the soma. We conclude that dendritic photostimulation of ChR2 with short light pulses provides a powerful tool to investigate population encoding of simulated synaptic potentials generated in dendrites at different distances from the soma.	[Malyshev, Aleksey; Volgushev, Maxim] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Malyshev, Aleksey; Volgushev, Maxim] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Goz, Roman; LoTurco, Joseph J.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Connecticut; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; University of Connecticut	Volgushev, M (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	maxim.volgushev@uconn.edu	Volgushev, Maxim/AAO-6793-2020; Malyshev, Alexey/P-2775-2015; Malyshev, Aleksey/R-8471-2018	Volgushev, Maxim/0000-0002-8080-1136; Malyshev, Aleksey/0000-0002-4633-7691	National Institutes of Health [R01MH087631]; Startup funds from the University of Connecticut; Russian Science Foundation [14-25-00072]; Russian Foundation for Basic Research [15-04-06286, 13-04-40332]; Humboldt Research Award from the Alexander von Humboldt-Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Startup funds from the University of Connecticut; Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Humboldt Research Award from the Alexander von Humboldt-Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the grant R01MH087631 from the National Institutes of Health and Startup funds from the University of Connecticut to MV; grants #14-25-00072 from the Russian Science Foundation and #15-04-06286 and #13-04-40332 from the Russian Foundation for Basic Research to AM. MV was partially supported by Humboldt Research Award from the Alexander von Humboldt-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Boucsein C, 2009, J NEUROSCI, V29, P1006, DOI 10.1523/JNEUROSCI.3424-08.2009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Higgs MH, 2009, J NEUROSCI, V29, P1285, DOI 10.1523/JNEUROSCI.3728-08.2009; Ilin V, 2013, J NEUROSCI, V33, P2281, DOI 10.1523/JNEUROSCI.0771-12.2013; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kondgen H, 2008, CEREB CORTEX, V18, P2086, DOI 10.1093/cercor/bhm235; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Maher BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034053; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Malyshev A, 2013, EUR J NEUROSCI, V38, P3181, DOI 10.1111/ejn.12338; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Miura K, 2007, J NEUROSCI, V27, P13802, DOI 10.1523/JNEUROSCI.2452-07.2007; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; Oviedo HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033831; Ramos RL, 2006, CEREB CORTEX, V16, P1323, DOI 10.1093/cercor/bhj074; Schoenenberger P, 2008, BRAIN CELL BIOL, V36, P119, DOI 10.1007/s11068-008-9025-8; Silberberg G, 2004, J NEUROPHYSIOL, V91, P704, DOI 10.1152/jn.00415.2003; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Tchumatchenko T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00184; Tchumatchenko T, 2011, J NEUROSCI, V31, P12171, DOI 10.1523/JNEUROSCI.2182-11.2011; Volgushev M, 2003, EUR J NEUROSCI, V17, P1768, DOI 10.1046/j.1460-9568.2003.02609.x; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	32	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122286	10.1371/journal.pone.0122286	http://dx.doi.org/10.1371/journal.pone.0122286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850004	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800116
J	Gao, XN; Lin, J; Gao, L; Deng, AL; Lu, XL; Li, YH; Wang, LL; Yu, L				Gao, Xiaoning; Lin, Ji; Gao, Li; Deng, Ailing; Lu, Xiaolin; Li, Yonghui; Wang, Lili; Yu, Li			High Expression of c-kit mRNA Predicts Unfavorable Outcome in Adult Patients with t (8;21) Acute Myeloid Leukemia	PLOS ONE			English	Article							T(8/21); CANCER; AML; MUTATIONS; AML1-ETO; DISEASE; T(8/21)(Q22,Q22); LEUKEMOGENESIS; PROGNOSIS; INV(16)	The reason that a certain subgroup of acute myeloid leukemia (AML) patients with t(8; 21) translocation (generating the AML1/ETO fusion gene) displays a poor survival remains elusive. The proto-oncogene c-kit is expressed in approximately 80% of AML cases. The kinase domain mutation of the c-kit gene, one of the most common gain-of-function mutations associated with t(8; 21) AML, predicts higher relapse risk and poor prognosis. However, the role of c-kit high expression in t(8; 21) AML remains poorly understood. Here we evaluated the prognostic significance of c-kit expression levels in AML patients. The mRNA expression of c-kit was determined by real-time quantitative reverse transcription PCR in 132 adult AML patients. Patients were grouped into quartiles according to c-kit expression levels (Q1-Q4, each quartile containing 25% of patients) and divided into c-kit high (Q4; n = 33) and c-kit low (Q1-Q3; n = 99). High c-kit expression was associated with AML1/ETO-positive and with c-kit mutation. Of note, 35.8% of the AML1/ETO-positive AML patients carrying wild-type c-kit expressed high levels of c-kit, suggesting that other factors are involved in c-kit overexpression. High c-kit expression was associated with inferior overall and event-free survival in AML1/ETO-positive patients and was independently predictive for overall and event-free survival in multivariate analyses in a c-kit mutation-independent manner. Thus, high c-kit expression serves as a reliable molecular marker for poor prognosis, supporting a pathogenetic role of c-kit signaling in AML1/ETO-positive AML. AML1/ETO-positive patients with high c-kit expression might benefit from early treatment modifications and molecular target therapies.	[Gao, Xiaoning; Deng, Ailing; Lu, Xiaolin; Li, Yonghui; Wang, Lili; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Hematol, Beijing, Peoples R China; [Lin, Ji] Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Inst Basic Med, Beijing, Peoples R China; [Gao, Li] China Japan Friendship Hosp, Dept Hematol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; China-Japan Friendship Hospital	Yu, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Dept Hematol, Beijing, Peoples R China.	liyu301@vip.163.com	wang, lili/HDL-7210-2022; lu, xl/HDO-8340-2022	Yu, Li/0000-0001-6872-2665	National Natural Science Foundation of China [81170518, 81000221, 81370010, 81171820, 81370635]; National Public Health Grand Research Foundation [201202017]; Capital Public Health Project [Z111107067311070]; Beijing Natural Science Foundation [7122169, 7112126]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Public Health Grand Research Foundation; Capital Public Health Project; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was partially supported by grants from the National Natural Science Foundation of China (81170518 to LY; 81000221 and 81370010 to XNG; 81171820 to JL and 81370635 to YHL), the National Public Health Grand Research Foundation (201202017 to LY), the Capital Public Health Project (Z111107067311070 to LY), and the Beijing Natural Science Foundation (7122169 to XNG and 7112126 to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2007, GENE, V401, P38, DOI 10.1016/j.gene.2007.06.017; Boissel N, 2006, LEUKEMIA, V20, P965, DOI 10.1038/sj.leu.2404188; Byrd JC, 1999, J CLIN ONCOL, V17, P3767, DOI 10.1200/JCO.1999.17.12.3767; CHESON BD, 1990, J CLIN ONCOL, V8, P813, DOI 10.1200/JCO.1990.8.5.813; de Jonge HJM, 2010, BLOOD, V116, P1747, DOI 10.1182/blood-2010-03-270991; Ferrara F, 2002, HAEMATOLOGICA, V87, P306; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Gao XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055481; Gorin NC, 2008, J CLIN ONCOL, V26, P3183, DOI 10.1200/JCO.2007.15.3106; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; IKEDA H, 1991, BLOOD, V78, P2962; Jiao B, 2009, LEUKEMIA, V23, P1598, DOI 10.1038/leu.2009.104; Krystal GW, 1996, CANCER RES, V56, P370; Kuchenbauer F, 2006, BRIT J HAEMATOL, V134, P616, DOI 10.1111/j.1365-2141.2006.06229.x; Kuhnl A, 2011, BLOOD, V118, P6362, DOI 10.1182/blood-2011-04-350850; Leroy H, 2005, LEUKEMIA, V19, P367, DOI 10.1038/sj.leu.2403627; Li YH, 2013, BLOOD, V121, P499, DOI 10.1182/blood-2012-07-444729; Lin P, 2008, MODERN PATHOL, V21, P1029, DOI 10.1038/modpathol.2008.92; Marcucci G, 2005, J CLIN ONCOL, V23, P5705, DOI 10.1200/JCO.2005.15.610; Narimatsu H, 2008, LEUKEMIA, V22, P428, DOI 10.1038/sj.leu.2404905; Nguyen S, 2002, BLOOD, V99, P3517, DOI 10.1182/blood.V99.10.3517; Paschka P, 2006, J CLIN ONCOL, V24, P3904, DOI 10.1200/JCO.2006.06.9500; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Schlenk RF, 2004, J CLIN ONCOL, V22, P3741, DOI 10.1200/JCO.2004.03.012; Schnittger S, 2006, BLOOD, V107, P1791, DOI 10.1182/blood-2005-04-1466; Shimada A, 2006, BLOOD, V107, P1806, DOI 10.1182/blood-2005-08-3408; Viehmann S, 2003, LEUKEMIA, V17, P1130, DOI 10.1038/sj.leu.2402959; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yasuda A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-46; Yoo SJ, 2005, HAEMATOLOGICA, V90, P1493; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298	35	28	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124241	10.1371/journal.pone.0124241	http://dx.doi.org/10.1371/journal.pone.0124241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860287	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300134
J	Moghadamtousi, SZ; Rouhollahi, E; Karimian, H; Fadaeinasab, M; Firoozinia, M; Abdulla, MA; Kadir, HA				Moghadamtousi, Soheil Zorofchian; Rouhollahi, Elham; Karimian, Hamed; Fadaeinasab, Mehran; Firoozinia, Mohammad; Abdulla, Mahmood Ameen; Kadir, Habsah Abdul			The Chemopotential Effect of Annona muricata Leaves against Azoxymethane-Induced Colonic Aberrant Crypt Foci in Rats and the Apoptotic Effect of Acetogenin Annomuricin E in HT-29 Cells: A Bioassay-Guided Approach	PLOS ONE			English	Article							NUCLEAR ANTIGEN PCNA; LIPID-PEROXIDATION; OXIDATIVE STRESS; ANTIOXIDANT STATUS; MEDIATED PATHWAY; NATURAL-PRODUCTS; CANCER-CELLS; EXTRACT; EXPRESSION; FAMILY	Annona muricata has been used in folk medicine for the treatment of cancer and tumors. This study evaluated the chemopreventive properties of an ethyl acetate extract of Annona muricata leaves (EEAML) on azoxymethane-induced colonic aberrant crypt foci (ACF) in rats. Moreover, the cytotoxic compound of EEAML (Annomuricin E) was isolated, and its apoptosis-inducing effect was investigated against HT-29 colon cancer cell line using a bioassay-guided approach. This experiment was performed on five groups of rats: negative control, cancer control, EEAML (250 mg/kg), EEAML (500 mg/kg) and positive control (5-fluorouracil). Methylene blue staining of colorectal specimens showed that application of EEAML at both doses significantly reduced the colonic ACF formation compared with the cancer control group. Immunohistochemistry analysis showed the down-regulation of PCNA and Bcl-2 proteins and the up-regulation of Bax protein after administration of EEAML compared with the cancer control group. In addition, an increase in the levels of enzymatic antioxidants and a decrease in the malondialdehyde level of the colon tissue homogenates were observed, suggesting the suppression of lipid peroxidation. Annomuricin E inhibited the growth of HT-29 cells with an IC50 value of 1.62 +/- 0.24 mu g/ml after 48 h. The cytotoxic effect of annomuricin E was further substantiated by G1 cell cycle arrest and early apoptosis induction in HT-29 cells. Annomuricin E triggered mitochondria-initiated events, including the dissipation of the mitochondrial membrane potential and the leakage of cytochrome c from the mitochondria. Prior to these events, annomuricin E activated caspase 3/7 and caspase 9. Upstream, annomuricin E induced a time-dependent upregulation of Bax and downregulation of Bcl-2 at the mRNA and protein levels. In conclusion, these findings substantiate the usage of Annona muricata leaves in ethnomedicine against cancer and highlight annomuricin E as one of the contributing compounds in the anticancer activity of Annona muricata leaves.	[Moghadamtousi, Soheil Zorofchian; Kadir, Habsah Abdul] Univ Malaya, Fac Sci, Inst Biol Sci, Biochem Program,Biomol Res Grp, Kuala Lumpur, Malaysia; [Rouhollahi, Elham; Karimian, Hamed; Abdulla, Mahmood Ameen] Univ Malaya, Fac Sci, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Fadaeinasab, Mehran] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Kadir, HA (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Biochem Program,Biomol Res Grp, Kuala Lumpur, Malaysia.	habsah@um.edu.my	ABDUL KADIR, HABSAH/B-8561-2010; Fadaeinasab, Mehran/A-8810-2016	Fadaeinasab, Mehran/0000-0002-2501-894X	University of Malaya High Impact Research Chancellery [UM.C/625/1/HIR/175]; University of Malaya Research Grant [RP001-2012C]; Postgraduate Research Fund [PG118-2013A]	University of Malaya High Impact Research Chancellery; University of Malaya Research Grant; Postgraduate Research Fund	This research was supported by the University of Malaya High Impact Research Chancellery (UM.C/625/1/HIR/175), University of Malaya Research Grant (RP001-2012C), and Postgraduate Research Fund (PG118-2013A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7; Adewole SO, 2006, AFR J BIOMED RES, V9, P173, DOI [10.4314/ajbr.v9i3.48903, DOI 10.4314/AJBR.V9I3.48903]; Adewole SO, 2009, AFR J TRADIT COMPLEM, V6, P30; Alali FQ, 1999, J NAT PROD, V62, P504, DOI 10.1021/np980406d; Almagrami AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096004; Alrawi SJ, 2006, ANTICANCER RES, V26, P107; Bardi DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109424; Bardi DA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/918460; Baskar R, 2007, INDIAN J EXP BIOL, V45, P480; Bermejo A, 2005, NAT PROD REP, V22, P269, DOI 10.1039/b500186m; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; BIRD RP, 1995, CANCER LETT, V93, P55, DOI 10.1016/0304-3835(95)03788-X; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Brumatti G, 2008, METHODS, V44, P235, DOI 10.1016/j.ymeth.2007.11.010; Cerea G, 2003, ANTICANCER RES, V23, P1951; Chen WL, 2003, AM J CHINESE MED, V31, P523, DOI 10.1142/S0192415X0300120X; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; DELEON MP, 1988, CANCER RES, V48, P4121; Demircan B, 2005, PAIN CLINIC, V17, P383; DESCHNER EE, 1983, J NATL CANCER I, V70, P279; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Ezirim A., 2013, INDIAN J DRUGS DIS, V2, P241; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Fenoglio-Preiser CM, 1999, TOXICOL PATHOL, V27, P632, DOI 10.1177/019262339902700604; Foong CP, 2012, REV BRAS FARMACOGN, V22, P1301, DOI 10.1590/S0102-695X2012005000096; FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8; Fulda S, 2010, PLANTA MED, V76, P1075, DOI 10.1055/s-0030-1249961; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Garber JC, 2011, GUIDE CARE USE LAB A; George VC, 2012, ASIAN PAC J CANCER P, V13, P699, DOI 10.7314/APJCP.2012.13.2.699; George VC, 2014, J FOOD SCI TECHNOL, P1; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Gourineni VP, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/983038; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guo Y.W., 2013, ISRN ONCOL, DOI DOI 10.1155/2013/645817; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hajrezaie M, 2014, SCI WORLD J, DOI 10.1155/2014/540463; Hajrezaie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091246; HENDRICKSE CW, 1994, BRIT J SURG, V81, P1219, DOI 10.1002/bjs.1800810849; Ionov Y, 2000, P NATL ACAD SCI USA, V97, P10872, DOI 10.1073/pnas.190210897; ISOZAKI H, 1994, SURG TODAY, V24, P494, DOI 10.1007/BF01884567; Karimian H, 2014, DRUG DES DEV THER, V8, P1481, DOI 10.2147/DDDT.S68818; Karimian H, 2014, MOLECULES, V19, P9478, DOI 10.3390/molecules19079478; Kim G, 1998, J NAT PROD, V61, P432, DOI 10.1021/np970534m; Komiya M, 2013, JPN J CLIN ONCOL, V43, P685, DOI 10.1093/jjco/hyt053; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; LEWIS MA, 1993, PESTIC BIOCHEM PHYS, V45, P15, DOI 10.1006/pest.1993.1003; Liaw CC, 2010, PLANTA MED, V76, P1390, DOI 10.1055/s-0030-1250006; Liew SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087286; Liochev SI, 2011, FREE RADIC BIOL MED, V60, P1; LIPKIN M, 1983, CANCER RES, V43, P1899; Lissoni P, 1999, EUR J CANCER, V35, P1688, DOI 10.1016/S0959-8049(99)00159-8; Lovborg H, 2004, MOL CANCER THER, V3, P521; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; MAYER A, 1993, CANCER, V71, P2454, DOI 10.1002/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2; Meguid NA, 2011, BIOL TRACE ELEM RES, V143, P58, DOI 10.1007/s12011-010-8840-9; Minari J, 2014, EGYPT J MED HUM GENE, V15, P327, DOI DOI 10.1016/J.EJMHG.2014.05.001; Mishra BB, 2011, EUR J MED CHEM, V46, P4769, DOI 10.1016/j.ejmech.2011.07.057; Mishra S, 2013, GLOB J PHARM RES, V2, P1613; Moghadamtousi SZ, 2014, J ETHNOPHARMACOL, V156, P277, DOI 10.1016/j.jep.2014.08.011; Moghadamtousi SZ, 2014, DRUG DES DEV THER, V8, P2099, DOI 10.2147/DDDT.S70096; Moghadamtousi SZ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-299; Moghadamtousi SZ, 2014, SCI WORLD J, DOI 10.1155/2014/768323; MORRE DJ, 1994, LIFE SCI, V56, P343; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakanishi Y, 2003, J MED CHEM, V46, P3185, DOI 10.1021/jm020548b; Naryzhny SN, 2007, FEBS LETT, V581, P4917, DOI 10.1016/j.febslet.2007.09.022; Naziroglu M, 2012, J RECEPT SIG TRANSD, V32, P134, DOI 10.3109/10799893.2012.672994; Nirmala P, 2011, EUR J PHARMACOL, V654, P75, DOI 10.1016/j.ejphar.2010.11.034; Oberlies NH, 1997, CANCER LETT, V115, P73, DOI 10.1016/S0304-3835(97)04716-2; Oberlies NH, 1997, J MED CHEM, V40, P2102, DOI 10.1021/jm9700169; Ocker M, 2012, EUR SURG RES, V48, P111, DOI 10.1159/000336875; Pandurangan AK, 2012, ASIAN PAC J CANCER P, V13, P1569, DOI 10.7314/APJCP.2012.13.4.1569; Park MT, 2003, J BIOCHEM MOL BIOL, V36, P60; Raju J, 2008, WORLD J GASTROENTERO, V14, P6632, DOI 10.3748/wjg.14.6632; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; RUPPRECHT JK, 1990, J NAT PROD, V53, P237, DOI 10.1021/np50068a001; Shin HR, 2000, CANCER CAUSE CONTROL, V11, P565, DOI 10.1023/A:1008980200583; Shwter AN, 2014, J ETHNOPHARMACOL, V151, P1194, DOI 10.1016/j.jep.2013.12.044; Skrzydlewska E, 2005, WORLD J GASTROENTERO, V11, P403, DOI 10.3748/wjg.v11.i3.403; Sturm I, 2001, J CLIN ONCOL, V19, P2272, DOI 10.1200/JCO.2001.19.8.2272; Taylor P, 2014, J ETHNOPHARMACOL, V158, P246, DOI 10.1016/j.jep.2014.10.034; Thomson M, 2003, CURR CANCER DRUG TAR, V3, P67, DOI 10.2174/1568009033333736; VACA CE, 1988, MUTAT RES, V195, P137, DOI 10.1016/0165-1110(88)90022-X; Velmurugan B, 2010, MOL CARCINOGEN, V49, P641, DOI 10.1002/mc.20643; Venkateshwarlu Eggadi, 2014, World Applied Sciences Journal, V32, P444; Wang ZY, 2011, J ETHNOPHARMACOL, V133, P751, DOI 10.1016/j.jep.2010.11.004; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Yuan SSF, 2003, LIFE SCI, V72, P2853, DOI 10.1016/S0024-3205(03)00190-5	93	49	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122288	10.1371/journal.pone.0122288	http://dx.doi.org/10.1371/journal.pone.0122288			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860620	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300039
J	Osaki, T; Kakegawa, T; Kageyama, T; Enomoto, J; Nittami, T; Fukuda, J				Osaki, Tatsuya; Kakegawa, Takahiro; Kageyama, Tatsuto; Enomoto, Junko; Nittami, Tadashi; Fukuda, Junji			Acceleration of Vascular Sprouting from Fabricated Perfusable Vascular-Like Structures	PLOS ONE			English	Article							IN-VITRO MODEL; ELECTROCHEMICAL DETACHMENT; SKELETAL-MUSCLE; PHORBOL ESTERS; CELLS; ANGIOGENESIS; PROLIFERATION; CONSTRUCTS; ACTIVATION; APOPTOSIS	Fabrication of vascular networks is essential for engineering three-dimensional thick tissues and organs in the emerging fields of tissue engineering and regenerative medicine. In this study, we describe the fabrication of perfusable vascular-like structures by transferring endothelial cells using an electrochemical reaction as well as acceleration of subsequent endothelial sprouting by two stimuli: phorbol 12-myristate 13-acetate (PMA) and fluidic shear stress. The electrochemical transfer of cells was achieved using an oligopeptide that formed a dense molecular layer on a gold surface and was then electrochemically desorbed from the surface. Human umbilical vein endothelial cells (HUVECs), adhered to gold-coated needles (phi 600 mu m) via the oligopeptide, were transferred to collagen gel along with electrochemical desorption of the molecular layer, resulting in the formation of endothelial cell-lined vascular-like structures. In the following culture, the endothelial cells migrated into the collagen gel and formed branched luminal structures. However, this branching process was strikingly slow (> 14 d) and the cell layers on the internal surfaces became disrupted in some regions. To address these issues, we examined the effects of the protein kinase C (PKC) activator, PMA, and shear stress generated by medium flow. Addition of PMA at an optimum concentration significantly accelerated migration, vascular network formation, and its stabilization. Exposure to shear stress reoriented the cells in the direction of the medium flow and further accelerated vascular network formation. Because of the synergistic effects, HUVECs began to sprout as early as 3 d of perfusion culture and neighboring vascular-like structures were bridged within 5 d. Although further investigations of vascular functions need to be performed, this approach may be an effective strategy for rapid fabrication of perfusable microvascular networks when engineering three-dimensional fully vascularized tissues and organs.	[Osaki, Tatsuya; Kakegawa, Takahiro] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Osaki, Tatsuya; Kakegawa, Takahiro; Kageyama, Tatsuto; Enomoto, Junko; Nittami, Tadashi; Fukuda, Junji] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 240, Japan	University of Tsukuba; Yokohama National University	Fukuda, J (corresponding author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki, Japan.	fukuda@ynu.ac.jp	Fukuda, Junji/R-6620-2019; Fukuda, Junji/B-9257-2011	Fukuda, Junji/0000-0002-7194-8099; Fukuda, Junji/0000-0002-7194-8099; Kageyama, Tatsuto/0000-0001-6248-3755; Osaki, Tatsuya/0000-0001-7174-0629; Enomoto, Junko/0000-0002-4177-7380	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25289291, 26630423, 26106712]; New Energy and Industrial Technology Development Organization [11B09003d]; ALCA, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [15J02349, 26106712] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); ALCA, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, 25289291, 26630423, 26106712 (http://www.mext.go.jp/english/) to (JF) and New Energy and Industrial Technology Development Organization, 11B09003d (http://www.nedo.go.jp/english/index.html) to (JF) and ALCA, Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html) to (JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres C, 2006, BIOMATERIALS, V27, P5524, DOI 10.1016/j.biomaterials.2006.06.014; Baum O, 2004, AM J PHYSIOL-HEART C, V287, pH2300, DOI 10.1152/ajpheart.00065.2004; Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bellan LM, 2009, SOFT MATTER, V5, P1354, DOI 10.1039/b819905a; Bhogal RH, 2010, LIVER TRANSPLANT, V16, P1303, DOI 10.1002/lt.22157; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Busuttil V, 2002, ONCOGENE, V21, P3213, DOI 10.1038/sj.onc.1205433; Chen SF, 2009, BIOMATERIALS, V30, P5892, DOI 10.1016/j.biomaterials.2009.07.001; Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314; Cuchiara MP, 2010, BIOMATERIALS, V31, P5491, DOI 10.1016/j.biomaterials.2010.03.031; Duda DG, 2004, TRENDS MOL MED, V10, P143, DOI 10.1016/j.molmed.2004.02.001; Folkman J., 1984, BIOL ENDOTHELIAL CEL, P412; Frerich B, 2001, INT J ORAL MAX SURG, V30, P414, DOI 10.1054/ijom.2001.0130; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j; GROSS JL, 1983, P NATL ACAD SCI-BIOL, V80, P2623, DOI 10.1073/pnas.80.9.2623; HECKER E, 1967, NATURWISSENSCHAFTEN, V54, P282, DOI 10.1007/BF00620887; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Huang X, 2010, ANN BIOMED ENG, V38, P1965, DOI 10.1007/s10439-010-9986-5; Inaba R, 2009, BIOMATERIALS, V30, P3573, DOI 10.1016/j.biomaterials.2009.03.045; Kakegawa T, 2013, TISSUE ENG PT A, V19, P290, DOI [10.1089/ten.tea.2011.0739, 10.1089/ten.TEA.2011.0739]; Karsan A, 1997, AM J PATHOL, V151, P1775; Koh CJ, 2004, J AM SOC NEPHROL, V15, P1113, DOI 10.1097/01.ASN.0000119683.59068.F0; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; LANGILLE BL, 1993, J CARDIOVASC PHARM, V21, pS11; Ling Y, 2007, LAB CHIP, V7, P756, DOI 10.1039/b615486g; Martou G, 2006, J APPL PHYSIOL, V101, P1335, DOI 10.1152/japplphysiol.00278.2006; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Miller J.S., 2012, NAT MATER, V11; Mochizuki N, 2013, J TISSUE ENG REGEN M, V7, P236, DOI 10.1002/term.519; MONTESANO R, 1985, CELL, V42, P469, DOI 10.1016/0092-8674(85)90104-7; Morimoto Y, 2013, BIOMATERIALS, V34, P9413, DOI 10.1016/j.biomaterials.2013.08.062; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Okano T, 1998, CELL TRANSPLANT, V7, P435, DOI 10.1016/S0963-6897(98)00030-X; Park IC, 2001, INT J ONCOL, V18, P1077; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; PRIES AR, 1995, CIRC RES, V77, P1017, DOI 10.1161/01.RES.77.5.1017; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Seano G, 2013, BLOOD, V121, pE129, DOI 10.1182/blood-2012-08-452292; Seto Y, 2010, BIOMATERIALS, V31, P2209, DOI 10.1016/j.biomaterials.2009.11.104; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Takei T, 2006, BIOTECHNOL BIOENG, V95, P1, DOI 10.1002/bit.20903; Therriault D, 2003, NAT MATER, V2, P265, DOI 10.1038/nmat863; Tkachenko E, 2009, LAB CHIP, V9, P1085, DOI 10.1039/b812184b; Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	51	28	29	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123735	10.1371/journal.pone.0123735	http://dx.doi.org/10.1371/journal.pone.0123735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860890	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300112
J	Rausa, M; Pagani, A; Nai, A; Campanella, A; Gilberti, ME; Apostoli, P; Camaschella, C; Silvestri, L				Rausa, Marco; Pagani, Alessia; Nai, Antonella; Campanella, Alessandro; Gilberti, Maria Enrica; Apostoli, Pietro; Camaschella, Clara; Silvestri, Laura			Bmp6 Expression in Murine Liver Non Parenchymal Cells: A Mechanism to Control their High Iron Exporter Activity and Protect Hepatocytes from Iron Overload?	PLOS ONE			English	Article							HEPCIDIN EXPRESSION; GENE-EXPRESSION; HEMOJUVELIN; RECEPTORS; TMPRSS6	Bmp6 is the main activator of hepcidin, the liver hormone that negatively regulates plasma iron influx by degrading the sole iron exporter ferroportin in enterocytes and macrophages. Bmp6 expression is modulated by iron but the molecular mechanisms are unknown. Although hepcidin is expressed almost exclusively by hepatocytes (HCs), Bmp6 is produced also by non-parenchymal cells (NPCs), mainly sinusoidal endothelial cells (LSECs). To investigate the regulation of Bmp6 in HCs and NPCs, liver cells were isolated from adult wild type mice whose diet was modified in iron content in acute or chronic manner and in disease models of iron deficiency (Tmprss6 KO mouse) and overload (Hjv KO mouse). With manipulation of dietary iron in wild-type mice, Bmp6 and Tfr1 expression in both HCs and NPCs was inversely related, as expected. When hepcidin expression is abnormal in murine models of iron overload (Hjv KO mice) and deficiency (Tmprss6 KO mice), Bmp6 expression in NPCs was not related to Tfr1. Despite the low Bmp6 in NPCs from Tmprss6 KO mice, Tfr1 mRNA was also low. Conversely, despite body iron overload and high expression of Bmp6 in NPCs from Hjv KO mice, Tfr1 mRNA and protein were increased. However, in the same cells ferritin L was only slightly increased, but the iron content was not, suggesting that Bmp6 in these cells reflects the high intracellular iron import and export. We propose that NPCs, sensing the iron flux, not only increase hepcidin through Bmp6 with a paracrine mechanism to control systemic iron homeostasis but, controlling hepcidin, they regulate their own ferroportin, inducing iron retention or release and further modulating Bmp6 production in an autocrine manner. This mechanism, that contributes to protect HC from iron loading or deficiency, is lost in disease models of hepcidin production.	[Rausa, Marco; Pagani, Alessia; Nai, Antonella; Campanella, Alessandro; Camaschella, Clara; Silvestri, Laura] Ist Sci San Raffaele, IRCCS, Div Genet & Cell Biol, I-20132 Milan, Italy; [Rausa, Marco; Pagani, Alessia; Nai, Antonella; Campanella, Alessandro; Camaschella, Clara; Silvestri, Laura] Univ Vita Salute San Raffaele, Milan, Italy; [Gilberti, Maria Enrica; Apostoli, Pietro] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Unit Occupat Hlth & Ind Hyg, Brescia, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Brescia	Camaschella, C (corresponding author), Ist Sci San Raffaele, IRCCS, Div Genet & Cell Biol, I-20132 Milan, Italy.	camaschella.clara@hsr.it; silvestri.laura@hsr.it	Pagani, Alessia/AAN-4301-2020; Nai, Antonella/AAB-8749-2019; Silvestri, Laura/A-1417-2015; Campanella, Alessandro/N-8315-2015	Pagani, Alessia/0000-0003-2374-4988; Nai, Antonella/0000-0002-0739-5282; Silvestri, Laura/0000-0002-8726-9808; Campanella, Alessandro/0000-0002-3463-1199	Telethon Fondazione Onlus [GGP12025]; Ministero Sanita, MIUR-PRIN (Progetto di Rilevante Interesse Nazionale); Ricerca Finalizzata [RF-2010-2312048]	Telethon Fondazione Onlus(Fondazione Telethon); Ministero Sanita, MIUR-PRIN (Progetto di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)); Ricerca Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF))	This work was partially supported by the "Telethon Fondazione Onlus" Grant GGP12025; the Ministero Sanita, MIUR-PRIN (Progetto di Rilevante Interesse Nazionale) 2010-2011; and the Ricerca Finalizzata RF-2010-2312048 to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Campanella A, 2004, BIOCHEMISTRY-US, V43, P195, DOI 10.1021/bi035386f; Enns CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060534; Feng Q, 2012, AM J PHYSIOL-GASTR L, V302, pG1397, DOI 10.1152/ajpgi.00020.2012; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kautz L, 2011, HAEMATOL-HEMATOL J, V96, P199, DOI 10.3324/haematol.2010.031963; Knittel T, 1997, EXP CELL RES, V232, P263, DOI 10.1006/excr.1997.3504; Liu W, 2011, PROTEOMICS, V11, P3556, DOI 10.1002/pmic.201100157; Meynard D, 2011, BLOOD, V118, P747, DOI 10.1182/blood-2011-04-348698; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Riba M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069694; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Zhang AS, 2011, BLOOD, V117, P1687, DOI 10.1182/blood-2010-06-287292; Zhang ZZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084906	29	50	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122696	10.1371/journal.pone.0122696	http://dx.doi.org/10.1371/journal.pone.0122696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860887	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300056
J	Brown, KA; Parks, KE; Bethell, CA; Johnson, SE; Mulligan, M				Brown, Kerry A.; Parks, Katherine E.; Bethell, Colin A.; Johnson, Steig E.; Mulligan, Mark			Predicting Plant Diversity Patterns in Madagascar: Understanding the Effects of Climate and Land Cover Change in a Biodiversity Hotspot	PLOS ONE			English	Article							NO-ANALOG COMMUNITIES; SPECIES DISTRIBUTIONS; TROPICAL FORESTS; RANGE SHIFTS; DEFORESTATION; CONSERVATION; PRECIPITATION; TEMPERATURE; FUTURE; VULNERABILITY	Climate and land cover change are driving a major reorganization of terrestrial biotic communities in tropical ecosystems. In an effort to understand how biodiversity patterns in the tropics will respond to individual and combined effects of these two drivers of environmental change, we use species distribution models (SDMs) calibrated for recent climate and land cover variables and projected to future scenarios to predict changes in diversity patterns in Madagascar. We collected occurrence records for 828 plant genera and 2186 plant species. We developed three scenarios, (i.e., climate only, land cover only and combined climate-land cover) based on recent and future climate and land cover variables. We used this modelling framework to investigate how the impacts of changes to climate and land cover influenced biodiversity across ecoregions and elevation bands. There were large-scale climate- and land cover-driven changes in plant biodiversity across Madagascar, including both losses and gains in diversity. The sharpest declines in biodiversity were projected for the eastern escarpment and high elevation ecosystems. Sharp declines in diversity were driven by the combined climate-land cover scenarios; however, there were subtle, region-specific differences in model outputs for each scenario, where certain regions experienced relatively higher species loss under climate or land cover only models. We strongly caution that predicted future gains in plant diversity will depend on the development and maintenance of dispersal pathways that connect current and future suitable habitats. The forecast for Madagascar's plant diversity in the face of future environmental change is worrying: regional diversity will continue to decrease in response to the combined effects of climate and land cover change, with habitats such as ericoid thickets and eastern lowland and sub-humid forests particularly vulnerable into the future.	[Brown, Kerry A.] Univ Kingston, Sch Geog Geol & Environm, Ctr Earth & Environm Sci Res, London, England; [Parks, Katherine E.] Univ Southampton, Fac Engn & Environm, Ctr Environm Sci, Southampton, Hants, England; [Bethell, Colin A.] Univ Kingston, High Performance Comp Cluster, Fac Sci Engn & Comp, Fac Sci, London, England; [Johnson, Steig E.] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB, Canada; [Mulligan, Mark] Univ London, Kings Coll London, Dept Geog, London SW3 6LX, England	Kingston University; University of Southampton; Kingston University; University of Calgary; University of London; King's College London	Brown, KA (corresponding author), Univ Kingston, Sch Geog Geol & Environm, Ctr Earth & Environm Sci Res, London, England.	k.brown@kingston.ac.uk	Mulligan, Mark/V-9275-2019; Brown, Kerry/U-5082-2019	Mulligan, Mark/0000-0002-0132-0888; Johnson, Steig/0000-0003-2257-8949; BROWN, KERRY/0000-0002-6342-8966	Madagascar National Parks (MNP); Madagascar Institute pour la Conservation des Ecosystemes Tropicaux (MICET); Institute for the Conservation of Tropical Environments (ICTE); Madagascar Biodiversity Partnership (MBP); Natural Environment Research Council [NE/K010417/1] Funding Source: researchfish; NERC [NE/K010417/1] Funding Source: UKRI	Madagascar National Parks (MNP); Madagascar Institute pour la Conservation des Ecosystemes Tropicaux (MICET); Institute for the Conservation of Tropical Environments (ICTE); Madagascar Biodiversity Partnership (MBP); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank Madagascar National Parks (MNP), Madagascar Institute pour la Conservation des Ecosystemes Tropicaux (MICET), Institute for the Conservation of Tropical Environments (ICTE), and Madagascar Biodiversity Partnership (MBP) for valuable support. We thank six anonymous reviewers for comments on the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; Anderson-Teixeira KJ, 2013, GLOBAL CHANGE BIOL, V19, P2001, DOI 10.1111/gcb.12194; Annan JD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025259; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Asner GP, 2010, CONSERV LETT, V3, P395, DOI 10.1111/j.1755-263X.2010.00133.x; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; BRIEGLEB BP, 1992, J GEOPHYS RES-ATMOS, V97, P7603, DOI 10.1029/92JD00291; Brown KA, 2013, BIOL CONSERV, V161, P118, DOI 10.1016/j.biocon.2013.03.014; Busch J, 2012, CONSERV BIOL, V26, P408, DOI 10.1111/j.1523-1739.2012.01838.x; Bush MB, 2002, GLOBAL ECOL BIOGEOGR, V11, P463, DOI 10.1046/j.1466-822X.2002.00305.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Coe MT, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0155; Coe MT, 2009, J HYDROL, V369, P165, DOI 10.1016/j.jhydrol.2009.02.043; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Dewar RE, 2007, P NATL ACAD SCI USA, V104, P13723, DOI 10.1073/pnas.0704346104; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Elmqvist T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000402; ESRI, 2012, ARCGIS REL 10 1; Feeley KJ, 2012, GLOBAL CHANGE BIOL, V18, P2636, DOI 10.1111/j.1365-2486.2012.02719.x; Ferrer-Paris JR, 2013, DIVERS DISTRIB, V19, P215, DOI 10.1111/ddi.12012; Freeman E., 2012, PRESENCEABSENCE 1 1; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; GREEN GM, 1990, SCIENCE, V248, P212, DOI 10.1126/science.248.4952.212; Grinand C, 2013, REMOTE SENS ENVIRON, V139, P68, DOI 10.1016/j.rse.2013.07.008; Hannah L, 2008, BIOL LETTERS, V4, P590, DOI 10.1098/rsbl.2008.0270; Hansen M., 2006, VEGETATION CONTINUOU; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hong-Wa C, 2012, PLANT ECOL EVOL, V145, P302, DOI 10.5091/plecevo.2012.742; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Kreyling J, 2010, DIVERS DISTRIB, V16, P593, DOI 10.1111/j.1472-4642.2010.00675.x; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lathuilliere MJ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024024; Laurance WF, 2011, BIOL CONSERV, V144, P548, DOI 10.1016/j.biocon.2010.10.010; Liu FD, 2010, EUR J FOREST RES, V129, P1093, DOI 10.1007/s10342-010-0394-z; Mace GM, 2008, MOL ECOL, V17, P9, DOI 10.1111/j.1365-294X.2007.03455.x; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McConnell WJ, 2014, EARTH CONSERV DEV, P67; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Moat J., 2007, ATLAS VEGETATION MAD; Mulligan M., 2010, SIMTERRA CONSISTENT; Mulligan M, 2010, WATER INT, V35, P472, DOI 10.1080/02508060.2010.516330; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nobre P, 2009, J CLIMATE, V22, P5686, DOI 10.1175/2009JCLI2757.1; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Platts PJ, 2013, ECOGRAPHY, V36, P518, DOI 10.1111/j.1600-0587.2012.07805.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; R Development Core Team, 2012, R LANG ENV STAT COMP; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Rodriguez-Castaneda G, 2013, GLOBAL ECOL BIOGEOGR, V22, P118, DOI 10.1111/j.1466-8238.2012.00795.x; Sagar R, 2003, FOREST ECOL MANAG, V186, P61, DOI 10.1016/S0378-1127(03)00235-4; Satake A, 2008, GLOBAL ENVIRON CHANG, V18, P768, DOI 10.1016/j.gloenvcha.2008.07.007; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; Tadross M, 2008, CLIMATE CHANGE MADGA; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Vieilledent G, 2013, ECOL EVOL, V3, P1702, DOI 10.1002/ece3.550; Watson JEM, 2014, CONSERV LETT, V7, P1, DOI 10.1111/conl.12083; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238	70	32	33	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122721	10.1371/journal.pone.0122721	http://dx.doi.org/10.1371/journal.pone.0122721			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856241	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000352588500051
J	Komarnitki, I; Tomczyk, J; Ciszek, B; Zalewska, M				Komarnitki, Iulian; Tomczyk, Jacek; Ciszek, Bogdan; Zalewska, Marta			Proposed Classification of Auriculotemporal Nerve, Based on the Root System	PLOS ONE			English	Article							INFRATEMPORAL FOSSA; ANATOMY	The topography of the auriculotemporal nerve (ATN) root system is the main criterion of this nerve classification. Previous publications indicate that ATN may have between one and five roots. Most common is a one-or two-root variant of the nerve structure. The problem of many publications is the inconsistency of nomenclature which concerns the terms "roots", "connecting branches", or "branches" that are used to identify the same structures. This study was performed on 80 specimens (40 adults and 40 fetuses) to propose a classification based on: (i) the number of roots, (ii) way of root division, and (iii) configuration of interradicular fibers that form the ATN trunk. This new classification is a remedy for inconsistency of nomenclature of ATN in the infratemporal fossa. This classification system has proven beneficial when organizing all ATN variants described in previous studies and could become a helpful tool for surgeons and dentists. Examination of ATN from the infratemporal fossa of fetuses (the youngest was at 18 weeks gestational age) showed that, at that stage, the nerve is fully developed.	[Komarnitki, Iulian; Ciszek, Bogdan] Med Univ Warsaw, Dept Descript & Clin Anat, Warsaw, Poland; [Tomczyk, Jacek] Cardinal Stefan Wyszynski Univ, Dept Biol Anthropol, Warsaw, Poland; [Zalewska, Marta] Med Univ Warsaw, Dept Environm Hazard Prevent & Allergol, Warsaw, Poland	Medical University of Warsaw; Cardinal Stefan Wyszynski University in Warsaw; Medical University of Warsaw	Komarnitki, I (corresponding author), Med Univ Warsaw, Dept Descript & Clin Anat, Warsaw, Poland.	anatomy@onet.eu	Ciszek, Bogdan/N-7879-2018	Ciszek, Bogdan/0000-0002-0740-5049; Zalewska, Marta/0000-0002-8163-961X				Agur A.M., 2013, GRANTS ATLAS ANATOMY; Andersen NB, 2001, SURG RADIOL ANAT, V23, P97; Anil A, 2003, BRIT J ORAL MAX SURG, V41, P236, DOI 10.1016/S0266-4356(03)00113-X; BAUMEL JJ, 1971, AM J ANAT, V130, P431, DOI 10.1002/aja.1001300405; Chim H, 2012, PLAST RECONSTR SURG, V130, P336, DOI 10.1097/PRS.0b013e3182589dd5; Dias GJ, 2015, ANAT SCI INT, V90, P216, DOI 10.1007/s12565-014-0247-9; Fernandes PRB, 2003, CRANIO, V21, P165, DOI 10.1080/08869634.2003.11746246; GRAY H, 1995, GRAYS ANATOMY; Gulekon N, 2005, CLIN ANAT, V18, P15, DOI 10.1002/ca.20068; Janis JE, 2010, PLAST RECONSTR SURG, V125, P1422, DOI 10.1097/PRS.0b013e3181d4fb05; Kim HK, 2003, J ORAL REHABIL, V30, P189, DOI 10.1046/j.1365-2842.2003.01020.x; Komarnitki I, 2012, FOLIA MORPHOL, V71, P187; KRIZAN Z, 1956, Pract Otorhinolaryngol (Basel), V18, P144; Kwak HH, 2004, SURG RADIOL ANAT, V26, P494, DOI 10.1007/s00276-004-0259-6; McCoul ED, 2011, OPER TECH OTOLARYNGO, V22, P285; Murayama RA, 2009, INT ENDOD J, V42, P845, DOI 10.1111/j.1365-2591.2009.01599.x; Ngeow WC, 2009, BRIT DENT J, V207, P19, DOI 10.1038/sj.bdj.2009.559; Prades JM, 2003, SURG RADIOL ANAT, V25, P180, DOI 10.1007/s00276-003-0126-x; RIESSNER D, 1952, AMA ARCH SURG, V65, P831, DOI 10.1001/archsurg.1952.01260020825006; Riva N, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00041; ROBERT R, 1989, SURG RADIOL ANAT, V11, P307, DOI 10.1007/BF02098703; Sabit I, 2002, SURG NEUROL, V58, P21, DOI 10.1016/S0090-3019(02)00764-4; Schmalfuss IM, 2002, AM J NEURORADIOL, V23, P303; Schmidt BL, 1998, ORAL SURG ORAL MED O, V86, P165, DOI 10.1016/S1079-2104(98)90119-6; SHAHINIAN H, 1995, SKULL BASE SURG, V5, P73, DOI 10.1055/s-2008-1058937; Soni S, 2009, J ORAL MAXIL SURG, V67, P448, DOI 10.1016/j.joms.2008.09.012; Speciali Jose Geraldo, 2005, Curr Pain Headache Rep, V9, P277; Stuginski-Barbosa J, 2012, J HEADACHE PAIN, V13, P415, DOI 10.1007/s10194-012-0439-4; Thotakura B, 2003, SINGAP MED J, V54, P149; Wei Y, 2007, AM J ROENTGENOL, V189, P488, DOI 10.2214/AJR.07.2212	30	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123120	10.1371/journal.pone.0123120	http://dx.doi.org/10.1371/journal.pone.0123120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856464	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500075
J	Lange, S; Donges, JF; Volkholz, J; Kurths, J				Lange, Stefan; Donges, Jonathan F.; Volkholz, Jan; Kurths, Juergen			Local Difference Measures between Complex Networks for Dynamical System Model Evaluation	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; BRAIN NETWORKS; PRECIPITATION CHARACTERISTICS; HIERARCHICAL ORGANIZATION; GRAPH SIMILARITY; CLIMATE; ASSOCIATION; PERFORMANCE; SIMULATION; SCHEMES	A faithful modeling of real-world dynamical systems necessitates model evaluation. A recent promising methodological approach to this problem has been based on complex networks, which in turn have proven useful for the characterization of dynamical systems. In this context, we introduce three local network difference measures and demonstrate their capabilities in the field of climate modeling, where these measures facilitate a spatially explicit model evaluation. Building on a recent study by Feldhoff et al. [1] we comparatively analyze statistical and dynamical regional climate simulations of the South American monsoon system. Three types of climate networks representing different aspects of rainfall dynamics are constructed from the modeled precipitation space-time series. Specifically, we define simple graphs based on positive as well as negative rank correlations between rainfall anomaly time series at different locations, and such based on spatial synchronizations of extreme rain events. An evaluation against respective networks built from daily satellite data provided by the Tropical Rainfall Measuring Mission 3B42 V7 reveals far greater differences in model performance between network types for a fixed but arbitrary climate model than between climate models for a fixed but arbitrary network type. We identify two sources of uncertainty in this respect. Firstly, climate variability limits fidelity, particularly in the case of the extreme event network; and secondly, larger geographical link lengths render link misplacements more likely, most notably in the case of the anticorrelation network; both contributions are quantified using suitable ensembles of surrogate networks. Our model evaluation approach is applicable to any multidimensional dynamical system and especially our simple graph difference measures are highly versatile as the graphs to be compared may be constructed in whatever way required. Generalizations to directed as well as edge-and node-weighted graphs are discussed.	[Lange, Stefan; Kurths, Juergen] Humboldt Univ, Dept Phys, D-10099 Berlin, Germany; [Lange, Stefan; Donges, Jonathan F.; Volkholz, Jan; Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Donges, Jonathan F.] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Kurths, Juergen] Univ Aberdeen, Inst Complex Syst & Math Biol, Aberdeen, Scotland	Humboldt University of Berlin; Potsdam Institut fur Klimafolgenforschung; Stockholm University; University of Aberdeen	Lange, S (corresponding author), Humboldt Univ, Dept Phys, D-10099 Berlin, Germany.	slange@pik-potsdam.de	Donges, Jonathan F./HCI-2311-2022	Lange, Stefan/0000-0003-2102-8873; Donges, Jonathan/0000-0001-5233-7703	DFG/FAPESP [IRTG 1740/TRP 2011/50151-0]; Stordalen Foundation (via the PB. net network); German Federal Ministry of Education and Research (project GLUES)	DFG/FAPESP; Stordalen Foundation (via the PB. net network); German Federal Ministry of Education and Research (project GLUES)	This paper was developed within the scope of the IRTG 1740/TRP 2011/50151-0, funded by the DFG/FAPESP. JFD thanks the Stordalen Foundation (via the PB. net network) and the German Federal Ministry of Education and Research (project GLUES) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Agoston MK, 2005, COMPUTER GRAPHICS GE, V1, P301; Andrade RFS, 2008, PHYS LETT A, V372, P5265, DOI 10.1016/j.physleta.2008.06.044; Bachner S, 2008, METEOROL Z, V17, P407, DOI 10.1127/0941-2948/2008/0300; Bagnoli M, 2005, ECON THEOR, V26, P445, DOI 10.1007/s00199-004-0514-4; Baldauf M, 2011, MON WEATHER REV, V139, P3887, DOI 10.1175/MWR-D-10-05013.1; Barnett L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056115; Bechtold P, 2008, Q J ROY METEOR SOC, V134, P1337, DOI 10.1002/qj.289; Bechtold P, 2014, J ATMOS SCI, V71, P734, DOI 10.1175/JAS-D-13-0163.1; Berkopec A, 2007, J DISCRET ALGORITHMS, V5, P341, DOI 10.1016/j.jda.2006.01.001; Blondel VD, 2004, SIAM REV, V46, P647, DOI 10.1137/S0036144502415960; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boers N, 2013, GEOPHYS RES LETT, V40, P4386, DOI 10.1002/grl.50681; Braconnot P, 2007, CLIM DYNAM, V29, P501, DOI 10.1007/s00382-007-0244-y; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carvalho LMV, 2004, J CLIMATE, V17, P88, DOI 10.1175/1520-0442(2004)017<0088:TSACZI>2.0.CO;2; Castro CL, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004721; Dai A, 2006, J CLIMATE, V19, P4605, DOI 10.1175/JCLI3884.1; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Doms G., 2013, DESCRIPTION NONHYDRO, DOI [10.5676/DWD_pub/nwv/cosmo-doc_5.00_II, DOI 10.5676/DWD_PUB/NWV/COSMO-DOC_5.00_II]; Donges JF, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48007; Donges JF, 2009, EUR PHYS J-SPEC TOP, V174, P157, DOI 10.1140/epjst/e2009-01098-2; Erbach-Schoenberg EZ, 2014, SOC SCI COMPUT REV, V32, P373, DOI 10.1177/0894439313511934; Feldhoff JH, 2014, CLIM DYN IN PRESS; FIELLER EC, 1957, BIOMETRIKA, V44, P470, DOI 10.2307/2332878; FIELLER EC, 1961, BIOMETRIKA, V48, P29, DOI 10.1093/biomet/48.1-2.29; Fisher R, 1921, METRON, V1, P1, DOI DOI 10.1093/BIOMET/9.1-2.22; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fountalis I, 2014, CLIM DYNAM, V42, P879, DOI 10.1007/s00382-013-1729-5; Giorgi F., 2009, Bulletin - World Meteorological Organization, V58, P175; Graham R.L., 1989, CONCRETE MATH FDN CO; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hartman D, 2011, CHAOS, V21, DOI 10.1063/1.3553181; Heitzig J, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20678-7; Ho Joshua W K, 2011, Biophys Rev, V3, P1, DOI 10.1007/s12551-010-0041-4; HORMANN W, 1994, COMPUTING, V52, P89, DOI 10.1007/BF02243398; Huff F. A., 1969, J APPL METEOROL CLIM, V8, P542, DOI [10.1175/1520-0450(1969)008%3C0542:SCOSMA%3E2.0.CO;2, DOI 10.1175/1520-0450(1969)008<0542:SCOSMA>2.0.CO;2, 10.1175/1520-0450(1969)0082.0.CO;2, DOI 10.1175/1520-0450(1969)0082.0.CO;2]; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [10.5169/seals.266450, DOI 10.5169/SEALS.266450, DOI 10.5169/SEALS-266450]; Jones C, 2002, J CLIMATE, V15, P905, DOI 10.1175/1520-0442(2002)015&lt;0905:AABPIT&gt;2.0.CO;2; Jones PW, 1999, MON WEATHER REV, V127, P2204, DOI 10.1175/1520-0493(1999)127<2204:FASOCR>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kendall MG, 1945, BIOMETRIKA, V33, P239, DOI 10.2307/2332303; Koutra D., 2013, P 2013 SIAM INT C DA, P162, DOI DOI 10.1137/1.9781611972832.18; Lange S, 2014, CLIM DYN IN PRESS; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Levermann A, 2014, NATURE, V506, P27, DOI 10.1038/506027a; Lorrain F., 1971, J MATH SOCIOL, V1, P49, DOI [10.1080/0022250X.1971.9989788, DOI 10.1080/0022250X.1971.9989788, 10.1080/0022250x.1971.9989788]; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Ludescher J, 2013, P NATL ACAD SCI USA, V110, P11742, DOI 10.1073/pnas.1309353110; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Malik N, 2012, CLIM DYNAM, V39, P971, DOI 10.1007/s00382-011-1156-4; Marengo JA, 2012, INT J CLIMATOL, V32, P1, DOI 10.1002/joc.2254; Marshall GJ, 2002, J CLIMATE, V15, P659, DOI 10.1175/1520-0442(2002)015<0659:TIAGHA>2.0.CO;2; MURPHY AH, 1993, WEATHER FORECAST, V8, P281, DOI 10.1175/1520-0434(1993)008<0281:WIAGFA>2.0.CO;2; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nikulin G, 2012, J CLIMATE, V25, P6057, DOI 10.1175/JCLI-D-11-00375.1; NoguesPaegle J, 1997, MON WEATHER REV, V125, P279, DOI 10.1175/1520-0493(1997)125<0279:AWADCO>2.0.CO;2; Orlowsky B, 2008, THEOR APPL CLIMATOL, V92, P209, DOI 10.1007/s00704-007-0352-y; Papadimitriou P, 2010, J INTERNET SERV APPL, V1, P19, DOI 10.1007/s13174-010-0003-x; Petkovsek M, 1996, A B; Quiroga RQ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041904; Radebach A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052807; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rheinwalt A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/28002; Rockel B, 2008, METEOROL Z, V17, P347, DOI 10.1127/0941-2948/2008/0309; Rockel B, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009461; Salton G., 1989, AUTOMATIC TEXT PROCE, VVolume 169; Scott LS, 2007, CURR DIR PSYCHOL SCI, V16, P197, DOI 10.1111/j.1467-8721.2007.00503.x; Simpson SL, 2013, STAT SURV, V7, P1, DOI 10.1214/13-SS103; Smiatek G, 2008, METEOROL Z, V17, P395, DOI 10.1127/0941-2948/2008/0302; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Steinhaeuser K, 2014, CLIM DYNAM, V42, P1665, DOI 10.1007/s00382-013-1761-5; THIEBAUX HJ, 1984, J CLIM APPL METEOROL, V23, P800, DOI 10.1175/1520-0450(1984)023<0800:TIAEOE>2.0.CO;2; Trenberth KE, 2001, J CLIMATE, V14, P1499, DOI 10.1175/1520-0442(2001)014<1499:QORITT>2.0.CO;2; Tsonis AA, 2004, PHYSICA A, V333, P497, DOI 10.1016/j.physa.2003.10.045; Tsonis AA, 2006, B AM METEOROL SOC, V87, P585, DOI 10.1175/BAMS-87-5-585; Vera C, 2006, J CLIMATE, V19, P4977, DOI 10.1175/JCLI3896.1; Vertes PE, 2012, P NATL ACAD SCI USA, V109, P5868, DOI 10.1073/pnas.1111738109; Ward E, 2011, ADV WATER RESOUR, V34, P1222, DOI 10.1016/j.advwatres.2011.05.007; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Werner PC, 1997, CLIMATE RES, V8, P171, DOI 10.3354/cr008171; Woolley-Meza O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069829; Zager LA, 2008, APPL MATH LETT, V21, P86, DOI 10.1016/j.aml.2007.01.006; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103; Zhou JY, 1998, J CLIMATE, V11, P1020, DOI 10.1175/1520-0442(1998)011<1020:DAMCEO>2.0.CO;2	93	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0118088	10.1371/journal.pone.0118088	http://dx.doi.org/10.1371/journal.pone.0118088			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856374	Green Published, gold			2022-12-27	WOS:000352588500003
J	Lau, YM; Cheung, TH; Yeo, WN; Mo, F; Yu, MY; Lee, KM; Ho, WCS; Yeung, ACM; Law, PTY; Chan, PKS				Lau, Yat Ming; Cheung, Tak Hong; Yeo, Winnie; Mo, Frankie; Yu, Mei Yung; Lee, Kun Min; Ho, Wendy C. S.; Yeung, Apple C. M.; Law, Priscilla T. Y.; Chan, Paul K. S.			Prognostic Implication of Human Papillomavirus Types and Species in Cervical Cancer Patients Undergoing Primary Treatment	PLOS ONE			English	Article							RISK HPV INFECTION; SOUTHERN CHINESE; RADICAL SURGERY; NEOPLASIA; CARCINOMA; ASSOCIATION; GENOTYPE; CLASSIFICATION; METAANALYSIS; POPULATION	High-risk human papillomavirus (HPV) types are associated with cervical cancer. It is well established that individual HPV types vary in oncogenicity, but current data on their prognostic implication remain controversial. We examined the association between HPV types/species and the survival of 236 Chinese women aged 26-87 (mean 54.4) years after receiving primary treatment for cervical cancer. Overall, 45.8% were of FIGO stage I, 41.9% stage II, and 12.3% stage III. The four most prevalent types found were HPV-16 (60.2%), HPV-18 (21.6%), HPV-52 (11.9%), and HPV-58 (9.3%). Overall, 19.5% of patients had multiple-type infections, 78.4% harboured one or more alpha-9 species, and 28.8% harboured one or more alpha-7 species. After a median follow-up of 8.0 years, 156 (66.1%) patients survived. The 3-year overall survival rate was 75.5%. Factors independently associated with a poorer 3-year overall survival were age >60 years, tumour size >4 cm, lymph node involvement and treatment with radiotherapy+/-chemotherapy. Univariate analysis showed HPV-16 single-type infection was associated with a marginally poorer disease-specific survival (71.6% vs. 87.0%, HR: 1.71, 95% CI = 1.01-2.90), whereas non-HPV-16 alpha-9 species was associated with a better disease-specific survival (90.0% vs. 76.2%, HR: 0.36, 95% CI = 0.16-0.79). However, on multivariate analysis, HPV infection status irrespective of different grouping methods, including individual types, species, single-type or co-infection, did not carry any significant prognostic significance. In conclusion, we did not observe anyassociation between infection with a particular HPV type/species and survival. An HPV type-based stratification in treatment and follow-up plan could not be recommended.	[Lau, Yat Ming] United Christian Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China; [Cheung, Tak Hong] Chinese Univ Hong Kong, Fac Med, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Yeo, Winnie; Mo, Frankie] Chinese Univ Hong Kong, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China; [Yeo, Winnie; Mo, Frankie] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China; [Yeo, Winnie; Mo, Frankie] Chinese Univ Hong Kong, Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Yeo, Winnie; Mo, Frankie] Chinese Univ Hong Kong, Hong Kong Canc Inst, Hong Kong, Hong Kong, Peoples R China; [Yeo, Winnie; Mo, Frankie] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Yu, Mei Yung] Chinese Univ Hong Kong, Fac Med, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Ho, Wendy C. S.; Yeung, Apple C. M.; Law, Priscilla T. Y.; Chan, Paul K. S.] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	United Christian Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong	Chan, PKS (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk	Mo, Frankie/AAG-8079-2021; Chan, Paul KS/J-9360-2013; Yeo, Winnie/R-4792-2018; Mo, Frankie/AAC-9230-2022; Lau, Yat-Ming/ABE-3515-2020	Chan, Paul KS/0000-0002-6360-4608; Yeo, Winnie/0000-0002-0863-8469; Mo, Frankie/0000-0002-0566-3212; Lau, Yat-Ming/0000-0002-9888-0207	GlaxoSmithKline; F. Hoffmann-La Roche	GlaxoSmithKline(GlaxoSmithKline); F. Hoffmann-La Roche(Hoffmann-La Roche)	The authors have read the journal's policy and they have the following competing interests: Paul K. S. Chan is participating in clinical trials supported by GlaxoSmithKline and F. Hoffmann-La Roche, and has received honoraria as advisory board member, and travel support to attend academic conferences from GlaxoSmithKline. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Briolat J, 2007, INT J CANCER, V121, P2198, DOI 10.1002/ijc.22959; Burger RA, 1996, JNCI-J NATL CANCER I, V88, P1361, DOI 10.1093/jnci/88.19.1361; Zampronha RDC, 2013, CLINICS, V68, P809, DOI 10.6061/clinics/2013(06)14; Chan DPC, 2005, J INFECT DIS, V192, P1749, DOI 10.1086/497342; Chan PKS, 2007, J MED VIROL, V79, P970, DOI 10.1002/jmv.20805; Chan PKS, 2007, GYNECOL ONCOL, V105, P736, DOI 10.1016/j.ygyno.2007.02.013; Chan PKS, 2012, INT J CANCER, V131, P692, DOI 10.1002/ijc.26404; Chan PKS, 2009, INT J CANCER, V125, P1671, DOI 10.1002/ijc.24495; Chan PKS, 2006, INT J CANCER, V118, P1430, DOI 10.1002/ijc.21528; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Cogliano V, 2005, LANCET ONCOL, V6, P204, DOI 10.1016/S1470-2045(05)70086-3; de Cremoux P, 2009, INT J CANCER, V124, P778, DOI 10.1002/ijc.24075; de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; EIFEL PJ, 1995, GYNECOL ONCOL, V59, P38, DOI 10.1006/gyno.1995.1265; Fauquet CM, 2005, VIRUS TAXONOMY CLASS; Huang LW, 2004, CANCER-AM CANCER SOC, V100, P327, DOI 10.1002/cncr.20003; IKENBERG H, 1994, INT J CANCER, V59, P322, DOI 10.1002/ijc.2910590306; International Agency for Research on Cancer, GLOBOCAN 2012 EST CA; Lai CH, 2007, J CLIN ONCOL, V25, P3628, DOI 10.1200/JCO.2007.11.2995; Lai HC, 1999, INT J CANCER, V84, P553, DOI 10.1002/(SICI)1097-0215(19991222)84:6&lt;553::AID-IJC2&gt;3.0.CO;2-4; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Li Y, 2013, J VIROL, V87, P9313, DOI 10.1128/JVI.01154-13; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Pilch H, 2001, INT J GYNECOL CANCER, V11, P39, DOI 10.1046/j.1525-1438.2001.011001039.x; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schwartz SM, 2001, J CLIN ONCOL, V19, P1906, DOI 10.1200/JCO.2001.19.7.1906; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Tong SY, 2007, INT J GYNECOL CANCER, V17, P1307, DOI 10.1111/j.1525-1438.2007.00933.x; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129; Wang CC, 2010, INT J RADIAT ONCOL, V78, P1111, DOI 10.1016/j.ijrobp.2009.09.021; Wright JD, 2005, GYNECOL ONCOL, V98, P84, DOI 10.1016/j.ygyno.2005.03.038; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	35	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122557	10.1371/journal.pone.0122557	http://dx.doi.org/10.1371/journal.pone.0122557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855986	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500041
J	Pascoal-Xavier, MA; Figueiredo, ACC; Gomes, LI; Peruhype-Magalhaes, V; Calzavara-Silva, CE; Costa, MA; Reis, IA; Bonjardim, CA; Kroon, EG; de Oliveira, JG; Ferreira, PCP				Pascoal-Xavier, Marcelo Antonio; Cancado Figueiredo, Anna Carolina; Gomes, Luciana Inacia; Peruhype-Magalhaes, Vanessa; Calzavara-Silva, Carlos Eduardo; Costa, Marcelo Azevedo; Reis, Ilka Afonso; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; de Oliveira, Jaquelline G.; Peregrino Ferreira, Paulo Cesar			RAP1 GTPase Overexpression is Associated with Cervical Intraepithelial Neoplasia	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; G-PROTEINS; EXPRESSION; CANCER; BRD4; RAS; TUMORIGENESIS; P16(INK4A); ACTIVATION	RAP1 (RAS proximate 1), a small GTP-binding protein of the RAS superfamily, is a putative oncogene that is highly expressed in several malignant cell lines and types of cancers, including some types of squamous cell carcinoma. However, the participation of RAP1 in cervical carcinogenesis is unknown. We conducted a cross-sectional study of paraffin-embedded cervical biopsies to determine the association of RAP1 with cervical intraepithelial neoplasia (CIN). Standard and quantitative immunohistochemistry assessment of RAP1 expression in fixed tissue was performed on 183 paraffin-embedded cervical biopsies that were classified as normal or non-dysplastic mucosa (NDM) (n = 33); CIN grade 1 (n = 84) and CIN grade 2/3 (n = 66). A gradual increase in RAP1 expression in NDM < CIN 1 < CIN 2/3 (p<0.001) specimens was observed and was in agreement with the histopathologic diagnosis. A progressive increase in the RAP1 expression levels increased the risk of CIN 1 [ odds ratio (OR) = 3.50; 95% confidence interval (CI) 1.30-10.64] 3.5 fold and the risk of CIN 2/3 (OR=19.86, 95% CI 6.40-70.79) nearly 20 fold when compared to NDM. In addition, stereotype ordinal regression analysis showed that this progressive increase in RAP1 expression more strongly impacted CIN 2/3 than CIN 1. Our findings suggest that RAP1 may be a useful biomarker for the diagnosis of CIN.	[Pascoal-Xavier, Marcelo Antonio; Bonjardim, Claudio Antonio; Kroon, Erna Geessien; Peregrino Ferreira, Paulo Cesar] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Cancado Figueiredo, Anna Carolina; Gomes, Luciana Inacia; Peruhype-Magalhaes, Vanessa; Calzavara-Silva, Carlos Eduardo; de Oliveira, Jaquelline G.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Costa, Marcelo Azevedo] Univ Fed Minas Gerais, Escola Engn, Dept Engn Prod, Belo Horizonte, MG, Brazil; [Reis, Ilka Afonso] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Estat, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	de Oliveira, JG (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	jaque@cpqrr.fiocruz.br	Reis, Ilka Afonso/AAG-8007-2019; Calzavara-Silva, Carlos/ABF-2829-2021; Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019; De Oliveira, Jaquelline/ABE-3725-2021; Reis, Ilka Afonso/AAO-5375-2021	Calzavara-Silva, Carlos/0000-0002-1406-6401; Kroon, Erna Geessien/0000-0003-2721-3826; Reis, Ilka Afonso/0000-0001-7199-8590; Costa, Marcelo/0000-0002-2330-5056	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This research was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-www.cnpq.br), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - www.capes.gov.br), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG - www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu Mery Natali Silva, 2008, Cad. Saúde Pública, V24, ps581, DOI 10.1590/S0102-311X2008001600010; Ahn J, 2009, STAT MED, V28, P3139, DOI 10.1002/sim.3693; ANDERSON JA, 1984, J R STAT SOC B, V46, P1; Banerjee Rajat, 2012, Small GTPases, V3, P192, DOI 10.4161/sgtp.20413; Banerjee R, 2011, CELL SIGNAL, V23, P1110, DOI 10.1016/j.cellsig.2011.02.002; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Chakrabarti O, 2004, J VIROL, V78, P5934, DOI 10.1128/JVI.78.11.5934-5945.2004; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Furstenau DK, 2011, BREAST CANCER RES TR, V129, P361, DOI 10.1007/s10549-010-1227-y; Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Gao QS, 1999, MOL CELL BIOL, V19, P733; Gloerich M, 2011, TRENDS CELL BIOL, V21, P615, DOI 10.1016/j.tcb.2011.07.001; Tiburcio MGS, 2014, EUR J GYNAECOL ONCOL, V35, P284; Goto M, 2010, CLIN CANCER RES, V16, P65, DOI 10.1158/1078-0432.CCR-09-1122; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007; Husnjak K, 2000, J VIROL METHODS, V88, P125, DOI 10.1016/S0166-0934(00)00194-4; Kim WJ, 2012, CANCER LETT, V320, P65, DOI 10.1016/j.canlet.2012.01.022; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Lafuente EM, 2007, LEUKEMIA LYMPHOMA, V48, P987, DOI 10.1080/10428190701242341; Lobato S, 2012, J GYNECOL ONCOL, V23, P11, DOI 10.3802/jgo.2012.23.1.11; Mazibrada J, 2008, GYNECOL ONCOL, V108, P112, DOI 10.1016/j.ygyno.2007.08.095; McBride AA, 2004, TRENDS MICROBIOL, V12, P527, DOI 10.1016/j.tim.2004.10.002; McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06; Mendoza-Catalan MA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-116; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Nellore A, 2009, J CLIN ENDOCR METAB, V94, P1026, DOI 10.1210/jc.2008-1042; Nonogaki Suely, 2005, J Low Genit Tract Dis, V9, P219, DOI 10.1097/01.lgt.0000179861.67574.6b; Portari EA, 2013, INT J GYNECOL PATHOL, V32, P501, DOI 10.1097/PGP.0b013e31826f5cf6; Schmid MC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060226, 10.1371/journal.pone.0061623]; Singh L, 2003, J VIROL, V77, P1614, DOI 10.1128/JVI.77.2.1614-1620.2003; Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005; von Knebel Doeberitz M, 2012, EXPERT REV PROTEOMIC, V9, P149, DOI [10.1586/epr.12.13, DOI 10.1586/EPR.12.13]; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123531	10.1371/journal.pone.0123531	http://dx.doi.org/10.1371/journal.pone.0123531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856570	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500096
J	Xia, WJ; Chen, WZ; Zhang, ZG; Wu, D; Wu, P; Chen, ZG; Li, C; Huang, J				Xia, Wenjie; Chen, Wuzhen; Zhang, Zhigang; Wu, Dang; Wu, Pin; Chen, Zhigang; Li, Chao; Huang, Jian			Prognostic Value, Clinicopathologic Features and Diagnostic Accuracy of Interleukin-8 in Colorectal Cancer: A Meta-Analysis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CLINICAL-SIGNIFICANCE; CXC-CHEMOKINES; PROGRESSION; ANGIOGENESIS; EXPRESSION; BIOMARKERS; CARCINOMA; INFLAMMATION; ASSOCIATION	Background The prognostic value and diagnostic accuracy of Interleukin-8 (IL-8) in colorectal cancer have been assessed with several studies, but the conclusions were inconclusive. Thus we performed a meta-analysis to evaluate the impact of IL-8 expression on colorectal cancer prognosis, clinicopathologic features and diagnostic accuracy. Methods Comprehensive search strategies were used to search relevant literature in the PubMed, EBSCO and the ISI Web of Science databases. The correlation between IL-8 expression and prognosis, clinicopathologic features and diagnostic accuracy was analyzed. Results A total of 18 articles met the inclusion criteria, including 1509 patients for clinicopathologic features or prognosis evaluation and 725 participants for diagnostic evaluation. The results suggested that overexpression of IL-8 was significantly associated with poor prognosis in colorectal cancer (HR = 1.54, 95%CI 1.03-2.32), especially in Union for International Cancer Control (UICC) stage IV patients (HR = 2.28, 95%CI 1.60-3.25). With further subgroup analysis, we found that high IL-8 level in serum was significantly correlated with poor prognosis (HR = 2.13, 95%CI 1.49-3.05). In addition, significant correlations were observed between high IL-8 expression and advanced stage (OR = 3.01, 95%CI 1.98-4.56), lymphatic metastasis (OR = 2.24, 95%CI 1.39-3.63), and liver metastasis (OR = 3.47, 95%CI 1.74-6.89). Moreover, IL-8 had high diagnostic accuracy, with pooled sensitivity 0.70(95%CI 0.66-0.74), specificity 0.91(95%CI 0.86-0.94), positive likelihood ratio (LR) 7.00(95%CI 2.48-19.73), negative LR 0.24(95%CI 0.09-0.64), diagnostic OR 24.00(95%CI 5.52-104.38). Conclusions This study showed that IL-8 could be a potential indicator for detecting colorectal cancer and predicting prognosis. In addition, high IL-8 level was significantly correlated with advanced stage, lymphatic metastasis, liver metastasis.	[Xia, Wenjie; Chen, Wuzhen; Zhang, Zhigang; Wu, Dang; Wu, Pin; Chen, Zhigang; Li, Chao; Huang, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Wenjie; Chen, Wuzhen; Zhang, Zhigang; Wu, Dang; Wu, Pin; Chen, Zhigang; Huang, Jian] Zhejiang Univ, Prov Key Lab Mol Biol Med Sci, Key Lab Canc Prevent & Intervent, Canc Inst,Natl Minist Educ,Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Huang, J (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	drhuangjian@zju.edu.cn	Chen, Wuzhen/ABA-4680-2020	Chen, Wuzhen/0000-0003-0210-6645; Huang, Jian/0000-0003-3340-5007	National Natural Science Foundation of China [81272672]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This work was supported by the National Natural Science Foundation of China (NO. 81272672) (www.nsfc.gov.cn), and the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (HJ) (http://www.zjwst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atta-ur-Rahman, 1999, CURR PHARM DESIGN, V5, P241; Bailey C, 2007, CLIN EXP METASTAS, V24, P121, DOI 10.1007/s10585-007-9060-3; Bruhn MA, 2014, INT J CANCER, V135, P731, DOI 10.1002/ijc.28698; Bunger S, 2013, BIOPRESERV BIOBANK, V11, P379, DOI 10.1089/bio.2013.0050; Chen ZY, 2014, INT J CANC J INT CAN; Cheng XS, 2014, CANCER LETT, V348, P77, DOI 10.1016/j.canlet.2014.03.008; Connell W, 2004, AM J GASTROENTEROL, V99, P1631, DOI 10.1111/j.1572-0241.2004.40829.x; Doll D, 2010, INT J COLORECTAL DIS, V25, P573, DOI 10.1007/s00384-010-0901-1; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FINLAY IG, 1986, BRIT J SURG, V73, P732, DOI 10.1002/bjs.1800730918; Gales Dominique, 2013, ISRN Oncol, V2013, P859154, DOI 10.1155/2013/859154; Hamilton TD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-542; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu LX, 2012, ASIAN PAC J CANCER P, V13, P5075, DOI 10.7314/APJCP.2012.13.10.5075; Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jin WJ, 2014, WORLD J GASTROENTERO, V20, P16334, DOI 10.3748/wjg.v20.i43.16334; Kaminska J, 2005, TUMOR BIOL, V26, P186, DOI 10.1159/000086951; Kantola T, 2012, BRIT J CANCER, V107, P1729, DOI 10.1038/bjc.2012.456; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Liu YM, 2013, CANCER MED-US, V2, P234, DOI 10.1002/cam4.71; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; Masuya D, 2001, CANCER, V92, P2628, DOI 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F; Oladipo O, 2011, BRIT J CANCER, V104, P480, DOI 10.1038/sj.bjc.6606055; Palena C, 2012, FUTURE ONCOL, V8, P713, DOI [10.2217/FON.12.59, 10.2217/fon.12.59]; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Poon RTP, 2003, ANN SURG, V238, P9, DOI 10.1097/01.sla.0000075047.47175.35; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Sgourakis G, 2014, TUMOR BIOL, V35, P5993, DOI 10.1007/s13277-014-1794-3; Shimazaki J, 2013, ONCOLOGY-BASEL, V84, P356, DOI 10.1159/000350836; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Terada H, 2005, EUR SURG RES, V37, P166, DOI 10.1159/000085964; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; UEDA T, 1994, J GASTROENTEROL, V29, P423, DOI 10.1007/BF02361238; Vallbohmer D, 2005, J CLIN ONCOL, V23, P3536, DOI 10.1200/jco.2005.23.16_suppl.3536; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Yan Z, 2012, ONCOL REP, V28, P1036, DOI 10.3892/or.2012.1891; YOSHIMURA T, 1987, J IMMUNOL, V139, P788; Zhang PJ, 2013, FUTURE ONCOL, V9, P1017, DOI [10.2217/FON.13.71, 10.2217/fon.13.71]	43	32	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123484	10.1371/journal.pone.0123484	http://dx.doi.org/10.1371/journal.pone.0123484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856316	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500092
J	Yu, XY; Zhang, DD; Shi, BS; Ren, GX; Peng, XH; Fang, Z; Kozlowski, M; Zhou, XH; Zhang, XN; Wu, M; Wang, C; Yuan, ZH				Yu, Xiaoyu; Zhang, Dandan; Shi, Bisheng; Ren, Guangxu; Peng, Xiuhua; Fang, Zhong; Kozlowski, Maya; Zhou, Xiaohui; Zhang, Xiaonan; Wu, Min; Wang, Cong; Yuan, Zhenghong			Oral Administered Particulate Yeast-Derived Glucan Promotes Hepatitis B Virus Clearance in a Hydrodynamic Injection Mouse Model	PLOS ONE			English	Article							BIOLOGICAL RESPONSE MODIFIERS; BETA-GLUCANS; IMMUNE-RESPONSES; DENDRITIC CELLS; HBV INFECTION; RECEPTOR; DECTIN-1; CANCER; LIVER; DISCOVERY	Hepatitis B virus (HBV) persistent infection is associated with ineffective immune response for the clearance of virus. Immunomodulators represent an important class of therapeutics, which potentially could be beneficial for the treatment of HBV infection. The particulate yeast-derived glucan (PYDG) has been shown to enhance the innate and adaptive immune responses. We therefore, assessed the efficacy of PYDG in enhancing HBV specific immune responses by employing the hydrodynamic injection-based (HDI) HBV transfection mouse model. Mice were intragatric administered PYDG daily for 9 weeks post pAAV/HBV1.2 hydrodynamic injection. PYDG treatment significantly promoted HBV DNA clearance and production of HBsAb compared to control mice. PYDG treatment resulted in recruitment of macrophages, dendritic cells (DCs) and effector T cells to the liver microenvironment, accompanied by a significantly augmented DCs maturation and HBV-specific IFN-gamma and TNF-alpha production by T cell. In addition, enhanced production of Th1 cytokines in liver tissue interstitial fluid (TIF) was associated with PYDG administration. Live imaging showed the accumulation of PYDG in the mouse liver. Our results demonstrate that PYDG treatment significantly enhances HBV-specific Th1 immune responses, accompanied by clearance of HBV DNA, and therefore holds promise for further development of therapeutics against chronic hepatitis B.	[Yu, Xiaoyu; Zhang, Dandan; Peng, Xiuhua; Zhou, Xiaohui; Zhang, Xiaonan; Wu, Min; Wang, Cong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Yu, Xiaoyu; Shi, Bisheng; Ren, Guangxu; Fang, Zhong; Yuan, Zhenghong] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Kozlowski, Maya] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	Fudan University; Fudan University; University of Ottawa	Yuan, ZH (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.	zhyuan@shaphc.org		Zhang, Xiaonan/0000-0002-1286-7280; Ren, Guangxu/0000-0003-2378-260X	National Program on Key Basic Research Project of China [2012CB519005]; National Natural Science Foundation of China [81101242]	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Program on Key Basic Research Project of China (2012CB519005) and National Natural Science Foundation of China (81101242).	Albeituni SH, 2013, ANTI-CANCER AGENT ME, V13, P689, DOI 10.2174/1871520611313050003; Bauer T, 2011, DIGEST DIS, V29, P423, DOI 10.1159/000329809; Bertoletti A, 2013, POSTGRAD MED J, V89, P294, DOI 10.1136/postgradmedj-2011-301073rep; Bian GL, 2009, VACCINE, V28, P187, DOI 10.1016/j.vaccine.2009.09.101; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Chen Z, 2008, CLIN IMMUNOL, V128, P400, DOI 10.1016/j.clim.2008.04.006; Ferwerda G, 2008, CELL MICROBIOL, V10, P2058, DOI 10.1111/j.1462-5822.2008.01188.x; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Hong F, 2004, J IMMUNOL, V173, P797, DOI 10.4049/jimmunol.173.2.797; Huang LR, 2006, P NATL ACAD SCI USA, V103, P17862, DOI 10.1073/pnas.0608578103; Komai-Koma M, 2004, P NATL ACAD SCI USA, V101, P3029, DOI 10.1073/pnas.0400171101; Kulka ACaM, 2010, RECENT PATENTS ENDOC, P175; Lanford RE, 2013, GASTROENTEROLOGY, V144, P1508, DOI 10.1053/j.gastro.2013.02.003; Li B, 2010, CLIN CANCER RES, V16, P5153, DOI 10.1158/1078-0432.CCR-10-0820; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Locarnini S, 2010, ANTIVIR THER, V15, P3, DOI 10.3851/IMP1619; Luca G, 1999, SCIENCE, V284, P825; Mantovani MS, 2008, MUTAT RES-REV MUTAT, V658, P154, DOI 10.1016/j.mrrev.2007.07.002; Qi CJ, 2011, BLOOD, V117, P6825, DOI 10.1182/blood-2011-02-339812; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Schurich A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003208; Seto WK, 2014, J GASTROEN HEPATOL, V29, P1028, DOI 10.1111/jgh.12476; Sun W, 2010, J PROTEOME RES, V9, P1020, DOI 10.1021/pr9009172; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Vetvicka V, 2011, WORLD J CLIN ONCOL, V2, P115, DOI 10.5306/wjco.v2.i2.115; WILTROUT RH, 1984, J EXP MED, V160, P1431, DOI 10.1084/jem.160.5.1431; Wursthorn K, 2010, GUT, V59, P1430, DOI 10.1136/gut.2009.195834; Zhang XY, 2012, J HEPATOL, V57, P522, DOI 10.1016/j.jhep.2012.05.004	30	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123559	10.1371/journal.pone.0123559	http://dx.doi.org/10.1371/journal.pone.0123559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856080	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500098
J	Ayala, DC; Morin, D; Buckpitt, AR				Ayala, Daniel C.; Morin, Dexter; Buckpitt, Alan R.			Simultaneous Quantification of Multiple Urinary Naphthalene Metabolites by Liquid Chromatography Tandem Mass Spectrometry	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; AFLATOXIN BIOMARKERS; EXPOSURE; STEREOSELECTIVITY; NAPHTHOLS; NASAL; OXIDE; LUNG; AIR	Naphthalene is an environmental toxicant to which humans are exposed. Naphthalene causes dose-dependent cytotoxicity to murine airway epithelial cells but a link between exposure and human pulmonary disease has not been established. Naphthalene toxicity in rodents depends on P450 metabolism. Subsequent biotransformation results in urinary elimination of several conjugated metabolites. Glucuronide and sulfate conjugates of naphthols have been used as markers of naphthalene exposure but, as the current studies demonstrate, these assays provide a limited view of the range of metabolites generated from the parent hydrocarbon. Here, we present a liquid chromatography tandem mass spectrometry method for measurement of the glucuronide and sulfate conjugates of 1-naphthol as well as the mercapturic acids and N-acetyl glutathione conjugates from naphthalene epoxide. Standard curves were linear over 2 log orders. On column detection limits varied from 0.91 to 3.4 ng; limits of quantitation from 1.8 to 6.4 ng. The accuracy of measurement of spiked urine standards was -13.1 to + 5.2% of target and intra-day and inter-day variability averaged 7.2 (+/- 4.5) and 6.8 (+/- 5.0) %, respectively. Application of the method to urine collected from mice exposed to naphthalene at 15 ppm (4 hrs) showed that glutathione-derived metabolites accounted for 60-70% of the total measured metabolites and sulfate and glucuronide conjugates were eliminated in equal amounts. The method is robust and directly measures several major naphthalene metabolites including those derived from glutathione conjugation of naphthalene epoxide. The assays do not require enzymatic deconjugation, extraction or derivatization thus simplifying sample work up.	[Ayala, Daniel C.; Morin, Dexter; Buckpitt, Alan R.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Ayala, Daniel C.] Univ Calif Davis, Grad Program, Forens Sci, Davis, CA 95618 USA	University of California System; University of California Davis; University of California System; University of California Davis	Buckpitt, AR (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	arbuckpitt@ucdavis.edu			NIEHS Superfund Basic Science Research Program [P42 04699]	NIEHS Superfund Basic Science Research Program	These studies were supported by the NIEHS Superfund Basic Science Research Program P42 04699. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolucci G, 2000, RAPID COMMUN MASS SP, V14, P967, DOI 10.1002/(SICI)1097-0231(20000615)14:11<967::AID-RCM973>3.0.CO;2-C; Bernabei M, 2003, J CHROMATOGR A, V985, P197, DOI 10.1016/S0021-9673(02)01826-5; Bieniek G, 1997, SCAND J WORK ENV HEA, V23, P414, DOI 10.5271/sjweh.263; Bieniek G, 1998, AM J IND MED, V34, P445, DOI 10.1002/(SICI)1097-0274(199811)34:5<445::AID-AJIM5>3.0.CO;2-P; BOYLAND E, 1958, BIOCHEM J, V68, P440, DOI 10.1042/bj0680440; BUCKPITT A, 1992, J PHARMACOL EXP THER, V261, P364; Buckpitt A, 2002, DRUG METAB REV, V34, P791, DOI 10.1081/DMR-120015694; Buckpitt A, 2013, TOXICOL APPL PHARM, V270, P97, DOI 10.1016/j.taap.2013.04.006; BUCKPITT AR, 1986, TOXICOLOGY, V41, P333, DOI 10.1016/0300-483X(86)90186-1; Chao YCE, 2006, ENVIRON HEALTH PERSP, V114, P182, DOI 10.1289/ehp.8288; Cho TM, 2006, DRUG METAB DISPOS, V34, P176, DOI 10.1124/dmd.105.005785; DOROUGH HW, 1964, J AGR FOOD CHEM, V12, P294, DOI 10.1021/jf60134a001; HORNING MG, 1980, DRUG METAB DISPOS, V8, P404; Jerrett M, 2008, ENVIRON HEALTH PERSP, V116, P1433, DOI 10.1289/ehp.10968; Kitteringham NR, 1996, J PHARMACOL EXP THER, V278, P1018; Li Z, 2008, ENVIRON RES, V107, P320, DOI 10.1016/j.envres.2008.01.013; Li Z, 2006, ANAL CHEM, V78, P5744, DOI 10.1021/ac0606094; Pakenham G, 2002, DRUG METAB DISPOS, V30, P247, DOI 10.1124/dmd.30.3.247; Preuss R, 2003, INT ARCH OCC ENV HEA, V76, P556, DOI 10.1007/s00420-003-0458-1; ROZMAN K, 1982, DRUG CHEM TOXICOL, V5, P265, DOI 10.3109/01480548209041057; Scinicariello F, 2014, ENVIRON HEALTH PERSP, V122, P299, DOI 10.1289/ehp.1307234; Serdar B, 2003, ENVIRON HEALTH PERSP, V111, P1760, DOI 10.1289/ehp.6275; Sobus JR, 2009, ANN OCCUP HYG, V53, P551, DOI 10.1093/annhyg/mep041; Tang LL, 2008, CARCINOGENESIS, V29, P411, DOI 10.1093/carcin/bgn008; TSURUDA LS, 1995, DRUG METAB DISPOS, V23, P129; Van Eeckhaut A, 2009, J CHROMATOGR B, V877, P2198, DOI 10.1016/j.jchromb.2009.01.003; Walton M, 2001, CHEM RES TOXICOL, V14, P919, DOI 10.1021/tx010063a; WARREN DL, 1982, CHEM-BIOL INTERACT, V40, P287, DOI 10.1016/0009-2797(82)90152-1; West JAA, 2003, TOXICOL SCI, V75, P161, DOI 10.1093/toxsci/kfg156; YAGI H, 1975, J AM CHEM SOC, V97, P3185, DOI 10.1021/ja00844a044; Yuan W, 2007, CHEM RES TOXICOL, V20, P316, DOI 10.1021/tx600340c; Zielinska B, 2004, ENVIRON SCI TECHNOL, V38, P2557, DOI 10.1021/es030518d	32	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121937	10.1371/journal.pone.0121937	http://dx.doi.org/10.1371/journal.pone.0121937			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853821	Green Submitted, gold, Green Published			2022-12-27	WOS:000352478400055
J	Martini, M; Bufalari, I; Stazi, MA; Aglioti, SM				Martini, Matteo; Bufalari, Ilaria; Stazi, Maria Antonietta; Aglioti, Salvatore Maria			Is That Me or My Twin? Lack of Self-Face Recognition Advantage in Identical Twins	PLOS ONE			English	Article							ATTACHMENT STYLE; OWN FACE; RECOGNIZING FAMILIAR; ADULT ATTACHMENT; MIRROR; ACTIVATION; FASTER; BRAIN; REPRESENTATIONS; ORIENTATION	Despite the increasing interest in twin studies and the stunning amount of research on face recognition, the ability of adult identical twins to discriminate their own faces from those of their co-twins has been scarcely investigated. One's own face is the most distinctive feature of the bodily self, and people typically show a clear advantage in recognizing their own face even more than other very familiar identities. Given the very high level of resemblance of their faces, monozygotic twins represent a unique model for exploring self-face processing. Herein we examined the ability of monozygotic twins to distinguish their own face from the face of their co-twin and of a highly familiar individual. Results show that twins equally recognize their own face and their twin's face. This lack of self-face advantage was negatively predicted by how much they felt physically similar to their co-twin and by their anxious or avoidant attachment style. We speculate that in monozygotic twins, the visual representation of the self-face overlaps with that of the co-twin. Thus, to distinguish the self from the co-twin, monozygotic twins have to rely much more than control participants on the multisensory integration processes upon which the sense of bodily self is based. Moreover, in keeping with the notion that attachment style influences perception of self and significant others, we propose that the observed self/co-twin confusion may depend upon insecure attachment.	[Martini, Matteo; Bufalari, Ilaria; Aglioti, Salvatore Maria] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Martini, Matteo; Bufalari, Ilaria; Aglioti, Salvatore Maria] IRCCS Fdn Santa Lucia, I-00100 Rome, Italy; [Martini, Matteo] IDIBAPS, Barcelona 08036, Spain; [Martini, Matteo] Univ E London, Sch Psychol, London E15 4LZ, England; [Stazi, Maria Antonietta] Italian Natl Inst Hlth, Natl Twin Registry, I-00161 Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of East London; Istituto Superiore di Sanita (ISS)	Martini, M (corresponding author), Univ Roma La Sapienza, Dept Psychol, Via Marsi 78, I-00185 Rome, Italy.	matteo.martini@uniroma1.it	stazi, maria a/K-4597-2016; Aglioti, Salvatore M/E-9829-2012; Bufalari, Ilaria/J-5810-2016	Bufalari, Ilaria/0000-0001-8675-5436; Aglioti, Salvatore Maria/0000-0001-8175-7563; Martini, Matteo/0000-0002-3505-1284	Italian Ministry of Health [GR-2011-02351798, RF-2010-2312912]; EU Information and Communication Technologies [FP7-ICT-2009-5, 257695]	Italian Ministry of Health(Ministry of Health, Italy); EU Information and Communication Technologies	IB is funded by the Italian Ministry of Health (GR-2011-02351798). SMA is funded by EU Information and Communication Technologies Grant (VERE project, FP7-ICT-2009-5, Prot. Num. 257695), and by the Italian Ministry of Health (and RF-2010-2312912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Barbaranelli C, 2003, ANALISI DEI DATI TEC; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; BARTHOLOMEW K, 1990, J SOC PERS RELAT, V7, P147, DOI 10.1177/0265407590072001; Bredart S, 2006, Q J EXP PSYCHOL, V59, P46, DOI 10.1080/17470210500343678; Bredart S, 2003, PERCEPTION, V32, P805, DOI 10.1068/p3354; Breen N, 2001, NEUROCASE, V7, P239, DOI 10.1093/neucas/7.3.239; Butler DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072586; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Dan O, 2012, BIOL PSYCHOL, V91, P212, DOI 10.1016/j.biopsycho.2012.06.003; Davis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028800; de Waal FBM, 2005, P NATL ACAD SCI USA, V102, P11140, DOI 10.1073/pnas.0503935102; Devue C, 2009, COGNITION, V111, P114, DOI 10.1016/j.cognition.2009.01.003; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; FEENEY JA, 1994, HEALTH PSYCHOL, V13, P334, DOI 10.1037/0278-6133.13.4.334; FORBES CA, 1987, AUST J PSYCHOL, V39, P43, DOI 10.1080/00049538708259034; Fossati A, 2003, J SOC PERS RELAT, V20, P55, DOI 10.1177/02654075030201003; Frith CD, 2014, THE COGNITIVE NEUROP; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Irani F, 2006, SCHIZOPHR RES, V88, P151, DOI 10.1016/j.schres.2006.07.016; Kasriel J, 1976, THE ZYGOSITY OF TWIN; Keenan K, 2003, CHILD DEV, V74, P1930, DOI 10.1046/j.1467-8624.2003.00647.x; Keyes H, 2010, Q J EXP PSYCHOL, V63, P840, DOI 10.1080/17470211003611264; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; Kircher TT, 2007, SCHIZOPHR RES, V94, P264, DOI 10.1016/j.schres.2007.04.029; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; KLATZKY RL, 1984, MEM COGNITION, V12, P60, DOI 10.3758/BF03196998; Laroi Frank, 2007, Cogn Neuropsychiatry, V12, P554, DOI 10.1080/13546800701707223; Li Jingguang, 2010, Commun Integr Biol, V3, P295; Ma YN, 2010, J EXP PSYCHOL HUMAN, V36, P619, DOI 10.1037/a0015797; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Mealey L, 1999, J PERS SOC PSYCHOL, V76, P151, DOI 10.1037/0022-3514.76.1.151; Meyer B, 2004, J PERS DISORD, V18, P320, DOI 10.1521/pedi.18.4.320.40344; Miyakoshi M, 2010, NEUROIMAGE, V50, P1666, DOI 10.1016/j.neuroimage.2010.01.030; Nicole S., 1995, Acta Geneticae Medicae et Gemellologiae, V44, P107; Phillips M L, 1996, Cogn Neuropsychiatry, V1, P153, DOI 10.1080/135468096396613; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Platek SA, 2002, SCHIZOPHR RES, V57, P81, DOI 10.1016/S0920-9964(01)00310-3; Platek SM, 2006, HUM BRAIN MAPP, V27, P91, DOI 10.1002/hbm.20168; Platek SM, 2004, CONSCIOUS COGN, V13, P197, DOI 10.1016/j.concog.2003.10.001; Platek SM, 2008, BRAIN RES, V1232, P173, DOI 10.1016/j.brainres.2008.07.010; Platek SM, 2008, NEUROSCI LETT, V437, P76, DOI 10.1016/j.neulet.2008.03.040; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P849, DOI 10.1016/j.neuropsychologia.2008.12.027; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Polk TA, 2007, J NEUROSCI, V27, P13921, DOI 10.1523/JNEUROSCI.4001-07.2007; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; Robbins R, 2003, COGNITION, V88, P79, DOI 10.1016/S0010-0277(03)00020-9; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Rooney B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00066; Saether L, 2008, PERCEPTION, V37, P1227, DOI 10.1068/p5833; Saito Takako, 2005, Shinrigaku Kenkyu, V75, P517; Segal NL, 1998, PERS INDIV DIFFER, V25, P317, DOI 10.1016/S0191-8869(98)00050-6; Stein MB, 2002, ARCH GEN PSYCHIAT, V59, P1027, DOI 10.1001/archpsyc.59.11.1027; Stevenage SV, 1998, BRIT J PSYCHOL, V89, P39, DOI 10.1111/j.2044-8295.1998.tb02672.x; Strodl E, 2003, PERS RELATIONSHIP, V10, P171, DOI 10.1111/1475-6811.00044; Sugiura M, 2008, NEUROIMAGE, V42, P414, DOI 10.1016/j.neuroimage.2008.03.054; Sui J, 2006, NEUROREPORT, V17, P423, DOI 10.1097/01.wnr.0000203357.65190.61; Sui J, 2009, Q J EXP PSYCHOL, V62, P844, DOI 10.1080/17470210802559393; Tacikowski P, 2010, BIOL PSYCHOL, V84, P318, DOI 10.1016/j.biopsycho.2010.03.009; Tajadura-Jimenez A, 2012, CONSCIOUS COGN, V21, P1725, DOI 10.1016/j.concog.2012.10.004; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; Taylor MJ, 2009, HUM BRAIN MAPP, V30, P2008, DOI 10.1002/hbm.20646; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Townsend J. T., 1983, STOCHASTIC MODELING; Troje NF, 1999, PERCEPTION, V28, P483, DOI 10.1068/p2901; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; VALENTINE T, 1986, CAN J PSYCHOL, V40, P300, DOI 10.1037/h0080101; Vrticka P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002868; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; WOODWARD J, 1988, ACTA GENET MED GEMEL, V37, P173, DOI 10.1017/S0001566000004098; Yoon HW, 2005, INT J NEUROSCI, V115, P839, DOI 10.1080/00207450590882235; YOUNG AW, 1985, PERCEPTION, V14, P737, DOI 10.1068/p140737; Zazzo R, 2009, PUF PARIS, V17, P153; Zhu Q, 2010, CURR BIOL, V20, P137, DOI 10.1016/j.cub.2009.11.067	81	9	9	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120900	10.1371/journal.pone.0120900	http://dx.doi.org/10.1371/journal.pone.0120900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853249	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000352478400022
J	Miyamoto, N; Hirata, K; Kanehisa, H; Yoshitake, Y				Miyamoto, Naokazu; Hirata, Kosuke; Kanehisa, Hiroaki; Yoshitake, Yasuhide			Validity of Measurement of Shear Modulus by Ultrasound Shear Wave Elastography in Human Pennate Muscle	PLOS ONE			English	Article							ELASTIC-MODULUS; TISSUE ELASTICITY; CONTRACTION; FORCE; VIVO; FEASIBILITY; HARDNESS	Ultrasound shear wave elastography is becoming a valuable tool for measuring mechanical properties of individual muscles. Since ultrasound shear wave elastography measures shear modulus along the principal axis of the probe (i.e., along the transverse axis of the imaging plane), the measured shear modulus most accurately represents the mechanical property of the muscle along the fascicle direction when the probe's principal axis is parallel to the fascicle direction in the plane of the ultrasound image. However, it is unclear how the measured shear modulus is affected by the probe angle relative to the fascicle direction in the same plane. The purpose of the present study was therefore to examine whether the angle between the principal axis of the probe and the fascicle direction in the same plane affects the measured shear modulus. Shear modulus in seven specially-designed tissue-mimicking phantoms, and in eleven human in-vivo biceps brachii and medial gastrocnemius were determined by using ultrasound shear wave elastography. The probe was positioned parallel or 20 degrees obliquely to the fascicle across the B-mode images. The reproducibility of shear modulus measurements was high for both parallel and oblique conditions. Although there was a significant effect of the probe angle relative to the fascicle on the shear modulus in human experiment, the magnitude was negligibly small. These findings indicate that the ultrasound shear wave elastography is a valid tool for evaluating the mechanical property of pennate muscles along the fascicle direction.	[Miyamoto, Naokazu; Hirata, Kosuke; Kanehisa, Hiroaki; Yoshitake, Yasuhide] Natl Inst Fitness & Sports Kanoya, Kagoshima, Japan	National Institute Fitness & Sports Kanoya	Miyamoto, N (corresponding author), Natl Inst Fitness & Sports Kanoya, Kagoshima, Japan.	miyamoto@nifs-k.jp	Yoshitake, Yasuhide/X-4181-2018	Hirata, Kosuke/0000-0001-9142-6717	JSPS KAKENHI [25702038]; Grants-in-Aid for Scientific Research [15K12646] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25702038. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bouillard K, 2012, J APPL PHYSIOL, V113, P1353, DOI 10.1152/japplphysiol.00858.2012; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005; Couade M, 2011, IEEE T MED IMAGING, V30, P295, DOI 10.1109/TMI.2010.2076829; Eby SF, 2013, J BIOMECH, V46, P2381, DOI 10.1016/j.jbiomech.2013.07.033; Ema R, 2013, EUR J APPL PHYSIOL, V113, P2691, DOI 10.1007/s00421-013-2700-1; Gennisson JL, 2010, ULTRASOUND MED BIOL, V36, P789, DOI 10.1016/j.ultrasmedbio.2010.02.013; Kawakami Y, 1998, J APPL PHYSIOL, V85, P398, DOI 10.1152/jappl.1998.85.2.398; Koo TK, 2013, J BIOMECH, V46, P2053, DOI 10.1016/j.jbiomech.2013.05.016; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lee WN, 2012, IEEE T MED IMAGING, V31, P554, DOI 10.1109/TMI.2011.2172690; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Niitsu M, 2011, ACTA RADIOL, V52, P99, DOI 10.1258/ar.2010.100190; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Shinohara M, 2010, MUSCLE NERVE, V42, P438, DOI 10.1002/mus.21723; Taniguchi K, 2014, SCAND J MED SCI SPOR; Yanagisawa O, 2011, CLIN RADIOL, V66, P815, DOI 10.1016/j.crad.2011.03.012; Yoshitake Y, 2014, MUSCLE NERVE, V50, P103, DOI 10.1002/mus.24104	20	72	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124311	10.1371/journal.pone.0124311	http://dx.doi.org/10.1371/journal.pone.0124311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853777	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400136
J	Obregon, C; Graf, L; Chung, KF; Cesson, V; Nicod, LP				Obregon, Carolina; Graf, Lukas; Chung, Kian Fan; Cesson, Valerie; Nicod, Laurent P.			Nitric Oxide Sustains IL-1 beta Expression in Human Dendritic Cells Enhancing Their Capacity to Induce IL-17-Producing T-Cells	PLOS ONE			English	Article							IFN-GAMMA; DIFFERENTIATION; MACROPHAGES; ACTIVATION; RELEASE; IL-17; SIPB; MATURATION; MECHANISM; DEFENSE	The role played by lung dendritic cells (DCs) which are influenced by external antigens and by their redox state in controlling inflammation is unclear. We studied the role played by nitric oxide (NO) in DC maturation and function. Human DCs were stimulated with a long-acting NO donor, DPTA NONOate, prior to exposure to lipopolysaccharide (LPS). Dose- and time-dependent experiments were performed with DCs with the aim of measuring the release and gene expression of inflammatory cytokines capable of modifying T-cell differentiation, towardsTh1, Th2 and Th17 cells. NO changed the pattern of cytokine release by LPS-matured DCs, dependent on the concentration of NO, as well as on the timing of its addition to the cells during maturation. Addition of NO before LPS-induced maturation strongly inhibited the release of IL-12, while increasing the expression and release of IL-23, IL-1 beta and IL-6, which are all involved in Th17 polarization. Indeed, DCs treated with NO efficiently induced the release of IL-17 by T-cells through IL-1 beta. Our work highlights the important role that NO may play in sustaining inflammation during an infection through the preferential differentiation of the Th17 lineage.	[Obregon, Carolina; Cesson, Valerie; Nicod, Laurent P.] Ctr Hospitalier Univ Vaudois, Serv Pneumol, Lausanne, Switzerland; [Obregon, Carolina; Cesson, Valerie; Nicod, Laurent P.] Univ Lausanne, Lausanne, Switzerland; [Graf, Lukas] Univ Hosp Bern, Clin & Polyclin Pneumol, CH-3010 Bern, Switzerland; [Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Airways Dis Sect, London, England	University of Lausanne; University of Bern; University Hospital of Bern; Imperial College London	Obregon, C (corresponding author), Ctr Hospitalier Univ Vaudois, Serv Pneumol, Lausanne, Switzerland.	carolina.obregon-espinel@chuv.ch	Chung, Kian Fan/B-1872-2012; Nicod, Laurent/ABD-3360-2020	Chung, Kian Fan/0000-0001-7101-1426; Nicod, Laurent P/0000-0002-0905-916X	Swiss National Science Foundation [310030-120210]; Swiss Society of Pneumology grant; National Institute for Health Research [NF-SI-0509-10080] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society of Pneumology grant; National Institute for Health Research(National Institute for Health Research (NIHR))	Support for this work was provided by Swiss National Science Foundation grant: 310030-120210, http://www.snf.ch/en/theSNSF/profile/Pages/default.aspx (LN CO); and the Swiss Society of Pneumology grant, http://www.pneumo.ch/nc/fr/pagedaccueil.html (CO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; AMANO F, 1995, FEBS LETT, V368, P425, DOI 10.1016/0014-5793(95)00700-J; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnes PJ, 2006, CHEST, V129, P151, DOI 10.1378/chest.129.1.151; Brindicci C, 2005, EUR RESPIR J, V26, P52, DOI 10.1183/09031936.04.00125304; Chang Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-43; Chun E, 2010, J CLIN IMMUNOL, V30, P459, DOI 10.1007/s10875-009-9363-z; Corinti S, 2003, J INTERF CYTOK RES, V23, P423, DOI 10.1089/107999003322277838; Dreher D, 2002, J LEUKOCYTE BIOL, V72, P743; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; Grant RW, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00050; Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396; Kaiser L, 2006, AM J RESP CRIT CARE, V174, P1392, DOI 10.1164/rccm.200604-489OC; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Kim YM, 1998, J IMMUNOL, V161, P4122; Lee SW, 2011, J IMMUNOL, V186, P6972, DOI 10.4049/jimmunol.1100485; Lim KG, 2008, CHEST, V133, P1232, DOI 10.1378/chest.07-1712; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; MENTZER SJ, 1986, CELL IMMUNOL, V101, P312, DOI 10.1016/0008-8749(86)90144-9; Mills KHG, 2013, J LEUKOCYTE BIOL, V93, P489, DOI 10.1189/jlb.1012543; Mulrennan Siobhan A, 2004, Treat Respir Med, V3, P79, DOI 10.2165/00151829-200403020-00002; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Nanzer AM, 2013, J ALLERGY CLIN IMMUN, V132, P297, DOI 10.1016/j.jaci.2013.03.037; Nath N, 2010, J NEUROIMMUNE PHARM, V5, P240, DOI 10.1007/s11481-009-9187-x; Niedbala W, 2013, J IMMUNOL, V191, P164, DOI 10.4049/jimmunol.1202580; Obermajer N, 2013, J EXP MED, V210, P1433, DOI 10.1084/jem.20121277; Obregon C, 2003, INFECT IMMUN, V71, P4382, DOI 10.1128/IAI.71.8.4382-4388.2003; Obregon C, 2009, AM J PATHOL, V175, P696, DOI 10.2353/ajpath.2009.080716; Paolucci C, 2003, J LEUKOCYTE BIOL, V73, P253, DOI 10.1189/jlb.0902447; Roelen DL, 2008, TRANSPL IMMUNOL, V19, P220, DOI 10.1016/j.trim.2008.06.004; Saini D, 2011, J HEART LUNG TRANSPL, V30, P624, DOI 10.1016/j.healun.2011.01.708; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Searing DA, 2011, CURR OPIN PEDIATR, V23, P314, DOI 10.1097/MOP.0b013e3283461926; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shirahata S, 1997, BIOCHEM BIOPH RES CO, V234, P269, DOI 10.1006/bbrc.1997.6622; Turpaev K, 2005, FREE RADICAL BIO MED, V38, P1392, DOI 10.1016/j.freeradbiomed.2005.02.002; Vanaudenaerde BM, 2011, AM J RESP CRIT CARE, V183, P977, DOI 10.1164/rccm.201007-1196PP; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200; Xu WL, 2006, FREE RADICAL BIO MED, V41, P19, DOI 10.1016/j.freeradbiomed.2006.01.037; Yang JJ, 2013, J EXP MED, V210, P1447, DOI 10.1084/jem.20122494	47	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120134	10.1371/journal.pone.0120134	http://dx.doi.org/10.1371/journal.pone.0120134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853810	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400010
J	van der Sluijs, JV; Ten Have, M; Rijnders, C; van Marwijk, H; de Graaf, R; van der Feltz-Cornelis, C				van der Sluijs, Jonna van Eck; Ten Have, Margreet; Rijnders, Cees; van Marwijk, Harm; de Graaf, Ron; van der Feltz-Cornelis, Christina			Medically Unexplained and Explained Physical Symptoms in the General Population: Association with Prevalent and Incident Mental Disorders	PLOS ONE			English	Article							PRIMARY-CARE; SOMATOFORM DISORDERS; HEALTH SURVEY; SOMATIC SYMPTOMS; ANXIETY SYMPTOMS; DEPRESSION; PREDICTORS; CLASSIFICATION; COMORBIDITY; FLUOXETINE	Background Clinical studies have shown that Medically Unexplained Symptoms (MUS) are related to common mental disorders. It is unknown how often common mental disorders occur in subjects who have explained physical symptoms (PHY), MUS or both, in the general population, what the incidence rates are, and whether there is a difference between PHY and MUS in this respect. Aim To study the prevalence and incidence rates of mood, anxiety and substance use disorders in groups with PHY, MUS and combined MUS and PHY compared to a no-symptoms reference group in the general population. Method Data were derived from the Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2), a nationally representative face-to-face survey of the general population aged 1864 years. We selected subjects with explained physical symptoms only (n=1952), with MUS only (n=177), with both MUS and PHY (n=209), and a reference group with no physical symptoms (n=4168). The assessment of common mental disorders was through the Composite International Diagnostic Interview 3.0. Multivariate logistic regression analyses were used to examine the association between group membership and the prevalence and first-incidence rates of comorbid mental disorders, adjusted for socio-demographic characteristics. Results MUS were associated with the highest prevalence rates of mood and anxiety disorders, and combined MUS and PHY with the highest prevalence rates of substance disorder. Combined MUS and PHY were associated with a higher incidence rate of mood disorder only (OR 2.9 (95% CI:1.27,6.74)). Conclusion In the general population, PHY, MUS and the combination of both are related to mood and anxiety disorder, but odds are highest for combined MUS and PHY in relation to substance use disorder. Combined MUS and PHY are related to a greater incidence of mood disorder. These findings warrant further research into possibilities to improve recognition and early intervention in subjects with combined MUS and PHY.	[van der Sluijs, Jonna van Eck; van der Feltz-Cornelis, Christina] GGz Breburg, Topclin Ctr Body Mind & Hlth, Tilburg, Netherlands; [van der Sluijs, Jonna van Eck; van der Feltz-Cornelis, Christina] Tilburg Univ, Tranzo Dept, NL-5000 LE Tilburg, Netherlands; [Ten Have, Margreet; de Graaf, Ron] Netherlands Inst Mental Hlth & Addict, Utrecht, Netherlands; [Rijnders, Cees; van der Feltz-Cornelis, Christina] GGz Breburg, Dept Residency Training, Tilburg, Netherlands; [van Marwijk, Harm] Univ Manchester, Ctr Primary Care, Inst Populat Hlth, Manchester, Lancs, England; [van Marwijk, Harm] Vrije Univ Amsterdam Med Ctr, Inst Hlth & Care Res, Dept Gen Practice & Elderly Care Med & EMGO, Amsterdam, Netherlands	Tilburg University; Trimbos Institute; University of Manchester; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van der Sluijs, JV (corresponding author), GGz Breburg, Topclin Ctr Body Mind & Hlth, Tilburg, Netherlands.	J.vanEckvanderSluijs@ggzbreburg.nl	Van Marwijk, Harm/K-6306-2013; Van der Feltz-Cornelis, Christina/R-7107-2016	Van Marwijk, Harm/0000-0001-6206-485X; Van der Feltz-Cornelis, Christina/0000-0001-6925-8956	EU; Achmea Social Insurance Company; Netherlands Organisation for Scientific Research (NWO); Eli Lilly; GGz Ingeest; Arkin; Dutch Ministry of Health; Netherlands Organisation for Health Research and Development (ZonMw); European Science Foundation	EU(European Commission); Achmea Social Insurance Company; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Eli Lilly(Eli Lilly); GGz Ingeest; Arkin; Dutch Ministry of Health; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Science Foundation(European Science Foundation (ESF)European Commission)	JES is employed at the Topclinical Centre for Body, Mind and Health, GGz Breburg and Tilburg University. MH is employed at the Netherlands Institute of Mental Health and Addiction. CR is employed at the Department of Residency training, GGz Breburg. HM is employed at VU University medical centre and at Centre for Primary Care, Institution of Population Health, University of Manchester. RG is employed at the Netherlands Institute of Mental Health and Addiction. CFC is employed at the Topclinical Centre for Body, Mind and Health, GGz Breburg and Tilburg University. CFC received grants from the EU FP7 programme, Achmea Social Insurance Company, Netherlands Organisation for Scientific Research (NWO), Eli Lilly, GGz Ingeest, Arkin, Dutch Ministry of Health, the Netherlands Organisation for Health Research and Development (ZonMw) and European Science Foundation. CFC received royalties for books on psychiatry. CFC received money for lectures from Eli Lilly. The employers/funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Allen LA, 2001, PSYCHOSOMATICS, V42, P63, DOI 10.1176/appi.psy.42.1.63; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P8; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026; [Anonymous], 2010, J PSYCHOSOM RES, DOI DOI 10.1016/J.JPSYCH0RES.2009.09.011; [Anonymous], 2012, GEZ ZORG CIJF; Arnold IA, 2006, PSYCHOSOMATICS, V47, P498, DOI 10.1176/appi.psy.47.6.498; Arnold IA, 2009, PSYCHOSOMATICS, V50, P515, DOI 10.1176/appi.psy.50.5.515; Association A.P., 2000, DIAGNOSTIC STAT MANU; Bair MJ, 2008, PSYCHOSOM MED, V70, P890, DOI 10.1097/PSY.0b013e318185c510; Baker MM, 2001, NBER WORKING PAPER S; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Burton C, 2011, PSYCHOL MED, V41, P555, DOI 10.1017/S0033291710001017; CBS vademecum, 2005, CBS VRAG CHRON ZIEKT; de Graaf R, 2013, J AFFECT DISORD; de Graaf R, 2013, COMPR PSYCHIAT, V54, P1131, DOI 10.1016/j.comppsych.2013.05.012; de Graaf R, 2012, SOC PSYCH PSYCH EPID, V47, P203, DOI 10.1007/s00127-010-0334-8; de Graaf R, 2010, INT J METH PSYCH RES, V19, P125, DOI 10.1002/mpr.317; De Waal MWM, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-5; de Waal MWM, 2005, J PSYCHOSOM RES, V59, P89, DOI 10.1016/j.jpsychores.2005.02.011; De Waal MWM, 2004, BRIT J PSYCHIAT, V184, P470, DOI 10.1192/bjp.184.6.470; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; Dimsdale JE, 2013, PSYCHIATRIE, V10, P30; Escobar JI, 2010, J PSYCHOSOM RES, V69, P1, DOI 10.1016/j.jpsychores.2010.01.001; Graaf R. de, 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P388; Guthrie E, 2002, BMJ-BRIT MED J, V325, P701, DOI 10.1136/bmj.325.7366.701; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Henningsen P, 2003, PSYCHOSOM MED, V65, P528, DOI 10.1097/01.PSY.0000075977.90337.E7; Hilderink PH, 2013, AGEING RES REV, V12, P151, DOI 10.1016/j.arr.2012.04.004; Hoedeman R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-305; Hoedeman R, 2010, J OCCUP REHABIL, V20, P264, DOI 10.1007/s10926-010-9239-3; Hoedeman R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-440; Huijbregts KML, 2010, PSYCHOTHER PSYCHOSOM, V79, P389, DOI 10.1159/000320899; Huijbregts KML, 2013, J PSYCHOSOM RES, V74, P179, DOI 10.1016/j.jpsychores.2013.01.004; Huijbregts KML, 2010, J PSYCHOSOM RES, V68, P511, DOI 10.1016/j.jpsychores.2009.11.009; HUIJBREGTS KM, 2010, J PSYCHOSOM RES, V68, P9; Keeley RD, 2004, J GEN INTERN MED, V19, P615, DOI 10.1111/j.1525-1497.2004.30611.x; Knight M, 2001, J PUBLIC HEALTH MED, V23, P179, DOI 10.1093/pubmed/23.3.179; Korber S, 2011, J PSYCHOSOM RES, V71, P142, DOI 10.1016/j.jpsychores.2011.01.006; Konnopka A, 2012, PSYCHOTHER PSYCHOSOM, V81, P265, DOI 10.1159/000337349; Kroenke K, 1997, AM J MED, V103, P339, DOI 10.1016/S0002-9343(97)00241-6; Kroenke K, 1994, Arch Fam Med, V3, P774; Mergl R, 2007, DEPRESS ANXIETY, V24, P185, DOI 10.1002/da.20192; National Center for Health Statistics, 1994, EV NAT HLTH INT SURV, V2; Papakostas GI, 2008, PSYCHIAT RES, V161, P116, DOI 10.1016/j.psychres.2008.02.011; Papakostas GI, 2004, J CLIN PSYCHIAT, V65, P543; Papakostas GI, 2003, PSYCHIAT RES, V118, P39, DOI 10.1016/S0165-1781(03)00063-5; Rosendal M, 2007, EUR J PSYCHIAT, V21, P25, DOI 10.4321/s0213-61632007000100004; Rosmalen JGM, 2011, PSYCHOL MED, V41, P1133, DOI 10.1017/S0033291710001625; Schulberg HC, 2001, J FAM PRACTICE, V50, P535; Simon GE, 1999, NEW ENGL J MED, V341, P1329, DOI 10.1056/NEJM199910283411801; Skinner C.J., 1989, ANAL COMPLEX SURVEYS; Steinbrecher N, 2011, PSYCHOSOMATICS, V52, P263, DOI 10.1016/j.psym.2011.01.007; Swanson LM, 2010, FAM PRACT, V27, P487, DOI 10.1093/fampra/cmq051; van der Feltz-Cornelis CM, 2006, PSYCHOTHER PSYCHOSOM, V75, P282, DOI 10.1159/000093949; van der Feltz-Cornelis Christina M, 2011, Ned Tijdschr Geneeskd, V155, pA1244; van der Feltz-Cornelis CM, 2010, NEUROPSYCH DIS TREAT, V6, P375; van der Feltz-Cornelis CM, 2010, J PSYCHOSOM RES, V68, P97, DOI 10.1016/j.jpsychores.2009.09.011; van der Feltz-Cornelis CM, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-29; Verhaak PFM, 2009, GEN HOSP PSYCHIAT, V31, P46, DOI 10.1016/j.genhosppsych.2008.09.011; Volker D, 2013, NEUROPSYCH DIS TREAT, V9, P529, DOI 10.2147/NDT.S43969; Walker EA, 1997, PSYCHOSOM MED, V59, P565, DOI 10.1097/00006842-199711000-00002; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1	64	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123274	10.1371/journal.pone.0123274	http://dx.doi.org/10.1371/journal.pone.0123274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853676	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400098
J	Xia, P; Hu, XY; Wang, J; Hu, BB; Xu, QL; Zhou, ZJ; Lou, M				Xia, Ping; Hu, Xing-Yue; Wang, Jin; Hu, Bei-Bei; Xu, Qing-Lin; Zhou, Zhi-Jie; Lou, Min			Risk Factors for Subdural Haematoma in Patients with Spontaneous Intracranial Hypotension	PLOS ONE			English	Article							CEREBROSPINAL-FLUID LEAKS; EPIDURAL BLOOD PATCH; RANDOMIZED CLINICAL-TRIALS; ORTHOSTATIC HEADACHE; BRAIN; METAANALYSIS; MANAGEMENT; THERAPY; ADULTS	Subdural haematoma (SDH) is a potentially life-threatening complication in patients with spontaneous intracranial hypotension (SIH). In serious cases, SIH patients who present with SDHs develop neurological deficits, a decreased level of consciousness, or cerebral herniation, and may even require an urgent neurosurgical drainage. Despite numerous publications on SDHs, few report its potential risk factors in patients with SIH. In this study, we retrospectively investigated 93 consecutive SIH patients and divided them into an SDH group (n = 25) and a non-SDH (NSDH) group (n = 68). The clinical and radiographic characteristics of these 93 patients were analyzed, and then univariate analysis and further multiple logistic regression analysis were performed to identify the potential risk factors for the development of SDHs. The univariate analysis showed that advanced age, male gender, longer clinical course, dural enhancement, and the venous distension sign were associated with the development of SDHs. However, multivariate analysis only included the latter three factors. Our study reveals important radiological manifestations for predicting the development of SDHs in patients with SIH.	[Xia, Ping; Hu, Xing-Yue; Wang, Jin; Hu, Bei-Bei; Xu, Qing-Lin] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Neurol, Hangzhou 310016, Zhejiang, Peoples R China; [Xia, Ping; Hu, Xing-Yue; Wang, Jin; Hu, Bei-Bei; Xu, Qing-Lin; Zhou, Zhi-Jie] Zhejiang Univ, Sir Run Run Shaw Inst Clin Med, Hangzhou 310016, Zhejiang, Peoples R China; [Zhou, Zhi-Jie] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Orthopaed Surg, Hangzhou 310016, Zhejiang, Peoples R China; [Lou, Min] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zhou, ZJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Neurol, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China.	zzj-0708@163.com; louminhz@163.com			National Natural Science Fund of China [81301587]; Natural Science Fund of Zhejiang Province [LQ13H060002]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	The study was sponsored by the National Natural Science Fund of China (81301587), and the Natural Science Fund of Zhejiang Province (LQ13H060002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2005, J NEUROSURG, V102, P1130, DOI 10.3171/jns.2005.102.6.1130; Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Aspegren OP, 2013, CLIN NEUROL NEUROSUR, V115, P981, DOI 10.1016/j.clineuro.2012.10.008; Beck J, 2014, J NEUROSURG, P1; Brightbill TC, 2000, HEADACHE, V40, P292, DOI 10.1046/j.1526-4610.2000.00043.x; Chen HH, 2008, J CHIN MED ASSOC, V71, P147, DOI 10.1016/S1726-4901(08)70007-8; Chu E, 2013, J MED IMAG RADIAT ON, V57, P455, DOI 10.1111/1754-9485.12072; Chung SJ, 2006, NEUROLOGY, V67, P1088, DOI 10.1212/01.wnl.0000237338.44702.61; Connolly BJ, 2014, STROKE, V45, P1672, DOI 10.1161/STROKEAHA.114.005430; Connolly BJ, 2013, J STROKE CEREBROVASC, V22, P444, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.007; de Noronha RJ, 2003, J NEUROL NEUROSUR PS, V74, P752, DOI 10.1136/jnnp.74.6.752; Duray MC, 2013, ACTA NEUROL BELG, V113, P537, DOI 10.1007/s13760-013-0252-0; Farb RI, 2007, AM J NEURORADIOL, V28, P1489, DOI 10.3174/ajnr.A0621; Ferrante E, 2010, EUR J NEUROL, V17, P715, DOI 10.1111/j.1468-1331.2009.02913.x; Forghani R, 2008, NEURORADIOLOGY, V50, P1025, DOI 10.1007/s00234-008-0445-z; Garcia-Morales I, 2001, CEPHALALGIA, V21, P703, DOI 10.1046/j.1468-2982.2001.00226.x; Hashizume K, 2013, CLIN NEUROL NEUROSUR, V115, P1403, DOI 10.1016/j.clineuro.2013.01.022; Jiang Yun, 2014, Zhejiang Da Xue Xue Bao Yi Xue Ban, V43, P83; Kanat A, 2010, J NEUROSURG SCI, V54, P99; Kuramae T, 2011, NEUROL MED-CHIR, V51, P518, DOI 10.2176/nmc.51.518; Lai TH, 2007, CEPHALALGIA, V27, P133, DOI 10.1111/j.1468-2982.2006.01249.x; Lindvall P, 2009, J CLIN NEUROSCI, V16, P1287, DOI 10.1016/j.jocn.2009.01.001; Loya JJ, 2012, J NEUROSURG, V117, P615, DOI 10.3171/2012.4.JNS112030; Murakami M, 2000, NEUROL MED-CHIR, V40, P484, DOI 10.2176/nmc.40.484; Nakajima Hiroshi, 1996, Neurologia Medico-Chirurgica, V36, P647, DOI 10.2176/nmc.36.647; Paldino Michael, 2003, Neurosurg Focus, V15, pECP2; Quinones-Hinojosa Alfredo, 2003, Neurosurg Focus, V15, pE3; REICH JB, 1993, ANN NEUROL, V33, P159, DOI 10.1002/ana.410330205; Sato Y, 1997, CEPHALALGIA, V17, P42, DOI 10.1046/j.1468-2982.1997.1701042.x; Sato Y, 1998, CEPHALALGIA, V18, P60, DOI 10.1046/j.1468-2982.1998.1801060.x; Schievink WI, 2008, CEPHALALGIA, V28, DOI 10.1111/j.1468-2982.2008.01776.x; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Schievink WI, 2005, J NEUROSURG, V103, P608, DOI 10.3171/jns.2005.103.4.0608; Schievink WI, 2010, J NEUROSURG, V112, P295, DOI 10.3171/2008.10.JNS08428; Sim YW, 2012, J KOREAN NEUROSURG S, V52, P234, DOI 10.3340/jkns.2012.52.3.234; Thomke F, 1999, NERVENARZT, V70, P909, DOI 10.1007/s001150050595; Wang J, 2014, CHINESE MED J-PEKING, V127, P2063, DOI 10.3760/cma.j.issn.0366-6999.20132966; [王谨 WANG Jin], 2009, [中华神经科杂志, Chinese Journal of Neurology], V42, P319; Xia P, 2011, NEUROSURG QUART, V21, P185, DOI 10.1097/WNQ.0b013e31821264d5; Yang AIL, 2012, BRAIN INJURY, V26, P1731, DOI 10.3109/02699052.2012.698364	40	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123616	10.1371/journal.pone.0123616	http://dx.doi.org/10.1371/journal.pone.0123616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853681	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400108
J	Kim, JT; Heo, SH; Lee, JS; Choi, MJ; Choi, KH; Nam, TS; Lee, SH; Park, MS; Kim, BC; Kim, MK; Cho, KH				Kim, Joon-Tae; Heo, Suk-Hee; Lee, Ji Sung; Choi, Min-Ji; Choi, Kang-Ho; Nam, Tai-Seung; Lee, Seung-Han; Park, Man-Seok; Kim, Byeong C.; Kim, Myeong-Kyu; Cho, Ki-Hyun			Aspirin Resistance in the Acute Stages of Acute Ischemic Stroke Is Associated with the Development of New Ischemic Lesions	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; ANTIPLATELET THERAPY; ARTERY-DISEASE; RECURRENCE; GUIDELINES; SEVERITY; EVENTS; DRUGS	Background Aspirin is a primary antiplatelet agent for the secondary prevention of ischemic stroke. However, if aspirin fails to inhibit platelet function, as is expected in acute ischemic stroke (AIS), it may increase the rate of early clinical events. Therefore, we sought to determine whether aspirin resistance in the acute stage was associated with early radiological events, including new ischemic lesions (NILs). Methods This study was a single-center, prospective, observational study conducted between April 2012 and May 2013. Aspirin 300 mg was initially administered followed by maintenance doses of 100 mg daily. The acute aspirin reaction unit (aARU) was consistently measured after 3 hours of aspirin loading. An aARU value >= 550 IU was defined as biological aspirin resistance (BAR). NILs on follow-up diffusion-weighted imaging (DWI) were defined as lesions separate from index lesions, which were not detected on the initial DWI. Results A total of 367 patients were analyzed in this study. BAR in aARU was detected in 60 patients (16.3%). On follow-up DWI, 81 patients (22.1%) had NILs, which were frequently in the same territory as the index lesions (79%), pial infarcts (61.7%), and located within the cortex (59.3%). BAR was independently associated with NILs on follow-up DWI (adjusted OR 2.00, 95% CIs 1.01-3.96; p = 0.047). Conclusion In conclusion, BAR in aARU could be associated with NILs on follow-up DWI in AIS. Therefore, a further prospective study with a longer follow-up period is necessary to evaluate the clinical implications of aARU in AIS.	[Kim, Joon-Tae; Choi, Min-Ji; Choi, Kang-Ho; Nam, Tai-Seung; Lee, Seung-Han; Park, Man-Seok; Kim, Byeong C.; Kim, Myeong-Kyu; Cho, Ki-Hyun] Chonnam Natl Univ Hosp, Dept Neurol, Gwangju, South Korea; [Heo, Suk-Hee] Chonnam Natl Univ, Hwasun Hosp, Dept Radiol, Hwasun, Jeonnam, South Korea; [Lee, Ji Sung] Asan Med Ctr, Clin Trial Ctr, Seoul, South Korea	Chonnam National University; Chonnam National University Hospital; Chonnam National University; University of Ulsan; Asan Medical Center	Kim, JT (corresponding author), Chonnam Natl Univ Hosp, Dept Neurol, Gwangju, South Korea.	alldelight2@jnu.ac.kr; mspark@jnu.ac.kr		Lee, Seung-Han/0000-0002-4410-646X	Chonnam National University Hospital Biomedical Research Institute [CRI 13041-21]; Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Chonnam National University Hospital Biomedical Research Institute; Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant (CRI 13041-21) Chonnam National University Hospital Biomedical Research Institute. This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Addad F, 2010, J THROMB THROMBOLYS, V29, P108, DOI 10.1007/s11239-009-0335-1; Alawneh JA, 2009, STROKE, V40, pE443, DOI 10.1161/STROKEAHA.108.532465; Bugnicourt JM, 2011, CLIN NEUROL NEUROSUR, V113, P196, DOI 10.1016/j.clineuro.2010.11.004; Chen WH, 2007, AM J MED, V120, P631, DOI 10.1016/j.amjmed.2006.10.021; COLEMAN J, 2004, POINT CARE, V3, P77, DOI DOI 10.1097/01.P0C.0000127153.41926.BA; Dichiara J, 2007, PLATELETS, V18, P414, DOI 10.1080/09537100701206824; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jeon SB, 2010, EUR NEUROL, V64, P51, DOI 10.1159/000315147; Johnson ES, 1999, ARCH INTERN MED, V159, P1248, DOI 10.1001/archinte.159.11.1248; Johnston KC, 2009, STROKE, V40, P1332, DOI 10.1161/STROKEAHA.108.528976; Kang DW, 2006, ARCH NEUROL-CHICAGO, V63, P1730, DOI 10.1001/archneur.63.12.1730; Kang DW, 2003, ANN NEUROL, V54, P66, DOI 10.1002/ana.10592; Kang DW, 2004, NEUROLOGY, V63, P2261, DOI 10.1212/01.WNL.0000147295.50029.67; Kerr DM, 2012, STROKE, V43, P1401, DOI 10.1161/STROKEAHA.111.644484; KIM J, 2013, NATL GEOGR, V224, P8; Lee DK, 2005, STROKE, V36, P2583, DOI 10.1161/01.STR.0000189999.19948.14; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; McCabe DJH, 2005, PLATELETS, V16, P269, DOI 10.1080/09537100400020567; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; Rocca B, 2005, J THROMB HAEMOST, V3, P1597, DOI 10.1111/j.1538-7836.2005.01380.x; Rocca Bianca, 2012, Thrombosis, V2012, P376721, DOI 10.1155/2012/376721; Schwammenthal Y, 2008, CEREBROVASC DIS, V25, P355, DOI 10.1159/000118382; van Werkum JW, 2008, PLATELETS, V19, P479, DOI 10.1080/09537100802317918; Weimar C, 2005, ARCH NEUROL-CHICAGO, V62, P393, DOI 10.1001/archneur.62.3.393; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Zheng ASY, 2013, JAMA NEUROL, V70, P208, DOI 10.1001/jamaneurol.2013.601	28	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120743	10.1371/journal.pone.0120743	http://dx.doi.org/10.1371/journal.pone.0120743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849632	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800031
J	Onuma, Y; Higuchi, K; Aiki, Y; Shu, YJ; Asada, M; Asashima, M; Suzuki, M; Imamura, T; Ito, Y				Onuma, Yasuko; Higuchi, Kumiko; Aiki, Yasuhiko; Shu, Yujing; Asada, Masahiro; Asashima, Makoto; Suzuki, Masashi; Imamura, Toru; Ito, Yuzuru			A Stable Chimeric Fibroblast Growth Factor (FGF) Can Successfully Replace Basic FGF in Human Pluripotent Stem Cell Culture	PLOS ONE			English	Article							SELF-RENEWAL; LINES; MAINTENANCE; RECEPTORS	Fibroblast growth factors (FGFs) are essential for maintaining self-renewal in human embryonic stem cells and induced pluripotent stem cells. Recombinant basic FGF (bFGF or FGF2) is conventionally used to culture pluripotent stem cells; however, because of the instability of bFGF, repeated addition of fresh bFGF into the culture medium is required in order to maintain its concentration. In this study, we demonstrate that a heat-stable chimeric variant of FGF, termed FGFC, can be successfully used for maintaining human pluripotent stem cells. FGFC is a chimeric protein composed of human FGF1 and FGF2 domains that exhibits higher thermal stability and protease resistance than do both FGF1 and FGF2. Both human embryonic stem cells and induced pluripotent stem cells were maintained in ordinary culture medium containing FGFC instead of FGF2. Comparison of cells grown in FGFC with those grown in conventional FGF2 media showed no significant differences in terms of the expression of pluripotency markers, global gene expression, karyotype, or differentiation potential in the three germ lineages. We therefore propose that FGFC may be an effective alternative to FGF2, for maintenance of human pluripotent stem cells.	[Onuma, Yasuko; Higuchi, Kumiko; Aiki, Yasuhiko; Shu, Yujing; Asashima, Makoto; Suzuki, Masashi; Ito, Yuzuru] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Asada, Masahiro; Suzuki, Masashi; Imamura, Toru] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Signaling Mol Res Grp, Tsukuba, Ibaraki 3058566, Japan; [Suzuki, Masashi] Ibaraki Univ, Grad Sch Sci & Engn, Mito, Ibaraki 3108512, Japan; [Imamura, Toru] Tokyo Univ Technol, Sch Biosci & Biotechnol, Cell Regulat Lab, Tokyo 1920982, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Ibaraki University; Tokyo University of Technology	Ito, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba Cent 4,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	yuzu-itou@aist.go.jp	Suzuki, Masashi/M-1696-2018; Asashima, Makoto/O-8389-2018; ASADA, MASAHIRO/M-4086-2018; Onuma, Yasuko/L-7083-2018; Ito, Yuzuru/M-1085-2018	Suzuki, Masashi/0000-0002-7218-0923; Asashima, Makoto/0000-0002-0012-026X; ASADA, MASAHIRO/0000-0001-6092-2080; Onuma, Yasuko/0000-0002-9330-194X; Ito, Yuzuru/0000-0001-7923-865X	NCHHSTP CDC HHS [UA1 PS000063] Funding Source: Medline	NCHHSTP CDC HHS		Avery S, 2006, STEM CELLS DEV, V15, P729, DOI 10.1089/scd.2006.15.729; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; Dvorak P, 2005, FOLIA HISTOCHEM CYTO, V43, P203; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Lotz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056289; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; Motomura K, 2008, BBA-GEN SUBJECTS, V1780, P1432, DOI 10.1016/j.bbagen.2008.08.001; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishino K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013017; Onuma Y, 2013, BIOCHEM BIOPH RES CO, V431, P524, DOI 10.1016/j.bbrc.2013.01.025; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211	22	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0118931	10.1371/journal.pone.0118931	http://dx.doi.org/10.1371/journal.pone.0118931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850016	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800009
J	Karisnan, K; Bakker, AJ; Song, Y; Noble, PB; Pillow, JJ; Pinniger, GJ				Karisnan, Kanakeswary; Bakker, Anthony J.; Song, Yong; Noble, Peter B.; Pillow, J. Jane; Pinniger, Gavin J.			Interleukin-1 Receptor Antagonist Protects against Lipopolysaccharide Induced Diaphragm Weakness in Preterm Lambs	PLOS ONE			English	Article							MUSCLE FATIGUE RESISTANCE; NECROSIS-FACTOR-ALPHA; INTRAAMNIOTIC ENDOTOXIN; IL-6 PRODUCTION; FETAL; CHORIOAMNIONITIS; INFLAMMATION; DYSFUNCTION; ACTIVATION; MATURATION	Chorioamnionitis (inflammation of the fetal membranes) is strongly associated with preterm birth and in utero exposure to inflammation significantly impairs contractile function in the preterm lamb diaphragm. The fetal inflammatory response to intra-amniotic (IA) lipopolysaccharide (LPS) is orchestrated via interleukin 1 (IL-1). We aimed to determine if LPS induced contractile dysfunction in the preterm diaphragm is mediated via the IL-1 pathway. Pregnant ewes received IA injections of recombinant human IL-1 receptor antagonist (rhIL-1ra) (Anakinra; 100 mg) or saline (Sal) 3 h prior to second IA injections of LPS (4 mg) or Sal at 119d gestational age (GA). Preterm lambs were killed after delivery at 121d GA (term = 150 d). Muscle fibres dissected from the right hemi-diaphragm were mounted in an in vitro muscle test system for assessment of contractile function. The left hemi-diaphragm was snap frozen for molecular and biochemical analyses. Maximum specific force in lambs exposed to IA LPS (Sal/LPS group) was 25% lower than in control lambs (Sal/Sal group; p= 0.025). LPS-induced diaphragm weakness was associated with higher plasma IL-6 protein, diaphragm IL-1 beta mRNA and oxidised glutathione levels. Pre-treatment with rhIL-1ra (rhIL-1ra/LPS) ameliorated the LPS-induced diaphragm weakness and blocked systemic and local inflammatory responses, but did not prevent the rise in oxidised glutathione. These findings indicate that LPS induced diaphragm dysfunction is mediated via IL-1 and occurs independently of oxidative stress. Therefore, the IL-1 pathway represents a potential therapeutic target in the management of impaired diaphragm function in preterm infants.	[Karisnan, Kanakeswary; Bakker, Anthony J.; Song, Yong; Noble, Peter B.; Pillow, J. Jane; Pinniger, Gavin J.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia; [Song, Yong; Noble, Peter B.; Pillow, J. Jane] Univ Western Australia, Ctr Neonatal Res & Educ, Sch Paediat & Child Hlth, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Pinniger, GJ (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia.	gavin.pinniger@uwa.edu.au	Pillow, Jane/A-3335-2009; Pinniger, Gavin/F-1421-2013	Pillow, Jane/0000-0002-6500-0138; Pinniger, Gavin/0000-0002-4400-0817; Song, Yong/0000-0002-8178-5641; Noble, Peter/0000-0001-9028-7751	National Health and Medical Research Council (NHMRC) Project [APP1010665]; NHMRC Career Development Fellowship (PNB) [1045824]	National Health and Medical Research Council (NHMRC) Project(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship (PNB)(National Health and Medical Research Council (NHMRC) of Australia)	This study is supported by National Health and Medical Research Council (NHMRC) Project Grant APP1010665 and a NHMRC Career Development Fellowship (PNB, 1045824) URL: www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry CA, 2011, REPROD SCI, V18, P1092, DOI 10.1177/1933719111404609; Callahan LA, 2001, AM J RESP CELL MOL, V24, P210, DOI 10.1165/ajrcmb.24.2.4075; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Dimitriou G, 2003, PEDIATR PULM, V35, P17, DOI 10.1002/ppul.10209; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; El Khoury N, 2014, J BIOL CHEM, V289, P21896, DOI 10.1074/jbc.M114.549642; ELIAS JA, 1990, J IMMUNOL, V145, P161; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Friedrich O, 2014, AM J RESP CELL MOL, V50, P1096, DOI 10.1165/rcmb.2013-0059OC; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Hudock KM, 2012, AM J RESP CELL MOL, V47, P436, DOI 10.1165/rcmb.2012-0104OC; Javen I, 1996, J PHYSIOL-LONDON, V494, P839, DOI 10.1113/jphysiol.1996.sp021537; JIRIK FR, 1989, J IMMUNOL, V142, P144; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2009, AM J RESP CRIT CARE, V179, P955, DOI 10.1164/rccm.200811-1728OC; KEENS TG, 1978, J APPL PHYSIOL, V44, P909, DOI 10.1152/jappl.1978.44.6.909; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Labbe K, 2010, CRIT CARE, V14, DOI 10.1186/cc9295; Lavin T, 2013, PEDIATR PULM, V48, P640, DOI 10.1002/ppul.22762; LESOUEF PN, 1988, J APPL PHYSIOL, V65, P1040, DOI 10.1152/jappl.1988.65.3.1040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo GJ, 2003, AM J PHYSIOL-REG I, V284, pR1249, DOI 10.1152/ajpregu.00490.2002; MAXWELL LC, 1983, J APPL PHYSIOL, V54, P551, DOI 10.1152/jappl.1983.54.2.551; Oishi K, 1997, Environ Health Prev Med, V2, P89, DOI 10.1007/BF02931972; Reid MB, 2002, AM J RESP CRIT CARE, V166, P479, DOI 10.1164/rccm.2202005; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SIECK GC, 1991, J APPL PHYSIOL, V71, P458, DOI 10.1152/jappl.1991.71.2.458; Song Y, 2013, AM J RESP CELL MOL, V49, P866, DOI 10.1165/rcmb.2013-0107OC; Song Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073457; Song Y, 2012, ANAT REC, V295, P864, DOI 10.1002/ar.22436; Supinski GS, 2009, J APPL PHYSIOL, V107, P1389, DOI 10.1152/japplphysiol.00341.2009; Supinski GS, 2014, RESP PHYSIOL NEUROBI, V196, P63, DOI 10.1016/j.resp.2014.02.015; Viscardi RM, 2004, PEDIATR RES, V55, P1009, DOI 10.1203/01.pdr.0000127015.60185.8a; WATCHKO JF, 1993, J APPL PHYSIOL, V75, P1341, DOI 10.1152/jappl.1993.75.3.1341; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P19, DOI 10.1016/S0002-9378(97)70432-0	37	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124390	10.1371/journal.pone.0124390	http://dx.doi.org/10.1371/journal.pone.0124390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860718	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300138
J	Matsunaga, S; Kishi, T; Iwata, N				Matsunaga, Shinji; Kishi, Taro; Iwata, Nakao			Memantine Monotherapy for Alzheimer's Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DOUBLE-BLIND; MODERATE; DEMENTIA; INVENTORY; DONEPEZIL; EFFICACY; TRIALS	Background We performed an updated meta-analysis of randomized placebo-controlled trials testing memantine monotherapy for patients with Alzheimer's disease (AD). Methods The meta-analysis included randomized controlled trials of memantine monotherapy for AD, omitting those in which patients were also administered a cholinesterase inhibitor. Cognitive function, activities of daily living, behavioral disturbances, global function, stage of dementia, drug discontinuation rate, and individual side effects were compared between memantine monotherapy and placebo groups. The primary outcomes were cognitive function and behavioral disturbances; the others were secondary outcomes. Results Nine studies including 2433 patients that met the study's inclusion criteria were identified. Memantine monotherapy significantly improved cognitive function [standardized mean difference (SMD)=-0.27, 95% confidence interval (CI)=-0.39 to -0.14, p=0.0001], behavioral disturbances (SMD=-0.12, 95% CI=-0.22 to -0.01, p=0.03), activities of daily living (SMD=-0.09, 95% CI=-0.19 to -0.00, p=0.05), global function assessment (SMD=-0.18, 95% CI=-0.27 to -0.09, p=0.0001), and stage of dementia (SMD=-0.23, 95% CI=-0.33 to -0.12, p=0.0001) scores. Memantine was superior to placebo in terms of discontinuation because of inefficacy [risk ratio (RR)=0.36, 95% CI=0.17 to 0.74, p=0.006, number needed to harm (NNH)=non significant]. Moreover, memantine was associated with less agitation compared with placebo (RR=0.68, 95% CI=0.49 to 0.94, p=0.02, NNH=non significant). There were no significant differences in the rate of discontinuation because of all causes, all adverse events, and individual side effects other than agitation between the memantine monotherapy and placebo groups. Conclusions Memantine monotherapy improved cognition, behavior, activities of daily living, global function, and stage of dementia and was well-tolerated by AD patients. However, the effect size in terms of efficacy outcomes was small and thus there is limited evidence of clinical benefit.	[Matsunaga, Shinji; Kishi, Taro; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan	Fujita Health University	Matsunaga, S (corresponding author), Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan.	shinjim@fujita-hu.ac.jp	zhong, feng/G-4623-2015	IWATA, Nakao/0000-0003-3189-6076				[Anonymous], 1988, J C STAT POWER ANAL; Asada T, 1999, JAPANESE J GERIATRIC, V10, P825; Bakchine S, 2007, J ALZHEIMERS DIS, V11, P471; Berman K, 2012, AM J GERIAT PSYCHIAT, V20, P104, DOI 10.1097/JGP.0b013e31822001a6; Boada M, 2013, DEMENT GERIATR COGN, V35, P23, DOI 10.1159/000345989; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Danysz W, 2003, INT J GERIATR PSYCH, V18, pS23, DOI 10.1002/gps.938; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 2005, J INT NEUROPSYCH SOC, V11, P446, DOI 10.1017/S1355617705050502; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Kishi T, 2013, J PSYCHIATR RES, V47, P1143, DOI 10.1016/j.jpsychires.2013.04.013; Kitamura S., 2011, JPN J GERIATR PSYCHI, V22, P453; Lockhart IA, 2011, DEMENT GER COGN D EX, V1, P212, DOI 10.1159/000330032; McShane R, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003154.pub5, DOI 10.1002/14651858.CD003154.PUB5]; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; Nakamura Y, 2011, JPN J GERIATR PSYCHI, V22, P464; Nakamura Y, 2014, EXPERT OPIN PHARMACO, V15, P913, DOI 10.1517/14656566.2014.902446; Olin JT, 1996, J GERIATR PSYCH NEUR, V9, P176, DOI 10.1177/089198879600900404; PANISSET M, 1994, ARCH NEUROL-CHICAGO, V51, P41, DOI 10.1001/archneur.1994.00540130067012; Peskind ER, 2006, AM J GERIAT PSYCHIAT, V14, P704, DOI 10.1097/01.JGP.0000224350.82719.83; Reisberg B., 2003, NEW ENGL J MED, V348, P1333, DOI [10.1056/NEJMoa013128, DOI 10.1056/NEJMOA013128]; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Schmidt R, 2008, J NEUROL NEUROSUR PS, V79, P1312, DOI 10.1136/jnnp.2007.141648; Sclan S G, 1992, Int Psychogeriatr, V4 Suppl 1, P55; van Dyck CH, 2007, ALZ DIS ASSOC DIS, V21, P136, DOI 10.1097/WAD.0b013e318065c495; Wang T, 2013, J CLIN PSYCHOPHARM, V33, P636, DOI 10.1097/JCP.0b013e31829a876a	33	122	134	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123289	10.1371/journal.pone.0123289	http://dx.doi.org/10.1371/journal.pone.0123289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860130	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300091
J	Tang, YL; Jiang, JH; Wang, S; Liu, Z; Tang, XQ; Peng, J; Yang, YZ; Gu, HF				Tang, Ya Ling; Jiang, Jian Hong; Wang, Shuang; Liu, Zhu; Tang, Xiao Qing; Peng, Juan; Yang, Yong-Zong; Gu, Hong-Feng			TLR4/NF-kappa B Signaling Contributes to Chronic Unpredictable Mild Stress-Induced Atherosclerosis in ApoE(-/-) Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; PSYCHOSOCIAL FACTORS; ACCELERATES ATHEROSCLEROSIS; PSYCHOLOGICAL STRESS; DENDRITIC CELLS; INFLAMMATION; DISEASE; TOLL-LIKE-RECEPTOR-4; DIFFERENTIATION; ASSOCIATIONS	Objective Chronic stress is an important risk factor for atherosclerotic diseases. Our previous studies have shown that chronic unpredictable mild stress (CUMS) accelerates atherosclerosis and up-regulates TLR4/NF-kappa B expression in apoE(-/-) mice. However, TLR4/NF-kappa B signaling whether directly contributes to the development of atherosclerosis in CUMS mice is unclear. We hypothesized that the interference of TLR4/NF-kappa B can ameliorate CUMS-induced inflammation and atherosclerosis in apoE(-/-) mice. Methods ApoE(-/-) mice were exposed to 12 weeks CUMS. Ad-siRNA TLR4 was given by tail vein injection (10 mu l/mouse, every 5 days), and PDTC (an inhibitor of NF-kappa B) was given by intraperitoneal injection (60 mg/kg, once a day). Plasma corticosterone concentrations were determined by solid-phase I-125 radioimmunoassay. Atherosclerosis lesions in aortic sinuses were evaluated and quantified by IMAGEPRO PLUS. Western blotting was used to detect the expression of TLR4, NF-kappa B, and IL-1 beta in aortas of the mice. Plasma lipid profiles, IL-1 beta, TNF-alpha, and MCP-1 were measured by ELISA. Results Our results indicated that CUMS apoE(-/-) mice treatment with siRNA TLR4 significantly decreased atherosclerosis and down-regulated TLR4, NF-kappa B, and inflammatory cytokines. PDTC also remarkably reduced atherosclerosis and the levels of IL-1 beta, TNF-alpha and MCP-1 in plasma. However, Treatment with siRNA TLR4 or PDTC had no effect on plasma corticosterone levels, and lipid profiles. Conclusions TLR4/NF-kappa B pathway may participate in CUMS-induced atherosclerosis through activation of proinflammatory cytokines in apoE(-/-) mice. Our data may provide a new potential therapeutic target for prevention of CUMS-induced atherosclerosis.	[Tang, Ya Ling; Wang, Shuang; Peng, Juan; Yang, Yong-Zong; Gu, Hong-Feng] Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Peoples R China; [Jiang, Jian Hong; Liu, Zhu] Univ South China, Chuanshan Coll, Hengyang 421001, Peoples R China; [Tang, Xiao Qing; Gu, Hong-Feng] Univ South China, Dept Physiol, Hengyang 421001, Peoples R China; [Tang, Xiao Qing; Gu, Hong-Feng] Univ South China, Inst Neurosci, Hengyang 421001, Peoples R China	University of South China; University of South China; University of South China; University of South China	Gu, HF (corresponding author), Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Peoples R China.	ghf513@sina.com			National Natural Science Foundation of China [81170278]; construct program of the key discipline in Hunan province, China (Basic Medicine Sciences in University of South China); Foundation of Hunan Educational Committee [09C835, 2012cshcx3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); construct program of the key discipline in Hunan province, China (Basic Medicine Sciences in University of South China); Foundation of Hunan Educational Committee	This work was supported by grants from the National Natural Science Foundation of China (grant no. 81170278), the construct program of the key discipline in Hunan province, China (Basic Medicine Sciences in University of South China), and the Foundation of Hunan Educational Committee (09C835, 2012cshcx3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernberg E, 2012, ATHEROSCLEROSIS, V221, P359, DOI 10.1016/j.atherosclerosis.2011.11.041; Black PH, 2006, MED HYPOTHESES, V67, P879, DOI 10.1016/j.mehy.2006.04.008; Caso JR, 2008, STROKE, V39, P1314, DOI 10.1161/STROKEAHA.107.498212; Castro-Diehl C, 2014, PSYCHONEUROENDOCRINO, V41, P132, DOI 10.1016/j.psyneuen.2013.12.013; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; Everson-Rose SA, 2014, STROKE, V45, P2318, DOI 10.1161/STROKEAHA.114.004815; Gu HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112683; [顾洪丰 Gu Hongfeng], 2011, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V19, P6; Gu HF, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/613879; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hu ZP, 2013, J PINEAL RES, V55, P388, DOI 10.1111/jpi.12085; KAPLAN JR, 1983, SCIENCE, V220, P733; Kiechl S, 2003, ANN MED, V35, P164, DOI 10.1080/07853890310008215; Kumari M, 2003, STRESS, V6, P297, DOI 10.1080/10253890310001619461; Lewthwaite J, 2002, CIRCULATION, V106, P196, DOI 10.1161/01.CIR.0000021121.26290.2C; Li HL, 2007, J CELL MOL MED, V11, P88, DOI 10.1111/j.1582-4934.2007.00011.x; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lu XT, 2013, J CARDIOVASC PHARM, V62, P6, DOI 10.1097/FJC.0b013e3182858fac; Lu XT, 2012, PSYCHOSOM MED, V74, P604, DOI 10.1097/PSY.0b013e31825d0b71; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Ohira T, 2008, PSYCHOSOM MED, V70, P141, DOI 10.1097/PSY.0b013e318160686a; Pasterkamp G, 2004, EUR J CLIN INVEST, V34, P328, DOI 10.1111/j.1365-2362.2004.01338.x; Powell ND, 2009, BRAIN BEHAV IMMUN, V23, P225, DOI 10.1016/j.bbi.2008.09.010; Pryshchep O, 2008, CIRCULATION, V118, P1276, DOI 10.1161/CIRCULATIONAHA.108.789172; Ranjit N, 2007, ARCH INTERN MED, V167, P174, DOI 10.1001/archinte.167.2.174; Roemmich JN, 2009, PSYCHOPHYSIOLOGY, V46, P293, DOI 10.1111/j.1469-8986.2008.00776.x; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Rozkova D, 2006, CLIN IMMUNOL, V120, P260, DOI 10.1016/j.clim.2006.04.567; Tramullas M, 2014, BIOL PSYCHIAT, V76, P340, DOI 10.1016/j.biopsych.2013.11.004; Wang HX, 2007, J INTERN MED, V261, P245, DOI 10.1111/j.1365-2796.2006.01759.x; Wang RP, 2011, STRESS, V14, P567, DOI 10.3109/10253890.2011.571729; Weber MD, 2013, BRAIN BEHAV IMMUN, V32, P112, DOI 10.1016/j.bbi.2013.03.004; Xing SS, 2014, J INT MED RES, V42, P958, DOI 10.1177/0300060514534645; Yalcin I, 2005, EUR J PHARMACOL, V514, P165, DOI 10.1016/j.ejphar.2005.03.029; Zhai JX, 2012, MOL BIOL REP, V39, P6763, DOI 10.1007/s11033-012-1501-7; Zuany-Amorim C, 2002, NAT REV DRUG DISCOV, V1, P797, DOI 10.1038/nrd914	40	36	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123685	10.1371/journal.pone.0123685	http://dx.doi.org/10.1371/journal.pone.0123685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860573	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300109
J	Mckay, AJ; Patel, RKK; Majeed, A				Mckay, Ailsa J.; Patel, Raju K. K.; Majeed, Azeem			Strategies for Tobacco Control in India: A Systematic Review	PLOS ONE			English	Review							PREVENTION PROGRAM; DENTAL STUDENTS; SMOKING-CESSATION; CONTROL POLICY; HEALTH; ADOLESCENTS; KNOWLEDGE; KERALA; INTERVENTION; INTENTIONS	Background Tobacco control needs in India are large and complex. Evaluation of outcomes to date has been limited. Aim To review the extent of tobacco control measures, and the outcomes of associated trialled interventions, in India. Methods Information was identified via database searches, journal hand-searches, reference and citation searching, and contact with experts. Studies of any population resident in India were included. Studies where outcomes were not yet available, not directly related to tobacco use, or not specific to India, were excluded. Pre-tested proformas were used for data extraction and quality assessment. Studies with reliability concerns were excluded from some aspects of analysis. The Framework Convention on Tobacco Control (FCTC) was use as a framework for synthesis. Heterogeneity limited meta-analysis options. Synthesis was therefore predominantly narrative. Results Additional to the Global Tobacco Surveillance System data, 80 studies were identified, 45 without reliability concerns. Most related to education (FCTC Article 12) and tobacco-use cessation (Article 14). They indicated widespread understanding of tobacco-related harm, but less knowledge about specific consequences of use. Healthcare professionals reported low confidence in cessation assistance, in keeping with low levels of training. Training for schoolteachers also appeared suboptimal. Educational and cessation assistance interventions demonstrated positive impact on tobacco use. Studies relating to smoke-free policies (Article 8), tobacco advertisements and availability (Articles 13 and 16) indicated increasingly widespread smoke-free policies, but persistence of high levels of SHS exposure, tobacco promotions and availability-including to minors. Data relating to taxation/pricing and packaging (Articles 6 and 11) were limited. We did not identify any studies of product regulation, alternative employment strategies, or illicit trade (Articles 9, 10, 15 and 17). Conclusions Tobacco-use outcomes could be improved by school/community-based and adult education interventions, and cessation assistance, facilitated by training for health professionals and schoolteachers. Additional tobacco control measures should be assessed.	[Mckay, Ailsa J.; Majeed, Azeem] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Patel, Raju K. K.] London North West Healthcare NHS Trust, London, England	Imperial College London	Mckay, AJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	ailsa.mckay08@imperial.ac.uk		Majeed, Azeem/0000-0002-2357-9858	Department of Primary Care AMP; Public Health at Imperial College London from NW London NIHR Collaboration for Leadership in Applied Health Research Care (CLAHRC); Imperial NIHR Biomedical Research Centre	Department of Primary Care AMP; Public Health at Imperial College London from NW London NIHR Collaboration for Leadership in Applied Health Research Care (CLAHRC); Imperial NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	The Department of Primary Care & Public Health at Imperial College London is grateful for support from the NW London NIHR Collaboration for Leadership in Applied Health Research & Care (CLAHRC) and the Imperial NIHR Biomedical Research Centre. The views expressed in this publication are those of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora M, 2008, AM J HEALTH BEHAV, V32, P283; Arora M, 2012, TOB CONTROL, V21, P482, DOI 10.1136/tc.2011.043539; Arora M, 2011, GLOB HEALTH PROMOT, V18, P9, DOI 10.1177/1757975910393163; Arora M, 2010, HEALTH PROMOT INT, V25, P143, DOI 10.1093/heapro/daq008; Basu S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001480; Bate SL, 2009, PREV SCI, V10, P116, DOI 10.1007/s11121-008-0113-x; Bedi RS, 1995, LUNG INDIA, V13, P51; Bhatia V, 2009, 14TH WORLD CONFERENC; Brown HS, 2013, HEALTH PROMOT INT, V28, P178, DOI 10.1093/heapro/dar095; Centre for Reviews and Dissemination, 2008, SYSTEMATIC REV CRDS; Chandrashekar J, 2011, ORAL HLTH PREV DENT, V9, P243; Dongre A. R., 2008, Indian Journal of Cancer, V45, P100; Effective Public Health Practice Project, QUAL ASS TOOL QUANT; ERC Statistics International Plc, THE WORLD CIGARETTE; Eriksen M, 2012, TOBACCO ATLAS; Flay Brian R, 2009, Tob Induc Dis, V5, P7, DOI 10.1186/1617-9625-5-7; Goel S, 2012, TOB CONTROL, V21, P458; Goenka S, 2010, HEALTH EDUC RES, V25, P917, DOI 10.1093/her/cyq042; Goswami H., 2006, TOBACCO MOVIES IMPAC; Halawany HS, 2013, ASIAN PAC J CANCER P, V14, P3619, DOI 10.7314/APJCP.2013.14.6.3619; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Jha P, 2008, NEW ENGL J MED, V358, P1, DOI [10.1056/, DOI 10.1056/NEJMP0707917]; John RM, 2009, TOB CONTROL, V18, P138, DOI 10.1136/tc.2008.027466; John RM, 2007, INDIAN J MED RES, V125, P599; Kashiwabara Mina, 2011, Indian J Public Health, V55, P234, DOI 10.4103/0019-557X.89937; Kaur Jagdish, 2011, Indian J Public Health, V55, P220, DOI 10.4103/0019-557X.89941; Kumar MS, 2012, J SUBST ABUSE TREAT, V43, P53, DOI 10.1016/j.jsat.2011.10.026; Lal PG, 2011, INT J TUBERC LUNG D, V15, P565, DOI 10.5588/ijtld.10.0372; Mathew JL, 2011, INDIAN PEDIATR, V48, P191, DOI 10.1007/s13312-011-0051-8; Mekemson C, 2002, TOB CONTROL, V11, pI81, DOI 10.1136/tc.11.suppl_1.i81; Mohanty VR, 2013, ASIAN PAC J CANCER P, V14, P2673, DOI 10.7314/APJCP.2013.14.4.2673; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Mony Prem K, 2011, Indian J Community Med, V36, P104, DOI 10.4103/0970-0218.84127; Murugaboopathy V, 2013, J DENT EDUC, V77, P510; Murukutla N, 2012, TOB CONTROL, V21, P12, DOI 10.1136/tc.2010.039438; NOTANI PN, 1991, HEALTH EDUC RES, V6, P121, DOI 10.1093/her/6.1.121; Panda R, 2013, AUSTRALAS MED J, V6, P115, DOI 10.4066/AMJ.2013.1617; Pednekar Mangesh S, 2004, Indian J Public Health, V48, P147; Perry CL, 2009, AM J PUBLIC HEALTH, V99, P899, DOI 10.2105/AJPH.2008.145433; Planning Commission Government of India, 2013, TWELFTH FIVE YEAR PL, VIII; Planning Commission Government of India, 2008, ELEVENTH FIVE YEAR P, VII; Pradeepkumar AS, 2008, INT J TUBERC LUNG D, V12, P1139; Public Health Foundation of India, 2013, SHORT TERM COURS TOB; Quazi Syed Z, 2011, ANN TROP MED PUBLIC, V4, P74, DOI 10.4103/1755-6783.85756; Rajasundaram P, 2011, J DENT EDUC, V75, P1603; Raute LJ, 2011, ASIAN PAC J CANCER P, V12, P1233; Reddy KS, 2002, AM J HEALTH BEHAV, V26, P173, DOI 10.5993/AJHB.26.3.2; Resource Centre for Tobacco Free India, 2007, GOV IND IN NAT PROGR; Sansone GC, 2012, INT J ENV RES PUB HE, V9, P564, DOI 10.3390/ijerph9020564; Sharma I, 2010, Indian J Cancer, V47 Suppl 1, P63, DOI 10.4103/0019-509X.63874; Sharma Rameshwar, 2004, Indian J Cancer, V41, P162; Singh P, 2010, LUNG INDIA, V27, P11, DOI 10.4103/0970-2113.59262; Singh V, 2012, LUNG INDIA, V29, P203, DOI 10.4103/0970-2113.99095; Sinha DN, 2012, INDIAN J CANCER, V49, P379, DOI 10.4103/0019-509X.107743; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P132; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P111; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P123; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P144; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P128; Sinha Dhirendra N, 2004, Indian J Public Health, V48, P118; Sinha DN, 2008, J SCHOOL HEALTH, V78, P368, DOI 10.1111/j.1746-1561.2008.00316.x; Sorensen G, 2005, PREV MED, V41, P417, DOI 10.1016/j.ypmed.2004.09.048; Sorensen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034982; Srivastava S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-263; Stead LF, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005231.pub2; Stigler MH, 2011, HEALTH EDUC BEHAV, V38, P231, DOI 10.1177/1090198110372330; Sunley EM, 2008, INDIA THE TAX TREATM; Thankappan KR, 2013, NATL MED J INDIA, V26, P18; Thankappan KR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-47; Thankappan KR, 2009, INDIAN J MED RES, V129, P249; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Thresia CU, 2009, HEALTH EDUC RES, V24, P839, DOI 10.1093/her/cyp020; Tiwari RR, 2006, REGIONAL HLTH FORUM, V3, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2011, SMOK FREE MOV EV ACT; World Health Organization, 2013, WHO REPORT ON THE GL; World Health Organization, 2011, WHO REPORT ON THE GL; World Health Organization Centers for Disease Control and Prevention and the Canadian Public Health Association, 2013, GLOBAL TOBACCO SURVE	78	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122610	10.1371/journal.pone.0122610	http://dx.doi.org/10.1371/journal.pone.0122610			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856462	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500046
J	Mofakham, S; Zochowski, M				Mofakham, Sima; Zochowski, Michal			Measuring Predictability of Autonomous Network Transitions into Bursting Dynamics	PLOS ONE			English	Article							EPILEPTIC SEIZURES; SMALL-WORLD; FIRING PATTERNS; HUMAN BRAIN; SYNCHRONIZATION; CONNECTIVITY; COMPUTATION; NEURONS; WAVES; TIME	Understanding spontaneous transitions between dynamical modes in a network is of significant importance. These transitions may separate pathological and normal functions of the brain. In this paper, we develop a set of measures that, based on spatio-temporal features of network activity, predict autonomous network transitions from asynchronous to synchronous dynamics under various conditions. These metrics quantify spike-timing distributions within a narrow time window as a function of the relative location of the active neurons. We applied these metrics to investigate the properties of these transitions in excitatory-only and excitatory-and-inhibitory networks and elucidate how network topology, noise level, and cellular heterogeneity affect both the reliability and the timeliness of the predictions. The developed measures can be calculated in real time and therefore potentially applied in clinical situations.	[Mofakham, Sima; Zochowski, Michal] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [Zochowski, Michal] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Zochowski, Michal] RB Zajonc Inst Social Studies, PL-00183 Warsaw, Poland	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Warsaw	Zochowski, M (corresponding author), Univ Michigan, Biophys Program, 930N Univ, Ann Arbor, MI 48109 USA.	michalz@umich.edu		Zochowski, Michal/0000-0002-1722-986X	National Science foundation [CMMI 1029388, PoLS 1058034]	National Science foundation(National Science Foundation (NSF))	This work was supported by the National Science foundation (CMMI 1029388 and PoLS 1058034).	Abeles M., 1991, CORTICONICS; Andrzejak RG, 2009, CLIN NEUROPHYSIOL, V120, P1465, DOI 10.1016/j.clinph.2009.05.019; Andrzejak RG, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.010901; Ansmann G, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052911; Aschenbrenner-Scheibe R, 2003, BRAIN, V126, P2616, DOI 10.1093/brain/awg265; BABB TL, 1987, ELECTROEN CLIN NEURO, V66, P467, DOI 10.1016/0013-4694(87)90093-9; Braun HA, 2011, CHAOS, V21, DOI 10.1063/1.3671326; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Campbell SR, 1999, NEURAL COMPUT, V11, P1595, DOI 10.1162/089976699300016160; Chaovalitwongse W, 2005, EPILEPSY RES, V64, P93, DOI 10.1016/j.eplepsyres.2005.03.009; da Silva FHL, 2003, IEEE T BIO-MED ENG, V50, P540, DOI 10.1109/TBME.2003.810703; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Engel AK, 2005, NAT REV NEUROSCI, V6, P35, DOI 10.1038/nrn1585; FRANASZCZUK PJ, 1994, ELECTROEN CLIN NEURO, V91, P413, DOI 10.1016/0013-4694(94)90163-5; Goldberg JA, 2004, J NEUROSCI, V24, P6003, DOI 10.1523/JNEUROSCI.4848-03.2004; GOLOMB D, 1993, PHYS REV E, V48, P4810, DOI 10.1103/PhysRevE.48.4810; GOLOMB D, 1994, PHYSICA D, V72, P259, DOI 10.1016/0167-2789(94)90214-3; HANSEL D, 1992, PHYS REV LETT, V68, P718, DOI 10.1103/PhysRevLett.68.718; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hong H, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026139; HOPFIELD JJ, 1995, P NATL ACAD SCI USA, V92, P6655, DOI 10.1073/pnas.92.15.6655; Jiruska P, 2010, J NEUROSCI, V30, P5690, DOI 10.1523/JNEUROSCI.0535-10.2010; Karnatak R, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022917; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Lapicque L., 1907, J PHYSIOL PATH GEN, V9, P620, DOI DOI 10.1007/S00422-007-0189-6; Le Van Quyen M, 1999, NEUROREPORT, V10, P2149; Lehnertz K, 1998, PHYS REV LETT, V80, P5019, DOI 10.1103/PhysRevLett.80.5019; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Mormann F, 2005, CLIN NEUROPHYSIOL, V116, P569, DOI 10.1016/j.clinph.2004.08.025; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Newman MEJ, 2000, PHYS REV LETT, V84, P3201, DOI 10.1103/PhysRevLett.84.3201; Osorio I, 2011, INITIATION TERMINATI, P341; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Schelter B, 2006, CHAOS, V16, DOI 10.1063/1.2137623; Schiff SJ, 2000, CLIN NEUROPHYSIOL, V111, P953, DOI 10.1016/S1388-2457(00)00259-5; Snyder DE, 2008, J NEURAL ENG, V5, P392, DOI 10.1088/1741-2560/5/4/004; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Tsodyks M, 2000, J NEUROSCI, V20; Tuckwell H.C., 1988, LINEAR CABLE THEORY, V1; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; Wu JY, 1999, J NEUROSCI, V19, P5005; Ziburkus J, 2006, J NEUROPHYSIOL, V95, P3948, DOI 10.1152/jn.01378.2005	51	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122225	10.1371/journal.pone.0122225	http://dx.doi.org/10.1371/journal.pone.0122225			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855975	Green Published, gold			2022-12-27	WOS:000352588500034
J	Tamburo, E; Varrica, D; Dongarra, G; Grimaldi, LME				Tamburo, Elisa; Varrica, Daniela; Dongarra, Gaetano; Grimaldi, Luigi Maria Edoardo			Trace Elements in Scalp Hair Samples from Patients with Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; REFERENCE VALUES; CEREBROSPINAL-FLUID; ALUMINUM; METALS; ZINC; IRON; EPIDEMIOLOGY; HYPOTHESIS; TOXICITY	Background Epidemiological studies have suggested a possible role of trace elements (TE) in the etiology of several neurological diseases including Multiple Sclerosis (MS). Hair analysis provides an easy tool to quantify TE in human subjects, including patients with neurodegenerative diseases. Objective To compare TE levels in scalp hair from patients with MS and healthy controls from the same geographic area (Sicily). Methods ICP-MS was used to determine the concentrations of 21 elements (Ag, Al, As, Ba, Cd, Co, Cr, Cu, Fe, Li, Mn, Mo, Ni, Pb, Rb, Sb, Se, Sr, U, V and Zn) in scalp hair of 48 patients with relapsing-remitting Multiple Sclerosis compared with 51 healthy controls. Results MS patients showed a significantly lower hair concentration of aluminum and rubidium (median values: Al = 3.76 mu g/g vs. 4.49 mu g/g and Rb = 0.007 mu g/g vs. 0.01 mu g/g;) and higher hair concentration of U (median values U: 0.014 mu g/g vs. 0.007 mu g/g) compared to healthy controls. The percentages of MS patients showing hair elemental concentrations greater than the 95th percentile of controls were 20% for Ni, 19% for Ba and U, and 15% for Ag, Mo and Se. Conversely, the percentages of MS patients showing hair elemental concentrations lower than the 5th percentile of healthy controls were 27% for Al, 25% for Rb, 22% for Ag, 19% for Fe, and 16% for Pb. No significant association was found between levels of each TE and age, disease duration or Expanded Disability Status Scale (EDSS) score. After stratification by gender, healthy subjects did not show any significant difference in trace element levels, while MS patients showed significant differences (p<0.01) for the concentrations of Ag, Cr, Fe, Ni and Sr. No significant differences were also found, at p<0.01, in relation to the use of cigarettes, consume of water, vegetables and place of living. Conclusion The different distributions of TE in hair of MS patients compared to controls provides an additional indirect evidence of metabolic imbalance of chemical elements in the pathogenesis of this disease. The increase in U and decrease in Al and Rb levels in MS compared to controls require further assessments as well as the observed different distributions of other elements.	[Tamburo, Elisa; Varrica, Daniela; Dongarra, Gaetano] Univ Palermo, Dipartimento Sci Terra & Mare DiSTeM, Palermo, Sicily, Italy; [Grimaldi, Luigi Maria Edoardo] Fdn Ist San Raffaele G Giglio Cefalu, UO Neurol, Cefalu, Sicily, Italy	University of Palermo	Tamburo, E (corresponding author), Univ Palermo, Dipartimento Sci Terra & Mare DiSTeM, Palermo, Sicily, Italy.	elisatamburo@libero.it	Grimaldi, Luigi/L-2614-2019; Tamburo, Elisa/O-6523-2016	Varrica, Daniela/0000-0003-1491-8325; Tamburo, Elisa/0000-0002-5713-4398				Barnett V., 1984, OUTLIERS STAT DATA; BETTS RP, 1978, J NEUROL NEUROSUR PS, V41, P791, DOI 10.1136/jnnp.41.9.791; Birke M, 2010, J GEOCHEM EXPLOR, V107, P217, DOI 10.1016/j.gexplo.2010.05.005; Bomboi Giuseppe, 2005, Ann Ist Super Sanita, V41, P205; Bondy SC, 2014, TOXICOLOGY, V315, P1, DOI 10.1016/j.tox.2013.10.008; Chojnacka K, 2010, ENVIRON TOXICOL PHAR, V29, P314, DOI 10.1016/j.etap.2010.03.010; CLAUSEN J, 1988, BIOL TRACE ELEM RES, V15, P179, DOI 10.1007/BF02990136; CREASON JP, 1975, CLIN CHEM, V21, P603; Daxon EG., 2005, DEPLETED URANIUM AER; De Prisco PP, 2010, BIOMED RES-INDIA, V21, P131; DIXON WJ, 1950, ANN MATH STAT, V21, P488, DOI 10.1214/aoms/1177729747; DOMINGO JL, 2000, REV TOXICOL, V17, P3; Dongarra G, 2012, ENVIRON TOXICOL PHAR, V34, P160, DOI 10.1016/j.etap.2012.03.005; Dongarra G, 2011, ENVIRON TOXICOL PHAR, V32, P27, DOI 10.1016/j.etap.2011.03.003; EBERS GC, 1994, J NEUROIMMUNOL, V54, P1, DOI 10.1016/0165-5728(94)90225-9; Ebers GC, 1998, MULTIPLE SCLEROSIS; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Exley C, 2005, SUB CELL BIOCHEM, V38, P225; Exley C, 2006, MULT SCLER J, V12, P533, DOI 10.1177/1352458506071323; Exley C, 2011, MONATSH CHEM, V142, P357, DOI 10.1007/s00706-010-0417-y; Falchuk KH, 1998, MOL CELL BIOCHEM, V188, P41, DOI 10.1023/A:1006808119862; Flaten TP, 2001, BRAIN RES BULL, V55, P187, DOI 10.1016/S0361-9230(01)00459-2; Forte G, 2005, J TRACE ELEM MED BIO, V19, P195, DOI 10.1016/j.jtemb.2005.08.003; Forte G, 2004, J NEURAL TRANSM, V111, P1031, DOI 10.1007/s00702-004-0124-0; Frisardi V, 2010, J ALZHEIMERS DIS, V20, P17, DOI 10.3233/JAD-2009-1340; Fulgenzi A, 2012, BIOMETALS, V25, P569, DOI 10.1007/s10534-012-9537-7; Fung YK, 1997, J TOXICOL-CLIN TOXIC, V35, P49, DOI 10.3109/15563659709001165; Giacoppo S, 2014, BIOL TRACE ELEM RES, V161, P151, DOI 10.1007/s12011-014-0094-5; Goldhaber SB, 2003, REGUL TOXICOL PHARM, V38, P232, DOI 10.1016/S0273-2300(02)00020-X; Goncalves PP, 2007, J INORG BIOCHEM, V101, P1291, DOI 10.1016/j.jinorgbio.2007.06.002; Gonzalez-Munoz MJ, 2008, FOOD CHEM TOXICOL, V46, P49, DOI 10.1016/j.fct.2007.06.036; GOOD PF, 1992, BRAIN RES, V593, P343, DOI 10.1016/0006-8993(92)91334-B; GOOD PF, 1992, ANN NEUROL, V31, P286, DOI 10.1002/ana.410310310; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Johnson S, 2000, MED HYPOTHESES, V55, P239, DOI 10.1054/mehy.2000.1051; Kurttio P, 2005, ENV HLTH PERSP, V113, P1; LEGGETT RW, 1994, HEALTH PHYS, V67, P589, DOI 10.1097/00004032-199412000-00002; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; LeVine SM, 1997, BRAIN RES, V760, P298, DOI 10.1016/S0006-8993(97)00470-8; LOMBECK I, 1980, BIOL TRACE ELEM RES, V2, P193, DOI 10.1007/BF02785354; Matsuzaki S, 2004, J NEUROCHEM, V88, P1345, DOI 10.1111/j.1471-4159.2004.02290.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B; Mikulewicz M, 2013, ENVIRON TOXICOL PHAR, V36, P1077, DOI 10.1016/j.etap.2013.09.012; Murray RK, 2000, HARPERS BIOCH, V25th; Nicoletti A, 2014, PLOS ONE, V8, P1; Nicoletti A, 2011, MULT SCLER J, V17, P273, DOI 10.1177/1352458510386995; Nowak B, 1998, SCI TOTAL ENVIRON, V209, P59, DOI 10.1016/S0048-9697(97)00298-2; Percy ME, 2011, J INORG BIOCHEM, V105, P1505, DOI 10.1016/j.jinorgbio.2011.08.001; Prasad AS, 2004, FREE RADICAL BIO MED, V37, P1182, DOI 10.1016/j.freeradbiomed.2004.07.007; Purdey M, 2004, MED HYPOTHESES, V62, P746, DOI 10.1016/j.mehy.2003.12.034; Rivera-Mancia S, 2010, CHEM-BIOL INTERACT, V186, P184, DOI 10.1016/j.cbi.2010.04.010; Rodella LF, 2008, HISTOL HISTOPATHOL, V23, P433, DOI 10.14670/HH-23.433; Rodushkin I, 2000, SCI TOTAL ENVIRON, V262, P21, DOI 10.1016/S0048-9697(00)00531-3; Rondeau Virginie, 2002, Rev Environ Health, V17, P107; Ryabukin, 1978, IAEARL50; RYAN DE, 1978, CLIN CHEM, V24, P1996; SADOVNICK AD, 1993, CAN J NEUROL SCI, V20, P17, DOI 10.1017/S0317167100047351; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sayre LM, 2000, CELL MOL BIOL, V46, P731; SCHIFFER RB, 1994, NEUROLOGY, V44, P1987, DOI 10.1212/WNL.44.10.1987-a; SCHULTEN HR, 1983, EXPERIENTIA, V39, P736, DOI 10.1007/BF01990300; Sela H, 2007, INT J MASS SPECTROM, V261, P199, DOI 10.1016/j.ijms.2006.09.018; Senofonte O, 2000, J TRACE ELEM MED BIO, V14, P6, DOI 10.1016/S0946-672X(00)80017-6; Soetan K. O., 2010, African Journal of Food Science, V4, P200; StatSoft Inc, STATISTICA DAT AN SO; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Subramanian KS, 1996, SPECTROCHIM ACTA B, V51, P291, DOI 10.1016/0584-8547(95)01425-X; Valera P, 2014, ENVIRON GEOCHEM HLTH, V36, P79, DOI 10.1007/s10653-013-9520-4; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Varrica D, 2014, SCI TOTAL ENVIRON, V470, P117, DOI 10.1016/j.scitotenv.2013.09.058; Vinceti M, 2013, NEUROTOXICOLOGY, V38, P25, DOI 10.1016/j.neuro.2013.05.016; Visconti Andrea, 2005, Ann Ist Super Sanita, V41, P217; Walton JR, 2013, J ALZHEIMERS DIS, V35, P7, DOI 10.3233/JAD-121909; Walton JR, 2009, J INORG BIOCHEM, V103, P1548, DOI 10.1016/j.jinorgbio.2009.07.027; Watt RK, 1999, CELL MOL LIFE SCI, V56, P604, DOI 10.1007/s000180050456; WATTS DL, 2010, TRACE ELEM NEWSLETTE, V21, P1; Zapadniuk B V, 1992, Lik Sprava, P111	78	19	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122142	10.1371/journal.pone.0122142	http://dx.doi.org/10.1371/journal.pone.0122142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856388	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500032
J	Gordeev, EG; Ananikov, VP				Gordeev, Evgeniy G.; Ananikov, Valentine P.			Computational Study of a Model System of Enzyme-Mediated [4+2] Cycloaddition Reaction	PLOS ONE			English	Article							DIELS-ALDER REACTION; GAUSSIAN-BASIS SETS; CORRELATED MOLECULAR CALCULATIONS; DENSITY-FUNCTIONAL THEORY; MAIN-GROUP THERMOCHEMISTRY; AB-INITIO; NONCOVALENT INTERACTIONS; PERICYCLIC-REACTIONS; ACTIVATION BARRIERS; REACTION ENERGETICS	A possible mechanistic pathway related to an enzyme-catalyzed [4+2] cycloaddition reaction was studied by theoretical calculations at density functional (B3LYP, O3LYP, M062X) and semiempirical levels (PM6-DH2, PM6) performed on a model system. The calculations were carried out for the key [4+2] cycloaddition step considering enzyme-catalyzed biosynthesis of Spinosyn A in a model reaction, where a reliable example of a biological Diels-Alder reaction was reported experimentally. In the present study it was demonstrated that the [4+2] cycloaddition reaction may benefit from moving along the energetically balanced reaction coordinate, which enabled the catalytic rate enhancement of the [4+2] cycloaddition pathway involving a single transition state. Modeling of such a system with coordination of three amino acids indicated a reliable decrease of activation energy by similar to 18.0 kcal/mol as compared to a non-catalytic transformation.	[Gordeev, Evgeniy G.; Ananikov, Valentine P.] Russian Acad Sci, Zelinsky Inst Organ Chem, Moscow, Russia	Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry	Ananikov, VP (corresponding author), Russian Acad Sci, Zelinsky Inst Organ Chem, Leninsky Prospekt 47, Moscow, Russia.	val@ioc.ac.ru	Ananikov, Valentine/AHC-8917-2022; Gordeev, Evgeniy G./AAE-2462-2022	Gordeev, Evgeniy G./0000-0002-0545-5720; Ananikov, Valentine/0000-0002-6447-557X	Russian Foundation for Basic Research [14-03-31752]; Russian Science Foundation (RSF) [14-50-00126]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation (RSF)(Russian Science Foundation (RSF))	EGG acknowledges support from Russian Foundation for Basic Research (grant: 14-03-31752), VPA acknowledges support from Russian Science Foundation (RSF grant 14-50-00126). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananikov VP, 2011, CHEM SCI, V2, P2332, DOI 10.1039/c1sc00380a; Ananikov VP, 2003, J PHYS ORG CHEM, V16, P253, DOI 10.1002/poc.613; Ananikov VP, 2001, J PHYS ORG CHEM, V14, P109, DOI 10.1002/1099-1395(200102)14:2<109::AID-POC344>3.0.CO;2-J; Anastas P. T., 1998, GREEN CHEM THEORY PR; Appukkuttan P, 2010, CHEM SOC REV, V39, P1467, DOI 10.1039/b815717k; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Balcells D, 2007, NEW J CHEM, V31, P333, DOI 10.1039/b615528f; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bokach NA, 2010, RUSS CHEM REV+, V79, P89, DOI 10.1070/RC2010v079n02ABEH004083; Cohen AJ, 2001, MOL PHYS, V99, P607, DOI 10.1080/00268970010023435; Coxon JM, 1999, SYNLETT, P1681; Dinadayalane TC, 2002, J PHYS CHEM A, V106, P1627, DOI 10.1021/jp013910r; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; El-Sayed I, 2003, EUR J ORG CHEM, V2003, P813, DOI 10.1002/ejoc.200390123; Ess DH, 2005, J PHYS CHEM A, V109, P9542, DOI 10.1021/jp052504v; Fringuelli F., 2002, DIELS ALDER REACTION; Frisch M.J., 2016, GAUSSIAN 16 REV C 01; Gayatri G, 2011, INDIAN J CHEM A, V50, P1579; Goerigk L, 2010, J CHEM THEORY COMPUT, V6, P107, DOI 10.1021/ct900489g; Goldstein E, 1996, J AM CHEM SOC, V118, P6036, DOI 10.1021/ja9601494; GONZALEZ C, 1990, J PHYS CHEM-US, V94, P5523, DOI 10.1021/j100377a021; GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; Grimme S, 2011, WIRES COMPUT MOL SCI, V1, P211, DOI 10.1002/wcms.30; Guner V, 2003, J PHYS CHEM A, V107, P11445, DOI 10.1021/jp035501w; Guner VA, 2004, J PHYS CHEM A, V108, P2959, DOI 10.1021/jp0369286; Hess BA, 2012, ORG BIOMOL CHEM, V10, P7503, DOI 10.1039/c2ob25827g; Hratchian HP, 2005, J CHEM THEORY COMPUT, V1, P61, DOI 10.1021/ct0499783; Hratchian HP, 2004, J CHEM PHYS, V120, P9918, DOI 10.1063/1.1724823; Isiorho EA, 2014, BIOCHEMISTRY-US, V53, P4292, DOI 10.1021/bi5003629; Isiorho EA, 2012, BIOCHEMISTRY-US, V51, P1213, DOI 10.1021/bi201860q; Ivachtchenko AV, 2010, RUSS CHEM REV+, V79, P787, DOI 10.1070/RC2010v079n09ABEH004086; Johnson ER, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3021474; Jones GO, 2006, J PHYS CHEM A, V110, P1216, DOI 10.1021/jp052055z; Kamp MW, 2008, NAT PROD REP, V25, P1001, DOI [10.1039/b600517a, DOI 10.1039/B600517A]; Kasahara K, 2010, CHEMBIOCHEM, V11, P1245, DOI 10.1002/cbic.201000173; Kelly WL, 2011, NATURE, V473, P35, DOI 10.1038/473035a; Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k; Kim HJ, 2012, CURR OPIN CHEM BIOL, V16, P124, DOI 10.1016/j.cbpa.2011.12.017; Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981; Kim RR, 2010, J AM CHEM SOC, V132, P2983, DOI 10.1021/ja908395r; Kobayashi S., 2001, CYCLOADDITION REACTI; Korth M, 2010, J CHEM THEORY COMPUT, V6, P3808, DOI 10.1021/ct100408b; Korth M, 2010, J CHEM THEORY COMPUT, V6, P344, DOI 10.1021/ct900541n; Korth M, 2009, J CHEM THEORY COMPUT, V5, P993, DOI 10.1021/ct800511q; Lassila JK, 2010, CURR OPIN CHEM BIOL, V14, P676, DOI 10.1016/j.cbpa.2010.08.010; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lei YL, 2011, PROTEIN SCI, V20, P1566, DOI 10.1002/pro.685; Linder M, 2011, J CHEM INF MODEL, V51, P1906, DOI 10.1021/ci200177d; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; Nicolaou KC, 2002, ANGEW CHEM INT EDIT, V41, P1668, DOI 10.1002/1521-3773(20020517)41:10<1668::AID-ANIE1668>3.0.CO;2-Z; Oikawa H, 2004, NAT PROD REP, V21, P321, DOI 10.1039/b305068h; Prathyusha V, 2012, J ORG CHEM, V77, P5371, DOI 10.1021/jo300812q; Qiao KJ, 2011, METAB ENG, V13, P723, DOI 10.1016/j.ymben.2011.09.008; Razzak M, 2011, NAT CHEM BIOL, V7, P865, DOI [10.1038/NCHEMBIO.709, 10.1038/nchembio.709]; Riley KE, 2011, WIRES COMPUT MOL SCI, V1, P3, DOI 10.1002/wcms.8; Ringe D, 2008, SCIENCE, V320, P1428, DOI 10.1126/science.1159747; Riplinger C, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4821834; Riplinger C, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4773581; Sheldon RA, 2000, PURE APPL CHEM, V72, P1233, DOI 10.1351/pac200072071233; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Stewart James J. P., STEWART COMPUTATIONA; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Taber DF, 1984, INTRAMOLECULAR DIELS, V18; Takao K, 2005, CHEM REV, V105, P4779, DOI 10.1021/cr040632u; Tantillo DJ, 2010, ORG LETT, V12, P1164, DOI 10.1021/ol9028435; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Townsend CA, 2011, CHEMBIOCHEM, V12, P2267, DOI 10.1002/cbic.201100431; TROST BM, 1995, ANGEW CHEM INT EDIT, V34, P259, DOI 10.1002/anie.199502591; Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200; Wessig P, 2008, CHEM REV, V108, P2051, DOI 10.1021/cr0783986; WOON DE, 1993, J CHEM PHYS, V98, P1358, DOI 10.1063/1.464303; WOON DE, 1994, J CHEM PHYS, V100, P2975, DOI 10.1063/1.466439; Zhao Y, 2008, J CHEM THEORY COMPUT, V4, P1849, DOI 10.1021/ct800246v; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a; Zhao Y, 2011, J CHEM THEORY COMPUT, V7, P669, DOI 10.1021/ct1006604; Zhao Y, 2011, CHEM PHYS LETT, V502, P1, DOI 10.1016/j.cplett.2010.11.060	82	17	18	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0119984	10.1371/journal.pone.0119984	http://dx.doi.org/10.1371/journal.pone.0119984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853669	gold, Green Submitted, Green Published			2022-12-27	WOS:000352478400008
J	Michael, N; Lowel, S; Bischof, HJ				Michael, Neethu; Loewel, Siegrid; Bischof, Hans-Joachim			Features of the Retinotopic Representation in the Visual Wulst of a Laterally Eyed Bird, the Zebra Finch (Taeniopygia guttata)	PLOS ONE			English	Article							RECEPTIVE-FIELD PROPERTIES; PIGEON COLUMBA-LIVIA; CASTANOTIS-GOULD; STRIATE CORTEX; OPTIC TECTUM; BINOCULAR INTEGRATION; EVOKED-RESPONSES; NUCLEUS ROTUNDUS; SINGLE NEURONS; GANGLION-CELLS	The visual wulst of the zebra finch comprises at least two retinotopic maps of the contralateral eye. As yet, it is not known how much of the visual field is represented in the wulst neuronal maps, how the organization of the maps is related to the retinal architecture, and how information from the ipsilateral eye is involved in the activation of the wulst. Here, we have used auto-fluorescent flavoprotein imaging and classical anatomical methods to investigate such characteristics of the most posterior map of the multiple retinotopic representations. We found that the visual wulst can be activated by visual stimuli from a large part of the visual field of the contralateral eye. Horizontally, the visual field representation extended from -5 degrees beyond the beak tip up to +125 degrees laterally. Vertically, a small strip from -10 degrees below to about +25 degrees above the horizon activated the visual wulst. Although retinal ganglion cells had a much higher density around the fovea and along a strip extending from the fovea towards the beak tip, these areas were not overrepresented in the wulst map. The wulst area activated from the foveal region of the ipsilateral eye, overlapped substantially with the middle of the three contralaterally activated regions in the visual wulst, and partially with the other two. Visual wulst activity evoked by stimulation of the frontal visual field was stronger with contralateral than with binocular stimulation. This confirms earlier electrophysiological studies indicating an inhibitory influence of the activation of the ipsilateral eye on wulst activity elicited by stimulating the contralateral eye. The lack of a foveal overrepresentation suggests that identification of objects may not be the primary task of the zebra finch visual wulst. Instead, this brain area may be involved in the processing of visual information necessary for spatial orientation.	[Michael, Neethu; Loewel, Siegrid] Univ Gottingen, Dept Syst Neurosci, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Bischof, Hans-Joachim] Univ Bielefeld, Verhaltensforsch, D-33615 Bielefeld, Germany; [Michael, Neethu] Gottingen Grad Sch Neurosci Biophys & Mol Biosci, Gottingen, Germany	University of Gottingen; University of Bielefeld	Michael, N (corresponding author), Univ Gottingen, Dept Syst Neurosci, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	nmichae@gwdg.de			Federal Ministry of Education and Research (Bundesministerium fur Bilding und Forschung, BMBF) [01GQ0810]; Deutsche Forschungsgemeinschaft (DFG) [BI 245/21-1, LO 442/8-1, LO 442/8-2]; Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (DFG Grant) [GSC 226/2]	Federal Ministry of Education and Research (Bundesministerium fur Bilding und Forschung, BMBF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (DFG Grant)	This study was funded by grants from the Federal Ministry of Education and Research (Bundesministerium fur Bilding und Forschung, BMBF, http://www.bmbf.de/)-grant number 01GQ0810 (S.L), the Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/index.jsp)-grant numbers BI 245/21-1, LO 442/8-1 and LO 442/8-2, Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (DFG Grant GSC 226/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN JM, 1976, SCIENCE, V191, P572, DOI 10.1126/science.814619; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; BAGNOLI P, 1980, ARCH ITAL BIOL, V118, P72; Beckmann R, 1982, VISNEUROSCI, V10, P237; BILGE M, 1971, Q J EXP PHYSIOL CMS, V56, P242, DOI 10.1113/expphysiol.1971.sp002125; BISCHOF HJ, 1990, CELL TISSUE RES, V262, P307, DOI 10.1007/BF00309886; Bischof HJ, 1997, EUR J MORPHOL, V35, P246, DOI 10.1076/ejom.35.4.246.13080; BISCHOF HJ, 1981, BRAIN RES BULL, V7, P435, DOI 10.1016/0361-9230(81)90042-3; BISCHOF HJ, 1988, J COMP PHYSIOL A, V163, P329, DOI 10.1007/BF00604008; Bowmaker James K., 2012, P441; BOWMAKER JK, 1977, VISION RES, V17, P1129, DOI 10.1016/0042-6989(77)90147-X; BOWMAKER JK, 1977, VISION RES, V17, P17, DOI 10.1016/0042-6989(77)90195-X; BREDENKOTTER M, 1990, VISUAL NEUROSCI, V5, P155, DOI 10.1017/S0952523800000201; BREDENKOTTER M, 1990, BRAIN RES, V515, P343, DOI 10.1016/0006-8993(90)90620-Q; Budzynski CA, 2002, EUR J NEUROSCI, V15, P197, DOI 10.1046/j.0953-816x.2001.01833.x; CLARKE PGH, 1976, Q J EXP PHYSIOL CMS, V61, P351, DOI 10.1113/expphysiol.1976.sp002366; CLARKE R, 1968, Journal of the Royal Microscopical Society, V88, P189; Dennisenko G, 1881, ARCH MIKROSK ANAT, P733; Duijni M., 1959, Archives Neerlandaises de Zoologie, V13, P128; ENGELAGE J, 1988, EXP BRAIN RES, V70, P79; FITE KV, 1975, BRAIN BEHAV EVOLUT, V12, P97, DOI 10.1159/000124142; GALIFRET Y, 1968, Z ZELLFORSCH MIK ANA, V86, P535, DOI 10.1007/BF00324864; GANDAL CHARLES P., 1956, JOUR AMER VET MED ASSOC, V128, P332; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Gunturkun O, 1999, BEHAV BRAIN RES, V98, P193, DOI 10.1016/S0166-4328(98)00084-9; Gunturkun Onur, 1993, P115; Hellmann B, 2001, J COMP NEUROL, V429, P94, DOI 10.1002/1096-9861(20000101)429:1<94::AID-CNE8>3.0.CO;2-5; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Howarth M, 2014, CURR BIOL, V24, P1241, DOI 10.1016/j.cub.2014.04.014; INZUNZA O, 1991, ANAT REC, V229, P271, DOI 10.1002/ar.1092290214; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KARTEN HJ, 1973, J COMP NEUROL, V150, P253, DOI 10.1002/cne.901500303; Keary N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038697; Keary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011912; Kirmse W, 1990, ZOOL JB PHYSL, P217; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; LOWEL S, 1987, J COMP NEUROL, V255, P401, DOI 10.1002/cne.902550307; Martin GR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0040; MARTINOYA C, 1984, NEUROSCI LETT, V45, P335, DOI 10.1016/0304-3940(84)90248-9; Mathews GVT Bird Navigation, 1955, CAMBRIDGE MONOGRAPHS, V3; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; Meyer D.B., 1977, VISUAL SYSTEM VERTEB, V5, P550; MICELI D, 1987, J HIRNFORSCH, V28, P45; Michael N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085225; MORONEY MK, 1987, J COMP PHYSIOL A, V160, P137, DOI 10.1007/BF00609721; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Nair G, 2011, DOC OPHTHALMOL, V122, P163, DOI 10.1007/s10633-011-9271-4; Nakamura A, 1998, NEUROIMAGE, V7, P377, DOI 10.1006/nimg.1998.0332; NALBACH HO, 1990, VISION RES, V30, P529, DOI 10.1016/0042-6989(90)90065-S; Ng BSW, 2010, J NEUROSCI, V30, P6713, DOI 10.1523/JNEUROSCI.4078-09.2010; Nieder A, 2000, J NEUROPHYSIOL, V83, P2967, DOI 10.1152/jn.2000.83.5.2967; NIXDORF BE, 1982, BRAIN RES, V248, P9, DOI 10.1016/0006-8993(82)91142-8; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; Orban GA, 1984, NEURAL OPERATIONS VI; PEARSON R, 1972, AVIAN BRAIN; PETTIGREW JD, 1976, SCIENCE, V193, P675, DOI 10.1126/science.948741; Rasband W., 2006, IMAGEJ; REMY M, 1991, J COMP NEUROL, V305, P57, DOI 10.1002/cne.903050107; Rosa MGP, 1997, J NEUROPHYSIOL, V77, P3193, DOI 10.1152/jn.1997.77.6.3193; Schmidt A, 2001, BRAIN RES, V923, P20, DOI 10.1016/S0006-8993(01)03192-4; Scholl B, 2013, J NEUROPHYSIOL, V109, P3013, DOI 10.1152/jn.01021.2012; SENGPIEL F, 1995, NEUROREPORT, V6, P2235, DOI 10.1097/00001756-199511000-00032; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Shimizu Toru, 2012, P473; Sillman A.J., 1973, P349; STONE J, 1965, J COMP NEUROL, V124, P337, DOI 10.1002/cne.901240305; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VANESSEN DC, 1979, ANNU REV NEUROSCI, V2, P227, DOI 10.1146/annurev.ne.02.030179.001303; Voogd J, 2004, J COMP NEUROL, V470, P107, DOI 10.1002/cne.11022; Voss J, 2003, J COMP PHYSIOL A, V189, P545, DOI 10.1007/s00359-003-0430-2; Voss J, 2009, J EXP BIOL, V212, P1568, DOI 10.1242/jeb.024950; Walls GL, 1942, VERTEBRATE EYE; WANG YC, 1993, VISUAL NEUROSCI, V10, P21, DOI 10.1017/S0952523800003199; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; Watanabe S, 2011, BEHAV BRAIN RES, V222, P51, DOI 10.1016/j.bbr.2011.03.035; WILSON P, 1980, BRAIN RES, V188, P333, DOI 10.1016/0006-8993(80)90035-9; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	82	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124917	10.1371/journal.pone.0124917	http://dx.doi.org/10.1371/journal.pone.0124917			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853253	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400148
J	Michelsen, B; Fiane, R; Diamantopoulos, AP; Soldal, DM; Hansen, IJW; Sokka, T; Kavanaugh, A; Haugeberg, G				Michelsen, Brigitte; Fiane, Ragnhild; Diamantopoulos, Andreas P.; Soldal, Dag Magnar; Hansen, Inger Johanne W.; Sokka, Tuulikki; Kavanaugh, Arthur; Haugeberg, Glenn			A Comparison of Disease Burden in Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis	PLOS ONE			English	Article							BODY-MASS INDEX; ANKYLOSING-SPONDYLITIS; CLASSIFICATION CRITERIA; RECOMMENDATIONS; MANAGEMENT; PREVALENCE; VALIDATION; SCORES; EFFICACY; FEATURES	Objective The main objective of this study was to compare disease burden in rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (ax-SpA). Methods In this cross-sectional study, all the RA (1093), PsA (365) and ax-SpA (333) patients who visited the out-patient clinic of the Hospital of Southern Norway Trust during the year 2013 were included; the RA patients all had a RA diagnosis verified by the treating rheumatologist, the PsA patients all fulfilled the ClASsification for Psoriatic ARthritis (CASPAR) criteria and the ax-SpA patients all fulfilled the Assessment of SpondyloArthritis international Society (ASAS) classification criteria for ax-SpA. Patient-reported health status, demographic variables, medications, and composite scores of disease activity were assessed. The main analyses were performed using General Linear Models adjusted for age, sex and multiple comparisons. Correlation analyses were performed using Spearman's rho. Results The reported pain, joint pain, patient's global assessment and fatigue were similar in PsA and ax-SpA, but significantly lower in RA. The 28-joint Disease Activity Score (DAS28) (0.3 +/- 0.1, p = 0.003), Clinical Disease Activity Index (CDAI) (1.0 +/- 0.4, p = 0.028) and Routine Assessment of Patient Index Data 3 (RAPID3) (0.4 +/- 0.1, p = 0.004) were all significantly higher in PsA vs. RA. RAPID3 showed moderate to high correlation with DAS28 (rho = 0.521, p<0.001) and CDAI (rho = 0.768, p<0.001) in RA and PsA, and with Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) (rho = 0.902, p<0.001) and Bath Ankylosing Spondylitis Functional Index (BASFI) (0.865, p<0.001) in ax-SpA and PsA. Conclusion In conclusion, patient-reported outcome measures were similar in our population of PsA and ax-SpA patients, but significantly lower for the RA patients. Composite disease activity measures were lower in RA than in PsA and ax-SpA, but the magnitude of these differences was small and probably not of clinical significance. Our study indicates that disease burden in RA, PsA and ax-SpA may be more similar than previously demonstrated.	[Michelsen, Brigitte; Diamantopoulos, Andreas P.; Soldal, Dag Magnar; Hansen, Inger Johanne W.; Haugeberg, Glenn] Hosp Southern Norway Trust, Dept Rheumatol, Kristiansand, Norway; [Fiane, Ragnhild; Diamantopoulos, Andreas P.] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Sokka, Tuulikki] Jyvaskyla Cent Hosp, Jyvaskyla, Finland; [Kavanaugh, Arthur] Univ Calif San Diego, Div Rheumatol, Allergy Immunol, San Diego, CA 92103 USA; [Haugeberg, Glenn] Univ Agder, Hosp Southern Norway Trust, Fac Hlth & Sport Sci, Kristiansand, Norway	Norwegian University of Science & Technology (NTNU); Central Finland Central Hospital; University of California System; University of California San Diego; University of Agder	Michelsen, B (corresponding author), Hosp Southern Norway Trust, Dept Rheumatol, Kristiansand, Norway.	brigitte_michelsen@yahoo.no			Pfizer	Pfizer(Pfizer)	The authors received no specific funding for this work. GH has received an unrestricted grant from Pfizer. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bakland G, 2005, ARTHRIT RHEUM-ARTHR, V53, P850, DOI 10.1002/art.21577; Baraliakos X, 2011, BEST PRACT RES CL RH, V25, P825, DOI 10.1016/j.berh.2011.11.006; Barnabe C, 2012, J RHEUMATOL, V39, P1221, DOI 10.3899/jrheum.111393; Bhole VM, 2012, RHEUMATOLOGY, V51, P552, DOI 10.1093/rheumatology/ker349; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; CALIN A, 1994, J RHEUMATOL, V21, P2281; Chen J, 2013, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004524.PUB4; Danve A, 2013, ARTRITIS RHEUM, V65; Fransen J, 2006, ANN RHEUM DIS, V65, P1373, DOI 10.1136/ard.2006.051706; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Gossec L, 2012, ANN RHEUM DIS, V71, P4, DOI 10.1136/annrheumdis-2011-200350; Gross RL, 2014, ARTHRITIS RHEUMATOL; Haroon M, 2012, J RHEUMATOL, V39, P7, DOI 10.3899/jrheum.120232; Heiberg T, 2002, ARTHRIT RHEUM-ARTHR, V47, P391, DOI 10.1002/art.10515; Husted JA, 2001, ARTHRIT RHEUM-ARTHR, V45, P151; Jamnitski A, 2013, ANN RHEUM DIS, V72, P467, DOI 10.1136/annrheumdis-2011-201194corr1; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P1777, DOI 10.1136/annrheumdis-2012-202035; Kirwan John R, 2005, J Rheumatol, V32, P2250; Kvamme MK, 2010, J RHEUMATOL, V37, P26, DOI 10.3899/jrheum.090449; Labitigan M, 2014, ARTHRIT CARE RES, V66, P600, DOI 10.1002/acr.22185; Lindqvist URC, 2008, J RHEUMATOL, V35, P668; Louie GH, 2009, CLIN EXP RHEUMATOL, V27, pS83; Madland TM, 2005, J RHEUMATOL, V32, P1918; Mease PJ, 2014, DRUGS, V74, P423, DOI 10.1007/s40265-014-0191-y; Nam JL, 2014, ANN RHEUM DIS, V73, P516, DOI 10.1136/annrheumdis-2013-204577; Ogdie A, 2014, ANN RHEUM DIS, V73, P149, DOI 10.1136/annrheumdis-2012-202424; PINCUS T, 1983, ARTHRITIS RHEUM-US, V26, P1346, DOI 10.1002/art.1780261107; Pincus T, 2007, BEST PRACT RES CL RH, V21, P789, DOI 10.1016/j.berh.2007.02.009; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rahman P, 2001, J RHEUMATOL, V28, P1041; Reddy SM, 2010, J RHEUMATOL, V37, P2566, DOI 10.3899/jrheum.100483; Riise T, 2000, J RHEUMATOL, V27, P1386; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Ruiz-Esquide V, 2012, REUMATOL CLIN, V8, P342, DOI [10.1016/j.reuma.2012.02.011, 10.1016/j.reumae.2012.06.007]; Salaffi F, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-25; Schett G, 2013, NAT MED, V19, P822, DOI 10.1038/nm.3260; Schett G, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/1478-6354-13-S1-S4, 10.1186/ar3095]; Schoels M, 2010, ANN RHEUM DIS, V69, P638, DOI 10.1136/ard.2009.123976; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Smolen JS, 2014, ANN RHEUM DIS, V73, P6, DOI 10.1136/annrheumdis-2013-203419; Sokka T, 2013, CLIN EXP RHEUMATOL, V31, P409; Studenic P, 2012, ARTHRITIS RHEUM-US, V64, P2814, DOI 10.1002/art.34543; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van den Berg R, 2012, RHEUMATOLOGY, V51, P1388, DOI 10.1093/rheumatology/kes066; Zink A, 2006, J RHEUMATOL, V33, P86	49	81	83	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123582	10.1371/journal.pone.0123582	http://dx.doi.org/10.1371/journal.pone.0123582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853482	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000352478400105
J	Nagao, S; Ueda, M; Osuka, H; Komori, H; Kamikubo, H; Kataoka, M; Higuchi, Y; Hirota, S				Nagao, Satoshi; Ueda, Mariko; Osuka, Hisao; Komori, Hirofumi; Kamikubo, Hironari; Kataoka, Mikio; Higuchi, Yoshiki; Hirota, Shun			Domain-Swapped Dimer of Pseudomonas aeruginosa Cytochrome c(551): Structural Insights into Domain Swapping of Cytochrome c Family Proteins	PLOS ONE			English	Article							ACID SIDE-CHAIN; HYDROGENOBACTER-THERMOPHILUS; FERRICYTOCHROME-C; OLIGOMER FORMATION; FOLDING MECHANISM; CRYSTAL-STRUCTURE; AMYLOID FORMATION; ALPHA-HELIX; STATE; HEME	Cytochrome c (cyt c) family proteins, such as horse cyt c, Pseudomonas aeruginosa cytochrome c(551) (PA cyt c(551)), and Hydrogenobacter thermophilus cytochrome c(552) (HT cyt c(552)), have been used as model proteins to study the relationship between the protein structure and folding process. We have shown in the past that horse cyt c forms oligomers by domain swapping its C-terminal helix, perturbing the Met-heme coordination significantly compared to the monomer. HT cyt c(552) forms dimers by domain swapping the region containing the N-terminal alpha-helix and heme, where the heme axial His and Met ligands belong to different protomers. Herein, we show that PA cyt c(551) also forms domain-swapped dimers by swapping the region containing the N-terminal a-helix and heme. The secondary structures of the M61A mutant of PA cyt c(551) were perturbed slightly and its oligomer formation ability decreased compared to that of the wild-type protein, showing that the stability of the protein secondary structures is important for domain swapping. The hinge loop of domain swapping for cyt c family proteins corresponded to the unstable region specified by hydrogen exchange NMR measurements for the monomer, although the swapping region differed among proteins. These results show that the unstable loop region has a tendency to become a hinge loop in domain-swapped proteins.	[Nagao, Satoshi; Ueda, Mariko; Osuka, Hisao; Kamikubo, Hironari; Kataoka, Mikio; Hirota, Shun] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan; [Osuka, Hisao; Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Ako, Hyogo 6781297, Japan; [Komori, Hirofumi] Kagawa Univ, Fac Educ, Takamatsu, Kagawa 7608522, Japan; [Komori, Hirofumi; Higuchi, Yoshiki] RIKEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan	Nara Institute of Science & Technology; University of Hyogo; Kagawa University; RIKEN	Hirota, S (corresponding author), Nara Inst Sci & Technol, Grad Sch Mat Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	hirota@ms.naist.jp	Kataoka, Mikio/H-4402-2011; Hirota, Shun/AAD-2651-2021	Hirota, Shun/0000-0003-3227-8376; Nagao, Satoshi/0000-0003-1674-7697; Higuchi, Yoshiki/0000-0001-8284-5709	JSPS [26288080, 24750163]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by Grants-in-Aid for Young Scientists (B) (No. 24750163 (S.N.)) and for Scientific Research (B) (No. 26288080 (S.H.)) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Banci L, 1997, BIOCHEMISTRY-US, V36, P9867, DOI 10.1021/bi970724w; Battistuzzi G, 1997, BIOCHEMISTRY-US, V36, P16247, DOI 10.1021/bi971535g; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BERTRAND P, 1995, BIOCHEMISTRY-US, V34, P11071, DOI 10.1021/bi00035a012; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Dehouck Y, 2003, J MOL BIOL, V330, P1215, DOI 10.1016/S0022-2836(03)00614-4; Deshpande MS, 2014, BIOCHEMISTRY-US, V53, P4696, DOI 10.1021/bi500497s; DICKERSON RE, 1971, J BIOL CHEM, V246, P1511; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISHER WR, 1973, J BIOL CHEM, V248, P3188; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gianni S, 2003, J MOL BIOL, V330, P1145, DOI 10.1016/S0022-2836(03)00689-2; Gianni S, 2001, J MOL BIOL, V309, P1177, DOI 10.1006/jmbi.2001.4728; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hasegawa J, 1999, J BIOL CHEM, V274, P37533, DOI 10.1074/jbc.274.53.37533; Hayashi Y, 2012, BIOCHEMISTRY-US, V51, P8608, DOI 10.1021/bi3011303; Hirota S, 2010, P NATL ACAD SCI USA, V107, P12854, DOI 10.1073/pnas.1001839107; HONG XL, 1989, FEBS LETT, V246, P105, DOI 10.1016/0014-5793(89)80262-5; Huang YQ, 2012, PROTEINS, V80, P1610, DOI 10.1002/prot.24055; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; MATSUURA Y, 1982, J MOL BIOL, V156, P389, DOI 10.1016/0022-2836(82)90335-7; Mauk AG, 1997, J BIOL INORG CHEM, V2, P119, DOI 10.1007/s007750050115; Michel LV, 2008, J BIOL INORG CHEM, V13, P837, DOI 10.1007/s00775-008-0370-y; Michel LV, 2007, BIOCHEMISTRY-US, V46, P11753, DOI 10.1021/bi701177j; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nugraheni AD, 2013, J BIOL INORG CHEM, V18, P383, DOI 10.1007/s00775-013-0982-8; Oikawa K, 2005, J BIOL CHEM, V280, P5527, DOI 10.1074/jbc.M412392200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parui PP, 2013, BIOCHEMISTRY-US, V52, P8732, DOI 10.1021/bi400986g; Lopez-Alonso JP, 2010, J AM CHEM SOC, V132, P1621, DOI 10.1021/ja9081638; Ptitsyn OB, 1998, J MOL BIOL, V278, P655, DOI 10.1006/jmbi.1997.1620; Russell BS, 2003, J BIOL INORG CHEM, V8, P156, DOI 10.1007/s00775-002-0401-z; Russell BS, 2000, P NATL ACAD SCI USA, V97, P8312, DOI 10.1073/pnas.150239397; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Takayama SJ, 2005, BIOCHEMISTRY-US, V44, P5488, DOI 10.1021/bi047498s; TANIGUCHI VT, 1980, PURE APPL CHEM, V52, P2275, DOI 10.1351/pac198052102275; Travaglini-Allocatelli C, 1999, J MOL BIOL, V289, P1459, DOI 10.1006/jmbi.1999.2852; Travaglini-Allocatelli C, 2005, J BIOL CHEM, V280, P25729, DOI 10.1074/jbc.M502628200; Travaglini-Allocatelli C, 2004, TRENDS BIOCHEM SCI, V29, P535, DOI 10.1016/j.tibs.2004.08.004; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Wang ZH, 2011, ORG BIOMOL CHEM, V9, P4766, DOI 10.1039/c1ob05552f; Yamamoto Y, 2002, J AM CHEM SOC, V124, P11574, DOI 10.1021/ja025597s; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yang SC, 2005, J MOL BIOL, V352, P202, DOI 10.1016/j.jmb.2005.06.062; Zegers I, 1999, P NATL ACAD SCI USA, V96, P818, DOI 10.1073/pnas.96.3.818	60	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123653	10.1371/journal.pone.0123653	http://dx.doi.org/10.1371/journal.pone.0123653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853415	Green Published, gold			2022-12-27	WOS:000352478400113
J	Bojovic, O; Panja, D; Bittins, M; Bramham, CR; Tjolsen, A				Bojovic, Ognjen; Panja, Debabrata; Bittins, Margarethe; Bramham, Clive R.; Tjolsen, Arne			Time Course of Immediate Early Gene Protein Expression in the Spinal Cord following Conditioning Stimulation of the Sciatic Nerve in Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DORSAL-HORN; FOS EXPRESSION; SYNAPTIC PLASTICITY; LASTING ALLODYNIA; DYNORPHIN-A; LTP; ZIF268; ARC; CONSOLIDATION	Long-term potentiation induced by conditioning electrical stimulation of afferent fibers is a widely studied form of synaptic plasticity in the brain and the spinal cord. In the spinal cord dorsal horn, long-term potentiation is induced by a series of high-frequency trains applied to primary afferent fibers. Conditioning stimulation (CS) of sciatic nerve primary afferent fibers also induces expression of immediate early gene proteins in the lumbar spinal cord. However, the time course of immediate early gene expression and the rostral-caudal distribution of expression in the spinal cord have not been systematically studied. Here, we examined the effects of sciatic nerve conditioning stimulation (10 stimulus trains, 0.5 ms stimuli, 7.2 mA, 100 Hz, train duration 2 s, 8 s intervals between trains) on cellular expression of immediate early genes, Arc, c-Fos and Zif268, in anesthetized rats. Immunohistochemical analysis was performed on sagittal sections obtained from Th13-L5 segments of the spinal cord at 1, 2, 3, 6 and 12 h post-CS. Strikingly, all immediate early genes exhibited a monophasic increase in expression with peak increases detected in dorsal horn neurons at 2 hours post-CS. Regional analysis showed peak increases at the location between the L3 and L4 spinal segments. Both Arc, c-Fos and Zif268 remained significantly elevated at 2 hours, followed by a sharp decrease in immediate early gene expression between 2 and 3 hours post-CS. Colocalization analysis performed at 2 hours post-CS showed that all c-Fos and Zif268 neurons were positive for Arc, while 30% and 43% of Arc positive neurons were positive for c-Fos and Zif268, respectively. The present study identifies the spinal cord level and time course of immediate early gene (IEGP) expression of relevance for analysis of IEGPs function in neuronal plasticity and nociception.	[Bojovic, Ognjen; Panja, Debabrata; Bittins, Margarethe; Bramham, Clive R.; Tjolsen, Arne] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	University of Bergen	Bojovic, O (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, N-5009 Bergen, Norway.	ognjen.bojovic@biomed.uib.no	Bramham, Clive/Q-1854-2018; Panja, Debabrata/E-8595-2010	Bramham, Clive/0000-0001-5958-7115; Panja, Debabrata/0000-0003-4774-1167	University of Bergen, Dept. of Biomedicine	University of Bergen, Dept. of Biomedicine	The University of Bergen, Dept. of Biomedicine, is financing the Ph.D. project of Ognjen Bojovic who is employeed as a Ph.D. student (www.uib.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2008, NEUROBIOL LEARN MEM, V89, P260, DOI 10.1016/j.nlm.2007.10.001; Ahmad Asma Hayati, 2002, Malays J Med Sci, V9, P3; Bliss T. V., 2007, HIPPOCAMPUS BOOK; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; BULLITT E, 1989, BRAIN RES, V493, P391, DOI 10.1016/0006-8993(89)91177-3; Catheline G, 1999, PAIN, V80, P347, DOI 10.1016/S0304-3959(98)00234-6; COGHILL RC, 1993, J NEUROPHYSIOL, V69, P703, DOI 10.1152/jn.1993.69.3.703; Davis S, 2003, BEHAV BRAIN RES, V142, P17, DOI 10.1016/S0166-4328(02)00421-7; Dolan S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-91; Gill KM, 2007, NEUROBIOL LEARN MEM, V87, P583, DOI 10.1016/j.nlm.2006.12.011; GOBEL S, 1979, BRAIN RES, V175, P335, DOI 10.1016/0006-8993(79)91012-6; Haugan F, 2008, NEUROSCIENCE, V154, P1568, DOI 10.1016/j.neuroscience.2008.05.010; Hossaini M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-43; Hu NW, 2003, J NEUROPHYSIOL, V89, P2354, DOI 10.1152/jn.01027.2002; Hughes DI, 2013, NEUROSCIENCE, V237, P7, DOI 10.1016/j.neuroscience.2013.01.028; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Ko SW, 2005, J PAIN, V6, P12, DOI 10.1016/j.jpain.2004.10.001; Korb E, 2013, NAT NEUROSCI, V16, P874, DOI 10.1038/nn.3429; Langlet C, 2001, BRAIN RES, V905, P72, DOI 10.1016/S0006-8993(01)02507-0; Laughlin TM, 1997, PAIN, V72, P253, DOI 10.1016/S0304-3959(97)00046-8; Liang FY, 1996, BRAIN RES, V729, P246, DOI 10.1016/0006-8993(96)00552-5; LIGHT AR, 1979, J COMP NEUROL, V186, P117, DOI 10.1002/cne.901860202; Liu XG, 1997, J NEUROPHYSIOL, V78, P1973, DOI 10.1152/jn.1997.78.4.1973; Liu YP, 2013, MED HYPOTHESES, V81, P192, DOI 10.1016/j.mehy.2013.05.006; MAO JR, 1992, PAIN, V50, P89, DOI 10.1016/0304-3959(92)90116-S; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; MUNGLANI R, 1995, BRIT J ANAESTH, V75, P186, DOI 10.1093/bja/75.2.186; Nyberg F, 1995, NEUROPEPTIDES SPINAL; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; RICHTER D, 2001, CELL POLARITY SUBCEL; Rodriguez JJ, 2008, J CELL MOL MED, V12, P671, DOI 10.1111/j.1582-4934.2007.00105.x; Rygh LJ, 2006, EUR J NEUROSCI, V24, P761, DOI 10.1111/j.1460-9568.2006.04968.x; Sandkuhler J, 2007, LONG TERM POTENTIATI, P1058; Steward O, 2001, P NATL ACAD SCI USA, V98, P7062, DOI 10.1073/pnas.131146398; Svendsen F, 1997, NEUROREPORT, V8, P3427, DOI 10.1097/00001756-199711100-00002; Vanderah TW, 1996, PAIN, V68, P275, DOI 10.1016/S0304-3959(96)03225-3; Waibl H, 1973, ADV ANATOMY EMBRIOLO; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; Zou X, 2001, NEUROSCIENCE, V106, P171, DOI 10.1016/S0306-4522(01)00175-0	46	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123604	10.1371/journal.pone.0123604	http://dx.doi.org/10.1371/journal.pone.0123604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860146	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300105
J	Brisset, JC; Hoff, BA; Chenevert, TL; Jacobson, JA; Boes, JL; Galban, S; Rehemtulla, A; Johnson, TD; Pienta, KJ; Galban, CJ; Meyer, CR; Schakel, T; Nicolay, K; Alva, AS; Hussain, M; Ross, BD				Brisset, Jean-Christophe; Hoff, Benjamin A.; Chenevert, Thomas L.; Jacobson, Jon A.; Boes, Jennifer L.; Galban, Stefanie; Rehemtulla, Alnawaz; Johnson, Timothy D.; Pienta, Kenneth J.; Galban, Craig J.; Meyer, Charles R.; Schakel, Timothy; Nicolay, Klaas; Alva, Ajjai S.; Hussain, Maha; Ross, Brian D.			Integrated Multimodal Imaging of Dynamic Bone-Tumor Alterations Associated with Metastatic Prostate Cancer	PLOS ONE			English	Article							FUNCTIONAL DIFFUSION MAP; PARAMETRIC RESPONSE MAP; ANDROGEN INDEPENDENCE; THERAPY RESPONSE; WEIGHTED MRI; DW-MRI; BIOMARKER; PROGRESSION; PREDICT; ESTABLISHMENT	Bone metastasis occurs for men with advanced prostate cancer which promotes osseous growth and destruction driven by alterations in osteoblast and osteoclast homeostasis. Patients can experience pain, spontaneous fractures and morbidity eroding overall quality of life. The complex and dynamic cellular interactions within the bone microenvironment limit current treatment options thus prostate to bone metastases remains incurable. This study uses voxel-based analysis of diffusion-weighted MRI and CT scans to simultaneously evaluate temporal changes in normal bone homeostasis along with prostate bone metatastsis to deliver an improved understanding of the spatiotemporal local microenvironment. Dynamic tumor-stromal interactions were assessed during treatment in mouse models along with a pilot prospective clinical trial with metastatic hormone sensitive and castration resistant prostate cancer patients with bone metastases. Longitudinal changes in tumor and bone imaging metrics during delivery of therapy were quantified. Studies revealed that voxel-based parametric response maps (PRM) of DW-MRI and CT scans could be used to quantify and spatially visualize dynamic changes during prostate tumor growth and in response to treatment thereby distinguishing patients with stable disease from those with progressive disease (p<0.05). These studies suggest that PRM imaging biomarkers are useful for detection of the impact of prostate tumor-stromal responses to therapies thus demonstrating the potential of multi-modal PRM image-based biomarkers as a novel means for assessing dynamic alterations associated with metastatic prostate cancer. These results establish an integrated and clinically translatable approach which can be readily implemented for improving the clinical management of patients with metastatic bone disease.	[Brisset, Jean-Christophe; Hoff, Benjamin A.; Chenevert, Thomas L.; Jacobson, Jon A.; Boes, Jennifer L.; Galban, Craig J.; Meyer, Charles R.; Ross, Brian D.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Galban, Stefanie; Rehemtulla, Alnawaz] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Johnson, Timothy D.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.; Alva, Ajjai S.; Hussain, Maha] Univ Michigan, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Schakel, Timothy] Univ Med Ctr Utrecht, Dept Radiotherapy, Utrecht, Netherlands; [Nicolay, Klaas] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Utrecht University; Utrecht University Medical Center; Eindhoven University of Technology	Ross, BD (corresponding author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.	bdross@umich.edu	Pienta, Kenneth/E-7679-2015; Brisset, Jean-Christophe/M-1227-2014	Pienta, Kenneth/0000-0002-4138-2186; Brisset, Jean-Christophe/0000-0002-7947-3622; Nicolay, Klaas/0000-0002-4179-616X; Jacobson, Jon/0000-0002-3676-6628; Chenevert, Thomas/0000-0003-1476-4274	National Institutes of Health [R01CA136892, P01CA087634]; University of Michigan Cancer Center; NATIONAL CANCER INSTITUTE [P01CA087634, R01CA136892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant R01CA136892 and P01CA087634 and the clinical trial was supported by a grant from the University of Michigan Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelDayem HM, 1997, SEMIN NUCL MED, V27, P355, DOI 10.1016/S0001-2998(97)80008-6; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Bains LJ, 2012, CANCER IMAGING, V12, P395, DOI 10.1102/1470-7330.2012.9047; Blackledge MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091779; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Carlin Bruce I., 2000, Cancer, V88, P2989, DOI 10.1002/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.3.CO;2-H; Chiba Y, 2012, J NEUROSURG, V116, P835, DOI 10.3171/2011.12.JNS111255; Cook GJR, 2011, EUR J NUCL MED MOL I, V38, P7, DOI 10.1007/s00259-010-1576-0; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Costelloe CM, 2010, J CANCER, V1, P80; Craft N, 1999, CANCER RES, V59, P5030; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellingson BM, 2012, NEURO-ONCOLOGY, V14, P333, DOI 10.1093/neuonc/nor220; Ellingson BM, 2012, MAGN RESON MED, V67, P237, DOI 10.1002/mrm.23003; Ellingson BM, 2011, NEURO-ONCOLOGY, V13, P1151, DOI 10.1093/neuonc/nor079; Ellingson BM, 2010, J MAGN RESON IMAGING, V31, P538, DOI 10.1002/jmri.22068; Esposito M, 2014, PHARMACOL THERAPEUT, V141, P222, DOI 10.1016/j.pharmthera.2013.10.006; Galban CJ, 2009, TRANSL ONCOL, V2, P184, DOI 10.1593/tlo.09175; Galban CJ, 2009, NAT MED, V15, P572, DOI 10.1038/nm.1919; Galban S, 2010, CURR PHARM BIOTECHNO, V11, P701, DOI 10.2174/138920110792246627; Glendenning J, 2013, SEMIN NUCL MED, V43, P317, DOI 10.1053/j.semnuclmed.2013.02.002; Hamaoka T, 2004, J CLIN ONCOL, V22, P2942, DOI 10.1200/jco.2004.08.181; Hamstra DA, 2008, J CLIN ONCOL, V26, P3387, DOI 10.1200/JCO.2007.15.2363; Harris RJ, 2012, NEURO-ONCOLOGY, V14, P1079, DOI 10.1093/neuonc/nos141; Hiramatsu R, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-192; Hoff BA, 2012, BONE, V51, P78, DOI 10.1016/j.bone.2012.04.005; Hoff BA, 2010, MAGN RESON MED, V64, P1499, DOI 10.1002/mrm.22507; KAIGHN ME, 1979, INVEST UROL, V17, P16; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Kransdorf MJ, 2013, SEMIN MUSCULOSKEL R, V17, P145, DOI 10.1055/s-0033-1343070; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Lee KC, 2007, NEOPLASIA, V9, P1003, DOI 10.1593/neo.07954; Lee KC, 2007, CANCER RES, V67, P3524, DOI 10.1158/0008-5472.CAN-06-4236; Lemasson B, 2013, TRANSL ONCOL, V6, P554, DOI 10.1593/tlo.13532; Ma B, 2009, LECT NOTES COMPUT SC, V5636, P276; Meyer C R, 1997, Med Image Anal, V1, P195, DOI 10.1016/S1361-8415(97)85010-4; Miller TT, 2008, RADIOLOGY, V246, P662, DOI 10.1148/radiol.2463061038; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Moffat BA, 2004, MAGN RESON MATER PHY, V17, P249, DOI 10.1007/s10334-004-0079-z; Moffat BA, 2006, NEOPLASIA, V8, P259, DOI 10.1593/neo.05844; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Nickerson T, 2001, CANCER RES, V61, P6276; Onukwugha E, 2014, J GERIATR ONCOL; Padhani AR, 2014, J MAGN RESON IMAGING, V39, P1049, DOI 10.1002/jmri.24548; Reischauer C, 2010, RADIOLOGY, V257, P523, DOI 10.1148/radiol.10092469; Ross Brian D, 1994, Q Magn Reson Biol Med, V1, P89; Rozel S, 2009, J CELL BIOCHEM, V107, P58, DOI 10.1002/jcb.22056; Saman DM, 2014, DM-DIS MON, V60, P150, DOI 10.1016/j.disamonth.2014.02.003; Taichman RS, 2007, J CLIN INVEST, V117, P2351, DOI 10.1172/JCI31791; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Thoeny HC, 2010, J MAGN RESON IMAGING, V32, P2, DOI 10.1002/jmri.22167; Tsien C, 2010, J CLIN ONCOL, V28, P2293, DOI 10.1200/JCO.2009.25.3971; Williams TM, 2013, TRANSL ONCOL, V6, P133, DOI 10.1593/tlo.13214; Wondergem M, 2013, NUCL MED COMMUN, V34, P935, DOI 10.1097/MNM.0b013e328364918a	55	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123877	10.1371/journal.pone.0123877	http://dx.doi.org/10.1371/journal.pone.0123877			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859981	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300118
J	Falcone, M; Russo, A; Giannella, M; Cangemi, R; Scarpellini, MG; Bertazzoni, G; Alarcon, JM; Taliani, G; Palange, P; Farcomeni, A; Vestri, A; Bouza, E; Violi, F; Venditti, M				Falcone, Marco; Russo, Alessandro; Giannella, Maddalena; Cangemi, Roberto; Scarpellini, Maria Gabriella; Bertazzoni, Giuliano; Martinez Alarcon, Jose; Taliani, Gloria; Palange, Paolo; Farcomeni, Alessio; Vestri, Annarita; Bouza, Emilio; Violi, Francesco; Venditti, Mario			Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset Pneumonia	PLOS ONE			English	Article							CARE-ASSOCIATED PNEUMONIA; HEALTH; MANAGEMENT; SURVEILLANCE; INFECTIONS; GUIDELINES; CRITERIA; OUTCOMES; SCORE	Introduction The diffusion of multidrug-resistant (MDR) bacteria has created the need to identify risk factors for acquiring resistant pathogens in patients living in the community. Objective To analyze clinical features of patients with community-onset pneumonia due to MDR pathogens, to evaluate performance of existing scoring tools and to develop a bedside risk score for an early identification of these patients in the Emergency Department. Patients and Methods This was an open, observational, prospective study of consecutive patients with pneumonia, coming from the community, from January 2011 to January 2013. The new score was validated on an external cohort of 929 patients with pneumonia admitted in internal medicine departments participating at a multicenter prospective study in Spain. Results A total of 900 patients were included in the study. The final logistic regression model consisted of four variables: 1) one risk factor for HCAP, 2) bilateral pulmonary infiltration, 3) the presence of pleural effusion, and 4) the severity of respiratory impairment calculated by use of PaO2/FiO(2) ratio. A new risk score, the ARUC score, was developed; compared to Aliberti, Shorr, and Shindo scores, this point score system has a good discrimination performance (AUC 0.76, 95% CI 0.71-0.82) and calibration (Hosmer-Lemeshow, chi(2) = 7.64; p = 0.469). The new score outperformed HCAP definition in predicting etiology due to MDR organism. The performance of this bedside score was confirmed in the validation cohort (AUC 0.68, 95% CI 0.60-0.77). Conclusion Physicians working in ED should adopt simple risk scores, like ARUC score, to select the most appropriate antibiotic regimens. This individualized approach may help clinicians to identify those patients who need an empirical broad-spectrum antibiotic therapy.	[Falcone, Marco; Russo, Alessandro; Palange, Paolo; Venditti, Mario] Univ Roma La Sapienza, Policlin Umberto I, Dept Publ Hlth & Infect Dis, I-00185 Rome, Italy; [Falcone, Marco; Scarpellini, Maria Gabriella; Bertazzoni, Giuliano] Univ Roma La Sapienza, Policlin Umberto I, Dept Emergency Med, I-00185 Rome, Italy; [Giannella, Maddalena] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Infect Dis Unit, St Orsola Malpighi Hosp, Bologna, Italy; [Cangemi, Roberto; Violi, Francesco] Univ Roma La Sapienza, Policlin Umberto I, Dept Internal Med & Med Specialties, I-00185 Rome, Italy; [Martinez Alarcon, Jose] Gen Hosp, Dept Microbiol, Ciudad Real, Spain; [Taliani, Gloria] Univ Roma La Sapienza, Policlin Umberto I, Dept Clin Med, I-00185 Rome, Italy; [Farcomeni, Alessio; Vestri, Annarita] Univ Roma La Sapienza, Policlin Umberto I, Dept Publ Hlth & Infect Dis, Stat Sect, I-00185 Rome, Italy; [Bouza, Emilio] Hosp Gen Univ Gregorio Maranon, Dept Clin Microbiol & Infect Dis, Madrid, Spain	Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; University Hospital Sapienza Rome; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; University Hospital Sapienza Rome; General University Gregorio Maranon Hospital	Falcone, M (corresponding author), Univ Roma La Sapienza, Policlin Umberto I, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	marcofalc@libero.it	Torres, OH/D-2215-2012; GIANNELLA, MADDALENA/K-9090-2016; Violi, Francesco/K-1509-2016; RUSSO, ALESSANDRO/K-5381-2016; Bouza, Emilio/D-8661-2014; Falcone, Marco/K-7614-2016; Farcomeni, Alessio/K-8719-2016	Torres, OH/0000-0002-0305-8211; GIANNELLA, MADDALENA/0000-0001-8273-7601; Violi, Francesco/0000-0002-6610-7068; RUSSO, ALESSANDRO/0000-0003-3846-4620; Bouza, Emilio/0000-0001-6967-9267; Falcone, Marco/0000-0003-3813-8796; Farcomeni, Alessio/0000-0002-7104-5826; VENDITTI, Mario/0000-0003-2639-0281; Cangemi, Roberto/0000-0002-4097-2061	Programa de Centros de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias [CB06/06/0058]	Programa de Centros de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias	The ENEMI-II study was partially supported by the Programa de Centros de Investigacion Biomedica en Red (CIBER) de Enfermedades Respiratorias CB06/06/0058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other specific funding for this work.	Aliberti S, 2013, THORAX; Aliberti S, 2012, CLIN INFECT DIS, V54, P470, DOI 10.1093/cid/cir840; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Corrao S, 2014, CLIN INFECT DIS; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ewig S, 2012, CURR OPIN INFECT DIS, V25, P166, DOI 10.1097/QCO.0b013e32835023fb; Ewig S, 2010, LANCET INFECT DIS, V10, P279, DOI 10.1016/S1473-3099(10)70032-3; Falcone M, 2014, THORAX; Falcone M, 2012, INTERN EMERG MED, V7, P523, DOI 10.1007/s11739-012-0795-8; Falcone M, 2012, INTERN EMERG MED, V7, P415, DOI 10.1007/s11739-012-0796-7; Falcone M, 2011, INT J INFECT DIS, V15, pE545, DOI 10.1016/j.ijid.2011.04.005; Falcone M, 2011, INTERN EMERG MED, V6, P431, DOI 10.1007/s11739-011-0521-y; Falcone M, 2011, LANCET INFECT DIS, V11, P11, DOI 10.1016/S1473-3099(10)70301-7; Giannella M, 2012, CLIN MICROBIOL INFEC, V18, P786, DOI 10.1111/j.1469-0691.2011.03757.x; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Khawaja A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-94; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maruyama T, 2013, CLIN INFECT DIS, V57, P1373, DOI 10.1093/cid/cit571; Orsi GB, 2011, EXPERT REV ANTI-INFE, V9, P653, DOI [10.1586/ERI.11.77, 10.1586/eri.11.77]; Russo A, 2013, INTERN EMERG MED; Shindo Y, 2013, AM J RESP CRIT CARE, V188, P985, DOI 10.1164/rccm.201301-0079OC; Shorr AF, 2008, ARCH INTERN MED, V168, P2205, DOI 10.1001/archinte.168.20.2205; Shorr AF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-268; Shorr AF, 2012, CLIN INFECT DIS, V54, P193, DOI 10.1093/cid/cir813; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; VISSER MR, 1992, EUR J CLIN MICROBIOL, V11, P979, DOI 10.1007/BF01967786; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x	28	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0119528	10.1371/journal.pone.0119528	http://dx.doi.org/10.1371/journal.pone.0119528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860142	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300007
J	He, F; Nie, WC; Tong, ZT; Yuan, SM; Gong, T; Liao, Y; Bi, EF; Gao, XD				He, Fei; Nie, Wen-Chao; Tong, Zongtian; Yuan, Si-Min; Gong, Ting; Liao, Yuan; Bi, Erfei; Gao, Xiang-Dong			The GTPase-Activating Protein Rga1 Interacts with Rho3 GTPase and May Regulate Its Function in Polarized Growth in Budding Yeast	PLOS ONE			English	Article							RAS SUPERFAMILY GENES; SACCHAROMYCES-CEREVISIAE; SNARE COMPLEX; CELL POLARIZATION; CDC42P GTPASE; SEPTIN RING; EXOCYTOSIS; FAMILY; DISTINCT; EXOCYST	In budding yeast, Rga1 negatively regulates the Rho GTPase Cdc42 by acting as a GTPase-activating protein (GAP) for Cdc42. To gain insight into the function and regulation of Rga1, we overexpressed Rga1 and an N-terminally truncated Rga1-C538 (a.a. 538-1007) segment. Overexpression of Rga1-C538 but not full-length Rga1 severely impaired growth and cell morphology in wild-type cells. We show that Rga1 is phosphorylated during the cell cycle. The lack of phenotype for full-length Rga1 upon overexpression may result from a negative regulation by G1-specific Pho85, a cyclin-dependent kinase (CDK). From a high-copy suppressor screen, we isolated RHO3, SEC9, SEC1, SSO1, SSO2, and SRO7, genes involved in exocytosis, as suppressors of the growth defect caused by Rga1-C538 overexpression. Moreover, we detected that Rga1 interacts with Rho3 in two-hybrid and bimolecular fluorescence complementation (BiFC) assays. Rga1 preferentially interacts with the GTP-bound form of Rho3 and the interaction requires the GAP domain and additional sequence upstream of the GAP domain. Our data suggest that the interaction of Rga1 with Rho3 may regulate Rho3's function in polarized bud growth.	[He, Fei; Nie, Wen-Chao; Yuan, Si-Min; Gong, Ting; Liao, Yuan; Gao, Xiang-Dong] Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China; [Gao, Xiang-Dong] Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Wuhan, Peoples R China; [Tong, Zongtian; Bi, Erfei] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Wuhan University; University of Pennsylvania; Pennsylvania Medicine	Gao, XD (corresponding author), Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China.	xdgao@whu.edu.cn		Gao, Xiang-Dong/0000-0002-1008-2324	National Natural Science Foundation of China [30871347, 31370124]; National Institutes of Health [GM59216]; National Infrastructure of Natural Resources for Science and Technology Program of China [NIMR-2014-8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Infrastructure of Natural Resources for Science and Technology Program of China	work was supported by the National Natural Science Foundation of China (grant no. 30871347 and 31370124) to XDG, and by the National Institutes of Health (grant GM59216) to EB, and by National Infrastructure of Natural Resources for Science and Technology Program of China (no. NIMR-2014-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Aguilar RC, 2006, P NATL ACAD SCI USA, V103, P4116, DOI 10.1073/pnas.0510513103; Archambault V, 2004, MOL CELL, V14, P699, DOI 10.1016/j.molcel.2004.05.025; Bi EF, 1996, MOL CELL BIOL, V16, P5264; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Chen GC, 1996, MOL CELL BIOL, V16, P1376; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; Doignon F, 1999, FEBS LETT, V459, P458, DOI 10.1016/S0014-5793(99)01293-4; Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Gao XD, 2003, J CELL BIOL, V162, P635, DOI 10.1083/jcb.200302038; Gao XD, 2007, MOL BIOL CELL, V18, P2542, DOI 10.1091/mbc.e06-09-0822; Gladfelter AS, 2002, J CELL BIOL, V156, P315, DOI 10.1083/jcb.200109062; Gong T, 2013, EUKARYOT CELL, V12, P368, DOI 10.1128/EC.00277-12; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; James P, 1996, GENETICS, V144, P1425; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Marquitz AR, 2002, EMBO J, V21, P4012, DOI 10.1093/emboj/cdf416; MATSUI Y, 1992, GENE, V114, P43, DOI 10.1016/0378-1119(92)90705-T; MATSUI Y, 1992, MOL CELL BIOL, V12, P5690, DOI 10.1128/MCB.12.12.5690; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; PETERSON J, 1994, J CELL BIOL, V127, P1395, DOI 10.1083/jcb.127.5.1395; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Prouzet-Mauleon V, 2008, J BIOL CHEM, V283, P33249, DOI 10.1074/jbc.M805161200; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Rose A H, 1975, Methods Cell Biol, V12, P1; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; Smith GR, 2002, EUKARYOT CELL, V1, P469, DOI 10.1128/EC.1.3.469-480.2002; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Sopko R, 2007, EMBO J, V26, P4487, DOI 10.1038/sj.emboj.7601847; STEVENSON BJ, 1995, GENE DEV, V9, P2949, DOI 10.1101/gad.9.23.2949; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Togneri J, 2006, P NATL ACAD SCI USA, V103, P17730, DOI 10.1073/pnas.0605448103; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; WALWORTH NC, 1992, MOL CELL BIOL, V12, P2017, DOI 10.1128/MCB.12.5.2017; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wu H, 2010, MOL CELL BIOL, V30, P5207, DOI 10.1128/MCB.00366-10; Wu H, 2010, MOL BIOL CELL, V21, P430, DOI 10.1091/mbc.E09-06-0501; Zhang XY, 2005, J CELL BIOL, V170, P273, DOI 10.1083/jcb.200502055; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; ZHENG Y, 1994, J BIOL CHEM, V269, P2369; ZHENG Y, 1993, J BIOL CHEM, V268, P24629	53	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123326	10.1371/journal.pone.0123326	http://dx.doi.org/10.1371/journal.pone.0123326			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860339	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300093
J	Kashou, NH; Zampini, AR				Kashou, Nasser H.; Zampini, Angelica R.			Oculomotor Neurocircuitry, a Structural Connectivity Study of Infantile Nystagmus Syndrome	PLOS ONE			English	Article							RETICULARIS TEGMENTI-PONTIS; DOMINANT CONGENITAL NYSTAGMUS; EYE-MOVEMENTS; OPTIC TRACT; WAVE-FORMS; CEREBELLAR ACTIVATION; EFFERENT CONNECTIONS; AFFERENT-PROJECTIONS; RETROGRADE TRANSPORT; SPATIAL ORIENTATION	Infantile Nystagmus Syndrome (INS) is one of the leading causes of significant vision loss in children and affects about 1 in 1000 to 6000 births. In the present study, we are the first to investigate the structural pathways of patients and controls using diffusion tensor imaging (DTI). Specifically, three female INS patients from the same family were scanned, two sisters and a mother. Six regions of interest (ROIs) were created manually to analyze the number of tracks. Additionally, three ROI masks were analyzed using TBSS (Tract-Based Spatial Statistics). The number of fiber tracks was reduced in INS subjects, compared to normal subjects, by 15.9%, 13.9%, 9.2%, 18.6%, 5.3%, and 2.5% for the pons, cerebellum (right and left), brainstem, cerebrum, and thalamus. Furthermore, TBSS results indicated that the fractional anisotropy (FA) values for the patients were lower in the superior ventral aspects of the pons of the brainstem than in those of the controls. We have identified some brain regions that may be actively involved in INS. These novel findings would be beneficial to the neuroimaging clinical and research community as they will give them new direction in further pursuing neurological studies related to oculomotor function and provide a rational approach to studying INS.	[Kashou, Nasser H.; Zampini, Angelica R.] Wright State Univ, BioMed Imaging Lab, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Kashou, NH (corresponding author), Wright State Univ, BioMed Imaging Lab, Dayton, OH 45435 USA.	nasser.kashou@wright.edu	Kashou, Nasser/D-6535-2018	Kashou, Nasser/0000-0001-5639-9637				Abadi RV, 2002, J ROY SOC MED, V95, P231, DOI 10.1258/jrsm.95.5.231; Abadi RV, 2002, BRIT J OPHTHALMOL, V86, P1152, DOI 10.1136/bjo.86.10.1152; Andersson JLR, 2007, NONLINEAR OPTIMISATI; Andersson JLR, 2007, NONLINEAR REGISTRATI; BLANKS RHI, 1983, EXP BRAIN RES, V52, P293; BLANKS RHI, 1990, J NEUROCYTOL, V19, P628, DOI 10.1007/BF01188032; BRODAL P, 1980, EXP BRAIN RES, V38, P19; BRODAL P, 1980, EXP BRAIN RES, V38, P29; BRODAL P, 1982, J COMP NEUROL, V204, P44, DOI 10.1002/cne.902040106; Brooks VB., 1981, HDB PHYSL 1, P1480, DOI DOI 10.1002/CPHY.CP010228; Broomhead DS, 2000, BIOL CYBERN, V82, P391, DOI 10.1007/s004220050593; ButtnerEnnever JA, 1996, J COMP NEUROL, V373, P90, DOI 10.1002/(SICI)1096-9861(19960909)373:1<90::AID-CNE8>3.0.CO;2-8; Cabot A, 1999, AM J HUM GENET, V64, P1141, DOI 10.1086/302324; Cesarelli Mario, 2000, Documenta Ophthalmologica, V101, P59, DOI 10.1023/A:1002702609387; Clement RA, 2002, VISION RES, V42, P2123, DOI 10.1016/S0042-6989(02)00124-4; Cohen B, 1999, J VESTIBUL RES-EQUIL, V9, P163; COHEN B, 1972, EXP NEUROL, V36, P101, DOI 10.1016/0014-4886(72)90139-2; Dell'Osso L. F., 2002, Documenta Ophthalmologica, V104, P249, DOI 10.1023/A:1015299930849; Dell'Osso LF, 2005, DUANES CLIN OPHTHALM; DELLOSSO LF, 1979, ARCH OPHTHALMOL-CHIC, V97, P462, DOI 10.1001/archopht.1979.01020010212004; DELLOSSO LF, 1975, DOC OPHTHALMOL, V39, P155, DOI 10.1007/BF00578761; DELLOSSO LF, 1992, DOC OPHTHALMOL, V79, P1, DOI 10.1007/BF00160130; DICKINSON CM, 1986, OPHTHAL PHYSL OPT, V6, P303, DOI 10.1111/j.1475-1313.1986.tb00720.x; Dieterich M, 2000, NEUROLOGY, V54, P148, DOI 10.1212/WNL.54.1.148; FORT P, 1989, J COMP NEUROL, V283, P285, DOI 10.1002/cne.902830209; Gamlin PDR, 2006, PROG BRAIN RES, V151, P379, DOI 10.1016/S0079-6123(05)51012-4; GLICKSTEIN M, 1994, J COMP NEUROL, V349, P51, DOI 10.1002/cne.903490105; GONZALORUIZ A, 1990, EXP BRAIN RES, V80, P600; Goodale Melvyn A., 2004, SIGHT UNSEEN EXPLORA; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Helmchen C, 2003, NEUROLOGY, V61, P412, DOI 10.1212/01.WNL.0000073271.66866.51; Hertle RW, 2004, J AAPOS, V8, P539, DOI 10.1016/j.jaapos.2004.08.005; Hertle RW, 2003, OPHTHALMOLOGY, V110, P2097, DOI 10.1016/S0161-6420(03)00802-9; Hoffmann S, 2004, AM J OPHTHALMOL, V138, P439, DOI 10.1016/j.ajo.2004.04.065; HOLSTEGE G, 1986, BRAIN RES, V374, P306, DOI 10.1016/0006-8993(86)90425-7; HOLSTEGE G, 1984, BRAIN RES, V311, P7, DOI 10.1016/0006-8993(84)91393-3; HOLSTEGE G, 1982, J COMP NEUROL, V209, P139, DOI 10.1002/cne.902090204; Hufner K, 2007, NEUROLOGY, V69, P1128, DOI 10.1212/01.wnl.0000276953.00969.48; ITOH K, 1983, BRAIN RES, V274, P332, DOI 10.1016/0006-8993(83)90713-8; Jacobs JB, 2004, J VISION, V4, P604, DOI 10.1167/4.7.7; Jacobs JB, 2009, INVEST OPHTH VIS SCI, V50, P4685, DOI 10.1167/iovs.09-3387; JANSEN J, 1954, ASPECTS CEREBELLAR A; Kalla R, 2006, NEUROLOGY, V66, P281, DOI 10.1212/01.wnl.0000194242.28018.d9; Kashou NH, 2010, BRAIN RES, V1336, P10, DOI 10.1016/j.brainres.2010.04.017; Kato I, 1995, BRAIN RES, V705, P109, DOI 10.1016/0006-8993(95)01145-5; Kerrison JB, 1998, AM J OPHTHALMOL, V125, P64, DOI 10.1016/S0002-9394(99)80236-0; Kheradmand Amir, 2011, Front Neurol, V2, P53, DOI 10.3389/fneur.2011.00053; LANGER T, 1985, J COMP NEUROL, V235, P1, DOI 10.1002/cne.902350102; Leguire L E, 1990, J Pediatr Ophthalmol Strabismus, V27, P32; Leguire L E, 1998, J AAPOS, V2, P257, DOI 10.1016/S1091-8531(98)90080-5; Liu P, 2008, J NEUROPHYSIOL, V100, P1098, DOI 10.1152/jn.01043.2007; Maybodi Mitra, 2003, Curr Opin Ophthalmol, V14, P276, DOI 10.1097/00055735-200310000-00008; Mellott ML, 1999, ARCH OPHTHALMOL-CHIC, V117, P1630; MUSTARI MJ, 1994, J COMP NEUROL, V349, P111, DOI 10.1002/cne.903490108; Nagao S, 1997, J COMP NEUROL, V382, P480, DOI 10.1002/(SICI)1096-9861(19970616)382:4<480::AID-CNE5>3.0.CO;2-Z; Nagao S, 2004, CEREBELLUM, V3, P11, DOI 10.1080/14734220310012181; Nakahara H, 2003, OTOLARYNG HEAD NECK, V128, P598, DOI 10.1016/S0194-5998(02)23210-6; Oetting W S, 2000, Ophthalmic Genet, V21, P227, DOI 10.1076/1381-6810(200012)21:4;1-H;FT227; Pierrot-Deseilligny C, 2005, BRAIN, V128, P1237, DOI 10.1093/brain/awh532; Purves D, 2012, PRINCIPLES COGNITIVE; Rafal R, 2004, J NEUROL NEUROSUR PS, V75, P1602, DOI 10.1136/jnnp.2003.017038; Reinecke R D, 1997, J AAPOS, V1, P67, DOI 10.1016/S1091-8531(97)90002-1; RON S, 1973, J NEUROPHYSIOL, V36, P1004, DOI 10.1152/jn.1973.36.6.1004; Rucker Janet C, 2005, Curr Treat Options Neurol, V7, P69, DOI 10.1007/s11940-005-0008-0; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; SCALIA F, 1972, J COMP NEUROL, V145, P223, DOI 10.1002/cne.901450208; SCALIA F, 1972, Brain Behavior and Evolution, V6, P237, DOI 10.1159/000123712; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Sharma P, 2000, J AAPOS, V4, P287, DOI 10.1067/mpa.2000.107900; Simmers AJ, 1999, CURR EYE RES, V18, P194, DOI 10.1076/ceyr.18.3.194.5374; Simpson J I, 1988, Rev Oculomot Res, V2, P335; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smits M, 2007, AM J NEURORADIOL, V28, P1354, DOI 10.3174/ajnr.A0538; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Staempfli P, 2008, NEUROIMAGE, V39, P119, DOI 10.1016/j.neuroimage.2007.08.025; Stahl J S, 2001, Curr Neurol Neurosci Rep, V1, P471, DOI 10.1007/s11910-001-0109-4; Taibbi G, 2008, CLIN OPHTHALMOL, V2, P585; TAKADA M, 1984, NEUROSCI LETT, V50, P251, DOI 10.1016/0304-3940(84)90494-4; THIELERT CD, 1993, J COMP NEUROL, V337, P113, DOI 10.1002/cne.903370108; Thier P, 2006, PROG BRAIN RES, V151, P293, DOI 10.1016/S0079-6123(05)51010-0; TOMASCH J, 1969, BRAIN RES, V13, P476, DOI 10.1016/0006-8993(69)90261-3; Voogd J, 2006, PROG BRAIN RES, V151, P231, DOI 10.1016/S0079-6123(05)51008-2; Wang ZI, 2008, VISION RES, V48, P1409, DOI 10.1016/j.visres.2008.03.007; Wang Z, 2006, J AAPOS, V10, P552, DOI 10.1016/j.jaapos.2006.08.021; Wang ZI, 2007, J AAPOS, V11, P135, DOI 10.1016/j.jaapos.2006.10.012; Wang ZI, ADV UNDERSTANDING ME; Watanabe Y, 2004, J NEUROPHYSIOL, V92, P1756, DOI 10.1152/jn.00995.2003; Watkins RJ, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/460956; Wearne S, 1998, J NEUROPHYSIOL, V79, P2690, DOI 10.1152/jn.1998.79.5.2690; WEBER JT, 1985, BRAIN BEHAV EVOLUT, V26, P117, DOI 10.1159/000118771; YAMADA J, 1987, J COMP NEUROL, V265, P224, DOI 10.1002/cne.902650207	94	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0125380	10.1371/journal.pone.0125380	http://dx.doi.org/10.1371/journal.pone.0125380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860806	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300153
J	Pisula, E; Kawa, R; Danielewicz, D; Pisula, W				Pisula, Ewa; Kawa, Rafal; Danielewicz, Dorota; Pisula, Wojciech			The Relationship between Temperament and Autistic Traits in a Non-Clinical Students Sample	PLOS ONE			English	Article							SPECTRUM QUOTIENT AQ; PERSONALITY-TRAITS; MULTIPLE-INCIDENCE; PARENTS; PHENOTYPE; BEHAVIOR; ASSOCIATIONS; RELIABILITY; EXPERIENCES; ATTACHMENT	Since temperament affects the development of social behaviours and interpersonal relations, the possible links between autistic traits and temperament are of particular interest. The purpose of the study was to explore the relationships between autistic traits and temperamental characteristics in the framework of the Regulative Temperament Theory by Strelau, and the Emotionality, Activity and Sociability theory by Buss and Plomin, with particular emphasis on gender differences. The Autism Spectrum Quotient (AQ), Formal Characteristics of Behaviour - Temperament Inventory and Temperament Survey for Adults were administered. The participants were 593 university students, including 364 females and 229 males. Results showed positive correlations between autistic traits and Emotional Reactivity, Perseveration, Distress, Fear and Anger, and negative correlations with Activity, Briskness, Endurance and Sociability. The results of multiple regression analyses involving the Autism Spectrum Quotient score as a dependent measure were different for females and males. Results of exploratory PCA analysis showed that AQ score, Sociability and Activity loaded one factor (with AQ loading being opposite to two others). High AQ scorers demonstrated higher Emotional Reactivity, Perseveration, Distress and Anger, and lower Briskness, Endurance, Activity and Sociability as compared to norms for the general population. In this study we showed that temperament measures were able to identify items that correlated in parts with autistic traits, while other items were obverse. The relationships between temperament and autistic traits differ slightly between genders. We assume that with regard to the broader autism phenotype, temperaments might be helpful in characterizing healthy control samples.	[Pisula, Ewa; Kawa, Rafal] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Danielewicz, Dorota] Maria Grzegorzewska Acad Special Educ, Inst Appl Psychol, Warsaw, Poland; [Pisula, Wojciech] Polish Acad Sci, Inst Psychol, Warsaw, Poland	University of Warsaw; The Maria Grzegorzewska University; Polish Academy of Sciences; Institute of Psychology of the Polish Academy of Sciences	Pisula, E (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	ewa.pisula@psych.uw.edu.pl	Pisula, Wojciech/AAR-3618-2020	Pisula, Wojciech/0000-0001-5777-0549; Pisula, Ewa/0000-0002-7458-5043	Polish National Science Centre [N N106 352940]; Warsaw University	Polish National Science Centre; Warsaw University	The study was supported by a grant from the Polish National Science Centre (N N106 352940) and by the Warsaw University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; [Anonymous], 1983, TEMPERAMENT PERSONAL; Austin EJ, 2005, PERS INDIV DIFFER, V38, P451, DOI 10.1016/j.paid.2004.04.022; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102251; Bishop DVM, 2006, AM J MED GENET B, V141B, P117, DOI 10.1002/ajmg.b.30267; Bolte S, 2007, J AUTISM DEV DISORD, V37, P243, DOI 10.1007/s10803-006-0165-3; BOLTON P, 1994, J CHILD PSYCHOL PSYC, V35, P877, DOI 10.1111/j.1469-7610.1994.tb02300.x; Brunye TT, 2012, PERS INDIV DIFFER, V52, P84, DOI 10.1016/j.paid.2011.09.004; Buss A., 1984, TEMPERAMENT EARLY DE; Buss A. H., 1975, TEMPERAMENT THEORY P; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Constantino JN, 2006, AM J PSYCHIAT, V163, P294, DOI 10.1176/appi.ajp.163.2.294; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Crane L, 2009, AUTISM, V13, P215, DOI 10.1177/1362361309103794; Currenti SA, 2010, CELL MOL NEUROBIOL, V30, P161, DOI 10.1007/s10571-009-9453-8; Davis TE, 2010, RES AUTISM SPECT DIS, V4, P305, DOI 10.1016/j.rasd.2009.10.002; Dodds L, 2011, J AUTISM DEV DISORD, V41, P891, DOI 10.1007/s10803-010-1114-8; DORSHAV NK, 1984, J GENET PSYCHOL, V144, P39; EAVES L, 1975, J PERS SOC PSYCHOL, V32, P102, DOI 10.1037/h0076862; Folstein SE, 1998, J AUTISM DEV DISORD, V28, P439, DOI 10.1023/A:1026008606672; Frazier TW, 2010, ASSESSMENT, V17, P308, DOI 10.1177/1073191109356534; Gabriels RL, 2005, RES DEV DISABIL, V26, P169, DOI 10.1016/j.ridd.2004.05.003; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Hoekstra RA, 2007, ARCH PEDIAT ADOL MED, V161, P372, DOI 10.1001/archpedi.161.4.372; Horder J, 2014, J AUTISM DEV DISORD, V44, P1461, DOI 10.1007/s10803-013-2012-7; Hurst RM, 2007, PERS INDIV DIFFER, V43, P1938, DOI 10.1016/j.paid.2007.06.012; Ingersoll B, 2011, J AUTISM DEV DISORD, V41, P1646, DOI 10.1007/s10803-011-1192-2; Jaworowska A., 2001, KWESTIONARIUSZ INTEL; Kloosterman PH, 2011, PERS INDIV DIFFER, V50, P310, DOI 10.1016/j.paid.2010.10.015; Klusek J, 2014, AUTISM, V18, P106, DOI 10.1177/1362361312464529; Kunihira Y, 2006, J AUTISM DEV DISORD, V36, P553, DOI 10.1007/s10803-006-0094-1; Lam KSL, 2008, J CHILD PSYCHOL PSYC, V49, P1193, DOI 10.1111/j.1469-7610.2008.01944.x; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Losh M, 2008, AM J MED GENET B, V147B, P424, DOI 10.1002/ajmg.b.30612; Matczak A., 2001, KWESTIONARIUSZ KOMPE; Murphy M, 2000, PSYCHOL MED, V30, P1411, DOI 10.1017/S0033291799002949; Murray AL, 2014, J AUTISM DEV DISORD, V44, P55, DOI 10.1007/s10803-013-1851-6; Nuske HJ, 2013, COGNITION EMOTION, V27, P1042, DOI 10.1080/02699931.2012.762900; Oniszczenko W., 1997, KWESTIONARIUSZ TEMPE; Pisula E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075236; PIVEN J, 1994, PSYCHOL MED, V24, P783, DOI 10.1017/S0033291700027938; Piven J, 1997, AM J MED GENET, V74, P398, DOI 10.1002/(SICI)1096-8628(19970725)74:4<398::AID-AJMG11>3.3.CO;2-K; PIVEN J, 1991, J AM ACAD CHILD PSY, V30, P471, DOI 10.1097/00004583-199105000-00019; PLOMIN R, 1995, J CHILD PSYCHOL PSYC, V36, P33, DOI 10.1111/j.1469-7610.1995.tb01655.x; RUTTER M, 1987, BRIT J PSYCHIAT, V150, P443, DOI 10.1192/bjp.150.4.443; Samson AC, 2014, J AUTISM DEV DISORD, V44, P1766, DOI 10.1007/s10803-013-2022-5; Samson AC, 2012, EMOTION, V12, P659, DOI 10.1037/a0027975; Sasson NJ, 2013, AUTISM, V17, P655, DOI 10.1177/1362361312455704; Seifer R, 1996, DEV PSYCHOL, V32, P12, DOI 10.1037/0012-1649.32.1.12; Stewart ME, 2009, PERS INDIV DIFFER, V47, P224, DOI 10.1016/j.paid.2009.03.004; Strelau J., 1998, TEMPERAMENT PSYCHOL; Tavassoli T, 2014, AUTISM, V18, P428, DOI 10.1177/1362361313477246; Umemura T, 2014, INFANT BEHAV DEV, V37, P352, DOI 10.1016/j.infbeh.2014.05.007; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P873, DOI 10.1016/j.paid.2006.04.003; Worobey J, 2001, PERS INDIV DIFFER, V31, P461, DOI 10.1016/S0191-8869(00)00154-9; Zawadzki B, 1997, FORMULNA CHARAKTERYS; Zmijewska A, 2009, PSYCHOL ETOLOGIA GEN, V20, P51	59	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124364	10.1371/journal.pone.0124364	http://dx.doi.org/10.1371/journal.pone.0124364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25860508	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300136
J	Takashima, T; Kishi, T; Onozawa, K; Rikitake, S; Miyazono, M; Otsuka, T; Irie, H; Iwakiri, R; Fujimoto, K; Ikeda, Y				Takashima, Tsuyoshi; Kishi, Tomoya; Onozawa, Koji; Rikitake, Shuichi; Miyazono, Motoaki; Otsuka, Takateru; Irie, Hiroyuki; Iwakiri, Ryuichi; Fujimoto, Kazuma; Ikeda, Yuji			Significance of Technetium-99m Human Serum Albumin Diethylenetriamine Pentaacetic Acid Scintigraphy in Patients with Nephrotic Syndrome	PLOS ONE			English	Article							INTERSTITIAL NEPHRITIS; PROXIMAL TUBULE; GENE-EXPRESSION; RAT; HOMEOSTASIS; KIDNEY; CATABOLISM; CELLS	It is thought that a large amount of albumin leaking from the glomerulus in nephrotic syndrome (NS) is reabsorbed at the proximal tubule and catabolized. Therefore, it is possible the final quantity of urinary protein does not always reflect the amount of leakage of protein from the glomerulus. We experienced two cases without nephrotic range proteinuria thought to involve hypoproteinemia due to the same pathophysiology as NS. On these patients, we performed protein leakage scintigraphy with technetium-99m human serum albumin diethylenetriamine pentaacetic acid ((99)mTc-HSAD) to exclude a diagnosis of protein-losing gastro-enteropathy and observed diffuse positive accumulation in the kidneys with more intense uptake in the kidney than the liver on the anterior view 24 hours after (99)mTc-HSAD administration. In healthy adults intravenously given 99mTc-HSAD, the same dynamics are observed as in albumin metabolism, and the organ radioactivity of the liver and kidneys after 24 hours is equal. Therefore, we thought it was possible that the renal uptake 24 hours after (99)mTc-HSAD administration was a characteristic finding of NS. In order to confirm it, the subjects were divided into two groups: the NS group (n = 10) and the non-NS group (n = 7). We defined more intense uptake in the kidney than the liver on the anterior view 24 hours after (99)mTc-HSAD administration as Dense Kidney (+). Furthermore, we designed regions of interest in the right and left kidneys and liver on anterior and posterior images, then calculated the kidney-liver ratio. Nine of the ten patients had Dense Kidney (+) in the NS group, compared to none in the non-NS group. And the kidney-liver ratio was significantly higher in the NS group than in the non-NS group on each view in the bilateral kidneys. In conclusion, our results suggest that the renal uptake 24 hours after (99)mTc-HSAD administration is a characteristic finding of NS.	[Takashima, Tsuyoshi; Kishi, Tomoya; Rikitake, Shuichi; Miyazono, Motoaki; Iwakiri, Ryuichi; Fujimoto, Kazuma; Ikeda, Yuji] Saga Univ, Dept Internal Med, Fac Med, Saga 840, Japan; [Onozawa, Koji] Ureshino Med Ctr, Dept Nephrol, Ureshino, Japan; [Otsuka, Takateru; Irie, Hiroyuki] Saga Univ, Dept Radiol, Fac Med, Saga 840, Japan	Saga University; Saga University	Takashima, T (corresponding author), Saga Univ, Dept Internal Med, Fac Med, Saga 840, Japan.	takashim@cc.saga-u.ac.jp		Rikitake, Shuichi/0000-0002-7533-2961				Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; GALASKE RG, 1978, PFLUG ARCH EUR J PHY, V375, P269, DOI 10.1007/BF00582441; Gekle M, 2005, ANNU REV PHYSIOL, V67, P573, DOI 10.1146/annurev.physiol.67.031103.154845; Glassock RJ, 2015, NEPHROL DIAL TRANSPL, V30, P12, DOI 10.1093/ndt/gfu077; HAMADA S, 1988, Kaku Igaku, V25, P381; HAYASHIDA K, 1988, Kaku Igaku, V25, P1155; ISHII K, 1989, Kaku Igaku, V26, P35; KATZ J, 1964, J LAB CLIN MED, V63, P680; KATZ J, 1960, AM J PHYSIOL, V198, P814, DOI 10.1152/ajplegacy.1960.198.4.814; KAWAMURA Y, 1989, Kaku Igaku, V26, P433; KAYSEN GA, 1984, KIDNEY INT, V25, P107, DOI 10.1038/ki.1984.15; KAYSEN GA, 1984, AM J PHYSIOL, V247, pF192, DOI 10.1152/ajprenal.1984.247.1.F192; KAYSEN GA, 1986, KIDNEY INT, V29, P572, DOI 10.1038/ki.1986.36; Kelepouris E, 2014, UPTODATE; Komatsu Y, 1990, Nihon Jinzo Gakkai Shi, V32, P1243; LINTON AL, 1980, ANN INTERN MED, V93, P735, DOI 10.7326/0003-4819-93-5-735; LINTON AL, 1985, CLIN NEPHROL, V24, P84; MOSHAGE HJ, 1987, J CLIN INVEST, V79, P1635, DOI 10.1172/JCI113000; NISHIZAWA S, 1988, Kaku Igaku, V25, P1189; PIETRANGELO A, 1992, J CLIN INVEST, V89, P1755, DOI 10.1172/JCI115778; PRAGA M, 1991, AM J KIDNEY DIS, V17, P330, DOI 10.1016/S0272-6386(12)80483-5; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Sato Tomoyasu, 1996, Kaku Igaku, V33, P1091; SHIRAKAMI Y, 1987, Kaku Igaku, V24, P475; Slattery C, 2008, KIDNEY INT, V74, P1480, DOI 10.1038/ki.2008.463; Suehiro T, 2006, NIHON SHONI JINZOBYO, V19, P141; SUN XH, 1993, AM J PHYSIOL, V264, pF441, DOI 10.1152/ajprenal.1993.264.3.F441; SUN XH, 1994, KIDNEY INT, V45, P1381, DOI 10.1038/ki.1994.180; Takashima T, 2014, CEN CASE REP, V3, P172, DOI 10.1007/s13730-014-0112-7; TAMAKI N, 1988, Kaku Igaku, V25, P579; TORIZUKA K, 1988, Kaku Igaku, V25, P1201; WOOD BC, 1978, ARCH INTERN MED, V138, P1665, DOI 10.1001/archinte.138.11.1665; YAMADA M, 1988, Kaku Igaku, V25, P1291	33	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123036	10.1371/journal.pone.0123036	http://dx.doi.org/10.1371/journal.pone.0123036			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859658	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300074
J	Zhang, JY; Liu, HL; Liang, X; Zhang, M; Wang, RK; Peng, G; Li, JY				Zhang, Jingyang; Liu, Hongling; Liang, Xue; Zhang, Min; Wang, Renke; Peng, Guang; Li, Jiyao			Investigation of Salivary Function and Oral Microbiota of Radiation Caries-Free People with Nasopharyngeal Carcinoma	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; INTENSITY-MODULATED RADIOTHERAPY; FLOW-RATE; WHOLE SALIVA; PYROSEQUENCING ANALYSIS; BACTERIAL COMMUNITIES; DENTAL-CARIES; CANCER; HEAD; HYPOSALIVATION	Radiation caries have been reported to be correlated with radiotherapy-induced destruction of salivary function and changes in oral microbiota. There have been no published reports detailing patients who have remained radiation caries-free following radiotherapy for nasopharyngeal carcinoma. The aim of this study was to investigate the relationship between salivary function, oral microbiota and the absence of radiation caries. Twelve radiation caries-free patients and nine patients exhibiting radiation caries following irradiated nasopharyngeal carcinoma were selected. V40, the dose at which the volume of the contralateral parotid gland receives more than 40 Gy, was recorded. Stimulated saliva flow rate, pH values and buffering capacity were examined to assess salivary function. Stimulated saliva was used for molecular profiling by Denaturing Gradient Gel Electrophoresis. Mutans streptococci and Lactobacilli in saliva were also cultivated. There were no significant differences in V40 between radiation caries-free individuals and those with radiation caries. Compared with normal values, the radiation caries-free group had significantly decreased simulated saliva flow rate, while there were no significant differences in the saliva pH value and buffering capacity. Similar results were observed in the radiation caries group. There was no statistical difference in microbial diversity, composition and log CFU counts in cultivation from the radiation caries-free group and the radiation caries group. Eleven genera were detected in these two groups, among which Streptococcus spp. and Neisseria spp. had the highest distribution. Our results suggest that changes in salivary function and in salivary microbiota do not explain the absence of radiation caries in radiation caries-free individuals.	[Zhang, Jingyang; Liu, Hongling; Liang, Xue; Zhang, Min; Wang, Renke; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China; [Zhang, Jingyang; Liu, Hongling; Zhang, Min; Wang, Renke; Li, Jiyao] Sichuan Univ, Dept Operat Dent & Endodont, West China Sch Stomatol, Chengdu 610041, Peoples R China; [Liang, Xue; Peng, Guang] Sichuan Univ, Radiat Phys Ctr, Ctr Canc, West China Hosp, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, JY (corresponding author), West China Coll Stomatol, Dept Operat Dent & Endodont, Chengdu, Peoples R China.	jiyaoliscu@163.com		Zhang, Jingyang/0000-0003-4236-6222	National Science & Technology Pillar Program during the 12th Five-year Plan Period [20911BAZ03171]; Chinese National Natural Science Fund for Young Scholars [31200389]; Chinese National Natural Science Fund [81371135]	National Science & Technology Pillar Program during the 12th Five-year Plan Period; Chinese National Natural Science Fund for Young Scholars; Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This investigation was supported by the National Science & Technology Pillar Program during the 12th Five-year Plan Period (No. 20911BAZ03171), the Chinese National Natural Science Fund for Young Scholars (No. 31200389), and the Chinese National Natural Science Fund (No. 81371135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar Gabrielle P, 2009, J Contemp Dent Pract, V10, P83; Al-Nawas B, 2006, SUPPORT CARE CANCER, V14, P291, DOI 10.1007/s00520-005-0895-3; Almstahl A, 2008, ORAL DIS, V14, P541, DOI 10.1111/j.1601-0825.2007.01416.x; Almstahl A, 2003, ARCH ORAL BIOL, V48, P337, DOI 10.1016/S0003-9969(02)00200-5; Almstahl A, 2003, ORAL MICROBIOL IMMUN, V18, P1, DOI 10.1034/j.1399-302X.2003.180101.x; Almstahl A, 1999, J DENT RES, V78, P1410, DOI 10.1177/00220345990780080601; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Belstrom D, 2014, CARIES RES, V48, P368, DOI 10.1159/000357502; BENARYEH H, 1975, INT J ORAL MAXILLOF, V4, P205, DOI 10.1016/S0300-9785(75)80027-5; Boon N, 2002, FEMS MICROBIOL ECOL, V39, P101, DOI 10.1111/j.1574-6941.2002.tb00911.x; BROWN LR, 1978, J DENT RES, V57, P882, DOI 10.1177/00220345780570090901; Campus G, 2012, CARIES RES, V46, P16, DOI 10.1159/000334932; Chao K, 2001, RADIOTHERAPY ONCOLOG, V61; Cocolin L, 2000, FEMS MICROBIOL LETT, V189, P81, DOI 10.1016/S0378-1097(00)00257-3; Dal Bello F, 2006, SYST APPL MICROBIOL, V29, P69, DOI 10.1016/j.syapm.2005.07.002; DREIZEN S, 1977, J DENT RES, V56, P99, DOI 10.1177/00220345770560022101; DREIZEN S, 1976, CANCER, V38, P273, DOI 10.1002/1097-0142(197607)38:1<273::AID-CNCR2820380141>3.0.CO;2-8; Eliasson L, 2005, ARCH ORAL BIOL, V50, P293, DOI 10.1016/j.archoralbio.2004.08.009; Epstein J B, 1992, J Can Dent Assoc, V58, P217; Epstein JB, 1998, ORAL SURG ORAL MED O, V86, P286, DOI 10.1016/S1079-2104(98)90173-1; GOLD OG, 1973, ARCH ORAL BIOL, V18, P1357, DOI 10.1016/0003-9969(73)90109-X; Haffajee AD, 2009, J PERIODONTAL RES, V44, P511, DOI 10.1111/j.1600-0765.2008.01154.x; Hu YJ, 2013, INT J ORAL SCI, V5, P21, DOI 10.1038/ijos.2013.15; Hu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056343; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; JANSMA J, 1992, INT J RADIAT ONCOL, V24, P359, DOI 10.1016/0360-3016(92)90692-B; Jham Bruno Correia, 2006, Rev. Bras. Otorrinolaringol., V72, P704, DOI 10.1590/S0034-72992006000500019; Jiang W, 2014, MICROB ECOL, V67, P962, DOI 10.1007/s00248-014-0372-y; Joyston-Bechal S, 1992, Int Dent J, V42, P47; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kielbassa A, 2001, J CLIN DENT, V13, P104; Kielbassa A M, 2001, Schweiz Monatsschr Zahnmed, V111, P1060; Kielbassa AM, 2006, LANCET ONCOL, V7, P326, DOI 10.1016/S1470-2045(06)70658-1; Kielbassa AM, 2006, CARIES RES, V40, P130, DOI 10.1159/000091059; Kielbassa AM, 2000, CARIES RES, V34, P41, DOI 10.1159/000016568; Kwong DLW, 2004, CANCER, V101, P1584, DOI 10.1002/cncr.20552; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Li Y, 2005, J DENT RES, V84, P559, DOI 10.1177/154405910508400614; Li Y, 2007, J CLIN MICROBIOL, V45, P3082, DOI 10.1128/JCM.00771-07; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; LIZI EC, 1992, BRIT DENT J, V173, P24, DOI 10.1038/sj.bdj.4807926; Llena-Puy Carmen, 2006, Med Oral Patol Oral Cir Bucal, V11, pE449; Luo AH, 2012, ORAL DIS, V18, P595, DOI 10.1111/j.1601-0825.2012.01915.x; Marta GN, 2014, RADIOTHER ONCOL, V110, P9, DOI 10.1016/j.radonc.2013.11.010; Meng LY, 2005, CARIES RES, V39, P484, DOI 10.1159/000088184; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Ono K, 2006, ARCH ORAL BIOL, V51, P345, DOI 10.1016/j.archoralbio.2005.09.001; Ortholan C, 2009, INT J RADIAT ONCOL, V73, P178, DOI 10.1016/j.ijrobp.2008.03.068; Pow EHN, 2006, INT J RADIAT ONCOL, V66, P981, DOI 10.1016/j.ijrobp.2006.06.013; Roesink JM, 2000, RADIOTHER ONCOL, V55, P131, DOI 10.1016/S0167-8140(00)00154-7; Rudney JD, 2003, ARCH ORAL BIOL, V48, P475, DOI 10.1016/S0003-9969(03)00043-8; SHANNON IL, 1977, J DENT RES, V56, P693, DOI 10.1177/00220345770560062201; Shao ZY, 2011, J RADIAT RES, V52, P834, DOI 10.1269/jrr.11085; Silverman S, 1999, ORAL SURG ORAL MED O, V88, P122, DOI 10.1016/S1079-2104(99)70103-4; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; SPAK CJ, 1994, CARIES RES, V28, P388, DOI 10.1159/000262007; Tao Y, 2013, ARCH ORAL BIOL, V58, P1129, DOI 10.1016/j.archoralbio.2013.04.005; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P213, DOI 10.1177/154411130301400306; Wang RK, 2012, MICROB ECOL, V64, P152, DOI 10.1007/s00248-012-0013-2; WATANABE K, 1993, J DENT RES, V72, P1040, DOI 10.1177/00220345930720060801; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zarco MF, 2012, ORAL DIS, V18, P109, DOI 10.1111/j.1601-0825.2011.01851.x; Zhang W, 2013, MICROB ECOL, V66, P385, DOI 10.1007/s00248-012-0160-5	64	11	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123137	10.1371/journal.pone.0123137	http://dx.doi.org/10.1371/journal.pone.0123137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860481	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300080
J	Andreassen, OA; Desikan, RS; Wang, Y; Thompson, WK; Schork, AJ; Zuber, V; Doncheva, NT; Ellinghaus, E; Albrecht, M; Mattingsdal, M; Franke, A; Lie, BA; Mills, I; Aukrust, P; McEvoy, LK; Djurovic, S; Karlsen, TH; Dale, AM				Andreassen, Ole A.; Desikan, Rahul S.; Wang, Yunpeng; Thompson, Wesley K.; Schork, Andrew J.; Zuber, Verena; Doncheva, Nadezhda T.; Ellinghaus, Eva; Albrecht, Mario; Mattingsdal, Morten; Franke, Andre; Lie, Benedicte A.; Mills, Ian; Aukrust, Pal; McEvoy, Linda K.; Djurovic, Srdjan; Karlsen, Tom H.; Dale, Anders M.			Abundant Genetic Overlap between Blood Lipids and Immune-Mediated Diseases Indicates Shared Molecular Genetic Mechanisms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; RHEUMATOID-ARTHRITIS; CROHN DISEASE; PUBLIC-HEALTH; IDENTIFIES 7; RISK LOCUS; ATHEROSCLEROSIS; INFLAMMATION; METABOLISM	Epidemiological studies suggest a relationship between blood lipids and immune-mediated diseases, but the nature of these associations is not well understood. We used genome-wide association studies (GWAS) to investigate shared single nucleotide polymorphisms (SNPs) between blood lipids and immune-mediated diseases. We analyzed data from GWAS (n similar to 200,000 individuals), applying new False Discovery Rate (FDR) methods, to investigate genetic overlap between blood lipid levels [triglycerides (TG), low density lipoproteins (LDL), high density lipoproteins (HDL)] and a selection of archetypal immune-mediated diseases (Crohn's disease, ulcerative colitis, rheumatoid arthritis, type 1 diabetes, celiac disease, psoriasis and sarcoidosis). We found significant polygenic pleiotropy between the blood lipids and all the investigated immune-mediated diseases. We discovered several shared risk loci between the immune-mediated diseases and TG (n = 88), LDL (n = 87) and HDL (n = 52). Three-way analyses differentiated the pattern of pleiotropy among the immune-mediated diseases. The new pleiotropic loci increased the number of functional gene network nodes representing blood lipid loci by 40%. Pathway analyses implicated several novel shared mechanisms for immune pathogenesis and lipid biology, including glycosphingolipid synthesis (e.g. FUT2) and intestinal host-microbe interactions (e.g. ATG16L1). We demonstrate a shared genetic basis for blood lipids and immune-mediated diseases independent of environmental factors. Our findings provide novel mechanistic insights into dyslipidemia and immune-mediated diseases and may have implications for therapeutic trials involving lipid-lowering and anti-inflammatory agents.	[Andreassen, Ole A.; Wang, Yunpeng; Zuber, Verena; Mattingsdal, Morten; Djurovic, Srdjan] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, N-0407 Oslo, Norway; [Andreassen, Ole A.; Wang, Yunpeng; Zuber, Verena; Mattingsdal, Morten; Djurovic, Srdjan] Oslo Univ Hosp, Div Mental Hlth & Addict, N-0407 Oslo, Norway; [Desikan, Rahul S.; Wang, Yunpeng; Schork, Andrew J.; McEvoy, Linda K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92093 USA; [Schork, Andrew J.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Schork, Andrew J.] Univ Calif San Diego, Cognit Sci Grad Program, La Jolla, CA 92093 USA; [Zuber, Verena; Mills, Ian] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA 92093 USA; [Zuber, Verena; Mills, Ian] Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, N-0407 Oslo, Norway; [Doncheva, Nadezhda T.; Albrecht, Mario] Oslo Univ Hosp, N-0407 Oslo, Norway; [Ellinghaus, Eva; Franke, Andre] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Albrecht, Mario] Univ Kiel, Inst Clin Mol Biol, D-24118 Kiel, Germany; [Albrecht, Mario] Univ Med Greifswald, Inst Biometr & Med Informat, Dept Bioinformat, D-17475 Greifswald, Germany; [Albrecht, Mario; Lie, Benedicte A.] Graz Univ Technol, Inst Knowledge Discovery, A-8010 Graz, Austria; [Mattingsdal, Morten] BioTechMed Graz, A-8010 Graz, Austria; [Aukrust, Pal; Djurovic, Srdjan] Sorlandet Hosp, N-3000 Kristiansand, Norway; [Mills, Ian] Univ Oslo, Dept Med Genet, N-0407 Oslo, Norway; [Mills, Ian] Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, N-0407 Oslo, Norway; [Karlsen, Tom H.] Oslo Univ Hosp, Dept Urol, N-0407 Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, KG Jebsen Inflammat Res Ctr, Internal Med Res Inst,Div Canc Med Surg & Transpl, N-0407 Oslo, Norway; [Karlsen, Tom H.] Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0407 Oslo, Norway; [Karlsen, Tom H.] Univ Bergen, Inst Med, Div Gastroenterol, N-5000 Bergen, Norway; [Dale, Anders M.] Oslo Univ Hosp, Rikshosp, Norwegian PSC Res Ctr, Dept Transplantat Med,Div Canc Med Surg & Transpl, N-0407 Oslo, Norway; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Oslo; University of Oslo; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oslo; University of Oslo; Max Planck Society; University of Kiel; Greifswald Medical School; Graz University of Technology; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Bergen; University of Oslo; National Hospital Norway; University of California System; University of California San Diego	Andreassen, OA (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, N-0407 Oslo, Norway.	o.a.andreassen@medisin.uio.no; amdale@ucsd.edu	Mattingsdal, Morten/Q-9367-2016; Mills, Ian/AAK-9292-2020; Franke, Andre/B-2151-2010; Andreassen, Ole A./AAY-7531-2020; Wang, Yunpeng/W-8871-2018; Albrecht, Mario/B-6694-2008; Ellinghaus, Eva/E-6490-2012	Mattingsdal, Morten/0000-0003-4440-0324; Mills, Ian/0000-0001-5347-5083; Franke, Andre/0000-0003-1530-5811; Wang, Yunpeng/0000-0001-9831-1090; Albrecht, Mario/0000-0002-3103-9624; Ellinghaus, Eva/0000-0003-2914-3382; Djurovic, Srdjan/0000-0002-8140-8061; Doncheva, Nadezhda T./0000-0002-8806-6850; Zuber, Verena/0000-0001-9827-1877	Research Council of Norway; South-East Norway Regional Health Authority; KG Jebsen Foundation, NIH; German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104400] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); South-East Norway Regional Health Authority; KG Jebsen Foundation, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the Research Council of Norway, the South-East Norway Regional Health Authority, KG Jebsen Foundation, NIH, the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN). OAA and AMD had full access to all the data in the study and had final responsibility for the decision to submit for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andreassen OA, 2015, MOL PSYCHIATR, V20, P207, DOI 10.1038/mp.2013.195; Andreassen OA, 2014, INT J EPIDEMIOL, V43, P1205, DOI 10.1093/ije/dyu090; Andreassen OA, 2014, HYPERTENSION, V63, P819, DOI 10.1161/HYPERTENSIONAHA.113.02077; Andreassen OA, 2014, SCHIZOPHRENIA BULL, V40, P13, DOI 10.1093/schbul/sbt168; Andreassen OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003455; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bartoloni E, 2011, ARTHRIT CARE RES, V63, P178, DOI 10.1002/acr.20322; Biyyani RSRS, 2010, J CLIN LIPIDOL, V4, P478, DOI 10.1016/j.jacl.2010.08.021; Bowie RV, 2012, AM J PHYSIOL-GASTR L, V302, pG781, DOI 10.1152/ajpgi.00002.2011; Chodick G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000336; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Fischer A, 2012, AM J RESP CRIT CARE, V186, P877, DOI 10.1164/rccm.201204-0708OC; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Garces SP, 2008, ANN RHEUM DIS, V67, P895, DOI 10.1136/ard.2007.078287; Hahn BH, 2007, J AUTOIMMUN, V28, P69, DOI 10.1016/j.jaut.2007.02.004; Hofmann S, 2013, EUR RESPIR J, V41, P888, DOI 10.1183/09031936.00033812; Jamnitski A, 2013, ANN RHEUM DIS, V72, P467, DOI 10.1136/annrheumdis-2011-201194corr1; Jenkins DJA, 2005, METABOLISM, V54, P103, DOI 10.1016/j.metabol.2004.07.019; Kaddurah-Daouk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025482; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Martinelli N, 2009, J NUTRIGENET NUTRIGE, V2, P129, DOI 10.1159/000238177; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nisar A, 2012, JCPSP-J COLL PHYSICI, V22, P235, DOI 04.2012/JCPSP.235239; Norata GD, 2012, ATHEROSCLEROSIS, V220, P11, DOI 10.1016/j.atherosclerosis.2011.06.045; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pietrzak A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535612; Piquer BR, 2006, METABOLISM, V55, P980, DOI 10.1016/j.metabol.2006.03.006; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Salazar A, 1998, ATHEROSCLEROSIS, V136, P133, DOI 10.1016/S0021-9150(97)00198-6; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schlicker A, 2010, NUCLEIC ACIDS RES, V38, pD244, DOI 10.1093/nar/gkp979; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith GD, 2005, LANCET, V366, P1484, DOI 10.1016/S0140-6736(05)67601-5; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Toms TE, 2011, ANN RHEUM DIS, V70, P1025, DOI 10.1136/ard.2010.144634; van Halm VP, 2007, ANN RHEUM DIS, V66, P184, DOI 10.1136/ard.2006.051672; Verges B, 2009, DIABETES METAB, V35, P353, DOI 10.1016/j.diabet.2009.04.004; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wei D, 2010, DIABETES, V59, P471, DOI 10.2337/db09-0284; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams HRT, 2012, DIGEST DIS SCI, V57, P2157, DOI 10.1007/s10620-012-2127-2; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366	63	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123057	10.1371/journal.pone.0123057	http://dx.doi.org/10.1371/journal.pone.0123057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853426	Green Published, gold			2022-12-27	WOS:000352478400095
J	Bernarde, C; Keravec, M; Mounier, J; Gouriou, S; Rault, G; Ferec, C; Barbier, G; Hery-Arnaud, G				Bernarde, Cedric; Keravec, Marlene; Mounier, Jerome; Gouriou, Stephanie; Rault, Gilles; Ferec, Claude; Barbier, Georges; Hery-Arnaud, Genevieve			Impact of the CFTR-Potentiator Ivacaftor on Airway Microbiota in Cystic Fibrosis Patients Carrying A G551D Mutation	PLOS ONE			English	Article							IN-VITRO; DIVERSITY; BACTERIA; COMMUNITIES; INFECTIONS; SPUTUM	Background Airway microbiota composition has been clearly correlated with many pulmonary diseases, and notably with cystic fibrosis (CF), an autosomal genetic disorder caused by mutation in the CF transmembrane conductance regulator (CFTR). Recently, a new molecule, ivacaftor, has been shown to re-establish the functionality of the G551D-mutated CFTR, allowing significant improvement in lung function. Objective and Methods The purpose of this study was to follow the evolution of the airway microbiota in CF patients treated with ivacaftor, using quantitative PCR and pyrosequencing of 16S rRNA amplicons, in order to identify quantitative and qualitative changes in bacterial communities. Three G551D children were followed up longitudinally over a mean period of more than one year covering several months before and after initiation of ivacaftor treatment. Results 129 operational taxonomy units (OTUs), representing 64 genera, were identified. There was no significant difference in total bacterial load before and after treatment. Comparison of global community composition found no significant changes in microbiota. Two OTUs, however, showed contrasting dynamics: after initiation of ivacaftor, the relative abundance of the anaerobe Porphyromonas 1 increased (p<0.01) and that of Streptococcus 1 (S. mitis group) decreased (p<0.05), possibly in relation to the anti-Gram-positive properties of ivacaftor. The anaerobe Prevotella 2 correlated positively with the pulmonary function test FEV-1 (r=0.73, p<0.05). The study confirmed the presumed positive role of anaerobes in lung function. Conclusion Several airway microbiota components, notably anaerobes (obligate or facultative anaerobes), could be valuable biomarkers of lung function improvement under ivacaftor, and could shed light on the pathophysiology of lung disease in CF patients.	[Bernarde, Cedric; Keravec, Marlene; Mounier, Jerome; Gouriou, Stephanie; Barbier, Georges; Hery-Arnaud, Genevieve] Univ Brest, EA 3882, Lab Univ Biodivers & Ecol Microbienne, Brest, France; [Rault, Gilles] CRCM Mixte, Ctr Perharidy, Roscoff, France; [Ferec, Claude] INSERM, UMR1078, Brest, France; [Hery-Arnaud, Genevieve] CHRU Brest, Dept Bacteriol Virol Hyg & Parasitol Mycol, Brest, France; [Ferec, Claude] CHRU Brest, Genet Mol Lab, Brest, France; [Ferec, Claude] Univ Brest, Fac Med & Sci Sante, Brest, France; [Ferec, Claude] Etab Francais Sang Bretagne, Brest, France	Universite de Bretagne Occidentale; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale	Hery-Arnaud, G (corresponding author), Univ Brest, EA 3882, Lab Univ Biodivers & Ecol Microbienne, Brest, France.	hery@univ-brest.fr	Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710; Mounier, Jerome/0000-0002-8290-6898	French Cystic Fibrosis Association "Vaincre la Mucoviscidose" [RC20120600696]	French Cystic Fibrosis Association "Vaincre la Mucoviscidose"	This study was supported by a grant to GHA from the French Cystic Fibrosis Association "Vaincre la Mucoviscidose" (contract No. RC20120600696). http://www.vaincrelamuco.org/ewb_pages/p/projets-finances.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, REFERENTIEL MICROBIO, P90; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caldas RR, 2015, J CYST FIBROS, V14, P6, DOI 10.1016/j.jcf.2014.04.008; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Crabbe A, 2014, PATHOG DIS, V71, P1, DOI 10.1111/2049-632X.12180; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Ferec C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009480; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Le Gall F, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-143; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Maeda Y, 2011, J CYST FIBROS, V10, P133, DOI 10.1016/j.jcf.2010.11.003; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; Price KE, MICROBIOME, V27; Quinn RA, 2014, MBIO, V5, DOI 10.1128/mBio.00956-13; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Reznikov LR, 2014, J CYST FIBROS, V13, P515, DOI 10.1016/j.jcf.2014.02.004; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rogers GB, 2015, THORAX, V70, P74, DOI 10.1136/thoraxjnl-2014-205826; Rowe SM, 2014, AM J RESP CRIT CARE, V190, P175, DOI 10.1164/rccm.201404-0703OC; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Van Hoogmoed CG, 2008, ORAL MICROBIOL IMMUN, V23, P43, DOI 10.1111/j.1399-302X.2007.00388.x; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; WHITE C, 1952, BIOMETRICS, V8, P33, DOI 10.2307/3001523; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zhao JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04345; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	47	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124124	10.1371/journal.pone.0124124	http://dx.doi.org/10.1371/journal.pone.0124124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853698	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400135
J	Ebshiana, AA; Snowden, SG; Thambisetty, M; Parsons, R; Hye, A; Legido-Quigley, C				Ebshiana, Amera A.; Snowden, Stuart G.; Thambisetty, Madhav; Parsons, Richard; Hye, Abdul; Legido-Quigley, Cristina			Metabolomic Method: UPLC-q-ToF Polar and Non-Polar Metabolites in the Healthy Rat Cerebellum Using an In-Vial Dual Extraction	PLOS ONE			English	Article							MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; LIQUID-CHROMATOGRAPHY; ION SUPPRESSION; ELECTROSPRAY-IONIZATION; LC-MS; DIAGNOSIS; DISORDERS; PLASMA; PHASE	Unbiased metabolomic analysis of biological samples is a powerful and increasingly commonly utilised tool, especially for the analysis of bio-fluids to identify candidate biomarkers. To date however only a small number of metabolomic studies have been applied to studying the metabolite composition of tissue samples, this is due, in part to a number of technical challenges including scarcity of material and difficulty in extracting metabolites. The aim of this study was to develop a method for maximising the biological information obtained from small tissue samples by optimising sample preparation, LC-MS analysis and metabolite identification. Here we describe an in-vial dual extraction (IVDE) method, with reversed phase and hydrophilic liquid interaction chromatography (HILIC) which reproducibly measured over 4,000 metabolite features from as little as 3mg of brain tissue. The aqueous phase was analysed in positive and negative modes following HILIC separation in which 2,838 metabolite features were consistently measured including amino acids, sugars and purine bases. The non-aqueous phase was also analysed in positive and negative modes following reversed phase separation gradients respectively from which 1,183 metabolite features were consistently measured representing metabolites such as phosphatidylcholines, sphingolipids and triacylglycerides. The described metabolomics method includes a database for 200 metabolites, retention time, mass and relative intensity, and presents the basal metabolite composition for brain tissue in the healthy rat cerebellum.	[Ebshiana, Amera A.; Parsons, Richard; Legido-Quigley, Cristina] Kings Coll London, Inst Pharmaceut Sci, London SE1 9NH, England; [Snowden, Stuart G.; Hye, Abdul] Kings Coll London, Inst Psychiat, Dept Old Age Psychiat, London SE5 8AF, England; [Thambisetty, Madhav] Natl Inst Aging, Lab Behav Neurosci, Clin & Translat Neurosci Unit, Baltimore, MD USA	University of London; King's College London; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Legido-Quigley, C (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.	cristina.legido_quigley@kcl.ac.uk		Legido-Quigley, Cristina/0000-0002-4018-214X; Snowden, Stuart/0000-0002-9419-5819; Parsons, Richard Bramwell/0000-0001-5618-3780; Hye, Abdul/0000-0003-2237-4823	Butterfield Trust; Libyan Cultural Bureau London; NATIONAL INSTITUTE ON AGING [ZIAAG000200, P50AG005146] Funding Source: NIH RePORTER	Butterfield Trust; Libyan Cultural Bureau London; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been supported by grants from the Butterfield Trust and the Libyan Cultural Bureau London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Antignac JP, 2005, ANAL CHIM ACTA, V529, P129, DOI 10.1016/j.aca.2004.08.055; Crockford DJ, 2006, ANAL CHEM, V78, P363, DOI 10.1021/ac051444m; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; Inoue K, 2013, SCI REP, P3; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012; Kleijn RJ, 2007, FEMS YEAST RES, V7, P216, DOI 10.1111/j.1567-1364.2006.00180.x; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Llorach R, 2009, J PROTEOME RES, V8, P5060, DOI 10.1021/pr900470a; Mallet CR, 2004, RAPID COMMUN MASS SP, V18, P49, DOI 10.1002/rcm.1276; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Michopoulos F, 2009, J PROTEOME RES, V8, P2114, DOI 10.1021/pr801045q; Muller C, 2002, J CHROMATOGR B, V773, P47, DOI 10.1016/S1570-0232(02)00142-3; NIEDERMEYER E, 1985, J NEUROL, V232, P1, DOI 10.1007/BF00314032; Pan ZZ, 2007, ANAL BIOANAL CHEM, V387, P525, DOI 10.1007/s00216-006-0687-8; Proitsi P, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.127; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rice ML, 2005, APPL PSYCHOLINGUIST, V26, P7, DOI 10.1017/S0142716405050034; Salek RM, 2010, NEUROCHEM INT, V56, P937, DOI 10.1016/j.neuint.2010.04.001; Sato Y, 2012, J LIPID RES, V53, P567, DOI 10.1194/jlr.M022376; Snowden S, 2012, BIOANALYSIS, V4, P2265, DOI [10.4155/bio.12.218, 10.4155/BIO.12.218]; Spijker S, 2011, NEUROMETHODS, V57, P13, DOI 10.1007/978-1-61779-111-6_2; US Department of Health and Human Services FaDA Centre for Drug Evaluation and Research (CDER) Centre for Veterinary Medicine (CVM), 2001, BIO METH VAL; Whiley L, 2014, NEUROBIOL AGING, V35, P271, DOI 10.1016/j.neurobiolaging.2013.08.001; Whiley L, 2012, ANAL CHEM, V84, P5992, DOI 10.1021/ac300716u; Wishart DS, 2011, BIOANALYSIS, V3, P1769, DOI [10.4155/bio.11.155, 10.4155/BIO.11.155]; Zhang T, 2012, ANAL CHEM, V84, P1994, DOI 10.1021/ac2030738	32	14	14	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122883	10.1371/journal.pone.0122883	http://dx.doi.org/10.1371/journal.pone.0122883			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853858	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400083
J	Han, Y; Shao, Y; Liu, TT; Qu, YL; Li, W; Liu, ZG				Han, Yun; Shao, Yi; Liu, Tingting; Qu, Yang-Luowa; Li, Wei; Liu, Zuguo			Therapeutic Effects of Topical Netrin-4 Inhibits Corneal Neovascularization in Alkali-Burn Rats	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; GENE-EXPRESSION; ANGIOGENESIS; RECEPTOR; GUIDANCE; IDENTIFICATION; INFLAMMATION; ACTIVATION; MOLECULES; NEOGENIN	Netrins are secreted molecules involved in axon guidance and angiogenesis. However, the role of netrins in the vasculature remains unclear. Netrin-4 and netrin-1 have been found to be either pro-or antiangiogenic factors. Previously, we found that netrin-1 acts as an antiangiogenic factor in rats by inhibiting alkali burn-induced corneal neovascularization. Here, we further investigate the effects of netrin-4, another member of the same netrin family, on neovascularization in vitro and in vivo. We found that netrin-4 functions similarly as netrin-1 in angiogenesis. In vitro angiogenesis assay shows that netrin-4 affected human umbilical vein endothelial cell (HUVEC) tube formation, viability and proliferation, apoptosis, migration, and invasion in a dose-dependent manner. Netrin-4 was topically applied in vivo to alkali-burned rat corneas on day 0 (immediately after injury) and/or day 10 post-injury. Netrin-4 subsequently suppressed and reversed corneal neovascularization. Netrin-4 inhibited corneal epithelial and stromal cell apoptosis, inhibited vascular endothelial growth factor (VEGF), but promoted pigment epithelium-derived factor (PEDF) expression, decreased NK-KB p65 expression, and inhibits neutrophil and macrophage infiltration. These results indicate that netrin-4 shed new light on its potential roles in treatmenting for angiogenic diseases that affect the ocular surface, as well as other tissues.	[Han, Yun; Liu, Tingting; Qu, Yang-Luowa; Li, Wei; Liu, Zuguo] Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China; [Han, Yun; Liu, Tingting; Qu, Yang-Luowa; Li, Wei; Liu, Zuguo] Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Fujian, Peoples R China; [Shao, Yi] Nanchang Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanchang, Jiangxi, Peoples R China	Xiamen University; Nanchang University	Liu, ZG (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China.	zuguoliu@xmu.edu.cn	Li, Wei/P-8985-2015; liu, ting/GZM-3326-2022	Li, Wei/0000-0001-7458-2590; 	National Natural Science Foundation of China (NSFC) [81300729, 81160118, 81330022]; ShanHai Foundation of China [2013SH008]; Clinical Medicine Research Special purpose Foundation of China [L2012052]; Education Department Youth Scientific Research Foundation [GJJ14170]; Health Department Tradition Chinese Medicine Science and Technology Foundation [2012A087]; National Natural Science Foundation of China NSFC [81270978]; National Fund Committee on both sides of the Taiwan Straits joint project [U1205025]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); ShanHai Foundation of China; Clinical Medicine Research Special purpose Foundation of China; Education Department Youth Scientific Research Foundation; Health Department Tradition Chinese Medicine Science and Technology Foundation; National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); National Fund Committee on both sides of the Taiwan Straits joint project	1. This work was supported by grants from the National Natural Science Foundation of China (NSFC No. 81300729[YH], No. 81160118 [YS]), the ShanHai Foundation of China (No. 2013SH008 [YH]), the Clinical Medicine Research Special purpose Foundation of China (No. L2012052 [YS]), Education Department Youth Scientific Research Foundation (No. GJJ14170 [YS]), Health Department Tradition Chinese Medicine Science and Technology Foundation (No. 2012A087 [YS]). 2. YH and YS designed the study, collected and analyzed the data. YH decision to publish and preparation the manuscript. 3. This work was also supported by grants from the international major project in National Natural Science Foundation of China (NSFC No. 81330022), the National Natural Science Foundation of China NSFC No. 81270978), the National Fund Committee on both sides of the Taiwan Straits joint project (No. U1205025). The funders had roles in purchasing reagent, data collection and analysis and decision to publish the manuscript.	Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; Bijman MNA, 2006, MOL CANCER THER, V5, P2348, DOI 10.1158/1535-7163.MCT-06-0242; Bijnsdorp IV, 2010, NUCLEOS NUCLEOT NUCL, V29, P482, DOI 10.1080/15257771003730201; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Eichmann A, 2005, CURR OPIN NEUROBIOL, V15, P108, DOI 10.1016/j.conb.2005.01.008; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Eveno C, 2011, AM J PATHOL, V178, P1861, DOI 10.1016/j.ajpath.2010.12.019; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Freitas C, 2008, ANGIOGENESIS, V11, P23, DOI 10.1007/s10456-008-9096-2; Han Y, 2012, INVEST OPHTH VIS SCI, V53, P1285, DOI 10.1167/iovs.11-8722; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; Hoang S, 2009, J CEREBR BLOOD F MET, V29, P385, DOI 10.1038/jcbfm.2008.128; Hu YZ, 2012, NEOPLASIA, V14, P219, DOI 10.1593/neo.111396; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Lambert E, 2012, J BIOL CHEM, V287, P3987, DOI 10.1074/jbc.M111.289371; Laria C, 1997, OPHTHALMIC RES, V29, P145, DOI 10.1159/000268009; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Larrivee B, 2007, GENE DEV, V21, P2433, DOI 10.1101/gad.437807; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Li YN, 2012, EXP EYE RES, V96, P24, DOI 10.1016/j.exer.2012.01.007; Liu XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016712; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mwaikambo BR, 2006, INVEST OPHTH VIS SCI, V47, P4356, DOI 10.1167/iovs.05-1656; Nacht M, 2009, EXP CELL RES, V315, P784, DOI 10.1016/j.yexcr.2008.11.018; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Ortego J, 1996, INVEST OPHTH VIS SCI, V37, P2759; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Planck SR, 1997, OCUL IMMUNOL INFLAMM, V5, P95, DOI 10.3109/09273949709085057; Stuart PM, 2003, INVEST OPHTH VIS SCI, V44, P93, DOI 10.1167/iovs.02-0299; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Yamada J, 2003, EXP EYE RES, V76, P161, DOI 10.1016/S0014-4835(02)00293-2	42	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122951	10.1371/journal.pone.0122951	http://dx.doi.org/10.1371/journal.pone.0122951			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853509	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400087
J	Ledger, PM; Miras, Y; Poux, M; Milcent, PY				Ledger, Paul M.; Miras, Yannick; Poux, Matthieu; Milcent, Pierre Yves			The Palaeoenvironmental Impact of Prehistoric Settlement and Proto-Historic Urbanism: Tracing the Emergence of the Oppidum of Corent, Auvergne, France	PLOS ONE			English	Article							RELEVANT SOURCE AREA; LAND-USE CHANGES; CULTURAL LANDSCAPES; VEGETATION HISTORY; RHONE VALLEY; POLLEN; RECORD; SITE	Early human societies and their interactions with the natural world have been extensively explored in palaeoenvironmental studies across Central and Western Europe. Yet, despite an extensive body of scholarship, there is little consideration of the environmental impacts of proto-historic urbanisation. Typically palaeoenvironmental studies of Bronze and Iron Age societies discuss human impact in terms of woodland clearance, landscape openness and evidence for agriculture. Although these features are clearly key indicators of human settlement, and characterise Neolithic and early to Middle Bronze Age impacts at Corent, they do not appear to represent defining features of a protohistoric urban environment. The Late Iron Age Gallic Oppidum of Corent is remarkable for the paucity of evidence for agriculture and strong representation of apophytes associated with disturbance. Increased floristic diversity - a phenomenon also observed in more recent urban environments - was also noted. The same, although somewhat more pronounced, patterns are noted for the Late Bronze Age and hint at the possibility of a nascent urban area. High percentages of pollen from non-native trees such as Platanus, Castanea and Juglans in the late Bronze Age and Gallic period also suggest trade and cultural exchange, notably with the Mediterranean world. Indeed, these findings question the validity of applying Castanea and Juglans as absolute chronological markers of Romanisation. These results clearly indicate the value of local-scale palaeoecological studies and their potential for tracing the phases in the emergence of a proto-historic urban environment.	[Ledger, Paul M.] Univ Blaise Pascal, Clermont Univ, Maison Sci Homme, Clermont Ferrand, France; [Ledger, Paul M.] CNRS, MSH, USR 3550, Clermont Ferrand, France; [Ledger, Paul M.; Miras, Yannick] CNRS, GEOLAB, UMR 6042, Clermont Ferrand, France; [Ledger, Paul M.] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Miras, Yannick] Univ Blaise Pascal, Clermont Univ, GEOLAB, Clermont Ferrand, France; [Poux, Matthieu] Univ Lyon 2, ARAR, UMR 5138, Archeol & Archeometrie, Lyon, France; [Milcent, Pierre Yves] Univ Toulouse Jean Jaures, TRACES, UMR 5608, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Universite de Limoges; University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite de Limoges; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Lyon 2; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Ledger, PM (corresponding author), Univ Blaise Pascal, Clermont Univ, Maison Sci Homme, BP 10448, Clermont Ferrand, France.	p.ledger@abdn.ac.uk	Miras, Yannick/AAC-3110-2019		Conseil Regional d'Auvergne	Conseil Regional d'Auvergne(Region Auvergne-Rhone-Alpes)	The study was funded by the Conseil Regional d'Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S., 1978, DANMARKS GEOLOGISKE, V1978, P69; Andrieu-Ponel V, 2000, HOLOCENE, V10, P341, DOI 10.1191/095968300669147926; [Anonymous], 2007, AGE FER BOUCLE LOIRE; Antonetti P, 2006, ATALS FLORE AUVERGNE; Bennett KD, 2014, PSIMPOLL PSCOMB PROG; Berglund BE, 2003, QUATERN INT, V105, P7, DOI 10.1016/S1040-6182(02)00144-1; Berglund BE, 1996, PALAEOECOLOGICAL EVE; Beug H.J, 2004, LEITFADEN POLLENBEST; Birks H.H., 1988, CULTURAL LANDSCAPE P, P179; Birks HJB, 1992, HOLOCENE, V2, P1, DOI 10.1177/095968369200200101; BIRKS HJB, 1970, NEW PHYTOL, V69, P807, DOI 10.1111/j.1469-8137.1970.tb02464.x; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; BROWN TA, 1989, QUATERNARY RES, V32, P205, DOI 10.1016/0033-5894(89)90076-8; Brun C, 2011, VEG HIST ARCHAEOBOT, V20, P135, DOI 10.1007/s00334-010-0277-8; Bunting MJ, 2004, HOLOCENE, V14, P651, DOI 10.1191/0959683604hl744rp; BUNTING MJ, 2000, HUMAN ECODYNAMICS, P63; Cabanis M, 2013, QUATERNAIRE, V24, P129; CLARK R L, 1982, Pollen et Spores, V24, P523; Collis J, 1984, OPPIDA EARLIST TOWNS; Davies AL, 2004, HOLOCENE, V14, P233, DOI 10.1191/0959683604hl701rp; de Beaulieu J.-L., 1988, CAHIERS MICROPALE ON, V3, P5; Dimbleby G.W., 1985, PALYNOLOGY ARCHAEOLO; Doyen E, 2013, HOLOCENE, V23, P961, DOI 10.1177/0959683612475142; Edwards K.J., 1982, ARCHAEOLOGICAL ASPEC, V146, P5; EDWARDS KJ, 1997, SCOTLAND ENV ARCHAEO, P63; Ejarque A, 2010, J ARCHAEOL SCI, V37, P1; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Fernandez-Gotz M, 2014, ANTIQUITY, V88, P304, DOI 10.1017/S0003598X00050468; Fernandez-Gotz M, 2013, ANTIQUITY, V87, P473, DOI 10.1017/S0003598X00049073; Galinie H, 2009, AGE FER BOUCLE LOIRE, P199; Grimm E.C., 1993, TILIA PROGRAM ANAL D; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Guichard V, 1992, RAPPORT CAMPAGN FOUI; Hatte C, 2013, RADIOCARBON, V55, P979, DOI 10.1017/S0033822200058124; Hellman S, 2009, REV PALAEOBOT PALYNO, V153, P245, DOI 10.1016/j.revpalbo.2008.08.006; Hellman S, 2009, REV PALAEOBOT PALYNO, V153, P259, DOI 10.1016/j.revpalbo.2008.08.008; Hillbrand M, 2014, HOLOCENE, V24, P559, DOI 10.1177/0959683614522307; Hjelle KL, 1997, REV PALAEOBOT PALYNO, V99, P1, DOI 10.1016/S0034-6667(97)00041-9; IVERSEN JOHS, 1941, DANMARKS GEOL UNDERS OGELSE 2 RALKKE, V66, P1; Jouffroy-Bapicot I, 2013, HOLOCENE, V23, P1888, DOI 10.1177/0959683613508161; Juvigne E, 1988, REV SCI NATURELLES A, V53, P7; Kolaczek P, 2013, REV PALAEOBOT PALYNO, V189, P29, DOI 10.1016/j.revpalbo.2012.11.006; Lavrieux M, 2013, HOLOCENE, V23, P1317, DOI 10.1177/0959683613484616; Ledger PM, 2015, BOREAS, V44, P197, DOI 10.1111/bor.12089; Leps J, 2003, MULTIVARIATE ANAL EC; Mercuri AM, 2013, QUATERN INT, V303, P24, DOI 10.1016/j.quaint.2013.01.005; Michelin Y, 2001, QUATERNAIRE, V1-2, P31; Milcent P.-Y., 2014, TRANSALPINARE MELANG, P181, DOI DOI 10.1016/B978-0-444-53156-8.00019-2; Milcent P.-Y., 2004, MEMOIRE 34 SOC PREHI, V1; Milcent P.-Y., 2014, B APRAB, V12, P89; Milcent P-Y, 2012, FRAGE PROTOURBANISAT, P91; Milcent PY, 2009, AGE BRONZE AGE FER F, P453; Miras Y, 2004, VEG HIST ARCHAEOBOT, V13, P91, DOI 10.1007/s00334-004-0033-z; Miras Yannick, 2009, Revue des Sciences Naturelles d'Auvergne, V73, P71; Moore P.D., 1991, BLACKWELL SCI PUBLI; Nehlig P, 2003, GEOLOGUES, V130-131, P1; PEGLAR SM, 1993, REV PALAEOBOT PALYNO, V76, P1, DOI 10.1016/0034-6667(93)90079-A; Petite C, 2011, ASPECTS ROMANISATION, V21, P335; Poux M, 2001, CORENT RAPPORT FOUIL, P1; Poux M., 2012, CORENT VOYAGE COEUR, DOI DOI 10.1016/j.sedgeo.2010.04.012; PRAT B, 2006, THESIS U BLAISE PASC; REILLE M, 1993, QUATERNARY SCI REV, V12, P47, DOI 10.1016/0277-3791(93)90048-Q; Reille M., 1992, POLLEN SPORES EUROPE; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Richard H., 2007, ENV CULTURES AGE BRO, P227; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Seppa H, 1997, VEG HIST ARCHAEOBOT, V6, P91, DOI 10.1007/BF01261957; STOCKMARR J, 1971, Pollen et Spores, V13, P615; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tixier, 1985, REV ARCHEOLOGIQUE CT, V24, P17, DOI [10.1016/j.acvd.2013.12.002, DOI 10.1016/J.ACVD.2013.12.002]; Trement F., 2007, GALLIA ARCHE OLOGIE, V64, P289, DOI DOI 10.1177/0959683619826637; van Geel B, 2003, J ARCHAEOL SCI, V30, P873, DOI 10.1016/S0305-4403(02)00265-0; Van Geel B., 2001, TRACKING ENV CHANGE, V3, P99, DOI DOI 10.1007/0-306-47668-1_6; van Geel B, 2006, NOVA HEDWIGIA, V82, P313, DOI 10.1127/0029-5035/2006/0082-0313	74	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121517	10.1371/journal.pone.0121517	http://dx.doi.org/10.1371/journal.pone.0121517			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CF3WA	25853251	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400040
J	Kempker, JA; West, KG; Kempker, RR; Siwamogsatham, O; Alvarez, JA; Tangpricha, V; Ziegler, TR; Martin, GS				Kempker, Jordan A.; West, Kathryn G.; Kempker, Russell R.; Siwamogsatham, Oranan; Alvarez, Jessica A.; Tangpricha, Vin; Ziegler, Thomas R.; Martin, Greg S.			Vitamin D Status and the Risk for Hospital-Acquired Infections in Critically Ill Adults: A Prospective Cohort Study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; SYSTEMIC INFLAMMATORY RESPONSE; RESPIRATORY-TRACT INFECTION; D-RECEPTOR POLYMORPHISMS; HIGH-DOSE VITAMIN-D-3; D DEFICIENCY; ANTIMICROBIAL PEPTIDE; D LEVEL; ASSOCIATION; CARE	Introduction To identify patient characteristics associated with low serum 25-hydroxyvitamin D (25(OH) D) concentrations in the medical intensive care unit (ICU) and examine the relationship between serum 25(OH) D and the risk for hospital-acquired infections. Methods This is a prospective observational cohort of adult patients admitted to the medical ICU at an urban safety net teaching hospital in Atlanta, Georgia from November 1, 2011 through October 31, 2012 with an anticipated ICU stay >= 1 day. Phlebotomy for serum 25(OH) D measurement was performed on all patients within 5 days of ICU admission. Patients were followed for 30 days or until death or hospital discharge, whichever came first. Hospital-acquired infections were determined using standardized criteria from review of electronic medical record. Results Among the 314 patients analyzed, 178 (57%) had a low vitamin D at a serum 25(OH) D concentration < 15 ng/mL. The patient characteristics associated with low vitamin D included admission during winter months (28% vs. 18%, P = 0.04), higher PaO2/FiO2 (275 vs. 226 torr, P = 0.03) and a longer time from ICU admission to study phlebotomy (1.8 vs. 1.5 days, P = 0.02). A total of 36 (11%) patients were adjudicated as having a hospital-acquired infection and in multivariable analysis adjusting for gender, alcohol use, APACHE II score, time to study phlebotomy, ICU length of stay and net fluid balance, serum 25(OH) D levels < 15 ng/mL were not associated with risk for hospital-acquired infections (HR 0.85, 95% CI 0.40-1.80, P = 0.7). Conclusions In this prospective, observational cohort of adults admitted to a single-center medical ICU, we did not find a significant association between low 25(OH)D and the risk for hospital-acquired infections.	[Kempker, Jordan A.; Martin, Greg S.] Emory Univ, Sch Med, Div Pulm Allergy Crit Care & Sleep Med, Atlanta, GA 30322 USA; [West, Kathryn G.; Tangpricha, Vin] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Kempker, Russell R.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Siwamogsatham, Oranan; Alvarez, Jessica A.; Ziegler, Thomas R.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA; [Tangpricha, Vin] Atlanta VA Med Ctr, Div Endocrinol Metab & Lipids, Atlanta, GA USA	Emory University; Emory University; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center	Kempker, JA (corresponding author), Emory Univ, Sch Med, Div Pulm Allergy Crit Care & Sleep Med, 615 Michael St,Suite 205, Atlanta, GA 30322 USA.	jkempke@emory.edu	Tangpricha, Vin/A-8645-2009; Martin, Greg/B-4085-2009; Kempker, Jordan/GVS-8815-2022	Tangpricha, Vin/0000-0002-4021-5853; Martin, Greg/0000-0002-9684-7593; 	National Institutes of Health [UL1 TR000454, T32 AA13528, K23 AI103044, T32 DK007298-32S1, K01 DK102851, K23 AR054334, K24 DK096574, R01 FD-003440, R21 HL110044]; FOOD AND DRUG ADMINISTRATION [R01FD003440] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL110044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI103044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR054334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK096574, T32DK007298, K01DK102851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in part, by National Institutes of Health grants UL1 TR000454 (Atlanta Clinical and Translational Science Institute), T32 AA13528 (JAK), K23 AI103044 (RRK), T32 DK007298-32S1 and K01 DK102851 (JAA), K23 AR054334 (VT), K24 DK096574 (TRZ), R01 FD-003440 (GSM) and R21 HL110044 (GSM, TRZ). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein K, 2014, JAMA-J AM MED ASSOC, V312, P1520, DOI 10.1001/jama.2014.13204; Amrein K, 2014, CRIT CARE, V18, DOI 10.1186/cc13790; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Braun A, 2011, CRIT CARE MED, V39, P671, DOI 10.1097/CCM.0b013e318206ccdf; Braun AB, 2012, CRIT CARE MED, V40, P3170, DOI 10.1097/CCM.0b013e318260c928; Braun AB, 2012, CRIT CARE MED, V40, P63, DOI 10.1097/CCM.0b013e31822d74f3; Flynn L, 2012, AM J SURG, V203, P379, DOI 10.1016/j.amjsurg.2011.09.012; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gray A, 2005, CLIN NUTR, V24, P746, DOI 10.1016/j.clnu.2005.02.008; Hertting O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015580; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Holick MF, 2010, NEW ENGL J MED, V357, P266; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hosmer D., 2008, APPLIED SURVIVAL ANA; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krishnan A, 2010, CRIT CARE, V14, DOI 10.1186/cc9341; Lange N, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.12.014; Lappe JM, 2012, DERM-ENDOCRINOL, V4, P95, DOI 10.4161/derm.19833; Leaf DE, 2014, AM J RESP CRIT CARE, V190, P533, DOI 10.1164/rccm.201405-0988OC; Leow L, 2011, RESPIROLOGY, V16, P611, DOI 10.1111/j.1440-1843.2011.01924.x; Lucidarme O, 2010, INTENS CARE MED, V36, P1609, DOI 10.1007/s00134-010-1875-8; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; McKinney JD, 2011, J AM MED DIR ASSOC, V12, P208, DOI 10.1016/j.jamda.2010.04.004; Moromizato T, 2014, CRIT CARE MED, V42, P97, DOI 10.1097/CCM.0b013e31829eb7af; Nair P, 2013, INTENS CARE MED, V39, P267, DOI 10.1007/s00134-012-2713-y; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Quraishi SA, 2015, JPEN-PARENTER ENTER, V39, P47, DOI 10.1177/0148607113511991; Quraishi SA, 2014, CRIT CARE MED, V42, P1365, DOI 10.1097/CCM.0000000000000210; Quraishi SA, 2014, JAMA SURG, V149, P112, DOI 10.1001/jamasurg.2013.3176; Quraishi SA, 2013, AM J CLIN NUTR, V98, P952, DOI 10.3945/ajcn.113.058909; Rathored J, 2012, INT J TUBERC LUNG D, V16, P1522, DOI 10.5588/ijtld.12.0122; Reid D, 2011, AM J CLIN NUTR, V93, P1006, DOI 10.3945/ajcn.110.008490; Remmelts HHF, 2012, CLIN INFECT DIS, V55, P1488, DOI 10.1093/cid/cis751; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Roth DE, 2008, J INFECT DIS, V197, P676, DOI 10.1086/527488; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Su LX, 2013, CHINESE MED J-PEKING, V126, P2725, DOI 10.3760/cma.j.issn.0366-6999.20121859; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Venkatram S, 2011, CRIT CARE, V15, DOI 10.1186/cc10585; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6; Waldron JL, 2013, J CLIN PATHOL, V00, P1; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003	46	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122136	10.1371/journal.pone.0122136	http://dx.doi.org/10.1371/journal.pone.0122136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849649	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800103
J	Lyons, C; Fernandes, P; Fanning, LJ; Houston, A; Brint, E				Lyons, Caitriona; Fernandes, Philana; Fanning, Liam J.; Houston, Aileen; Brint, Elizabeth			Engagement of Fas on Macrophages Modulates Poly I:C Induced Cytokine Production with Specific Enhancement of IP-10	PLOS ONE			English	Article							NF-KAPPA-B; DOMAIN-CONTAINING PROTEIN; HEPATITIS-C VIRUS; RIG-I; DEATH DOMAIN; INDUCED APOPTOSIS; INFECTED-CELLS; ACTIVATION; FADD; IL-1-BETA	Viral double-stranded RNA (dsRNA) is recognised by pathogen recognition receptors such as Toll-Like Receptor 3 (TLR3) and retinoic acid inducible gene-I (RIG-I), and results in cytokine and interferon production. Fas, a well characterised death receptor, has recently been shown to play a role in the inflammatory response. In this study we investigated the role of Fas in the anti-viral immune response. Stimulation of Fas on macrophages did not induce significant cytokine production. However, activation of Fas modified the response of macrophages to the viral dsRNA analogue poly I:C. In particular, poly I:C-induced IP-10 production was significantly enhanced. A similar augmentation of IP-10 by Fas was observed following stimulation with both poly A:U and Sendai virus. Fas activation suppressed poly I:C-induced phosphorylation of the MAP kinases p38 and JNK, while overexpression of the Fas adaptor protein, Fas-associated protein with death domain (FADD), activated AP-1 and inhibited poly I:C-induced IP-10 production. Consistent with an inhibitory role for AP-1 in IP-10 production, mutation of the AP-1 binding site on the IP-10 promoter resulted in augmented poly I:C-induced IP-10. These results demonstrate that engagement of the Fas receptor plays a role in modifying the innate immune response to viral RNA.	[Lyons, Caitriona; Brint, Elizabeth] Natl Univ Ireland Univ Coll Cork, Dept Pathol, Cork, Ireland; [Fernandes, Philana; Fanning, Liam J.; Houston, Aileen] Natl Univ Ireland Univ Coll Cork, Dept Med, Cork, Ireland; [Houston, Aileen; Brint, Elizabeth] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	University College Cork; University College Cork; University College Cork	Houston, A (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Med, Cork, Ireland.	a.houston@ucc.ie	Houston, Aileen/ABF-2473-2020; FANNING, LIAM J/F-5281-2015	Houston, Aileen/0000-0003-1362-5256; FANNING, LIAM J/0000-0001-6629-8418; Brint, Elizabeth/0000-0001-9214-149X	Science Foundation Ireland [10/RFP/CAN2894, 10/RFP/BIC2737]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors would like to acknowledge Science Foundation Ireland for financial support (grant numbers 10/RFP/CAN2894 and 10/RFP/BIC2737. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Bannerman DD, 2002, J CLIN INVEST, V109, P419, DOI 10.1172/JCI14774; Baum A, 2011, VIRULENCE, V2, P166, DOI 10.4161/viru.2.2.15481; Berkova Z, 2009, JNCI-J NATL CANCER I, V101, P399, DOI 10.1093/jnci/djn516; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Brint EK, 2002, J BIOL CHEM, V277, P49205, DOI 10.1074/jbc.M209685200; Brownell J, 2014, J VIROL, V88, P1582, DOI 10.1128/JVI.02007-13; Brownell J, 2013, CLIN CANCER RES, V19, P1347, DOI 10.1158/1078-0432.CCR-12-0928; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fernandes P, 2014, J IMMUNOL; Fujimoto I, 1998, CELL DEATH DIFFER, V5, P426, DOI 10.1038/sj.cdd.4400362; Fukui M, 2003, J IMMUNOL, V171, P1868, DOI 10.4049/jimmunol.171.4.1868; Garvey TL, 2002, J VIROL, V76, P697, DOI 10.1128/JVI.76.2.697-706.2002; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Krzyzowska M, 2014, IMMUNOBIOLOGY, V219, P64, DOI 10.1016/j.imbio.2013.08.002; Krzyzowska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070308; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee SM, 2011, CELL IMMUNOL, V271, P157, DOI 10.1016/j.cellimm.2011.06.019; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Roskams T, 2000, J PATHOL, V191, P150; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Young JA, 2011, J BIOL CHEM, V286, P6521, DOI 10.1074/jbc.M110.172288; Yount JS, 2008, J IMMUNOL, V180, P4910, DOI 10.4049/jimmunol.180.7.4910; Zhande R, 2007, MOL CELL BIOL, V27, P7394, DOI 10.1128/MCB.00600-07; Zhang X, 2015, J CELL MOL MED, V19, P555, DOI 10.1111/jcmm.12456	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123635	10.1371/journal.pone.0123635	http://dx.doi.org/10.1371/journal.pone.0123635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849666	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800247
J	Vitorino, HA; Mantovanelli, L; Zanotto, FP; Esposito, BP				Vitorino, Hector Aguilar; Mantovanelli, Luca; Zanotto, Flavia Pinheiro; Esposito, Breno Pannia			Iron Metallodrugs: Stability, Redox Activity and Toxicity against Artemia salina	PLOS ONE			English	Article							3 AGE CLASSES; IN-VITRO; IRON(III) COMPLEXES; TMH-FERROCENE; LABILE IRON; BOUND-IRON; METALS; LARVAE; (3,5,5-TRIMETHYLHEXANOYL)FERROCENE; BIOAVAILABILITY	Iron metallodrugs comprise mineral supplements, anti-hypertensive agents and, more recently, magnetic nanomaterials, with both therapeutic and diagnostic roles. As biologically-active metal compounds, concern has been raised regarding the impact of these compounds when emitted to the environment and associated ecotoxicological effects for the fauna. In this work we assessed the relative stability of several iron compounds (supplements based on glucoheptonate, dextran or glycinate, as well as 3,5,5-trimethylhexanoyl (TMH) derivatives of ferrocene) against high affinity models of biological binding, calcein and aprotransferrin, via a fluorimetric method. Also, the redox-activity of each compound was determined in a physiologically relevant medium. Toxicity toward Artemia salina at different developmental stages was measured, as well as the amount of lipid peroxidation. Our results show that polymer-coated iron metallodrugs are stable, non-redox-active and non-toxic at the concentrations studied (up to 300 mu M). However, TMH derivatives of ferrocene were less stable and more redox-active than the parent compound, and TMH-ferrocene displayed toxicity and lipid peroxidation to A. salina, unlike the other compounds. Our results indicate that iron metallodrugs based on polymer coating do not present direct toxicity at low levels of emission; however other iron species (eg. metallocenes), may be deleterious for aquatic organisms. We suggest that ecotoxicity depends more on metal speciation than on the total amount of metal present in the metallodrugs. Future studies with discarded metallodrugs should consider the chemical speciation of the metal present in the composition of the drug.	[Vitorino, Hector Aguilar; Esposito, Breno Pannia] Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil; [Mantovanelli, Luca; Zanotto, Flavia Pinheiro] Univ Sao Paulo, Inst Biociencias, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Esposito, BP (corresponding author), Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil.	breno@iq.usp.br	ZANOTTO, FLAVIA P/D-4620-2012; Vitorino, Hector Aguilar/T-5780-2019; Pannia Esposito, Breno/B-7136-2008	Vitorino, Hector Aguilar/0000-0002-6891-0524; PINHEIRO ZANOTTO, FLAVIA/0000-0001-5941-0432; Pannia Esposito, Breno/0000-0002-1447-435X	Coordination for the Improvement of Higher Education Personnel, Brazil; Sao Paulo Research Foundation, Brazil [2011/50318-1]	Coordination for the Improvement of Higher Education Personnel, Brazil; Sao Paulo Research Foundation, Brazil	HAV received a PhD grant from Coordination for the Improvement of Higher Education Personnel, Brazil. This work was funded by Sao Paulo Research Foundation, Brazil (2011/50318-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al-Bari M Abdul Alim, 2007, Pak J Biol Sci, V10, P2423, DOI 10.3923/pjbs.2007.2423.2429; Ali AA, 2011, CHAOS SOLITON FRACT, V44, P306, DOI 10.1016/j.chaos.2011.02.007; Ashtari K, 2012, INT J BIOL MACROMOL, V50, P1063, DOI 10.1016/j.ijbiomac.2011.12.025; Barahona MV, 1996, B ENVIRON CONTAM TOX, V56, P271, DOI 10.1007/s001289900041; Biot C, 1997, J MED CHEM, V40, P3715, DOI 10.1021/jm970401y; Bound JP, 2006, ENVIRON TOXICOL PHAR, V21, P301, DOI 10.1016/j.etap.2005.09.006; BREUER W, 1995, AM J PHYSIOL-CELL PH, V268, pC1354, DOI 10.1152/ajpcell.1995.268.6.C1354; Breuer W, 2001, ANAL BIOCHEM, V299, P194, DOI 10.1006/abio.2001.5378; Carland M, 2005, METALLOTHERAPEUTIC D, P313, DOI 10.1002/0470864052; Silva TD, 2009, J COORD CHEM, V62, P958, DOI 10.1080/00958970802385845; Esposito BP, 2002, EUR J CLIN INVEST, V32, P42, DOI 10.1046/j.1365-2362.2002.0320s1042.x; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Eybl V, 2002, TOXICOL LETT, V128, P169, DOI 10.1016/S0378-4274(01)00541-0; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Gambardella C, 2014, ENVIRON MONIT ASSESS, V186, P4249, DOI 10.1007/s10661-014-3695-8; Graminha AE, 2008, POLYHEDRON, V27, P547, DOI 10.1016/j.poly.2007.10.008; Heilmann JB, 2008, J ORGANOMET CHEM, V693, P1716, DOI 10.1016/j.jorganchem.2007.12.011; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Li SH, 2013, BIOMATERIALS, V34, P902, DOI 10.1016/j.biomaterials.2012.10.069; Libralato G, 2014, MAR ENVIRON RES, V101, P38, DOI 10.1016/j.marenvres.2014.08.002; Lykkesfeldt J, 2007, J BIOCHEM MOL TOXIC, V21, P145, DOI 10.1002/jbt.20170; Malecki EA, 2002, BIOL TRACE ELEM RES, V86, P73, DOI 10.1385/BTER:86:1:73; Malecki EA, 1999, FASEB J, V13, pA573; Mizutani K, 2012, BBA-GEN SUBJECTS, V1820, P203, DOI 10.1016/j.bbagen.2011.08.003; Mohamed Azza H., 2014, Canadian Journal of Pure and Applied Sciences, V8, P3019; NIELSEN P, 1993, INT J BIOCHEM, V25, P223, DOI 10.1016/0020-711X(93)90010-C; NIELSEN P, 1993, BIOCHEM PHARMACOL, V45, P385, DOI 10.1016/0006-2952(93)90074-7; Robb SJ, 1998, BRAIN RES, V788, P125, DOI 10.1016/S0006-8993(97)01543-6; Ronconi L, 2007, COORDIN CHEM REV, V251, P1633, DOI 10.1016/j.ccr.2006.11.017; SanchezFortun S, 1997, B ENVIRON CONTAM TOX, V59, P445, DOI 10.1007/s001289900498; Slaveykova VI, 2005, ENVIRON CHEM, V2, P9, DOI 10.1071/EN04076; STRAHM U, 1979, J PHYS CHEM-US, V83, P1689, DOI 10.1021/j100476a003; Wade LG., 2002, ORGANIC CHEM; Worms I, 2006, BIOCHIMIE, V88, P1721, DOI 10.1016/j.biochi.2006.09.008; Wu X., 2005, METALLOTHERAPEUTIC D, P179	37	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121997	10.1371/journal.pone.0121997	http://dx.doi.org/10.1371/journal.pone.0121997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849743	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800091
J	Pec, GJ; Karst, J; Sywenky, AN; Cigan, PW; Erbilgin, N; Simard, SW; Cahill, JF				Pec, Gregory J.; Karst, Justine; Sywenky, Alexandra N.; Cigan, Paul W.; Erbilgin, Nadir; Simard, Suzanne W.; Cahill, James F., Jr.			Rapid Increases in Forest Understory Diversity and Productivity following a Mountain Pine Beetle (Dendroctonus ponderosae) Outbreak in Pine Forests	PLOS ONE			English	Article							BOREAL FOREST; PLANT-COMMUNITIES; TREE REGENERATION; VEGETATION; DYNAMICS; FIRE; MORTALITY; COMPETITION; MECHANISMS; SUCCESSION	The current unprecedented outbreak of mountain pine beetle (Dendroctonus ponderosae) in lodgepole pine (Pinus contorta) forests of western Canada has resulted in a landscape consisting of a mosaic of forest stands at different stages of mortality. Within forest stands, understory communities are the reservoir of the majority of plant species diversity and influence the composition of future forests in response to disturbance. Although changes to stand composition following beetle outbreaks are well documented, information on immediate responses of forest understory plant communities is limited. The objective of this study was to examine the effects of D. ponderosae-induced tree mortality on initial changes in diversity and productivity of understory plant communities. We established a total of 110 1-m(2) plots across eleven mature lodgepole pine forests to measure changes in understory diversity and productivity as a function of tree mortality and below ground resource availability across multiple years. Overall, understory community diversity and productivity increased across the gradient of increased tree mortality. Richness of herbaceous perennials increased with tree mortality as well as soil moisture and nutrient levels. In contrast, the diversity of woody perennials did not change across the gradient of tree mortality. Understory vegetation, namely herbaceous perennials, showed an immediate response to improved growing conditions caused by increases in tree mortality. How this increased pulse in understory richness and productivity affects future forest trajectories in a novel system is unknown.	[Pec, Gregory J.; Karst, Justine; Sywenky, Alexandra N.; Cahill, James F., Jr.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Karst, Justine; Cigan, Paul W.; Erbilgin, Nadir] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Simard, Suzanne W.] Univ British Columbia, Dept Forest & Conservat Sci, Vancouver, BC V5Z 1M9, Canada	University of Alberta; University of Alberta; University of British Columbia	Pec, GJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	gpec@ualberta.ca	Pec, Gregory/L-8542-2013; Erbilgin, Nadir/F-3675-2014; Cahill, James/B-6147-2015	Pec, Gregory/0000-0002-6781-9112; Erbilgin, Nadir/0000-0001-9912-8095; Karst, Justine/0000-0003-0497-1552; Cahill, James/0000-0002-4110-1516	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Discovery Grant; University of Alberta Doctoral Recruitment Scholarship; University of Alberta Undergraduate Research Initiative (URI) award; Alberta Conservation Association (ACA) Biodiversity Grant	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Alberta Doctoral Recruitment Scholarship; University of Alberta Undergraduate Research Initiative (URI) award; Alberta Conservation Association (ACA) Biodiversity Grant	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Grant awarded to JFC Jr., SWS, NE, and J. Cooke and an NSERC Discovery Grant awarded to JFC Jr., SWS, and NE. GJP was supported by a University of Alberta Doctoral Recruitment Scholarship, AS by a University of Alberta Undergraduate Research Initiative (URI) award and PWC was supported by an Alberta Conservation Association (ACA) Biodiversity Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman GD, 1977, ROLE MOUNTAIN PINE B; Amoroso MM, 2013, FOREST ECOL MANAG, V310, P300, DOI 10.1016/j.foreco.2013.08.037; Astrup R, 2008, FOREST ECOL MANAG, V256, P1743, DOI 10.1016/j.foreco.2008.07.025; Axelson JN, 2009, FOREST ECOL MANAG, V257, P1874, DOI 10.1016/j.foreco.2009.01.047; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Barton K, 2009, R PACKAGE VERSION 1; Beckingham J.D., 1996, 9 CAN FOR SERV NW RE; Bock MD, 2002, CAN J FOREST RES, V32, P713, DOI 10.1139/X02-014; Bradbury S, 2004, CAN J FOREST RES, V34, P1220, DOI 10.1139/X04-010; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton P. J., 2008, BC Journal of Ecosystems and Management, V9, P9; Cater TC, 2000, ECOLOGY, V81, P1086, DOI 10.1890/0012-9658(2000)081[1086:DEOCOM]2.0.CO;2; Chen Han Y. H., 2002, Environmental Reviews, V10, P137, DOI 10.1139/a02-007; Chipman SJ, 2002, ECOL APPL, V12, P588, DOI 10.1890/1051-0761(2002)012[0588:UVPSDI]2.0.CO;2; Cigan P, 2015, PLANT SOIL, P1; Coates KD, 2009, ABUNDANCE SECONDARY; Collins BJ, 2011, FOREST ECOL MANAG, V261, P2168, DOI 10.1016/j.foreco.2011.03.016; Diskin M, 2011, CAN J FOREST RES, V41, P782, DOI [10.1139/X10-247, 10.1139/x10-247]; Dordel J, 2008, FOREST ECOL MANAG, V255, P3563, DOI 10.1016/j.foreco.2008.02.018; Edburg SL, 2012, FRONT ECOL ENVIRON, V10, P416, DOI 10.1890/110173; EHRENFELD JG, 1980, B TORREY BOT CLUB, V107, P29, DOI 10.2307/2484848; Fornwalt PJ, 2014, J VEG SCI, V25, P805, DOI 10.1111/jvs.12128; Greene DF, 1999, CAN J FOREST RES, V29, P824, DOI 10.1139/cjfr-29-6-824; Griffin JM, 2013, FOREST ECOL MANAG, V291, P228, DOI 10.1016/j.foreco.2012.11.029; Haeussler S, 2004, CAN J FOREST RES, V34, P274, DOI [10.1139/x03-274, 10.1139/X03-274]; Hart SA, 2008, ECOL MONOGR, V78, P123, DOI 10.1890/06-2140.1; Hart SA, 2006, CRIT REV PLANT SCI, V25, P381, DOI 10.1080/07352680600819286; Huisinga KD, 2005, J TORREY BOT SOC, V132, P590, DOI 10.3159/1095-5674(2005)132[590:EOAIPF]2.0.CO;2; Kayes LJ, 2012, FOREST ECOL MANAG, V263, P57, DOI 10.1016/j.foreco.2011.09.035; Klutsch JG, 2009, FOREST ECOL MANAG, V258, P641, DOI 10.1016/j.foreco.2009.04.034; KOVACIC DA, 1985, FOREST ECOL MANAG, V13, P53, DOI 10.1016/0378-1127(85)90005-2; Lewis K, 2011, WOOD FIBER SCI, V43, P130; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McIntosh ACS, 2013, FOREST ECOL MANAG, V295, P11, DOI 10.1016/j.foreco.2012.12.050; MESSIER C, 1993, FOREST ECOL MANAG, V60, P181, DOI 10.1016/0378-1127(93)90080-7; Mitchell Russel G., 1998, Western Journal of Applied Forestry, V13, P23; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; PUTZ FE, 1992, FOREST ECOL MANAG, V49, P267, DOI 10.1016/0378-1127(92)90140-5; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Randall MJ, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400069; Rhoades CC, 2013, P NATL ACAD SCI USA, V110, P1756, DOI 10.1073/pnas.1221029110; ROMME WH, 1986, AM NAT, V127, P484, DOI 10.1086/284497; Royo AA, 2006, CAN J FOREST RES, V36, P1345, DOI 10.1139/X06-025; Safranyik L, 2010, CAN ENTOMOL, V142, P415, DOI 10.4039/n08-CPA01; Safranyik L, 2006, THE MOUNTAIN PINE BE, P304; Stone WE, 1996, VEGETATIO, V122, P1, DOI 10.1007/BF00052811; STUART JD, 1989, CAN J FOREST RES, V19, P1096, DOI 10.1139/x89-166; Treu R, 2014, ECOLOGY, V95, P1096, DOI 10.1890/13-1233.1; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; Wang GG, 2005, CAN J FOREST RES, V35, P254, DOI [10.1139/x04-177, 10.1139/X04-177]; Zuur Alain F., 2009, P1	51	39	40	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124691	10.1371/journal.pone.0124691	http://dx.doi.org/10.1371/journal.pone.0124691			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859663	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300144
J	Eells, JB; Varela-Stokes, A; Guo-Ross, SX; Kummari, E; Smith, HM; Cox, E; Lindsay, DS				Eells, Jeffrey B.; Varela-Stokes, Andrea; Guo-Ross, Shirley X.; Kummari, Evangel; Smith, Holly M.; Cox, Erin; Lindsay, David S.			Chronic Toxoplasma gondii in Nurr1-Null Heterozygous Mice Exacerbates Elevated Open Field Activity	PLOS ONE			English	Article							PREPULSE INHIBITION DEFICITS; VENTRAL TEGMENTAL AREA; KNOCK-OUT MICE; ENDOGENOUS KYNURENIC ACID; DOPAMINE NEURONS; GENE-EXPRESSION; BEHAVIORAL ABNORMALITIES; PREFRONTAL CORTEX; INFECTIOUS AGENTS; ACOUSTIC STARTLE	Latent infection with Toxoplasma gondii is common in humans (approximately 30% of the global population) and is a significant risk factor for schizophrenia. Since prevalence of T. gondii infection is far greater than prevalence of schizophrenia (0.5-1%), genetic risk factors are likely also necessary to contribute to schizophrenia. To test this concept in an animal model, Nurr1-null heterozygous (+/-) mice and wild-type (+/+) mice were evaluate using an emergence test, activity in an open field and with a novel object, response to bobcat urine and prepulse inhibition of the acoustic startle response (PPI) prior to and 6 weeks after infection with T. gondii. In the emergence test, T. gondii infection significantly decreased the amount of time spent in the cylinder. Toxoplasma gondii infection significantly elevated open field activity in both +/+ and +/- mice but this increase was significantly exacerbated in +/- mice. T. gondii infection reduced PPI in male +/- mice but this was not statistically significant. Aversion to bobcat urine was abolished by T. gondii infection in +/+ mice. In female +/- mice, aversion to bobcat urine remained after T. gondii infection while the male +/- mice showed no aversion to bobcat urine. Antibody titers of infected mice were a critical variable associated with changes in open field activity, such that an inverted U shaped relationship existed between antibody titers and the percent change in open field activity with a significant increase in activity at low and medium antibody titers but no effect at high antibody titers. These data demonstrate that the Nurr1 +/- genotype predisposes mice to T. gondii-induced alterations in behaviors that involve dopamine neurotransmission and are associated with symptoms of schizophrenia. We propose that these alterations in murine behavior were due to further exacerbation of the altered dopamine neurotransmission in Nurr1 +/- mice.	[Eells, Jeffrey B.; Varela-Stokes, Andrea; Guo-Ross, Shirley X.; Kummari, Evangel; Smith, Holly M.; Cox, Erin] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Lindsay, David S.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA	Mississippi State University; Virginia Polytechnic Institute & State University	Eells, JB (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	eells@cvm.msstate.edu	Lindsay, David S/G-8891-2016; Kummari, Evangel/J-6019-2019; Varela-Stokes, Andrea/AAA-7417-2020	Lindsay, David S/0000-0002-0592-8321; Cox, Eric/0000-0003-4281-2990	NIH HHS [T35 OD010432] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD010432] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abi-Dargham A, 2004, INT J NEUROPSYCHOPH, V7, pS1, DOI 10.1017/S1461145704004110; Ancin I, 2013, SCHIZOPHRENIA BULL, V39, P555, DOI 10.1093/schbul/sbr176; Arias I, 2012, SCHIZOPHR RES, V136, P128, DOI 10.1016/j.schres.2011.10.026; Ayhan Y, 2009, BEHAV BRAIN RES, V204, P274, DOI 10.1016/j.bbr.2009.04.010; Blomstrom A, 2012, SCHIZOPHR RES, V140, P25, DOI 10.1016/j.schres.2012.06.035; BRAFF DL, 1995, CLIN NEUROSCI, V3, P131; Braff DL, 1999, AM J PSYCHIAT, V156, P596; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Brown AS, 2005, AM J PSYCHIAT, V162, P767, DOI 10.1176/appi.ajp.162.4.767; Buervenich S, 2000, AM J MED GENET, V96, P808, DOI 10.1002/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E; Carruthers VB, 2007, SCHIZOPHRENIA BULL, V33, P745, DOI 10.1093/schbul/sbm008; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chen YH, 2001, AM J MED GENET, V105, P753, DOI 10.1002/ajmg.10036; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Duncan EJ, 2003, PSYCHOPHARMACOLOGY, V167, P63, DOI 10.1007/s00213-002-1372-z; Eastwood SL, 1997, MOL PSYCHIATR, V2, P322, DOI 10.1038/sj.mp.4000238; Eells JB, 2006, NEUROSCIENCE, V140, P1117, DOI 10.1016/j.neuroscience.2005.12.065; Eells JB, 2002, NEUROSCI RES COMMUN, V30, P173, DOI 10.1002/nrc.10029; Eells JB, 2002, BEHAV BRAIN RES, V136, P267, DOI 10.1016/S0166-4328(02)00185-7; Eells JB, 2006, BRAIN RES BULL, V70, P186, DOI 10.1016/j.brainresbull.2006.05.004; Eells JB, 2012, J MOL NEUROSCI, V46, P545, DOI 10.1007/s12031-011-9642-z; Erhardt S, 2004, BIOL PSYCHIAT, V56, P255, DOI 10.1016/j.biopsych.2004.06.006; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Fernagut PO, 2002, EUR J NEUROSCI, V15, P2053, DOI 10.1046/j.1460-9568.2002.02047.x; Flegr J, 2007, SCHIZOPHRENIA BULL, V33, P757, DOI 10.1093/schbul/sbl074; Flegr J, 2013, TRENDS PARASITOL, V29, P156, DOI 10.1016/j.pt.2013.01.007; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gulinello M, 2010, MICROBES INFECT, V12, P528, DOI 10.1016/j.micinf.2010.03.009; HAY J, 1984, Z PARASITENKD, V70, P575, DOI 10.1007/BF00926588; HAY J, 1983, ANN TROP MED PARASIT, V77, P483, DOI 10.1080/00034983.1983.11811741; HAY J, 1985, Z PARASITENKD, V71, P459, DOI 10.1007/BF00928348; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Hinze-Selch D, 2007, SCHIZOPHRENIA BULL, V33, P782, DOI 10.1093/schbul/sbm010; Holub D, 2013, ACTA PSYCHIAT SCAND, V127, P227, DOI 10.1111/acps.12031; Horacek J, 2012, WORLD J BIOL PSYCHIA, V13, P501, DOI 10.3109/15622975.2011.573809; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P337, DOI 10.1080/00034983.1980.11687350; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; Kadkhodaei B, 2013, P NATL ACAD SCI USA, V110, P2360, DOI 10.1073/pnas.1221077110; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Keller WR, 2013, J PSYCHOPHARMACOL, V27, P337, DOI 10.1177/0269881112467089; Kuepper R, 2012, HANDB EXP PHARMACOL, V212, P1, DOI 10.1007/978-3-642-25761-2_1; Lacroix L, 2000, BEHAV BRAIN RES, V107, P111, DOI 10.1016/S0166-4328(99)00118-7; Lau CI, 2013, REV NEUROSCIENCE, V24, P389, DOI 10.1515/revneuro-2013-0011; LIEBERMAN JA, 1993, SCHIZOPHRENIA BULL, V19, P371, DOI 10.1093/schbul/19.2.371; Light G A, 1999, Curr Psychiatry Rep, V1, P31, DOI 10.1007/s11920-999-0008-y; Linderholm KR, 2007, NEUROPHARMACOLOGY, V53, P918, DOI 10.1016/j.neuropharm.2007.09.003; Linderholm KR, 2012, SCHIZOPHRENIA BULL, V38, P426, DOI 10.1093/schbul/sbq086; Lodge DJ, 2011, TRENDS PHARMACOL SCI, V32, P507, DOI 10.1016/j.tips.2011.05.001; Ludewig K, 2003, BIOL PSYCHIAT, V54, P121, DOI 10.1016/S0006-3223(02)01925-X; Ludewig K, 2002, SCHIZOPHR RES, V55, P129, DOI 10.1016/S0920-9964(01)00198-0; Mackeprang T, 2002, BIOL PSYCHIAT, V52, P863, DOI 10.1016/S0006-3223(02)01409-9; McConkey GA, 2013, J EXP BIOL, V216, P113, DOI 10.1242/jeb.074153; Miller CL, 2006, BRAIN RES, V1073, P25, DOI 10.1016/j.brainres.2005.12.056; Miyake N, 2011, CNS NEUROSCI THER, V17, P104, DOI 10.1111/j.1755-5949.2010.00230.x; Moore TM, 2008, SYNAPSE, V62, P764, DOI 10.1002/syn.20550; Mortensen PB, 2007, SCHIZOPHRENIA BULL, V33, P741, DOI 10.1093/schbul/sbm009; Mouri A, 2013, NEUROBIOL DIS, V53, P61, DOI 10.1016/j.nbd.2012.10.025; Muller N, 2006, NEUROTOX RES, V10, P131; Muller N, 2013, PSYCHIAT DANUB, V25, P292; Nagai T, 2011, BIOL PHARM BULL, V34, P1364, DOI 10.1248/bpb.34.1364; Need AC, 2012, AM J HUM GENET, V91, P303, DOI 10.1016/j.ajhg.2012.06.018; Notarangelo FM, 2014, SCHIZOPHR RES, V152, P261, DOI 10.1016/j.schres.2013.11.011; Olsson SK, 2009, INT J NEUROPSYCHOPH, V12, P501, DOI 10.1017/S1461145708009383; Parsons CG, 1997, J PHARMACOL EXP THER, V283, P1264; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Ralph RJ, 2001, J PHARMACOL EXP THER, V298, P148; Ralph RJ, 2001, J NEUROSCI, V21, P305, DOI 10.1523/JNEUROSCI.21-01-00305.2001; Ramanathan S, 2014, J CLIN NEUROSCI, V21, P722, DOI 10.1016/j.jocn.2013.07.017; Rojas P, 2007, MOL PSYCHIATR, V12, P756, DOI 10.1038/sj.mp.4001993; Sacchetti P, 2001, J NEUROCHEM, V76, P1565, DOI 10.1046/j.1471-4159.2001.00181.x; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2007, SCHIZOPHRENIA BULL, V33, P652, DOI 10.1093/schbul/sbm030; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Seeman MV, 2014, PROG NEURO-PSYCHOPH, V48, P155, DOI 10.1016/j.pnpbp.2013.10.003; Seeman P, 2013, EUR NEUROPSYCHOPHARM, V23, P999, DOI 10.1016/j.euroneuro.2013.06.005; Seeman P, 2011, CNS NEUROSCI THER, V17, P118, DOI 10.1111/j.1755-5949.2010.00162.x; Sesack SR, 2002, PHYSIOL BEHAV, V77, P513, DOI 10.1016/S0031-9384(02)00931-9; SIMS TA, 1990, ANN TROP MED PARASIT, V84, P141, DOI 10.1080/00034983.1990.11812447; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Spielewoy C, 2000, BEHAV PHARMACOL, V11, P279, DOI 10.1097/00008877-200006000-00011; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; STIBBS HH, 1985, ANN TROP MED PARASIT, V79, P153, DOI 10.1080/00034983.1985.11811902; Stone TW, 2013, TRENDS PHARMACOL SCI, V34, P136, DOI 10.1016/j.tips.2012.09.006; SWERDLOW NR, 1990, PSYCHOPHARMACOLOGY, V101, P414, DOI 10.1007/BF02244063; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P727, DOI 10.1093/schbul/sbm026; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Torrey EF, 2003, EMERG INFECT DIS, V9, P1375, DOI 10.3201/eid0911.030143; Vuillermot S, 2011, GENES BRAIN BEHAV, V10, P589, DOI 10.1111/j.1601-183X.2011.00698.x; Vuillermot S, 2011, BRAIN BEHAV IMMUN, V25, P1316, DOI 10.1016/j.bbi.2011.06.012; Vyas A, 2007, NEUROSCIENCE, V148, P342, DOI 10.1016/j.neuroscience.2007.06.021; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Wonodi I, 2011, ARCH GEN PSYCHIAT, V68, P665, DOI 10.1001/archgenpsychiatry.2011.71; Xiao J, 2014, NEUROSCIENCE, V268, P128, DOI 10.1016/j.neuroscience.2014.03.015; Xiao J, 2012, NEUROSCIENCE, V206, P39, DOI 10.1016/j.neuroscience.2011.12.051; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; Yolken RH, 2009, PARASITE IMMUNOL, V31, P706, DOI 10.1111/j.1365-3024.2009.01131.x; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	114	19	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119280	10.1371/journal.pone.0119280	http://dx.doi.org/10.1371/journal.pone.0119280			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855987	Green Published, gold			2022-12-27	WOS:000352588500006
J	Hanke, K; Hartz, A; Manz, M; Bendiks, M; Heitmann, F; Orlikowsky, T; Muller, A; Olbertz, D; Kuhn, T; Siegel, J; von der Wense, A; Wieg, C; Kribs, A; Stein, A; Pagel, J; Herting, E; Gopel, W; Hartel, C				Hanke, Kathrin; Hartz, Annika; Manz, Maike; Bendiks, Meike; Heitmann, Friedhelm; Orlikowsky, Thorsten; Mueller, Andreas; Olbertz, Dirk; Kuehn, Thomas; Siegel, Jens; von der Wense, Axel; Wieg, Christian; Kribs, Angela; Stein, Anja; Pagel, Julia; Herting, Egbert; Goepel, Wolfgang; Haertel, Christoph		German Neonatal Network GNN	Preterm Prelabor Rupture of Membranes and Outcome of Very-Low-Birth-Weight Infants in the German Neonatal Network	PLOS ONE			English	Article							27 WEEKS GESTATION; PREMATURE RUPTURE; INTENTIONAL DELIVERY; SURVEILLANCE SYSTEM; RISK-FACTOR; MANAGEMENT; DIAGNOSIS; SURVIVAL; CARE; CHORIOAMNIONITIS	Objective It was the aim of our study to evaluate the independent effect of preterm prelabor rupture of membranes (PPROM) as a cause of preterm delivery on mortality during primary hospital stay and significant morbidities in very-low-birth-weight (VLBW) infants <32 weeks of gestation. Design Observational, epidemiological study design. Setting Population-based cohort, German Neonatal Network (GNN). Population 6102 VLBW infants were enrolled in GNN from 2009-2012, n=4120 fulfilled criteria for primary analysis (<32 gestational weeks, no pre-eclampsia, HELLP (highly elevated liver enzymes and low platelets syndrome) or placental abruption as cause of preterm birth). Methods Multivariable logistic regression analyses included PPROM as potential risk factors for adverse outcomes and well established items such as gestational age in weeks, birth weight, antenatal steroids, center, inborn delivery, multiple birth, gender and being small-for-gestational-age. Results PPROM as cause of preterm delivery had no independent effect on the risk of early-onset sepsis, clinical sepsis and blood-culture proven sepsis, while gestational age proved to be the most important contributor to sepsis risk. The diagnosis of PPROM was associated with an increased risk for bronchopulmonary dysplasia (BPD; OR: 1.25, 95% CI: 1.02-1.55, p=0.03) but not with other major outcomes. Conclusions The diagnosis of PPROM per se is not associated with adverse outcome in VLBW infants <32 weeks apart from a moderately increased risk for BPD. Randomized controlled trials with primary neonatal outcomes are needed to determine which subgroup of VLBW infants benefit from expectant or intentional management of PPROM.	[Hanke, Kathrin; Hartz, Annika; Pagel, Julia; Herting, Egbert; Goepel, Wolfgang; Haertel, Christoph] Univ Lubeck, Dept Pediat, Lubeck, Germany; [Manz, Maike] Univ Lubeck, Dept Womens Hlth & Obstet, Lubeck, Germany; [Bendiks, Meike] Univ Kiel, Dept Pediat, Kiel, Germany; [Heitmann, Friedhelm] Childrens Hosp Dortmund, Dortmund, Germany; [Orlikowsky, Thorsten] Univ Aachen, Dept Pediat, Aachen, Germany; [Olbertz, Dirk] Childrens Hosp, Rostock, Germany; [Kuehn, Thomas] Vivantes Childrens Hosp Berlin Neukolln, Berlin, Germany; [Siegel, Jens] Childrens Hosp Auf der Bult Hanover, Hannover, Germany; [von der Wense, Axel] Childrens Hosp Hamburg Altona, Hamburg, Germany; [Wieg, Christian] Childrens Hosp Aschaffenburg, Aschaffenburg, Germany; [Kribs, Angela] Univ Cologne, Dept Pediat, D-50931 Cologne, Germany; [Stein, Anja] Univ Essen Gesamthsch, Dept Pediat, Essen, Germany	University of Lubeck; University of Lubeck; University of Kiel; RWTH Aachen University; University of Rostock; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Duisburg Essen	Hartel, C (corresponding author), Univ Lubeck, Dept Pediat, Lubeck, Germany.	christoph.haertel@uksh.de	Härtel, Christoph/ABD-8841-2020	Stein, Anja/0000-0002-0497-4609	German government (Bundesministerium fur Bildung und Forschung, German Ministry of Education and Research)	German government (Bundesministerium fur Bildung und Forschung, German Ministry of Education and Research)	This study is supported by a grant of the German government (Bundesministerium fur Bildung und Forschung, German Ministry of Education and Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mandeel H, 2013, J MATERN-FETAL NEO M, V26, P83, DOI 10.3109/14767058.2012.718388; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; BLOTT M, 1988, ARCH DIS CHILD, V63, P683, DOI 10.1136/adc.63.6.683-a; Evans DJ, 2001, ARCH DIS CHILD-FETAL, V84, pF79, DOI 10.1136/fn.84.2.F79; Finnstrom O, 1997, ACTA PAEDIATR, V86, P503, DOI 10.1111/j.1651-2227.1997.tb08921.x; Furman B, 2000, EUR J OBSTET GYN R B, V92, P209, DOI 10.1016/S0301-2115(99)00257-2; Furman B, 2001, J Matern Fetal Med, V10, P107; Geffers C, 2008, J HOSP INFECT, V68, P214, DOI 10.1016/j.jhin.2008.01.016; Hartling L, 2006, J MATERN-FETAL NEO M, V19, P177, DOI 10.1080/14767050500451470; Hartling L, 2012, ARCH DIS CHILD-FETAL, V97, pF8, DOI 10.1136/adc.2010.210187; Manuck TA, 2009, OBSTET GYNECOL, V114, P29, DOI 10.1097/AOG.0b013e3181ab6fd3; Medina TM, 2006, AM FAM PHYSICIAN, V73, P659; Mercer BM, 2005, OBSTET GYN CLIN N AM, V32, P411, DOI 10.1016/j.ogc.2005.03.003; Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9; Messerschmidt A, 2011, NEONATOLOGY, V99, P146, DOI 10.1159/000313969; Newman DE, 2009, ARCH GYNECOL OBSTET, V280, P7, DOI 10.1007/s00404-008-0836-8; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Roberts D, 2014, ULTRASOUND OBST GYN, V43, P490, DOI 10.1002/uog.13258; Schleussner E, 2013, DTSCH ARZTEBL INT, V110, P227, DOI 10.3238/arztebl.2013.0227; Schucker JL, 1996, SEMIN PERINATOL, V20, P389, DOI 10.1016/S0146-0005(96)80006-1; Schwab F, 2007, J HOSP INFECT, V65, P319, DOI 10.1016/j.jhin.2006.12.020; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Simhan HN, 2005, BJOG-INT J OBSTET GY, V112, P32, DOI 10.1111/j.1471-0528.2005.00582.x; Strunk T, 2012, PEDIATRICS, V129, pE134, DOI 10.1542/peds.2010-3493; Thomas W, 2011, NEONATOLOGY, V99, P177, DOI 10.1159/000320170; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; van der Ham DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001208; van der Heyden JL, 2013, EUR J OBSTET GYN R B, V170, P125, DOI 10.1016/j.ejogrb.2013.06.012; van Teeffelen ASP, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-128; Van Teeffelen S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009952.pub2; Verspyck E, 2014, ACTA PAEDIATR, V103, P256, DOI 10.1111/apa.12489; Voigt M, 2010, J PERINAT MED, V38, P289, DOI [10.1515/JPM.2010.031, 10.1515/jpm.2010.031]; Waters TP, 2009, AM J OBSTET GYNECOL, V201, P230, DOI 10.1016/j.ajog.2009.06.049; Williams O, 2012, NEONATOLOGY, V101, P83, DOI 10.1159/000329445	34	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122564	10.1371/journal.pone.0122564	http://dx.doi.org/10.1371/journal.pone.0122564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856083	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500042
J	Salinero-Fort, MA; Andres-Rebollo, FJS; de Burgos-Lunar, C; Gomez-Campelo, P; Chico-Moraleja, RM; de Andres, AL; Jimenez-Garcia, R				Salinero-Fort, Miguel A.; San Andres-Rebollo, Francisco J.; de Burgos-Lunar, Carmen; Gomez-Campelo, Paloma; Chico-Moraleja, Rosa M.; Lopez de Andres, Ana; Jimenez-Garcia, Rodrigo		MADIABETES Grp	Five-Year Incidence of Chronic Kidney Disease (Stage 3-5) and Associated Risk Factors in a Spanish Cohort: The MADIABETES Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; DIABETES-MELLITUS; RENAL-FUNCTION; CARDIOVASCULAR EVENTS; ATHEROSCLEROSIS RISK; METABOLIC SYNDROME; ESTIMATED GFR; ALBUMINURIA; POPULATION	Objective To evaluate the incidence rate of Chronic Kidney Disease (CKD) stage 3-5 (persistent decreased kidney function under 60 mL/min per 1.73 m(2)) among patients with type 2 diabetes over five years, to identify the risk factors associated with CKD, and develop a risk table to predict five-year CKD stage 3-5 risk stratification for clinical use. Design The MADIABETES Study is a prospective cohort study of 3,443 outpatients with type 2 diabetes mellitus, sampled from 56 primary health care centers (131 general practitioners) in Madrid (Spain). Results The cumulative incidence of CKD stage 3-5 at five-years was 10.23% (95% CI = 9.12-11.44) and the incidence density was 2.07 (95% CI = 1.83-2.33) cases per 1,000 patient-months or 2.48 (95% CI = 2.19-2.79) cases per 100 patient-years. The highest hazard ratio (HR) for developing CKD stage 3-5 was albuminuria >= 300 mg/g (HR = 4.57; 95% CI=2.46-8.48). Furthermore, other variables with a high HR were age over 74 years (HR = 3.20; 95% CI = 2.13-4.81), a history of Hypertension (HR = 2.02; 95% CI = 1.42-2.89), Myocardial Infarction (HR = 1.72; 95% IC = 1.25-2.37), Dyslipidemia (HR = 1.68; 95% CI = 1.30-2.17), duration of diabetes mellitus >= 10 years (HR = 1.46; 95% CI = 1.14-1.88) and Systolic Blood Pressure > 149 mmHg (HR = 1.52; 95% CI = 1.02-2.24). Conclusions After a five-year follow-up, the cumulative incidence of CKD is concordant with rates described in Spain and other countries. Albuminuria >= 300 mg/g and age over 74 years were the risk factors more strongly associated with developing CKD (Stage 3-5). Blood Pressure, lipid and albuminuria control could reduce CKD incidence of CKD in patients with T2DM.	[Salinero-Fort, Miguel A.] Inst Invest Hosp Univ La Paz IdiPAZ, Red Invest Serv Salud Enfermedades Cronicas REDIS, Serv Madrileno Salud, Gerencia Atenc Primaria Gerencia Adjunta Planific, Madrid, Spain; [San Andres-Rebollo, Francisco J.] Serv Madrileno Salud, Ctr Salud Las Calesas, Madrid, Spain; [de Burgos-Lunar, Carmen] Inst Invest Hosp Univ La Paz IdiPAZ, Red Invest Serv Salud Enfermedades Cronicas REDIS, Serv Med Prevent, Hosp Univ La Paz,Serv Madrileno Salud, Madrid, Spain; [Gomez-Campelo, Paloma] Inst Invest Hosp Univ La Paz IdiPAZ, Plataforma Apoyo Invest Novel, Madrid, Spain; [Chico-Moraleja, Rosa M.; Lopez de Andres, Ana] Hosp Cent Def Gomez Ulla, Unidad Med Interna, Serv Madrileno Salud, Madrid, Spain; [Jimenez-Garcia, Rodrigo] Rey Juan Carlos Univ, Prevent Med & Publ Hlth Dept, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Universidad Rey Juan Carlos	Salinero-Fort, MA (corresponding author), Inst Invest Hosp Univ La Paz IdiPAZ, Red Invest Serv Salud Enfermedades Cronicas REDIS, Serv Madrileno Salud, Gerencia Atenc Primaria Gerencia Adjunta Planific, Madrid, Spain.	miguel.salinero@salud.madrid.org	Lopez-de-Andres, Ana/AAD-8703-2019; Jimenez-Garcia, Rodrigo/D-4953-2019; de Santa Pau, Enrique Carrillo/AAV-7544-2021; ALVAREZ EMBARBA, BEATRIZ/AHE-8612-2022; Lopez-de-Andres, Ana/D-4498-2019; SALINERO-FORT, MIGUEL A./GOP-2536-2022; Garcia-Garcia, Francisco Jose/R-9258-2017	Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; ALVAREZ EMBARBA, BEATRIZ/0000-0002-2084-3051; Lopez-de-Andres, Ana/0000-0001-5551-5181; SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; Serrano Serrano, Maria Encarnacion/0000-0003-3150-2348; Vich Perez, Pilar/0000-0002-6702-909X; Garcia-Garcia, Francisco Jose/0000-0003-3690-6069; Gomez Campelo, Paloma/0000-0003-2299-1741	National R+D+I (Research + Development + Innovation) Plan of the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III [PI10/02796, PI12/01806]	National R+D+I (Research + Development + Innovation) Plan of the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III	This work was supported by a grant from the 2008-2011 National R+D+I (Research + Development + Innovation) Plan of the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III (PI10/02796 and PI12/01806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afghahi H, 2011, NEPHROL DIAL TRANSPL, V26, P1236, DOI 10.1093/ndt/gfq535; Agarwal R, 2006, KIDNEY INT, V69, P1175, DOI 10.1038/sj.ki.5000247; Arauz-Pacheco Carlos, 2003, Diabetes Care, V26 Suppl 1, pS80; Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; Bosomworth NJ, 2011, CAN FAM PHYSICIAN, V57, P417; Brancati FL, 1997, JAMA-J AM MED ASSOC, V278, P2069, DOI 10.1001/jama.278.23.2069; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; de Burgos-Lunar C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-146; Diaz-Lopez A, 2012, AM J KIDNEY DIS, V60, P380, DOI 10.1053/j.ajkd.2012.02.334; Domenech JM, 2008, ANALISIS SUPERVIVENC; Drury PL, 2011, DIABETOLOGIA, V54, P32, DOI 10.1007/s00125-010-1854-1; Dunkler D, 2013, JAMA INTERN MED, V173, P1682, DOI 10.1001/jamainternmed.2013.9051; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gunzler D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-124; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Herget-Rosenthal S, 2013, PREV MED, V57, P357, DOI 10.1016/j.ypmed.2013.06.010; Hillege HL, 2003, EUR HEART J, V24, P412, DOI 10.1016/S0195-668X(02)00526-2; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; HUMPHREY LL, 1989, ANN INTERN MED, V111, P788, DOI 10.7326/0003-4819-111-10-788; Jenkins AJ, 2003, KIDNEY INT, V64, P817, DOI 10.1046/j.1523-1755.2003.00164.x; Jerums G, 2008, AM J NEPHROL, V28, P614, DOI 10.1159/000117461; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Kshirsagar AV, 2008, ARCH INTERN MED, V168, P2466, DOI 10.1001/archinte.168.22.2466; LANE PH, 1992, DIABETES, V41, P581, DOI 10.2337/diabetes.41.5.581; LEE ET, 1994, DIABETES, V43, P572, DOI 10.2337/diabetes.43.4.572; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MacIsaac R, 2004, DIABETES CARE, V27, P195, DOI 10.2337/diacare.27.1.195; Marrugat J, 2003, REV ESP CARDIOL, V56, P253, DOI 10.1157/13043951; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Newman DJ, 2005, HLTH TECHNOLOGY ASSE, V9, pxiii; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; O'Seaghdha CM, 2012, AM J MED, V125, P270, DOI 10.1016/j.amjmed.2011.09.009; Parving H.-H, 2004, BRENNER RECTORS KIDN, P1777; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Rodriguez-Poncelas A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-46; Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y; Rutledge JC, 2010, NAT REV NEPHROL, V6, P361, DOI 10.1038/nrneph.2010.59; Salinero-Fort MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076417; Selvin E, 2010, J DIABETES, V2, P118, DOI 10.1111/j.1753-0407.2010.00070.x; So WY, 2006, DIABETES CARE, V29, P2046, DOI 10.2337/dc06-0248; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stewart JH, 2006, DIABETIC MED, V23, P1364; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Thakar CV, 2011, CLIN J AM SOC NEPHRO, V6, P2567, DOI 10.2215/CJN.01120211; Thomas G, 2011, CLIN J AM SOC NEPHRO, V6, P2364, DOI 10.2215/CJN.02180311; Tozawa M, 2002, KIDNEY INT, V62, P1743, DOI 10.1046/j.1523-1755.2002.00626.x; TSALAMANDRIS C, 1994, DIABETES, V43, P649, DOI 10.2337/diabetes.43.5.649; Wassink AMJ, 2008, EUR HEART J, V29, P213, DOI 10.1093/eurheartj/ehm582; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Zoppini G, 2009, NUTR METAB CARDIOVAS, V19, P580, DOI 10.1016/j.numecd.2008.11.003; Zoppini G, 2012, CLIN J AM SOC NEPHRO, V7, P401, DOI 10.2215/CJN.07650711; Zoppini G, 2012, DIABETES CARE, V35, P99, DOI 10.2337/dc11-1346	59	19	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122030	10.1371/journal.pone.0122030	http://dx.doi.org/10.1371/journal.pone.0122030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856231	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500030
J	Wang, S; Parthasarathy, S; Nishiyama, Y; Endo, Y; Nemoto, T; Yamauchi, K; Asakura, T; Takeda, M; Terauchi, T; Kainosho, M; Ishii, Y				Wang, Songlin; Parthasarathy, Sudhakar; Nishiyama, Yusuke; Endo, Yuki; Nemoto, Takahiro; Yamauchi, Kazuo; Asakura, Tetsuo; Takeda, Mitsuhiro; Terauchi, Tsutomu; Kainosho, Masatsune; Ishii, Yoshitaka			Nano-Mole Scale Side-Chain Signal Assignment by H-1-Detected Protein Solid-State NMR by Ultra-Fast Magic-Angle Spinning and Stereo-Array Isotope Labeling	PLOS ONE			English	Article							HIGH-RESOLUTION; STRUCTURAL-CHARACTERIZATION; MOLECULAR-STRUCTURE; SECONDARY-STRUCTURE; INVERSE DETECTION; AMYLOID FIBRILS; SPECTROSCOPY; MAS; RESONANCE; DYNAMICS	We present a general approach in H-1-detected C-13 solid-state NMR (SSNMR) for side-chain signal assignments of 10-50 nmol quantities of proteins using a combination of a high magnetic field, ultra-fast magic-angle spinning (MAS) at similar to 80 kHz, and stereo-array-isotope-labeled (SAIL) proteins [Kainosho M. et al., Nature 440, 52-57, 2006]. First, we demonstrate that H-1 indirect detection improves the sensitivity and resolution of C-13 SSNMR of SAIL proteins for side-chain assignments in the ultra-fast MAS condition. H-1-detected SSNMR was performed for micro-crystalline ubiquitin (similar to 55 nmol or similar to 0.5mg) that was SAIL-labeled at seven isoleucine (Ile) residues. Sensitivity was dramatically improved by H-1-detected 2D H-1/C-13 SSNMR by factors of 5.4-9.7 and 2.1-5.0, respectively, over C-13-detected 2D H-1/C-13 SSNMR and 1D C-13 CPMAS, demonstrating that 2D H-1-detected SSNMR offers not only additional resolution but also sensitivity advantage over 1D C-13 detection for the first time. High H-1 resolution for the SAIL-labeled side-chain residues offered reasonable resolution even in the 2D data. A H-1-detected 3D C-13/C-13/H-1 experiment on SAIL-ubiquitin provided nearly complete H-1 and C-13 assignments for seven Ile residues only within similar to 2.5 h. The results demonstrate the feasibility of side-chain signal assignment in this approach for as little as 10 nmol of a protein sample within similar to 3 days. The approach is likely applicable to a variety of proteins of biological interest without any requirements of highly efficient protein expression systems.	[Wang, Songlin; Parthasarathy, Sudhakar; Ishii, Yoshitaka] Dept Chem, Chicago, IL 60637 USA; [Wang, Songlin; Parthasarathy, Sudhakar; Ishii, Yoshitaka] Univ Illinois, Chicago, IL USA; [Nishiyama, Yusuke; Endo, Yuki; Nemoto, Takahiro] JEOL RESONANCE Inc, Akishima, Tokyo, Japan; [Nishiyama, Yusuke] RIKEN, CLST JEOL Collaborat Ctr, Yokohama, Kanagawa, Japan; [Yamauchi, Kazuo] Nazarbayev Univ, Sch Sci & Technol, Astana, Kazakhstan; [Yamauchi, Kazuo] King Abdullah Univ Sci & Technol, Nucl Magnet Resonance Core Lab, Thuwal, Saudi Arabia; [Asakura, Tetsuo] Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 184, Japan; [Takeda, Mitsuhiro; Kainosho, Masatsune] Nagoya Univ, Struct Biol Res Ctr, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Terauchi, Tsutomu] SAIL Technol Co Inc, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Kainosho, Masatsune] Tokyo Metropolitan Univ, Ctr Prior Areas, Tokyo 158, Japan; [Ishii, Yoshitaka] Univ Illinois, Struct Biol Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Jeol Ltd; JEOL Japan; RIKEN; Nazarbayev University; King Abdullah University of Science & Technology; Tokyo University of Agriculture & Technology; Nagoya University; Tokyo Metropolitan University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ishii, Y (corresponding author), Dept Chem, Chicago, IL 60637 USA.	yishii@uic.edu	Asakura, Tetsuo/B-9970-2013; Ishii, Yoshitaka/F-4558-2014; Wang, Songlin/M-8088-2017	Asakura, Tetsuo/0000-0003-4472-6105; Ishii, Yoshitaka/0000-0002-7724-6469; Nishiyama, Yusuke/0000-0001-7136-1127	U.S. National Science Foundation [CHE 957793, CHE 1310363]; Dreyfus Foundation Teacher-Scholar Award program; National Institutes of Health HEI grant [1S10 RR025105]; JEOL RESONANCE Inc.; SAIL Technologies Co., Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025105] Funding Source: NIH RePORTER; Division Of Chemistry [1310363] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [26119005, 26248050] Funding Source: KAKEN	U.S. National Science Foundation(National Science Foundation (NSF)); Dreyfus Foundation Teacher-Scholar Award program; National Institutes of Health HEI grant; JEOL RESONANCE Inc.; SAIL Technologies Co., Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported primarily by grants to YI from the U.S. National Science Foundation (CHE 957793 and CHE 1310363) and the Dreyfus Foundation Teacher-Scholar Award program. The instrumentation of the 750 MHz SSNMR at UIC was supported by an National Institutes of Health HEI grant (1S10 RR025105) to YI. JEOL RESONANCE Inc. and SAIL Technologies Co., Inc. provided support in the form of salaries for authors YN, YE, TN and TT, but they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated above.	Althaus SM, 2014, SOLID STATE NUCL MAG, V57-58, P17, DOI 10.1016/j.ssnmr.2013.11.001; Barbet-Massin E, 2014, J AM CHEM SOC, V136, P12489, DOI 10.1021/ja507382j; Chevelkov V, 2006, ANGEW CHEM INT EDIT, V45, P3878, DOI 10.1002/anie.200600328; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Goobes G, 2006, P NATL ACAD SCI USA, V103, P16083, DOI 10.1073/pnas.0607193103; Guo CM, 2014, J BIOMOL NMR, V60, P219, DOI 10.1007/s10858-014-9870-y; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hoop CL, 2014, BIOCHEMISTRY-US, V53, P6653, DOI 10.1021/bi501010q; Huber M, 2012, PHYS CHEM CHEM PHYS, V14, P5239, DOI 10.1039/c2cp23872a; Igumenova TI, 2004, J AM CHEM SOC, V126, P6720, DOI 10.1021/ja030547o; Ishii Y, 2000, J MAGN RESON, V142, P199, DOI 10.1006/jmre.1999.1976; Ishii Y, 2001, J CHEM PHYS, V114, P8473, DOI 10.1063/1.1359445; Ishii Y, 2001, J AM CHEM SOC, V123, P2921, DOI 10.1021/ja015505j; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Kainosho M, 2009, Q REV BIOPHYS, V42, P247, DOI 10.1017/S0033583510000016; Knight MJ, 2011, ANGEW CHEM INT EDIT, V50, P11697, DOI 10.1002/anie.201106340; Kobayashi T, 2013, ANGEW CHEM INT EDIT, V52, P14108, DOI 10.1002/anie.201305475; Kotecha M, 2007, MAGN RESON CHEM, V45, pS221, DOI 10.1002/mrc.2151; Lange A, 2009, CHEM PHYS LETT, V468, P100, DOI 10.1016/j.cplett.2008.11.089; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Marchetti A, 2012, ANGEW CHEM INT EDIT, V51, P10756, DOI 10.1002/anie.201203124; Nadaud PS, 2010, J AM CHEM SOC, V132, P9561, DOI 10.1021/ja103545e; Nishiyama Y, 2014, J MAGN RESON, V244, P1, DOI 10.1016/j.jmr.2014.04.008; Parthasarathy S, 2013, ACCOUNTS CHEM RES, V46, P2127, DOI 10.1021/ar4000482; Paulson EK, 2003, J AM CHEM SOC, V125, P15831, DOI 10.1021/ja037315+; Reif B, 2012, J MAGN RESON, V216, P1, DOI 10.1016/j.jmr.2011.12.017; Rienstra CM, 2002, P NATL ACAD SCI USA, V99, P10260, DOI 10.1073/pnas.152346599; Schneider R, 2011, J MOL BIOL, V412, P121, DOI 10.1016/j.jmb.2011.06.045; Schnell I, 2002, J AM CHEM SOC, V124, P10938, DOI 10.1021/ja026657x; SHAKA AJ, 1983, J MAGN RESON, V52, P335, DOI 10.1016/0022-2364(83)90207-X; Suiter CL, 2014, J BIOMOL NMR, V59, P57, DOI 10.1007/s10858-014-9824-4; Takahashi H, 2010, J MAGN RESON, V203, P253, DOI 10.1016/j.jmr.2010.01.005; TORII K, 1971, ACTA CRYSTALL B-STRU, VB 27, P2237, DOI 10.1107/S0567740871005612; VARUGHESE KI, 1976, PRAMANA, V6, P189, DOI 10.1007/BF02875209; Vyalikh A, 2014, J PHYS CHEM B, V118, P724, DOI 10.1021/jp410299x; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wickramasinghe NP, 2009, NAT METHODS, V6, P215, DOI [10.1038/nmeth.1300, 10.1038/NMETH.1300]; Zhou DH, 2007, J AM CHEM SOC, V129, P11791, DOI 10.1021/ja073462m	40	12	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122714	10.1371/journal.pone.0122714	http://dx.doi.org/10.1371/journal.pone.0122714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856081	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500049
J	Meena, MK; Ghawana, S; Sardar, A; Dwivedi, V; Khandal, H; Roy, R; Chattopadhyay, D				Meena, Mukesh Kumar; Ghawana, Sanjay; Sardar, Atish; Dwivedi, Vikas; Khandal, Hitaishi; Roy, Riti; Chattopadhyay, Debasis			Investigation of Genes Encoding Calcineurin B-Like Protein Family in Legumes and Their Expression Analyses in Chickpea (Cicer arietinum L.)	PLOS ONE			English	Article							DRAFT GENOME SEQUENCE; CALCIUM SENSOR CBL10; ABIOTIC STRESS; SALT TOLERANCE; TRANSCRIPTOME ANALYSIS; SIGNALING NETWORK; COLD-ACCLIMATION; ION HOMEOSTASIS; ARABIDOPSIS; KINASE	Calcium ion (Ca2+) is a ubiquitous second messenger that transmits various internal and external signals including stresses and, therefore, is important for plants' response process. Calcineurin B-like proteins (CBLs) are one of the plant calcium sensors, which sense and convey the changes in cytosolic Ca2+-concentration for response process. A search in four leguminous plant (soybean, Medicago truncatula, common bean and chickpea) genomes identified 9 to 15 genes in each species that encode CBL proteins. Sequence analyses of CBL peptides and coding sequences (CDS) suggested that there are nine original CBL genes in these legumes and some of them were multiplied during whole genome or local gene duplication. Coding sequences of chickpea CBL genes (CaCBL) were cloned from their cDNAs and sequenced, and their annotations in the genome assemblies were corrected accordingly. Analyses of protein sequences and gene structures of CBL family in plant kingdom indicated its diverse origin but showed a remarkable conservation in overall protein structure with appearance of complex gene structure in the course of evolution. Expression of CaCBL genes in different tissues and in response to different stress and hormone treatment were studied. Most of the CaCBL genes exhibited high expression in flowers. Expression profile of CaCBL genes in response to different abiotic stresses and hormones related to development and stresses (ABA, auxin, cytokinin, SA and JA) at different time intervals suggests their diverse roles in development and plant defence in addition to abiotic stress tolerance. These data not only contribute to a better understanding of the complex regulation of chickpea CBL gene family, but also provide valuable information for further research in chickpea functional genomics.	[Meena, Mukesh Kumar; Ghawana, Sanjay; Sardar, Atish; Dwivedi, Vikas; Khandal, Hitaishi; Roy, Riti; Chattopadhyay, Debasis] Natl Inst Plant Genome Res, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Chattopadhyay, D (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India.	debasis@nipgr.ac.in	Meena, Mukesh/GNH-5631-2022	Meena, Mukesh Kumar/0000-0002-8847-2023; Sardar, Atish/0000-0002-8737-1175; Chattopadhyay, Debasis/0000-0002-5754-4987	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR12919/AGR/02/676/2009]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The work was funded by the Department of Biotechnology, Ministry of Science and Technology, Government of India under the project 'Next generation challenge program in chickpea genomics' (BT/PR12919/AGR/02/676/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht V, 2003, PLANT J, V36, P457, DOI 10.1046/j.1365-313X.2003.01892.x; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2010, PLANT J, V61, P211, DOI 10.1111/j.1365-313X.2009.04045.x; Boominathan P, 2004, PLANT PHYSIOL, V135, P1608, DOI 10.1104/pp.104.043141; Buchel AS, 1999, PLANT MOL BIOL, V40, P387, DOI 10.1023/A:1006144505121; Chen L, 2012, J EXP BOT, V63, P6211, DOI 10.1093/jxb/ers273; Cheong YH, 2003, PLANT CELL, V15, P1833, DOI 10.1105/tpc.012393; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cuellar T, 2013, PLANT J, V73, P1006, DOI 10.1111/tpj.12092; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; de la Torre F, 2013, PLANT CELL, V25, P2748, DOI 10.1105/tpc.113.113530; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Eckert C, 2014, PLANT J, V78, P146, DOI 10.1111/tpj.12456; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; Held K, 2011, CELL RES, V21, P1116, DOI 10.1038/cr.2011.50; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huang CL, 2011, PLANT SCI, V181, P57, DOI 10.1016/j.plantsci.2011.03.011; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim BG, 2007, PLANT J, V52, P473, DOI 10.1111/j.1365-313X.2007.03249.x; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Kudla J, 1999, P NATL ACAD SCI USA, V96, P4718, DOI 10.1073/pnas.96.8.4718; Kurusu T, 2010, PLANT SIGNAL BEHAV, V5, P1045, DOI [10.4161/psb.5.8.12407, 10.1104/pp.109.151852]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li Z, 2013, REGEN MED, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0056412; Li ZY, 2012, BIOCHEM BIOPH RES CO, V427, P731, DOI 10.1016/j.bbrc.2012.09.128; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lyzenga WJ, 2013, J EXP BOT, V64, P2779, DOI 10.1093/jxb/ert123; Mahs A, 2013, MOL PLANT, V6, P1149, DOI 10.1093/mp/sst095; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; MONROY AF, 1993, PLANT PHYSIOL, V102, P1227, DOI 10.1104/pp.102.4.1227; MONROY AF, 1995, PLANT CELL, V7, P321, DOI 10.1105/tpc.7.3.321; MONTGOMERY J, 1993, P NATL ACAD SCI USA, V90, P5939, DOI 10.1073/pnas.90.13.5939; Nagae M, 2003, J BIOL CHEM, V278, P42240, DOI 10.1074/jbc.M303630200; Nurnberger T, 2001, TRENDS PLANT SCI, V6, P372, DOI 10.1016/S1360-1385(01)02019-2; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Piao HL, 2010, MOL CELLS, V30, P19, DOI 10.1007/s10059-010-0084-1; Ren XL, 2013, PLANT J, V74, P258, DOI 10.1111/tpj.12123; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shi JR, 1999, PLANT CELL, V11, P2393, DOI 10.1105/tpc.11.12.2393; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang RJ, 2012, CELL RES, V22, P1650, DOI 10.1038/cr.2012.161; Tripathi V, 2009, PLANT J, V58, P778, DOI 10.1111/j.1365-313X.2009.03812.x; Tsou PL, 2012, PLANTA, V235, P539, DOI 10.1007/s00425-011-1522-9; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhang HC, 2013, PLANT CELL REP, V32, P611, DOI 10.1007/s00299-013-1394-5	66	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123640	10.1371/journal.pone.0123640	http://dx.doi.org/10.1371/journal.pone.0123640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853855	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400111
J	Pereira, LA; Hugo, HJ; Malaterre, J; Xu, HL; Sonza, S; Cures, A; Purcell, DFJ; Ramsland, PA; Gerondakis, S; Gonda, TJ; Ramsay, RG				Pereira, Lloyd A.; Hugo, Honor J.; Malaterre, Jordane; Xu Huiling; Sonza, Secondo; Cures, Alina; Purcell, Damian F. J.; Ramsland, Paul A.; Gerondakis, Steven; Gonda, Thomas J.; Ramsay, Robert G.			MYB Elongation Is Regulated by the Nucleic Acid Binding of NF kappa B p50 to the Intronic Stem-Loop Region	PLOS ONE			English	Article							RNA-POLYMERASE-II; HIV-1 TAT PROTEIN; C-MYB; P-TEFB; TRANSCRIPTIONAL ELONGATION; GENE-EXPRESSION; MESSENGER-RNA; HIGH-AFFINITY; IN-VITRO; P50/P65 HETERODIMER	MYB transcriptional elongation is regulated by an attenuator sequence within intron 1 that has been proposed to encode a RNA stem loop (SLR) followed by a polyU tract. We report that NF kappa Bp50 can bind the SLR polyU RNA and promote MYB transcriptional elongation together with NF kappa Bp65. We identified a conserved lysine-rich motif within the Rel homology domain (RHD) of NF kappa Bp50, mutation of which abrogated the interaction of NF kappa Bp50 with the SLR polyU and impaired NF kappa Bp50 mediated MYB elongation. We observed that the TAR RNA-binding region of Tat is homologous to the NF kappa Bp50 RHD lysine-rich motif, a finding consistent with HIV Tat acting as an effector of MYB transcriptional elongation in an SLR dependent manner. Furthermore, we identify the DNA binding activity of NF kappa Bp50 as a key component required for the SLR polyU mediated regulation of MYB. Collectively these results suggest that the MYB SLR polyU provides a platform for proteins to regulate MYB and reveals novel nucleic acid binding properties of NF kappa Bp50 required for MYB regulation.	[Pereira, Lloyd A.; Malaterre, Jordane; Xu Huiling; Cures, Alina; Ramsay, Robert G.] Peter MacCallum Canc Ctr, Differentiat & Transcript Lab, Melbourne, Vic 8006, Australia; [Pereira, Lloyd A.; Malaterre, Jordane; Xu Huiling; Ramsay, Robert G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia; [Xu Huiling; Ramsay, Robert G.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Hugo, Honor J.] St Vincents Inst Med Res, Victorian Breast Canc Consortium, Invas & Metastasis Unit, Fitzroy, Vic 3065, Australia; [Sonza, Secondo; Purcell, Damian F. J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Ramsland, Paul A.] Burnet Inst, Ctr Immunol, Melbourne, Vic 3004, Australia; [Ramsland, Paul A.] Univ Melbourne, Dept Surg Austin Hlth, Melbourne, Vic 3084, Australia; [Ramsland, Paul A.] Monash Univ, Dept Immunol, Alfred Med Res & Educ Precinct, Melbourne, Vic 3004, Australia; [Gerondakis, Steven] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Gonda, Thomas J.] Univ Queensland, Sch Pharm, Woolloongabba, Qld 4102, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; Burnet Institute; Austin Research Institute; University of Melbourne; Monash University; Monash University; University of Queensland	Ramsay, RG (corresponding author), Peter MacCallum Canc Ctr, Differentiat & Transcript Lab, Locked Bag 1, Melbourne, Vic 8006, Australia.	rob.ramsay@petermac.org	Ramsay, Robert G/C-3291-2015; Purcell, Damian F/G-5068-2011	Ramsay, Robert G/0000-0001-5003-0433; Ramsland, Paul/0000-0002-2107-2738; Hugo, Honor/0000-0001-9436-5286	National Health and Medical Research Council of Australia [487922]; Australian Research Council [DP0985025]; National Institutes of Health [5-R21-AI-54158-2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI054158] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Health and Medical Research Council of Australia, https://www.nhmrc.gov.au/, 487922, RR, Australian Research Council, DP0985025, http://www.arc.gov.au/, RR and National Institutes of Health grant, 5-R21-AI-54158-2, http://www.nih.gov/, RR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; BARNETT RW, 1993, NUCLEIC ACIDS RES, V21, P151, DOI 10.1093/nar/21.1.151; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; Biroccio A, 2001, AM J PATHOL, V158, P1289, DOI 10.1016/S0002-9440(10)64080-1; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Cassiday LA, 2002, NUCLEIC ACIDS RES, V30, P4118, DOI 10.1093/nar/gkf512; Cheasley D, 2011, STEM CELLS, V29, P2042, DOI 10.1002/stem.761; Chen FE, 1999, PROTEIN ENG, V12, P423, DOI 10.1093/protein/12.5.423; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239; Ciznadija D, 2009, CELL DEATH DIFFER, V16, P1530, DOI 10.1038/cdd.2009.94; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; D'Orso I, 2012, MOL CELL BIOL, V32, P4780, DOI 10.1128/MCB.00206-12; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Fromm G, 2013, CELL, V153, P930, DOI 10.1016/j.cell.2013.04.011; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Huang DB, 2003, P NATL ACAD SCI USA, V100, P9268, DOI 10.1073/pnas.1632011100; Hugo H, 2006, GENE CHROMOSOME CANC, V45, P1143, DOI 10.1002/gcc.20378; Kaehlcke K, 2003, MOL CELL, V12, P167, DOI 10.1016/S1097-2765(03)00245-4; Keene RG, 1999, NUCLEIC ACIDS RES, V27, P3173, DOI 10.1093/nar/27.15.3173; Khan MTH, 2012, CURR TOP MED CHEM, V12, P814; Lauder A, 2001, MOL CELL BIOL, V21, P5797, DOI 10.1128/MCB.21.17.5797-5805.2001; Lebruska LL, 1999, BIOCHEMISTRY-US, V38, P3168, DOI 10.1021/bi982515x; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Mathews DH, 2007, CURR PROTOC NUCL ACI; Miao RY, 2011, CANCER RES, V71, P7029, DOI 10.1158/0008-5472.CAN-11-1015; Mitra P, 2012, NUCLEIC ACIDS RES, V40, P5988, DOI 10.1093/nar/gks286; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; RAMSAY RG, 1989, ONCOGENE RES, V4, P259; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; REDDY CD, 1989, P NATL ACAD SCI USA, V86, P7326, DOI 10.1073/pnas.86.19.7326; Reiter NJ, 2008, NUCLEIC ACIDS RES, V36, P1227, DOI 10.1093/nar/gkm1141; RUBEN SM, 1992, MOL CELL BIOL, V12, P444, DOI 10.1128/MCB.12.2.444; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shilatifard A, 1998, FASEB J, V12, P1437, DOI 10.1096/fasebj.12.14.1437; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith CA, 2000, MOL CELL, V6, P1067, DOI 10.1016/S1097-2765(00)00105-2; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Suhasini M, 1997, ONCOGENE, V15, P1859, DOI 10.1038/sj.onc.1201530; Suhasini M, 1999, ONCOGENE, V18, P7360, DOI 10.1038/sj.onc.1203158; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; Thompson MA, 1997, ONCOGENE, V14, P1715, DOI 10.1038/sj.onc.1201007; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; TOTH CR, 1995, J BIOL CHEM, V270, P7661, DOI 10.1074/jbc.270.13.7661; WATSON RJ, 1988, ONCOGENE, V2, P267; WATSON RJ, 1988, MOL CELL BIOL, V8, P3938, DOI 10.1128/MCB.8.9.3938; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wurster SE, 2008, RNA, V14, P1037, DOI 10.1261/rna.878908; Wurster SE, 2009, NUCLEIC ACIDS RES, V37, P6214, DOI 10.1093/nar/gkp670; Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	59	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122919	10.1371/journal.pone.0122919	http://dx.doi.org/10.1371/journal.pone.0122919			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853889	gold, Green Published			2022-12-27	WOS:000352478400084
J	Petropoulos, IN; Green, P; Chan, AWS; Alam, U; Fadavi, H; Marshall, A; Asghar, O; Efron, N; Tavakoli, M; Malik, RA				Petropoulos, Ioannis N.; Green, Patrick; Chan, Agnes W. S.; Alam, Uazman; Fadavi, Hassan; Marshall, Andrew; Asghar, Omar; Efron, Nathan; Tavakoli, Mitra; Malik, Rayaz A.			Corneal Confocal Microscopy Detects Neuropathy in Patients with Type 1 Diabetes without Retinopathy or Microalbuminuria	PLOS ONE			English	Article							NERVE-FIBER DAMAGE; PERIPHERAL NEUROPATHY; PREVALENCE; RISK; POLYNEUROPATHY; COMPLICATIONS; NEPHROPATHY; PROGRESSION; SURROGATE; SEVERITY	Objective Corneal innervation is increasingly used as a surrogate marker of human diabetic peripheral neuropathy (DPN) however its temporal relationship with the other microvascular complications of diabetes is not fully established. In this cross-sectional, observational study we aimed to assess whether neuropathy occurred in patients with type 1 diabetes, without retinopathy or microalbuminuria. Materials and Methods All participants underwent detailed assessment of peripheral neuropathy [neuropathy disability score (NDS), vibration perception threshold (VPT), peroneal motor nerve conduction velocity (PMNCV), sural sensory nerve conduction velocity (SSNCV) and in vivo corneal confocal microscopy (IVCCM)], retinopathy (digital fundus photography) and albuminuria status [albumin: creatinine ratio (ACR)]. Results 53 patients with Type 1 diabetes with (n=37) and without retinopathy (n= 16) were compared to control subjects (n=27). SSNCV, corneal nerve fibre (CNFD) and branch (CNBD) density and length (CNFL) were reduced significantly (p<0.001) in diabetic patients without retinopathy compared to control subjects. Furthermore, CNFD, CNBD and CNFL were also significantly (p<0.001) reduced in diabetic patients without microalbuminuria (n=39), compared to control subjects. Greater neuropathic severity was associated with established retinopathy and microalbuminuria. Conclusions IVCCM detects early small fibre damage in the absence of retinopathy or microalbuminuria in patients with Type 1 diabetes.	[Petropoulos, Ioannis N.; Green, Patrick; Alam, Uazman; Fadavi, Hassan; Marshall, Andrew; Asghar, Omar; Tavakoli, Mitra; Malik, Rayaz A.] Univ Manchester, Ctr Endocrinol & Diabet, Inst Human Dev, Manchester, Lancs, England; [Petropoulos, Ioannis N.; Green, Patrick; Alam, Uazman; Fadavi, Hassan; Marshall, Andrew; Asghar, Omar; Tavakoli, Mitra; Malik, Rayaz A.] Manchester Acad Hlth Sci Ctr, Cent Manchester Natl Hlth Syst Fdn Trust, Manchester, Lancs, England; [Petropoulos, Ioannis N.; Malik, Rayaz A.] Qatar Fdn, Weill Cornell Med Coll Qatar, Div Res, Doha, Qatar; [Chan, Agnes W. S.] Queen Marys Univ, Barts & London Natl Hlth Syst Trust, London, England; [Efron, Nathan] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Efron, Nathan] Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld 4001, Australia	University of Manchester; University of Manchester; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Barts Health NHS Trust; University of London; Queen Mary University London; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Malik, RA (corresponding author), Univ Manchester, Ctr Endocrinol & Diabet, Inst Human Dev, Manchester, Lancs, England.	ram2045@qatar-med.cornell.edu	Efron, Nathan/I-9766-2012; Green, Patrick/AAD-7594-2020; Malik, Rayaz/H-9231-2019; Marshall, Andrew/AAE-5203-2019; Alam, Uazman/I-9173-2019; Tavakoli, Mitra/F-6707-2011; TAVAKOLI, MITRA/N-1402-2016	Efron, Nathan/0000-0002-7037-779X; Malik, Rayaz/0000-0002-7188-8903; Alam, Uazman/0000-0002-3190-1122; TAVAKOLI, MITRA/0000-0003-2319-1543; Green, Patrick/0000-0002-4805-7298	National Institutes of Health [R105991]; Juvenile Diabetes Research Foundation International [27-2008-362]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation)	This study was sponsored by awards from the National Institutes of Health, grant number R105991 (http://www.nih.gov/) and the Juvenile Diabetes Research Foundation International, grant number 27-2008-362 (http://www.jdrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2012, CLIN EXP OPTOM, V95, P256, DOI 10.1111/j.1444-0938.2012.00733.x; Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Ahmed A, 2012, DIABETES CARE, V35, P821, DOI 10.2337/dc11-1396; [Anonymous], 1981, INVEST OPHTH VIS SCI, V21, P210; Bitirgen G, 2014, DIABETIC MED, V31, P431, DOI 10.1111/dme.12324; Candrilli SD, 2007, J DIABETES COMPLICAT, V21, P306, DOI 10.1016/j.jdiacomp.2006.08.002; Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y; Dyck PJ, 1999, DIABETES CARE, V22, P1479, DOI 10.2337/diacare.22.9.1479; Edwards K, 2012, CLIN EXP OPTOM, V95, P348, DOI 10.1111/j.1444-0938.2012.00740.x; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Grunwald JE, 2012, ARCH OPHTHALMOL-CHIC, V130, P1136, DOI 10.1001/archophthalmol.2012.1800; Ishibashi F, 2012, J DIABETES INVEST, V3, P191, DOI 10.1111/j.2040-1124.2011.00157.x; Kohner EM, 1998, ARCH OPHTHALMOL-CHIC, V116, P297, DOI 10.1001/archopht.116.3.297; KROLEWSKI AS, 1992, DIABETES, V41, P430, DOI 10.2337/diabetes.41.4.430; Lorenzi M, 2010, INVEST OPHTH VIS SCI, V51, P6770, DOI 10.1167/iovs.10-5785; Lovestam-Adrian M, 1999, DIABETES RES CLIN PR, V45, P15, DOI 10.1016/S0168-8227(99)00055-8; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; Nitoda E, 2012, CURR EYE RES, V37, P898, DOI 10.3109/02713683.2012.683507; Petropoulos IN, 2013, CORNEA, V32, pE83, DOI 10.1097/ICO.0b013e3182749419; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Ra H, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-29; RASSAM SMB, 1995, EXP PHYSIOL, V80, P53, DOI 10.1113/expphysiol.1995.sp003834; Sampson G, 2012, DIABETOLOGIA, V1-7, DOI [10.1007/s00125-012-2694-y, DOI 10.1007/S00125-012-2694-Y]; Shahidi AM, 2012, DIABETIC MED, V29, pE106, DOI 10.1111/j.1464-5491.2012.03588.x; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Vagenas D, 2012, OPTOMETRY VISION SCI, V89, P812, DOI 10.1097/OPX.0b013e31824ee8c9; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wu T, 2012, DIABETIC MED, V29, pE297, DOI 10.1111/j.1464-5491.2012.03678.x; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; Zhivov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052157	31	55	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123517	10.1371/journal.pone.0123517	http://dx.doi.org/10.1371/journal.pone.0123517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853247	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400103
J	Rice, J; Roberts, H; Burton, J; Pan, J; States, V; Rai, SN; Galandiuk, S				Rice, Jonathan; Roberts, Henry; Burton, James; Pan, Jianmin; States, Vanessa; Rai, Shesh N.; Galandiuk, Susan			Assay Reproducibility in Clinical Studies of Plasma miRNA	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; DIAGNOSTIC BIOMARKER; COLORECTAL-CANCER; HEART-FAILURE; MARKERS; BLOOD; EXPRESSION; SIGNATURE	There are increasing reports of plasma miRNAs as biomarkers of human disease but few standards in methodologic reporting, leading to inconsistent data. We systematically reviewed plasma miRNA studies published between July 2013-June 2014 to assess methodology. Six parameters were investigated: time to plasma extraction, methods of RNA extraction, type of miRNA, quantification, cycle threshold (Ct) setting, and methods of statistical analysis. We compared these data with a proposed standard methodologic technique. Beginning with initial screening for 380 miRNAs using microfluidic array technology and validation in an additional cohort of patients, we compared 11 miRNAs that exhibited differential expression between 16 patients with benign colorectal neoplasms (advanced adenomas) and 16 patients without any neoplasm (controls). Plasma was isolated immediately, 12, 24, 48, or 72 h following phlebotomy. miRNA was extracted using two different techniques (Trizol LS with pre-amplification or modified miRNeasy). We performed Taq-man- based RT-PCR assays for the 11 miRNAs with subsequent analyses using a variable Ct setting or a fixed Ct set at 0.01, 0.03, 0.05, or 0.5. Assays were performed in duplicate by two different operators. RNU6 was the internal reference. Systematic review yielded 74 manuscripts meeting inclusion criteria. One manuscript (1.4%) documented all 6 methodological parameters, while < 5% of studies listed Ct setting. In our proposed standard technique, plasma extraction <= 12 h provided consistent Delta Ct. miRNeasy extraction yielded higher miRNA concentrations and fewer non-expressed miRNAs compared to Trizol LS (1/704 miRNAs [0.14%] vs 109/704 miRNAs [15%], not expressed, respectively). A fixed Ct bar setting of 0.03 yielded the most reproducible data, provided that < 10% miRNA were non-expressed. There was no significant intra-operator variability. There was significant inter-operator variation using Trizol LS extraction, while this was negligible using modified miRNeasy. For standardized reporting, we recommend plasma extraction <= 12 h, using modified miRNeasy extraction and utilizing a 0.03 Ct.	[Rice, Jonathan; Roberts, Henry; Burton, James; States, Vanessa; Galandiuk, Susan] Univ Louisville, Sch Med, Price Inst Surg Res, Hiram C Polk Jr MD Dept Surg, Louisville, KY 40292 USA; [Pan, Jianmin; Rai, Shesh N.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinformat & Biostat, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Galandiuk, S (corresponding author), Univ Louisville, Sch Med, Price Inst Surg Res, Hiram C Polk Jr MD Dept Surg, Louisville, KY 40292 USA.	s0gala01@louisville.edu			Wendell Cherry Chair Clinical Trial Research Fund	Wendell Cherry Chair Clinical Trial Research Fund	This publication is made possible in part by the John W. and Caroline Price Family Trust as well as gifts from Donald and Irene Dizney and the Alagia Family Foundation. Dr. Rai is partly supported by the Wendell Cherry Chair Clinical Trial Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achberger S, 2014, MOL IMMUNOL, V58, P182, DOI 10.1016/j.molimm.2013.11.018; Aushev VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078649; Ayaz L, 2013, J CANCER RES CLIN, V139, P1499, DOI 10.1007/s00432-013-1469-2; Benson EA, 2013, DRUG METAB DISPOS, V41, P1778, DOI 10.1124/dmd.113.052357; Bhatnagar S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00002; Cai H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0452-0; Cambon AC BK, 2014, MODEL ASSISTED STATI; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069239; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; Cho WCS, 2012, EXPERT REV MOL DIAGN, V12, P315, DOI [10.1586/ERM.12.21, 10.1586/erm.12.21]; Cho William C. S., 2011, Frontiers in Genetics, V2, P7, DOI 10.3389/fgene.2011.00007; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Dmitrienko A MG, 2005, ANALYSIS OF CLINICAL; Dong Y, 2011, BRIT J CANCER, V104, P893, DOI 10.1038/bjc.2011.57; Du J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063390; Ellis KL, 2013, EUR J HEART FAIL, V15, P1138, DOI 10.1093/eurjhf/hft078; Fan Kuan-Lu, 2013, Indian Heart J, V65, P12, DOI 10.1016/j.ihj.2012.12.022; Fayyad-Kazan H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-31; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fleiss JL, 1986, DESIGN AND ANALYSIS; Freedman Jane E, 2012, F1000Res, V1, P50, DOI 10.12688/f1000research.1-50.v1; Gandhi R, 2013, ANN NEUROL, V73, P729, DOI 10.1002/ana.23880; Ganepola GAP, 2014, WORLD J GASTRO ONCOL, V6, P22, DOI 10.4251/wjgo.v6.i1.22; Garcia R, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000211; Ge QY, 2011, CLIN CHIM ACTA, V412, P1989, DOI 10.1016/j.cca.2011.07.010; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-12; Giraldez MD, 2013, CLIN GASTROENTEROL H, V11, P681, DOI 10.1016/j.cgh.2012.12.009; Gonen M, 2006, THIRTY FIRST ANNUAL, P210; Gorur A, 2013, MOL BIOL REP, V40, P2091, DOI 10.1007/s11033-012-2267-7; Gourzones C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-119; Hirajima S, 2013, BRIT J CANCER, V108, P1822, DOI 10.1038/bjc.2013.148; Huang JJ, 2012, MED ONCOL, V29, P2402, DOI 10.1007/s12032-012-0210-3; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Ichikawa Makiko, 2013, Methods Mol Biol, V1024, P247, DOI 10.1007/978-1-62703-453-1_20; Jia SZ, 2013, HUM REPROD, V28, P322, DOI 10.1093/humrep/des413; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Kawano Y, 2013, J INFECT DIS, V208, P771, DOI 10.1093/infdis/jit222; Khoo SK, 2012, J PARKINSON DIS, V2, P321, DOI 10.3233/JPD-012144; Kin K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000745; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kishimoto T, 2013, CANCER SCI, V104, P1626, DOI 10.1111/cas.12300; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Kumar S, 2013, INDIAN J BIOCHEM BIO, V50, P210; Laterza OF, 2013, BIOMARK MED, V7, P205, DOI [10.2217/bmm.12.107, 10.2217/BMM.12.107]; Leidner RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057841; Leuenberger N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066309; Li C, 2013, J SURG ONCOL, V108, P89, DOI 10.1002/jso.23358; Li HL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/970265; Li YQ, 2013, CLINICS, V68, P75, DOI 10.6061/clinics/2013(01)OA12; Lu J, 2014, BRIT J CANCER, V110, P392, DOI 10.1038/bjc.2013.751; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; Marfella R, 2013, EUR J HEART FAIL, V15, P1277, DOI 10.1093/eurjhf/hft088; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moldovan Leni, 2013, Methods Mol Biol, V1024, P129, DOI 10.1007/978-1-62703-453-1_10; Moret I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082753; Murata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069118; Nair N, 2013, MOL CELL BIOCHEM, V376, P33, DOI 10.1007/s11010-012-1546-x; Ng EKO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053141; Olivieri F, 2013, INT J CARDIOL, V167, P531, DOI 10.1016/j.ijcard.2012.01.075; Ouyang L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0340-7; Parikh Victoria N, 2013, Methods Mol Biol, V1024, P157, DOI 10.1007/978-1-62703-453-1_12; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Pepe MS, 2003, THE STATISTICAL EVAL; Prats-Puig A, 2013, J CLIN ENDOCR METAB, V98, pE1655, DOI 10.1210/jc.2013-1496; Quackenbush JF, 2014, METHODS MOL BIOL, V1102, P641, DOI 10.1007/978-1-62703-727-3_34; Rai SN RH, 2012, OPEN ACCESS MEDICAL; Roncarati R, 2014, J AM COLL CARDIOL, V63, P920, DOI 10.1016/j.jacc.2013.09.041; Rong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073272; Sanfiorenzo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054596; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Schetter AJ, 2012, CANCER J, V18, P244, DOI 10.1097/PPO.0b013e318258b78f; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Shapira I, 2014, BRIT J CANCER, V110, P976, DOI 10.1038/bjc.2013.795; Shimizu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058159; Shrivastava S, 2013, HEPATOLOGY, V58, P863, DOI 10.1002/hep.26296; Soeda S, 2013, INT J MOL MED, V31, P533, DOI 10.3892/ijmm.2013.1251; Sozzi G, 2014, J CLIN ONCOL, V32, P768, DOI 10.1200/JCO.2013.50.4357; Suryawanshi S, 2013, CLIN CANCER RES, V19, P1213, DOI 10.1158/1078-0432.CCR-12-2726; Szabo DR, 2014, LAB INVEST, V94, P331, DOI 10.1038/labinvest.2013.148; Takahashi K, 2013, TOXICOL APPL PHARM, V272, P154, DOI 10.1016/j.taap.2013.05.018; Technologies L, 2013, PROTOCOL FOR CREATIN; Technologies L, 2010, TRIZOL LS REAGENT; Teixeira AL, 2014, TUMOR BIOL, V35, P4057, DOI 10.1007/s13277-013-1531-3; Tian Q, 2014, EJSO-EUR J SURG ONC, V40, P67, DOI 10.1016/j.ejso.2013.08.024; Tsukamoto O, 2014, GYNECOL ONCOL, V132, P715, DOI 10.1016/j.ygyno.2014.01.029; Wang ES, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-165; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wedge DC, 2011, ANAL CHEM, V83, P6689, DOI 10.1021/ac2012224; Westermann AM, 2014, ANTICANCER RES, V34, P665; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Winther TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058236; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586; Yamamoto M, 2013, ENVIRON HEALTH PERSP, V121, P670, DOI 10.1289/ehp.1205963; Yu H, 2014, GENE, V534, P60, DOI 10.1016/j.gene.2013.10.024; Zanutto S, 2014, BRIT J CANCER, V110, P1001, DOI 10.1038/bjc.2013.819; Zeng RC, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0477-z; Zhao J, 2013, BIOCHEM BIOPH RES CO, V438, P439, DOI 10.1016/j.bbrc.2013.07.095; Zheng WD, 2013, CLIN BIOCHEM, V46, P1566, DOI 10.1016/j.clinbiochem.2013.06.024	101	31	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121948	10.1371/journal.pone.0121948	http://dx.doi.org/10.1371/journal.pone.0121948			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853871	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400056
J	Ricigliano, VAG; Handel, AE; Sandve, GK; Annibali, V; Ristori, G; Mechelli, R; Cader, MZ; Salvetti, M				Ricigliano, Vito A. G.; Handel, Adam E.; Sandve, Geir K.; Annibali, Viviana; Ristori, Giovanni; Mechelli, Rosella; Cader, M. Zameel; Salvetti, Marco			EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BACILLE-CALMETTE-GUERIN; LEUKEMIA-CELLS; CHIP-SEQ; HYPERBROWSER; ACTIVATION; GENES; MAP	Epstein-Barr virus (EBV) is a non-heritable factor that associates with multiple sclerosis (MS). However its causal relationship with the disease is still unclear. The virus establishes a complex co-existence with the host that includes regulatory influences on gene expression. Hence, if EBV contributes to the pathogenesis of MS it may do so by interacting with disease predisposing genes. To verify this hypothesis we evaluated EBV nuclear antigen 2 (EBNA2, a protein that recent works by our and other groups have implicated in disease development) binding inside MS associated genomic intervals. We found that EBNA2 binding occurs within MS susceptibility sites more than expected by chance (factor of observed vs expected overlap [O/E] = 5.392-fold, p < 2.0e-05). This remains significant after controlling for multiple genomic confounders. We then asked whether this observation is significant per se or should also be viewed in the context of other disease relevant gene-environment interactions, such as those attributable to vitamin D. We therefore verified the overlap between EBNA2 genomic occupancy and vitamin D receptor (VDR) binding sites. EBNA2 shows a striking overlap with VDR binding sites (O/E = 96.16-fold, p < 2.0e-05), even after controlling for the chromatin accessibility state of shared regions (p < 0.001). Furthermore, MS susceptibility regions are preferentially targeted by both EBNA2 and VDR than by EBNA2 alone (enrichment difference = 1.722-fold, p = 0.0267). Taken together, these findings demonstrate that EBV participates in the gene-environment interactions that predispose to MS.	[Ricigliano, Vito A. G.; Cader, M. Zameel] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Ricigliano, Vito A. G.] IRCCS, Fdn Santa Lucia, Neuroimmunol Unit, Rome, Italy; [Handel, Adam E.] Univ Oxford, Med Res Council Funct Genom Unit, Oxford OX1 3PT, England; [Handel, Adam E.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Handel, Adam E.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Sandve, Geir K.] Univ Oslo, Dept Informat, Blindern, Norway; [Annibali, Viviana; Ristori, Giovanni; Mechelli, Rosella; Salvetti, Marco] Univ Roma La Sapienza, Fac Med & Psychol, Ctr Expt Neurol Therapies CENTERS, Neurol, I-00185 Rome, Italy; [Annibali, Viviana; Ristori, Giovanni; Mechelli, Rosella; Salvetti, Marco] Univ Roma La Sapienza, Fac Med & Psychol, Dept Neurosci Mental Hlth & Sensory Organs, I-00185 Rome, Italy	University of Oxford; IRCCS Santa Lucia; University of Oxford; University of Oxford; University of Oxford; University of Oslo; Sapienza University Rome; Sapienza University Rome	Mechelli, R (corresponding author), Univ Roma La Sapienza, Fac Med & Psychol, Ctr Expt Neurol Therapies CENTERS, Neurol, I-00185 Rome, Italy.	rosella.mechelli@uniroma1.it	Salvetti, Marco/K-3836-2016; Whelan, Timothy/D-3185-2017; Evans, Diane/F-9258-2017; Mechelli, Rosella/AAB-4967-2022	Whelan, Timothy/0000-0001-9844-2023; Mechelli, Rosella/0000-0001-5842-3100; Handel, Adam/0000-0001-8385-6346; Cader, Zameel/0000-0002-6952-406X; Ricigliano, Vito A. G./0000-0002-8860-3548; Sandve, Geir Kjetil/0000-0002-4959-1409; RISTORI, Giovanni/0000-0002-6598-6777	Oxford Biomedical Research Centre; Fondazione Italiana Sclerosi Multipla [2011/R/31]; National Institute for Health Research [ACF-2011-18-008] Funding Source: researchfish	Oxford Biomedical Research Centre; Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); National Institute for Health Research(National Institute for Health Research (NIHR))	M.Z.C. is supported by Oxford Biomedical Research Centre; M.S. is supported by Fondazione Italiana Sclerosi Multipla (grant number 2011/R/31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almohmeed YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061110; Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Banwell B, 2007, LANCET NEUROL, V6, P773, DOI 10.1016/S1474-4422(07)70196-5; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Brenner SR, 2014, NEUROLOGY, V82, P41, DOI [10.1212/01.wnl.0000438216.93319.ab, DOI 10.1212/01.WNL.0000438216.93319.AB]; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Cree BAC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011296; Disanto G, 2012, HUM MOL GENET, V21, P3575, DOI 10.1093/hmg/dds189; Disanto G, 2011, EXPERT REV NEUROTHER, V11, P1221, DOI [10.1586/ern.11.97, 10.1586/ERN.11.97]; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Handel AE, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-163; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kakalacheva K, 2011, FEBS LETT, V585, P3724, DOI 10.1016/j.febslet.2011.04.006; Koch MW, 2013, NAT REV NEUROL, V9, P35, DOI 10.1038/nrneurol.2012.226; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lossius A, 2012, VIRUSES-BASEL, V4, P3701, DOI 10.3390/v4123701; Maier S, 2006, J VIROL, V80, P9761, DOI 10.1128/JVI.00665-06; McClellan MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003636; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mechelli R, NEUROLOGY IN PRESS; Mechelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063300; Pelajo CF, 2010, AUTOIMMUN REV, V9, P507, DOI 10.1016/j.autrev.2010.02.011; Pender MP, 2011, NEUROSCIENTIST, V17, P351, DOI 10.1177/1073858410381531; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Querol L, 2013, NEUROLOGY, V81, P956, DOI 10.1212/WNL.0b013e3182a43b48; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; REITSMA PH, 1983, NATURE, V306, P492, DOI 10.1038/306492a0; Ristori G, 1999, NEUROLOGY, V53, P1588, DOI 10.1212/WNL.53.7.1588; Ristori G, 2014, NEUROLOGY, V82, P41, DOI 10.1212/01.wnl.0000438216.93319.ab; Rohan JNP, 2009, ENDOCRINOLOGY, V150, P2046, DOI 10.1210/en.2008-1395; Sandve GK, 2013, NUCLEIC ACIDS RES, V41, pW133, DOI 10.1093/nar/gkt342; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Simon KC, 2012, CURR OPIN NEUROL, V25, P246, DOI 10.1097/WCO.0b013e3283533a7e; Terrier B, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4060; Yenamandra SP, 2010, CELL MOL LIFE SCI, V67, P4249, DOI 10.1007/s00018-010-0441-4; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao B, 2011, P NATL ACAD SCI USA, V108, P14902, DOI 10.1073/pnas.1108892108	44	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0119605	10.1371/journal.pone.0119605	http://dx.doi.org/10.1371/journal.pone.0119605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853421	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400005
J	Thompson, ML; Mzilikazi, N; Bennett, NC; McKechnie, AE				Thompson, Michelle L.; Mzilikazi, Nomakwezi; Bennett, Nigel C.; McKechnie, Andrew E.			Solar Radiation during Rewarming from Torpor in Elephant Shrews: Supplementation or Substitution of Endogenous Heat Production?	PLOS ONE			English	Article							EVAPORATIVE WATER-LOSS; MAXIMUM METABOLIC-RATE; NONSHIVERING THERMOGENESIS; THERMAL-ACCLIMATION; DJUNGARIAN HAMSTER; SUMMIT METABOLISM; HETEROTHERMY; BASKING; PATTERNS; RODENTIA	Many small mammals bask in the sun during rewarming from heterothermy, but the implications of this behaviour for their energy balance remain little understood. Specifically, it remains unclear whether solar radiation supplements endogenous metabolic thermogenesis (i.e., rewarming occurs through the additive effects of internally-produced and external heat), or whether solar radiation reduces the energy required to rewarm by substituting (i.e, replacing) metabolic heat production. To address this question, we examined patterns of torpor and rewarming rates in eastern rock elephant shrews (Elephantulus myurus) housed in outdoor cages with access to either natural levels of solar radiation or levels that were experimentally reduced by means of shade cloth. We also tested whether acclimation to solar radiation availability was manifested via phenotypic flexibility in basal metabolic rate (BMR), non-shivering thermogenesis (NST) capacity and/or summit metabolism (M-sum). Rewarming rates varied significantly among treatments, with elephant shrews experiencing natural solar radiation levels rewarming faster than conspecifics experiencing solar radiation levels equivalent to approximately 20% or 40% of natural levels. BMR differed significantly between individuals experiencing natural levels of solar radiation and conspecifics experiencing approximately 20% of natural levels, but no between-treatment difference was evident for NST capacity or Msum. The positive relationship between solar radiation availability and rewarming rate, together with the absence of acclimation in maximum non-shivering and total heat production capacities, suggests that under the conditions of this study solar radiation supplemented rather than substituted metabolic thermogenesis as a source of heat during rewarming from heterothermy.	[Thompson, Michelle L.; Mzilikazi, Nomakwezi; McKechnie, Andrew E.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0028 Hatfield, South Africa; [Bennett, Nigel C.] Univ Pretoria, South African Res Chair Mammal Behav Ecol & Physi, Dept Zool & Entomol, ZA-0028 Hatfield, South Africa	University of Pretoria; University of Pretoria	McKechnie, AE (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Private Bag X20, ZA-0028 Hatfield, South Africa.	aemckechnie@zoology.up.ac.za	; Bennett, Nigel/E-4238-2010	Mzilikazi, Nomakwezi/0000-0002-0038-7431; Bennett, Nigel/0000-0001-9748-2947	National Research Foundation; University of Pretoria	National Research Foundation; University of Pretoria	This work was supported by the National Research Foundation - www.nrf.ac.za (AEM NCB NM) and the University of Pretoria - www.up.ac.za (AEM NCB). Funding covered equipment, running costs and a student bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay RMR, 2001, CAN J ZOOL, V79, P1885, DOI 10.1139/cjz-79-10-1885; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; Careau V, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1104; Cooper CE, 2009, PHYSIOL BIOCHEM ZOOL, V82, P438, DOI 10.1086/603654; Cooper CE, 2003, J EXP BIOL, V206, P2771, DOI 10.1242/jeb.00484; Dawson TJ, 2014, J COMP PHYSIOL B, V184, P273, DOI 10.1007/s00360-013-0794-8; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2003, J COMP PHYSIOL B, V173, P55, DOI 10.1007/s00360-002-0311-y; Geiser F, 2002, NATURWISSENSCHAFTEN, V89, P412, DOI 10.1007/s00114-002-0349-4; Geiser F, 2007, J COMP PHYSIOL B, V177, P885, DOI 10.1007/s00360-007-0186-z; Genz A., 2021, MVTNORM MULTIVARIATE; HELDMAIER G, 1989, J BIOL RHYTHM, V4, P251, DOI 10.1177/074873048900400211; HELDMAIER G, 1981, SCIENCE, V212, P917, DOI 10.1126/science.7233183; HELDMAIER G, 1981, OECOLOGIA, V48, P265, DOI 10.1007/BF00347975; HINDS DS, 1993, J EXP BIOL, V182, P41; Justo R, 2005, LIFE SCI, V76, P1147, DOI 10.1016/j.lfs.2004.08.019; Lovegrove BG, 2005, J COMP PHYSIOL B, V175, P231, DOI 10.1007/s00360-005-0477-1; Lovegrove BG, 2001, J COMP PHYSIOL B, V171, P1, DOI 10.1007/s003600000139; Lovegrove BG, 1999, J COMP PHYSIOL B, V169, P11, DOI 10.1007/s003600050188; Marom S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P944, DOI 10.1086/505999; McKechnie AE, 2007, J AVIAN BIOL, V38, P261, DOI 10.1111/j.2007.0908-8857.04116.x; McKechnie Andrew E., 2004, Biological Papers of the University of Alaska, V27, P63; Minnaar IA, 2014, J EXP BIOL, V217, P1363, DOI 10.1242/jeb.098400; Mzilikazi N, 2006, J COMP PHYSIOL B, V176, P75, DOI 10.1007/s00360-005-0035-x; Mzilikazi N, 2004, PHYSIOL BIOCHEM ZOOL, V77, P285, DOI 10.1086/381470; Mzilikazi N, 2002, OECOLOGIA, V133, P307, DOI 10.1007/s00442-002-1052-z; Mzilikazi N, 2007, AM J PHYSIOL-REG I, V293, pR2120, DOI 10.1152/ajpregu.00427.2007; Nespolo RF, 2001, J ARID ENVIRON, V48, P581, DOI 10.1006/jare.2000.0778; Nespolo RF, 2001, PHYSIOL BIOCHEM ZOOL, V74, P325, DOI 10.1086/320420; Nespolo RF, 1999, J MAMMAL, V80, P742, DOI 10.2307/1383243; Novoa FF, 2005, REV CHIL HIST NAT, V78, P207; PINHEIRO J., 2009, NLME LINEAR NONLINEA; Rezende EL, 2009, J EXP BIOL, V212, P2795, DOI 10.1242/jeb.032789; RUF T, 1992, PHYSIOL ZOOL, V65, P994, DOI 10.1086/physzool.65.5.30158554; Schleucher E., 2006, ACTA ZOOL SINICA, V52, P393; Smit B, 2011, J BIOL RHYTHM, V26, P241, DOI 10.1177/0748730411402632; Swanson DL, 1996, J THERM BIOL, V21, P221, DOI 10.1016/0306-4565(96)00005-8; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; TUCKER VA, 1965, J CELL COMPAR PHYSL, V65, P393, DOI 10.1002/jcp.1030650313; WALSBERG GE, 1988, J COMP PHYSIOL B, V158, P213, DOI 10.1007/BF01075835; Walsberg GE, 1997, PHYSIOL ZOOL, V70, P150, DOI 10.1086/639566; WALSBERG GE, 1995, J EXP BIOL, V198, P1499; WANG LCH, 1979, CAN J ZOOL, V57, P149, DOI 10.1139/z79-012; Warnecke L, 2008, NATURWISSENSCHAFTEN, V95, P73, DOI 10.1007/s00114-007-0293-4; Warnecke L, 2010, J COMP PHYSIOL B, V180, P437, DOI 10.1007/s00360-009-0417-6; Willis CKR, 2007, PHYSIOL BIOCHEM ZOOL, V80, P643, DOI 10.1086/521085; Wunder BA, 1996, ADAPTATIONS COLD	48	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120442	10.1371/journal.pone.0120442	http://dx.doi.org/10.1371/journal.pone.0120442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853244	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400013
J	Zoumot, Z; Kemp, SV; Singh, S; Bicknell, SR; McNulty, WH; Hopkinson, NS; Ross, ET; Shah, PL				Zoumot, Zaid; Kemp, Samuel V.; Singh, Suveer; Bicknell, Stephen R.; McNulty, William H.; Hopkinson, Nicholas S.; Ross, Ewen T.; Shah, Pallav L.			Endobronchial Coils for Severe Emphysema Are Effective Up to 12 Months following Treatment: Medium Term and Cross-Over Results from a Randomised Controlled Trial	PLOS ONE			English	Article							LUNG-VOLUME REDUCTION; THERMAL VAPOR ABLATION; DYNAMIC HYPERINFLATION; HEALTH-STATUS; SURVIVAL; EXERCISE; EFFICACY; THERAPY; VALVES	Background There is a clinical need for therapeutic options to reduce hyperinflation associated with severe emphysema. Endobronchial Coils (coils) are nitinol devices implanted bronchoscopically under fluoroscopic guidance to re-tension the lung. We report the medium term effectiveness and safety of coils in a study of patients with emphysema. Methods Forty five subjects with severe airflow obstruction and hyperinflation received bilateral sequential treatment with coils (30 day interval between treatments) as part of a randomised controlled trial with a primary endpoint 90 days after the final treatment (Clinicaltrials.gov NCT01334307). Further assessments were made at 180 and 360 days and in this study the primary outcome was the effect of coil treatment on the St. George's Respiratory Questionnaire (SGRQ) 360 days following treatment. Results At 360 days following treatment, there was an improvement in the SGRQ score of -6.1 +/- 14.0 points (p = 0.01) compared to baseline. Improvements in secondary outcomes were seen with increases in forced expiratory volume in the first second of 8.9 +/- 22.2% (p = 0.002) and 6-minute walking distance of 34.1 +/- 52.4m (p = 0.003). The safety profile was acceptable out to 360 days post-treatment. Conclusions Statistically and clinically meaningful benefits in quality of life, exercise capacity and pulmonary function in patients treated with coils are sustained twelve months after treatment.	[Zoumot, Zaid; Kemp, Samuel V.; McNulty, William H.; Hopkinson, Nicholas S.; Shah, Pallav L.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England; [Zoumot, Zaid; Kemp, Samuel V.; McNulty, William H.; Hopkinson, Nicholas S.; Shah, Pallav L.] Univ London Imperial Coll Sci Technol & Med, London, England; [Zoumot, Zaid; Kemp, Samuel V.; Singh, Suveer; McNulty, William H.; Shah, Pallav L.] Chelsea & Westminster Hosp NHS Fdn Trust, London, England; [Zoumot, Zaid] Cleveland Clin, Resp & Crit Care Inst, Abu Dhabi, U Arab Emirates; [Kemp, Samuel V.] Sherwood Forest Hosp NHS Fdn Trust, Ashfield, Notts, England; [Bicknell, Stephen R.; Ross, Ewen T.] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland	Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; Imperial College London; Cleveland Clinic Foundation; Gartnavel Royal Hospital	Shah, PL (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Biomed Res Unit, London, England.	pallav.shah@ic.ac.uk	Shah, Pallav L/AAB-2758-2019	Shah, Pallav L/0000-0002-9052-4638; McNulty, William/0000-0002-1315-7942; Kemp, Samuel/0000-0002-6639-0166	PneumRx Inc.; MRC [MC_PC_12032] Funding Source: UKRI; Medical Research Council [MC_PC_12032] Funding Source: researchfish	PneumRx Inc.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This trial was sponsored and funded by PneumRx Inc. The sponsor designed the trial with the corresponding author (PLS), assisted ZZ with the statistical analyses, and facilitated monitoring of safety and independent audit, collection, and storage of data.	Benzo R, 2009, AM J RESP CRIT CARE, V180, P239, DOI 10.1164/rccm.200809-1383OC; Clark SJ, 2014, CLIN MED, V14, P122, DOI 10.7861/clinmedicine.14-2-122; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Ford ES, 2013, CHEST, V143, P1395, DOI 10.1378/chest.12-1135; Gompelmann D, 2012, RESPIRATION, V83, P400, DOI 10.1159/000336239; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Herth FJF, 2012, EUR RESPIR J, V39, P1334, DOI 10.1183/09031936.00161611; Herth Felix J F, 2010, Ther Adv Respir Dis, V4, P225, DOI 10.1177/1753465810368553; Hopkinson NS, 2011, EUR RESPIR J, V37, P1346, DOI 10.1183/09031936.00100110; Hopkinson NS, 2005, AM J RESP CRIT CARE, V171, P453, DOI 10.1164/rccm.200407-961OC; Jones Paul W, 2005, COPD, V2, P75; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Kramer MR, 2012, CHEST, V142, P1111, DOI 10.1378/chest.12-0421; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magnussen H, 2012, THORAX, V67, P302, DOI 10.1136/thoraxjnl-2011-201038; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; Puhan MA, 2008, EUR RESPIR J, V32, P637, DOI 10.1183/09031936.00140507; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shah PL, 2011, LANCET, V378, P997, DOI 10.1016/S0140-6736(11)61050-7; Shah PL, 2013, LANCET RESP MED, V1, P233, DOI 10.1016/S2213-2600(13)70047-X; Slebos DJ, 2011, CHEST, DOI [10.1378/chest.110730, DOI 10.1378/CHEST.110730]; Snell G, 2012, EUR RESPIR J, V39, P1326, DOI 10.1183/09031936.00092411	24	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122656	10.1371/journal.pone.0122656	http://dx.doi.org/10.1371/journal.pone.0122656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853697	gold, Green Submitted, Green Published			2022-12-27	WOS:000352478400072
J	Brinks, R; Hoyer, A; Kuss, O; Rathmann, W				Brinks, Ralph; Hoyer, Annika; Kuss, Oliver; Rathmann, Wolfgang			Projected Effect of Increased Active Travel in German Urban Regions on the Risk of Type 2 Diabetes	PLOS ONE			English	Article							PREVALENCE; MELLITUS; SMOKING; COSTS	Background Future transportation policy is likely to reduce emissions in the cities and urban regions by strengthening active travel. Increased walking and cycling are known to have positive effects on health outcomes. This work estimates effects of increased active travel on type 2 diabetes in Germany, where 64% of the population live in urban regions. Methods Based on the effect size of an increased active travel scenario reported from a recent meta-analysis, we project the change in the life time risk, the proportion of prevented cases and the change in diabetes free life time in a German birth cohort (born 1985) compared to business as usual. Results The absolute risk reduction of developing type 2 diabetes before the age of 80 is 6.4% [95% confidence interval: 3.7-9.7%] for men and 4.7% [2.2-7.7%] for women, respectively. Compared to business as usual, the increased active travel scenario prevents 14.0% [8.1-21.2%] of the future cases of diabetes in men and 15.8%[9.3-23.1%] in women. Diabetes free survival increases by 1.7 [1.0-2.7] years in men and 1.4 [0.6-2.3] in women. Conclusions Our projection predicts a substantial impact of increased active travel on the future burden of type 2 diabetes. The most striking effect may be seen in the number of prevented cases. In all urban regions with an increased active travel transport policy, about one out of seven male and one out of six female cases can be prevented.	[Brinks, Ralph; Hoyer, Annika; Kuss, Oliver; Rathmann, Wolfgang] Inst Epidemiol & Biometry, German Diabet Ctr, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ)	Brinks, R (corresponding author), Inst Epidemiol & Biometry, German Diabet Ctr, Dusseldorf, Germany.	ralph.brinks@ddz.uni-duesseldorf.de		Kuss, Oliver/0000-0003-3301-5869				Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; [Anonymous], 2013, DIABETES ATLAS; Brinks R, 2014, THEOR POPUL BIOL, V92, P62, DOI 10.1016/j.tpb.2013.11.006; Brinks R, 2012, EUR J EPIDEMIOL, V27, P791, DOI 10.1007/s10654-012-9726-2; Bundesinstitut fur Stadt-und Raumforschung, 2012, BEVOLKERUNGSWACHSTUM; Bundesministerium fur Verkehr Bau und Stadtentwicklung, 2012, NATIONALER RADVERKEH; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Destatis Statistisches Bundesamt, 2013, VERKEHRSUNFALLE ZEIT; Efron B., 1993, MONOGRAPHS ON STATIS; Heidemann C, 2013, BUNDESGESUNDHEITSBLA, V56, P668, DOI 10.1007/s00103-012-1662-5; Imai K, 2007, J AM STAT ASSOC, V102, P1199, DOI 10.1198/016214507000000040; Intergovernmental Panel on Climate Change, 2014, FIFTH ASSESSMENT REP; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Kalbfleisch J., 2002, THE STATISTICAL ANAL; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Mann JI, 2004, NUTR METAB CARDIOVAS, V14, P373, DOI 10.1016/S0939-4753(04)80028-0; Oakley JE, 2004, J R STAT SOC B, V66, P751, DOI 10.1111/j.1467-9868.2004.05304.x; Organisation for Economic Co-operation and Development (OECD), 2013, URBAN POPULATION IN; Persson LG, 2006, SCAND J PRIM HEALTH, V24, P75, DOI 10.1080/02813430500439395; Spijkerman AMW, 2014, DIABETES CARE, V37, P3164, DOI 10.2337/dc14-1020; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Waldeyer R, 2013, DIABETIC MED, V30, P999, DOI 10.1111/dme.12177; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	24	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122145	10.1371/journal.pone.0122145	http://dx.doi.org/10.1371/journal.pone.0122145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849819	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800104
J	Chen, YJ; Lu, CT; Huang, KY; Wu, HY; Chen, YJ; Lee, TY				Chen, Yi-Ju; Lu, Cheng-Tsung; Huang, Kai-Yao; Wu, Hsin-Yi; Chen, Yu-Ju; Lee, Tzong-Yi			GSHSite: Exploiting an Iteratively Statistical Method to Identify S-Glutathionylation Sites with Substrate Specificity	PLOS ONE			English	Article							PHOSPHORYLATION SITES; OXIDATIVE STRESS; PROTEIN GLUTATHIONYLATION; WEB SERVER; PSI-BLAST; PREDICTION; SEQUENCES; CYSTEINE; IDENTIFICATION; THIOREDOXIN	S-glutathionylation, the covalent attachment of a glutathione (GSH) to the sulfur atom of cysteine, is a selective and reversible protein post-translational modification (PTM) that regulates protein activity, localization, and stability. Despite its implication in the regulation of protein functions and cell signaling, the substrate specificity of cysteine S-glutathionylation remains unknown. Based on a total of 1783 experimentally identified S-glutathionylation sites from mouse macrophages, this work presents an informatics investigation on S-glutathionylation sites including structural factors such as the flanking amino acids composition and the accessible surface area (ASA). TwoSampleLogo presents that positively charged amino acids flanking the S-glutathionylated cysteine may influence the formation of S-glutathionylation in closed three-dimensional environment. A statistical method is further applied to iteratively detect the conserved substrate motifs with statistical significance. Support vector machine (SVM) is then applied to generate predictive model considering the substrate motifs. According to five-fold cross-validation, the SVMs trained with substrate motifs could achieve an enhanced sensitivity, specificity, and accuracy, and provides a promising performance in an independent test set. The effectiveness of the proposed method is demonstrated by the correct identification of previously reported S-glutathionylation sites of mouse thioredoxin (TXN) and human protein tyrosine phosphatase 1b (PTP1B). Finally, the constructed models are adopted to implement an effective web-based tool, named GSHSite (http://csb.cse.yzu.edu.tw/GSHSite/), for identifying uncharacterized GSH substrate sites on the protein sequences.	[Chen, Yi-Ju; Wu, Hsin-Yi; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Lu, Cheng-Tsung; Huang, Kai-Yao; Lee, Tzong-Yi] Yuan Ze Univ, Dept Comp Sci & Engn, Taoyuan, Taiwan; [Lee, Tzong-Yi] Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Taoyuan, Taiwan	Academia Sinica - Taiwan; Yuan Ze University; Yuan Ze University	Chen, YJ (corresponding author), Acad Sinica, Inst Chem, Taipei, Taiwan.	yujuchen@gate.sinica.edu.tw; francis@saturn.yzu.edu.tw	Chen, Yi-Ju/AFU-9499-2022; Chen, Yu-Ju/E-9481-2015; Chen, Yi-Ju/AAP-9052-2021	Chen, Yu-Ju/0000-0002-3178-6697; Chen, Yi-Ju/0000-0002-7203-9188	Ministry of Science and Technology of Taiwan [MOST 103-2221-E-155-020-MY3, 103-2633-E-155-002, 100-2628-M-001-003-MY4]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The authors sincerely appreciate the Ministry of Science and Technology of Taiwan for financially supporting this research under Contract Number MOST 103-2221-E-155-020-MY3 and 103-2633-E-155-002 to TYL and 100-2628-M-001-003-MY4 to YiJC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOINFORMATICS, V19, P1849, DOI 10.1093/bioinformatics/btg249; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bretana NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040694; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Chang C.-C., 2011, ACM T INTEL SYST TEC, V2, P1, DOI [10.1145/1961189.1961199, DOI 10.1145/1961189.1961199]; Chang WC, 2009, J COMPUT CHEM; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Chiang BY, 2012, ANGEW CHEM INT EDIT, V51, P5871, DOI 10.1002/anie.201200321; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dosztanyi Z, 2003, NUCLEIC ACIDS RES, V31, P3359, DOI 10.1093/nar/gkg589; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2013, BBA-GEN SUBJECTS, V1830, P3165, DOI 10.1016/j.bbagen.2013.02.009; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hsu JBK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027567; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang HD, 2005, J COMPUT CHEM, V26, P1032, DOI 10.1002/jcc.20235; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lee TY, 2012, BIOINFORMATICS, V28, P2293, DOI 10.1093/bioinformatics/bts436; Lee TY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-261; Lee TY, 2011, BIOINFORMATICS, V27, P1780, DOI 10.1093/bioinformatics/btr291; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017331; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Lu CT, 2011, J COMPUT AID MOL DES, V25, P987, DOI 10.1007/s10822-011-9477-2; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Mucchielli-Giorgi MHM, 2002, PROTEINS, V46, P243, DOI 10.1002/prot.10047; Newman SF, 2007, J NEUROSCI RES, V85, P1506, DOI 10.1002/jnr.21275; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shien DM, 2009, J COMPUT CHEM, V30, P1532, DOI 10.1002/jcc.21232; Silva GM, 2008, FEBS J, V275, P2942, DOI 10.1111/j.1742-4658.2008.06441.x; Su D, 2014, FREE RADICAL BIO MED, V67, P460, DOI 10.1016/j.freeradbiomed.2013.12.004; Sun CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055512; Sun MA, 2012, BIOINFORMATICS, V28, P2551, DOI 10.1093/bioinformatics/bts468; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu C, 2010, MOL CELL PR IN PRESS; Wu CG, 2011, J PROTEOMICS, V74, P2498, DOI 10.1016/j.jprot.2011.06.001; Wu C, 2010, MOL CELL PROTEOMICS, V9, P2262, DOI 10.1074/mcp.M110.000034; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359	50	30	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0118752	10.1371/journal.pone.0118752	http://dx.doi.org/10.1371/journal.pone.0118752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849935	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800008
J	Mucke, J; Mohlenbruch, M; Kickingereder, P; Kieslich, PJ; Baumer, P; Gumbinger, C; Purrucker, J; Mundiyanapurath, S; Schlemmer, HP; Bendszus, M; Radbruch, A				Mucke, Johanna; Moehlenbruch, Markus; Kickingereder, Philipp; Kieslich, Pascal J.; Baeumer, Philipp; Gumbinger, Christoph; Purrucker, Jan; Mundiyanapurath, Sibu; Schlemmer, Heinz-Peter; Bendszus, Martin; Radbruch, Alexander			Asymmetry of Deep Medullary Veins on Susceptibility Weighted MRI in Patients with Acute MCA Stroke Is Associated with Poor Outcome	PLOS ONE			English	Article							ISCHEMIC-STROKE; CLINICAL-APPLICATIONS; SCALE; NXY-059; BURDEN; SIZE	Background and Purpose Due to its sensitivity to deoxyhemoglobin, susceptibility weighted imaging (SWI) enables the visualization of deep medullary veins (DMV) in patients with acute stroke, which are difficult to depict under physiological circumstances. This study assesses the asymmetric appearance of prominent DMV as an independent predictor for stroke severity and outcome. Materials and Methods SWI of 86 patients with acute middle cerebral artery (MCA) stroke were included. A scoring system from 0 (no visible DMV) to 3 (very prominent DMV) was applied for both hemispheres separately. A difference of scores between ipsi- and contralateral side was defined as asymmetric (AMV+). Occurrence of AMV+ was correlated with the National Institute of Health Stroke Scale (NIHSS) Score on admission and discharge, as well as the modified Rankin Scale (mRS) at discharge. Ordinal regression analysis was used to evaluate NIHSS and mRS as predictors of stroke severity, clinical course of disease and outcome. Results 55 patients displayed AMV+ while 31 did not show an asymmetry (AMV-). Median NIHSS on admission was 17 (11-21) in the AMV+ group and 9 (5-15) in the AMV-group (p = 0.001). On discharge median NIHSS was 11 (5-20) for AMV+ and 5 (2-14) for AMV-(p = 0.005). The median mRS at discharge was 4 (3-5) in the AMV+ group and 3 (1-4) in AMV-(p = 0.001). Odds ratio was 3.19 (95% CI: 1.24-8.21) for AMV+ to achieve a higher mRS than AMV-(p = 0.016). Conclusion The asymmetric appearance of DMV on SWI is a fast and easily evaluable parameter for the prediction of stroke severity and can be used as an additional imaging parameter in patients with acute MCA stroke.	[Mucke, Johanna; Moehlenbruch, Markus; Kickingereder, Philipp; Baeumer, Philipp; Bendszus, Martin; Radbruch, Alexander] Heidelberg Univ, Dept Neuroradiol, INF 400, D-69120 Heidelberg, Germany; [Kieslich, Pascal J.] Univ Mannheim, Dept Psychol, D-68131 Mannheim, Germany; [Gumbinger, Christoph; Purrucker, Jan; Mundiyanapurath, Sibu] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany; [Schlemmer, Heinz-Peter; Radbruch, Alexander] German Canc Res Ctr, Dept Radiol, INF 280, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Mannheim; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, INF 400, D-69120 Heidelberg, Germany.	a.radbruch@dkfz.de	Vollmuth, Philipp/AAK-3267-2021; Radbruch, Alexander/ABA-6277-2021; Mucke, Johanna/AAG-7722-2020	Kieslich, Pascal J./0000-0002-0853-9364; Gumbinger, Christoph/0000-0002-6137-1169; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Radbruch, Alexander/0000-0001-6238-6525; Mundiyanapurath, Sibu/0000-0003-4637-4641				Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Barreto AD, 2008, STROKE, V39, P3231, DOI 10.1161/STROKEAHA.108.521054; Bath P, 2009, STROKE, V40, P888, DOI 10.1161/STROKEAHA.108.519207; Friedman DP, 1997, AM J ROENTGENOL, V168, P1103, DOI 10.2214/ajr.168.4.9124123; Gasparotti R, 2011, INSIGHTS IMAGING, V2, P335, DOI 10.1007/s13244-011-0086-3; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HOOSHMAND I, 1974, NEURORADIOLOGY, V7, P75, DOI 10.1007/BF00341874; Jensen-Kondering U, 2013, WORLD J RADIOL, V5, P156, DOI 10.4329/wjr.v5.i4.156; Kane I, 2009, J NEUROL, V256, P1832, DOI 10.1007/s00415-009-5202-7; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Lee M, 2012, INT J STROKE, V7, P293, DOI 10.1111/j.1747-4949.2011.00726.x; Lees KR, 2006, STROKE, V37, P2970, DOI 10.1161/01.STR.0000249410.91473.44; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063013; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Nazliel B, 2008, STROKE, V39, P2264, DOI 10.1161/STROKEAHA.107.508127; Parthasarathy R, 2013, STROKE A JOURNAL OF; Puetz V, 2008, INT J STROKE, V3, P230, DOI 10.1111/j.1747-4949.2008.00221.x; Purrucker JC, 2014, J NEUROL NEUROSURG P; Radbruch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063459; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Santhosh K, 2009, CLIN RADIOL, V64, P74, DOI 10.1016/j.crad.2008.04.022; Saver JL, 2007, STROKE, V38, P414, DOI 10.1161/01.STR.0000254580.39297.3c; Scott SC, 1997, J CLIN EPIDEMIOL, V50, P45, DOI 10.1016/S0895-4356(96)00312-5; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Somford DM, 2002, RADIOLOGY, V223, P667, DOI 10.1148/radiol.2233011017; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; Viallon M, 2010, EUR NEUROL, V64, P286, DOI 10.1159/000321162; Woo D, 1999, STROKE, V30, P2355, DOI 10.1161/01.STR.30.11.2355	34	37	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120801	10.1371/journal.pone.0120801	http://dx.doi.org/10.1371/journal.pone.0120801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849958	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800033
J	Omidvar, V; Fellner, M				Omidvar, Vahid; Fellner, Martin			DNA Methylation and Transcriptomic Changes in Response to Different Lights and Stresses in 7B-1 Male-Sterile Tomato	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; CYTOSINE METHYLATION; HYPOCOTYL ELONGATION; SEED-GERMINATION; GENE-EXPRESSION; ABIOTIC-STRESS; ARABIDOPSIS; RNA; PROTEIN; GROWTH	We reported earlier that 7B-1 mutant in tomato (Solanum lycopersicum L., cv. Rutgers), an ABA overproducer, is defective in blue light (B) signaling leading to B-specific resistance to abiotic and biotic stresses. Using a methylation-sensitive amplified polymorphism (MSAP) assay, a number of genes were identified, which were differentially methylated between 7B-1 and its wild type (WT) seedlings in white (W), blue (B), red (R) lights and dark (D) or in response to exogenous ABA and mannitol-induced stresses. The genomic methylation level was almost similar in different lights between 7B-1 and WT seedlings, while significant differences were observed in response to stresses in D, but not B. Using a cDNA-AFLP assay, several transcripts were identified, which were differentially regulated between 7B-1 and WT by B or D or in response to stresses. Blue light receptors cryptochrome 1 and 2 (CRY1 and CRY2) and phototropin 1 and 2 (PHOT1 and PHOT2) were not affected by the 7B-1 mutation at the transcriptional level, instead the mutation had likely affected downstream components of the light signaling pathway. 5-azacytidine (5-azaC) induced DNA hypomethylation, inhibited stem elongation and differentially regulated the expression of a number of genes in 7B-1. In addition, it was shown that mir167 and mir390 were tightly linked to auxin signaling pathway in 5-azaC-treated 7B-1 seedlings via the regulation of auxin-response factor (ARF) transcripts. Our data showed that DNA methylation remodeling is an active epigenetic response to different lights and stresses in 7B-1 and WT, and highlighted the differences in epigenetic and transcriptional regulation of light and stress responses between 7B-1 and WT. Furthermore, it shed lights on the crosstalk between DNA hypomethylation and miRNA regulation of ARFs expression. This information could also be used as a benchmark for future studies of male-sterility in other crops.	[Omidvar, Vahid] Palacky Univ, Lab Growth Regulators, Grp Mol Physiol, CR-77147 Olomouc, Czech Republic; ASCR, Inst Expt Bot, Olomouc, Czech Republic	Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Omidvar, V (corresponding author), Palacky Univ, Lab Growth Regulators, Grp Mol Physiol, CR-77147 Olomouc, Czech Republic.	Vahid.omidvar@upol.cz; Martin.fellner@upol.cz	Fellner, Martin/B-2068-2010		Operational Programs Education for Competitiveness-European Social Fund [CZ.1.07/2.3.00/30.0004]; Ministry of Education, Youth and Sports [LO1204]	Operational Programs Education for Competitiveness-European Social Fund; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Operational Programs Education for Competitiveness-European Social Fund, project no. CZ.1.07/2.3.00/30.0004 to MF, and by Ministry of Education, Youth and Sports, project no. LO1204.	Ahmad JN, 2013, PLANT PATHOL, V62, P205, DOI 10.1111/j.1365-3059.2012.02605.x; Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Barak S, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.977729; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bergougnoux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045255; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bossdorf O, 2010, EVOL ECOL, V24, P541, DOI 10.1007/s10682-010-9372-7; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chaulk SG, 2000, BIOCHEMISTRY-US, V39, P10448, DOI 10.1021/bi0009136; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Cho JN, 2012, DEV CELL, V22, P736, DOI 10.1016/j.devcel.2012.01.024; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Ding JH, 2012, MOL PLANT, V5, P1210, DOI 10.1093/mp/sss095; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Fellner M, 2002, PLANTA, V214, P675, DOI 10.1007/s004250100671; Fellner M, 2001, J EXP BOT, V52, P725, DOI 10.1093/jexbot/52.357.725; Gonzalez RM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-94; Guilfoyle TJ, 2001, J PLANT GROWTH REGUL, V20, P281, DOI 10.1007/s003440010026; Hlavinka J, 2013, PLANT SCI, V209, P75, DOI 10.1016/j.plantsci.2013.04.010; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; Khan A, 2014, PLANT J, V79, DOI 10.1111/tpj.12533; Kim H, 2014, J EXP BOT, V65, P453, DOI 10.1093/jxb/ert397; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li TC, 2011, AFR J BIOTECHNOL, V10, P6220; Li YS, 2013, MOL BIOTECHNOL, V54, P703, DOI 10.1007/s12033-012-9614-8; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorsch JR, 2002, CELL, V109, P797, DOI 10.1016/S0092-8674(02)00804-8; Lu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-721; Marfil CF, 2012, PLANT CELL REP, V31, P1449, DOI 10.1007/s00299-012-1260-x; Mason G, 2008, PLANT MOL BIOL REP, V26, P156, DOI 10.1007/s11105-008-0031-x; Motchoulski A, 1999, SCIENCE, V286, P961, DOI 10.1126/science.286.5441.961; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Oh E, 2014, ELIFE, V3, DOI 10.7554/eLife.03031; Pedmale UV, 2007, J BIOL CHEM, V282, P19992, DOI 10.1074/jbc.M702551200; Portis E, 2004, PLANT SCI, V166, P169, DOI 10.1016/j.plantsci.2003.09.004; Raduwan H, 2013, J BIOL CHEM, V288, P8380, DOI 10.1074/jbc.M112.359935; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Sawhney V. K., 1997, Pollen biotechnology for crop production and improvement., P183, DOI 10.1017/CBO9780511525469.010; Sawhney VK, 2004, J HORTIC SCI BIOTECH, V79, P138, DOI 10.1080/14620316.2004.11511726; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Shan XH, 2013, J PLANT BIOL, V56, P32, DOI 10.1007/s12374-012-0251-3; Sheoran IS, 2009, J PROTEOMICS, V71, P624, DOI 10.1016/j.jprot.2008.10.006; Singh A, 2012, PLANT SIGNAL BEHAV, V7, P847, DOI 10.4161/psb.20385; Singh A, 2012, J BIOL CHEM, V287, P25995, DOI 10.1074/jbc.M111.333906; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Szalontai B, 2012, J PLANT PHYSIOL, V169, P1767, DOI 10.1016/j.jplph.2012.07.010; Tatra GS, 2000, PHYSIOL PLANTARUM, V109, P313, DOI 10.1034/j.1399-3054.2000.100313.x; Thanananta T, 2006, AFR J BIOTECHNOL, V5, P1375; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Ueno K, 2005, PLANT CELL PHYSIOL, V46, P955, DOI 10.1093/pcp/pci104; Vashisht AA, 2005, PLANT J, V44, P76, DOI 10.1111/j.1365-313X.2005.02511.x; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Wang WS, 2011, J GENET GENOMICS, V38, P419, DOI 10.1016/j.jgg.2011.07.006; Wang Y, 2014, P NATL ACAD SCI USA, V111, P533, DOI 10.1073/pnas.1305438111; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836; Xin M, 2001, BMC PLANT BIOL, V11, P61; Xing DH, 2011, WIRES RNA, V2, P445, DOI 10.1002/wrna.59; Yan HR, 2014, PLANT CELL PHYSIOL, V55, P2060, DOI 10.1093/pcp/pcu133; Yu YW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004025; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462	70	21	23	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121864	10.1371/journal.pone.0121864	http://dx.doi.org/10.1371/journal.pone.0121864			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849771	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800080
J	Khannoon, ER; Evans, SE				Khannoon, Eraqi R.; Evans, Susan E.			The Development of the Skull of the Egyptian Cobra Naja h. haje (Squamata: Serpentes: Elapidae)	PLOS ONE			English	Article							INCUBATION-TEMPERATURE; EMBRYONIC-DEVELOPMENT; SNAKE; MOBILIZATION; CALCIUM; PATTERNS	Background The study of craniofacial development is important in understanding the ontogenetic processes behind morphological diversity. A complete morphological description of the embryonic skull development of the Egyptian cobra, Naja h. haje, is lacking and there has been little comparative discussion of skull development either among elapid snakes or between them and other snakes. Methodology/Principal Findings We present a description of skull development through a full sequence of developmental stages of the Egyptian cobra, and compare it to other snakes. Associated soft tissues of the head are noted where relevant. The first visible ossification centres are in the supratemporal, prearticular and surangular, with slight ossification visible in parts of the maxilla, prefrontal, and dentary. Epiotic centres of ossification are present in the supraoccipital, and the body of the supraoccipital forms from the tectum posterior not the tectum synoticum. The venom glands are visible as distinct bodies as early at stage 5 and enlarge later to extend from the otic capsule to the maxilla level with the anterior margin of the eye. The gland becomes more prominent shortly before hatching, concomitant with the development of the fangs. The tongue shows incipient forking at stage 5, and becomes fully bifid at stage 6. Conclusions/Significance We present the first detailed staging series of cranial development for the Egyptian cobra, Naja h. haje. This is one of the first studies since the classical works of G. de Beer and W. Parker that provides a detailed description of cranial development in an advanced snake species. It allows us to correct errors and misinterpretations in previous accounts which were based on a small sample of specimens of uncertain age. Our results highlight potentially significant variation in supraoccipital formation among squamates and the need for further research in this area.	[Khannoon, Eraqi R.] Fayoum Univ, Fac Sci, Dept Zool, Al Fayyum 63514, Egypt; [Evans, Susan E.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	Egyptian Knowledge Bank (EKB); Fayoum University; University of London; University College London	Khannoon, ER (corresponding author), Fayoum Univ, Fac Sci, Dept Zool, Al Fayyum 63514, Egypt.	err00@fayoum.edu.eg	Evans, Susan/C-1888-2008	Evans, Susan/0000-0002-0799-4154				Boback SM, 2012, ZOOLOGY, V115, P38, DOI 10.1016/j.zool.2011.09.001; Booth DT, 2006, PHYSIOL BIOCHEM ZOOL, V79, P274, DOI 10.1086/499988; Boughner JC, 2007, ZOOLOGY, V110, P212, DOI 10.1016/j.zool.2007.01.005; BURGER J, 1990, J HERPETOL, V24, P158, DOI 10.2307/1564223; Carroll RL, 1988, VERTEBRATE PALEONTOL; Cundall David, 2008, Contributions to Herpetology, V23, P349; d'A Bellairs A, 1981, MORPHOLOGY F, V11, P1; de Beer G., 1937, DEV VERTEBRATE SKULL; Deeming DC., 1991, EGG INCUBATION ITS E; Deiques CH, 2002, ACTA ZOOL-STOCKHOLM, V83, P175; El Toubi MR, 1965, PROC EGYPT ACAD SCI, V18, P73; El-Toubi M. R, 1970, Anat. Anz., V127, P233; ELTOUBI MR, 1973, ACTA ANAT, V85, P593; FRANKLIN MA, 1945, COPEIA, P68; HALUSKA F, 1983, J MORPHOL, V178, P37, DOI 10.1002/jmor.1051780104; Hanken J., 1981, Functional Photography, V16, P22; Hofstadler-Deiques C, 2005, ANAT REC PART A, V286A, P938, DOI 10.1002/ar.a.20227; Jackson K, 2002, ZOOLOGY, V105, P203, DOI 10.1078/0944-2006-00077; Kamal A. M, 1970, Acta zool., Stockh., V51, P31; KAMAL AM, 1965, J MORPHOL, V116, P247, DOI 10.1002/jmor.1051160206; Kamal AM, 1970, ACTA ZOOLOGICA, P19; Kamal AM, 1970, ACTA ZOOLOGICA, P1; Khannoon E, 2013, ACTA ZOOLOGICA, V95, P472; KORNEVA L G, 1969, Zoologicheskii Zhurnal, V48, P110; PACKARD MJ, 1994, ISR J ZOOL, V40, P481; Parker W. K., 1879, PHILOS T ROY SOC LON, V170, P595, DOI [10. 1098/rstl. 1879. 0075, DOI 10.1098/RSTL.1879.0075]; Parker W. K., 1879, PHILOS T ROY SOC LON, V169, P385, DOI DOI 10.1098/RSTL.1878.0012; Polachowski KM, 2013, ZOOLOGY, V116, P36, DOI 10.1016/j.zool.2012.07.003; Rieppel O, 2001, J MORPHOL, V249, P252, DOI 10.1002/jmor.1053; Stewart JR, 2010, HERPETOL CONSERV BIO, V5, P341; Stewart JR, 2004, COMP BIOCHEM PHYS A, V139, P335, DOI 10.1016/j.cbpb.2004.09.016	31	23	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122185	10.1371/journal.pone.0122185	http://dx.doi.org/10.1371/journal.pone.0122185			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860015	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300034
J	Ul-Haq, Z; Saeed, M; Halim, SA; Khan, W				Ul-Haq, Zaheer; Saeed, Maria; Halim, Sobia Ahsan; Khan, Waqasuddin			3D Structure Prediction of Human beta 1-Adrenergic Receptor via Threading-Based Homology Modeling for Implications in Structure-Based Drug Designing	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; I-TASSER; IDENTIFICATION; INHIBITORS; RHODOPSIN	Dilated cardiomyopathy is a disease of left ventricular dysfunction accompanied by impairment of the beta(1)-adrenergic receptor (beta(1)-AR) signal cascade. The disturbed beta(1)-AR function may be based on an elevated sympathetic tone observed in patients with heart failure. Prolonged adrenergic stimulation may induce metabolic and electrophysiological disturbances in the myocardium, resulting in tachyarrhythmia that leads to the development of heart failure in human and sudden death. Hence, beta(1)-AR is considered as a promising drug target but attempts to develop effective and specific drug against this tempting pharmaceutical target is slowed down due to the lack of 3D structure of Homo sapiens beta(1)-AR (hs beta ADR1). This study encompasses elucidation of 3D structural and physicochemical properties of hs beta ADR1 via threading-based homology modeling. Furthermore, the docking performance of several docking programs including Surflex-Dock, FRED, and GOLD were validated by re-docking and cross-docking experiments. GOLD and Surflex-Dock performed best in re-docking and cross docking experiments, respectively. Consequently, Surflex-Dock was used to predict the binding modes of four hs beta ADR1 agonists. This study provides clear understanding of hs beta ADR1 structure and its binding mechanism, thus help in providing the remedial solutions of cardiovascular, effective treatment of asthma and other diseases caused by malfunctioning of the target protein.	[Ul-Haq, Zaheer; Saeed, Maria; Khan, Waqasuddin] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan; [Halim, Sobia Ahsan] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore, Pakistan	University of Karachi; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab	Ul-Haq, Z (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Pakistan.	zaheer.qasmi@iccs.edu	Halim, Sobia Ahsan/ADO-2156-2022; Khan, Waqasuddin/AAF-7771-2019; Saeed, Maria/D-6703-2015; Ul-Haq, Zaheer/E-3061-2010; Saeed, Maria/AAJ-3530-2020	Halim, Sobia Ahsan/0000-0001-8526-7799; Ul-Haq, Zaheer/0000-0002-8530-8711; Saeed, Maria/0000-0001-6223-6375; Khan, Waqasuddin/0000-0001-7995-8163	Higher Education Commission, Pakistan	Higher Education Commission, Pakistan(Higher Education Commission of Pakistan)	This work was funded by Higher Education Commission, Pakistan (http://www.hec.gov.pk/Pages/HECMain.aspx).	Alewijnse AE, 2000, MOL PHARMACOL, V57, P890; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2006, SYBYL MOLECULAR MODE; [Anonymous], 2012, 10 CHEM COMP GROUP I; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bywater RP, 2005, J MOL RECOGNIT, V18, P60, DOI 10.1002/jmr.685; *CAMBR CRYT DAT CT, 2006, GOLD VERS 3 0; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Congreve M, 2010, BRIT J PHARMACOL, V159, P986, DOI 10.1111/j.1476-5381.2009.00476.x; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Dolan MA, 2008, PROTEINS, V72, P1243, DOI 10.1002/prot.22022; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Dror O, 2004, CURR MED CHEM, V11, P71, DOI 10.2174/0929867043456287; Eichhorn EJ, 1996, CIRCULATION, V94, P2285, DOI 10.1161/01.CIR.94.9.2285; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Halim SA, 2013, MOL DIVERS, V17, P345, DOI 10.1007/s11030-013-9431-4; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Huang C. C., 1996, PAC S BIOCOMPUT, P724, DOI DOI 10.1142/9789814531399; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; Kalatskaya I, 2004, J BIOL CHEM, V279, P31268, DOI 10.1074/jbc.M401796200; Khan KM, 2014, J COMPUT AID MOL DES, V28, P577, DOI 10.1007/s10822-014-9745-z; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; Millar RP, 2010, MOL ENDOCRINOL, V24, P261, DOI 10.1210/me.2009-0473; Moukhametzianov R, 2011, P NATL ACAD SCI USA, V108, P8228, DOI 10.1073/pnas.1100185108; Muthumala A, 2008, EUR J HEART FAIL, V10, P3, DOI 10.1016/j.ejheart.2007.11.008; Patny A, 2006, CURR MED CHEM, V13, P1667, DOI 10.2174/092986706777442002; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakarya O, 2010, MOL BIOL EVOL, V27, P1058, DOI 10.1093/molbev/msp311; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Sandilands A, 2004, PHARMACOGENETICS, V14, P343, DOI 10.1097/00008571-200406000-00003; Santos N. M. D., 2006, J BIOL CHEM, V281, P12896; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Sirois S, 2004, J CHEM INF COMP SCI, V44, P1111, DOI 10.1021/ci034270n; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Taylor MRG, 2007, PHARMACOGENOMICS J, V7, P29, DOI 10.1038/sj.tpj.6500393; Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091; Ul-Haq Z, 2012, J MOL GRAPH MODEL, V36, P48, DOI 10.1016/j.jmgm.2012.02.003; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Weinstein H, 2005, DRUG ADDICTION AAPS, P265; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	53	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122223	10.1371/journal.pone.0122223	http://dx.doi.org/10.1371/journal.pone.0122223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860348	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300037
J	Xu, YA; Cao, JL; Huang, S; Feng, D; Zhang, W; Zhu, XL; Yan, XM				Xu, Yanan; Cao, Jingli; Huang, Shan; Feng, Di; Zhang, Wei; Zhu, Xueliang; Yan, Xiumin			Characterization of Tetratricopeptide Repeat-Containing Proteins Critical for Cilia Formation and Function	PLOS ONE			English	Article							INTRAFLAGELLAR TRANSPORT; ZEBRAFISH PRONEPHROS; CORE COMPLEX; CILIOGENESIS; GENES; CELLS; EXPRESSION; MECHANISM; MOTILITY; DEFECTS	Cilia formation and function require a special set of trafficking machinery termed intraflagellar transport (IFT), consisting mainly of protein complexes IFT-A, IFT-B, BBSome, and microtubule- dependent molecular motors. Tetratricopeptide repeat-containing (TTC) proteins are widely involved in protein complex formation. Nine of them are known to serve as components of the IFT or BBSome complexes. How many TTC proteins are cilia-related and how they function, however, remain unclear. Here we show that twenty TTC genes were upregulated by at least 2-fold during the differentiation of cultured mouse tracheal epithelial cells (MTECs) into multiciliated cells. Our systematic screen in zebrafish identified four novel TTC genes, ttc4, -9c, -36, and -39c, that are critical for cilia formation and motility. Accordingly, their zebrafish morphants displayed typical ciliopathy-related phenotypes, including curved body, abnormal otolith, hydrocephalus, and defective left-right patterning. The morphants of ttc4 and ttc25, a known cilia-related gene, additionally showed pronephric cyst formation. Immunoprecipitation indicated associations of TTC4, -9c, -25, -36, and -39c with components or entire complexes of IFT-A, IFT-B, or BBSome, implying their participations in IFT or IFT-related activities. Our results provide a global view for the relationship between TTC proteins and cilia.	[Xu, Yanan; Cao, Jingli; Huang, Shan; Zhang, Wei; Zhu, Xueliang; Yan, Xiumin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Feng, Di; Zhu, Xueliang] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Zhu, XL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, 320 Yueyang Rd, Shanghai, Peoples R China.	yanx@sibcb.ac.cn; xlzhu@sibcb.ac.cn		Cao, Jingli/0000-0001-5938-6604	National Basic Research Program of China [2012CB945003]; National Natural Science Foundation of China [31330045, 31271427, 31471323]; Shanghai Municipal Science and Technology Commission [12JC1409900]; Chinese Academy of Sciences [XDA01010107]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Chinese Academy of Sciences (XDA01010107), National Basic Research Program of China (2012CB945003), National Natural Science Foundation of China (31330045, 31271427 and 31471323), and Shanghai Municipal Science and Technology Commission (12JC1409900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Arjona FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004267; Bhogaraju Sagar, 2013, Cilia, V2, P10, DOI 10.1186/2046-2530-2-10; Borovina A, 2013, CELL REP, V5, P37, DOI 10.1016/j.celrep.2013.08.043; Burgess S, 2002, DEVELOPMENT, V129, P905; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Choksi SP, 2014, DEVELOPMENT, V141, P3410, DOI 10.1242/dev.108209; Crevel G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001737; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Fang LH, 2013, NATURE, V498, P118, DOI 10.1038/nature12166; Franklin JB, 2010, MOL MICROBIOL, V78, P173, DOI 10.1111/j.1365-2958.2010.07322.x; Gao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023386; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Guemez-Gamboa A, 2014, NEURON, V82, P511, DOI 10.1016/j.neuron.2014.04.024; Hao LM, 2009, J CELL SCI, V122, P889, DOI 10.1242/jcs.023861; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Hostetter CL, 2003, DEV DYNAM, V228, P514, DOI 10.1002/dvdy.10371; Ishikawa H, 2014, ELIFE, V3, DOI 10.7554/eLife.01566; Ishikawa H, 2012, CURR BIOL, V22, P414, DOI 10.1016/j.cub.2012.01.031; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Liu QH, 2008, MOL BIOTECHNOL, V40, P231, DOI 10.1007/s12033-008-9080-5; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Novarino G, 2011, CELL, V147, P70, DOI 10.1016/j.cell.2011.09.014; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Radicke S, 2005, J PHYSIOL-LONDON, V565, P751, DOI 10.1113/jphysiol.2005.087312; Renaud O, 2011, NAT PROTOC, V6, P1897, DOI 10.1038/nprot.2011.408; Riley BB, 1997, DEV BIOL, V191, P191, DOI 10.1006/dbio.1997.8736; Shan YL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000116; Shen YD, 2008, DEV CELL, V14, P342, DOI 10.1016/j.devcel.2008.01.001; Simons M, 2006, KIDNEY INT, V70, P854, DOI 10.1038/sj.ki.5001534; Stooke-Vaughan GA, 2012, DEVELOPMENT, V139, P1777, DOI 10.1242/dev.079947; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Taschner M, 2014, J CELL BIOL, V207, P269, DOI 10.1083/jcb.201408002; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; Tsao PN, 2009, DEVELOPMENT, V136, P2297, DOI 10.1242/dev.034884; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wei Q, 2012, NAT CELL BIOL, V14, P950, DOI 10.1038/ncb2560; Yang J, 2005, EMBO J, V24, P1, DOI 10.1038/sj.emboj.7600496; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zhang Q, 2012, MOL BIOL CELL, V23, P3069, DOI 10.1091/mbc.E12-01-0019; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhao CT, 2007, MECH DEVELOP, V124, P605, DOI 10.1016/j.mod.2007.04.004; Zhao HJ, 2013, NAT CELL BIOL, V15, P1434, DOI 10.1038/ncb2880	56	31	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124378	10.1371/journal.pone.0124378	http://dx.doi.org/10.1371/journal.pone.0124378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860617	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300137
J	Bhadra, S; Jiang, YS; Kumar, MR; Johnson, RF; Hensley, LE; Ellington, AD				Bhadra, Sanchita; Jiang, Yu Sherry; Kumar, Mia R.; Johnson, Reed F.; Hensley, Lisa E.; Ellington, Andrew D.			Real-Time Sequence-Validated Loop-Mediated Isothermal Amplification Assays for Detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)	PLOS ONE			English	Article							RECOMBINASE POLYMERASE AMPLIFICATION; CLINICAL-FEATURES; SAUDI-ARABIA; QUANTIFICATION; INFECTION; DIAGNOSIS; ALIGNMENT; SPECIFICITY; COMPUTATION; IMPROVES	The Middle East respiratory syndrome coronavirus (MERS-CoV),an emerging human coronavirus, causes severe acute respiratory illness with a 35% mortality rate. In light of the recent surge in reported infections we have developed asymmetric five-primer reverse transcription loop-mediated isothermal amplification (RT-LAMP) assays for detection of MERS-CoV. Isothermal amplification assays will facilitate the development of portable point-of-care diagnostics that are crucial for management of emerging infections. The RT-LAMP assays are designed to amplify MERS-CoV genomic loci located within the open reading frame (ORF) 1a and ORF1b genes and upstream of the E gene. Additionally we applied one-step strand displacement probes (OSD) for real-time sequence-specific verification of LAMP amplicons. Asymmetric amplification effected by incorporating a single loop primer in each assay accelerated the time-to-result of the OSD-RT-LAMP assays. The resulting assays could detect 0.02 to 0.2 plaque forming units (PFU) (5 to 50 PFU/ml) of MERS-CoV in infected cell culture supernatants within 30 to 50 min and did not cross-react with common human respiratory pathogens.	[Bhadra, Sanchita; Jiang, Yu Sherry; Ellington, Andrew D.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Dept Chem & Biochem, Austin, TX 78712 USA; [Kumar, Mia R.; Johnson, Reed F.] NIAID, Emerging Viral Pathogens Sect, NIH, Ft Detrick, MD USA; [Hensley, Lisa E.] NIAID, Integrated Res Facil, NIH, Ft Detrick, MD USA	University of Texas System; University of Texas Austin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ellington, AD (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Dept Chem & Biochem, Austin, TX 78712 USA.	ellingtonlab@gmail.com		Hensley, Lisa/0000-0003-1188-4342; Bhadra, Sanchita/0000-0002-4956-2405	Welch Foundation [F-1654]; Defense Advanced Research Projects Agency [HR0011-11-2-0018]; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID); Integrated Research Facility (NIAID, Division of Clinical Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001025] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Integrated Research Facility (NIAID, Division of Clinical Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Welch Foundation (F-1654) and by the Defense Advanced Research Projects Agency (HR0011-11-2-0018). This work was also supported, in part, by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases (NIAID) the Integrated Research Facility (NIAID, Division of Clinical Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Wahed A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071642, 10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, PLOS CURR, V5, DOI [10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8, DOI 10.1371/CURRENTS.OUTBREAKS.0BF719E352E7478F8AD85FA30127DDB8]; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Bermingham A, 2012, EUROSURVEILLANCE, V17, P6; Bialek SR, 2014, MMWR-MORBID MORTAL W, V63, P431; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Briese T, 2014, MBIO, V5, DOI 10.1128/mBio.01146-14; Buchholz U, 2013, EUROSURVEILLANCE, V18, P6; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; Chen X, 2010, CURR OPIN BIOTECH, V21, P392, DOI 10.1016/j.copbio.2010.05.003; Chou PH, 2011, J VIROL METHODS, V173, P67, DOI 10.1016/j.jviromet.2011.01.009; Corman VM, 2012, EUROSURVEILLANCE, V17, P2; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Corman VM, 2014, J CLIN VIROL, V60, P168, DOI 10.1016/j.jcv.2014.03.012; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; Cotten M, 2013, EMERG INFECT DIS, V19, P736, DOI 10.3201/eid1905.130057; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fauci AS, 2008, NAT REV DRUG DISCOV, V7, P12, DOI 10.1038/nrd2491; Fuchs B, 1999, MOL BIOTECHNOL, V12, P237, DOI 10.1385/MB:12:3:237; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Henke W, 1997, NUCLEIC ACIDS RES, V25, P3957, DOI 10.1093/nar/25.19.3957; Holmes D, 2014, LANCET, V383, P1793, DOI 10.1016/S0140-6736(14)60866-7; Hoshika Shuichi, 2008, Nucleic Acids Symp Ser (Oxf), P129, DOI 10.1093/nass/nrn066; JET Schanke, 2000, US patent Appl No, Patent No. [PCT/US2000/013960, 2000013960]; Jiang YS, 2015, ANAL CHEM, V87, P3314, DOI 10.1021/ac504387c; Jung C, 2010, ANAL CHEM, V82, P5937, DOI 10.1021/ac100606m; Lambert D, 2007, J MOL BIOL, V370, P993, DOI 10.1016/j.jmb.2007.03.080; Levesque-Sergerie JP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-93; Li BL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr504; Li QQ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e5; Lutz S, 2010, LAB CHIP, V10, P887, DOI 10.1039/b921140c; Mahony J, 2013, J CLIN VIROL, V58, P127, DOI 10.1016/j.jcv.2013.06.006; Mailles A, 2013, Euro Surveill, V18; Memish ZA, 2014, CLIN MICROBIOL INFEC, V20, P469, DOI 10.1111/1469-0691.12562; Meyer B, 2014, VIRUS RES, V194, P175, DOI 10.1016/j.virusres.2014.03.018; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Patel JC, 2014, J INFECT DIS, V210, P1180, DOI 10.1093/infdis/jiu252; Pyrc K, 2011, J VIROL METHODS, V175, P133, DOI 10.1016/j.jviromet.2011.04.024; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Raj VS, 2014, CURR OPIN VIROL, V5, P58, DOI 10.1016/j.coviro.2014.01.010; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; Rohrman BA, 2012, LAB CHIP, V12, P3082, DOI 10.1039/c2lc40423k; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Shen F, 2011, ANAL CHEM, V83, P3533, DOI 10.1021/ac200247e; Shirato K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-139; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Sun B, 2013, ANAL CHEM, V85, P1540, DOI 10.1021/ac3037206; Tani H, 2007, ANAL CHEM, V79, P5608, DOI 10.1021/ac070041e; Weissensteiner T, 1996, BIOTECHNIQUES, V21, P1102; World Health Organization, MIDDL E RESP SYNDR C; World Health Organization, 2015, LAB TEST MIDDL E RES; Yan L, 2014, CHEM COMMUN, V50, P7147, DOI 10.1039/c4cc02532f; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/NCHEM.1246, 10.1038/nchem.1246]; Zhang DY, 2011, NAT CHEM, V3, P103, DOI [10.1038/nchem.957, 10.1038/NCHEM.957]; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s	68	86	92	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123126	10.1371/journal.pone.0123126	http://dx.doi.org/10.1371/journal.pone.0123126			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856093	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500077
J	Rizos, E; Siafakas, N; Katsantoni, E; Skourti, E; Salpeas, V; Rizos, I; Tsoporis, JN; Kastania, A; Filippopoulou, A; Xiros, N; Margaritis, D; Parker, TG; Papageorgiou, C; Zoumpourlis, V				Rizos, Emmanouil; Siafakas, Nikolaos; Katsantoni, Eleni; Skourti, Eleni; Salpeas, Vassilios; Rizos, Ioannis; Tsoporis, James N.; Kastania, Anastasia; Filippopoulou, Anastasia; Xiros, Nikolaos; Margaritis, Demetrios; Parker, Thomas G.; Papageorgiou, Charalabos; Zoumpourlis, Vassilios			Let-7, Mir-98 and Mir-181 as Biomarkers for Cancer and Schizophrenia	PLOS ONE			English	Article							LUNG-CANCER; EXPRESSION; MICRORNAS; NEURODEGENERATION; DISORDERS; PROGNOSIS; MIGRATION; ONCOGENE; INVASION; TARGETS	Recent evidence supports a role of microRNAs in cancer and psychiatric disorders such as schizophrenia and bipolar disorder, through their regulatory role on the expression of multiple genes. The rather rare co-morbidity of cancer and schizophrenia is an old hypothesis which needs further research on microRNAs as molecules that might exert their oncosuppressive or oncogenic activity in the context of their role in psychiatric disorders. The expression pattern of a variety of different microRNAs was investigated in patients (N = 6) suffering from schizophrenia termed control, patients with a solid tumor (N = 10) and patients with both schizophrenia and tumor (N = 8). miRNA profiling was performed on whole blood samples using the miRCURY LNA microRNA Array technology (6th & 7th generation). A subset of 3 microRNAs showed a statistically significant differential expression between the control and the study groups. Specifically, significant down-regulation of the let-7p-5p, miR-98-5p and of miR-183-5p in the study groups (tumor alone and tumorand schizophrenia) was observed (p<0.05). The results of the present study showed that let-7, miR-98 and miR-183 may play an important oncosuppressive role through their regulatory impact in gene expression irrespective of the presence of schizophrenia, although a larger sample size is required to validate these results. Nevertheless, further studies are warranted in order to highlight a possible role of these and other micro-RNAs in the molecular pathways of schizophrenia.	[Rizos, Emmanouil; Filippopoulou, Anastasia; Margaritis, Demetrios; Papageorgiou, Charalabos] Univ Athens, Sch Med, Dept Psychiat 2, Univ ATTIKON Gen Hosp, Athens 11528, Greece; [Siafakas, Nikolaos] Univ Athens, Sch Med, Microbiol Lab, Univ ATTIKON Gen Hosp, Athens 11528, Greece; [Katsantoni, Eleni] Acad Athens, Div Hematol & Oncol, Biomed Res Fdn, Athens, Greece; [Skourti, Eleni; Zoumpourlis, Vassilios] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Unit Biomed Applicat, Athens, Greece; [Salpeas, Vassilios; Rizos, Ioannis] Univ Athens, Cardiol Dept 2, Univ Gen Hosp ATTIKON, Athens 11528, Greece; [Tsoporis, James N.; Parker, Thomas G.] St Michaels Hosp, Li Ka Shing Knowledge Inst Biomed Sci, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Kastania, Anastasia] Athens Univ Econ & Business, Dept Informat, Athens, Greece; [Xiros, Nikolaos] Attikon Univ Hosp, Oncol Unit, Dept Propaedeut Internal Med 2, Athens, Greece; [Filippopoulou, Anastasia] Democritus Univ Thrace, Sch Med, Univ Gen Hosp Alexandroupolis, Dept Psychiat, Alexandroupolis, Greece	Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Academy of Athens; National Hellenic Research Foundation; National & Kapodistrian University of Athens; University Hospital Attikon; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Athens University of Economics & Business; University Hospital Attikon; Democritus University of Thrace	Rizos, E (corresponding author), Univ Athens, Sch Med, Dept Psychiat 2, Univ ATTIKON Gen Hosp, Athens 11528, Greece.	erizos@med.uoa.gr	Siafakas, Nikolaos/ABA-6124-2021; Siafakas, Nikolas/AAI-3324-2020	Siafakas, Nikolaos/0000-0002-0088-143X; Papageorgiou, Charalabos/0000-0001-7635-1956; Katsantoni, Eleni/0000-0001-8249-6035; SKOURTI, ELENI/0000-0001-6008-0549				Abraham D, 2011, CLIN CANCER RES, V17, P4772, DOI 10.1158/1078-0432.CCR-11-0242; Aherne A, 2004, HUM MOL GENET, V13, P641, DOI 10.1093/hmg/ddh061; Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Asikainen S, 2010, J MOL NEUROSCI, V41, P210, DOI 10.1007/s12031-009-9325-1; Babashah S, 2011, EUR J CANCER, V47, P1127, DOI 10.1016/j.ejca.2011.02.008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BUYSSE DJ, 1994, AM J PSYCHIAT, V151, P1351; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chang S, 2009, HUM MOL GENET, V18, pR18, DOI 10.1093/hmg/ddp072; Chou FHC, 2011, SCHIZOPHR RES, V129, P97, DOI 10.1016/j.schres.2011.02.018; Day E, 2013, INT J EXP PATHOL, V94, P203, DOI 10.1111/iep.12021; De Smaele E, 2010, BRAIN RES, V1338, P100, DOI 10.1016/j.brainres.2010.03.103; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; First MR, 1997, SEMIN NEPHROL, V17, P373; Fu LL, 2012, INT J BIOCHEM CELL B, V44, P733, DOI 10.1016/j.biocel.2012.02.004; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Iacoangeli A, 2010, BRAIN RES, V1338, P36, DOI 10.1016/j.brainres.2010.03.042; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Le HTT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033140; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Mercer TR, 2008, NEUROSCIENTIST, V14, P434, DOI 10.1177/1073858408319187; Miller BH, 2010, BRAIN RES, V1338, P89, DOI 10.1016/j.brainres.2010.03.035; Niwa R, 2008, DEV BIOL, V315, P418, DOI 10.1016/j.ydbio.2007.12.044; Patel K, 2014, CANCER LETT, V347, P54, DOI 10.1016/j.canlet.2014.01.020; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rizos E, 2012, ONCOL REP, V28, P2200, DOI 10.3892/or.2012.2052; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tan L, 2014, J ALZHEIMERS DIS, V40, P1017, DOI 10.3233/JAD-132144; Tang HF, 2014, PHARMAZIE, V69, P287, DOI 10.1691/ph.2014.3849; Thumar J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-45; Xia Y, 2014, TUMOR BIOL, V35, P5143, DOI 10.1007/s13277-014-1663-0; Xiao JA, 2011, INT J CARDIOL, V148, P110, DOI 10.1016/j.ijcard.2011.01.029; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030; Zucchi FCR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056967	40	19	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123522	10.1371/journal.pone.0123522	http://dx.doi.org/10.1371/journal.pone.0123522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856466	Green Published, gold			2022-12-27	WOS:000352588500095
J	Zhai, H; Mu, YM; Wang, CM; Yan, X				Zhai Hong; Mu Yuming; Wang Chunmei; Yan Xue			The Value of Myocardial Torsion and Aneurysm Volume for Evaluating Cardiac Function in Rabbit with Left Ventricular Aneurysm	PLOS ONE			English	Article							TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; MAGNETIC-RESONANCE; SYSTOLIC FUNCTION; HEART-FAILURE; INFARCTION; DEFORMATION; CATECHOLAMINES; HYPERTENSION; VALIDATION; ISCHEMIA	Objective This study aimed to investigate the effect of left ventricular aneurysm (LVA) volume and left ventricular global torsion on cardiac function by real time three-dimensional echocardiography (RT-3DE) and two-dimensional speckle tracking imaging(2D-STI), to determine the accuracy of RT-3DE and 2D-STI in assessing LV function. Methods Thirty New Zealand rabbit models of with LVA were prepared by ligation of the middle segment of the left anterior descending and left circumflex arteries. Four weeks postprocedure, RT-3DE was conducted to obtain data on LVEF, left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and LVA volume (LVAV), Peak rotation angles at the mitral valve annulus level (MV-ROT), peak rotation angles at the apical level (AP-ROT), and left ventricular global torsion angles (LV-TOR) were measured by 2D-STI. Results Compared with controls, LVEDV and LVESV were significantly increased in the LVA group, while LVEF, MV-ROT, AP-ROT, and LV-TOR were consistently reduced (p<0.01). Moreover, LVEF correlated with LVA volume and LV torsion angle (r=-0.778 and 0.821, p<0.01). LVA volume/LVEDV had the strongest inverse relationship with LVEF (r=-0.911, p<0.01). Conclusion LVA volume, LVA volume/LVEDV, and LV torsion may be used as an indicator for evaluation of cardiac function after LVA. Moreover, LVA volume/LVEDV may be a more sensitive and reliable marker of cardiac function after LVA formation.	[Zhai Hong] Xinjiang Med Univ, Affiliated Tradit Chinese Med Hosp, Dept Ultrasonog, Urumqi, Xinjiang Uygur, Peoples R China; [Mu Yuming; Wang Chunmei; Yan Xue] Xinjiang Med Univ, Affiliated Hosp 1, Dept Echocardiog, Urumqi, Xinjiang Uygur, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Mu, YM (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Echocardiog, Urumqi, Xinjiang Uygur, Peoples R China.	zhaishuanghai@sina.com	Mu, Yuming/AAO-9354-2020					Altay H, 2011, CASE REPORTS MED, V7, P1; Anwar AM, 2008, ECHOCARDIOGR-J CARD, V25, P983, DOI 10.1111/j.1540-8175.2008.00746.x; Bansal M, 2008, J AM SOC ECHOCARDIOG, V21, P887, DOI 10.1016/j.echo.2008.01.011; Battaloglu B, 2007, TEX HEART I J, V34, P154; Bu LP, 2005, J AM SOC ECHOCARDIOG, V18, P299, DOI 10.1016/j.echo.2004.11.002; BUCHALTER MB, 1994, CARDIOVASC RES, V28, P629, DOI 10.1093/cvr/28.5.629; Chen OD, 2012, CHINESE MED J-PEKING, V125, P3416, DOI 10.3760/cma.j.issn.0366-6999.2012.19.010; Corsi C, 2005, CIRCULATION, V112, P1161, DOI 10.1161/CIRCULATIONAHA.104.513689; Fan HG, 2009, CHINESE MED J-PEKING, V122, P1963, DOI 10.3760/cma.j.issn.0366-6999.2009.17.001; Fuchs E, 2004, EUR J HEART FAIL, V6, P715, DOI 10.1016/j.ejheart.2003.12.018; Gutierrez-Chico JL, 2005, AM J CARDIOL, V95, P809, DOI 10.1016/j.amjcard.2004.11.046; Han W, 2008, CHINESE MED J-PEKING, V121, P1543, DOI 10.1097/00029330-200808020-00008; Ikeda M, 2001, Ann Thorac Cardiovasc Surg, V7, P346; Kim WJ, 2009, CIRC-CARDIOVASC IMAG, V2, P123, DOI 10.1161/CIRCIMAGING.108.794719; KROEKER CAG, 1993, AM J PHYSIOL, V265, pH1444, DOI 10.1152/ajpheart.1993.265.4.H1444; Lang RM, 2006, J AM COLL CARDIOL, V48, P2053, DOI 10.1016/j.jacc.2006.07.047; Langeland S, 2005, CIRCULATION, V112, P2157, DOI 10.1161/CIRCULATIONAHA.105.554006; Li XC, 2009, CHINESE MED J-PEKING, V122, P2981, DOI 10.3760/cma.j.issn.0366-6999.2009.24.012; Liang HY, 2006, AM J CARDIOL, V98, P1581, DOI 10.1016/j.amjcard.2006.07.038; Mor-Avi V, 2004, CIRCULATION, V110, P1814, DOI 10.1161/01.CIR.0000142670.65971.5F; Mu YM, 2010, ECHOCARDIOGR-J CARD, V27, P415, DOI 10.1111/j.1540-8175.2009.01028.x; Mu YM, 2010, ECHOCARDIOGR-J CARD, V27, P146, DOI 10.1111/j.1540-8175.2009.00984.x; Nucifora G, 2010, CIRC-CARDIOVASC IMAG, V3, P433, DOI 10.1161/CIRCIMAGING.109.926196; Prakash K, 2004, ECHOCARDIOGR-J CARD, V21, P257, DOI 10.1111/j.0742-2822.2004.03071.x; RADEMAKERS FE, 1992, CIRCULATION, V85, P1572, DOI 10.1161/01.CIR.85.4.1572; Ran H, 2012, ECHOCARDIOGR-J CARD, V29, P688, DOI 10.1111/j.1540-8175.2012.01690.x; Sengupta Partho P, 2008, Heart Fail Clin, V4, P315, DOI 10.1016/j.hfc.2008.03.001; Sugeng L, 2006, CIRCULATION, V114, P654, DOI 10.1161/CIRCULATIONAHA.106.626143; Takeuchi M, 2007, EUR HEART J, V28, P2756, DOI 10.1093/eurheartj/ehm440; Takeuchi M, 2007, J AM SOC ECHOCARDIOG, V20, P36, DOI 10.1016/j.echo.2006.06.019; Tibayan FA, 2004, CIRCULATION, V110, pII109, DOI 10.1161/01.CIR.0000138385.05471.41; Yao J, 2012, CHINESE MED J-PEKING, V125, P214, DOI 10.3760/cma.j.issn.0366-6999.2012.02.010; Zhang P, 2005, J THORAC CARDIOV SUR, V130, P1032, DOI 10.1016/j.jtcvs.2005.05.039; Zheng Zhe, 2009, Interact Cardiovasc Thorac Surg, V9, P431, DOI 10.1510/icvts.2009.207134	34	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121876	10.1371/journal.pone.0121876	http://dx.doi.org/10.1371/journal.pone.0121876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855970	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500027
J	Gohari, IM; Parreira, VR; Nowell, VJ; Nicholson, VM; Oliphant, K; Prescott, JF				Gohari, Iman Mehdizadeh; Parreira, Valeria R.; Nowell, Victoria J.; Nicholson, Vivian M.; Oliphant, Kaitlyn; Prescott, John F.			A Novel Pore-Forming Toxin in Type A Clostridium perfringens Is Associated with Both Fatal Canine Hemorrhagic Gastroenteritis and Fatal Foal Necrotizing Enterocolitis	PLOS ONE			English	Article							ADULT HORSES; GENE; EXPRESSION; NETB; IDENTIFICATION; DIFFICILE; ENTERITIS; DIARRHEA; FECES; CPB2	A role for type A Clostridium perfringens in acute hemorrhagic and necrotizing gastroenteritis in dogs and in necrotizing enterocolitis of neonatal foals has long been suspected but incompletely characterized. The supernatants of an isolate made from a dog and from a foal that died from these diseases were both found to be highly cytotoxic for an equine ovarian (EO) cell line. Partial genome sequencing of the canine isolate revealed three novel putative toxin genes encoding proteins related to the pore-forming Leukocidin/Hemolysin Superfamily; these were designated netE, netF, and netG. netE and netF were located on one large conjugative plasmid, and netG was located with a cpe enterotoxin gene on a second large conjugative plasmid. Mutation and complementation showed that only netF was associated with the cytotoxicity. Although netE and netG were not associated with cytotoxicity, immuno-blotting with specific antisera showed these proteins to be expressed in vitro. There was a highly significant association between the presence of netF with type A strains isolated from cases of canine acute hemorrhagic gastroenteritis and foal necrotizing enterocolitis. netE and netF were found in all cytotoxic isolates, as was cpe, but netG was less consistently present. Pulsed-field gel electrophoresis showed that netF-positive isolates belonged to a clonal population; some canine and equine netF-positive isolates were genetically indistinguishable. Equine antisera to recombinant Net proteins showed that only antiserum to rNetF had high supernatant cytotoxin neutralizing activity. The identifica-tion of this novel necrotizing toxin is an important advance in understanding the virulence of type A C. perfringens in specific enteric disease of animals.	[Gohari, Iman Mehdizadeh; Parreira, Valeria R.; Nowell, Victoria J.; Nicholson, Vivian M.; Oliphant, Kaitlyn; Prescott, John F.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	University of Guelph	Prescott, JF (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	prescott@uoguelph.ca			Natural Sciences and Engineering Discovery Grant; Ontario Ministry of Agriculture, Food and Rural Affairs (Proof of Principle grant program); Ontario Centres of Excellence (C4 Proof of Principle grant program); Equine Guelph - University of Guelph	Natural Sciences and Engineering Discovery Grant; Ontario Ministry of Agriculture, Food and Rural Affairs (Proof of Principle grant program); Ontario Centres of Excellence (C4 Proof of Principle grant program); Equine Guelph - University of Guelph	Funding was provided from Natural Sciences and Engineering Discovery Grant, by the Ontario Ministry of Agriculture, Food and Rural Affairs (Proof of Principle grant program), and by the Ontario Centres of Excellence (C4 Proof of Principle grant program). Equine Guelph - University of Guelph funds supported the initial steps of this study.	Alonzo F, 2014, MICROBIOL MOL BIOL R, V78, P199, DOI 10.1128/MMBR.00055-13; Bacciarini LN, 2003, VET PATHOL, V40, P376, DOI 10.1354/vp.40-4-376; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Bannam TL, 2011, MBIO, V2, DOI 10.1128/mBio.00190-11; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BURROWS CF, 1977, J AM ANIM HOSP ASSOC, V13, P451; Chalmers G, 2008, VET MICROBIOL, V127, P116, DOI 10.1016/j.vetmic.2007.08.008; Chase K, 2009, J HERED, V100, pS37, DOI 10.1093/jhered/esp011; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; da Costa SPF, 2014, TOXINS, V6, P1049, DOI 10.3390/toxins6031049; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Deguchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005598; Diab SS, 2012, VET PATHOL, V49, P255, DOI 10.1177/0300985811404710; Donahue M, 2002, EQUINE DIS Q, V10, P4; Donaldson MT, 1999, J AM VET MED ASSOC, V215, P358; East LM, 1998, J AM VET MED ASSOC, V212, P1751; East LM, 2000, PREV VET MED, V46, P61, DOI 10.1016/S0167-5877(00)00131-8; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; GLASER AL, 1995, J GEN VIROL, V76, P2223, DOI 10.1099/0022-1317-76-9-2223; Gohari IM, 2014, CAN J VET RES, V78, P1; Hazlett MJ, 2011, J VET DIAGN INVEST, V23, P373, DOI 10.1177/104063871102300232; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Herholz C, 1999, J CLIN MICROBIOL, V37, P358, DOI 10.1128/JCM.37.2.358-361.1999; Hibberd MC, 2011, J CLIN MICROBIOL, V49, P1556, DOI 10.1128/JCM.01884-10; HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158; Huyet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066673; Jost BH, 2006, VET MICROBIOL, V116, P158, DOI 10.1016/j.vetmic.2006.03.025; KANOE M, 1990, MICROBIOS, V64, P153; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Kircanski J, 2012, VET MICROBIOL, V159, P371, DOI 10.1016/j.vetmic.2012.04.007; Kircanski J, 2012, J VET DIAGN INVEST, V24, P895, DOI 10.1177/1040638712453584; Lepp D, 2013, J BACTERIOL, V195, P1152, DOI 10.1128/JB.01032-12; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Li JH, 2013, MICROBIOL MOL BIOL R, V77, P208, DOI 10.1128/MMBR.00062-12; Ma ML, 2014, INFECT IMMUN, V82, P2958, DOI 10.1128/IAI.01848-14; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marks SL, 2012, INFECTIOUS DISEASES, P393; McGavin MD, 2007, PATHOLOGIC BASIS OF; Netherwood T, 1998, VET J, V155, P289, DOI 10.1016/S1090-0233(05)80025-5; Nowell VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032271; Obana N, 2011, J BACTERIOL, V193, P4417, DOI 10.1128/JB.00262-11; Ohtani K, 2010, ANAEROBE, V16, P258, DOI 10.1016/j.anaerobe.2009.10.003; Parreira VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049753; Popoff MR, 2013, TOXICON, V75, P63, DOI 10.1016/j.toxicon.2013.05.003; PRESCOTT JF, 1978, VET REC, V103, P116, DOI 10.1136/vr.103.6.116; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; QUIGLEY JD, 1995, J DAIRY SCI, V78, P1573, DOI 10.3168/jds.S0022-0302(95)76780-7; Roth F, 1999, FEMS IMMUNOL MED MIC, V24, P353, DOI 10.1016/S0928-8244(99)00053-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasaki J, 1999, J VET MED SCI, V61, P175, DOI 10.1292/jvms.61.175; Savva CG, 2013, J BIOL CHEM, V288, P3512, DOI 10.1074/jbc.M112.430223; Schlegel BJ, 2012, CAN VET J, V53, P555; Shimizu T, 2002, MOL MICROBIOL, V43, P257, DOI 10.1046/j.1365-2958.2002.02743.x; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thompson DR, 2006, VET MICROBIOL, V113, P25, DOI 10.1016/j.vetmic.2005.10.015; Tillotson K, 2002, J AM VET MED ASSOC, V220, P342, DOI 10.2460/javma.2002.220.342; Timoney JF, 2005, VET REC, V157, P810, DOI 10.1136/vr.157.25.810; TRAUBDARGATZ JL, 1993, VET CLIN N AM-EQUINE, V9, P411, DOI 10.1016/S0749-0739(17)30407-8; Unterer S, 2014, J VET INTERN MED, V28, P52, DOI 10.1111/jvim.12236; Vilei EM, 2005, MOL MICROBIOL, V57, P1570, DOI 10.1111/j.1365-2958.2005.04789.x; Waters M, 2005, J CLIN MICROBIOL, V43, P4002, DOI 10.1128/JCM.43.8.4002-4009.2005; Weese JS, 2001, J VET INTERN MED, V15, P374, DOI 10.1892/0891-6640(2001)015&lt;0374:TRODAE&gt;2.3.CO;2; Yan XX, 2013, MBIO, V4, DOI 10.1128/mBio.00019-13; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	67	75	78	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122684	10.1371/journal.pone.0122684	http://dx.doi.org/10.1371/journal.pone.0122684			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853427	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400077
J	Hamilton, RJ; Bird, T; Gereniu, C; Pita, J; Ramohia, PC; Walter, R; Goerlich, C; Limpus, C				Hamilton, Richard J.; Bird, Tomas; Gereniu, Collin; Pita, John; Ramohia, Peter C.; Walter, Richard; Goerlich, Clara; Limpus, Colin			Solomon Islands Largest Hawksbill Turtle Rookery Shows Signs of Recovery after 150 Years of Excessive Exploitation	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ERETMOCHELYS-IMBRICATA; FISHERIES; GEORGIA	The largest rookery for hawksbill turtles in the oceanic South Pacific is the Arnavon Islands, which are located in the Manning Strait between Isabel and Choiseul Province, Solomon Islands. The history of this rookery is one of overexploitation, conflict and violence. Throughout the 1800s Roviana headhunters from New Georgia repeatedly raided the Manning Strait to collect hawksbill shell which they traded with European whalers. By the 1970s the Arnavons hawksbill population was in severe decline and the national government intervened, declaring the Arnavons a sanctuary in 1976. But this government led initiative was short lived, with traditional owners burning down the government infrastructure and resuming intensive harvesting in 1982. In 1991 routine beach monitoring and turtle tagging commenced at the Arnavons along with extensive community consultations regarding the islands' future, and in 1995 the Arnavon Community Marine Conservation Area (ACMCA) was established. Around the same time national legislation banning the sale of all turtle products was passed. This paper represents the first analysis of data from 4536 beach surveys and 845 individual turtle tagging histories obtained from the Arnavons between 1991-2012. Our results and the results of others, reveal that many of the hawksbill turtles that nest at the ACMCA forage in distant Australian waters, and that nesting on the Arnavons occurs throughout the year with peak nesting activity coinciding with the austral winter. Our results also provide the first known evidence of recovery for a western pacific hawksbill rookery, with the number of nests laid at the ACMCA and the remigration rates of turtles doubling since the establishment of the ACMCA in 1995. The Arnavons case study provides an example of how changes in policy, inclusive community-based management and long term commitment can turn the tide for one of the most charismatic and endangered species on our planet.	[Hamilton, Richard J.; Goerlich, Clara] Nature Conservancy, Asia Pacific Div, Brisbane, Qld 4101, Australia; [Hamilton, Richard J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Bird, Tomas] Univ Southampton, Sch Geog & Environm, Southampton SO17 1BJ, Hants, England; [Gereniu, Collin] Nature Conservancy, Solomon Islands Field Off, Honiara, Solomon Islands; [Pita, John] Nature Conservancy, Isabel Environm Off, Buala, Isabel Province, Solomon Islands; [Ramohia, Peter C.] Minist Environm Climate Change Disaster Managemen, ADB Coral Triangle Pacific Project, Honiara, Solomon Islands; [Walter, Richard] Univ Otago, Dept Anthropol & Archaeol, Dunedin, New Zealand; [Goerlich, Clara] Univ Wurzburg, D-97070 Wurzburg, Germany; [Limpus, Colin] Queensland Govt, Dept Environm & Heritage Protect, Threatened Species Unit, Brisbane, Qld 4102, Australia	James Cook University; University of Southampton; University of Otago; University of Wurzburg	Hamilton, RJ (corresponding author), Nature Conservancy, Asia Pacific Div, 245 Riverside Dr, Brisbane, Qld 4101, Australia.	rhamilton@tnc.org		Hamilton, Richard/0000-0002-0076-4276	community of Katupika; community of Kia; community of Wagina	community of Katupika; community of Kia; community of Wagina	The success of the ACMCA would not be possible without the dedication and commitment of the ACMCA conservation officers of past and present who have devoted so much of their life's towards preserving this small but precious part of the world. This paper is dedicated to them. We also acknowledge the ACMCA board members and the support of the communities of Katupika, Kia and Wagina. We thank N. Peterson for producing Figs. 1 and 2. Finally we thank W. Atu, H. Kaniki, Chief L. Mikie, P. Thomas and C. Siota for their efforts over the years to ensure that the ACMCA is a success.	Allen MS, 2007, CORAL REEFS, V26, P959, DOI 10.1007/s00338-007-0234-x; Allen Zoe C., 2010, Endangered Species Research, V11, P195, DOI 10.3354/esr00281; Beggs Jennifer A., 2007, Endangered Species Research, V3, P159, DOI 10.3354/esr003159; Bell I, 2012, AQUAT CONSERV, V22, P673, DOI 10.1002/aqc.2245; Bell I, 2012, MAR ECOL PROG SER, V446, P275, DOI 10.3354/meps09481; Bennett Judith A., 1987, WEALTH SOLOMONS HIST; BRODERICK D, 1997, P 17 ANN S SEA TURTL, P15; Delcroix E, 2014, ORYX, V48, P95, DOI 10.1017/S0030605311000792; Hamilton R, 2008, IMPACT POACHING MARI; Hamilton RJ, 2012, BIOL CONSERV, V145, P246, DOI 10.1016/j.biocon.2011.11.020; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Horrocks Julia A., 2001, Chelonian Conservation and Biology, V4, P107; Humber F, 2014, DIVERS DISTRIB, V20, P579, DOI 10.1111/ddi.12183; James R., 2012, RIDGES REEFS CONSERV; Kinch Jeff, 2009, Traffic Bulletin, V22, P62; Leary T, 1992, HAWKSBILL GREEN TURT; Limpus C.J., 2008, AUSTR HAWKSBILL TURT; LIMPUS CJ, 1992, WILDLIFE RES, V19, P457, DOI 10.1071/WR9920457; Link WA, 2003, BIOMETRICS, V59, P1123, DOI 10.1111/j.0006-341X.2003.00129.x; Mahanty S., 2002, DEV B, V58, P88; McKeown A., 1977, MARINE TURTLES SOLOM; MCKINNON JM, 1975, OCEANIA, V45, P290, DOI 10.1002/j.1834-4461.1975.tb01872.x; Miller JD, 1998, WILDLIFE RES, V25, P89, DOI 10.1071/WR96086; Milliken T, 1987, JAPANESE SEA TURTLE; Moncada FG, 2012, BIOL CONSERV, V148, P191, DOI 10.1016/j.biocon.2012.01.011; Mortimer J.A., 2002, SEA TURTLE BIOL CONS; Mortimer J.A., 2008, IUCN 2008 RED LIST T; Parker DM, 2009, PAC SCI, V63, P371, DOI 10.2984/049.063.0306; PARMENTER CJ, 1983, COPEIA, P271, DOI 10.2307/1444731; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pike DA, 2014, GLOBAL CHANGE BIOL, V20, P7, DOI 10.1111/gcb.12397; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Ramohia P, 2000, SUMMARY RESULTS PEAK; Ramohia P, 1992, HAWKSBILL GREEN TURT; Ramohia PC., 1994, REPORT SREEP REGIONA; Ramohia PC, 1996, REPORT SPREP REGIONA; RICHARDS AH, 1994, MAR POLLUT BULL, V29, P90, DOI 10.1016/0025-326X(94)90431-6; Sheppard PJ, 2000, J POLYNESIAN SOC, V109, P9; VAUGHAN P, 1980, MARINE TURTLE NEWSLE, V16, P6; VAUGHAN P. W., 1981, MARINE TURTLES REV T; Walter R., 2011, REPORT CULTURAL HERI; Walter RK, 2014, ECOL SOC, V19, DOI 10.5751/ES-06646-190441; Watson JT, 2014, CONSERV BIOL, V28, P1012, DOI 10.1111/cobi.12268; Zelenietz Martin, 1979, PACIFICATION MELANES, P91	44	27	28	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121435	10.1371/journal.pone.0121435	http://dx.doi.org/10.1371/journal.pone.0121435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853880	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000352478400039
J	Kenney, SP; Meng, XJ				Kenney, Scott P.; Meng, Xiang-Jin			Identification and Fine Mapping of Nuclear and Nucleolar Localization Signals within the Human Ribosomal Protein S17	PLOS ONE			English	Article							DIAMOND-BLACKFAN ANEMIA; RNA-POLYMERASE; EUKARYOTIC RIBOSOME; DOMAINS; COMPLEX; BIOGENESIS; SEQUENCE; SUBUNIT; REVEALS; IMPORT	Human ribosomal protein S17 (RPS17) is mutated in Diamond-Blackfan Anemia (DBA), a bone marrow disorder that fails to produce sufficient red blood cells leading to anemia. Recently, an RPS17 protein sequence was also found to be naturally inserted in the genome of hepatitis E virus (HEV) from patients chronically-infected by HEV. The role of RPS17 in HEV replication and pathogenesis remains unknown due to the lack of knowledge about how RPS17 functions at a molecular level. Understanding the biological function of RPS17 is critical for elucidating its role in virus infection and DBA disease processes. In this study we probed the subcellular distribution of normal and mutant RPS17 proteins in a human liver cell line (Huh7). RPS17 was primarily detected within the nucleus, and more specifically within the nucleoli. Using a transient expression system in which RPS17 or truncations were expressed as fusions with enhanced yellow fluorescent protein (eYFP), we were able to identify and map, for the first time, two separate nuclear localization signals (NLSs), one to the first 13 amino acids of the amino-terminus of RPS17 and the other within amino acids 30-60. Additionally, we mapped amino acid sequences required for nucleolar accumulation of RPS17 to amino acids 60-70. Amino acids 60-70 possess a di-RG motif that may be necessary for nucleolar retention of RPS17. The results from this study enhance our knowledge of RSP17 and will facilitate future mechanistic studies about the roles of RSP17 in hepatitis E and DBA disease processes.	[Kenney, Scott P.; Meng, Xiang-Jin] Virginia Polytech Inst & State Univ, Coll Vet Med, Virginia Tech, Ctr Mol Med & Infect Dis,Dept Biomed Sci & Pathob, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Meng, XJ (corresponding author), Virginia Polytech Inst & State Univ, Coll Vet Med, Virginia Tech, Ctr Mol Med & Infect Dis,Dept Biomed Sci & Pathob, Blacksburg, VA 24061 USA.	xjmeng@vt.edu	Meng, X.J./B-8769-2009	Meng, X.J./0000-0002-2739-1334; Kenney, Scott/0000-0002-7449-2066	National Institutes of Health [R01 AI074667, R01 AI050611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050611, R01AI074667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants (R01 AI074667, and R01 AI050611) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annilo T, 1998, BIOCHEM BIOPH RES CO, V249, P759, DOI 10.1006/bbrc.1998.9187; ARIS JP, 1991, P NATL ACAD SCI USA, V88, P931, DOI 10.1073/pnas.88.3.931; Aspesi A, 2014, GENE, V545, P282, DOI 10.1016/j.gene.2014.04.077; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Beyer AR, 2013, J VIROL, V87, P1069, DOI 10.1128/JVI.02463-12; BOMMER UA, 1988, FEBS LETT, V233, P114, DOI 10.1016/0014-5793(88)81366-8; Bouvet P, 1998, J BIOL CHEM, V273, P19025, DOI 10.1074/jbc.273.30.19025; BUGLER B, 1982, EUR J BIOCHEM, V128, P475; Chang SN, 2000, FEBS LETT, V484, P22, DOI 10.1016/S0014-5793(00)02118-9; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; CREANCIER L, 1993, MOL BIOL CELL, V4, P1239, DOI 10.1091/mbc.4.12.1239; Da Costa L, 2003, BLOOD, V101, P5039, DOI 10.1182/blood-2002-12-3878; Dingwall C, 1998, CURR BIOL, V8, pR922, DOI 10.1016/S0960-9822(98)00010-4; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dresios J, 2006, MOL MICROBIOL, V59, P1651, DOI 10.1111/j.1365-2958.2006.05054.x; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; FILIPENKO ML, 1995, BIOORG KHIM+, V21, P349; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Gregory LA, 2007, NUCLEIC ACIDS RES, V35, P5913, DOI 10.1093/nar/gkm626; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kubota S, 1999, ONCOGENE, V18, P1503, DOI 10.1038/sj.onc.1202429; Kundu-Michalik S, 2008, MOL BIOL EVOL, V25, P580, DOI 10.1093/molbev/msn002; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LISCHWE MA, 1982, J BIOL CHEM, V257, P4600; Lochmann TL, 2013, VIRUS RES, V171, P304, DOI 10.1016/j.virusres.2012.09.011; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; OLSON MOJ, 1975, J MOL BIOL, V97, P611, DOI 10.1016/S0022-2836(75)80062-3; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Russo G, 1997, J BIOL CHEM, V272, P5229, DOI 10.1074/jbc.272.8.5229; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Serin G, 1997, J BIOL CHEM, V272, P13109, DOI 10.1074/jbc.272.20.13109; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Thomson E, 2013, J CELL SCI, V126, P4815, DOI 10.1242/jcs.111948; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; Wu B, 2008, PROTEIN SCI, V17, P583, DOI 10.1110/ps.073272208; Zirwes RF, 1997, MOL BIOL CELL, V8, P231, DOI 10.1091/mbc.8.2.231	47	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124396	10.1371/journal.pone.0124396	http://dx.doi.org/10.1371/journal.pone.0124396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853866	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400138
J	Rivera-Barahona, A; Sanchez-Alcudia, R; Viecelli, HM; Rufenacht, V; Perez, B; Ugarte, M; Haberle, J; Thony, B; Desviat, LR				Rivera-Barahona, Ana; Sanchez-Alcudia, Rocio; Viecelli, Hiu Man; Ruefenacht, Veronique; Perez, Belen; Ugarte, Magdalena; Haeberle, Johannes; Thoeny, Beat; Ruiz Desviat, Lourdes			Functional Characterization of the spf/ash Splicing Variation in OTC Deficiency of Mice and Man	PLOS ONE			English	Article							ORNITHINE TRANSCARBAMYLASE DEFICIENCY; UREA CYCLE DISORDERS; MUTATIONS; GENE; DISEASE; MOUSE; SITE; THERAPEUTICS; DELIVERY; CARBAMOYLTRANSFERASE	The spf/ash mouse model of ornithine transcarbamylase (OTC) deficiency, a severe urea cycle disorder, is caused by a mutation (c.386G>A; p.R129H) in the last nucleotide of exon 4 of the Otc gene, affecting the 5' splice site and resulting in partial use of a cryptic splice site 48 bp into the adjacent intron. The equivalent nucleotide change and predicted amino acid change is found in OTC deficient patients. Here we have used liver tissue and minigene assays to dissect the transcriptional profile resulting from the "spf/ash" mutation in mice and man. For the mutant mouse, we confirmed liver transcripts corresponding to partial intron 4 retention by the use of the c.386+48 cryptic site and to normally spliced transcripts, with exon 4 always containing the c.386G>A (p.R129H) variant. In contrast, the OTC patient exhibited exon 4 skipping or c.386G>A (p.R129H)-variant exon 4 retention by using the natural or a cryptic splice site at nucleotide position c.386+4. The corresponding OTC tissue enzyme activities were between 3-6% of normal control in mouse and human liver. The use of the cryptic splice sites was reproduced in minigenes carrying murine or human mutant sequences. Some normally spliced transcripts could be detected in minigenes in both cases. Antisense oligonucleotides designed to block the murine cryptic +48 site were used in minigenes in an attempt to redirect splicing to the natural site. The results highlight the relevance of in depth investigations of the molecular mechanisms of splicing mutations and potential therapeutic approaches. Notably, they emphasize the fact that findings in animal models may not be applicable for human patients due to the different genomic context of the mutations.	[Rivera-Barahona, Ana; Sanchez-Alcudia, Rocio; Perez, Belen; Ruiz Desviat, Lourdes] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Rivera-Barahona, Ana; Sanchez-Alcudia, Rocio; Perez, Belen; Ugarte, Magdalena; Ruiz Desviat, Lourdes] CIBERER, Madrid, Spain; [Rivera-Barahona, Ana; Sanchez-Alcudia, Rocio; Perez, Belen; Ugarte, Magdalena; Ruiz Desviat, Lourdes] Hosp La Paz, Inst Invest Biomed, IdiPAZ, Madrid, Spain; [Viecelli, Hiu Man; Ruefenacht, Veronique; Haeberle, Johannes] Univ Childrens Hosp, Div Metab, Zurich, Switzerland; [Viecelli, Hiu Man; Ruefenacht, Veronique; Haeberle, Johannes] Univ Childrens Hosp, CRC, Zurich, Switzerland; [Perez, Belen; Ugarte, Magdalena; Ruiz Desviat, Lourdes] CEDEM, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University Children's Hospital Zurich; University Children's Hospital Zurich	Desviat, LR (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	lruiz@cbm.csic.es	Rivera, Ana/X-2910-2019; DESVIAT, LOURDES R/L-3055-2013	Rivera, Ana/0000-0002-7376-6176; DESVIAT, LOURDES R/0000-0003-0492-3323; Haberle, Johannes/0000-0003-0635-091X; Grisch-Chan, Hiu Man/0000-0002-5343-2013; Thony, Beat/0000-0002-8420-4769	Ministerio de Economia y Competitividad [SAF2010-17272]; Fundacion Ramon Areces; Centro de Diagnostico de Enfermedades Moleculares	Ministerio de Economia y Competitividad(Spanish Government); Fundacion Ramon Areces; Centro de Diagnostico de Enfermedades Moleculares	This work was supported by Grant SAF2010-17272 from Ministerio de Economia y Competitividad (to LRD), Institutional grant from Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa, University fellowship (to AR), and a Postdoctoral fellowship from Centro de Diagnostico de Enfermedades Moleculares (to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis EF, 2012, HUM MOL GENET, V21, P2389, DOI 10.1093/hmg/dds045; Arrabal L, 2011, NEUROGENETICS, V12, P183, DOI 10.1007/s10048-011-0279-4; Ausems MGEM, 1997, AM J MED GENET, V68, P236, DOI 10.1002/(SICI)1096-8628(19970120)68:2<236::AID-AJMG23>3.0.CO;2-U; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Baralle M, 2006, FEBS LETT, V580, P4449, DOI 10.1016/j.febslet.2006.07.018; BRIAND P, 1983, BIOCHIM BIOPHYS ACTA, V760, P389, DOI 10.1016/0304-4165(83)90379-3; BROWN GW, 1959, J BIOL CHEM, V234, P1769; Cavallari N, 2012, BBA-MOL BASIS DIS, V1822, P1109, DOI 10.1016/j.bbadis.2012.03.001; CAVARD C, 1988, NUCLEIC ACIDS RES, V16, P2099, DOI 10.1093/nar/16.5.2099; Clavero S, 2004, HUM GENET, V115, P239, DOI 10.1007/s00439-004-1147-1; Cunningham SC, 2011, MOL THER, V19, P854, DOI 10.1038/mt.2011.32; De Conti L, 2012, RNA BIOL, V9, P911, DOI 10.4161/rna.20386; DEMARS R, 1976, P NATL ACAD SCI USA, V73, P1693, DOI 10.1073/pnas.73.5.1693; Desviat LR, 2012, METHODS MOL BIOL, V867, P37, DOI 10.1007/978-1-61779-767-5_3; Engel K, 2008, MOL GENET METAB, V94, P292, DOI 10.1016/j.ymgme.2008.03.009; GARCIAPEREZ MA, 1995, HUM GENET, V95, P183; Genet S, 2000, J INHERIT METAB DIS, V23, P669, DOI 10.1023/A:1005614409241; Haberle J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-32; Hammond SM, 2011, TRENDS GENET, V27, P196, DOI 10.1016/j.tig.2011.02.004; Hartmann L, 2010, AM J HUM GENET, V87, P480, DOI 10.1016/j.ajhg.2010.08.016; Heintz C, 2012, MOL GENET METAB, V106, P403, DOI 10.1016/j.ymgme.2012.05.013; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Lanpher BC, 1993, GENEREVIEWS; Lee JH, 2014, PEDIATR NEUROL, V51, P354, DOI 10.1016/j.pediatrneurol.2014.03.029; MATSUURA T, 1994, HUM MUTAT, V3, P402, DOI 10.1002/humu.1380030415; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; Moller LB, 2000, AM J HUM GENET, V66, P1211, DOI 10.1086/302857; Perez B, 2014, NUCLEIC ACID THER, V24, P48, DOI 10.1089/nat.2013.0453; Perez B, 2010, J INHERIT METAB DIS, V33, P397, DOI 10.1007/s10545-010-9135-1; Perez-Carro R, 2014, CLIN GENET, V86, P167, DOI 10.1111/cge.12243; Roca X, 2008, GENOME RES, V18, P77, DOI 10.1101/gr.6859308; Ruegger CM, 2014, J INHERIT METAB DIS, V37, P21, DOI 10.1007/s10545-013-9624-0; Sehgal A, 2013, J HEPATOL, V59, P1354, DOI 10.1016/j.jhep.2013.05.045; Shchelochkov OA, 2009, MOL GENET METAB, V96, P97, DOI 10.1016/j.ymgme.2008.11.167; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Tuchman M, 1996, HUM GENET, V97, P274, DOI 10.1007/BF02185751; TUCHMAN M, 1994, HUM MUTAT, V4, P57, DOI 10.1002/humu.1380040109; VERES G, 1987, SCIENCE, V237, P415, DOI 10.1126/science.3603027; Yamaguchi S, 2006, HUM MUTAT, V27, P626, DOI 10.1002/humu.20339; Yuste-Checa P, 2015, CLIN GENET, V87, P42, DOI 10.1111/cge.12402	43	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122966	10.1371/journal.pone.0122966	http://dx.doi.org/10.1371/journal.pone.0122966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853564	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400088
J	Daqrouq, K; Alhmouz, R; Balamesh, A; Memic, A				Daqrouq, Khaled; Alhmouz, Rami; Balamesh, Ahmed; Memic, Adnan			Application of Wavelet Transform for PDZ Domain Classification	PLOS ONE			English	Article							PREDICTION; RECOGNITION; TRAFFICKING; COMPLEX; ORGANIZATION; SPECIFICITY; AFFINITY	PDZ domains have been identified as part of an array of signaling proteins that are often unrelated, except for the well-conserved structural PDZ domain they contain. These domains have been linked to many disease processes including common Avian influenza, as well as very rare conditions such as Fraser and Usher syndromes. Historically, based on the interactions and the nature of bonds they form, PDZ domains have most often been classified into one of three classes (class I, class II and others - class III), that is directly dependent on their binding partner. In this study, we report on three unique feature extraction approaches based on the bigram and trigram occurrence and existence rearrangements within the domain's primary amino acid sequences in assisting PDZ domain classification. Wavelet packet transform (WPT) and Shannon entropy denoted by wavelet entropy (WE) feature extraction methods were proposed. Using 115 unique human and mouse PDZ domains, the existence rearrangement approach yielded a high recognition rate (78.34%), which outperformed our occurrence rearrangements based method. The recognition rate was (81.41%) with validation technique. The method reported for PDZ domain classification from primary sequences proved to be an encouraging approach for obtaining consistent classification results. We anticipate that by increasing the database size, we can further improve feature extraction and correct classification.	[Daqrouq, Khaled; Alhmouz, Rami; Balamesh, Ahmed] King Abdulaziz Univ, Fac Engn, Dept Elect & Comp Engn, Jeddah 21589, Saudi Arabia; [Memic, Adnan] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21589, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Memic, A (corresponding author), King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21589, Saudi Arabia.	amemic@kau.edu.sa	Al-Hmouz, Rami/K-1233-2012; Balamesh, Ahmed S/A-1602-2012; Memić, Adnan/I-6138-2013	Al-Hmouz, Rami/0000-0001-8710-0706; Balamesh, Ahmed S/0000-0002-0901-2847; Memić, Adnan/0000-0003-4639-8168	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia [903-004-D1434]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia; DSR	This study was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, Saudi Arabia under Grant no. (903-004-D1434). The authors thank the DSR for the technical and financial support.	Atal BS, 2006, IEEE SIGNAL PROC MAG, V23, P154, DOI 10.1109/MSP.2006.1598091; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; COIFMAN RR, 1992, IEEE T INFORM THEORY, V38, P713, DOI 10.1109/18.119732; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Daqrouq K, 2013, SPEECH COMMUN, V55, P641, DOI 10.1016/j.specom.2013.01.002; Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Ernst A, 2014, J MOL BIOL, V426, P3509, DOI 10.1016/j.jmb.2014.08.012; Ernst A, 2010, MOL BIOSYST, V6, P1782, DOI 10.1039/c0mb00061b; Ernst A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000416; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Gujral TS, 2013, CHEM BIOL, V20, P816, DOI 10.1016/j.chembiol.2013.04.021; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harris BZ, 2001, J CELL SCI, V114, P3219; Hui S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-27; Hui S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-507; Jin RZ, 2013, PROTEIN PEPTIDE LETT, V20, P1018; Kalyoncu S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-357; LAINE A, 1993, IEEE T PATTERN ANAL, V15, P1186, DOI 10.1109/34.244679; Luck K, 2012, FEBS LETT, V586, P2648, DOI 10.1016/j.febslet.2012.03.056; MACKOWIAK PA, 1992, JAMA-J AM MED ASSOC, V268, P1578, DOI 10.1001/jama.268.12.1578; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Mu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088286; Nakariyakul S, 2014, BBA-PROTEINS PROTEOM, V1844, P165, DOI 10.1016/j.bbapap.2013.04.008; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Pan LF, 2009, P NATL ACAD SCI USA, V106, P5575, DOI 10.1073/pnas.0901819106; Ponting CP, 1997, BIOESSAYS, V19, P469, DOI 10.1002/bies.950190606; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Rashid M, 2010, CURR PROTEIN PEPT SC, V11, P589, DOI 10.2174/138920310794109120; Roberts KE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002477; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Shao XJ, 2011, BIOINFORMATICS, V27, P383, DOI 10.1093/bioinformatics/btq657; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Wiedemann U, 2004, J MOL BIOL, V343, P703, DOI 10.1016/j.jmb.2004.08.064; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122873	10.1371/journal.pone.0122873	http://dx.doi.org/10.1371/journal.pone.0122873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860375	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300065
J	Laas, P; Simm, J; Lips, I; Lips, U; Kisand, V; Metsis, M				Laas, Peeter; Simm, Jaak; Lips, Inga; Lips, Urmas; Kisand, Veljo; Metsis, Madis			Redox-Specialized Bacterioplankton Metacommunity in a Temperate Estuary	PLOS ONE			English	Article							BACTERIAL COMMUNITY COMPOSITION; CENTRAL BALTIC SEA; PELAGIC REDOXCLINES; WATER COLUMN; GOTLAND DEEP; DIVERSITY; DYNAMICS; BLACK; SUCCESSION; GULF	This study explored the spatiotemporal dynamics of the bacterioplankton community composition in the Gulf of Finland (easternmost sub-basin of the Baltic Sea) based on phylogenetic analysis of 16S rDNA sequences acquired from community samples via pyrosequencing. Investigations of bacterioplankton in hydrographically complex systems provide good insight into the strategies by which microbes deal with spatiotemporal hydrographic gradients, as demonstrated by our research. Many ribotypes were closely affiliated with sequences isolated from environments with similar steep physiochemical gradients and/or seasonal changes, including seasonally anoxic estuaries. Hence, one of the main conclusions of this study is that marine ecosystems where oxygen and salinity gradients co-occur can be considered a habitat for a cosmopolitan metacommunity consisting of specialized groups occupying niches universal to such environments throughout the world. These niches revolve around functional capabilities to utilize different electron receptors and donors (including trace metal and single carbon compounds). On the other hand, temporal shifts in the bacterioplankton community composition at the surface layer were mainly connected to the seasonal succession of phytoplankton and the inflow of freshwater species. We also conclude that many relatively abundant populations are indigenous and well-established in the area.	[Laas, Peeter; Lips, Inga; Lips, Urmas] Tallinn Univ Technol, Marine Syst Inst, EE-19086 Tallinn, Estonia; [Simm, Jaak] Katholieke Univ Leuven, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Dept Elect Engn ESAT, Leuven, Belgium; [Simm, Jaak] iMinds Med IT, Leuven, Belgium; [Simm, Jaak] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia; [Kisand, Veljo] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Metsis, Madis] Univ Tartu, Inst Math & Nat Sci, EE-50090 Tartu, Estonia	Tallinn University of Technology; KU Leuven; IMEC; Tallinn University of Technology; University of Tartu; University of Tartu	Laas, P (corresponding author), Tallinn Univ Technol, Marine Syst Inst, EE-19086 Tallinn, Estonia.	peeter.laas@msi.ttu.ee	Kisand, Veljo/H-2466-2012; Lips, Inga/N-5000-2019; Lips, Urmas/F-8628-2011; Metsis, Madis/F-7080-2016; Laas, Peeter/O-1466-2019	Kisand, Veljo/0000-0002-5535-1639; Lips, Inga/0000-0001-6556-6281; Lips, Urmas/0000-0002-9823-6294; Metsis, Madis/0000-0003-1667-677X; Laas, Peeter/0000-0001-9393-9022	Estonian Ministry of Education and Research [IUT19-6]; Estonian Science Foundation [8930, 9023]; Research Council KU Leuven [GOA/10/09 MaNet, CoE PFV/10/016 SymBioSys]; Flemish Government (IOF, Hercules Stitching, iMinds Medical Information Technologies SBO); Intel, Janssen Pharmaceutica; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Science Foundation; Research Council KU Leuven(KU Leuven); Flemish Government (IOF, Hercules Stitching, iMinds Medical Information Technologies SBO); Intel, Janssen Pharmaceutica; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study was funded by the Institutional research funding IUT (IUT19-6) of the Estonian Ministry of Education and Research and by the Estonian Science Foundation grants no. 8930 and 9023. Jaak Simm was also funded by Research Council KU Leuven (GOA/10/09 MaNet, CoE PFV/10/016 SymBioSys) and PhD/Postdoc grants from Flemish Government (IOF, Hercules Stitching, iMinds Medical Information Technologies SBO 2014), by Intel, Janssen Pharmaceutica and by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenius P., 1998, BOREAL ENVIRON RES, V3, P97; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Berndmeyer C, 2013, ORG GEOCHEM, V55, P103, DOI 10.1016/j.orggeochem.2012.11.010; Brettar I, 2006, APPL ENVIRON MICROB, V72, P1364, DOI 10.1128/AEM.72.2.1364-1372.2006; Brown MV, 2014, MAR GENOM, V15, P17, DOI 10.1016/j.margen.2014.03.002; Brown MV, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.28; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Crump BC, 2007, APPL ENVIRON MICROB, V73, P6802, DOI 10.1128/AEM.00648-07; DETMER AE, 1993, MAR ECOL PROG SER, V99, P197, DOI 10.3354/meps099197; Eckert EM, 2012, ENVIRON MICROBIOL, V14, P794, DOI 10.1111/j.1462-2920.2011.02639.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eiler A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00140; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Funkey CP, 2014, ENVIRON SCI TECHNOL, V48, P2598, DOI 10.1021/es404395a; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Glaubitz S, 2013, APPL ENVIRON MICROB, V79, P2767, DOI 10.1128/AEM.03777-12; Glaubitz S, 2010, FEMS MICROBIOL ECOL, V74, P32, DOI 10.1111/j.1574-6941.2010.00944.x; Glaubitz S, 2009, ENVIRON MICROBIOL, V11, P326, DOI 10.1111/j.1462-2920.2008.01770.x; Grote J, 2007, APPL ENVIRON MICROB, V73, P7155, DOI 10.1128/AEM.00466-07; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; Grote J, 2008, APPL ENVIRON MICROB, V74, P7546, DOI 10.1128/AEM.01186-08; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Heyer J, 2002, MICROBIOL-SGM, V148, P2831, DOI 10.1099/00221287-148-9-2831; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Hubbell Stephen P., 2001, V32, pi; Itoh T, 2011, INT J SYST EVOL MICR, V61, P1281, DOI 10.1099/ijs.0.023044-0; Jakobs G, 2013, BIOGEOSCIENCES, V10, P7863, DOI 10.5194/bg-10-7863-2013; Jezbera J, 2006, ENVIRON MICROBIOL, V8, P1330, DOI 10.1111/j.1462-2920.2006.01026.x; Jones SE, 2009, ENVIRON MICROBIOL, V11, P2463, DOI 10.1111/j.1462-2920.2009.01977.x; Jones SE, 2009, ENVIRON MICROBIOL, V11, P905, DOI 10.1111/j.1462-2920.2008.01814.x; Kemp PF, 2004, LIMNOL OCEANOGR-METH, V2, P114, DOI 10.4319/lom.2004.2.114; Kisand V, 2005, LIMNOL OCEANOGR, V50, P945, DOI 10.4319/lo.2005.50.3.0945; Kisand V, 2003, APPL ENVIRON MICROB, V69, P3607, DOI 10.1128/AEM.69.6.3607-3616.2003; Koskinen K, 2011, FEMS MICROBIOL ECOL, V75, P99, DOI 10.1111/j.1574-6941.2010.00987.x; Laas P, 2014, J MARINE SYST, V129, P127, DOI 10.1016/j.jmarsys.2013.07.016; Labrenz M, 2007, AQUAT MICROB ECOL, V46, P177, DOI 10.3354/ame046177; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Langenheder S, 2012, ISME J, V6, P1107, DOI 10.1038/ismej.2011.177; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lindstrom ES, 2006, LIMNOL OCEANOGR, V51, P339, DOI 10.4319/lo.2006.51.1.0339; Lindstrom ES, 2012, ENV MICROBIOL REP, V4, P1, DOI 10.1111/j.1758-2229.2011.00257.x; Lips I, 2014, J MARINE SYST, V129, P135, DOI 10.1016/j.jmarsys.2013.06.002; Logares R, 2013, ISME J, V7, P937, DOI 10.1038/ismej.2012.168; Logue JB, 2010, ISME J, V4, P729, DOI 10.1038/ismej.2009.156; Lyra C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054326; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Ostman O, 2010, ECOL LETT, V13, P118, DOI 10.1111/j.1461-0248.2009.01413.x; Pernthaler J, 2001, APPL ENVIRON MICROB, V67, P2145, DOI 10.1128/AEM.67.5.2145-2155.2001; Pinhassi J, 2000, AQUAT MICROB ECOL, V21, P245, DOI 10.3354/ame021245; Pinhassi J, 1999, AQUAT MICROB ECOL, V17, P13, DOI 10.3354/ame017013; Pitkaenen H., 2008, V197, P285, DOI 10.1007/978-3-540-73524-3_13; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Riemann L, 2008, APPL ENVIRON MICROB, V74, P503, DOI 10.1128/AEM.01983-07; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmale O, 2012, BIOGEOSCIENCES, V9, P4969, DOI 10.5194/bg-9-4969-2012; Schmale O, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043115; Simek K, 2001, MICROB ECOL, V42, P359, DOI 10.1007/s00248-001-0014-z; Sjostedt J, 2012, APPL ENVIRON MICROB, V78, P1361, DOI 10.1128/AEM.05542-11; Sloan WT, 2006, ENVIRON MICROBIOL, V8, P732, DOI 10.1111/j.1462-2920.2005.00956.x; Smith DJ, 2013, APPL ENVIRON MICROB, V79, P1134, DOI 10.1128/AEM.03029-12; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Thureborn P, 2013, PLOS ONE, P8, DOI [10.1371/journal.pone.0074983, DOI 10.1371/J0URNAL.P0NE.0074983]; Trouwborst RE, 2006, SCIENCE, V313, P1955, DOI 10.1126/science.1132876; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Woodcock S, 2007, FEMS MICROBIOL ECOL, V62, P171, DOI 10.1111/j.1574-6941.2007.00379.x; Wright JJ, 2012, NAT REV MICROBIOL, V10, P381, DOI 10.1038/nrmicro2778; Yakushev EV, 2007, MAR CHEM, V107, P388, DOI 10.1016/j.marchem.2007.06.003; Zaikova E, 2010, ENVIRON MICROBIOL, V12, P172, DOI 10.1111/j.1462-2920.2009.02058.x	93	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122304	10.1371/journal.pone.0122304	http://dx.doi.org/10.1371/journal.pone.0122304			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860812	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300041
J	Mbonye, MK; Burnett, SM; Naikoba, S; Colebunders, R; Wouters, K; Weaver, MR; Van Geertruyden, JP				Mbonye, Martin Kayitale; Burnett, Sarah M.; Naikoba, Sarah; Colebunders, Robert; Wouters, Kristien; Weaver, Marcia R.; Van Geertruyden, Jean Pierre			Malaria Care in Infants Aged under Six Months in Uganda: An Area of Unmet Needs!	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PLASMODIUM-FALCIPARUM; AFRICAN INFANTS; CASE-MANAGEMENT; CHILDREN; ANTIMALARIALS; PRESCRIPTION; COMBINATION; CHALLENGES; ANTIBODIES	Background Little information exists on malaria burden, artemisinin-based combination therapy (ACT) use, and malaria care provided to infants under six months of age. The perception that malaria may be rare in this age group has led to lack of clinical trials and evidence-based treatment guidelines. The objective of this study was to identify malaria parasitemia positivity rate (MPPR) among patients under six months, and practices and predictors of malaria diagnosis and treatment in this population. Methods Cross-sectional data collected from October 2010 to September 2011 on 25,997 individual outpatients aged <6 months from 36 health facilities across Uganda were analysed. Findings Malaria was suspected in 18,415 (70.8%) patients, of whom 7,785 (42.3%) were tested for malaria. Of those tested, the MPPR was 36.1%, with 63.9% testing negative, of which 1,545 (31.1%) were prescribed an antimalarial. Among children <5kgs, off-label prescription of ACT was high (104/285, 36.5%). Younger age (1-6 days, aOR=0.47, p=0.01; 7-31 days, aOR=0.43, p<0.001; and 1-2 months, aOR=0.61, p<0.001), pneumonia (aOR=0.78, p=0.01) or cough/cold (aOR=0.65, p<0.001) diagnosis, and fever (aOR=0.56, p=0.01) reduced the odds of receiving a malaria test. Fever (aOR=2.22, p<0.001), anemia diagnosis (aOR=3.51, p=0.01), consulting midwives (aOR=3.58, p=0.04) and other less skilled providers (aOR=4.75, p<0.001) relative to medical officers, consulting at hospitals (aOR=3.31, p=0.03), visiting health facilities in a medium-high malaria transmission area (aOR=2.20, p<0.001), and visiting during antimalarial (aOR=1.82, p=0.04) or antibiotic (aOR=2.23, p=0.04) shortages increased the odds of prescribing an antimalarial despite a negative malaria test result. Conclusions We found high malaria suspicion but low testing rates in outpatient children aged <6 months. Among those tested, MPPR was high. Despite a negative malaria test result, many infants were prescribed antimalarials. Off-label ACT prescription was common in children weighing <5kgs. Evidence-based malaria guidelines for infants weighing <5 kilograms and aged <6 months are urgently needed.	[Mbonye, Martin Kayitale; Naikoba, Sarah] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Wouters, Kristien] Univ Antwerp Hosp, Dept Sci Coordinat & Biostat, Antwerp, Belgium; [Burnett, Sarah M.] Accordia Global Hlth Fdn, Washington, DC USA; [Mbonye, Martin Kayitale; Burnett, Sarah M.; Naikoba, Sarah; Colebunders, Robert; Van Geertruyden, Jean Pierre] Univ Antwerp, Fac Med & Hlth Sci, Unit Int Hlth, B-2020 Antwerp, Belgium; [Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Weaver, Marcia R.] Univ Washington, I TECH, Dept Global Hlth, Seattle, WA 98195 USA	Makerere University; University of Antwerp; University of Antwerp; Institute of Tropical Medicine (ITM); University of Washington; University of Washington Seattle	Mbonye, MK (corresponding author), Makerere Univ, Infect Dis Inst, Kampala, Uganda.	mbonyemarti@yahoo.com	Wouters, Kristien/ADM-4146-2022; Van geertruyden, Jean-Pierre/S-3254-2019; Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Colebunders, Robert/0000-0002-1919-1340	Bill & Melinda Gates Foundation [94298]; VLIR-UOS via the HEFS Platform Harvest Call [ZIUS2013VOA0902]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); VLIR-UOS via the HEFS Platform Harvest Call; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	IDCAP was supported through grant number 94298 to Accordia Global Health Foundation from the Bill & Melinda Gates Foundation. Preparation of this manuscript was supported by VLIR-UOS via the HEFS Platform Harvest Call (ZIUS2013VOA0902). The content expressed within this article is that of the authors and does not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation and VLIR-UOS. Both funders did not influence the study design, data collection, analysis and interpretation, the writing of this manuscript, nor the decision to submit the manuscript for publication.	Afolabi BM, 2001, AM J TROP MED HYG, V65, P822, DOI 10.4269/ajtmh.2001.65.822; [Anonymous], 2014, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0107965; [Anonymous], 2011, UN ACC MAL DIAGN TES; [Anonymous], 2003, IMPR DAT QUAL GUID D; Billig EMW, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-396; Bjorkman A, 2010, CLIN INFECT DIS, V51, P512, DOI 10.1086/655689; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; Clarke SP, 2008, PATIENT SAFETY QUALI, V2, P2; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; D'Alessandro U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-400; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Godfrey MG, 2011, OBSTET GYNAECOLOGIST, V7, P5; Gove S, 1999, ARCH DIS CHILD, V81, P473, DOI 10.1136/adc.81.6.473; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; Hamer DH, 2007, JAMA-J AM MED ASSOC, V297, P2227, DOI 10.1001/jama.297.20.2227; IHME, 2013, GBD 2010 AG SPEC MOR; Jensen TP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-213; Kane R. L., 2007, NURSE STAFFING QUALI; Kassim OO, 2000, J TROP PEDIATRICS, V46, P92, DOI 10.1093/tropej/46.2.92; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; KENGEYAKAYONDO JF, 1994, ACTA TROP, V58, P267, DOI 10.1016/0001-706X(94)90020-5; KNBS, 2010, 2010 KEN MAL IND SUR; Larru B, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-310; Macdonald G., 1950, Tropical Diseases Bulletin, V47, P915; Mbonye MK, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-165; Mbonye MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084945; Miceli A, 2012, INT J INFECT DIS, V16, pE708, DOI 10.1016/j.ijid.2012.07.003; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Mwaniki MK, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-313; Naikoba S, 2012, INT J CARE PATHWAYS, V16, P152, DOI DOI 10.1177/2040402613479342; Namagembe A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-44; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Njozi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1097; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Oladosu OO, 2012, OVERDIAGNOSIS OVERTR, V2013; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Riley EM, 2000, INFECT IMMUN, V68, P5856, DOI 10.1128/IAI.68.10.5856-5863.2000; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; Rubin DB, 1987, MULTIPLE IMPUTATION, DOI [10.1002/sim.6008, DOI 10.1002/SIM.6008]; Sears D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-252; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Stanisic DI, 2003, J IMMUNOL, V171, P5461, DOI 10.4049/jimmunol.171.10.5461; Steinhardt LC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-64; Strom GEA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-228; Thomson J G, 1935, Proc R Soc Med, V28, P391; UBOS, 2009, UG MAL IND SURV CALV; UBOS MI ME, 2007, UG CHILD VERB AUT ST; Uganda Government, 2004, HLTH SECT STRAT PLAN; Uganda Government, 2010, STAT ABSTR 2010; Uganda Government, 2010, HLTH SECT STRAT INV; Uganda Government, 2005, NAT POL MAL TREATM 2; Uganda Government, 2010, HUM RES HLTH AUD REP; vanHensbroek MB, 1996, AM J TROP MED HYG, V54, P237, DOI 10.4269/ajtmh.1996.54.237; Weaver MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103017; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, GUID TREATM MAL, DOI [10.1186/1475-2875-9-212, DOI 10.1186/1475-2875-9-212]; WHO, 2013, MAL IN INF; WHO, 2005, HLTH SYST PROF UG; WHO, 2006, WHO CHILD GROWTH STA; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004; Yeka A, 2009, LANCET INFECT DIS, V9, P448, DOI 10.1016/S1473-3099(09)70109-4; Zurovac D, 2008, TROP MED INT HEALTH, V13, P784, DOI 10.1111/j.1365-3156.2008.02072.x; Zurovac D, 2008, TROP MED INT HEALTH, V13, P99, DOI 10.1111/j.1365-3156.2007.01980.x	67	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123283	10.1371/journal.pone.0123283	http://dx.doi.org/10.1371/journal.pone.0123283			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860016	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300090
J	Bagci, E; Heijlen, M; Vergauwen, L; Hagenaars, A; Houbrechts, AM; Esguerra, CV; Blust, R; Darras, VM; Knapen, D				Bagci, Enise; Heijlen, Marjolein; Vergauwen, Lucia; Hagenaars, An; Houbrechts, Anne M.; Esguerra, Camila V.; Blust, Ronny; Darras, Veerle M.; Knapen, Dries			Deiodinase Knockdown during Early Zebrafish Development Affects Growth, Development, Energy Metabolism, Motility and Phototransduction	PLOS ONE			English	Article							TYPE-2 IODOTHYRONINE DEIODINASE; THYROID-HORMONE ACTION; EMBRYONIC-DEVELOPMENT; MUSCLE DEVELOPMENT; GLUCOSE-TOLERANCE; SKELETAL-MUSCLE; GENE-EXPRESSION; MESSENGER-RNA; STRIPED BASS; MYOSIN HEAVY	Thyroid hormone (TH) balance is essential for vertebrate development. Deiodinase type 1 (D1) and type 2 (D2) increase and deiodinase type 3 (D3) decreases local intracellular levels of T-3, the most important active TH. The role of deiodinase-mediated TH effects in early vertebrate development is only partially understood. Therefore, we investigated the role of deiodinases during early development of zebrafish until 96 hours post fertilization at the level of the transcriptome (microarray), biochemistry, morphology and physiology using morpholino (MO) knockdown. Knockdown of D1+ D2 (D1D2MO) and knockdown of D3 (D3MO) both resulted in transcriptional regulation of energy metabolism and (muscle) development in abdomen and tail, together with reduced growth, impaired swim bladder inflation, reduced protein content and reduced motility. The reduced growth and impaired swim bladder inflation in D1D2MO could be due to lower levels of T3 which is known to drive growth and development. The pronounced upregulation of a large number of transcripts coding for key proteins in ATP-producing pathways in D1D2MO could reflect a compensatory response to a decreased metabolic rate, also typically linked to hypothyroidism. Compared to D1D2MO, the effects were more pronounced or more frequent in D3MO, in which hyperthyroidism is expected. More specifically, increased heart rate, delayed hatching and increased carbohydrate content were observed only in D3MO. An increase of the metabolic rate, a decrease of the metabolic efficiency and a stimulation of gluconeogenesis using amino acids as substrates may have been involved in the observed reduced protein content, growth and motility in D3MO larvae. Furthermore, expression of transcripts involved in purine metabolism coupled to vision was decreased in both knockdown conditions, suggesting that both may impair vision. This study provides new insights, not only into the role of deiodinases, but also into the importance of a correct TH balance during vertebrate embryonic development.	[Bagci, Enise; Knapen, Dries] Univ Antwerp, Dept Biol, System Physiol & Ecotoxicol Res SPHERE, B-2020 Antwerp, Belgium; [Bagci, Enise; Vergauwen, Lucia; Hagenaars, An; Blust, Ronny; Knapen, Dries] Univ Antwerp, Dept Vet Sci, Vet Physiol & Biochem, Zebrafishlab, B-2160 Antwerp, Belgium; [Heijlen, Marjolein; Houbrechts, Anne M.; Darras, Veerle M.] Katholieke Univ Leuven, Dept Biol, Anim Physiol & Neurobiol Sect, Lab Comparat Endocrinol, B-3000 Louvain, Belgium; [Esguerra, Camila V.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, B-3000 Louvain, Belgium	University of Antwerp; University of Antwerp; KU Leuven; KU Leuven	Knapen, D (corresponding author), Univ Antwerp, Dept Biol, System Physiol & Ecotoxicol Res SPHERE, B-2020 Antwerp, Belgium.	dries.knapen@uantwerpen.be	Hagenaars, An/AAS-1914-2021; Esguerra, Camila/N-6159-2015; Vergauwen, Lucia/AAP-5933-2021	Esguerra, Camila/0000-0002-2271-8094; Vergauwen, Lucia/0000-0002-6534-7473; Knapen, Dries/0000-0003-0472-8114	FWO Research Project (Research Foundation Flanders, Fonds Wetenschappelijk Onderzoek-Vlaanderen) [G.0528.10N]; Cefic Long-range Research Initiative [LRI-ECO20-UA]; ECETOC; FWO Research Project; Cefic-LRI project; Industrial Research Fund of the KU Leuven	FWO Research Project (Research Foundation Flanders, Fonds Wetenschappelijk Onderzoek-Vlaanderen)(FWO); Cefic Long-range Research Initiative; ECETOC; FWO Research Project(FWO); Cefic-LRI project; Industrial Research Fund of the KU Leuven	This work was funded by an FWO Research Project (Research Foundation Flanders, Fonds Wetenschappelijk Onderzoek-Vlaanderen, http://www.fwo.be/) [A functional genomics study in zebrafish to elucidate the role of thyroid hormones and deiodinases in early embryonic development; G.0528.10N], and by the Cefic Long-range Research Initiative (http://www.cefic-lri.org/) [Development of an alternative testing strategy for the fish early life-stage test for predicting chronic toxicity; LRI-ECO20-UA] with support of ECETOC. Enise Bagci and Marjolein Heijlen were supported by the FWO Research Project. Lucia Vergauwen was supported by the Cefic-LRI project. Camila V. Esguerra was funded by the Industrial Research Fund of the KU Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Blanton ML, 2007, CRIT REV TOXICOL, V37, P97, DOI 10.1080/10408440601123529; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohnsack BL, 2013, DEV BIOL, V373, P300, DOI 10.1016/j.ydbio.2012.11.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CL, 1988, J EXP ZOOL, V248, P168, DOI 10.1002/jez.1402480207; BROWN CL, 1989, FISH PHYSIOL BIOCHEM, V7, P295, DOI 10.1007/BF00004720; Brown DD, 1997, P NATL ACAD SCI USA, V94, P13011, DOI 10.1073/pnas.94.24.13011; BUTLERBROWNE GS, 1990, ANAT EMBRYOL, V181, P513; Campinho MA, 2014, MOL ENDOCRINOL, V28, P1136, DOI 10.1210/me.2014-1032; Campos-Barros A, 2000, P NATL ACAD SCI USA, V97, P1287, DOI 10.1073/pnas.97.3.1287; Das B, 2002, P NATL ACAD SCI USA, V99, P12230, DOI 10.1073/pnas.182430599; De Coen WM, 2003, ENVIRON TOXICOL CHEM, V22, P1632, DOI [10.1897/1551-5028(2003)22&lt;1632:TMBLRB&gt;2.0.CO;2, 10.1002/etc.5620220727]; Dentice M, 2007, P NATL ACAD SCI USA, V104, P14466, DOI 10.1073/pnas.0706754104; Dong W, 2013, AQUAT TOXICOL, V132, P190, DOI 10.1016/j.aquatox.2013.02.008; Giordano N, 2001, CLIN EXP RHEUMATOL, V19, P661; Goglia F, 2005, BIOCHEMISTRY-MOSCOW+, V70, P164, DOI 10.1007/s10541-005-0097-0; Goglia F, 2002, BIOSCIENCE REP, V22, P17, DOI 10.1023/A:1016056905347; Guo CC, 2014, ENDOCRINOLOGY, V155, P4069, DOI 10.1210/en.2013-2029; Harpavat S, 2003, THYROID, V13, P1013, DOI 10.1089/105072503770867183; Harrison AP, 1996, BRIT J NUTR, V76, P841, DOI 10.1079/BJN19960091; Hashimoto K, 2009, ENDOCRINOLOGY, V150, P3417, DOI 10.1210/en.2009-0059; Heijlen M, 2014, ENDOCRINOLOGY, V155, P1547, DOI 10.1210/en.2013-1660; Heijlen M, 2013, GEN COMP ENDOCR, V188, P289, DOI 10.1016/j.ygcen.2013.04.004; HOLT J, 1993, INT J DEV BIOL, V37, P467; Knapen D, 2009, TRENDS BIOTECHNOL, V27, P406, DOI 10.1016/j.tibtech.2009.03.007; Kohrle J, 1999, MOL CELL ENDOCRINOL, V151, P103, DOI 10.1016/S0303-7207(99)00040-4; KREINES K, 1965, DIABETES, V14, P740, DOI 10.2337/diab.14.11.740; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lindsey BW, 2010, ZEBRAFISH, V7, P85, DOI 10.1089/zeb.2009.0616; Liu CR, 2007, J ENDOCRINOL, V195, P429, DOI 10.1677/JOE-07-0253; Liu YY, 2010, TRENDS ENDOCRIN MET, V21, P166, DOI 10.1016/j.tem.2009.11.004; Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x; MAXON HR, 1975, ARCH INTERN MED, V135, P1477, DOI 10.1001/archinte.135.11.1477; Mohn A, 2002, DIABETIC MED, V19, P70, DOI 10.1046/j.1464-5491.2002.00635.x; MORGAN HE, 1991, CIRCULATION, V83, P13, DOI 10.1161/01.CIR.83.1.13; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Oommen O. V, 2006, Journal of Endocrinology and Reproduction, V10, P96; Opitz R, 2006, TOXICOL APPL PHARM, V212, P1, DOI 10.1016/j.taap.2005.06.014; OPPENHEIMER JH, 1991, J CLIN INVEST, V87, P125, DOI 10.1172/JCI114961; Orozco A, 2005, THYROID, V15, P799, DOI 10.1089/thy.2005.15.799; Perry SF, 2001, COMP BIOCHEM PHYS A, V129, P37, DOI 10.1016/S1095-6433(01)00304-X; Potenza M, 2009, ENDOCR PRACT, V15, P254, DOI 10.4158/EP.15.3.254; Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X; REDDY PK, 1991, GEN COMP ENDOCR, V81, P484, DOI 10.1016/0016-6480(91)90176-7; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; ROE JH, 1966, ANAL BIOCHEM, V15, P245, DOI 10.1016/0003-2697(66)90028-5; Saini V, 2012, CLIN BIOCHEM, V45, P212, DOI 10.1016/j.clinbiochem.2011.10.012; Sclep G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-400; Sevilla-Romero E, 2002, OPHTHALMIC RES, V34, P181, DOI 10.1159/000063885; Shimizu Y, 2002, J VET MED SCI, V64, P677, DOI 10.1292/jvms.64.677; SINGH SP, 1978, ENDOCRINOLOGY, V102, P182, DOI 10.1210/endo-102-1-182; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Thisse C, 2003, GENE EXPR PATTERNS, V3, P525, DOI 10.1016/S1567-133X(03)00054-1; Torrance CJ, 1997, ENDOCRINOLOGY, V138, P1204, DOI 10.1210/en.138.3.1204; Vatine GD, 2013, J BIOL CHEM, V288, P169, DOI 10.1074/jbc.M112.413831; Vergauwen L, 2010, COMP BIOCHEM PHYS A, V157, P149, DOI 10.1016/j.cbpa.2010.06.160; Walpita CN, 2007, GEN COMP ENDOCR, V152, P206, DOI 10.1016/j.ygcen.2007.02.020; Walpita CN, 2010, GEN COMP ENDOCR, V166, P134, DOI 10.1016/j.ygcen.2009.09.011; Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457; Weiss RE, 1998, ENDOCRINOLOGY, V139, P4945, DOI 10.1210/en.139.12.4945; Yehuda-Shnaidman E, 2014, ENDOCR REV, V35, P35, DOI 10.1210/er.2013-1006; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	66	36	36	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123285	10.1371/journal.pone.0123285	http://dx.doi.org/10.1371/journal.pone.0123285			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855985	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500083
J	Nimdet, K; Chaiyakunapruk, N; Vichansavakul, K; Ngorsuraches, S				Nimdet, Khachapon; Chaiyakunapruk, Nathorn; Vichansavakul, Kittaya; Ngorsuraches, Surachat			A Systematic Review of Studies Eliciting Willingness-to-Pay per Quality-Adjusted Life Year: Does It Justify CE Threshold?	PLOS ONE			English	Review							COST-EFFECTIVENESS THRESHOLDS; HEALTH-STATE UTILITIES; DECISION-MAKING; OF-LIFE; CARE; OUTCOMES; QALYS; RISK; WTP	Background A number of studies have been conducted to estimate willingness to pay (WTP) per quality-adjusted life years (QALY) in patients or general population for various diseases. However, there has not been any systematic review summarizing the relationship between WTP per QALY and cost-effectiveness (CE) threshold based on World Health Organization (WHO) recommendation. Objective To systematically review willingness-to-pay per quality-adjusted-life-year (WTP per QALY) literature, to compare WTP per QALY with Cost-effectiveness (CE) threshold recommended by WHO, and to determine potential influencing factors. Methods We searched MEDLINE, EMBASE, Psyinfo, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Center of Research Dissemination (CRD), and EconLit from inception through 15 July 2014. To be included, studies have to estimate WTP per QALY in health-related issues using stated preference method. Two investigators independently reviewed each abstract, completed full-text reviews, and extracted information for included studies. We compared WTP per QALY to GDP per capita, analyzed, and summarized potential influencing factors. Results Out of 3,914 articles founded, 14 studies were included. Most studies (92.85%) used contingent valuation method, while only one study used discrete choice experiments. Sample size varied from 104 to 21,896 persons. The ratio between WTP per QALY and GDP per capita varied widely from 0.05 to 5.40, depending on scenario outcomes (e.g., whether it extended/saved life or improved quality of life), severity of hypothetical scenarios, duration of scenario, and source of funding. The average ratio of WTP per QALY and GDP per capita for extending life or saving life (2.03) was significantly higher than the average for improving quality of life (0.59) with the mean difference of 1.43 (95% CI, 1.81 to 1.06). Conclusion This systematic review provides an overview summary of all studies estimating WTP per QALY studies. The variation of ratio of WTP per QALY and GDP per capita depended on several factors may prompt discussions on the CE threshold policy. Our research work provides a foundation for defining future direction of decision criteria for an evidence-informed decision making system.	[Nimdet, Khachapon; Vichansavakul, Kittaya; Ngorsuraches, Surachat] Prince Songkla Univ, Fac Pharmaceut Sci, Hat Yai, Thailand; [Chaiyakunapruk, Nathorn] Monash Univ Malaysia, Sch Pharm, Selangor, Malaysia; [Chaiyakunapruk, Nathorn] Naresuan Univ, Fac Pharmaceut Sci, Dept Pharm Practice, Ctr Pharmaceut Outcomes Res, Phitsanulok, Thailand; [Chaiyakunapruk, Nathorn] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Chaiyakunapruk, Nathorn] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Prince of Songkla University; Monash University; Monash University Sunway; Naresuan University; University of Wisconsin System; University of Wisconsin Madison; University of Queensland	Chaiyakunapruk, N (corresponding author), Monash Univ Malaysia, Sch Pharm, Selangor, Malaysia.	nathorn.chaiyakunapruk@monash.edu		Ngorsuraches, Surachat/0000-0002-2327-224X				Appleby J, 2007, BRIT MED J, V335, P358, DOI 10.1136/bmj.39308.560069.BE; Baker R, 2011, HEALTH ECON POLICY L, V6, P435, DOI 10.1017/S1744133111000181; Bala MV, 1998, J CLIN EPIDEMIOL, V51, P667, DOI 10.1016/S0895-4356(98)00036-5; Bateman IJ, 2002, EV CALUATION STATED; Blumenschein K, 1998, ANN ALLERG ASTHMA IM, V80, P189, DOI 10.1016/S1081-1206(10)62954-7; Bobinac A, 2013, HEALTH ECON, V22, P1272, DOI 10.1002/hec.2879; Bobinac A, 2010, VALUE HEALTH, V13, P1046, DOI 10.1111/j.1524-4733.2010.00781.x; Boersma C, 2010, VALUE HEALTH, V13, P853, DOI 10.1111/j.1524-4733.2010.00736.x; Borgstrom F, 2006, OSTEOPOROSIS INT, V17, P1459, DOI 10.1007/s00198-006-0107-0; Bridges John F P, 2003, Appl Health Econ Health Policy, V2, P213; Byrne MM, 2005, MED DECIS MAKING, V25, P655, DOI 10.1177/0272989X05282638; Dolan P, 2002, J HEALTH ECON, V21, P827, DOI 10.1016/S0167-6296(02)00011-5; Donaldson C, 1999, SOC SCI MED, V49, P551, DOI 10.1016/S0277-9536(99)00173-2; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Franic DM, 2005, J CLIN EPIDEMIOL, V58, P291, DOI 10.1016/j.jclinepi.2004.10.005; Franic DM, 2012, J FLUENCY DISORD, V37, P300, DOI 10.1016/j.jfludis.2012.04.005; Gafni A, 2006, ENVIRON RESOUR ECON, V34, P407, DOI 10.1007/s10640-006-0008-x; George B, 2001, PHARMACOECONOMICS, V19, P1103, DOI 10.2165/00019053-200119110-00004; Gold MR, 1996, COST EFFECTIVENESS H; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Gyrd-Hansen D, 2003, HEALTH ECON, V12, P1049, DOI 10.1002/hec.799; Gyrd-Hansen D., 2007, ISPOR CONNECTION, V13, P5; Gyrd-Hansen D, 2012, HEALTH ECON, V21, P222, DOI 10.1002/hec.1709; Hammitt JK, 2002, RISK ANAL, V22, P985, DOI 10.1111/1539-6924.00265; Haninger K, 2011, RISK ANAL, V31, P1363, DOI 10.1111/j.1539-6924.2011.01617.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Hutton J, 1992, Health Econ, V1, P213; Institute for Health and Clinical Excellence, 2013, GUID METH TECHN APPR; Johannesson M, 1998, HEALTH ECON, V7, P1, DOI 10.1002/(SICI)1099-1050(199802)7:1<1::AID-HEC327>3.0.CO;2-U; Johnson FR, 2005, MED DECIS MAKING, V25, P607, DOI 10.1177/0272989X05283084; King JT, 2005, MED DECIS MAKING, V25, P667, DOI 10.1177/0272989X05282640; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lieu TA, 2009, PHARMACOECONOMICS, V27, P1005, DOI 10.2165/11314000-000000000-00000; Louviere JJ, 2010, J CHOICE MODEL, V3, P57; Pinto-Prades JL, 2009, J HEALTH ECON, V28, P553, DOI 10.1016/j.jhealeco.2009.02.003; Lundberg L, 1999, BRIT J DERMATOL, V141, P1067, DOI 10.1046/j.1365-2133.1999.03207.x; Mangham LJ, 2009, HEALTH POLICY PLANN, V24, P151, DOI 10.1093/heapol/czn047; Martin-Fernandez J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-287; Mason Helen, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P575, DOI 10.1586/14737167.8.6.575; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; Neumann PJ, 2000, HEALTH AFFAIR, V19, P92, DOI 10.1377/hlthaff.19.2.92; Nuijten MJC, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00029; Olsen JA, 2001, HEALTH ECON, V10, P39, DOI 10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E; OOSTERHOFF J, 1994, STAT PROBABIL LETT, V20, P401, DOI 10.1016/0167-7152(94)90132-5; Pinto-Prades JL, 2014, SOC SCI MED, V113, P5, DOI 10.1016/j.socscimed.2014.04.039; Richardson J, 2014, HEALTH ECON, V23, P792, DOI 10.1002/hec.2950; Robinson A, 2013, SOC SCI MED, V92, P92, DOI 10.1016/j.socscimed.2013.05.013; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Shiroiwa Takeru, 2013, Cost Eff Resour Alloc, V11, P22, DOI 10.1186/1478-7547-11-22; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Thavorncharoensap M, 2013, CLINICOECONOMIC OUTC, V5, P29, DOI 10.2147/CEOR.S38062; The World Bank, OFF EXCH RAT LCU PER; Tolbert DV, 2014, AM J IND MED, V57, P757, DOI 10.1002/ajim.22322; Weinstein MC, 2008, MED CARE, V46, P343, DOI 10.1097/MLR.0b013e31816a7144; World Bank, GDP PER CAP CURR US; World Health Organization, CHOOS INT ARE COST E; World Health Organization, 2001, MACR HLTH INV HLTH E; Zethraeus N, 1998, HEALTH ECON, V7, P31, DOI 10.1002/(SICI)1099-1050(199802)7:1<31::AID-HEC316>3.0.CO;2-7; Zhao FL, 2010, VALUE HEALTH, V13, pA538, DOI 10.1016/S1098-3015(11)73237-5	60	62	63	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122760	10.1371/journal.pone.0122760	http://dx.doi.org/10.1371/journal.pone.0122760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25855971	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500055
J	Sun, Y; Xu, F; Zhang, T; Liu, ML; Wang, DY; Chen, YL; Liu, Q				Sun, Yuan; Xu, Fan; Zhang, Ting; Liu, Manli; Wang, Danyang; Chen, Yile; Liu, Quan			Orthokeratology to Control Myopia Progression: A Meta-Analysis	PLOS ONE			English	Article							CHILDHOOD MYOPIA; CONTACT-LENSES; OPHTHALMOLOGY; PREVALENCE; ATROPINE; CHILDREN; SAFETY	Objective To evaluate the clinical treatment effects of orthokeratology to slow the progression of myopia. Methods Several well-designed controlled studies have investigated the effects of orthokeratology in school-aged children. We conducted this meta-analysis to better evaluate the existing evidence. Relevant studies were identified in the Medline and Embase database without language limitations. The main outcomes included axial length and vitreous chamber depth reported as the mean +/- standard deviation. The results were pooled and assessed with a fixed-effects model analysis. Subgroup analyses were performed according to geographical location and study design. Results Of the seven eligible studies, all reported axial length changes after 2 years, while two studies reported vitreous chamber depth changes. The pooled estimates indicated that change in axial length in the ortho-k group was 0.27 mm (95% confidence interval [CI]: 0.22, 0.32) less than the control group. Myopic progression was reduced by approximately 45%. The combined results revealed that the difference in vitreous chamber depth between the two groups was 0.22 mm (95% confidence interval [CI]: 0.14, 0.31). None of the studies reported severe adverse events. Conclusion The overall findings suggest that ortho-k can slow myopia progression in school-aged children.	[Sun, Yuan; Xu, Fan; Zhang, Ting; Liu, Manli; Wang, Danyang; Chen, Yile; Liu, Quan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Fan] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Ophthalmol, Nanning, Guangxi Provinc, Peoples R China	Sun Yat Sen University	Liu, Q (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	drliuquan@163.com			Natural Science Foundation of China [81261130021]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grants from the Natural Science Foundation of China (81261130021). The URL is http://isisn.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charm J, 2013, OPTOMETRY VISION SCI, V90, P530, DOI 10.1097/OPX.0b013e318293657d; Chen CN, 2013, INVEST OPHTH VIS SCI, V54, P6510, DOI 10.1167/iovs.13-12527; Chen Z, 2012, OPTOMETRY VISION SCI, V89, P1636, DOI 10.1097/OPX.0b013e31826c1831; Cheung SW, 2013, INVEST OPHTH VIS SCI, V54, P1613, DOI 10.1167/iovs.12-10434; Chia A, 2012, OPHTHALMOLOGY, V119, P347, DOI 10.1016/j.ophtha.2011.07.031; Cho P, 2005, CURR EYE RES, V30, P71, DOI 10.1080/02713680590907256; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; Chua WH, 2006, OPHTHALMOLOGY, V113, P2285, DOI 10.1016/j.ophtha.2006.05.062; Guyatt G, 2011, J CLIN EPIDEMIOL, V64, P383, DOI 10.1016/j.jclinepi.2010.04.026; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jessen GN., 1962, CONTACTO, V6, P200; Kakita T, 2011, INVEST OPHTH VIS SCI, V52, P2170, DOI 10.1167/iovs.10-5485; Koffler BH, 2013, AM J OPHTHALMOL, V156, P1076, DOI 10.1016/j.ajo.2013.04.039; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Santodomingo-Rubido J, 2012, INVEST OPHTH VIS SCI, V53, P5060, DOI 10.1167/iovs.11-8005; Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x; Swarbrick HA, 1998, OPTOMETRY VISION SCI, V75, P791, DOI 10.1097/00006324-199811000-00019; Van Meter WS, 2008, OPHTHALMOLOGY, V115, P2301, DOI 10.1016/j.ophtha.2008.06.034; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Walline JJ, 2009, BRIT J OPHTHALMOL, V93, P1181, DOI 10.1136/bjo.2008.151365; Walline JJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004916.pub3	24	90	101	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124535	10.1371/journal.pone.0124535	http://dx.doi.org/10.1371/journal.pone.0124535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855979	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500118
J	Sung, JE				Sung, Jee Eun			Age-Related Changes in Sentence Production Abilities and Their Relation to Working-Memory Capacity: Evidence from a Verb-Final Language	PLOS ONE			English	Article							WORD-ORDER; COMPREHENSION	Objectives This study investigated the best predictor to capture age-related changes in passive-sentence production using a constrained sentence-production paradigm and explored the role of working-memory capacity in relation to the task demands of the sentence-production tasks. Methods A total of 60 participants participated in the study ranging in age from 21 to 86. All were administered a syntactic-priming and a sentence-completion task under either canonical or noncanonical word-order conditions. Results Age was significantly and negatively correlated with sentence-production tasks, and the most demanding condition with a noncanonical word order under the syntactic priming paradigm was the best predictor of aging. Working-memory capacity was significantly and positively correlated with all conditions, but the significant correlation remained only for the most demanding condition (the priming task with a noncanonical word order) after controlling for age. Discussion Sentence-production abilities were vulnerable to aging, and these effects manifested most clearly when the task demands were high enough to tax individuals' cognitive capacity. Working-memory capacity partially accounted for age-related changes in sentence-production abilities.	Ewha Womans Univ, Dept Commun Disorders, Seoul, South Korea	Ewha Womans University	Sung, JE (corresponding author), Ewha Womans Univ, Dept Commun Disorders, Seoul, South Korea.	jeesung@ewha.ac.kr			National Research Foundation of Korea Grant - Korean Government [NRF-2014-S1A5A8018080]; EWHA Womans University EWHA Global Top 5 Grant	National Research Foundation of Korea Grant - Korean Government; EWHA Womans University EWHA Global Top 5 Grant	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2014-S1A5A8018080); EWHA Womans University under 2012 EWHA Global Top 5 Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann LJP, 2006, LANG COGNITIVE PROC, V21, P322, DOI 10.1080/0169096054400006; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; Bock K, 2000, J EXP PSYCHOL GEN, V129, P177, DOI 10.1037//0096-3445.129.2.177; BOCK K, 1990, COGNITION, V35, P1, DOI 10.1016/0010-0277(90)90035-I; Bornkessel I, 2002, COGNITION, V85, pB21, DOI 10.1016/S0010-0277(02)00076-8; Cho S, 2002, J CHILD LANG, V29, P897, DOI 10.1017/S0305000902005317; Cho SW, 1981, THESIS U CALGARY CAN; Chung GyeongheeNo, 1994, THESIS U TEXAS AUSTI; DAVIS GA, 1989, J SPEECH HEAR RES, V32, P143, DOI 10.1044/jshr.3201.143; DeDe G, 2004, PSYCHOL AGING, V19, P601, DOI 10.1037/0882-7974.19.4.601; Fanselow G, 2000, CONSTRAINTS LANGUAGE, P171; Fiebach CJ, 2001, J PSYCHOLINGUIST RES, V30, P321, DOI 10.1023/A:1010447102554; Hagiwara H, 2007, J COGNITIVE NEUROSCI, V19, P175, DOI 10.1162/jocn.2007.19.2.175; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kang Yeonwook, 2006, [Korean Journal of Psychology: General, 한국심리학회지:일반], V25, P1; Kemper S, 2001, PSYCHOL AGING, V16, P600, DOI 10.1037//0882-7974.16.4.600; Kemper S, 2004, J GERONTOL B-PSYCHOL, V59, P220, DOI [10.1093/geronb/59.5.P220, DOI 10.1093/GERONB/59.5.P220]; Kemper S., 2001, HDB PSYCHOL AGING, V5th, P378; Kemper S, PSYCH SOC NEW ORL LA; Kemper S, 2003, J GERONTOL B-PSYCHOL, V58, P260, DOI [10.1093/geronb/58.5.P260, DOI 10.1093/GERONB/58.5.P260]; Kemper S, 2006, J GERONTOL B-PSYCHOL, V61, pP327, DOI 10.1093/geronb/61.6.P327; Kemtes KA, 1997, PSYCHOL AGING, V12, P362, DOI 10.1037/0882-7974.12.2.362; Kim Seongchan., 1995, LANG RES, V31, P687; Light L. L., 1990, HDB PSYCHOL AGING, P275, DOI [DOI 10.1016/B978-0-12-101280-9.50022-X, 10.1016/b978-0-12-101280-9. 50022-x]; Martin S.E., 1992, ACID DREAMS COMPLETE; MORRIS RG, 1988, MEM COGNITION, V16, P362, DOI 10.3758/BF03197047; No G, 2009, HDB E ASIAN PSYCHOLI, P50; NORMAN S, 1991, J GERONTOL, V46, pP346, DOI 10.1093/geronj/46.6.P346; OBLER LK, 1991, APPL PSYCHOLINGUIST, V12, P433, DOI 10.1017/S0142716400005865; Park S, 2005, THESIS CORNELL U ITH; Perfect TJ, 2000, DEBATES PSYCHOL, P1; Rochon E, 2000, J SPEECH LANG HEAR R, V43, P395, DOI 10.1044/jslhr.4302.395; Segaert K, 2013, BRAIN LANG, V124, P174, DOI 10.1016/j.bandl.2012.12.003; Sung JE, 2011, COMMUN SCI DISORD-CS, V16, P185; Waters G, 2005, MEMORY, V13, P403, DOI 10.1080/09658210344000459; Waters GS, 2003, BEHAV RES METH INS C, V35, P550, DOI 10.3758/BF03195534; WATERS GS, 1995, COGN NEUROPSYCHOL, V12, P1, DOI 10.1080/02643299508251990; Waters GS, 2001, PSYCHOL AGING, V16, P128, DOI 10.1037/0882-7974.16.1.128; Yeom TH, 1992, A MANUAL FOR K WAIS	40	22	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119424	10.1371/journal.pone.0119424	http://dx.doi.org/10.1371/journal.pone.0119424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856161	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500008
J	Yin, HY; Ben-Abu, Y; Wang, HW; Li, AF; Nevo, E; Kong, LR				Yin, Huayan; Ben-Abu, Yuval; Wang, Hongwei; Li, Anfei; Nevo, Eviatar; Kong, Lingrang			Natural Selection Causes Adaptive Genetic Resistance in Wild Emmer Wheat against Powdery Mildew at "Evolution Canyon" Microsite, Mt. Carmel, Israel	PLOS ONE			English	Article							CHROMOSOMAL LOCATION; TRITICUM-DICOCCOIDES; HORDEUM-SPONTANEUM; ECOLOGICAL STRESS; COMMON WHEAT; BARLEY; DIVERSITY; MICROSATELLITES; HISTORY	Background "Evolution Canyon" (ECI) at Lower Nahal Oren, Mount Carmel, Israel, is an optimal natural microscale model for unraveling evolution in action highlighting the basic evolutionary processes of adaptation and speciation. A major model organism in ECI is wild emmer, Triticum dicoccoides, the progenitor of cultivated wheat, which displays dramatic interslope adaptive and speciational divergence on the tropical-xeric "African" slope (AS) and the temperate-mesic "European" slope (ES), separated on average by 250 m. Methods We examined 278 single sequence repeats (SSRs) and the phenotype diversity of the resistance to powdery mildew between the opposite slopes. Furthermore, 18 phenotypes on the AS and 20 phenotypes on the ES, were inoculated by both Bgt E09 and a mixture of powdery mildew races. Results In the experiment of genetic diversity, very little polymorphism was identified intra-slope in the accessions from both the AS or ES. By contrast, 148 pairs of SSR primers (53.23%) amplified polymorphic products between the phenotypes of AS and ES. There are some differences between the two wild emmer wheat genomes and the inter-slope SSR polymorphic products between genome A and B. Interestingly, all wild emmer types growing on the south-facing slope (SFS=AS) were susceptible to a composite of Blumeria graminis, while the ones growing on the north-facing slope (NFS=ES) were highly resistant to Blumeria graminis at both seedling and adult stages. Conclusion/Significance Remarkable inter-slope evolutionary divergent processes occur in wild emmer wheat, T. dicoccoidesat EC I, despite the shot average distance of 250 meters. The AS, a dry and hot slope, did not develop resistance to powdery mildew, whereas the ES, a cool and humid slope, did develop resistance since the disease stress was strong there. This is a remarkable demonstration in host-pathogen interaction on how resistance develops when stress causes an adaptive result at a micro-scale distance.	[Yin, Huayan; Wang, Hongwei; Li, Anfei; Kong, Lingrang] Shandong Agr Univ, State Key Lab Crop Biol, Shandong Key Lab Crop Biol, Coll Agron, Tai An 271018, Shandong, Peoples R China; [Ben-Abu, Yuval] Sapir Acad Coll, Projects & Phys Sect, IL-79165 Dn Hof Ashkelon, Israel; [Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-3498838 Haifa, Israel	Shandong Agricultural University; University of Haifa	Nevo, E (corresponding author), Univ Haifa, Inst Evolut, 199 Aba Khoushy Ave, IL-3498838 Haifa, Israel.	nevo@research.haifa.ac.il; lkong@sdau.edu.cn	Abu, Yuval Ben/AAD-1402-2020	Wang, Hongwei/0000-0002-6611-7813	Ancell-Teicher Research Foundation of Genetics and Molecular Evolution; National Natural Science Foundation of China (NSFC) [31471488]; 973 developmental program [2014CB138100]; Advanced Seed Engineering Project of Shandong Province	Ancell-Teicher Research Foundation of Genetics and Molecular Evolution; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 developmental program(National Basic Research Program of China); Advanced Seed Engineering Project of Shandong Province	This study was funded by Ancell-Teicher Research Foundation of Genetics and Molecular Evolution, National Natural Science Foundation of China (NSFC) (31471488), 973 developmental program (2014CB138100) and Advanced Seed Engineering Project of Shandong Province provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-David R, 2010, THEOR APPL GENET, V121, P499, DOI 10.1007/s00122-010-1326-5; Chen XM, 2005, PLANT BREEDING, V124, P225, DOI 10.1111/j.1439-0523.2005.01094.x; Cronin JK, 2007, P NATL ACAD SCI USA, V104, P2773, DOI 10.1073/pnas.0611226104; Dvorak J, 2005, GENETICS, V171, P323, DOI 10.1534/genetics.105.041632; Ganal Martin W., 2007, P1, DOI 10.1007/978-1-4020-6297-1_1; Gupta PK, 2002, THEOR APPL GENET, V104, P473, DOI 10.1007/s001220100690; Hua W, 2009, THEOR APPL GENET, V119, P223, DOI 10.1007/s00122-009-1031-4; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Inda LA, 2008, MOL PHYLOGENET EVOL, V46, P932, DOI 10.1016/j.ympev.2007.11.022; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; KASHI Y, 1999, MICROSATELLITES EVOL, P10; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; King DG, 1999, EVOLUTIONARY THEORY AND PROCESSES: MODERN PERSPECTIVES, P65; Korol A, 2006, ISR J ECOL EVOL, V52, P507, DOI 10.1560/IJEE_52_3-4_507; Li GQ, 2009, THEOR APPL GENET, V119, P531, DOI 10.1007/s00122-009-1061-y; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2003, HEREDITY, V90, P150, DOI 10.1038/sj.hdy.6800190; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Li YC, 1998, BARLEY GENETICS NEWS, V28, P58; Liu ZY, 2002, EUPHYTICA, V123, P21, DOI 10.1023/A:1014471113511; McIntosh R. A., 2007, CATALOGUE GENE SYMBO; Mohler V, 2005, EUPHYTICA, V142, P161, DOI 10.1007/s10681-005-1251-x; MOSEMAN JG, 1984, EUPHYTICA, V33, P41, DOI 10.1007/BF00022748; Nevo E, 2005, BIOL J LINN SOC, V84, P205, DOI 10.1111/j.1095-8312.2005.00425.x; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, HEREDITY, V78, P373, DOI 10.1038/hdy.1997.60; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 2004, DYNAMICAL GENETICS, V81, P7736; Nevo E, 2014, ISRAEL J EC IN PRESS; NEVO E, 2002, TRITICUM DICOCCOIDES, P364; Nevo E., 2009, TRENDS EVOL BIOL, V1, P3; Nevo E, 2006, ISR J PLANT SCI, V54, P1, DOI 10.1560/G56R-340J-5624-015N; Nevo E, 2014, J SYST EVOL, V52, P673, DOI 10.1111/jse.12124; Nevo E, 2012, P NATL ACAD SCI USA, V109, P2960, DOI 10.1073/pnas.1120633109; Owuor ED, 1997, MOL ECOL, V6, P1177, DOI 10.1046/j.1365-294X.1997.00296.x; READER SM, 1991, EUPHYTICA, V53, P57, DOI 10.1007/BF00032033; Roder MS, 1998, GENETICS, V149, P2007; Rong JK, 2000, EUPHYTICA, V115, P121, DOI 10.1023/A:1003950431049; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Urban K., 2011, ADV GENETIC RES, P67; Xie WL, 2008, EUPHYTICA, V164, P603, DOI 10.1007/s10681-008-9703-8; Xie WL, 2012, THEOR APPL GENET, V124, P911, DOI 10.1007/s00122-011-1756-8; Yang ZJ, 2009, MOL ECOL, V18, P2063, DOI 10.1111/j.1365-294X.2009.04140.x	44	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122344	10.1371/journal.pone.0122344	http://dx.doi.org/10.1371/journal.pone.0122344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856164	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500036
J	Alam, N; Hajizadeh, M; Dumont, A; Fournier, P				Alam, Nazmul; Hajizadeh, Mohammad; Dumont, Alexandre; Fournier, Pierre			Inequalities in Maternal Health Care Utilization in Sub-Saharan African Countries: A Multiyear and Multi-Country Analysis	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; SERVICES; MORTALITY; ACCESS; BARRIERS; INTERVENTIONS; DETERMINANTS; INEQUITIES; BANGLADESH; SURVIVAL	To assess social inequalities in the use of antenatal care (ANC), facility based delivery (FBD), and modern contraception (MC) in two contrasting groups of countries in sub-Saharan Africa divided based on their progress towards maternal mortality reduction. Six countries were included in this study. Three countries (Ethiopia, Madagascar, and Uganda) had <350 MMR in 2010 with >4.5% average annual reduction rate while another three (Cameroon, Zambia, and Zimbabwe) had >550 MMR in 2010 with only <1.5% average annual reduction rate. All of these countries had at least three rounds of Demographic and Health Surveys (DHS) before 2012. We measured rate ratios and differences, as well as relative and absolute concentration indices in order to examine within-country geographical and wealth-based inequalities in the utilization of ANC, FBD, and MC. In the countries which have made sufficient progress (i.e. Ethiopia, Madagascar, and Uganda), ANC use increased by 8.7, 9.3 and 5.7 percent, respectively, while the utilization of FBD increased by 4.7, 0.7 and 20.2 percent, respectively, over the last decade. By contrast, utilization of these services either plateaued or decreased in countries which did not make progress towards reducing maternal mortality, with the exception of Cameroon. Utilization of MC increased in all six countries but remained very low, with a high of 40.5% in Zimbabwe and low of 16.1% in Cameroon as of 2011. In general, relative measures of inequalities were found to have declined overtime in countries making progress towards reducing maternal mortality. In countries with insufficient progress towards maternal mortality reduction, these indicators remained stagnant or increased. Absolute measures for geographical and wealth-based inequalities remained high invariably in all six countries. The increasing trend in the utilization of maternal care services was found to concur with a steady decline in maternal mortality. Relative inequality declined overtime in countries which made progress towards reducing maternal mortality.	[Alam, Nazmul; Fournier, Pierre] Univ Montreal Hosp CR CHUM, Res Ctr, Montreal, PQ, Canada; [Alam, Nazmul; Fournier, Pierre] Univ Montreal, Sch Publ Hlth, Montreal, PQ, Canada; [Hajizadeh, Mohammad] Dalhousie Univ, Sch Hlth Adm, Halifax, NS, Canada; [Dumont, Alexandre] Univ Paris 05, Inst Dev Res, Paris, France	Universite de Montreal; Dalhousie University; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Alam, N (corresponding author), Univ Montreal Hosp CR CHUM, Res Ctr, Montreal, PQ, Canada.	nazmul.alam@umontreal.ca	Dumont, Alexandre/I-9429-2016	Dumont, Alexandre/0000-0003-3826-0193; Hajizadeh, Mohammad/0000-0002-4591-8531; Alam, Nazmul/0000-0001-6119-8178				Abdool Karim Q, 2010, LANCET, V375, P1948, DOI 10.1016/S0140-6736(10)60747-7; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Ahmed S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011190; Alfonso YN, 2013, HLTH POLICY PLANNING; Ali AAA, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-67; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; Arsenault C, 2013, B WORLD HEALTH ORGAN, V91, P207, DOI 10.2471/BLT.12.108969; Bank W., 2013, WORLS DEV INDICATORS; Birmeta K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-256; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Chakraborty N, 2003, HEALTH PROMOT INT, V18, P327, DOI 10.1093/heapro/dag414; Choulagai B, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-49; Chowdhury AMR, 2013, LANCET, V382, P1734, DOI 10.1016/S0140-6736(13)62148-0; CLELAND JG, 1988, SOC SCI MED, V27, P1357, DOI 10.1016/0277-9536(88)90201-8; Colbourn T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004150; Colvin CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108150; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; Dingle A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-51; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; Hajizadeh M, 2014, INT J EQUITY HEALTH, V13, DOI [10.1186/s12939-014-0120-4, 10.1186/1475-9276-13-18]; Hofman JJ, 2008, INT J GYNECOL OBSTET, V102, P191, DOI 10.1016/j.ijgo.2008.04.001; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Hulton LA, 2007, SOC SCI MED, V64, P2083, DOI 10.1016/j.socscimed.2007.01.019; Landes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047337; Letamo G, 2003, J HEALTH POPUL NUTR, V21, P40; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Alvarez JL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-462; Mohanty SK, 2009, J BIOSOC SCI, V41, P381, DOI 10.1017/S002193200800309X; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Nguyen HTH, 2012, SOC SCI MED, V74, P989, DOI 10.1016/j.socscimed.2011.11.030; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Prata N, 2010, WOMENS HEALTH, V6, P311, DOI 10.2217/WHE.10.8; Rahman MH, 2008, J BIOSOC SCI, V40, P19, DOI 10.1017/S0021932007002258; Ridde V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033082; Ronsmans C, 2003, TROP MED INT HEALTH, V8, P940, DOI 10.1046/j.1365-3156.2003.01111.x; Rutstein SO, 2004, DHS COMP REPORTS, V6; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Shrestha S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093029; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P993, DOI 10.1111/tmi.12121; Tey NP, 2013, SCI WORLD J, DOI 10.1155/2013/423403; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; Wagstaff A, 2005, HEALTH ECON, V14, P429, DOI 10.1002/hec.953; World Bank, 2000, WORLD DEV IND 2000; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Zere E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-252; Zere E, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-16	51	63	63	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120922	10.1371/journal.pone.0120922	http://dx.doi.org/10.1371/journal.pone.0120922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853423	Green Published, gold			2022-12-27	WOS:000352478400023
J	Burzynska, AZ; Wong, CN; Voss, MW; Cooke, GE; McAuley, E; Kramer, AF				Burzynska, Agnieszka Z.; Wong, Chelsea N.; Voss, Michelle W.; Cooke, Gillian E.; McAuley, Edward; Kramer, Arthur F.			White Matter Integrity Supports BOLD Signal Variability and Cognitive Performance in the Aging Human Brain	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; DEFAULT MODE NETWORK; EPISODIC MEMORY; PHYSIOLOGICAL NOISE; VOXELWISE ANALYSIS; AGE; DIFFUSION; FMRI; ABILITIES; WORKING	Decline in cognitive performance in old age is linked to both suboptimal neural processing in grey matter (GM) and reduced integrity of white matter (WM), but the whole-brain structure-function-cognition associations remain poorly understood. Here we apply a novel measure of GM processing-moment-to-moment variability in the blood oxygenation level-dependent signal (SDBOLD)-to study the associations between GM function during resting state, performance on four main cognitive domains (i.e., fluid intelligence, perceptual speed, episodic memory, vocabulary), and WM microstructural integrity in 91 healthy older adults (aged 60-80 years). We modeled the relations between whole-GM SDBOLD with cognitive performance using multivariate partial least squares analysis. We found that greater SDBOLD was associated with better fluid abilities and memory. Most of regions showing behaviorally relevant SDBOLD (e.g., precuneus and insula) were localized to inter-or intra-network "hubs" that connect and integrate segregated functional domains in the brain. Our results suggest that optimal dynamic range of neural processing in hub regions may support cognitive operations that specifically rely on the most flexible neural processing and complex cross-talk between different brain networks. Finally, we demonstrated that older adults with greater WM integrity in all major WM tracts had also greater SDBOLD and better performance on tests of memory and fluid abilities. We conclude that SDBOLD is a promising functional neural correlate of individual differences in cognition in healthy older adults and is supported by overall WM integrity.	[Burzynska, Agnieszka Z.; Wong, Chelsea N.; Cooke, Gillian E.; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Voss, Michelle W.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Iowa; University of Illinois System; University of Illinois Urbana-Champaign	Burzynska, AZ (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, 405 N Mathews Ave, Urbana, IL 61801 USA.	agaburza@illinois.edu	burzynska, agnieszka/ACX-5166-2022; Kramer, Arthur/AAB-2937-2019	Kramer, Arthur/0000-0001-5870-2724	National Institute on Aging (NIA) grant [R37-AG025667]; Abbott Nutrition through Center of Nutrition, Learning and Memory at the University of Illinois; "Changing Viewpoints" grant from Robert Bosch Foundation; NATIONAL INSTITUTE ON AGING [R37AG025667] Funding Source: NIH RePORTER	National Institute on Aging (NIA) grant; Abbott Nutrition through Center of Nutrition, Learning and Memory at the University of Illinois; "Changing Viewpoints" grant from Robert Bosch Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (NIA) grant (R37-AG025667) and a grant from Abbott Nutrition through the Center of Nutrition, Learning and Memory at the University of Illinois. AZB was supported by the "Changing Viewpoints" grant from the Robert Bosch Foundation.	Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bennett G.K., 1997, DIFFERENTIAL APTITUD; Birn RM, 2012, NEUROIMAGE, V62, P864, DOI 10.1016/j.neuroimage.2012.01.016; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Birren JE., 2006, HDB PSYCHOL AGING, V6th; Borghesani PR, 2013, NEUROPSYCHOLOGIA, V51, P1435, DOI 10.1016/j.neuropsychologia.2013.03.005; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Burzynska AZ, 2013, J NEUROSCI, V 33, P17150, DOI 10.1523/JNEUROSCI.1426-13.2013; Burzynska AZ, 2011, CEREB CORTEX; Burzynska AZ, 2011, HUM BRAIN MAPP; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Cavanaugh J.C., 2006, ADULT DEV AGING; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Charlton RA, 2010, NEUROPSYCHOLOGIA, V48, P114, DOI 10.1016/j.neuropsychologia.2009.08.018; Charlton RA, 2013, PSYCHOL AGING, V28, P768, DOI 10.1037/a0032668; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Craik FIM, 2000, HDB AGING COGNITION; de Munck JC, 2008, NEUROIMAGE, V42, P112, DOI 10.1016/j.neuroimage.2008.04.244; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Ekstrom R.B., 1976, MANUAL KIT FACTOR RE; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Garrett DD, 2013, CEREB CORTEX; Garrett DD, 2013, CEREB CORTEX, V23, P684, DOI 10.1093/cercor/bhs055; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Garrett DD, 2010, J NEUROSCI, V30, P4914, DOI 10.1523/JNEUROSCI.5166-09.2010; Ghosh A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000196; Grady CL, 2014, BRAIN IMAGING BEHAV, V8, P274, DOI 10.1007/s11682-013-9253-0; Grayson DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088297; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Haasz J, 2013, NEUROIMAGE, V83, P372, DOI 10.1016/j.neuroimage.2013.06.040; Hafkemeijer A, 2012, BBA-MOL BASIS DIS, V1822, P431, DOI 10.1016/j.bbadis.2011.07.008; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Joyce KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012200; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; Lockhart SN, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00056; Madden DJ, 2012, BBA-MOL BASIS DIS, V1822, P386, DOI 10.1016/j.bbadis.2011.08.003; McIntosh AR, 2010, ARCH ITAL BIOL, V148, P323; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Metzler-Baddeley C, 2011, J NEUROSCI, V31, P13236, DOI 10.1523/JNEUROSCI.2317-11.2011; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Raven J., 1962, ADV PROGR MATRICES S; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2004, INTELLIGENCE, V32, P541, DOI 10.1016/j.intell.2004.07.003; Salthouse TA, 1996, NEUROPSYCHOLOGY, V10, P272, DOI 10.1037/0894-4105.10.2.272; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Salthouse TA, 1993, J GERONTOL, V48; Salthouse TA, 2011, PSYCHOL BULL, V137, P753, DOI 10.1037/a0023262; Salthouse TA, 2010, NEUROPSYCHOLOGY, V24, P563, DOI 10.1037/a0019026; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Woodcock R. W., 1990, WOODCOCK JOHNSON PSY; Zachary R, 1986, SHIPLEY I LIVING SCA; Zhu Z, 2013, CEREB CORTEX, DOI 10.1093/cercor/bht212; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	86	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120315	10.1371/journal.pone.0120315	http://dx.doi.org/10.1371/journal.pone.0120315			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853882	gold, Green Submitted, Green Published			2022-12-27	WOS:000352478400012
J	Campanozzi, A; Avallone, S; Barbato, A; Iacone, R; Russo, O; De Filippo, G; D'Angelo, G; Pensabene, L; Malamisura, B; Cecere, G; Micillo, M; Francavilla, R; Tetro, A; Lombardi, G; Tonelli, L; Castellucci, G; Ferraro, L; Di Biase, R; Lezo, A; Salvatore, S; Paoletti, S; Siani, A; Galeone, D; Strazzullo, P				Campanozzi, Angelo; Avallone, Sonia; Barbato, Antonio; Iacone, Roberto; Russo, Ornella; De Filippo, Gianpaolo; D'Angelo, Giuseppina; Pensabene, Licia; Malamisura, Basilio; Cecere, Gaetano; Micillo, Maria; Francavilla, Ruggiero; Tetro, Anna; Lombardi, Giuliano; Tonelli, Lisa; Castellucci, Giuseppe; Ferraro, Luigi; Di Biase, Rita; Lezo, Antonella; Salvatore, Silvia; Paoletti, Silvia; Siani, Alfonso; Galeone, Daniela; Strazzullo, Pasquale		MINISAL-GIRCSI Program Study Grp	High Sodium and Low Potassium Intake among Italian Children: Relationship with Age, Body Mass and Blood Pressure	PLOS ONE			English	Article							DIETARY SALT INTAKE; CARDIOVASCULAR-DISEASE; METAANALYSIS; EXCRETION; CONSUMPTION; ADOLESCENTS; OBESITY; STROKE	Background Hypertension is the leading cause of death in developed countries and reduction of salt intake is recommended as a key preventive measure. Objective To assess the dietary sodium and potassium intakes in a national sample of Italian children and adolescents and to examine their relationships with BMI and blood pressure (BP) in the framework of the MINISAL survey, a program supported by the Italian Ministry of Health. Population and Methods The study population included 1424 healthy subjects (766 boys, 658 girls) aged 6-18 years (mean age: 10.1 +/- 2.9) who were consecutively recruited in participating National Health Service centers in 10 Italian regions. Electrolyte intake was estimated from 24 hour urine collections tested for completeness by the concomitant measurement of creatinine content. Anthropometric indices and BP were measured with standardized procedures. Results The average estimated sodium intake was 129 mmol (7.4 g of salt) per day among boys and 117 mmol (6.7 g of salt) among girls. Ninety-three percent of the boys and 89% of the girls had a consumption higher than the recommended age-specific standard dietary target. The estimated average daily potassium intakes were 39 mmol (1.53 g) and 36 mmol (1.40 g), respectively, over 96% of the boys and 98% of the girls having a potassium intake lower than the recommended adequate intake. The mean sodium/potassium ratio was similar among boys and girls (3.5 and 3.4, respectively) and over 3-fold greater than the desirable level. Sodium intake was directly related to age, body mass and BP in the whole population. Conclusions The Italian pediatric population is characterized by excessive sodium and deficient potassium intake. These data suggest that future campaigns should focus on children and adolescents as a major target in the framework of a population strategy of cardiovascular prevention.	[Campanozzi, Angelo; D'Angelo, Giuseppina] Univ Foggia, Pediat, Foggia, Italy; [Avallone, Sonia; Barbato, Antonio; Iacone, Roberto; Russo, Ornella; De Filippo, Gianpaolo; Strazzullo, Pasquale] Univ Naples Federico II, Sch Med, ESH Excellence Ctr Hypertens, Dept Clin Med & Surg, Naples, Italy; [De Filippo, Gianpaolo] Hop Bicetre, AP HP, Serv Endocrinol & Diabetol Pediat, Le Kremlin Bicetre, France; [Pensabene, Licia] Magna Graecia Univ Catanzaro, Pediat, Catanzaro, Italy; [Malamisura, Basilio] Pediat Hosp Cava Tirreni SA, Ancona, Italy; [Cecere, Gaetano; Micillo, Maria] ASL Naples, Pediat, Naples, Italy; [Francavilla, Ruggiero] Univ Bari, Pediat, Bari, Italy; [Tetro, Anna] San Paolo Hosp, Pediat, Bari, Italy; [Lombardi, Giuliano] Santo Spirito Hosp, Pediat, Pescara, Italy; [Tonelli, Lisa] Univ Marche, Pediat, Ancona, Italy; [Castellucci, Giuseppe; Ferraro, Luigi] ASL Umbria, Pediat, Perugia, Italy; [Di Biase, Rita] Univ Modena, Pediat, I-41100 Modena, Italy; [Lezo, Antonella] Univ Turin, Pediat, I-10124 Turin, Italy; [Salvatore, Silvia] Univ Insubria, Pediat, Varese, Italy; [Paoletti, Silvia] ASL Roma, Pediat, Rome, Italy; [Siani, Alfonso] CNR, Inst Food Sci & Technol, Epidemiol & Populat Genet, Avellino, AS, Italy; Italian Minist Hlth, Ctr Dis Prevent & Control, Rome, Italy	University of Foggia; University of Naples Federico II; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Magna Graecia University of Catanzaro; Universita degli Studi di Bari Aldo Moro; Marche Polytechnic University; Universita di Modena e Reggio Emilia; University of Turin; University of Insubria; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Strazzullo, P (corresponding author), Univ Naples Federico II, Sch Med, ESH Excellence Ctr Hypertens, Dept Clin Med & Surg, Naples, Italy.	strazzul@unina.it	Salvatore, Silvia/AAL-4325-2020; Barbato, Antonio/AAG-3313-2020; Campanozzi, Angelo/AAR-6227-2020; Siani, Alfonso/B-7925-2015; Pensabene, Licia/AAW-2755-2020; FRANCAVILLA, RUGGIERO/S-1391-2019; Iacone, Roberto/M-2867-2016; De+Filippo, Gianpaolo/AAE-5584-2019	Campanozzi, Angelo/0000-0002-3489-2524; FRANCAVILLA, RUGGIERO/0000-0002-4603-974X; Iacone, Roberto/0000-0003-3360-3855; Barbato, Antonio/0000-0002-4660-821X; Salvatore, Silvia/0000-0003-4339-556X	Italian Ministry of Health through MINISAL-GIRCSI intervention program; Italian Ministry of Health through MENO SALE PIU SALUTE intervention program	Italian Ministry of Health through MINISAL-GIRCSI intervention program; Italian Ministry of Health through MENO SALE PIU SALUTE intervention program	This publication has been made possible thanks to the support of the Italian Ministry of Health through funding of the MINISAL-GIRCSI and MENO SALE PIU SALUTE intervention programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Ad hoc Committee of the Italian Society of Human Nutrition (SINU) and the Institute for Food Research and Nutrition (INRAN), 2012, 35 SINU SCI M BOL OC; [Anonymous], 2002, VITAL HLTH STAT; Beauchamp GK, 2009, J PEDIATR GASTR NUTR, V48, pS25, DOI 10.1097/MPG.0b013e31819774a5; Bordini B, 2011, PEDIATR REV, V32, P281, DOI 10.1542/pir.32-7-281; COOPER R, 1983, HYPERTENSION, V5, P135, DOI 10.1161/01.HYP.5.1.135; D'Elia L, 2011, J AM COLL CARDIOL, V57, P1210, DOI 10.1016/j.jacc.2010.09.070; Donfrancesco C, 2013, NUTR METAB CARDIOVAS, V23, P850, DOI 10.1016/j.numecd.2012.04.004; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628; He FJ, 2008, PHYSIOL PLANTARUM, V133, P725, DOI 10.1111/j.1399-3054.2007.01033.x; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; He FJ, 2006, HYPERTENSION, V48, P861, DOI 10.1161/01.HYP.0000245672.27270.4a; *I MED NAT AC, 2010, STRAT RED SOD INT US; Jennings A, 2010, INT J FOOD SCI NUTR, V61, P68, DOI 10.3109/09637480903229009; Kristbjornsdottir OK, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-94; Lava SA, 2014, PEDIAT NEPHROL; Manci G, 2013, J HYPERTENS, V31, P1281, DOI [DOI 10.1097/01.HJH.0000431740.32696.CC, 10.1093/eurheartj/eht151]; Marras AR, 2009, CARDIOL YOUNG, V19, P233, DOI 10.1017/S1047951109003722; McGill CR, 2008, J AM COLL NUTR, V27, P44, DOI 10.1080/07315724.2008.10719673; Meneton P, 2009, EUR J CLIN NUTR, V63, P1169, DOI 10.1038/ejcn.2009.57; Remer T, 2002, AM J CLIN NUTR, V75, P561, DOI 10.1093/ajcn/75.3.561; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; SimonsMorton DG, 1997, PEDIATR NEPHROL, V11, P244, DOI 10.1007/s004670050271; Stein LJ, 2012, AM J CLIN NUTR, V95, P123, DOI 10.3945/ajcn.111.014282; Strazzullo P, 2012, NUTR METAB CARDIOVAS, V22, P787, DOI 10.1016/j.numecd.2012.04.003; Strazzullo P, 2012, NUTR METAB CARDIOVAS, V22, P161, DOI 10.1016/j.numecd.2011.10.004; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Thomson BM, 2008, BR J NUTR, V9, P614; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1	31	51	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121183	10.1371/journal.pone.0121183	http://dx.doi.org/10.1371/journal.pone.0121183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853242	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400031
J	Gregory, NJ; Lopez, B; Graham, G; Marshman, P; Bate, S; Kargas, N				Gregory, Nicola Jean; Lopez, Beatriz; Graham, Gemma; Marshman, Paul; Bate, Sarah; Kargas, Niko			Reduced Gaze Following and Attention to Heads when Viewing a "Live" Social Scene	PLOS ONE			English	Article							JOINT VISUAL-ATTENTION; EYE-GAZE; SACCADE GENERATION; COGNITIVE-ETHOLOGY; CUES; INFORMATION; DIRECTION; ALLOCATION; SHIFTS; OVERT	Social stimuli are known to both attract and direct our attention, but most research on social attention has been conducted in highly controlled laboratory settings lacking in social context. This study examined the role of social context on viewing behaviour of participants whilst they watched a dynamic social scene, under three different conditions. In two social groups, participants believed they were watching a live webcam of other participants. The socially-engaged group believed they would later complete a group task with the people in the video, whilst the non-engaged group believed they would not meet the people in the scene. In a third condition, participants simply free-viewed the same video with the knowledge that it was pre-recorded, with no suggestion of a later interaction. Results demonstrated that the social context in which the stimulus was viewed significantly influenced viewing behaviour. Specifically, participants in the social conditions allocated less visual attention towards the heads of the actors in the scene and followed their gaze less than those in the free-viewing group. These findings suggest that by underestimating the impact of social context in social attention, researchers risk coming to inaccurate conclusions about how we attend to others in the real world.	[Gregory, Nicola Jean; Bate, Sarah] Bournemouth Univ, Fac Sci & Technol, Psychol Res Ctr, Poole BH12 5BB, Dorset, England; [Gregory, Nicola Jean; Lopez, Beatriz; Graham, Gemma; Marshman, Paul; Kargas, Niko] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	Bournemouth University; University of Portsmouth	Gregory, NJ (corresponding author), Bournemouth Univ, Fac Sci & Technol, Psychol Res Ctr, Poole BH12 5BB, Dorset, England.	ngregory@bournemouth.ac.uk	Gregory, Nicola/H-8057-2019	Lopez, Beatriz/0000-0001-5621-6044; Kargas, Niko/0000-0002-0052-5363	Bournemouth University Fusion Investment Fund Staff Networking and Mobility Award; Department of Psychology, University of Portsmouth	Bournemouth University Fusion Investment Fund Staff Networking and Mobility Award; Department of Psychology, University of Portsmouth	NG and SB were supported by a Bournemouth University Fusion Investment Fund Staff Networking and Mobility Award. BL and NG were supported by a research grant from the Department of Psychology, University of Portsmouth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DIAGNOSTIC AND STATI; BARONCOHEN S, 1995, BRIT J DEV PSYCHOL, V13, P379, DOI 10.1111/j.2044-835X.1995.tb00687.x; BARONCOHEN S, 1996, BRIT J PSYCHIAT, V168, P158, DOI DOI 10.1192/BJP.168.2.158; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; Birmingham E, 2009, VISION RES, V49, P2992, DOI 10.1016/j.visres.2009.09.014; Bonifacci P, 2008, COGN PROCESS, V9, P127, DOI 10.1007/s10339-007-0198-3; BUTTERWORTH G, 1991, BRIT J DEV PSYCHOL, V9, P55, DOI 10.1111/j.2044-835X.1991.tb00862.x; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Chawarska K, 2003, CHILD DEV, V74, P1108, DOI 10.1111/1467-8624.00595; D'Entremont B, 1997, INFANT BEHAV DEV, V20, P569, DOI 10.1016/S0163-6383(97)90048-5; Dodd MD, 2011, ATTEN PERCEPT PSYCHO, V73, P24, DOI 10.3758/s13414-010-0001-x; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Fletcher-Watson S, 2009, NEUROPSYCHOLOGIA, V47, P248, DOI 10.1016/j.neuropsychologia.2008.07.016; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Fox E, 2007, EMOTION, V7, P478, DOI 10.1037/1528-3542.7.3.478; Freeth M, 2010, J AUTISM DEV DISORD, V40, P534, DOI 10.1007/s10803-009-0893-2; Freeth M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053286; Freeth M, 2011, J AUTISM DEV DISORD, V41, P364, DOI 10.1007/s10803-010-1053-4; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Gallup AC, 2012, BIOL LETTERS, V8, P520, DOI 10.1098/rsbl.2012.0160; Gallup AC, 2012, P NATL ACAD SCI USA, V109, P7245, DOI 10.1073/pnas.1116141109; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; Graham R, 2010, VIS COGN, V18, P331, DOI 10.1080/13506280802689281; Gregory NJ, 2012, PERCEPTION, V41, P131, DOI 10.1068/p7085; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson JM., 1992, EYE MOVEMENTS VISUAL, P260, DOI [DOI 10.1007/978-1-4612-2852-3_15, 10.1007/978-1-4612-2852-3_15]; Hietanen JK, 2006, NEUROIMAGE, V33, P406, DOI 10.1016/j.neuroimage.2006.06.048; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kawakami K, 2014, J PERS SOC PSYCHOL, V107, P1, DOI 10.1037/a0036838; Kingstone A, 2008, BRIT J PSYCHOL, V99, P317, DOI 10.1348/000712607X251243; Kingstone A, 2009, CURR OPIN NEUROBIOL, V19, P52, DOI 10.1016/j.conb.2009.05.004; Koval MJ, 2005, EXP BRAIN RES, V167, P475, DOI 10.1007/s00221-005-0206-8; Kuhn G, 2008, VIS COGN, V16, P391, DOI 10.1080/13506280701479750; Kuhn G, 2007, PERCEPT PSYCHOPHYS, V69, P966, DOI 10.3758/BF03193934; Kuhn G, 2006, CURR BIOL, V16, pR950, DOI 10.1016/j.cub.2006.10.012; Kuhn G, 2010, EXP BRAIN RES, V201, P155, DOI 10.1007/s00221-009-2019-7; Kuhn G, 2009, VIS COGN, V17, P925, DOI 10.1080/13506280902826775; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Laidlaw KEW, 2011, P NATL ACAD SCI USA, V108, P5548, DOI 10.1073/pnas.1017022108; Langton SRH, 1999, VIS COGN, V6, P541, DOI 10.1080/135062899394939; Langton SRH, 2000, J EXP PSYCHOL HUMAN, V26, P747, DOI 10.1037//0096-1523.26.2.747; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025117; MORISSETTE P, 1995, BRIT J DEV PSYCHOL, V13, P163, DOI 10.1111/j.2044-835X.1995.tb00671.x; Peters RJ, 2005, VISION RES, V45, P2397, DOI 10.1016/j.visres.2005.03.019; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Quadflieg S, 2004, PSYCHON B REV, V11, P826, DOI 10.3758/BF03196708; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Risko EF, 2011, ATTEN PERCEPT PSYCHO, V73, P291, DOI 10.3758/s13414-010-0042-1; Sato W, 2010, PSYCHOLOGIA, V53, P27, DOI 10.2117/psysoc.2010.27; SCAIFE M, 1975, NATURE, V253, P265, DOI 10.1038/253265a0; Skarratt PA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00196; Smilek D, 2006, BRAIN RES, V1080, P101, DOI 10.1016/j.brainres.2005.12.090; Stoesz BM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00193; Swettenham J, 2003, PHILOS T R SOC B, V358, P325, DOI 10.1098/rstb.2002.1203; TAJFEL H, 1974, SOC SCI INFORM, V13, P65, DOI 10.1177/053901847401300204; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; Vecera SP, 2006, NEUROPSYCHOLOGIA, V44, P150, DOI 10.1016/j.neuropsychologia.2005.04.010; Walter H, 2005, BRAIN RES BULL, V67, P368, DOI 10.1016/j.brainresbull.2005.06.016; Yarbus A. L., 1967, EYE MOVEMENTS AND VI; Zwickel J, 2010, PSYCHON B REV, V17, P257, DOI 10.3758/PBR.17.2.257	67	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121792	10.1371/journal.pone.0121792	http://dx.doi.org/10.1371/journal.pone.0121792			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853239	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352478400049
J	Santos, JI; Pereda, M; Zurro, D; Alvarez, M; Caro, J; Galan, JM; Godino, IBI				Ignacio Santos, Jose; Pereda, Maria; Zurro, Debora; Alvarez, Myrian; Caro, Jorge; Manuel Galan, Jose; Briz i Godino, Ivan			Effect of Resource Spatial Correlation and Hunter-Fisher-Gatherer Mobility on Social Cooperation in Tierra del Fuego	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; EVOLUTIONARY GAMES; PRISONERS-DILEMMA; LEVY FLIGHTS; RECIPROCITY; ALTRUISM; NETWORKS; MODELS	This article presents an agent-based model designed to explore the development of cooperation in hunter-fisher-gatherer societies that face a dilemma of sharing an unpredictable resource that is randomly distributed in space. The model is a stylised abstraction of the Yamana society, which inhabited the channels and islands of the southernmost part of Tierra del Fuego (Argentina-Chile). According to ethnographic sources, the Yamana developed cooperative behaviour supported by an indirect reciprocity mechanism: whenever someone found an extraordinary confluence of resources, such as a beached whale, they would use smoke signals to announce their find, bringing people together to share food and exchange different types of social capital. The model provides insight on how the spatial concentration of beachings and agents' movements in the space can influence cooperation. We conclude that the emergence of informal and dynamic communities that operate as a vigilance network preserves cooperation and makes defection very costly.	[Ignacio Santos, Jose; Pereda, Maria; Manuel Galan, Jose] Univ Burgos, INSISOC, Escuela Politecn Super, Burgos, Spain; [Zurro, Debora] CSIC, IMF, CaSEs, Dept Archaeol & Anthropol, Barcelona, Spain; [Alvarez, Myrian] Consejo Nacl Invest Cient & Tecn, CADIC, Ushuaia, Argentina; [Caro, Jorge] Univ Autonoma Barcelona, Dept Sociol, GSADI, CaSEs, E-08193 Barcelona, Spain; [Caro, Jorge] Nexus IC Gran Capita, Barcelona Supercomputing Ctr, CNS, Barcelona, Spain; [Briz i Godino, Ivan] Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England	Universidad de Burgos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institucion Mila y Fontanals (IMF); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Autonomous University of Barcelona; University of York - UK	Santos, JI (corresponding author), Univ Burgos, INSISOC, Escuela Politecn Super, Edif La Milanera, Burgos, Spain.	jisantos@ubu.es	Santos, José I/K-5924-2014; Alvarez, Myrian/ACH-5015-2022; Pereda, María/K-1865-2014; Galán, José Manuel/B-9782-2009; Briz Godino, Ivan/C-2119-2015; Zurro, Debora/L-3965-2014	Santos, José I/0000-0002-6653-043X; Pereda, María/0000-0002-6151-1176; Galán, José Manuel/0000-0003-3360-7602; Briz Godino, Ivan/0000-0002-6262-9360; Zurro, Debora/0000-0003-2498-9338; Caro Saiz, Jorge/0000-0002-5065-4841	Spanish MICINN [CSD2010-00034, HAR2009-06996]; government of Castilla y Leon [GREX251-2009]; Argentine CONICET [PIP-0706]; Wenner-Gren Foundation for Anthropological Research "Social Aggregation: A Yamana Society's Short Term Episode to Analyse Social Interaction, Tierra del Fuego, Argentina"	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); government of Castilla y Leon; Argentine CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Wenner-Gren Foundation for Anthropological Research "Social Aggregation: A Yamana Society's Short Term Episode to Analyse Social Interaction, Tierra del Fuego, Argentina"	The authors acknowledge support from the following projects: the Spanish MICINN http://www.idi.mineco.gob.es/ CSD2010-00034 (SimulPast CONSOLIDER-INGENIO 2010) and HAR2009-06996; the government of Castilla y Leon http://www.jcyl.es/ GREX251-2009; the Argentine CONICET http://www.conicet.gov.ar/ PIP-0706; and the Wenner-Gren Foundation for Anthropological Research http://www.wennergren.org/ "Social Aggregation: A Yamana Society's Short Term Episode to Analyse Social Interaction, Tierra del Fuego, Argentina". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JM, 2008, COMPANION PHILOS BIO; Ames K.M., 2002, FORAGING COLLECTING, P19; Apicella CL, 2012, NATURE, V481, P497, DOI 10.1038/nature10736; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axtell RL, 2001, SOCIAL DYNAMICS, P191; Barlett W, 1870, S AM MISSIONARY MAGA, V1970, P99; Baronchelli A, 2013, CHAOS SOLITON FRACT, V56, P101, DOI 10.1016/j.chaos.2013.07.013; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Bowles S, 1998, EVOL HUM BEHAV, V19, P3, DOI 10.1016/S1090-5138(98)00015-4; Bowles S, 2003, DAHL WS ENV, P429; Bowles S, 2004, J ECON BEHAV ORGAN, V55, P1, DOI 10.1016/j.jebo.2003.06.005; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bridges Lucas., 1952, ULTIMO CONFIN TIERRA; Bridges T, 1877, COMMUNICATION; Bridges T, 1872, S AM MISSIONARY MAGA, V1872, P123; Bridges T., 1933, YAMANA ENGLISH DICT; Bridges T, 1875, S AM MISSIONARY MAGA, V1875, P158; Bridges T, 1882, COMMUNICATION UNPUB; Briz I, 2011, ANAL ETNOARCHEOLOGIA, P169; Briz I, 2009, ANTIQUITY, P83; Briz I, 2013, BRIT ARCHAEOLOGICAL, V2472, P81; Godino IBI, 2014, J ARCHAEOL METHOD TH, V21, P343, DOI 10.1007/s10816-013-9194-3; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; Cohen MD, 2001, RATION SOC, V13, P5, DOI 10.1177/104346301013001001; David N, 2001, ETHNOARCHAEOLOGY ACT; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Estevez J, 1996, TREBALLS ETNOARQUEOL, V1, P17; Fort H, 2005, JASSS-J ARTIF SOC S, V8; Galan JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020474; Goodall NP, 2014, PRESENCE SO RIGHT WH, P1987; Gotts NM, 2003, ARTIF INTELL REV, V19, P3, DOI 10.1023/A:1022120928602; GOULD RA, 1985, AM ANTIQUITY, V50, P117, DOI 10.2307/280637; Gould RA, 1980, LIVING ARCHAEOLOGY N; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grove M, 2009, J ANTHROPOL ARCHAEOL, V28, P222, DOI 10.1016/j.jaa.2009.01.003; Gusinde M, 1937, FEUERLAND INDIANER, VII; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; HIRSHLEIFER J, 1978, AM ECON REV, V68, P238; Hyades P, 1884, B SOC ANTHROPOL PAR, VVII, P147; Hyades P, 1891, ANTROP ETHNOGRAPHIE; Iranzo J, 2011, J THEOR BIOL, V278, P1, DOI 10.1016/j.jtbi.2011.02.020; James Alex, 2011, J R Soc Interface, V8, P1233, DOI 10.1098/rsif.2011.0200; Jimenez R, 2008, J THEOR BIOL, V250, P475, DOI 10.1016/j.jtbi.2007.10.010; KELLY RL, 1992, ANNU REV ANTHROPOL, V21, P43, DOI 10.1146/annurev.an.21.100192.000355; KREPS DM, 1982, J ECON THEORY, V27, P245, DOI 10.1016/0022-0531(82)90029-1; Letter Bridges T., 1876, S AM MISSIONARY MAGA, V1876, P79; Liaw A., 2002, R NEWS, V2, P118; Liu YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030689; Lothrop S. K., 1928, INDIANS TIERRA FUEGO; MacLeod C. D., 2005, Journal of Cetacean Research and Management, V7, P309; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Martial LF., 1888, MISSION SCI CAP HORN; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Morgan C, 2009, J ANTHROPOL ARCHAEOL, V28, P382, DOI 10.1016/j.jaa.2009.07.004; Nemeth A, 2007, JASSS-J ARTIF SOC S, V10; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Orquera L., 1999, VIDA MAT SOCIAL YAMA; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perreault C, 2011, J ANTHROPOL ARCHAEOL, V30, P62, DOI 10.1016/j.jaa.2010.10.003; Poza DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017661; Radicchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029910; Raichlen David A, 2014, Proc Natl Acad Sci U S A, V111, P728, DOI 10.1073/pnas.1318616111; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Santos JI, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/482481; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/28005; Therneau TM., 1997, INTRO RECURSIVE PART, V61; Ushuwia Bridges T., 1872, S AM MISSIONARY MAGA, V1872, P87; Ushuwia Bridges T., 1876, S AM MISSIONARY MAGA, V1876, P56; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2011, PHYS FORAGING INTRO, DOI [10.1073/pnas.1318616111, DOI 10.1073/PNAS.1318616111]; Wang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084954; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Whallon R, 2006, J ANTHROPOL ARCHAEOL, V25, P259, DOI 10.1016/j.jaa.2005.11.004; Wilensky U., 1999, NETLOGO; Zurro D, 2010, REV ARQUEOLOGIA AM, V28, P171	84	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121888	10.1371/journal.pone.0121888	http://dx.doi.org/10.1371/journal.pone.0121888			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853728	Green Published, gold			2022-12-27	WOS:000352478400054
J	Oh, SW; Han, KH; Han, SY				Oh, Se Won; Han, Kum Hyun; Han, Sang Youb			Associations between Renal Hyperfiltration and Serum Alkaline Phosphatase	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; METABOLIC SYNDROME; HEMODIALYSIS-PATIENTS; RISK; MICROALBUMINURIA; DIAGNOSIS; DISEASE	Renal hyperfiltration, which is associated with renal injury, occurs in diabetic or obese individuals. Serum alkaline phosphatase (ALP) level is also elevated in patients with diabetes (DM) or metabolic syndrome (MS), and increased urinary excretion of ALP has been demonstrated in patients who have hyperfiltration and tubular damage. However, little was investigated about the association between hyperfiltration and serum ALP level. A retrospective observational study of the 21,308 adults in the Korea National Health and Nutrition Examination Survey IV-V databases (2008-2011) was performed. Renal hyperfiltration was defined as exceeding the age- and sex-specific 97.5(th) percentile. We divided participants into 4 groups according to their estimated glomerular filtration rate (eGFR): > 120, 90-119, 60-89, and < 60 mL/min/1.73 m(2). The participants with eGFR > 120 mL/min/1.73 m(2) showed the highest risk for MS, in the highest ALP quartiles (3.848, 95% CI, 1.876-7.892), compared to the lowest quartile. Similarly, the highest risk for DM, in the highest ALP quartiles, was observed in participants with eGFR > 120 ml/min/1.73 m(2) (2.166, 95% CI, 1.084-4.329). ALP quartiles were significantly associated with albuminuria in participants with eGFR >= 60 ml/min/1.73m(2). The highest ALP quartile had a 1.631-fold risk elevation for albuminuria with adjustment of age and sex. (95% CI, 1.158-2.297, P = 0.005). After adjustment, the highest ALP quartile had a 1.624-fold risk elevation, for renal hyperfiltration (95% CI, 1.204-2.192, P = 0.002). In addition, hyperfiltration was significantly associated with hemoglobin, triglyceride, white blood cell count, DM, smoking, and alcohol consumption (P<0.05). The relationship between serum ALP and metabolic disorders is stronger in participants with an upper-normal range of eGFR. Higher ALP levels are significantly associated with renal hyperfiltration in Korean general population.	[Oh, Se Won; Han, Kum Hyun; Han, Sang Youb] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med,Div Nephrol, Goyang, South Korea	Inje University	Han, SY (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med,Div Nephrol, Goyang, South Korea.	hansy@paik.ac.kr	Oh, Se Won/G-2632-2017	Oh, Se Won/0000-0003-3795-9322				Blayney MJ, 2008, KIDNEY INT, V74, P655, DOI 10.1038/ki.2008.248; Bulum T, 2014, RENAL FAILURE, V36, P372, DOI 10.3109/0886022X.2013.872569; Canales BK, 2012, NUTRITION, V28, P76, DOI 10.1016/j.nut.2011.03.003; Chagnac A, 2008, NEPHROL DIAL TRANSPL, V23, P3946, DOI 10.1093/ndt/gfn379; De Carvalho JAM, 2011, CLIN CHIM ACTA, V412, P1407, DOI 10.1016/j.cca.2011.04.015; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Ficociello LH, 2009, DIABETES CARE, V32, P889, DOI 10.2337/dc08-1560; Fletcher S, 1997, NEPHRON, V75, P412, DOI 10.1159/000189578; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Heemskerk S, 2007, PFLUG ARCH EUR J PHY, V454, P321, DOI 10.1007/s00424-007-0210-x; Heemskerk S, 2009, CRIT CARE MED, V37, P417, DOI 10.1097/CCM.0b013e31819598af; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Jorna FH, 2004, NEPHROL DIAL TRANSPL, V19, P1168, DOI 10.1093/ndt/gfh018; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Kim MK, 2013, ENDOCR J, V60, P321, DOI 10.1507/endocrj.EJ12-0331; Krishnamurthy VR, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2010.11.030; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; NOUWEN EJ, 1994, KIDNEY INT, pS43; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Palatini P, 2012, NEPHROL DIAL TRANSPL, V27, P1708, DOI 10.1093/ndt/gfs037; Salgueira M, 2005, NEFROLOGIA, V25, P668; TAPSON JS, 1988, NEPHRON, V48, P126, DOI 10.1159/000184890; Thomas MC, 2005, ADV CHRONIC KIDNEY D, V12, P177, DOI 10.1053/j.ackd.2005.01.008; Tobar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075547; VERPOOTEN GF, 1989, KIDNEY INT, V36, P617, DOI 10.1038/ki.1989.238; Wong H, 2004, AM J KIDNEY DIS, V43, P624, DOI 10.1053/j.ajkd.2003.12.026; Wuerzner G, 2010, AM J KIDNEY DIS, V56, P303, DOI 10.1053/j.ajkd.2010.03.017; Zerbini G, 2006, DIABETES, V55, P2620, DOI 10.2337/db06-0592	32	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122921	10.1371/journal.pone.0122921	http://dx.doi.org/10.1371/journal.pone.0122921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853240	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400085
J	Vishwanathan, SA; Morris, MR; Wolitski, RJ; Luo, W; Rose, CE; Blau, DM; Tsegaye, T; Zaki, SR; Garber, DA; Jenkins, LT; Henning, TC; Patton, DL; Hendry, RM; McNicholl, JM; Kersh, EN				Vishwanathan, Sundaram A.; Morris, Monica R.; Wolitski, Richard J.; Luo, Wei; Rose, Charles E.; Blau, Dianna M.; Tsegaye, Theodros; Zaki, Sherif R.; Garber, David A.; Jenkins, Leecresia T.; Henning, Tara C.; Patton, Dorothy L.; Hendry, R. Michael; McNicholl, Janet M.; Kersh, Ellen N.			Rectal Application of a Highly Osmolar Personal Lubricant in a Macaque Model Induces Acute Cytotoxicity but Does Not Increase Risk of SHIV Infection	PLOS ONE			English	Article							ANAL INTERCOURSE; HIV; SEX; MEN; TRANSMISSION; MICROBICIDES; EFFICACY; TRIALS; SAFETY; DAMAGE	Background Personal lubricant use is common during anal intercourse. Some water-based products with high osmolality and low pH can damage genital and rectal tissues, and the polymer polyquaternium 15 (PQ15) can enhance HIV replication in vitro. This has raised concerns that lubricants with such properties may increase STD/HIV infection risk, although in vivo evidence is scarce. We use a macaque model to evaluate rectal cytotoxicity and SHIV infection risk after use of a highly osmolar (>8,000 mOsm/kg) water-based lubricant with pH of 4.4, and containing PQ15. Methods Cytotoxicity was documented by measuring inflammatory cytokines and epithelial tissue sloughing during six weeks of repeated, non-traumatic lubricant or control buffer applications to rectum and anus. We measured susceptibility to SHIVSF162P3 infection by comparing virus doses needed for rectal infection in twenty-one macaques treated with lubricant or control buffer 30 minutes prior to virus exposure. Results Lubricant increased pro-inflammatory cytokines and tissue sloughing while control buffer (phosphate buffered saline; PBS) did not. However, the estimated AID(50) (50% animal infectious dose) was not different in lubricant-and control buffer-treated macaques (p = 0.4467; logistic regression models). Conclusions Although the test lubricant caused acute cytotoxicity in rectal tissues, it did not increase susceptibility to infection in this macaque model. Thus neither the lubricant-induced type/extent of inflammation nor the presence of PQ15 affected infection risk. This study constitutes a first step in the in vivo evaluation of lubricants with regards to HIV transmission.	[Vishwanathan, Sundaram A.; Morris, Monica R.; Wolitski, Richard J.; Luo, Wei; Rose, Charles E.; Tsegaye, Theodros; Garber, David A.; Jenkins, Leecresia T.; Henning, Tara C.; Hendry, R. Michael; McNicholl, Janet M.; Kersh, Ellen N.] Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA; [Blau, Dianna M.] Natl Ctr Emerging & Zoonot Infect Dis, Ctr Dis Control & Prevent, Atlanta, GA USA; [Patton, Dorothy L.] Univ Washington, Seattle, WA 98195 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle	Kersh, EN (corresponding author), Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30329 USA.	ekersh@cdc.gov			Centers for Disease Control (CDC)	Centers for Disease Control (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Centers for Disease Control (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens E, 2008, SEX TRANSM DIS, V35, P512, DOI 10.1097/OLQ.0b013e3181644669; Begay O, 2011, AIDS RES HUM RETROV, V27, P1019, DOI [10.1089/aid.2010.0252, 10.1089/AID.2010.0252]; Calabrese SK, 2013, AIDS PATIENT CARE ST, V27, P77, DOI 10.1089/apc.2012.0355; Carballo-Dieguez A, 2000, AM J PUBLIC HEALTH, V90, P1117, DOI 10.2105/AJPH.90.7.1117; Chenine AL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000265; Dezzutti CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048328; Fuchs EJ, 2007, J INFECT DIS, V195, P703, DOI 10.1086/511279; Gorbach PM, 2012, SEX TRANSM DIS, V39, P59, DOI 10.1097/OLQ.0b013e318235502b; Gross M, 1998, SEX TRANSM DIS, V25, P296, DOI 10.1097/00007435-199807000-00005; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Henning T, 2014, J MED PRIMATOL, V43, P135, DOI 10.1111/jmp.12103; Herbenick D, 2013, J SEX MED, V10, P474, DOI 10.1111/jsm.12021; Javanbakht M, 2010, SEX HEALTH, V7, P193, DOI 10.1071/SH09062; Jozkowski KN, 2013, J SEX MED, V10, P484, DOI 10.1111/jsm.12022; Kinsler JJ, 2010, INT J STD AIDS, V21, P567, DOI 10.1258/ijsa.2010.010134; Maguire RA, 2001, SEX TRANSM DIS, V28, P259, DOI 10.1097/00007435-200105000-00003; Nguyen D, 2004, J BIOL REG HOMEOS AG, V18, P268; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Patton DL, 2002, SEX TRANSM DIS, V29, P581, DOI 10.1097/00007435-200210000-00004; Patton DL, 2009, SEX TRANSM DIS, V36, P350, DOI 10.1097/OLQ.0b013e318195c31a; Pickett J, 2008, LESS SILENCE MORE SC; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; SPOUGE JL, 1992, P NATL ACAD SCI USA, V89, P7581, DOI 10.1073/pnas.89.16.7581; Sudol KM, 2004, SEX TRANSM DIS, V31, P346, DOI 10.1097/00007435-200406000-00005; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; WHO FHI UNFPA, 2012, WHORHR1233 FHI UNFPA; World Health Organization, 2014, POL BRIEF CONS GUID	28	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120021	10.1371/journal.pone.0120021	http://dx.doi.org/10.1371/journal.pone.0120021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853710	Green Submitted, gold, Green Published			2022-12-27	WOS:000352478400009
J	Zhao, XM; Hao, HS; Du, WH; Zhu, HB				Zhao, Xueming; Hao, Haisheng; Du, Weihua; Zhu, Huabin			Effect of Vitrification on the MicroRNA Transcriptome in Mouse Blastocysts	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; STRAW OPS VITRIFICATION; IN-VIVO; MITOCHONDRIAL-FUNCTION; BOVINE EMBRYOS; KEY REGULATOR; VITRO; CRYOPRESERVATION; METHYLATION; KINASE	Vitrification is commonly used in the cryopreservation of mammalian blastocysts to overcome the temporal and spatial limitations of embryo transfer. Previous studies have shown that the implantation ability of vitrified blastocysts is impaired and that microRNAs (miRNAs) regulate the critical genes for embryo implantation. However, little information is available about the effect of vitrification on the miRNA transcriptome in blastocysts. In the present study, the miRNA transcriptomes in fresh and vitrified mouse blastocysts were analyzed by miRNA Taqman assay based method, and the results were validated using quantitative real-time PCR (qRT-PCR). Then, the differentially expressed miRNAs were assessed using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Overall, 760 known mouse miRNAs were detected in the vitrified and fresh mouse blastocysts. Of these, the expression levels of five miRNAs differed significantly: in the vitrified blastocysts, four miRNAs (mmu-miR-199a-5p, mmu-miR-329-3p, mmu-miR-136-5p and mmu-miR-16-1-3p) were upregulated, and one (mmu-miR-212-3p) was downregulated. The expression levels of all miRNAs measured by the miRNA Taqman assay based method and qRT-PCR were consistent. The four upregulated miRNAs were predicted to regulate 877 candidate target genes, and the downregulated miRNA was predicted to regulate 231 genes. The biological analysis further showed that the differentially expressed miRNAs mainly regulated the implantation of embryos. In conclusion, the results of our study showed that vitrification significantly altered the miRNA transcriptome in mouse blastocysts, which may decrease the implantation potential of vitrified blastocysts.	[Zhao, Xueming; Hao, Haisheng; Du, Weihua; Zhu, Huabin] Chinese Acad Agr Sci, Inst Anim Sci, Embryo Biotechnol & Reprod Lab, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Zhu, HB (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Embryo Biotechnol & Reprod Lab, Beijing 100193, Peoples R China.	zhuhuabin@caas.cn			National Natural Science Foundation of China [31472100]; Basic Research Fund of IAS, CAAS [2014ywf-yb-2]; Agricultural Science and Technology Innovation Program [ASTIP-IAS06-2014, ASTIP-IAS-TS-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Fund of IAS, CAAS; Agricultural Science and Technology Innovation Program	This work was supported by grants from the National Natural Science Foundation of China (31472100), the Basic Research Fund of IAS, CAAS (2014ywf-yb-2) and The Agricultural Science and Technology Innovation Program (ASTIP-IAS06-2014, ASTIP-IAS-TS-5).	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Aksu DA, 2012, MOL REPROD DEV, V79, P613, DOI 10.1002/mrd.22068; Amanai M, 2006, BIOL REPROD, V75, P877, DOI 10.1095/biolreprod.106.056499; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Chaen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048933; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chatzimeletiou K, 2012, HUM REPROD, V27, P106, DOI 10.1093/humrep/der344; Cruz JR, 1999, FERTIL STERIL, V72, P218, DOI 10.1016/S0015-0282(99)00258-7; Dammer EB, 2008, J BIOL CHEM, V283, P6925, DOI 10.1074/jbc.M708432200; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fabian D, 2005, MOL REPROD DEV, V70, P155, DOI 10.1002/mrd.20129; Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690; Gomez E, 2009, REPROD DOMEST ANIM, V44, P194, DOI 10.1111/j.1439-0531.2007.01026.x; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hawkins SM, 2010, ANN ENDOCRINOL-PARIS, V71, P144, DOI 10.1016/j.ando.2010.02.020; Huang CC, 2005, HUM REPROD, V20, P122, DOI 10.1093/humrep/deh540; Kaneko Y, 2012, J MORPHOL, V273, P639, DOI 10.1002/jmor.20010; Kemp CR, 2007, FUNC DEV EMBRYOL, V1, P1; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Li J, 2009, ANAL CHEM, V81, P5446, DOI 10.1021/ac900598d; Li LF, 2012, MOL REPROD DEV, V79, P229, DOI 10.1002/mrd.22018; Lin PY, 2009, FERTIL STERIL, V92, P1764, DOI 10.1016/j.fertnstert.2009.05.011; Louden E, 2008, REPRODUCTION, V136, P335, DOI 10.1530/REP-08-0161; Mamo S, 2006, MOL REPROD DEV, V73, P1380, DOI 10.1002/mrd.20588; Martin PM, 2003, BIOL REPROD, V69, P1101, DOI 10.1095/biolreprod.103.018010; McCallie B, 2010, FERTIL STERIL, V93, P2374, DOI 10.1016/j.fertnstert.2009.01.069; Milroy C, 2011, FERTIL STERIL, V95, P2094, DOI 10.1016/j.fertnstert.2011.02.011; Moce ML, 2010, THERIOGENOLOGY, V73, P704, DOI 10.1016/j.theriogenology.2009.11.010; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Mondou E, 2012, MOL HUM REPROD, V18, P425, DOI 10.1093/molehr/gas015; Murphy CR, 2000, HUM REPROD, V15, P182, DOI 10.1093/humrep/15.suppl_3.182; Nedambale TL, 2004, THERIOGENOLOGY, V62, P437, DOI 10.1016/j.theriogenology.2003.10.020; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Roa W, 2010, CLIN INVEST MED, V33, pE124; Saenz-de-Juano MD, 2014, REPRODUCTION, V147, P789, DOI 10.1530/REP-14-0019; Salvetti P, 2010, THERIOGENOLOGY, V74, P847, DOI 10.1016/j.theriogenology.2010.04.009; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen XH, 2009, J REPROD DEVELOP, V55, P534, DOI 10.1262/jrd.20231; Sommerfeld V, 1999, CRYOBIOLOGY, V38, P95, DOI 10.1006/cryo.1999.2159; Son WY, 2003, HUM REPROD, V18, P137, DOI 10.1093/humrep/deg029; Spinaci M, 2012, VET RES COMMUN, V36, P165, DOI 10.1007/s11259-012-9527-9; Stinshoff H, 2011, THERIOGENOLOGY, V76, P1433, DOI 10.1016/j.theriogenology.2011.06.013; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tesfaye D, 2009, MOL REPROD DEV, V76, P665, DOI 10.1002/mrd.21005; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vicente JS, 2013, CRYOBIOLOGY, V67, P321, DOI 10.1016/j.cryobiol.2013.09.165; Wang YM, 2013, CELL REP, V4, P99, DOI 10.1016/j.celrep.2013.05.027; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wang ZY, 2010, FERTIL STERIL, V93, P2729, DOI 10.1016/j.fertnstert.2010.03.025; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411; Wikland M, 2010, HUM REPROD, V25, P1699, DOI 10.1093/humrep/deq117; Xiao BX, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-172; Yan LY, 2010, REPROD FERT DEVELOP, V22, P920, DOI 10.1071/RD09312; Zhao XM, 2007, ANIM BIOTECHNOL, V18, P203, DOI 10.1080/10495390701201663; Zhao XM, 2012, MOL REPROD DEV, V79, P445, DOI 10.1002/mrd.22052; Zhao XM, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.014; Zhao XM, 2012, J INTEGR AGR, V11, P446, DOI 10.1016/S2095-3119(12)60030-6; Zhao XM, 2011, MOL REPROD DEV, V78, P942, DOI 10.1002/mrd.21389; Zhao XM, 2011, FERTIL STERIL, V95, P2786, DOI 10.1016/j.fertnstert.2011.04.089	71	23	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123451	10.1371/journal.pone.0123451	http://dx.doi.org/10.1371/journal.pone.0123451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853900	gold, Green Submitted, Green Published			2022-12-27	WOS:000352478400102
J	Chen, CL; Liu, SS; Liu, Q; Niu, JH; Liu, P; Zhao, JL; Jian, H				Chen, Changlong; Liu, Shusen; Liu, Qian; Niu, Junhai; Liu, Pei; Zhao, Jianlong; Jian, Heng			An ANNEXIN-Like Protein from the Cereal Cyst Nematode Heterodera avenae Suppresses Plant Defense	PLOS ONE			English	Article							INNATE IMMUNITY; MOLECULAR CHARACTERIZATION; GLOBODERA-ROSTOCHIENSIS; FUNCTIONAL-ANALYSIS; PARASITIC NEMATODE; DISEASE RESISTANCE; SIGNALING NETWORKS; KINASE KINASE; CELL-DEATH; GENE	Parasitism genes encoding secreted effector proteins of plant-parasitic nematodes play important roles in facilitating parasitism. An annexin-like gene was isolated from the cereal cyst nematode Heterodera avenae (termed Ha-annexin) and had high similarity to annexin 2, which encodes a secreted protein of Globodera pallida. Ha-annexin encodes a predicted 326 amino acid protein containing four conserved annexin domains. Southern blotting revealed that there are at least two homologies in the H. avenae genome. Ha-annexin transcripts were expressed within the subventral gland cells of the pre-parasitic second-stage juveniles by in situ hybridization. Additionally, expression of these transcripts were relatively higher in the parasitic second-stage juveniles by quantitative real-time RT-PCR analysis, coinciding with the time when feeding cell formation is initiated. Knockdown of Ha-annexin by method of barley stripe mosaic virus-based host-induced gene silencing (BSMV-HIGS) caused impaired nematode infections at 7 dpi and reduced females at 40 dpi, indicating important roles of the gene in parasitism at least in early stage in vivo. Transiently expression of Ha-ANNEXIN in onion epidermal cells and Nicotiana benthamiana leaf cells showed the whole cell-localization. Using transient expression assays in N. benthamiana, we found that Ha-ANNEXIN could suppress programmed cell death triggered by the pro-apoptotic mouse protein BAX and the induction of marker genes of PAMP-triggered immunity (PTI) in N. benthamiana. In addition, Ha-ANNEXIN targeted a point in the mitogen-activated protein kinase (MAPK) signaling pathway downstream of two kinases MKK1 and NPK1 in N. benthamiana.	[Chen, Changlong; Liu, Shusen; Liu, Qian; Liu, Pei; Zhao, Jianlong; Jian, Heng] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [Liu, Shusen] Anhui Acad Agr Sci, Inst Plant Protect & Agroprod Safety, Hefei, Anhui, Peoples R China; [Niu, Junhai] Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China	China Agricultural University; Anhui Academy of Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences	Jian, H (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China.	hengjian@cau.edu.cn	Jian, Heng/Y-2845-2019		National Key Basic Research Program of China [2013CB127501]; Special Fund for Agro-scientific Research in the Public Interest in China [201503114, 200903040]	National Key Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest in China	This research was supported by funding from the National Key Basic Research Program of China (No. 2013CB127501) and the Special Fund for Agro-scientific Research in the Public Interest in China (Nos. 201503114 and 200903040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Bayer EM, 2006, PROTEOMICS, V6, P301, DOI 10.1002/pmic.200500046; Becker A, 2010, TRENDS PLANT SCI, V15, P1, DOI 10.1016/j.tplants.2009.09.002; Bindschedler LV, 2008, PHYTOCHEMISTRY, V69, P1962, DOI 10.1016/j.phytochem.2008.04.007; Bonfil David J., 2004, Precision Agriculture, V5, P329, DOI 10.1023/B:PRAG.0000040804.97462.02; BYBD DW, 1983, J NEMATOL, V15, P142; Chen S. H., 2013, CELL TRANSPLANT, V12, P12, DOI DOI 10.1016/J.TECTO.2012.08.030; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; CHRISTMAS P, 1991, J BIOL CHEM, V266, P2499; Chronis D, 2013, PLANT J, V74, P185, DOI 10.1111/tpj.12125; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; Daigle SN, 1999, J CELL SCI, V112, P1901; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; de Boer JM, 1998, J NEMATOL, V30, P309; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Farrow SC, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00524; Fioretti L, 2001, NEMATOLOGY, V3, P45, DOI 10.1163/156854101300106883; Gao BL, 2003, MOL PLANT MICROBE IN, V16, P720, DOI 10.1094/MPMI.2003.16.8.720; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hewezi T, 2013, MOL PLANT MICROBE IN, V26, P9, DOI 10.1094/MPMI-05-12-0106-FI; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Kumar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096311; Kwon HK, 2005, PLANT CELL PHYSIOL, V46, P843, DOI 10.1093/pcp/pci089; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Laohavisit A, 2009, PLANT SCI, V177, P532, DOI 10.1016/j.plantsci.2009.09.008; Lee WS, 2012, PLANT PHYSIOL, V160, P582, DOI 10.1104/pp.112.203489; Li RJ, 2015, PLANT CELL REP, V34, P5, DOI 10.1007/s00299-014-1676-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long H, 2013, PLANT PATHOL, V62, P953, DOI 10.1111/ppa.12000; Long HB, 2012, EUR J PLANT PATHOL, V134, P391, DOI 10.1007/s10658-012-9997-1; Long HB, 2012, NEMATOLOGY, V14, P571, DOI 10.1163/156854111X614674; Manning VA, 2010, NEW PHYTOL, V187, P1034, DOI 10.1111/j.1469-8137.2010.03363.x; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1348, DOI 10.1094/MPMI-19-1348; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Nicol J., 2004, COMMUN AGRIC APPL BI, V72, P677; Panwar V, 2013, PLANT MOL BIOL, V81, P595, DOI 10.1007/s11103-013-0022-7; Patel N, 2010, J EXP BOT, V61, P235, DOI 10.1093/jxb/erp293; Peng DeLiang, 2009, Cereal cyst nematodes: status, research and outlook. Proceedings of the First Workshop of the International Cereal Cyst Nematode Initiative, Antalya, Turkey, 21-23 October 2009, P29; Postma WJ, 2012, PLANT PHYSIOL, V160, P944, DOI 10.1104/pp.112.200188; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Thakur PK, 2014, INDIAN J EXP BIOL, V52, P223; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wang XH, 2005, MOL PLANT PATHOL, V6, P187, DOI [10.1111/j.1364-3703.2005.00270.x, 10.1111/J.1364-3703.2005.00270.X]; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468	58	44	50	13	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122256	10.1371/journal.pone.0122256	http://dx.doi.org/10.1371/journal.pone.0122256			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849616	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800113
J	Curtis, KM; Aenlle, KK; Frisch, RN; Howard, GA				Curtis, Kevin M.; Aenlle, Kristina K.; Frisch, Rachel N.; Howard, Guy A.			TAp63 gamma and Delta Np63 beta Promote Osteoblastic Differentiation of Human Mesenchymal Stem Cells: Regulation by Vitamin D3 Metabolites	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; OSTEOGENIC DIFFERENTIATION; P53 HOMOLOG; P63; LIMB; PLURIPOTENT; EXPANSION; VARIANTS; KNOCKOUT; ISOFORMS	The transcription factor p63 is required for skeletal formation, and is important for the regulation of 1a, 25(OH)(2)D-3 receptor (VDR) in human mesenchymal stem cells (hMSC). Herein we report that TAp63 gamma and Delta Np63 beta appear to be an integral part of the osteoblastic differentiation of hMSC and are differentially regulated by the vitamin D-3 metabolites 1a,25(OH)(2)D-3 and 24R,25(OH)(2)D-3. We compared the endogenous expression of p63 isoforms (TA- and Delta Np63) and splice variants (p63 alpha, -beta, -gamma), in naive hMSC and during osteoblastic differentiation of hMSC. TAp63 alpha and -beta were the predominant p63 variants in naive, proliferating hMSC. In contrast, under osteoblastic differentiation conditions, expression of p63 changed from the TAp63 alpha and -beta to the TAp63 gamma and Delta Np63 beta variants. Transient overexpression of the p63 variants demonstrated that TAp63 beta, Delta Np63 beta, and Delta Np63 gamma increased alkaline phosphatase activity and Delta Np63 alpha and -gamma increased the expression of mRNA for osteocalcin and osterix. Our results support the hypothesis that TAp63 alpha and -beta promote a naive state in hMSC. Moreover, TAp63 gamma is increased during and promotes early osteoblastic differentiation through the expression of pro-osteogenic genes; VDR, Osterix, Runx2 and Osteopontin Delta Np63 beta also appears to support osteogenic maturation through increased alkaline phosphatase activity. Treatment with 1a, 25(OH)(2)D-3 increased the expression of mRNA for.Np63, while addition of 24R, 25(OH) 2D3 increased the expression of TA- and Delta Np63 gamma variants. These novel findings demonstrate for the first time that p63 variants are differentially expressed in naive hMSC (TAp63 alpha, beta), are important during the osteoblastic differentiation of hMSC (TAp63 gamma and Delta Np63 beta), and are differentially regulated by the vitamin D3 metabolites, 1a, 25(OH)(2)D-3 and 24R, 25(OH)(2)D-3. The molecular nuances and mechanisms of osteoblastic differentiation presented here will hopefully improve our understanding of bone development, complications in bone repair (mal-and non-union fractures), osteoporosis and possibly lead to new modalities of treatment.	[Curtis, Kevin M.; Aenlle, Kristina K.; Frisch, Rachel N.; Howard, Guy A.] Bruce W Carter Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Miami, FL 33125 USA; [Curtis, Kevin M.; Aenlle, Kristina K.; Frisch, Rachel N.; Howard, Guy A.] Bruce W Carter Vet Affairs Med Ctr, Res Serv, Miami, FL USA; [Curtis, Kevin M.; Howard, Guy A.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Howard, Guy A.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA	Geriatric Research Education & Clinical Center; University of Miami; University of Miami	Howard, GA (corresponding author), Bruce W Carter Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Miami, FL 33125 USA.	GHoward1@med.miami.edu			Department of Veterans Affairs Merit Review, National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health Award [5F32AR062990-03]; Department of Medicine, University of Miami Miller School of Medicine; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR062990] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review, National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health Award; Department of Medicine, University of Miami Miller School of Medicine; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was funded through a Department of Veterans Affairs Merit Review (GAH), National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health Award Number 5F32AR062990-03 (KMC), and by funds from the Department of Medicine, University of Miami Miller School of Medicine. Dr. Guy Howard is the recipient of a Senior Research Career Scientist award from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aenlle KK, 2014, MOL ENDOCRINOL, V28, P722, DOI 10.1210/me.2013-1286; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen KT, 2012, BONE, V51, P69, DOI 10.1016/j.bone.2012.04.002; Cheng W, 2006, DEVELOPMENT, V133, P4783, DOI 10.1242/dev.02621; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Curtis KM, 2014, MOL ENDOCRINOL, V28, P644, DOI 10.1210/me.2013-1241; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; D'Ippolito G, 2006, REJUV RES, V9, P10, DOI 10.1089/rej.2006.9.10; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Delcroix GJR, 2010, DIFFERENTIATION, V80, P213, DOI 10.1016/j.diff.2010.07.001; Gu JX, 2013, INT J CLIN EXP PATHO, V6, P2872; Kim S, 2009, EXP DERMATOL, V18, P1016, DOI 10.1111/j.1600-0625.2009.00894.x; Kommagani R, 2006, ONCOGENE, V25, P3745, DOI 10.1038/sj.onc.1209412; Li FF, 2012, GENE, V495, P95, DOI 10.1016/j.gene.2011.12.057; Linsley C, 2013, TISSUE ENG PT A, V19, P1416, DOI [10.1089/ten.tea.2012.0523, 10.1089/ten.TEA.2012.0523]; Liu SB, 2013, J BIOANAL BIOMED S, VS3, P004, DOI [10.4172/1948-593X.S3-004, DOI 10.4172/1948-593X.S3-004]; Lu YJ, 2013, GENE, V519, P251, DOI 10.1016/j.gene.2013.02.021; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Ogawa E, 2008, J BIOL CHEM, V283, P34241, DOI 10.1074/jbc.M804101200; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Sareen D, 2014, STEM CELL TRANSL MED, V3, P1002, DOI 10.5966/sctm.2014-0076; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Studer D, 2012, TISSUE ENG PART C-ME, V18, P761, DOI 10.1089/ten.tec.2012.0081; Talos F, 2010, CELL DEATH DIFFER, V17, P184, DOI 10.1038/cdd.2009.158; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; Warner SMB, 2013, AM J RESP CELL MOL, V49, P978, DOI 10.1165/rcmb.2012-0447OC; Weinstein RS, 2012, ENDOCRIN METAB CLIN, V41, P595, DOI 10.1016/j.ecl.2012.04.004; Wolff S, 2009, CELL DEATH DIFFER, V16, P1108, DOI 10.1038/cdd.2009.25; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026504	37	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123642	10.1371/journal.pone.0123642	http://dx.doi.org/10.1371/journal.pone.0123642			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849854	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800248
J	Hasegawa, J; Hidaka, H; Kuriyama, S; Obara, T; Hashimoto, K; Tateda, Y; Okumura, Y; Kobayashi, T; Katori, Y				Hasegawa, Jun; Hidaka, Hiroshi; Kuriyama, Shinichi; Obara, Taku; Hashimoto, Ken; Tateda, Yutaka; Okumura, Yuri; Kobayashi, Toshimitsu; Katori, Yukio			Change in and Long-Term Investigation of Neuro-Otologic Disorders in Disaster-Stricken Fukushima Prefecture: Retrospective Cohort Study before and after the Great East Japan Earthquake	PLOS ONE			English	Article							MENIERES-DISEASE; SYMPTOMS; ZOSTER; HEALTH; LIFE	On March 11, 2011, Japan's northeast Pacific coast was hit by a gigantic earthquake and subsequent tsunami. Soma City in Fukushima Prefecture is situated approximately 44 km north of Fukushima Daiichi Nuclear Power Plant. Soma General Hospital is the only hospital in Soma City that provides full-time otolaryngological medical care. We investigated the changes in new patients from one year before to three years after the disaster. We investigated 18,167 new patients treated at our department during the four years from April 1, 2010 to March 31, 2014. Of the new patients, we categorized the diagnoses into Meniere's disease, acute low-tone sensorineural hearing loss, vertigo, sudden deafness, tinnitus, and facial palsy as neuro-otologic symptoms. We also investigated the changes in the numbers of patients whom we examined at that time concerning other otolaryngological disorders, including epistaxis, infectious diseases of the laryngopharynx, and allergic rhinitis. The total number of new patients did not change remarkably on a year-to-year basis. Conversely, cases of vertigo, Meniere's disease, and acute low-tone sensorineural hearing loss increased in number immediately after the disaster, reaching a plateau in the second year and slightly decreasing in the third year. Specifically, 4.8% of patients suffering from these neuro-otologic diseases had complications from depression and other mental diseases. With regard to new patients in our department, there was no apparent increase in the number of patients suffering from diseases other than neuro-otologic diseases, including epistaxis, and allergic rhinitis. Patients suffering from vertigo and/or dizziness increased during the first few years after the disaster. These results are attributed to the continuing stress and tension of the inhabitants. This investigation of those living in the disaster area highlights the need for long-term support.	[Hasegawa, Jun] Soma Gen Hosp, Dept Otorhinolaryngol, Soma, Fukushima, Japan; [Hasegawa, Jun; Hidaka, Hiroshi; Tateda, Yutaka; Okumura, Yuri; Kobayashi, Toshimitsu; Katori, Yukio] Tohoku Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Sendai, Miyagi 980, Japan; [Kuriyama, Shinichi] Tohoku Univ, Int Res Inst Disaster Sci IRIDeS, Dept Disaster Publ Hlth, Sendai, Miyagi 980, Japan; [Kuriyama, Shinichi] Tohoku Univ, Grad Sch Med, Dept Mol Epidemiol Environm, Sendai, Miyagi 980, Japan; [Kuriyama, Shinichi] Tohoku Univ, Grad Sch Med, Genome Res Ctr, Sendai, Miyagi 980, Japan; [Kuriyama, Shinichi; Obara, Taku] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Div Mol Epidemiol, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Hasegawa, J (corresponding author), Soma Gen Hosp, Dept Otorhinolaryngol, Soma, Fukushima, Japan.	junha@orl.med.tohoku.ac.jp	Hidaka, Hiroshi/N-2957-2016	Hidaka, Hiroshi/0000-0001-5214-3159; xing zhi, shi zhi/0000-0003-3289-5681	Ministry of Education, Science, and Culture of Japan [26462594]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A portion of this study was supported by Grand-in-Aid No. 26462594 (to H. Hidaka) from the Ministry of Education, Science, and Culture of Japan. The funders had no role in study design, data collection, and analysis. The authors declare no other funding or sources of support.	ABRAMSON JH, 1965, BRIT J PREV SOC MED, V19, P103; Aoki Y, 2014, SOC PSYCHIAT PSYCHIA; Beasley NJP, 1996, J LARYNGOL OTOL, V110, P1107, DOI 10.1017/S002221510013590X; Berliner, 2013, OTOLARYNG HEAD NECK, V149, P914, DOI DOI 10.1177/0194599813506546; Brandt T., 1999, VERTIGO ITS MULTISEN; COKER NJ, 1989, ARCH OTOLARYNGOL, V115, P1355; Furuta Y, 2000, NEUROLOGY, V55, P708, DOI 10.1212/WNL.55.5.708; Hallpike C S, 1938, Proc R Soc Med, V31, P1317; Honma M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00749; Ishii T, 2013, J BONE MINER METAB, V31, P613, DOI 10.1007/s00774-013-0482-5; Kanno T, 2014, J GASTROENTEROL, V15, P483; Kukihara H, 2014, PSYCHIAT CLIN NEUROS, V21, P1; Matsuo T, 1986, Auris Nasus Larynx, V13, P11; Merchant SN, 2005, OTOL NEUROTOL, V26, P151, DOI 10.1097/00129492-200503000-00004; PARNES LS, 1992, LARYNGOSCOPE, V102, P988; Sheu JJ, 2012, ACTA OTO-LARYNGOL, V132, P167, DOI 10.3109/00016489.2011.633227; Shibahara S, 2011, TOHOKU J EXP MED, V223, P305, DOI 10.1620/tjem.223.305; Shimono M, 2013, OTOL NEUROTOL, V34, P1241, DOI 10.1097/MAO.0b013e3182990e81; Suzuki H, 2014, ANN OTO RHINOL LARYN, V18, P1; Takahashi M, 2005, ORL-J OTO-RHIN-LARYN, V67, P300, DOI 10.1159/000089412; Takahashi M, 2001, ACTA OTO-LARYNGOL, V121, P254; Tevzadze N, 2007, Georgian Med News, P36; Tsai KY, 2007, J PSYCHIATR RES, V41, P90, DOI 10.1016/j.jpsychires.2005.10.004; Tsubokura M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-267; Yamaki T, 2014, DISASTER MED PUBLIC, V23, P1; Yamamoto T, 2000, ACTA OTO-LARYNGOL, V120, P504, DOI 10.1080/000164800750046009; YARDLEY L, 1994, CLIN OTOLARYNGOL, V19, P109, DOI 10.1111/j.1365-2273.1994.tb01192.x; Yardley L, 2001, J NERV MENT DIS, V189, P321, DOI 10.1097/00005053-200105000-00009	28	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122631	10.1371/journal.pone.0122631	http://dx.doi.org/10.1371/journal.pone.0122631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849607	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800150
J	Kawahara, T; Miyamoto, H; Ito, H; Terao, H; Uemura, H; Kubota, Y; Matsuzaki, J				Kawahara, Takashi; Miyamoto, Hiroshi; Ito, Hiroki; Terao, Hideyuki; Uemura, Hiroji; Kubota, Yoshinobu; Matsuzaki, Junichi			Discolored Ureteral Stents: Findings in Urinalysis and Urine Culture	PLOS ONE			English	Article							ENDOUROLOGICAL MANAGEMENT; ENCRUSTATION; INCRUSTATION; BIOFILM	Objective Discolored ureteral stents are sometimes encountered in daily clinical practice; however, the mechanism(s) underlying the development of discolored ureteral stents remain unknown. In this study, we retrospectively analyzed the characteristics of discolored ureteral stents based on the results of a urinalysis and urine culture. Materials & Methods We identified a total of 26 patients with discolored ureteral stents and compared the findings in the urinalyses and urine culture in 21 discolored versus 45 non-colored ureteral stents. Results The median and mean (+/- SD) duration of stenting time was 78.0 and 81.3 (+/- 21.3) days for the discolored ureteral stents and 69.0 and 74.9 (+/- 19.8) days for the non-colored ureteral stents, respectively (P = 0.25). The discolored ureteral stents were associated with a higher mean urine pH than the non-colored ureteral stents (mean: 6.4 vs 6.0, P < 0.05). There were no significant differences between the two groups in the RBC (P = 0.51) and WBC (P = 0.35) counts in the urinalyses. In addition, the rate of a positive culture in the patients with discolored stents [20 of 21 (95.2%)] was significantly (P < 0.01) higher than that observed in the patients with non-colored ureteral stents [33 of 45 (73.3%)]. Conclusions In this study, the subjects with discolored ureteral stents showed a significantly higher likelihood of having a positive urine culture and also demonstrated higher pH values in the urinalyses. However, no clear cut-off point to predict discoloration was indicated.	[Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Uemura, Hiroji; Kubota, Yoshinobu] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan; [Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Matsuzaki, Junichi] Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Kawahara, Takashi; Miyamoto, Hiroshi] Johns Hopkins Univ, Sch Med, Dept Pathol & Urol, Baltimore, MD USA	Yokohama City University; Johns Hopkins University	Kawahara, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan.	takashi_tk2001@yahoo.co.jp		Miyamoto, Hiroshi/0000-0001-7610-7769	Department of Defense Prostate Cancer Research Program [W81XWH-13-1-0412]	Department of Defense Prostate Cancer Research Program(United States Department of Defense)	This work was supported by Department of Defense Prostate Cancer Research Program (W81XWH-13-1-0412): HM.	Borboroglu PG, 2000, J UROLOGY, V164, P648, DOI 10.1016/S0022-5347(05)67272-2; Bultitude MF, 2003, UROLOGY, V62, P622, DOI 10.1016/S0090-4295(03)00506-5; Chew B, 2012, J ENDOUROL; ELFAQIH SR, 1991, J UROLOGY, V146, P1487, DOI 10.1016/S0022-5347(17)38146-6; Joshi H, 2012, J ENDOUROL, V26, P924, DOI 10.1089/end.2012.0192; Kawahara T, 2012, BMJ CASE REP, V2012; Kawahara T, 2012, J ENDOUROL, V26, P178, DOI 10.1089/end.2011.0385; Kawahara T, 2012, UROL INT, V88, P48, DOI 10.1159/000332431; KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x; Kim TH, 2012, J BIOMED MATER RES A, V100A, P1512, DOI 10.1002/jbm.a.34086; Mohan-Pillai K, 1999, J ENDOUROL, V13, P377, DOI 10.1089/end.1999.13.377; Murthy KVR, 2010, INT BRAZ J UROL, V36, P420, DOI 10.1590/S1677-55382010000400005; Robert M, 1997, UROL INT, V58, P100, DOI 10.1159/000282959; SCHULZE KA, 1985, UROLOGY, V25, P616, DOI 10.1016/0090-4295(85)90293-6; Wollin TA, 1998, J ENDOUROL, V12, P101, DOI 10.1089/end.1998.12.101; Xu CL, 2009, LASER MED SCI, V24, P140, DOI 10.1007/s10103-007-0537-8; ZIMSKIND PD, 1967, J UROLOGY, V97, P840, DOI 10.1016/S0022-5347(17)63130-6	17	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122984	10.1371/journal.pone.0122984	http://dx.doi.org/10.1371/journal.pone.0122984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849790	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800188
J	Borst, LB; Suyemoto, MM; Scholl, EH; Fuller, FJ; Barnes, HJ				Borst, Luke B.; Suyemoto, M. Mitsu; Scholl, Elizabeth H.; Fuller, Fredrick J.; Barnes, H. John			Comparative Genomic Analysis Identifies Divergent Genomic Features of Pathogenic Enterococcus cecorum Including a Type IC CRISPR-Cas System, a Capsule Locus, an epa-Like Locus, and Putative Host Tissue Binding Proteins	PLOS ONE			English	Article							EXPERIMENTAL REPRODUCTION; GENE-CLUSTER; FAECALIS; BROILER; SPONDYLITIS; RESISTANCE; EVOLUTION; CLASSIFICATION; OSTEOMYELITIS; PERITONITIS	Enterococcus cecorum (EC) is the dominant enteric commensal of adult chickens and contributes to the gut consortia of many avian and mammalian species. While EC infection is an uncommon zoonosis, like other enterococcal species it can cause life-threating nosocomial infection in people. In contrast to other enterococci which are considered opportunistic pathogens, emerging pathogenic strains of EC cause outbreaks of musculoskeletal disease in broiler chickens. Typical morbidity and mortality is comparable to other important infectious diseases of poultry. In molecular epidemiologic studies, pathogenic EC strains were found to be genetically clonal. These findings suggested acquisition of specific virulence determinants by pathogenic EC. To identify divergent genomic features and acquired virulence determinants in pathogenic EC; comparative genomic analysis was performed on genomes of 3 pathogenic and 3 commensal strains of EC. Pathogenic isolates had smaller genomes with a higher GC content, and they demonstrated large regions of synteny compared to commensal isolates. A molecular phylogenetic analysis demonstrated sequence divergence in pathogenic EC genomes. At a threshold of 98% identity, 414 predicted proteins were identified that were highly conserved in pathogenic EC but not in commensal EC. Among these, divergent CRISPR-cas defense loci were observed. In commensal EC, the type IIA arrangement typical for enterococci was present; however, pathogenic EC had a type IC locus, which is novel in enterococci but commonly observed in streptococci. Potential mediators of virulence identified in this analysis included a polysaccharide capsular locus similar to that recently described for E. faecium, an epa-like locus, and cell wall associated proteins which may bind host extracellular matrix. This analysis identified specific genomic regions, coding sequences, and predicted proteins which may be related to the divergent evolution and increased virulence of emerging pathogenic strains of EC.	[Borst, Luke B.; Suyemoto, M. Mitsu; Fuller, Fredrick J.; Barnes, H. John] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA; [Scholl, Elizabeth H.] N Carolina State Univ, Coll Agr & Life Sci, Coll Sci, Bioinformat Consulting & Serv Core,Bioinformat Re, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Borst, LB (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	luke_borst@ncsu.edu		Fuller, Frederick/0000-0002-6650-4186; Borst, Luke/0000-0002-2736-1960	NCSU-CVM funds	NCSU-CVM funds	This study was funded through internal NCSU-CVM funds. The funders had no role in study design, data collection and anaylsis, decision to publish, or preparation of the manuscript.	Ahmed FZ, 2011, DIAGN MICR INFEC DIS, V70, P525, DOI 10.1016/j.diagmicrobio.2011.04.001; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; [Anonymous], 2014, ENT COMM LEAD CAUS D; ARDUINO RC, 1994, INFECT IMMUN, V62, P5587, DOI 10.1128/IAI.62.12.5587-5594.1994; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Armour N.K., 2011, POULT INF PROF, V117, P1; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz T., 2007, World Poultry, V23, P44; Boerlin P, 2012, VET MICROBIOL, V157, P405, DOI 10.1016/j.vetmic.2012.01.001; Borst LB, 2014, AVIAN DISEASES IN PR; Borst LB, 2012, AVIAN PATHOL, V41, P479, DOI 10.1080/03079457.2012.718070; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Brede DA, 2011, J BACTERIOL, V193, P2377, DOI 10.1128/JB.00183-11; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; De Baere T, 2000, J CLIN MICROBIOL, V38, P3511, DOI 10.1128/JCM.38.9.3511-3512.2000; De Herdt P, 2009, VLAAMS DIERGEN TIJDS, V78, P44; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; DEVRIESE LA, 1991, J APPL BACTERIOL, V71, P46; DEVRIESE LA, 1983, INT J SYST BACTERIOL, V33, P772, DOI 10.1099/00207713-33-4-772; Devriese LA, 2002, VLAAMS DIERGEN TIJDS, V71, P219; Gilmore MS, 2002, ENTEROCOCCI: PATHOGENESIS, MOLECULAR BIOLOGY, AND ANTIBIOTIC RESISTANCE, P301; Gilmore MS, 2014, ENTEROCOCCI COMMENSA; Gingerich E, 2009, SPINAL ABSCESSES HIT; Goh SH, 2000, J CLIN MICROBIOL, V38, P3953, DOI 10.1128/JCM.38.11.3953-3959.2000; Greub G, 1997, EUR J CLIN MICROBIOL, V16, P594, DOI 10.1007/BF02447923; Hendrickx APA, 2009, INFECT IMMUN, V77, P5097, DOI 10.1128/IAI.00275-09; Hsueh PR, 2000, J CLIN MICROBIOL, V38, P2450; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Jackson CR, 2004, J CLIN MICROBIOL, V42, P3558, DOI 10.1128/JCM.42.8.3558-3565.2004; Jung A, 2012, TIERAERZTL PRAX G N, V40, P94; Jung A, 2013, AVIAN PATHOL, V42, P552, DOI 10.1080/03079457.2013.850151; Kense MJ, 2011, AVIAN PATHOL, V40, P603, DOI 10.1080/03079457.2011.619165; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Makrai L, 2011, ACTA VET HUNG, V59, P11, DOI 10.1556/AVet.59.2011.1.2; Manson JM, 2010, P NATL ACAD SCI USA, V107, P12269, DOI 10.1073/pnas.1000139107; Martin LT, 2011, AVIAN DIS, V55, P273, DOI 10.1637/9614-121410-Reg.1; McBride SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000582; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Naser SM, 2005, MICROBIOL-SGM, V151, P2141, DOI 10.1099/mic.0.27840-0; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Ozawa Y, 2000, SYST APPL MICROBIOL, V23, P230, DOI 10.1016/S0723-2020(00)80009-0; PALMER K, 2012, APPL ENVIRON MICROB, V78, DOI DOI 10.1128/MBIO.00318-11; Palmer KL, 2010, MBIO, V1, DOI 10.1128/mBio.00227-10; Palmer KL, 2010, J BACTERIOL, V192, P2469, DOI 10.1128/JB.00153-10; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Peppoloni S, 2011, MICROBIOL-SGM, V157, P1816, DOI 10.1099/mic.0.047381-0; Poyart C, 2000, J CLIN MICROBIOL, V38, P415; Qin X, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-135; Rakita RM, 2000, FEMS IMMUNOL MED MIC, V28, P291, DOI 10.1111/j.1574-695X.2000.tb01489.x; Robbins KM, 2012, AVIAN DIS, V56, P768, DOI 10.1637/10253-052412-Case.1; Sava IG, 2010, CLIN MICROBIOL INFEC, V16, P533, DOI 10.1111/j.1469-0691.2010.03213.x; Sillapaa J, 2008, MICROBIOL-SGM, V154, P3199, DOI 10.1099/mic.0.2008/017319-0; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Spraggon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010919; Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426; System CAHaFSL, 2009, 2008 ANN REP; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan CK, 2010, J INFECTION, V61, P34, DOI 10.1016/j.jinf.2010.04.007; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Vandamme P, 1996, J CLIN MICROBIOL, V34, P2572, DOI 10.1128/JCM.34.10.2572-2576.1996; Wijetunge DS, 2012, J VET DIAGN INVEST, V24, P1166, DOI 10.1177/1040638712463563; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Woo PCY, 2004, J CLIN MICROBIOL, V42, P919, DOI 10.1128/JCM.42.2.919-922.2004; Wood AM, 2002, VET REC, V150, P27; Xu Y, 1998, INFECT IMMUN, V66, P4313; Xu Y, 1997, INFECT IMMUN, V65, P4207, DOI 10.1128/IAI.65.10.4207-4215.1997; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000; Zeng J, 2004, J CLIN MICROBIOL, V42, P1149, DOI 10.1128/JCM.42.3.1149-1154.2004	73	23	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121294	10.1371/journal.pone.0121294	http://dx.doi.org/10.1371/journal.pone.0121294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860249	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300022
J	Daft, PG; Yang, Y; Napierala, D; Zayzafoon, M				Daft, Paul G.; Yang, Yang; Napierala, Dobrawa; Zayzafoon, Majd			The Growth and Aggressive Behavior of Human Osteosarcoma Is Regulated by a CaMKII-Controlled Autocrine VEGF Signaling Mechanism	PLOS ONE			English	Article							SUPPRESSES TUMOR-GROWTH; PROTEIN-KINASE-II; CELL-CYCLE ARREST; INDUCIBLE FACTOR-1; ANGIOGENIC FACTORS; FACTOR EXPRESSION; ALPHA; BEVACIZUMAB; ACTIVATION; RECEPTORS	Osteosarcoma (OS) is a hyperproliferative malignant tumor that requires a high vascular density to maintain its large volume. Vascular Endothelial Growth Factor (VEGF) plays a crucial role in angiogenesis and acts as a paracrine and autocrine agent affecting both endothelial and tumor cells. The alpha-Ca2+/Calmodulin kinase two (alpha-CaMKII) protein is an important regulator of OS growth. Here, we investigate the role of alpha-CaMKII-induced VEGF in the growth and tumorigenicity of OS. We show that the pharmacologic and genetic inhibition of alpha-CaMKII results in decreases in VEGF gene expression (50%) and protein secretion (55%), while alpha-CaMKII overexpression increases VEGF gene expression (250%) and protein secretion (1,200%). We show that aggressive OS cells (143B) express high levels of VEGF receptor 2 (VEGFR-2) and respond to exogenous VEGF (100nm) by increasing intracellular calcium (30%). This response is ameliorated by the VEGFR inhibitor CBO-P11, suggesting that secreted VEGF results in autocrine stimulated alpha-CaMKII activation. Furthermore, we show that VEGF and alpha-CaMKII inhibition decreases the transactivation of the HIF-1 alpha and AP-1 reporter constructs. Additionally, chromatin immunoprecipitation assay shows significantly decreased binding of HIF-1 alpha and AP-1 to their responsive elements in the VEGF promoter. These data suggest that alpha-CaMKII regulates VEGF transcription by controlling HIF-1 alpha and AP-1 transcriptional activities. Finally, CBO-P11, KN-93 (CaMKII inhibitor) and combination therapy significantly reduced tumor burden in vivo. Our results suggest that VEGF-induced OS tumor growth is controlled by CaMKII and dual therapy by CaMKII and VEGF inhibitors could be a promising therapy against this devastating adolescent disease.	[Daft, Paul G.; Yang, Yang; Zayzafoon, Majd] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Napierala, Dobrawa] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Inst Oral Hlth Res, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Zayzafoon, M (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	majd@uab.edu		Napierala, Dobrawa/0000-0002-7383-1011	National Institutes of Health/National Cancer Institute [2P01CA098912]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [5R01AR053898-05]; NATIONAL CANCER INSTITUTE [R01CA151538, P01CA098912] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053898] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institutes of Health/National Cancer Institute (#2P01CA098912 to MZ; http://www.cancer.gov/) and the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (#5R01AR053898-05 to MZ; http://www.niams.nih.gov/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai J, 2009, PEDIATR BLOOD CANCER, V53, P1035, DOI 10.1002/pbc.22178; Bellamy WT, 1999, CANCER RES, V59, P728; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Chandra A, 2005, SURGERY, V138, P780, DOI 10.1016/j.surg.2005.07.010; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Choo MK, 2009, BONE, V45, P579, DOI 10.1016/j.bone.2009.05.009; Daft PG, 2013, MOL CANCER RES, V11, P349, DOI 10.1158/1541-7786.MCR-12-0572; Dellapasqua S, 2008, J CLIN ONCOL, V26, P4899, DOI 10.1200/JCO.2008.17.4789; Dias S, 2001, P NATL ACAD SCI USA, V98, P10857, DOI 10.1073/pnas.191117498; Ferrer FA, 1999, UROLOGY, V54, P567, DOI 10.1016/S0090-4295(99)00156-9; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Guidi AJ, 1996, CANCER-AM CANCER SOC, V78, P454; Hall MC, 2003, J BIOL CHEM, V278, P10304, DOI 10.1074/jbc.M212334200; Huang Z, 2004, WORLD J GASTROENTERO, V10, P463, DOI 10.3748/wjg.v10.i4.463; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hurwitz Herbert, 2004, Clin Colorectal Cancer, V4 Suppl 2, pS62, DOI 10.3816/CCC.2004.s.010; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Garcia JMJ, 2008, CLIN TRANSL ONCOL, V10, P583, DOI 10.1007/s12094-008-0254-7; Kaya M, 2000, CLIN CANCER RES, V6, P572; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Kim BW, 2008, CELL SIGNAL, V20, P714, DOI 10.1016/j.cellsig.2007.12.009; Klettner A, 2010, CUTAN OCUL TOXICOL, V29, P122, DOI 10.3109/15569521003745685; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Ma SL, 2009, J BIOL CHEM, V284, P24773, DOI 10.1074/jbc.M109.028621; Mattern J, 1996, BRIT J CANCER, V73, P931, DOI 10.1038/bjc.1996.166; Najdi R, 2009, ONCOGENE, V28, P4133, DOI 10.1038/onc.2009.271; Ohba T, 2014, MOL CANCER RES, V12, P1100, DOI 10.1158/1541-7786.MCR-14-0037; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Reardon DA, 2009, BRIT J CANCER, V101, P1986, DOI 10.1038/sj.bjc.6605412; Rokhlin OW, 2007, CANCER BIOL THER, V6, P732, DOI 10.4161/cbt.6.5.3975; Rubin P, 2010, SEMIN RADIAT ONCOL, V20, P3, DOI 10.1016/j.semradonc.2009.08.001; Salnikow K, 2002, MOL CELL BIOL, V22, P1734, DOI 10.1128/MCB.22.6.1734-1741.2002; Shi Q, 2001, CANCER RES, V61, P4143; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Si JT, 2008, CANCER RES, V68, P3733, DOI 10.1158/0008-5472.CAN-07-2509; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; Suzuki K, 1996, CANCER RES, V56, P3004; TISCHER E, 1991, J BIOL CHEM, V266, P11947; URIBEBOTERO G, 1977, AM J CLIN PATHOL, V67, P427; Wang C, 2009, J BIOL CHEM, V284, P3804, DOI 10.1074/jbc.M807191200; Wang CM, 2008, J BIOL CHEM, V283, P11565, DOI 10.1074/jbc.M800436200; Wang ES, 2004, BLOOD, V104, P2893, DOI 10.1182/blood-2004-01-0226; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010456; Westra J, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-61; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Yang M, 2003, P NATL ACAD SCI USA, V100, P14259, DOI 10.1073/pnas.2436101100; Yoshiji H, 1996, CANCER RES, V56, P2013; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Yuan KY, 2007, LAB INVEST, V87, P938, DOI 10.1038/labinvest.3700658; Zayzafoon M, 2005, J BIOL CHEM, V280, P7049, DOI 10.1074/jbc.M412680200	52	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121568	10.1371/journal.pone.0121568	http://dx.doi.org/10.1371/journal.pone.0121568			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860662	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300026
J	Wang, X; Chen, DJ; Wang, YQ; Xie, J				Wang, Xia; Chen, Dijia; Wang, Yuqi; Xie, Jun			De novo Transcriptome Assembly and the Putative Biosynthetic Pathway of Steroidal Sapogenins of Dioscorea composita	PLOS ONE			English	Article							SAPONIN BIOSYNTHESIS; BETA-AMYRIN; PLANT	The plant Dioscorea composita has important applications in the medical and energy industries, and can be used for the extraction of steroidal sapogenins (important raw materials for the synthesis of steroidal drugs) and bioethanol production. However, little is known at the genetic level about how sapogenins are biosynthesized in this plant. Using Illumina deep sequencing, 62,341 unigenes were obtained by assembling its transcriptome, and 27,720 unigenes were annotated. Of these, 8,022 unigenes were mapped to 243 specific pathways, and 531 unigenes were identified to be involved in 24 secondary metabolic pathways. 35 enzymes, which were encoded by 79 unigenes, were related to the biosynthesis of steroidal sapogenins in this transcriptome database, covering almost all the nodes in the steroidal pathway. The results of real-time PCR experiments on ten related transcripts (HMGR, MK, SQLE, FPPS, DXS, CAS, HMED, CYP51, DHCR7, and DHCR24) indicated that sapogenins were mainly biosynthesized by the mevalonate pathway. The expression of these ten transcripts in the tuber and leaves was found to be much higher than in the stem. Also, expression in the shoots was low. The nucleotide and protein sequences and conserved domains of four related genes (HMGR, CAS, SQS, and SMT1) were highly conserved between D. composita and D. zingiberensis; but expression of these four genes is greater in D. composita. However, there is no expression of these key enzymes in potato and no steroidal sapogenins are synthesized.	[Wang, Xia; Chen, Dijia; Wang, Yuqi; Xie, Jun] South China Agr Univ, Inst New Energy & New Mat, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Xia; Chen, Dijia; Wang, Yuqi; Xie, Jun] Guangdong Regular Higher Educ Inst, Key Lab Biomass Energy, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Xia; Chen, Dijia; Wang, Yuqi; Xie, Jun] Minist Agr, Key Lab Energy Plants Resource & Utilizat, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University; Ministry of Agriculture & Rural Affairs	Xie, J (corresponding author), South China Agr Univ, Inst New Energy & New Mat, Guangzhou 510642, Guangdong, Peoples R China.	xiejun@scau.edu.cn			"Twelfth Five-Year" National Science and Technology Support Project of China [2015BAD15B03, 2011BAD22B01]; DongGuan Innovative Research Team Program [2014607101005]; Key Science & Technology Project of Guangdong Province of China [2011B090400437]	"Twelfth Five-Year" National Science and Technology Support Project of China; DongGuan Innovative Research Team Program; Key Science & Technology Project of Guangdong Province of China	The work was supported by "Twelfth Five-Year" National Science and Technology Support Project of China (2015BAD15B03), the DongGuan Innovative Research Team Program (2014607101005), the Key Science & Technology Project of Guangdong Province of China (2011B090400437), and the "Twelfth Five-Year" National Science and Technology Support Project of China (2011BAD22B01).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chappell J, 2002, CURR OPIN PLANT BIOL, V5, P151, DOI 10.1016/S1369-5266(02)00241-8; Deying T, 2003, TROPICAL AGR SCI TEC, V26, P16; Gonzalez-Lamothe R, 2009, INT J MOL SCI, V10, P3400, DOI 10.3390/ijms10083400; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Huilan Z., 1990, ACTA BOT YUNNANICA, V12, P75; Jenner H, 2005, PLANTA, V220, P503, DOI 10.1007/s00425-004-1434-z; Kohara A, 2007, PHYTOCHEMISTRY, V68, P478, DOI 10.1016/j.phytochem.2006.11.020; Laurent P, 2003, NATURWISSENSCHAFTEN, V90, P524, DOI 10.1007/s00114-003-0471-y; Li R, 2006, J MASS SPECTROM, V41, P1, DOI 10.1002/jms.988; Logacheva MD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-30; Minato D, 2013, TETRAHEDRON, V69, P8019, DOI 10.1016/j.tet.2013.06.105; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Osbourn AE, 2003, NEW PHYTOL, V159, P101, DOI 10.1046/j.1469-8137.2003.00759.x; Osbourn AE, 2003, PHYTOCHEMISTRY, V62, P1, DOI 10.1016/S0031-9422(02)00393-X; Palazon J, 2006, FITOTERAPIA, V77, P216, DOI 10.1016/j.fitote.2006.02.005; Perez-Labrada K, 2011, TETRAHEDRON, V67, P7713, DOI 10.1016/j.tet.2011.08.003; Rodriguez MCS, 2010, PLANT J, V63, P212, DOI 10.1111/j.1365-313X.2010.04243.x; Sautour M, 2007, J NAT MED, V61, P91, DOI 10.1007/s11418-006-0126-3; Sawai S, 2006, PLANT SCI, V170, P247, DOI 10.1016/j.plantsci.2005.08.027; Schaller H, 2004, PLANT PHYSIOL BIOCH, V42, P465, DOI 10.1016/j.plaphy.2004.05.012; Shunli Y, 2004, CHINESE TRANDITIONAL, V35, P1213; Suzuki H, 2002, PLANT J, V32, P1033, DOI 10.1046/j.1365-313X.2002.01497.x; Szakiel Anna, 2005, Phytochemistry Reviews, V4, P151, DOI 10.1007/s11101-005-4053-9; Takagi K, 2011, PLANT CELL REP, V30, P1835, DOI 10.1007/s00299-011-1091-1; Tava A, 2011, PHYTOCHEM REV, V10, P459, DOI 10.1007/s11101-010-9169-x; Wang YB, 2007, BIOORGAN MED CHEM, V15, P2528, DOI 10.1016/j.bmc.2007.01.058; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zhang Chunqiu, 2008, Food Science, China, V29, P302; Zhang XX, 2013, J PHARMACEUT BIOMED, V84, P117, DOI 10.1016/j.jpba.2013.02.005	33	16	16	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124560	10.1371/journal.pone.0124560	http://dx.doi.org/10.1371/journal.pone.0124560			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860891	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300140
J	Kubiak, BB; Galiano, D; de Freitas, TRO				Kubiak, Bruno Busnello; Galiano, Daniel; Ochotorena de Freitas, Thales Renato			Sharing the Space: Distribution, Habitat Segregation and Delimitation of a New Sympatric Area of Subterranean Rodents	PLOS ONE			English	Article							CTENOMYS-AUSTRALIS; FOSSORIAL RODENTS; POCKET GOPHERS; TUCO-TUCOS; OCTODONTIDAE; TALARUM; MINUTUS; DIVERGENCE; SYSTEMS; MAMMALS	Subterranean rodents of the genus Ctenomys usually present an allopatric or parapatric distribution. Currently, two cases of sympatry have been recognized for the genus in the coastal dunes of southern Argentina and southern Brazil. In this context, they are ideal models to test hypotheses about the factors that delimit the patterns of space use and to understand interspecific interactions in small mammals. We investigated the vegetation structure, plant biomass and soil hardness selected by two species of subterranean rodents (Ctenomys flamarioni and C. minutus) when distributed in sympatry and allopatry from nine different areas along the line of coastal dunes in southern Brazil. In addition, our work presents a new record of a third area of sympatry for the genus Ctenomys. Ctenomys flamarioni and C. minutus show habitat segregation in the area where they occur in sympatry. These species show segregation in their selection of microhabitats, differing in relation to soil hardness, plant biomass, and plant cover. Ctenomys flamarioni showed a distinction in habitat selection when occurring in allopatry and sympatry, whereas C. minutus selected the same habitat characteristics under both conditions. A possible explanation to the observed pattern is that these species have acquired different adaptations over time which allows them the ability to exploit different resources and thus avoid competitive interactions all together.	[Kubiak, Bruno Busnello; Ochotorena de Freitas, Thales Renato] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil; [Galiano, Daniel] Univ Reg Alto Uruguai & Missoes, Programa Posgrad Ecol, Erechim, RS, Brazil; [Ochotorena de Freitas, Thales Renato] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Federal do Rio Grande do Sul	Kubiak, BB (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Anim, Porto Alegre, RS, Brazil.	busnelo@hotmail.com	Kubiak, Bruno Busnello/B-5883-2016; Galiano, Daniel/ABV-4574-2022; Freitas, Thales Renato Ochotorena de/G-1160-2012; Galiano, Daniel/O-1671-2013	Kubiak, Bruno Busnello/0000-0002-3996-5411; Freitas, Thales Renato Ochotorena de/0000-0002-1019-9303; Galiano, Daniel/0000-0003-1428-8634	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian Ministry of Science and Technology; Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Science and Technology; Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	Funding was provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Ministry of Science and Technology, and the Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, REV BRASILEIRA GEOCI, DOI DOI 10.25249/0375-7536.2000303474476; BORGHI CE, 1994, Z SAUGETIERKD, V59, P52; BUSCH C, 1989, COMP BIOCHEM PHYS A, V93, P345, DOI 10.1016/0300-9629(89)90048-0; Busch C, 2000, LIFE UNDERGROUND, P183; Cameron GN, 2000, LIFE UNDERGROUND, P227; Choate JR, 1998, J MAMMAL, V79, P1416; COMPARATORE VM, 1992, Z SAUGETIERKD, V57, P47; Contreras J. R., 1965, Physis Buenos Aires, V25, P169; CONTRERAS LC, 1990, PROG CLIN BIOL RES, V335, P231; Cutrera AP, 2010, J MAMMAL, V91, P1425, DOI 10.1644/10-MAMM-A-057.1; DEFREITAS TRO, 1994, CYTOGENET CELL GENET, V67, P193, DOI 10.1159/000133821; DEFREITAS TRO, 1995, STUD NEOTROP FAUNA E, V30, P53, DOI 10.1080/01650529509360941; Freygang CC, 2004, GENETICA, V121, P125, DOI 10.1023/B:GENE.0000040376.56321.be; Galiano D, 2014, ACTA THERIOL, V59, P583, DOI 10.1007/s13364-014-0193-x; Galiano D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097301; Gause G. F., 1934, STRUGGLE EXISTENCE; HICKMAN GC, 1977, TEX J SCI, V29, P235; KENNERLY TE, 1959, EVOLUTION, V13, P247, DOI 10.2307/2405877; LACEY EA, 2000, LIFE UNDERGROUND; LESSA EP, 1989, J MAMMAL, V70, P689, DOI 10.2307/1381704; Lopes CM, 2015, HEREDITY, V114, P525, DOI 10.1038/hdy.2014.109; Lopes CM, 2013, HEREDITY, V111, P293, DOI 10.1038/hdy.2013.49; Lovy M, 2012, J ZOOL, V286, P145, DOI 10.1111/j.1469-7998.2011.00860.x; MALIZIA AI, 1991, ACTA THERIOL, V36, P87, DOI 10.4098/AT.arch.91-5; Massarini IA, 2005, CARYOLOGIA, V58, P21; MILLER RS, 1964, ECOLOGY, V45, P256, DOI 10.2307/1933839; NEVO E, 1979, ANNU REV ECOL SYST, V10, P269, DOI 10.1146/annurev.es.10.110179.001413; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; PEARSON OP, 1984, J ZOOL, V202, P225; R Development Core Team, 2012, R LANG ENV STAT COMP; REICHMAN OJ, 1972, J MAMMAL, V53, P21, DOI 10.2307/1378824; Reig O.A., 1990, Progress in Clinical and Biological Research, V335, P71; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Stolf R, 1991, REV BRAS CIENC SOLO, V15, P229, DOI DOI 10.1590/S0100-06832014000300009; THAELER C S JR, 1968, University of California Publications in Zoology, V86, P1; Tilman D, 1997, SPATIAL ECOLOGY ROLE; VASSALLO AI, 1992, BEHAVIOUR, V120, P40, DOI 10.1163/156853992X00192; VASSALLO AI, 1993, BEHAVIOUR, V127, P247, DOI 10.1163/156853993X00047; Villwock J.A, 1986, QUATERNARY S AM ANTA, P79	39	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123220	10.1371/journal.pone.0123220	http://dx.doi.org/10.1371/journal.pone.0123220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856399	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500080
J	Li, PP; Kwok, AHY; Jiang, JW; Ran, TT; Xu, DQ; Wang, WW; Leung, FC				Li, Pengpeng; Kwok, Amy H. Y.; Jiang, Jingwei; Ran, Tingting; Xu, Dongqing; Wang, Weiwu; Leung, Frederick C.			Comparative Genome Analyses of Serratia marcescens FS14 Reveals Its High Antagonistic Potential	PLOS ONE			English	Article							VI SECRETION SYSTEM; PROTEIN SECRETION; COG DATABASE; PSEUDOMONAS; SEQUENCE; EVOLUTION; ALIGNMENT; BACTERIA; METHYLTRANSFERASE; CLASSIFICATION	S. marcescensFS14 was isolated from an Atractylodes macrocephala Koidzplant that was infected by Fusarium oxysporum and showed symptoms of root rot. With the completion of the genome sequence of FS14, the first comprehensive comparative-genomic analysis of the Serratia genus was performed. Pan-genome and COG analyses showed that the majority of the conserved core genes are involved in basic cellular functions, while genomic factors such as prophages contribute considerably to genome diversity. Additionally, a Type I restriction-modification system, a Type III secretion system and tellurium resistance genes are found in only some Serratia species. Comparative analysis further identified that S. marcescens FS14 possesses multiple mechanisms for antagonism against other microorganisms, including the production of prodigiosin, bacteriocins, and multi-antibiotic resistant determinants as well as chitinases. The presence of two evolutionarily distinct Type VI secretion systems (T6SSs) in FS14 may provide further competitive advantages for FS14 against other microbes. To our knowledge, this is the first report of comparative analysis on T6SSs in the genus, which identifies four types of T6SSs in Serratia spp.. Competition bioassays of FS14 against the vital plant pathogenic bacterium Ralstonia solanacearum and fungi Fusarium oxysporumand Sclerotinia sclerotiorum were performed to support our genomic analyses, in which FS14 demonstrated high antagonistic activities against both bacterial and fungal phytopathogens.	[Li, Pengpeng; Kwok, Amy H. Y.; Jiang, Jingwei; Leung, Frederick C.] Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China; [Ran, Tingting; Xu, Dongqing; Wang, Weiwu] Nanjing Agr Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China; [Jiang, Jingwei; Leung, Frederick C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; University of Hong Kong	Leung, FC (corresponding author), Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China.	fcleung.njau@gmail.com	wang, weiwu/AAD-1490-2022	, weiwu/0000-0001-6922-9207; , Tingting/0000-0002-5541-3553; Xu, Dongqing/0000-0002-8388-2330	Bioinformatics Center of Nanjing Agricultural University	Bioinformatics Center of Nanjing Agricultural University	The work was supported by Bioinformatics Center of Nanjing Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Aylward FO, 2013, GENOME ANNOUNC, V1; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Buczolits S, 2002, INT J SYST EVOL MICR, V52, P445, DOI 10.1099/00207713-52-2-445; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Chung WC, 2013, GENOME ANNOUNC, V1; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Coulthurst SJ, 2013, RES MICROBIOL, V164, P640, DOI 10.1016/j.resmic.2013.03.017; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; De Vleesschauwer D., 2003, CAB REV, V2, P189; Demain AL, 1995, WHY DO MICROOGRANISM, P205; Denny TP, 2006, PLANT-ASSOCIATED BACTERIA, P573; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ee R, 2014, SENSORS-BASEL, V14, P5136, DOI 10.3390/s140305136; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; FLYG C, 1980, J GEN MICROBIOL, V120, P173; Frankowski J, 2001, ARCH MICROBIOL, V176, P421, DOI 10.1007/s002030100347; Fukami-Kobayashi Kaoru, 2002, Tanpakushitsu Kakusan Koso, V47, P1237; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Grimont F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P219, DOI 10.1007/0-387-30746-x_11; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lamelas A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002357; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Liu SW, 2012, ACTA CRYSTALLOGR F, V68, P898, DOI 10.1107/S1744309112024001; Luque-Almagro VM, 2013, ENVIRON MICROBIOL, V15, P253, DOI 10.1111/j.1462-2920.2012.02875.x; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Mela F, 2011, ISME J, V5, P1494, DOI 10.1038/ismej.2011.29; MONREAL J, 1969, CAN J MICROBIOL, V15, P689, DOI 10.1139/m69-122; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Muller H, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00020-13; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Nakaya A, 2013, NUCLEIC ACIDS RES, V41, pD353, DOI 10.1093/nar/gks1239; Nei M., 2000, MOL EVOLUTION PHYLOG; Neupane S, 2012, STAND GENOMIC SCI, V7, P22, DOI 10.4056/sigs.2966299; Oberto J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-4; Parani K, 2011, INDIAN J MICROBIOL, V51, P247, DOI 10.1007/s12088-011-0065-x; Pouillot F, 2007, MICROBIOL-SGM, V153, P2426, DOI 10.1099/mic.0.2007/005736-0; Proenca DN, 2012, J BACTERIOL, V194, P3764, DOI 10.1128/JB.00670-12; Purushotham P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036714; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shyntum DY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-163; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Suzuki K, 2002, BIOSCI BIOTECH BIOCH, V66, P1075, DOI 10.1271/bbb.66.1075; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; THOMASHOW LS, 1990, APPL ENVIRON MICROB, V56, P908, DOI 10.1128/AEM.56.4.908-912.1990; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Wang WL, 2013, ARCH ORAL BIOL, V58, P384, DOI 10.1016/j.archoralbio.2012.09.001; Weise T, 2014, FEMS MICROBIOL LETT, V352, P45, DOI 10.1111/1574-6968.12359; Williamson NR, 2007, FUTURE MICROBIOL, V2, P605, DOI 10.2217/17460913.2.6.605; Williamson NR, 2006, NAT REV MICROBIOL, V4, P887, DOI 10.1038/nrmicro1531; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Zarei M, 2011, BRAZ J MICROBIOL, V42, P1016, DOI [10.1590/S1517-83822011000300022, 10.1590/S1517-838220110003000022]; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	74	38	41	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123061	10.1371/journal.pone.0123061	http://dx.doi.org/10.1371/journal.pone.0123061			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856195	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500071
J	Lorin, C; Vanloubbeeck, Y; Baudart, S; Ska, M; Bayat, B; Brauers, G; Clarinval, G; Donner, MN; Marchand, M; Koutsoukos, M; Mettens, P; Cohen, J; Voss, G				Lorin, Clarisse; Vanloubbeeck, Yannick; Baudart, Sebastien; Ska, Michael; Bayat, Babak; Brauers, Geoffroy; Clarinval, Geraldine; Donner, Marie-Noelle; Marchand, Martine; Koutsoukos, Marguerite; Mettens, Pascal; Cohen, Joe; Voss, Gerald			Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYPROTEIN HIV-1 VACCINE; MUCOSAL IMMUNE-RESPONSES; HIGHLY PATHOGENIC SIV; RHESUS-MONKEYS; CENTRAL MEMORY; LYMPHOCYTE-RESPONSES; ELITE CONTROLLERS; EFFICACY TRIAL; DOUBLE-BLIND	HIV-1-specific CD4(+) and CD8(+) T lymphocytes are important for HIV-1 replication control. F4/AS01 consists of F4 recombinant fusion protein (containing clade B Gag/p24, Pol/RT, Nef and Gag/p17) formulated in AS01 Adjuvant System, and was shown to induce F4-specific polyfunctional CD4(+) T-cell responses in humans. While replication-incompetent recombinant HIV-1/SIV antigen-expressing human adenoviral vectors can elicit highfrequency antigen-specific CD8(+) T-cell responses, their use is hampered by widespread pre-existing immunity to human serotypes. Non-human adenovirus serotypes associated with lower prevalence may offer an alternative strategy. We evaluated the immunogenicity of AdC7-GRN ('A'), a recombinant chimpanzee adenovirus type 7 vector expressing clade B Gag, RT and Nef, and F4/AS01 ('P'), when delivered intramuscularly in homologous (PP or AA) and heterologous (AAPP or PPAA) prime-boost regimens, in macaques and mice. Vaccine-induced HIV-1-antigen-specific T cells in peripheral blood (macaques), liver, spleen, and intestinal and genital mucosa (mice) were characterized by intracellular cytokine staining. Vaccine-specific IgG antibodies (macaques) were detected using ELISA. In macaques, only the heterologous prime-boost regimens induced polyfunctional, persistent and balanced CD4(+) and CD8(+) T-cell responses specific to each HIV-1 vaccine antigen. AdC7-GRN priming increased the polyfunctionality of F4/AS01-induced CD4+ T cells. Approximately 50% of AdC7-GRN-induced memory CD8(+) T cells exhibited an effectormemory phenotype. HIV-1-specific antibodies were detected with each regimen. In mice, antigen-specific CD4(+) and CD8(+) T-cell responses were detected in the mucosal and systemic anatomical compartments assessed. When administered in heterologous primeboost regimens, AdC7-GRN and F4/AS01 candidate vaccines acted complementarily in inducing potent and persistent peripheral blood HIV-1-specific CD4(+) and CD8(+) T-cell responses and antibodies in macaques. Besides, adenoviral vector priming modulated the cytokine-expression profile of the protein-induced CD4(+) T cells. Each regimen induced HIV-1-specific T-cell responses in systemic/local tissues in mice. This suggests that prime-boost regimens combining adjuvanted protein and low-seroprevalent chimpanzee adenoviral vectors represent an attractive vaccination strategy for clinical evaluation.	[Lorin, Clarisse; Vanloubbeeck, Yannick; Baudart, Sebastien; Ska, Michael; Bayat, Babak; Brauers, Geoffroy; Clarinval, Geraldine; Donner, Marie-Noelle; Marchand, Martine; Koutsoukos, Marguerite; Mettens, Pascal; Cohen, Joe; Voss, Gerald] GSK Vaccines, Rixensart, Belgium	GlaxoSmithKline	Lorin, C (corresponding author), GSK Vaccines, Rixensart, Belgium.	clarisse.m.lorin@gsk.com			GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This study was funded by GlaxoSmithKline Biologicals SA, the employer of all authors at the time of the study. GlaxoSmithKline Biologicals SA was involved in: design and conduct of the study; data collection, analysis and interpretation; manuscript preparation, review and the decision to submit for publication. There are no products in development or marketed products to declare.	Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Belyakov IM, 2001, NAT MED, V7, P1320, DOI 10.1038/nm1201-1320; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Boaz MJ, 2002, J IMMUNOL, V169, P6376, DOI 10.4049/jimmunol.169.11.6376; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Capone S, 2013, EXPERT REV VACCINES, V12, P379, DOI [10.1586/erv.13.15, 10.1586/ERV.13.15]; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; Cervasi B, 2013, J VIROL, V87, P9420, DOI 10.1128/JVI.01456-13; Chen H, 2010, J VIROL, V84, P10522, DOI 10.1128/JVI.00450-10; Colloca S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002925; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Farina SF, 2001, J VIROL, V75, P11603, DOI 10.1128/JVI.75.23.11603-11613.2001; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Fitzgerald JC, 2003, J IMMUNOL, V170, P1416, DOI 10.4049/jimmunol.170.3.1416; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Genesca M, 2009, J INTERN MED, V265, P67, DOI 10.1111/j.1365-2796.2008.02051.x; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Harrer T, 2014, VACCINE, V32, P2657, DOI 10.1016/j.vaccine.2013.10.030; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Iyasere C, 2003, J VIROL, V77, P10900, DOI 10.1128/JVI.77.20.10900-10909.2003; Jansen CA, 2006, TRENDS IMMUNOL, V27, P119, DOI 10.1016/j.it.2006.01.004; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Kaufman DR, 2010, J VIROL, V84, P5986, DOI 10.1128/JVI.02563-09; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Keefer MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041936; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kulkarni V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086254; Leroux-Roels G, 2014, CLIN VACCINE IMMUNOL, V21, P302, DOI 10.1128/CVI.00617-13; Li HL, 2011, J VIROL, V85, P11007, DOI 10.1128/JVI.05346-11; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Masek-Hammerman K, 2010, J VIROL, V84, P9810, DOI 10.1128/JVI.01157-10; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Peiperl L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013579; Penaloza-MacMaster P, 2013, J VIROL, V87, P1373, DOI 10.1128/JVI.02058-12; Pillai VKB, 2011, VACCINE, V29, P5399, DOI 10.1016/j.vaccine.2011.05.083; Pinto AR, 2003, J IMMUNOL, V171, P6774, DOI 10.4049/jimmunol.171.12.6774; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Quinn KM, 2013, J IMMUNOL, V190, P2720, DOI 10.4049/jimmunol.1202861; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reyes-Sandoval A, 2004, J VIROL, V78, P7392, DOI 10.1128/JVI.78.14.7392-7399.2004; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Roshorm Y, 2012, EUR J IMMUNOL, V42, P3243, DOI 10.1002/eji.201242624; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Santra S, 2009, VACCINE, V27, P5837, DOI 10.1016/j.vaccine.2009.07.050; Schultheiss T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-24; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tatsis N, 2006, GENE THER, V13, P421, DOI 10.1038/sj.gt.3302675; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Tatsis N, 2009, J IMMUNOL, V182, P6587, DOI 10.4049/jimmunol.0900317; Vaccari M, 2005, J IMMUNOL, V175, P3502, DOI 10.4049/jimmunol.175.6.3502; Van Braeckel E, 2013, VACCINE, V31, P3739, DOI 10.1016/j.vaccine.2013.05.021; Van Braeckel E, 2012, HUM VACC IMMUNOTHER, V8, P1795, DOI 10.4161/hv.21760; Van Braeckel E, 2011, CLIN INFECT DIS, V52, P522, DOI 10.1093/cid/ciq160; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Zhi Y, 2006, HUM GENE THER, V17, P500, DOI 10.1089/hum.2006.17.500	86	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122835	10.1371/journal.pone.0122835	http://dx.doi.org/10.1371/journal.pone.0122835			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856308	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500058
J	Rother, DC; Pizo, MA; Siqueira, T; Rodrigues, RR; Jordano, P				Rother, Debora Cristina; Pizo, Marco Aurelio; Siqueira, Tadeu; Rodrigues, Ricardo Ribeiro; Jordano, Pedro			Community-Wide Spatial and Temporal Discordances of Seed-Seedling Shadows in a Tropical Rainforest	PLOS ONE			English	Article							DISPERSAL; PATTERNS; RECRUITMENT; DYNAMICS	Several factors decrease plant survival throughout their lifecycles. Among them, seed dispersal limitation may play a major role by resulting in highly aggregated (contagious) seed and seedling distributions entailing increased mortality. The arrival of seeds, furthermore, may not match suitable environments for seed survival and, consequently, for seedling establishment. In this study, we investigated spatio-temporal patterns of seed and seedling distribution in contrasting microhabitats (bamboo and non-bamboo stands) from the Brazilian Atlantic Forest. Spatial distribution patterns, spatial concordance between seed rain and seedling recruitment between subsequent years in two fruiting seasons (2004-2005 and 2007-2009), and the relation between seeds and seedlings with environmental factors were examined within a spatially-explicit framework. Density and species richness of both seeds and seedlings were randomly distributed in non-bamboo stands, but showed significant clustering in bamboo stands. Seed and seedling distributions showed across-year inconsistency, suggesting a marked spatial decoupling of the seed and seedling stages. Generalized linear mixed effects models indicated that only seed density and seed species richness differed between stand types while accounting for variation in soil characteristics. Our analyses provide evidence of marked recruitment limitation as a result of the interplay between biotic and abiotic factors. Because bamboo stands promote heterogeneity in the forest, they are important components of the landscape. However, at high densities, bamboos may limit recruitment for the plant community by imposing marked discordances of seed arrival and early seedling recruitment.	[Rother, Debora Cristina] Univ Estadual Paulista, Dept Bot, Sao Paulo, Brazil; [Pizo, Marco Aurelio] Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil; [Siqueira, Tadeu] Univ Estadual Paulista, Dept Ecol, Sao Paulo, Brazil; [Rother, Debora Cristina; Rodrigues, Ricardo Ribeiro] Univ Sao Paulo, Escola Super Agr Luiz Queiroz, Dept Ciencias Biol, Lab Ecol & Restauracao Florestal, Sao Paulo, Brazil; [Jordano, Pedro] CSIC, Estn Biol Donana, Integrat Ecol Grp, E-41080 Seville, Spain	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Rother, DC (corresponding author), Univ Estadual Paulista, Dept Bot, Sao Paulo, Brazil.	deborarother@gmail.com	Rother, Débora/AAL-4792-2020; Rodrigues, Ricardo Ribeiro/D-5557-2012; Jordano, Pedro/A-5162-2008; Rother, Débora/F-5646-2012; Siqueira, Tadeu/A-6978-2009	Rother, Débora/0000-0002-3670-8372; Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736; Jordano, Pedro/0000-0003-2142-9116; Rother, Débora/0000-0002-3670-8372; Siqueira, Tadeu/0000-0001-5069-2904	Sao Paulo Research Foundation (FAPESP) [03/11073-7, 99/09635-0]; Brazilian National Research Council (CNPq) [143107/2006-2]; Junta de Andalucia, Spain [RNM2010-5731]; CYTED-XII project [409AC0369]; Ciencia sem Fronteiras grant [CNPq 401258/2012-2]; Ministerio de Economia y Competitividad [SEV-2012-0262]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); CYTED-XII project; Ciencia sem Fronteiras grant; Ministerio de Economia y Competitividad(Spanish Government)	This study received financial support from the Sao Paulo Research Foundation (FAPESP 03/11073-7) and from the Brazilian National Research Council (CNPq 143107/2006-2) to DCR, and was framed within the Biota project supported by Sao Paulo Research Foundation (FAPESP 99/09635-0) granted to RRR (project leader). MAP received a research grant from CNPq (303559/2008-0), and PJ was granted by an Excellence grant from Junta de Andalucia, Spain (RNM2010-5731), CYTED-XII project 409AC0369, a Ciencia sem Fronteiras grant CNPq 401258/2012-2), as well as a Severo Ochoa Excellence Award from the Ministerio de Economia y Competitividad (SEV-2012-0262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G. T. R., 2007, THESIS U FEDERAL SAO; Balcomb SR, 2003, ECOL MONOGR, V73, P625, DOI 10.1890/02-4036; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2012.2532, 10.1098/rspb.2013.0548]; Bjornstad O. N., 2013, NCF SPATIAL NONPARAM; BOTREL REJANE T., 2002, Braz. J. Bot., V25, P195, DOI 10.1590/S0100-84042002000200008; Carvalho Douglas Antônio de, 2005, Acta Bot. Bras., V19, P91, DOI 10.1590/S0102-33062005000100010; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Conrad K. F., 2001, SADIESHELL VERSION 1; CUSTODIO FILHO A., 2002, THESIS U SAO PAULO S; dos Reis MS, 2000, BIOTROPICA, V32, P894, DOI 10.1646/0006-3606(2000)032[0894:MACONP]2.0.CO;2; EMPRESA BRASILEIRA DE PESQUISA AGROPECUARIA (Embrapa), 1997, MANUAL METODOS ANALI, V2; Fantini AC, 2007, FOREST ECOL MANAG, V242, P185, DOI 10.1016/j.foreco.2007.01.005; Galetti M, 1998, J APPL ECOL, V35, P286, DOI 10.1046/j.1365-2664.1998.00294.x; Garcia D, 2005, J ECOL, V93, P693, DOI 10.1111/j.1365-2745.2005.01004.x; Giulietti AM, 2001, FLORA FANEROGAMICA E, P38; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hampe A, 2008, J ECOL, V96, P668, DOI 10.1111/j.1365-2745.2008.01364.x; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Jordano P, 2000, ECOL MONOGR, V70, P591, DOI 10.1890/0012-9615(2000)070[0591:SDETQC]2.0.CO;2; JORDANO P, 1995, ECOSCIENCE, V2, P230, DOI 10.1080/11956860.1995.11682288; Jordano P., 2004, ECOLOG A BOSQUE MEDI, P229, DOI DOI 10.1016/J.WATRES.2013.08.031; Lima RAF, 2012, BIOL CONSERV, V147, P32, DOI 10.1016/j.biocon.2012.01.015; Londono X, 2002, NOVON, V12, P64, DOI 10.2307/3393241; Manhaes AP, 2007, AN 8 C EC BRAS CAX M, DOI [10.1016/S0176-1617(85)80065-1, DOI 10.1016/S0176-1617(85)80065-1]; Montti L, 2014, ACTA OECOL, V54, P36, DOI 10.1016/j.actao.2013.03.004; Muler AE, 2014, FOREST ECOL MANAG, V324, P117, DOI 10.1016/j.foreco.2013.09.001; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Oliveira-Filho A. T., 2001, Edinburgh Journal of Botany, V58, P139; Ouborg NJ, 1999, J ECOL, V87, P551, DOI 10.1046/j.1365-2745.1999.00389.x; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; R Development Core Team, 2014, R LANG ENV STAT COMP, DOI [10.1016/j.jneumeth.2014.06.019, DOI 10.1016/J.JNEUMETH.2014.06.019]; Raven P.H., 2005, BIOL PLANTS; Rey PJ, 2000, J ECOL, V88, P622, DOI 10.1046/j.1365-2745.2000.00472.x; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Rother DC, 2009, FOREST ECOL MANAG, V257, P885, DOI 10.1016/j.foreco.2008.10.022; Rother DC, 2013, PERSPECT PLANT ECOL, V15, P86, DOI 10.1016/j.ppees.2012.12.004; Rother DC, 2013, EMU, V113, P52, DOI 10.1071/MU12017; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schupp E. W., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P19, DOI 10.1079/9780851995250.0019; SCHUPP EW, 1989, ECOLOGY, V70, P562, DOI 10.2307/1940206; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; SCHUPP EW, 1995, ECOSCIENCE, V2, P267, DOI 10.1080/11956860.1995.11682293; Schurr FM, 2008, J ECOL, V96, P628, DOI 10.1111/j.1365-2745.2008.01371.x; Silveira M, 2005, FLORESTA ABERTA COM; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Wenny DG, 1998, P NATL ACAD SCI USA, V95, P6204, DOI 10.1073/pnas.95.11.6204; Wenny DG, 2001, EVOL ECOL RES, V3, P51; Winder L, 2001, ECOL LETT, V4, P568, DOI 10.1046/j.1461-0248.2001.00269.x; Zuur Alain F., 2009, P1; [No title captured]	54	8	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123346	10.1371/journal.pone.0123346	http://dx.doi.org/10.1371/journal.pone.0123346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856393	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500088
J	Arts, N; Cane, S; Hennequart, M; Lamy, J; Bommer, G; Van den Eynde, B; De Plaen, E				Arts, Nathalie; Cane, Stefania; Hennequart, Marc; Lamy, Juliette; Bommer, Guido; Van den Eynde, Benoit; De Plaen, Etienne			microRNA-155, Induced by Interleukin-1 beta, Represses the Expression of Microphthalmia-Associated Transcription Factor (MITF-M) in Melanoma Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TUMORAL IMMUNE RESISTANCE; CYTOLYTIC T-LYMPHOCYTES; GROWTH-FACTOR-BETA; HLA-A2 MELANOMAS; ANTIGEN; GENE; MOUSE; 2,3-DIOXYGENASE; IDENTIFICATION	Loss of expression of surface antigens represents a significant problem for cancer immunotherapy. Microphthalmia-associated transcription factor (MITF-M) regulates melanocyte fate by driving expression of many differentiation genes, whose protein products can be recognized by cytolytic T lymphocytes. We previously reported that interleukin-1 beta (IL-1 beta) can downregulate MITF-M levels. Here we show that downregulation of MITF-M expression by IL-1 beta was paralleled by an upregulation of miR-155 expression in four melanoma lines. We confirmed that miR-155 was able to target endogenous MITF-M in melanoma cells and demonstrated a role for miR-155 in the IL-1 beta-induced repression of MITF-M by using an antagomiR. Notably, we also observed a strong negative correlation between MITF-M and miR-155 levels in a mouse model of melanoma. Taken together, our results indicate that MITF-M downregulation by inflammatory stimuli might be partly due to miR-155 upregulation. This could represent a novel mechanism of melanoma immune escape in an inflammatory microenvironment.	[Arts, Nathalie; Cane, Stefania; Hennequart, Marc; Lamy, Juliette; Van den Eynde, Benoit; De Plaen, Etienne] Ludwig Inst Canc Res, Brussels, Belgium; [Arts, Nathalie; Cane, Stefania; Hennequart, Marc; Lamy, Juliette; Van den Eynde, Benoit; De Plaen, Etienne] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Bommer, Guido] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	De Plaen, E (corresponding author), Ludwig Inst Canc Res, Brussels, Belgium.	Etienne.Deplaen@bru.licr.org	Bommer, Guido/A-8425-2011	Bommer, Guido/0000-0001-6898-4884; Cane, Stefania/0000-0003-4324-4681; Hennequart, Marc/0000-0003-4360-6830	Fonds National de la Recherche Scientifique (FNRS) (Belgium); Centre du Cancer (Cliniques Universitaires Saint-Luc, UCL, Belgium); Fondation Contre le Cancer (Belgium); FNRS (FRSM) [3.4.559.08.F]	Fonds National de la Recherche Scientifique (FNRS) (Belgium)(Fonds de la Recherche Scientifique - FNRS); Centre du Cancer (Cliniques Universitaires Saint-Luc, UCL, Belgium); Fondation Contre le Cancer (Belgium); FNRS (FRSM)(Fonds de la Recherche Scientifique - FNRS)	N.A. was supported by a FRIA Grant from the Fonds National de la Recherche Scientifique (FNRS) (Belgium) and the Centre du Cancer (Cliniques Universitaires Saint-Luc, UCL, Belgium). S.C., M.H., and J.L. were supported by a Televie Grant from the Fonds National de la Recherche Scientifique (FNRS) (Belgium). This work was supported in part by Grants from the Fondation Contre le Cancer (Belgium) and from the FNRS (FRSM, Grant 3.4.559.08.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RE, 2011, PIGM CELL MELANOMA R, V24, P1088, DOI 10.1111/j.1755-148X.2011.00931.x; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; BENNICELLI JL, 1989, CANCER RES, V49, P930; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Englaro W, 1999, ONCOGENE, V18, P1553, DOI 10.1038/sj.onc.1202446; Gallimore A, 2008, IMMUNOLOGY, V123, P157, DOI 10.1111/j.1365-2567.2007.02748.x; Gauthy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076186; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Haflidadottir BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011574; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; HOUGHTON AN, 1987, J EXP MED, V165, P812, DOI 10.1084/jem.165.3.812; Huijbers IJ, 2006, CANCER RES, V66, P3278, DOI 10.1158/0008-5472.CAN-05-3216; Kholmanskikh O, 2010, INT J CANCER, V127, P1625, DOI 10.1002/ijc.25182; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Le Poole IC, 2002, AM J PATHOL, V160, P521, DOI 10.1016/S0002-9440(10)64871-7; Mann M, 2010, P NATL ACAD SCI USA, V107, P15804, DOI 10.1073/pnas.0915022107; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Saez-Ayala M, 2013, CANCER CELL, V24, P105, DOI 10.1016/j.ccr.2013.05.009; SCHWARTZENTRUBER DJ, 1991, J IMMUNOL, V146, P3674; Shibahara S, 2001, J INVEST DERM SYMP P, V6, P99, DOI 10.1046/j.0022-202x.2001.00010.x; Soudja SM, 2010, CANCER RES, V70, P3515, DOI 10.1158/0008-5472.CAN-09-4354; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; SWOPE VB, 1991, J INVEST DERMATOL, V96, P180, DOI 10.1111/1523-1747.ep12460991; Thomas AJ, 2008, PIGM CELL MELANOMA R, V21, P598, DOI 10.1111/j.1755-148X.2008.00506.x; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; Voelter Verena, 2008, Cancer Immun, V8, P6; Watanabe KI, 2002, PIGM CELL RES, V15, P201, DOI 10.1034/j.1600-0749.2002.01080.x; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zarour H, 1996, J INVEST DERMATOL, V107, P63, DOI 10.1111/1523-1747.ep12298177	42	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122517	10.1371/journal.pone.0122517	http://dx.doi.org/10.1371/journal.pone.0122517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853464	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400069
J	Button, KS; Kounali, D; Stapinski, L; Rapee, RM; Lewis, G; Munafo, MR				Button, Katherine S.; Kounali, Daphne; Stapinski, Lexine; Rapee, Ronald M.; Lewis, Glyn; Munafo, Marcus R.			Fear of Negative Evaluation Biases Social Evaluation Inference: Evidence from a Probabilistic Learning Task	PLOS ONE			English	Article							AUTOMATIC SELF-ASSOCIATIONS; INTERACTION ANXIETY; EVALUATION SCALE; BRIEF VERSION; PHOBIA; DISORDER; VALIDITY; VALIDATION; DEPRESSION; MINDS	Background Fear of negative evaluation (FNE) defines social anxiety yet the process of inferring social evaluation, and its potential role in maintaining social anxiety, is poorly understood. We developed an instrumental learning task to model social evaluation learning, predicting that FNE would specifically bias learning about the self but not others. Methods During six test blocks (3 self-referential, 3 other-referential), participants (n = 100) met six personas and selected a word from a positive/negative pair to finish their social evaluation sentences "I think [you are / George is] ...". Feedback contingencies corresponded to 3 rules, liked, neutral and disliked, with P[positive word correct] = 0.8, 0.5 and 0.2, respectively. Results As FNE increased participants selected fewer positive words (beta = -0.4, 95% CI -0.7, -0.2, p = 0.001), which was strongest in the self-referential condition (FNE x condition 0.28, 95% CI 0.01, 0.54, p = 0.04), and the neutral and dislike rules (FNE x condition x rule, p = 0.07). At low FNE the proportion of positive words selected for self-neutral and self-disliked greatly exceeded the feedback contingency, indicating poor learning, which improved as FNE increased. Conclusions FNE is associated with differences in processing social-evaluative information specifically about the self. At low FNE this manifests as insensitivity to learning negative self-referential evaluation. High FNE individuals are equally sensitive to learning positive or negative evaluation, which although objectively more accurate, may have detrimental effects on mental health.	[Button, Katherine S.; Kounali, Daphne] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Stapinski, Lexine] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia; [Rapee, Ronald M.] Macquarie Univ, Ctr Emot Hlth, Sydney, NSW 2109, Australia; [Lewis, Glyn] UCL, Mental Hlth Sci Unit, London, England; [Munafo, Marcus R.] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol, Avon, England; [Munafo, Marcus R.] Univ Bristol, Sch Expt Psychol, UK Ctr Tobacco & Alcohol Studies, Bristol, Avon, England	University of Bristol; University of New South Wales Sydney; Macquarie University; University of London; University College London; University of Bristol; University of Bristol	Button, KS (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	kate.button@bristol.ac.uk	Lewis, Glyn/E-9944-2012; Munafo, Marcus/AAE-2306-2020; Kounali, Daphne/AAE-3630-2020	Lewis, Glyn/0000-0001-5205-8245; Munafo, Marcus/0000-0002-4049-993X; Kounali, Daphne/0000-0002-6392-6690; Button, Katherine/0000-0003-4332-8789; Rapee, Ronald/0000-0002-1724-1076; Stapinski, Lexine/0000-0002-3656-4655	Medical Research Council; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; National Institute for Health Research, under the UK Clinical Research Collaboration; MRC [MC_UU_12013/6] Funding Source: UKRI; Medical Research Council [MC_UU_12013/6] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research, under the UK Clinical Research Collaboration; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research was funded by a Medical Research Council, http://www.mrc.ac.uk/, doctoral studentship awarded to KSB. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MJ, 2004, J ABNORM PSYCHOL, V113, P136, DOI 10.1037/0021-843X.113.1.136; Amin N, 1998, BEHAV RES THER, V36, P945, DOI 10.1016/S0005-7967(98)00060-6; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Brookes S T, 2001, Health Technol Assess, V5, P1; Brown EJ, 1997, PSYCHOL ASSESSMENT, V9, P21, DOI 10.1037/1040-3590.9.1.21; Button KS, 2012, J BEHAV THER EXP PSY, V43, P1082, DOI 10.1016/j.jbtep.2012.05.004; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Clark D. M., 1995, SOCIALPHOBIA DIAGNOS, P69, DOI DOI 10.1017/S1352465808004487; Clark DM, 2002, BIOL PSYCHIAT, V51, P92, DOI 10.1016/S0006-3223(01)01296-3; Collins KA, 2005, J ANXIETY DISORD, V19, P345, DOI 10.1016/j.janxdis.2004.02.003; Cox BJ, 1995, SOCIAL PHOBIA CLIN R, P278; de Jong PJ, 2009, J BEHAV THER EXP PSY, V40, P359, DOI 10.1016/j.jbtep.2009.02.001; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Garner M, 2006, BEHAV RES THER, V44, P201, DOI 10.1016/j.brat.2004.12.007; Gilbert P, 2001, PSYCHIAT CLIN N AM, V24, P723, DOI 10.1016/S0193-953X(05)70260-4; Glashouwer KA, 2010, PSYCHOL MED, V40, P1101, DOI 10.1017/S0033291709991371; Glashouwer KA, 2011, J ABNORM PSYCHOL, V120, P607, DOI 10.1037/a0023205; Heimberg RG, 2010, SOCIAL ANXIETY: CLINICAL, DEVELOPMENTAL, AND SOCIAL PERSPECTIVES, 2ND EDITION, P395, DOI 10.1016/B978-0-12-375096-9.00015-8; Hermann C, 2004, J ABNORM PSYCHOL, V113, P646, DOI 10.1037/0021-843X.113.4.646; Hirsch C, 1997, BEHAV RES THER, V35, P1123, DOI 10.1016/S0005-7967(97)00069-7; Hirsch CR, 2000, J ABNORM PSYCHOL, V109, P705, DOI 10.1037//0021-843X.109.4.705; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kucera H., 1967, COMPUTATIONAL ANAL P; LEARY MR, 1983, PERS SOC PSYCHOL B, V9, P371, DOI 10.1177/0146167283093007; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Miskovic V, 2012, NEUROSCI BIOBEHAV R, V36, P459, DOI 10.1016/j.neubiorev.2011.08.002; Nelson HE., 1982, NATL ADULT READING T; Rapee RM, 1997, BEHAV RES THER, V35, P741, DOI 10.1016/S0005-7967(97)00022-3; Salemink E, 2009, J ANXIETY DISORD, V23, P676, DOI 10.1016/j.janxdis.2009.02.006; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Wallace ST, 1997, J ABNORM PSYCHOL, V106, P416, DOI 10.1037/0021-843X.106.3.416; Weich S, 2011, BRIT J PSYCHIAT, V199, P23, DOI 10.1192/bjp.bp.111.091496; Weisman O, 2011, BEHAV RES THER, V49, P399, DOI 10.1016/j.brat.2011.03.010; World Health Organization, 1992, INT STAT CLASS DIS R; Zadro L, 2004, J EXP SOC PSYCHOL, V40, P560, DOI 10.1016/j.jesp.2003.11.006	41	12	12	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0119456	10.1371/journal.pone.0119456	http://dx.doi.org/10.1371/journal.pone.0119456			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853835	gold, Green Submitted, Green Published			2022-12-27	WOS:000352478400003
J	Choi, SI; Maeng, YS; Kim, TI; Lee, Y; Kim, YS; Kim, EK				Choi, Seung-Il; Maeng, Yong-Sun; Kim, Tae-Im; Lee, Yangsin; Kim, Yong-Sun; Kim, Eung Kweon			Lysosomal Trafficking of TGFBIp via Caveolae-Mediated Endocytosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; KERATO-EPITHELIN MUTATIONS; EXTRACELLULAR-MATRIX; LIPID RAFTS; CELL-LINE; ENDOTHELIAL-CELLS; PROTEIN TGFBI; INTEGRIN; BETA-IG-H3; RECEPTOR	Transforming growth factor-beta-induced protein (TGFBIp) is ubiquitously expressed in the extracellular matrix (ECM) of various tissues and cell lines. Progressive accumulation of mutant TGFBIp is directly involved in the pathogenesis of TGFBI-linked corneal dystrophy. Recent studies reported that mutant TGFBIp accumulates in cells; however, the trafficking of TGFBIp is poorly understood. Therefore, we investigated TGFBIp trafficking to determine the route of its internalization and secretion and to elucidate its roles in the pathogenesis of granular corneal dystrophy type 2 (GCD2). Our data indicate that newly synthesized TGFBIp was secreted via the endoplasmic reticulum/Golgi-dependent secretory pathway, and this secretion was delayed in the corneal fibroblasts of patients with GCD2. We also found that TGFBIp was internalized by caveolae-mediated endocytosis, and the internalized TGFBIp accumulated after treatment with bafilomycin A1, an inhibitor of lysosomal degradation. In addition, the proteasome inhibitor MG 132 inhibits the endocytosis of TGFBIp. Co-immunoprecipitation revealed that TGFBIp interacted with integrin alpha(V)beta(3). Moreover, treatment with arginine-glycine-aspartic acid (RGD) tripeptide suppressed the internalization of TGFBIp. These insights on TGFBIp trafficking could lead to the identification of novel targets and the development of new therapies for TGFBI-linked corneal dystrophy.	[Choi, Seung-Il; Maeng, Yong-Sun; Kim, Tae-Im; Kim, Eung Kweon] Yonsei Univ, Coll Med, Corneal Dystrophy Res Inst, Dept Ophthalmol, Seoul, South Korea; [Kim, Tae-Im; Kim, Eung Kweon] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Inst Vis Res,Brain Korea Plus Project Med Sci 21, Seoul, South Korea; [Lee, Yangsin] Yonsei Univ, Grad Sch, Dept Integrated Omics Biomed Sci, Seoul, South Korea; [Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Anyang, South Korea; [Kim, Yong-Sun] Hallym Univ, Coll Med, Dept Microbiol, Chunchon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Hallym University; Hallym University	Kim, EK (corresponding author), Yonsei Univ, Coll Med, Corneal Dystrophy Res Inst, Dept Ophthalmol, Seoul, South Korea.	eungkkim@yuhs.ac		Maeng, Yong-Sun/0000-0003-1694-8405; choi, seung-il/0000-0001-7168-8795; Kim, Eung Kweon/0000-0002-1453-8042; Kim, Tae-im/0000-0001-6414-3842	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF 2013R1A1A2012958]; National Research Foundation of Korea (NRF) grant - Korean government (MEST) [2011-0028699]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Research Foundation of Korea (NRF) grant - Korean government (MEST)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF 2013R1A1A2012958) and by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2011-0028699). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Billings PC, 2000, J CELL BIOCHEM, V79, P261, DOI 10.1002/1097-4644(20001101)79:2<261::AID-JCB90>3.0.CO;2-#; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Cheng ZL, 2010, BIOSCIENCE REP, V30, P201, DOI 10.1042/BSR20090158; Choi SI, 2013, J PINEAL RES, V54, P361, DOI 10.1111/jpi.12039; Choi SI, 2012, AUTOPHAGY, V8, P1782, DOI 10.4161/auto.22067; Choi SI, 2011, INVEST OPHTH VIS SCI, V52, P3293, DOI 10.1167/iovs.10-6405; Choi SI, 2009, AM J PATHOL, V175, P248, DOI 10.2353/ajpath.2009.081001; Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dieudonne SC, 2000, J CELL BIOCHEM, V76, P231, DOI 10.1002/(SICI)1097-4644(20000201)76:2<231::AID-JCB7>3.0.CO;2-X; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Friguet B, 2000, ANN NY ACAD SCI, V908, P143; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; GODYNA S, 1995, J CELL BIOL, V129, P1403, DOI 10.1083/jcb.129.5.1403; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jester JV, 2003, INVEST OPHTH VIS SCI, V44, P1850, DOI 10.1167/iovs.02-0973; Johnson MS, 2009, BBA-BIOMEMBRANES, V1788, P779, DOI 10.1016/j.bbamem.2008.12.013; Jurkunas UV, 2009, INVEST OPHTH VIS SCI, V50, P1129, DOI 10.1167/iovs.08-2525; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Kim BH, 2005, NEUROREPORT, V16, P425, DOI 10.1097/00001756-200504040-00002; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Kim JE, 2000, J CELL BIOCHEM, V77, P169, DOI 10.1002/(SICI)1097-4644(20000501)77:2<169::AID-JCB1>3.0.CO;2-L; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; Kim TI, 2011, AM J PATHOL, V179, P684, DOI 10.1016/j.ajpath.2011.04.005; Klintworth GK, 1999, AM J OPHTHALMOL, V128, P747, DOI 10.1016/S0002-9394(99)00358-X; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; LEBARON RG, 1995, J INVEST DERMATOL, V104, P844, DOI 10.1111/1523-1747.ep12607024; Lim JS, 2010, AGING CELL, V9, P243, DOI 10.1111/j.1474-9726.2010.00554.x; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Marchina E, 1996, INT J BIOCHEM CELL B, V28, P1141, DOI 10.1016/1357-2725(96)00055-6; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Memmo LM, 1998, J CELL SCI, V111, P425; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Munier FL, 2002, INVEST OPHTH VIS SCI, V43, P949; MURPHYULLRICH JE, 1987, J CELL BIOL, V105, P1603, DOI 10.1083/jcb.105.4.1603; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Park SW, 2004, EXP MOL MED, V36, P211, DOI 10.1038/emm.2004.29; Park WY, 2000, J BIOL CHEM, V275, P20847, DOI 10.1074/jbc.M908162199; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Peters PJ, 2006, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.CB0407S30, DOI 10.1002/0471143030.CB0407S30]; Poole AR, 2003, BIOCHEM SOC SYMP, V70, P115, DOI 10.1042/bss0700115; RAUB TJ, 1989, EXP CELL RES, V184, P407, DOI 10.1016/0014-4827(89)90340-6; Rawe IM, 1997, INVEST OPHTH VIS SCI, V38, P893; Runager K, 2008, EXP EYE RES, V87, P298, DOI 10.1016/j.exer.2007.12.001; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Shang F, 2004, EXP EYE RES, V78, P1, DOI 10.1016/j.exer.2003.10.003; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simon KO, 1997, J BIOL CHEM, V272, P29380, DOI 10.1074/jbc.272.46.29380; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Son HN, 2013, BBA-MOL CELL RES, V1833, P2378, DOI 10.1016/j.bbamcr.2013.06.012; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; VANAMERSFOORT ES, 1994, CYTOMETRY, V17, P294, DOI 10.1002/cyto.990170404; VanNhieu GT, 1996, J BIOL CHEM, V271, P7665, DOI 10.1074/jbc.271.13.7665; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wheaton K, 2001, J CELL PHYSIOL, V187, P226, DOI 10.1002/jcp.1071; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200; Yuan C, 2004, MOL VIS, V10, P351; Zamilpa R, 2009, MATRIX BIOL, V28, P347, DOI 10.1016/j.matbio.2009.05.004; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62	89	24	24	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0119561	10.1371/journal.pone.0119561	http://dx.doi.org/10.1371/journal.pone.0119561			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853243	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400004
J	Eberlein, U; Peper, M; Fernandez, M; Lassmann, M; Scherthan, H				Eberlein, Uta; Peper, Michel; Fernandez, Maria; Lassmann, Michael; Scherthan, Harry			Calibration of the gamma-H2AX DNA Double Strand Break Focus Assay for Internal Radiation Exposure of Blood Lymphocytes	PLOS ONE			English	Article							IN-VIVO FORMATION; RADIOIODINE THERAPY; DOSE-RESPONSE; 53BP1; REPAIR; DAMAGE; DOSIMETRY; PHOSPHORYLATION; ACCUMULATION; IRRADIATION	DNA double strand break (DSB) formation induced by ionizing radiation exposure is indicated by the DSB biomarkers gamma-H2AX and 53BP1. Knowledge about DSB foci formation in-vitro after internal irradiation of whole blood samples with radionuclides in solution will help us to gain detailed insights about dose-response relationships in patients after molecular radiotherapy (MRT). Therefore, we studied the induction of radiation-induced co-localizing gamma-H2AX and 53BP1 foci as surrogate markers for DSBs in-vitro, and correlated the obtained foci per cell values with the in-vitro absorbed doses to the blood for the two most frequently used radionuclides in MRT (I-131 and Lu-177). This approach led to an in-vitro calibration curve. Overall, 55 blood samples of three healthy volunteers were analyzed. For each experiment several vials containing a mixture of whole blood and radioactive solutions with different concentrations of isotonic NaCl-diluted radionuclides with known activities were prepared. Leukocytes were recovered by density centrifugation after incubation and constant blending for 1 h at 37 degrees C. After ethanol fixation they were subjected to two-color immunofluorescence staining and the average frequencies of the co-localizing gamma-H2AX and 53BP1 foci/nucleus were determined using a fluorescence microscope equipped with a red/green double band pass filter. The exact activity was determined in parallel in each blood sample by calibrated germanium detector measurements. The absorbed dose rates to the blood per nuclear disintegrations occurring in 1 ml of blood were calculated for both isotopes by a Monte Carlo simulation. The measured blood doses in our samples ranged from 6 to 95 mGy. A linear relationship was found between the number of DSB-marking foci/nucleus and the absorbed dose to the blood for both radionuclides studied. There were only minor nuclide-specific intra-and inter-subject deviations.	[Eberlein, Uta; Fernandez, Maria; Lassmann, Michael] Univ Wurzburg, Dept Nucl Med, D-97070 Wurzburg, Germany; [Peper, Michel; Scherthan, Harry] Univ Ulm, Bundeswehr Inst Radiobiol, Munich, Germany	University of Wurzburg; Ulm University	Eberlein, U (corresponding author), Univ Wurzburg, Dept Nucl Med, D-97070 Wurzburg, Germany.	eberlein_u@ukw.de	Lassmann, Michael/D-6809-2019	Lassmann, Michael/0000-0002-2556-1977	Deutsche Forschungsgemeinschaft (DFG) [LA 2304/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG), grant number LA 2304/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Beels L, 2012, EUR J RADIOL, V81, P1495, DOI 10.1016/j.ejrad.2011.04.063; Beels L, 2010, INT J RADIAT BIOL, V86, P760, DOI 10.3109/09553002.2010.484479; Beels L, 2009, CIRCULATION, V120, P1903, DOI 10.1161/CIRCULATIONAHA.109.880385; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doai M, 2013, ANN NUCL MED, V27, P233, DOI 10.1007/s12149-012-0678-0; Eberlein U, 2014, EUR J NUCL MED MOL I, V41, pS284; Eberlein U, 2013, EUR J NUCL MED MOL I, V40, pS160; Eckerman KF, 2008, MIRD RADIONUCLIDE DA; Golfier S, 2009, RADIAT PROT DOSIM, V134, P55, DOI 10.1093/rpd/ncp061; Hanscheid H, 2014, PHYS MED BIOL, V59, P1515, DOI 10.1088/0031-9155/59/6/1515; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025113; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Kuo LJ, 2008, IN VIVO, V22, P305; Laboratoire National Henri Becquerel, 2014, LABORATOIRE NATIONAL; Lamkowski A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087458; Lassmann M, 2015, CURR RADIOPHARM, V8, P139, DOI 10.2174/1874471008666150313104212; Lassmann M, 2010, J NUCL MED, V51, P1318, DOI 10.2967/jnumed.109.071357; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; May MS, 2012, EUR J NUCL MED MOL I, V39, P1712, DOI 10.1007/s00259-012-2201-1; National Institute of Standards and Technology (NIST)., 2014, COMPOSITIONS OF MATE; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pelowitz DB, 2011, REPORT NO LA UR 11 0; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Roch-Lefevre S, 2010, RADIAT RES, V174, P185, DOI 10.1667/RR1775.1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2013, RADIAT RES, V180, P149, DOI 10.1667/RR3238.1; Rothkamm K, 2007, RADIOLOGY, V242, P244, DOI 10.1148/radiol.2421060171; Sak A, 2007, INT J RADIAT BIOL, V83, P639, DOI 10.1080/09553000701596118; Scherthan H, 2008, BIOCHEM BIOPH RES CO, V371, P694, DOI 10.1016/j.bbrc.2008.04.127; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Vandevoorde C, 2015, EUR RADIOL, V25, P800, DOI 10.1007/s00330-014-3463-8; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200	38	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123174	10.1371/journal.pone.0123174	http://dx.doi.org/10.1371/journal.pone.0123174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853575	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400097
J	Hudspith, VA; Belcher, CM; Kelly, R; Hu, FS				Hudspith, Victoria A.; Belcher, Claire M.; Kelly, Ryan; Hu, Feng Sheng			Charcoal Reflectance Reveals Early Holocene Boreal Deciduous Forests Burned at High Intensities	PLOS ONE			English	Article							FIRE SEVERITY; TEMPERATURE; HISTORY; REGIMES; BIOMASS; LITTER; CARBON; WOOD	Wildfire size, frequency, and severity are increasing in the Alaskan boreal forest in response to climate warming. One of the potential impacts of this changing fire regime is the alteration of successional trajectories, from black spruce to mixed stands dominated by aspen, a vegetation composition not experienced since the early Holocene. Such changes in vegetation composition may consequently alter the intensity of fires, influencing fire feedbacks to the ecosystem. Paleorecords document past wildfire-vegetation dynamics and as such, are imperative for our understanding of how these ecosystems will respond to future climate warming. For the first time, we have used reflectance measurements of macroscopic charcoal particles (>180 mu m) from an Alaskan lake-sediment record to estimate ancient charring temperatures (termed pyrolysis intensity). We demonstrate that pyrolysis intensity increased markedly from an interval of birch tundra 11 ky ago (mean 1.52% Ro; 485 degrees C), to the expansion of trees on the landscape similar to 10.5 ky ago, remaining high to the present (mean 3.54%Ro; 640 degrees C) irrespective of stand composition. Despite differing flammabilities and adaptations to fire, the highest pyrolysis intensities derive from two intervals with distinct vegetation compositions. 1) the expansion of mixed aspen and spruce woodland at 10 cal. kyr BP, and 2) the establishment of black spruce, and the modern boreal forest at 4 cal. kyr BP. Based on our analysis, we infer that predicted expansion of deciduous trees into the boreal forest in the future could lead to high intensity, but low severity fires, potentially moderating future climate-fire feedbacks.	[Hudspith, Victoria A.; Kelly, Ryan; Hu, Feng Sheng] Univ Illinois, Dept Plant Biol, Urbana, IL USA; [Belcher, Claire M.] Univ Exeter, Dept Geog, Hatherly Labs, PalaeoFire Lab, Exeter EX4 4QJ, Devon, England	University of Illinois System; University of Illinois Urbana-Champaign; University of Exeter	Hudspith, VA (corresponding author), Univ Exeter, Dept Geog, Hatherly Labs, PalaeoFire Lab, Exeter EX4 4QJ, Devon, England.	v.a.hudspith@exeter.ac.uk			National Science Foundation Grant [ARC-0612366]; European Research Council Starter Grant [ERC-2013-StG-335891-ECOFLAM]	National Science Foundation Grant(National Science Foundation (NSF)); European Research Council Starter Grant	This research was supported by a National Science Foundation Grant ARC-0612366 (awarded to FSH) and a European Research Council Starter Grant ERC-2013-StG-335891-ECOFLAM to CMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PM, 1994, QUATERNARY SCI REV, V13, P71, DOI 10.1016/0277-3791(94)90125-2; Ascough PL, 2011, GEOCHIM COSMOCHIM AC, V75, P2361, DOI 10.1016/j.gca.2011.02.002; Barrett K, 2013, REMOTE SENS ENVIRON, V130, P171, DOI 10.1016/j.rse.2012.11.017; Beck PSA, 2011, GLOBAL CHANGE BIOL, V17, P2853, DOI 10.1111/j.1365-2486.2011.02412.x; Belcher CM, 2010, NAT GEOSCI, V3, P426, DOI 10.1038/NGEO871; Blanchette RA, 2000, INT BIODETER BIODEGR, V46, P189, DOI 10.1016/S0964-8305(00)00077-9; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Chapin III FS, 2006, ALASKAS CHANGING BOR, P285; Clegg BF, 2011, P NATL ACAD SCI USA, V108, P19299, DOI 10.1073/pnas.1110913108; Davies GM, 2009, J APPL ECOL, V46, P1054, DOI 10.1111/j.1365-2664.2009.01681.x; de Magalhaes RMQ, 2012, J ECOL, V100, P1153, DOI 10.1111/j.1365-2745.2012.01987.x; Dibble AC, 2007, INT J WILDLAND FIRE, V16, P426, DOI 10.1071/WF05103; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Hu F. S., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P829, DOI 10.1007/s11027-005-9015-4; Hudspith VA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00714; HUGGETT C, 1980, FIRE MATER, V4, P61, DOI 10.1002/fam.810040202; Inoue J, 2003, J GEOSCI-OSAKA CITY, V46, P127; Johnstone J, 2006, ECOSYSTEMS, V9, P14, DOI 10.1007/s10021-004-0042-x; Johnstone JF, 2011, LANDSCAPE ECOL, V26, P487, DOI 10.1007/s10980-011-9574-6; JONES TP, 1991, B SOC GEOL FR, V162, P193; Kasischke E. S., 2006, ALASKAS CHANGING BOR, P285; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Kelly R, 2013, P NATL ACAD SCI USA, V110, P13055, DOI 10.1073/pnas.1305069110; Lynch JA, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000332; Lynch JA, 2004, J ECOL, V92, P477, DOI 10.1111/j.0022-0477.2004.00879.x; Mack MC, 2008, ECOSYSTEMS, V11, P209, DOI 10.1007/s10021-007-9117-9; Margolis EQ, 2007, CAN J FOREST RES, V37, P2227, DOI 10.1139/X07-079; Mcparland LC, 2007, PALAIOS, V22, P528, DOI 10.2110/palo.2005.p05-138r; McParland LC, 2009, ARCHAEOL ANTHROP SCI, V1, P249, DOI 10.1007/s12520-009-0018-z; Nossov DR, 2013, ENVIRON RES LETT, V8, P1; Prescott CE, 2000, CAN J FOREST RES, V30, P1742, DOI 10.1139/cjfr-30-11-1742; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; R Core Team, 2021, R LANGUAGE ENV STAT; Rundel P. W., 1981, Encyclopedia of Plant Physiology. New Series. Volume 12A. Physiological plant ecology I. Responses to the physical environment. [Lange, O.L.; Nobel, P.S.; Osmond, C.B.; Ziegler, H. (Editors)], P501; Schemel CF, 2008, EXP THERM FLUID SCI, V32, P1381, DOI 10.1016/j.expthermflusci.2007.11.011; SCOTT AC, 1994, PALAEOGEOGR PALAEOCL, V106, P91, DOI 10.1016/0031-0182(94)90005-1; Scott AC, 2010, PALAEOGEOGR PALAEOCL, V291, P11, DOI 10.1016/j.palaeo.2009.12.012; Shenoy A, 2011, FOREST ECOL MANAG, V261, P381, DOI 10.1016/j.foreco.2010.10.021; Smith T, 2008, 170 ONT FOR RES I; Stocks BJ, 2004, CAN J FOREST RES, V34, P1548, DOI 10.1139/X04-054; Stocks BJ, 2001, ADV GLOB CHANGE RES, V7, P233; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Urbas J., 1993, FIRE MATER, V17, P205; Viereck LA, 1980, 6 BLM DEP INT; Virkkula A, 2013, ATMOS CHEM PHYS DISC, V13, P21703	45	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120835	10.1371/journal.pone.0120835	http://dx.doi.org/10.1371/journal.pone.0120835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853712	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400018
J	Jensen, RH; Mollerup, S; Mourier, T; Hansen, TA; Fridholm, H; Nielsen, LP; Willerslev, E; Hansen, AJ; Vinner, L				Jensen, Randi Holm; Mollerup, Sarah; Mourier, Tobias; Hansen, Thomas Arn; Fridholm, Helena; Nielsen, Lars Peter; Willerslev, Eske; Hansen, Anders Johannes; Vinner, Lasse			Target-Dependent Enrichment of Virions Determines the Reduction of High-Throughput Sequencing in Virus Discovery	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; IDENTIFICATION; INFECTION; AMPLIFICATION; CORONAVIRUS; CASKI	Viral infections cause many different diseases stemming both from well-characterized viral pathogens but also from emerging viruses, and the search for novel viruses continues to be of great importance. High-throughput sequencing is an important technology for this purpose. However, viral nucleic acids often constitute a minute proportion of the total genetic material in a sample from infected tissue. Techniques to enrich viral targets in high-throughput sequencing have been reported, but the sensitivity of such methods is not well established. This study compares different library preparation techniques targeting both DNA and RNA with and without virion enrichment. By optimizing the selection of intact virus particles, both by physical and enzymatic approaches, we assessed the effectiveness of the specific enrichment of viral sequences as compared to non-enriched sample preparations by selectively looking for and counting read sequences obtained from shotgun sequencing. Using shotgun sequencing of total DNA or RNA, viral targets were detected at concentrations corresponding to the predicted level, providing a foundation for estimating the effectiveness of virion enrichment. Virion enrichment typically produced a 1000-fold increase in the proportion of DNA virus sequences. For RNA virions the gain was less pronounced with a maximum 13-fold increase. This enrichment varied between the different sample concentrations, with no clear trend. Despite that less sequencing was required to identify target sequences, it was not evident from our data that a lower detection level was achieved by virion enrichment compared to shotgun sequencing.	[Jensen, Randi Holm; Mollerup, Sarah; Mourier, Tobias; Hansen, Thomas Arn; Fridholm, Helena; Willerslev, Eske; Hansen, Anders Johannes; Vinner, Lasse] Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Copenhagen, Denmark; [Nielsen, Lars Peter] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	University of Copenhagen; Statens Serum Institut	Jensen, RH (corresponding author), Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Copenhagen, Denmark.	randi.jensen@snm.ku.dk	Willerslev, Eske/AAA-5686-2019; Hansen, Anders Johannes/A-5608-2013; Willerslev, Eske/A-9619-2011	Hansen, Anders Johannes/0000-0002-1890-2702; Willerslev, Eske/0000-0002-7081-6748; Mollerup, Sarah/0000-0003-2429-4018; Vinner, Lasse/0000-0002-3081-3702	Danish National Advanced Technology foundation - The GenomeDenmark platform [019-2011-2]	Danish National Advanced Technology foundation - The GenomeDenmark platform	This work was supported by the Danish National Advanced Technology foundation - The GenomeDenmark platform, grant no. 019-2011-2 (http://hoejteknologifonden.dk).	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Bexfield N, 2011, VET J, V190, P191, DOI 10.1016/j.tvjl.2010.10.014; Chan JFW, 2013, J FORMOS MED ASSOC, V112, P372, DOI 10.1016/j.jfma.2013.05.010; Chandriani S, 2013, P NATL ACAD SCI USA, V110, pE1407, DOI 10.1073/pnas.1219217110; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Culley AI, 2003, NATURE, V424, P1054, DOI 10.1038/nature01886; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Delwart E, 2012, CURR OPIN VIROL, V2, P344, DOI 10.1016/j.coviro.2012.02.012; Drosten C, 2006, CLIN CHEM, V52, P1258, DOI 10.1373/clinchem.2006.066498; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Erlandsson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022631; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GENDELMAN HE, 1987, VIROLOGY, V160, P323, DOI 10.1016/0042-6822(87)90002-X; Geng HY, 2013, SCI CHINA LIFE SCI, V56, P683, DOI 10.1007/s11427-013-4519-8; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Gullapalli Rama R, 2012, J Pathol Inform, V3, P40, DOI 10.4103/2153-3539.103013; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hu Y, 2005, J VIROL METHODS, V127, P80, DOI 10.1016/j.jviromet.2005.02.016; Johne R, 2009, TRENDS MICROBIOL, V17, P205, DOI 10.1016/j.tim.2009.02.004; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kapoor A, 2013, MBIO, V4, DOI 10.1128/mBio.00216-13; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Kircher M, 2011, NUCLEIC ACIDS RES, V40, P1; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; LIZARD G, 1993, J IMMUNOL METHODS, V157, P31, DOI 10.1016/0022-1759(93)90067-H; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; McClenahan SD, 2014, BIOLOGICALS, V42, P34, DOI 10.1016/j.biologicals.2013.11.002; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725; Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011; Moore RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019838; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Vinner L, 2014, INVESTIGATION OF HUM; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001; zur Hausen H, 2009, INT J CANCER, V125, P1764, DOI 10.1002/ijc.24365	51	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122636	10.1371/journal.pone.0122636	http://dx.doi.org/10.1371/journal.pone.0122636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853649	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400071
J	Trinick, RE; Bunni, L; Thorburn, K; Hackett, AP; Dalzell, M; McNamara, PS				Trinick, Ruth E.; Bunni, Lara; Thorburn, Kent; Hackett, Angela P.; Dalzell, Mark; McNamara, Paul S.			An Observational Study Examining the Relationship between Respiratory Symptoms, Airway Inflammation and Bacteriology in Children with Severe Neurodisability	PLOS ONE			English	Article							CYSTIC-FIBROSIS; BRONCHOALVEOLAR LAVAGE; PSEUDOMONAS-AERUGINOSA; CEREBRAL-PALSY; PCR; QUESTIONNAIRE; ASPIRATION; SPECIMENS; SAMPLES; BLOOD	Background Children with severe neurodisability (ND) commonly suffer from chronic respiratory symptoms that impact greatly on quality of life, and lead to recurrent hospital admissions. This morbidity (and its causes) is poorly described, despite being well recognised by paediatricians. In this study, we characterised respiratory symptoms in children with ND at times of stability and deterioration. We also assessed the relationship between respiratory symptoms, lower airway inflammatory markers and levels of infection/colonisation. Methods ND children were recruited upon admission for elective surgery (Elective-ND [n = 16]), or acutely upon admission to Intensive Care (PICU-ND [n = 19]), and compared to healthy control children [n = 12]. Parents completed a validated respiratory symptom questionnaire in which symptoms associated with activity were removed (total maximal score of 108). Bronchoalveolar lavage (BAL) was collected, and BAL neutrophil counts, IL-8 and TGF beta-1 levels measured. BAL microbial analysis was performed using a 16S/18S rRNA gene based assay and Pseudomonas aeruginosa PCR. Results All ND children had high levels of respiratory symptoms (median [IQR] symptom score PICU-ND, 55[38-64]; Elective-ND, 26[7-45]; Control, 4[0-7]: p<0.01), which affected their families, particularly at nighttime. Elective-ND patients with a total respiratory symptom score >20 invariably had BAL neutrophilia. Elective patients with 16S/18S microbial rDNA positive BAL had higher neutrophil counts (positive, 33[18-70]%; negative, 8[4-38]%: p<0.05) and generally higher symptom scores (positive, 17[5-32]; negative, 5[0-9]: p = 0.097). Streptococcus mitis was commonly identified in BAL from ND children; Pseudomonas aeruginosa was not identified in any sample. Conclusions Children with severe ND often have high levels of chronic respiratory symptoms, which may relate to lower airway inflammation. Bacterial airway colonisation, particularly with oral commensals, may play a role in both symptom generation and inflammation.	[Trinick, Ruth E.; Thorburn, Kent; Dalzell, Mark; McNamara, Paul S.] Alder Hey Childrens Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Trinick, Ruth E.; Bunni, Lara; Hackett, Angela P.; McNamara, Paul S.] Univ Liverpool, Alder Hey Childrens Hosp, Inst Translat Med, Child Hlth, Liverpool L69 3BX, Merseyside, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool	McNamara, PS (corresponding author), Alder Hey Childrens Hosp NHS Fdn Trust, Eaton Rd, Liverpool, Merseyside, England.	mcnamp@liverpool.ac.uk		McNamara, Paul/0000-0002-7055-6034	SPARKS (Children's Medical Research Charity) [08LIV]; Alder Hey Children's Charity; Sparks Charity [08LIV01] Funding Source: researchfish	SPARKS (Children's Medical Research Charity); Alder Hey Children's Charity; Sparks Charity	This study was funded by SPARKS (Children's Medical Research Charity, grant no. 08LIV) and the Alder Hey Children's Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Blic J, 2000, EUR RESPIR J, V15, P217; DeVos D, 1997, J CLIN MICROBIOL, V35, P1295, DOI 10.1128/JCM.35.6.1295-1299.1997; FDA, 2009, GUID IND PAT REP OUT; Fothergill JL, 2010, J MED MICROBIOL, V59, P472, DOI 10.1099/jmm.0.015875-0; Gilchrist FJ, 2011, ARCH DIS CHILD, V96, P215, DOI 10.1136/adc.2009.177618; Handschur M, 2009, COMP IMMUNOL MICROB, V32, P207, DOI 10.1016/j.cimid.2007.10.005; Horz HP, 2008, J MICROBIOL METH, V72, P98, DOI 10.1016/j.mimet.2007.10.007; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Piccione JC, 2012, PEDIATR PULM, V47, P447, DOI 10.1002/ppul.21587; Powell CVE, 2002, ARCH DIS CHILD, V87, P376, DOI 10.1136/adc.87.5.376; Primhak RA, 2011, ARCH DIS CHILD, V96, P389, DOI 10.1136/adc.2009.180653; Seddon PC, 2003, ARCH DIS CHILD, V88, P75, DOI 10.1136/adc.88.1.75; Smith S, 2004, EUR AC CHILDH DIS AN, V40; Thorburn K, 2009, PEDIATR CRIT CARE ME, V10, P222, DOI 10.1097/PCC.0b013e31819368ac; Trinick R, 2012, EUR RESPIR J, V39, P899, DOI 10.1183/09031936.00070311; Weir K, 2009, EUR RESPIR J, V33, P604, DOI 10.1183/09031936.00090308; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2759, DOI 10.1128/JCM.00567-09; Westbom L, 2011, DEV MED CHILD NEUROL, V53, P808, DOI 10.1111/j.1469-8749.2011.04027.x	18	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124627	10.1371/journal.pone.0124627	http://dx.doi.org/10.1371/journal.pone.0124627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853250	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400139
J	Chen, Q; Wang, LF; Ge, LN; Gao, Y; Wang, H				Chen, Qi; Wang, Lufei; Ge, Lina; Gao, Yuan; Wang, Hang			The Anxiolytic Effect of Midazolam in Third Molar Extraction: A Systematic Review	PLOS ONE			English	Article							INTRAVENOUS SEDATION; DOUBLE-BLIND; PREMEDICATION; CLONIDINE; SURGERY; ANXIETY	Purpose To assess the efficacy of midazolam for anxiety control in third molar extraction surgery. Methods Electronic retrievals were conducted in Medline (via PubMed, 1950-2013.12), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2013, Issue 3), Embase (via OVID 1974-2013.12), and the System for Information on Grey Literature in Europe (SIGLE). The bibliographies of relevant clinical trials were also checked. Randomized controlled trials satisfying the inclusion criteria were evaluated, with data extraction done independently by two well-trained investigators. Disagreements were resolved by discussion or by consultation with a third member of the review team. Results Ten studies were included, but meta-analysis could not be conducted because of the significant differences among articles. All but one article demonstrated that midazolam could relieve anxiety. One article demonstrated that propofol offered superior anxiolysis, with more rapid recovery than with midazolam. Compared with lorazepam and diazepam, midazolam did not distinctly dominate in its sedative effect, but was safer. Two articles used midazolam in multidrug intravenous sedation and proved it to be more effective than midazolam alone. Conclusion It was found, by comparison and analysis, that midazolam might be effective for use for anxiety control during third molar extraction and can be safely administered by a dedicated staff member. It can also be used with other drugs to obtain better sedative effects, but the patient's respiratory function must be monitored closely, because multidrug sedation is also more risky.	[Chen, Qi; Wang, Lufei; Ge, Lina; Gao, Yuan; Wang, Hang] Sichuan Univ, State Key Lab Oral Dis, Dept Oral & Maxillofacial Surg, West China Stomatol Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Wang, H (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Dept Oral & Maxillofacial Surg, West China Stomatol Hosp, Chengdu 610064, Sichuan, Peoples R China.	Dr.hangwang@gmail.com	Ge, Li/T-3955-2018	Ge, Li/0000-0002-1824-8034				Bell GW, 2000, BRIT J ORAL MAX SURG, V38, P596, DOI 10.1054/bjom.2000.0473; Bennett CR, 1978, CONSCIOUS SEDATION D, P143; BROWN CR, 1979, ANESTHESIOLOGY, V50, P467, DOI 10.1097/00000542-197905000-00017; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dionne RA, 2001, J AM DENT ASSOC, V132, P740, DOI 10.14219/jada.archive.2001.0271; DIONNE RA, 1984, J DENT RES, V63, P842, DOI 10.1177/00220345840630060501; DIXON RA, 1986, ANAESTHESIA, V41, P276, DOI 10.1111/j.1365-2044.1986.tb12788.x; Eberhart LHJ, 2000, ANASTH INTENSIV NOTF, V35, P388, DOI 10.1055/s-2000-12055; Foley J, 2002, BRIT DENT J, V193, P161, DOI 10.1038/sj.bdj.4801512a; Gross JB, 1996, ANESTHESIOLOGY, V84, P459; Jerjes W, 2005, ORAL SURG ORAL MED O, V100, P564, DOI 10.1016/j.tripleo.2005.02.087; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; LANGLOIS S, 1987, BRIT J CLIN PHARMACO, V23, P273, DOI 10.1111/j.1365-2125.1987.tb03045.x; Leitch JA, 2004, ANAESTHESIA, V59, P853, DOI 10.1111/j.1365-2044.2004.03761.x; Malamed SF, 2003, SEDATION GUIDE PATIE, P412; MILGROM P, 1994, J ORAL MAXIL SURG, V52, P219, DOI 10.1016/0278-2391(94)90285-2; Milgrom P, 1993, Anesth Prog, V40, P57; Moore PA, 1997, ORAL SURG ORAL MED O, V84, P5, DOI 10.1016/S1079-2104(97)90285-7; Pereira-Santos D, 2013, J CRANIOFAC SURG, V24, P1636, DOI 10.1097/SCS.0b013e3182a15dfc; Schlag C, 2013, CAN J GASTROENTEROL, V27, P582, DOI 10.1155/2013/852454; SHANNON I. T., 1960, ORAL SURG ORAL MED AND ORAL PATHOL, V13, P878, DOI 10.1016/0030-4220(60)90019-0; Studer FR, 2012, ORAL MAXILLOFAC SURG, V16, P341, DOI 10.1007/s10006-012-0319-8; VANDERBIJL P, 1987, INT J ORAL MAX SURG, V16, P325, DOI 10.1016/S0901-5027(87)80154-6; VANDERBIJL P, 1991, J ORAL MAXIL SURG, V49, P672, DOI 10.1016/S0278-2391(10)80224-1; Wan Kuo, 2007, Zhonghua Kou Qiang Yi Xue Za Zhi, V42, P568	25	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121410	10.1371/journal.pone.0121410	http://dx.doi.org/10.1371/journal.pone.0121410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849859	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800056
J	Freund, Y; Bloom, B; Bokobza, J; Baarir, N; Laribi, S; Harris, T; Navarro, V; Bernard, M; Pearse, R; Riou, B; Hausfater, P				Freund, Yonathan; Bloom, Benjamin; Bokobza, Jerome; Baarir, Nacera; Laribi, Said; Harris, Tim; Navarro, Vincent; Bernard, Maguy; Pearse, Rupert; Riou, Bruno; Hausfater, Pierre		BISTRO Investigators	Predictive Value of S100-B and Copeptin for Outcomes following Seizure: The BISTRO International Cohort Study	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; EARLY EPILEPSY; BRAIN-DAMAGE; PROTEIN; RECURRENCE; MANAGEMENT; MARKER; RISK; ILAE; EPIDEMIOLOGY	Objective To evaluate the performance of S100-B protein and copeptin, in addition to clinical variables, in predicting outcomes of patients attending the emergency department (ED) following a seizure. Methods We prospectively included adult patients presented with an acute seizure, in four EDs in France and the United Kingdom. Participants were followed up for 28 days. The primary endpoint was a composite of seizure recurrence, all-cause mortality, hospitalization or rehospitalisation, or return visit in the ED within seven days. Results Among the 389 participants included in the analysis, 156 (40%) experienced the primary endpoint within seven days and 195 (54%) at 28 days. Mean levels of both S100-B (0.11 mu g/l [95% CI 0.07-0.20] vs 0.09 mu g/l [0.07-0.14]) and copeptin (23 pmol/l [9-104] vs 17 pmol/l [84-3]) were higher in participants meeting the primary endpoint. However, both biomarkers were poorly predictive of the primary outcome with a respective area under the receiving operator characteristic curve of 0.57 [0.51-0.64] and 0.59 [0.54-0.64]. Multivariable logistic regression analysis identified higher age (odds ratio [OR] 1.3 per decade [1.1-1.5]), provoked seizure (OR 4.93 [2.5-9.8]), complex partial seizure (OR 4.09 [1.8-9.1]) and first seizure (OR 1.83 [1.1-3.0]) as independent predictors of the primary outcome. A second regression analysis including the biomarkers showed no additional predictive benefit (S100-B OR 3.89 [0.80-18.9] copeptin OR 1 [1.00-1.00]). Conclusion The plasma biomarkers S100-B and copeptin did not improve prediction of poor outcome following seizure. Higher age, a first seizure, a provoked seizure and a partial complex seizure are independently associated with adverse outcomes.	[Freund, Yonathan; Riou, Bruno; Hausfater, Pierre] Univ Paris 06, Sorbonne Univ, UMRS INSERM 1166, IHU ICAN, Paris, France; [Freund, Yonathan; Bokobza, Jerome; Riou, Bruno; Hausfater, Pierre] Hop La Pitie Salpetriere, AP HP, Emergency Dept, Paris, France; [Bloom, Benjamin; Harris, Tim] Royal London Hosp, Emergency Dept, London E1 1BB, England; [Baarir, Nacera] Hop Tenon, AP HP, Emergency Dept, F-75970 Paris, France; [Laribi, Said] Hop Lariboisiere, AP HP, Emergency Dept, F-75475 Paris, France; [Navarro, Vincent] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Paris, France; [Bernard, Maguy] Hop La Pitie Salpetriere, AP HP, Dept Biochem, Paris, France; [Pearse, Rupert] Royal London Hosp, Adult Crit Care Unit, London E1 1BB, England; [Bernard, Maguy] Univ Paris 5 Paris Cite, Paris, France; [Bloom, Benjamin; Pearse, Rupert] Queen Mary Univ London, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Barts Health NHS Trust; Royal London Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Barts Health NHS Trust; Royal London Hospital; UDICE-French Research Universities; Universite Paris Cite; University of London; Queen Mary University London	Freund, Y (corresponding author), Univ Paris 06, Sorbonne Univ, UMRS INSERM 1166, IHU ICAN, Paris, France.	yonathanfreund@gmail.com	Laribi, Said/S-3693-2016; bokobza, jerome/AAC-9671-2020; Pearse, Rupert/H-5426-2011	Laribi, Said/0000-0003-4648-4672; Pearse, Rupert/0000-0002-4373-5934; Bloom, Ben/0000-0002-3016-4925; Freund, Yonathan/0000-0002-0262-3848	ThermoFisher BRAHMS; French society of emergency medicine (SFMU); Assistance Publique-Hopitaux de Paris; National Institute for Health Research [RP_2014-04-022, CS/08/08/17] Funding Source: researchfish	ThermoFisher BRAHMS; French society of emergency medicine (SFMU); Assistance Publique-Hopitaux de Paris; National Institute for Health Research(National Institute for Health Research (NIHR))	Roche Diagnostics France (Meylan, France) provided free reagents and kits for S100B assays, and Thermo Fisher scientific B.R.A.H.M.S (Aktiengesellschaft, Hennigsdorf, Germany) provided free reagents and kits for copeptin assays. ThermoFisher BRAHMS provided the copeptin assays free of charge, and funded our biochemistry technicians' time of work in order to process all the analysis. Roche diagnostic provided the S100B assays free of charge. The corresponding author had full access to all the data in the study and final responsibility for the decision to submit for publication. Yonathan Freund received a grant from the French society of emergency medicine (SFMU) and from the Assistance Publique-Hopitaux de Paris for this study. The funders had no role in the study design, data collection, analysis, and interpretation, or the writing of the report.	Atici Y, 2012, SEIZURE-EUR J EPILEP, V21, P175, DOI 10.1016/j.seizure.2011.11.003; BERG AT, 1991, NEUROLOGY, V41, P965, DOI 10.1212/WNL.41.7.965; Bottiger BW, 2001, CIRCULATION, V103, P2694; Breen DP, 2005, POSTGRAD MED J, V81, P715, DOI 10.1136/pgmj.2004.031203; Brown JWL, 2014, J NEUROL NEUROSUR PS, V2013; Choquet C, 2008, EUR J EMERG MED, V15, P261, DOI 10.1097/MEJ.0b013e3282fce63d; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gabayan GZ, 2013, ANN EMERG MED, V62, P136, DOI 10.1016/j.annemergmed.2013.01.017; Holland P, 2009, EPILEPSIA, V50, P1030, DOI 10.1111/j.1528-1167.2008.01819.x; Huff JS, 2014, ANN EMERG MED, V63, P437, DOI 10.1016/j.annemergmed.2014.01.018; Huff JS, 2001, ACAD EMERG MED, V8, P622, DOI 10.1111/j.1553-2712.2001.tb00175.x; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)70383-0; KRUMHOLZ A, 1989, EPILEPSIA, V30, P175, DOI 10.1111/j.1528-1157.1989.tb05451.x; Lawn N, 2014, EPILEPSY BEHAV, V33, P122, DOI 10.1016/j.yebeh.2014.02.008; Marinas A, 2011, EPILEPSY BEHAV, V21, P223, DOI 10.1016/j.yebeh.2011.01.025; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Mikkonen K, 2012, SEIZURE-EUR J EPILEP, V21, P144, DOI 10.1016/j.seizure.2011.10.006; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Pallin DJ, 2008, INT J EMERG MED, V1, P97, DOI 10.1007/s12245-008-0024-4; Panayiotopoulos CP, 2012, EPILEPSIA, V53, P399, DOI 10.1111/j.1528-1167.2011.03381.x; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; RATHLEV NK, 1994, ANN EMERG MED, V23, P513, DOI 10.1016/S0196-0644(94)70070-2; Sauvin G, 2013, ACAD EMERG MED, V20, P33, DOI 10.1111/acem.12052; Song KJ, 2010, RESUSCITATION, V81, P337, DOI 10.1016/j.resuscitation.2009.10.012; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; TARDY B, 1995, AM J EMERG MED, V13, P1, DOI 10.1016/0735-6757(95)90229-5; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-34	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122405	10.1371/journal.pone.0122405	http://dx.doi.org/10.1371/journal.pone.0122405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849778	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800128
J	Martagon, AJ; Lin, JZ; Cimini, SL; Webb, P; Phillips, KJ				Martagon, Alexandro J.; Lin, Jean Z.; Cimini, Stephanie L.; Webb, Paul; Phillips, Kevin J.			The Amelioration of Hepatic Steatosis by Thyroid Hormone Receptor Agonists Is Insufficient to Restore Insulin Sensitivity in Ob/Ob Mice	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; BETA AGONISTS; CHOLESTEROL; DISEASE; PATHOGENESIS; CONTRIBUTES; METABOLISM; RESISTANCE; IMPROVES; EXCESS	Thyroid hormone receptor (TR) agonists have been proposed as therapeutic agents to treat non-alcoholic fatty liver disease (NAFLD) and insulin resistance. We investigated the ability of the TR agonists GC-1 and KB2115 to reduce hepatic steatosis in ob/ob mice. Both compounds markedly reduced hepatic triglyceride levels and ameliorated hepatic steatosis. However, the amelioration of fatty liver was not sufficient to improve insulin sensitivity in these mice and reductions in hepatic triglycerides did not correlate with improvements in insulin sensitivity or glycemic control. Instead, the effects of TR activation on glycemia varied widely and were found to depend upon the time of treatment as well as the compound and dosage used. Lower doses of GC-1 were found to further impair glycemic control, while a higher dose of the same compound resulted in substantially improved glucose tolerance and insulin sensitivity, despite all doses being equally effective at reducing hepatic triglyceride levels. Improvements in glycemic control and insulin sensitivity were observed only in treatments that also increased body temperature, suggesting that the induction of thermogenesis may play a role in mediating these beneficial effects. These data illustrate that the relationship between TR activation and insulin sensitivity is complex and suggests that although TR agonists may have value in treating NAFLD, their effect on insulin sensitivity must also be considered.	[Martagon, Alexandro J.; Lin, Jean Z.; Cimini, Stephanie L.; Webb, Paul; Phillips, Kevin J.] Houston Methodist Res Inst, Diabet & Metab Dis Program, Houston, TX 77030 USA; [Martagon, Alexandro J.] Escuela Biotecnol Alimentos, Inst Tecnol & Estudios Superiores Monterrey, Monterrey, NL, Mexico; [Lin, Jean Z.] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; Tecnologico de Monterrey; University of Houston System; University of Houston	Phillips, KJ (corresponding author), Houston Methodist Res Inst, Diabet & Metab Dis Program, Houston, TX 77030 USA.	KPhillips@HoustonMethodist.org	Martagon, Alexandro/P-2609-2019	Martagon, Alexandro/0000-0003-2135-6295; egge, Stephanie/0000-0001-8232-0443	NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK090849]; Tecnologico de Monterrey, Direccion de Posgrado de la Escuela de Medicina [0020ENS325]; Consejo Nacional de Ciencia y Tecnologia [387520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090849] Funding Source: NIH RePORTER	NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Tecnologico de Monterrey, Direccion de Posgrado de la Escuela de Medicina; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases DK090849 (PW). A.J.M. was supported by Tecnologico de Monterrey, Direccion de Posgrado de la Escuela de Medicina (0020ENS325) and Consejo Nacional de Ciencia y Tecnologia (387520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bryzgalova G, 2008, J STEROID BIOCHEM, V111, P262, DOI 10.1016/j.jsbmb.2008.06.010; Cable EE, 2009, HEPATOLOGY, V49, P407, DOI 10.1002/hep.22572; Charlton M, 2001, LIVER TRANSPLANT, V7, P608, DOI 10.1053/jlts.2001.25453; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Contos MJ, 2001, LIVER TRANSPLANT, V7, P363, DOI 10.1053/jlts.2001.23011; DeFronzo RA, 1997, DIABETES REV, V5, P177; Dimitriadis GD, 2001, EXP CLIN ENDOCR DIAB, V109, pS225, DOI 10.1055/s-2001-18584; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Hoppener JWM, 1999, DIABETOLOGIA, V42, P427, DOI 10.1007/s001250051175; Klieverik LP, 2009, P NATL ACAD SCI USA, V106, P5966, DOI 10.1073/pnas.0805355106; Ladenson PW, 2010, NEW ENGL J MED, V362, P906, DOI 10.1056/NEJMoa0905633; Lam BP, 2009, ANN HEPATOL, V8, pS51, DOI 10.1016/S1665-2681(19)31827-7; Lin JZ, 2012, ENDOCRINOLOGY, V153, P6136, DOI 10.1210/en.2011-2081; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MULLER MJ, 1980, LIFE SCI, V27, P827; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Perra A, 2008, FASEB J, V22, P2981, DOI 10.1096/fj.08-108464; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rohdenburg GL, 1920, ENDOCRINOLOGY, V4, P63, DOI 10.1210/endo-4-1-63; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schwabedissen HEMZ, 2011, HEPATOLOGY, V54, P644, DOI 10.1002/hep.24391; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; Trost SU, 2000, ENDOCRINOLOGY, V141, P3057, DOI 10.1210/en.141.9.3057; Vatner DF, 2013, AM J PHYSIOL-ENDOC M, V305, pE89, DOI 10.1152/ajpendo.00573.2012; Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095; Vujovic M, 2009, ENDOCRINOLOGY, V150, P2940, DOI 10.1210/en.2008-1085; Wei YZ, 2009, AM J PATHOL, V174, P1329, DOI 10.2353/ajpath.2009.080697; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325	41	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122987	10.1371/journal.pone.0122987	http://dx.doi.org/10.1371/journal.pone.0122987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849936	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800189
J	Fryxell, RTT; Freyman, K; Ulloa, A; Hendricks, B; Paulsen, D; Odoi, A; Moncayo, A				Fryxell, Rebecca T. Trout; Freyman, Kimberly; Ulloa, Armando; Hendricks, Brian; Paulsen, Dave; Odoi, Agricola; Moncayo, Abelardo			Cemeteries Are Effective Sites For Monitoring La Crosse Virus (LACv) and these Environments May Play a Role in LACv Infection	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; HABITAT PREFERENCES; LARVAL COMPETITION; MOSQUITOS DIPTERA; EASTERN TENNESSEE; CULICIDAE; ENCEPHALITIS; TRISERIATUS; TRANSMISSION; ABUNDANCE	La Crosse encephalitis (LAC) is the leading arboviral disease among children, and was previously limited to the upper Midwest. In 2012 nine pediatric cases of LAC occurred in eastern Tennessee, including one fatal case. In an attempt to identify sites near an active LACv infection and describe the abundance and distribution of potential LACv vectors near a fatal LAC case in the Appalachian region, we initiated an end of season study using a combination of questing and oviposition mosquito traps placed at forty-nine sites consisting of cemeteries and houses within 16 radial kilometers of two pediatric infections. LACv was isolated from three Aedes triseriatus pools collected from cemeteries and spatial clustering analysis identified clusters of Ae. triseriatus and Ae. albopictus populations that overlapped in the same area as the 2012 LACv cases. Results indicate cemeteries are effective sites for monitoring LACv. The role of cemeteries and specific environmental features will be the focus of future investigations.	[Fryxell, Rebecca T. Trout; Hendricks, Brian; Paulsen, Dave] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Freyman, Kimberly; Moncayo, Abelardo] Tennessee Dept Hlth, Nashville, TN USA; [Ulloa, Armando] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico; [Odoi, Agricola] Univ Tennessee, Dept Biomed & Diagnost Serv, Knoxville, TN 37901 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Tennessee Department Health; Instituto Nacional de Salud Publica; University of Tennessee System; University of Tennessee Knoxville	Fryxell, RTT (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	RFryxell@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737; Trout Fryxell, Rebecca/0000-0003-2133-0220	University of Tennessee Institute of Agriculture (Hatch project) [TENN00433]; Tennessee Department of Health	University of Tennessee Institute of Agriculture (Hatch project); Tennessee Department of Health	Funding for this project was provided by the University of Tennessee Institute of Agriculture (Hatch project TENN00433) and the Tennessee Department of Health.	Armistead JS, 2012, J MED ENTOMOL, V49, P1318, DOI 10.1603/ME11261; Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403; BEIER JC, 1983, J MED ENTOMOL, V20, P76, DOI 10.1093/jmedent/20.1.76; BEIER JC, 1983, ENVIRON ENTOMOL, V12, P434, DOI 10.1093/ee/12.2.434; Bevins SN, 2008, BIOL INVASIONS, V10, P1109, DOI 10.1007/s10530-007-9188-8; Borucki MK, 2002, MICROBES INFECT, V4, P341, DOI 10.1016/S1286-4579(02)01547-2; Centers for Disease Control and Prevention, 2012, CROSS ENC; Darsie RFJ, 2005, IDENTIFICATION GEOGR; Erwin PC, 2002, AM J EPIDEMIOL, V155, P1060, DOI 10.1093/aje/155.11.1060; Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807; Haddow AD, 2009, J VECTOR ECOL, V34, P70, DOI [10.1111/j.1948-7134.2009.00009.x, 10.3376/038.034.0109]; Haddow AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006145; Hughes MT, 2006, J MED ENTOMOL, V43, P757, DOI 10.1603/0022-2585(2006)43[757:CPOATA]2.0.CO;2; Jones TF, 1999, CLIN INFECT DIS, V28, P93, DOI 10.1086/515087; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2014, SATSCAN USER GUIDE V; Kulldorff M, 2005, INFORM MANAGEMENT SE, V2005; Kuno G, 1996, J CLIN MICROBIOL, V34, P1184, DOI 10.1128/JCM.34.5.1184-1188.1996; Lambert A, 2015, J EMERG INF IN PRESS; Lambert AJ, 2005, J CLIN MICROBIOL, V43, P1885, DOI 10.1128/JCM.43.4.1885-1889.2005; Lambert AJ, 2010, EMERG INFECT DIS, V16, P856, DOI 10.3201/eid1605.100170; Leisnham PT, 2012, ECOHEALTH, V9, P217, DOI 10.1007/s10393-012-0773-7; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; Nasci RS, 2000, J MED ENTOMOL, V37, P559, DOI 10.1603/0022-2585-37.4.559; NOVAK MG, 1993, ENVIRON ENTOMOL, V22, P311, DOI 10.1093/ee/22.2.311; PANTUWATANA S, 1974, AM J TROP MED HYG, V23, P246; Reese SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-76; Sanford MR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-225; Sardelis MR, 2002, J MED ENTOMOL, V39, P635, DOI 10.1603/0022-2585-39.4.635; SAUL SH, 1978, AM NAT, V112, P333, DOI 10.1086/283276; Szumlas DE, 1996, J MED ENTOMOL, V33, P598, DOI 10.1093/jmedent/33.4.598; THOMPSON WH, 1977, SCIENCE, V196, P530, DOI 10.1126/science.850794; United States Geological Survey, 2013, CROSS ENC HUM 2013; Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]; WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140; Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015; WOODRUFF BA, 1992, AM J EPIDEMIOL, V136, P320, DOI 10.1093/oxfordjournals.aje.a116497; Yee DA, 2012, J MED ENTOMOL, V49, P482, DOI 10.1603/ME11227; Yoshioka M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-225	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122895	10.1371/journal.pone.0122895	http://dx.doi.org/10.1371/journal.pone.0122895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860584	Green Published, gold			2022-12-27	WOS:000352590300067
J	Mahauad-Fernandez, WD; Borcherding, NC; Zhang, WZ; Okeoma, CM				Mahauad-Fernandez, Wadie D.; Borcherding, Nicholas C.; Zhang, Weizhou; Okeoma, Chioma M.			Bone Marrow Stromal Antigen 2 (BST-2) DNA Is Demethylated in Breast Tumors and Breast Cancer Cells	PLOS ONE			English	Article							HUMANIZED ANTI-HM1.24 ANTIBODY; GENE-EXPRESSION; PROMOTER HYPOMETHYLATION; MOLECULAR MARKERS; MULTIPLE-MYELOMA; CD4+T CELLS; TETHERIN; METHYLATION; GENOMICS; RELEASE	Background Bone marrow stromal antigen 2 (BST-2) is a known anti-viral gene that has been recently identified to be overexpressed in many cancers, including breast cancer. BST-2 is critical for the invasiveness of breast cancer cells and the formation of metastasis in vivo. Although the regulation of BST-2 in immune cells is unraveling, it is unknown how BST-2 expression is regulated in breast cancer. We hypothesized that meta-analyses of BST-2 gene expression and BST-2 DNA methylation profiles would illuminate mechanisms regulating elevated BST-2 expression in breast tumor tissues and cells. Materials and Methods We performed comprehensive meta-analyses of BST-2 gene expression and BST-2 DNA methylation in The Cancer Genome Atlas (TCGA) and various Gene Expression Omnibus (GEO) datasets. BST-2 expression levels and BST-2 DNA methylation status at specific CpG sites on the BST-2 gene were compared for various breast tumor molecular subtypes and breast cancer cell lines. Results We show that BST-2 gene expression is inversely associated with the methylation status at specific CpG sites in primary breast cancer specimens and breast cancer cell lines. BST-2 demethylation is significantly more prevalent in primary tumors and cancer cells than in normal breast tissues or normal mammary epithelial cells. Demethylation of the BST-2 gene significantly correlates with its mRNA expression. These studies provide the initial evidence that significant differences exist in BST-2 DNA methylation patterns between breast tumors and normal breast tissues, and that BST-2 expression patterns in tumors and cancer cells correlate with hypomethylated BST-2 DNA. Conclusion Our study suggests that the DNA methylation pattern and expression of BST-2 may play a role in disease pathogenesis and could serve as a biomarker for the diagnosis of breast cancer.	[Mahauad-Fernandez, Wadie D.; Okeoma, Chioma M.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Mahauad-Fernandez, Wadie D.; Zhang, Weizhou; Okeoma, Chioma M.] Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA USA; [Borcherding, Nicholas C.; Zhang, Weizhou] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Borcherding, Nicholas C.; Zhang, Weizhou] Univ Iowa, Coll Med, Med Scientist Training Program, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Okeoma, CM (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	chioma-okeoma@uiowa.edu		Borcherding, Nicholas/0000-0003-1427-6342; Okeoma, Chioma/0000-0001-7737-6493	National Institutes of Health [T32 GM007337, P30CA086862]; American Cancer Society [IRG-77-004-34]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Institutes of Health under Award Numbers T32 GM007337 (NB) and P30CA086862. Our work also benefited from Grant IRG-77-004-34 from the American Cancer Society, administered through The Holden Comprehensive Cancer Center at The University of Iowa. The results here are in whole or part based upon data generated by the TCGA Research Network (http://cancergenome.nih.gov/).	Alvarez RA, 2014, J VIROL, V88, P6031, DOI 10.1128/JVI.00449-14; Arias JF, 2014, P NATL ACAD SCI USA, V111, P6425, DOI 10.1073/pnas.1321507111; BEDFORD MT, 1987, CANCER RES, V47, P5274; Bego MG, 2012, J VIROL, V86, P3513, DOI 10.1128/JVI.06971-11; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Cai DQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-102; Casey T, 2009, BREAST CANCER RES TR, V114, P47, DOI 10.1007/s10549-008-9982-8; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Coit P, 2013, J AUTOIMMUN, V43, P78, DOI 10.1016/j.jaut.2013.04.003; Cole G, 2012, BIOCHEMISTRY-US, V51, P5033, DOI 10.1021/bi201747t; Cui W, 2010, CANCER SCI, V101, P927, DOI 10.1111/j.1349-7006.2010.01495.x; De Capoa A, 2003, ONCOL REP, V10, P545; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; Ehrlich M, 2002, J NUTR, V132, p2424S, DOI 10.1093/jn/132.8.2424S; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Fang KH, 2014, LARYNGOSCOPE; Ferguson AT, 1997, J BIOL CHEM, V272, P32260, DOI 10.1074/jbc.272.51.32260; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; GOTO T, 1994, BLOOD, V84, P1922; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hibi K, 2009, ANTICANCER RES, V29, P2215; Jones PH, 2013, CELL SIGNAL; Jones PH, 2013, VIROLOGY, V444, P124, DOI 10.1016/j.virol.2013.05.042; Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010; Jones PH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-50; Jones PH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-10; Jovanovic J, 2010, MOL ONCOL, V4, P242, DOI 10.1016/j.molonc.2010.04.002; Kawai S, 2008, CANCER SCI, V99, P2461, DOI 10.1111/j.1349-7006.2008.00968.x; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Li SX, 2014, J IMMUNOL, V193, P306, DOI 10.4049/jimmunol.1400490; Madison MN, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0102-z; Mahauad-Fernandez WD, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0493-8; Mahauad-Fernandez WD, 2014, J GEN VIROL; Mehta HV, 2012, J IMMUNOL, V189, P4088, DOI 10.4049/jimmunol.1200777; Mehta HV, 2012, J IMMUNOL; Milicic A, 2008, CANCER RES, V68, P7760, DOI 10.1158/0008-5472.CAN-08-0020; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ono K, 1999, MOL IMMUNOL, V36, P387, DOI 10.1016/S0161-5890(99)00029-2; Pham TNQ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-15; Putnik M, 2012, BIOCHEM BIOPH RES CO, V426, P26, DOI 10.1016/j.bbrc.2012.08.007; Radpour R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027355; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; RAZIN A, 1984, BIOCHIM BIOPHYS ACTA, V782, P331, DOI 10.1016/0167-4781(84)90043-5; RAZIN A, 1977, P NATL ACAD SCI USA, V74, P2725, DOI 10.1073/pnas.74.7.2725; Riaz M, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3415; Sauter D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00163; Sayeed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067191; Schliemann C, 2010, BLOOD, V115, P736, DOI 10.1182/blood-2009-08-239004; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Schweiger MR, 2013, BRIEF FUNCT GENOMICS, V12, P411, DOI 10.1093/bfgp/elt024; Silveira NJF, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-56; Son KS, 2010, BREAST, V19, P484, DOI 10.1016/j.breast.2010.05.011; Tai YT, 2012, BLOOD, V119, P2074, DOI 10.1182/blood-2011-06-364521; Tao YG, 2011, NUCLEIC ACIDS RES, V39, P9508, DOI 10.1093/nar/gkr611; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wainwright DA, 2011, EXP MOL PATHOL, V91, P440, DOI 10.1016/j.yexmp.2011.04.012; Wang W, 2009, LUNG CANCER, V63, P23, DOI 10.1016/j.lungcan.2008.04.009; Wang ZQ, 2006, INT J CANCER, V118, P1436, DOI 10.1002/ijc.21499; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wong YF, 2007, ONCOGENE, V26, P1971, DOI 10.1038/sj.onc.1209986; Yamamoto S, 2014, CANCER CELL, V25, P762, DOI 10.1016/j.ccr.2014.04.024; Yersal O, 2014, WORLD J CLIN ONCOL, V5, P412, DOI 10.5306/wjco.v5.i3.412; Yi EH, 2013, BIOCHEM BIOPH RES CO, V435, P685, DOI 10.1016/j.bbrc.2013.05.043; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	71	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123931	10.1371/journal.pone.0123931	http://dx.doi.org/10.1371/journal.pone.0123931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860442	Green Published, gold			2022-12-27	WOS:000352590300122
J	Tran-Gia, J; Wech, T; Bley, T; Kostler, H				Tran-Gia, Johannes; Wech, Tobias; Bley, Thorsten; Koestler, Herbert			Model-Based Acceleration of Look-Locker T1 Mapping	PLOS ONE			English	Article							RELAXATION-TIMES; HUMAN BRAIN; GOLDEN-RATIO; T-1; RECONSTRUCTION; QUANTIFICATION; FLASH	Mapping the longitudinal relaxation time T-1 has widespread applications in clinical MRI as it promises a quantitative comparison of tissue properties across subjects and scanners. Due to the long scan times of conventional methods, however, the use of quantitative MRI in clinical routine is still very limited. In this work, an acceleration of Inversion-Recovery Look-Locker (IR-LL) T-1 mapping is presented. A model-based algorithm is used to iteratively enforce an exponential relaxation model to a highly undersampled radially acquired IR-LL dataset obtained after the application of a single global inversion pulse. Using the proposed technique, a T-1 map of a single slice with 1.6mm in-plane resolution and 4mm slice thickness can be reconstructed from data acquired in only 6s. A time-consuming segmented IR experiment was used as gold standard for T-1 mapping in this work. In the subsequent validation study, the model-based reconstruction of a single-inversion IR-LL dataset exhibited a T-1 difference of less than 2.6% compared to the segmented IR-LL reference in a phantom consisting of vials with T1 values between 200ms and 3000ms. In vivo, the T-1 difference was smaller than 5.5% in WM and GM of seven healthy volunteers. Additionally, the T-1 values are comparable to standard literature values. Despite the high acceleration, all model-based reconstructions were of a visual quality comparable to fully sampled references. Finally, the reproducibility of the T-1 mapping method was demonstrated in repeated acquisitions. In conclusion, the presented approach represents a promising way for fast and accurate T-1 mapping using radial IR-LL acquisitions without the need of any segmentation.	[Tran-Gia, Johannes; Wech, Tobias; Bley, Thorsten; Koestler, Herbert] Univ Wurzburg, Dept Diagnost & Intervent Radiol, D-97070 Wurzburg, Germany; [Wech, Tobias; Bley, Thorsten; Koestler, Herbert] Univ Wurzburg, CHFC Wurzburg, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Tran-Gia, J (corresponding author), Univ Wurzburg, Dept Diagnost & Intervent Radiol, D-97070 Wurzburg, Germany.	E_Tran_J@ukw.de	Köstler, Herbert/B-2089-2010	Köstler, Herbert/0000-0001-6207-9226; Tran-Gia, Johannes/0000-0001-9552-7750	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation (DFG); University of Wurzburg	German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	JT-G was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wurzburg. Also, the costs for the open access publication itself will be borne by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CRAWLEY AP, 1988, MAGN RESON MED, V7, P23, DOI 10.1002/mrm.1910070104; DEICHMANN R, 1992, J MAGN RESON, V96, P608, DOI 10.1016/0022-2364(92)90347-A; Deichmann R, 2005, MAGNET RESON MED, V54, P20, DOI 10.1002/mrm.20552; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Doneva M, 2010, MAGN RESON MED, V64, P1114, DOI 10.1002/mrm.22483; Ehses P, 2013, MAGN RESON MED, V69, P71, DOI 10.1002/mrm.24225; Ethofer T, 2003, MAGN RESON MED, V50, P1296, DOI 10.1002/mrm.10640; Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Neeb H, 2008, NEUROIMAGE, V42, P1094, DOI 10.1016/j.neuroimage.2008.03.060; Preibisch C, 2009, MAGN RESON MED, V61, P125, DOI 10.1002/mrm.21776; Rubinstein R., 2008, EFFICIENT IMPLEMENTA; Seiberlich N, 2008, MAGN RESON MED, V59, P930, DOI 10.1002/mrm.21565; Seiberlich N, 2007, MAGN RESON MED, V58, P1257, DOI 10.1002/mrm.21435; Shah NJ, 2001, NEUROIMAGE, V14, P1175, DOI 10.1006/nimg.2001.0886; Steinhoff S, 2001, MAGN RESON MED, V46, P131, DOI 10.1002/mrm.1168; Sumpf TJ, 2011, J MAGN RESON IMAGING, V34, P420, DOI 10.1002/jmri.22634; Tran-Gia J, 2014, MAGN RESON IMAGING, V32, P1021, DOI 10.1016/j.mri.2014.05.012; Tran-Gia J, 2013, MAGN RESON MED, V70, P1524, DOI 10.1002/mrm.24600; Venkatesan R, 1998, MAGNET RESON MED, V40, P592, DOI 10.1002/mrm.1910400412; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Winkelmann S, 2007, IEEE T MED IMAGING, V26, P68, DOI 10.1109/TMI.2006.885337; Zhu DC, 2005, MAGNET RESON MED, V54, P725, DOI 10.1002/mrm.20602; ZUR Y, 1991, MAGNET RESON MED, V21, P251, DOI 10.1002/mrm.1910210210	25	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122611	10.1371/journal.pone.0122611	http://dx.doi.org/10.1371/journal.pone.0122611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860381	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300051
J	Antwerpen, MH; Prior, K; Mellmann, A; Hoppner, S; Splettstoesser, WD; Harmsen, D				Antwerpen, Markus H.; Prior, Karola; Mellmann, Alexander; Hoeppner, Sebastian; Splettstoesser, Wolf D.; Harmsen, Dag			Rapid High Resolution Genotyping of Francisella tularensis by Whole Genome Sequence Comparison of Annotated Genes ("MLST+")	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; SUBSP HOLARCTICA; MULTIPLE-LOCUS; TULAREMIA; PHYLOGEOGRAPHY; REEMERGENCE; GERMANY; AGENT	The zoonotic disease tularemia is caused by the bacterium Francisella tularensis. This pathogen is considered as a category A select agent with potential to be misused in bioterrorism. Molecular typing based on DNA-sequence like canSNP-typing or MLVA has become the accepted standard for this organism. Due to the organism's highly clonal nature, the current typing methods have reached their limit of discrimination for classifying closely related sub-populations within the subspecies F. tularensis ssp. holarctica. We introduce a new gene-by- gene approach, MLST+, based on whole genome data of 15 sequenced F. tularensis ssp. holarctica strains and apply this approach to investigate an epidemic of lethal tularemia among non-human primates in two animal facilities in Germany. Due to the high resolution of MLST+ we are able to demonstrate that three independent clones of this highly infectious pathogen were responsible for these spatially and temporally restricted outbreaks.	[Antwerpen, Markus H.; Splettstoesser, Wolf D.] Bundeswehr, Inst Microbiol, D-80937 Munich, Germany; [Prior, Karola; Hoeppner, Sebastian; Harmsen, Dag] Univ Munster, Dept Periodontol, D-48149 Munster, Germany; [Mellmann, Alexander] Univ Munster, Inst Hyg, D-48149 Munster, Germany; [Splettstoesser, Wolf D.] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany	Bundeswehr Institute of Microbiology (IMB); University of Munster; University of Munster; University of Rostock	Antwerpen, MH (corresponding author), Bundeswehr, Inst Microbiol, Neuherbergstr 12, D-80937 Munich, Germany.	markusantwerpen@bundeswehr.org		Antwerpen, Markus/0000-0003-4013-8808; Mellmann, Alexander/0000-0002-0649-5185	German Ministry of Health [BMG]; Robert-Koch-Institute [FKZ 1369-372]; European Community's Seventh Framework Program [278864]	German Ministry of Health [BMG]; Robert-Koch-Institute; European Community's Seventh Framework Program(European Commission)	This work was supported in part by the German Ministry of Health [BMG] and the Robert-Koch-Institute under contract FKZ 1369-372 and by the European Community's Seventh Framework Program [grant number FP7/2007-2013 to DH] under Grant Agreement No 278864 in the framework of the EU PathoNGenTrace project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antwerpen M, 2011, EUR J CLIN MICROBIOL, V30, P923, DOI 10.1007/s10096-011-1177-2; Chanturia G, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-139; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Cody AJ, 2013, J CLIN MICROBIOL, V51, P2526, DOI 10.1128/JCM.00066-13; Dempsey MP, 2007, APPL ENVIRON MICROB, V73, P7465, DOI 10.1128/AEM.00646-07; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; Farlow J, 2001, J CLIN MICROBIOL, V39, P3186, DOI 10.1128/JCM.39.9.3186-3192.2001; Gyuranecz M, 2012, EMERG INFECT DIS, V18, P1379, DOI 10.3201/eid1808.111826; Gyuranecz M, 2012, EMERG INFECT DIS, V18, P290, DOI 10.3201/eid1802.111305; Hornstra HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026201; Inouye M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-338; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2001, J CLIN MICROBIOL, V39, P3140, DOI 10.1128/JCM.39.9.3140-3146.2001; Johansson A, 2010, J AOAC INT, V93, P1930; Karlsson E, 2013, ENVIRON MICROBIOL, V15, P634, DOI 10.1111/1462-2920.12052; Kaysser P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-157; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Kuroda M, 2012, J CLIN MICROBIOL, V50, P1810, DOI 10.1128/JCM.06715-11; Larsson P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000472; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Matz-Rensing K, 2007, VET PATHOL, V44, P327, DOI 10.1354/vp.44-3-327; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Nubel U, 2006, J BACTERIOL, V188, P5319, DOI 10.1128/JB.01662-05; Petersen JM, 2008, EMERG INFECT DIS, V14, P1928, DOI 10.3201/eid1412.080482; Pilo P, 2009, EMERG INFECT DIS, V15, P2049, DOI 10.3201/eid1512.080805; Raoult D, 2011, EUR J CLIN MICROBIOL, V30, P935, DOI 10.1007/s10096-010-1151-4; Sjodin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-268; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Splettstoesser WD, 2007, EPIDEMIOL INFECT, V135, P1256, DOI 10.1017/S0950268807008035; Svensson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008360; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vogler AJ, 2009, LETT APPL MICROBIOL, V48, P140, DOI 10.1111/j.1472-765X.2008.02484.x; Vogler AJ, 2009, J BACTERIOL, V191, P2474, DOI 10.1128/JB.01786-08	37	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123298	10.1371/journal.pone.0123298	http://dx.doi.org/10.1371/journal.pone.0123298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856198	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500085
J	Kwon, HJ; Xing, WM; Chan, K; Niedziela-Majka, A; Brendza, KM; Kirschberg, T; Kato, D; Link, JO; Cheng, GF; Liu, XH; Sakowicz, R				Kwon, Hyock Joo; Xing, Weimei; Chan, Katie; Niedziela-Majka, Anita; Brendza, Katherine M.; Kirschberg, Thorsten; Kato, Darryl; Link, John O.; Cheng, Guofeng; Liu, Xiaohong; Sakowicz, Roman			Direct Binding of Ledipasvir to HCV NS5A: Mechanism of Resistance to an HCV Antiviral Agent	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NONSTRUCTURAL PROTEIN 5A; CRYSTAL-STRUCTURE; RNA REPLICATION; INHIBITOR; DOMAIN; PHOSPHORYLATION; SOFOSBUVIR; MODES	Ledipasvir, a direct acting antiviral agent (DAA) targeting the Hepatitis C Virus NS5A protein, exhibits picomolar activity in replicon cells. While its mechanism of action is unclear, mutations that confer resistance to ledipasvir in HCV replicon cells are located in NS5A, suggesting that NS5A is the direct target of ledipasvir. To date co-precipitation and cross-linking experiments in replicon or NS5A transfected cells have not conclusively shown a direct, specific interaction between NS5A and ledipasvir. Using recombinant, full length NS5A, we show that ledipasvir binds directly, with high affinity and specificity, to NS5A. Ledipasvir binding to recombinant NS5A is saturable with a dissociation constant in the low nanomolar range. A mutant form of NS5A (Y93H) that confers resistance to ledipasvir shows diminished binding to ledipasvir. The current study shows that ledipasvir inhibits NS5A through direct binding and that resistance to ledipasvir is the result of a reduction in binding affinity to NS5A mutants.	[Kwon, Hyock Joo; Xing, Weimei; Chan, Katie; Niedziela-Majka, Anita; Brendza, Katherine M.; Kirschberg, Thorsten; Kato, Darryl; Link, John O.; Cheng, Guofeng; Liu, Xiaohong; Sakowicz, Roman] Gilead Sci Inc, Foster City, CA 94404 USA	Gilead Sciences	Kwon, HJ (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	HyockJoo.Kwon@gilead.com			Gilead Sciences, Inc.	Gilead Sciences, Inc.(Gilead Sciences)	Gilead Sciences, Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Ascher DB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04765; Belda O, 2012, VIRUS RES, V170, P1, DOI 10.1016/j.virusres.2012.09.007; Bhattacharya D, 2014, J GEN VIROL, V95, P363, DOI 10.1099/vir.0.054569-0; Cheng G, 2012, J HEPATOL, V56, pS464, DOI 10.1016/S0168-8278(12)61184-2; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Fridell RA, 2011, J VIROL, V85, P7312, DOI 10.1128/JVI.00253-11; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Hwang J, 2010, J VIROL, V84, P12480, DOI 10.1128/JVI.01319-10; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lambert SM, 2014, PROTEIN SCI, V23, P723, DOI 10.1002/pro.2456; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Lee C, 2011, VIROLOGY, V414, P10, DOI 10.1016/j.virol.2011.03.026; Link JO, 2014, J MED CHEM, V57, P2033, DOI 10.1021/jm401499g; Love RA, 2009, J VIROL, V83, P4395, DOI 10.1128/JVI.02352-08; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; O'Boyle DR, 2013, VIROLOGY, V444, P343, DOI 10.1016/j.virol.2013.06.032; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Qiu DK, 2011, J GEN VIROL, V92, P2502, DOI 10.1099/vir.0.034801-0; Robinson M, 2010, ANTIMICROB AGENTS CH, V54, P3099, DOI 10.1128/AAC.00289-10; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; TANFORD C, 1976, BIOCHIM BIOPHYS ACTA, V457, P133, DOI 10.1016/0304-4157(76)90009-5; Targett-Adams P, 2011, J VIROL, V85, P6353, DOI 10.1128/JVI.00215-11; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Wong KA, 2013, ANTIMICROB AGENTS CH, V57, P6333, DOI 10.1128/AAC.02193-12	36	31	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122844	10.1371/journal.pone.0122844	http://dx.doi.org/10.1371/journal.pone.0122844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856426	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500060
J	Rac, J; Haas, F; Schumacher, A; Middeldorp, JM; Delecluse, HJ; Speck, RF; Bernasconi, M; Nadal, D				Rac, Juergen; Haas, Florian; Schumacher, Andrina; Middeldorp, Jaap M.; Delecluse, Henri-Jacques; Speck, Roberto F.; Bernasconi, Michele; Nadal, David			Telomerase Activity Impacts on Epstein-Barr Virus Infection of AGS Cells	PLOS ONE			English	Article							NORMAL EPITHELIAL-CELLS; ORAL HAIRY LEUKOPLAKIA; MEMBRANE-PROTEIN 1; B-CELLS; NUCLEAR ANTIGEN-2; EBV INFECTION; TERMINAL DIFFERENTIATION; STABLE REPLICATION; VIRAL GENOME; LINES HNE-1	The Epstein-Barr virus (EBV) is transmitted from host-to-host via saliva and is associated with epithelial malignancies including nasopharyngeal carcinoma (NPC) and some forms of gastric carcinoma (GC). Nevertheless, EBV does not transform epithelial cells in vitro where it is rapidly lost from infected primary epithelial cells or epithelial tumor cells. Longterm infection by EBV, however, can be established in hTERT-immortalized nasopharyngeal epithelial cells. Here, we hypothesized that increased telomerase activity in epithelial cells enhances their susceptibility to infection by EBV. Using HONE-1, AGS and HEK293 cells we generated epithelial model cell lines with increased or suppressed telomerase activity by stable ectopic expression of hTERT or of a catalytically inactive, dominant negative hTERT mutant. Infection experiments with recombinant prototypic EBV (rB95.8), recombinant NPC EBV (rM81) with increased epithelial cell tropism compared to B95.8, or recombinant B95.8 EBV with BZLF1-knockout that is not able to undergo lytic replication, revealed that infection frequencies positively correlate with telomerase activity in AGS cells but also partly depend on the cellular background. AGS cells with increased telomerase activity showed increased expression mainly of latent EBV genes, suggesting that increased telomerase activity directly acts on the EBV infection of epithelial cells by facilitating latent EBV gene expression early upon virus inoculation. Thus, our results indicate that infection of epithelial cells by EBV is a very selective process involving, among others, telomerase activity and cellular background to allow for optimized host-to-host transmission via saliva.	[Rac, Juergen; Haas, Florian; Schumacher, Andrina; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Expt Infect Dis & Canc Res, Zurich, Switzerland; [Rac, Juergen; Haas, Florian; Schumacher, Andrina; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Div Infect Dis, Zurich, Switzerland; [Rac, Juergen; Haas, Florian; Schumacher, Andrina; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Hosp Epidemiol, Zurich, Switzerland; [Rac, Juergen; Haas, Florian; Schumacher, Andrina; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Middeldorp, Jaap M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Middeldorp, Jaap M.] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Amsterdam, Netherlands; [Delecluse, Henri-Jacques] German Canc Res Ctr, Div Pathogenesis Virus Associated Tumors, Heidelberg, Germany; [Speck, Roberto F.] Univ Zurich, Univ Zurich Hosp, Dept Med, Div Infect Dis, Zurich, Switzerland; [Speck, Roberto F.] Univ Zurich, Univ Zurich Hosp, Dept Med, Hosp Epidemiol, Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Nadal, D (corresponding author), Univ Zurich, Univ Childrens Hosp Zurich, Expt Infect Dis & Canc Res, Zurich, Switzerland.	david.nadal@kispi.uzh.ch	Bernasconi, Michele/GOH-1815-2022; Bernasconi, Michele/C-6734-2008; Speck, Roberto F/O-2433-2016; Bernasconi, Michele/CAG-2492-2022	Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Speck, Roberto/0000-0002-8453-1137; Middeldorp, Jaap Michiel/0000-0002-0765-4125; Delecluse, Henri-Jacques/0000-0002-1744-6274	Olga-Mayenfisch Foundation; Velux Foundation; Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation; Hermann Klaus Foundation; Kurt and Senta Herrmann Foundation; Foundation for Scientific Research of the University of Zurich	Olga-Mayenfisch Foundation; Velux Foundation(Velux Fonden); Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation; Hermann Klaus Foundation; Kurt and Senta Herrmann Foundation; Foundation for Scientific Research of the University of Zurich	This work was supported by Olga-Mayenfisch Foundation (RS), Velux Foundation (veluxstiftung. ch, DN), Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation (DN), Hermann Klaus Foundation (DN), Kurt and Senta Herrmann Foundation (DN) and the Foundation for Scientific Research of the University of Zurich (DN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099163; BARRANCO SC, 1983, CANCER RES, V43, P1703; Bernasconi M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-43; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Buettner M, 2012, J GEN VIROL, V93, P1059, DOI 10.1099/vir.0.038661-0; Crowe DL, 2005, INT J ONCOL, V27, P847; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Ding L, 2005, INT J BIOCHEM CELL B, V37, P1881, DOI 10.1016/j.biocel.2005.04.012; Dirmeier U, 2003, CANCER RES, V63, P2982; Dorner M, 2008, J VIROL, V82, P4400, DOI 10.1128/JVI.02630-07; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Feederle R, 2007, INT J CANCER, V121, P588, DOI 10.1002/ijc.22727; Feller LL, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-31; Frangou P, 2005, J INFECT DIS, V191, P238, DOI 10.1086/426823; Fukayama M, 2011, PATHOL RES PRACT, V207, P529, DOI 10.1016/j.prp.2011.07.004; Giunco S, 2013, CLIN CANCER RES, V19, P2036, DOI 10.1158/1078-0432.CCR-12-2537; GLASER R, 1989, P NATL ACAD SCI USA, V86, P9524, DOI 10.1073/pnas.86.23.9524; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hadinoto V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000496; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herrmann K, 2002, J GEN VIROL, V83, P2995, DOI 10.1099/0022-1317-83-12-2995; Hoebe EK, 2012, J VIROL, V86, P11322, DOI 10.1128/JVI.01161-12; Hoebe EK, 2013, REV MED VIROL, V23, P367, DOI 10.1002/rmv.1758; Hudnall SD, 2005, MODERN PATHOL, V18, P519, DOI 10.1038/modpathol.3800369; Hutt-Fletcher LM, 2014, P NATL ACAD SCI USA, V111, P16242, DOI 10.1073/pnas.1418974111; Iizasa H, 2012, VIRUSES-BASEL, V4, P3420, DOI 10.3390/v4123420; Ishii Hiroshi, 2007, NEPALIS INSIDE OUTSI, V1, P1, DOI DOI 10.1002/JMV.20853; Iskra S, 2010, J VIROL, V84, P3612, DOI 10.1128/JVI.01400-09; Jeon JP, 2009, MOL CELLS, V27, P143, DOI 10.1007/s10059-009-0018-y; Jochum S, 2012, P NATL ACAD SCI USA, V109, pE1396, DOI 10.1073/pnas.1115906109; Kataoka H, 1997, DIFFERENTIATION, V62, P203; Kieff E, 2007, FIELDS VIROLOGY, P2603; Kumar SKS, 2005, J EXP CLIN CANC RES, V24, P639; Ladell K, 2007, CELL MICROBIOL, V9, P2055, DOI 10.1111/j.1462-5822.2007.00937.x; Laichalk LL, 2005, J VIROL, V79, P1296, DOI 10.1128/JVI.79.2.1296-1307.2005; Lee KH, 2008, PATHOBIOLOGY, V75, P364, DOI 10.1159/000164221; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Mei YP, 2006, CANCER LETT, V232, P189, DOI 10.1016/j.canlet.2005.02.010; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; NIEDERMAN JC, 1976, NEW ENGL J MED, V294, P1355, DOI 10.1056/NEJM197606172942501; Niedobitek G, 2000, J CLIN PATHOL-MOL PA, V53, P37, DOI 10.1136/mp.53.1.37; NIEDOBITEK G, 1991, J GEN VIROL, V72, P3035, DOI 10.1099/0022-1317-72-12-3035; O'Flatharta C, 2002, J CLIN PATHOL, V55, P602, DOI 10.1136/jcp.55.8.602; Patel V, 2012, ADV EXP MED BIOL, V720, P27, DOI 10.1007/978-1-4614-0254-1_3; Pegtel DM, 2004, J VIROL, V78, P12613, DOI 10.1128/JVI.78.22.12613-12624.2004; Port RJ, 2013, J PATHOL, V231, P367, DOI 10.1002/path.4245; Qu YP, 2013, CLIN CHIM ACTA, V424, P53, DOI 10.1016/j.cca.2013.05.002; RAWLINS DR, 1985, CELL, V42, P859, DOI 10.1016/0092-8674(85)90282-X; Shannon-Lowe C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001338; Shannon-Lowe C, 2009, J VIROL, V83, P7749, DOI 10.1128/JVI.00108-09; Strong MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003341; Sugimoto M, 2004, CANCER RES, V64, P3361, DOI 10.1158/0008-5472.CAN-04-0079; SUNG NS, 1991, J VIROL, V65, P2164, DOI 10.1128/JVI.65.5.2164-2169.1991; Temple RM, 2014, P NATL ACAD SCI USA, V111, P16544, DOI 10.1073/pnas.1400818111; Terrin L, 2008, J VIROL, V82, P10175, DOI 10.1128/JVI.00321-08; Terrin L, 2007, INT J CANCER, V121, P576, DOI 10.1002/ijc.22661; Tsai MH, 2013, CELL REP, V5, P458, DOI 10.1016/j.celrep.2013.09.012; Tsang CM, 2012, P NATL ACAD SCI USA, V109, pE3473, DOI 10.1073/pnas.1202637109; Tsang CM, 2010, INT J CANCER, V127, P1570, DOI 10.1002/ijc.25173; Tsao SW, 2012, SEMIN CANCER BIOL, V22, P137, DOI 10.1016/j.semcancer.2012.02.004; Tugizov SM, 2003, NAT MED, V9, P307, DOI 10.1038/nm830; Walling DM, 2003, J INFECT DIS, V188, P883, DOI 10.1086/378072; Walling DM, 2001, J INFECT DIS, V184, P1499, DOI 10.1086/323992; Wiech T, 2008, VIRCHOWS ARCH, V452, P621, DOI 10.1007/s00428-008-0594-9; WOISETSCHLAEGER M, 1991, P NATL ACAD SCI USA, V88, P3942, DOI 10.1073/pnas.88.9.3942; Wu HC, 2003, LAB INVEST, V83, P797, DOI 10.1097/01.LAB.0000074896.03561.FB; Xiao JQ, 2007, VIROLOGY, V359, P382, DOI 10.1016/j.virol.2006.09.047; YAO K, 1990, INT J CANCER, V45, P83, DOI 10.1002/ijc.2910450116; Yasumoto S, 1996, ONCOGENE, V13, P433; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Yip YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078395; Yoshizaki T, 2013, CANCER LETT, V337, P1, DOI 10.1016/j.canlet.2013.05.018; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; YOUNG LS, 1991, J VIROL, V65, P2868, DOI 10.1128/JVI.65.6.2868-2874.1991; ZIMBERSTROBL U, 1991, J VIROL, V65, P415, DOI 10.1128/JVI.65.1.415-423.1991; ZIMBERSTROBL U, 1993, EMBO J, V12, P167, DOI 10.1002/j.1460-2075.1993.tb05642.x; zur Hausen A, 2004, J CLIN PATHOL, V57, P487, DOI 10.1136/jcp.2003.014068	85	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123645	10.1371/journal.pone.0123645	http://dx.doi.org/10.1371/journal.pone.0123645			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856387	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352588500101
J	Trong, TT; Riera, F; Rinaldi, K; Briki, W; Hue, O				Than Tran Trong; Riera, Florence; Rinaldi, Kevin; Briki, Walid; Hue, Olivier			Ingestion of a Cold Temperature/Menthol Beverage Increases Outdoor Exercise Performance in a Hot, Humid Environment	PLOS ONE			English	Article							CYCLING TIME-TRIAL; ICE SLURRY INGESTION; CORE TEMPERATURE; THERMOREGULATORY RESPONSES; RUNNING PERFORMANCE; BODY-TEMPERATURE; HEAT-STORAGE; CAPACITY; WARM	Purpose A recent laboratory study demonstrated that the ingestion of a cold/menthol beverage improved exercise performance in a hot and humid environment during 20 km of all-out cycling. Therefore, the aim of this study was to determine whether the ingestion of cold water/ice-slurry with menthol would improve performance in hot and humid outdoor conditions. Methods Ten trained males completed three trials of five blocks consisting of 4-km cycling and 1.5-km running. During warm-up, every block and recovery, the athletes drank 190 ml of aromatized (i.e., with 0.05 mL of menthol) beverage at three temperatures: Neutral (ambient temperature) (28.7 degrees C +/- 0.5 degrees C), Cold (3.1 degrees C +/- 0.6 degrees C) or Ice-slurry (0.17 degrees C +/- 0.07 degrees C). Trial time,core temperature (T-co), heart rate (HR), rate of perceived exertion (RPE), thermal sensation (TS) and thermal comfort (TC) were assessed. Results Ice-slurry/menthol increased performance by 6.2% and 3.3% compared with neutral water/menthol and cold water/menthol, respectively. No between-trial differences were noted for Tco, HR, RPE, TC and TS was lower with ice-slurry/menthol and cold water/menthol compared with neutral water/menthol. Conclusion A low drink temperature combined with menthol lessens the performance decline in hot/humid outdoor conditions (i.e., compared with cold water alone). Performances were better with no difference in psycho-physiological stress (Tco, HR and RPE) between trials. The changes in perceptual parameters caused by absorbing a cold/menthol beverage reflect the psychological impact. The mechanism leading to these results seems to involve brain integration of signals from physiological and psychological sources.	[Than Tran Trong; Riera, Florence; Rinaldi, Kevin; Briki, Walid; Hue, Olivier] Univ Antilles Guyane, Lab ACTES EA 3596, Point A Pitre, France		Riera, F (corresponding author), Univ Antilles Guyane, Lab ACTES EA 3596, Campus Fouillole, Point A Pitre, France.	florence.riera@gmail.com	Riera, Florence/AAG-5588-2020	Riera, Florence/0000-0002-3778-7295; Hue, Olivier/0000-0002-2155-0816; Briki, Walid/0000-0002-6298-811X				Barwood MJ, 2012, BRIT J SPORT MED, V46, P936, DOI 10.1136/bjsports-2011-090536; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Briki W, 2014, PSYCHOL SPORT EXERC, V15, P216, DOI 10.1016/j.psychsport.2013.11.006; Brotherhood JR, 2008, J SCI MED SPORT, V11, P6, DOI 10.1016/j.jsams.2007.08.017; Burdon C, 2010, J SPORT SCI, V28, P1147, DOI 10.1080/02640414.2010.489197; Burdon CA, 2013, INT J SPORT NUTR EXE, V23, P458, DOI 10.1123/ijsnem.23.5.458; Castle PC, 2012, EUR J APPL PHYSIOL, V112, P377, DOI 10.1007/s00421-011-1988-y; Cheung SS, 2007, PROG BRAIN RES, V162, P45, DOI 10.1016/S0079-6123(06)62004-9; Dugas JP, 2010, INT J SPORT PHYSIOL, V5, P559, DOI 10.1123/ijspp.5.4.559; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; GREEN BG, 1985, PERCEPT PSYCHOPHYS, V38, P110, DOI 10.3758/BF03198847; Guest S, 2007, PHYSIOL BEHAV, V92, P975, DOI 10.1016/j.physbeh.2007.07.004; Hodder SG, 2007, INT J BIOMETEOROL, V51, P233, DOI 10.1007/s00484-006-0050-y; Hue O, 2012, J SPORT SCI MED, V11, P156; Hue O, 2011, INT J SPORT PHYSIOL, V6, P443, DOI 10.1123/ijspp.6.4.443; Ihsan M, 2010, INT J SPORT PHYSIOL, V5, P140, DOI 10.1123/ijspp.5.2.140; Lee JKW, 2008, MED SCI SPORT EXER, V40, P1637, DOI 10.1249/MSS.0b013e318178465d; Lee JKW, 2008, J SPORT SCI, V26, P583, DOI 10.1080/02640410701697388; Levels K, 2013, INT J SPORT PHYSIOL, V8, P307, DOI 10.1123/ijspp.8.3.307; MONTAIN SJ, 1992, J APPL PHYSIOL, V73, P1340, DOI 10.1152/jappl.1992.73.4.1340; Mundel T, 2010, EUR J APPL PHYSIOL, V109, P59, DOI 10.1007/s00421-009-1180-9; Periard JD, 2011, EUR J APPL PHYSIOL, V111, P1561, DOI 10.1007/s00421-010-1781-3; Pryor RR, 2014, PREHOSPITAL EMERGENC; Riera F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103718; Ross MLR, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-55; Saunders AG, 2005, ACTA PHYSIOL SCAND, V183, P241, DOI 10.1111/j.1365-201X.2004.01400.x; Siegel R, 2010, MED SCI SPORT EXER, V42, P717, DOI 10.1249/MSS.0b013e3181bf257a; Stanley J, 2010, EUR J APPL PHYSIOL, V110, P1163, DOI 10.1007/s00421-010-1607-3; Stevens CJ, 2013, J SPORT SCI, V31, P1271, DOI 10.1080/02640414.2013.779740; Tucker R, 2006, J PHYSIOL-LONDON, V574, P905, DOI 10.1113/jphysiol.2005.101733; Tyler CJ, 2010, EUR J APPL PHYSIOL, V110, P1063, DOI 10.1007/s00421-010-1567-7; Voltaire B, 2003, J SPORT MED PHYS FIT, V43, P306; Voltaire B, 2002, CAN J APPL PHYSIOL, V27, P551, DOI 10.1139/h02-031; Yeo ZW, 2012, INT J SPORTS MED, V33, P859, DOI 10.1055/s-0032-1304643	34	27	27	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123815	10.1371/journal.pone.0123815	http://dx.doi.org/10.1371/journal.pone.0123815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856401	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500107
J	Wee, YS; Weis, JJ; Gahring, LC; Rogers, SW; Weis, JH				Wee, Yin Shen; Weis, Janis J.; Gahring, Lorise C.; Rogers, Scott W.; Weis, John H.			Age-Related Onset of Obesity Corresponds with Metabolic Dysregulation and Altered Microglia Morphology in Mice Deficient for Ifitm Proteins	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR EXPRESSION; INDUCED TRANSMEMBRANE PROTEIN-3; WEST NILE VIRUS; INSULIN-RESISTANCE; GENE-EXPRESSION; NEUROPEPTIDE-Y; BLOOD-GLUCOSE; LEPTIN ACTION; SENSITIVITY; REVEALS	The IfitmDel mouse lacks all five of the Ifitm genes via LoxP deletion. This animal breeds normally with no obvious defect in development. The IfitmDel animals exhibit a steady and significantly enhanced weight gain relative to wild-type controls beginning about three months of age and under normal feeding conditions. The increased weight corresponds with elevated fat mass, and in tolerance tests they are hyporesponsive to insulin but respond normally to glucose. Both young (4 mo) and older (12 mo) IfitmDel mice have enhanced levels of serum leptin suggesting a defect in leptin/ leptin receptor signaling. Analysis of the gene expression profiles in the hypothalamus of IfitmDel animals, compared to WT, demonstrated an altered ratio of Pomc and Npy neuropeptide expression, which likely impairs the satiation response of the IfitmDel animal leading to an increased eating behavior. Also elevated in hypothalamus of IfitmDel mice were pro-inflammatory cytokine expression and reduced IL-10. Anatomical analysis of the hypothalamus using immunohistochemistry revealed that microglia exhibit an abnormal morphology in IfitmDel animals and respond abnormally to Poly: IC challenge. These abnormalities extend the phenotype of the IfitmDel mouse beyond abnormal responses to viral challenge to include a metabolic phenotype and weight gain. Further, this novel phenotype for the IfitmDel mouse could be related to abnormal neuropeptide production, inflammatory status and microglia status in the hypothalamus.	[Wee, Yin Shen; Weis, Janis J.; Weis, John H.] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA; [Gahring, Lorise C.; Rogers, Scott W.] Vet Affairs Med Ctr, GRECC, Salt Lake City, UT 84148 USA; [Gahring, Lorise C.] Univ Utah, Sch Med, Dept Internal Med, Div Geriatr, Salt Lake City, UT USA; [Rogers, Scott W.] Dept Neurobiol & Anat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Weis, JH (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA.	john.weis@path.utah.edu			National Institutes of Health [AI32773, AI45521, DA025057]; VA Merit grant [I01BX001798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI045521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025057] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	National Institutes of Health grants AI32773 (JHW) and AI45521 (JJW), DA025057 (LCG, SWR) and a VA Merit grant I01BX001798 (LCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alafuzoff Irina, 2000, Journal of Alzheimer's Disease, V2, P37; Alver A, 2004, J ENZYM INHIB MED CH, V19, P181, DOI 10.1080/14756360310001650228; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Arion D, 2007, EUR J NEUROSCI, V25, P1843, DOI 10.1111/j.1460-9568.2007.05396.x; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Bowles NE, 2014, MOL GENET GENOM MED, V2, P356, DOI 10.1002/mgg3.79; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brown CR, 2008, INFECT IMMUN, V76, P5500, DOI 10.1128/IAI.00808-08; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Chan YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034508; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Gahring LC, 2004, J COMP NEUROL, V468, P334, DOI 10.1002/cne.10943; Gahring LC, 2008, HIPPOCAMPUS, V18, P737, DOI 10.1002/hipo.20430; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Ibi D, 2013, GLIA, V61, P679, DOI 10.1002/glia.22461; Iwamoto K, 2004, MOL PSYCHIATR, V9, P406, DOI 10.1038/sj.mp.4001437; JAFFE EA, 1989, J IMMUNOL, V143, P3961; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; Klymiuk I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044609; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; MA Y, 1994, INFECT IMMUN, V62, P3663, DOI 10.1128/IAI.62.9.3663-3671.1994; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MATSUMOTO AK, 1993, J EXP MED, V178, P1407, DOI 10.1084/jem.178.4.1407; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; Rogers SW, 2008, HIPPOCAMPUS, V18, P750, DOI 10.1002/hipo.20454; Roundy K, 2003, J BONE MINER RES, V18, P278, DOI 10.1359/jbmr.2003.18.2.278; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; Smith RA, 2006, GENES IMMUN, V7, P113, DOI 10.1038/sj.gene.6364278; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Supuran CT, 2008, EXPERT OPIN EMERG DR, V13, P383, DOI [10.1517/14728214.13.2.383, 10.1517/14728214.13.2.383 ]; Tanaka Satomi S., 2002, Gene Expression Patterns, V2, P297, DOI 10.1016/S0925-4773(02)00384-2; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Tanaka SS, DEV DYN; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Wee YS, 2012, INNATE IMMUN-LONDON, V18, P834, DOI 10.1177/1753425912443392; Yang RH, 2007, CIRC RES, V101, P545, DOI 10.1161/CIRCRESAHA.107.156596; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	58	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123218	10.1371/journal.pone.0123218	http://dx.doi.org/10.1371/journal.pone.0123218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856311	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500079
J	Chikovani, I; Makhashvili, N; Gotsadze, G; Patel, V; Mckee, M; Uchaneishvili, M; Rukhadze, N; Roberts, B				Chikovani, Ivdity; Makhashvili, Nino; Gotsadze, George; Patel, Vikram; Mckee, Martin; Uchaneishvili, Maia; Rukhadze, Natia; Roberts, Bayard			Health Service Utilization for Mental, Behavioural and Emotional Problems among Conflict-Affected Population in Georgia: A Cross-Sectional Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INTERNALLY DISPLACED PERSONS; CARE UTILIZATION; UNMET NEED; ILLNESS; WAR; METAANALYSIS; ASSOCIATION; PREVALENCE; DISABILITY	Background There is large gap in mental illness treatment globally and potentially especially so in war-affected populations. The study aim was to examine health care utilization patterns for mental, behavioural and emotional problems among the war-affected adult population in the Republic of Georgia. Methods A cross-sectional household survey was conducted among 3600 adults affected by 1990s and 2008 armed conflicts in Georgia. Service use was measured for the last 12 months for any mental, emotional or behavioural problems. TSQ, PHQ-9 and GAD-7 were used to measure current symptoms of PTSD, depression and anxiety. Descriptive and regression analyses were used. Results Respondents were predominantly female (65.0%), 35.8% were unemployed, and 56.0% covered by the government insurance scheme. From the total sample, 30.5% had symptoms of at least one current mental disorder. Among them, 39.0% sought care for mental problems, while 33.1% expressed facing barriers to accessing care and so did not seek care. General practitioners (29%) and neurologists (26%) were consulted by the majority of those with a current mental disorder who accessed services, while use of psychiatric services was far more limited. Pharmacotherapy was the predominant type of care (90%). Female gender (OR 1.50, 95% CI: 1.25, 1.80), middle-age (OR 1.83, 95% CI: 1.48, 2.26) and older-age (OR 1.62, 95% CI: 1.19, 2.21), possession of the state insurance coverage (OR 1.55, 95% CI: 1.30, 1.86), current PTSD symptoms (OR 1.56, 95% CI: 1.29, 1.90) and depression (OR 2.12, 95% CI: 1.70, 2.65) were associated with higher rates of health service utilization, while employed were less likely to use services (OR 0.71, 95% CI: 0.55, 0.89). Conclusions Reducing financial access barriers and increasing awareness and access to local care required to help reduce the burden of mental disorders among conflict-affected persons in Georgia.	[Chikovani, Ivdity; Gotsadze, George; Uchaneishvili, Maia; Rukhadze, Natia] Curatio Int Fdn, Tbilisi, Georgia; [Makhashvili, Nino] Global Initiat Psychiat, Tbilisi, Georgia; [Makhashvili, Nino] Ilia State Univ, Tbilisi, Georgia; [Patel, Vikram; Mckee, Martin; Roberts, Bayard] London Sch Hyg & Trop Med, London WC1, England	Ilia State University; University of London; London School of Hygiene & Tropical Medicine	Uchaneishvili, M (corresponding author), Curatio Int Fdn, Tbilisi, Georgia.	m.uchaneishvili@curatio.com	Chikovani, Ivdity/AAL-9870-2020; McKee, Marc D/E-2187-2011; makhashvili, nino/ABF-4921-2021; Mckee, Martin/E-6673-2018; Gotsadze, George/B-1129-2008	McKee, Marc D/0000-0001-8349-965X; makhashvili, nino/0000-0002-2365-2939; Mckee, Martin/0000-0002-0121-9683; Gotsadze, George/0000-0002-8429-7125; Roberts, Bayard/0000-0003-4482-5859; Patel, Vikram/0000-0003-1066-8584; Chikovani, Ivdity/0000-0001-6925-4904; Uchaneishvili, Maia/0000-0003-1659-6614	Wellcome Trust [093562/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the Wellcome Trust, grant number (093562/Z/10/Z). http://www.wellcome.ac.uk. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey S, 2011, CAN J PSYCHIAT, V56, pB1; Alonso J, 2007, BRIT J PSYCHIAT, V190, P299, DOI 10.1192/bjp.bp.106.022004; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P47; Amnesty International, 2010, WAIT ROOM INT DISPL; Andrews G, 2001, BRIT J PSYCHIAT, V178, P145, DOI 10.1192/bjp.178.2.145; Balabanova D, 2012, HEALTH SERV RES, V47, P840, DOI 10.1111/j.1475-6773.2011.01323.x; Bauhoff S, 2011, HEALTH ECON, V20, P1362, DOI 10.1002/hec.1673; Brewin CR, 2002, BRIT J PSYCHIAT, V181, P158, DOI 10.1192/bjp.181.2.158; Bush PW, 2009, PSYCHIAT SERV, V60, P1024, DOI 10.1176/appi.ps.60.8.1024; Calhoun PS, 2002, AM J PSYCHIAT, V159, P2081, DOI 10.1176/appi.ajp.159.12.2081; Costello EJ, 1998, RES COMM ME, V9, P165; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Eytan A, 2006, J TRAUMA STRESS, V19, P57, DOI 10.1002/jts.20098; Eytan A, 2012, EUR J PUBLIC HEALTH, V22, P638, DOI 10.1093/eurpub/ckr096; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Franciskovic T, 2008, CROAT MED J, V49, P483, DOI 10.3325/cmj.2008.4.483; Franciskovic Tanja, 2013, Acta Med Acad, V42, P4, DOI 10.5644/ama2006-124.65; Gotsadze G, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-69; IDMC Georgia, 2012, IDP PROF; John Hopkins Bloomberg School of Public Health. Aging in Displacement, 2012, AG DISPL ASS HLTH ST; Kartha A, 2008, MED CARE, V46, P388, DOI 10.1097/MLR.0b013e31815dc5d2; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Makhashvili N, 2014, J TRAUMA STRESS, V27, P509, DOI 10.1002/jts.21949; Makhashvili N, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001366; Mann CE, 2004, PSYCHIAT SERV, V55, P185, DOI 10.1176/appi.ps.55.2.185; Ministry of Internally Displaced Persons from the Occupied Territories, 2013, ACC REF GEORG; Morina N, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-39; Ortega Alexander N, 2002, Ment Health Serv Res, V4, P131, DOI 10.1023/A:1019707012403; Porter M, 2005, JAMA-J AM MED ASSOC, V294, P602, DOI 10.1001/jama.294.5.602; Prins M, 2011, SOC PSYCH PSYCH EPID, V46, P1033, DOI 10.1007/s00127-010-0266-3; Rao H, 2009, J PSYCHIATR MENT HLT, V16, P279, DOI 10.1111/j.1365-2850.2008.01369.x; Roberts B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098299; Roberts B, 2013, INT J ENV RES PUB HE, V10, P2185, DOI 10.3390/ijerph10062185; Rusch N, 2011, PSYCHIAT SERV, V62, P675, DOI [10.1176/appi.ps.62.6.675, 10.1176/ps.62.6.pss6206_0675]; Sabes-Figuera R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029603; Schnurr PP, 2000, J NERV MENT DIS, V188, P496, DOI 10.1097/00005053-200008000-00004; Singh N S, 2012, PSYCH SOC SERV TRAIN; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; ten Have M, 2010, SOC PSYCH PSYCH EPID, V45, P153, DOI 10.1007/s00127-009-0050-4; UNICEF USAID HSSP, 2011, SURV BARR ACC SOC SE; van Ommeren M., 1999, TRANSCULT PSYCHIATRY, V36, P285, DOI [10.1177/136346159903600304, DOI 10.1177/136346159903600304]; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; WHO/Children of Georgia, 2009, CHILDR GEORG ASS MEN; World Health Organisation, 2010, MH GAP INT GUID MENT; Zoidze A, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-45	47	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122673	10.1371/journal.pone.0122673	http://dx.doi.org/10.1371/journal.pone.0122673			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853246	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352478400076
J	Lee, D; Kim, EJ; Kilgore, PE; Kim, SA; Takahashi, H; Ohnishi, M; Anh, DD; Dong, BQ; Kim, JS; Tomono, J; Miyamoto, S; Notomi, T; Kim, DW; Seki, M				Lee, DoKyung; Kim, Eun Jin; Kilgore, Paul E.; Kim, Soon Ae; Takahashi, Hideyuki; Ohnishi, Makoto; Dang Duc Anh; Dong, Bai Qing; Kim, Jung Soo; Tomono, Jun; Miyamoto, Shigehiko; Notomi, Tsugunori; Kim, Dong Wook; Seki, Mitsuko			Clinical Evaluation of a Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of Neisseria meningitidis in Cerebrospinal Fluid	PLOS ONE			English	Article							INFLUENZAE TYPE-B; POLYMERASE-CHAIN-REACTION; HAEMOPHILUS-INFLUENZAE; MENINGOCOCCAL DISEASE; BACTERIAL-MENINGITIS; COLORIMETRIC DETECTION; PCR; EPIDEMIOLOGY; DIAGNOSIS; CHILDREN	Background Neisseria meningitidis (Nm) is a leading causative agent of bacterial meningitis in humans. Traditionally, meningococcal meningitis has been diagnosed by bacterial culture. However, isolation of bacteria from patients' cerebrospinal fluid (CSF) is time consuming and sometimes yields negative results. Recently, polymerase chain reaction (PCR)-based diagnostic methods of detecting Nm have been considered the gold standard because of their superior sensitivity and specificity compared with culture. In this study, we developed a loop-mediated isothermal amplification (LAMP) method and evaluated its ability to detect Nm in cerebrospinal fluid (CSF). Methodology/Principal Findings We developed a meningococcal LAMP assay (Nm LAMP) that targets the ctrA gene. The primer specificity was validated using 16 strains of N. meningitidis (serogroup A, B, C, D, 29-E, W-135, X, Y, and Z) and 19 non-N. meningitidis species. Within 60 min, the Nm LAMP detected down to ten copies per reaction with sensitivity 1000-fold more than that of conventional PCR. The LAMP assays were evaluated using a set of 1574 randomly selected CSF specimens from children with suspected meningitis collected between 1998 and 2002 in Vietnam, China, and Korea. The LAMP method was shown to be more sensitive than PCR methods for CSF samples (31 CSF samples were positive by LAMP vs. 25 by PCR). The detection rate of the LAMP method was substantially higher than that of the PCR method. In a comparative analysis of the PCR and LAMP assays, the clinical sensitivity, specificity, positive predictive value, and negative predictive value of the LAMP assay were 100%, 99.6%, 80.6%, and 100%, respectively. Conclusions/Significance Compared to PCR, LAMP detected Nm with higher analytical and clinical sensitivity. This sensitive and specific LAMP method offers significant advantages for screening patients on a population basis and for diagnosis in clinical settings.	[Lee, DoKyung; Kim, Eun Jin; Kim, Dong Wook] Hanyang Univ, Coll Pharm, Dept Pharm, Ansan, South Korea; [Lee, DoKyung; Kim, Eun Jin; Kim, Dong Wook] Hanyang Univ, Pharmacol Res Inst, Ansan, South Korea; [Kilgore, Paul E.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharm Practice, Detroit, MI USA; [Kim, Soon Ae] Int Vaccine Inst, Translat Res Div, Seoul, South Korea; [Takahashi, Hideyuki; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Dang Duc Anh] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Dong, Bai Qing] Guangxi Zhuang Autonomous Reg Hlth Bur, Nanning, Guangxi, Peoples R China; [Kim, Jung Soo] Chonbuk Natl Univ, Sch Med, Jeonju 561756, South Korea; [Tomono, Jun; Miyamoto, Shigehiko] Kaneka Corp, Osaka, Japan; [Notomi, Tsugunori] Eiken Chem Co Ltd, Ohtawara, Tochigi, Japan; [Seki, Mitsuko] Nihon Univ, Sch Dent, Dept Oral Hlth Sci, Tokyo 101, Japan; [Seki, Mitsuko] Nihon Univ, Sch Dent, Dent Res Ctr, Tokyo 101, Japan	Hanyang University; Hanyang University; Wayne State University; International Vaccine Institute; National Institute of Infectious Diseases (NIID); National Institute of Hygiene & Epidemiology (NIHE); Jeonbuk National University; Kaneka Corporation; Nihon University; Nihon University	Kim, DW (corresponding author), Hanyang Univ, Coll Pharm, Dept Pharm, Ansan, South Korea.	dongwook@hanyang.ac.kr; seki.mitsuko@nihon-u.ac.jp	Kilgore, Paul E/L-1462-2013; Kilgore, Paul/AAD-2869-2019; Kim, Dong Wook/H-8253-2015	Kilgore, Paul E/0000-0003-3214-4482; Kilgore, Paul/0000-0003-3214-4482; Kim, Dong Wook/0000-0001-5351-7597; Kim, Soon Ae/0000-0002-5945-2832	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS) Bilateral Joint Research Projects/Seminars (JSPS's Counterpart Institutions); Japan Society for the Promotion of Science (JSPS) Bilateral Joint Research Projects/Seminars (National Research Foundation of Korea, NRF); National Research Foundation (NRF) of Korea [2012R1A2A2A01009741];  [10201004]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Bilateral Joint Research Projects/Seminars (JSPS's Counterpart Institutions); Japan Society for the Promotion of Science (JSPS) Bilateral Joint Research Projects/Seminars (National Research Foundation of Korea, NRF); National Research Foundation (NRF) of Korea(National Research Foundation of Korea); 	MS was supported by the Grant-in-Aid for Scientific Research (C) (No. 10201004) and a grant to promote multi-disciplinary research projects from the Ministry of Education, Culture, Sports, Science and Technology of Japan. MS and DWK were supported by the Japan Society for the Promotion of Science (JSPS) Bilateral Joint Research Projects/Seminars (JSPS's Counterpart Institutions; National Research Foundation of Korea, NRF). DWK was supported by the grant 2012R1A2A2A01009741 from National Research Foundation (NRF) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anh DD, 2006, AM J TROP MED HYG, V74, P509, DOI 10.4269/ajtmh.2006.74.509; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P282; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Isenberg HD., 1998, ESSENTIAL PROCEDURES; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kennedy WA, 2007, EPIDEMIOL INFECT, V135, P1217, DOI 10.1017/S0950268806007734; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042954; Kim DW, 2011, J CLIN MICROBIOL, V49, P3621, DOI 10.1128/JCM.00515-11; Kim JS, 2004, VACCINE, V22, P3952, DOI 10.1016/j.vaccine.2004.04.003; Kim SA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-310; McKenna JP, 2011, DIAGN MICR INFEC DIS, V69, P137, DOI 10.1016/j.diagmicrobio.2010.10.008; Miyamoto S, 2015, ANAL BIOCHEM, V473, P28, DOI 10.1016/j.ab.2014.12.016; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Huy NT, 2012, FEMS MICROBIOL LETT, V337, P25, DOI 10.1111/1574-6968.12002; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Taha MK, 2005, J CLIN MICROBIOL, V43, P144, DOI 10.1128/JCM.43.1.144-149.2005; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tzanakaki G, 2003, FEMS IMMUNOL MED MIC, V39, P31, DOI 10.1016/S0928-8244(03)00175-5; Verma R, 2012, HUM VACC IMMUNOTHER, V8, P1904, DOI 10.4161/hv.21666; Vyse A, 2011, EPIDEMIOL INFECT, V139, P967, DOI 10.1017/S0950268811000574; World Health Organization, 2010, IN VACC RES REP 2008, DOI [10.1371/journal.pone.0095708, DOI 10.1371/JOURNAL.PONE.0095708]; Wylie PAL, 1997, BRIT MED J, V315, P774, DOI 10.1136/bmj.315.7111.774	27	50	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122922	10.1371/journal.pone.0122922	http://dx.doi.org/10.1371/journal.pone.0122922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853422	gold, Green Published			2022-12-27	WOS:000352478400086
J	Pan, BP; Ren, YP; Gao, J; Gao, H				Pan, Baoping; Ren, Yipeng; Gao, Jing; Gao, Hong			De novo RNA-Seq Analysis of the Venus Clam, Cyclina sinensis, and the Identification of Immune-Related Genes	PLOS ONE			English	Article							CDNA CLONING; EXPRESSION; DISCOVERY; PHYLOGENIES; HEMOCYTES; GENOMICS	The Venus clam, Cyclina sinensis, is one of the most important bivalves in China. In recent years, increasing expansive morbidity has occurred in breeding areas, imposing significant losses on the national economy. To understand the molecular mechanisms of immune-related genes, we analyzed and sequenced hemolymph samples that were injected with two pathogenic microorganisms using the Illumina Miseq system. After trimming, more than 12 M PE reads with an average length greater than 410 bp were assembled into 70,079 transcripts with a mean length of 980 bp. Using a homology analysis, 102 (135 transcripts) potentially immune-related genes were identified, and most of them exhibited a similar pattern in both samples. These data indicated that the response of the clam to both types of bacterial infection might follow a similar molecular mechanism. Using the TreeFam method, 9,904 gene families and 1,031 unique families of the clam were preliminarily classified in comparison to five related species. A significant number of SSRs were identified, which could facilitate the identification of polymorphisms in Venus clam populations. These data-sets will improve our knowledge of the molecular mechanisms driving the immune response to bacterial infection in clam populations and will provide basic data about clam breeding and disease control.	[Pan, Baoping; Ren, Yipeng; Gao, Jing; Gao, Hong] Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Tianjin 300387, Peoples R China	Tianjin Normal University	Pan, BP (corresponding author), Tianjin Normal Univ, Tianjin Key Lab Anim & Plant Resistance, Tianjin 300387, Peoples R China.	baopingpan@126.com		Ren, Yipeng/0000-0001-8890-022X	Applied Basic Research Programs of the Science and Technology Commission Foundation of Tianjin P.R. China [12JCZDJC22800, 09JCZDJC19300, 14JCZDJC34200]	Applied Basic Research Programs of the Science and Technology Commission Foundation of Tianjin P.R. China	This work was supported by the Applied Basic Research Programs of the Science and Technology Commission Foundation of Tianjin P.R. China (Key program 12JCZDJC22800, 09JCZDJC19300 and 14JCZDJC34200), http://www.tstc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Benjamini Y, 2001, ANN STAT, V29, P1165; Cao H, 2004, SCI FISH FARMING, V6, P403; Carroll RL, 1997, PATTERNS PROCESSES V; Castoe TA, 2009, CYTOGENET GENOME RES, V127, P112, DOI 10.1159/000295342; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; [戈蕾 GE Lei], 2007, [微生物学通报, Microbiology], V34, P584; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gueguen Y, 2003, GENE, V303, P139, DOI 10.1016/S0378-1119(02)01149-6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Liang Y.B., 2000, MARINE ENV SCI, V19, P5, DOI 10.3969/j.issn.1007-6336.2000.01.002; Liu Ke-jun, 2011, Sichuan Journal of Zoology, V30, P802; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Bao-Ping, 2010, Oceanologia et Limnologia Sinica, V41, P901; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Song LS, 2006, FISH SHELLFISH IMMUN, V21, P335, DOI 10.1016/j.fsi.2005.12.011; Song LS, 2006, DEV COMP IMMUNOL, V30, P265, DOI 10.1016/j.dci.2005.04.001; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang HB, 2012, J HYDROECOLOGY, V3, P330; Wang HZ, 1991, ZHEJINAG FAUNA; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wang RC, 1993, SHELLFISH AQUACULTUR, P208; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; Zhang YP, 2014, PLOS ONE, V9, DOI [10.5339/gcsp.2014.19, DOI 10.5339/GCSP.2014.19]; Zhu L, 2008, FISH SHELLFISH IMMUN, V25, P231, DOI 10.1016/j.fsi.2008.05.004	38	14	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123296	10.1371/journal.pone.0123296	http://dx.doi.org/10.1371/journal.pone.0123296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853714	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400099
J	Price, BW; Henry, CS; Hall, AC; Mochizuki, A; Duelli, P; Brooks, SJ				Price, Ben W.; Henry, Charles S.; Hall, Andie C.; Mochizuki, Atsushi; Duelli, Peter; Brooks, Stephen J.			Singing from the Grave: DNA from a 180 Year Old Type Specimen Confirms the Identity of Chrysoperla carnea (Stephens)	PLOS ONE			English	Article							COMMON GREEN LACEWINGS; NEUROPTERA CHRYSOPIDAE; MUSEUM SPECIMENS; EVOLUTION; BARCODES	Historically serving as repositories for morphologically-based taxonomic research, natural history collections are now increasingly being targeted in studies utilizing DNA data. The development of advanced molecular techniques has facilitated extraction of useable DNA from old specimens, including type material. Sequencing diagnostic molecular markers from type material enables accurate species designation, especially where modern taxonomic hypotheses confirm morphologically cryptic species complexes. One such example is Chrysoperla carnea (Stephens), which belongs to a complex of about 20 cryptic species, most of which can only be reliably distinguished by their pre-mating courtship songs or by DNA analysis. The subtle morphological variation in the group has led to disagreement over the previous designation of the lectotype for C. carnea, an issue that has been further compounded because Chrysoperla carnea is a highly valued biological control agent in arable crops. Archival DNA extraction and sequencing from the 180 year old lectotype specimen, combined with Bayesian and Likelihood based phylogenetic analyses of modern specimens from the entire complex, were used to establish unambiguously the true identity of Chrysoperla carnea.	[Price, Ben W.; Brooks, Stephen J.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Henry, Charles S.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Hall, Andie C.] Nat Hist Museum, Core Res Labs, London SW7 5BD, England; [Mochizuki, Atsushi] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 305, Japan; [Duelli, Peter] WSL Swiss Fed Res Inst, Birmensdorf, Switzerland	Natural History Museum London; University of Connecticut; Natural History Museum London; National Institute for Agro-Environmental Sciences (NIAES) Japan; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Henry, CS (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	charles.henry@uconn.edu	Price, Benjamin/Y-5971-2019	Price, Benjamin/0000-0001-5497-4087; Duelli, Peter/0000-0001-8862-8262; Hall, Andie/0000-0001-5546-7255	Natural History Museum Life Sciences Departmental Investment Fund [SDF13002]	Natural History Museum Life Sciences Departmental Investment Fund	Funding for the molecular analyses was provided through the Natural History Museum Life Sciences Departmental Investment Fund (SDF13002) to BWP and SJB.	Andersen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045549; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bluemel JK, 2011, MOL ECOL RESOUR, V11, P770, DOI 10.1111/j.1755-0998.2011.03008.x; Brooks S.J., 1994, Bulletin of the Natural History Museum Entomology Series, V63, P137; Canard Michel, 2007, Annali del Museo Civico di Storia Naturale di Ferrara, V8, P173; Duelli P, 2014, ANN ENTOMOL SOC AM, V107, P382, DOI 10.1603/AN13139; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Han T, 2014, J ASIA-PAC ENTOMOL, V17, P679, DOI 10.1016/j.aspen.2014.06.007; Haruyama N, 2008, ANN ENTOMOL SOC AM, V101, P971, DOI 10.1603/0013-8746-101.6.971; Hausmann A, 2011, SPIXIANA, V34, P47; Heintzman PD, 2014, MOL ECOL RESOUR, V14, P606, DOI 10.1111/1755-0998.12205; Henry C.S., 2001, P29, DOI 10.1017/CBO9780511666117.004; Henry CS, 2014, SYST ENTOMOL, V39, P380, DOI 10.1111/syen.12061; Henry CS, 2013, BIOL REV, V88, P787, DOI 10.1111/brv.12027; Henry CS, 2012, BIOL J LINN SOC, V105, P776, DOI 10.1111/j.1095-8312.2011.01845.x; Henry CS, 1996, SYST ENTOMOL, V21, P205, DOI 10.1046/j.1365-3113.1996.d01-11.x; Henry CS, 2002, ANN ENTOMOL SOC AM, V95, P172, DOI 10.1603/0013-8746(2002)095[0172:DTTCCI]2.0.CO;2; Hernandez-Triana LM, 2014, MOL ECOL RESOUR, V14, P508, DOI 10.1111/1755-0998.12208; Kirchman JJ, 2010, BIOL LETTERS, V6, P112, DOI 10.1098/rsbl.2009.0545; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leraut P., 1991, Entomologica Gallica, V2, P75; Miller MA, 2012, 1 C EXTR SCI ENG DIS; Moriniere J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109719; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sonet G, 2011, BONN ZOOL MONOGR, P117; STEPHENS J. F, 1835, ILLUSTRATIONS BRIT E, V6; Strutzenberger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049710; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thierry Dominique, 2013, Acoreana, P73; Thierry D, 2011, BIOL J LINN SOC, V102, P292, DOI 10.1111/j.1095-8312.2010.01569.x; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Tin MMY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096793; Van Houdt JKJ, 2010, MOL ECOL RESOUR, V10, P459, DOI 10.1111/j.1755-0998.2009.02800.x; Wells MM, 1998, ENDLESS FORMS, P217; Zwickl D. J, 2006, GENETIC ALGORITHM AP	35	23	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121127	10.1371/journal.pone.0121127	http://dx.doi.org/10.1371/journal.pone.0121127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853856	Green Published, gold			2022-12-27	WOS:000352478400029
J	van de Put, MAJ; Vehof, J; Hooymans, JMM; Los, LI				van de Put, Mathijs A. J.; Vehof, Jelle; Hooymans, Johanna. M. M.; Los, Leonoor I.			Postoperative Metamorphopsia in Macula-Off Rhegmatogenous Retinal Detachment: Associations with Visual Function, Vision Related Quality of Life, and Optical Coherence Tomography Findings	PLOS ONE			English	Article							SURGERY	Purpose To evaluate postoperative metamorphopsia in macula-off rhegmatogenous retinal detachment (RRD) and its association with visual function, vision related quality of life, and optical coherence tomography (OCT) findings. Methods 45 patients with primary macula-off RRD were included. At 12 months postoperatively, data on metamorphopsia using sine amsler charts (SAC), best corrected visual acuity (BCVA), letter contrast sensitivity, color vision (saturated and desaturated color confusion indexes), critical print size, reading acuity, the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25), and OCT, were obtained. Results Metamorphopsia was present in 39 patients (88.6%), with most of them (n = 35, 77.8%) showing only mild metamorphopsia (SAC score = 1). Patients with metamorphopsia had significantly worse postoperative BCVA (p = 0.02), critical print size (p<0.0005), and reading acuity (p = 0.001) compared to patients without metamorphopsia. Other visual function outcomes and NEI-VFQ-25 overall composite score were all also somewhat lower in patients with metamorphopsia, but this did not reach statistical significance. No association with OCT findings was present. Conclusion The prevalence of postoperative metamorphopsia in macula-off RRD patients is high, however, the degree of metamorphopsia is relatively low. When metamorphopsia is present, visual functions seem to be compromised, while vision related quality of life is only mildly affected.	[van de Put, Mathijs A. J.; Vehof, Jelle; Hooymans, Johanna. M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Vehof, Jelle] St Thomas Hosp, Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Hooymans, Johanna. M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands	University of Groningen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Groningen	van de Put, MAJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	m.a.j.van.de.put@umcg.nl						Bouwens MD, 2003, GRAEF ARCH CLIN EXP, V241, P89, DOI 10.1007/s00417-002-0613-5; BOWMAN KJ, 1982, ACTA OPHTHALMOL, V60, P907; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; Cappello E, 2009, RETINA-J RET VIT DIS, V29, P1111, DOI 10.1097/IAE.0b013e3181a3b832; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; LIEM ATA, 1994, OPHTHALMOLOGY, V101, P1945; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Okamoto F, 2008, AM J OPHTHALMOL, V146, P85, DOI 10.1016/j.ajo.2008.02.011; Okamoto F, 2014, AM J OPHTHALMOL, V157, P214, DOI 10.1016/j.ajo.2013.08.007; Okamoto F, 2010, INVEST OPHTH VIS SCI, V51, P744, DOI 10.1167/iovs.09-3992; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Ricker LJAG, 2011, RETINA-J RET VIT DIS, V31, P1505, DOI 10.1097/IAE.0b013e31820a6910; Rossetti A, 2010, EYE, V44, P4012, DOI [10.1021/es903673q, DOI 10.1021/ES903673Q]; Shiragami C, 2010, OPHTHALMOLOGY, V117, P86, DOI 10.1016/j.ophtha.2009.06.025; Van de Put M, 2013, ACTA OPHTHALMOL, V91, DOI 10.1111/j.1755-3768.2013.2411.x; van de Put MAJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099787; Van de Put MAJ, 2013, OPHTHALMOLOGY, V120, P616, DOI 10.1016/j.ophtha.2012.09.001; Van der Sterre GW, NATL EYE I VISUAL FU; Wang Y, 2005, ACTA OPHTHALMOL SCAN, V83, P168, DOI 10.1111/j.1600-0420.2005.00413.x	21	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120543	10.1371/journal.pone.0120543	http://dx.doi.org/10.1371/journal.pone.0120543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853573	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400016
J	de Oliveira, JT; Santos, AL; Gomes, C; Barros, R; Ribeiro, C; Mendes, N; de Matos, AJ; Vasconcelos, MH; Oliveira, MJ; Reis, CA; Gartner, F				de Oliveira, Joana T.; Santos, Ana L.; Gomes, Catarina; Barros, Rita; Ribeiro, Claudia; Mendes, Nuno; de Matos, Augusto J.; Helena Vasconcelos, M.; Oliveira, Maria Jose; Reis, Celso A.; Gaertner, Fatima			Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate Induces Canine Mammary Cancer Cell Aggressiveness	PLOS ONE			English	Article							BREAST-CANCER; LEWIS-X; EXPRESSION; SIALIDASE; SIALYLATION; INFLUENZA; CARCINOMA; SURVIVAL; ROLES; GLYCOSYLATION	Oseltamivir phosphate is a widely used anti-influenza sialidase inhibitor. Sialylation, governed by sialyltransferases and sialidases, is strongly implicated in the oncogenesis and progression of breast cancer. In this study we evaluated the biological behavior of canine mammary tumor cells upon oseltamivir phosphate treatment (a sialidase inhibitor) in vitro and in vivo. Our in vitro results showed that oseltamivir phosphate impairs sialidase activity leading to increased sialylation in CMA07 and CMT-U27 canine mammary cancer cells. Surprisingly, oseltamivir phosphate stimulated, CMT-U27 cell migration and invasion capacity in vitro, in a dose-dependent manner. CMT-U27 tumors xenograft of oseltamivir phosphate-treated nude mice showed increased sialylation, namely alpha 2,6 terminal structures and SLe(x) expression. Remarkably, a trend towards increased lung metastases was observed in oseltamivir phosphate-treated nude mice. Taken together, our findings revealed that oseltamivir impairs canine mammary cancer cell sialidase activity, altering the sialylation pattern of canine mammary tumors, and leading, surprisingly, to in vitro and in vivo increased mammary tumor aggressiveness.	[de Oliveira, Joana T.; Santos, Ana L.; Gomes, Catarina; Barros, Rita; Ribeiro, Claudia; Mendes, Nuno; Helena Vasconcelos, M.; Oliveira, Maria Jose; Reis, Celso A.; Gaertner, Fatima] Univ Porto, Inst Invest & Inovacao Saude, P-4200465 Oporto, Portugal; [de Oliveira, Joana T.; Santos, Ana L.; Gomes, Catarina; Barros, Rita; Ribeiro, Claudia; Mendes, Nuno; Helena Vasconcelos, M.; Reis, Celso A.; Gaertner, Fatima] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal; [de Oliveira, Joana T.; de Matos, Augusto J.; Reis, Celso A.; Gaertner, Fatima] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4200465 Oporto, Portugal; [de Oliveira, Joana T.] Lusophone Univ Humanities & Technol, Fac Vet Med, Lisbon, Portugal; [de Matos, Augusto J.] Food & Agrarian Sci & Technol Inst ICETA, Anim Sci & Study Cent CECA, Oporto, Portugal; [Helena Vasconcelos, M.] Univ Porto, Fac Pharm, Dept Biol Sci, P-4200465 Oporto, Portugal; [Oliveira, Maria Jose] Univ Porto, Inst Biomed Engn INEB, P-4200465 Oporto, Portugal; [Oliveira, Maria Jose; Reis, Celso A.] Univ Porto, Fac Med, Dept Pathol & Oncol, P-4200465 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Lusofona University; Universidade de Lisboa; Universidade do Porto; Universidade do Porto; Universidade do Porto	de Oliveira, JT (corresponding author), Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.	joanao@ipatimup.pt	Gomes, Catarina/AAU-4636-2020; Vasconcelos, M. Helena/J-9547-2013; Barros, Rita/C-1072-2012; REIS, Celso A/B-9969-2008; Gomes, Catarina/CAJ-5505-2022; Gomes, Catarina/AAC-3325-2021; Oliveira, Maria Jose/K-3275-2013; Ribeiro, Ana Claudia/E-6906-2015; Gartner, Maria de Fatima/A-3530-2010	Barros, Rita/0000-0002-1667-7329; REIS, Celso A/0000-0002-0286-6639; Gomes, Catarina/0000-0002-0352-6783; Oliveira, Maria Jose/0000-0002-0724-0272; Ribeiro, Ana Claudia/0000-0002-1723-5055; Vasconcelos, M. Helena/0000-0002-7801-4643; Mendes, Nuno/0000-0002-0570-2277; Gartner, Maria de Fatima/0000-0002-5302-0086	Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao (POCI) do Quadro Comunitario de Apoio III"; Portuguese Foundation for Science and Technology;  [PTDC/CVT/117610/2010]	Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao (POCI) do Quadro Comunitario de Apoio III"; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); 	This work was supported by the Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao 2010 (POCI 2010) do Quadro Comunitario de Apoio III" and Project grant no. PTDC/CVT/117610/2010. RB (SFRH/BPD/68276/2010) and CG (SFRH/BPD/96510/2013) acknowledge the Portuguese Foundation for Science and Technology. Institute of Molecular Pathology and Immunology is an Associate Laboratory of the Portuguese Ministry of Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology.	Amith Schammim R, 2010, J Vis Exp, DOI 10.3791/2142; Brown JR, 2006, CLIN CANCER RES, V12, P2894, DOI 10.1158/1078-0432.CCR-05-2745; Bull C, 2013, MOL CANCER THER, V12, P1935, DOI 10.1158/1535-7163.MCT-13-0279; Carvalho AS, 2010, INT J BIOCHEM CELL B, V42, P80, DOI 10.1016/j.biocel.2009.09.010; Chavas LMG, 2010, J MED CHEM, V53, P2998, DOI 10.1021/jm100078r; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Cheng P, 2005, WORLD J GASTROENTERO, V11, P5117; Coory M, 2014, J CLIN EPIDEMIOL, V67, P966, DOI 10.1016/j.jclinepi.2014.03.006; Crain SM, 2004, BRAIN RES, V995, P260, DOI 10.1016/j.brainres.2003.09.068; Croce MV, 2007, PATHOL ONCOL RES, V13, P130, DOI 10.1007/BF02893488; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; de la Cruz MSD, 2014, PRIMARY CARE, V41, P283, DOI 10.1016/j.pop.2014.02.006; de Oliveira JT, 2009, VET J, V182, P491, DOI 10.1016/j.tvjl.2008.09.007; de Oliveira JT, 2010, GLYCOBIOLOGY, V20, P1341, DOI 10.1093/glycob/cwq103; de Oliveira JT, 2011, INT J DEV BIOL, V55, P823, DOI 10.1387/ijdb.113359jt; Engelhard D, 2013, TRANSPL INFECT DIS, V15, P219, DOI 10.1111/tid.12054; Finlay TM, 2010, GLYCOCONJUGATE J, V27, P583, DOI 10.1007/s10719-010-9302-5; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gilmour AM, 2013, CELL SIGNAL, V25, P2587, DOI 10.1016/j.cellsig.2013.08.008; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; HELLMEN E, 1992, IN VITRO CELL DEV-AN, V28A, P309, DOI 10.1007/BF02877054; Holmes S, 2013, CANCER EPIDEMIOL, V37, P881, DOI 10.1016/j.canep.2013.09.001; Horm TM, 2013, CELL ADHES MIGR, V7, P187, DOI 10.4161/cam.23131; Ibrahim NK, 2013, J CANCER, V4, P577, DOI 10.7150/jca.7028; Izumi Y, 2007, NEUROSCI LETT, V426, P54, DOI 10.1016/j.neulet.2007.08.054; Jandus C, 2011, BIOCHEM PHARMACOL, V82, P323, DOI 10.1016/j.bcp.2011.05.018; Jayant S, 2007, PHARM RES, V24, P2120, DOI 10.1007/s11095-007-9406-1; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Jeschke U, 2005, ANTICANCER RES, V25, P1615; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; Marcos Nuno T, 2011, Front Biosci (Elite Ed), V3, P1443; Matos AJF, 2012, VET J, V193, P24, DOI 10.1016/j.tvjl.2011.12.019; Matsuura N, 1997, JPN J CLIN ONCOL, V27, P135, DOI 10.1093/jjco/27.3.135; MIYAGI T, 1993, J BIOL CHEM, V268, P26435; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Moore ML, 2007, J IMMUNOL, V178, P2651, DOI 10.4049/jimmunol.178.5.2651; Morimoto K, 2008, DRUG METAB DISPOS, V36, P6, DOI 10.1124/dmd.107.017699; O I, 2000, BIOCHEM BIOPH RES CO, V268, P106, DOI 10.1006/bbrc.1999.2061; O'Shea LK, 2014, ONCOTARGETS THER, V7, P117, DOI 10.2147/OTT.S55344; Ochoa-Alvarez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041845; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Sarkar AK, 1997, J BIOL CHEM, V272, P25608, DOI 10.1074/jbc.272.41.25608; Sawada M, 2002, INT J CANCER, V97, P180, DOI 10.1002/ijc.1598; Sawada M, 1998, ACTA BIOCHIM POL, V45, P343, DOI 10.18388/abp.1998_4229; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; Seto B, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-29; Tsai CS, 2013, P NATL ACAD SCI USA, V110, P2466, DOI 10.1073/pnas.1222183110; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wilson JC, 2003, CURR DRUG TARGETS, V4, P389, DOI 10.2174/1389450033491019; Woronowicz A, 2007, GLYCOBIOLOGY, V17, P10, DOI 10.1093/glycob/cwl049; Ye TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085887; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; YOGEESWARAN G, 1981, SCIENCE, V212, P1514, DOI 10.1126/science.7233237; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	60	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121590	10.1371/journal.pone.0121590	http://dx.doi.org/10.1371/journal.pone.0121590			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850034	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800069
J	Diogo, D; Bastarache, L; Liao, KP; Graham, RR; Fulton, RS; Greenberg, JD; Eyre, S; Bowes, J; Cui, J; Lee, A; Pappas, DA; Kremer, JM; Barton, A; Coenen, MJH; Franke, B; Kiemeney, LA; Mariette, X; Richard-Miceli, C; Canhao, H; Fonseca, JE; de Vries, N; Tak, PP; Crusius, JBA; Nurmohamed, MT; Kurreeman, F; Mikuls, TR; Okada, Y; Stahl, EA; Larson, DE; Deluca, TL; O'Laughlin, M; Fronick, CC; Fulton, LL; Kosoy, R; Ransom, M; Bhangale, TR; Ortmann, W; Cagan, A; Gainer, V; Karlson, EW; Kohane, I; Murphy, SN; Martin, J; Zhernakova, A; Klareskog, L; Padyukov, L; Worthington, J; Mardis, ER; Seldin, MF; Gregersen, PK; Behrens, T; Raychaudhuri, S; Denny, JC; Plenge, RM				Diogo, Dorothee; Bastarache, Lisa; Liao, Katherine P.; Graham, Robert R.; Fulton, Robert S.; Greenberg, Jeffrey D.; Eyre, Steve; Bowes, John; Cui, Jing; Lee, Annette; Pappas, Dimitrios A.; Kremer, Joel M.; Barton, Anne; Coenen, Marieke J. H.; Franke, Barbara; Kiemeney, Lambertus A.; Mariette, Xavier; Richard-Miceli, Corrine; Canhao, Helena; Fonseca, Joao E.; de Vries, Niek; Tak, Paul P.; Crusius, J. Bart A.; Nurmohamed, Michael T.; Kurreeman, Fina; Mikuls, Ted R.; Okada, Yukinori; Stahl, Eli A.; Larson, David E.; Deluca, Tracie L.; O'Laughlin, Michelle; Fronick, Catrina C.; Fulton, Lucinda L.; Kosoy, Roman; Ransom, Michael; Bhangale, Tushar R.; Ortmann, Ward; Cagan, Andrew; Gainer, Vivian; Karlson, Elizabeth W.; Kohane, Isaac; Murphy, Shawn N.; Martin, Javier; Zhernakova, Alexandra; Klareskog, Lars; Padyukov, Leonid; Worthington, Jane; Mardis, Elaine R.; Seldin, Michael F.; Gregersen, Peter K.; Behrens, Timothy; Raychaudhuri, Soumya; Denny, Joshua C.; Plenge, Robert M.			TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; COMMON VARIANTS; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; MEDICAL-RECORDS; LIPID-LEVELS; ANTI-TNF; RISK; GENES	Despite the success of genome-wide association studies (GWAS) in detecting a large number of loci for complex phenotypes such as rheumatoid arthritis (RA) susceptibility, the lack of information on the causal genes leaves important challenges to interpret GWAS results in the context of the disease biology. Here, we genetically fine-map the RA risk locus at 19p13 to define causal variants, and explore the pleiotropic effects of these same variants in other complex traits. First, we combined Immunochip dense genotyping (n = 23,092 case/control samples), Exomechip genotyping (n = 18,409 case/control samples) and targeted exon-sequencing (n = 2,236 case/controls samples) to demonstrate that three protein- coding variants in TYK2 (tyrosine kinase 2) independently protect against RA: P1104A (rs34536443, OR = 0.66, P = 2.3x10(-21)), A928V (rs35018800, OR = 0.53, P = 1.2x10(-9)), and I684S (rs12720356, OR = 0.86, P = 4.6x10(-7)). Second, we show that the same three TYK2 variants protect against systemic lupus erythematosus (SLE, P-omnibus = 6x10(-18)), and provide suggestive evidence that two of the TYK2 variants (P1104A and A928V) may also protect against inflammatory bowel disease (IBD; P-omnibus = 0.005). Finally, in a phenome-wide association study (PheWAS) assessing >500 phenotypes using electronic medical records (EMR) in >29,000 subjects, we found no convincing evidence for association of P1104A and A928V with complex phenotypes other than autoimmune diseases such as RA, SLE and IBD. Together, our results demonstrate the role of TYK2 in the pathogenesis of RA, SLE and IBD, and provide supporting evidence for TYK2 as a promising drug target for the treatment of autoimmune diseases.	[Diogo, Dorothee; Liao, Katherine P.; Cui, Jing; Pappas, Dimitrios A.; Okada, Yukinori; Stahl, Eli A.; Karlson, Elizabeth W.; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Diogo, Dorothee; Okada, Yukinori; Stahl, Eli A.; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA USA; [Diogo, Dorothee; Okada, Yukinori; Stahl, Eli A.; Raychaudhuri, Soumya; Plenge, Robert M.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Diogo, Dorothee; Raychaudhuri, Soumya] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Bastarache, Lisa; Denny, Joshua C.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Graham, Robert R.; Bhangale, Tushar R.; Ortmann, Ward; Behrens, Timothy] Genentech Inc, ITGR Human Genet Grp, San Francisco, CA 94080 USA; [Fulton, Robert S.; Larson, David E.; Deluca, Tracie L.; O'Laughlin, Michelle; Fronick, Catrina C.; Fulton, Lucinda L.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Greenberg, Jeffrey D.] NYU, Hosp Joint Dis, New York, NY USA; [Eyre, Steve; Bowes, John; Barton, Anne; Worthington, Jane; Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Lee, Annette; Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Pappas, Dimitrios A.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Kremer, Joel M.] Albany Med Coll, Albany, NY 12208 USA; [Kremer, Joel M.] Ctr Rheumatol, Albany, NY USA; [Coenen, Marieke J. H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Psychiat & Human Genet, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands; [Mariette, Xavier; Richard-Miceli, Corrine] Univ Paris Sud, Orsay, France; [Mariette, Xavier; Richard-Miceli, Corrine] Hop Bicetre, INSERM, AP HP, U1012, Paris, France; [Canhao, Helena; Fonseca, Joao E.] Univ Lisbon, Fac Med, Inst Mol Med, Rheumatol Res Unit, P-1699 Lisbon, Portugal; [Canhao, Helena; Fonseca, Joao E.] Hosp Santa Maria, CHLN, Dept Rheumatol, Lisbon, Portugal; [de Vries, Niek; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Amsterdam Rheumatol & Immunol Ctr, NL-1105 AZ Amsterdam, Netherlands; [Crusius, J. Bart A.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Immunogenet Lab, Amsterdam, Netherlands; [Nurmohamed, Michael T.] Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Kurreeman, Fina; Zhernakova, Alexandra] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Mikuls, Ted R.; Seldin, Michael F.] Omaha VA, Div Rheumatol & Immunol, Omaha, NE USA; [Mikuls, Ted R.; Seldin, Michael F.] Univ Nebraska Med Ctr, Omaha, NE USA; [Kosoy, Roman; Ransom, Michael] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Cagan, Andrew; Gainer, Vivian; Kohane, Isaac; Murphy, Shawn N.] Partners Healthcare, Informat Syst, Charlestown, MA USA; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Zhernakova, Alexandra] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Klareskog, Lars; Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Klareskog, Lars; Padyukov, Leonid] Karolinska Univ Hosp Solna, Stockholm, Sweden; [Denny, Joshua C.] Vanderbilt Univ, Dept Med, Nashville, TN USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Partners Healthcare System; Vanderbilt University; Roche Holding; Genentech; Washington University (WUSTL); New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; University of Manchester; Northwell Health; Columbia University; Albany Medical College; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California Davis; Partners Healthcare System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Groningen; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Vanderbilt University	Diogo, D (corresponding author), Merck Res Labs, Boston, MA 02115 USA.	dorothee.diogo@merck.com	Martin, Javier/B-8141-2008; Franke, Barbara/D-4836-2009; Zhernakova, Alexandra/ABA-9372-2020; Canhao, Helena/C-9611-2018; Coenen, Marieke/A-2159-2010; Martín, María/HDL-9512-2022; Denny, Josh/AAL-3359-2021; Mardis, Elaine/W-2202-2019; Kiemeney, Lambertus A./D-3357-2009; Martín, Javier/AAV-5209-2021; Padyukov, Leonid/A-4890-2009; Barton, Anne/N-2053-2014; de Vries, Niek/J-9348-2013	Martin, Javier/0000-0002-2202-0622; Franke, Barbara/0000-0003-4375-6572; Canhao, Helena/0000-0003-1894-4870; Coenen, Marieke/0000-0001-8796-2031; Denny, Josh/0000-0002-3049-7332; Kiemeney, Lambertus A./0000-0002-2368-1326; Padyukov, Leonid/0000-0003-2950-5670; Barton, Anne/0000-0003-3316-2527; Zhernakova, Alexandra/0000-0002-4574-0841; Larson, David/0000-0001-7934-5906; DIOGO, DOROTHEE/0000-0003-2913-5913; Nurmohamed, Michael/0000-0002-6274-1934; Raychaudhuri, Soumya/0000-0002-1901-8265; de Vries, Niek/0000-0002-6257-8604	National Institutes of Health (NIH) [U01-GM092691, R01-AR063759]; NIH [U01-GM092691, R01-AR057108, R01-AR056768, R01-AR059648]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049880, R01AR063759, UH2AR067677, R01AR059648, R01AR057108, K08AR060257, R01AR056768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	DD was supported by grants from the National Institutes of Health (NIH) (U01-GM092691 and R01-AR063759). RMP was supported by grants from the NIH (R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Argiriadi MA, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-22; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Canhao H, 2011, ACTA REUMATOL PORT, V36, P45; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Couturier N, 2011, BRAIN, V134, P693, DOI 10.1093/brain/awr010; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Curtis JR, 2011, ANN RHEUM DIS, V70, P1401, DOI 10.1136/ard.2010.146365; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Diogo D, 2014, CURR OPIN RHEUMATOL, V26, P85, DOI 10.1097/BOR.0000000000000012; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Falush D, 2003, GENETICS, V164, P1567; Faubion WA, 2013, AM J GASTROENTEROL, V108, P1891, DOI 10.1038/ajg.2013.354; Flannick J, 2014, NAT GENET; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Garber K, 2013, NAT BIOTECHNOL, V31, P3, DOI 10.1038/nbt0113-3; Garber K, 2011, NAT BIOTECHNOL, V29, P467, DOI 10.1038/nbt0611-467; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Gregersen PK, 1998, ARTHRIT CARE RES, V11, P1, DOI 10.1002/art.1790110102; Guthridge JM, 2014, AM J HUM GENET, V94, P586, DOI 10.1016/j.ajhg.2014.03.008; Hebbring SJ, 2013, GENES IMMUN, V14, P187, DOI 10.1038/gene.2013.2; Hebbring SJ, 2014, IMMUNOLOGY, V141, P157, DOI 10.1111/imm.12195; Hellquist A, 2009, J RHEUMATOL, V36, P1631, DOI 10.3899/jrheum.081160; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johansen CT, 2012, CIRC-CARDIOVASC GENE, V5, P66, DOI 10.1161/CIRCGENETICS.111.960864; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Kilic SS, 2012, J PEDIATR-US, V160, P1055, DOI 10.1016/j.jpeds.2012.01.056; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kremer JM, 2006, AUTOIMMUN REV, V5, P46, DOI 10.1016/j.autrev.2005.07.006; Kremer JM, 2012, ARTHRITIS RHEUM-US, V64, P970, DOI 10.1002/art.33419; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2013, J IMMUNOL, V190, P2335, DOI 10.4049/jimmunol.1203118; Liao KP, 2014, ANN RHEUM DIS, V73, P1170, DOI 10.1136/annrheumdis-2012-203202; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Liu CY, 2008, MOL MED, V14, P575, DOI 10.2119/2008-00056.Liu; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manjarrez-Orduno N, 2012, NAT GENET, V44, P1227, DOI 10.1038/ng.2439; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mero IL, 2010, EUR J HUM GENET, V18, P502, DOI 10.1038/ejhg.2009.195; Miceli-Richard C, 2008, ANN RHEUM DIS, V67, P478, DOI 10.1136/ard.2007.074104; Mikuls TR, 2011, RHEUMATOLOGY, V50, P101, DOI 10.1093/rheumatology/keq232; Mima T, 2009, CURR OPIN RHEUMATOL, V21, P224, DOI 10.1097/BOR.0b013e3283295fec; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Morris DL, 2014, GENES IMMUN, V15, P210, DOI 10.1038/gene.2014.6; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Patkar NM, 2009, J CLIN EPIDEMIOL, V62, P321, DOI 10.1016/j.jclinepi.2008.06.006; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; Petri M, 2009, LUPUS, V18, P980, DOI 10.1177/0961203309105529; Plant D, 2011, ARTHRITIS RHEUM-US, V63, P645, DOI 10.1002/art.30130; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Ritchie MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Shameer K, 2014, HUM GENET, V133, P95, DOI 10.1007/s00439-013-1355-7; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sokka T, 2003, CLIN EXP RHEUMATOL, V21, pS146; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Van Limbergen J, 2013, INFLAMM BOWEL DIS, V19, pE79, DOI 10.1097/mib.0b013e318280e790; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020	94	85	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122271	10.1371/journal.pone.0122271	http://dx.doi.org/10.1371/journal.pone.0122271			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849893	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800115
J	Ishii, R; Tokuda, T; Tatebe, H; Ohmichi, T; Kasai, T; Nakagawa, M; Mizuno, T; El-Agnaf, OMA				Ishii, Ryotaro; Tokuda, Takahiko; Tatebe, Harutsugu; Ohmichi, Takuma; Kasai, Takashi; Nakagawa, Masanori; Mizuno, Toshiki; El-Agnaf, Omar M. A.			Decrease in Plasma Levels of alpha-Synuclein Is Evident in Patients with Parkinson's Disease after Elimination of Heterophilic Antibody Interference	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; DRUG-NAIVE PATIENTS; CEREBROSPINAL-FLUID; ELEVATED LEVELS; NERVOUS-SYSTEM; LEWY BODIES; DEMENTIA; CSF; PATHOLOGY; PROTEIN	There is substantial biochemical, pathological, and genetic evidence that alpha-synuclein (Asyn) is a principal molecule in the pathogenesis of Parkinson disease (PD). We previously reported that total A-syn levels in cerebrospinal fluid (CSF), measured with the specific enzyme-linked immunosorbent assay (ELISA) developed by ourselves, were decreased in patients with PD, and suggested the usefulness of A-syn in CSF and plasma as a biomarker for the diagnosis of PD. After our report, a considerable number of studies have investigated the levels A-syn in CSF and in blood, but have reported inconclusive results. Such discrepancies have often been attributed not only to the use of different antibodies in the ELISAs but also to interference from hemolysis. In this study we measured the levels of A-syn in CSF and plasma by using our own sandwich ELISA with or without heterophilic antibody (HA) inhibitor in 30 patients with PD and 58 age-matched controls. We thereby revealed that HA interfered with ELISA measurements of A-syn and are accordingly considered to be an important confounder in A-syn ELISAs. HA produced falsely exaggerated signals in A-syn ELISAs more prominently in plasma samples than in CSF samples. After elimination of HA interference, it was found that hemolysis did not have a significant effect on the signals obtained using our A-syn ELISA. Furthermore, plasma levels of A-syn were significantly lower in the PD group compared with the control group following elimination of HA interference with an HA inhibitor. Our results demonstrate that HA was a major confounder that should be controlled in A-syn ELISAs, and that plasma A-syn could be a useful biomarker for the diagnosis of PD if adequately quantified following elimination of HA interference.	[Ishii, Ryotaro; Tokuda, Takahiko; Tatebe, Harutsugu; Ohmichi, Takuma; Kasai, Takashi; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Kyoto, Japan; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Zaitaku Homecare, Kyoto, Japan; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Med Educ & Primary Care, Kyoto, Japan; [Nakagawa, Masanori] Kyoto Prefectural Univ Med, Med Ctr N, Kyoto, Japan; [El-Agnaf, Omar M. A.] Qatar Fdn, Educ City, HBKU, Coll Sci Engn & Technol, Doha, Qatar	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Tokuda, T (corresponding author), Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan.	ttokuda@koto.kpu-m.ac.jp	Ishii, Ryotaro/K-4595-2019; Mizuno, Toshiki/AAH-7155-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [23591252]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid (No. 23591252 to T.T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts MB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.001; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bartels EM, 2013, METHODS, V61, P18, DOI 10.1016/j.ymeth.2012.12.015; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; Cersosimo MG, 2013, J NEUROL, V260, P1332, DOI 10.1007/s00415-012-6801-2; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Foulds PG, 2012, NEUROBIOL DIS, V45, P188, DOI 10.1016/j.nbd.2011.08.003; Foulds PG, 2011, FASEB J, V25, P4127, DOI 10.1096/fj.10-179192; Fumimura Y, 2007, J NEUROPATH EXP NEUR, V66, P354, DOI 10.1097/nen.0b013e3180517454; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Ikemura M, 2008, J NEUROPATH EXP NEUR, V67, P945, DOI 10.1097/NEN.0b013e318186de48; Kang JH, 2013, JAMA NEUROL, V70, P1277, DOI 10.1001/jamaneurol.2013.3861; Kasai T, 2014, J NEUROL, V261, P1203, DOI 10.1007/s00415-014-7334-7; Kricka LJ, 1999, CLIN CHEM, V45, P942; Laske C, 2011, DEMENT GERIATR COGN, V31, P413, DOI 10.1159/000329763; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Levinson SS, 2002, CLIN CHIM ACTA, V325, P1, DOI 10.1016/S0009-8981(02)00275-9; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Mitsui J, 2006, J NEUROL SCI, V243, P101, DOI 10.1016/j.jns.2005.11.034; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2013, NEUROSCI LETT, V532, P44, DOI 10.1016/j.neulet.2012.11.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Preissner CM, 2003, J CLIN ENDOCR METAB, V88, P3069, DOI 10.1210/jc.2003-030122; Reesink FE, 2010, J ALZHEIMERS DIS, V22, P87, DOI 10.3233/JAD-2010-100186; Sehlin D, 2010, J ALZHEIMERS DIS, V21, P1295, DOI 10.3233/JAD-2010-100609; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Smith LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052285; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tamaoka A, 1996, J NEUROL SCI, V141, P65, DOI 10.1016/0022-510X(96)00143-8; Tateno F, 2012, ALZ DIS ASSOC DIS, V26, P213, DOI 10.1097/WAD.0b013e31823899cc; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Wennstrom M, 2012, J ALZHEIMERS DIS, V29, P125, DOI [10.3233/JAD-2011-111655, 10.3233/JAD-2012-111655]; Woulfe JM, 2002, NEUROLOGY, V58, P1435, DOI 10.1212/WNL.58.9.1435	39	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123162	10.1371/journal.pone.0123162	http://dx.doi.org/10.1371/journal.pone.0123162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849645	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800211
J	Petersen, MK				Petersen, Michael Kai			Latent Semantics of Action Verbs Reflect Phonetic Parameters of Intensity and Emotional Content	PLOS ONE			English	Article							SPEECH; ORGANIZATION; ENCODES	Conjuring up our thoughts, language reflects statistical patterns of word co-occurrences which in turn come to describe how we perceive the world. Whether counting how frequently nouns and verbs combine in Google search queries, or extracting eigenvectors from term document matrices made up of Wikipedia lines and Shakespeare plots, the resulting latent semantics capture not only the associative links which form concepts, but also spatial dimensions embedded within the surface structure of language. As both the shape and movements of objects have been found to be associated with phonetic contrasts already in toddlers, this study explores whether articulatory and acoustic parameters may likewise differentiate the latent semantics of action verbs. Selecting 3 x 20 emotion-, face-, and handrelated verbs known to activate premotor areas in the brain, their mutual cosine similarities were computed using latent semantic analysis LSA, and the resulting adjacency matrices were compared based on two different large scale text corpora: HAWIK and TASA. Applying hierarchical clustering to identify common structures across the two text corpora, the verbs largely divide into combined mouth and hand movements versus emotional expressions. Transforming the verbs into their constituent phonemes, and projecting them into an articulatory space framed by tongue height and formant frequencies, the clustered small and large size movements appear differentiated by front versus back vowels corresponding to increasing levels of arousal. Whereas the clustered emotional verbs seem characterized by sequences of close versus open jaw produced phonemes, generating up-or downwards shifts in formant frequencies that may influence their perceived valence. Suggesting, that the latent semantics of action verbs reflect parameters of intensity and emotional polarity that appear correlated with the articulatory contrasts and acoustic characteristics of phonemes.	Tech Univ Denmark, DTU Compute, Cognit Syst, DK-2800 Lyngby, Denmark	Technical University of Denmark	Petersen, MK (corresponding author), Tech Univ Denmark, DTU Compute, Cognit Syst, Bldg 324, DK-2800 Lyngby, Denmark.	mkai@dtu.dk		Petersen, Michael Kai/0000-0002-2156-9226				Barsalou L., 2008, SYMBOLS EMBODIMENT D, P245, DOI [DOI 10.1093/ACPROF:OSO/9780199217274.003.0013, 10.1093/acprof:oso/9780199217274.003.0013, DOI 10.1093/ACPROF:OSO/9780199217274.003]; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Boussidan A, 2009, DISTRIBUTIONAL SEMAN, P35; Bradley MM, 2010, ECTIVE NORMS ENGLISH; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Catford J. C., 1988, PRACTICAL INTRO PHON; Changizi M., 2011, HARNESSED LANGUAGE M; CMU, 1976, CMU PRON DICT; Engel AK, 2013, TRENDS COGN SCI, V17, P202, DOI 10.1016/j.tics.2013.03.006; Furnas G. W., 1988, 11th International Conference on Research and Development in Information Retrieval, P465; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Glenberg A. M., 2011, CORTEX; Graziano MSA, 2002, NEURON, V36, P349, DOI 10.1016/S0896-6273(02)01003-6; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Ladefoged P, 1989, WORKING PAPERS PHONE, P73; Lako George, 1999, PHILOS FLESH EMBODIE; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Landauer TK, 2013, HDB LATENT SEMANTIC; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Louwerse MM, 2012, COGNITIVE SCI, V36, P1556, DOI 10.1111/cogs.12000; Louwerse MM, 2011, TOP COGN SCI, V3, P273, DOI 10.1111/j.1756-8765.2010.01106.x; Louwerse MM, 2009, COGNITIVE SCI, V33, P51, DOI 10.1111/j.1551-6709.2008.01003.x; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Monaghan P, 2007, COGNITIVE PSYCHOL, V55, P259, DOI 10.1016/j.cogpsych.2006.12.001; Moreno-Dominguez D, 2014, HUM BRAIN MAPP, V35, P5000, DOI 10.1002/hbm.22528; Moseley R., 2011, CEREB CORTEX, P1; MURPHY GL, 1993, J MEM LANG, V32, P301, DOI 10.1006/jmla.1993.1016; Myers-Schulz B, 2013, COGNITION EMOTION, V27, P1105, DOI 10.1080/02699931.2012.754739; Otis K., 2008, P 30 ANN C COGNITIVE, P65; Petersen MK, 2012, LSA SOFTWARE HAWIK C; Pulvermuller F, 2013, TRENDS COGN SCI, V17, P458, DOI 10.1016/j.tics.2013.06.004; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Recio G, 2014, BRAIN LANG, V134, P34, DOI 10.1016/j.bandl.2014.03.009; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x	46	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121575	10.1371/journal.pone.0121575	http://dx.doi.org/10.1371/journal.pone.0121575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849977	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800068
J	Faure, B; Schaeffer, SW; Fisher, CR				Faure, Baptiste; Schaeffer, Stephen W.; Fisher, Charles R.			Species Distribution and Population Connectivity of Deep-Sea Mussels at Hydrocarbon Seeps in the Gulf of Mexico	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; BATHYMODIOLUS-CHILDRESSI; CHARACTER DISPLACEMENT; INTEGRATED SOFTWARE; BIVALVIA; VENT; DIVERSITY; MYTILIDAE; GENETICS; ENDOSYMBIONTS	Hydrocarbon seepage is widespread and patchy in the Gulf of Mexico, and six species of symbiont containing bathymodiolin mussels are found on active seeps over wide and overlapping depth and geographic ranges. We use mitochondrial genes to discriminate among the previously known and a newly discovered species and to assess the connectivity among populations of the same species in the northern Gulf of Mexico (GoM). Our results generally validate the morphologically based distribution of the three previously known GoM species of Bathymodiolus, although we found that approximately 10% of the morphologically based identifications were incorrect and this resulted in some inaccuracies with respect to their previously assigned depth and geographical distribution patterns. These data allowed us to confirm that sympatry of two species of Bathymodiolus within a single patch of mussels is common. A new species of bathymodiolin, Bathymodiolus sp. nov., closely related to B. heckerae was also discovered. The two species live at the same depths but have not been found in sympatry and both have small effective population sizes. We found evidence for genetic structure within populations of the three species of Bathymodiolinae for which we had samples from multiple sites and suggest limited connectivity for populations at some sites. Despite relatively small sample sizes, genetic diversity indices suggest the largest population sizes for B. childressi and Tamu fisheri and the smallest for B. heckerae and B. sp. nov. among the GoM bathymodiolins. Moreover, we detected an excess of rare variants indicating recent demographic changes and population expansions for the four species of bathymodiolins from the Gulf of Mexico.	[Faure, Baptiste; Schaeffer, Stephen W.; Fisher, Charles R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Faure, B (corresponding author), Serv Rech & Dev, Biotope, Meze, France.	bfaure@biotope.fr	Schaeffer, Stephen/AAA-2303-2021	Schaeffer, Stephen/0000-0003-2070-5342	French Ministry of Foreign Affairs; BOEM [1435-01-05-39187, M08PC20038]; National Oceanic and Atmospheric Administration's Office of Ocean Exploration and Research	French Ministry of Foreign Affairs; BOEM; National Oceanic and Atmospheric Administration's Office of Ocean Exploration and Research	This work was supported by a Lavoisier grant from the French Ministry of Foreign Affairs and by subcontracts to CRF from BOEM contracts 1435-01-05-39187 and M08PC20038 to TDI Brooks, with vessel and submergence facilities support provided by National Oceanic and Atmospheric Administration's Office of Ocean Exploration and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano SM, 2009, BIOL BULL-US, V216, P149, DOI 10.1086/BBLv216n2p149; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Becker EL, 2010, DEEP-SEA RES PT II, V57, P1957, DOI 10.1016/j.dsr2.2010.05.002; Bergquist DC, 2004, LIMNOL OCEANOGR, V49, P706, DOI 10.4319/lo.2004.49.3.0706; Bergquist DC, 2003, MAR ECOL-P S Z N I, V24, P31, DOI 10.1046/j.1439-0485.2003.03800.x; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Carney SL, 2006, DEEP-SEA RES PT I, V53, P1061, DOI 10.1016/j.dsr.2006.03.002; Cassens I, 2005, SYST BIOL, V54, P363, DOI 10.1080/10635150590945377; Cordes EE, 2005, MAR ECOL PROG SER, V305, P17, DOI 10.3354/meps305017; Cordes EE, 2009, ANNU REV MAR SCI, V1, P143, DOI 10.1146/annurev.marine.010908.163912; CRADDOCK C, 1995, MAR BIOL, V121, P477, DOI 10.1007/BF00349456; Dobzhansky T., 1937; Doyle J. J., 1987, PHYTOCHEM B, P11; Duperron S, 2007, ENVIRON MICROBIOL, V9, P1423, DOI 10.1111/j.1462-2920.2007.01259.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faure B, 2007, GENE, V406, P99, DOI 10.1016/j.gene.2007.06.025; Faure B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006485; FELSENSTEIN J, 1985, SYST ZOOL, V34, P300, DOI 10.2307/2413149; FISHER C, 2007, OCEANOGRAPHY, V20, P68; FISHER CR, 1993, PSZNI MAR ECOL, V14, P277; FISHER CR, 1993, BIOGEOCHEMISTRY OF GLOBAL CHANGE, P606; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galtier N, 2000, GENETICS, V155, P981; Gause GF, 1932, J EXP BIOL, V9, P389; Gavrilets S, 2003, EVOLUTION, V57, P2197; Genio L, 2008, J SHELLFISH RES, V27, P53, DOI 10.2983/0730-8000(2008)27[53:NROBMC]2.0.CO;2; Gustafson RG, 1998, MALACOLOGIA, V40, P63; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HUDSON RR, 1987, GENETICS, V116, P153; Iwasaki H, 2006, MAR BIOL, V149, P1111, DOI 10.1007/s00227-006-0268-6; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LI WH, 1991, FUNDAMENTALS MOL EVO; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Loso JB, 2000, P NATL ACAD SCI USA, V97, P5693, DOI 10.1073/pnas.97.11.5693; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mayr E, 1942, SYSTEMATICS ORIGIN S; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nei M., 1987, MOL EVOLUTIONARY GEN; NIX ER, 1995, MAR BIOL, V122, P605, DOI 10.1007/BF00350682; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Olu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011967; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Plouviez S, 2009, MOL ECOL, V18, P3903, DOI 10.1111/j.1365-294X.2009.04325.x; Plouviez S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081555; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Rice AM, 2007, J EVOLUTION BIOL, V20, P448, DOI 10.1111/j.1420-9101.2006.01187.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schaeffer SW, 2002, GENET RES, V80, P163, DOI 10.1017/S0016672302005955; SLATKIN M, 1980, ECOLOGY, V61, P163, DOI 10.2307/1937166; Smith EB, 2000, ECOLOGY, V81, P2392, DOI 10.1890/0012-9658(2000)081[2392:GACOSM]2.0.CO;2; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thubaut J, 2013, ECOL EVOL, V3, P4748, DOI 10.1002/ece3.749; van der Heijden K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039994; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Won YJ, 2002, CAH BIOL MAR, V43, P387; Won YJ, 2008, J SHELLFISH RES, V27, P129, DOI 10.2983/0730-8000(2008)27[129:AOCBDM]2.0.CO;2	63	21	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0118460	10.1371/journal.pone.0118460	http://dx.doi.org/10.1371/journal.pone.0118460			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859657	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300004
J	Hu, Y; Sun, QW; Li, XL; Wang, M; Cai, DM; Li, X; Zhao, RQ				Hu, Yun; Sun, Qinwei; Li, Xiaoliang; Wang, Min; Cai, Demin; Li, Xi; Zhao, Ruqian			In Ovo Injection of Betaine Affects Hepatic Cholesterol Metabolism through Epigenetic Gene Regulation in Newly Hatched Chicks	PLOS ONE			English	Article							CORTICOSTERONE CORT; PECTORALIS MAJOR; DNA METHYLATION; SUPPLEMENTATION; EXPRESSION; CHOLINE; HYPERMETHYLATION; DEFICIENCY; METHIONINE; TRANSPORT	Betaine is reported to regulate hepatic cholesterol metabolism in mammals. Chicken eggs contain considerable amount of betaine, yet it remains unknown whether and how betaine in the egg affects hepatic cholesterol metabolism in chicks. In this study, eggs were injected with betaine at 2.5 mg/egg and the hepatic cholesterol metabolism was investigated in newly hatched chicks. Betaine did not affect body weight or liver weight, but significantly increased the serum concentration (P < 0.05) and the hepatic content (P < 0.01) of cholesterol. Accordingly, the cholesterol biosynthetic enzyme HMGCR was up-regulated (P < 0.05 for both mRNA and protein), while CYP7A1 which converts cholesterol to bile acids was down-regulated (P < 0.05 for mRNA and P = 0.07 for protein). Moreover, hepatic protein content of the sterol-regulatory element binding protein 1 which regulates cholesterol and lipid biosynthesis, and the mRNA abundance of ATP binding cassette sub-family A member 1 (ABCA1) which mediates cholesterol counter transport were significantly (P < 0.05) increased in betaine-treated chicks. Meanwhile, hepatic protein contents of DNA methyltransferases 1 and adenosylhomocysteinase-like 1 were increased (P < 0.05), which was associated with global genomic DNA hypermethylation (P < 0.05) and diminished gene repression mark histone H3 lysine 27 trimethylation (P < 0.05). Furthermore, CpG methylation level on gene promoters was found to be increased (P < 0.05) for CYP7A1 yet decreased (P < 0.05) for ABCA1. These results indicate that in ovo betaine injection regulates hepatic cholesterol metabolism in chicks through epigenetic mechanisms including DNA and histone methylations.	[Hu, Yun; Sun, Qinwei; Li, Xiaoliang; Wang, Min; Cai, Demin; Li, Xi; Zhao, Ruqian] Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Sun, QW (corresponding author), Nanjing Agr Univ, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	sqw@njau.edu.cn	Cai, Demin/AAT-7742-2021	Cai, Demin/0000-0003-0500-5292	Special Fund for Agro-scientific Research in the Public Interest [201003011]; Fundamental Research Funds for the Central Universities [KYZ201212]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201003011), the Fundamental Research Funds for the Central Universities (KYZ201212) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2014, HORM BEHAV, V65, P97, DOI 10.1016/j.yhbeh.2013.12.002; Alirezaei M, 2012, BRIT POULTRY SCI, V53, P699, DOI 10.1080/00071668.2012.728283; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Biniszkiewicz D, 2002, MOL CELL BIOL, V22, P2124, DOI 10.1128/MCB.22.7.2124-2135.2002; Cai DM, 2014, BRIT J NUTR, V112, P1459, DOI 10.1017/S0007114514002402; Cordero P, 2013, GENES NUTR, V8, P105, DOI 10.1007/s12263-012-0300-z; Davison JM, 2009, J BIOL CHEM, V284, P1982, DOI 10.1074/jbc.M807651200; Duan YJ, 2014, COMP BIOCHEM PHYS A, V176, P59, DOI 10.1016/j.cbpa.2014.07.010; Duan YJ, 2014, COMP BIOCHEM PHYS A, V169, P90, DOI 10.1016/j.cbpa.2013.12.019; Eklund M, 2005, NUTR RES REV, V18, P31, DOI 10.1079/NRR200493; Faust PL, 2014, BIOCHIMIE, V98, P75, DOI 10.1016/j.biochi.2013.10.019; Fernandez-Figares I, 2012, ANIMAL, V6, P1058, DOI 10.1017/S1751731111002308; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Kalhan SC, 2011, J BIOL CHEM, V286, P5266, DOI 10.1074/jbc.M110.185991; Khesht FA, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-20; Kim SK, 2005, J HEPATOL, V42, P907, DOI 10.1016/j.jhep.2005.01.017; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Lever M, 2010, CLIN BIOCHEM, V43, P732, DOI 10.1016/j.clinbiochem.2010.03.009; Levinson SS, 2015, CLIN CHIM ACTA, V439, P154, DOI 10.1016/j.cca.2014.10.018; Li X, 2014, EUR J NUTR; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Monte MJ, 2009, WORLD J GASTROENTERO, V15, P804, DOI 10.3748/wjg.15.804; Mudd SH, 2011, AM J MED GENET C, V157C, P3, DOI 10.1002/ajmg.c.30293; Mulligan JD, 2003, J BIOL CHEM, V278, P13356, DOI 10.1074/jbc.M212377200; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Obeid R, 2013, NUTRIENTS, V5, P3481, DOI 10.3390/nu5093481; Ratriyanto A, 2009, ASIAN AUSTRAL J ANIM, V22, P1461, DOI 10.5713/ajas.2009.80659; Sayed MAM, 2011, POULTRY SCI, V90, P157, DOI 10.3382/ps.2009-00594; Schwab U, 2011, EUR J CLIN NUTR, V65, P70, DOI 10.1038/ejcn.2010.230; Schwab U, 2002, AM J CLIN NUTR, V76, P961, DOI 10.1093/ajcn/76.5.961; Schwahn BC, 2007, ATHEROSCLEROSIS, V195, pE100, DOI 10.1016/j.atherosclerosis.2007.06.030; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Su L, 2012, DOMEST ANIM ENDOCRIN, V43, P26, DOI 10.1016/j.domaniend.2012.01.007; SUGIYAMA K, 1986, J NUTR SCI VITAMINOL, V32, P537, DOI 10.3177/jnsv.32.537; Szyf M, 2001, FRONT BIOSCI-LANDMRK, V6, pD599, DOI 10.2741/szyf; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Woollett LA, 2005, AM J CLIN NUTR, V82, P1155, DOI 10.1093/ajcn/82.6.1155; Zeisel SH, 2003, J NUTR, V133, P1302; Zhang YQ, 2004, J NUTR, V134, P2205, DOI 10.1093/jn/134.9.2205	40	33	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122643	10.1371/journal.pone.0122643	http://dx.doi.org/10.1371/journal.pone.0122643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860502	gold, Green Submitted, Green Published			2022-12-27	WOS:000352590300052
J	Pathak, R; Shao, LJ; Ghosh, SP; Zhou, DH; Boerma, M; Weiler, H; Hauer-Jensen, M				Pathak, Rupak; Shao, Lijian; Ghosh, Sanchita P.; Zhou, Daohong; Boerma, Marjan; Weiler, Hartmut; Hauer-Jensen, Martin			Thrombomodulin Contributes to Gamma Tocotrienol-Mediated Lethality Protection and Hematopoietic Cell Recovery in Irradiated Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TOTAL-BODY IRRADIATION; ACTIVATED PROTEIN-C; ENDOTHELIAL THROMBOMODULIN; SEVERE SEPSIS; DEPENDENT MECHANISM; RADIATION-INJURY; UP-REGULATION; ANTIOXIDANT; DYSFUNCTION	Systemic administration of recombinant thrombomodulin (TM) confers radiation protection partly by accelerating hematopoietic recovery. The uniquely potent radioprotector gamma tocotrienol (GT3), in addition to being a strong antioxidant, inhibits the enzyme hydroxymethyl-glutaryl-coenzyme A reductase (HMGCR) and thereby likely modulates the expression of TM. We hypothesized that the mechanism underlying the exceptional radioprotective properties of GT3 partly depends on the presence of endothelial TM. In vitro studies confirmed that ionizing radiation suppresses endothelial TM (about 40% at 4 hr after 5 Gy gamma-irradiation) and that GT3 induces TM expression (about 2 fold at the mRNA level after 5 mu M GT3 treatment for 4 hr). In vivo survival studies showed that GT3 was significantly more effective as a radioprotector in TM wild type (TM+/+) mice than in mice with low TM function (TMPro/-). After exposure to 9 Gy TBI, GT3 pre-treatment conferred 85% survival in TM+/+ mice compared to only 50% in TMPro/-. Thus, GT3-mediated radiation lethality protection is partly dependent on endothelial TM. Significant post-TBI recovery of hematopoietic cells, particularly leukocytes, was observed in TM+/+ mice (p = 0.003), but not in TMPro/- mice, despite the fact that GT3 induced higher levels of granulocyte colony stimulating factor (GCSF) in TMPro/- mice (p = 0.0001). These data demonstrate a critical, G-CSF-independent, role for endothelial TM in GT3-mediated lethality protection and hematopoietic recovery after exposure to TBI and may point to new strategies to enhance the efficacy of current medical countermeasures in radiological/nuclear emergencies.	[Pathak, Rupak; Shao, Lijian; Zhou, Daohong; Boerma, Marjan; Hauer-Jensen, Martin] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Coll Pharm, Little Rock, AR 72205 USA; [Ghosh, Sanchita P.] USUHS, Armed Forces Radiobiol Res Inst, Bethesda, MD USA; [Weiler, Hartmut] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Weiler, Hartmut] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Hauer-Jensen, Martin] Cent Arkansas Vet Healthcare Syst, Surg Serv, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; United States Department of Defense; Versiti Blood Center of Wisconsin; Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Pathak, R (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Div Radiat Hlth, Coll Pharm, Little Rock, AR 72205 USA.	rpathak@uams.edu	Shao, Lijian/AAA-1074-2020	Ghosh, Sanchita/0000-0002-0261-460X	National Institutes of Health (NIH) [R37 CA71382, U19 AI67798]; US Veterans Administration; Arkansas Space Grant Consortium through National Aeronautics and Space Administration [NNX13AB29A]; National Space Biomedical Research Institute through National Aeronautics and Space Administration [RE03701, NCC 9-58]; NIH [R01 CA148679, R01 CA122023]; Edward P. Evans Foundation; NATIONAL CANCER INSTITUTE [R37CA071382, R01CA148679, R01CA122023] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Veterans Administration(US Department of Veterans Affairs); Arkansas Space Grant Consortium through National Aeronautics and Space Administration; National Space Biomedical Research Institute through National Aeronautics and Space Administration; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) grants R37 CA71382 and U19 AI67798 (MH-J), the US Veterans Administration (MH-J), Arkansas Space Grant Consortium through National Aeronautics and Space Administration grant NNX13AB29A (RP), National Space Biomedical Research Institute (RE03701) through National Aeronautics and Space Administration NCC 9-58 (MB), NIH grant R01 CA148679 (MB), NIH grant R01 CA122023 (DZ), and the Edward P. Evans Foundation (DZ and MH-J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa N, 2011, SHOCK, V35, P349, DOI 10.1097/SHK.0b013e318204c019; Andrulis M, 2012, HAEMATOL-HEMATOL J, V97, P1674, DOI 10.3324/haematol.2011.061051; Basu S, 2000, BLOOD, V95, P3725; Berbee M, 2012, GENES NUTR, V7, P75, DOI 10.1007/s12263-011-0228-8; Berbee M, 2009, RADIAT RES, V171, P596, DOI 10.1667/RR1632.1; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Califano F, 2000, Eur Rev Med Pharmacol Sci, V4, P59; Casserly B, 2012, CRIT CARE MED, V40, P1417, DOI 10.1097/CCM.0b013e31823e9f45; CONWAY EM, 1988, MOL CELL BIOL, V8, P5588, DOI 10.1128/MCB.8.12.5588; Fu Q, 2008, CIRC RES, V103, P369, DOI 10.1161/CIRCRESAHA.108.174607; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Ghosh SP, 2009, INT J RADIAT BIOL, V85, P598, DOI 10.1080/09553000902985128; Grinnell BW, 2001, CRIT CARE MED, V29, pS53, DOI 10.1097/00003246-200107001-00020; Hauer-Jensen M, 2004, CRIT CARE MED, V32, pS325, DOI 10.1097/01.CCM.0000126358.15697.75; Hauer-Jensen M, 1999, RADIAT ONCOL INVESTI, V7, P238, DOI 10.1002/(SICI)1520-6823(1999)7:4<238::AID-ROI5>3.0.CO;2-4; Ito T, 2011, J THROMB HAEMOST, V9, P168, DOI 10.1111/j.1538-7836.2011.04319.x; Kulkarni S, 2013, CYTOKINE, V62, P278, DOI 10.1016/j.cyto.2013.03.009; Kulkarni S, 2010, RADIAT RES, V173, P738, DOI 10.1667/RR1824.1; Kulkarni SS, 2012, INT IMMUNOPHARMACOL, V14, P495, DOI 10.1016/j.intimp.2012.09.001; Maeda K, 2005, BLOOD, V106, P879, DOI 10.1182/blood-2005-02-0456; Ogawa Y, 2012, J TRAUMA ACUTE CARE, V72, P1150, DOI 10.1097/TA.0b013e3182516ab5; Palframan RT, 1998, J EXP MED, V188, P1621, DOI 10.1084/jem.188.9.1621; PARKER RA, 1993, J BIOL CHEM, V268, P11230; PEARCE BC, 1992, J MED CHEM, V35, P3595, DOI 10.1021/jm00098a002; Qureshi SH, 2009, BIOCHEMISTRY-US, V48, P8261, DOI 10.1021/bi900921t; Richter KK, 1997, RADIOTHER ONCOL, V44, P65, DOI 10.1016/S0167-8140(97)00063-7; Ross CC, 2008, RADIAT RES, V169, P408, DOI 10.1667/RR1148.1; Shi JM, 2003, BLOOD COAGUL FIBRIN, V14, P575, DOI 10.1097/00001721-200309000-00010; TANIKAWA S, 1990, BLOOD, V76, P445; Wang JR, 2002, AM J PATHOL, V160, P2063, DOI 10.1016/S0002-9440(10)61156-X; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Williams JP, 2004, RADIAT RES, V161, P560, DOI 10.1667/RR3168; Yan SB, 2001, CHEST, V120, P915, DOI 10.1378/chest.120.3.915; Yoshida Y, 2003, CHEM PHYS LIPIDS, V123, P63, DOI 10.1016/S0009-3084(02)00164-0	34	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122511	10.1371/journal.pone.0122511	http://dx.doi.org/10.1371/journal.pone.0122511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860286	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300050
J	Simamura, E; Arikawa, T; Ikeda, T; Shimada, H; Shoji, H; Masuta, H; Nakajima, Y; Otani, H; Yonekura, H; Hatta, T				Simamura, Eriko; Arikawa, Tomohiro; Ikeda, Takayuki; Shimada, Hiroki; Shoji, Hiroki; Masuta, Hiroko; Nakajima, Yuriko; Otani, Hiroki; Yonekura, Hideto; Hatta, Toshihisa			Melanocortins Contribute to Sequential Differentiation and Enucleation of Human Erythroblasts via Melanocortin Receptors 1, 2 and 5	PLOS ONE			English	Article							RED-BLOOD-CELLS; MOLECULAR-CLONING; EX-VIVO; ERYTHROPOIETIN RECEPTOR; HEMATOPOIETIC STEM; ERYTHROID-CELLS; PRECURSOR CELLS; IN-VITRO; EXPRESSION; PROTEIN	In this study, we showed that adrenocorticotropic hormone (ACTH) promoted erythroblast differentiation and increased the enucleation ratio of erythroblasts. Because ACTH was contained in hematopoietic medium as contamination, the ratio decreased by the addition of anti-ACTH antibody (Ab). Addition of neutralizing Abs (nAbs) for melanocortin receptors (MCRs) caused erythroblast accumulation at specific stages, i.e., the addition of anti-MC2R nAb led to erythroblast accumulation at the basophilic stage (baso-E), the addition of anti-MC1R nAb caused accumulation at the polychromatic stage (poly-E), and the addition of anti-MC5R nAb caused accumulation at the orthochromatic stage (ortho-E). During erythroblast differentiation, ERK, STAT5, and AKT were consecutively phosphorylated by erythropoietin (EPO). ERK, STAT5, and AKT phosphorylation was inhibited by blocking MC2R, MC1R, and MC5R, respectively. Finally, the phosphorylation of myosin light chain 2, which is essential for the formation of contractile actomyosin rings, was inhibited by anti-MC5R nAb. Taken together, our study suggests that MC2R and MC1R signals are consecutively required for the regulation of EPO signal transduction in erythroblast differentiation, and that MC5R signal transduction is required to induce enucleation. Thus, melanocortin induces proliferation and differentiation at baso-E, and polarization and formation of an actomyosin contractile ring at ortho-E are required for enucleation.	[Simamura, Eriko; Shimada, Hiroki; Masuta, Hiroko; Nakajima, Yuriko; Hatta, Toshihisa] Kanazawa Med Univ, Sch Med, Dept Anat, Uchinada, Ishikawa 9200293, Japan; [Arikawa, Tomohiro; Shoji, Hiroki] Kanazawa Med Univ, Sch Med, Dept Biol, Uchinada, Ishikawa 9200293, Japan; [Ikeda, Takayuki; Yonekura, Hideto] Kanazawa Med Univ, Sch Med, Dept Biochem, Uchinada, Ishikawa 9200293, Japan; [Otani, Hiroki] Shimane Univ, Fac Med, Dept Dev Biol, Izumo, Shimane 6938601, Japan	Kanazawa Medical University; Kanazawa Medical University; Kanazawa Medical University; Shimane University	Hatta, T (corresponding author), Kanazawa Med Univ, Sch Med, Dept Anat, Uchinada, Ishikawa 9200293, Japan.	thatta@kanazawa-med.ac.jp		Ikeda, Takayuki/0000-0001-9546-2248	Japan Society for the Promotion of Science [23591606, 22390216, 20238025, 23592423, 24590245, 25293241, 24659512, 24791726]; Research for Promoting Technological Seeds [07-035]; High-Technology Research Centre of Kanazawa Medical University [H2010-14]; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan; Kanazawa Medical University [C2009-3, C2010-2, S2010-8, S2008-10, S1201022]; Grants-in-Aid for Scientific Research [24590245, 25293241, 24659512] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research for Promoting Technological Seeds(Japan Science & Technology Agency (JST)); High-Technology Research Centre of Kanazawa Medical University; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Kanazawa Medical University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (23591606, 22390216, 20238025, 23592423 and 24590245, 25293241, 24659512, 24791726), by Research for Promoting Technological Seeds (07-035), by a grant for project research from the High-Technology Research Centre of Kanazawa Medical University (H2010-14), by the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan and by grants for promoting research from Kanazawa Medical University (C2009-3, C2010-2, S2010-8, S2008-10 and S1201022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DJ, 2004, TOXICOL SCI, V79, P82, DOI 10.1093/toxsci/kfh095; Alvaro JD, 1996, MOL PHARMACOL, V50, P583; Andersen GN, SCAND J IMMUNOL; Bagley RG, 2003, CANCER RES, V63, P5866; Becher E, 1999, ANN NY ACAD SCI, V885, P188; Catania A, 1996, PEPTIDES, V17, P675, DOI 10.1016/0196-9781(96)00037-X; Chen CM, 2004, BLOOD, V104, P73, DOI 10.1182/blood-2003-04-1340; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; Chhajlani V, 1996, BIOCHEM MOL BIOL INT, V38, P73; CHHAJLANI V, 1993, BIOCHEM BIOPH RES CO, V195, P866, DOI 10.1006/bbrc.1993.2125; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; Chida D, 2007, P NATL ACAD SCI USA, V104, P18205, DOI 10.1073/pnas.0706953104; Chin H, 1998, BLOOD, V91, P3734; Chute JP, 2006, STEM CELLS, V24, P1315, DOI 10.1634/stemcells.2005-0029; FATHI Z, 1995, NEUROCHEM RES, V20, P107, DOI 10.1007/BF00995160; Fujimi A, 2008, INT J HEMATOL, V87, P339, DOI 10.1007/s12185-008-0062-y; GANTZ I, 1994, BIOCHEM BIOPH RES CO, V200, P1214, DOI 10.1006/bbrc.1994.1580; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Hadley ME, 1999, ANN NY ACAD SCI, V885, P1; Haseyama Y, 1999, BLOOD, V94, P1568, DOI 10.1182/blood.V94.5.1568.417a07_1568_1577; Hebiguchi M, 2008, INT J HEMATOL, V88, P498, DOI 10.1007/s12185-008-0200-6; Herraiz C, 2009, FEBS LETT, V583, P3269, DOI 10.1016/j.febslet.2009.09.023; Ji P, 2008, NAT CELL BIOL, V10, P314, DOI 10.1038/ncb1693; Kask A, 1998, ENDOCRINOLOGY, V139, P5006, DOI 10.1210/en.139.12.5006; Kerenyi MA, 2008, BLOOD, V112, P3878, DOI 10.1182/blood-2008-02-138339; Klingmuller U, 1997, P NATL ACAD SCI USA, V94, P3016, DOI 10.1073/pnas.94.7.3016; Konstantinidis DG, 2012, BLOOD, V119, P6118, DOI 10.1182/blood-2011-09-379263; LABBE O, 1994, BIOCHEMISTRY-US, V33, P4543, DOI 10.1021/bi00181a015; Lindberg C, 2005, NEUROTOX RES, V8, P267, DOI 10.1007/BF03033980; LIOTTA AS, 1984, J NEUROSCI, V4, P956; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MCNIECE IK, 1991, EXP HEMATOL, V19, P226; Menon MP, 2006, BLOOD, V107, P2662, DOI 10.1182/blood-2005-02-0684; Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245; Moller CL, 2011, MOL CELL ENDOCRINOL, V341, P9, DOI 10.1016/j.mce.2011.03.010; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467; Nimura M, 2006, ANAT EMBRYOL, V211, P109, DOI 10.1007/s00429-005-0066-9; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Oda A, 1998, BLOOD, V92, P443, DOI 10.1182/blood.V92.2.443.414k25_443_451; Ohmizono Y, 1997, LEUKEMIA, V11, P524, DOI 10.1038/sj.leu.2400588; Ratajczak J, 2001, BRIT J HAEMATOL, V115, P195, DOI 10.1046/j.1365-2141.2001.03058.x; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Sakamoto H, 2000, J BIOL CHEM, V275, P35857, DOI 10.1074/jbc.M006317200; Sato Y, 2010, BIOCHEM BIOPH RES CO, V403, P253, DOI 10.1016/j.bbrc.2010.11.002; Simamura E, 2011, CONGENIT ANOM, V51, P47, DOI 10.1111/j.1741-4520.2011.00316.x; Simamura E, 2010, ENDOCRINOLOGY, V151, P1853, DOI 10.1210/en.2009-0985; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; SKUTELSKY E, 1970, EXP CELL RES, V60, P427, DOI 10.1016/0014-4827(70)90536-7; SKUTELSKY E, 1967, J CELL BIOL, V33, P625, DOI 10.1083/jcb.33.3.625; Slominski A, 1996, J CLIN ENDOCR METAB, V81, P2746, DOI 10.1210/jc.81.7.2746; STAR RA, 1995, P NATL ACAD SCI USA, V92, P8016, DOI 10.1073/pnas.92.17.8016; TARBUTT RG, 1970, J EMBRYOL EXP MORPH, V24, P429; Ubukawa K, 2012, BLOOD, V119, P1036, DOI 10.1182/blood-2011-06-361907; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; van der Kraan M, 1998, ENDOCRINOLOGY, V139, P2348, DOI 10.1210/en.139.5.2348; Van Handel B, 2010, BLOOD, V116, P3321, DOI 10.1182/blood-2010-04-279489; Wang JX, 2012, J CELL SCI, V125, P340, DOI 10.1242/jcs.088286; Webb TR, 2009, ENDOCRINOLOGY, V150, P720, DOI 10.1210/en.2008-0941	59	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123232	10.1371/journal.pone.0123232	http://dx.doi.org/10.1371/journal.pone.0123232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860801	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300083
J	An, K; Elkassabany, NM; Liu, JB				An, Ke; Elkassabany, Nabil M.; Liu, Jiabin			Dexamethasone as Adjuvant to Bupivacaine Prolongs the Duration of Thermal Antinociception and Prevents Bupivacaine-Induced Rebound Hyperalgesia via Regional Mechanism in a Mouse Sciatic Nerve Block Model	PLOS ONE			English	Article							BRACHIAL-PLEXUS BLOCKADE; LOCAL-ANESTHETICS; WALLERIAN DEGENERATION; SCHWANN-CELLS; ROPIVACAINE; NEUROTOXICITY; INJURY; RAT; LIDOCAINE; ANALGESIA	Background Dexamethasone has been studied as an effective adjuvant to prolong the analgesia duration of local anesthetics in peripheral nerve block. However, the route of action for dexamethasone and its potential neurotoxicity are still unclear. Methods A mouse sciatic nerve block model was used. The sciatic nerve was injected with 60ul of combinations of various medications, including dexamethasone and/or bupivacaine. Neurobehavioral changes were observed for 2 days prior to injection, and then continuously for up to 7 days after injection. In addition, the sciatic nerves were harvested at either 2 days or 7 days after injection. Toluidine blue dyeing and immunohistochemistry test were performed to study the short-term and long-term histopathological changes of the sciatic nerves. There were six study groups: normal saline control, bupivacaine (10mg/kg) only, dexamethasone (0.5mg/kg) only, bupivacaine (10mg/kg) combined with low-dose (0.14mg/kg) dexamethasone, bupivacaine (10mg/kg) combined with high-dose (0.5mg/kg) dexamethasone, and bupivacaine (10mg/kg) combined with intramuscular dexamethasone (0.5mg/kg). Results High-dose perineural dexamethasone, but not systemic dexamethasone, combined with bupivacaine prolonged the duration of both sensory and motor block of mouse sciatic nerve. There was no significant difference on the onset time of the sciatic nerve block. There was "rebound hyperalgesia" to thermal stimulus after the resolution of plain bupivacaine sciatic nerve block. Interestingly, both low and high dose perineural dexamethasone prevented bupivacaine-induced hyperalgesia. There was an early phase of axon degeneration and Schwann cell response as represented by S-100 expression as well as the percentage of demyelinated axon and nucleus in the plain bupivacaine group compared with the bupivacaine plus dexamethasone groups on post-injection day 2, which resolved on post-injection day 7. Furthermore, we demonstrated that perineural dexamethasone, but not systemic dexamethasone, could prevent axon degeneration and demyelination. There was no significant caspase-dependent apoptosis process in the mouse sciatic nerve among all study groups during our study period. Conclusions Perineural, not systemic, dexamethasone added to a clinical concentration of bupivacaine may not only prolong the duration of sensory and motor blockade of sciatic nerve, but also prevent the bupivacaine-induced reversible neurotoxicity and short-term "rebound hyperalgesia" after the resolution of nerve block.	[An, Ke; Elkassabany, Nabil M.; Liu, Jiabin] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [An, Ke] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Sun Yat Sen University	Liu, JB (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	Jiabin.Liu@uphs.upenn.edu		LIU, JIABIN/0000-0002-1029-2786				Bailard NS, 2014, AM J HEALTH-SYST PH, V71, P373, DOI 10.2146/ajhp130336; Brummett CM, 2009, ANESTHESIOLOGY, V111, P1111, DOI 10.1097/ALN.0b013e3181bbcc26; Bulka CM, 2014, REGIONAL ANESTHESIA; Chang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089563; Clark RD, 2008, CURR TOP MED CHEM, V8, P813, DOI 10.2174/156802608784535011; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Cummings KC, 2011, BRIT J ANAESTH, V107, P446, DOI 10.1093/bja/aer159; Desmet M, 2013, BRIT J ANAESTHESIA; Drasner K, 2002, REGION ANESTH PAIN M, V27, P576, DOI 10.1053/rapm.2002.37410; Fredrickson MJ, 2013, REGION ANESTH PAIN M, V38, P300, DOI 10.1097/AAP.0b013e318292c121; Gordon SM, 2008, ANESTH ANALG, V106, P321, DOI 10.1213/01.ane.0000296474.79437.23; HARGREAVES KM, 1988, J BIOL CHEM, V263, P19392; Hulata D, 2008, J NEUROSCI METH, V172, P236, DOI 10.1016/j.jneumeth.2008.05.002; Janda A, 2013, REGION ANESTH PAIN M, V38, P151, DOI 10.1097/AAP.0b013e3182813aae; JOHANSSON A, 1990, ACTA ANAESTH SCAND, V34, P335, DOI 10.1111/j.1399-6576.1990.tb03097.x; Kawanishi R, 2014, LOCAL REG ANESTH, V7, P5, DOI 10.2147/LRA.S59158; Kidd GJ, 2013, HAND CLINIC, V115, P55, DOI 10.1016/B978-0-444-52902-2.00005-9; Kim HJ, 2014, KOREAN J PAIN, V27, P112, DOI 10.3344/kjp.2014.27.2.112; Kolarczyk LM, 2011, REGION ANESTH PAIN M, V36, P220, DOI 10.1097/AAP.0b013e3182176f5a; Kroin JS, 2010, REGION ANESTH PAIN M, V35, P343, DOI 10.1097/AAP.0b013e3181e82df0; Long TR, 2002, J CLIN ANESTH, V14, P546, DOI 10.1016/S0952-8180(02)00408-7; Makwana M, 2005, FEBS J, V272, P2628, DOI 10.1111/j.1742-4658.2005.04699.x; Martinez V, 2014, BRIT J ANAESTHESIA; MATA M, 1990, J NEUROCYTOL, V19, P432, DOI 10.1007/BF01188409; Merritt CK, 2014, BEST PRACT RES-CLIN, V28, P41, DOI 10.1016/j.bpa.2014.02.002; Movafegh A, 2006, ANESTH ANALG, V102, P263, DOI 10.1213/01.ane.0000189055.06729.0a; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; MYERS RR, 1986, ANESTHESIOLOGY, V64, P29, DOI 10.1097/00000542-198601000-00006; Parrington SJ, 2010, REGION ANESTH PAIN M, V35, P422, DOI 10.1097/AAP.0b013e3181e85eb9; Rahangdale R, 2014, ANESTH ANALG, V118, P1113, DOI 10.1213/ANE.0000000000000137; Cereda CMS, 2012, ANESTH ANALG, V115, P1234, DOI 10.1213/ANE.0b013e318266f3d9; Salzer James L, 2012, J Peripher Nerv Syst, V17 Suppl 3, P14, DOI 10.1111/j.1529-8027.2012.00425.x; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; SELANDER D, 1993, REGION ANESTH, V18, P461; Shishido H, 2002, SPINE, V27, P581, DOI 10.1097/00007632-200203150-00005; Tandoc MN, 2011, J ANESTH, V25, P704, DOI 10.1007/s00540-011-1180-x; Tang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091571, 10.1371/journal.pone.0073402]; Williams BA, 2007, REGION ANESTH PAIN M, V32, P186, DOI 10.1016/j.rapm.2006.10.011; Williams BA, 2012, INT ANESTHESIOL CLIN, V50, P126, DOI 10.1097/AIA.0b013e31821a00d0; Williams BA, 2011, REGION ANESTH PAIN M, V36, P225, DOI 10.1097/AAP.0b013e3182176f70; Zink W, 2008, CURR OPIN ANESTHESIO, V21, P645, DOI 10.1097/ACO.0b013e32830c214c	41	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123459	10.1371/journal.pone.0123459	http://dx.doi.org/10.1371/journal.pone.0123459			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856078	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500091
J	Ferreira, VH; Nazli, A; Dizzell, SE; Mueller, K; Kaushic, C				Ferreira, Victor H.; Nazli, Aisha; Dizzell, Sara E.; Mueller, Kristen; Kaushic, Charu			The Anti-Inflammatory Activity of Curcumin Protects the Genital Mucosal Epithelial Barrier from Disruption and Blocks Replication of HIV-1 and HSV-2	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; LONG TERMINAL REPEAT; TUMOR-NECROSIS-FACTOR; NEISSERIA-GONORRHOEAE; IMMUNE ACTIVATION; CELL-LINE; MICROBIAL TRANSLOCATION; GENE-EXPRESSION; FACTOR-ALPHA	Inflammation is a known mechanism that facilitates HIV acquisition and the spread of infection. In this study, we evaluated whether curcumin, a potent and safe anti-inflammatory compound, could be used to abrogate inflammatory processes that facilitate HIV-1 acquisition in the female genital tract (FGT) and contribute to HIV amplification. Primary, human genital epithelial cells (GECs) were pretreated with curcumin and exposed to HIV-1 or HIV glycoprotein 120 (gp120), both of which have been shown to disrupt epithelial tight junction proteins, including ZO-1 and occludin. Pre-treatment with curcumin prevented disruption of the mucosal barrier by maintaining ZO-1 and occludin expression and maintained trans-epithelial electric resistance across the genital epithelium. Curcumin pre-treatment also abrogated the gp120-mediated upregulation of the proinflammatory cytokines tumor necrosis factor-a and interleukin (IL)-6, which mediate barrier disruption, as well as the chemokines IL-8, RANTES and interferon gamma-induced protein-10 (IP-10), which are capable of recruiting HIV target cells to the FGT. GECs treated with curcumin and exposed to the sexually transmitted co-infecting microbes HSV-1, HSV-2 and Neisseria gonorrhoeae were unable to elicit innate inflammatory responses that indirectly induced activation of the HIV promoter and curcumin blocked Toll-like receptor (TLR)-mediated induction of HIV replication in chronically infected T-cells. Finally, curcumin treatment resulted in significantly decreased HIV-1 and HSV-2 replication in chronically infected T-cells and primary GECs, respectively. All together, our results suggest that the use of anti-inflammatory compounds such as curcumin may offer a viable alternative for the prevention and/or control of HIV replication in the FGT.	[Ferreira, Victor H.; Nazli, Aisha; Dizzell, Sara E.; Mueller, Kristen; Kaushic, Charu] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Ferreira, Victor H.; Nazli, Aisha; Dizzell, Sara E.; Mueller, Kristen; Kaushic, Charu] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada	McMaster University; McMaster University	Kaushic, C (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	kaushic@mcmaster.ca	Ferreira, Victor H/AAY-8861-2021	Ferreira, Victor H/0000-0002-1472-9711; Kaushic, Charu/0000-0002-7088-2569; Nazli, Aisha/0000-0001-7410-9963	Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR); Canadian Foundation for AIDS Research (CANFAR); CIHR New Investigator Award; OHTN	Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for AIDS Research (CANFAR); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); OHTN	This study was supported by operating grants from Ontario HIV Treatment Network (OHTN), Canadian Institutes of Health Research (CIHR) and Canadian Foundation for AIDS Research (CANFAR). CK was supported by a CIHR New Investigator Award and an Applied HIV Chair Award from OHTN. VHF received an OHTN Studentship Award and holds a Banting & Best CIHR Doctoral Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Barnabas RV, 2012, CURR HIV RES, V10, P228, DOI 10.2174/157016212800618156; Barthelemy S, 1998, RES VIROLOGY, V149, P43, DOI 10.1016/S0923-2516(97)86899-9; Basnet P, 2012, J PHARM SCI-US, V101, P598, DOI 10.1002/jps.22785; Berginc K, 2012, AAPS PHARMSCITECH, V13, P1045, DOI 10.1208/s12249-012-9837-9; Bourne KZ, 1999, ANTIVIR RES, V42, P219, DOI 10.1016/S0166-3542(99)00020-0; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; CHAN MMY, 1995, BIOCHEM PHARMACOL, V49, P1551, DOI 10.1016/0006-2952(95)00171-U; Chang CC, 2013, IMMUNOL REV, V254, P114, DOI 10.1111/imr.12063; Chen A, 2003, AIDS, V17, P625, DOI 10.1097/00002030-200303070-00019; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; DAHL TA, 1989, ARCH MICROBIOL, V151, P183, DOI 10.1007/BF00414437; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Di Santo R., 2005, Farmaco (Lausanne), V60, P409, DOI 10.1016/j.farmac.2005.03.008; Ferreira VH, 2011, J INFECT DIS, V204, P299, DOI 10.1093/infdis/jir260; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Gandapu U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023388; Gillgrass AE, 2005, J VIROL, V79, P3117, DOI 10.1128/JVI.79.5.3117-3126.2005; Gota VS, 2010, J AGR FOOD CHEM, V58, P2095, DOI 10.1021/jf9024807; Guo LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070565; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Gupta SC, 2011, NAT PROD REP, V28, P1937, DOI 10.1039/c1np00051a; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; James J S, 1996, AIDS Treat News, P1; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Jordan WC, 1996, J NATL MED ASSOC, V88, P333; Kaushic C, 2011, METHODS; Kaushic C, 2011, METHODS, V55, P114, DOI 10.1016/j.ymeth.2011.09.022; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Klotman ME, 2008, J IMMUNOL, V180, P6176, DOI 10.4049/jimmunol.180.9.6176; Kutluay SB, 2008, VIROLOGY, V373, P239, DOI 10.1016/j.virol.2007.11.028; Levine WC, 1998, J INFECT DIS, V177, P167, DOI 10.1086/513820; LI CJ, 1993, P NATL ACAD SCI USA, V90, P1839, DOI 10.1073/pnas.90.5.1839; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; MacDonald EM, 2007, BIOL REPROD, V77, P1049, DOI 10.1095/biolreprod.107.063933; MAZUMDER A, 1995, BIOCHEM PHARMACOL, V49, P1165, DOI 10.1016/0006-2952(95)98514-A; McClelland RS, 2002, AIDS, V16, P2425, DOI 10.1097/00002030-200212060-00007; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Moghadamtousi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186864; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Paiardini M, 2013, IMMUNOL REV, V254, P78, DOI 10.1111/imr.12079; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Qiu M, 2013, J VIROL, V87, P8675, DOI 10.1128/JVI.00869-13; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Riva DA, 2008, ARCH VIROL, V153, P561, DOI 10.1007/s00705-007-0023-4; Rotchford K, 2000, SEX TRANSM DIS, V27, P243, DOI 10.1097/00007435-200005000-00001; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; Sui Z, 1993, Bioorg Med Chem, V1, P415, DOI 10.1016/S0968-0896(00)82152-5; UNAIDS, 2011, WORLD REF DAY 2019 H; Vlietinck AJ, 1998, PLANTA MED, V64, P97, DOI 10.1055/s-2006-957384; Wessler S, 2005, BIOL CHEM, V386, P481, DOI 10.1515/BC.2005.057; WESTMORELAND D, 1976, J VIROL, V18, P92, DOI 10.1128/JVI.18.1.92-102.1976; Wira C. R, 2015, NAT REV IMMUNOL; Zandi K, 2010, NAT PROD COMMUN, V5, P1935; Zhang HS, 2011, J CELL PHYSIOL, V226, P3385, DOI 10.1002/jcp.22691; Zhang JZ, 2005, J IMMUNOL, V174, P7995, DOI 10.4049/jimmunol.174.12.7995	70	64	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124903	10.1371/journal.pone.0124903	http://dx.doi.org/10.1371/journal.pone.0124903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856395	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500123
J	Jue, NK; Brule, T; Coleman, FC; Koenig, CC				Jue, Nathaniel K.; Brule, Thierry; Coleman, Felicia C.; Koenig, Christopher C.			From Shelf to Shelf: Assessing Historical and Contemporary Genetic Differentiation and Connectivity across the Gulf of Mexico in Gag, Mycteroperca microlepis	PLOS ONE			English	Article							WEST FLORIDA SHELF; EFFECTIVE POPULATION-SIZE; SNAPPER LUTJANUS-CAMPECHANUS; MITOCHONDRIAL-DNA DIVERSITY; EPINEPHELUS-MORIO; UNITED-STATES; RED GROUPER; COMPARATIVE PHYLOGEOGRAPHY; UNSAMPLED POPULATIONS; MICROSATELLITE LOCI	Describing patterns of connectivity among populations of species with widespread distributions is particularly important in understanding the ecology and evolution of marine species. In this study, we examined patterns of population differentiation, migration, and historical population dynamics using microsatellite and mitochondrial loci to test whether populations of the epinephelid fish, Gag, Mycteroperca microlepis, an important fishery species, are genetically connected across the Gulf of Mexico and if so, whether that connectivity is attributable to either contemporary or historical processes. Populations of Gag on the Campeche Bank and the West Florida Shelf show significant, but low magnitude, differentiation. Time since divergence/expansion estimates associated with historical population dynamics indicate that any population or spatial expansions indicated by population genetics would have likely occurred in the late Pleistocene. Using coalescent-based approaches, we find that the best model for explaining observed spatial patterns of contemporary genetic variation is one of asymmetric gene flow, with movement from Campeche Bank to the West Florida Shelf. Both estimated migration rates and ecological data support the hypothesis that Gag populations throughout the Gulf of Mexico are connected via present day larval dispersal. Demonstrating this greatly expanded scale of connectivity for Gag highlights the influence of "ghost" populations (sensu Beerli) on genetic patterns and presents a critical consideration for both fisheries management and conservation of this and other species with similar genetic patterns.	[Jue, Nathaniel K.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32303 USA; [Brule, Thierry] CINVESTAV Merida, Merida 97310, Mexico; [Coleman, Felicia C.; Koenig, Christopher C.] Florida State Univ, Coastal & Marine Lab, St Teresa, FL 32358 USA	State University System of Florida; Florida State University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; State University System of Florida; Florida State University	Jue, NK (corresponding author), Florida State Univ, Dept Biol Sci, Tallahassee, FL 32303 USA.	n.jue@uconn.edu		Koenig, Christopher/0000-0002-2592-7975; Jue, Nathaniel/0000-0003-3769-5638	National Oceanic and Atmospheric Assocation National Marine Fisheries Service [NA04NMF4540213, NA07NMF4330120, NA17FF2876]; U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program; Disney National Wildlife Refuge Centennial Scholar program; Department of Biological Science at Florida State University	National Oceanic and Atmospheric Assocation National Marine Fisheries Service; U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program(United States Environmental Protection Agency); Disney National Wildlife Refuge Centennial Scholar program; Department of Biological Science at Florida State University	This research was supported by grants from the National Oceanic and Atmospheric Assocation National Marine Fisheries Service (Grant numbers: NA04NMF4540213, NA07NMF4330120, NA17FF2876), the U.S. Environmental Protection Agency's Science to Achieve Results (STAR) program, the Disney National Wildlife Refuge Centennial Scholar program, and small grants from the Department of Biological Science at Florida State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bagley MJ, 1999, MAR BIOL, V134, P609, DOI 10.1007/s002270050576; Ball AO, 2007, MAR BIOL, V150, P1321, DOI 10.1007/s00227-006-0425-y; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Beerli P., 2008, MIGRATE VERSION 3 0; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bilodeau AL, 2005, EVOLUTION, V59, P2125; Blanchon P, 2009, NATURE, V458, P881, DOI 10.1038/nature07933; BOWEN BW, 1990, MAR BIOL, V107, P371, DOI 10.1007/BF01313418; Buonaccorsi VP, 2001, MAR BIOL, V138, P37, DOI 10.1007/s002270000439; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Chapman RW, 1999, MAR BIOTECHNOL, V1, P137, DOI 10.1007/PL00011761; Coleman FC, 1996, ENVIRON BIOL FISH, V47, P129, DOI 10.1007/BF00005035; Coleman FC, 2011, PROF GEOGR, V63, P456, DOI 10.1080/00330124.2011.585076; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; Cornuet JM, 1996, GENETICS, V144, P2001; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cunningham C.W., 1994, Experientia Supplementum (Basel), V69, P405; Cushman EL, 2009, CAN J FISH AQUAT SCI, V66, P1821, DOI 10.1139/F09-140; Duvernell DD, 2008, MOL ECOL, V17, P1344, DOI 10.1111/j.1365-294X.2007.03648.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fauvelot C, 2002, MAR BIOL, V141, P773, DOI 10.1007/s00227-002-0869-7; Fitzhugh GR, 2005, B MAR SCI, V77, P377; Fu YX, 1997, GENETICS, V147, P915; Garber AF, 2004, MAR BIOTECHNOL, V6, P175, DOI 10.1007/s10126-003-0023-7; Gold JR, 1998, J HERED, V89, P404, DOI 10.1093/jhered/89.5.404; Gonzalez EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-252; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; HARPENDING HC, 1994, HUM BIOL, V66, P591; He RY, 2003, J PHYS OCEANOGR, V33, P465, DOI 10.1175/1520-0485(2003)033<0465:ALCICS>2.0.CO;2; Hetland RD, 1999, GEOPHYS RES LETT, V26, P2239, DOI 10.1029/1999GL900463; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Johnson DR, 2013, T AM FISH SOC, V142, P50, DOI 10.1080/00028487.2012.720630; Jue NK, 2006, J FISH BIOL, V69, P217, DOI 10.1111/j.1095-8649.2006.01273.x; Jue NK, 2014, MAR BIOL, V161, P1905, DOI 10.1007/s00227-014-2473-z; Karlsson S, 2009, MAR BIOL, V156, P1841, DOI 10.1007/s00227-009-1217-y; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KEENER P, 1988, B MAR SCI, V42, P376; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Knutsen H, 2011, MOL ECOL, V20, P768, DOI 10.1111/j.1365-294X.2010.04979.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Koenig CC, 1998, T AM FISH SOC, V127, P44, DOI 10.1577/1548-8659(1998)127<0044:AAASOJ>2.0.CO;2; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lee T, 2005, EVOLUTION, V59, P2139; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; Lombardi-Carlson L, 2008, FISH RES, V91, P239, DOI 10.1016/j.fishres.2007.12.001; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Matschiner M, 2009, MOL ECOL, V18, P2574, DOI 10.1111/j.1365-294X.2009.04220.x; McGovern JC, 2005, B MAR SCI, V76, P47; McGovern JC, 1998, FISH B-NOAA, V96, P797; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; McMillen-Jackson AL, 2003, MOL ECOL, V12, P2895, DOI 10.1046/j.1365-294X.2003.01955.x; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Mobley KB, 2010, J BIOGEOGR, V37, P1363, DOI 10.1111/j.1365-2699.2010.02288.x; Nadachowska K, 2009, MOL BIOL EVOL, V26, P829, DOI 10.1093/molbev/msp004; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pruett C, 2005, MAR BIOL, V147, P593, DOI 10.1007/s00227-005-1615-8; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rezak R., 1985, REEFS BANKS NW GULF; Richards VP, 2007, MOL ECOL, V16, P139, DOI 10.1111/j.1365-294X.2006.03145.x; Richardson LR, 1997, FISH B-NOAA, V95, P174; Rivera MAJ, 2003, MAR BIOTECHNOL, V5, P126, DOI 10.1007/s10126-002-0093-y; Rocha LA, 2007, CORAL REEFS, V26, P501, DOI 10.1007/s00338-007-0261-7; Rocha-Olivares A, 2000, J FISH BIOL, V57, P1134, DOI 10.1006/jfbi.2000.1379; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ryman N, 2006, MOL ECOL NOTES, V6, P285, DOI 10.1111/j.1471-8286.2005.01146.x; Ryman N, 2001, MOL ECOL, V10, P2361, DOI 10.1046/j.0962-1083.2001.01345.x; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Schneider S, 1999, GENETICS, V152, P1079; SEDAR, 2006, SEDAR SE DAT ASS REV; SEDAR, 2009, SEDAR SE DAT ASS REV; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; Switzer TS, 2012, T AM FISH SOC, V141, P707, DOI 10.1080/00028487.2012.675913; TAJIMA F, 1989, GENETICS, V123, P585; Theisen TC, 2008, MOL ECOL, V17, P4233, DOI 10.1111/j.1365-294X.2008.03913.x; van OosterHout C, 2003, MICROCHECKER 2 2 1; Walsh MR, 2006, ECOL LETT, V9, P142, DOI 10.1111/j.1461-0248.2005.00858.x; Waples RS, 2008, FISH FISH, V9, P423, DOI 10.1111/j.1467-2979.2008.00303.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; White TA, 2009, MOL ECOL, V18, P2563, DOI 10.1111/j.1365-294X.2009.04218.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zatcoff MS, 2004, MAR BIOL, V144, P769, DOI 10.1007/s00227-003-1236-z; Zatcoff MS, 2002, MOL ECOL NOTES, V2, P217, DOI 10.1046/j.1471-8286.2002.00194.x	90	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0120676	10.1371/journal.pone.0120676	http://dx.doi.org/10.1371/journal.pone.0120676			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856095	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500014
J	Liu, H; Wang, FX; Yang, XY				Liu, Hui; Wang, Fei-xue; Yang, Xiao-yang			More Dialectical Thinking, Less Creativity? The Relationship between Dialectical Thinking Style and Creative Personality: The Case of China	PLOS ONE			English	Article							INDIVIDUALISM-COLLECTIVISM; ARTISTIC CREATIVITY; CULTURAL INFLUENCES; MODEL; INTELLIGENCE	People use dialectical thinking to be holistic, reconcile contradictions, and emphasize changes when processing information and managing problems. Using a questionnaire survey, this study examined the relationship between dialectical thinking and creative personality in the Chinese culture, which encourages a holistic and collective thinking style. Undergraduates majoring in different subjects and adults in different professions were surveyed. The results showed that 1) compared with undergraduates majoring in art and adults from the design industry, undergraduates majoring in other disciplines significantly showed the least creative personality; 2) the highest score for dialectical thinking was found in the group of undergraduates who majored in other disciplines, followed by the adult group, and the undergraduates majoring in art had the lowest score; and 3) A negative relationship between dialectical thinking and creative personality was found mostly in the UMA group. The limitations of this study and suggestions for future research are discussed.	[Liu, Hui; Wang, Fei-xue; Yang, Xiao-yang] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yang, XY (corresponding author), Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China.	yxyang@mail.sysu.edu.cn			Chinese Ministry of Education [11YJC190031]; Fundamental Research Funds for the Central Universities [13wkpy39]; Sun Yat-Sen University [90026-3284000]	Chinese Ministry of Education(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Sun Yat-Sen University	This work was supported by the 2011 youth research fund of social sciences and humanities sponsored by Chinese Ministry of Education, Grant number: 11YJC190031; the Fundamental Research Funds for the Central Universities, Grant number: 13wkpy39; and the 985-3 Research Program of Sun Yat-Sen University, Grant number: 90026-3284000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alland Jr A, 1977, ARTISTIC ANIMAL INQU; AMABILE TM, 1979, J PERS SOC PSYCHOL, V37, P221, DOI 10.1037/0022-3514.37.2.221; AMABILE TM, 1983, J PERS SOC PSYCHOL, V45, P357, DOI 10.1037/0022-3514.45.2.357; [Anonymous], PSYCHOL SCI; ARLIN PK, 1976, INT J AGING HUM DEV, V7, P247, DOI 10.2190/2UNG-NGJN-HR24-YTEU; Arlin PK, 1998, CREATIVITY RES J, V11, P347, DOI 10.1207/s15326934crj1104_8; Arlin PK, 1989, ADULT DEV, V1, P197; Baer J, 2004, CREATIVITY RES J, V16, P113, DOI 10.1207/s15326934crj1601_11; BASSECHES M, 1980, HUM DEV, V23, P400, DOI 10.1159/000272600; Beghetto RA, 2011, PSYCHOL AESTHET CREA, V5, P342, DOI 10.1037/a0022834; Bontempo R., 1992, M AM AC MAN LAS VEG; Chiu C. Y., 2000, HONG KONG J SOCIAL S, V18, P33; Choi I, 2002, PERS SOC PSYCHOL B, V28, P1508, DOI 10.1177/014616702237578; Csikszentmihalyi M., 1996, CREATIVITY FLOW PSYC; Csikszentmihalyi M., 1999, HDB CREATIVITY, P313; Csikszentmihalyi M., 1988, NATURE CREATIVITY, P325; DAVIDSON AR, 1976, INT J PSYCHOL, V11, P1, DOI 10.1080/00207597608247343; DIEHL M, 1987, J PERS SOC PSYCHOL, V53, P497, DOI 10.1037/0022-3514.53.3.497; Dong Q, 1993, DEV CHILDRENS CREATI; Feist G J, 1998, Pers Soc Psychol Rev, V2, P290, DOI 10.1207/s15327957pspr0204_5; Feist G. J., 1999, HDB CREATIVITY, P273; Finke R.A., 1995, CREATIVE COGNITION A, P1; Friedman RS, 2001, J PERS SOC PSYCHOL, V81, P1001, DOI 10.1037/0022-3514.81.6.1001; Gino F, 2012, J PERS SOC PSYCHOL, V102, P445, DOI 10.1037/a0026406; Glover J. A., 1989, HDB CREATIVITY, P199, DOI DOI 10.1080/0729436890080102; Goncalo JA, 2006, ORGAN BEHAV HUM DEC, V100, P96, DOI 10.1016/j.obhdp.2005.11.003; Grierson E, 2011, EDUC PHILOS THEORY, V43, P336, DOI 10.1111/j.1469-5812.2009.00550.x; Guilford J. P, 1968, INTELLIGENCE CREATIV; GUILFORD JP, 1982, PSYCHOL REV, V89, P48, DOI 10.1037/0033-295X.89.1.48; Guo K., 2012, CHINA J HLTH PSYCHOL, V20, P1101, DOI [10.13342/j.cnki.cjhp.2012.07.034, DOI 10.13342/J.CNKI.CJHP.2012.07.034]; Hass RW, 2014, PSYCHOL AESTHET CREA, V8, P44, DOI 10.1037/a0035368; [侯玉波 Hou Yubo], 2002, [心理学报, Acta Psychologica Sinica], V34, P106; [Hu Weiping 胡卫平], 2004, [心理学报, Acta Psychologica Sinica], V36, P718; Huang J, 2012, INDIGENOUS PSYCHOL S, V38, P3; Kaufman JC, 2008, CREATIVITY RES J, V20, P171, DOI 10.1080/10400410802059929; KERSHNER JR, 1985, J PERS SOC PSYCHOL, V48, P1033, DOI 10.1037/0022-3514.48.4.1033; Liu J, 2011, THESIS FUJIAN NORMAL, P81; Maddux WW, 2009, J PERS SOC PSYCHOL, V96, P1047, DOI 10.1037/a0014861; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Mayer J, 2011, J PERS SOC PSYCHOL, V101, P1262, DOI 10.1037/a0024407; Miller Joan G., 1994, CROSS-CULT RES, V28, P3, DOI DOI 10.1177/106939719402800101; Nakamura J, 2001, AM PSYCHOL, V56, P337, DOI 10.1037/0003-066X.56.4.337; Necka E, 2006, INTERNATIONAL HANDBOOK OF CREATIVITY, P270; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Niu WH, 2001, INT J PSYCHOL, V36, P225, DOI 10.1080/00207590143000036; Paletz SBF, 2009, CREATIVITY RES J, V21, P139, DOI 10.1080/10400410902858683; Peng KP, 1999, AM PSYCHOL, V54, P741, DOI 10.1037/0003-066X.54.9.741; Qian MH, 2010, CREATIVITY RES J, V22, P62, DOI 10.1080/10400410903579585; Riegel K. F., 1973, HUM DEV, V18, P430, DOI [DOI 10.1159/000271287, 10.1159/000271287]; Rothenberg A, 1996, CREATIVITY RES J, V9, P207, DOI 10.1207/s15326934crj0902&3_8; Runco MA, 2004, ANNU REV PSYCHOL, V55, P657, DOI 10.1146/annurev.psych.55.090902.141502; Rutland M, 2009, DES TECHNOL ED AN IN, V14, P56; Schimmack U, 2002, COGNITION EMOTION, V16, P705, DOI 10.1080/02699930143000590; Simonton D. K., 1997, GENIUS CREATIVITY SE; Simonton D.K., 1994, GREATNESS WHO MAKES; Simonton D.K., 1984, GENIUS CREATIVITY LE; Simonton DK, 2014, PSYCHOL AESTHET CREA, V8, P53, DOI 10.1037/a0035367; Simonton DK, 2009, REV GEN PSYCHOL, V13, P315, DOI 10.1037/a0017141; SIMONTON DK, 1992, PERS SOC PSYCHOL B, V18, P452, DOI 10.1177/0146167292184009; Simonton DK, 2003, PSYCHOL BULL, V129, P475, DOI 10.1037/0033-2909.129.4.475; Simonton DK, 2000, AM PSYCHOL, V55, P151, DOI 10.1037/0003-066X.55.1.151; SIMONTON DK, 1991, J PERS SOC PSYCHOL, V60, P607, DOI 10.1037/0022-3514.60.4.607; Song H, 2012, THESIS ZHENGZHOU U, P56; Spencer-Rodgers J, 2004, PERS SOC PSYCHOL B, V30, P1416, DOI 10.1177/0146167204264243; Sternberg R. J., 1999, HDB CREATIVITY; Sternberg R.J., 1999, HDB CREAT, V1, P3; Sternberg RJ, 1996, AM PSYCHOL, V51, P677, DOI 10.1037/0003-066X.51.7.677; Tardiff TZ, 1998, NATURE CREATIVITY CO, P429; Treffinger D, 2002, ASSESSING CREATIVITY, P121; Triandis HC, 1996, AM PSYCHOL, V51, P407, DOI 10.1037/0003-066X.51.4.407; Wang F, 2006, SCI RES MON, V16, P114; Wang F, 2011, 9 BIENN C AS ASS SOC; Wang X, 2003, THESIS BEIJING NORMA; Wu C. H., 2005, INDIGENOUS PSYCHOL R, V24, P247, DOI DOI 10.6254/2005.24.247; Wu J, 2006, 2006 ANN AC C CHIN S, P348; Yang CL, 2008, 2008 FIRST IEEE INTERNATIONAL CONFERENCE ON UBI-MEDIA COMPUTING AND WORKSHOPS, PROCEEDINGS, P63, DOI 10.1109/UMEDIA.2008.4570867; Yang Z, 2012, THESIS 3 XIANGYA MED, P173; Yi XF, 2013, CREATIVITY RES J, V25, P97, DOI 10.1080/10400419.2013.752260; Zha P, 2006, CREATIVITY RES J, V18, P355, DOI 10.1207/s15326934crj1803_10; [张晓燕 Zhang Xiaoyan], 2011, [心理学报, Acta Psychologica Sinica], V43, P42; Zhou L, 2011, 2011 ANN C TAIW PSYC; Zou Z, 2003, J BEJING U TECHNOLOG, V2, P93	83	6	6	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122926	10.1371/journal.pone.0122926	http://dx.doi.org/10.1371/journal.pone.0122926			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856372	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500066
J	Mori, H; Kobara, H; Tsushimi, T; Nishiyama, N; Fujihara, S; Masaki, T				Mori, Hirohito; Kobara, Hideki; Tsushimi, Takaaki; Nishiyama, Noriko; Fujihara, Shintaro; Masaki, Tsutomu			Unavoidable Human Errors of Tumor Size Measurement during Specimen Attachment after Endoscopic Resection: A Clinical Prospective Study	PLOS ONE			English	Article							EARLY GASTRIC-CANCER; LYMPH-NODE METASTASIS; SUBMUCOSAL DISSECTION; RISK	Objective Objective evaluation of resected specimen and tumor size is critical because the tumor diameter after endoscopic submucosal dissection affects therapeutic strategies. In this study, we investigated whether the true tumor diameter of gastrointestinal cancer specimens measured by flexible endoscopy is subjective by testing whether the specimen is correctly attached to the specimen board after endoscopic submucosal dissection resection and whether the size differs depending on the endoscopist who attached the specimen. Methods Seventy-two patients diagnosed with early gastric cancer who satisfied the endoscopic submucosal dissection expanded-indication guideline were enrolled. Three endoscopists were randomly selected before every endoscopic submucosal dissection. Each endoscopist separately attached the same resected specimen, measured the maximum resection diameter and tumor size, and removed the lesion from the attachment board. Results The resected specimen diameters of the 3 endoscopists were 44.5 +/- 13.9 mm (95% Confidence Interval (CI): 23-67), 37.4 +/- 12.0 mm (95% CI: 18-60), and 41.1 +/- 13.3 mm (95% CI: 20-63) mm. Comparison among 3 groups (Kruskal Wallis H-test), there were significant differences (H = 6.397, P = 0.040), and recorded tumor sizes were 38.3 +/- 13.1 mm (95% CI: 16-67), 31.1 +/- 11.2 mm (95% CI: 12.5-53.3), and 34.8 +/- 12.8 (95% CI: 11.5-62.3) mm. Comparison among 3 groups, there were significant differences (H = 6.917, P = 0.031). Conclusions Human errors regarding the size of attached resected specimens are unavoidable, but it cannot be ignored because it affects the patient's additional treatment and/or surgical intervention. We must develop a more precise methodology to obtain accurate tumor size.	[Mori, Hirohito; Kobara, Hideki; Nishiyama, Noriko; Fujihara, Shintaro; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan; [Mori, Hirohito; Tsushimi, Takaaki] Ehime Rosai Hosp, Dept Surg Gastroenterol, Niihama, Japan	Kagawa University	Mori, H (corresponding author), Kagawa Univ, Dept Gastroenterol & Neurol, Takamatsu, Kagawa 760, Japan.	hiro4884@med.kagawa-u.ac.jp	Fujihara, Shintaro/AAW-6092-2021	Fujihara, Shintaro/0000-0002-1250-6012				Abe S, 2015, GASTRIC CANCER, V18, P188, DOI 10.1007/s10120-014-0341-7; Abe S, 2013, ENDOSCOPY, V45, P703, DOI 10.1055/s-0033-1344396; Arber DA, 2002, APPL IMMUNOHISTO M M, V10, P183, DOI 10.1097/00022744-200206000-00015; Bourne R, 2013, MAGN RESON MED, V70, P1160, DOI 10.1002/mrm.24549; Chen R, 2014, CHINESE MED J-PEKING, V127, P560, DOI 10.3760/cma.j.issn.0366-6999.20123235; Coda S, 2009, ENDOSCOPY, V41, P421, DOI 10.1055/s-0029-1214642; Gotoda Takuji, 2000, Gastric Cancer, V3, P219, DOI 10.1007/PL00011720; Iizuka H, 2010, DIGEST ENDOSC, V22, P282, DOI 10.1111/j.1443-1661.2010.01008.x; Kim JY, 2013, HUM PATHOL, V44, P2829, DOI 10.1016/j.humpath.2013.07.037; Lee HH, 2013, ANN SURG ONCOL, V20, P3534, DOI 10.1245/s10434-013-3124-1; Mori H, 2012, ENDOSCOPY, V44, P641, DOI 10.1055/s-0032-1309815; Mori H, 2012, J GASTROEN HEPATOL, V27, P81, DOI 10.1111/j.1440-1746.2011.06833.x; Odagaki T, 2013, WORLD J GASTROENTERO, V19, P3157, DOI 10.3748/wjg.v19.i20.3157; Ono H, 2001, GUT, V48, P225, DOI 10.1136/gut.48.2.225; Park WY, 2013, HUM PATHOL, V44, P2132, DOI 10.1016/j.humpath.2013.04.006; Shin JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085205; Sugimoto M, 2012, DIAGN THER ENDOSC; Toyonaga T, 2013, SURG ENDOSC, V27, P1000, DOI 10.1007/s00464-012-2555-2	18	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121798	10.1371/journal.pone.0121798	http://dx.doi.org/10.1371/journal.pone.0121798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856397	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500025
J	Otto, S; Mensel, B; Friedrich, N; Schafer, S; Mahlke, C; von Bernstorff, W; Bock, K; Hosten, N; Kuhn, JP				Otto, Stephan; Mensel, Birger; Friedrich, Nele; Schaefer, Sophia; Mahlke, Christoph; von Bernstorff, Wolfram; Bock, Karen; Hosten, Norbert; Kuehn, Jens-Peter			Predictors of Technical Success and Rate of Complications of Image-Guided Percutaneous Transthoracic Lung Needle Biopsy of Pulmonary Tumors	PLOS ONE			English	Article							ASPIRATION BIOPSY; RISK-FACTORS; DIAGNOSTIC-ACCURACY; CT; PNEUMOTHORAX	Purpose To investigate predictors of technical success and complications of computed tomography (CT)-guided percutaneous transthoracic needle biopsy of potentially malignant pulmonary tumors. Material and Methods From 2008 to 2009, technical success and rate of complications of CT-guided percutaneous transthoracic lung needle biopsies of patients with suspicious pulmonary tumors were retrospectively evaluated. The influence on technical success and rate of complications was assessed for intervention-related predictors (lesion diameter, length of biopsy pathway, number of pleural transgressions, and needle size) and patient-related predictors (age, gender, reduced lung function). In addition, technical success and rate of complications were compared between different interventional radiologists. Results One hundred thirty-eight patients underwent biopsies by 15 interventional radiologists. The overall technical success rate was 84.1% and was significantly different between interventional radiologists (range 25%-100%; p<0.01). Intervention-related and patient-related predictors did not influence the technical success rate. The overall complication rate was 59.4% with 39.1% minor complications and 21.0% major complications. The rate of complications was influenced by lesion diameter and distance of biopsy pathway. Interventional radiologist-related rates of complications were not statistically different. Conclusions Technical success of percutaneous, transthoracic lung needle biopsies of pulmonary tumors is probably dependent on the interventional radiologist. In addition, lesion diameter and length of biopsy pathway are predictors of the rate of complications.	[Otto, Stephan; Mensel, Birger; Schaefer, Sophia; Mahlke, Christoph; Bock, Karen; Hosten, Norbert; Kuehn, Jens-Peter] Univ Med Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Friedrich, Nele] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [von Bernstorff, Wolfram] Univ Med Greifswald, Dept Surg, Div Gen Visceral Thorac & Vasc Surg, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School	Kuhn, JP (corresponding author), Univ Med Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany.	kuehn@uni-greifswald.de						Asai N, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-196; Choi CM, 2004, CHEST, V126, P1516, DOI 10.1378/chest.126.5.1516; Chojniak R, COMPUT TOMOGR, DOI [10.1148/radiol.11103506, DOI 10.1148/RADIOL.11103506]; Chojniak Rubens, 2006, Sao Paulo Med. J., V124, P10, DOI 10.1590/S1516-31802006000100003; Collings CL, 1999, RADIOLOGY, V210, P59, DOI 10.1148/radiology.210.1.r99ja1759; Cox JE, 1999, RADIOLOGY, V212, P165, DOI 10.1148/radiology.212.1.r99jl33165; Guimaraes MD, 2013, CLIN RADIOL, V68, pE353, DOI 10.1016/j.crad.2013.02.002; Guimaraes MD, 2014, CLINICS, V69, P335, DOI 10.6061/clinics/2014(05)07; Guimaraes MD, 2011, EUR J RADIOL, V80, pE488, DOI 10.1016/j.ejrad.2010.09.038; Guimaraes MD, 2009, CLINICS, V64, P1139, DOI 10.1590/S1807-59322009001200002; Herth FJF, 2006, RESPIRATION, V73, P399, DOI 10.1159/000093369; Kazerooni EA, 1996, RADIOLOGY, V198, P371, DOI 10.1148/radiology.198.2.8596834; Klein JS, 1996, RADIOLOGY, V198, P715, DOI 10.1148/radiology.198.3.8628859; Li HQ, 1996, AM J ROENTGENOL, V167, P105, DOI 10.2214/ajr.167.1.8659351; Loh SE, 2013, ANN ACAD MED SINGAP, V42, P285; Montaudon M, 2004, EUR RADIOL, V14, P1234, DOI 10.1007/s00330-004-2250-3; Saji H, 2002, CHEST, V121, P1521, DOI 10.1378/chest.121.5.1521; SINNER WN, 1980, FORTSCHR RONTG NEUEN, V132, P363, DOI 10.1055/s-2008-1056580; Tsukada H, 2000, AM J ROENTGENOL, V175, P239, DOI 10.2214/ajr.175.1.1750239; WESTCOTT JL, 1988, RADIOLOGY, V169, P593, DOI 10.1148/radiology.169.3.3055026; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003; Winn N, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-53; Wu CC, 2011, AM J ROENTGENOL, V196, pW678, DOI 10.2214/AJR.10.4659; Yasufuku K, 2006, CHEST, V130, P710, DOI 10.1378/chest.130.3.710; Yeow KM, 2004, CHEST, V126, P748, DOI 10.1378/chest.126.3.748; Yeow KM, 2001, J VASC INTERV RADIOL, V12, P1305, DOI 10.1016/S1051-0443(07)61556-5; Yildirim E, 2009, EUR J RADIOL, V70, P57, DOI 10.1016/j.ejrad.2008.01.006; Yu Liao Shin, 2002, Rev. Hosp. Clin., V57, P15, DOI 10.1590/S0041-87812002000100003	28	20	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124947	10.1371/journal.pone.0124947	http://dx.doi.org/10.1371/journal.pone.0124947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855983	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500125
J	Fladseth, K; Gafos, M; Newell, ML; McGrath, N				Fladseth, Kristin; Gafos, Mitzy; Newell, Marie Louise; McGrath, Nuala			The Impact of Gender Norms on Condom Use among HIV-Positive Adults in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							SEXUAL RISK BEHAVIOR; CAPE-TOWN; ANTIRETROVIRAL TREATMENT; WOMEN; INFECTION; PREVENTION; POWER; MEN; PERSPECTIVES; DISCLOSURE	Critical to preventing the spread of HIV is promoting condom use among HIV-positive individuals. Previous studies suggest that gender norms (social and cultural constructions of the ways that women and men are expected to behave) may be an important determinant of condom use. However, the relationship has not been evaluated among HIV-positive women and men in South Africa. We examined gender norms and condom use at last sex among 550 partnerships reported by 530 sexually-active HIV-positive women (372) and men (158) who had sought care, but not yet initiated antiretroviral therapy in a high HIV-prevalence rural setting in KwaZulu-Natal, South Africa between January 2009 and March 2011. Participants enrolled in the cohort study completed a baseline questionnaire that detailed their socio-demographic characteristics, socio-economic circumstances, religion, HIV testing history and disclosure of HIV status, stigma, social capital, gender norms and self-efficacy. Gender norms did not statistically differ between women and men (p = 0.18). Overall, condoms were used at last sex in 58% of partnerships. Although participants disclosed their HIV status in 66% of the partnerships, 60% did not have knowledge of their partner's HIV status. In multivariable logistic regression, run separately for each sex, women younger than 26 years with more equitable gender norms were significantly more likely to have used a condom at last sex than those of the same age group with inequitable gender norms (OR = 8.88, 95% CI 2.95-26.75); the association between condom use and gender norms among women aged 26+ years and men of all ages was not statistically significant. Strategies to address gender inequity should be integrated into positive prevention interventions, particularly for younger women, and supported by efforts at a societal level to decrease gender inequality.	[Fladseth, Kristin] London Sch Hyg & Trop Med, London WC1, England; [Gafos, Mitzy] UCL, Med Res Council Clin Trials Unit, London, England; [Newell, Marie Louise; McGrath, Nuala] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Newell, Marie Louise; McGrath, Nuala] Univ Southampton, Fac Med & Social & Human Sci, Southampton, Hants, England	University of London; London School of Hygiene & Tropical Medicine; Medical Research Council Clinical Trials Unit; University of London; University College London; University of Kwazulu Natal; University of Southampton	McGrath, N (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa.	N.McGrath@soton.ac.uk	Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; McGrath, Nuala/0000-0002-1039-0159; Gafos, Mitzy/0000-0002-7894-1498	Wellcome Trust [WT083495MA, 065377/Z01/H]; Medical Research Council [MC_UU_12023/23] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NM was supported by a Wellcome Trust (http://www.wellcome.ac.uk/) fellowship grant (#WT083495MA); the Africa Centre receives core support from the Wellcome Trust (#065377/Z01/H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach JD, 2011, GLOB PUBLIC HEALTH, V6, pS293, DOI 10.1080/17441692.2011.594451; Chimbindi Natsayi Z, 2010, Open AIDS J, V4, P88, DOI 10.2174/1874613601004010088; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cutrona C.E., 1987, ADV PERSONAL RELATIO, V1, P37; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Eisele TP, 2008, AIDS BEHAV, V12, P570, DOI 10.1007/s10461-007-9279-7; Eisele TP, 2009, AIDS BEHAV, V13, P1097, DOI 10.1007/s10461-008-9473-2; Gafos M, 2010, HOW MANY WOMEN REALL, P22; Gilbert C, 2008, PROCEEDINGS OF MICRO; Hallman, 2004, SOCIOECONOMIC DISADV; Houlihan CF, 2010, INTJ EPIDEMIOL; Hunter M, 2005, CULT HEALTH SEX, V7, P209, DOI 10.1080/13691050412331293458; Hunter Mark., 2010, LOVE TIME AIDS INEQU; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Johnson LF, 2012, S AFR J HIV MED, P22; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; Kalichman SC, 2010, EUR J PUBLIC HEALTH, V20, P202, DOI 10.1093/eurpub/ckp127; Kiene SM, 2006, AIDS, V20, P1781, DOI 10.1097/01.aids.0000242827.05120.55; Langen Tabitha T, 2005, Afr Health Sci, V5, P188; Lurie M, 2008, JAIDS-J ACQ IMM DEF, V47, P484, DOI 10.1097/QAI.0b013e3181648de8; MacPhail C, 2009, CULT HEALTH SEX, V11, P485, DOI 10.1080/13691050902803537; Maharaj P, 2004, STUD FAMILY PLANN, V35, P116, DOI 10.1111/j.1728-4465.2004.00013.x; Mantell JE, 2011, HEALTH EDUC RES, V26, P859, DOI 10.1093/her/cyr041; Mantell JE, 2009, CULT HEALTH SEX, V11, P139, DOI 10.1080/13691050802521155; McGrath N, 2013, AIDS; McGrath N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18048; McGrath N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-121; Mugoya GC, 2013, AIDS CARE; Nattrass N, 2008, FEM ECON, V14, P19, DOI 10.1080/13545700802266452; Ncube N, 2010, INT J LEARNING, V16, P489; Noar SM, 2006, ARCH SEX BEHAV, V35, P327, DOI 10.1007/s10508-006-9028-4; O'Sullivan LF, 2006, CULT HEALTH SEX, V8, P99, DOI 10.1080/13691050600665048; Olley BO, 2005, AIDS CARE, V17, P550, DOI 10.1080/09540120412331319741; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Pettifor A, 2012, CULT HEALTH SEX, V14, P477, DOI 10.1080/13691058.2012.667575; Pool R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011632; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; Sayles JN, 2008, AIDS BEHAV, V12, P748, DOI 10.1007/s10461-008-9375-3; Shisana O, 2010, SOUTH AFRICAN NATION; Simbayi LC, 2007, SEX TRANSM INFECT, V83, P29, DOI 10.1136/sti.2006.019893; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; South African National AIDS Commission (SANAC), 2012, GLOB AIDS RESP PROGR; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Susser I, 2009, AIDS SEX AND CULTURE; The South African Department of Health, 2013, THE SOUTH AFRICAN AN; Varga C.A., 1997, HLTH TRANSITION R S3, V7, P45; Venkatesh KK, 2012, AIDS BEHAV, V16, P139, DOI 10.1007/s10461-011-9941-y; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; Wechsberg WM, 2010, J PREV INTERV COMMUN, V38, P132, DOI 10.1080/10852351003640799; Wong LH, 2009, JAIDS-J ACQ IMM DEF, V50, P215, DOI 10.1097/QAI.0b013e3181900172; Younge SN, 2008, ADOLESCENCE, V43, P927; Zaidi J, 2013, AIDS	55	28	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122671	10.1371/journal.pone.0122671	http://dx.doi.org/10.1371/journal.pone.0122671			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853870	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000352478400075
J	Foulkes, L; Bird, G; Gokcen, E; McCrory, E; Viding, E				Foulkes, Lucy; Bird, Geoffrey; Gokcen, Elif; McCrory, Eamon; Viding, Essi			Common and Distinct Impacts of Autistic Traits and Alexithymia on Social Reward	PLOS ONE			English	Article							SPECTRUM DISORDERS; CHILDREN; ADOLESCENTS; DEPRESSION; INDIVIDUALS; RECOGNITION; IMPAIRMENTS; LONELINESS; FRIENDSHIP; REPUTATION	According to the social motivation hypothesis of autism, individuals with high levels of autistic traits experience reduced levels of reward from social interactions. However, empirical evidence to date has been mixed, with some studies reporting lower levels of social reward in individuals with Autism Spectrum Disorder (ASD), and others finding no difference when compared to typically developing controls. Alexithymia, a subclinical condition associated with the reduced ability to identify and describe one's own emotions, has been found to account for other affective difficulties observed inconsistently in individuals with ASD. The current study used a nonclinical sample (N = 472) to explore the associations between autistic traits and the value of six types of social reward, as measured by the Social Reward Questionnaire. In addition, we measured alexithymia to assess if this accounted for associations between autistic traits and social reward. There were three main findings. Firstly, higher levels of autistic traits were associated with significantly less enjoyment of admiration and sociability, and adding alexithymia to these models did not account for any additional variance. Secondly, both autistic traits and alexithymia were uniquely associated with reduced levels of enjoyment of prosocial interactions and sexual relationships. Thirdly, autistic traits were associated with higher levels of enjoyment of passivity and negative social potency, but these associations were no longer significant once alexithymia was taken into account, suggesting that co-occurring alexithymia accounted for these apparent associations. Overall, the current findings provide a novel and more nuanced picture of the relationship between autistic traits and social reward.	[Foulkes, Lucy; Gokcen, Elif; McCrory, Eamon; Viding, Essi] UCL, Dept Clin Educ & Hlth Psychol, London, England; [Bird, Geoffrey] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, London, England; [Bird, Geoffrey] UCL, Inst Cognit Neurosci, London, England	University of London; University College London; University of London; King's College London; University of London; University College London	Foulkes, L (corresponding author), UCL, Dept Clin Educ & Hlth Psychol, London, England.	l.foulkes.11@ucl.ac.uk	Bird, Geoff/AAA-3652-2020	Viding, Essi/0000-0001-8468-8874; Bird, Geoffrey/0000-0002-2310-0202	UK Medical Research Council [MR/J500422/1]; Medical Research Council [1066249] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Four-Year PhD studentship in Mental Health from the UK Medical Research Council (MR/J500422/1) awarded to LF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Berthoz S, 1999, EUR PSYCHIAT, V14, P372, DOI 10.1016/S0924-9338(99)00233-3; Berthoz S., 2011, OXFORD HDB SOCIAL NE, P906, DOI DOI 10.1093/OXFORDHB/9780195342161.013.0060; Berthoz S, 2013, PSYCHIAT RES, V208, P257, DOI 10.1016/j.psychres.2013.05.014; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Blanchard JJ, 2001, J ABNORM PSYCHOL, V110, P363, DOI 10.1037//0021-843X.110.3.363; BOURKE MP, 1992, BRIT J PSYCHIAT, V161, P240, DOI 10.1192/bjp.161.2.240; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cage E, 2013, AUTISM RES, V6, P433, DOI 10.1002/aur.1313; Calder L, 2013, AUTISM, V17, P296, DOI 10.1177/1362361312467866; Chevallier C, 2012, J AUTISM DEV DISORD, V42, P1504, DOI 10.1007/s10803-011-1364-0; Chevallier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031107; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Cook R, 2013, PSYCHOL SCI, V24, P723, DOI 10.1177/0956797612463582; Cremers HR, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00439; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Deckers A, 2014, RES AUTISM SPECT DIS, V8, P449, DOI 10.1016/j.rasd.2013.12.019; Delmonte S, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-7; Dewinter J, 2013, J CLIN NURS, V22, P3467, DOI 10.1111/jocn.12397; Ewing L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079493; FeldmanHall O, 2013, CORTEX, V49, P899, DOI 10.1016/j.cortex.2012.10.015; Filipek PA, 1999, J AUTISM DEV DISORD, V29, P439, DOI 10.1023/A:1021943802493; Foulkes L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00201; Foulkes L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106000; Frewen PA, 2008, J TRAUMA STRESS, V21, P243, DOI 10.1002/jts.20320; Frith U, 2005, CURR BIOL, V15, pR786, DOI 10.1016/j.cub.2005.09.033; Gougeon NA, 2010, AM J SEX EDUC, V5, P328, DOI 10.1080/15546128.2010.527237; Grynberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042429; Grynberg D, 2010, PERS INDIV DIFFER, V49, P845, DOI 10.1016/j.paid.2010.07.013; Happe F, 2008, NEUROPSYCHOL REV, V18, P287, DOI 10.1007/s11065-008-9076-8; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; Humphrey N, 2011, AUTISM, V15, P397, DOI 10.1177/1362361310387804; Humphreys TP, 2009, PERS INDIV DIFFER, V46, P43, DOI 10.1016/j.paid.2008.09.002; Izuma K, 2011, P NATL ACAD SCI USA, V108, P17302, DOI 10.1073/pnas.1107038108; Jameel L, 2014, J AUTISM DEV DISORD, V44, P1846, DOI 10.1007/s10803-014-2056-3; Jobe LE, 2007, PERS INDIV DIFFER, V42, P1479, DOI 10.1016/j.paid.2006.10.021; Kohls G, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-10; Krach S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00022; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Machin GC, 2009, PERS INDIV DIFFER, V46, P412, DOI 10.1016/j.paid.2008.11.010; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Orsmond GI, 2004, J AUTISM DEV DISORD, V34, P245, DOI 10.1023/B:JADD.0000029547.96610.df; Pankert A, 2014, J NEURAL TRANSM, V121, P1199, DOI 10.1007/s00702-014-1210-6; PARKER JDA, 1993, PSYCHOTHER PSYCHOSOM, V59, P197, DOI 10.1159/000288664; PRINCE JD, 1993, J RES PERS, V27, P15, DOI 10.1006/jrpe.1993.1002; Richey JA, 2014, SOC COGN AFFECT NEUR, V9, P367, DOI 10.1093/scan/nss146; Robinson EB, 2012, BEHAV GENET, V42, P245, DOI 10.1007/s10519-011-9500-3; Scimeca G, 2013, ARCH SEX BEHAV, V42, P117, DOI 10.1007/s10508-012-0006-8; Scott-Van Zeeland AA, 2010, AUTISM RES, V3, P53, DOI 10.1002/aur.122; Stavropoulos KKM, 2014, J CHILD PSYCHOL PSYC, V55, P1398, DOI 10.1111/jcpp.12270; Stewart ME, 2006, AUTISM, V10, P103, DOI 10.1177/1362361306062013; Taylor GJ, 2000, CAN J PSYCHIAT, V45, P134, DOI 10.1177/070674370004500203; Travers J, 2010, EDUC TRAIN AUTISM DE, V45, P284; Wheelwright S, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-10; White SW, 2009, CLIN PSYCHOL REV, V29, P216, DOI 10.1016/j.cpr.2009.01.003; Whitehouse AJO, 2009, J ADOLESCENCE, V32, P309, DOI 10.1016/j.adolescence.2008.03.004; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288	63	28	28	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121018	10.1371/journal.pone.0121018	http://dx.doi.org/10.1371/journal.pone.0121018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853670	Green Published, gold			2022-12-27	WOS:000352478400026
J	He, W; Pedersen, SC; Gupta, AK; Simmons, JA; Muller, R				He, Weikai; Pedersen, Scott C.; Gupta, Anupam K.; Simmons, James A.; Mueller, Rolf			Lancet Dynamics in Greater Horseshoe Bats, Rhinolophus ferrumequinum	PLOS ONE			English	Article							FORAGING BEHAVIOR; ACOUSTIC FOVEA; ECHOLOCATION; CHIROPTERA; WIDTH	Echolocating greater horseshoe bats (Rhinolophus ferrumequinum) emit their biosonar pulses nasally, through nostrils surrounded by fleshy appendages ('noseleaves') that diffract the outgoing ultrasonic waves. Movements of one noseleaf part, the lancet, were measured in live bats using two synchronized high speed video cameras with 3D stereo reconstruction, and synchronized with pulse emissions recorded by an ultrasonic microphone. During individual broadcasts, the lancet briefly flicks forward (flexion) and is then restored to its original position. This forward motion lasts tens of milliseconds and increases the curvature of the affected noseleaf surfaces. Approximately 90% of the maximum displacements occurred within the duration of individual pulses, with 70% occurring towards the end. Similar lancet motions were not observed between individual pulses in a sequence of broadcasts. Velocities of the lancet motion were too small to induce Doppler shifts of a biologically-meaningful magnitude, but the maximum displacements were significant in comparison with the overall size of the lancet and the ultrasonic wavelengths. Three finite element models were made from micro-CT scans of the noseleaf post mortem to investigate the acoustic effects of lancet displacement. The broadcast beam shapes were found to be altered substantially by the observed small lancet movements. These findings demonstrate that-in addition to the previously described motions of the anterior leaf and the pinna-horseshoe bat biosonar has a third degree of freedom for fast changes that can happen on the time scale of the emitted pulses or the returning echoes and could provide a dynamic mechanism for the encoding of sensory information.	[He, Weikai; Mueller, Rolf] Shandong Univ, Sch Phys, SDU VT Int Lab, Jinan, Shandong, Peoples R China; [Pedersen, Scott C.] S Dakota State Univ, Dept Biol Microbiol, Brookings, SD 57007 USA; [Gupta, Anupam K.; Mueller, Rolf] Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA; [Simmons, James A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Shandong University; South Dakota State University; Virginia Polytechnic Institute & State University; Brown University	Muller, R (corresponding author), Virginia Tech, Dept Mech Engn, Blacksburg, VA 24061 USA.	rolf.mueller@vt.edu			National Natural Science Foundation of China [451069]; NSF [1053130]; Ministry of Education of the People's Republic of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF(National Science Foundation (NSF)); Ministry of Education of the People's Republic of China(Ministry of Education, China)	Funding provided by National Natural Science Foundation of China, http://www.nsfc.gov.cn, grant number: 451069, RM, NSF, http://www.nsf.gov, award id 1053130, RM and Ministry of Education of the People's Republic of China, http://www.moe.gov.cn, RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulagnier S, 2008, IUCN RED LIST THREAT; Bradski G., 2008, LEARNING OPENCV COMP; BRUNS V, 1980, HEARING RES, V3, P27, DOI 10.1016/0378-5955(80)90006-4; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034685; Gao L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.214301; HARTLEY DJ, 1988, J ACOUST SOC AM, V84, P1201, DOI 10.1121/1.396621; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; JONES G, 1989, BEHAV ECOL SOCIOBIOL, V25, P183, DOI 10.1007/BF00302917; Matsuta N, 2013, J EXP BIOL, V216, P1210, DOI 10.1242/jeb.081398; NEUWEILER G, 1987, BEHAV ECOL SOCIOBIOL, V20, P53, DOI 10.1007/BF00292166; SCHNEIDER H, 1960, Z VERGL PHYSIOL, V44, P1, DOI 10.1007/BF00297861; SCHNITZLER HU, 1977, J COMP PHYSIOL, V116, P51, DOI 10.1007/BF00605516; SCHNITZLER HU, 1973, J COMP PHYSIOL, V82, P79, DOI 10.1007/BF00714171; SCHNITZLER HU, 1983, ADV VERTEBRATE NEURO, P801, DOI DOI 10.1007/978-1-4684-4412-4_39; SCHULLER G, 1979, J COMP PHYSIOL, V132, P47, DOI 10.1007/BF00617731; Siemers BM, 2004, BEHAV ECOL SOCIOBIOL, V56, P464, DOI 10.1007/s00265-004-0807-4; Vanderelst D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00191; Vanderelst D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011893; Weinbeer M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1337, DOI 10.1007/s00265-007-0364-8; Zhuang Q, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218701; Zhuang Q, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051902	21	20	21	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121700	10.1371/journal.pone.0121700	http://dx.doi.org/10.1371/journal.pone.0121700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853738	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400045
J	Das, L; Vinayak, M				Das, Laxmidhar; Vinayak, Manjula			Long Term Effect of Curcumin in Restoration of Tumour Suppressor p53 and Phase-II Antioxidant Enzymes via Activation of Nrf2 Signalling and Modulation of Inflammation in Prevention of Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GLUTATHIONE-S-TRANSFERASE; NITRIC-OXIDE SYNTHASE; TGF-BETA; NAD(P)H-QUINONE OXIDOREDUCTASE-1; NRF2-MEDIATED ANTIOXIDANT; SULFHYDRYL-GROUPS; IN-VIVO; EXPRESSION; INDUCTION	Inhibition of carcinogenesis may be a consequence of attenuation of oxidative stress via activation of antioxidant defence system, restoration and stabilization of tumour suppressor proteins along with modulation of inflammatory mediators. Previously we have delineated significant role of curcumin during its long term effect in regulation of glycolytic pathway and angiogenesis, which in turn results in prevention of cancer via modulation of stress activated genes. Present study was designed to investigate long term effect of curcumin in regulation of Nrf2 mediated phase-II antioxidant enzymes, tumour suppressor p53 and inflammation under oxidative tumour microenvironment in liver of T-cell lymphoma bearing mice. Inhibition of Nrf2 signalling observed during lymphoma progression, resulted in down regulation of phase-II antioxidant enzymes, p53 as well as activation of inflammatory signals. Curcumin potentiated significant increase in Nrf2 activation. It restored activity of phase-II antioxidant enzymes like GST, GR, NQO1, and tumour suppressor p53 level. In addition, curcumin modulated inflammation via upregulation of TGF-beta and reciprocal regulation of iNOS and COX2. The study suggests that during long term effect, curcumin leads to prevention of cancer by inducing phase-II antioxidant enzymes via activation of Nrf2 signalling, restoration of tumour suppressor p53 and modulation of inflammatory mediators like iNOS and COX2 in liver of lymphoma bearing mice.	[Das, Laxmidhar; Vinayak, Manjula] Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Ctr Adv Study, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Vinayak, M (corresponding author), Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Ctr Adv Study, Varanasi 221005, Uttar Pradesh, India.	manjulavinayak@rediffmail.com			Department of Science and Technology, Government of India [SR/S0/AS-97/2007]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The work was supported by grants from the Department of Science and Technology (Grant No.-SR/S0/AS-97/2007), Government of India to MV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Andorfer JH, 2004, CARCINOGENESIS, V25, P359, DOI 10.1093/carcin/bgh023; Are C, 2010, HPB, V12, P498, DOI 10.1111/j.1477-2574.2010.00219.x; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; Churchman AT, 2009, J CELL MOL MED, V13, P2282, DOI 10.1111/j.1582-4934.2009.00874.x; Cianchi F., 2005, CURR ENZYM INHIB, V1, P97, DOI [10.2174/1573408054022207, DOI 10.2174/1573408054022207]; Clark DA, 1998, INT J BIOCHEM CELL B, V30, P293, DOI 10.1016/S1357-2725(97)00128-3; Das L, 2014, LEUKEMIA LYMPHOMA, V55, P2627, DOI 10.3109/10428194.2014.889824; Das L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099583; Das L, 2014, INT IMMUNOPHARMACOL, V20, P141, DOI 10.1016/j.intimp.2014.02.024; Das L, 2012, BIOSCIENCE REP, V32, P161, DOI 10.1042/BSR20110043; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Elston R, 2012, CROSSTALK P53 TGF BE, P1; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; GOLDIE H, 1951, CANCER RES, V11, P73; Gundala SR, 2013, CARCINOGENESIS, V34, P2039, DOI 10.1093/carcin/bgt141; Hahm KB, 2002, ALIMENT PHARM THERAP, V16, P115, DOI 10.1046/j.1365-2036.16.s2.3.x; Han C, 2004, J BIOL CHEM, V279, P44344, DOI 10.1074/jbc.M404852200; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hirst DG, 2007, FRONT BIOSCI-LANDMRK, V12, P3406, DOI 10.2741/2322; Hou WC, 2004, ELECTROPHORESIS, V25, P2926, DOI 10.1002/elps.200406041; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; JONES DA, 1993, J BIOL CHEM, V268, P9049; Kalo E, 2012, J CELL SCI, V125, P5578, DOI 10.1242/jcs.106815; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; Landi S, 2000, MUTAT RES-REV MUTAT, V463, P247, DOI 10.1016/S1383-5742(00)00050-8; Lechner M, 2005, SEMIN CANCER BIOL, V15, P277, DOI 10.1016/j.semcancer.2005.04.004; Li WG, 2008, BIOCHEM PHARMACOL, V76, P1485, DOI 10.1016/j.bcp.2008.07.017; Lim SC, 2007, YONSEI MED J, V48, P495, DOI 10.3349/ymj.2007.48.3.495; Lohm S, 2005, CLIN EXP METASTAS, V22, P341, DOI 10.1007/s10585-005-0431-3; Mani H, 2002, BIOFACTORS, V16, P29, DOI 10.1002/biof.5520160104; Mantovani A, 2005, NATURE, V435, P752, DOI 10.1038/435752a; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; Michaeloudes C, 2011, AM J RESP CRIT CARE, V184, P894, DOI 10.1164/rccm.201011-1780OC; Na HK, 2008, FOOD CHEM TOXICOL, V46, P1271, DOI 10.1016/j.fct.2007.10.006; O'Connor JC, 2008, INVEST OPHTH VIS SCI, V49, P4237, DOI 10.1167/iovs.08-1963; Perez JL, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-51; Reisman D, 1998, SEMIN CANCER BIOL, V8, P317, DOI 10.1006/scbi.1998.0094; RICCI G, 1984, ANAL BIOCHEM, V143, P226, DOI 10.1016/0003-2697(84)90657-2; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sebestyen A, 2005, CYTOKINE, V30, P228, DOI 10.1016/j.cyto.2005.01.013; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shin J-W, 2011, CANC PREVENTION RE S, V4, pB67; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Sonveaux P, 2009, EUR J CANCER, V45, P1352, DOI 10.1016/j.ejca.2008.12.018; Takai E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076346; Tandoan B., 2006, FABAD J PHARM SCI, V31, P230; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Tsvetkov P, 2005, P NATL ACAD SCI USA, V102, P5535, DOI 10.1073/pnas.0501828102; Uotila P, 2001, UROL RES, V29, P25, DOI 10.1007/s002400000148; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang HM, 2000, CANCER RES, V60, P5862; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Wrobel RL, 2002, PLANT PHYSIOL BIOCH, V40, P265, DOI 10.1016/S0981-9428(02)01361-X; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zhu H, 2008, EXP BIOL MED, V233, P463, DOI 10.3181/0711-RM-304	62	72	76	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124000	10.1371/journal.pone.0124000	http://dx.doi.org/10.1371/journal.pone.0124000			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860911	gold, Green Submitted, Green Published			2022-12-27	WOS:000352590300127
J	Gutjahr, C; Siegler, H; Haga, K; Iino, M; Paszkowski, U				Gutjahr, Caroline; Siegler, Heike; Haga, Ken; Iino, Moritoshi; Paszkowski, Uta			Full Establishment of Arbuscular Mycorrhizal Symbiosis in Rice Occurs Independently of Enzymatic Jasmonate Biosynthesis	PLOS ONE			English	Article							ALLENE-OXIDE-CYCLASE; PLANT DEFENSE; ACID; COLONIZATION; PHYTOCHROME; PATHWAY; ROOTS; IDENTIFICATION; SALICYLATE; INDUCTION	Development of the mutualistic arbuscular mycorrhiza (AM) symbiosis between most land plants and fungi of the Glomeromycota is regulated by phytohormones. The role of jasmonate (JA) in AM colonization has been investigated in the dicotyledons Medicago truncatula, tomato and Nicotiana attenuata and contradicting results have been obtained with respect to a neutral, promotive or inhibitory effect of JA on AM colonization. Furthermore, it is currently unknown whether JA plays a role in AM colonization of monocotyledonous roots. Therefore we examined whether JA biosynthesis is required for AM colonization of the monocot rice. To this end we employed the rice mutant constitutive photomorphogenesis 2 (cpm2), which is deficient in JA biosynthesis. Through a time course experiment the amount and morphology of fungal colonization did not differ between wild-type and cpm2 roots. Furthermore, no significant difference in the expression of AM marker genes was detected between wild type and cpm2. However, treatment of wild-type roots with 50 mu M JA lead to a decrease of AM colonization and this was correlated with induction of the defense gene PR4. These results indicate that JA is not required for AM colonization of rice but high levels of JA in the roots suppress AM development likely through the induction of defense.	[Gutjahr, Caroline; Siegler, Heike; Paszkowski, Uta] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland; [Gutjahr, Caroline] Univ Munich LMU, Inst Genet, Bioctr Martinsried, Martinsried, Germany; [Haga, Ken; Iino, Moritoshi] Osaka City Univ, Grad Sch Sci, Bot Gardens, Katano, Osaka, Japan	University of Lausanne; University of Munich; Osaka Metropolitan University	Gutjahr, C (corresponding author), Univ Lausanne, Dept Plant Mol Biol, Biophore Bldg, Lausanne, Switzerland.	caroline.gutjahr@lmu.de	Gutjahr, Caroline/H-8390-2013	Gutjahr, Caroline/0000-0001-6163-745X; Paszkowski, Uta/0000-0002-7279-7632	German National Merit Foundation; Roche Foundation (Switzerland); SNF 'professeur boursier' [PP00A-110874, PP00P3-130704]	German National Merit Foundation; Roche Foundation (Switzerland); SNF 'professeur boursier'	CG was supported by a PhD fellowship of the German National Merit Foundation (Studienstiftung des Deutschen Volkes); http://www.studienstiftung.de/ and the Roche Foundation (Switzerland). Research in the UP laboratory was supported by the SNF 'professeur boursier' grants PP00A-110874 and PP00P3-130704; http://www.snf.ch/en/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Carbonnel S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00462; Fernandez I, 2014, J CHEM ECOL, V40, P791, DOI 10.1007/s10886-014-0473-6; Foo E, 2013, ANN BOT-LONDON, V111, P769, DOI 10.1093/aob/mct041; Guimil S, 2005, P NATL ACAD SCI USA, V102, P8066, DOI 10.1073/pnas.0502999102; Gutjahr C, 2014, CURR OPIN PLANT BIOL, V20, P26, DOI 10.1016/j.pbi.2014.04.003; Gutjahr C, 2013, ANNU REV CELL DEV BI, V29, P593, DOI 10.1146/annurev-cellbio-101512-122413; Gutjahr C, 2009, MOL PLANT MICROBE IN, V22, P763, DOI 10.1094/MPMI-22-7-0763; Gutjahr C, 2008, PLANT CELL, V20, P2989, DOI 10.1105/tpc.108.062414; Haga K, 2004, PLANT CELL PHYSIOL, V45, P119, DOI 10.1093/pcp/pch025; Hause B, 2002, PLANT PHYSIOL, V130, P1213, DOI 10.1104/pp.006007; Hause B, 2007, PHYTOCHEMISTRY, V68, P101, DOI 10.1016/j.phytochem.2006.09.025; Hause B, 2009, PHYTOCHEMISTRY, V70, P1589, DOI 10.1016/j.phytochem.2009.07.003; Isayenkov S, 2005, PLANT PHYSIOL, V139, P1401, DOI 10.1104/pp.105.069054; Isayenkov S, 2004, J PLANT PHYSIOL, V161, P1379, DOI 10.1016/j.jplph.2004.04.012; Javot H, 2007, PLANT CELL ENVIRON, V30, P310, DOI 10.1111/j.1365-3040.2006.01617.x; Herrera-Medina MJ, 2008, J PLANT GROWTH REGUL, V27, P221, DOI 10.1007/s00344-008-9049-4; Landgraf R, 2012, PLANT CELL ENVIRON, V35, P1344, DOI 10.1111/j.1365-3040.2012.02495.x; Moreno JE, 2009, P NATL ACAD SCI USA, V106, P4935, DOI 10.1073/pnas.0900701106; Nadal M, 2013, CURR OPIN PLANT BIOL, V16, P473, DOI 10.1016/j.pbi.2013.06.005; Nahar K, 2011, PLANT PHYSIOL, V157, P305, DOI 10.1104/pp.111.177576; Nordstrom KJV, 2013, NAT BIOTECHNOL, V31, P325, DOI 10.1038/nbt.2515; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Riedel T, 2008, PLANT CELL ENVIRON, V31, P1203, DOI 10.1111/j.1365-3040.2008.01827.x; Riemann M, 2003, PLANT PHYSIOL, V133, P1820, DOI 10.1104/pp.103.027490; Riemann M, 2013, PLANT J, V74, P226, DOI 10.1111/tpj.12115; Robson F, 2010, PLANT CELL, V22, P1143, DOI 10.1105/tpc.109.067728; Sawers RJH, 2008, TRENDS PLANT SCI, V13, P93, DOI 10.1016/j.tplants.2007.11.006; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sun JH, 2006, PLANT J, V46, P961, DOI 10.1111/j.1365-313X.2006.02751.x; Suzuki A, 2011, P NATL ACAD SCI USA, V108, P16837, DOI 10.1073/pnas.1105892108; Tejeda-Sartorius M, 2008, PHYSIOL PLANTARUM, V133, P339, DOI 10.1111/j.1399-3054.2008.01081.x; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Yang SY, 2012, PLANT CELL, V24, P4236, DOI 10.1105/tpc.112.104901; Zhou GX, 2009, PLANT J, V60, P638, DOI 10.1111/j.1365-313X.2009.03988.x	39	28	29	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123422	10.1371/journal.pone.0123422	http://dx.doi.org/10.1371/journal.pone.0123422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860838	gold, Green Submitted, Green Published			2022-12-27	WOS:000352590300098
J	Hansell, NK; Halford, GS; Andrews, G; Shum, DHK; Harris, SE; Davies, G; Franic, S; Christoforou, A; Zietsch, B; Painter, J; Medland, SE; Ehli, EA; Davies, GE; Steen, VM; Lundervold, AJ; Reinvang, I; Montgomery, GW; Espeseth, T; Pol, HEH; Starr, JM; Martin, NG; Le Hellard, S; Boomsma, DI; Deary, IJ; Wright, MJ				Hansell, Narelle K.; Halford, Graeme S.; Andrews, Glenda; Shum, David H. K.; Harris, Sarah E.; Davies, Gail; Franic, Sanja; Christoforou, Andrea; Zietsch, Brendan; Painter, Jodie; Medland, Sarah E.; Ehli, Erik A.; Davies, Gareth E.; Steen, Vidar M.; Lundervold, Astri J.; Reinvang, Ivar; Montgomery, Grant W.; Espeseth, Thomas; Pol, Hilleke E. Hulshoff; Starr, John M.; Martin, Nicholas G.; Le Hellard, Stephanie; Boomsma, Dorret I.; Deary, Ian J.; Wright, Margaret J.			Genetic Basis of a Cognitive Complexity Metric	PLOS ONE			English	Article							NETHERLANDS TWIN REGISTER; TRANSITIVE INFERENCE; PREFRONTAL CORTEX; WORKING-MEMORY; ENVIRONMENTAL-INFLUENCES; RELATIONAL INTEGRATION; HIPPOCAMPAL; CAPACITY; ASSOCIATION; ABILITIES	Relational complexity (RC) is a metric reflecting capacity limitation in relational processing. It plays a crucial role in higher cognitive processes and is an endophenotype for several disorders. However, the genetic underpinnings of complex relational processing have not been investigated. Using the classical twin model, we estimated the heritability of RC and genetic overlap with intelligence (IQ), reasoning, and working memory in a twin and sibling sample aged 15-29 years (N = 787). Further, in an exploratory search for genetic loci contributing to RC, we examined associated genetic markers and genes in our Discovery sample and selected loci for replication in four independent samples (ALSPAC, LBC1936, NTR, NCNG), followed by meta-analysis (N> 6500) at the single marker level. Twin modelling showed RC is highly heritable (67%), has considerable genetic overlap with IQ (59%), and is a major component of genetic covariation between reasoning and working memory (72%). At the molecular level, we found preliminary support for four single-marker loci (one in the gene DGKB), and at a gene-based level for the NPS gene, having influence on cognition. These results indicate that genetic sources influencing relational processing are a key component of the genetic architecture of broader cognitive abilities. Further, they suggest a genetic cascade, whereby genetic factors influencing capacity limitation in relational processing have a flow-on effect to more complex cognitive traits, including reasoning and working memory, and ultimately, IQ.	[Hansell, Narelle K.; Wright, Margaret J.] QIMR Berghofer Med Res Inst, Neuroimaging Genet, Brisbane, Qld, Australia; [Halford, Graeme S.; Andrews, Glenda; Shum, David H. K.] Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4111, Australia; [Halford, Graeme S.; Andrews, Glenda; Shum, David H. K.] Griffith Univ, Behav Basis Hlth Program, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Andrews, Glenda] Griffith Univ, Sch Appl Psychol, Southport, Qld 4215, Australia; [Harris, Sarah E.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Harris, Sarah E.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Davies, Gail; Starr, John M.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Franic, Sanja; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Christoforou, Andrea; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, KG Jebsen Ctr Psychosis Res, Bergen, Norway; [Christoforou, Andrea; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Dept Clin Sci, Norwegian Ctr Mental Disorders Res NORMENT, Bergen, Norway; [Christoforou, Andrea; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Ctr Med Genet & Mol Med, Dr Einar Martens Res Grp Biol Psychiat, N-5021 Bergen, Norway; [Zietsch, Brendan; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Brisbane, Qld, Australia; [Zietsch, Brendan] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Painter, Jodie] QIMR Berghofer Med Res Inst, Mol Genet Epidemiol, Brisbane, Qld, Australia; [Medland, Sarah E.] QIMR Berghofer Med Res Inst, Quantitat Genet, Brisbane, Qld, Australia; [Ehli, Erik A.; Davies, Gareth E.] Avera McKennan Hosp, Avera Inst Human Genet, Sioux Falls, SD USA; [Ehli, Erik A.; Davies, Gareth E.] Univ Hlth Ctr, Sioux Falls, SD USA; [Lundervold, Astri J.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway; [Lundervold, Astri J.] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Lundervold, Astri J.] Haraldsplass Deaconess Hosp, Ctr Res Aging & Dementia, Bergen, Norway; [Reinvang, Ivar; Espeseth, Thomas] Univ Oslo, Dept Psychol, Oslo, Norway; [Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Mol Epidemiol, Brisbane, Qld, Australia; [Espeseth, Thomas] Oslo Univ Hosp, Norwegian Ctr Mental Disorders Res NORMENT, N-0450 Oslo, Norway; [Espeseth, Thomas] Oslo Univ Hosp, KG Jebsen Ctr Psychosis Res, Div Mental Hlth & Addict, N-0450 Oslo, Norway; [Pol, Hilleke E. Hulshoff] Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland	QIMR Berghofer Medical Research Institute; Griffith University; Griffith University; Menzies Health Institute Queensland; Griffith University; University of Edinburgh; University of Edinburgh; University of Edinburgh; Vrije Universiteit Amsterdam; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; QIMR Berghofer Medical Research Institute; University of Queensland; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Bergen; University of Bergen; University of Oslo; QIMR Berghofer Medical Research Institute; University of Oslo; University of Oslo; Utrecht University; Utrecht University Medical Center; University of Edinburgh	Hansell, NK (corresponding author), QIMR Berghofer Med Res Inst, Neuroimaging Genet, Brisbane, Qld, Australia.	Narelle.Hansell@qimrberghofer.edu.au	Hansell, Narelle K/A-4553-2016; Zietsch, Brendan/F-7497-2016; Deary, Ian J/C-6297-2009; Medland, Sarah/AAT-7595-2020; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Shum, David/A-3914-2008; Martin, Nicholas/R-9235-2019; Boomsma, Dorret I/AAX-4470-2020; Medland, Sarah E/C-7630-2013; Wright, Margaret Jane/A-4560-2016; Painter, Jodie N/AAC-6332-2019; Montgomery, Grant W/B-7148-2008; Lundervold, Astri/AAH-9796-2021; Andrews, Glenda/H-5665-2012	Hansell, Narelle K/0000-0002-8229-9741; Zietsch, Brendan/0000-0003-0274-6140; Deary, Ian J/0000-0002-1733-263X; Medland, Sarah/0000-0003-1382-380X; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Shum, David/0000-0002-4810-9262; Martin, Nicholas/0000-0003-4069-8020; Medland, Sarah E/0000-0003-1382-380X; Wright, Margaret Jane/0000-0001-7133-4970; Painter, Jodie N/0000-0002-4992-2458; Montgomery, Grant W/0000-0002-4140-8139; Lundervold, Astri/0000-0002-6819-6164; Le Hellard, Stephanie/0000-0002-8085-051X; Halford, Graeme/0000-0003-0711-0061; Andrews, Glenda/0000-0001-8047-9151	Australian Discovery Sample: Australian Research Council [DP1093900]; Griffith Medical Research Council Project Grant; National Health and Medical Research Institute [389891]; Replication Samples (i) the Scottish [LBC1936]; Age UK; Biotechnology and Biological Sciences Research Council [BB/F019394/1]; National Institutes of Health [RC2 MH089951, 1RC2 MH089995]; Research Council of Norway (FUGE grants) [151904, 183327]; Psykisk Helse grant [175345]; RCN [154313/V50, 177458/V50]; Helse Sorost RHF [2012086]; Helse Vest RHF [911397, 911687]; Dr Einar Martens Fund; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0700704] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C514623/1] Funding Source: researchfish; Medical Research Council [MC_PC_15018, G0700704, MR/K026992/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081802, U24MH068457, RC2MH089951, RC2MH089995] Funding Source: NIH RePORTER	Australian Discovery Sample: Australian Research Council(Australian Research Council); Griffith Medical Research Council Project Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Institute; Replication Samples (i) the Scottish; Age UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway (FUGE grants)(Research Council of Norway); Psykisk Helse grant; RCN; Helse Sorost RHF; Helse Vest RHF; Dr Einar Martens Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Australian Discovery Sample: Australian Research Council, www.arc.gov.au/, (DP1093900 to NGM MJW GSH DHKS, GA); Griffith Medical Research Council Project Grant, www.griffith.edu.au/, (to GSH NGM DHKS MJW GA); National Health and Medical Research Institute, www.nhmrc.gov.au/, (Medical Bioinformatics Genomics Proteomics Program, 389891, to NGM); Replication Samples (i) the Scottish LBC1936 (IJD SEH GD JMS); Age UK, www.ageuk.org.uk/,(The Disconnected Mind project) - supported phenotype collection; Biotechnology and Biological Sciences Research Council, www.bbsrc.com/, (BB/F019394/1) - funded genotyping; work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (MR/K026992/1); Medical Research Council, www.mrc.ac.uk/, (ii) the Dutch NTR Sample (DIB HEHP EAE GED SF): European Research Council, erc.europa.eu/, (ERC 230374); The Netherlands Organization for Scientific Research, www.nwo.nl/; Neuroscience Campus Amsterdam, www.neurosciencecampus-amsterdam.nl/; and genotyping support from Rutgers University Cell and DNA Repository, www.rucdr.org/, (NIMH U24 MH06845706); Avera Institute, www.avera.org/; National Institutes of Health, www.nih.gov/, (NIH R01 HD042157-01A1, MH081802, Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995), Genetic Association Information Network of the Foundation for the National Institutes of Health, (iii) the Norwegian NCNG Sample (SLH AC TE VMS IR AJL): Bergen Research Foundation, www.bfstiftelse.no/; University of Bergen, www.uib.no/; Research Council of Norway, www.forskningsradet.no/, (including FUGE grant numbers 151904 and 183327, Psykisk Helse grant number 175345, RCN grants 154313/V50 to IR and 177458/V50 to TE), Helse Sorost RHF, www.helse-sorost.no/om-oss/, (2012086 to TE); Helse Vest RHF, www.helse-vest. no/, (911397, 911687 to AJL); and Dr Einar Martens Fund, (iv) the English ALSPAC Sample (contributed data only, analysed by NKH): The UK Medical Research Council, www.mrc.ac.uk/; Wellcome Trust, www.wellcome.ac.uk/, (092731); and the University of Bristol, www.bris.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G, 2002, COGNITIVE PSYCHOL, V45, P153, DOI 10.1016/S0010-0285(02)00002-6; Andrews G, 2006, MEM COGNITION, V34, P1325, DOI 10.3758/BF03193275; Andrews G, 2014, J COGN PSYCHOL, V26, P588, DOI 10.1080/20445911.2014.909434; Andrews G, 2013, BRAIN COGNITION, V81, P44, DOI 10.1016/j.bandc.2012.09.003; Andrews G, 2010, MEM COGNITION, V38, P928, DOI 10.3758/MC.38.7.928; Armstrong K, 2012, SCHIZOPHRENIA BULL, V38, P622, DOI 10.1093/schbul/sbq145; Astur RS, 2004, BEHAV NEUROSCI, V118, P667, DOI 10.1037/0735-7044.118.4.667; Bartels M, 2007, TWIN RES HUM GENET, V10, P3, DOI 10.1375/twin.10.1.3; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Bergen SE, 2007, TWIN RES HUM GENET, V10, P423, DOI 10.1375/twin.10.3.423; Birney D. P., 2002, Thinking & Reasoning, V8, P109, DOI 10.1080/13546780143000161; Birney DP, 2012, EUR J PSYCHOL ASSESS, V28, P216, DOI 10.1027/1015-5759/a000146; Birney DP, 2006, EDUC PSYCHOL MEAS, V66, P146, DOI 10.1177/0013164405278570; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bunch KM, 2007, COGNITIVE DEV, V22, P376, DOI 10.1016/j.cogdev.2007.01.004; Bunch KM, 2012, DEV NEUROPSYCHOL, V37, P134, DOI 10.1080/87565641.2011.632457; Casey BJ, 2010, J AM ACAD CHILD PSY, V49, P1189, DOI 10.1016/j.jaac.2010.08.017; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cholerton B, 2013, EUR J PHARMACOL, V719, P170, DOI 10.1016/j.ejphar.2013.08.008; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Christoforou A, 2014, GENES BRAIN BEHAV, V13, P663, DOI 10.1111/gbb.12152; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Cocchi L, 2014, CEREB CORTEX, V24, P2283, DOI 10.1093/cercor/bht075; Coleman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1187, DOI 10.1093/schbul/sbp039; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Dumontheil I, 2008, DEV MED CHILD NEUROL, V50, P168, DOI 10.1111/j.1469-8749.2008.02026.x; Ersland KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031687; Espeseth T, 2012, TWIN RES HUM GENET, V15, P442, DOI 10.1017/thg.2012.8; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Finkel D, 1998, DEV PSYCHOL, V34, P1400, DOI 10.1037/0012-1649.34.6.1400; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Gamo NJ, 2011, BEHAV NEUROSCI, V125, P282, DOI 10.1037/a0023165; Hermo XG, 2014, PSICOTHEMA, V26, P1, DOI 10.7334/psicothema2012.210; Halford GS, 2007, TRENDS COGN SCI, V11, P236, DOI 10.1016/j.tics.2007.04.001; Halford GS, 2010, TRENDS COGN SCI, V14, P497, DOI 10.1016/j.tics.2010.08.005; Halford GS, 2004, THINK REASONING, V10, P123, DOI 10.1080/13546780442000033; Halford GS, 1998, BEHAV BRAIN SCI, V21, P803, DOI 10.1017/S0140525X98001769; Halford GS, 2005, PSYCHOL SCI, V16, P70, DOI 10.1111/j.0956-7976.2005.00782.x; Halford GS, 2006, HDB CHILD PSYCHOL, V2; Halford GS, CATEGORIZIN IN PRESS; Halford GS, REASONING M IN PRESS; Haworth CMA, 2010, MOL PSYCHIATR, V15, P1112, DOI 10.1038/mp.2009.55; Hellard S, 2014, SCAND J PSYCHOL, V55, P255, DOI 10.1111/sjop.12112; Hozumi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-99; Ingelsson E, 2010, DIABETES, V59, P1266, DOI [10.2337/DB09-1568, 10.2337/db09-1568]; Jackson D. N., 1998, MULTIDIMENSIONAL APT; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kitamura T, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-13; Koike S, 2013, J PSYCHIATR RES, V47, P1240, DOI 10.1016/j.jpsychires.2013.05.009; Krawczyk DC, 2011, CORTEX, V47, P588, DOI 10.1016/j.cortex.2010.04.008; Lennertz L, 2012, INT J NEUROPSYCHOPH, V15, P1205, DOI 10.1017/S1461145711001623; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Luciano M, 2001, BEHAV GENET, V31, P581, DOI 10.1023/A:1013397428612; McArdle JJ, 2009, BEHAV GENET, V39, P472, DOI 10.1007/s10519-009-9272-1; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; McGue M, 2013, BEHAV GENET, V43, P363, DOI 10.1007/s10519-013-9606-x; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Neale MC, 1992, METHODOLOGY GENETIC; Okamura N, 2011, NEUROPSYCHOPHARMACOL, V36, P744, DOI 10.1038/npp.2010.207; Paz-Alonso PM, 2013, SCHIZOPHR RES, V147, P320, DOI 10.1016/j.schres.2013.04.007; Plomin R, 2013, PSYCHOL SCI, V24, P562, DOI 10.1177/0956797612457952; Posthuma D, 2000, BEHAV GENET, V30, P147, DOI 10.1023/A:1001959306025; Ragland JD, 2012, SCHIZOPHRENIA BULL, V38, P114, DOI 10.1093/schbul/sbr146; Ranganath C, 2008, BIOL PSYCHIAT, V64, P18, DOI 10.1016/j.biopsych.2008.04.011; Reynolds CA, 2005, DEV PSYCHOL, V41, P3, DOI 10.1037/0012-1649.41.1.3; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Shirai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011602; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Tucker-Drob EM, 2014, PSYCHOL BULL, V140, P949, DOI 10.1037/a0035893; Tucker-Drob EM, 2013, CURR DIR PSYCHOL SCI, V22, P349, DOI 10.1177/0963721413485087; Waltz JA, 2004, NEUROPSYCHOLOGY, V18, P296, DOI 10.1037/0894-4105.18.2.296; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wechsler D., 1997, WECHSLER ADULT INTEL; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yurgelun-Todd D, 2007, CURR OPIN NEUROBIOL, V17, P251, DOI 10.1016/j.conb.2007.03.009; Zielinski TA, 2010, EUR J COGN PSYCHOL, V22, P391, DOI 10.1080/09541440902830509	84	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123886	10.1371/journal.pone.0123886	http://dx.doi.org/10.1371/journal.pone.0123886			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25860228	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300120
J	Peixoto, RB; Machado-Silva, F; Marotta, H; Enrich-Prast, A; Bastviken, D				Peixoto, Roberta B.; Machado-Silva, Fausto; Marotta, Humberto; Enrich-Prast, Alex; Bastviken, David			Spatial versus Day-To-Day Within-Lake Variability in Tropical Floodplain Lake CH4 Emissions - Developing Optimized Approaches to Representative Flux Measurements	PLOS ONE			English	Article							METHANE EMISSIONS; CARBON-DIOXIDE; WETLANDS; RELEASE	Inland waters (lakes, rivers and reservoirs) are now understood to contribute large amounts of methane (CH4) to the atmosphere. However, fluxes are poorly constrained and there is a need for improved knowledge on spatiotemporal variability and on ways of optimizing sampling efforts to yield representative emission estimates for different types of aquatic ecosystems. Low-latitude floodplain lakes and wetlands are among the most high-emitting environments, and here we provide a detailed investigation of spatial and day-to-day variability in a shallow floodplain lake in the Pantanal in Brazil over a five-day period. CH4 flux was dominated by frequent and ubiquitous ebullition. A strong but predictable spatial variability (decreasing flux with increasing distance to the shore or to littoral vegetation) was found, and this pattern can be addressed by sampling along transects from the shore to the center. Although no distinct day-to-day variability were found, a significant increase in flux was identified from measurement day 1 to measurement day 5, which was likely attributable to a simultaneous increase in temperature. Our study demonstrates that representative emission assessments requires consideration of spatial variability, but also that spatial variability patterns are predictable for lakes of this type and may therefore be addressed through limited sampling efforts if designed properly (e.g., fewer chambers may be used if organized along transects). Such optimized assessments of spatial variability are beneficial by allowing more of the available sampling resources to focus on assessing temporal variability, thereby improving overall flux assessments.	[Peixoto, Roberta B.; Machado-Silva, Fausto; Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Dept Ecol, Biogeochem Lab, BR-68020 Rio De Janeiro, Brazil; [Marotta, Humberto] Univ Fed Fluminense, Sedimentary & Environm Proc Lab LAPSA UFF, Dept Geog, Inst Geosci, Niteroi, RJ, Brazil; [Enrich-Prast, Alex; Bastviken, David] Linkoping Univ, Dept Themat Studies Environm Change, S-58183 Linkoping, Sweden	Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Linkoping University	Peixoto, RB (corresponding author), Univ Fed Rio de Janeiro, Dept Ecol, Biogeochem Lab, BR-68020 Rio De Janeiro, Brazil.	bbpeixoto34@hotmail.com	Marotta, Humberto/F-9554-2012; Peixoto, Roberta B/P-6303-2017; Prast, Alex Enrich/AAL-4722-2021; Enrich-Prast, Alex/H-5391-2012	Marotta, Humberto/0000-0002-2828-6595; Peixoto, Roberta B/0000-0002-8053-2730; Prast, Alex Enrich/0000-0003-3561-0936; Bastviken, David/0000-0003-0038-2152; Machado-Silva, Fausto/0000-0002-2165-3284	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Capes; Swedish Research Council Vetenskapsradet; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swedish Research Council Vetenskapsradet(Swedish Research Council); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research is a product from the Coordenacao de Aperfeicoamento de Pessoal de Novel Superior and Swedish Foundation for International Cooperation in Research and Higher Education (Capes/Stint) exchange program. The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Capes for financing different projects to AEP and the Swedish Research Council Vetenskapsradet for funding DB. AEP received a research grant from CNPq.	Alvala PC, 1999, BIOTECNOL CIENCIA DE, V7, P40; Aura Christopher Mulanda, 2011, Lakes & Reservoirs Research and Management, V16, P265, DOI 10.1111/j.1440-1770.2011.00485.x; BARTLETT KB, 1990, J GEOPHYS RES-ATMOS, V95, P16773, DOI 10.1029/JD095iD10p16773; BARTLETT KB, 1988, J GEOPHYS RES-ATMOS, V93, P1571, DOI 10.1029/JD093iD02p01571; Bastviken D, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002238; Bastviken D, 2011, SCIENCE, V331, P50, DOI 10.1126/science.1196808; Bastviken D, 2010, ENVIRON SCI TECHNOL, V44, P5450, DOI 10.1021/es1005048; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Calheiros D. F., 2003, THESIS; Caraco N, 2006, BIOSCIENCE, V56, P219, DOI 10.1641/0006-3568(2006)056[0219:VPAEOO]2.0.CO;2; Casper P, 2000, BIOGEOCHEMISTRY, V49, P1, DOI 10.1023/A:1006269900174; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 2010, LIMNOL OCEANOGR-METH, V8, P285, DOI 10.4319/lom.2010.8.285; Conrad R, 2011, BIOGEOSCIENCES, V8, P795, DOI 10.5194/bg-8-795-2011; DelSontro T, 2011, ENVIRON SCI TECHNOL, V45, P9866, DOI 10.1021/es2005545; DEVOL AH, 1988, J GEOPHYS RES-ATMOS, V93, P1583, DOI 10.1029/JD093iD02p01583; Galfalk M, 2013, J GEOPHYS RES-BIOGEO, V118, P770, DOI 10.1002/jgrg.20064; Hamilton S. K., 2002, The ecohydrology of South American rivers and wetlands, P133; Hamilton SK, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000306; Holler T, 2011, ISME J, V5, P1946, DOI 10.1038/ismej.2011.77; Juutinen S, 2009, BIOGEOSCIENCES, V6, P209, DOI 10.5194/bg-6-209-2009; Juutinen S, 2003, BIOL FERT SOILS, V38, P10, DOI 10.1007/s00374-003-0618-1; Juutinen S, 2003, GLOBAL CHANGE BIOL, V9, P413, DOI 10.1046/j.1365-2486.2003.00595.x; Mann CJ, 1996, AQUAT BOT, V53, P61, DOI 10.1016/0304-3770(95)01012-2; Marani L, 2007, ATMOS ENVIRON, V41, P1627, DOI 10.1016/j.atmosenv.2006.10.046; Marotta H, 2014, NAT CLIM CHANGE, V4, P467, DOI [10.1038/NCLIMATE2222, 10.1038/nclimate2222]; Methane Bastviken D., 2009, ENCYCLOPEDIA OF INLA, P783; Natchimuthu S, 2014, BIOGEOCHEMISTRY, V119, P403, DOI 10.1007/s10533-014-9976-z; Nguyen TD, 2010, BIOGEOCHEMISTRY, V100, P185, DOI 10.1007/s10533-010-9415-8; Reeburgh W.S., 2003, TREATISE GEOCHEM, V4, P347; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; SALAS HJ, 1991, WATER RES, V25, P341, DOI 10.1016/0043-1354(91)90015-I; Segers R, 1998, BIOGEOCHEMISTRY, V41, P23, DOI 10.1023/A:1005929032764; SORRELL BK, 1994, AQUAT BOT, V47, P197, DOI 10.1016/0304-3770(94)90053-1; Wuebbles DJ, 2002, EARTH-SCI REV, V57, P177, DOI 10.1016/S0012-8252(01)00062-9; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164	36	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123319	10.1371/journal.pone.0123319	http://dx.doi.org/10.1371/journal.pone.0123319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860229	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300092
J	Rijlaarsdam, MA; Tax, DMJ; Gillis, AJM; Dorssers, LCJ; Koestler, DC; de Ridder, J; Looijenga, LHJ				Rijlaarsdam, Martin A.; Tax, David M. J.; Gillis, Ad J. M.; Dorssers, Lambert C. J.; Koestler, Devin C.; de Ridder, Jeroen; Looijenga, Leendert H. J.			Genome Wide DNA Methylation Profiles Provide Clues to the Origin and Pathogenesis of Germ Cell Tumors	PLOS ONE			English	Article							CARCINOMA IN-SITU; YOLK-SAC TUMOR; INACTIVE X-CHROMOSOME; C-KIT PROTOONCOGENE; EMBRYONAL CARCINOMA; SPERMATOCYTIC SEMINOMA; DIFFERENTIAL EXPRESSION; CHROMATIN MODIFICATIONS; PROMOTER METHYLATION; IMPRINTING ANALYSIS	The cell of origin of the five subtypes (I-V) of germ cell tumors (GCTs) are assumed to be germ cells from different maturation stages. This is (potentially) reflected in their methylation status as fetal maturing primordial germ cells are globally demethylated during migration from the yolk sac to the gonad. Imprinted regions are erased in the gonad and later become uniparentally imprinted according to fetal sex. Here, 91 GCTs (type I-IV) and four cell lines were profiled (Illumina's HumanMethylation450BeadChip). Data was pre-processed controlling for cross hybridization, SNPs, detection rate, probe-type bias and batch effects. The annotation was extended, covering snRNAs/microRNAs, repeat elements and imprinted regions. A Hidden Markov Model-based genome segmentation was devised to identify differentially methylated genomic regions. Methylation profiles allowed for separation of clusters of non-seminomas (type II), seminomas/dysgerminomas (type II), spermatocytic seminomas (type III) and teratomas/dermoid cysts (type I/IV). The seminomas, dysgerminomas and spermatocytic seminomas were globally hypomethylated, in line with previous reports and their demethylated precursor. Differential methylation and imprinting status between subtypes reflected their presumed cell of origin. Ovarian type I teratomas and dermoid cysts showed (partial) sex specific uniparental maternal imprinting. The spermatocytic seminomas showed uniparental paternal imprinting while testicular teratomas exhibited partial imprinting erasure. Somatic imprinting in type II GCTs might indicate a cell of origin after global demethylation but before imprinting erasure. This is earlier than previously described, but agrees with the totipotent/embryonic stem cell like potential of type II GCTs and their rare extra-gonadal localization. The results support the common origin of the type I teratomas and show strong similarity between ovarian type I teratomas and dermoid cysts. In conclusion, we identified specific and global methylation differences between GCT subtypes, providing insight into their developmental timing and underlying developmental biology. Data and extended annotation are deposited at GEO (GSE58538 and GPL18809).	[Rijlaarsdam, Martin A.; Gillis, Ad J. M.; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands; [Tax, David M. J.; de Ridder, Jeroen] Delft Univ Technol, Delft Bioinformat Lab, Fac Elect Engn Math & Comp Sci Intelligent Syst, Delft, Netherlands; [Koestler, Devin C.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Delft University of Technology; University of Kansas; University of Kansas Medical Center	Looijenga, LHJ (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands.	l.looijenga@erasmusmc.nl	Looijenga, Leendert/B-8145-2019	Looijenga, Leendert/0000-0002-8146-1911; de Ridder, Jeroen/0000-0002-0828-3477; Rijlaarsdam, Martin/0000-0002-2528-8077	Translational Grant, Erasmus MC	Translational Grant, Erasmus MC	MR is supported by a Translational Grant, Erasmus MC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, J BIOL CHEM, V288, P22460, DOI 10.1074/jbc.M113.474072; Almstrup K, 2010, BRIT J CANCER, V103, P1269, DOI 10.1038/sj.bjc.6605880; Amatruda JF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-313; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; ANDREWS PW, 1980, INT J CANCER, V26, P269, DOI 10.1002/ijc.2910260304; Andrews PW, 1996, INT J CANCER, V66, P806, DOI 10.1002/(SICI)1097-0215(19960611)66:6<806::AID-IJC17>3.0.CO;2-0; Azevedo MF, 2013, J CLIN ENDOCRINOL ME; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonnard C, 2012, NAT GENET, V44, P709, DOI 10.1038/ng.2259; Boublikova L, 2014, CRIT REV ONCOL HEMAT, V89, P366, DOI 10.1016/j.critrevonc.2013.10.001; Bremmer F, 2012, ANTICANCER RES, V32, P341; Bussey KJ, 2001, GENE CHROMOSOME CANC, V32, P342, DOI 10.1002/gcc.1199; Chen YT, 2011, HUM REPROD, V26, P3232, DOI 10.1093/humrep/der330; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Chung CC, 2013, NAT GENET, V45, P680, DOI 10.1038/ng.2634; Cools M, 2006, ENDOCR REV, V27, P468, DOI 10.1210/er.2006-0005; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; de Haas EC, 2010, CANCER-AM CANCER SOC, V116, P5628, DOI 10.1002/cncr.25300; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; de Jong J, 2008, GENE CHROMOSOME CANC, V47, P185, DOI 10.1002/gcc.20520; De Jong J, 2007, ONCOL REP, V18, P127; de Napoles M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000860; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Deuve JL, 2011, ANNU REV CELL DEV BI, V27, P611, DOI 10.1146/annurev-cellbio-092910-154020; Devouassoux-Shisheboran M, 2003, APMIS, V111, P212, DOI 10.1034/j.1600-0463.2003.11101251.x; DEVOUASSOUXSHIS.M, 2003, APMIS, V111, P224; Dieckmann KP, 2004, WORLD J UROL, V22, P2, DOI 10.1007/s00345-004-0398-8; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Ebisch IMW, 2007, FERTIL STERIL, V87, P619, DOI 10.1016/j.fertnstert.2006.07.1510; Eckert D, 2008, CELL TISSUE RES, V331, P529, DOI 10.1007/s00441-007-0527-y; Eini R, 2013, INT J DEV BIOL, V57, P319, DOI 10.1387/ijdb.130020re; Fan R, 2012, FETAL PEDIATR PATHOL, V31, P21, DOI 10.3109/15513815.2011.618874; Farini D, 2007, DEV BIOL, V306, P572, DOI 10.1016/j.ydbio.2007.03.031; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Fogh J, 1978, NATL CANC I MONOGR, V5-9; Frost RJA, 2010, P NATL ACAD SCI USA, V107, P11847, DOI 10.1073/pnas.1007158107; Fukushima S, 2014, ACTA NEUROPATHOL; FUNK CD, 1992, P NATL ACAD SCI USA, V89, P3962, DOI 10.1073/pnas.89.9.3962; Furukawa S, 2009, CANCER SCI, V100, P698, DOI 10.1111/j.1349-7006.2009.01102.x; Gillis AJM, 2013, MOL ONCOL, V7, P1083, DOI 10.1016/j.molonc.2013.08.002; Gkountela S, 2013, NAT CELL BIOL, V15, P113, DOI 10.1038/ncb2638; Gobel U, 2000, ANN ONCOL, V11, P263, DOI 10.1023/A:1008360523160; Goddard NC, 2007, INT J ANDROL, V30, P337, DOI 10.1111/j.1365-2605.2007.00769.x; GRAHAM PL, 1993, DEV GENET, V14, P471, DOI 10.1002/dvg.1020140608; GRAHAM PL, 1993, GENETICS, V133, P919; Griffeth RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062103; Hoei-Hansen CE, 2004, CLIN CANCER RES, V10, P8521, DOI 10.1158/1078-0432.CCR-04-1285; Honecker F, 2004, J PATHOL, V203, P849, DOI 10.1002/path.1587; Honecker F, 2006, J PATHOL, V208, P395, DOI 10.1002/path.1872; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; IZQUIERDO MA, 1995, J PATHOL, V177, P253, DOI 10.1002/path.1711770307; Jeyapalan JN, 2011, BRIT J CANCER, V105, P575, DOI 10.1038/bjc.2011.218; Josephson R, 2007, STEM CELLS, V25, P437, DOI 10.1634/stemcells.2006-0236; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kano K, 2010, MOL REPROD DEV, V77, P29, DOI 10.1002/mrd.21093; Kato N, 2006, HUM PATHOL, V37, P48, DOI 10.1016/j.humpath.2005.09.008; Kato N, 2003, AM J PATHOL, V163, P387, DOI 10.1016/S0002-9440(10)63668-1; Kawakami T, 2006, ONCOGENE, V25, P3225, DOI 10.1038/sj.onc.1209362; Kawakami T, 2004, LANCET, V363, P40, DOI 10.1016/S0140-6736(03)15170-7; Kawasaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03658; Kempkensteffen C, 2006, J CANCER RES CLIN, V132, P765, DOI 10.1007/s00432-006-0124-6; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Koul S, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-16; Kratz CP, 2011, INT J ANDROL, V34, pE98, DOI 10.1111/j.1365-2605.2011.01156.x; Kratz CP, 2011, J MED GENET, V48, P473, DOI 10.1136/jmedgenet-2011-100001; Kratz CP, 2010, BEST PRACT RES CL EN, V24, P503, DOI 10.1016/j.beem.2010.01.005; Kristensen DG, 2014, BRIT J CANCER, V110, P668, DOI 10.1038/bjc.2013.727; Kristensen DM, 2008, MOL CELL ENDOCRINOL, V288, P111, DOI 10.1016/j.mce.2008.02.018; Kristensen DG, 2013, INT J DEV BIOL, V57, P309, DOI 10.1387/ijdb.130142ka; Kristensen DG, 2012, CANCER GENET-NY, V205, P425, DOI 10.1016/j.cancergen.2012.05.003; Le Bouffant R, 2011, DEVELOPMENT, V138, P5393, DOI 10.1242/dev.068452; Leman ES, 2010, INDIAN J UROL, V26, P76, DOI 10.4103/0970-1591.60450; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Leroy X, 2002, J HISTOCHEM CYTOCHEM, V50, P283, DOI 10.1177/002215540205000216; Lim J, 2011, J PATHOL, V224, P473, DOI 10.1002/path.2919; Lind GE, 2006, J PATHOL, V210, P441, DOI 10.1002/path.2064; Lind GE, 2007, APMIS, V115, P1147, DOI 10.1111/j.1600-0463.2007.apm_660.xml.x; Looijenga LHJ, 2013, INT J DEV BIOL, V57, P241, DOI 10.1387/ijdb.130026ll; Looijenga LHJ, 2011, J PATHOL, V224, P431, DOI 10.1002/path.2939; Looijenga LHJ, 2009, J PATHOL, V218, P146, DOI 10.1002/path.2522; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Looijenga LHJ, 1997, AM J PATHOL, V151, P581; Mamsen LS, 2012, INT J DEV BIOL, V56, P771, DOI 10.1387/ijdb.120202lm; Manton KJ, 2005, BRIT J CANCER, V92, P760, DOI 10.1038/sj.bjc.6602373; Marabita F, 2013, EPIGENETICS-US, V8, P333, DOI 10.4161/epi.24008; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Matsui Y, 2014, MOL REPROD DEV, V81, P160, DOI 10.1002/mrd.22214; McIntyre A, 2005, CANCER RES, V65, P8085, DOI 10.1158/0008-5472.CAN-05-0471; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; Messerschmidt DM, 2012, EPIGENETICS-US, V7, P969, DOI 10.4161/epi.21337; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Mirabello L, 2012, INT J MOL EPIDEMIOL, V3, P213; Mithraprabhu S, 2009, REPRODUCTION, V138, P743, DOI 10.1530/REP-08-0537; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nettersheim D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082881; Nettersheim D, 2012, GENE CHROMOSOME CANC, V51, P717, DOI 10.1002/gcc.21958; Nettersheim D, 2011, GENE CHROMOSOME CANC, V50, P1033, DOI 10.1002/gcc.20918; Nettersheim D, 2011, EPIGENETICS-US, V6, P114, DOI 10.4161/epi.6.1.13433; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279; Oatley JM, 2012, PHYSIOL REV, V92, P577, DOI 10.1152/physrev.00025.2011; Ohhata T, 2013, CELL MOL LIFE SCI, V70, P2443, DOI 10.1007/s00018-012-1174-3; Oosterhuis JW, 2007, INT J ANDROL, V30, P256, DOI 10.1111/j.1365-2605.2007.00793.x; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Orso F, 2004, BIOCHEM J, V377, P429, DOI 10.1042/BJ20031133; Payer B, 2011, HUM GENET, V130, P265, DOI 10.1007/s00439-011-1024-7; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rajpert-De Meyts E, 2003, HISTOPATHOLOGY, V42, P217, DOI 10.1046/j.1365-2559.2003.01587.x; Rapley EA, 2004, BRIT J CANCER, V90, P2397, DOI 10.1038/sj.bjc.6601880; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rathi A, 2003, CLIN CANCER RES, V9, P3674; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rescorla FJ, 1999, SEMIN SURG ONCOL, V16, P144, DOI 10.1002/(SICI)1098-2388(199903)16:2<144::AID-SSU6>3.3.CO;2-D; Rijlaarsdam MA, 2011, BRIT J CANCER, V105, P854, DOI 10.1038/bjc.2011.270; Rijlaarsdam MA, 2014, SEMIN CANC BIOL; Rijlaarsdam MA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-141; Rorth M, 2000, SCAND J UROL NEPHROL, V34, P166, DOI 10.1080/00365590050509896; Ross JA, 1999, CANCER, V85, P1389, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1389::AID-CNCR24>3.0.CO;2-V; Rossi P, 2003, ANDROLOGIA, V35, P71, DOI 10.1046/j.1439-0272.2003.00539.x; Ruark E, 2013, NAT GENET; Runyan C, 2006, DEVELOPMENT, V133, P4861, DOI 10.1242/dev.02688; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Salpea P, 2012, NUCLEIC ACIDS RES, V40, P6477, DOI 10.1093/nar/gks312; Sarkardeh H, 2014, J ASSIST REPROD GENE; Schneider DT, 2001, CANCER RES, V61, P7268; Schumacher FR, 2013, HUM MOL GENET, V22, P2748, DOI 10.1093/hmg/ddt109; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Sievers S, 2005, GENE CHROMOSOME CANC, V44, P256, DOI 10.1002/gcc.20237; Smiraglia DJ, 2002, ONCOGENE, V21, P3909, DOI 10.1038/sj.onc.1205488; Sonne SB, 2010, INT J DEV BIOL, V54, P755, DOI 10.1387/ijdb.082668ss; STROHMEYER T, 1995, J UROLOGY, V153, P511, DOI 10.1097/00005392-199502000-00073; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; TESHIMA S, 1988, LAB INVEST, V59, P328; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turnbull C, 2011, INT J ANDROL, V34, pE86, DOI 10.1111/j.1365-2605.2011.01162.x; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Ushida H, 2012, MOL CARCINOGEN, V51, P711, DOI 10.1002/mc.20831; van der Zwan YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098330; Van der Zwan YG, 2013, INT J DEV BIOL, V57, P299, DOI 10.1387/ijdb.130017ll; VANGURP RJHLM, 1994, JNCI-J NATL CANCER I, V86, P1070, DOI 10.1093/jnci/86.14.1070; Verdorfer R, 2004, J PATHOL, V204, P277, DOI 10.1002/path.1634; Verkerk AJMH, 1997, ONCOGENE, V14, P95, DOI 10.1038/sj.onc.1200802; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; WANG N, 1980, CANCER RES, V40, P796; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; Woodward PJ, 2004, WHO CLASSIFICATION T, P17; Wu JW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-64; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yang S, 2012, CELL PROLIFERAT, V45, P299, DOI 10.1111/j.1365-2184.2012.00827.x; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017; Zhang C, 2005, GENE CHROMOSOME CANC, V43, P104, DOI 10.1002/gcc.20160; Zimmerman DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081962	161	42	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122146	10.1371/journal.pone.0122146	http://dx.doi.org/10.1371/journal.pone.0122146			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859847	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300033
J	Shi, Y; Wang, JH; Xin, ZY; Duan, ZP; Wang, GQ; Li, F				Shi, Yue; Wang, Jihan; Xin, Zhuoyuan; Duan, Zipeng; Wang, Guoqing; Li, Fan			Transcription Factors and microRNA-Co-Regulated Genes in Gastric Cancer Invasion in Ex Vivo	PLOS ONE			English	Article							COLORECTAL-CANCER; CELL SURVIVAL; METASTASIS; EXPRESSION; CARCINOGENESIS; IDENTIFICATION; MORTALITY; CARCINOMA; NETWORK; GROWTH	Aberrant miRNA expression abnormally modulates gene expression in cells and can contribute to tumorigenesis in humans. This study identified functionally relevant differentially expressed genes using the transcription factors and miRNA-co-regulated network analysis for gastric cancer. The TF-miRNA co-regulatory network was constructed based on data obtained from cDNA microarray and miRNA expression profiling of gastric cancer tissues. The network along with their co-regulated genes was analyzed using Database for Annotation, Visualization and Integrated Discovery (DAVID) and Transcriptional Regulatory Element Database (TRED). We found eighteen (17 up-regulated and 1 down-regulated) differentially expressed genes that were co-regulated by transcription factors and miRNAs. KEGG pathway analysis revealed that these genes were part of the extracellular matrix-receptor interaction and focal adhesion signaling pathways. In addition, qRT-PCR and Western blot data showed an increase in COL1A1 and decrease in NCAM1 mRNA and protein levels in gastric cancer tissues. Thus, these data provided the first evidence to illustrate that altered gene network was associated with gastric cancer invasion. Further study with a large sample size and more functional experiments is needed to confirm these data and contribute to diagnostic and treatment strategies for gastric cancer.	[Shi, Yue; Wang, Jihan; Xin, Zhuoyuan; Duan, Zipeng; Wang, Guoqing; Li, Fan] Jilin Univ, Coll Basic Med, Dept Pathogenobiol, Key Lab Zoonosis,Chinese Minist Educ, Changchun 130023, Jilin, Peoples R China; [Wang, Guoqing; Li, Fan] Jilin Univ, Key Lab Bion Engn, Minist Educ China, Changchun 130023, Peoples R China	Jilin University; Jilin University; Ministry of Education, China	Wang, GQ (corresponding author), Jilin Univ, Coll Basic Med, Dept Pathogenobiol, Key Lab Zoonosis,Chinese Minist Educ, Changchun 130023, Jilin, Peoples R China.	qing8110@gmail.com; lifan@jlu.edu.cn			National Natural Science Foundation of China [81320108025, 81472662, 81271897, 81401712]; Jilin Key Laboratory of Biomedical Materials; Foundation of Jilin Province Science and Technology Department [20130522013JH, 20140414048GH]; Norman Bethune Program of Jilin University [2012219]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Key Laboratory of Biomedical Materials; Foundation of Jilin Province Science and Technology Department; Norman Bethune Program of Jilin University	This work was supported by grants from National Natural Science Foundation of China (#81320108025 and #81472662). It is also supported in part by National Natural Science Foundation of China (#81271897 and #81401712), Jilin Key Laboratory of Biomedical Materials, Foundation of Jilin Province Science and Technology Department (#20130522013JH and #20140414048GH) and the Norman Bethune Program of Jilin University (#2012219).	Almeida MI, 2012, GASTROENTEROLOGY, V142, P886, DOI 10.1053/j.gastro.2011.12.047; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aytes A, 2013, P NATL ACAD SCI USA, V110, pE3506, DOI 10.1073/pnas.1303558110; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernard W, 2014, WORLD CANC REPORT 20; Bijian K, 2004, AM J PHYSIOL-RENAL, V286, pF255, DOI 10.1152/ajprenal.00259.2003; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; EDVARDSEN K, 1994, INT J CANCER, V58, P116, DOI 10.1002/ijc.2910580119; Fischer H, 2001, CARCINOGENESIS, V22, P875, DOI 10.1093/carcin/22.6.875; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guo P, 2012, ANN ONCOL, V23, P2755, DOI 10.1093/annonc/mds069; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; HAVENITH MG, 1988, CANCER-AM CANCER SOC, V62, P2207, DOI 10.1002/1097-0142(19881115)62:10<2207::AID-CNCR2820621023>3.0.CO;2-L; Hayashi Y, 2013, GUT, V62, P1536, DOI 10.1136/gutjnl-2011-301625; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Junnila S, 2010, GENE CHROMOSOME CANC, V49, P28, DOI 10.1002/gcc.20715; Keld R, 2011, BRIT J CANCER, V105, P124, DOI 10.1038/bjc.2011.187; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Lee YS, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r55; Lipsick JS, 2010, P NATL ACAD SCI USA, V107, P17067, DOI 10.1073/pnas.1012402107; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Miao RY, 2011, CANCER RES, V71, P7029, DOI 10.1158/0008-5472.CAN-11-1015; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Shi DB, 2014, CANCER PREV RES, V7, P266, DOI 10.1158/1940-6207.CAPR-13-0271; St Croix B, 2000, SCIENCE, V289, P1197; Stepanenko I, 2003, ANN NY ACAD SCI, V1010, P16, DOI 10.1196/annals.1299.003; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Tsuzuki T, 1998, J CLIN PATHOL, V51, P13, DOI 10.1136/jcp.51.1.13; Wang M, 2012, FEBS LETT, V586, P2382, DOI 10.1016/j.febslet.2012.05.050; Wu P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.13; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zheng B, 2012, ONCOGENE, V31, P4509, DOI 10.1038/onc.2011.581	37	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122882	10.1371/journal.pone.0122882	http://dx.doi.org/10.1371/journal.pone.0122882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860484	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300066
J	Bassuk, AG; Yeh, S; Wu, S; Martin, DF; Tsang, SH; Gakhar, L; Mahajan, VB				Bassuk, Alexander G.; Yeh, Steven; Wu, Shu; Martin, Daniel F.; Tsang, Stephen H.; Gakhar, Lokesh; Mahajan, Vinit B.			Structural Modeling of a Novel CAPN5 Mutation that Causes Uveitis and Neovascular Retinal Detachment	PLOS ONE			English	Article							FLUOCINOLONE ACETONIDE IMPLANT; PROTEASE CALPAIN; TRANSDUCTION; INHIBITION; DISEASE	CAPN5 mutations have been linked to autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV), a blinding autoimmune eye disease. Here, we link a new CAPN5 mutation to ADNIV and model the three-dimensional structure of the resulting mutant protein. In our study, a kindred with inflammatory vitreoretinopathy was evaluated by clinical eye examinations, DNA sequencing, and protein structural modeling to investigate the disease-causing mutation. Two daughters of an affected mother demonstrated symptoms of stage III ADNIV, with posterior uveitis, cystoid macular edema, intraocular fibrosis, retinal neovascularization, retinal degeneration, and cataract. The women also harbored a novel guanine to thymine (c.750G>T, p.Lys250Asn) missense mutation in exon 6 of CAPN5, a gene that encodes a calcium-activated cysteine protease, calpain-5. Modeling based on the structures of all known calpains revealed the mutation falls within a calcium-sensitive flexible gating loop that controls access to the catalytic groove. Three-dimensional modeling placed the new mutation in a region adjacent to two previously identified disease-causing mutations, all three of which likely disrupt hydrogen bonding within the gating loop, yielding a CAPN5 with altered enzymatic activity. This is the third case of a CAPN5 mutation leading to inherited uveitis and neovascular vitreoretinopathy, suggesting patients with ADNIV features should be tested for CAPN5 mutations. Structural modeling of novel variants can be used to support mechanistic consequences of the disease-causing variants.	[Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Bassuk, Alexander G.; Wu, Shu; Mahajan, Vinit B.] Univ Iowa, Omics Lab, Iowa City, IA 52242 USA; [Yeh, Steven] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Martin, Daniel F.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Tsang, Stephen H.] Columbia Univ, Bernard & Shirlee Brown Glaucoma Lab, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Barbara & Donald Jonas Lab Regenerat Med, Dept Ophthalmol, New York, NY USA; [Tsang, Stephen H.] Columbia Univ, Barbara & Donald Jonas Lab Regenerat Med, Dept Pathol & Cell Biol, New York, NY USA; [Gakhar, Lokesh] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gakhar, Lokesh] Univ Iowa, Prot Crystallog Facil, Iowa City, IA USA; [Mahajan, Vinit B.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA USA	University of Iowa; University of Iowa; Emory University; Cleveland Clinic Foundation; Columbia University; Columbia University; Columbia University; University of Iowa; University of Iowa; University of Iowa	Mahajan, VB (corresponding author), Univ Iowa, Omics Lab, Iowa City, IA 52242 USA.	mahajanlab@gmail.com	Gakhar, Lokesh/F-2113-2010; Gakhar, Lokesh/P-8356-2019	Gakhar, Lokesh/0000-0002-3319-1902; Gakhar, Lokesh/0000-0002-3319-1902; Mahajan, Vinit/0000-0003-1886-1741; Bassuk, Alexander/0000-0002-4067-2157	National Institutes of Health [K08EY020530, R01EY016822]; Doris Duke Charitable Foundation [2013103]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [K08EY020530, R01EY024665, R01EY016822] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health Grants K08EY020530 (VBM) and R01EY016822 (VBM); Doris Duke Charitable Foundation Grant #:2013103 (VBM); and Research to Prevent Blindness (VBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BI0506S15; Azuma M, 2008, SURV OPHTHALMOL, V53, P150, DOI 10.1016/j.survophthal.2007.12.006; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Franz T, 2004, MOL CELL BIOL, V24, P1649, DOI 10.1128/MCB.24.4.1649-1654.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Mahajan VB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003001; Moldoveanu T, 2004, J MOL BIOL, V343, P1313, DOI 10.1016/j.jmb.2004.09.016; Moldoveanu T, 2003, NAT STRUCT BIOL, V10, P371, DOI 10.1038/nsb917; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Nelson Nnamdi G, 2014, BMC Res Notes, V7, P642, DOI 10.1186/1756-0500-7-642; Rowell HA, 2012, CLIN OPHTHALMOL, V6, P2037, DOI 10.2147/OPTH.S40086; Saez ME, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-1; Sato K, 2001, BIOL CHEM, V382, P743, DOI 10.1515/BC.2001.090; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Tlucek PS, 2013, CLIN OPHTHALMOL, V7, P1093, DOI 10.2147/OPTH.S43939; Tlucek PS, 2012, ARCH OPHTHALMOL-CHIC, V130, P1395, DOI 10.1001/archophthalmol.2012.1971; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1046/j.1365-2613.2000.00169.x; Wert KJ, 2014, HUM MOL GENET, V23, P2665, DOI 10.1093/hmg/ddt661; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361	27	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122352	10.1371/journal.pone.0122352	http://dx.doi.org/10.1371/journal.pone.0122352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856303	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500037
J	Clayton, ML; Frattaroli, S; Palmer, A; Pollack, KM				Clayton, Megan L.; Frattaroli, Shannon; Palmer, Anne; Pollack, Keshia M.			The Role of Partnerships in US Food Policy Council Policy Activities	PLOS ONE			English	Article								Food Policy Councils (FPC) help to identify and address the priorities of local, state, and regional food systems with the goal of improving food systems through policy. There is limited research describing FPCs' strategies for accomplishing this goal. As part of a larger study examining FPC policy efforts, this paper investigates the role of partnerships in food systems policy change. We conducted interviews with representatives from 12 purposefully selected FPCs in the United States and 6 policy experts identified by the selected FPC representatives to document and describe their policy work. One theme that emerged from those interviews was the role of partners. Interviewees described a range of partners (e.g., stakeholders from government, business, and education) and credited FPC partnerships with advancing their policy goals by increasing the visibility and credibility of FPCs, focusing their policy agenda, connecting FPCs to key policy inputs (e.g., local food community knowledge and priorities), and obtaining stakeholder buy-in for policy initiatives. Partnerships were also described as barriers to policy progress when partners were less engaged or had either disproportionate or little influence in a given food sector. Despite these challenges, partnerships were found to be valuable for FPCs efforts to effectively engage in the food policy arena.	[Clayton, Megan L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA; [Frattaroli, Shannon; Pollack, Keshia M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Clayton, Megan L.; Palmer, Anne] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Livable Future, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Clayton, ML (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, 624 North Broadway St, Baltimore, MD 21205 USA.	mclayto5@jhu.edu		Clayton, Megan/0000-0001-9878-9174	Johns Hopkins Center for a Livable Future	Johns Hopkins Center for a Livable Future	The work was funded by the Johns Hopkins Center for a Livable Future with a gift from the GRACE Communications Foundation (www.gracelinks.org), which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boron S, 2003, FOOD POLICY COUNCILS; Campbell M, 2004, J PLAN EDUC RES, V23, P241; Clancy K., 2007, REMAKING N AM FOOD S; Dahlberg K, 1994, FOOD POLICY COUNCILS; Feenstra Gail., 2002, AGR HUM VALUES, V19, P99, DOI [10.1023/A:1016095421310, DOI 10.1023/A:1016095421310]; GmbH SSD, ATLAS TI; Harper A, 2009, FOOD POLICY COUNCILS, P21; Hassanein N, 2003, J RURAL STUD, V19, P77, DOI 10.1016/S0743-0167(02)00041-4; Hodgson K., 2011, FOOD POLICY COUNCILS; Joseph H, 1997, COMMUNITY FOOD SECUR; Meadows D.H., 2008, THINKING SYSTEMS PRI; Scherb A, 2012, J AGRIC FOOD SYST CO, V2, P3, DOI 10.5304/jafscd.2012.024.007; Schiff R, 2007, EXAMINATION ORG STRU; Schiff R, 2008, J HUNGER ENVIRON NUT, V3, P206, DOI 10.1080/19320240802244017; Suarez-Balcazar Y, 2006, AM J COMMUN PSYCHOL, V38, P113, DOI 10.1007/s10464-006-9067-y; Wegener J, 2012, J HUNGER ENVIRON NUT, V7, P137, DOI 10.1080/19320248.2012.707115	16	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122870	10.1371/journal.pone.0122870	http://dx.doi.org/10.1371/journal.pone.0122870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856089	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500063
J	Parikh, PJ; Cole, KJ				Parikh, Pranav J.; Cole, Kelly J.			Effects of Transcranial Direct Current Stimulation on the Control of Finger Force during Dexterous Manipulation in Healthy Older Adults	PLOS ONE			English	Article							DIGIT-OBJECT INTERFACE; HUMAN PRIMARY MOTOR; AGE-RELATED-CHANGES; SKILL ACQUISITION; GRIP; MECHANISMS; FRICTION; YOUNG	The contribution of poor finger force control to age-related decline in manual dexterity is above and beyond ubiquitous behavioral slowing. Altered control of the finger forces can impart unwanted torque on the object affecting its orientation, thus impairing manual performance. Anodal transcranial direct current stimulation (tDCS) over primary motor cortex (M1) has been shown to improve the performance speed on manual tasks in older adults. However, the effects of anodal tDCS over M1 on the finger force control during object manipulation in older adults remain to be fully explored. Here we determined the effects of anodal tDCS over M1 on the control of grip force in older adults while they manipulated an object with an uncertain mechanical property. Eight healthy older adults were instructed to grip and lift an object whose contact surfaces were unexpectedly made more or less slippery across trials using acetate and sandpaper surfaces, respectively. Subjects performed this task before and after receiving anodal or sham tDCS over M1 on two separate sessions using a cross-over design. We found that older adults used significantly lower grip force following anodal tDCS compared to sham tDCS. Friction measured at the finger-object interface remained invariant after anodal and sham tDCS. These findings suggest that anodal tDCS over M1 improved the control of grip force during object manipulation in healthy older adults. Although the cortical networks for representing objects and manipulative actions are complex, the reduction in grip force following anodal tDCS over M1 might be due to a cortical excitation yielding improved processing of object-specific sensory information and its integration with the motor commands for production of manipulative forces. Our findings indicate that tDCS has a potential to improve the control of finger force during dexterous manipulation in older adults.	[Parikh, Pranav J.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85226 USA; [Cole, Kelly J.] Univ Iowa, Dept Hlth & Human Physiol, Motor Control Labs, Iowa City, IA 52242 USA	Arizona State University; Arizona State University-Tempe; University of Iowa	Parikh, PJ (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85226 USA.	pranavjp@gmail.com						Aoki T, 2006, EXP BRAIN RES, V172, P425, DOI 10.1007/s00221-006-0350-9; Chouinard PA, 2005, J NEUROSCI, V25, P2277, DOI 10.1523/JNEUROSCI.4649-04.2005; Cole KJ, 2006, EXP BRAIN RES, V175, P285, DOI 10.1007/s00221-006-0553-0; Cole KJ, 2010, EXP BRAIN RES, V201, P239, DOI 10.1007/s00221-009-2030-z; COLE KJ, 1993, EXP BRAIN RES, V95, P523; Cole KJ, 2002, EXP BRAIN RES, V143, P35, DOI 10.1007/s00221-001-0965-9; Cole KJ, 1998, EXP BRAIN RES, V121, P263, DOI 10.1007/s002210050459; Cole KJ, 2001, EXP BRAIN RES, V136, P535, DOI 10.1007/s002210000613; Cole KJ, 1999, J NEUROSCI, V19, P3238; Dayanidhi S., 2014, J GERONTOL A-BIOL, V1, P1, DOI DOI 10.1093/GER0NA/GLU009; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Hlustik P, 2001, CEREB CORTEX, V11, P312, DOI 10.1093/cercor/11.4.312; Hummel FC, 2010, NEUROBIOL AGING, V31, P2160, DOI 10.1016/j.neurobiolaging.2008.12.008; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kinoshita H, 1996, EUR J APPL PHYSIOL, V74, P450; Kornatz KW, 2005, J APPL PHYSIOL, V98, P2072, DOI 10.1152/japplphysiol.01149.2004; Latash ML, 2012, J APPL PHYSIOL, V112, P1093, DOI 10.1152/japplphysiol.00160.2012; Lauro LJR, 2014, CORTEX, V58, P99, DOI 10.1016/j.cortex.2014.05.003; Lawrence EL, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00053; Martina ISJ, 1998, J NEUROL NEUROSUR PS, V65, P743, DOI 10.1136/jnnp.65.5.743; McFadden JL, 2011, BRAIN STIMUL, V4, P38, DOI 10.1016/j.brs.2010.05.002; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Niu X, 2008, EXP BRAIN RES, V190, P225, DOI 10.1007/s00221-008-1466-x; Nowak DA, 2001, EUR J NEUROSCI, V14, P756, DOI 10.1046/j.0953-816x.2001.01697.x; Nowak DA, 2009, CORTEX, V45, P473, DOI 10.1016/j.cortex.2007.11.010; Olafsdottir H, 2007, J APPL PHYSIOL, V102, P1490, DOI 10.1152/japplphysiol.00966.2006; Parikh PJ, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.255; Parikh PJ, 2013, EXP BRAIN RES, V227, P9, DOI 10.1007/s00221-013-3451-2; Parikh PJ, 2012, J APPL PHYSIOL, V112, P1095, DOI 10.1152/japplphysiol.01385.2011; Parikh PJ, 2011, NEUROSCI LETT, V494, P94, DOI 10.1016/j.neulet.2011.02.066; Paulus W, 2011, NEUROPSYCHOL REHABIL, V21, P602, DOI 10.1080/09602011.2011.557292; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; WESTLING G, 1984, EXP BRAIN RES, V53, P277; Zimerman M, 2013, ANN NEUROL, V73, P10, DOI 10.1002/ana.23761	38	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124137	10.1371/journal.pone.0124137	http://dx.doi.org/10.1371/journal.pone.0124137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855984	Green Published, gold			2022-12-27	WOS:000352588500111
J	Pasanen, L; Holmstrom, L; Sillanpaa, MJ				Pasanen, Leena; Holmstrom, Lasse; Sillanpaa, Mikko J.			Bayesian LASSO, Scale Space and Decision Making in Association Genetics	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; VARIABLE SELECTION; PENALIZED REGRESSION; SHRINKAGE ANALYSIS; GENOMIC SELECTION; FEATURES; MODEL; PERFORMANCE; PREDICTION; MARKERS	Background LASSO is a penalized regression method that facilitates model fitting in situations where there are as many, or even more explanatory variables than observations, and only a few variables are relevant in explaining the data. We focus on the Bayesian version of LASSO and consider four problems that need special attention: (i) controlling false positives, (ii) multiple comparisons, (iii) collinearity among explanatory variables, and (iv) the choice of the tuning parameter that controls the amount of shrinkage and the sparsity of the estimates. The particular application considered is association genetics, where LASSO regression can be used to find links between chromosome locations and phenotypic traits in a biological organism. However, the proposed techniques are relevant also in other contexts where LASSO is used for variable selection. Results We separate the true associations from false positives using the posterior distribution of the effects (regression coefficients) provided by Bayesian LASSO. We propose to solve the multiple comparisons problem by using simultaneous inference based on the joint posterior distribution of the effects. Bayesian LASSO also tends to distribute an effect among collinear variables, making detection of an association difficult. We propose to solve this problem by considering not only individual effects but also their functionals (i.e. sums and differences). Finally, whereas in Bayesian LASSO the tuning parameter is often regarded as a random variable, we adopt a scale space view and consider a whole range of fixed tuning parameters, instead. The effect estimates and the associated inference are considered for all tuning parameters in the selected range and the results are visualized with color maps that provide useful insights into data and the association problem considered. The methods are illustrated using two sets of artificial data and one real data set, all representing typical settings in association genetics.	[Pasanen, Leena; Holmstrom, Lasse; Sillanpaa, Mikko J.] Univ Oulu, Dept Math Sci, Oulu, Finland; [Sillanpaa, Mikko J.] Univ Oulu, Dept Biol, Oulu, Finland; [Sillanpaa, Mikko J.] Bioctr Oulu, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu	Pasanen, L (corresponding author), Univ Oulu, Dept Math Sci, Oulu, Finland.	Leena.Pasanen@oulu.fi		Sillanpaa, Mikko J./0000-0003-2808-2768	Academy of Finland [250862]	Academy of Finland(Academy of Finland)	Funding for the research was provided by the Academy of Finland grant no. 250862 (http://www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS DF, 1974, J ROY STAT SOC B MET, V36, P99; Bayarri MJ, 2004, STAT SCI, V19, P58, DOI 10.1214/088342304000000116; Berry DA, 1999, J STAT PLAN INFER, V82, P215, DOI 10.1016/S0378-3758(99)00044-0; Cai XD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-211; Che Xiaohong, 2010, Int J Plant Genomics, V2010, P893206, DOI 10.1155/2010/893206; CHURCHILL GA, 1994, GENETICS, V138, P963; Conti DV, 2003, AM J HUM GENET, V72, P351, DOI 10.1086/346117; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; De Los Campos G, 2012, BLR BAYESIAN LINEAR; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Erasto P, 2005, J COMPUT GRAPH STAT, V14, P569, DOI 10.1198/106186005X59315; Erasto P, 2007, J STAT COMPUT SIM, V77, P421, DOI 10.1080/10629360600711988; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; GEORGE EI, 1993, J AM STAT ASSOC, V88, P881, DOI 10.2307/2290777; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Godtliebsen F, 2005, COMPUT STAT DATA AN, V48, P317, DOI 10.1016/j.csda.2004.01.010; Green P.J., 1993, NONPARAMETRIC REGRES, DOI DOI 10.1201/B15710; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hall P, 2009, STAT SINICA, V19, P449; Hans C, 2009, BIOMETRIKA, V96, P835, DOI 10.1093/biomet/asp047; Hastie T., 2009, UNSUPERVISED LEARNIN; Heuven Henri C M, 2010, BMC Proc, V4 Suppl 1, pS12; Holmstrom L, 2010, WILEY INTERDISCIPLIN, V2, P526, DOI [10.1002/wics.115, DOI 10.1002/WICS.115]; Holmstrom L, 2010, WILEY INTERDISCIP RE, V2, P150, DOI 10.1002/wics.79; Hoti F, 2006, HEREDITY, V97, P4, DOI 10.1038/sj.hdy.6800817; Karkkainen HP, 2012, GENETICS, V191, P969, DOI 10.1534/genetics.112.139014; Knurr T, 2011, GENET RES, V93, P303, DOI 10.1017/S0016672311000164; Lee A, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1712; Li JH, 2011, BIOINFORMATICS, V27, P516, DOI 10.1093/bioinformatics/btq688; Li ZT, 2012, THEOR APPL GENET, V125, P419, DOI 10.1007/s00122-012-1892-9; Lindeberg T., 1994, SCALE SPACE THEORY C; Mutshinda CM, 2012, GENETICS, V192, P1483, DOI 10.1534/genetics.111.130278; Mutshinda CM, 2012, THEOR APPL GENET, V125, P1575, DOI 10.1007/s00122-012-1936-1; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Robert C.P., 2010, INTRO MONTE CARLO ME; Sahana G, 2010, GENET EPIDEMIOL, V34, P455, DOI 10.1002/gepi.20499; Sillanpaa MJ, 2012, HEREDITY, V108, P134, DOI 10.1038/hdy.2011.56; Silva FF, 2011, LIVEST SCI, V142, P310, DOI 10.1016/j.livsci.2011.09.010; Sun W, 2010, GENETICS, V185, P349, DOI 10.1534/genetics.110.114280; THOMPSON EA, 1994, STAT SCI, V9, P355, DOI 10.1214/ss/1177010381; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tinker NA, 1996, CROP SCI, V36, P1053, DOI 10.2135/cropsci1996.0011183X003600040040x; Ventrucci M, 2011, BIOSTATISTICS, V12, P51, DOI 10.1093/biostatistics/kxq040; Xu S, 2010, HEREDITY, V105, P483, DOI 10.1038/hdy.2009.180; Xu SZ, 2007, BIOMETRICS, V63, P513, DOI 10.1111/j.1541-0420.2006.00711.x; Xu SZ, 2003, GENETICS, V163, P789; Yang RQ, 2007, GENETICS, V176, P1169, DOI 10.1534/genetics.106.064279; Yi NJ, 2008, GENETICS, V179, P1045, DOI 10.1534/genetics.107.085589; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	50	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0120017	10.1371/journal.pone.0120017	http://dx.doi.org/10.1371/journal.pone.0120017			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856391	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500011
J	Pizarro, C; Schueler, R; Hammerstingl, C; Tuleta, I; Nickenig, G; Skowasch, D				Pizarro, Carmen; Schueler, Robert; Hammerstingl, Christoph; Tuleta, Izabela; Nickenig, Georg; Skowasch, Dirk			Impact of Endoscopic Lung Volume Reduction on Right Ventricular Myocardial Function	PLOS ONE			English	Article							SEVERE EMPHYSEMA; ENDOBRONCHIAL VALVES; RISK-FACTORS; PULMONARY; EXERCISE; THERAPY; STRAIN; COPD; PREDICTORS; MORTALITY	Introduction Endoscopic lung volume reduction (ELVR) provides a minimally invasive therapy for patients with severe lung emphysema. As its impact on right ventricular (RtV) function is undefined, we examined the extent of RtV functional changes following ELVR, as assessed by use of speckle tracking-based RtV deformation analysis. Methods We enrolled 32 patients with severe emphysematous COPD scheduled for bronchoscopic LVR using endobronchial valves (Zephyr, PulmonX, Inc.), comprising 16 matched clinical responders and 16 non-responders. Echocardiography was conducted one day prior to ELVR and at an eight-week postprocedural interval. Results Patients were predominantly of late middle-age (65.8 +/- 8.7yrs), male (62.5%) and presented advanced COPD emphysema (means FEV1 and RV: 32.6% and 239.1% of predicted, respectively). After ELVR, RtV apical longitudinal strain improved significantly in the total study cohort (-7.96 +/- 7.02% vs. -13.35 +/- 11.48%, p=0.04), whereas there were no significant changes in other parameters of RtV function such as RtV global longitudinal strain, TAPSE or pulmonary arterial systolic pressure. In responding patients, 6MWT-improvement correlated with a decrease in NT-proBNP (Pearson's r: -0.53, p=0.03). However, clinical non-responders did not exhibit any RtV functional improvement. Discussion ELVR beneficially impacts RtV functional parameters. Speckle tracking-based RtV apical longitudinal strain analysis allows early determination of RtV contractile gain and identification of clinical responsiveness.	[Pizarro, Carmen; Schueler, Robert; Hammerstingl, Christoph; Tuleta, Izabela; Nickenig, Georg; Skowasch, Dirk] Univ Hosp Bonn, Dept Internal Med 2, Cardiol Pneumol & Angiol, Bonn, Germany	University of Bonn	Pizarro, C (corresponding author), Univ Hosp Bonn, Dept Internal Med 2, Cardiol Pneumol & Angiol, Bonn, Germany.	carmen.pizarro@ukb.uni-bonn.de	Schueler, Robert/D-7407-2017; Hammerstingl, Christoph/GQQ-3316-2022		Pulmonx, Inc., Redwood City, Calif., USA	Pulmonx, Inc., Redwood City, Calif., USA	This study has been funded by Pulmonx, Inc., Redwood City, Calif., USA. None of the authors had any ownership interest in the Company. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2006, RESPIRATION, V73, P311, DOI 10.1159/000088092; Argula RG, 2013, CHEST, V144, P1578, DOI 10.1378/chest.12-2826; Blessberger H, 2010, HEART, V96, P716, DOI 10.1136/hrt.2007.141002; Burgess MI, 2002, J AM SOC ECHOCARDIOG, V15, P633, DOI 10.1067/mje.2002.118526; Danbrauskaite V, 2007, J AM SOC ECHOCARDIOG, V20, P1172, DOI 10.1016/j.echo.2007.02.005; Douglas PS, 2011, J AM SOC ECHOCARDIOG, V24, P229, DOI 10.1016/j.echo.2010.12.008; Eberhardt R, 2015, RESPIRATION, V89, P41, DOI 10.1159/000368369; Fine NM, 2015, ECHOCARDIOGR-J CARD, V32, P787, DOI 10.1111/echo.12806; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Hammerstingl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038519; Hardegree EL, 2013, AM J CARDIOL, V111, P143, DOI 10.1016/j.amjcard.2012.08.061; Herth FJF, 2012, EUR RESPIR J, V39, P1334, DOI 10.1183/09031936.00161611; Hilde JM, 2013, J AM COLL CARDIOL, V62, P1103, DOI 10.1016/j.jacc.2013.04.091; Holland AE, 2010, ARCH PHYS MED REHAB, V91, P221, DOI 10.1016/j.apmr.2009.10.017; Hopkinson NS, 2005, AM J RESP CRIT CARE, V171, P453, DOI 10.1164/rccm.200407-961OC; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Jurcut R, 2010, EUR J ECHOCARDIOGR, V11, P81, DOI 10.1093/ejechocard/jep234; Leitman M, 2004, J AM SOC ECHOCARDIOG, V17, P1021, DOI 10.1016/j.echo.2004.06.019; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mantri S, 2009, J BRONCHOL INTERN PU, V16, P141, DOI 10.1097/LBR.0b013e3181a40a3e; Marti S, 2006, EUR RESPIR J, V27, P689, DOI 10.1183/09031936.06.00076405; Martinez FJ, 2005, SEMIN RESP CRIT CARE, V26, P167, DOI 10.1055/s-2005-869537; Mineo TC, 2002, AM J RESP CRIT CARE, V165, P489, DOI 10.1164/ajrccm.165.4.2108129; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Naunheim KS, 2006, J THORAC CARDIOV SUR, V131, P43, DOI 10.1016/j.jtcvs.2005.09.006; O'Donnell DE, 2008, J APPL PHYSIOL, V105, P753, DOI 10.1152/japplphysiol.90336.2008b; QUANJER PH, 1994, REV MAL RESPIR, V11, P5; Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011; Sachdev A, 2011, CHEST, V139, P1299, DOI 10.1378/chest.10-2015; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Weitzenblum E, 2009, Chron Respir Dis, V6, P177, DOI 10.1177/1479972309104664; WISE RA, 1995, AM J RESP CRIT CARE, V151, P675	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121377	10.1371/journal.pone.0121377	http://dx.doi.org/10.1371/journal.pone.0121377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856379	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500017
J	Snajder, M; Mihelic, M; Turk, D; Ulrih, NP				Snajder, Marko; Mihelic, Marko; Turk, Dusan; Ulrih, Natasa Poklar			Codon Optimisation Is Key for Pernisine Expression in Escherichia coli	PLOS ONE			English	Article							HYPERTHERMOPHILIC ARCHAEON; AEROPYRUM-PERNIX; BIOCHEMICAL FUNDAMENTALS; PROTEIN EXPRESSION; SUBTILISIN; PURIFICATION; SUPERFAMILY; CLONING; GENE	Background Pernisine is an extracellular serine protease from the hyperthermophilic Archaeon Aeropyrum pernix K1. Low yields from the natural host and expression problems in heterologous hosts have limited the potential applications of pernisine in industry. Methodology/Principal Findings The challenges of pernisine overexpression in Escherichia coli were overcome by codon preference optimisation and de-novo DNA synthesis. The following forms of the pernisine gene were cloned into the pMCSGx series of vectors and expressed in E. coli cells: wildtype (pernisine(wt)), codon-optimised (pernisine(co)), and codon-optimised with a S355A mutation of a predicted active site (pernisine(S355Aco)). The fusion-tagged pernisines were purified using fast protein liquid chromatography equipped with Ni2+ chelate and gel filtration chromatography columns. The identities of the resultant proteins were confirmed with N-terminal sequencing, tandem mass spectrometry analysis, and immunodetection. Pernisine(wt) was not expressed in E. coli at detectable levels, while pernisineco and pernisineS355Aco were expressed and purified as 55-kDa proforms with yields of around 10 mg per litre E. coli culture. After heat activation of purified pernisine, the proteolytic activity of the mature pernisineco was confirmed using zymography, at a molecular weight of 36 kDa, while the mutant pernisineS355Aco remained inactive. Enzymatic performances of pernisine evaluated under different temperatures and pHs demonstrate that the optimal enzymatic activity of the recombinant pernisine is ca. 100 degrees C and pH 7.0, respectively. Conclusions/Significance These data demonstrate that codon optimisation is crucial for pernisine overexpression in E. coli, and that the proposed catalytic Ser355 has an important role in pernisine activity, but not in its activation process. Pernisine is activated by autoproteolytical cleavage of its N-terminal proregion. We have also confirmed that the recombinant pernisine retains the characteristics of native pernisine, as a calcium modulated thermostable serine protease.	[Snajder, Marko; Ulrih, Natasa Poklar] Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia; [Mihelic, Marko; Turk, Dusan; Ulrih, Natasa Poklar] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia; [Mihelic, Marko; Turk, Dusan] Jozef Stefan Inst, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Ulrih, NP (corresponding author), Univ Ljubljana, Biotech Fac, Ljubljana, Slovenia.	natasa.poklar@bf.uni-lj.si	Ulrih, Natasa Poklar/B-2015-2008	, marko/0000-0003-2494-2222; Turk, Dusan/0000-0003-0205-6609; Poklar Ulrih, Natasa/0000-0002-2731-9973	Research Programme (Biochemical and Biophysical-Chemical Characterisation of Natural Compounds) [P4-0121]; Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBIP);  [OP13.2.1.8.01.0037]	Research Programme (Biochemical and Biophysical-Chemical Characterisation of Natural Compounds); Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBIP); 	This study was funded by the Research Programme P4-0121 (Biochemical and Biophysical-Chemical Characterisation of Natural Compounds), the Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBIP) and the operation number OP13.2.1.8.01.0037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angov E, 2011, METHODS MOL BIOL, V705, P1, DOI 10.1007/978-1-61737-967-3_1; Beynon RJ, 1996, BUFFER SOLUTIONS, Vviii; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Catara G, 2003, EXTREMOPHILES, V7, P391, DOI 10.1007/s00792-003-0337-4; Dominy BN, 2004, PROTEINS, V57, P128, DOI 10.1002/prot.20190; Elena C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00021; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Gvritishvili AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015056; Hirata A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-19; Hu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058393; Koga Y, 2014, APPL MICROBIOL BIOT, V98, P2113, DOI 10.1007/s00253-013-5091-7; Menzella HG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-15; Milek I, 2005, CAN J MICROBIOL, V51, P805, DOI 10.1139/W05-060; Palmieri G, 2009, MOL CELL PROTEOMICS, V8, P2570, DOI 10.1074/mcp.M900012-MCP200; Pulido M, 2006, APPL ENVIRON MICROB, V72, P4154, DOI 10.1128/AEM.02696-05; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Sako Y, 1996, INT J SYST BACTERIOL, V46, P1070, DOI 10.1099/00207713-46-4-1070; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Smith CA, 1999, J MOL BIOL, V294, P1027, DOI 10.1006/jmbi.1999.3291; Snajder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039548; Song HF, 2014, CURR MICROBIOL, V68, P293, DOI 10.1007/s00284-013-0476-5; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Volonte F, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-53; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang Q, 2012, J BIOMED BIOTECHNOL, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0035344; Wang YR, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-30; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Zylicz-Stachula A, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-7	31	8	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123288	10.1371/journal.pone.0123288	http://dx.doi.org/10.1371/journal.pone.0123288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856104	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500084
J	Lee, JH; Asakawa, DS; Dennerlein, JT; Jindrich, DL				Lee, Jong Hwa; Asakawa, Deanna S.; Dennerlein, Jack T.; Jindrich, Devin L.			Finger Muscle Attachments for an OpenSim Upper-Extremity Model	PLOS ONE			English	Article							FLEXOR DIGITORUM SUPERFICIALIS; MOMENT ARMS; INDEX FINGER; BIOMECHANICAL MODEL; KINEMATIC MODEL; DYNAMIC-MODEL; TENDON; FORCES; OPTIMIZATION; PATTERNS	We determined muscle attachment points for the index, middle, ring and little fingers in an OpenSim upper-extremity model. Attachment points were selected to match both experimentally measured locations and mechanical function (moment arms). Although experimental measurements of finger muscle attachments have been made, models differ from specimens in many respects such as bone segment ratio, joint kinematics and coordinate system. Likewise, moment arms are not available for all intrinsic finger muscles. Therefore, it was necessary to scale and translate muscle attachments from one experimental or model environment to another while preserving mechanical function. We used a two-step process. First, we estimated muscle function by calculating moment arms for all intrinsic and extrinsic muscles using the partial velocity method. Second, optimization using Simulated Annealing and Hooke-Jeeves algorithms found muscle-tendon paths that minimized root mean square (RMS) differences between experimental and modeled moment arms. The partial velocity method resulted in variance accounted for (VAF) between measured and calculated moment arms of 75.5% on average (range from 48.5% to 99.5%) for intrinsic and extrinsic index finger muscles where measured data were available. RMS error between experimental and optimized values was within one standard deviation (S.D) of measured moment arm (mean RMS error = 1.5 mm < measured S.D = 2.5 mm). Validation of both steps of the technique allowed for estimation of muscle attachment points for muscles whose moment arms have not been measured. Differences between modeled and experimentally measured muscle attachments, averaged over all finger joints, were less than 4.9 mm (within 7.1% of the average length of the muscle-tendon paths). The resulting non-proprietary musculoskeletal model of the human fingers could be useful for many applications, including better understanding of complex multi-touch and gestural movements.	[Lee, Jong Hwa] Arizona State Univ, Dept Mech & Aerosp Engn, Tempe, AZ 85287 USA; [Asakawa, Deanna S.; Jindrich, Devin L.] Calif State Univ, Dept Kinesiol, San Marcos, CA 92078 USA; [Dennerlein, Jack T.] Northeastern Univ, Bouve Coll Hlth Sci, Dept Phys Therapy Movement & Rehabil Sci, Boston, MA 02115 USA	Arizona State University; Arizona State University-Tempe; California State University System; California State University San Marcos; Northeastern University	Jindrich, DL (corresponding author), Calif State Univ, Dept Kinesiol, San Marcos, CA 92078 USA.	djindrich@csusm.edu		Dennerlein, Jack/0000-0001-7703-643X	National Science Foundation [NSF 0964220]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF 0964220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN KN, 1979, J BIOMECH, V12, P775, DOI 10.1016/0021-9290(79)90163-5; AN KN, 1983, J BIOMECH, V16, P419, DOI 10.1016/0021-9290(83)90074-X; AN KN, 1981, J BIOMECH, V14, P659, DOI 10.1016/0021-9290(81)90048-8; ARMSTRONG TJ, 1978, J BIOMECH, V11, P119, DOI 10.1016/0021-9290(78)90004-0; Arnold A S, 2000, Comput Aided Surg, V5, P108, DOI 10.3109/10929080009148877; Biggs J, 1999, MED ENG PHYS, V21, P625, DOI 10.1016/S1350-4533(99)00095-8; Brand P. W., 1999, CLIN MECH HAND; Brochier T, 2004, J NEUROPHYSIOL, V92, P1770, DOI 10.1152/jn.00976.2003; BROOK N, 1995, MED ENG PHYS, V17, P54, DOI 10.1016/1350-4533(95)90378-O; BUCHNER HJ, 1988, J BIOMECH, V21, P459, DOI 10.1016/0021-9290(88)90238-2; Chao E.Y., 1989, BIOMECHANICS HAND BA; CHOLEWICKI J, 1994, J BIOMECH, V27, P1287, DOI 10.1016/0021-9290(94)90282-8; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1995, COMPUT BIOL MED, V25, P21, DOI 10.1016/0010-4825(95)98882-E; Dennerlein JT, 1999, J ORTHOPAED RES, V17, P178, DOI 10.1002/jor.1100170205; Dennerlein JT, 1998, J BIOMECH, V31, P295, DOI 10.1016/S0021-9290(98)00006-2; Fowler NK, 2001, J BIOMECH, V34, P791, DOI 10.1016/S0021-9290(01)00021-5; Franko OI, 2011, J BIOMECH, V44, P1987, DOI 10.1016/j.jbiomech.2011.04.025; Garner BA, 2003, ANN BIOMED ENG, V31, P207, DOI 10.1114/1.1540105; Garner BRIAN A., 2000, Comput Methods Biomech Biomed Engin, V3, P1, DOI 10.1080/10255840008915251; Gatti CJ, 2009, ANN BIOMED ENG, V37, P1342, DOI 10.1007/s10439-009-9710-5; Gorden CC, 1989, ANTHROPOMETIC SURVEY; Greiner T.M., 1991, ECONOMICS; HOLLISTER A, 1992, J ORTHOPAED RES, V10, P454, DOI 10.1002/jor.1100100319; Holzbaur KRS, 2005, ANN BIOMED ENG, V33, P829, DOI 10.1007/s10439-005-3320-7; Hu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094533; Hu X, 2011, J NEUROPHYSIOL, V105, P1633, DOI 10.1152/jn.00537.2010; JACOBSON MD, 1992, J HAND SURG-AM, V17A, P804, DOI 10.1016/0363-5023(92)90446-V; Johnson WL, 2008, J BIOMECH, V41, P610, DOI 10.1016/j.jbiomech.2007.10.004; Kamper DG, 2006, CLIN BIOMECH, V21, P361, DOI 10.1016/j.clinbiomech.2005.11.005; Kane T. R., 1985, DYNAMICS THEORY APPL; Kelley C.T., 1999, ITERATIVE METHODS OP; Kinney AL, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023255; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kociolek AM, 2011, J BIOMECH, V44, P1967, DOI 10.1016/j.jbiomech.2011.05.002; Lee J.H., 2014, ANN BIOMED ENG; Lee J W, 1990, Proc Inst Mech Eng H, V204, P169, DOI 10.1243/PIME_PROC_1990_204_251_02; LEIJNSE JNAL, 1995, J BIOMECH, V28, P237, DOI 10.1016/0021-9290(94)00070-K; Li ZZ, 2008, ERGONOMICS, V51, P1672, DOI 10.1080/00140130802287280; LIEBER RL, 1990, J HAND SURG-AM, V15A, P244, DOI 10.1016/0363-5023(90)90103-X; LIEBER RL, 1992, J HAND SURG-AM, V17A, P787, DOI 10.1016/0363-5023(92)90444-T; Lopes MM, 2011, CLIN BIOMECH, V26, P930, DOI 10.1016/j.clinbiomech.2011.03.014; Manal K, 2002, COMPUT BIOL MED, V32, P25, DOI 10.1016/S0010-4825(01)00024-5; Martin JR, 2012, CLIN BIOMECH, V27, P453, DOI 10.1016/j.clinbiomech.2011.11.008; Murray WM, 2002, J BIOMECH, V35, P19, DOI 10.1016/S0021-9290(01)00173-7; Novick A., 1995, CLIN ORTHOP RELTAT R, V320, P188; Oh S, 2007, J ULTRAS MED, V26, P149, DOI 10.7863/jum.2007.26.2.149; Rankin JW, 2012, J BIOMECH, V45, P1739, DOI 10.1016/j.jbiomech.2012.03.010; Sancho-Bru JL, 2001, J BIOMECH, V34, P1491, DOI 10.1016/S0021-9290(01)00106-3; Saul K., 2014, COMPUT METHOD BIOMEC, P1; Shin GS, 2011, ERGONOMICS, V54, P733, DOI 10.1080/00140139.2011.592604; SPOOR CW, 1976, J BIOMECH, V9, P561, DOI 10.1016/0021-9290(76)90096-8; Valero-Cuevas FJ, 1998, J BIOMECH, V31, P693, DOI 10.1016/S0021-9290(98)00082-7; Valero-Cuevas FJ, 2003, J BIOMECH, V36, P1019, DOI 10.1016/S0021-9290(03)00061-7; Vilimek M, 2007, ACTA BIOENG BIOMECH, V9, P41; Wang KM, 2014, J HAND SURG-AM, V39, P149, DOI 10.1016/j.jhsa.2013.06.029; Wohlman SJ, 2013, J BIOMECH, V46, P1014, DOI 10.1016/j.jbiomech.2012.10.044; Wu JZ, 2008, J BIOMECH, V41, P668, DOI 10.1016/j.jbiomech.2007.09.025; Yoshii Y, 2011, J ORTHOP RES, V29, P1465, DOI 10.1002/jor.21428	59	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121712	10.1371/journal.pone.0121712	http://dx.doi.org/10.1371/journal.pone.0121712			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853869	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400047
J	Li, AM; Zhang, JY; Zhou, ZY; Wang, L; Liu, YJ; Liu, YJ				Li, Aimin; Zhang, Junying; Zhou, Zhongyin; Wang, Lei; Liu, Yujuan; Liu, Yajun			ALDB: A Domestic-Animal Long Noncoding RNA Database	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENOME-WIDE IDENTIFICATION; GENE; GENERATION; EVOLUTION; TRANSCRIPTOME; ANNOTATION; BLAST	Background Long noncoding RNAs (lncRNAs) have attracted significant attention in recent years due to their important roles in many biological processes. Domestic animals constitute a unique resource for understanding the genetic basis of phenotypic variation and are ideal models relevant to diverse areas of biomedical research. With improving sequencing technologies, numerous domestic-animal lncRNAs are now available. Thus, there is an immediate need for a database resource that can assist researchers to store, organize, analyze and visualize domestic-animal lncRNAs. Results The domestic-animal lncRNA database, named ALDB, is the first comprehensive database with a focus on the domestic-animal lncRNAs. It currently archives 12,103 pig intergenic lncRNAs (lincRNAs), 8,923 chicken lincRNAs and 8,250 cow lincRNAs. In addition to the annotations of lincRNAs, it offers related data that is not available yet in existing lncRNA databases (lncRNAdb and NONCODE), such as genome-wide expression profiles and animal quantitative trait loci (QTLs) of domestic animals. Moreover, a collection of interfaces and applications, such as the Basic Local Alignment Search Tool (BLAST), the Generic Genome Browser (GBrowse) and flexible search functionalities, are available to help users effectively explore, analyze and download data related to domestic-animal lncRNAs. Conclusions ALDB enables the exploration and comparative analysis of lncRNAs in domestic animals. A user-friendly web interface, integrated information and tools make it valuable to researchers in their studies.	[Li, Aimin; Zhang, Junying; Liu, Yajun] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China; [Li, Aimin] Xian Univ Technol, Sch Comp Sci & Engn, Xian, Shaanxi, Peoples R China; [Zhou, Zhongyin] Univ Sci & Technol China, Sch Life Sci, Dept Mol & Cell Biol, Hefei 230026, Peoples R China; [Zhou, Zhongyin] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Liu, Yujuan] CMST Dev Co Ltd, Xian DongXing Branch, Xian, Shaanxi, Peoples R China; [Liu, Yajun] Xian Univ Technol, Higher Technol Coll, Xian, Shaanxi, Peoples R China	Xidian University; Xi'an University of Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Xi'an University of Technology	Zhang, JY (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China.	jyzhang@mail.xidian.edu.cn		Zhou, Zhong-Yin/0000-0002-9715-9821; Li, Aimin/0000-0002-6983-2310	Natural Science Foundation of China [61070137, 91130006, 61201312, 61303122]; Research Fund for the Doctoral Program of Higher Education of China [20130203110017]; Fundamental Research Funds for the Central Universities of China [BDY171416, JB140306]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grants 61070137, 91130006, 61201312 and 61303122; and the Research Fund for the Doctoral Program of Higher Education of China (http://www.moe.edu.cn/, 20130203110017); and the Fundamental Research Funds for the Central Universities of China (http://www.moe.edu. cn/, BDY171416 and JB140306). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Aboyoun P. H., 2013, GENOMICRANGES REPRES; Albert FW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002962; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Huang W, 2012, ANIM GENET, V43, P674, DOI 10.1111/j.1365-2052.2012.02325.x; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Jin JJ, 2013, BIOINFORMATICS, V29, P1068, DOI 10.1093/bioinformatics/btt107; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Niazi F, 2012, RNA, V18, P825, DOI 10.1261/rna.029520.111; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Qu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042638; Roberts RM, 2009, SCIENCE, V324, P468, DOI 10.1126/science.1168521; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang H, 2014, GENOME RES; Warren ST, 1993, NAT GENET, V3; Weikard R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-789; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Yang J-H, 2012, NUCLEIC ACIDS RES; Zhou ZY, 2014, GENOME BIOL EVOL, V6, P1387, DOI 10.1093/gbe/evu113	48	67	73	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124003	10.1371/journal.pone.0124003	http://dx.doi.org/10.1371/journal.pone.0124003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853886	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400129
J	Silva, AT; Hatry, C; Thiem, JD; Gutowsky, LFG; Hatin, D; Zhu, DZ; Dawson, JW; Katopodis, C; Cooke, SJ				Silva, Ana T.; Hatry, Charles; Thiem, Jason D.; Gutowsky, Lee F. G.; Hatin, Daniel; Zhu, David Z.; Dawson, Jeffery W.; Katopodis, Christos; Cooke, Steven J.			Behaviour and Locomotor Activity of a Migratory Catostomid during Fishway Passage	PLOS ONE			English	Article							SWIMMING PERFORMANCE; ENERGY-EXPENDITURE; PHYSIOLOGY; REDHORSE; COSTS; FLOW; ACCELEROMETER; ACCELERATION; FLEXIBILITY; STURGEON	Fishways have been developed to restore longitudinal connectivity in rivers. Despite their potential for aiding fish passage, fishways may represent a source of significant energetic expenditure for fish as they are highly turbulent environments. Nonetheless, our understanding of the physiological mechanisms underpinning fishway passage of fish is still limited. We examined swimming behaviour and activity of silver redhorse (Moxostoma anisurum) during its upriver spawning migration in a vertical slot fishway. We used an accelerometer-derived instantaneous activity metric (overall dynamic body acceleration) to estimate location-specific swimming activity. Silver redhorse demonstrated progressive increases in activity during upstream fishway passage. Moreover, location-specific passage duration decreased with an increasing number of passage attempts. Turning basins and the most upstream basin were found to delay fish passage. No relationship was found between basin-specific passage duration and activity and the respective values from previous basins. The results demonstrate that successful fishway passage requires periods of high activity. The resultant energetic expenditure may affect fitness, foraging behaviour and increase susceptibility to predation, compromising population sustainability. This study highlights the need to understand the physiological mechanisms underpinning fishway passage to improve future designs and interpretation of biological evaluations.	[Silva, Ana T.; Hatry, Charles; Thiem, Jason D.; Gutowsky, Lee F. G.; Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Hatin, Daniel] Faune & Parcs, Minist Forets, Quebec City, PQ, Canada; [Zhu, David Z.] Univ Alberta, Dept Civil & Environm Engn, Edmonton, AB, Canada; [Dawson, Jeffery W.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Katopodis, Christos] Katopodis Ecohydraul Ltd, Winnipeg, MB, Canada	Carleton University; University of Alberta; Carleton University	Silva, AT (corresponding author), Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada.	anamtsilva@isa.ulisboa.pt	Cooke, Steven J/F-4193-2010; Thiem, Jason/ABB-2169-2021	Cooke, Steven J/0000-0002-5407-0659; Thiem, Jason/0000-0002-5585-8560; T. Silva, Ana/0000-0003-3605-6164; Gutowsky, Lee/0000-0003-1244-9465	NSERC HydroNet Strategic Network Grant; Canadian Wildlife Federation; Quebec MRNF; Post-Doc Fellowship from NSERC HydroNet; NSERC-CGSM (Alexander Graham Bell) scholarship; Ontario graduate scholarship (OGS); Carleton University; Canada Research Chair program; Katopodis Ecohydraulics Ltd.	NSERC HydroNet Strategic Network Grant; Canadian Wildlife Federation; Quebec MRNF; Post-Doc Fellowship from NSERC HydroNet; NSERC-CGSM (Alexander Graham Bell) scholarship; Ontario graduate scholarship (OGS)(Ontario Graduate Scholarship); Carleton University; Canada Research Chair program(Canada Research Chairs); Katopodis Ecohydraulics Ltd.	Project funding was provided by an NSERC HydroNet Strategic Network Grant. Equipment support was provided by the Canada Foundation for Innovation, the Ontario Research Fund and the NSERC RTI program. Additional support was provided by the Canadian Wildlife Federation. Significant financial contribution was also provided by the Quebec MRNF. ATS was supported by a Post-Doc Fellowship from NSERC HydroNet, CH was supported by an NSERC-CGSM (Alexander Graham Bell) scholarship, an Ontario graduate scholarship (OGS), and additional graduate scholarships from Carleton University. JDT was supported by a President's graduate scholarship from Carleton University and Cooke SJ was supported by the Canada Research Chair program. Katopodis Ecohydraulics Ltd., provided support in the form of devidends for author CK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section".	Alexandre CM, 2013, ECOL ENG, V51, P191, DOI 10.1016/j.ecoleng.2012.12.047; BOISCLAIR D, 1989, CAN J FISH AQUAT SCI, V46, P1859, DOI 10.1139/f89-234; Bouten CVC, 1997, IEEE T BIO-MED ENG, V44, P136, DOI 10.1109/10.554760; Brown Richard S., 1999, North American Journal of Fisheries Management, V19, P867, DOI 10.1577/1548-8675(1999)019&lt;0867:ETCTRF&gt;2.0.CO;2; Bunt CM, 2012, RIVER RES APPL, V28, P457, DOI 10.1002/rra.1565; Bunt CM, 2001, ECOL FRESHW FISH, V10, P57, DOI 10.1111/j.1600-0633.2001.tb00194.x; Bunt CM, 1999, THESIS; Burnett NJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P587, DOI 10.1086/677219; Burnham K. P., 2002, MODEL SELECTION AND; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Castro-Santos T, 2009, AMERICAN FISHERIES S; Cleasby IR, 2011, BEHAV ECOL SOCIOBIOL, V65, P2361, DOI 10.1007/s00265-011-1254-7; Collins MR, 2002, J APPL ICHTHYOL, V18, P491, DOI 10.1046/j.1439-0426.2002.00386.x; Cooke SJ, 2005, BIOL CONSERV, V121, P317, DOI 10.1016/j.biocon.2004.05.015; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cooke SJ, 2013, ECOL ENG, V58, P123, DOI 10.1016/j.ecoleng.2013.06.005; Cotel AJ, 2006, T AM FISH SOC, V135, P610, DOI 10.1577/T04-196.1; DILL LM, 1983, CAN J FISH AQUAT SCI, V40, P398, DOI 10.1139/f83-058; Fulton CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054033; Gleiss AC, 2009, TAGGING AND TRACKING; Gleiss AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1350; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gleiss AC, 2010, J EXP MAR BIOL ECOL, V385, P85, DOI 10.1016/j.jembe.2010.01.012; Green JA, 2009, J EXP BIOL, V212, P745, DOI 10.1242/jeb.030049; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Hasler CT, 2009, ENVIRON REV, V17, P179, DOI 10.1139/A09-008; Hatry C, 2014, PHYSIOL BIOCHEM ZOOL, V87, P148, DOI 10.1086/671900; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Hinch SG, 2000, T AM FISH SOC, V129, P598, DOI 10.1577/1548-8659(2000)129<0598:EOSSAA>2.0.CO;2; Kieffer J.D., 1992, Reviews in Fish Biology and Fisheries, V2, P125, DOI 10.1007/BF00042881; Lacey RWJ, 2012, RIVER RES APPL, V28, P429, DOI 10.1002/rra.1584; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Lucas M. C., 2001, MIGRATION OF FRESHWA; Lupandin AI, 2005, BIOL BULL+, V32, P461, DOI 10.1007/s10525-005-0125-z; Lyons GN, 2013, COMP BIOCHEM PHYS A, V166, P278, DOI 10.1016/j.cbpa.2013.06.024; Mallen-Cooper M, 2007, FISHERIES MANAG ECOL, V14, P319, DOI 10.1111/j.1365-2400.2007.00557.x; Marriner BA, 2014, ECOL ENG, V63, P88, DOI 10.1016/j.ecoleng.2013.12.010; McElroy B, 2012, ECOLOGY, V93, P29, DOI 10.1890/11-1082.1; McNab BK, 2002, THE PHYSIOLOGICAL EC; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Noonan MJ, 2012, FISH FISH, V13, P450, DOI 10.1111/j.1467-2979.2011.00445.x; Odling-Smee L, 2003, FISH FISH, V4, P235, DOI 10.1046/j.1467-2979.2003.00127.x; Ohlberger J, 2005, J EXP ZOOL PART A, V303A, P657, DOI 10.1002/jez.a.181; Payne NL, 2014, J EXP BIOL, V217, P317, DOI 10.1242/jeb.093922; Peake S, 1997, CAN J FISH AQUAT SCI, V54, P1361, DOI 10.1139/cjfas-54-6-1361; Pinheiro J, 2012, NONLINEAR MIXED EFFE; Pope SB, 2000, TURBULENT FLOWS CAMB; Przybilla A, 2010, J EXP BIOL, V213, P2976, DOI 10.1242/jeb.041632; Ristroph L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178103; Robson AA, 2012, J R SOC INTERFACE, V9, P1486, DOI 10.1098/rsif.2011.0713; Roscoe DW, 2011, RIVER RES APPL, V27, P693, DOI 10.1002/rra.1384; Sato K, 2002, J EXP BIOL, V205, P1189; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Silva AT, 2012, ECOL ENG, V44, P314, DOI 10.1016/j.ecoleng.2012.04.015; Silva AT, 2011, RIVER RES APPL, V27, P360, DOI 10.1002/rra.1363; Standen EM, 2002, CAN J FISH AQUAT SCI, V59, P1809, DOI 10.1139/F02-151; Tarrade L, 2008, HYDROBIOLOGIA, V609, P177, DOI 10.1007/s10750-008-9416-y; Thiem J, 2013, THESIS; Thiem J. D., 2011, Endangered Species Research, V15, P1, DOI 10.3354/esr00360; Tomlinson S, 2014, TRENDS ECOL EVOL, V29, P280, DOI 10.1016/j.tree.2014.03.003; Walsh SJ, 1998, ENVIRON BIOL FISH, V51, P429, DOI 10.1023/A:1007486632102; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; Winter J.D., 1983, P371; Wright S, 2014, MAR ECOL PROG SER, V496, P19, DOI 10.3354/meps10528; Yoda K, 2001, J EXP BIOL, V204, P685; Young JL, 2006, FISH FISH, V7, P262, DOI 10.1111/j.1467-2979.2006.00225.x; Zuur AF, 2009, USE R, pVII	71	22	22	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123051	10.1371/journal.pone.0123051	http://dx.doi.org/10.1371/journal.pone.0123051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853245	Green Published, gold			2022-12-27	WOS:000352478400094
J	Witas, HW; Ploszaj, T; Jedrychowska-Danska, K; Witas, PJ; Maslowska, A; Jerszynska, B; Kozlowski, T; Osipowicz, G				Witas, Henryk W.; Ploszaj, Tomasz; Jedrychowska-Danska, Krystyna; Witas, Piotr J.; Maslowska, Alicja; Jerszynska, Blandyna; Kozlowski, Tomasz; Osipowicz, Grzegorz			Hunting for the LCT-13910*T Allele between the Middle Neolithic and the Middle Ages Suggests Its Absence in Dairying LBK People Entering the Kuyavia Region in the 8th Millennium BP	PLOS ONE			English	Article							LACTASE-PERSISTENCE; POSITIVE SELECTION; ANCIENT DNA; EVOLUTIONARY GENETICS; LACTOSE DIGESTION; HUMAN GENOME; POPULATION; FREQUENCY; HISTORY; ADAPTATION	Populations from two medieval sites in Central Poland, Stary Brzesc Kujawski-4 (SBK-4) and Gruczno, represented high level of lactase persistence (LP) as followed by the LCT-13910*T allele's presence (0.86 and 0.82, respectively). It was twice as high as in contemporaneous Cedynia (0.4) and Srodka (0.43), both located outside the region, higher than in modern inhabitants of Poland (0.51) and almost as high as in modern Swedish population (0.9). In an attempt to explain the observed differences its frequency changes in time were followed between the Middle Neolithic and the Late Middle Ages in successive dairying populations on a relatively small area (radius similar to 60km) containing the two sites. The introduction of the T allele to Kuyavia 7.4 Ka BP by dairying LBK people is not likely, as suggested by the obtained data. It has not been found in any of Neolithic samples dated between 6.3 and 4.5 Ka BP. The identified frequency profile indicates that both the introduction and the beginning of selection could have taken place approx. 4 millennia after first LBK people arrived in the region, shifting the value of LP frequency from 0 to more than 0.8 during less than 130 generations. We hypothesize that the selection process of the T allele was rather rapid, starting just after its introduction into already milking populations and operated via high rates of fertility and mortality on children after weaning through life-threatening conditions, favoring lactose-tolerant individuals. Facing the lack of the T allele in people living on two great European Neolithization routes, the Danubian and Mediterranean ones, and based on its high frequency in northern Iberia, its presence in Scandinavia and estimated occurrence in Central Poland, we propose an alternative Northern Route of its spreading as very likely. None of the successfully identified nuclear alleles turned out to be deltaF508 CFTR.	[Witas, Henryk W.; Ploszaj, Tomasz; Jedrychowska-Danska, Krystyna; Maslowska, Alicja] Med Univ Lodz, Dept Mol Biol, Lodz, Poland; [Witas, Piotr J.] Nicholas Copernicus Univ, Inst Phys, PL-87100 Torun, Poland; [Jerszynska, Blandyna] Adam Mickiewicz Univ, Dept Anthropol, Poznan, Poland; [Kozlowski, Tomasz] Nicholas Copernicus Univ, Dept Anthropol, Torun, Poland; [Osipowicz, Grzegorz] Nicholas Copernicus Univ, Dept Archaeol, Torun, Poland	Medical University Lodz; Nicolaus Copernicus University; Adam Mickiewicz University; Nicolaus Copernicus University; Nicolaus Copernicus University	Witas, HW (corresponding author), Med Univ Lodz, Dept Mol Biol, Lodz, Poland.	henryk.witas@umed.lodz.pl	Kozłowski, Tomasz/O-3284-2015; Osipowicz, Grzegorz/O-5013-2015; Ploszaj, Tomasz/S-9849-2016; Witas, Henryk Wlodzimierz/S-9450-2016	Osipowicz, Grzegorz/0000-0002-4393-655X; Ploszaj, Tomasz/0000-0002-9503-278X; Witas, Henryk Wlodzimierz/0000-0002-8402-2084; Jedrychowska-Danska, Krystyna/0000-0001-9262-4010; Kozlowski, Tomasz/0000-0001-5242-6095	Polish Ministry of Science and Higher Education [N N109 286737]; National Science Center (NCN) [N 2013/08/M/HS3/00379]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Center (NCN)(National Science Centre, Poland)	The work was funded by the scientific project no. N N109 286737 from the Polish Ministry of Science and Higher Education and the National Science Center (NCN) under the scientific project no. N 2013/08/M/HS3/00379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon R, 2010, FOOD NUTR RES, V54, DOI 10.3402/fnr.v54i0.5141; Angel J.L., 1984, PALEOPATHOLOGY ORIGI, P51; ASHWORTH A, 1982, HUM NUTR-CLIN NUTR, V36, P279; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bollongino R, 2006, BIOL LETTERS, V2, P155, DOI 10.1098/rsbl.2005.0404; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G, 2014, J HUM EVOL, DOI [10.1016/j.jhevol.2014.1006.1017, DOI 10.1016/J.JHEVOL.2014.1006.1017]; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Chudziak W, 2000, ARCHEOLOGIA BYDGOSKO, P55; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Collins M., 1998, ANCIENT BIOMOLECULES, V2, P209; Copley MS, 2005, J ARCHAEOL SCI, V32, P523, DOI 10.1016/j.jas.2004.08.006; Craig OE, 2005, ANTIQUITY, V79, P882, DOI 10.1017/S0003598X00115017; Craig OE, 2011, P NATL ACAD SCI USA, V108, P17910, DOI 10.1073/pnas.1107202108; Cramp LJE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2372; Dabney J, 2013, COLD SPRING HARB PER, V5; Deguilloux MF, 2012, EVOL ANTHROPOL, V21, P24, DOI 10.1002/evan.20341; Dittmann K, 2000, Anthropol Anz, V58, P345; ENARD D, 2014, GENOME RES; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FLATZ G, 1973, LANCET, V2, P76; Fung T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085925; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gerbault P, 2011, PHILOS T R SOC B, V366, P863, DOI 10.1098/rstb.2010.0268; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gronenborn D, 2009, DOC PRAEHIST, V36, P97, DOI 10.4312/dp.36.5; GRYGIEL R, 1986, J FIELD ARCHAEOL, V13, P121, DOI 10.1179/009346986791535762; Grygiel R, 2004, NEOLIT POCZ TKI EPOK; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Henneberg M, 1975, PRZEGL ANTROPOLOGICZ, V41, P159; Holden C, 1997, HUM BIOL, V69, P605; Hu M, 2012, HUM GENET, V131, P665, DOI 10.1007/s00439-011-1111-9; Huhne-Osterloh G, 1989, Anthropol Anz, V47, P11; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Isaksson S, 2012, J ARCHAEOL SCI, V39, P3600, DOI 10.1016/j.jas.2012.06.018; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Kapica Z., 1970, MONOGRAFIA BRZESCIA, P7; Kelley JL, 2008, ANNU REV GENOM HUM G, V9, P143, DOI 10.1146/annurev.genom.9.081307.164411; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Kruttli A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086251; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; Leonardi M, 2012, INT DAIRY J, V22, P88, DOI 10.1016/j.idairyj.2011.10.010; Lorkiewicz W, 2012, BIOL WCZESNOROLNICZY; Malmstrom H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-89; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nowak M, 2013, IANSA, VIV, P85; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Plantinga TS, 2012, EUR J HUM GENET, V20, P778, DOI 10.1038/ejhg.2011.254; Ploszaj T, 2011, CENT EUR J BIOL, V6, P176, DOI 10.2478/s11535-010-0114-1; Richards M, 2003, ANNU REV ANTHROPOL, V32, P135, DOI 10.1146/annurev.anthro.32.061002.093207; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Salque M, 2013, NATURE, V493, P522, DOI 10.1038/nature11698; Shennan S, 2007, J ARCHAEOL SCI, V34, P1339, DOI 10.1016/j.jas.2006.10.031; SMITH G, 2008, BALLET REV, V36, P17, DOI DOI 10.1038/EJHG.2008.156; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Sverrisdottir OO, 2014, MOL BIOL EVOL, V31, P975, DOI 10.1093/molbev/msu049; Sverrisdottir OO, 2014, THESIS; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wilde S., 2014, P NATL ACAD SCI US; Winters M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021247; Witas HW, 2010, INT J IMMUNOGENET, V37, P155, DOI 10.1111/j.1744-313X.2010.00896.x; Witas HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073682; Witas Henryk W., 2006, Anthropologischer Anzeiger, V64, P41; Zawicki P, 2008, INFECT GENET EVOL, V8, P146, DOI 10.1016/j.meegid.2007.11.003	78	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122384	10.1371/journal.pone.0122384	http://dx.doi.org/10.1371/journal.pone.0122384			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CF3WA	25853887	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400066
J	Abaid, N; Macinko, J; Silver, D; Porfiri, M				Abaid, Nicole; Macinko, James; Silver, Diana; Porfiri, Maurizio			The Effect of Geography and Citizen Behavior on Motor Vehicle Deaths in the United States	PLOS ONE			English	Article							PUBLIC-HEALTH LAW; SEAT-BELT; OBESITY; ALCOHOL; PROGRAM; NETWORK; PACKAGE	Death due to motor vehicle collisions (MVCs) remains a leading cause of death in the US and alcohol plays a prominent role in a large proportion of these fatalities nationwide. Rates for these incidents vary widely among states and over time. Here, we explore the extent to which driving volume, alcohol consumption, legislation, political ideology, and geographical factors influence MVC deaths across states and time. We specify structural equation models for extracting associations between the factors and outcomes for MVC deaths and compute correlation functions of states' relative geographic and political positions to elucidate the relative contribution of these factors. We find evidence that state-level variation in MVC deaths is associated with time-varying driving volume, alcohol consumption, and legislation. These relationships are modulated by state spatial proximity, whereby neighboring states are found to share similar MVC death rates over the thirty-year observation period. These results support the hypothesis that neighboring states exhibit similar risk and protective characteristics, despite differences in political ideology.	[Abaid, Nicole] Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Macinko, James] Univ Calif Los Angeles, Dept Hlth Policy & Management, Los Angeles, CA USA; [Macinko, James] Univ Calif Los Angeles, Dept Community Hlth Sci, Los Angeles, CA USA; [Silver, Diana] NYU, Dept Nutr Food Studies & Publ Hlth, New York, NY USA; [Porfiri, Maurizio] New York Univ Polytech Sch Engn, Dept Mech & Aerosp Engn, Brooklyn, NY USA	Virginia Polytechnic Institute & State University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; New York University; New York University; New York University Tandon School of Engineering	Abaid, N (corresponding author), Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	nabaid@vt.edu		Porfiri, Maurizio/0000-0002-1480-3539; Macinko, James/0000-0001-8055-5441	National Science Foundation [CMMI-1129820, CMMI-0745753]; National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism [1R21AA021523-01A1]; New York University under a SEED grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021523] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); New York University under a SEED grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Science Foundation under Grant # CMMI-1129820 and Grant # CMMI-0745753, the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism under Grant # 1R21AA021523-01A1, and by New York University under a SEED grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, LIV SAV FED MOT VEH; Auchincloss AH, 2008, AM J EPIDEMIOL, V168, P1, DOI 10.1093/aje/kwn118; Berry F. S., 2007, THEORIES POLICY PROC; Blachman DR, 2008, AM J PREV MED, V35, pS285, DOI 10.1016/j.amepre.2008.06.003; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollen K. A., 1993, TESTING STRUCTURAL E; Burris S, 2011, PUBLIC HEALTH REP, V126, P22, DOI 10.1177/00333549111260S305; Burris SC, 2011, J LAW MED ETHICS, V39, P15, DOI 10.1111/j.1748-720X.2011.00558.x; Carpenter CS, 2008, J HEALTH ECON, V27, P642, DOI 10.1016/j.jhealeco.2007.09.010; Cummings P, 2006, INJURY PREV, V12, P148, DOI 10.1136/ip.2005.010975; Dietz WH, 2009, MILBANK Q, V87, P215, DOI 10.1111/j.1468-0009.2009.00553.x; Donges JF, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48007; Fox J, 2006, STRUCT EQU MODELING, V13, P465, DOI 10.1207/s15328007sem1303_7; Gallos LK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00454; Hoyle R. H., 1995, STRUCTURAL EQUATION; Jackson MO, 2008, SOCIAL EC NETWORKS; JEWELL RT, 1995, APPL ECON, V27, P759, DOI 10.1080/00036849500000066; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Levy DT, 2007, HEALTH POLICY, V82, P167, DOI 10.1016/j.healthpol.2006.09.008; Macinko J, 2012, AM J PUBLIC HEALTH, V102, P1697, DOI 10.2105/AJPH.2012.300716; Macy MW, 2002, ANNU REV SOCIOL, V28, P143, DOI 10.1146/annurev.soc.28.110601.141117; Mari L, 2012, J R SOC INTERFACE, V9, P376, DOI 10.1098/rsif.2011.0304; Matrajt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013767; O'DONNELL M A, 1985, Journal of Public Health Policy, V6, P510, DOI 10.2307/3342050; Pomeranz JL, 2009, MILBANK Q, V87, P185, DOI 10.1111/j.1468-0009.2009.00552.x; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Silver D, STATE HLTH POLICY RE; Sun J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046125; Volden C, 2006, AM J POLIT SCI, V50, P294, DOI 10.1111/j.1540-5907.2006.00185.x	30	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123339	10.1371/journal.pone.0123339	http://dx.doi.org/10.1371/journal.pone.0123339			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25850105	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800225
J	Calderon, R; Hernandez, CL; Cuesta, P; Dugoujon, JM				Calderon, Rosario; Hernandez, Candela L.; Cuesta, Pedro; Dugoujon, Jean Michel			Surnames and Y-Chromosomal Markers Reveal Low Relationships in Southern Spain	PLOS ONE			English	Article							POPULATION STRUCTURES; FAMILY NAMES; GENETIC DIVERSITY; MIGRATORY EVENTS; HAPLOGROUP-J; EUROPE; DIFFERENTIATION; ANDALUSIANS; SIGNATURE; IRELAND	A sample of 416 males from western and eastern Andalusia has been jointly analyzed for surnames and Y-chromosome haplogroups and haplotypes. The observed number of different surnames was 222 (353 when the second surname of the Spanish system of naming is considered). The great majority of recorded surnames have a Castilian-Leonese origin, while Catalan or Basque surnames have not been found. A few Arab-related surnames appear but none discernible of Sephardic-Jewish descent. Low correlation among surnames with different population frequencies and Y-chromosome markers, at different levels of genetic resolution, has been observed in Andalusia. This finding could be explained mainly by the very low rate of monophyletic surnames because of the historical process of surname ascription and the resulting high frequencies of the most common Spanish surnames. The introduction of surnames in Spain during the Middle Ages coincided with Reconquest of the territories under Islamic rule, and Muslims and Jews progressively adopted the present male line surname system. Sampled surnames and Y-chromosome lineages fit well a power-law distribution and observed isonymy is very close to that of the general population. Besides, our data and results show that the reliability of the isonymy method should be questioned because of the high rate of polyphyletic surnames, even in small geographic regions and autochthonous populations. Random isonymy would be consistently dependent of the most common surname frequencies in the population.	[Calderon, Rosario; Hernandez, Candela L.] Univ Complutense, Fac Biol, Dept Zool & Antropol Fis, E-28040 Madrid, Spain; [Cuesta, Pedro] Univ Complutense, Ctr Proc Datos, E-28040 Madrid, Spain; [Dugoujon, Jean Michel] Univ Toulouse 3, CNRS, UMR 5288, Lab Anthropol Mol & Imagerie Synth AMIS, F-31062 Toulouse, France	Complutense University of Madrid; Complutense University of Madrid; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Calderon, R (corresponding author), Univ Complutense, Fac Biol, Dept Zool & Antropol Fis, E-28040 Madrid, Spain.	rcalfer@bio.ucm.es	Hernández, Candela L/K-3713-2014; Cuesta, Pedro/L-1157-2014; Calderon, Rosario/K-2514-2014	Hernández, Candela L/0000-0002-0816-7169; Calderon, Rosario/0000-0001-9196-5323	Spanish Ministry of Economy and Competitiveness (MINECO) [CGL2010-15191/BOS]; Complutense University of Madrid	Spanish Ministry of Economy and Competitiveness (MINECO); Complutense University of Madrid	This research was funded by the Spanish Ministry of Economy and Competitiveness (MINECO, http://www.mineco.gob.es/portal/site/mineco/idi) Project CGL2010-15191/BOS to RC. CLH has a predoctoral fellowship granted by Complutense University of Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso S, 2005, EUR J HUM GENET, V13, P1293, DOI 10.1038/sj.ejhg.5201482; Ambrosio B, 2010, ANN HUM BIOL, V37, P86, DOI 10.3109/03014460903229155; Ambrosio B, 2012, FORENSIC SCI INT-GEN, V6, pE66, DOI 10.1016/j.fsigen.2011.05.007; Ambrosio B, 2010, COLLEGIUM ANTROPOL, V34, P1215; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; Boattini A, 2012, HUM BIOL, V84, P235, DOI 10.3378/027.084.0302; Bowden GR, 2008, MOL BIOL EVOL, V25, P301, DOI 10.1093/molbev/msm255; Calderon R, 2006, HUM BIOL, V78, P663, DOI 10.1353/hub.2007.0008; Calvo Baeza J, 1991, APELLIDOS ESPANOLES; Colantonio SE, 2003, HUM BIOL, V75, P785, DOI 10.1353/hub.2004.0004; CROW JF, 1983, HUM BIOL, V55, P383; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2004, AM J HUM GENET, V74, P1014, DOI 10.1086/386294; Cruciani F, 2011, FORENSIC SCI INT-GEN, V5, pE49, DOI 10.1016/j.fsigen.2010.07.006; Darlu P, 2012, HUM BIOL, V84, P169, DOI 10.3378/027.084.0205; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Diez Melcon G, 1957, APELLIDOS CASTELLANO; Ewens W.J., MATH POPULATION GENE; EWENS WJ, 1974, THEOR POPUL BIOL, V6, P35, DOI 10.1016/0040-5809(74)90030-6; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fienberg S, 2001, SELECTED PALERS ISBA, P135; Fortes-Lima C, 2014, CR BIOL, V337, P646, DOI 10.1016/j.crvi.2014.08.004; Garcia- Carraffa A, ENCICLOPEDIA HERALDI; Hartl D., 1989, PRINCIPLES POPULATIO; Hernandez CL, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-11; Jobling MA, 2001, TRENDS GENET, V17, P353, DOI 10.1016/S0168-9525(01)02284-3; King TE, 2006, CURR BIOL, V16, P384, DOI 10.1016/j.cub.2005.12.048; King TE, 2009, TRENDS GENET, V25, P351, DOI 10.1016/j.tig.2009.06.003; King TE, 2009, MOL BIOL EVOL, V26, P1093, DOI 10.1093/molbev/msp022; Larmuseau MHD, 2012, HEREDITY, V109, P90, DOI 10.1038/hdy.2012.17; Lasker Gabriel, 1985, SURNAMES GENETIC STR; Lasker GW, 1988, HUMAN MATING PATTERN; Manni F, 2005, AM J PHYS ANTHROPOL, V126, P214, DOI 10.1002/ajpa.10429; McEvoy B, 2006, HUM GENET, V119, P212, DOI 10.1007/s00439-005-0131-8; McEvoy B, 2008, AM J PHYS ANTHROPOL, V136, P415, DOI 10.1002/ajpa.20823; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Miyazima S, 2000, PHYSICA A, V278, P282, DOI 10.1016/S0378-4371(99)00546-4; Moore LT, 2006, AM J HUM GENET, V78, P334, DOI 10.1086/500055; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Neuhauser C, 2003, HDB STAT GENETICS; Reales G, 2014, ANN HUM BIOL, V41, P443, DOI 10.3109/03014460.2013.877966; Reed WJ, 2003, PHYSICA A, V319, P579, DOI 10.1016/S0378-4371(02)01455-3; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Sykes B, 2000, AM J HUM GENET, V66, P1417, DOI 10.1086/302850; Winney B, 2012, EUR J HUM GENET, V20, P203, DOI 10.1038/ejhg.2011.127; Zanette DH, 2001, PHYSICA A, V295, P1, DOI 10.1016/S0378-4371(01)00046-2; ZEI G, 1983, ANN HUM GENET, V47, P329, DOI 10.1111/j.1469-1809.1983.tb01003.x	49	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123098	10.1371/journal.pone.0123098	http://dx.doi.org/10.1371/journal.pone.0123098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860017	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300076
J	Chang, GJ; Zhang, K; Xu, TL; Jin, D; Guo, JF; Zhuang, S; Shen, XZ				Chang, Guangjun; Zhang, Kai; Xu, Tianle; Jin, Di; Guo, Junfei; Zhuang, Su; Shen, Xiangzhen			Epigenetic Mechanisms Contribute to the Expression of Immune Related Genes in the Livers of Dairy Cows Fed a High Concentrate Diet	PLOS ONE			English	Article							SUBACUTE RUMINAL ACIDOSIS; INFLAMMATORY RESPONSE; HISTONE DEMETHYLASE; VITAMIN-D; LIPOPOLYSACCHARIDE; PROMOTER; TRANSCRIPTION; APOPTOSIS; ENDOTOXIN; PROTEINS	Purpose Epigenetic modifications critically regulate the expression of immune-related genes in response to inflammatory stimuli. It has been extensively reported that a high concentrate (HC) diet can trigger systemic inflammation in dairy cows, yet it is unclear whether epigenetic regulation is involved in the expression of immune genes in the livers of dairy cows. This study aimed to investigate the impact of epigenetic modifications on the expression of immune-related genes. Experimental Design In eight mid-lactating cows, we installed a rumen cannula and catheters of the portal and hepatic veins. Cows were randomly assigned to either the treatment group fed a high concentrate (HC) diet (60% concentrate + 40% forage, n = 4) or a control group fed a low concentrate (LC) diet (40% concentrate + 60% forage, n = 4). Results After 10 weeks of feeding, the rumen pH was reduced, and levels of lipopolysaccharide (LPS) in the rumen, and portal and hepatic veins were notably increased in the HC group compared with the LC group. The expression levels of detected immune response-related genes, including Toll-like receptor 4 (TLR4), cytokines, chemokines, and acute phase proteins, were significantly up-regulated in the livers of cows fed a HC diet. Chromatin loosening at the promoter region of four candidate immune-related genes (TLR4, LPS-binding protein, haptoglobin, and serum amyloid A3) was elicited, and was strongly correlated with enhanced expression of these genes in the HC group. Demethylation at the promoter region of all four candidate immune-related genes was accompanied by chromatin decompaction. Conclusion After HC diet feeding, LPS derived from the digestive tract translocated to the liver via the portal vein, enhancing hepatic immune gene expression. The up-regulation of these immune genes was mediated by epigenetic mechanisms, which involve chromatin remodeling and DNA methylation. Our findings suggest that modulating epigenetic mechanisms could provide novel ways to treat systemic inflammatory responses elicited by the feeding of a HC diet.	[Chang, Guangjun; Zhang, Kai; Xu, Tianle; Jin, Di; Guo, Junfei; Shen, Xiangzhen] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Zhuang, Su] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Shen, XZ (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	xzshen@njau.edu.cn			National Basic Research Program of China [2011CB100802]; National Natural Science Foundation of China [31172371]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The study was supported by funds from the National Basic Research Program of China (2011CB100802), the National Natural Science Foundation of China (31172371) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arambasic J, 2010, IUBMB LIFE, V62, P227, DOI 10.1002/iub.313; Bayarsaihan D, 2011, J DENT RES, V90, P9, DOI 10.1177/0022034510378683; Bieghs V, 2013, TRENDS IMMUNOL, V34, P446, DOI 10.1016/j.it.2013.04.005; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang GJ, 2015, VET J IN PRESS; Amormino SAD, 2013, HUM IMMUNOL, V74, P1231, DOI 10.1016/j.humimm.2013.04.037; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Doherty R, 2013, VET IMMUNOL IMMUNOP, V154, P102, DOI 10.1016/j.vetimm.2013.05.004; Dong GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107659; Dong GZ, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-48; Dong HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082850; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; Emmanuel DGV, 2008, J DAIRY SCI, V91, P606, DOI 10.3168/jds.2007-0256; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gozho GN, 2007, J DAIRY SCI, V90, P856, DOI 10.3168/jds.S0022-0302(07)71569-2; Gozho GN, 2005, J DAIRY SCI, V88, P1399, DOI 10.3168/jds.S0022-0302(05)72807-1; Green BB, 2014, VET IMMUNOL IMMUNOP, V157, P49, DOI 10.1016/j.vetimm.2013.10.015; Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489; Jourdan T, 2009, J NUTR, V139, P1901, DOI 10.3945/jn.109.111062; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Kirschning CJ, 1997, IMMUNOBIOLOGY, V198, P124; Kudo S, 1998, MOL CELL BIOL, V18, P5492, DOI 10.1128/MCB.18.9.5492; Larson MA, 2006, GENE, V380, P104, DOI 10.1016/j.gene.2006.05.019; Liaskou E., 2012, MEDIAT INFLAMM, V2012, P1, DOI DOI 10.1155/2012/949157; Liu JH, 2014, VET J, V201, P95, DOI 10.1016/j.tvjl.2014.03.025; Liu JH, 2014, BRIT J NUTR, V112, P416, DOI 10.1017/S0007114514000993; Liu SZ, 2011, MOL IMMUNOL, V48, P895, DOI 10.1016/j.molimm.2010.12.018; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MIMURA Y, 1995, GASTROENTEROLOGY, V109, P1969, DOI 10.1016/0016-5085(95)90765-3; Murata H, 2004, VET J, V168, P28, DOI 10.1016/S1090-0233(03)00119-9; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; De Oliveira NFP, 2011, J CLIN PERIODONTOL, V38, P975, DOI 10.1111/j.1600-051X.2011.01765.x; Pereira F, 2012, CELL CYCLE, V11, P1081, DOI 10.4161/cc.11.6.19508; Pereira F, 2011, HUM MOL GENET, V20, P4655, DOI 10.1093/hmg/ddr399; Plaizier JC, 2012, ANIM FEED SCI TECH, V172, P9, DOI 10.1016/j.anifeedsci.2011.12.004; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; Saturnino SF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-240; Shuto T, 2006, FASEB J, V20, P782, DOI 10.1096/fj.05-4934fje; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tao SY, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0235-2; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Vels L, 2009, J DAIRY SCI, V92, P922, DOI 10.3168/jds.2008-1209; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Yoshioka M, 1998, VET IMMUNOL IMMUNOP, V66, P301, DOI 10.1016/S0165-2427(98)00206-2; Zebeli Q, 2009, J DAIRY SCI, V92, P3800, DOI 10.3168/jds.2009-2178; Zhong J, 2006, BBA-MOL BASIS DIS, V1762, P468, DOI 10.1016/j.bbadis.2005.12.012; Zhou J, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0172-0	48	20	21	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123942	10.1371/journal.pone.0123942	http://dx.doi.org/10.1371/journal.pone.0123942			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860644	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300124
J	Zhang, L; McCarthy, DM; Sharma, N; Bhide, PG				Zhang, Lin; McCarthy, Deirdre M.; Sharma, Nutan; Bhide, Pradeep G.			Dopamine Receptor and Ga(olf) Expression in DYT1 Dystonia Mouse Models during Postnatal Development	PLOS ONE			English	Article							D2 RECEPTOR; CEREBRAL-CORTEX; GENE DYT1; TORSINA; HYPERACTIVITY; LOCALIZATION; BINDING; G(OLF)	Background DYT1 dystonia is a heritable, early-onset generalized movement disorder caused by a GAG deletion (Delta GAG) in the DYT1 gene. Neuroimaging studies and studies using mouse models suggest that DYT1 dystonia is associated with dopamine imbalance. However, whether dopamine imbalance is key to DYT1 or other forms of dystonia continues to be debated. Methodology/Principal Findings We used Dyt1 knock out (Dyt1 KO), Dyt1 Delta GAG knock-in (Dyt1 KI), and transgenic mice carrying one copy of the human DYT1 wild type allele (DYT1hWT) or human Delta GAG mutant allele (DYT1hMT). D1R, D2R, and Ga(olf) protein expression was analyzed by western blot in the frontal cortex, caudate-putamen and ventral midbrain in young adult (postnatal day 60; P60) male mice from all four lines; and in the frontal cortex and caudate putamen in juvenile (postnatal day 14; P14) male mice from the Dyt1 KI and KO lines. Dopamine receptor and Ga(olf) protein expression were significantly decreased in multiple brain regions of Dyt1 KI and Dyt1 KO mice and not significantly altered in the DYT1hMT or DYT1hWT mice at P60. The only significant change at P14 was a decrease in D1R expression in the caudate-putamen of the Dyt1KO mice. Conclusion/Significance We found significant decreases in key proteins in the dopaminergic system in multiple brain regions of Dyt1 KO and Dyt1 KI mouse lines at P60. Deletion of one copy of the Dyt1 gene (KO mice) produced the most pronounced effects. These data offer evidence that impaired dopamine receptor signaling may be an early and significant contributor to DYT1 dystonia pathophysiology.	[Zhang, Lin; McCarthy, Deirdre M.; Bhide, Pradeep G.] Florida State Univ, Dept Biomed Sci, Ctr Brain Repair, Coll Med, Tallahassee, FL 32306 USA; [Sharma, Nutan] Massachusetts Gen Hosp, Neurol, Boston, MA 02114 USA; [Sharma, Nutan] Harvard Univ, Sch Med, Boston, MA USA	State University System of Florida; Florida State University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Zhang, L (corresponding author), Florida State Univ, Dept Biomed Sci, Ctr Brain Repair, Coll Med, Tallahassee, FL 32306 USA.	lin.zhang@med.fsu.edu; pradeep.bhide@med.fsu.edu		Bhide, Pradeep/0000-0003-4236-9415	Brian Jackson Dystonia Research and Discovery Fund; NINDS [P01NS037409]	Brian Jackson Dystonia Research and Discovery Fund; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by the Brian Jackson Dystonia Research and Discovery Fund and NINDS P01NS037409.	Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; [Anonymous], 2012, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0033669; Araki KY, 2007, BRAIN RES, V1156, P31, DOI 10.1016/j.brainres.2007.04.043; Asanuma K, 2005, NEUROLOGY, V64, P347, DOI 10.1212/01.WNL.0000149764.34953.BF; Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.3.CO;2-Q; Augood SJ, 2002, NEUROLOGY, V59, P445, DOI 10.1212/WNL.59.3.445; Augood SJ, 1998, ANN NEUROL, V43, P669, DOI 10.1002/ana.410430518; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Bhide PG, 1996, J NEUROSCI, V16, P5523; BOUNDY VA, 1993, J NEUROCHEM, V60, P2181, DOI 10.1111/j.1471-4159.1993.tb03504.x; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Bressman, 2000, Curr Treat Options Neurol, V2, P275, DOI 10.1007/s11940-000-0009-y; Cao SS, 2010, DIS MODEL MECH, V3, P386, DOI 10.1242/dmm.003715; Chen YI, 2010, DEV NEUROSCI-BASEL, V32, P125, DOI 10.1159/000286215; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Fahn S, 1991, Int J Neurol, V25-26, P70; Fahn S, 1988, Adv Neurol, V50, P1; Fiorentini C, 2008, MOL PHARMACOL, V74, P59, DOI 10.1124/mol.107.043885; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Fuller J, 2013, STEREOT FUNCT NEUROS, V91, P190, DOI 10.1159/000345113; Granata A, 2009, J NEUROCHEM, V109, P1596, DOI 10.1111/j.1471-4159.2009.06095.x; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; KEEPERS GA, 1987, J CLIN PSYCHOPHARM, V7, P342; Marrero-Gonzalez PC, 2014, CURR DRUG SAF, V9, P60, DOI 10.2174/18715249113136660060; McCarthy DM, 2011, J NEUROSCI, V31, P13400, DOI 10.1523/JNEUROSCI.2944-11.2011; Mengual E, 2002, SYNAPSE, V43, P151, DOI 10.1002/syn.10033; Naumann M, 1998, MOVEMENT DISORD, V13, P319, DOI 10.1002/mds.870130219; Nishimura K, 2014, J STROKE CEREBROVASC, V23, P1267, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.028; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Sadnicka A, 2012, CLIN NEUROPHYSIOL, V123, P65, DOI 10.1016/j.clinph.2011.04.027; Sako W, 2010, NEUROSCIENCE, V170, P497, DOI 10.1016/j.neuroscience.2010.06.072; Sciamanna G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024261; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; STAEDT J, 1995, EUR ARCH PSY CLIN N, V245, P8, DOI 10.1007/BF02191538; Vasudevan A, 2006, BRAIN RES, V1073, P139, DOI 10.1016/j.brainres.2005.12.087; Vasudevan A, 2008, NAT NEUROSCI, V11, P429, DOI 10.1038/nn2074; Vemula SR, 2013, HUM MOL GENET, V22, P2510, DOI 10.1093/hmg/ddt102; Warner TT, 2010, BIOCHEM SOC T, V38, P452, DOI 10.1042/BST0380452; Yokoi F, 2008, J BIOCHEM, V143, P39, DOI 10.1093/jb/mvm191; Yokoi F, 2015, BEHAV BRAIN RES, V279, P202, DOI 10.1016/j.bbr.2014.11.037; Yokoi F, 2010, J BIOCHEM, V148, P459, DOI 10.1093/jb/mvq078; Zhang L, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-469; Zhu JM, 2012, J NEUROSCI, V32, P9410, DOI 10.1523/JNEUROSCI.1041-12.2012	46	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123104	10.1371/journal.pone.0123104	http://dx.doi.org/10.1371/journal.pone.0123104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860259	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300078
J	Vivien, R; Wyler, S; Lafont, M; Pawlowski, J				Vivien, Regis; Wyler, Sofia; Lafont, Michel; Pawlowski, Jan			Molecular Barcoding of Aquatic Oligochaetes: Implications for Biomonitoring	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; WORMS ANNELIDA; CLITELLATA; SEDIMENTS; PHYLOGENY; IDENTIFICATION; ASSEMBLAGES; DIVERSITY; RECOVERY; QUALITY	Aquatic oligochaetes are well recognized bioindicators of quality of sediments and water in watercourses and lakes. However, the difficult taxonomic determination based on morphological features compromises their more common use in eco-diagnostic analyses. To overcome this limitation, we investigated molecular barcodes as identification tool for broad range of taxa of aquatic oligochaetes. We report 185 COI and 52 ITS2 rDNA sequences for specimens collected in Switzerland and belonging to the families Naididae, Lumbriculidae, Enchytraeidae and Lumbricidae. Phylogenetic analyses allowed distinguishing 41 lineages separated by more than 10 % divergence in COI sequences. The lineage distinction was confirmed by Automatic Barcode Gap Discovery (ABGD) method and by ITS2 data. Our results showed that morphological identification underestimates the oligochaete diversity. Only 26 of the lineages could be assigned to morphospecies, of which seven were sequenced for the first time. Several cryptic species were detected within common morphospecies. Many juvenile specimens that could not be assigned morphologically have found their home after genetic analysis. Our study showed that COI barcodes performed very well as species identifiers in aquatic oligochaetes. Their easy amplification and good taxonomic resolution might help promoting aquatic oligochaetes as bioindicators for next generation environmental DNA biomonitoring of aquatic ecosystems.	[Vivien, Regis; Wyler, Sofia; Pawlowski, Jan] Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland	University of Geneva	Vivien, R (corresponding author), Univ Geneva, Dept Genet & Evolut, Geneva, Switzerland.	regisvivien@hotmail.com	Pawlowski, Jan/AAO-3306-2021; Vivien, Régis/AAN-2549-2020	Pawlowski, Jan/0000-0003-2421-388X; 	SWISSBOL; UNITEC; Fondation Schmidheiny	SWISSBOL; UNITEC; Fondation Schmidheiny	This work was supported by SWISSBOL (www.swissbol.ch), UNITEC (www.unige.ch/unitec/presentation.html) and the Fondation Schmidheiny (www.fondation-schmidheiny.ch/informations.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achurra A, 2013, INVERTEBR SYST, V27, P118, DOI 10.1071/IS12049; AFNOR, 2005, NF T 90 391; AFNOR, 2002, NF T 90 390; Armendariz L, 2012, LIMNOLOGICA, V42, P118, DOI 10.1016/j.limno.2011.09.005; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beauchamp KA, 2001, MOL PHYLOGENET EVOL, V19, P216, DOI 10.1006/mpev.2001.0923; Bely AE, 2004, MOL PHYLOGENET EVOL, V30, P50, DOI 10.1016/S1055-7903(03)00180-5; Brinkhurst RO, 1971, GUIDE IDENTIFICATION; Brinkhurst RO, 1966, WATER SEWAGE WORKS, V113, P434; Brodin Y, 2013, MOL ECOL RESOUR, V13, P996, DOI 10.1111/1755-0998.12053; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Crottini A, 2008, MOL PHYLOGENET EVOL, V48, P1189, DOI 10.1016/j.ympev.2008.06.012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Envall I, 2012, ZOOL J LINN SOC-LOND, V165, P495, DOI 10.1111/j.1096-3642.2012.00828.x; Erseus C, 2010, MOL PHYLOGENET EVOL, V57, P849, DOI 10.1016/j.ympev.2010.07.005; Erseus C, 2009, ANNELIDS IN MODERN BIOLOGY, P31; Erseus Christer, 2008, Zootaxa, V1744, P66; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gustafsson DR, 2009, MOL PHYLOGENET EVOL, V51, P182, DOI 10.1016/j.ympev.2008.12.016; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hallett SL, 2005, HYDROBIOLOGIA, V543, P305, DOI 10.1007/s10750-004-6954-9; Kvist S, 2010, MOL PHYLOGENET EVOL, V57, P687, DOI 10.1016/j.ympev.2010.08.018; Lafont M, 2006, HYDROBIOLOGIA, V564, P171, DOI 10.1007/s10750-005-1717-9; Lafont M., 2010, Ecohydrology and Hydrobiology, V10, P3, DOI 10.2478/v10104-009-0047-3; Lafont M., 1989, THESIS; Lafont Michel, 2012, Ecohydrology & Hydrobiology, V12, P9, DOI [10.2478/v10104-012-0004-4, 10.2478/v10104-011-0032-5]; Lang C, 1997, AQUAT SCI, V59, P26, DOI 10.1007/PL00001303; Lang Claude, 2009, Bulletin de la Societe Vaudoise des Sciences Naturelles, V91, P283; Lods-Crozet B, 2005, REV SUISSE ZOOL, V112, P543, DOI 10.5962/bhl.part.80313; Martinsson S, 2013, ZOOL SCR, V42, P612, DOI 10.1111/zsc.12032; Milbrink G, 2002, HYDROBIOLOGIA, V468, P53, DOI 10.1023/A:1015274323026; Navajas M, 1998, HEREDITY, V80, P742, DOI 10.1046/j.1365-2540.1998.00349.x; Prygiel J, 1999, HYDROBIOLOGIA, V410, P25, DOI 10.1023/A:1003799224961; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rodriguez P, 2011, THE POLLUTION BIOLOG; Rodriguez Pilar, 2010, Zootaxa, V2332, P21; Rougerie R, 2009, PESQUI AGROPECU BRAS, V44, P789, DOI 10.1590/S0100-204X2009000800002; Sarka J, 1994, HYDROBIOLOGIA, V322, P29, DOI DOI 10.1007/978-94-011-0842-3_26; Schmelz Ruediger M., 2010, Soil Organisms, V82, P1; SPERBER CHRISTINA, 1950, ZOOL BIDRAG UPPSALA, V29, P45; Sturmbauer C, 1999, MOL BIOL EVOL, V16, P967, DOI 10.1093/oxfordjournals.molbev.a026186; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Timm T, 2001, HYDROBIOLOGIA, V463, P223, DOI 10.1023/A:1013176229631; TIMM T., 2002, FRESHWATER OLIGOCHAE; Timm Tarmo, 2009, Lauterbornia, V66, P1; Tixier G, 2011, WATER SCI TECHNOL, V64, P1503, DOI 10.2166/wst.2011.155; Tkach V, 1999, ACTA PARASITOL, V44, P147; Verdonschot PFM, 2006, HYDROBIOLOGIA, V564, P127, DOI 10.1007/s10750-005-1714-z; Vivien R, 2015, REV SUISSE ZOOL IN P, V122; Vivien Regis, 2014, Ecohydrology & Hydrobiology, V14, P142, DOI 10.1016/j.ecohyd.2014.03.003; Vivien R, 2013, REV SUISSE ZOOL, V120, P415; Vivien R, 2013, REV SUISSE ZOOL, V120, P161; Vivien Regis, 2011, Bulletin de la Societe Vaudoise des Sciences Naturelles, V92, P153; Zhou H, 2010, ZOOL SCR, V39, P378, DOI 10.1111/j.1463-6409.2010.00429.x	57	32	38	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0125485	10.1371/journal.pone.0125485	http://dx.doi.org/10.1371/journal.pone.0125485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856230	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500127
J	Kawahara, T; Imawatari, R; Kawahara, C; Inazu, T; Suzuki, G				Kawahara, Tetsuya; Imawatari, Ryuichiro; Kawahara, Chie; Inazu, Tetsuya; Suzuki, Gen			Incidence of Type 2 Diabetes in Pre-Diabetic Japanese Individuals Categorized by HbA(1c) Levels: A Historical Cohort Study	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; MIDDLE-AGED JAPANESE; HEMOGLOBIN A1C; RISK-FACTORS; MELLITUS; WOMEN; US; METAANALYSIS; POPULATION; PREVENTION	Objective Reported incidence of type 2 diabetes estimated at the pre-diabetic stage differs widely (2.3-18.1% per year). Because clinicians need to know the risk of incident diabetes after a diagnosis of pre-diabetes, our objective was to estimate precise incidence of diabetes using baseline HbA(1c) levels. Methods A historical cohort study using electronic medical record data obtained between January 2008 and December 2013. A total of 52,781 individuals with HbA(1c) < 6.5% were assigned to one of six groups categorized by baseline HbA(1c) level: <= 5.5% (n=34,616), 5.6-5.7% (n=9,388), 5.8-5.9% (n= 4,664), 6.0-6.1% (n=2,338), 6.2-6.3% (n=1,257), and 6.4% (n=518). Participants were tracked until a subsequent diagnosis of diabetes or end of follow-up during a period of 5 years. Results During the follow-up period (mean 3.7 years), 4,369 participants developed diabetes. The incidence of diabetes in the first year was 0.7, 1.5, 2.9, 9.2, 30.4, and 44.0% in the six HbA(1c) groups, respectively. At five years the incidence was 3.6, 8.9, 13.8, 27.5, 51.6, and 67.8%, respectively (p < 0.0001 comparing the HbA(1c) <= 5.5% group to the other groups). After adjustment for confounding factors, the hazard ratios compared with the HbA(1c) <= 5.5% group were significantly elevated: 2.3 (95% CI 2.0-2.5), 3.4 (95% CI 2.9-3.7), 8.8 (95% CI 8.0-10.1), 26.3 (95% CI 23.3-30.1), and 48.7 (95% CI 40.8-58.1) in the five HbA(1c) groups (p < 0.0001). Conclusion By fractionating baseline HbA(1c) levels into narrower HbA(1c) range groups, accuracy of estimating the incidence of type 2 diabetes in subsequent years was increased. The risk of developing diabetes increased with increasing HbA(1c) levels, especially with the HbA(1c) level >= 6.2% in the first follow-up year.	[Kawahara, Tetsuya; Imawatari, Ryuichiro] Kokura Med Assoc, Hlth Testing Ctr, Kitakyushu, Fukuoka, Japan; [Imawatari, Ryuichiro] Kitakyushu Med Assoc Comm Hlth Promot, Kitakyushu, Fukuoka, Japan; [Imawatari, Ryuichiro] Kokura Med Assoc, Kitakyushu, Fukuoka, Japan; [Kawahara, Chie] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 807, Japan; [Inazu, Tetsuya] Ritsumeikan Univ, Dept Pharm, Shiga, Japan; [Suzuki, Gen] Int Univ Hlth & Welf Clin, Dept Internal Med, Otawara, Tochigi, Japan	University of Occupational & Environmental Health - Japan; Ritsumeikan University; International University of Health & Welfare	Kawahara, T (corresponding author), Kokura Med Assoc, Hlth Testing Ctr, Kitakyushu, Fukuoka, Japan.	k-tetsuy@med.uoeh-u.ac.jp		Kawahara, Tetsuya/0000-0002-1268-4871				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; American Diabetes A Economic costs of diabetes in the U.S, 2008, DIABETES CARE, V31, P596, DOI [10.2337/dc08-9017, DOI 10.2337/DC08-9017]; [Anonymous], 2008, HLTH SCREEN NINGEN D, V22, P874; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Bi YF, 2012, DIABETES-METAB RES, V28, P32, DOI 10.1002/dmrr.2352; Cheng PY, 2011, DIABETES CARE, V34, P610, DOI 10.2337/dc10-0625; Divajeva D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-456; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Edelman D, 2004, J GEN INTERN MED, V19, P1175, DOI 10.1111/j.1525-1497.2004.40178.x; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074699; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Herman WH, 2011, MED CLIN N AM, V95, P373, DOI 10.1016/j.mcna.2010.11.010; InternationalDiabetesFederation, 2013, DIAB ATL, P155; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Liu XQ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-729; Ministry of Education C Sports Science and Technology Ministry of Health Labour and Welfare, 2002, ETH GUID EP RES; Nakanishi N, 2004, DIABETOLOGIA, V47, P1768, DOI 10.1007/s00125-004-1528-y; Narayan KMV, 2007, DIABETES CARE, V30, P1562, DOI 10.2337/dc06-2544; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pradhan AD, 2007, AM J MED, V120, P720, DOI 10.1016/j.amjmed.2007.03.022; Rana JS, 2007, DIABETES CARE, V30, P53, DOI 10.2337/dc06-1456; Sato KK, 2009, DIABETES CARE, V32, P644, DOI 10.2337/dc08-1631; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077919; Shimazaki T, 2007, TRANSL RES, V149, P196, DOI 10.1016/j.trsl.2006.09.008; Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x; Upadhyay RP, 2013, DIABETES RES CLIN PR, V102, P1, DOI 10.1016/j.diabres.2013.06.011; van't Riet E, 2010, DIABETES CARE, V33, P763, DOI 10.2337/dc09-1586; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122698	10.1371/journal.pone.0122698	http://dx.doi.org/10.1371/journal.pone.0122698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853519	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400078
J	Mori, R; Yonemoto, N; Noma, H; Ochirbat, T; Barber, E; Soyolgerel, G; Nakamura, Y; Lkhagvasuren, O				Mori, Rintaro; Yonemoto, Naohiro; Noma, Hisashi; Ochirbat, Tumendemberel; Barber, Emma; Soyolgerel, Gochoo; Nakamura, Yasuhide; Lkhagvasuren, Oyun			The Maternal and Child Health (MCH) Handbook in Mongolia: A Cluster-Randomized, Controlled Trial	PLOS ONE			English	Article							CARE; CONTINUUM	Objective To assess the effectiveness of the Maternal and Child Health (MCH) handbook in Mongolia to increase antenatal clinic attendance, and to enhance health-seeking behaviors and other health outcomes. Methods A cluster randomized trial was conducted using the translated MCH handbook in Bulgan, Mongolia to assess its effectiveness in promoting antenatal care attendance. Pregnant women were recruited from 18 randomly allocated districts using shuffled, sealed envelopes. The handbook was implemented immediately for women at their first antenatal visit in the intervention group, and nine months later in the control group. The primary outcome was the number of antenatal care visits of all women residing in the selected districts. Cluster effects were adjusted for using generalized estimation equation. Masking was not possible among care providers, pregnant women and assessors. Findings Nine districts were allocated to the intervention group and the remainder to the control group. The intervention group (253 women) attended antenatal clinics on average 6.9 times, while the control group (248 women) attended 6.2 times. Socioeconomic status affected the frequency of clinic attendance: women of higher socioeconomic status visited antenatal clinics more often. Pregnancy complications were more likely to be detected among women using the handbook. Conclusion The MCH handbook promotes continuous care and showed an increase in antenatal visits among the intervention group. The intervention will help to identify maternal morbidities during pregnancy and promote health-seeking behaviors.	[Mori, Rintaro; Barber, Emma] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Yonemoto, Naohiro] Natl Ctr Neurol & Psychiat, Dept Psychopharmacol, Tokyo, Japan; [Noma, Hisashi] Inst Stat Math, Dept Data Sci, Tokyo, Japan; [Ochirbat, Tumendemberel] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo, Japan; [Soyolgerel, Gochoo] Minist Hlth, Med Care Policy Implementat & Coordinat, Ulaanbaatar, Mongolia; [Nakamura, Yasuhide] Osaka Univ, Grad Sch Human Sci, Dept Int Collaborat, Osaka, Japan; [Lkhagvasuren, Oyun] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada	National Center for Child Health & Development - Japan; National Center for Neurology & Psychiatry - Japan; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; University of Tokyo; Ministry of Health Mongolia; Osaka University; Simon Fraser University	Mori, R (corresponding author), Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan.	rintaromori@gmail.com	Naohiro, Yonemoto/Y-3761-2019	Noma, Hisashi/0000-0002-2520-9949; Mori, Rintaro/0000-0001-7656-6156	National Center for Global Health and Medicine, Tokyo, Japan	National Center for Global Health and Medicine, Tokyo, Japan	This study was funded by the National Center for Global Health and Medicine, Tokyo, Japan. The authors affirm that they have not entered into an agreement with the funder that may have limited our ability to complete the research as planned. They also confirm that all authors had full control of all primary data.	[Anonymous], MIN HLTH LAB WELF MA; Brown HC, 2004, COCHRANE DB SYST REV, V2, DOI [DOI 10.1002/14651858.CD002856.PUB2, 10.1002/14651858.CD002856.pub2]; Fujimoto S, 2001, Nihon Koshu Eisei Zasshi, V48, P486; Hagiwara A, 2013, J PUBLIC HEALTH POL, V34, P31, DOI 10.1057/jphp.2012.56; Hayes RJ, 2009, INTERD STAT, P3; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Llano R, 2011, LANCET, V378, P1255, DOI 10.1016/S0140-6736(11)61048-9; Ministry of Health UNICEF and WHO, 2010, POOR IN STAND CAR CO; Osaki K, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20429; Soyolgerel G, 2008, 6 INT C MAT CHILD HL; Takayanagi K, 1992, CLIN PERFORM QUAL HL, V1, P29; Takemi K, 2008, LANCET, V372, P13, DOI 10.1016/S0140-6736(08)60971-X; UNDP, 2004, MILL DEV GOALS NAT R; UNICEF, 2009, SIT AN CHILDR WOM MO; UNICEF Mongolia, CHILDR CHILD SURV; Varnell SP, 2004, AM J PUBLIC HEALTH, V94, P393, DOI 10.2105/AJPH.94.3.393; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2010, B WORLD HEALTH ORGAN, V88, P192, DOI [10.2471/BLT.08.061747, DOI 10.2471/BLT.08.061747]; WHO Aga Khan University PMNCH, 2011, ESS INT COMM GUID RE; World Health Organization, 2010, WORK IND FAM COMM IM	21	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0119772	10.1371/journal.pone.0119772	http://dx.doi.org/10.1371/journal.pone.0119772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853511	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400006
J	Vangipurapu, J; Stancakova, A; Kuulasmaa, T; Kuusisto, J; Laakso, M				Vangipurapu, Jagadish; Stancakova, Alena; Kuulasmaa, Teemu; Kuusisto, Johanna; Laakso, Markku			Both Fasting and Glucose-Stimulated Proinsulin Levels Predict Hyperglycemia and Incident Type 2 Diabetes: A Population-Based Study of 9,396 Finnish Men	PLOS ONE			English	Article							ACUTE INSULIN-RESPONSE; DISPROPORTIONATELY ELEVATED PROINSULIN; BETA-CELL DYSFUNCTION; INDEPENDENTLY PREDICT; HYPERPROINSULINEMIA; RESISTANCE; TOLERANCE; MELLITUS; SENSITIVITY; SECRETION	Background Hyperproinsulinemia is an indicator of beta-cell dysfunction, and fasting proinsulin levels are elevated in patients with hyperglycemia. It is not known whether proinsulin levels after a glucose load are better predictors of hyperglycemia and type 2 diabetes than fasting proinsulin. Methods Participants were 9,396 Finnish men (mean +/- SD, age 57.3 +/- 7.1 years, BMI 27.0 +/- 4.0 kg/ m(2)) of the population-based METabolic Syndrome In Men Study who were non-diabetic at the recruitment, and who participated in a 6-year follow-up study. Proinsulin and insulin levels were measured in the fasting state and 30 and 120 min after an oral glucose load. Area under the curve (AUC) and proinsulin to insulin ratios were calculated. Results Fasting proinsulin, proinsulin at 30 min and proinsulin AUC during the first 30 min of an oral glucose tolerance test significantly predicted both the worsening of hyperglycemia and type 2 diabetes after adjustment for confounding factors. Further adjustment for insulin sensitivity (Matsuda index) or insulin secretion (Disposition index) weakened these associations. Insulin sensitivity had a major impact on these associations. Conclusion Our results suggest that proinsulin in the fasting state and after an oral glucose load similarly predict the worsening of hyperglycemia and conversion to type 2 diabetes.	[Vangipurapu, Jagadish; Stancakova, Alena; Kuulasmaa, Teemu; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Fac Hlth Sci, Inst Clin Med, Internal Med, Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Laakso, M (corresponding author), Univ Eastern Finland, Fac Hlth Sci, Inst Clin Med, Internal Med, Kuopio, Finland.	markku.laakso@kuh.fi	Stancakova, Alena/AAN-6723-2020	Stancakova, Alena/0000-0002-1375-0252	Academy of Finland; Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; University of eastern Finland, Kuopio, Finland; EVO Grant from the Kuopio University Hospital [5263]	Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; University of eastern Finland, Kuopio, Finland; EVO Grant from the Kuopio University Hospital	This work has been supported by the grants from the Academy of Finland, the Finnish Diabetes Research Foundation, the Finnish Cardiovascular Research Foundation, the Strategic Research Funding from the University of eastern Finland, Kuopio, Finland, and EVO Grant 5263 from the Kuopio University Hospital to ML. The funding bodies named above had no role in the design and conduct of the study; collection management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	ALARCON C, 1995, J CLIN INVEST, V95, P1032, DOI 10.1172/JCI117748; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; BIRKELAND KI, 1994, DIABETES CARE, V17, P1307, DOI 10.2337/diacare.17.11.1307; Breuer TGK, 2010, EUR J ENDOCRINOL, V163, P551, DOI 10.1530/EJE-10-0330; Festa A, 2008, DIABETES, V57, P1638, DOI 10.2337/db07-0954; Grill V, 2002, AM J EPIDEMIOL, V155, P834, DOI 10.1093/aje/155.9.834; HAFFNER SM, 1994, DIABETES, V43, P1490, DOI 10.2337/diabetes.43.12.1490; Hanley AJG, 2002, DIABETES, V51, P1263, DOI 10.2337/diabetes.51.4.1263; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Kahn SE, 1997, DIABETES, V46, P1725, DOI 10.2337/diabetes.46.11.1725; Kahn SE, 1996, DIABETIC MED, V13, pS63; Larsson H, 1999, J CLIN ENDOCR METAB, V84, P2068, DOI 10.1210/jc.84.6.2068; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P3047, DOI 10.1007/s00125-011-2322-2; Lorenzo C, 2014, ACTA DIABETOL, V51, P617, DOI 10.1007/s00592-014-0565-3; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mykkanen L, 1997, DIABETES, V46, P1990, DOI 10.2337/diabetes.46.12.1990; MYKKANEN L, 1995, DIABETOLOGIA, V38, P1176, DOI 10.1007/BF00422366; Ozawa S, 2014, ENDOCR J, V61, P607, DOI 10.1507/endocrj.EJ13-0506; Pfutzner A, 2004, DIABETES CARE, V27, P682, DOI 10.2337/diacare.27.3.682; Pradhan AD, 2003, AM J MED, V114, P438, DOI 10.1016/S0002-9343(03)00061-5; RHODES CJ, 1994, DIABETES, V43, P511, DOI 10.2337/diabetes.43.4.511; Roder ME, 1998, J CLIN ENDOCR METAB, V83, P604, DOI 10.1210/jc.83.2.604; SAAD MF, 1990, J CLIN ENDOCR METAB, V70, P1247, DOI 10.1210/jcem-70-5-1247; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stumvoll M, 2001, J CLIN ENDOCR METAB, V86, P1235, DOI 10.1210/jc.86.3.1235; Vauhkonen IKJ, 2000, EUR J ENDOCRINOL, V143, P251, DOI 10.1530/eje.0.1430251; WARD WK, 1987, DIABETOLOGIA, V30, P698, DOI 10.1007/BF00296991; Wareham NJ, 1999, DIABETES CARE, V22, P262, DOI 10.2337/diacare.22.2.262; Weiss R, 2005, DIABETES, V54, P1735, DOI 10.2337/diabetes.54.6.1735; Zethelius B, 2004, DIABETES CARE, V27, P1433, DOI 10.2337/diacare.27.6.1433; Zethelius B, 2003, DIABETOLOGIA, V46, P20, DOI 10.1007/s00125-002-0995-2	35	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124028	10.1371/journal.pone.0124028	http://dx.doi.org/10.1371/journal.pone.0124028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853252	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400130
J	Watanabe, H; Morimoto, T; Natsuaki, M; Furukawa, Y; Nakagawa, Y; Kadota, K; Yamaji, K; Ando, K; Shizuta, S; Shiomi, H; Tada, T; Tazaki, J; Kato, Y; Hayano, M; Abe, M; Tamura, T; Shirotani, M; Miki, S; Matsuda, M; Takahashi, M; Ishii, K; Tanaka, M; Aoyama, T; Doi, O; Hattori, R; Kato, M; Suwa, S; Takizawa, A; Takatsu, Y; Shinoda, E; Eizawa, H; Takeda, T; Lee, JD; Inoko, M; Ogawa, H; Hamasaki, S; Horie, M; Nohara, R; Kambara, H; Fujiwara, H; Mitsudo, K; Nobuyoshi, M; Kita, T; Kastrati, A; Kimura, T				Watanabe, Hirotoshi; Morimoto, Takeshi; Natsuaki, Masahiro; Furukawa, Yutaka; Nakagawa, Yoshihisa; Kadota, Kazushige; Yamaji, Kyohei; Ando, Kenji; Shizuta, Satoshi; Shiomi, Hiroki; Tada, Tomohisa; Tazaki, Junichi; Kato, Yoshihiro; Hayano, Mamoru; Abe, Mitsuru; Tamura, Takashi; Shirotani, Manabu; Miki, Shinji; Matsuda, Mitsuo; Takahashi, Mamoru; Ishii, Katsuhisa; Tanaka, Masaru; Aoyama, Takeshi; Doi, Osamu; Hattori, Ryuichi; Kato, Masayuki; Suwa, Satoru; Takizawa, Akinori; Takatsu, Yoshiki; Shinoda, Eiji; Eizawa, Hiroshi; Takeda, Teruki; Lee, Jong-Dae; Inoko, Moriaki; Ogawa, Hisao; Hamasaki, Shuichi; Horie, Minoru; Nohara, Ryuji; Kambara, Hirofumi; Fujiwara, Hisayoshi; Mitsudo, Kazuaki; Nobuyoshi, Masakiyo; Kita, Toru; Kastrati, Adnan; Kimura, Takeshi		CREDO-Kyoto PCI CABG Registry Coho	Antiplatelet Therapy Discontinuation and the Risk of Serious Cardiovascular Events after Coronary Stenting: Observations from the CREDO-Kyoto Registry Cohort-2	PLOS ONE			English	Article							SIROLIMUS-ELUTING STENT; IMPLANTATION; THROMBOSIS; DURATION; OUTCOMES; PREDICTORS; INTERVENTION; EFFICACY; STROKE; TRIALS	Relation of antiplatelet therapy (APT) discontinuation with the risk of serious cardiovascular events has not been fully addressed yet. This study is aimed to evaluate the risk of ischemic event after APT discontinuation based on long-term APT status of large cohort. In the CREDO-Kyoto Registry Cohort-2 enrolling 15939 consecutive patients undergoing first coronary revascularization, 10470 patients underwent percutaneous coronary intervention either with bare-metal stents (BMS) only (N=5392) or sirolimus-eluting stents (SES) only (N=5078). Proportions of patients taking dual-APT were 67.3% versus 33.4% at 1-year, and 48.7% versus 24.3% at 5-year in the SES and BMS strata, respectively. We evaluated daily APT status (dual-, single-and no-APT) and linked the adverse events to the APT status just 1-day before the events. No-APT as compared with dual-or single-APT was associated with significantly higher risk for stent thrombosis (ST) beyond 1-month after SES implantation (cumulative incidence rates beyond 1-month: 1.23 versus 0.15/0.29, P<0.001/P<0.001), while higher risk of no-APT for ST was evident only until 6-month after BMS implantation (incidence rates between 1-and 6-month: 8.43 versus 0.71/1.20, P<0.001/P<0.001, and cumulative incidence rates beyond 6-month: 0.31 versus 0.11/0.08, P=0.16/P=0.08). No-APT as compared with dual-or single-APT was also associated with significantly higher risk for spontaneous myocardial infarction (MI) and stroke regardless of the types of stents implanted. Single-APT as compared with dual-APT was not associated with higher risk for serious adverse events, except for the marginally higher risk for ST in the SES stratum. In conclusion, discontinuation of both aspirin and thienopyridines was associated with increased risk for serious cardiovascular events including ST, spontaneous MI and stroke beyond 1-month after coronary stenting.	[Watanabe, Hirotoshi; Natsuaki, Masahiro; Shizuta, Satoshi; Shiomi, Hiroki; Tada, Tomohisa; Tazaki, Junichi; Kato, Yoshihiro; Hayano, Mamoru; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Internal Med, Div Genera Med, Nishinomiya, Hyogo 6638501, Japan; [Furukawa, Yutaka; Kita, Toru] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan; [Nakagawa, Yoshihisa] Tenri Hosp, Div Cardiol, Tenri, Nara 632, Japan; [Kadota, Kazushige; Mitsudo, Kazuaki] Kurashiki Cent Hosp, Div Cardiol, Kurashiki, Okayama, Japan; [Yamaji, Kyohei; Ando, Kenji; Nobuyoshi, Masakiyo] Kokura Mem Hosp, Div Cardiol, Kitakyushu, Fukuoka, Japan; [Abe, Mitsuru] Natl Hosp Org, Kyoto Med Ctr, Div Cardiol, Kyoto, Japan; [Tamura, Takashi] Japanese Red Cross Wakayama Med Ctr, Div Cardiol, Wakayama, Japan; [Shirotani, Manabu] Kinki Univ, Fac Med, Nara Hosp, Div Cardiol, Nara, Japan; [Miki, Shinji] Mitsubishi Kyoto Hosp, Div Cardiol, Kyoto, Japan; [Matsuda, Mitsuo] Kishiwada City Hosp, Div Cardiol, Kishiwada, Japan; [Takahashi, Mamoru] Shimabara Hosp, Div Cardiol, Kyoto, Japan; [Ishii, Katsuhisa] Kansai Elect Power Hosp, Div Cardiol, Osaka, Japan; [Tanaka, Masaru] Osaka Red Cross Hosp, Div Cardiol, Osaka, Japan; [Aoyama, Takeshi; Hattori, Ryuichi] Shimada Municipal Hosp, Div Cardiol, Shimada, Japan; [Doi, Osamu; Kambara, Hirofumi] Shizuoka Prefectural Gen Hosp, Div Cardiol, Shizuoka, Japan; [Kato, Masayuki] Maizuru Kyosai Hosp, Div Cardiol, Maizuru, Japan; [Suwa, Satoru] Juntendo Univ, Shizuoka Hosp, Div Cardiol, Shizuoka, Japan; [Takizawa, Akinori] Shizuoka City Shizuoka Hosp, Div Cardiol, Shizuoka, Japan; [Takatsu, Yoshiki; Fujiwara, Hisayoshi] Hyogo Kenritsu Amagasaki Hosp, Div Cardiol, Amagasaki, Hyogo, Japan; [Shinoda, Eiji] Hamamatsu Rosai Hosp, Div Cardiol, Hamamatsu, Shizuoka, Japan; [Eizawa, Hiroshi] Nishi Kobe Med Ctr, Div Cardiol, Kobe, Hyogo, Japan; [Takeda, Teruki] Koto Mem Hosp, Div Cardiol, Higashioumi, Japan; [Lee, Jong-Dae] Univ Fukui Hosp, Div Cardiol, Fukui, Japan; [Inoko, Moriaki] Kitano Hosp, Tazuke Kofukai Med Res Inst, Ctr Cardiovasc, Osaka, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Hamasaki, Shuichi] Kagoshima Univ, Grad Sch Med, Dept Cardiovasc Resp & Metab Med, Kagoshima 890, Japan; [Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc & Resp, Otsu, Shiga 52021, Japan; [Nohara, Ryuji] Hirakata Kohsai Hosp, Div Cardiol, Hirakata, Osaka, Japan; [Kastrati, Adnan] Deutsch Herzzentrum Munich, Munich, Germany	Kyoto University; Hyogo College of Medicine; Kobe City Medical Center General Hospital; Tenri Hospital; Kurashiki Central Hospital; Kokura Memorial Hospital; Kindai University (Kinki University); Osaka Red Cross Hospital; Shizuoka General Hospital; Juntendo University; Kobe City Medical Center General Hospital; University of Fukui; Kitano Hospital; Kumamoto University; Kagoshima University; Shiga University of Medical Science; German Heart Centre Munich	Kimura, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	taketaka@kuhp.kyoto-u.ac.jp	Watanabe, Hirotoshi/AAQ-2169-2020; , Kastrati/Y-2389-2019; Shiomi, Hiroki/ADJ-9510-2022; Horie, Minoru/ABG-7128-2020; Shizuta, Satoshi/AAL-5546-2021	Watanabe, Hirotoshi/0000-0002-9443-5915; Shiomi, Hiroki/0000-0001-7234-023X; 	CREDO-Kyoto PCI/CABG Registry Cohort-2 is Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo, Japan; Grants-in-Aid for Scientific Research [25293182] Funding Source: KAKEN	CREDO-Kyoto PCI/CABG Registry Cohort-2 is Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The source of funding of CREDO-Kyoto PCI/CABG Registry Cohort-2 is Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo, Japan (http://www.pmda.go.jp/). TK (T. Kimura) received the funding. PMDA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Brar SS, 2008, J AM COLL CARDIOL, V51, P2220, DOI 10.1016/j.jacc.2008.01.063; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Rodriguez LAG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4094; Rodriguez LAG, 2011, NEUROLOGY, V76, P740, DOI 10.1212/WNL.0b013e31820d62b5; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Kedhi E, 2012, EUROINTERVENTION, V8, P599, DOI 10.4244/EIJV8I5A92; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Kimura T, 2012, CARDIOVASC INTERV TH, V27, P181, DOI 10.1007/s12928-012-0109-0; Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059; Kimura T, 2011, CARDIOVASC INTERV TH, V26, P234, DOI 10.1007/s12928-011-0065-0; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Michael P, 2007, AM HEART J, V154, P846, DOI 10.1016/j.ahj.2007.08.028; Mulukutla SR, 2013, AM J CARDIOL, V111, P486, DOI 10.1016/j.amjcard.2012.10.030; Natsuaki M, 2014, CIRC-CARDIOVASC INTE, V7, P168, DOI 10.1161/CIRCINTERVENTIONS.113.000987; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275; Stone GW, 2008, AM J CARDIOL, V102, P1017, DOI 10.1016/j.amjcard.2008.05.050; Tada T, 2012, CIRC-CARDIOVASC INTE, V5, P381, DOI 10.1161/CIRCINTERVENTIONS.111.967463; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Weimar C, 2013, CEREBROVASC DIS, V35, P538, DOI 10.1159/000351144	34	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124314	10.1371/journal.pone.0124314	http://dx.doi.org/10.1371/journal.pone.0124314			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853836	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400137
J	Bianchi, N; Finotti, A; Ferracin, M; Lampronti, I; Zuccato, C; Breveglieri, G; Brognara, E; Fabbri, E; Borgatti, M; Negrini, M; Gambari, R				Bianchi, Nicoletta; Finotti, Alessia; Ferracin, Manuela; Lampronti, Ilaria; Zuccato, Cristina; Breveglieri, Giulia; Brognara, Eleonora; Fabbri, Enrica; Borgatti, Monica; Negrini, Massimo; Gambari, Roberto			Increase of microRNA-210, Decrease of Raptor Gene Expression and Alteration of Mammalian Target of Rapamycin Regulated Proteins following Mithramycin Treatment of Human Erythroid Cells	PLOS ONE			English	Article							GLOBIN MESSENGER-RNA; IN-VIVO; INDUCED INHIBITION; BETA-GLOBIN; S6 KINASE; DIFFERENTIATION; HYPOXIA; TRANSLATION; MIR-210; MTOR	Expression and regulation of microRNAs is an emerging issue in erythroid differentiation and globin gene expression in hemoglobin disorders. In the first part of this study microarray analysis was performed both in mithramycin-induced K562 cells and erythroid precursors from healthy subjects or beta-thalassemia patients producing low or high levels of fetal hemoglobin. We demonstrated that: (a) microRNA-210 expression is higher in erythroid precursors from beta-thalassemia patients with high production of fetal hemoglobin; (b) microRNA-210 increases as a consequence of mithramycin treatment of K562 cells and human erythroid progenitors both from healthy and beta-thalassemia subjects; (c) this increase is associated with erythroid induction and elevated expression of gamma-globin genes; (d) an anti-microRNA against microRNA-210 interferes with the mithramycin-induced changes of gene expression. In the second part of the study we have obtained convergent evidences suggesting raptor mRNA as a putative target of microRNA-210. Indeed, microRNA-210 binding sites of its 3'-UTR region were involved in expression and are targets of microRNA-210-mediated modulation in a luciferase reporter assays. Furthermore, (i) raptor mRNA and protein are down-regulated upon mithramycin-induction both in K562 cells and erythroid progenitors from healthy and beta-thalassemia subjects. In addition, (ii) administration of antimicroRNA-210 to K562 cells decreased endogenous microRNA-210 and increased raptor mRNA and protein expression. Finally, (iii) treatment of K562 cells with premicroRNA-210 led to a decrease of raptor mRNA and protein. In conclusion, microRNA-210 and raptor are involved in mithramycin-mediated erythroid differentiation of K562 cells and participate to the fine-tuning and control of gamma-globin gene expression in erythroid precursor cells.	[Bianchi, Nicoletta; Finotti, Alessia; Lampronti, Ilaria; Zuccato, Cristina; Breveglieri, Giulia; Brognara, Eleonora; Fabbri, Enrica; Borgatti, Monica; Gambari, Roberto] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Finotti, Alessia; Gambari, Roberto] Univ Ferrara, Ctr Biotechnol, Lab Dev Pharmacol & Pharmacogen Therapy Thalassae, I-44100 Ferrara, Italy; [Ferracin, Manuela; Negrini, Massimo] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Ferracin, Manuela; Negrini, Massimo] Univ Ferrara, Lab Technol Adv Therapies, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Gambari, R (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy.	gam@unife.it	Zuccato, Cristina/L-2919-2015; Breveglieri, Giulia/C-5806-2016; Gambari, Roberto/F-9555-2015; Finotti, Alessia/C-6268-2012; Ferracin, Manuela/K-2097-2016; Bianchi, Nicoletta/H-1902-2015; Borgatti, Monica/G-2611-2015; Negrini, Massimo/J-2377-2016; Fabbri, Enrica/O-8059-2015; Lampronti, Ilaria/F-5522-2016	Zuccato, Cristina/0000-0002-1380-0539; Breveglieri, Giulia/0000-0002-9013-1738; Gambari, Roberto/0000-0001-9205-6033; Finotti, Alessia/0000-0002-7638-515X; Ferracin, Manuela/0000-0002-1595-6887; Bianchi, Nicoletta/0000-0001-9280-6017; Borgatti, Monica/0000-0001-8470-2496; Negrini, Massimo/0000-0002-0007-1920; Fabbri, Enrica/0000-0002-9836-8262; Brognara, Eleonora/0000-0002-7845-5895; Lampronti, Ilaria/0000-0002-1972-7766	FondazioneCariparo (Cassa di Risparmio di Padova e Rovigo); CIB (ConsorzioInteruniversitarioBiotecnologie); UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of Beta-Thalassemia) [306201-FP7-HEALTH-2012-INNOVATION- 1]; Telethon [GGP10124]; COFIN; Associazione Veneta per la Lotta alla Talassemia (AVLT) Rovigo; Associazione per la Lotta alla Talassemia (ALT) Ferrara; AIRC	FondazioneCariparo (Cassa di Risparmio di Padova e Rovigo)(Fondazione Cariparo); CIB (ConsorzioInteruniversitarioBiotecnologie); UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of Beta-Thalassemia); Telethon(Fondazione Telethon); COFIN; Associazione Veneta per la Lotta alla Talassemia (AVLT) Rovigo; Associazione per la Lotta alla Talassemia (ALT) Ferrara; AIRC(Fondazione AIRC per la ricerca sul cancro)	Roberto Gambari is granted by FondazioneCariparo (Cassa di Risparmio di Padova e Rovigo), by CIB (ConsorzioInteruniversitarioBiotecnologie), by UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of Beta-Thalassemia; n.306201-FP7-HEALTH-2012-INNOVATION- 1), by Telethon (contract GGP10124) and by COFIN-2010. This research is also supported by Associazione Veneta per la Lotta alla Talassemia (AVLT) Rovigo, by Associazione per la Lotta alla Talassemia (ALT) Ferrara and by AIRC-2012.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bianchi N, 2001, BRIT J HAEMATOL, V113, P951, DOI 10.1046/j.1365-2141.2001.02843.x; Bianchi N, 1999, BRIT J HAEMATOL, V104, P258, DOI 10.1046/j.1365-2141.1999.01173.x; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Corn PG, 2008, CANCER BIOL THER, V7, P265, DOI 10.4161/cbt.7.2.5745; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; Daisy Narayan A, 2005, BRIT J HAEMATOL, V128, P562, DOI 10.1111/j.1365-2141.2004.05336.x; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Du TT, 2009, BIOCHEM BIOPH RES CO, V381, P688, DOI 10.1016/j.bbrc.2009.02.122; Dudkin L, 2001, CLIN CANCER RES, V7, P1758; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044651; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Feriotto G, 2008, ACTA HAEMATOL-BASEL, V119, P28, DOI 10.1159/000114204; FIBACH E, 1989, BLOOD, V73, P100; Fibach E, 2003, BLOOD, V102, P1276, DOI 10.1182/blood-2002-10-3096; Fibach E, 2006, EUR J HAEMATOL, V77, P437, DOI 10.1111/j.1600-0609.2006.00731.x; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Gambari R, 2007, CURR MED CHEM, V14, P199, DOI 10.2174/092986707779313318; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Goyal BR, 2009, FUND CLIN PHARMACOL, V23, P367, DOI 10.1111/j.1472-8206.2009.00694.x; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He J, 2013, NUCLEIC ACIDS RES, V41, P498, DOI 10.1093/nar/gks995; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Kawasome H, 1998, P NATL ACAD SCI USA, V95, P5033, DOI 10.1073/pnas.95.9.5033; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Kosaka N, 2008, BRIT J HAEMATOL, V142, P293, DOI 10.1111/j.1365-2141.2008.07151.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; Lawrie CH, 2007, BRIT J HAEMATOL, V137, P503, DOI 10.1111/j.1365-2141.2007.06611.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin CJ, 2009, MOL CANCER THER, V8, P1606, DOI 10.1158/1535-7163.MCT-08-1152; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Mischiati C, 2004, BRIT J HAEMATOL, V126, P612, DOI 10.1111/j.1365-2141.2004.05083.x; Nakada C, 2011, J PATHOL, V224, P280, DOI 10.1002/path.2860; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Noman MZ, 2012, CANCER RES, V72, P4929; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Sarakul O, 2013, BLOOD CELL MOL DIS, V51, P98, DOI 10.1016/j.bcmd.2013.03.005; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Spinello I, 2009, ONCOGENE, V28, P2276, DOI 10.1038/onc.2009.87; Sun K, 2011, ACTA PHARMACOL SIN, V32, P375, DOI 10.1038/aps.2010.206; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Van Der Kelen K, 2009, CRIT REV BIOCHEM MOL, V44, P143, DOI 10.1080/10409230902882090; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Wilton SD, 2005, CURR GENE THER, V5, P467, DOI 10.2174/156652305774329249; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207	79	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121567	10.1371/journal.pone.0121567	http://dx.doi.org/10.1371/journal.pone.0121567			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849663	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800066
J	Fishman, E; Boecker, L; Helbich, M				Fishman, Elliot; Bocker, Lars; Helbich, Marco			Adult Active Transport in the Netherlands: An Analysis of Its Contribution to Physical Activity Requirements	PLOS ONE			English	Article							WEATHER CONDITIONS; BICYCLE; TRAVEL; WORK; MODE	Introduction Modern, urban lifestyles have engineered physical activity out of everyday life and this presents a major threat to human health. The Netherlands is a world leader in active travel, particularly cycling, but little research has sought to quantify the cumulative amount of physical activity through everyday walking and cycling. Methods Using data collected as part of the Dutch National Travel Survey (2010 - 2012), this paper determines the degree to which Dutch walking and cycling contributes to meeting minimum level of physical activity of 150 minutes of moderate intensity aerobic activity throughout the week. The sample includes 74,465 individuals who recorded at least some travel on the day surveyed. As physical activity benefits are cumulative, all walking and cycling trips are analysed, including those to and from public transport. These trips are then converted into an established measure of physical activity intensity, known as metabolic equivalents of tasks. Multivariate Tobit regression models were performed on a range of socio-demographic, transport resources, urban form and meteorological characteristics. Results The results reveal that Dutch men and women participate in 24 and 28 minutes of daily physical activity through walking and cycling, which is 41% and 55% more than the minimum recommended level. It should be noted however that some 57% of the entire sample failed to record any walking or cycling, and an investigation of this particular group serves as an important topic of future research. Active transport was positively related with age, income, bicycle ownership, urban density and air temperature. Car ownership had a strong negative relationship with physically active travel. Conclusion The results of this analysis demonstrate the significance of active transport to counter the emerging issue of sedentary lifestyle disease. The Dutch experience provides other countries with a highly relevant case study in the creation of environments and cultures that support healthy, active living.	[Fishman, Elliot; Helbich, Marco] Univ Utrecht, Fac Geosci, Dept Human Geog & Spatial Planning, Utrecht, Netherlands; [Bocker, Lars] Univ Utrecht, Fac Geosci, Dept Innovat Environm & Energy Sci, Utrecht, Netherlands	Utrecht University; Utrecht University	Fishman, E (corresponding author), Univ Utrecht, Fac Geosci, Dept Human Geog & Spatial Planning, Utrecht, Netherlands.	info@sensibletransport.org.au		Bocker, Lars/0000-0001-8631-8391				Aaheim H.A., 2005, CICERO REPORT; Ahmed F., 2010, P 33 AUSTR TRANSP RE; Ahmed F, 2012, COMMUTER CYCLIST S S; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Aultman-Hall L, 2009, TRANSPORT RES REC, P35, DOI 10.3141/2140-0; Australian Bureau of Statistics, 2013, CENSUS 2011; Bauman A., 2008, CYCLING GETTING AUST; Bell AC, 2006, ASIA-PAC J PUBLIC HE, V18, P62, DOI 10.1177/10105395060180011001; Bocker L, 2014, WEATHER CLIM SOC, V6, P468, DOI 10.1175/WCAS-D-13-00066.1; Bocker L, 2013, J TRANSP GEOGR, V28, P176, DOI 10.1016/j.jtrangeo.2012.11.004; Buehler R, 2012, TRANSPORTATION, V39, P409, DOI 10.1007/s11116-011-9355-8; Cameron AC, 2013, REGRESSION ANALYSIS; Central Bureau of Statistics, 2014, RESEARCH TRAVEL IN N; Costagliola MA, 2014, SCI TOTAL ENVIRON, V468, P1043, DOI 10.1016/j.scitotenv.2013.09.025; Creemers L, 2014, THEORETICAL AND APPL, P1; Delbosc A, 2013, TRANSPORT REV, V33, P271, DOI 10.1080/01441647.2013.801929; Dieleman FM, 2002, URBAN STUD, V39, P507, DOI 10.1080/00420980220112801; Ewing R, 2014, HEALTH PLACE, V26, P118, DOI 10.1016/j.healthplace.2013.12.008; Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011; Garrard J, 2009, TAKING ACTION ON OBE; Giles-Corti B, 2014, EVIDENCE REVIEW LOW; Gojanovic B, 2011, MED SCI SPORT EXER, V43, P2204, DOI 10.1249/MSS.0b013e31821cbdc8; Goodman A, 2013, PLOS ONE, V8; Goodwin P, 2013, TRANSPORT REV, V33, P243, DOI 10.1080/01441647.2013.804133; Greene William H., 2003, ECONOMETRIC ANAL, V5; Hanson S., 1977, TRANSP RES REC, V629, P43; Harms L, 2013, 13TH WCTR; Heesch KC, 2014, PREV MED, V63, P29, DOI 10.1016/j.ypmed.2014.03.003; Heinen E, 2011, SUSTAIN URBAN AREAS, V43; Heinen E, 2011, TRANSPORT RES REC, P9, DOI 10.3141/2230-02; Heinen E, 2010, TRANSPORT REV, V30, P59, DOI 10.1080/01441640903187001; Helbich M, 2014, J TRANSP GEOGR, V38, P38, DOI 10.1016/j.jtrangeo.2014.05.009; Hertogh EM, 2010, MED SCI SPORT EXER, V42, P886, DOI 10.1249/MSS.0b013e3181c4d964; Hobbs Suzanne Havala, 2008, Healthc Pap, V9, P8; Loader C, 2014, CHARTING TRANSPORT; Louis J, 2012, AM J PHYS MED REHAB, V91, P931, DOI 10.1097/PHM.0b013e318269d9bb; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Merom D, 2010, AM J PREV MED, V39, P113, DOI 10.1016/j.amepre.2010.04.007; Ministerie van Infrastructure en Millieu, 2013, MOBILITEITSBALANS 20; Ministerie van Verkeer en Waterstaat, 2009, CYCLING IN THE NETHE; Mulley C, 2013, RES TRANSP BUS MANAG, V7, P27, DOI 10.1016/j.rtbm.2013.01.001; Onderzoek Verplaatsingen in Nederland, 2013, ONDERZOEKSBESCHRIJVI; Pucher J, 2012, URBAN IND ENVIRON, P1; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Pucher J, 2011, AM J PUBLIC HEALTH, V101, pS310, DOI 10.2105/AJPH.2010.300067; Pucher J, 2011, J TRANSP GEOGR, V19, P332, DOI 10.1016/j.jtrangeo.2010.02.007; Rietveld P, 2004, TRANSPORT RES A-POL, V38, P531, DOI 10.1016/j.tra.2004.05.003; Rissel C, 2012, THE CONVERSATION; Rissel C, 2012, INT J ENV RES PUB HE, V9, P2454, DOI 10.3390/ijerph9072454; Sabir M, 2011, WEATHER AND TRAVEL B; Scheepers E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073105; Schepers JP, 2014, ACCIDENT ANAL PREV, V73, P174, DOI 10.1016/j.aap.2014.09.010; Simons M, 2009, MED SCI SPORT EXER, V41, P2097, DOI 10.1249/MSS.0b013e3181a6aaa4; Sperlich B, 2012, EUR J APPL PHYSIOL, V112, P4015, DOI 10.1007/s00421-012-2382-0; Tully MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099636; Van Mechelen W, 1997, BRIT J SPORT MED, V31, P264, DOI 10.1136/bjsm.31.4.264; Veall M.R., 1996, J ECON SURV, V10, P241, DOI [10.1111/j.1467-6419.1996.tb00013.x, DOI 10.1111/J.1467-6419.1996.TB00013.X]; Woodcock J, 2014, BMJ, V348; World Health Organization, 2010, GLOBAL RECOMMENDATIO; World Health Organization, 2009, GLOBAL HEALTH RISKS	60	65	68	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121871	10.1371/journal.pone.0121871	http://dx.doi.org/10.1371/journal.pone.0121871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849902	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800081
J	Philipsen, A; Jorgensen, ME; Vistisen, D; Sandbaek, A; Almdal, TP; Christiansen, JS; Lauritzen, T; Witte, DR				Philipsen, Annelotte; Jorgensen, Marit E.; Vistisen, Dorte; Sandbaek, Annelli; Almdal, Thomas P.; Christiansen, Jens S.; Lauritzen, Torsten; Witte, Daniel R.			Associations between Ultrasound Measures of Abdominal Fat Distribution and Indices of Glucose Metabolism in a Population at High Risk of Type 2 Diabetes: The ADDITION-PRO Study	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; INSULIN-RESISTANCE ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; VISCERAL ADIPOSITY; TOLERANCE TEST; OLDER MEN; SENSITIVITY; OBESE; ULTRASONOGRAPHY; REPRODUCIBILITY	Aims Visceral adipose tissue measured by CT or MRI is strongly associated with an adverse metabolic risk profile. We assessed whether similar associations can be found with ultrasonography, by quantifying the strength of the relationship between different measures of obesity and indices of glucose metabolism in a population at high risk of type 2 diabetes. Methods A cross-sectional analysis of 1342 participants of the ADDITION-PRO study. We measured visceral adipose tissue and subcutaneous adipose tissue with ultrasonography, anthropometrics and body fat percentage by bioelectrical impedance. Indices of glucose metabolism were derived from a three point oral glucose tolerance test. Linear regression of obesity measures on indices of glucose metabolism was performed. Results Mean age was 66.2 years, BMI 26.9kg/m(2), subcutaneous adipose tissue 2.5cm and visceral adipose tissue 8.0cm. All measures of obesity were positively associated with indicators of glycaemia and inversely associated with indicators of insulin sensitivity. Associations were of equivalent magnitude except for subcutaneous adipose tissue and the visceral/subcutaneous adipose tissue ratio, which showed weaker associations. One standard deviation difference in BMI, visceral adipose tissue, waist circumference, waist/height ratio and body fat percentage corresponded approximately to 0.2mmol/l higher fasting glucose, 0.7mmol/l higher 2-hr glucose, 0.06-0.1% higher HbA1c, 30% lower HOMA index of insulin sensitivity, 20% lower Gutt's index of insulin sensitivity, and 100 unit higher Stumvoll's index of beta-cell function. After adjustment for waist circumference visceral adipose tissue was still significantly associated with glucose intolerance and insulin resistance, whereas there was a trend towards inverse or no associations with subcutaneous adipose tissue. After adjustment, a 1cm increase in visceral adipose tissue was associated with similar to 5% lower insulin sensitivity (p <= 0.0004) and similar to 0.18mmol/l higher 2-hr glucose (p <= 0.001). Conclusion Visceral and subcutaneous adipose tissue assessed by ultrasonography are significantly associated with glucose metabolism, even after adjustment for other measures of obesity.	[Philipsen, Annelotte; Jorgensen, Marit E.; Vistisen, Dorte] Steno Diabet Ctr AS, Gentofte, Denmark; [Sandbaek, Annelli; Lauritzen, Torsten; Witte, Daniel R.] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Almdal, Thomas P.] Gentofte Univ Hosp, Dept Internal Med F, Gentofte, Denmark; [Christiansen, Jens S.] Aarhus Univ Hosp, Dept Endocrinol, DK-8000 Aarhus, Denmark	Steno Diabetes Center; Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University	Philipsen, A (corresponding author), Steno Diabet Ctr AS, Gentofte, Denmark.	aphi@steno.dk	Witte, Daniel R/C-1722-2008; Witte, Daniel/AAF-9535-2019	Witte, Daniel R/0000-0002-0769-2922; Witte, Daniel/0000-0002-0769-2922; Jorgensen, Marit Eika/0000-0001-8356-5565; Vistisen, Dorte/0000-0001-5045-5351	European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes [74550801]; Steno Diabetes Center A/S	European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes; Steno Diabetes Center A/S	The ADDITION-PRO study was funded by an unrestricted grant from the European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes (74550801); and by internal research and equipment funds from Steno Diabetes Center A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemelmans RHH, 2012, OBESITY, V20, P834, DOI 10.1038/oby.2011.321; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; De Lucia, 2011, OBESITY, V19, P1892; Faber DR, 2010, ATHEROSCLEROSIS, V212, P274, DOI 10.1016/j.atherosclerosis.2010.04.029; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Hanley AJG, 2009, DIABETOLOGIA, V52, P2079, DOI 10.1007/s00125-009-1464-y; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Johansen NB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1078; Jorgensen ME, 2013, DIABETES CARE, V36, P2988, DOI 10.2337/dc12-2703; Kanhai DA, 2012, INT J OBESITY, V36, P695, DOI 10.1038/ijo.2011.115; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1002/oby.20135, 10.1038/oby.20135]; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Philipsen A, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.23; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; *R FDN STAT COMP, 2009, R LANG ENV STAT COMP; Rolfe ED, 2010, OBESITY, V18, P625, DOI 10.1038/oby.2009.309; Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.0801734; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Stumvoll M, 2001, DIABETES CARE, V24, P796, DOI 10.2337/diacare.24.4.796; Wagenknecht LE, 2003, DIABETES, V52, P2490, DOI 10.2337/diabetes.52.10.2490; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wander PL, 2013, DIABETES CARE, V36, P289, DOI 10.2337/dc12-0198; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	28	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123062	10.1371/journal.pone.0123062	http://dx.doi.org/10.1371/journal.pone.0123062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849815	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800200
J	Shrivastava, R; Koster, D; Kalme, S; Mayor, S; Neerathilingam, M				Shrivastava, Rohini; Koester, Darius; Kalme, Sheetal; Mayor, Satyajit; Neerathilingam, Muniasamy			Tailor-Made Ezrin Actin Binding Domain to Probe Its Interaction with Actin In-Vitro	PLOS ONE			English	Article							SUPPORTED LIPID-BILAYERS; ERM PROTEINS; PLASMA-MEMBRANE; TERMINAL DOMAIN; MICROSCOPY; LINKER; CELLS	Ezrin, a member of the ERM (Ezrin/Radixin/Moesin) protein family, is an Actin-plasma membrane linker protein mediating cellular integrity and function. In-vivo study of such interactions is a complex task due to the presence of a large number of endogenous binding partners for both Ezrin and Actin. Further, C-terminal actin binding capacity of the full length Ezrin is naturally shielded by its N-terminal, and only rendered active in the presence of Phosphatidylinositol bisphosphate (PIP2) or phosphorylation at the C-terminal threonine. Here, we demonstrate a strategy for the design, expression and purification of constructs, combining the Ezrin C-terminal actin binding domain, with functional elements such as fusion tags and fluorescence tags to facilitate purification and fluorescence microscopy based studies. For the first time, internal His tag was employed for purification of Ezrin actin binding domain based on in-silico modeling. The functionality (Ezrin-actin interaction) of these constructs was successfully demonstrated by using Total Internal Reflection Fluorescence Microscopy. This design can be extended to other members of the ERM family as well.	[Shrivastava, Rohini; Kalme, Sheetal; Neerathilingam, Muniasamy] Ctr Cellular & Mol Platforms NCBS TIFR, Prot Technol Core, GKVK Post, Bangalore, Karnataka, India; [Koester, Darius; Mayor, Satyajit] Tata Inst Fundamental Res GKVK, Natl Ctr Biol Sci, Bangalore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Neerathilingam, M (corresponding author), Ctr Cellular & Mol Platforms NCBS TIFR, Prot Technol Core, GKVK Post, Bangalore, Karnataka, India.	munish@ccamp.res.in	/AAO-4852-2020; Köster, Darius Vasco/Y-1387-2019	Köster, Darius Vasco/0000-0001-8530-5476	Indo Finland; TIFR, Department of Biotechnology, India	Indo Finland; TIFR, Department of Biotechnology, India	This study was supported by Indo Finland and TIFR, Department of Biotechnology, India.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; ANDREOLI C, 1994, J CELL SCI, V107, P2509; Ballestrem C, 1998, J CELL SCI, V111, P1649; Bretscher A, 1997, J CELL SCI, V110, P3011; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Herrig A, 2006, BIOCHEMISTRY-US, V45, P13025, DOI 10.1021/bi061064a; Hewitt SN, 2011, ACTA CRYSTALLOGR F, V67, P1006, DOI 10.1107/S1744309111022159; Janke M, 2008, BIOCHEMISTRY-US, V47, P3762, DOI 10.1021/bi702542s; KELLOGG DR, 1988, DEVELOPMENT, V103, P675; KUBALEK EW, 1994, J STRUCT BIOL, V113, P117, DOI 10.1006/jsbi.1994.1039; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Maniti O, 2013, BIOCHIMIE, V95, P3, DOI 10.1016/j.biochi.2012.09.033; Mingeot-Leclercq MP, 2008, NAT PROTOC, V3, P1654, DOI 10.1038/nprot.2008.149; Nye JA, 2008, LANGMUIR, V24, P4145, DOI 10.1021/la703788h; Roy C, 1997, J BIOL CHEM, V272, P20088, DOI 10.1074/jbc.272.32.20088; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866	21	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123428	10.1371/journal.pone.0123428	http://dx.doi.org/10.1371/journal.pone.0123428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860910	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300099
J	Bywater, RP				Bywater, Robert Paul			Prediction of Protein Structural Features from Sequence Data Based on Shannon Entropy and Kolmogorov Complexity	PLOS ONE			English	Article							SECONDARY STRUCTURE; CLASSIFICATION; DEFINITION; RESIDUES; FAMILIES; CONTACTS; FOLD	While the genome for a given organism stores the information necessary for the organism to function and flourish it is the proteins that are encoded by the genome that perhaps more than anything else characterize the phenotype for that organism. It is therefore not surprising that one of the many approaches to understanding and predicting protein folding and properties has come from genomics and more specifically from multiple sequence alignments. In this work I explore ways in which data derived from sequence alignment data can be used to investigate in a predictive way three different aspects of protein structure: secondary structures, inter-residue contacts and the dynamics of switching between different states of the protein. In particular the use of Kolmogorov complexity has identified a novel pathway towards achieving these goals.	Univ Oxford Magdalen Coll, Oxford OX1 4AU, England	University of Oxford	Bywater, RP (corresponding author), Univ Oxford Magdalen Coll, Oxford OX1 4AU, England.	robpbyw@gmail.com	Bywater, Robert Paul/AAY-1093-2020	Bywater, Robert Paul/0000-0002-3047-8123				ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Angov E, 2011, BIOTECHNOL J, V6, P650, DOI 10.1002/biot.201000332; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Brunak S, 1996, PROTEINS, V25, P237, DOI 10.1002/(SICI)1097-0134(199606)25:2<237::AID-PROT9>3.3.CO;2-Y; Bywater RP, 2013, J BIOMOL STRUCT DYN, V31, P351, DOI 10.1080/07391102.2012.703062; Crippen G. M., 1988, DISTANCE GEOMETRY AN; Dai Q, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-152; Emmert-Streib F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012256; Ferragina P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-252; Friedberg I, 2002, PROTEIN SCI, V11, P350, DOI 10.1110/ps.18602; Hayashida M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S13; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Ison JC, 2000, PROTEINS, V40, P330, DOI 10.1002/(SICI)1097-0134(20000801)40:2<330::AID-PROT120>3.3.CO;2-V; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOLMOGOROV AN, 1968, INT J COMPUT MATH, V2, P157, DOI 10.1080/00207166808803030; La Rosa M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S4; Lund O, 1996, PROTEIN SCI, V5, P2217, DOI 10.1002/pro.5560051108; MACKAY AL, 1974, ACTA CRYSTALLOGR A, VA 30, P440, DOI 10.1107/S0567739474000945; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mirny L, 2001, J MOL BIOL, V308, P123, DOI 10.1006/jmbi.2001.4602; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Oliveira L, 2003, PROTEINS, V52, P544, DOI 10.1002/prot.10490; Oliveira L, 2002, CHEMBIOCHEM, V3, P1010, DOI 10.1002/1439-7633(20021004)3:10<1010::AID-CBIC1010>3.0.CO;2-T; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; R Core Team, 2018, R LANG ENV STAT COMP; ROST B, 1993, P NATL ACAD SCI USA, V90, P7558, DOI 10.1073/pnas.90.16.7558; Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495; Seddon GM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120087; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Su JG, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3651480; Szabo N, 1996, INTRO ALGORITHMIC IN; Tao Xie, 1998, FEBS Letters, V434, P93, DOI 10.1016/S0014-5793(98)00955-7; Taylor WR, 2013, CURR OPIN STRUC BIOL, V23, P473, DOI 10.1016/j.sbi.2013.04.001; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Williams Robert W, 2013, Intrinsically Disord Proteins, V1, pe25724, DOI 10.4161/idp.25724	40	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119306	10.1371/journal.pone.0119306	http://dx.doi.org/10.1371/journal.pone.0119306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856073	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500007
J	Na, LX; Wu, XY; Feng, RN; Li, J; Han, TS; Lin, LQ; Lan, L; Yang, C; Li, Y; Sun, CH				Na, Lixin; Wu, Xiaoyan; Feng, Rennan; Li, Jie; Han, Tianshu; Lin, Liqun; Lan, Li; Yang, Chao; Li, Ying; Sun, Changhao			The Harbin Cohort Study on Diet, Nutrition and Chronic Non-Communicable Diseases: Study Design and Baseline Characteristics	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; METABOLIC PROFILE; CHINESE ADULTS; LIFE-STYLE; PREVALENCE; HEALTH; MORTALITY; SHANGHAI; MEN	Diet and nutrition have been reported to be associated with many common chronic diseases and blood-based assessment would be vital to investigate the association and mechanism, however, blood-based prospective studies are limited. The Harbin Cohort Study on Diet, Nutrition and Chronic Non-communicable Diseases was set up in 2010. From 2010 to 2012, 9,734 participants completed the baseline survey, including demographic characteristics, dietary intake, lifestyles and physical condition, and anthropometrics. A re-survey on 490 randomly selected participants was done by using the same methods which were employed in the baseline survey. For all participants, the mean age was 50 years and 36% of them were men. Approximately 99.4 % of cohort members donated blood samples. The mean total energy intake was 2671.7 kcal/day in men and 2245.9 kcal/day in women, the mean body mass index was 25.7 kg/m(2) in men and 24.6 kg/m(2) in women, with 18.4% being obese (>= 28 kg/m(2)), 12.7% being diabetic, and 29.5% being hypertensive. A good agreement was obtained for the physical measurements between the baseline survey and re-survey. The resources from the cohort and its fasting and postprandial blood samples collected both at baseline and in each follow-up will be valuable and powerful in investigating relationship between diet, nutrition and chronic diseases and discovering novel blood biomarkers and the metabolism of these biomarkers related to chronic diseases.	[Na, Lixin; Wu, Xiaoyan; Feng, Rennan; Li, Jie; Han, Tianshu; Lin, Liqun; Li, Ying; Sun, Changhao] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Natl Key Discipline, Harbin, Peoples R China; [Lan, Li; Yang, Chao] Harbin Ctr Dis Control & Prevent, Harbin, Peoples R China	Harbin Medical University	Li, Y (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Natl Key Discipline, Harbin, Peoples R China.	liying_helen@163.com; changhaosun2002@163.com	SUN, CHANG/GXM-3680-2022	Li, Jie/0000-0002-8359-3440; ying, li/0000-0002-7595-2474	National 12th Five-Year Scientific and Technical Program of China [2012BAI02B00]; State Key Program of National Natural Science of China [81130049]; National Natural Science Foundation of China [81202282]	National 12th Five-Year Scientific and Technical Program of China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National 12th Five-Year Scientific and Technical Program of China (grant 2012BAI02B00), State Key Program of National Natural Science of China (grant 81130049), and National Natural Science Foundation of China (grant 81202282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PREV CHRON DIS VIT I; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Cheng Y, 2012, J PROTEOME RES, V11, P1354, DOI 10.1021/pr201001a; Chu X, 2013, DIABETES, V62, P561, DOI 10.2337/db12-0139; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Ellis JK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-61; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Goldberg M, 2001, AM J EPIDEMIOL, V154, P373, DOI 10.1093/aje/154.4.373; Gurdeniz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069589; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hunter DJ, 2013, NEW ENGL J MED, V369, P1336, DOI 10.1056/NEJMra1109345; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Lee SA, 2008, OBESITY, V16, P1440, DOI 10.1038/oby.2008.58; Liu LY, 2013, CLIN CHEM, V59, P1338, DOI 10.1373/clinchem.2012.200527; Liu LY, 2013, J CHROMATOGR B, V927, P97, DOI 10.1016/j.jchromb.2013.01.038; Liu LY, 2010, J CHROMATOGR B, V878, P2817, DOI 10.1016/j.jchromb.2010.08.035; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Niu SR, 1998, BRIT MED J, V317, P1423, DOI 10.1136/bmj.317.7170.1423; Oliveira-Campos M, 2013, CIENC SAUDE COLETIVA, V18, P873, DOI [10.1590/S1413-81232013000300033, 10.1590/S1413-81232013000800033]; Omoleke SA, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.87.1899; Phaswana-Mafuya N, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20936; Sai XY, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-290; Shen GQ, 2011, J PROTEOME RES, V10, P1953, DOI 10.1021/pr101198q; Lopes ACS, 2011, CAD SAUDE PUBLICA, V27, P1185, DOI 10.1590/S0102-311X2011000600015; Takata Y, 2013, NUTR CANCER, V65, P51, DOI 10.1080/01635581.2013.741757; Wang C, 2011, J CHROMATOGR B, V879, P2871, DOI 10.1016/j.jchromb.2011.08.014; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wang MQ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-86; Wenzhi W, 2009, CHIN J FRONT MED SCI, V1, P49; Wikoff WR, 2007, CLIN CHEM, V53, P2169, DOI 10.1373/clinchem.2007.089011; Wu G, 2010, CHINESE J WOMEN CHIL, V1, P51; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yuan JM, 1998, INT J EPIDEMIOL, V27, P824, DOI 10.1093/ije/27.5.824; Zheng W, 2005, AM J EPIDEMIOL, V162, P1123, DOI 10.1093/aje/kwi322	40	25	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122598	10.1371/journal.pone.0122598	http://dx.doi.org/10.1371/journal.pone.0122598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856294	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500044
J	Nazarenko, MS; Markov, AV; Lebedev, IN; Freidin, MB; Sleptcov, AA; Koroleva, IA; Frolov, AV; Popov, VA; Barbarash, OL; Puzyrev, VP				Nazarenko, Maria S.; Markov, Anton V.; Lebedev, Igor N.; Freidin, Maxim B.; Sleptcov, Aleksei A.; Koroleva, Iuliya A.; Frolov, Aleksei V.; Popov, Vadim A.; Barbarash, Olga L.; Puzyrev, Valery P.			A Comparison of Genome-Wide DNA Methylation Patterns between Different Vascular Tissues from Patients with Coronary Heart Disease	PLOS ONE			English	Article							GENE-EXPRESSION; ATHEROSCLEROSIS; ARTERIES; ISLANDS	Epigenetic mechanisms of gene regulation in context of cardiovascular diseases are of considerable interest. So far, our current knowledge of the DNA methylation profiles for atherosclerosis affected and healthy human vascular tissues is still limited. Using the Illumina Infinium Human Methylation27 BeadChip, we performed a genome-wide analysis of DNA methylation in right coronary artery in the area of advanced atherosclerotic plaques, atherosclerotic-resistant internal mammary arteries, and great saphenous veins obtained from same patients with coronary heart disease. The resulting DNA methylation patterns were markedly different between all the vascular tissues. The genes hypomethylated in athero-prone arteries to compare with atherosclerotic-resistant arteries were predominately involved in regulation of inflammation and immune processes, as well as development. The great saphenous veins exhibited an increase of the DNA methylation age in comparison to the internal mammary arteries. Gene ontology analysis for genes harboring hypermethylated CpG-sites in veins revealed the enrichment for biological processes associated with the development. Four CpG-sites located within the MIR10B gene sequence and about 1 kb upstream of the HOXD4 gene were also confirmed as hypomethylated in the independent dataset of the right coronary arteries in the area of advanced atherosclerotic plaques in comparison with the other vascular tissues. The DNA methylation differences observed in vascular tissues of patients with coronary heart disease can provide new insights into the mechanisms underlying the development of pathology and explanation for the difference in graft patency after coronary artery bypass grafting surgery.	[Nazarenko, Maria S.; Markov, Anton V.; Freidin, Maxim B.; Sleptcov, Aleksei A.; Koroleva, Iuliya A.; Puzyrev, Valery P.] Res Inst Med Genet, Lab Populat Genet, Tomsk, Russia; [Lebedev, Igor N.] Res Inst Med Genet, Lab Cytogenet, Tomsk, Russia; [Nazarenko, Maria S.; Markov, Anton V.; Lebedev, Igor N.; Sleptcov, Aleksei A.; Puzyrev, Valery P.] Tomsk State Univ, Lab Human Ontogenet, Tomsk 634050, Russia; [Frolov, Aleksei V.] Res Inst Complex Problems Cardiovasc Dis, Lab Neurovascular Pathol, Kemerovo, Russia; [Popov, Vadim A.; Barbarash, Olga L.] Res Inst Complex Problems Cardiovasc Dis, Dept Multifocal Atherosclerosis, Kemerovo, Russia	Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; Tomsk State University; Russian Academy of Medical Sciences; Research Institute for Complex Issues of Cardiovascular Diseases; Russian Academy of Medical Sciences; Research Institute for Complex Issues of Cardiovascular Diseases	Nazarenko, MS (corresponding author), Res Inst Med Genet, Lab Populat Genet, Tomsk, Russia.	maria.nazarenko@medgenetics.ru	Lebedev, Igor/O-2470-2019; Freidin, Maxim B/A-8222-2014; Freydin, Maxim/A-5603-2011; Markov, Anton V/A-8252-2014; Nazarenko, Maria S/A-7917-2014; Puzyrev, Valery P/S-3144-2016; Koroleva, Iuliia/ABG-1804-2020; Koroleva, Iuliia/O-7618-2016; Puzyrev, Valery P/A-7925-2014; Lebedev, Igor N/K-7454-2012; Sleptcov, Alexei/A-8163-2014; Barbarash, Olga/A-4834-2017	Lebedev, Igor/0000-0002-0482-8046; Freidin, Maxim B/0000-0002-1439-6259; Freydin, Maxim/0000-0002-1439-6259; Markov, Anton V/0000-0002-5824-6439; Nazarenko, Maria S/0000-0002-0673-4094; Puzyrev, Valery P/0000-0002-2113-4556; Koroleva, Iuliia/0000-0003-1498-6934; Koroleva, Iuliia/0000-0003-1498-6934; Lebedev, Igor N/0000-0002-0482-8046; Sleptcov, Alexei/0000-0003-3226-1750; Popov, Vadim/0000-0003-1395-2951; Barbarash, Olga/0000-0002-4642-3610	Russian Federation [14.120.14.5096-SSch]; Russian Scientific Fund [14-15-00305]; National Program of Russian Academy of Medical Sciences "Human Proteome"; Russian Science Foundation [14-15-00305] Funding Source: Russian Science Foundation	Russian Federation(Russian Federation); Russian Scientific Fund(Russian Science Foundation (RSF)); National Program of Russian Academy of Medical Sciences "Human Proteome"; Russian Science Foundation(Russian Science Foundation (RSF))	This research was supported by the President's Grant for the Leading Scientific Schools of Russian Federation (No 14.120.14.5096-SSch), by the Russian Scientific Fund (No 14-15-00305) and by the National Program of Russian Academy of Medical Sciences "Human Proteome". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archacki SR, 2012, HUM MOL GENET, V21, P1364, DOI 10.1093/hmg/ddr574; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bidzhekov K, 2012, THROMB HAEMOSTASIS, V107, P619, DOI 10.1160/TH11-09-0607; Bijnens APJJ, 2006, ARTERIOSCL THROM VAS, V26, P1226, DOI 10.1161/01.ATV.0000219289.06529.f1; Castillo-Diaz SA, 2010, INT J MOL MED, V26, P691, DOI 10.3892/ijmm_00000515; Chen YA, 2011, GENOMICS, V97, P214, DOI 10.1016/j.ygeno.2010.12.004; Davies PF, 2014, VASC PHARMACOL, V62, P88, DOI 10.1016/j.vph.2014.05.007; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunn J, 2014, J CLIN INVEST, V124, P3187, DOI 10.1172/JCI74792; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fernandez AF, 2012, GENOME RES, V22, P407, DOI 10.1101/gr.119867.110; Goldschmidt-Clermont PJ, 2012, CURR ATHEROSCLER REP, V14, P201, DOI 10.1007/s11883-012-0244-1; Gorski DH, 2000, CIRC RES, V87, P865, DOI 10.1161/01.RES.87.10.865; Hiltunen M, 2002, VASC MED, V7, P5, DOI 10.1191/1358863x02vm418oa; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kim J, 2007, BBA-MOL BASIS DIS, V1772, P72, DOI 10.1016/j.bbadis.2006.10.004; Loop FD, 1996, NEW ENGL J MED, V334, P263, DOI 10.1056/NEJM199601253340411; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Muto A, 2010, CIRC J, V74, P1501, DOI 10.1253/circj.CJ-10-0495; Nazarenko MS, 2013, MOL BIOL+, V47, P352, DOI 10.1134/S0026893313030084; Okuda M, 2001, ARTERIOSCL THROM VAS, V21, P1483, DOI 10.1161/hq0901.095550; Olson FJ, 2010, BIOCHEM BIOPH RES CO, V401, P574, DOI 10.1016/j.bbrc.2010.09.103; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Seo D, 2004, ARTERIOSCL THROM VAS, V24, P1922, DOI 10.1161/01.ATV.0000141358.65242.1f; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Shen XK, 2011, J BIOL CHEM, V286, P26616, DOI 10.1074/jbc.M111.224212; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Webster ALH, 2013, CAN J CARDIOL, V29, P46, DOI 10.1016/j.cjca.2012.10.023; Zaina S, 2014, CURR OPIN LIPIDOL, V25, P148, DOI 10.1097/MOL.0000000000000059; Zawadzki Christophe, 2009, Atherosclerosis, V204, pe4, DOI 10.1016/j.atherosclerosis.2008.10.009; Zhu SK, 2005, CIRCULATION, V112, P1353, DOI 10.1161/CIRCULATIONAHA.104.519025; Zhu YQ, 2009, J NEUROPATH EXP NEUR, V68, P626, DOI 10.1097/NEN.0b013e3181a491ce	34	37	42	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122601	10.1371/journal.pone.0122601	http://dx.doi.org/10.1371/journal.pone.0122601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856389	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500045
J	Pomey, MP; Ghadiri, DP; Karazivan, P; Fernandez, N; Clavel, N				Pomey, Marie-Pascale; Ghadiri, Djahanchah P.; Karazivan, Philippe; Fernandez, Nicolas; Clavel, Nathalie			Patients as Partners: A Qualitative Study of Patients' Engagement in Their Health Care	PLOS ONE			English	Article							SHARED DECISION-MAKING; SELF-MANAGEMENT; CHRONIC DISEASE; INTERVENTIONS; EDUCATION; MODEL	To advocate for patients to be more actively involved with the healthcare services they receive, particularly patients living with chronic illness, the Faculty of Medicine of the University of Montreal and its affiliated hospitals developed the Patients as Partners concept where the patient is considered a full-fledged partner of the health care delivery team and the patient's experiential knowledge is recognized. This study aims to show how patients view their engagement with healthcare professionals regarding their direct care. Using theoretical sampling, 16 semi-structured interviews were conducted with patients with chronic illness who were familiar with the concept of Patients as Partners. Data analysis followed a constructivist grounded theory approach. Patients describe themselves as proactively engaging in three types of practice, regardless of health professionals' openness to their role as partners. The first is a process of continuous learning that allows them to acquire experiential knowledge about their health, as well as scientific information and technical know-how. The second involves their assessment of the healthcare they receive, in terms of its quality and how it aligns with their personal preferences. It includes their assessment of the quality of their relationship with the health professional and of the latter's scientific knowledge and technical know-how. The third type, adaptation practices, builds on patients' learning and assessments to compensate for and adapt to what has been perceived as optimal or non-optimal health or healthcare circumstances. Patients appear to play a more active and less docile role in their own direct care than suggested so far in the literature, regardless of the degree of reciprocity of the partnership or the degree to which the health professional seeks to encourage patient engagement.	[Pomey, Marie-Pascale; Clavel, Nathalie] Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada; [Ghadiri, Djahanchah P.] HEC Montreal, Dept Management, Montreal, PQ, Canada; [Karazivan, Philippe] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Fernandez, Nicolas] Univ Quebec, Fac Sci Educ, Montreal, PQ H3C 3P8, Canada	Universite de Montreal; Universite de Montreal; HEC Montreal; Universite de Montreal; University of Quebec; University of Quebec Montreal	Pomey, MP (corresponding author), Univ Montreal, Ecole Sante Publ, Montreal, PQ, Canada.	marie-pascale.pomey@umontreal.ca	Pomey, Marie-Pascale/AAL-9609-2021	Fernandez, Nicolas/0000-0002-3840-2641				Barello S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/905934; Barlow JH, 2004, CHILD CARE HLTH DEV, V30, P637, DOI 10.1111/j.1365-2214.2004.00474.x; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Battersby MW, 2008, AUST J PRIM HEALTH, V14, P66, DOI 10.1071/PY08009; Bauman AE, 2003, MED J AUSTRALIA, V179, P253, DOI 10.5694/j.1326-5377.2003.tb05532.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Carman KL, 2013, HEALTH AFFAIR, V32, P223, DOI 10.1377/hlthaff.2012.1133; Charmaz K., 2006, CONSTRUCTING GROUNDE, DOI [10.1093/geront/gns046, DOI 10.1093/GERONT/GNS046]; Cottingham AH, 2008, J GEN INTERN MED, V23, P715, DOI 10.1007/s11606-008-0543-y; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; Coulter A, 2012, J AMBUL CARE MANAG, V35, P80, DOI 10.1097/JAC.0b013e318249e0fd; (CPASS) Centre de pedagogie appliquee aux sciences de la sante, 2013, GUID IMPL PART SOINS; Creswell J. W., 2014, RES DESIGN QUALITATI; CSBE) Commissaire a la sante et au bien-etre, 2010, INF DROITS SENS RESP; Delbanco T, 2001, Health Expect, V4, P144, DOI 10.1046/j.1369-6513.2001.00145.x; Domecq JP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-89; Edwards M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-130; Fox S, 2013, PEW INTERNET AM LIFE; Gerring J, 2007, CASE STUDY RES PRINC; Glaser B. G., 2009, DISCOVERY GROUNDED T; Golay A, 2010, COLLECTION ED PATIEN; Grande SW, 2014, PATIENT EDUC COUNS, V95, P281, DOI 10.1016/j.pec.2014.01.016; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Health BCMo, 2011, PAT PART NOTH ME ME, p18p; Hibbard JH, 2010, PATIENT EDUC COUNS, V78, P377, DOI 10.1016/j.pec.2009.12.015; Ho JK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3300; Jouet E, 2010, PRATIQUES FORMATION, P58, DOI DOI 10.1016/J.SCITOTENV; Jouet E, 2012, SOCIALNO DELO, V51, P87; Karazivan P, ACAD MED IN PRESS; Karazivan P, 2011, POINT ADM SANTE SERV, V7, P6, DOI [10.1016/S0140-6736(14)60844-8, DOI 10.1016/S0140-6736(14)60844-8]; Lebel P, 2014, PROGRAMME PARTENAIRE; Legare F, 2012, PATIENT, V5, P1, DOI 10.2165/11592180-000000000-00000; Lehman WEK, 2002, J SUBST ABUSE TREAT, V22, P197, DOI 10.1016/S0740-5472(02)00233-7; LORIG K, 1985, ARTHRITIS RHEUM, V28, P680, DOI 10.1002/art.1780280612; LORIG K, 1984, GERONTOLOGIST, V24, P455; (NHS) National Health Service, 2001, EXP PAT NEW APPR CHR; (OMS) Organisation Mondiale de la Sante, 1998, PROGR INF CONT PROF, P51; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Picker Institute, 2013, PAT CTR CAR ROAD AH; Pomey MP, 2014, LE VIRAGE PATIENT PA; Robinson S, 2012, SOC SCI MED, V75, P2386, DOI 10.1016/j.socscimed.2012.09.014; Stewart M, 2000, J FAM PRACTICE, V49, P796; Stewart M, 1995, PATIENT CTR MED TRAN; Tattersall R, 2002, CLIN MED, V2, P227, DOI 10.7861/clinmedicine.2-3-227; Vanier M-C, 2014, MAC FDN C ENG PAT FA; Vanier Marie-Claude, 2013, J Allied Health, V42, pe97; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wyatt S, 2008, HEALTH TECHNOL SOC, P1	48	84	84	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122499	10.1371/journal.pone.0122499	http://dx.doi.org/10.1371/journal.pone.0122499			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856569	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500040
J	Vesterinen, HM; Connick, P; Irvine, CMJ; Sena, ES; Egan, KJ; Carmichael, GG; Tariq, A; Pavitt, S; Chataway, J; Macleod, MR; Chandran, S				Vesterinen, Hanna M.; Connick, Peter; Irvine, Cadi M. J.; Sena, Emily S.; Egan, Kieren J.; Carmichael, Gary G.; Tariq, Afiyah; Pavitt, Sue; Chataway, Jeremy; Macleod, Malcolm R.; Chandran, Siddharthan			Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis	PLOS ONE			English	Article							DOUBLE-BLIND; ANIMAL-MODELS; FLUOXETINE; IBUDILAST; THERAPY; QUALITY; TRIAL	Objective To develop and implement an evidence based framework to select, from drugs already licenced, candidate oral neuroprotective drugs to be tested in secondary progressive multiple sclerosis. Design Systematic review of clinical studies of oral putative neuroprotective therapies in MS and four other neurodegenerative diseases with shared pathological features, followed by systematic review and meta-analyses of the in vivo experimental data for those interventions. We presented summary data to an international multi-disciplinary committee, which assessed each drug in turn using pre-specified criteria including consideration of mechanism of action. Results We identified a short list of fifty-two candidate interventions. After review of all clinical and pre-clinical evidence we identified ibudilast, riluzole, amiloride, pirfenidone, fluoxetine, oxcarbazepine, and the polyunsaturated fatty-acid class (Linoleic Acid, Lipoic acid; Omega-3 fatty acid, Max EPA oil) as lead candidates for clinical evaluation. Conclusions We demonstrate a standardised and systematic approach to candidate identification for drug rescue and repurposing trials that can be applied widely to neurodegenerative disorders.	[Vesterinen, Hanna M.; Irvine, Cadi M. J.; Sena, Emily S.; Egan, Kieren J.; Carmichael, Gary G.; Tariq, Afiyah; Macleod, Malcolm R.] Univ Edinburgh, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland; [Connick, Peter; Chandran, Siddharthan] Univ Edinburgh, Anne Rowling Regenerat Neurol Clin, Edinburgh, Midlothian, Scotland; [Pavitt, Sue] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Chataway, Jeremy] Natl Hosp Neurol & Neurosurg, London, England	University of Edinburgh; University of Edinburgh; University of Leeds; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Macleod, MR (corresponding author), Univ Edinburgh, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland.	malcolm.macleod@ed.ac.uk; siddharthan.chandran@ed.ac.uk	Macleod, Malcolm Robert/B-2052-2010; Pavitt, Sue H/B-6383-2009	Macleod, Malcolm Robert/0000-0001-9187-9839; Pavitt, Susan/0000-0001-7447-440X; Connick, Peter/0000-0002-3892-8037; Chandran, Siddharthan/0000-0001-6827-1593; Egan, Kieren/0000-0002-1639-4281; Sena, Emily S/0000-0002-3282-8502	MS Society [946/11]; MRC [MC_PC_13089] Funding Source: UKRI; National Centre for the Replacement [NC/L000970/1] Funding Source: researchfish	MS Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Centre for the Replacement	This work was funded by MS Society 946/11 (http://www.mssociety.org.uk/.) No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, PSYCHOPHARMACOLOGY, V216, P75, DOI 10.1007/s00213-011-2190-y; Arun T, 2013, BRAIN, V136, P106, DOI 10.1093/brain/aws325; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Barkhof F, 2010, NEUROLOGY, V74, P1033, DOI 10.1212/WNL.0b013e3181d7d651; BATES D, 1989, J NEUROL NEUROSUR PS, V52, P18, DOI 10.1136/jnnp.52.1.18; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cavalla D, 2013, DRUG DISCOV TODAY, V18, P523, DOI 10.1016/j.drudis.2012.12.009; Chu XP, 2013, ADV EXP MED BIOL, V961, P419, DOI 10.1007/978-1-4614-4756-6_36; Dhib-Jalbut S, 2006, J NEUROIMMUNOL, V176, P198, DOI 10.1016/j.jneuroim.2006.03.027; Gibson SB, 2012, SEMIN NEUROL, V32, P173, DOI 10.1055/s-0032-1329193; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Hurle MR, 2013, CLIN PHARMACOL THER, V93, P335, DOI 10.1038/clpt.2013.1; Kapoor R, 2006, CURR OPIN NEUROL, V19, P255, DOI 10.1097/01.wco.0000227034.85576.16; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Kong EKC, 2002, NEUROCHEM RES, V27, P113, DOI 10.1023/A:1014862808126; Lassmann H, 2011, J NEURAL TRANSM, V118, P747, DOI 10.1007/s00702-011-0607-8; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Macleod MR, 2004, STROKE, V35, P1203, DOI 10.1161/01.STR.0000125719.25853.20; MCALPINE D, 2006, MCALPINES MULTIPLE S; Mead GE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009286.pub2; Meerpohl JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035732; Mostert JP, 2008, J NEUROL NEUROSUR PS, V79, P1027, DOI 10.1136/jnnp.2007.139345; Mostert Jop, 2013, ISRN Neurol, V2013, P370943, DOI 10.1155/2013/370943; Mostert JP, 2006, NEUROSCI LETT, V402, P22, DOI 10.1016/j.neulet.2006.03.042; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P1, DOI 10.1038/nrd3776; Mullard A, 2011, NAT REV DRUG DISCOV, V10, P399, DOI 10.1038/nrd3473; Ricigliano VAG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071198; Rolan P, 2009, EXPERT OPIN PHARMACO, V10, P2897, DOI 10.1517/14656560903426189; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Sams-Dodd F, 2005, DRUG DISCOV TODAY, V10, P139, DOI 10.1016/S1359-6446(04)03316-1; Schwab M, 2012, NATURE, V483, P267, DOI 10.1038/483267a; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Solaro C, 2007, NEUROL SCI, V28, P156, DOI 10.1007/s10072-007-0811-3; Stadelmann C, 2011, BBA-MOL BASIS DIS, V1812, P275, DOI 10.1016/j.bbadis.2010.07.007; Van der Worp HB, 2010, PLOS MED, V7, DOI [10.1371/journal.pmed.1000250, DOI 10.1371/JOURNAL.PMED.1000250]; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Vesterinen HM, 2014, J NEUROSCI METH, V221, P92, DOI 10.1016/j.jneumeth.2013.09.010; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Walker JE, 2005, MULT SCLER J, V11, P149, DOI 10.1191/1352458505ms1134oa; World Health Organization (WHO), 2008, ATL MULT SCLER RES W	43	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0117705	10.1371/journal.pone.0117705	http://dx.doi.org/10.1371/journal.pone.0117705			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856304	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352588500002
J	Longman, D; Wells, JCK; Stock, JT				Longman, Daniel; Wells, Jonathan C. K.; Stock, Jay T.			Can Persistence Hunting Signal Male Quality? A Test Considering Digit Ratio in Endurance Athletes	PLOS ONE			English	Article							RUNNING PERFORMANCE; REPRODUCTIVE SUCCESS; GENDER-DIFFERENCES; MATE SELECTION; ACHE FORAGERS; LENGTH RATIO; 2ND; TESTOSTERONE; ABILITY; FINGER	Various theories have been posed to explain the fitness payoffs of hunting success among hunter-gatherers. 'Having' theories refer to the acquisition of resources, and include the direct provisioning hypothesis. In contrast, 'getting' theories concern the signalling of male resourcefulness and other desirable traits, such as athleticism and intelligence, via hunting prowess. We investigated the association between androgenisation and endurance running ability as a potential signalling mechanism, whereby running prowess, vital for persistence hunting, might be used as a reliable signal of male reproductive fitness by females. Digit ratio (2D:4D) was used as a proxy for prenatal androgenisation in 439 males and 103 females, while a half marathon race (21km), representing a distance/duration comparable with that of persistence hunting, was used to assess running ability. Digit ratio was significantly and positively correlated with half-marathon time in males (right hand: r = 0.45, p < 0.001; left hand: r = 0.42, p < 0.001) and females (right hand: r = 0.26, p < 0.01; left hand: r = 0.23, p = 0.02). Sex-interaction analysis showed that this correlation was significantly stronger in males than females, suggesting that androgenisation may have experienced stronger selective pressure from endurance running in males. As digit ratio has previously been shown to predict reproductive success, our results are consistent with the hypothesis that endurance running ability may signal reproductive potential in males, through its association with prenatal androgen exposure. However, further work is required to establish whether and how females respond to this signalling for fitness.	[Longman, Daniel; Stock, Jay T.] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Wells, Jonathan C. K.] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of Cambridge; University of London; University College London	Longman, D (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England.	dannylongman@gmail.com	Stock, Jay T/B-6453-2011; Wells, Jonathan/A-4604-2009	Stock, Jay T/0000-0003-0147-8631; Wells, Jonathan/0000-0003-0411-8025; Longman, Danny/0000-0003-3025-7053				Altman J, 1988, RIGHTS GAME RIGHTS C; BAKER F, 1888, AM ANTHROPOL, V1, P51, DOI DOI 10.1525/AA.1888.1.1.02A00040; Bam J, 1997, MED SCI SPORT EXER, V29, P244, DOI 10.1097/00005768-199702000-00013; Baumeister RF, 2001, PERS SOC PSYCHOL REV, V5, P242, DOI 10.1207/S15327957PSPR0503_5; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Biesele Meagan, 2001, AFR STUDY MONOGR, V26, P67; Bird RB, 2005, CURR ANTHROPOL, V46, P221, DOI 10.1086/427115; Bird RB, 2001, BEHAV ECOL SOCIOBIOL, V50, P9; Bird RB, 2002, EVOL HUM BEHAV, V23, P297; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blurton Jones N. G., 2000, ADAPTATION HUMAN BEH, P65; Bribiescas RG, 2001, FOUND HUM B, P107; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Bunn H, 2001, HUNTING POWER SCAVEN; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Buunk BP, 2002, PERS RELATIONSHIP, V9, P271, DOI 10.1111/1475-6811.00018; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; Cashdan EA., 1990, RISK UNCERTAINTY TRI, P145; Cheuvront SN, 2005, SPORTS MED, V35, P1017, DOI 10.2165/00007256-200535120-00002; Coast JR, 2004, CAN J APPL PHYSIOL, V29, P139, DOI 10.1139/h04-010; Cohen J., 1983, APPL MULTIPLE REGRES; Dalla Vecchia L, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2013-000005; Dijkstra P, 2002, EUR J SOC PSYCHOL, V32, P829, DOI 10.1002/ejsp.125; Dion T, 2013, EUR J APPL PHYSIOL, V113, P3011, DOI 10.1007/s00421-013-2730-8; Duffield R, 2004, J SCI MED SPORT, V7, P302, DOI 10.1016/S1440-2440(04)80025-2; Eichenberger E, 2012, OPEN ACCESS J SPORTS, V3, P73, DOI 10.2147/OAJSM.S33836; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Enloe J., 2003, FARMING, V21, P1, DOI [10.3828/bfarm.2003.1.1, DOI 10.3828/BFARM.2003.1.1]; Frederick DA, 2007, PERS SOC PSYCHOL B, V33, P1167, DOI 10.1177/0146167207303022; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; Gallup AC, 2007, EVOL HUM BEHAV, V28, P423, DOI 10.1016/j.evolhumbehav.2007.07.001; GRIGGS RC, 1989, J APPL PHYSIOL, V66, P498, DOI 10.1152/jappl.1989.66.1.498; Gurven M, 2000, EVOL HUM BEHAV, V21, P263, DOI 10.1016/S1090-5138(00)00032-5; HAGERMAN FC, 1992, MED SCI SPORT EXER, V24, pS309; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; HAWKES K, 1993, CURR ANTHROPOL, V34, P341, DOI 10.1086/204182; HAWKES K, 1991, ETHOL SOCIOBIOL, V12, P29, DOI 10.1016/0162-3095(91)90011-E; Hawkes K, 2001, CURR ANTHROPOL, V42, P681, DOI 10.1086/322559; HAWKES K, 1993, CURR ANTHROPOL, V34, P706; Hawkes K., 1992, EVOL ECOL, P269; HEGLUND NC, 1988, J EXP BIOL, V138, P301; HILL K, 1993, CURR ANTHROPOL, V34, P701, DOI 10.1086/204213; Hill R, 2012, J SPORT SCI, V30, P129, DOI 10.1080/02640414.2011.637947; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Hoffman M, 2008, MED SCI SPORT EXER, V40, P2008; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Kadi F, 2008, BRIT J PHARMACOL, V154, P522, DOI 10.1038/bjp.2008.118; KAPLAN H, 1985, CURR ANTHROPOL, V26, P131, DOI 10.1086/203235; KAPLAN H, 1985, CURR ANTHROPOL, V26, P223, DOI 10.1086/203251; Kishigami N, 2000, SENRI ETHNOLOGICAL S, V53, P171; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Kostelanetz R, 1993, DICT AVANT GARDES; Kratochvil L, 2009, BIOL LETTERS, V5, P643, DOI 10.1098/rsbl.2009.0346; Lee R. B., MAN HUNTER, P3; Liebenberg L, 2006, CURR ANTHROPOL, V47, P1017, DOI 10.1086/508695; Lieberman D., 2006, 1 HUMANS ORIGIN EARL; Lippi G, 2010, BRIT MED BULL, V93, P27, DOI 10.1093/bmb/ldp007; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Manning JT, 2009, AM J HUM BIOL, V21, P210, DOI 10.1002/ajhb.20855; Manning JT, 2008, AM J HUM BIOL, V20, P451, DOI 10.1002/ajhb.20767; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT, 2000, EVOL HUM BEHAV, V21, P163, DOI 10.1016/S1090-5138(00)00029-5; Manning JT, 2005, ARCH SEX BEHAV, V34, P329, DOI 10.1007/s10508-005-3121-y; Manning JT, 2002, J SPORT MED PHYS FIT, V42, P446; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; McArdle WD., 2001, EXERCISE PHYSL ENERG; McDougall C., 2009, BORN RUN HIDDEN TRIB; Minetti AE, 2003, NATURE, V426, P785, DOI 10.1038/426785a; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Nettle D, 2008, AM NAT, V172, P658, DOI 10.1086/591690; Noakes T., 2003, LORE RUNNING; Okten A, 2002, EARLY HUM DEV, V70, P47, DOI 10.1016/S0378-3782(02)00073-7; Oomah SR, 2011, J AM SOC ECHOCARDIOG, V24, P207, DOI 10.1016/j.echo.2010.10.012; Patton JQ, 2005, EVOL HUM BEHAV, V26, P137, DOI 10.1016/j.evolhumbehav.2004.08.008; PATTON JQ, 2004, FDN HUMAN SOCIALITY, P96; Paul SN, 2006, BRIT J SPORT MED, V40, P981, DOI 10.1136/bjsm.2006.027193; Pennington C., 1963, TARAHUMARA MEXICO; Pokrywka L, 2005, AM J HUM BIOL, V17, P796, DOI 10.1002/ajhb.20449; Pollet TV, 2008, BIOL LETTERS, V4, P31, DOI 10.1098/rsbl.2007.0543; Preacher K, CALCULATION TEST DIF; Schapera I., 1930, KHOISAN PEOPLES S AF; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Smith EA, 2000, EVOL HUM BEHAV, V21, P245, DOI 10.1016/S1090-5138(00)00031-3; Smith EA, 2004, HUM NATURE-INT BIOS, V15, P343, DOI 10.1007/s12110-004-1013-9; Sparling PB, 1998, MED SCI SPORT EXER, V30, P1725, DOI 10.1097/00005768-199812000-00011; Speechly DP, 1996, MED SCI SPORT EXER, V28, P359, DOI 10.1097/00005768-199603000-00011; Steyn H. P., 1984, S AFRICAN ARCHAEOLOG, P117; Sugiyama L.S., 2000, HUMAN BEHAV ADAPTATI, P371; Tatem AJ, 2004, NATURE, V431, P525, DOI 10.1038/431525a; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Trivers R, 2013, HUM BIOL, V85, P623, DOI 10.3378/027.085.0409; Trumble BC, 2013, P R SOC B, V281; TUCKER VA, 1975, AM SCI, V63, P413; Weissner P, 1996, FOOD STATUS QUEST IN; Wells JCK, 2011, AM J HUM BIOL, V23, P291, DOI 10.1002/ajhb.21151; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0; Wilmore JH, 1999, PHYSL SPORT EXERCISE; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	100	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121560	10.1371/journal.pone.0121560	http://dx.doi.org/10.1371/journal.pone.0121560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853679	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400044
J	Ngan, LTM; Jang, MJ; Kwon, MJ; Ahn, YJ				Luong Thi My Ngan; Jang, Myeong Jin; Kwon, Min Jung; Ahn, Young Joon			Antiviral Activity and Possible Mechanism of Action of Constituents Identified in Paeonia lactiflora Root toward Human Rhinoviruses	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; RECEPTOR; RIBAVIRIN; 1,2,3,4,6-PENTA-O-GALLOYL-BETA-D-GLUCOSE; EXPRESSION; INHIBITORS; DISCOVERY; AGENTS; ICAM-1; ALPHA	Human rhinoviruses (HRVs) are responsible for more than half of all cases of the common cold and cost billions of USD annually in medical visits and missed school and work. An assessment was made of the antiviral activities and mechanisms of action of paeonol (PA) and 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose (PGG) from Paeonia lactiflora root toward HRV-2 and HRV-4 in MRC5 cells using a tetrazolium method and real-time quantitative reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assay. Results were compared with those of a reference control ribavirin. Based on 50% inhibitory concentration values, PGG was 13.4 and 18.0 times more active toward HRV-2 (17.89 mu M) and HRV-4 (17.33 mu M) in MRC5 cells, respectively, than ribavirin. The constituents had relatively high selective index values (3.3->8.5). The 100 mu g/mL PA and 20 mu g/mL PGG did not interact with the HRV-4 particles. These constituents inhibited HRV-4 infection only when they were added during the virus inoculation (0 h), the adsorption period of HRVs, but not after 1 h or later. Moreover, the RNA replication levels of HRVs were remarkably reduced in the MRC5 cultures treated with these constituents. These findings suggest that PGG and PA may block or reduce the entry of the viruses into the cells to protect the cells from the virus destruction and abate virus replication, which may play an important role in interfering with expressions of rhinovirus receptors (intercellular adhesion molecule-1 and low-density lipoprotein receptor), inflammatory cytokines (interleukin (IL)-6, IL-8, tumor necrosis factor, interferon beta, and IL-1 beta), and Toll-like receptor, which resulted in diminishing symptoms induced by HRV. Global efforts to reduce the level of synthetic drugs justify further studies on P. lactiflora root-derived materials as potential anti-HRV products or lead molecules for the prevention or treatment of HRV.	[Luong Thi My Ngan] Vietnam Natl Univ, Ho Chi Minh City Univ Sci, Fac Biol, Dept Plant Biotechnol & Biotransformat, Ho Chi Minh, Vietnam; [Jang, Myeong Jin; Kwon, Min Jung; Ahn, Young Joon] Seoul Natl Univ, Dept Agr Biotechnol, Biomodulat Major, Seoul, South Korea	Vietnam National University Hochiminh City; Seoul National University (SNU)	Ahn, YJ (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Biomodulat Major, Seoul, South Korea.	yjahn@snu.ac.kr		Luong, Ngan/0000-0003-0500-007X	Brain Korea 21 PLUS through the National Research Foundation of Korea - Ministry of Education of the Korean Government	Brain Korea 21 PLUS through the National Research Foundation of Korea - Ministry of Education of the Korean Government	Funding: This work was carried out with the support by the Brain Korea 21 PLUS through the National Research Foundation of Korea funded by the Ministry of Education of the Korean Government to Y.J. Ahn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIES K, 1990, J VIROL, V64, P1117, DOI 10.1128/JVI.64.3.1117-1123.1990; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Chiang LC, 2003, J ANTIMICROB CHEMOTH, V52, P194, DOI 10.1093/jac/dkg291; Choi HJ, 2010, LETT APPL MICROBIOL, V51, P1, DOI 10.1111/j.1472-765X.2010.02845.x; Choi HJ, 2009, PHYTOMEDICINE, V16, P35, DOI 10.1016/j.phymed.2008.10.012; Choi HJ, 2010, PHYTOTHER RES, V24, P1292, DOI 10.1002/ptr.3101; Choi HJ, 2009, ANTIVIR RES, V81, P77, DOI 10.1016/j.antiviral.2008.10.002; Couch RB, 2006, ELS             0424, DOI [10.1038/npg.els.0004240, DOI 10.1038/NPG.ELS.0004240]; DETOMMASI N, 1992, J NAT PROD, V55, P1067, DOI 10.1021/np50086a006; Garozzo Adriana, 2007, Antiviral Chemistry & Chemotherapy, V18, P277; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Ibarra KD, 2009, J VIROL, V83, P4538, DOI 10.1128/JVI.02280-08; ISHITSUKA H, 1982, ANTIMICROB AGENTS CH, V22, P611, DOI 10.1128/AAC.22.4.611; Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12; Jang YJ, 2009, ANTIVIR RES, V81, P226, DOI 10.1016/j.antiviral.2008.12.001; Jarvis SM, 1998, BRIT J PHARMACOL, V123, P1587, DOI 10.1038/sj.bjp.0701775; Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x; Jiangsu New Medical College, 1977, DICT CHIN TRAD MED, V1; Kitazato K, 2007, DRUG DISCOV THER, V1, P14; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SJ, 2006, BIOL PHARM BULL, V29, P2131, DOI 10.1248/bpb.29.2131; Liu A.-L., 2012, DIETARY PHYTOCHEMICA, V978, P93, DOI [10.1007/978-94-007-3926-0_3, DOI 10.1007/978-94-007-3926-0_3]; Liu G, 2011, ARCH VIROL, V156, P1359, DOI 10.1007/s00705-011-0989-9; Luong TMN, 2012, J AGR FOOD CHEM, V60, P9062, DOI 10.1021/jf3035034; Morgan D M, 1998, Methods Mol Biol, V79, P179; Newcomb DC, 2007, AM J PHYSIOL-LUNG C, V293, pL1021, DOI 10.1152/ajplung.00060.2007; Nizamutdinova IT, 2007, INT IMMUNOPHARMACOL, V7, P343, DOI 10.1016/j.intimp.2006.11.004; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Pitkaranta A, 1997, J CLIN MICROBIOL, V35, P1791; Pitkaranta A, 1998, PEDIATRICS, V102, P291, DOI 10.1542/peds.102.2.291; Pourianfar HR, 2012, INDIAN J VIROL, V23, P303, DOI 10.1007/s13337-012-0105-0; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Roelen CAM, 2011, WORK, V39, P305, DOI 10.3233/WOR-2011-1178; Rollinger JM, 2008, J MED CHEM, V51, P842, DOI 10.1021/jm701494b; Rollinger JM, 2011, MED RES REV, V31, P42, DOI 10.1002/med.20176; Rollinger JM, 2009, PLANTA MED, V75, P195, DOI 10.1055/s-0028-1088397; SAKAR MK, 1993, PHYTOCHEMISTRY, V33, P171, DOI 10.1016/0031-9422(93)85416-O; Savolainen Carita, 2003, Paediatr Respir Rev, V4, P91, DOI 10.1016/S1526-0542(03)00030-7; Spasova M, 2008, BIOORGAN MED CHEM, V16, P7457, DOI 10.1016/j.bmc.2008.06.010; Suzuki T, 2002, AM J RESP CRIT CARE, V165, P1113, DOI 10.1164/ajrccm.165.8.2103094; Tang W., 1992, CHINESE DRUGS PLANT; TSUCHIYA Y, 1985, CHEM PHARM BULL, V33, P3881, DOI 10.1248/cpb.33.3881; Turner RB, 1998, CLIN INFECT DIS, V26, P840, DOI 10.1086/513922; Turner RB, 2001, ANTIVIR RES, V49, P1, DOI 10.1016/S0166-3542(00)00135-2; UNCAPHER CR, 1991, VIROLOGY, V180, P814, DOI 10.1016/0042-6822(91)90098-V; VANHOOF L, 1984, PLANTA MED, V50, P513, DOI 10.1055/s-2007-969786; VLIETINCK AJ, 1991, J ETHNOPHARMACOL, V32, P141, DOI 10.1016/0378-8741(91)90112-Q; Waterer G, 2009, RESPIROLOGY, V14, P651, DOI 10.1111/j.1440-1843.2009.01554.x; Whiteman SC, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-8; Williams J E, 2001, Altern Med Rev, V6, P567; Yasuda H, 2006, EUR RESPIR J, V28, P51, DOI 10.1183/09031936.06.00058505; Zhao WH, 2007, J CHROMATOGR B, V850, P523, DOI 10.1016/j.jchromb.2006.11.002	56	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121629	10.1371/journal.pone.0121629	http://dx.doi.org/10.1371/journal.pone.0121629			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860871	gold, Green Submitted, Green Published			2022-12-27	WOS:000352590300028
J	Park, J; Wicki, J; Knoblaugh, SE; Chamberlain, JS; Lee, D				Park, Joshua; Wicki, Jacqueline; Knoblaugh, Sue E.; Chamberlain, Jeffrey S.; Lee, Donghoon			Multi-Parametric MRI at 14T for Muscular Dystrophy Mice Treated with AAV Vector-Mediated Gene Therapy	PLOS ONE			English	Article							MDX MOUSE MODEL; SKELETAL-MUSCLE; MAGNETIZATION-TRANSFER; MICRODYSTROPHIN EXPRESSION; NEUROMUSCULAR DISORDERS; BIOPSY; DIFFUSION; RELAXATION; PHENOTYPE; DELIVERY	The objective of this study was to investigate the efficacy of using quantitative magnetic resonance imaging (MRI) as a non-invasive tool for the monitoring of gene therapy for muscular dystrophy. The clinical investigations for this family of diseases often involve surgical biopsy which limits the amount of information that can be obtained due to the invasive nature of the procedure. Thus, other non-invasive tools may provide more opportunities for disease assessment and treatment responses. In order to explore this, dystrophic mdx(4cv) mice were systemically treated with a recombinant adeno-associated viral (AAV) vector containing a codon-optimized micro-dystrophin gene. Multi-parametric MRI of T2, magnetization transfer, and diffusion effects alongside 3-D volume measurements were then utilized to monitor disease/treatment progression. Mice were imaged at 10 weeks of age for pre-treatment, then again post-treatment at 8, 16, and 24 week time points. The efficacy of treatment was assessed by physiological assays for improvements in function and quantification of expression. Tissues from the hindlimbs were collected for histological analysis after the final time point for comparison with MRI results. We found that introduction of the micro-dystrophin gene restored some aspects of normal muscle histology and pathology such as decreased necrosis and resistance to contraction-induced injury. T2 relaxation values showed percentage decreases across all muscle types measured (tibialis anterior, gastrocnemius, and soleus) when treated groups were compared to untreated groups. Additionally, the differences between groups were statistically significant for the tibialis anterior as well. The diffusion measurements showed a wider range of percentage changes and less statistical significance while the magnetization transfer effect measurements showed minimal change. MR images displayed hyper-intense regions of muscle that correlated with muscle pathology in histological sections. T2 relaxation, alongside diffusion and magnetization transfer effects provides useful data towards the goal of non-invasively monitoring the treatment of muscular dystrophy.	[Park, Joshua; Lee, Donghoon] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Wicki, Jacqueline; Chamberlain, Jeffrey S.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Knoblaugh, Sue E.] Fred Hutchinson Canc Res Ctr, Comparat Med Shared Resources, Seattle, WA 98104 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Chamberlain, Jeffrey S.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lee, D (corresponding author), Univ Washington, Dept Radiol, Seattle, WA 98195 USA.	dhoonlee@uw.edu		Chamberlain, Jeffrey/0000-0001-5299-0059	National Institute Health (NIH) [R21EB008166]; NIH [R37AR040864, S10RR029021]; Provost office and Department of Radiology at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR065139, R37AR040864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB008166] Funding Source: NIH RePORTER	National Institute Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Provost office and Department of Radiology at the University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institute Health (NIH) R21EB008166: http://www.nibib.nih.gov, NIH R37AR040864: http://www.niams.nih.gov, NIH S10RR029021 and Bridge funding from the Provost office and Department of Radiology at the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2011, RADIOLOGY, V259, P127, DOI 10.1148/radiol.10091648; Athanasopoulos T, 2004, GENE THER, V11, pS109, DOI 10.1038/sj.gt.3302379; Banks GB, 2007, HUM MOL GENET, V16, P2105, DOI 10.1093/hmg/ddm158; Banks GB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000958; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe; COGGAN AR, 1995, J GERONTOL A-BIOL, V50, P30; COLE WC, 1993, MAGNET RESON MED, V29, P19, DOI 10.1002/mrm.1910290106; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Emery AEH, 2003, DUCHENNE MUSCULAR DY; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fabb SA, 2002, HUM MOL GENET, V11, P733, DOI 10.1093/hmg/11.7.733; Feng S, 2014, J MAGN RESON IMAGING, V40, P779, DOI 10.1002/jmri.24417; Filosto M, 2007, NEUROLOGY, V68, P181, DOI 10.1212/01.wnl.0000252252.29532.cc; Finanger EL, 2012, PHYS MED REH CLIN N, V23, P1, DOI 10.1016/j.pmr.2011.11.004; FULLERTON G D, 1982, Magnetic Resonance Imaging, V1, P209, DOI 10.1016/0730-725X(82)90172-2; Gadian DG, 1995, NUCLEAR MAGNETIC RES; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Gregorevic P, 2008, MOL THER, V16, P657, DOI 10.1038/mt.2008.28; Gregorevic P, 2006, NAT MED, V12, P787, DOI 10.1038/nm1439; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; HADAR H, 1983, AM J ROENTGENOL, V141, P895, DOI 10.2214/ajr.141.5.895; HAZLEWOOD CF, 1974, BIOPHYS J, V14, P583, DOI 10.1016/S0006-3495(74)85937-0; Heemskerk AM, 2007, RADIOLOGY, V243, P413, DOI 10.1148/radiol.2432060491; Heemskerk AM, 2006, MAGN RESON MED, V56, P272, DOI 10.1002/mrm.20953; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; Kobayashi YM, 2012, NEUROMUSCULAR DISORD, V22, P34, DOI 10.1016/j.nmd.2011.08.001; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1987, J NEURORADIOLOGY, V14, P295; LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; MATTILA KT, 1995, MAGN RESON MED, V33, P185, DOI 10.1002/mrm.1910330207; McDaniel JD, 1999, J COMPUT ASSIST TOMO, V23, P609, DOI 10.1097/00004728-199907000-00023; Mercuri E, 2005, CURR OPIN NEUROL, V18, P526, DOI 10.1097/01.wco.0000183947.01362.fe; Pacak CA, 2007, MOL THER, V15, P1775, DOI 10.1038/sj.mt.6300246; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; POSSE S, 1993, RADIOLOGY, V188, P719, DOI 10.1148/radiology.188.3.8351339; Pratt Stephen J P, 2013, BMC Res Notes, V6, P262, DOI 10.1186/1756-0500-6-262; Prayson RA, 2006, AM J CLIN PATHOL, V126, P843, DOI 10.1309/78B3MOTGJYT4RUUM; Qiao Y, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-73; Rall Susanne, 2012, Acta Myol, V31, P117; Rodino-Klapac LR, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-45; Roth SM, 2000, EUR J APPL PHYSIOL, V83, P239, DOI 10.1007/s004210000287; Saab G, 1999, MAGNET RESON MED, V42, P150, DOI 10.1002/(SICI)1522-2594(199907)42:1<150::AID-MRM20>3.0.CO;2-5; Salinero-Panigua E, 2004, REV NEUROLOGIA, V39, P821, DOI 10.33588/rn.3909.2003521; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Sinclair CDJ, 2010, MAGN RESON MED, V64, P1739, DOI 10.1002/mrm.22562; Stuckey DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028569; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; van Nierop BJ, 2010, J BIOMECH, V43, P570, DOI 10.1016/j.jbiomech.2009.07.043; Verhaert D, 2011, CIRC-CARDIOVASC IMAG, V4, P67, DOI 10.1161/CIRCIMAGING.110.960740; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Watchko J, 2002, HUM GENE THER, V13, P1451, DOI 10.1089/10430340260185085; Willis TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070993; Yoshimura M, 2004, MOL THER, V10, P821, DOI 10.1016/j.ymthe.2004.07.025	56	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124914	10.1371/journal.pone.0124914	http://dx.doi.org/10.1371/journal.pone.0124914			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856443	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500124
J	Rahman, F; Cotterchio, M; Cleary, SP; Gallinger, S				Rahman, Farah; Cotterchio, Michelle; Cleary, Sean P.; Gallinger, Steven			Association between Alcohol Consumption and Pancreatic Cancer Risk: A Case-Control Study	PLOS ONE			English	Article							COHORT-CONSORTIUM PANSCAN; POOLED-ANALYSIS; NETHERLANDS COHORT; CIGARETTE-SMOKING; DNA-ADDUCTS; TOBACCO; POLYMORPHISMS; EPIDEMIOLOGY; METAANALYSIS; HISTORY	Purpose Evidence is inconsistent regarding alcohol and pancreatic cancer risk, although heavy drinking may increase risk. Methods A population-based case-control study was conducted using 345 pancreas cancer cases diagnosed 2011-2012 and 1,285 frequency-matched controls from Ontario, Canada. Logistic regression was used to evaluate alcohol consumption and pancreatic cancer risk; data was also stratified by sex and smoking status to assess interaction. Results Alcohol consumption was not associated with pancreatic cancer risk (age-adjusted odds ratio=0.78, 95% CI: 0.58, 1.05 for 1 - 3 drinks/week; age-adjusted odds ratio=0.86, 95% CI: 0.63, 1.17 for 4 - 20 drinks/week), however there was a non-significant increased risk for heavy drinkers consuming >= 21 drinks/week (age-adjusted odds ratio=1.35, 95% CI: 0.81, 2.27). Cigarette smoking modified the alcohol-cancer relationship; among current smokers, heavy alcohol consumption was associated with a significantly increased pancreatic cancer risk (age-adjusted odds ratio=4.04, 95% CI: 1.58, 10.37), whereas this significant association with heavy drinking was not observed among non-smokers (age-adjusted odds ratio=2.01, 95% CI: 0.50, 8.18). Furthermore, light - moderate alcohol intake was associated with increased pancreas cancer risk among current smokers. Conclusions While alcohol was not significantly associated with pancreatic cancer risk, smoking status modified this relationship such that among current smokers, alcohol intake was associated with a greater than two-fold increased risk of pancreatic cancer. The results should be interpreted with caution due to small sample sizes within subgroups and correction for multiple comparisons should be considered. These findings should be replicated in larger studies where more precise estimates of risk can be obtained.	[Rahman, Farah; Cotterchio, Michelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Cotterchio, Michelle] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Cleary, Sean P.] Univ Hlth Network, Dept Surg, Toronto, ON, Canada; [Cleary, Sean P.] Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON, Canada; [Gallinger, Steven] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Toronto Gen Hosp, Div Gen Surg, Toronto, ON, Canada	University of Toronto; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Rahman, F (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	farah.rahman@mail.utoronto.ca	Gallinger, Steven/E-4575-2013	Cotterchio, Michelle/0000-0003-2862-7895; , Farah/0000-0002-0569-1467; Cleary, Sean/0000-0002-5274-9983	National Institutes of Health (as part of PACGENE consortium) [RO1 CA97075]; Canadian Institutes of Health Research [MOP-106631]; Dr. James Rossiter MPH Practicum Award; NATIONAL CANCER INSTITUTE [R01CA097075] Funding Source: NIH RePORTER	National Institutes of Health (as part of PACGENE consortium); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dr. James Rossiter MPH Practicum Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the National Institutes of Health (RO1 CA97075 to SG, as part of PACGENE consortium, http://www.nih.gov/), the Canadian Institutes of Health Research (MOP-106631 to MC, http://www.cihr-irsc.gc.ca/e/193.html), and the Dr. James Rossiter MPH Practicum Award (to FR, http://www.cihr-irsc.gc.ca/e/48447.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LN, 2009, CANCER CAUSE CONTROL, V20, P825, DOI 10.1007/s10552-009-9303-5; Anderson MA, 2012, AM J GASTROENTEROL, V107, P1730, DOI 10.1038/ajg.2012.288; [Anonymous], 2013, CAN CANC STAT 2013; Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Austin MA, 2013, CANCER EPIDEM BIOMAR, V22, P1913, DOI 10.1158/1055-9965.EPI-13-0518; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Bosetti C, 2012, ANN ONCOL, V23, P1880, DOI 10.1093/annonc/mdr541; Chowdhury P, 2006, WORLD J GASTROENTERO, V12, P7421, DOI 10.3748/wjg.v12.i46.7421; Chu D, 2010, J PANCREAS, V11, P203; Cotterchio M, 2014, CANCER EPIDEM BIOMAR, V23, P469, DOI 10.1158/1055-9965.EPI-13-0965; Duell EJ, 2012, MOL CARCINOGEN, V51, P40, DOI 10.1002/mc.20786; EKBOM A, 1994, J NATL CANCER I, V86, P625, DOI 10.1093/jnci/86.8.625; Genkinger JM, 2011, INT J CANCER, V129, P1708, DOI 10.1002/ijc.25794; Genkinger JM, 2009, CANCER EPIDEM BIOMAR, V18, P765, DOI 10.1158/1055-9965.EPI-08-0880; Gupta S, 2010, CANCER CAUSE CONTROL, V21, P1047, DOI 10.1007/s10552-010-9533-6; Heinen MM, 2010, CANCER EPIDEM BIOMAR, V19, P1612, DOI 10.1158/1055-9965.EPI-10-0121; Heinen MM, 2009, AM J EPIDEMIOL, V169, P1233, DOI 10.1093/aje/kwp028; Herreros-Villanueva M, 2013, WORLD J GASTROENTERO, V19, P638, DOI 10.3748/wjg.v19.i5.638; Jiao L, 2009, AM J EPIDEMIOL, V169, P1043, DOI 10.1093/aje/kwp034; Klein AP, 2004, CANCER RES, V64, P2634, DOI 10.1158/0008-5472.CAN-03-3823; Li DH, 2006, CARCINOGENESIS, V27, P103, DOI 10.1093/carcin/bgi171; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li DH, 2002, MUTAT RES-GEN TOX EN, V513, P37, DOI 10.1016/S1383-5718(01)00291-1; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Lucenteforte E, 2012, ANN ONCOL, V23, P374, DOI 10.1093/annonc/mdr120; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Meskar A, 2001, PATHOL BIOL, V49, P696, DOI 10.1016/S0369-8114(01)00235-8; Michaud DS, 2010, CANCER CAUSE CONTROL, V21, P1213, DOI 10.1007/s10552-010-9548-z; Michaud DS, 2001, CANCER EPIDEM BIOMAR, V10, P429; Miura Fumihiko, 2006, HPB (Oxford), V8, P337, DOI 10.1080/13651820500540949; POIKOLAINEN K, 1985, BRIT J ADDICT, V80, P215; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Rohrmann S, 2009, CANCER CAUSE CONTROL, V20, P785, DOI 10.1007/s10552-008-9293-8; Shin EJ, 2012, GASTROENTEROL CLIN N, V41, P143, DOI 10.1016/j.gtc.2011.12.001; Tramacere I, 2010, INT J CANCER, V126, P1474, DOI 10.1002/ijc.24936; Villeneuve PJ, 2000, EUR J CANCER PREV, V9, P49, DOI 10.1097/00008469-200002000-00007; Vrieling A, 2010, INT J CANCER, V126, P2394, DOI 10.1002/ijc.24907; Wang Feng, 2003, Mol Cancer, V2, P4, DOI 10.1186/1476-4598-2-4; Wang MY, 1998, CANCER RES, V58, P38; Wu DF, 2003, ALCOHOL RES HEALTH, V27, P277; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; Zavoral M, 2011, WORLD J GASTROENTERO, V17, P2897, DOI 10.3748/wjg.v17.i24.2897; Zheng W, 1993, CANCER CAUSE CONTROL, V4, P477	45	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124489	10.1371/journal.pone.0124489	http://dx.doi.org/10.1371/journal.pone.0124489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856529	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500116
J	Woolcott, OO; Richey, JM; Kabir, M; Chow, RH; Iyer, MS; Kirkman, EL; Stefanovski, D; Lottati, M; Kim, SP; Harrison, LN; Ionut, V; Zheng, D; Hsu, IR; Catalano, KJ; Chiu, JD; Bradshaw, H; Wu, Q; Bergman, RN				Woolcott, Orison O.; Richey, Joyce M.; Kabir, Morvarid; Chow, Robert H.; Iyer, Malini S.; Kirkman, Erlinda L.; Stefanovski, Darko; Lottati, Maya; Kim, Stella P.; Harrison, L. Nicole; Ionut, Viorica; Zheng, Dan; Hsu, Isabel R.; Catalano, Karyn J.; Chiu, Jenny D.; Bradshaw, Heather; Wu, Qiang; Bergman, Richard N.			High-Fat Diet-Induced Insulin Resistance Does Not Increase Plasma Anandamide Levels or Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets	PLOS ONE			English	Article							PERIPHERAL CANNABINOID RECEPTOR; ENDOCANNABINOID SYSTEM; BETA-CELL; PANCREATIC-ISLETS; VANILLOID RECEPTORS; ADIPOSE-TISSUE; MOUSE ISLETS; FULL AGONIST; RAT-BRAIN; SECRETION	Background Obesity has been associated with elevated plasma anandamide levels. In addition, anandamide has been shown to stimulate insulin secretion in vitro, suggesting that anandamide might be linked to hyperinsulinemia. Objective To determine whether high-fat diet-induced insulin resistance increases anandamide levels and potentiates the insulinotropic effect of anandamide in isolated pancreatic islets. Design and Methods Dogs were fed a high-fat diet (n = 9) for 22 weeks. Abdominal fat depot was quantified by MRI. Insulin sensitivity was assessed by the euglycemic-hyperinsulinemic clamp. Fasting plasma endocannabinoid levels were analyzed by liquid chromatography-mass spectrometry. All metabolic assessments were performed before and after fat diet regimen. At the end of the study, pancreatic islets were isolated prior to euthanasia to test the in vitro effect of anandamide on islet hormones. mRNA expression of cannabinoid receptors was determined in intact islets. The findings in vitro were compared with those from animals fed a control diet (n = 7). Results Prolonged fat feeding increased abdominal fat content by 81.3 +/- 21.6% (mean +/- S.E.M, P<0.01). In vivo insulin sensitivity decreased by 31.3 +/- 12.1% (P<0.05), concomitant with a decrease in plasma 2-arachidonoyl glycerol (from 39.1 +/- 5.2 to 15.7 +/- 2.0 nmol/L) but not anandamide, oleoyl ethanolamide, linoleoyl ethanolamide, or palmitoyl ethanolamide. In control-diet animals (body weight: 28.8 +/- 1.0 kg), islets incubated with anandamide had a higher basal and glucose-stimulated insulin secretion as compared with no treatment. Islets from fat-fed animals (34.5 +/- 1.3 kg; P<0.05 versus control) did not exhibit further potentiation of anandamide-induced insulin secretion as compared with control-diet animals. Glucagon but not somatostatin secretion in vitro was also increased in response to anandamide, but there was no difference between groups (P = 0.705). No differences in gene expression of CB1R or CB2R between groups were found. Conclusions In canines, high-fat diet-induced insulin resistance does not alter plasma anandamide levels or further potentiate the insulinotropic effect of anandamide in vitro.	[Woolcott, Orison O.; Kabir, Morvarid; Iyer, Malini S.; Stefanovski, Darko; Kim, Stella P.; Ionut, Viorica; Wu, Qiang; Bergman, Richard N.] Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Richey, Joyce M.; Chow, Robert H.; Lottati, Maya; Harrison, L. Nicole; Zheng, Dan; Hsu, Isabel R.; Catalano, Karyn J.; Chiu, Jenny D.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Kirkman, Erlinda L.] Univ So Calif, Dept Anim Resources, Los Angeles, CA 90033 USA; [Bradshaw, Heather] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Cedars Sinai Medical Center; University of Southern California; University of Southern California; Indiana University System; Indiana University Bloomington	Woolcott, OO (corresponding author), Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA.	Orison.Woolcott@cshs.org	Woolcott, Orison O./AAQ-3440-2020; Kolka, Cathryn/B-1526-2015; Kabir, Morvarid/P-8154-2018	Woolcott, Orison O./0000-0003-2905-972X; Kolka, Cathryn/0000-0002-6636-7062; Iyer, Malini S./0000-0001-7776-7216; Bergman, Richard/0000-0003-1539-4471; Kabir, Morvarid/0000-0003-0880-3767	Sanofiaventis; National Institutes of Health [DK29867, DK27619, DK60623, GM85791]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027619, R01DK060623, R01DK027619, R01DK029867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085791] Funding Source: NIH RePORTER	Sanofiaventis(Sanofi-Aventis); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by Sanofiaventis (to RNB) and the National Institutes of Health (Grants DK29867 and DK27619 to RNB; and DK60623 and GM85791 to RHC). The funders, including the NIH, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulnour J, 2014, OBESITY, V22, P211, DOI 10.1002/oby.20498; Ader M, 2005, DIABETES, V54, P862, DOI 10.2337/diabetes.54.3.862; Ader M, 2014, DIABETES, V63, P1914, DOI 10.2337/db13-1215; Alvheim AR, 2012, OBESITY, V20, P1984, DOI 10.1038/oby.2012.38; AMMON HPT, 1991, J ENDOCRINOL, V128, P27, DOI 10.1677/joe.0.1280027; Anderson RL, 2013, EUR J PHARMACOL, V706, P56, DOI 10.1016/j.ejphar.2013.02.034; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Bergman RN, 2007, DIABETES, V56, P1489, DOI 10.2337/db07-9903; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bermudez-Silva FJ, 2008, DIABETOLOGIA, V51, P476, DOI 10.1007/s00125-007-0890-y; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bradshaw HB, 2006, AM J PHYSIOL-REG I, V291, pR349, DOI 10.1152/ajpregu.00933.2005; Correa F, 2009, BIOCHEM PHARMACOL, V77, P86, DOI 10.1016/j.bcp.2008.09.014; De Petrocellis L, 2009, CELL CALCIUM, V45, P611, DOI 10.1016/j.ceca.2009.03.003; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Di Marzo V, 2012, PHILOS T R SOC B, V367, P3216, DOI 10.1098/rstb.2011.0382; Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Engeli S, 2014, OBESITY, V22, pE70, DOI 10.1002/oby.20728; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; Ginsberg HN, 2009, OBESITY, V17, P1821, DOI 10.1038/oby.2009.107; Gonsiorek W, 2000, MOL PHARMACOL, V57, P1045; Hamilton LC., 2008, STAT STATA UPDATED V, P387; HAYEK A, 1979, DIABETES, V28, P565, DOI 10.2337/diabetes.28.6.565; Jourdan T, 2013, NAT MED, V19, P1132, DOI 10.1038/nm.3265; Juan-Pico P, 2006, CELL CALCIUM, V39, P155, DOI 10.1016/j.ceca.2005.10.005; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; Kim SP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1581, DOI 10.1152/ajpendo.00351.2006; Kim SP, 2012, AM J PHYSIOL-ENDOC M, V302, pE1261, DOI 10.1152/ajpendo.00496.2011; Kim W, 2011, DIABETES, V60, P1198, DOI 10.2337/db10-1550; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Li C, 2011, DIABETES OBES METAB, V13, P903, DOI 10.1111/j.1463-1326.2011.01422.x; Li C, 2010, ISLETS, V2, P293, DOI 10.4161/isl.2.5.12729; Liu J, 2012, GASTROENTEROLOGY, V142, P1218, DOI 10.1053/j.gastro.2012.01.032; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Malenczyk K, 2013, J BIOL CHEM, V288, P32685, DOI 10.1074/jbc.M113.478354; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Matsumoto I, 2004, TRANSPLANTATION, V78, P880, DOI 10.1097/01.TP.0000134396.03440.1E; McKillop AM, 2013, BRIT J PHARMACOL, V170, P978, DOI 10.1111/bph.12356; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Nakata M, 2008, REGUL PEPTIDES, V145, P49, DOI 10.1016/j.regpep.2007.08.009; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Reggio PH, 2010, CURR MED CHEM, V17, P1468, DOI 10.2174/092986710790980005; Richey JM, 2009, AM J PHYSIOL-ENDOC M, V296, pE1311, DOI 10.1152/ajpendo.90972.2008; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Roberts LA, 2002, BRIT J PHARMACOL, V137, P421, DOI 10.1038/sj.bjp.0704904; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Ross RA, 2001, BRIT J PHARMACOL, V132, P631, DOI 10.1038/sj.bjp.0703850; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Shen MX, 1996, J NEUROSCI, V16, P4322; Showalter VM, 1996, J PHARMACOL EXP THER, V278, P989; Sipe JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008792; Smart D, 2000, BRIT J PHARMACOL, V129, P227, DOI 10.1038/sj.bjp.0703050; Song S, 2012, DIABETOLOGIA, V55, pS163; Song ZH, 1999, MOL PHARMACOL, V56, P834; STAGNER JI, 1988, DIABETES, V37, P1715, DOI 10.2337/diabetes.37.12.1715; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; Tharp WG, 2008, BIOCHEM BIOPH RES CO, V372, P595, DOI 10.1016/j.bbrc.2008.05.077; Troy-Fioramonti S, 2015, DIABETES, V64, P808, DOI 10.2337/db14-0721; Twitchell W, 1997, J NEUROPHYSIOL, V78, P43, DOI 10.1152/jn.1997.78.1.43; Valk P, 1997, BLOOD, V90, P1448, DOI 10.1182/blood.V90.4.1448.1448_1448_1457; Vilches-Flores A, 2013, CLIN SCI, V124, P467, DOI 10.1042/CS20120447; Vilches-Flores A, 2010, REGUL PEPTIDES, V163, P81, DOI 10.1016/j.regpep.2010.04.013; Wahl P, 2001, MOL PHARMACOL, V59, P9, DOI 10.1124/mol.59.1.9; Woolcott OO, 2012, PANCREAS, V41, P31, DOI 10.1097/MPA.0b013e318221fd0e; Yashiro H, 2012, J PHARMACOL EXP THER, V340, P483, DOI 10.1124/jpet.111.187708; ZIELMANN S, 1985, N-S ARCH PHARMACOL, V329, P299, DOI 10.1007/BF00501884	71	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123558	10.1371/journal.pone.0123558	http://dx.doi.org/10.1371/journal.pone.0123558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855974	Green Published, gold			2022-12-27	WOS:000352588500097
J	Yuan, JP; Wang, LW; Qu, AP; Chen, JM; Xiang, QM; Chen, C; Sun, SR; Pang, DW; Liu, J; Li, Y				Yuan, Jing Ping; Wang, Lin Wei; Qu, Ai Ping; Chen, Jia Mei; Xiang, Qing Ming; Chen, Chuang; Sun, Sheng-Rong; Pang, Dai-Wen; Liu, Juan; Li, Yan			Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer	PLOS ONE			English	Article							KI-67 LABELING INDEX; MOLECULAR CLASSIFICATION; PROGNOSTIC VALUE; PROLIFERATION INDEX; INTERNATIONAL KI67; ANTIBODY; REPRODUCIBILITY; RECOMMENDATIONS; QUANTIFICATION; EXPRESSION	Background As a marker for tumor cell proliferation, Ki67 has important impacts on breast cancer (BC) prognosis. Although immunohistochemical staining is the current standard method, variations in analytical practice make it difficult for pathologists to manually measure Ki67 index. This study was to develop a fluorescent spectrum-based quantitative analysis of Ki67 expression by quantum-dots (QDs) multiple imaging technique. Methods A QDs-based in situ multiple fluorescent imaging method was developed, which stained nuclear Ki67 as red signal and cytoplasmic cytokeratin (CK) as green signal. Both Ki67 and CK signals were automatically separated and quantified by professional spectrum analysis software. This technique was applied to tissue microarrays from 240 BC patients. Both Ki67 and CK values, and Ki67/CK ratio were obtained for each patient, and their prognostic value on 5-year disease free survival was assessed. Results This method simultaneously stains nuclear Ki67 and cytoplasmic CK with clear signal contrast, making it easy for signal separation and quantification. The total fluorescent signal intensities of both Ki67 sum and CK sum were obtained, and Ki67/CK ratio calculated. Ki67 sum and Ki67/CK ratio were each attributed into two grades by X-tile software based on the best P value principle. Multivariate analysis showed Ki67 grade (P = 0.047) and Ki67/CK grade (P = 0.004) were independent prognostic factors. Furthermore, area under curve (AUC) of ROC analysis for Ki67/CK grade (AUC: 0.683, 95%CI: 0.613-0.752) was higher than Ki67 grade (AUC: 0.665, 95%CI: 0.596-0.734) and HER-2 gene (AUC: 0.586, 95%CI: 0.510-0.661), but lower than N stage (AUC: 0.760, 95%CI: 0.696-0.823) and histological grade (AUC: 0.756, 95%CI: 0.692-0.820) on predicting the risk for recurrence. Conclusions A QDs-based quantitative and in situ multiple imaging on Ki67 and CK was developed to improve Ki67 assessment in BC, and Ki67/CK grade had better performance than Ki67 grade in predicting prognosis.	[Yuan, Jing Ping; Wang, Lin Wei; Chen, Jia Mei; Xiang, Qing Ming; Li, Yan] Wuhan Univ, Zhongnan Hosp, Dept Oncol, Hubei Key Lab Tumor Biol Behav, Wuhan 430072, Hubei, Peoples R China; [Yuan, Jing Ping; Wang, Lin Wei; Chen, Jia Mei; Xiang, Qing Ming; Li, Yan] Hubei Canc Clin Study Ctr, Wuhan, Hubei, Peoples R China; [Qu, Ai Ping; Liu, Juan] Wuhan Univ, Sch Comp, Wuhan 430072, Hubei, Peoples R China; [Chen, Chuang; Sun, Sheng-Rong] Wuhan Univ, Renmin Hosp, Dept Breast & Thyroid Surg, Wuhan 430072, Hubei, Peoples R China; [Pang, Dai-Wen] Wuhan Univ, Minist Educ, Key Lab Analyt Chem Biol & Med, Coll Chem & Mol Sci,State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Pang, Dai-Wen] Wuhan Univ, Wuhan Inst Biotechnol, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University; Wuhan University	Li, Y (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Oncol, Hubei Key Lab Tumor Biol Behav, Wuhan 430072, Hubei, Peoples R China.	liyansd2@163.com			Key Project of the National Natural Science Foundation of China [81230031/H18]; National Science Foundation of China [81201196/H18]; Program for New Century Excellent Talents in Universities [NCET-10-0644]; Key Project of the Fundamental Research Fund for the Central Universities [303274028]; Natural Science Funds of Hubei Province [2014CFB397]	Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Key Project of the Fundamental Research Fund for the Central Universities; Natural Science Funds of Hubei Province	This work is supported by Key Project of the National Natural Science Foundation of China (81230031/H18), the National Science Foundation of China (81201196/H18), Program for New Century Excellent Talents in Universities (NCET-10-0644), the Key Project of the Fundamental Research Fund for the Central Universities (303274028), the Natural Science Funds of Hubei Province (2014CFB397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Chen C, 2012, NANOMEDICINE-UK, V7, P411, DOI [10.2217/NNM.12.9, 10.2217/nnm.12.9]; Chen C, 2011, BIOMATERIALS, V32, P7592, DOI 10.1016/j.biomaterials.2011.06.029; Chen C, 2010, BIOMATERIALS, V31, P8818, DOI 10.1016/j.biomaterials.2010.07.091; Cummings MC, 2011, PATHOLOGY, V43, P1, DOI 10.1097/PAT.0b013e328341e0b5; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Engels CC, 2013, BREAST CANCER RES TR, V142, P323, DOI 10.1007/s10549-013-2748-y; Fasanella S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S7; Ferguson NL, 2013, BREAST J, V19, P22, DOI 10.1111/tbj.12059; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Geyer FC, 2012, ADV ANAT PATHOL, V19, P39, DOI 10.1097/PAP.0b013e31823fafa0; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054912; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Guiu S, 2012, ANN ONCOL, V23, P2997, DOI 10.1093/annonc/mds586; Hama Y, 2007, BREAST CANCER RES TR, V103, P23, DOI 10.1007/s10549-006-9347-0; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hu WQ, 2014, BIOMATERIALS, V35, P4125, DOI 10.1016/j.biomaterials.2014.01.059; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jonat W, 2011, ANN ONCOL, V22, P500, DOI 10.1093/annonc/mdq732; Laurinavicius A, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3639; LOPEZ F, 1991, CYTOMETRY, V12, P42, DOI 10.1002/cyto.990120107; Luo Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-24; Peng CW, 2011, BIOMATERIALS, V32, P2907, DOI 10.1016/j.biomaterials.2010.12.053; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Reyal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055901; Romero Q, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-118; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sun JZ, 2014, INT J NANOMED, V9, P1339, DOI 10.2147/IJN.S58881; Tambasco M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-140; Tang LH, 2012, AM J SURG PATHOL, V36, P1761, DOI 10.1097/PAS.0b013e318263207c; Tawfik O, 2007, VIRCHOWS ARCH, V450, P627, DOI 10.1007/s00428-007-0400-0; van de Vijver M., 2012, WHO CLASSIFICATION T; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Voros A, 2013, PATHOBIOLOGY, V80, P111, DOI 10.1159/000343795; Voros A, 2013, PATHOL ONCOL RES; Wang LW, 2014, ASIAN PAC J CANCER P, V15, P1621, DOI 10.7314/APJCP.2014.15.4.1621; Wang LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082314; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yang XQ, 2011, ASIAN PAC J CANCER P, V12, P3101; Yerushalmi Rinat, 2010, Lancet Oncol, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zabaglo L, 2010, J CLIN PATHOL, V63, P800, DOI 10.1136/jcp.2010.077578; Zhang H, 2009, BREAST CANCER RES TR, V114, P277, DOI 10.1007/s10549-008-0014-5	47	55	58	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122734	10.1371/journal.pone.0122734	http://dx.doi.org/10.1371/journal.pone.0122734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856425	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500053
J	Loesch, K; Galaviz, S; Hamoui, Z; Clanton, R; Akabani, G; Deveau, M; DeJesus, M; Ioerger, T; Sacchettini, JC; Wallis, D				Loesch, Kimberly; Galaviz, Stacy; Hamoui, Zaher; Clanton, Ryan; Akabani, Gamal; Deveau, Michael; DeJesus, Michael; Ioerger, Thomas; Sacchettini, James C.; Wallis, Deeann			Functional Genomics Screening Utilizing Mutant Mouse Embryonic Stem Cells Identifies Novel Radiation-Response Genes	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-8; CANCER-INITIATING CELLS; TERATOCARCINOMA CELLS; KLF8 TRANSCRIPTION; BINDING-PROTEIN; DNA-REPAIR; EXPRESSION; RADIOSENSITIZATION; RADIOTHERAPY; PALLIATION	Elucidating the genetic determinants of radiation response is crucial to optimizing and individualizing radiotherapy for cancer patients. In order to identify genes that are involved in enhanced sensitivity or resistance to radiation, a library of stable mutant murine embryonic stem cells (ESCs), each with a defined mutation, was screened for cell viability and gene expression in response to radiation exposure. We focused on a cancer-relevant subset of over 500 mutant ESC lines. We identified 13 genes; 7 genes that have been previously implicated in radiation response and 6 other genes that have never been implicated in radiation response. After screening, proteomic analysis showed enrichment for genes involved in cellular component disassembly (e.g. Dstn and Pex14) and regulation of growth (e.g. Adnp2, Epc1, and Ing4). Overall, the best targets with the highest potential for sensitizing cancer cells to radiation were Dstn and Map2k6, and the best targets for enhancing resistance to radiation were Iqgap and Vcan. Hence, we provide compelling evidence that screening mutant ESCs is a powerful approach to identify genes that alter radiation response. Ultimately, this knowledge can be used to define genetic variants or therapeutic targets that will enhance clinical therapy.	[Loesch, Kimberly; Galaviz, Stacy; Sacchettini, James C.; Wallis, Deeann] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Hamoui, Zaher; Clanton, Ryan; Akabani, Gamal] Texas A&M Univ, Dept Nucl Engn, College Stn, TX 77843 USA; [Akabani, Gamal] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Akabani, Gamal] Texas A&M Univ, Texas A&M Inst Preclin Studies, College Stn, TX 77843 USA; [Deveau, Michael] Texas A&M Univ, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [DeJesus, Michael; Ioerger, Thomas] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Wallis, D (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	dwallis@tamu.edu		Clanton, Ryan/0000-0002-3148-0575; De Jesus, Michael/0000-0003-3867-0299	Department of Defense Congressionally Directed Medical Research Program Peer Reviewed Cancer Research Program [CA093155]; U.S. Nuclear Regulatory Commission [NRS-38-10-923]; NATIONAL CANCER INSTITUTE [R43CA093155] Funding Source: NIH RePORTER	Department of Defense Congressionally Directed Medical Research Program Peer Reviewed Cancer Research Program; U.S. Nuclear Regulatory Commission; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense Congressionally Directed Medical Research Program Peer Reviewed Cancer Research Program [grant number CA093155]. This project is partially funded by the U.S. Nuclear Regulatory Commission, grant number NRS-38-10-923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres JL, 1998, ONCOGENE, V16, P2229, DOI 10.1038/sj.onc.1201752; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Chen G, 2012, MOL BIOL REP, V39, P9809, DOI 10.1007/s11033-012-1847-x; Chiani F, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap007; Choi KJ, 2011, ONCOL REP, V26, P55, DOI 10.3892/or.2011.1260; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; De-Zolt Silke, 2009, V530, P29, DOI 10.1007/978-1-59745-471-1_3; Dragun AE, 2011, CANCER-AM CANCER SOC, V117, P2590, DOI 10.1002/cncr.25821; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Fu WJ, 2010, J CANCER RES CLIN, V136, P1255, DOI 10.1007/s00432-010-0776-0; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Hensbergen PJ, 2005, J INVEST DERMATOL, V124, P818, DOI 10.1111/j.0022-202X.2005.23597.x; Higgins GS, 2010, CANCER RES, V70, P2984, DOI 10.1158/0008-5472.CAN-09-4040; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Kim KS, 2014, INT J RADIAT BIOL, V90, P71, DOI 10.3109/09553002.2014.859763; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Knott A, 2009, BIOGERONTOLOGY, V10, P181, DOI 10.1007/s10522-008-9165-3; Koch U, 2010, SEMIN CANCER BIOL, V20, P116, DOI 10.1016/j.semcancer.2010.02.003; Lagadec C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2479; Lahiri SK, 2012, AM J TRANSL RES, V4, P357; Li JC, 2010, GASTROENTEROLOGY, V139, P2146, DOI 10.1053/j.gastro.2010.08.004; Ling C, 2012, CANCER GENE THER, V19, P697, DOI 10.1038/cgt.2012.50; Lu H, 2012, J BIOL CHEM, V287, P43720, DOI 10.1074/jbc.M112.418053; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MCBURNEY MW, 1977, AM J PATHOL, V89, P685; Menzel T, 2011, EMBO REP, V12, P705, DOI 10.1038/embor.2011.99; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; Oakley DJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar028; PAPAIOANNOU VE, 1975, NATURE, V258, P70, DOI 10.1038/258070a0; PAPAIOANNOU VE, 1978, J EMBRYOL EXP MORPH, V44, P93; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Seigel GM, 2007, MOL VIS, V13, P823; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Sudo H, 2007, BIOCHEM BIOPH RES CO, V364, P695, DOI 10.1016/j.bbrc.2007.10.074; TONG D, 1982, CANCER, V50, P893, DOI 10.1002/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y; Uematsu M, 1998, CANCER-AM CANCER SOC, V82, P1062, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1062::AID-CNCR8>3.0.CO;2-G; Vaisnav M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104858; Vallis KA, 2002, RADIAT RES, V157, P8, DOI 10.1667/0033-7587(2002)157[0008:IORRGI]2.0.CO;2; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu JSY, 2003, INT J RADIAT ONCOL, V55, P594, DOI 10.1016/S0360-3016(02)04147-0; Yang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059319; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zhao D, 2014, CELL BIOCHEM BIOPHYS, V70, P887, DOI 10.1007/s12013-014-9995-3; Zhao YX, 2012, J RADIAT RES, V53, P686, DOI 10.1093/jrr/rrs024; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632	57	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120534	10.1371/journal.pone.0120534	http://dx.doi.org/10.1371/journal.pone.0120534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853515	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400015
J	Prickaerts, P; Niessen, HEC; Dahlmans, VEH; Spaapen, F; Salvaing, J; Vanhove, J; Geijselaers, C; Bartels, SJJ; Partouns, I; Neumann, D; Speel, EJ; Takihara, Y; Wouters, BG; Voncken, JW				Prickaerts, Peggy; Niessen, Hanneke E. C.; Dahlmans, Vivian E. H.; Spaapen, Frank; Salvaing, Juliette; Vanhove, Jolien; Geijselaers, Claudia; Bartels, Stefanie J. J.; Partouns, Iris; Neumann, Dietbert; Speel, Ernst-Jan; Takihara, Yoshihiro; Wouters, Bradly G.; Voncken, Jan Willem			MK3 Modulation Affects BMI1-Dependent and Independent Cell Cycle Check-Points	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MAMMARY EPITHELIAL-CELLS; CHROMATIN-ASSOCIATION; INDUCED SENESCENCE; NEGATIVE FEEDBACK; INK4A/ARF LOCUS; INK4A-ARF LOCUS; MAPKAP KINASES; POLYCOMB; CANCER	Although the MK3 gene was originally found deleted in some cancers, it is highly expressed in others. The relevance of MK3 for oncogenesis is currently not clear. We recently reported that MK3 controls ERK activity via a negative feedback mechanism. This prompted us to investigate a potential role for MK3 in cell proliferation. We here show that overexpression of MK3 induces a proliferative arrest in normal diploid human fibroblasts, characterized by enhanced expression of replication stress- and senescence-associated markers. Surprisingly, MK3 depletion evokes similar senescence characteristics in the fibroblast model. We previously identified MK3 as a binding partner of Polycomb Repressive Complex 1 (PRC1) proteins. In the current study we show that MK3 overexpression results in reduced cellular EZH2 levels and concomitant loss of epigenetic H3K27me3-marking and PRC1/chromatin-occupation at the CDKN2A/INK4A locus. In agreement with this, the PRC1 oncoprotein BMI1, but not the PCR2 protein EZH2, bypasses MK3-induced senescence in fibroblasts and suppresses P16INK4A expression. In contrast, BMI1 does not rescue the MK3 loss-of-function phenotype, suggesting the involvement of multiple different checkpoints in gain and loss of MK3 function. Notably, MK3 ablation enhances proliferation in two different cancer cells. Finally, the fibroblast model was used to evaluate the effect of potential tumorigenic MK3 driver-mutations on cell proliferation and M/SAPK signaling imbalance. Taken together, our findings support a role for MK3 in control of proliferation and replicative life-span, in part through concerted action with BMI1, and suggest that the effect of MK3 modulation or mutation on M/SAPK signaling and, ultimately, proliferation, is cell context-dependent.	[Prickaerts, Peggy; Dahlmans, Vivian E. H.; Spaapen, Frank; Salvaing, Juliette; Vanhove, Jolien; Geijselaers, Claudia; Bartels, Stefanie J. J.; Partouns, Iris; Neumann, Dietbert; Voncken, Jan Willem] Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Speel, Ernst-Jan] Maastricht Univ, Med Ctr, Dept Pathol, NL-6200 MD Maastricht, Netherlands; [Takihara, Yoshihiro] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Stem Cell Biol, Hiroshima, Japan; [Wouters, Bradly G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Wouters, Bradly G.] Univ Hlth Network, Campbell Family Inst Canc Res, Dept Radiat Oncol, Toronto, ON, Canada; [Wouters, Bradly G.] Univ Hlth Network, Campbell Family Inst Canc Res, Dept Med Biophys, Toronto, ON, Canada; [Wouters, Bradly G.] Maastricht Univ, Maastricht Radiat Oncol MaastRO Lab, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Hiroshima University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Maastricht University	Voncken, JW (corresponding author), Maastricht Univ, Med Ctr, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands.	w.voncken@maastrichtuniversity.nl	Niessen, Hanneke/B-7699-2009; Wouters, Bradly/T-1525-2017	Niessen, Hanneke/0000-0002-2639-0938; Wouters, Bradly/0000-0002-8187-592X; Neumann, Dietbert/0000-0002-4316-684X	Netherlands organization for Scientific Research (ZonMW-NWO) [908-02-040, 016.046.362, 864.10.007]; transnational University Limburg grant; Netherlands Genome Initiative (NGI) [050-72-422]; EMBO	Netherlands organization for Scientific Research (ZonMW-NWO)(Netherlands Organization for Scientific Research (NWO)); transnational University Limburg grant; Netherlands Genome Initiative (NGI); EMBO(European Molecular Biology Organization (EMBO))	Netherlands organization for Scientific Research (ZonMW-NWO): Research Support grant 908-02-040 (JWV), VIDI grant 016.046.362 (JWV); transnational University Limburg grant (JWV, BGW); Netherlands Genome Initiative (NGI) fellowship 050-72-422 (HN) and EMBO fellowship (HN). Netherlands Organization for Scientific Research (ZonMW-NWO): VIDI grant 864.10.007 (DN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRULAND OS, 1988, CANCER RES, V48, P5302; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Datta S, 2007, CANCER RES, V67, P10286, DOI 10.1158/0008-5472.CAN-07-1636; Debacq-Chainiaux F, 2010, ADV EXP MED BIOL, V694, P126; Di Micco R, 2007, TRENDS CELL BIOL, V17, P529, DOI 10.1016/j.tcb.2007.07.012; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; Ehlting C, 2011, J BIOL CHEM, V286, P24113, DOI 10.1074/jbc.M111.235275; Fan T, 2011, MOL CANCER RES, V9, P418, DOI 10.1158/1541-7786.MCR-10-0511; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Huysentruyt CJR, 2011, HISTOPATHOLOGY, V58, P1048, DOI 10.1111/j.1365-2559.2011.03859.x; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003; Kia SK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-16; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Ludwig S, 1996, MOL CELL BIOL, V16, P6687; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Maruyama J, 2009, CURR MED CHEM, V16, P1229, DOI 10.2174/092986709787846613; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MUNGER K, 1992, CANCER SURV, V12, P197; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; Oguro H, 2012, J EXP MED, V209, P445, DOI 10.1084/jem.20111709; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prezioso C, 2011, FEBS LETT, V585, P2067, DOI 10.1016/j.febslet.2011.04.062; Prickaerts P, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-12; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Protopopov AI, 2002, J GENE MED, V4, P397, DOI 10.1002/jgm.283; REYNOLDS PA, 2006, J BIOL CHEM; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Ronkina N, 2008, FRONT BIOSCI-LANDMRK, V13, P5511, DOI 10.2741/3095; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schwermann J, 2009, EMBO J; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Shiryaev A, 2010, CELL SIGNAL, V22, P1185, DOI 10.1016/j.cellsig.2010.03.002; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sithanandam G, 1996, MOL CELL BIOL, V16, P868; Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com; Sng JCG, 2004, BIOL PHARM BULL, V27, P606, DOI 10.1248/bpb.27.606; So AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019503; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; SPEEL EJM, 1992, J HISTOCHEM CYTOCHEM, V40, P1299, DOI 10.1177/40.9.1506667; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tang X, 2004, ONCOGENE; Tzatsos A, 2011, J BIOL CHEM, V286, P33061, DOI 10.1074/jbc.M111.257667; VIRE E, 2005, NATURE; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005	80	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0118840	10.1371/journal.pone.0118840	http://dx.doi.org/10.1371/journal.pone.0118840			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853770	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400002
J	Zhang, FQ; Xu, Y; Cao, HB; Jin, CH; Cheng, ZH; Wang, GQ; Shugart, YY				Zhang, Fuquan; Xu, Yong; Cao, Hongbao; Jin, Chunhui; Cheng, Zaohuo; Wang, Guoqiang; Shugart, Yin Yao			Mapsnp: An R Package to Plot a Genomic Map for Single Nucleotide Polymorphisms	PLOS ONE			English	Article							BROWSER; SOFTWARE	Single-nucleotide polymorphism (SNP) is one of the most common sources of genetic variations of the genome. Currently, SNPs are a main target for most genetic association studies. Visualizing genomic coordinates of SNPs, including their physical location relative to their host gene, and the structure of the relevant transcripts, may provide intuitive supplements to the understanding of their functions. Nevertheless, to date, no such easy-to-use programming tools exist. Therefore, we developed an R package, "mapsnp", to plot genomic map for a panel of SNPs within a genome region of interest, including the relative chromosome location and the transcripts in the region. mapsnp is a simple and flexible software package which can be used to visualize a genomic map for SNPs, integrating a chromosome ideogram, genomic coordinates, SNP locations and SNP labels.	[Zhang, Fuquan; Jin, Chunhui; Cheng, Zaohuo; Wang, Guoqiang] Nanjing Med Univ, Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China; [Zhang, Fuquan; Cao, Hongbao; Shugart, Yin Yao] NIMH, Intramural Res Program, Unit Stat Genom, NIH, Bethesda, MD 20892 USA; [Xu, Yong] Shanxi Med Univ, Hosp 1, Dept Psychiat, Taiyuan, Peoples R China	Nanjing Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Shanxi Medical University	Wang, GQ (corresponding author), Nanjing Med Univ, Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China.	wuwangguoqiang@126.com; kay1yao@mail.nih.gov		YAO, YIN/0000-0003-3053-8429; Zhang, Fuquan/0000-0003-3204-8191	Wuxi Hospital Management Center key joint scientific and technical project in medicine [YGZXL1315]; National Natural Science Foundation of China [81000583, 81278412]; China Postdoctoral Science Foundation [2013M541207]; Program for New Century Excellent Talents in University; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002930, ZIAMH002929] Funding Source: NIH RePORTER	Wuxi Hospital Management Center key joint scientific and technical project in medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Wuxi Hospital Management Center key joint scientific and technical project in medicine (YGZXL1315), the National Natural Science Foundation of China (81000583, 81278412), China Postdoctoral Science Foundation (2013M541207), Program for New Century Excellent Talents in University (YX), and Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi (YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Carlson M, 2014, TXDB HSAPIENS UCSC H; Durinck S, 2014, GENOMEGRAPHS PLOTTIN; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hahne F, 2014, GVIZ PLOTTING DATA A; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; RCoreTeam, 2014, R LANG ENV STAT COMP; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77; Zhang FQ, 2014, NEUROSCI LETT, V562, P24, DOI 10.1016/j.neulet.2013.12.001	14	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123609	10.1371/journal.pone.0123609	http://dx.doi.org/10.1371/journal.pone.0123609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853637	Green Submitted, gold, Green Published			2022-12-27	WOS:000352478400107
J	Fortanier, AC; Venekamp, RP; de Hoog, MLA; Uiterwaal, CSPM; van der Gugten, AC; van der Ent, CK; Hoes, AW; Schilder, AGM				Fortanier, Alexandre C.; Venekamp, Roderick P.; de Hoog, Marieke L. A.; Uiterwaal, Cuno S. P. M.; van der Gugten, Anne C.; van der Ent, Cornelis K.; Hoes, Arno W.; Schilder, Anne G. M.			Parent-Reported Symptoms of Acute Otitis Media during the First Year of Life: What Is beneath the Surface?	PLOS ONE			English	Article							CHILDREN; BURDEN; MANAGEMENT; COHORT	Background Most estimates of the incidence of acute otitis media (AOM) are based on general practitioner (GP) or pediatrician diagnoses. It is likely that these figures underestimate the community incidence of AOM since parents do not visit their doctor every time their child suffers from acute ear symptoms. The impact of these symptom episodes may be substantial since they affect the child's quality of life and parents' productivity. Methods To determine AOM symptoms in the community, we measured parent-reported AOM symptoms daily for 12 consecutive months in 1,260 children participating in a prospective birth cohort in the Netherlands. The mean age of these children was at study enrollment 0.9 months (standard deviation 0.6). A parent-reported AOM symptom episode was defined as fever (temperature 38 degrees C or above) plus at least one of the following symptoms: ear pain and ear discharge. These febrile AOM symptom episodes were linked to GP-consultations and diagnoses in the GP electronic health records. Results With an estimated 624 parent-reported symptom episodes per 1,000 child-years (95% CI: 577 to 674) incidence of febrile AOM symptoms during the child's first year is high. The GP was consulted in half of these symptom episodes and AOM was diagnosed in 49% of these consultations. Conclusions and Relevance The incidence of febrile AOM symptoms in the first year of life is high in Dutch children and leads to a GP-consultation in only half of the cases. This suggests that AOM symptomatology in the community is underestimated when focusing on GP-diagnosed AOM episodes alone, since a considerable proportion of febrile AOM symptom episodes are treated symptomatically by parents at home and do not come to the attention of the GP. Having data on community AOM symptomatology available for each country is important when the potential impact of preventive and therapeutic interventions for AOM are studied.	[Fortanier, Alexandre C.; Venekamp, Roderick P.; de Hoog, Marieke L. A.; Uiterwaal, Cuno S. P. M.; Hoes, Arno W.; Schilder, Anne G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Hoog, Marieke L. A.; Schilder, Anne G. M.] Univ Med Ctr Utrecht, Dept Otorhinolaryngol, Utrecht, Netherlands; [van der Gugten, Anne C.; van der Ent, Cornelis K.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol, Utrecht, Netherlands; [Schilder, Anne G. M.] UCL, Ear Inst, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of London; University College London	Venekamp, RP (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	r.p.venekamp@umcutrecht.nl		Venekamp, Roderick P/0000-0002-1446-9614; Van der Ent, Cornelis/0000-0002-2501-4121; Schilder, Anne/0000-0002-5496-4580	Netherlands Organization for Health Research and Development (ZonMW); University Medical Center Utrecht; GlaxoSmithKline, The Netherlands; National Institute for Health Research, Research Professorship Award (NIHR); National Institute for Health Research [NIHR-RP-011-045] Funding Source: researchfish	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); University Medical Center Utrecht; GlaxoSmithKline, The Netherlands(Netherlands GovernmentGlaxoSmithKline); National Institute for Health Research, Research Professorship Award (NIHR); National Institute for Health Research(National Institute for Health Research (NIHR))	The WHISTLER-project was supported by grants from The Netherlands Organization for Health Research and Development (ZonMW), by the University Medical Center Utrecht, and by an unrestricted grant from GlaxoSmithKline, The Netherlands. The evidENT team at UCL, United Kingdom is supported by a National Institute for Health Research, Research Professorship Award (NIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELMAN CLM, 1993, BRIT MED J, V306, P895, DOI 10.1136/bmj.306.6882.895; Barber C, 2014, INT J PEDIATR OTORHI, V78, P300, DOI 10.1016/j.ijporl.2013.11.030; Casey JR, 2013, PEDIATR INFECT DIS J, V32, P805, DOI 10.1097/INF.0b013e31828d9acc; Damoiseaux RAMJ, 2000, BRIT MED J, V320, P350, DOI 10.1136/bmj.320.7231.350; Greenberg D, 2003, EUR J PEDIATR, V162, P576, DOI 10.1007/s00431-003-1260-5; Katier N, 2004, EUR J EPIDEMIOL, V19, P895, DOI 10.1023/B:EJEP.0000040530.98310.0c; Kontiokari T, 1998, PEDIATR INFECT DIS J, V17, P676, DOI 10.1097/00006454-199808000-00003; Laine MK, 2010, PEDIATRICS, V125, pE1154, DOI 10.1542/peds.2009-2689; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Liese JG, 2014, EPIDEMIOL INFECT, V142, P1778, DOI 10.1017/S0950268813002744; Magnus MC, 2012, PEDIATR INFECT DIS J, V31, P951, DOI 10.1097/INF.0b013e31825d2f76; Mandel EM, 2008, INT J PEDIATR OTORHI, V72, P491, DOI 10.1016/j.ijporl.2007.12.008; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Schnabel E, 2009, EUR J PEDIATR, V168, P1251, DOI 10.1007/s00431-008-0921-9; Shaikh N, 2009, PEDIATR INFECT DIS J, V28, P5, DOI 10.1097/INF.0b013e318185a387; Stam J, 2012, ACTA PAEDIATR, V101, P929, DOI 10.1111/j.1651-2227.2012.02728.x; Tahtinen PA, 2009, FAM PRACT, V26, P488, DOI 10.1093/fampra/cmp055; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Uitti JM, 2013, PEDIATRICS, V131, pE398, DOI 10.1542/peds.2012-1188; Van Lier EA OP, 2013, 1502020012013 RIVM; VANBUCHEM FL, 1985, BRIT MED J, V290, P1033, DOI 10.1136/bmj.290.6474.1033; Wolleswinkel-van den Bosch J, 2010, VACCINE, V28, pG39, DOI [10.1016/j.vaccine.2010.06.014, DOI 10.1016/J.VACCINE.2010.06.014]; Yawn BP, 1996, CLIN THER, V18, P877, DOI 10.1016/S0149-2918(96)80048-8	23	15	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121572	10.1371/journal.pone.0121572	http://dx.doi.org/10.1371/journal.pone.0121572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849847	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800067
J	Huang, BL; Mackem, S				Huang, Bau-Lin; Mackem, Susan			Tamoxifen-Dependent, Inducible Bmp2CreER Drives Selective Recombinase Activity in Early Interdigital Mesenchyme and Digit Collateral Ligaments	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; VERTEBRATE LIMB; MOUSE; EXPRESSION; IDENTITY; TENDONS; MICE	During limb development, the interdigital mesenchyme has been proposed to play a signaling role instructing morphogenesis of different digit types, as well as undergoing programmed cell death necessary to free digits in animals not adapted for swimming or flying. We have generated a conditional, tamoxifen-dependent Cre line, Bmp2CreER, which drives highly selective recombination restricted to the distal limb mesoderm, largely restricted to the interdigits, and selectively active in digit ligament but not tendon progenitors at later stages. The Bmp2CreER provides a valuable new tool to dissect roles of interdigital mesenchyme and potentially investigate divergence of ligament and tendon lineages.	[Huang, Bau-Lin; Mackem, Susan] NCI Frederick, Canc & Dev Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Mackem, S (corresponding author), NCI Frederick, Canc & Dev Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA.	mackems@mail.nih.gov	Huang, Bau-Lin/S-4133-2019; Huang, Bau-Lin/K-8317-2019	Huang, Bau-Lin/0000-0003-3747-6697; 	Center for Cancer Research, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIABC011119] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Center for Cancer Research, National Cancer Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Grieshammer U, 2008, GENESIS, V46, P69, DOI 10.1002/dvg.20366; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; MARTIN P, 1990, International Journal of Developmental Biology, V34, P323; Nagy A., 2003, MANIPULATING MOUSE E, Vx; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Nguyen MT, 2009, DEV DYNAM, V238, P467, DOI 10.1002/dvdy.21846; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Pizette S, 1999, DEVELOPMENT, V126, P883; Pregizer S, 2009, CYTOKINE GROWTH F R, V20, P509, DOI 10.1016/j.cytogfr.2009.10.011; Rabinowitz AH, 2012, DEV BIOL, V368, P165, DOI 10.1016/j.ydbio.2012.05.035; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Watson SS, 2009, DEV DYNAM, V238, P693, DOI 10.1002/dvdy.21866; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zuzarte-Luis V, 2005, SEMIN CELL DEV BIOL, V16, P261, DOI 10.1016/j.semcdb.2004.12.004	25	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123325	10.1371/journal.pone.0123325	http://dx.doi.org/10.1371/journal.pone.0123325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850076	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800224
J	Mansouri, M; Salamonsen, RF; Lim, E; Akmeliawati, R; Lovell, NH				Mansouri, Mahdi; Salamonsen, Robert F.; Lim, Einly; Akmeliawati, Rini; Lovell, Nigel H.			Preload-Based Starling-Like Control for Rotary Blood Pumps: Numerical Comparison with Pulsatility Control and Constant Speed Operation	PLOS ONE			English	Article							LEFT-VENTRICULAR ASSIST; HEART-FAILURE PATIENTS; NONINVASIVE ESTIMATION; PHYSIOLOGICAL CONTROL; HEMODYNAMIC-RESPONSE; DEVICE; FLOW; PRESSURE; EXERCISE; PERFORMANCE	In this study, we evaluate a preload-based Starling-like controller for implantable rotary blood pumps (IRBPs) using left ventricular end-diastolic pressure (PLVED) as the feedback variable. Simulations are conducted using a validated mathematical model. The controller emulates the response of the natural left ventricle (LV) to changes in PLVED. We report the performance of the preload-based Starling-like controller in comparison with our recently designed pulsatility controller and constant speed operation. In handling the transition from a baseline state to test states, which include vigorous exercise, blood loss and a major reduction in the LV contractility (LVC), the preload controller outperformed pulsatility control and constant speed operation in all three test scenarios. In exercise, preload-control achieved an increase of 54% in mean pump flow ((Q) over bar (P)) with minimum loading on the LV, while pulsatility control achieved only a 5% increase in flow and a decrease in mean pump speed. In a hemorrhage scenario, the preload control maintained the greatest safety margin against LV suction. PLVED for the preload controller was 4.9 mmHg, compared with 0.4 mmHg for the pulsatility controller and 0.2 mmHg for the constant speed mode. This was associated with an adequate mean arterial pressure (MAP) of 84 mmHg. In transition to low LVC, (Q) over bar (P) for preload control remained constant at 5.22 L/min with a PLVED of 8.0 mmHg. With regards to pulsatility control, (Q) over bar (P) fell to the nonviable level of 2.4 L/min with an associated PLVED of 16 mmHg and a MAP of 55 mmHg. Consequently, pulsatility control was deemed inferior to constant speed mode with a PLVED of 11 mmHg and a (Q) over bar (P) of 5.13 L/min in low LVC scenario. We conclude that pulsatility control imposes a danger to the patient in the severely reduced LVC scenario, which can be overcome by using a preload-based Starling-like control approach.	[Mansouri, Mahdi; Lim, Einly] Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Salamonsen, Robert F.] Alfred Hosp, Dept Intens Care, Prahran, Vic 3181, Australia; [Salamonsen, Robert F.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Akmeliawati, Rini] Int Islamic Univ Malaysia, Dept Mechatron Engn, Kuala Lumpur, Malaysia; [Lovell, Nigel H.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia	Universiti Malaya; Florey Institute of Neuroscience & Mental Health; Monash University; International Islamic University Malaysia; University of New South Wales Sydney	Mansouri, M (corresponding author), Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia.	mh.mansouri@gmail.com	MANSOURI/J-5902-2015; Lovell, Nigel H/AGF-6679-2022; Akmeliawati, Rini/T-4776-2018; LIM, EINLY/B-8861-2010	MANSOURI/0000-0002-7702-3249; Lovell, Nigel H/0000-0003-1637-1079; LIM, EINLY/0000-0003-2037-4213; Akmeliawati, Rini/0000-0003-0660-2312; Mansouri, Majdi/0000-0001-6390-4304	Australian Research Council Linkages scheme; University of Malaya [UM.C/HIR/MOHE/ENG/50]	Australian Research Council Linkages scheme(Australian Research Council); University of Malaya(Universiti Malaya)	Australian Research Council Linkages scheme and the University of Malaya (UM.C/HIR/MOHE/ENG/50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 1999, ARTIF ORGANS, V23, P797, DOI 10.1046/j.1525-1594.1999.06426.x; AlOmari AH, 2011, PHYSIOL MEAS, V32, P1035, DOI 10.1088/0967-3334/32/8/004; AlOmari AH, 2009, PHYSIOL MEAS, V30, P371, DOI 10.1088/0967-3334/30/4/003; AlOmari AHH, 2013, PHYSIOL MEAS, V34, pR1, DOI 10.1088/0967-3334/34/1/R1; Arndt A, 2008, ARTIF ORGANS, V32, P761, DOI 10.1111/j.1525-1594.2008.00628.x; Arndt A, 2010, ARTIF ORGANS, V34, P726, DOI 10.1111/j.1525-1594.2010.01092.x; Bakouri MA, 2014, ARTIF ORGANS, V38, P587, DOI 10.1111/aor.12223; Bakshi VU, 2007, LINEAR CONTROL SYSTE; BERNE RM, 1981, ANNU REV PHYSIOL, V43, P357, DOI 10.1146/annurev.ph.43.030181.002041; Boston JR, 2003, IEEE ROBOT AUTOM MAG, V10, P54, DOI 10.1109/MRA.2003.1191711; Bullister E, 2002, ARTIF ORGANS, V26, P931, DOI 10.1046/j.1525-1594.2002.07126.x; Choi S, 2005, INT J CONTROL AUTOM, V3, P100; Choi S, 2007, ARTIF ORGANS, V31, P114, DOI 10.1111/j.1525-1594.2007.00350.x; Endo G, 2002, ASAIO J, V48, P83, DOI 10.1097/00002480-200201000-00016; Esmore DS, 2008, J HEART LUNG TRANSPL, V27, P479, DOI 10.1016/j.healun.2008.02.003; Farrar DJ, 2007, ASAIO J, V53, P310, DOI 10.1097/MAT.0b013e3180536694; Gaddum NR, 2014, ARTIF ORGANS, V38, pE46, DOI 10.1111/aor.12221; Giridharan G, 2005, P AMER CONTR CONF, P3823, DOI 10.1109/ACC.2005.1470570; Giridharan GA, 2002, ARTIF ORGANS, V26, P980, DOI 10.1046/j.1525-1594.2002.07136.x; Guyton A.C., 2005, HAEMOLYTIC ANOEMIA M, V10th, P388; Guyton AC, 1963, CIRCULATORY PHYSL CA, P237; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Jacquet L, 2011, ARTIF ORGANS, V35, P682, DOI 10.1111/j.1525-1594.2011.01227.x; Karantonis DM, 2006, ARTIF ORGANS, V30, P671, DOI 10.1111/j.1525-1594.2006.00283.x; Konieczny G, 2010, ACTA PHYS POL A, V118, P1183, DOI 10.12693/APhysPolA.118.1183; Letsou GV, 2013, EUR J CARDIO-THORAC, V44, P573, DOI 10.1093/ejcts/ezt106; Lim E, 2009, CHARACTERISATION CAR; Lim E, 2015, ARTIF ORGANS, V39, pE24, DOI 10.1111/aor.12370; Lim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077357; Lim E, 2012, ARTIF ORGANS, V36, pE125, DOI 10.1111/j.1525-1594.2012.01448.x; Lim E, 2012, ARTIF ORGANS, V36, pE110, DOI 10.1111/j.1525-1594.2012.01449.x; Lim E, 2010, IEEE T BIO-MED ENG, V57, P254, DOI 10.1109/TBME.2009.2031629; Maeda K, 1998, AM HEART J, V135, P825, DOI 10.1016/S0002-8703(98)70041-9; Mancini D, 1998, CIRCULATION, V98, P1178, DOI 10.1161/01.CIR.98.12.1178; Reesink K, 2007, ARTIF ORGANS, V31, P542, DOI 10.1111/j.1525-1594.2007.00420.x; Saito I, 2010, P 32 ANN INT C IEEE; Salamonsen RF, 2013, ARTIF ORGANS, V37, P695, DOI 10.1111/aor.12070; Salamonsen RF, 2011, ARTIF ORGANS, V35, pE47, DOI 10.1111/j.1525-1594.2010.01168.x; Salamonsen RF, 2012, ARTIF ORGANS, V36, P787, DOI 10.1111/j.1525-1594.2012.01457.x; Schima H, 2006, J HEART LUNG TRANSPL, V25, P167, DOI 10.1016/j.healun.2005.09.008; Slaughter MS, 2009, J HEART LUNG TRANSPL, V28, P39, DOI 10.1016/j.healun.2008.10.007; Starling EH, 1927, J PHYSIOL-LONDON, V52, P243; Troughton RW, 2011, J CARDIOVASC TRANSL, V4, P3, DOI 10.1007/s12265-010-9229-z; Wu Y, 2003, ARTIF ORGANS, V27, P926, DOI 10.1046/j.1525-1594.2003.00032.x; Zhou MD, 2012, BIOMED MICRODEVICES, V14, P235, DOI 10.1007/s10544-011-9601-z	45	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121413	10.1371/journal.pone.0121413	http://dx.doi.org/10.1371/journal.pone.0121413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849979	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800057
J	Moser, EK; Sun, J; Kim, TS; Braciale, TJ				Moser, Emily K.; Sun, Jie; Kim, Taeg S.; Braciale, Thomas J.			IL-21R Signaling Suppresses IL-17(+) Gamma Delta T Cell Responses and Production of IL-17 Related Cytokines in the Lung at Steady State and After Influenza A Virus Infection	PLOS ONE			English	Article							NEUTROPHIL RECRUITMENT; IMMUNOGLOBULIN-M; INTERLEUKIN-21; RECEPTOR; MICE; DIFFERENTIATION; PARTICIPATE; POPULATION; DEFICIENCY; EXPRESSION	Influenza A virus (IAV) infection of the respiratory tract elicits a robust immune response, which is required for efficient virus clearance but at the same time can contribute to lung damage and enhanced morbidity. IL-21 is a member of the type I cytokine family and has many different immune-modulatory functions during acute and chronic virus infections, although its role in IAV infection has not been fully evaluated. In this report we evaluated the contributions of IL-21/IL-21 receptor (IL-21R) signaling to host defense in a mouse model of primary IAV infection using IL-21R knock out (KO) mice. We found that lack of IL-21R signaling had no significant impact on virus clearance, adaptive T cell responses, or myeloid cell accumulations in the respiratory tract. However, a subset of inflammatory cytokines were elevated in the bronchoalveolar lavage fluid of IL-21R KO mice, including IL-17. Although there was only a small increase in Th17 cells in the lungs of IL-21R KO mice, we observed a dramatic increase in gamma delta (gamma delta) T cells capable of producing IL-17 both after IAV infection and at steady state in the respiratory tract. Finally, we found that IL-21R signaling suppressed the accumulation of IL-17(+) gamma delta T cells in the respiratory tract intrinsically. Thus, our study reveals a previously unrecognized role of IL-21R signaling in regulating IL-17 production by gamma delta T cells.	[Moser, Emily K.; Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA; [Moser, Emily K.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Sun, Jie] Indiana Univ, Herman B Wells Ctr Pediat, Indianapolis, IN 46204 USA; [Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; Indiana University System; Indiana University-Purdue University Indianapolis; University of Virginia	Braciale, TJ (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA.	tjb2r@virginia.edu	Moser, Emily/AAS-6618-2020	Moser, Emily/0000-0001-6386-5894	National Institutes of Health [AI-15608, AI-083024, HL-33391]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126647, R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083024, R01AI037293, R01AI015608, R37AI015608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants from the National Institutes of Health: AI-15608, AI-083024, and HL-33391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; Barin JG, 2012, EUR J IMMUNOL, V42, P726, DOI 10.1002/eji.201141737; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Baumgarth N, 2013, IMMUNOL REV, V255, P82, DOI 10.1111/imr.12094; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Harada Y, 2003, J EXP MED, V197, P1779, DOI 10.1084/jem.20021457; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; KAVALER J, 1991, EUR J IMMUNOL, V21, P2687, DOI 10.1002/eji.1830211107; Kisielow J, 2013, CURR OPIN IMMUNOL, V25, P181, DOI 10.1016/j.coi.2013.03.002; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kotlarz D, 2013, J EXP MED, V210, P433, DOI 10.1084/jem.20111229; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Leonard WJ, 2008, J LEUKOCYTE BIOL, V84, P348, DOI 10.1189/jlb.0308149; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Novy P, 2011, J IMMUNOL, V186, P2729, DOI 10.4049/jimmunol.1003009; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Rankin AL, 2011, J IMMUNOL, V186, P667, DOI 10.4049/jimmunol.0903207; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Reichel CA, 2012, BLOOD, V120, P880, DOI 10.1182/blood-2012-01-402164; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Sciammas R, 1999, MICROBES INFECT, V1, P203, DOI 10.1016/S1286-4579(99)80035-5; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vermijlen D, 2007, J IMMUNOL, V178, P4304, DOI 10.4049/jimmunol.178.7.4304; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	41	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120169	10.1371/journal.pone.0120169	http://dx.doi.org/10.1371/journal.pone.0120169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849970	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800021
J	Nagu, TJ; Aboud, S; Mwiru, R; Matee, M; Fawzi, W; Mugusi, F				Nagu, Tumaini J.; Aboud, Said; Mwiru, Ramadhani; Matee, Mecky; Fawzi, Wafaie; Mugusi, Ferdinand			Multi Drug and Other Forms of Drug Resistant Tuberculosis Are Uncommon among Treatment Naive Tuberculosis Patients in Tanzania	PLOS ONE			English	Article							MDR; TB	Background Surveillance and effective management of drug resistance is important to sustaining tuberculosis (TB) control efforts. We aimed to determine resistance rates to first line anti tuberculosis drugs and to describe factors associated with the resistance to any of the first line anti tuberculosis drugs in Dar es Salaam Tanzania. Materials Newly diagnosed, TB patients with neither history of tuberculosis treatment nor isoniazid prophylaxis were included into the study. Sputum specimens were cultured on either mycobacteria growth indicator tube 960 (MGIT 960) or Lowenstein Jenstein (LJ) medium supplemented with either glycerol (GLJ) or pyruvate (PLJ). Drug susceptibility for isoniazid, rifampicin, streptomycin and ethambutol was determined by either Lowenstein-Jensen (LJ) medium or mycobacteria growth indicator tube 960 (MGIT 960). Results A total of 933 newly diagnosed TB patients, were included into the study. Multi drug resistance (MDR) tuberculosis was detected among 2 (0.2%) patients. Resistance to any of the four tested drugs was detected among 54 (5.8%) patients. Mono-resistance to isoniazid, rifampicin, streptomycin and ethambutol were 21(2.3%), 3 (0.3%), 13 (1.4%), 9 (1.0%) respectively. Conclusion Primary resistance to first line anti tuberculosis drugs is still low in this setting. Continued vigilance including periodic national surveillance of anti-tuberculosis resistance is recommended.	[Nagu, Tumaini J.; Mugusi, Ferdinand] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Nagu, Tumaini J.] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Aboud, Said; Matee, Mecky] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Mwiru, Ramadhani] Management & Dev Hlth, Dar Es Salaam, Tanzania; [Fawzi, Wafaie] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Nagu, TJ (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania.	jtjoyce20@hotmail.com			global health scholarship program for junior scientists and Swedish International Development Agency (SIDA)	global health scholarship program for junior scientists and Swedish International Development Agency (SIDA)	This study was funded by the global health scholarship program for junior scientists and Swedish International Development Agency (SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard C, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.33.20555; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Dooley KE, 2013, J INFECT DIS, V207, P1352, DOI 10.1093/infdis/jis460; Kibiki GS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-51; Kruijshaar M, 2008, BMJ-BRIT MED J, V336, P1201, DOI [10.1136/bmj.39560.630613.80, DOI 10.1136/BMJ.39560.630613.80]; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Matee M, 2009, APMIS, V117, P263, DOI 10.1111/j.1600-0463.2008.02429.x; Ministry of Health and Social Welfare, MAN NAT TUB LEPR PRO; Ministry of Health and Social Welfare, 2012, NAT TUB LEPR PROGR A; Ministry of Health and Social Welfare National AIDS Control Programme, 2012, NAT GUID MAN HIV AID; Nagu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091229; Sanchez-Padilla E, 2013, INT J TUBERC LUNG D, V17, P1036, DOI 10.5588/ijtld.12.0842; Satti H, 2013, INT J TUBERC LUNG D, V17, P100, DOI 10.5588/ijtld.12.0344; Urassa Willy, 2008, BMC Res Notes, V1, P58, DOI 10.1186/1756-0500-1-58; van Heurck R, 2013, ACTA CLIN BELG, V68, P321, DOI 10.2143/ACB.3269; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2008, ANT DRUG RES WORLD W; World Health Organisation, 2014, ANT RES GLOB REP SUR, P43; World Health Organization, WHOHTMTB2009; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; YANG ZH, 1995, J CLIN MICROBIOL, V33, P1064, DOI 10.1128/JCM.33.5.1064-1069.1995; Zignol M, 2014, B WORLD HEALTH ORGAN, V90, P111	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0118601	10.1371/journal.pone.0118601	http://dx.doi.org/10.1371/journal.pone.0118601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849784	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800007
J	Rong, GH; Bai, WL; Dong, Z; Wang, CP; Lu, YY; Zeng, Z; Qu, JH; Lou, M; Wang, H; Gao, XD; Chang, XJ; An, LJ; Li, HY; Chen, Y; Hu, KQ; Yang, YP				Rong, Guanghua; Bai, Wenlin; Dong, Zheng; Wang, Chunping; Lu, Yinying; Zeng, Zhen; Qu, Jianhui; Lou, Min; Wang, Hong; Gao, Xudong; Chang, Xiujuan; An, Linjing; Li, Hongyan; Chen, Yan; Hu, Ke-Qin; Yang, Yongping			Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; CIRRHOSIS; COMPLICATIONS; CRYOTHERAPY; RESECTION	Background Accumulating evidences have suggested that percutaneous cryoablation could be a valuable alternative ablation therapy for HCC but there has been no large cohort-based analysis on its long-term outcomes. Methods A series of 866 patients with Child-Pugh class A-B cirrhosis and HCC within Milan criteria who underwent percutaneous cryoablation was long-term followed. The safety, efficacy, 5year survival, and prognostic factors of percutaneous cryoablation in the treatment of HCC were analyzed. Results A total of 1197 HCC lesions were ablated with 1401 cryoablation sessions. Complete response (CR) was achieved in 1163 (97.2%) lesions and 832 (96.1%) patients with 34 (2.8%) major complications, but no treatment-related mortality. After a median of 30.9 months follow-up, 502 (60.3%) patients who achieved CR developed different types of recurrence. The cumulative local tumor recurrence rate was 24.2% at 5-years. Multiple tumor lesions, tumor size > 3 cm, and repeated ablation of same lesion were independent risk factors associated with local recurrence. The 5-year overall survival (OS) rates were 59.5%. Age < 36 years, HCC family history, baseline hepatitis B virus DNA > 10(6) copies/ml, and three HCC lesions were independently and significantly negative predictors to the postcryoablation OS. Conclusions Percutaneous cryoablation is an effective therapy for patients with HCC within Milan criteria, with comparable efficacy, safety and long-term survival to the reported outcomes of radiofrequency ablation.	[Rong, Guanghua; Bai, Wenlin; Dong, Zheng; Wang, Chunping; Lu, Yinying; Zeng, Zhen; Qu, Jianhui; Lou, Min; Wang, Hong; Gao, Xudong; Chang, Xiujuan; An, Linjing; Li, Hongyan; Chen, Yan; Yang, Yongping] 302 Hosp, Ctr Therapeut Res Liver Canc, Beijing 100039, Peoples R China; [Hu, Ke-Qin] Univ Calif Irvine, Div Gastroenterol Hepatol, Orange, CA 92868 USA	Fifth Medical Center of Chinese PLA General Hospital; University of California System; University of California Irvine	Hu, KQ (corresponding author), Univ Calif Irvine, Div Gastroenterol Hepatol, 101 City Dr,Bldg 56,Ste 237, Orange, CA 92868 USA.	kqhu@uci.edu; yongpingyang@hotmail.com	RONG, GUANGHUA/G-6529-2012	RONG, GUANGHUA/0000-0002-6419-1227	Outstanding Medical Talents Foundation of PLA [04J020]; Chinese National Natural Science Foundation [81202362]; Capital Medical Research and Development Fund, China [2009-2041]	Outstanding Medical Talents Foundation of PLA; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Capital Medical Research and Development Fund, China	This work was funded by Outstanding Medical Talents Foundation of PLA (No. 04J020), Chinese National Natural Science Foundation (No. 81202362), and the Capital Medical Research and Development Fund (No. 2009-2041), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Choi D, 2007, EUR RADIOL, V17, P684, DOI 10.1007/s00330-006-0461-5; Dunne RM, 2014, EUR J RADIOL, V83, P632, DOI 10.1016/j.ejrad.2014.01.007; EASL-EORTC, 2011, J HEPATOL, V56, P908; Ei Shigenori, 2014, ANN SURG ONCOL, P1; Goldberg SN, 2005, J VASC INTERV RADIOL, V16, P765, DOI 10.1097/01.RVI.0000170858.46668.65; Haen SP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/160250; Hu KQ, 2014, J CLIN GASTROENTEROL, V48, P3, DOI [10.1097/MCG.0000000000000201, 10.1097/MCG.0b013e3182a6633d]; Hutchinson M, 2013, IMAGE GUIDED CANC TH, P491, DOI DOI 10.1007/978-1-4419-0751-6_35; Kim YS, 2013, J HEPATOL, V58, P89, DOI 10.1016/j.jhep.2012.09.020; Lai CL, 2013, HEPATOLOGY, V57, P399, DOI 10.1002/hep.25937; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Li ZW, 2013, ONCOL LETT, V6, P239, DOI 10.3892/ol.2013.1314; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Rossi S, 2011, HEPATOLOGY, V53, P136, DOI 10.1002/hep.23965; Seifert JK, 1999, WORLD J SURG, V23, P109, DOI 10.1007/PL00013173; Seifert JK, 2002, WORLD J SURG, V26, P1333, DOI 10.1007/s00268-002-6139-5; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; STEWART GJ, 1995, CRYOBIOLOGY, V32, P215, DOI 10.1006/cryo.1995.1021; Tatli S, 2010, DIAGN INTERV RADIOL, V16, P90, DOI 10.4261/1305-3825.DIR.1922-08.0; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Wang C, 2012, INFECT DIS INFO, V25, P312, DOI [10.1097/QCO.0b013e328352b664, DOI 10.1097/QC0.0B013E328352B664]; Wang CP, 2012, WORLD J GASTROENTERO, V18, P6587, DOI 10.3748/wjg.v18.i45.6587; Wang CP, 2015, HEPATOLOGY, V61, P1579, DOI 10.1002/hep.27548; Wang HW, 2005, RADIOLOGY, V235, P289, DOI 10.1148/radiol.2351030747; Yang YP, 2012, J HEPATO-BIL-PAN SCI, V19, P674, DOI 10.1007/s00534-011-0490-6; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x	28	47	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123065	10.1371/journal.pone.0123065	http://dx.doi.org/10.1371/journal.pone.0123065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849963	gold, Green Published			2022-12-27	WOS:000352477800201
J	Tsai, AC				Tsai, Alexander C.			Home Foreclosure, Health, and Mental Health: A Systematic Review of Individual, Aggregate, and Contextual Associations	PLOS ONE			English	Article							STRESSFUL LIFE EVENTS; WEST NILE VIRUS; GREAT RECESSION; MORTGAGE DELINQUENCY; SEARCH STRATEGIES; SUICIDAL-BEHAVIOR; PERSONAL DEBT; PUBLIC-HEALTH; CRISIS; RISK	Background The U.S. foreclosure crisis intensified markedly during the Great Recession of 2007-09, and currently an estimated five percent of U.S. residential properties are more than 90 days past due or in the process of foreclosure. Yet there has been no systematic assessment of the effects of foreclosure on health and mental health. Methods and Findings I applied systematic search terms to PubMed and PsycINFO to identify quantitative or qualitative studies about the relationship between home foreclosure and health or mental health. After screening the titles and abstracts of 930 publications and reviewing the full text of 76 articles, dissertations, and other reports, I identified 42 publications representing 35 unique studies about foreclosure, health, and mental health. The majority of studies (32 [91%]) concluded that foreclosure had adverse effects on health or mental health, while three studies yielded null or mixed findings. Only two studies examined the extent to which foreclosure may have disproportionate impacts on ethnic or racial minority populations. Conclusions Home foreclosure adversely affects health and mental health through channels operating at multiple levels: at the individual level, the stress of personally experiencing foreclosure was associated with worsened mental health and adverse health behaviors, which were in turn linked to poorer health status; at the community level, increasing degradation of the neighborhood environment had indirect, cross-level adverse effects on health and mental health. Early intervention may be able to prevent acute economic shocks from eventually developing into the chronic stress of foreclosure, with all of the attendant benefits this implies for health and mental health status. Programs designed to encourage early return of foreclosed properties back into productive use may have similar health and mental health benefits.	[Tsai, Alexander C.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Tsai, Alexander C.] Harvard Univ, Sch Med, Boston, MA USA; [Tsai, Alexander C.] Mbarara Univ Sci & Technol, Mbarara, Uganda	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mbarara University of Science & Technology	Tsai, AC (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.	actsai@partners.org	Tsai, Alexander C./F-4247-2015	Tsai, Alexander C./0000-0001-6397-7917	NIH [K23MH096620]; Robert Wood Johnson Health and Society Scholars Program; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH096620] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Health and Society Scholars Program(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The author received no specific funding for this work. The author acknowledges salary support from NIH K23MH096620 and the Robert Wood Johnson Health and Society Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelino M, 2013, J MONETARY ECON, V60, P835, DOI 10.1016/j.jmoneco.2013.08.002; Agarwal Sumit, 2012, 18311 NBER; Alley DE, 2011, AM J PUBLIC HEALTH, V101, P2293, DOI 10.2105/AJPH.2011.300245; Arcaya M, 2014, CIRCULATION, V129, P2262, DOI 10.1161/CIRCULATIONAHA.113.006205; Arcaya M, 2013, AM J PUBLIC HEALTH, V103, pE50, DOI 10.2105/AJPH.2013.301460; Ayers JW, 2012, J AFFECT DISORDERS, V142, P323, DOI 10.1016/j.jad.2012.05.005; Baggett T. P., 2013, POVERTY HLTH, P105; Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; Batson CD, 2015, URBAN AFF REV, V51, P205, DOI 10.1177/1078087414527080; Bennett GG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000087; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P367, DOI 10.1136/jech.54.5.367; Bocian DG, 2008, J ECON BUS, V60, P110, DOI 10.1016/j.jeconbus.2007.10.001; Bratt RG, 2002, HOUSING STUD, V17, P13, DOI 10.1080/02673030120105857; Brettle AJ, 2001, B MED LIBR ASSOC, V89, P353; Bridges S, 2010, J HEALTH ECON, V29, P388, DOI 10.1016/j.jhealeco.2010.02.003; Brooks-Gunn J, 2013, CHILD ABUSE NEGLECT, V37, P721, DOI 10.1016/j.chiabu.2013.08.004; Burgard SA, 2012, SOC SCI MED, V75, P2215, DOI 10.1016/j.socscimed.2012.08.020; Cagney KA, 2014, AM J PUBLIC HEALTH, V104, P498, DOI 10.2105/AJPH.2013.301566; Cannuscio CC, 2012, NURS OUTLOOK, V60, P134, DOI 10.1016/j.outlook.2011.08.004; Carroll B, 2009, HEALTH PLACE, V15, P540, DOI 10.1016/j.healthplace.2008.08.009; Chan SW, 2014, J REAL ESTATE FINANC, V48, P342, DOI 10.1007/s11146-012-9400-1; Collier-Goubil D, 2010, THESIS HOWARD U WASH; Cook TB, 2012, SUICIDE LIFE-THREAT, V42, P495, DOI 10.1111/j.1943-278X.2012.00107.x; Crump J, 2008, URBAN GEOGR, V29, P745, DOI 10.2747/0272-3638.29.8.745; Currie J, 2015, AM ECON J-ECON POLIC, V7, P63, DOI 10.1257/pol.20120325; Eady AM, 2008, J CLIN EPIDEMIOL, V61, P34, DOI 10.1016/j.jclinepi.2006.09.016; Ertl AC, 2013, THESIS MASSACHUSETTS; Fields D, 2010, HOUS POLICY DEBATE, V20, P647, DOI 10.1080/10511482.2010.503710; Fowler KA, 2014, AM J PUBLIC HEALTH, pe1; Freeman SA, 2008, J AGRIC SAF HEALTH, V14, P431, DOI 10.13031/2013.25280; Frioux S, 2014, MATERN CHILD HLTH J; Fullilove M.T., 2004, ROOT SHOCK TEARING C; Fullilove MT, 1996, AM J PSYCHIAT, V153, P1516; Gathergood J, 2012, ECON J, V122, P1094, DOI 10.1111/j.1468-0297.2012.02519.x; Gerardi K., 2010, FED RESERVE BANK ATL, V95, P1; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI 10.1093/eurpub/cks035; Granados JAT, 2014, AM J EPIDEMIOL, V180, P280, DOI 10.1093/aje/kwu128; Harding JP, 2009, J URBAN ECON, V66, P164, DOI 10.1016/j.jue.2009.07.003; HEDGES LV, 1980, PSYCHOL BULL, V88, P359, DOI 10.1037/0033-2909.88.2.359; Hintikka J, 1998, ACTA PSYCHIAT SCAND, V98, P493, DOI 10.1111/j.1600-0447.1998.tb10125.x; Houle JN, 2015, J EPIDEMIOL COMMUN H, V69, P382, DOI 10.1136/jech-2014-204637; Houle JN, 2014, SOC SCI MED, V118, P1, DOI 10.1016/j.socscimed.2014.07.054; Houle JN, 2014, AM J PUBLIC HEALTH, V104, P1073, DOI 10.2105/AJPH.2013.301774; Huang J, 2012, J DISABIL POLICY STU, V22, P237, DOI 10.1177/1044207311410428; Immergluck D, 2013, HOUS POLICY DEBATE, V23, P199, DOI 10.1080/10511482.2012.749933; Keene DE, 2014, SOC SCI MED, V118, P119, DOI 10.1016/j.socscimed.2014.07.063; Kelling G.L., 1982, ATLANTIC, V249, P29, DOI DOI 10.4135/9781412959193.n281; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Lacy K, 2012, AM BEHAV SCI, V56, P1565, DOI 10.1177/0002764212458279; Libman K, 2012, HOUS THEORY SOC, V29, P1, DOI 10.1080/14036096.2012.624881; Lin HZ, 2013, ECON LETT, V121, P449, DOI 10.1016/j.econlet.2013.09.004; McDonald S, 1999, Health Libr Rev, V16, P151; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; McLaughlin KA, 2012, PSYCHOL MED, V42, P1441, DOI 10.1017/S0033291711002613; Meltzer H, 2011, PSYCHOL MED, V41, P771, DOI 10.1017/S0033291710001261; Meltzer H, 2013, EUR J PUBLIC HEALTH, V23, P108, DOI 10.1093/eurpub/cks021; Melzer, 2014, 20353 NBER; Menzel NN, 2012, ISRN PUB HLTH, V740731; Modrek S, 2013, PUBLIC HEALTH REV, V35, DOI 10.1007/BF03391695; Mortgage Bankers Association, 2014, NAT DEL SURV 2014 1; Mugavero MJ, 2009, PSYCHOSOM MED, V71, P920, DOI 10.1097/PSY.0b013e3181bfe8d2; Mulia N, 2014, ALCOHOL CLIN EXP RES, V38, P1026, DOI 10.1111/acer.12301; Murphy RD, 2014, J URBAN HEALTH, V91, P17, DOI 10.1007/s11524-013-9813-z; Nettleton S, 1998, SOCIOL HEALTH ILL, V20, P731, DOI 10.1111/1467-9566.00127; Nettleton S, 2000, HOUSING STUD, V15, P463, DOI 10.1080/02673030050009285; Nettleton S., 2001, COMMUNITY WORK FAM, V4, P253, DOI DOI 10.1080/01405110120089332; Niedt C, 2013, HOUS POLICY DEBATE, V23, P159, DOI 10.1080/10511482.2012.702119; Oliver M., 1995, BLACK WEALTHWHITE WE; Osypuk TL, 2012, ANN EPIDEMIOL, V22, P379, DOI 10.1016/j.annepidem.2012.04.012; PEARLIN LI, 1989, J HEALTH SOC BEHAV, V30, P241, DOI 10.2307/2136956; PEARLIN LI, 1981, J HEALTH SOC BEHAV, V22, P337, DOI 10.2307/2136676; Pence BW, 2010, PSYCHOSOM MED, V72, P720, DOI 10.1097/PSY.0b013e3181e9eef3; Pevalin DJ, 2009, J EPIDEMIOL COMMUN H, V63, P949, DOI 10.1136/jech.2008.083477; Phillips JA, 2014, SOC SCI MED, V116, P22, DOI 10.1016/j.socscimed.2014.06.015; PLATT S, 1984, SOC SCI MED, V19, P93, DOI 10.1016/0277-9536(84)90276-4; Pollack CE, 2011, J URBAN HEALTH, V88, P469, DOI 10.1007/s11524-011-9564-7; Pollack CE, 2010, AM J PREV MED, V39, P515, DOI 10.1016/j.amepre.2010.08.002; Pollack CE, 2009, AM J PUBLIC HEALTH, V99, P1833, DOI 10.2105/AJPH.2009.161380; Ragins BR, 2014, PERS PSYCHOL, V67, P763, DOI 10.1111/peps.12065; RealtyTrac, 2014, YEAR END 2013 US FOR; Reeves A, 2014, BRIT J PSYCHIAT, V205, P246, DOI 10.1192/bjp.bp.114.144766; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Reisen WK, 2009, J MED ENTOMOL, V46, P139, DOI 10.1603/033.046.0118; Richardson T, 2013, CLIN PSYCHOL REV, V33, P1148, DOI 10.1016/j.cpr.2013.08.009; Robertson Christopher Tarver, 2008, Health Matrix Clevel, V18, P65; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Ross LM, 2011, SOC SCI QUART, V92, P140, DOI 10.1111/j.1540-6237.2011.00761.x; Roux AVD, 2014, CIRCULATION, V129, P2248, DOI 10.1161/CIRCULATIONAHA.114.009932; Rugh JS, 2010, AM SOCIOL REV, V75, P629, DOI 10.1177/0003122410380868; Saegert S, 2011, J URBAN HEALTH, V88, P390, DOI 10.1007/s11524-011-9584-3; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Saunders P., 1990, NATION HOME OWNERS; Schootman M, 2012, QUAL LIFE RES, V21, P133, DOI 10.1007/s11136-011-9929-0; Schuetz J, 2008, J HOUS ECON, V17, P306, DOI 10.1016/j.jhe.2008.09.004; Scully JA, 2000, EDUC PSYCHOL MEAS, V60, P864, DOI 10.1177/00131640021970952; SELVIN HC, 1958, AM J SOCIOL, V63, P607, DOI 10.1086/222356; Sharkey P, 2008, AM J SOCIOL, V113, P931, DOI 10.1086/522804; Sharkey P, 2011, AM J SOCIOL, V116, P1934, DOI 10.1086/660009; Shaw M, 2004, ANNU REV PUBL HEALTH, V25, P397, DOI 10.1146/annurev.publhealth.25.101802.123036; Skogan W.G., 1990, DISORDER DECLINE CRI; Stack S, 2007, SUICIDE LIFE-THREAT, V37, P103, DOI 10.1521/suli.2007.37.1.103; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Subramanian SV, 2009, INT J EPIDEMIOL, V38, P342, DOI 10.1093/ije/dyn359; Taylor MP, 2007, PSYCHOL MED, V37, P1027, DOI 10.1017/S0033291706009767; Thomson H, 2001, BRIT MED J, V323, P187, DOI 10.1136/bmj.323.7306.187; U. S. Departments of Housing and Urban Development and the Treasury, 2014, OB ADM EFF STAB HOUS; Uscher-Pines L, 2009, DISASTERS, V33, P1, DOI 10.1111/j.1467-7717.2008.01059.x; Vijayasiri G, 2012, ADDICT BEHAV, V37, P1019, DOI 10.1016/j.addbeh.2012.04.007; Wong SSL, 2004, STUD HEALTH TECHNOL, V107, P311; Wood JN, 2012, PEDIATRICS, V130, pE358, DOI 10.1542/peds.2011-3755; Zemore SE, 2013, J STUD ALCOHOL DRUGS, V74, P9, DOI 10.15288/jsad.2013.74.9	112	63	63	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123182	10.1371/journal.pone.0123182	http://dx.doi.org/10.1371/journal.pone.0123182			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849962	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800213
J	White, RL; Bennett, PM				White, Rachel L.; Bennett, Peter M.			Elevational Distribution and Extinction Risk in Birds	PLOS ONE			English	Article							CLIMATE-CHANGE; GLOBAL DISTRIBUTION; SPECIES RICHNESS; ALTITUDINAL MIGRATION; POPULATION DECLINES; RANGE SHIFTS; CONSERVATION; DIVERSITY; PATTERNS; THREAT	Mountainous regions are hotspots of terrestrial biodiversity. Unlike islands, which have been the focus of extensive research on extinction dynamics, fewer studies have examined mountain ranges even though they face increasing threats from human pressures - notably habitat conversion and climate change. Limits to the taxonomic and geographical extent and resolution of previously available information have precluded an explicit assessment of the relative role of elevational distribution in determining extinction risk. We use a new global species-level avian database to quantify the influence of elevational distribution (range, maximum and midpoint) on extinction risk in birds at the global scale. We also tested this relationship within biogeographic realms, higher taxonomic levels, and across phylogenetic contrasts. Potential confounding variables (i.e. phylogenetic, distributional, morphological, life history and niche breadth) were also tested and controlled for. We show that the three measures of elevational distribution are strong negative predictors of avian extinction risk, with elevational range comparable and complementary to that of geographical range size. Extinction risk was also found to be positively associated with body weight, development and adult survival, but negatively associated with reproduction and niche breadth. The robust and consistent findings from this study demonstrate the importance of elevational distribution as a key driver of variation in extinction dynamics in birds. Our results also highlight elevational distribution as a missing criterion in current schemes for quantifying extinction risk and setting species conservation priorities in birds. Further research is recommended to test for generality across non-avian taxa, which will require an advance in our knowledge of species' current elevational ranges and increased efforts to digitise and centralise such data.	[White, Rachel L.; Bennett, Peter M.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England	University of Kent	White, RL (corresponding author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.	rlwhite27@gmail.com		White, Rachel/0000-0003-0694-7847	University of Kent Postgraduate Research Scholarship	University of Kent Postgraduate Research Scholarship	This work was funded through a University of Kent Postgraduate Research Scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman S, 2004, ECOGRAPHY, V27, P299, DOI 10.1111/j.0906-7590.2004.03759.x; Badyaev AV, 1998, OIKOS, V82, P319, DOI 10.2307/3546972; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Bennett P. M., 2002, OX ECOL EV; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bennett PM, 1986, THESIS U SUSSEX; Bielby J, 2010, BIODIVERS CONSERV, V19, P113, DOI 10.1007/s10531-009-9709-0; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Blackburn TM, 2002, ECOL LETT, V5, P568, DOI 10.1046/j.1461-0248.2002.00360.x; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; Boyle WA, 2008, OECOLOGIA, V155, P397, DOI 10.1007/s00442-007-0897-6; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Caruso NM, 2013, DIVERS DISTRIB, V19, P38, DOI 10.1111/j.1472-4642.2012.00938.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Davies RG, 2006, P ROY SOC B-BIOL SCI, V273, P2127, DOI 10.1098/rspb.2006.3551; del Hoyo J, 2013, HDB BIRDS WORLD; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; Gage GS, 2004, ANIM CONSERV, V7, P161, DOI 10.1017/S1367943004001246; GASTON KJ, 1995, PHILOS T R SOC B, V347, P205, DOI 10.1098/rstb.1995.0022; GASTON KJ, 1994, ECOGRAPHY, V17, P198, DOI 10.1111/j.1600-0587.1994.tb00094.x; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hall J, 2009, BIOL CONSERV, V142, P2510, DOI 10.1016/j.biocon.2009.05.028; Hanna E, 2013, BIOL CONSERV, V158, P196, DOI 10.1016/j.biocon.2012.08.014; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hawkins BA, 2007, AM NAT, V170, pS16, DOI 10.1086/519009; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Keane A, 2005, BIOL CONSERV, V126, P216, DOI 10.1016/j.biocon.2005.05.011; Kruger O, 2008, ANIM CONSERV, V11, P83, DOI 10.1111/j.1469-1795.2007.00155.x; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Legendre P., 2012, R PROGR DOC; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; MACARTHUR RH, 1972, ECOLOGY, V53, P330, DOI 10.2307/1934090; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Mackas RH, 2010, CAN J ZOOL, V88, P369, DOI 10.1139/Z10-013; Manne LL, 1999, NATURE, V399, P258, DOI 10.1038/20436; Manne LL, 2001, ANIM CONSERV, V4, P221, DOI 10.1017/S1367943001001263; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Normand S, 2009, GLOBAL ECOL BIOGEOGR, V18, P437, DOI 10.1111/j.1466-8238.2009.00451.x; Norris K, 2004, P ROY SOC B-BIOL SCI, V271, P123, DOI 10.1098/rspb.2003.2576; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; ORME C. D. L., 2012, CAPER COMP ANAL PHYL; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Patterson BD, 1998, J BIOGEOGR, V25, P593, DOI 10.1046/j.1365-2699.1998.2530593.x; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Price M., 2011, MOUNTAIN FORESTS CHA; Purvis A, 2005, CONSERV BIOL SER, V8, P295; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rapacciuolo G, 2014, GLOBAL CHANGE BIOL, V20, P2841, DOI 10.1111/gcb.12638; Ripley B, 2012, MASS SUPPORT FUNCTIO; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodriguez-Rodriguez D, 2012, MT RES DEV, V32, P197, DOI 10.1659/MRD-JOURNAL-D-10-00111.1; Rodriguez-Rodriguez D, 2011, BIOL CONSERV, V144, P2978, DOI 10.1016/j.biocon.2011.08.023; Schnell JK, 2013, CONSERV BIOL, V27, P520, DOI 10.1111/cobi.12047; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Sibley CG, 1990, DISTRIBUTION TAXONOM; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sutherland WJ, 2003, NATURE, V423, P276, DOI 10.1038/nature01607; Tingley MW, 2013, ECOLOGY, V94, P598, DOI 10.1890/12-0928.1; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tobias JA, 2009, J EVOLUTION BIOL, V22, P623, DOI 10.1111/j.1420-9101.2008.01678.x; White RL, 2013, THESIS U KENT; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	89	26	28	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121849	10.1371/journal.pone.0121849	http://dx.doi.org/10.1371/journal.pone.0121849			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849620	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000352477800079
J	Won, JH; Tsogtbartarr, O; Son, W; Singh, A; Choi, KW; Cho, KO				Won, Jong-Hoon; Tsogtbartarr, Orkhon; Son, Wonseok; Singh, Amit; Choi, Kwang-Wook; Cho, Kyung-Ok			Cell Type-Specific Responses to Wingless, Hedgehog and Decapentaplegic Are Essential for Patterning Early Eye-Antenna Disc in Drosophila	PLOS ONE			English	Article							POLARITY GENE HEDGEHOG; MORPHOGENETIC FURROW; IMAGINAL DISKS; PERIPODIAL EPITHELIUM; PLANAR POLARITY; TRACHEAL SYSTEM; RETINA; HEAD; PROLIFERATION; INITIATION	The Drosophila eye-antenna imaginal disc (ead) is a flattened sac of two-layered epithelia, from which most head structures are derived. Secreted morphogens like Wingless (Wg), Hedgehog (Hh), and Decapentaplegic (Dpp) are important for early patterning of ead, but the underlying mechanisms are still largely unknown. To understand how these morphogens function in the ead of early larval stages, we used wg-LacZ and dpp-Gal4 markers for the examination of wild-type and mutant eads. We found that the ead immediately after hatching was crescent-shaped with the Bolwig's nerve at the ventral edge, suggesting that it consists of dorsal domain. In a subsequent step, transcriptional induction of dpp in the cells along the Bolwig's nerve was followed by rapid growth of the ventral domain. Both Wg and Hh were required for the formation of the ventral domain. Wg was crucial for the growth of the entire ead, but Hh was essential for cell division only in the dorsal domain. In the ventral domain, Hh regulated dpp transcription. Based on these data, we propose that signaling among distinct groups of cells expressing Wg, Dpp, or Hh in the ead of the first-instar larvae are critical for coordinated growth and patterning of ead.	[Won, Jong-Hoon; Tsogtbartarr, Orkhon; Son, Wonseok; Choi, Kwang-Wook; Cho, Kyung-Ok] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Singh, Amit] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dept Biol, Dayton, OH 45469 USA	Korea Advanced Institute of Science & Technology (KAIST); University of Dayton	Cho, KO (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Taejon 305701, South Korea.	kocho@kaist.ac.kr	Choi, Kwang-Wook/C-1707-2011; Singh, Amit/T-5619-2019; Cho, Kyung-Ok/C-1705-2011	Choi, Kwang-Wook/0000-0002-8997-3065; Singh, Amit/0000-0002-2962-2255; Son, Wonseok/0000-0003-1623-1236; Cho, Kyung-Ok/0000-0002-0760-2560	KAIST [G04080077, N10100001]; National Research Foundation [R1A1A301573]	KAIST; National Research Foundation	This research was supported by a KAIST Grant G04080077, N10100001, and National Research Foundation R1A1A301573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre C, 1999, DEVELOPMENT, V126, P5689; Atkins M, 2009, DEV DYNAM, V238, P2139, DOI 10.1002/dvdy.22034; Auerbach C., 1936, P R SOC EDINB, V58, P787; Baena-Lopez LA, 2012, CURR OPIN CELL BIOL, V24, P166, DOI 10.1016/j.ceb.2011.12.010; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027; Bolwig N, 1946, THESIS KOBENHAVNS U; Borod ER, 1998, DEV BIOL, V197, P187, DOI 10.1006/dbio.1998.8888; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; CARROLL SB, 1989, GENE DEV, V3, P905, DOI 10.1101/gad.3.6.905; Chanut F, 1997, DEVELOPMENT, V124, P559; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Crickmore MA, 2008, BIOESSAYS, V30, P843, DOI 10.1002/bies.20806; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Estella C, 2012, CURR TOP DEV BIOL, V98, P173, DOI 10.1016/B978-0-12-386499-4.00007-0; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Gibson MC, 2000, CELL, V103, P343, DOI 10.1016/S0092-8674(00)00125-2; Gibson MC, 2002, DEV CELL, V3, P451, DOI 10.1016/S1534-5807(02)00264-2; Hartenstein Volker, 1993; HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Ho KS, 2005, DEVELOPMENT, V132, P1401, DOI 10.1242/dev.01689; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jurgens G, 1993, TERMINAL REGIONS BOD, P687; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Kenyon KL, 2003, DEV CELL, V5, P403, DOI 10.1016/S1534-5807(03)00243-0; Lee OK, 2003, NAT CELL BIOL, V5, P987, DOI 10.1038/ncb1055; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Lim J, 2004, GENESIS, V39, P26, DOI 10.1002/gene.20022; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Vviii; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; MATHI SK, 1988, TISSUE CELL, V20, P461, DOI 10.1016/0040-8166(88)90077-8; McClure KD, 2005, DEVELOPMENT, V132, P5033, DOI 10.1242/dev.02092; MILNER MJ, 1984, ROUX ARCH DEV BIOL, V193, P406; MORATA G, 1979, DEV BIOL, V70, P355, DOI 10.1016/0012-1606(79)90033-2; Neumann CJ, 1996, DEVELOPMENT, V122, P1781; Pallavi SK, 2005, J CELL SCI, V118, P3363, DOI 10.1242/jcs.02464; Pignoni F, 1997, DEVELOPMENT, V124, P271; POSTLETHWAIT JH, 1971, DEV BIOL, V24, P477, DOI 10.1016/0012-1606(71)90061-3; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Reifegerste R, 1997, MECH DEVELOP, V68, P69, DOI 10.1016/S0925-4773(97)00127-5; Royet J, 1997, DEVELOPMENT, V124, P4793; SCHMIDTOTT U, 1994, P NATL ACAD SCI USA, V91, P8363, DOI 10.1073/pnas.91.18.8363; Schmucker D, 1997, DEVELOPMENT, V124, P937; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Stultz BG, 2006, DEV BIOL, V296, P329, DOI 10.1016/j.ydbio.2006.05.034; Takaesu NT, 2002, GENESIS, V34, P16, DOI 10.1002/gene.10109; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Wehrli M, 1998, DEVELOPMENT, V125, P1421; Wernet MF, 2012, CURR BIOL, V22, P12, DOI 10.1016/j.cub.2011.11.028; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; XU T, 1993, DEVELOPMENT, V117, P1223; YOUNOSSIHARTENSTEIN A, 1993, DEV BIOL, V158, P430, DOI 10.1006/dbio.1993.1201; ZECCA M, 1995, DEVELOPMENT, V121, P2265	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121999	10.1371/journal.pone.0121999	http://dx.doi.org/10.1371/journal.pone.0121999			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849899	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800092
J	Fukumoto, M; Kurisu, S; Yamada, T; Takenawa, T				Fukumoto, Miki; Kurisu, Shusaku; Yamada, Tesshi; Takenawa, Tadaomi			alpha-Actinin-4 Enhances Colorectal Cancer Cell Invasion by Suppressing Focal Adhesion Maturation	PLOS ONE			English	Article							ALPHA-ACTININ; STRESS FIBERS; GENE AMPLIFICATION; MOTILITY; SRC; EXPRESSION; ZYXIN; PHOSPHORYLATION; INVASIVENESS; PROGRESSION	alpha-Actinins (ACTNs) are known to crosslink actin filaments at focal adhesions in migrating cells. Among the four isoforms of mammalian ACTNs, ACTN1 and ACTN4 are ubiquitously expressed. Recently, ACTN4 was reported to enhance cancer cell motility, invasion, and metastasis. However, the mechanism by which ACTN4 drives these malignant phenotypes remains unclear. Here, we show that ACTN4, but not ACTN1, induces the formation of immature focal adhesions in DLD-1 cells, leading to the rapid turnover of focal adhesions. Interestingly, zyxin (ZYX) assembly to focal adhesions was markedly decreased in ACTN4-expressing DLD-1 cells, while the recruitment of paxillin (PAX) occurred normally. On the other hand, in ACTN1-expressing DLD-1 cells, PAX and ZYX were normally recruited to focal adhesions, suggesting that ACTN4 specifically impairs focal adhesion maturation by inhibiting the recruitment of ZYX to focal complexes. Using purified recombinant proteins, we found that ZYX binding to ACTN4 was defective under conditions where ZYX binding to ACTN1 was observed. Furthermore, Matrigel invasion of SW480 cells that express high endogenous levels of ACTN4 protein was inhibited by ectopic expression of ACTN1. Altogether, our results suggest that ZYX defective binding to ACTN4, which occupies focal adhesions instead of ACTN1, induces the formation of immature focal adhesions, resulting in the enhancement of cell motility and invasion.	[Fukumoto, Miki; Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Kurisu, Shusaku] Kobe Univ, Biosignal Res Ctr, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Yamada, Tesshi] Natl Canc Ctr, Div Pathol, Res Inst, Tokyo 1040045, Japan	Kobe University; Kobe University; National Cancer Center - Japan	Takenawa, T (corresponding author), Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	takenawa@med.kobe-u.ac.jp	Kurisu, Shusaku/AAB-1799-2022	Kurisu, Shusaku/0000-0002-4876-4419	Japan Society for the Promotion of Science (JSPS) through JSPS [25860215]; JSPS [23227005]	Japan Society for the Promotion of Science (JSPS) through JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS) through JSPS Grants-in-Aid for Scientific Research Grant 25860215 (to S. Kurisu) and JSPS Grants-in-Aid for Scientific Research Grant 23227005 (to T. Takenawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; BELKIN AM, 1987, FEBS LETT, V220, P291, DOI 10.1016/0014-5793(87)80832-3; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381; Foley KS, 2013, BIOCHEM J, V452, P477, DOI 10.1042/BJ20121824; Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Hauck CR, 2002, EMBO J, V21, P6289, DOI 10.1093/emboj/cdf631; Hayashida Y, 2005, CANCER RES, V65, P8836, DOI 10.1158/0008-5472.CAN-05-0718; Hoffman LM, 2012, MOL BIOL CELL, V23, P1846, DOI 10.1091/mbc.E11-12-1057; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Izaguirre G, 2001, J BIOL CHEM, V276, P28676, DOI 10.1074/jbc.M101678200; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; Miller NLG, 2013, J CELL SCI, V126, P5074, DOI 10.1242/jcs.135509; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Noro R, 2013, ANN ONCOL, V24, P2594, DOI 10.1093/annonc/mdt293; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; PAVALKO FM, 1993, J IMMUNOL, V151, P3795; PAVALKO FM, 1991, J CELL BIOL, V114, P481, DOI 10.1083/jcb.114.3.481; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shao HS, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.579185; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Shao HS, 2010, J BIOL CHEM, V285, P2591, DOI 10.1074/jbc.M109.035790; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; WACHSSTOCK DH, 1987, BIOCHEM BIOPH RES CO, V146, P554, DOI 10.1016/0006-291X(87)90564-X; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Welsch T, 2009, PANCREAS, V38, P968, DOI 10.1097/MPA.0b013e3181b28d6f; Yamamoto S, 2012, HISTOPATHOLOGY, V60, P1073, DOI 10.1111/j.1365-2559.2011.04163.x; Yoshii H, 2013, ONCOL REP, V30, P1073, DOI 10.3892/or.2013.2577; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	47	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120616	10.1371/journal.pone.0120616	http://dx.doi.org/10.1371/journal.pone.0120616			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860875	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300014
J	He, XY; Riceberg, J; Pulukuri, SM; Grossman, S; Shinde, V; Shah, P; Brownell, JE; Dick, L; Newcomb, J; Bence, N				He, Xingyue; Riceberg, Jessica; Pulukuri, Sai M.; Grossman, Steve; Shinde, Vaishali; Shah, Pooja; Brownell, James E.; Dick, Larry; Newcomb, John; Bence, Neil			Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor Proliferation	PLOS ONE			English	Article							CHROMOSOME SEGREGATION; SUMOYLATION; INHIBITOR; UBC9; EXPRESSION; ENZYME; IDENTIFICATION; SYSTEM; ROUTES	SUMOylation is a post-translational ubiquitin-like protein modification pathway that regulates important cellular processes including chromosome structure, kinetochore function, chromosome segregation, nuclear and sub-nuclear organization, transcription and DNA damage repair. There is increasing evidence that the SUMO pathway is dysregulated in cancer, raising the possibility that modulation of this pathway may have therapeutic potential. To investigate the importance of the SUMO pathway in the context of cancer cell proliferation and tumor growth, we applied lentivirus-based short hairpin RNAs (shRNA) to knockdown SUMO pathway genes in human cancer cells. shRNAs for SAE2 and UBC9 reduced SUMO conjugation activity and inhibited proliferation of human cancer cells. To expand upon these observations, we generated doxycycline inducible conditional shRNA cell lines for SAE2 to achieve acute and reversible SAE2 knockdown. Conditional SAE2 knockdown in U2OS and HCT116 cells slowed cell growth in vitro, and SAE2 knockdown induced multiple terminal outcomes including apoptosis, endoreduplication and senescence. Multinucleated cells became senescent and stained positive for the senescence marker, SA-beta Gal, and displayed elevated levels of p53 and p21. In an attempt to explain these phenotypes, we confirmed that loss of SUMO pathway activity leads to a loss of SUMOylated Topoisomerase II alpha and the appearance of chromatin bridges which can impair proper cytokinesis and lead to multinucleation. Furthermore, knockdown of SAE2 induces disruption of PML nuclear bodies which may further promote apoptosis or senescence. In an in vivo HCT116 xenograft tumor model, conditional SAE2 knockdown strongly impaired tumor growth. These data demonstrate that the SUMO pathway is required for cancer cell proliferation in vitro and tumor growth in vivo, implicating the SUMO pathway as a potential cancer therapeutic target.	[He, Xingyue; Riceberg, Jessica; Pulukuri, Sai M.; Grossman, Steve; Shinde, Vaishali; Shah, Pooja; Brownell, James E.; Dick, Larry; Newcomb, John] Takeda Pharmaceut Int Co, Oncol Drug Discovery Unit, Cambridge, MA 02139 USA; [Bence, Neil] Nurix Inc, San Francisco, CA USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.	He, XY (corresponding author), Takeda Pharmaceut Int Co, Oncol Drug Discovery Unit, Cambridge, MA 02139 USA.	xingyue.he@takeda.com; nbence@nurix-inc.com	Dick, Lawrence/ABA-8831-2021	Dick, Larry/0000-0002-6880-0405	Takeda Pharmaceuticals International Co.	Takeda Pharmaceuticals International Co.	Takeda Pharmaceuticals International Co. provided complete financial support for the study design, data collection and analysis, decision to publish, preparation of the manuscript, and salaries for authors XH, JR, SP, SG, VS, PS, JB, LD, JN, and NB, during the time when studies were conducted. The specific roles of these authors are articulated in the 'author contributions' section.	Almedawar S, 2012, CURR BIOL, V22, P1576, DOI 10.1016/j.cub.2012.06.046; Ban R, 2011, GENES CELLS, V16, P652, DOI 10.1111/j.1365-2443.2011.01521.x; Bogachek MV, 2014, CANCER CELL, V25, P748, DOI 10.1016/j.ccr.2014.04.008; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chen Shi-Feng, 2011, Chin J Cancer, V30, P638, DOI 10.5732/cjc.011.10084; Dasso M, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-5; Dawlaty MM, 2008, CELL, V133, P103, DOI 10.1016/j.cell.2008.01.045; Dieckhoff P, 2004, MOL MICROBIOL, V51, P1375, DOI 10.1046/j.1365-2958.2003.03910.x; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; Finkbeiner E, 2011, NUCLEUS-PHILA, V2, P527, DOI 10.4161/nucl.2.6.17604; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Guo LL, 2014, MOL CELL, V55, P15, DOI 10.1016/j.molcel.2014.04.030; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hirohama M, 2013, ACS CHEM BIOL, V8, P2635, DOI 10.1021/cb400630z; Hoellein A, 2014, BLOOD, V124, P2081, DOI 10.1182/blood-2014-06-584524; Ivanschitz L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00171; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Kanakousaki K, 2012, DEVELOPMENT, V139, P2751, DOI 10.1242/dev.082974; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kim YS, 2013, CHEM BIOL, V20, P604, DOI 10.1016/j.chembiol.2013.04.001; Kumar A, 2013, BIOORG MED CHEM LETT, V23, P5145, DOI 10.1016/j.bmcl.2013.07.022; Lee MT, 2009, DNA REPAIR, V8, P557, DOI 10.1016/j.dnarep.2009.01.004; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Moschos SJ, 2007, ONCOGENE, V26, P4216, DOI 10.1038/sj.onc.1210216; Moschos SJ, 2010, HUM PATHOL, V41, P1286, DOI 10.1016/j.humpath.2010.02.007; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Ouyang KJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000252; Robinson HMR, 2007, CELL CYCLE, V6, P1265, DOI 10.4161/cc.6.10.4225; Ryu H, 2010, J CELL BIOL, V191, P783, DOI 10.1083/jcb.201004033; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Swords RT, 2015, BRIT J HEMA IN PRESS; Nguyen TV, 2012, MOL CELL, V45, P210, DOI 10.1016/j.molcel.2011.12.026; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wan J, 2012, CURR PROTEIN PEPT SC, V13, P467, DOI 10.2174/138920312802430563; Wu FT, 2009, CLIN CANCER RES, V15, P1550, DOI 10.1158/1078-0432.CCR-08-0820; Zhu SS, 2009, MOL CELL, V33, P570, DOI 10.1016/j.molcel.2009.02.008	48	44	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123882	10.1371/journal.pone.0123882	http://dx.doi.org/10.1371/journal.pone.0123882			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860128	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300119
J	Li, MC; Wang, ZY; Yang, J; Guo, XL; Wang, T; Wang, SG; Yin, CP; Liu, JH; Ye, ZQ				Li, Mingchao; Wang, Zhengyun; Yang, Jun; Guo, Xiaolin; Wang, Tao; Wang, Shaogang; Yin, Chunping; Liu, Jihong; Ye, Zhangqun			Adjunctive Medical Therapy with alpha-Blocker after Extracorporeal Shock Wave Lithotripsy of Renal and Ureteral Stones: A Meta-Analysis	PLOS ONE			English	Article							EXPULSIVE THERAPY; TAMSULOSIN; CLEARANCE; EFFICACY; CALCULI; STEINSTRASSE; ANTAGONISTS; NIFEDIPINE; DOXAZOSIN; PAIN	Background Although some trials assessed the efficacy and safety of the alpha-blocker in facilitating renal and ureteral stones expulsion after extracorporeal shock wave lithotripsy (ESWL), the role of the alpha-blocker in facilitating upper urinary calculi expulsion after ESWL remain controversial. Aims To determine the efficacy and safety of the alpha-blocker in facilitating renal and ureteral stones expulsion after ESWL. Methods A literature search was carried out using the PubMed database, EMBASE and the Cochrane Library database to identify relevant studies. Two reviewers independently extracted data and assessed methodological quality. Pooled effect estimates were obtained using a fixed- and random-effects meta-analysis. Results The meta-analysis included 23 RCTs, alpha-blocker significantly enhanced expulsion rate of upper urinary tract calculi after ESWL (P<0.00001; RR 1.21; 95% CI 1.12-1.31), significantly promoted steinstrasse expulsion (P=0.03; RR 1.25; 95% CI 1.03-1.53), significantly shortened the discharge time of upper urinary tract calculi (P=0.0001; MD -2.12; 95% CI -3.20--1.04), significantly reduced the patient's pain VAS score (P=0.001; RR -1.0; 95% CI -1.61--0.39). Compared with the control group, dizziness (P=0.002; RR 5.48; 95% CI 1.91-15.77), anejaculation (P=0.02; RR 12.17; 95% CI 1.61-91.99) and headache (P=0.04; RR 4.03; 95% CI 1.04-15.72) in the alpha-blocker group was associated with a higher incidence. Conclusions Treatment with alpha-blocker after ESWL appears to be effective in enhancing expulsion rate of upper urinary tract calculi, shortening the discharge time of upper urinary tract calculi, reducing the patient's pain. The side effects of a-blocker were light and few.	[Li, Mingchao; Yang, Jun; Guo, Xiaolin; Wang, Tao; Wang, Shaogang; Liu, Jihong; Ye, Zhangqun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430030, Hubei, Peoples R China; [Wang, Zhengyun] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Resp & Crit Care Med, Wuhan 430030, Hubei, Peoples R China; [Yin, Chunping] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pharm, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Guo, XL (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Urol, Wuhan 430030, Hubei, Peoples R China.	guoxiaolin@tjh.tjmu.edu.cn; cpyin888@163.com	Wang, Shaogang/AGO-4944-2022	Wang, Shaogang/0000-0002-3206-1495				Agarwal MM, 2009, UROLOGY, V74, P989, DOI 10.1016/j.urology.2009.06.075; Ates F, 2012, UROL RES, V40, P537, DOI 10.1007/s00240-011-0455-x; Basri Cakiroglu, 2013, Curr Ther Res Clin Exp, V74, P33, DOI 10.1016/j.curtheres.2012.12.003; Bhagat SK, 2007, J UROLOGY, V177, P2185, DOI 10.1016/j.juro.2007.01.160; Carrasco J, 2014, BJU INT, V113, P942, DOI 10.1111/bju.12485; CHAUSSY C, 1980, LANCET, V2, P1265; Cho HJ, 2013, KOREAN J UROL, V54, P106, DOI 10.4111/kju.2013.54.2.106; Cui Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087634; Falahatkar S, 2011, J ENDOUROL, V25, P495, DOI 10.1089/end.2010.0439; Fan B, 2013, INT J UROL, V20, P818, DOI 10.1111/iju.12048; Georgiev MI, 2011, UROLOGY, V78, P1023, DOI 10.1016/j.urology.2011.01.073; Gravas S, 2007, UROL RES, V35, P231, DOI 10.1007/s00240-007-0106-4; Gul U, 2013, J ENDOUROL, V27, P612, DOI 10.1089/end.2012.0630; Hussein MM, 2010, SCAND J UROL NEPHROL, V44, P27, DOI 10.3109/00365590903359916; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Janane A, 2014, CUAJ-CAN UROL ASSOC, V8, pE8, DOI 10.5489/cuaj.1261; Kobayashi M, 2008, INT J UROL, V15, P495, DOI 10.1111/j.1442-2042.2008.02033.x; Kupeli B, 2004, UROLOGY, V64, P1111, DOI 10.1016/j.urology.2004.07.020; Micali S, 2007, UROL RES, V35, P133, DOI 10.1007/s00240-007-0085-5; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Moursy E, 2010, SCAND J UROL NEPHROL, V44, P315, DOI 10.3109/00365599.2010.494616; Naja V, 2008, UROLOGY, V72, P1006, DOI 10.1016/j.urology.2008.05.035; Park YH, 2013, KOREAN J UROL, V54, P527, DOI 10.4111/kju.2013.54.8.527; Phipps S, 2013, BJU INT, V112, pE129, DOI 10.1111/j.1464-410X.2012.11738.x; Resim S, 2005, UROLOGY, V66, P945, DOI 10.1016/j.urology.2005.05.029; Sayed MAB, 2008, SCAND J UROL NEPHROL, V42, P59, DOI 10.1080/00365590701571076; Singh SK, 2011, UROL J, V8, P14; Vicentini FC, 2011, UROLOGY, V78, P1016, DOI 10.1016/j.urology.2011.04.062; Wang CJ, 2009, UROL INT, V82, P166, DOI 10.1159/000200793; Wang Hui-jun, 2008, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V30, P506; Wang HJ, 2010, ASIAN J SURG, V33, P37, DOI 10.1016/S1015-9584(10)60007-3; Zaytoun OM, 2012, UROL RES, V40, P327, DOI 10.1007/s00240-011-0410-x; Zhu YF, 2010, BJU INT, V106, P256, DOI 10.1111/j.1464-410X.2009.09014.x	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122497	10.1371/journal.pone.0122497	http://dx.doi.org/10.1371/journal.pone.0122497			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860144	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300049
J	Gracia, IS; Suarez, OD; Garcia, GB; Kim, TK				Serrano Gracia, Ismael; Deniz Suarez, Oscar; Bueno Garcia, Gloria; Kim, Tae-Kyun			Fast Fight Detection	PLOS ONE			English	Article							VIOLENT SCENES; RECOGNITION; MOVIES; AUDIO	Action recognition has become a hot topic within computer vision. However, the action recognition community has focused mainly on relatively simple actions like clapping, walking, jogging, etc. The detection of specific events with direct practical use such as fights or in general aggressive behavior has been comparatively less studied. Such capability may be extremely useful in some video surveillance scenarios like prisons, psychiatric centers or even embedded in camera phones. As a consequence, there is growing interest in developing violence detection algorithms. Recent work considered the well-known Bag-of-Words framework for the specific problem of fight detection. Under this framework, spatio-temporal features are extracted from the video sequences and used for classification. Despite encouraging results in which high accuracy rates were achieved, the computational cost of extracting such features is prohibitive for practical applications. This work proposes a novel method to detect violence sequences. Features extracted from motion blobs are used to discriminate fight and non-fight sequences. Although the method is outperformed in accuracy by state of the art, it has a significantly faster computation time thus making it amenable for real-time applications.	[Serrano Gracia, Ismael; Deniz Suarez, Oscar; Bueno Garcia, Gloria] ETSI Ind, Dept Syst Engn & Automat, Ciudad Real, Castilla La Man, Spain; [Kim, Tae-Kyun] Univ London Imperial Coll Sci Technol & Med, Dept Elect & Elect Engn, London, England	Imperial College London	Gracia, IS (corresponding author), ETSI Ind, Dept Syst Engn & Automat, Ciudad Real, Castilla La Man, Spain.	ismael.serrano@uclm.es; oscar.deniz@uclm.es; gloria.bueno@uclm.es	Bueno, Gloria/K-6286-2014	Bueno, Gloria/0000-0002-7345-4869; Serrano Gracia, Ismael/0000-0002-3869-9369	Spain's Ministry of Economy and Competitiveness [TIN2011-24367]; European Union's Horizon research and innovation programme [643924]	Spain's Ministry of Economy and Competitiveness; European Union's Horizon research and innovation programme	This work has been partially supported by Project TIN2011-24367 from Spain's Ministry of Economy and Competitiveness. Also it has been partially supported by the European Union's Horizon 2020 research and innovation programme under grant agreement No 643924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nievas EB, 2011, LECT NOTES COMPUT SC, V6855, P332, DOI 10.1007/978-3-642-23678-5_39; Chen DT, 2008, IEEE ENG MED BIO, P5238, DOI 10.1109/IEMBS.2008.4650395; Chen LH, 2011, INT J PATTERN RECOGN, V25, P1161, DOI 10.1142/S0218001411009056; Chen M., 2010, P IEEE INFOCOM, P1, DOI DOI 10.1145/1730836.1730838; Cheng W.H, 2003, P 5 ACM SIGMM INT WO, P109, DOI DOI 10.1145/973264.973282; Clarin C.T., 2005, TECHNICAL REPORT; Demarty C., 2012, MEDIAEVAL 2012 WORKS; Deniz O., 2014, 9 INT C COMP VIS THE; Giannakopoulos T, 2006, LECT NOTES COMPUT SC, V3955, P502; Giannakopoulos T, 2010, LECT NOTES ARTIF INT, V6040, P91, DOI 10.1007/978-3-642-12842-4_13; Gong Y, 2008, LECT NOTES COMPUT SC, V5353, P317, DOI 10.1007/978-3-540-89796-5_33; Goto S, 2014, COMPUTER SCI; Guha T, 2012, IEEE T PATTERN ANAL, V34, P1576, DOI 10.1109/TPAMI.2011.253; Hassner T, 2012, 3 IEEE INT WORKSH SO; Heng Wang, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3169, DOI 10.1109/CVPR.2011.5995407; Laptev I, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P432, DOI 10.1109/iccv.2003.1238378; Lin JA, 2009, LECT NOTES COMPUT SC, V5879, P930; Nam J, 1998, 1998 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOL 1, P353, DOI 10.1109/ICIP.1998.723496; Patnaik S., 2012, SOFT COMPUTING TECHN; Poppe R, 2010, IMAGE VISION COMPUT, V28, P976, DOI 10.1016/j.imavis.2009.11.014; Shian- Ru K, 2013, REV VIDEO BASED HUMA, V2, P88, DOI [10. 3390/ computers2020088, DOI 10.3390/C0MPUTERS2020088]; Soomro Khurram, 2012, DATASET 101 HUMAN AC, V2; Turaga P, 2008, IEEE T CIRC SYST VID, V18, P1473, DOI 10.1109/TCSVT.2008.2005594; Wang D, 2012, 2012 IEEE NINTH INTERNATIONAL CONFERENCE ON ADVANCED VIDEO AND SIGNAL-BASED SURVEILLANCE (AVSS), P54, DOI 10.1109/AVSS.2012.16; Wang KY, 2012, COMM COM INF SC, V321, P137; Zajdel W, 2007, 2007 IEEE CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, P200, DOI 10.1109/AVSS.2007.4425310; Zou X., 2012, ISCIDE, P347	27	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120448	10.1371/journal.pone.0120448	http://dx.doi.org/10.1371/journal.pone.0120448			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860667	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300012
J	Shan, HT; Chen, FZ; Zhang, T; He, SH; Xu, L; Wei, AY				Shan, Haitao; Chen, Fengzhi; Zhang, Tao; He, Shuhua; Xu, Le; Wei, Anyang			Stem Cell Therapy for Erectile Dysfunction of Cavernous Nerve Injury Rats: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MAJOR PELVIC GANGLION; NEUROTROPHIC FACTOR; HUMAN ADIPOSE; BONE-MARROW; PERIPROSTATIC IMPLANTATION; INTRACAVERNOSAL INJECTION; MODEL; RECOVERY; MEMBRANE	Introduction Stem cell treatment is a novel therapeutic strategy for erectile dysfunction (ED) patients with bilateral cavernous nerve injury (CNI). The relative animal studies provide important clues to design pre-clinical studies and clinical studies further in the future. Purpose This study aims to evaluate the effects and influential factors of stem cell transplantation on ED rats with CNI. Materials and Methods We searched PubMed and EBSCO databases published before April 30, 2014 for pre-clinical studies to evaluate the efficacy of stem cell transplantation in the treatment of ED rats with CNI. A systematic review and a planned subgroup analysis were performed to identify whether or not some certain influential factors could bring significant effects on stem cell treatment. Results 12 studies with 319 rats were enrolled in this meta-analysis. Pooled analysis results confirmed the efficacy of stem cell transplantation. Subgroup analysis results showed that treatment effects were not related to CNI models, follow-up time, stem cell species, stem cell sources, markers and delivery approaches in the transplantation. Uncultured stem cells were poorly effective compared with cultured stem cells. Periprostatic implantation (PPI) with acellular scaffolds could promote cavernous nerve regeneration, but was less effective for smooth muscle cell recovery. Stem cells modified by NGF or BDNF combined with udenafil/bFGF seemed to be more effective than those modified by BDNF alone. Conclusion This meta-analysis shows that stem cell therapy can be performed to recover erectile function. Future studies should focus on nerve restoration and vascular cell recovery. The synergistic actions of multiple growth factors following stem cell transplantation should also be considered as beneficial strategies to obtain preferable effects.	[Shan, Haitao; Xu, Le] Southern Med Univ, Hexian Mem Affiliated Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Chen, Fengzhi; Zhang, Tao; He, Shuhua; Wei, Anyang] Southern Med Univ, Nanfang Hosp, Med Ctr Overseas Patients, Dept Urol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Wei, AY (corresponding author), Southern Med Univ, Nanfang Hosp, Med Ctr Overseas Patients, Dept Urol, Guangzhou, Guangdong, Peoples R China.	profwei@126.com						Albersen M, 2012, J SEX MED, V9, P385, DOI 10.1111/j.1743-6109.2011.02556.x; Albersen M, 2010, J SEX MED, V7, P3331, DOI 10.1111/j.1743-6109.2010.01875.x; Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; Basal S, 2013, BJU INT, V111, P658, DOI 10.1111/j.1464-410X.2012.11487.x; Bella AJ, 2007, EUR UROL, V52, P574, DOI 10.1016/j.eururo.2006.10.043; Bochinski D, 2004, BJU INT, V94, P904, DOI 10.1111/j.1464-410X.2003.05057.x; BURGERS JK, 1991, J UROLOGY, V146, P463, DOI 10.1016/S0022-5347(17)37825-4; Cellek S, 2012, J SEX MED, V9, P2770, DOI 10.1111/j.1743-6109.2012.02916.x; Choi WY, 2013, STEM CELLS DEV, V22, P2158, DOI 10.1089/scd.2012.0385; Condorelli RA, 2013, ANDROLOGY-US, V1, P533, DOI 10.1111/j.2047-2927.2013.00087.x; Fall PA, 2009, EUR UROL, V56, P716, DOI 10.1016/j.eururo.2008.09.059; Fandel TM, 2012, EUR UROL, V61, P201, DOI 10.1016/j.eururo.2011.07.061; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Grothe C, 2001, ANAT EMBRYOL, V204, P171, DOI 10.1007/s004290100205; Hsieh PS, 2003, BJU INT, V92, P470, DOI 10.1046/j.1464-410X.2003.04373.x; Jeong HH, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2013.01.022; Kendirci M, 2010, J UROLOGY, V184, P1560, DOI 10.1016/j.juro.2010.05.088; Kim HJ, 2011, KOREAN J UROL, V52, P560, DOI 10.4111/kju.2011.52.8.560; Kim IG, 2013, TISSUE ENG PT A, V19, P14, DOI [10.1089/ten.TEA.2011.0654, 10.1089/ten.tea.2011.0654]; Kim SJ, 2012, KOREAN J UROL, V53, P726, DOI 10.4111/kju.2012.53.10.726; Kim SJ, 2012, INT BRAZ J UROL, V38, P833, DOI 10.1590/1677-553820133806833; Kim Y, 2006, INT J IMPOT RES, V18, P329, DOI 10.1038/sj.ijir.3901434; Kovanecz I, 2012, J SEX MED, V9, P2814, DOI 10.1111/j.1743-6109.2012.02913.x; Lee SH, 2014, TISSUE ENG PT A, V20, P2446, DOI [10.1089/ten.tea.2013.0495, 10.1089/ten.TEA.2013.0495]; Lin CS, 2013, EXPERT OPIN BIOL TH, V13, P1585, DOI 10.1517/14712598.2013.847085; Lin CS, 2012, STEM CELLS DEV, V21, P2770, DOI 10.1089/scd.2012.0176; Lin CS, 2012, STEM CELLS DEV, V21, P343, DOI 10.1089/scd.2011.0303; Lin G, 2011, INT J IMPOT RES, V23, P268, DOI 10.1038/ijir.2011.38; Lin G, 2011, UROLOGY, V77, P1501; Miyamoto K, 2014, J SEX MED, V11, P1148, DOI 10.1111/jsm.12485; Mullerad M, 2006, J SEX MED, V3, P77, DOI 10.1111/j.1743-6109.2005.00158.x; Oliveri RS, 2014, NEUROBIOL DIS, V62, P338, DOI 10.1016/j.nbd.2013.10.014; Piao S, 2012, J SEX MED, V9, P1968, DOI 10.1111/j.1743-6109.2012.02760.x; Qi Z, 2012, CELL BIOL INT, V36, P857, DOI 10.1042/CBI20110637; Qiu XF, 2012, EUR UROL, V62, P720, DOI 10.1016/j.eururo.2012.02.003; Qiu XF, 2012, J SEX MED, V9, P1834, DOI 10.1111/j.1743-6109.2012.02753.x; Razavi S, 2013, DEV GROWTH DIFFER, V55, P648, DOI 10.1111/dgd.12072; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Taghi GM, 2012, CELL BIOL INT, V36, P1239, DOI 10.1042/CBI20110618; Woo JC, 2011, KOREAN J UROL, V52, P359, DOI 10.4111/kju.2011.52.5.359; Xie DH, 2006, J SEX MED, V3, P223, DOI 10.1111/j.1743-6109.2005.00174.x; Ying CC, 2014, CELL MOL NEUROBIOL, V34, P393, DOI 10.1007/s10571-013-0024-7; Ying CC, 2013, CELL MOL NEUROBIOL, V33, P233, DOI 10.1007/s10571-012-9890-7; You D, 2013, PROSTATE, V73, P278, DOI 10.1002/pros.22567; You D, 2013, UROLOGY, V81, P104, DOI 10.1016/j.urology.2012.08.046; Zhang D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093487; Zhang HY, 2011, ASIAN J ANDROL, V13, P231, DOI 10.1038/aja.2010.162; Zhang HY, 2012, ASIAN J ANDROL, V14, P145, DOI 10.1038/aja.2011.79	49	27	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121428	10.1371/journal.pone.0121428	http://dx.doi.org/10.1371/journal.pone.0121428			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860455	gold, Green Submitted, Green Published			2022-12-27	WOS:000352590300024
J	Sonoda, Y; Gohda, T; Suzuki, Y; Omote, K; Ishizaka, M; Matsuoka, J; Tomino, Y				Sonoda, Yuji; Gohda, Tomohito; Suzuki, Yusuke; Omote, Keisuke; Ishizaka, Masanori; Matsuoka, Joe; Tomino, Yasuhiko			Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTORS; ACID-BINDING PROTEIN; KIDNEY-FUNCTION; ALPHA; EXPRESSION; PATHOGENESIS; INFLAMMATION; ALBUMINURIA; PROGRESSION; ACTIVATION	The current study aimed to examine whether the levels of TNF receptors 1 and 2 (TNFR1 and TNFR2) in serum and urine were associated with other markers of kidney injury and renal histological findings, including TNFR expression, in IgA nephropathy (IgAN). The levels of the parameters of interest were measured by immunoassay in 106 biopsy-proven IgAN patients using samples obtained immediately before renal biopsy and in 34 healthy subjects. Renal histological findings were evaluated using immunohistochemistry. The levels of serum TNFRs were higher in IgAN patients than in healthy subjects. The levels of both TNFRs in serum or urine were strongly correlated with each other (r > 0.9). Serum TNFR levels were positively correlated with the urinary protein to creatinine ratio (UPCR) and four markers of tubular damage of interest (N-acetyl-beta-D-glucosaminidase [NAG], beta 2 microglobulin [beta 2m], liver-type fatty acid-binding protein [L-FABP], and kidney injury molecule-1 [KIM-1]) and negatively correlated with estimated glomerular filtration rate (eGFR). Patients in the highest tertile of serum TNFR levels showed more severe renal interstitial fibrosis than did those in the lowest or second tertiles. The tubulointerstitial TNFR2-, but not TNFR1-, positive area was significantly correlated with the serum levels of TNFRs and eGFR. Stepwise multiple regression analysis revealed that elevated serum TNFR1 or TNFR2 levels were a significant determinant of renal interstitial fibrosis after adjusting for eGFR, UPCR, and other markers of tubular damage. In conclusion, elevated serum TNFR levels were significantly associated with the severity of renal interstitial fibrosis in IgAN patients. However, the source of TNFRs in serum and urine remains unclear.	[Sonoda, Yuji; Gohda, Tomohito; Suzuki, Yusuke; Omote, Keisuke; Ishizaka, Masanori; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan; [Matsuoka, Joe] Juntendo Univ, Fac Med, Clin Res Ctr, Tokyo, Japan	Juntendo University; Juntendo University	Tomino, Y (corresponding author), Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan.	yasu@juntendo.ac.jp	GOHDA, TOMOHITO/Y-6867-2019	GOHDA, TOMOHITO/0000-0002-0513-4433				Al-Lamki RS, 2010, AM J PATHOL, V177, P943, DOI 10.2353/ajpath.2010.091218; BOHLE A, 1994, EXP NEPHROL, V2, P205; Carlsson AC, 2014, J AM SOC NEPHROL, V25, P1313, DOI 10.1681/ASN.2013080860; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chan LYY, 2005, KIDNEY INT, V67, P602, DOI 10.1111/j.1523-1755.2005.67116.x; DAMICO G, 1987, Q J MED, V64, P709; Fukuta H, 2008, CIRC J, V72, P212, DOI 10.1253/circj.72.212; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Hasegawa M, 2009, NEPHRON CLIN PRACT, V113, pC222, DOI 10.1159/000235242; Hoffmann U, 2009, AM J TRANSPLANT, V9, P675, DOI 10.1111/j.1600-6143.2008.02536.x; Idasiak-Piechocka I, 2010, NEPHROL DIAL TRANSPL, V25, P3948, DOI 10.1093/ndt/gfq310; Kanaguchi Y, 2011, NEPHROL DIAL TRANSPL, V26, P3465, DOI 10.1093/ndt/gfr110; Keller C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-9; Lee JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058007; Fernandez-Real JM, 2012, ACTA DIABETOL, V49, P301, DOI 10.1007/s00592-011-0349-y; Miura Y, 2011, TRANSPLANTATION, V91, P78, DOI 10.1097/TP.0b013e3181ff4f7f; Miyazawa I, 2011, DIABETES RES CLIN PR, V92, P174, DOI 10.1016/j.diabres.2011.01.008; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Ng DPK, 2008, DIABETOLOGIA, V51, P2318, DOI 10.1007/s00125-008-1162-1; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Niewczas MA, 2009, CLIN J AM SOC NEPHRO, V4, P62, DOI 10.2215/CJN.03010608; Reinhold SW, 2012, CYTOKINE, V57, P379, DOI 10.1016/j.cyto.2011.12.006; RISDON RA, 1968, LANCET, V2, P363; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Servais A, 2007, TRANSPLANTATION, V84, P1595, DOI 10.1097/01.tp.0000295749.50525.bd; Speeckaert MM, 2012, AM J NEPHROL, V36, P261, DOI 10.1159/000342333; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Tumlin JA, 2007, CLIN J AM SOC NEPHRO, V2, P1054, DOI 10.2215/CJN.04351206; Upadhyay A, 2011, NEPHROL DIAL TRANSPL, V26, P920, DOI 10.1093/ndt/gfq471; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Wu TF, 2007, J IMMUNOL, V179, P7166, DOI 10.4049/jimmunol.179.10.7166; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Zhu L, 2009, LUPUS, V18, P116, DOI 10.1177/0961203308094764; Zuo N, 2011, NEPHROL DIAL TRANSPL, V26, P2127, DOI 10.1093/ndt/gfq687	34	38	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122212	10.1371/journal.pone.0122212	http://dx.doi.org/10.1371/journal.pone.0122212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860248	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300036
J	Wang, Q; Li, XF; Ren, SX; Cheng, NN; Zhao, MC; Zhang, YS; Li, JY; Cai, WJ; Zhao, C; Cao, W; Zhou, CC				Wang, Qi; Li, Xuefei; Ren, Shengxiang; Cheng, Ningning; Zhao, Mingchuan; Zhang, Yishi; Li, Jiayu; Cai, Weijing; Zhao, Chao; Cao, Wa; Zhou, Caicun			Serum Levels of the Cancer-Testis Antigen POTEE and Its Clinical Significance in Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							FAMILY; PROTEINS; PARALOGS; GENES; IMMUNOTHERAPY; EXPRESSION; CARCINOMA; BIOMARKER; PROSTATE; TARGETS	Background POTEE (POTE ankyrin domain family, member E) is a newly identified cancer-testis antigen that has been found to be expressed in a wide variety of human cancers including cancers of the colon, prostate, lung, breast, ovary, and pancreas. Aim To measure the serum levels of POTEE in patients with non-small-cell lung cancer (NSCLC) and to explore the clinical significance of POTEE in NSCLC. Patients and Methods 104 NSCLC patients, 66 benign lung disease patients and 80 healthy volunteers were enrolled in this study from May 2013 to February 2014. Serum POTEE levels were measured using enzyme-linked immunosorbent assay (ELISA). Numerical variables were recorded as means +/- standard deviation (SD) and analyzed by independent t tests. Categorical variables were calculated as rates and were analyzed using a chi(2) test or Fisher's exact test. Survival curves were estimated and compared using the Kaplan-Meier method and log-rank tests. Results Serum POTEE levels were significantly higher in NSCLC patients than in benign lung disease patients and healthy controls (mean +/- SD [pg/ml], 324.38 +/- 13.84 vs. 156.93 +/- 17.38 and 139.09 +/- 15.80, P < 0.001) and were significantly correlated with TNM stage. Survival analysis revealed that patients with low serum POTEE had longer progression-free survival (PFS) than those with high serum POTEE (P=0.021). Cox multivariate analysis indicated that POTEE was an independent prognostic factor of progression-free survival (P=0.009, hazard ratio, 2.440). Conclusions Serum POTEE level in NSCLC patients is associated with TNM stage and is a potential prognostic factor.	[Wang, Qi; Li, Xuefei; Ren, Shengxiang; Cheng, Ningning; Zhao, Mingchuan; Zhang, Yishi; Li, Jiayu; Cai, Weijing; Zhao, Chao; Cao, Wa; Zhou, Caicun] Tongji Univ, Sch Med, Inst Canc, Dept Lung Canc & Immunol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China	Tongji University	Zhou, CC (corresponding author), Tongji Univ, Sch Med, Inst Canc, Dept Lung Canc & Immunol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China.	caicunzhoudr@163.com			National Natural Science Foundation of China [81401890, 81372392]; Key Project of the Science and Technology Commission of Shanghai Municipality [11JC1411300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Science and Technology Commission of Shanghai Municipality	This study was supported by grants from the National Natural Science Foundation of China (no. 81401890 and no. 81372392) and the Key Project of the Science and Technology Commission of Shanghai Municipality (no. 11JC1411300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruga A, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-61; Bera TK, 2008, STEM CELLS DEV, V17, P325, DOI 10.1089/scd.2007.0079; Bera TK, 2012, BIOCHEM BIOPH RES CO, V417, P1271, DOI 10.1016/j.bbrc.2011.12.125; Bera TK, 2006, CANCER RES, V66, P52, DOI 10.1158/0008-5472.CAN-05-3014; Bera TK, 2004, GENE, V337, P45, DOI 10.1016/j.gene.2004.05.009; Bera TK, 2002, P NATL ACAD SCI USA, V99, P16975, DOI 10.1073/pnas.262655399; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chen ZG, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-10; Das S, 2007, BIOCHEM BIOPH RES CO, V363, P751, DOI 10.1016/j.bbrc.2007.09.045; Ghafouri-Fard S, 2009, ARCH IRAN MED, V12, P395; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hahn Y, 2006, GENE, V366, P238, DOI 10.1016/j.gene.2005.07.045; Hofmann M, 2002, CANCER CYTOPATHOL, V96, P187, DOI 10.1002/cncr.10622; Hoon DSB, 2001, J INVEST DERMATOL, V117, P375, DOI 10.1046/j.0022-202x.2001.01417.x; Huang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064365; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Kuang P, 2012, LUNG CANCER, V77, P427, DOI 10.1016/j.lungcan.2012.03.016; Lee Y, 2006, P NATL ACAD SCI USA, V103, P17885, DOI 10.1073/pnas.0608344103; Liu XP, 2011, BRAIN RES, V1391, P125, DOI 10.1016/j.brainres.2011.03.042; Liu XF, 2009, APOPTOSIS, V14, P1237, DOI 10.1007/s10495-009-0392-0; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Mou DC, 2002, BRIT J CANCER, V86, P110, DOI 10.1038/sj.bjc.6600016; Obara W, 2012, JPN J CLIN ONCOL, V42, P591, DOI 10.1093/jjco/hys069; Old Lloyd J, 2008, Cancer Immun, V8 Suppl 1, P1; Redfield SM, 2013, AM J CANCER RES, V3, P278; Rosenberg SA, 1999, CA-CANCER J CLIN, V49, P70, DOI 10.3322/canjclin.49.2.70; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; Tufman A, 2010, CANCER BIOMARK, V6, P123, DOI 10.3233/CBM-2009-0124	30	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122792	10.1371/journal.pone.0122792	http://dx.doi.org/10.1371/journal.pone.0122792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860145	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300063
J	Chai, J; Feng, RJ; Shi, HR; Ren, MY; Zhang, YD; Wang, JY				Chai, Juan; Feng, Renjun; Shi, Hourui; Ren, Mengyun; Zhang, Yindong; Wang, Jingyi			Bioinformatic Identification and Expression Analysis of Banana MicroRNAs and Their Targets	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; PLANT MICRORNAS; SMALL RNAS; MIRNAS; SEQUENCE; PREDICTION; STRESS; GENOME; GENES; RICE	MicroRNAs (miRNAs) represent a class of endogenous non-coding small RNAs that play important roles in multiple biological processes by degrading targeted mRNAs or repressing mRNA translation. Thousands of miRNAs have been identified in many plant species, whereas only a limited number of miRNAs have been predicted in M. acuminata (A genome) and M. balbisiana (B genome). Here, previously known plant miRNAs were BLASTed against the Expressed Sequence Tag (EST) and Genomic Survey Sequence (GSS), a database of banana genes. A total of 32 potential miRNAs belonging to 13 miRNAs families were detected using a range of filtering criteria. 244 miRNA: target pairs were subsequently predicted, most of which encode transcription factors or enzymes that participate in the regulation of development, growth, metabolism, and other physiological processes. In order to validate the predicted miRNAs and the mutual relationship between miRNAs and their target genes, qRT-PCR was applied to detect the tissue-specific expression levels of 12 putative miRNAs and 6 target genes in roots, leaves, flowers, and fruits. This study provides some important information about banana pre-miRNAs, mature miRNAs, and miRNA target genes and these findings can be applied to future research of miRNA functions.	[Chai, Juan; Feng, Renjun; Shi, Hourui; Ren, Mengyun; Wang, Jingyi] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Key Lab Biol & Genet Resources Trop Crops, Minist Agr, Haikou, Hainan, Peoples R China; [Shi, Hourui; Ren, Mengyun; Zhang, Yindong] Hainan Univ, Coll Agron, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Hainan University	Wang, JY (corresponding author), Hainan Univ, Coll Agron, Haikou, Hainan, Peoples R China.	23300558@163.com; wangjingyi@itbb.org.cn	WANG, JINGYI/GSJ-1241-2022		Natural Science Foundation of Hainan Province [312050, 312051]; National Nonprofit Institute Research Grant of CATAS-ITBB [ITBB130201]; National Natural Science Foundation of China [31201603]; Major Technology Project of Hainan Province [ZDZX2013023-1]	Natural Science Foundation of Hainan Province; National Nonprofit Institute Research Grant of CATAS-ITBB; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Technology Project of Hainan Province	JYW and RJF received the grants from the Natural Science Foundation of Hainan Province (No. 312050, 312051), JYW received the grants from the National Nonprofit Institute Research Grant of CATAS-ITBB (No. ITBB130201), and RJF received the grants from the National Natural Science Foundation of China (No. 31201603) and the Major Technology Project of Hainan Province (No. ZDZX2013023-1). The grants from No. 312050 and ITBB130201 had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Archak Sunil, 2007, Genomics Proteomics & Bioinformatics, V5, P196, DOI 10.1016/S1672-0229(08)60007-8; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baurens FC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-149; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen XB, 2010, J INTEGR PLANT BIOL, V52, P946, DOI 10.1111/j.1744-7909.2010.00987.x; Colaiacovo M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-595; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Davey MW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-683; Dong QH, 2012, J HERED, V103, P268, DOI 10.1093/jhered/esr127; Dryanova A, 2008, GENOME, V51, P433, DOI 10.1139/G08-025; Du JF, 2010, CHINESE SCI BULL, V55, P1263, DOI 10.1007/s11434-010-0035-4; FAOSTAT, BAN PROD; Silva GFFE, 2014, PLANT J, V78, P604, DOI 10.1111/tpj.12493; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Gorodkin J, 2006, COMPUT BIOL CHEM, V30, P249, DOI 10.1016/j.compbiolchem.2006.04.006; Hake S, 2003, CURR BIOL, V13, pR851, DOI 10.1016/j.cub.2003.10.021; Jin WB, 2008, J PLANT RES, V121, P351, DOI 10.1007/s10265-007-0139-3; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khvorova A, 2007, CELL, V131, P41, DOI 10.1016/S0092-8674(03)00801-8; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Liang G, 2013, PLANTA, V238, P739, DOI 10.1007/s00425-013-1929-6; Liu ZH, 2010, J INTEGR PLANT BIOL, V52, P670, DOI 10.1111/j.1744-7909.2010.00959.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martens S, 2003, BIOCHEM ENG J, V14, P227, DOI 10.1016/S1369-703X(02)00224-3; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Murray F, 2003, PLANT J, V33, P481, DOI 10.1046/j.1365-313X.2003.01641.x; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Pani A, 2013, GENOM DATA, V1, P2, DOI 10.1016/j.gdata.2013.06.001; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Simmonds N. W., 1962, EVOLUTION BANANAS, P101; Song C, 2010, PLANT BIOLOGY, V12, P927, DOI 10.1111/j.1438-8677.2009.00300.x; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; Unver T, 2010, PLANT CELL REP, V29, P757, DOI 10.1007/s00299-010-0862-4; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Xie FL, 2007, FEBS LETT, V581, P1464, DOI 10.1016/j.febslet.2007.02.074; Ye KY, 2013, GENES GENOM, V35, P377, DOI 10.1007/s13258-013-0070-z; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zeng CY, 2010, NUCLEIC ACIDS RES, V38, P981, DOI 10.1093/nar/gkp1035; Zhang BH, 2007, GENE, V397, P26, DOI 10.1016/j.gene.2007.03.020; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang WW, 2009, COMPUT BIOL CHEM, V33, P84, DOI 10.1016/j.compbiolchem.2008.07.006; Zhou ZS, 2008, BIOCHEM BIOPH RES CO, V374, P538, DOI 10.1016/j.bbrc.2008.07.083; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	65	22	25	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123083	10.1371/journal.pone.0123083	http://dx.doi.org/10.1371/journal.pone.0123083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856313	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500072
J	Liao, Y; Chen, JW; Brandt, BW; Zhu, YF; Li, J; van Loveren, C; Deng, DM				Liao, Ying; Chen, Jianwei; Brandt, Bernd Willem; Zhu, Yuanfang; Li, Jiyao; van Loveren, Cor; Deng, Dong Mei			Identification and Functional Analysis of Genome Mutations in a Fluoride-Resistant Streptococcus mutans Strain	PLOS ONE			English	Article							HUMAN DENTAL PLAQUE; WIDE ASSOCIATION; SODIUM-FLUORIDE; READ ALIGNMENT; EXPRESSION; SPECIFICITY; TRANSPORT; BACTERIA; ENOLASE; ENAMEL	It is known that fluoride-resistant microorganisms are different from fluoride-sensitive ones in growth, adherence and metabolic activity. It was hypothesized that these phenotypic differences were due to stable genotypic changes in the fluoride-resistant strains. However, until now, no studies have reported these genotypic changes. The aim of this study is to identify such changes in a fluoride-resistant Streptococcus mutans strain (C180-2FR) using whole-genome shotgun (WGS) sequencing and to examine the potential function of the identified mutations by comparing gene expression between the fluoride-sensitive (C180-2) and C180-2FR strains. We performed 50 bp paired-end Illumina shotgun sequencing for both strains. Through extensive bioinformatic analysis, we were able to identify 8 single nucleotide polymorphisms (SNPs) in the genome of C180-2FR, which were further confirmed by Sanger sequencing. Expression of the genes containing or in proximity to the SNPs in C180-2 and C180-2FR was then quantified by real-time PCR. A gene cluster containing genes coding for fluoride antiporters was up-regulated 10-fold in C180-2FR when compared to that in C180-2, independent of growth phase. Two SNPs are located in this gene cluster, one in its promoter region and the other in its protein-coding region. In addition, one gene, which codes for a putative glycerol uptake facilitator protein, was found to be down-regulated by 60% in C180-2FR at an early growth phase. The promoter region of this gene contained a SNP. No difference in expression was found for the other SNP-containing genes. In summary, using WGS sequencing, we were able to uncover genetic changes in the genome of a fluoride-resistant strain. These findings can provide new insights into the mechanism of microbial fluoride resistance.	[Liao, Ying; Li, Jiyao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Liao, Ying; Brandt, Bernd Willem; van Loveren, Cor; Deng, Dong Mei] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Liao, Ying; Brandt, Bernd Willem; van Loveren, Cor; Deng, Dong Mei] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Chen, Jianwei; Zhu, Yuanfang] BGI Shenzhen, Shenzhen, Peoples R China	Sichuan University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Beijing Genomics Institute (BGI)	Deng, DM (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands.	d.deng@acta.nl	Deng, Dongmei/V-9230-2017; Liao, Ying/AAE-6821-2020; Chen, Jianwei/GQH-8813-2022	Chen, Jianwei/0000-0003-2332-4609; Brandt, Bernd/0000-0002-1155-1989	National Natural Science Foundation of China [81371135]; "Twelfth Five-Year" National Science and Technology Support Project [20911BAZ03171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Twelfth Five-Year" National Science and Technology Support Project	This research was supported by the National Natural Science Foundation of China (No. 81371135) and "Twelfth Five-Year" National Science and Technology Support Project (20911BAZ03171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Alam MT, 2014, GENOME BIOL EVOL, V6, P1174, DOI 10.1093/gbe/evu092; Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Amaechi BT, 2013, CARIES RES, V47, P399, DOI 10.1159/000348589; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Bartholmes P MA, 1990, J DENT RES, V69, P825; BIRKELAND JM, 1978, CARIES RES, V12, P38, DOI 10.1159/000260364; Bowden G H, 1990, J Dent Res, V69 Spec No, P653; Bowden GH, 1990, J DENT RES, V69, P682; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; BRUSSOCK SM, 1987, J DENT RES, V66, P1594, DOI 10.1177/00220345870660101701; Bryant J, 2012, FUTURE MICROBIOL, V7, P1283, DOI [10.2217/FMB.12.108, 10.2217/fmb.12.108]; BUNICK FJ, 1981, INFECT IMMUN, V34, P856, DOI 10.1128/IAI.34.3.856-863.1981; CHANSLEY PE, 1989, INFECT IMMUN, V57, P1968, DOI 10.1128/IAI.57.7.1968-1970.1989; CURRAN TM, 1994, FEMS MICROBIOL LETT, V119, P283; DESTOPPELAAR JD, 1967, ARCH ORAL BIOL, V12, P1199, DOI 10.1016/0003-9969(67)90069-6; DIRKS OB, 1978, CARIES RES, V12, P7, DOI 10.1159/000260359; Froger A, 2001, MICROBIOL-SGM, V147, P1129, DOI 10.1099/00221287-147-5-1129; Fu D, 2002, NOVART FDN SYMP, V245, P51; HAMILTON IR, 1969, CAN J MICROBIOL, V15, P287, DOI 10.1139/m69-052; HELDERMAN WHV, 1983, ARCH ORAL BIOL, V28, P599; HELLER KB, 1980, J BACTERIOL, V144, P274, DOI 10.1128/JB.144.1.274-278.1980; Hoelscher GL, 1996, CURR MICROBIOL, V32, P156, DOI 10.1007/s002849900028; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; LI YH, 1994, J DENT RES, V73, P1615, DOI 10.1177/00220345940730100601; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Lynch R J M, 2012, Adv Dent Res, V24, P63, DOI 10.1177/0022034512454295; Marquis RE, 2003, FEMS MICROBIOL REV, V26, P493, DOI 10.1111/j.1574-6976.2003.tb00627.x; Sheng J Y, 2000, Chin J Dent Res, V3, P7; Sheppard SK, 2013, P NATL ACAD SCI USA, V110, P11923, DOI 10.1073/pnas.1305559110; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; STRECKFUSS JL, 1980, J DENT RES, V59, P151, DOI 10.1177/00220345800590021501; ten Cate JM, 2004, CARIES RES, V38, P254, DOI 10.1159/000077763; Van Loveren C, 1990, J Dent Res, V69 Spec No, P676; van Loveren C, 2008, CARIES RES, V42, P429, DOI 10.1159/000159606; VANLOVEREN C, 1991, J DENT RES, V70, P1491, DOI 10.1177/00220345910700120401; VANLOVEREN C, 1991, ORAL MICROBIOL IMMUN, V6, P288; VANLOVEREN C, 1991, CARIES RES, V25, P424, DOI 10.1159/000261405; Zhu LK, 2012, ARCH ORAL BIOL, V57, P10, DOI 10.1016/j.archoralbio.2011.06.011	44	22	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122630	10.1371/journal.pone.0122630	http://dx.doi.org/10.1371/journal.pone.0122630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856576	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500047
J	Samra, S; Ghanim, M; Protasov, A; Branco, M; Mendel, Z				Samra, Shahar; Ghanim, Murad; Protasov, Alex; Branco, Manuela; Mendel, Zvi			Genetic Diversity and Host Alternation of the Egg Parasitoid Ooencyrtus pityocampae between the Pine Processionary Moth and the Caper Bug	PLOS ONE			English	Article							THAUMETOPOEA-WILKINSONI TAMS; TRICHOGRAMMA-PLATNERI NAGARKATTI; SCHIFF LEP; BIOLOGICAL-CONTROL; DNA POLYMORPHISM; HYMENOPTERA; CATERPILLAR; BATCHES; ISRAEL; APHID	The increased use of molecular tools for species identification in recent decades revealed that each of many apparently generalist parasitoids are actually a complex of morphologically similar congeners, most of which have a rather narrow host range. Ooencyrtus pityocampae (OP), an important egg parasitoid of the pine processionary moth (PPM), is considered a generalist parasitoid. OP emerges from PPM eggs after winter hibernation, mainly in spring and early summer, long before the eggs of the next PPM generation occurs. The occurrence of OP in eggs of the variegated caper bug (CB) Stenozygum coloratum in spring and summer suggests that OP populations alternate seasonally between PPM and CB. However, the identity of OP population on CB eggs seemed uncertain; unlike OP-PPM populations, the former displayed apparently high male/female ratios and lack of attraction to the PPM sex pheromone. We studied the molecular identities of the two populations since the morphological identification of the genus Ooencyrtus, and OP in particular, is difficult. Sequencing of COI and ITS2 DNA fragments and AFLP analysis of individuals from both hosts revealed no apparent differences between the OP-PPM and the OP-CB populations for both the Israeli and the Turkish OPs, which therefore supported the possibility of host alternation. Sequencing data extended our knowledge of the genetic structure of OP populations in the Mediterranean area, and revealed clear separation between East and West Mediterranean populations. The overall level of genetic diversity was rather small, with the Israeli population much less diverse than all others; possible explanations for this finding are discussed. The findings support the possibility of utilizing the CB and other hosts for enhancing biological control of the PPM.	[Samra, Shahar; Ghanim, Murad; Protasov, Alex; Mendel, Zvi] Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel; [Samra, Shahar] Hebrew Univ Jerusalem, Fac Agr, IL-76100 Rehovot, Israel; [Branco, Manuela] Univ Tecn Lisboa, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Universidade de Lisboa	Samra, S (corresponding author), Agr Res Org, Volcani Ctr, Dept Entomol, IL-50250 Bet Dagan, Israel.	Shaharsm1@gmail.com	Branco, Manuela/D-5274-2011	Branco, Manuela/0000-0002-8140-1257	Keren Kayemeth LeIsrael/The Jewish National Fund [131-1619-13]	Keren Kayemeth LeIsrael/The Jewish National Fund	This study was funded by The Keren Kayemeth LeIsrael/The Jewish National Fund (Project # 131-1619-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL H. G., 1933, ZOOGEOGRAPHICA, V2, P1; AMSEL HANS GEORG, 1935, VEROFFENTL DEUTSCHEN KOLON U UEBERSEE MUS BREMEN, V1, P223; [Anonymous], 1939, FOREST PROTECTION RE, P1936; [Anonymous], 2012, CHROMASPRO 1 6; Avci M, 2003, PHYTOPARASITICA, V31, P118, DOI 10.1007/BF02980780; Avci M, 2014, PROCESSIONARY MOTHS; Baker DA, 2003, MOL ECOL, V12, P3303, DOI 10.1046/j.1365-294X.2003.02010.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BATTISTI A, 1988, Redia, V71, P321; BATTISTI A, 1989, ENTOMOPHAGA, V34, P29, DOI 10.1007/BF02372584; Bell G, 1982, MASTERPIECE NATURE E; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Biger N, 2004, GREEN DRESS COUNTRY; Binazzi F, 2013, REDIA, V96, P79; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Borghuis A, 2004, BIOL CONTROL, V30, P90, DOI 10.1016/j.biocontrol.2003.09.015; BUXTON RD, 1983, OUTLOOK AGR, V12, P34, DOI 10.1177/003072708301200106; Chao A, 2010, PROGRAM USERS GUIDE; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; CHOW A, 1991, ECOL ENTOMOL, V16, P403, DOI 10.1111/j.1365-2311.1991.tb00233.x; Conti E, 2004, BIOL CONTROL, V29, P435, DOI 10.1016/j.biocontrol.2003.08.009; CORNELL H, 1978, ECOLOGY, V59, P297, DOI 10.2307/1936375; Devkota B., 1992, Bollettino di Zoologia Agraria e di Bachicoltura, V24, P147; DIXON AFG, 1971, ANN APPL BIOL, V68, P135, DOI 10.1111/j.1744-7348.1971.tb06450.x; DOUTT RL, 1959, ANNU REV ENTOMOL, V4, P161, DOI 10.1146/annurev.en.04.010159.001113; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frere I., 2005, Communications in Agricultural and Applied Biological Sciences, V70, P581; Gariepy TD, 2007, J APPL ENTOMOL, V131, P225, DOI 10.1111/j.1439-0418.2007.01145.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; HALPERIN J, 1990, J APPL ENTOMOL, V110, P1, DOI 10.1111/j.1439-0418.1990.tb00088.x; HALPERIN J, 1990, J APPL ENTOMOL, V109, P425, DOI 10.1111/j.1439-0418.1990.tb00073.x; Halperin J., 1968, La-Yaaran, V18, P117; HALPERIN J, 1980, PHYTOPARASITICA, V8, P83, DOI 10.1007/BF02994502; Halperin J, 1983, SPECIAL PUBLICATION, P71; Hardy OJ, 2008, J ECOL, V96, P849, DOI 10.1111/j.1365-2745.2008.01423.x; Hodar JA, 2004, BIODIVERS CONSERV, V13, P493, DOI 10.1023/B:BIOC.0000009495.95589.a7; Jiggins FM, 2003, GENETICS, V164, P5; Karshon R, 1981, NATURAL OCCURRENCES, P71; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kerdelhue C, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-220; KITT J, 1993, J APPL ENTOMOL, V115, P484, DOI 10.1111/j.1439-0418.1993.tb00418.x; Kolaczan CR, 2009, J EVOLUTION BIOL, V22, P1275, DOI 10.1111/j.1420-9101.2009.01742.x; Kugler J., 1985, PLANTS ANIMALS LAND; McDougall SJ, 1997, J APPL ENTOMOL, V121, P205, DOI 10.1111/j.1439-0418.1997.tb01394.x; MENDEL Z, 1990, J APPL ENTOMOL, V109, P311, DOI 10.1111/j.1439-0418.1990.tb00056.x; Mirchev P, 2004, J APPL ENTOMOL, V128, P533, DOI 10.1111/j.1439-0418.2004.00837.x; Mizrachi A., 2006, SEASONAL ACTIVITY AS; Mohammadpour M, 2014, BIOCONTROL, V59, P279, DOI 10.1007/s10526-014-9565-z; NEMEC V, 1985, ENTOMOL GEN, V10, P253; Noyes JS, 2014, WORLD WIDE WEB ELECT; PALMER SC, 1992, BIOCHEM SYST ECOL, V20, P219, DOI 10.1016/0305-1978(92)90056-J; Paulus J, 1912, NATURWISSENSCHAFTLIC, P436; Quicke D. L. J., 1997, PARASITIC WASPS; Rohlf FJ, 2008, NTSYSPC NUMERICAL TA; Rossbach A, 2005, J INSECT BEHAV, V18, P491, DOI 10.1007/s10905-005-5607-9; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Samra S, 2014, ALON HANOTEA, V68, P38; Santos HM, 2013, ECOL EVOL, V3, P5098, DOI 10.1002/ece3.865; Schmidt GH, 1997, PHYTOPARASITICA, V25, P275; Schmidt GH, 1999, J APPL ENTOMOL, V123, P449, DOI 10.1046/j.1439-0418.1999.00405.x; Simonato M, 2007, MOL ECOL, V16, P2273, DOI 10.1111/j.1365-294X.2007.03302.x; Simonato M, 2010, THESIS PADOVA U; Simonato M, 2012, ENTOMOL EXP APPL, V145, P124, DOI 10.1111/j.1570-7458.2012.01321.x; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; STARY P, 1993, J APPL ENTOMOL, V116, P187, DOI 10.1111/j.1439-0418.1993.tb01187.x; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; TAJIMA F, 1989, GENETICS, V123, P585; TIBERI R, 1990, J APPL ENTOMOL, V110, P14, DOI 10.1111/j.1439-0418.1990.tb00090.x; TSANKOV G, 1990, J APPL ENTOMOL, V110, P7, DOI 10.1111/j.1439-0418.1990.tb00089.x; Tsankov G, 1996, J APPL ENTOMOL, V120, P93, DOI 10.1111/j.1439-0418.1996.tb01572.x; Tsankov G., 1995, Bollettino di Zoologia Agraria e di Bachicoltura, V27, P53; Tsankov Georgi, 1999, Journal of the Entomological Research Society, V1, P1; Vet LEM, 1992, ECOLOGY INFOCHEMICAL; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Waage J., 1986, INSECT PARASITOIDS; Weisser WW, 1997, J APPL ENTOMOL, V121, P23, DOI 10.1111/j.1439-0418.1997.tb01365.x; WILKINSON D. C., 1926, BULL ENT RES [LONDON], V17, P163; Yotoko KSC, 2006, J ZOOL SYST EVOL RES, V44, P265, DOI 10.1111/j.1439-0469.2006.00377.x; Zhao H., 1990, Chinese Journal of Biological Control, V6, P186; Zovi D, 2008, ECOLOGY, V89, P1388, DOI 10.1890/07-0883.1	84	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122788	10.1371/journal.pone.0122788	http://dx.doi.org/10.1371/journal.pone.0122788			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856082	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500056
J	Wei, C; Wang, ZT; Song, ZC; Wang, KX; Wang, D; Au, WWL; Zhang, Y				Wei, Chong; Wang, Zhitao; Song, Zhongchang; Wang, Kexiong; Wang, Ding; Au, Whitlow W. L.; Zhang, Yu			Acoustic Property Reconstruction of a Neonate Yangtze Finless Porpoise's (Neophocaena asiaeorientalis) Head Based on CT Imaging	PLOS ONE			English	Article							BAIJI LIPOTES-VEXILLIFER; BEAM FORMATION; SOUND; PHOCAENOIDES	The reconstruction of the acoustic properties of a neonate finless porpoise's head was performed using X-ray computed tomography (CT). The head of the deceased neonate porpoise was also segmented across the body axis and cut into slices. The averaged sound velocity and density were measured, and the Hounsfield units (HU) of the corresponding slices were obtained from computed tomography scanning. A regression analysis was employed to show the linear relationships between the Hounsfield unit and both sound velocity and density of samples. Furthermore, the CT imaging data were used to compare the HU value, sound velocity, density and acoustic characteristic impedance of the main tissues in the porpoise's head. The results showed that the linear relationships between HU and both sound velocity and density were qualitatively consistent with previous studies on Indo-pacific humpback dolphins and Cuvier's beaked whales. However, there was no significant increase of the sound velocity and acoustic impedance from the inner core to the outer layer in this neonate finless porpoise's melon.	[Wei, Chong; Zhang, Yu] Xiamen Univ, Minist Educ, Key Lab Underwater Acoust Commun & Marine Informa, Xiamen 361005, Fujian, Peoples R China; [Wei, Chong; Au, Whitlow W. L.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Song, Zhongchang] Xiamen Univ, Coll Oceanog & Environm Sci, Xiamen 361005, Peoples R China; [Zhang, Yu] Xiamen Univ, Coll Ocean & Sci, Xiamen 361005, Peoples R China	Xiamen University; University of Hawaii System; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xiamen University; Xiamen University	Wang, D (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China.	wangd@ihb.ac.cn; yuzhang@xmu.edu.cn	Wei, Chong/E-2488-2019	Wei, Chong/0000-0002-2359-9285; Wang, Zhi-Tao/0000-0002-5734-7385	National Science Foundation of China [41276040, 11174240, 31170501, 31070347]; Natural Science Foundation of Fujian Province of China [2012J06010]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; China Scholarship Council; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; China Scholarship Council(China Scholarship Council); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was financially supported in part by the National Science Foundation of China [grants no. 41276040, no. 11174240, no. 31170501 and no. 31070347], the Natural Science Foundation of Fujian Province of China [grant no. 2012J06010], Ministry of Science and Technology of China [grant no. 2011BAG07B05-3], and State Oceanic Administration of China [grant no. 201105011-3]. One of the authors, Chong Wei, is supported by the China Scholarship Council. The Project was sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 1998, J ACOUST SOC AM, V104, P2511, DOI 10.1121/1.423757; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2001, J ACOUST SOC AM, V109, P1723, DOI 10.1121/1.1356705; Akamatsu T, 2002, FISHERIES SCI, V68, P294, DOI 10.2331/fishsci.68.sup1_294; AROYAN JL, 1992, J ACOUST SOC AM, V92, P2539, DOI 10.1121/1.404424; Aroyan JL, 2001, J ACOUST SOC AM, V110, P3305, DOI 10.1121/1.1401757; Cranford TW, 2008, ANAT REC, V291, P353, DOI 10.1002/ar.20652; Cranford TW, 2014, BIOACOUSTICS, V23, P161, DOI 10.1080/09524622.2013.843061; Cranford TW, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/016001; Cranford TW, 1996, J MORPHOL, V228, P223; Duck F.A., 1990, MED PHYS, V18; Duggan ZPZ, 2009, J COMP PHYSIOL B, V179, P783, DOI 10.1007/s00360-009-0360-6; HUA M, 1987, Acta Theriologica Sinica, V7, P85; Jing X, 1982, SCI CHINA, V2, P233; Krysl P, 2008, INT J NUMER METH ENG, V74, P754, DOI 10.1002/nme.2192; Krysl P, 2006, J ACOUST SOC AM, V120, P2328, DOI 10.1121/1.2257988; Li S, 1998, J ACOUST SOC AM, V117, P3288; Li SH, 2007, J ACOUST SOC AM, V121, P3938, DOI 10.1121/1.2721658; Robb RA, 1998, INTRO CHEM SEA; Soldevilla MS, 2005, J EXP BIOL, V208, P2319, DOI 10.1242/jeb.01624; Wang D, 2013, IUCN TED LIST THREAT; Wang Ding, 1996, Acta Hydrobiologica Sinica, V20, P127; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wei C., 2013, TECHNICAL ACOUSTIC 2, V32, P34; Wei C, 2014, J ACOUST SOC AM, V136, P423, DOI 10.1121/1.4883597	25	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121442	10.1371/journal.pone.0121442	http://dx.doi.org/10.1371/journal.pone.0121442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856588	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500019
J	Periwal, V; Patowary, A; Vellarikkal, SK; Gupta, A; Singh, M; Mittal, A; Jeyapaul, S; Chauhan, RK; Singh, AV; Singh, PK; Garg, P; Katoch, VM; Katoch, K; Chauhan, DS; Sivasubbu, S; Scaria, V				Periwal, Vinita; Patowary, Ashok; Vellarikkal, Shamsudheen Karuthedath; Gupta, Anju; Singh, Meghna; Mittal, Ashish; Jeyapaul, Shamini; Chauhan, Rajendra Kumar; Singh, Ajay Vir; Singh, Pravin Kumar; Garg, Parul; Katoch, Viswa Mohan; Katoch, Kiran; Chauhan, Devendra Singh; Sivasubbu, Sridhar; Scaria, Vinod			Comparative Whole-Genome Analysis of Clinical Isolates Reveals Characteristic Architecture of Mycobacterium tuberculosis Pangenome	PLOS ONE			English	Article							ESCHERICHIA-COLI; RESISTANT STRAINS; SEQUENCE; TOOL; EVOLUTION; ALIGNMENT; COMPLEX; GENES; IDENTIFICATION; ANNOTATION	The tubercle complex consists of closely related mycobacterium species which appear to be variants of a single species. Comparative genome analysis of different strains could provide useful clues and insights into the genetic diversity of the species. We integrated genome assemblies of 96 strains from Mycobacterium tuberculosis complex (MTBC), which included 8 Indian clinical isolates sequenced and assembled in this study, to understand its pangenome architecture. We predicted genes for all the 96 strains and clustered their respective CDSs into homologous gene clusters (HGCs) to reveal a hard-core, soft-core and accessory genome component of MTBC. The hard-core (HGCs shared amongst 100% of the strains) was comprised of 2,066 gene clusters whereas the soft-core (HGCs shared amongst at least 95% of the strains) comprised of 3,374 gene clusters. The change in the core and accessory genome components when observed as a function of their size revealed that MTBC has an open pangenome. We identified 74 HGCs that were absent from reference strains H37Rv and H37Ra but were present in most of clinical isolates. We report PCR validation on 9 candidate genes depicting 7 genes completely absent from H37Rv and H37Ra whereas 2 genes shared partial homology with them accounting to probable insertion and deletion events. The pangenome approach is a promising tool for studying strain specific genetic differences occurring within species. We also suggest that since selecting appropriate target genes for typing purposes requires the expected target gene be present in all isolates being typed, therefore estimating the core-component of the species becomes a subject of prime importance.	[Periwal, Vinita; Scaria, Vinod] CSIR, IGIB, GN Ramachandran Knowledge Ctr Genome Informat, Delhi 110007, India; [Patowary, Ashok; Vellarikkal, Shamsudheen Karuthedath; Singh, Meghna; Mittal, Ashish; Jeyapaul, Shamini; Chauhan, Rajendra Kumar; Sivasubbu, Sridhar] CSIR, IGIB, Genom & Mol Med, Delhi 110007, India; [Singh, Ajay Vir; Singh, Pravin Kumar; Garg, Parul; Katoch, Viswa Mohan; Katoch, Kiran; Chauhan, Devendra Singh] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Tajganj 282001, Agra, India; [Gupta, Anju] CSIR, Open Source Drug Discovery Unit, New Delhi 110001, India; [Periwal, Vinita; Vellarikkal, Shamsudheen Karuthedath; Singh, Meghna] AcSIR, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Open Source Drug Discovery; Academy of Scientific & Innovative Research (AcSIR)	Sivasubbu, S (corresponding author), CSIR, IGIB, Genom & Mol Med, Mall Rd, Delhi 110007, India.	sridhar@igib.in; vinods@igib.in	Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022; Singh, Pushpendra/T-4248-2018; Singh, Ajay/AAF-4414-2020; Patowary, Ashok/AAT-5305-2020; Singh, Meghna/AAV-5262-2020; Scaria, Vinod/AAS-3151-2021	Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Singh, Pushpendra/0000-0002-7277-115X; Patowary, Ashok/0000-0001-7507-3907; PERIWAL, VINITA/0000-0002-3583-0413; Scaria, Vinod/0000-0001-7644-7181; Chauhan, Devendra Singh/0000-0001-6519-3200; Singh, Meghna/0000-0002-7907-6571; Chauhan, Rajendra Kumar/0000-0002-3904-5332	Council of Scientific and Industrial Research (CSIR) India through Open Source Drug Discovery (OSDD) Programme [HCP001]; CSIR, India [SIP006, FAC002]	Council of Scientific and Industrial Research (CSIR) India through Open Source Drug Discovery (OSDD) Programme; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The project was funded by Council of Scientific and Industrial Research (CSIR) India through Open Source Drug Discovery (OSDD) Programme (HCP001). The Sequencing facility is supported through SIP006 and FAC002 Grant from CSIR, India and the computational analysis was performed at the CSIR centre for in-silico Biology at CSIR Institute of Genomics and Integrative Biology (IGIB).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asif SM, 2009, BIOINFORMATION, V4, P245, DOI 10.6026/97320630004245; Azhikina T, 2006, RES MICROBIOL, V157, P282, DOI 10.1016/j.resmic.2005.08.002; Bazira J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-81; Behr MA, 2013, ADV EXP MED BIOL, V783, P81, DOI 10.1007/978-1-4614-6111-1_4; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Doddapaneni H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-225; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kaas RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-469; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Malla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052297; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; Mestre O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016020; MILLAR JW, 1979, LANCET, V1, P1176; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Patowary A, 2012, HUM MUTAT, V33, P1133, DOI 10.1002/humu.22091; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Power PM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-273; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Raman K, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-109; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rowland K., 2012, TOTALLY DRUG RESISTA; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sougakoff W, 2011, CLIN MICROBIOL INFEC, V17, P800, DOI 10.1111/j.1469-0691.2011.03577.x; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Trost B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-258; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Vishnoi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-373; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zakham Fathiah, 2012, Microb Inform Exp, V2, P7, DOI 10.1186/2042-5783-2-7; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729	62	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122979	10.1371/journal.pone.0122979	http://dx.doi.org/10.1371/journal.pone.0122979			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853708	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400090
J	Raipuria, M; Bahari, H; Morris, MJ				Raipuria, Mukesh; Bahari, Hasnah; Morris, Margaret J.			Effects of Maternal Diet and Exercise during Pregnancy on Glucose Metabolism in Skeletal Muscle and Fat of Weanling Rats	PLOS ONE			English	Article							HYPOTHALAMIC GENE-EXPRESSION; APPETITE REGULATORS; WEIGHT-GAIN; INSULIN SENSITIVITY; GLUT4 EXPRESSION; OBESITY; INFLAMMATION; PGC-1-ALPHA; IMPACT; CHILDHOOD	Obesity during pregnancy contributes to the development of metabolic disorders in offspring. Maternal exercise may limit gestational weight gain and ameliorate these programming effects. We previously showed benefits of post-weaning voluntary exercise in offspring from obese dams. Here we examined whether voluntary exercise during pregnancy influences lipid and glucose homeostasis in muscle and fat in offspring of both lean and obese dams. Female Sprague-Dawley rats were fed chow (C) or high fat (F) diet for 6 weeks before mating. Half underwent voluntary exercise (CE/FE) with a running wheel introduced 10 days prior to mating and available until the dams delivered; others remained sedentary (CS/FS). Male and female pups were killed at postnatal day (PND) 19 and retroperitoneal fat and gastrocnemius muscle were collected for gene expression. Lean and obese dams achieved similar modest levels of exercise. At PND1, both male and female pups from exercised lean dams were significantly lighter (CE versus CS), with no effect in those from obese dams. At PND19, maternal obesity significantly increased offspring body weight and adiposity, with no effect of maternal exercise. Exercise significantly reduced insulin concentrations in males (CE/FE versus CS/FS), with reduced glucose in male FE pups. In males, maternal obesity significantly decreased muscle myogenic differentiation 1 (MYOD1) and glucose transporter type 4 (GLUT4) mRNA expressions (FS vs CS); these were normalized by exercise. Maternal exercise upregulated adipose GLUT4, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC1 alpha) mRNA expression in offspring of dams consuming chow. Modest voluntary exercise during pregnancy was associated with lower birth weight in pups from lean dams. Maternal exercise appeared to decrease the metabolic risk induced by maternal obesity, improving insulin/glucose metabolism, with greater effects in male than female offspring.	[Raipuria, Mukesh; Bahari, Hasnah; Morris, Margaret J.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia; [Bahari, Hasnah] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia	University of New South Wales Sydney; Universiti Putra Malaysia	Morris, MJ (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia.	m.morris@unsw.edu.au	Bahari, Hasnah/V-8166-2019; Morris, Margaret J/J-4285-2013	Bahari, Hasnah/0000-0001-8302-4136; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council of Australia (NHMRC) [568728]; Government of Madhya Pradesh State, India; Australian Centre for Perinatal Science (ACPS); Ministry of Higher Education Malaysia and Universiti Putra Malaysia	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Government of Madhya Pradesh State, India; Australian Centre for Perinatal Science (ACPS); Ministry of Higher Education Malaysia and Universiti Putra Malaysia	The work was in part funded by National Health and Medical Research Council of Australia (NHMRC 568728) to M.J. Morris. Mukesh Raipuria was sponsored by Government of Madhya Pradesh State, India and the Australian Centre for Perinatal Science (ACPS). Hasnah Bahari was sponsored by the Ministry of Higher Education Malaysia and Universiti Putra Malaysia.	Alfaradhi MZ, 2014, AM J PHYSIOL-REG I, DOI [10.1152/ajpregu.00049.02014, DOI 10.1152/AJPREGU.00049.02014]; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Bahari H, 2013, ENDOCRINOLOGY, V154, P3610, DOI 10.1210/en.2013-1059; Bayol SA, 2005, J PHYSIOL-LONDON, V567, P951, DOI 10.1113/jphysiol.2005.088989; Bayol SA, 2009, EUR J NUTR, V48, P62, DOI 10.1007/s00394-008-0760-5; Begum KS, 2011, CLIN EXP OBSTET GYN, V38, P14; BELL RJ, 1995, AUST NZ J OBSTET GYN, V35, P46, DOI 10.1111/j.1479-828X.1995.tb01829.x; Benkalfat NB, 2011, CLIN SCI, V121, P19, DOI 10.1042/CS20100534; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Boyle KE, 2013, J CLIN ENDOCR METAB, V98, pE1601, DOI 10.1210/jc.2013-1943; Carter LG, 2013, MED SCI SPORT EXER, V45, P832, DOI 10.1249/MSS.0b013e31827de953; Caruso V, 2013, J NEUROENDOCRINOL, V25, P742, DOI 10.1111/jne.12053; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chan CYY, 2013, EUR J NUTR, V52, P1721, DOI 10.1007/s00394-012-0475-5; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Du M, 2010, BIOL REPROD, V82, P4, DOI 10.1095/biolreprod.109.077099; Eisele PS, 2014, SEMIN IMMUNOPATHOL, V36, P27, DOI 10.1007/s00281-013-0406-4; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; Hokari F, 2010, J APPL PHYSIOL, V109, P332, DOI 10.1152/japplphysiol.00335.2009; Hopkins SA, 2010, J CLIN ENDOCR METAB, V95, P2080, DOI 10.1210/jc.2009-2255; Hussey SE, 2011, DIABETES OBES METAB, V13, P959, DOI 10.1111/j.1463-1326.2011.01426.x; Kennedy JW, 1999, DIABETES, V48, P1192, DOI 10.2337/diabetes.48.5.1192; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leibowitz KL, 2012, WORLD J PEDIATR, V8, P76, DOI 10.1007/s12519-011-0292-6; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077809; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Morris MJ, 2009, INT J OBESITY, V33, P115, DOI 10.1038/ijo.2008.213; Mottola MF, 2010, MED SCI SPORT EXER, V42, P265, DOI 10.1249/MSS.0b013e3181b5419a; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Rajia S, 2013, NUTR METAB CARDIOVAS, V23, P574, DOI 10.1016/j.numecd.2011.12.009; Rajia S, 2010, J NEUROENDOCRINOL, V22, P905, DOI 10.1111/j.1365-2826.2010.02005.x; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; REN JM, 1995, J CLIN INVEST, V95, P429, DOI 10.1172/JCI117673; REN JM, 1994, J BIOL CHEM, V269, P14396; Reynolds RM, 2013, BMJ, V347; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Simar D, 2012, NUTR METAB CARDIOVAS, V22, P269, DOI 10.1016/j.numecd.2010.11.007; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Tong JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE917, DOI 10.1152/ajpendo.90924.2008; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; van der Burg JW, 2013, EARLY HUM DEV, V89, P949, DOI 10.1016/j.earlhumdev.2013.09.014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vega CC, 2013, INT J OBES; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Zambrano E, 2013, NUTR REV, V71, pS42, DOI 10.1111/nure.12068	60	70	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120980	10.1371/journal.pone.0120980	http://dx.doi.org/10.1371/journal.pone.0120980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853572	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400025
J	Skalicka, V; Ringdal, K; Witvliet, MI				Skalicka, Vera; Ringdal, Kristen; Witvliet, Margot I.			Socioeconomic Inequalities in Mortality and Repeated Measurement of Explanatory Risk Factors in a 25 Years Follow-Up	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; BODY-MASS-INDEX; EDUCATIONAL INEQUALITIES; HEALTH BEHAVIORS; BLOOD-PRESSURE; WHITEHALL II; ASSOCIATION; TRENDS; HUNT	Background Socioeconomic inequalities in mortality can be explained by different groups of risk factors. However, little is known whether repeated measurement of risk factors can provide better explanation of socioeconomic inequalities in health. Our study examines the extent to which relative educational and income inequalities in mortality might be explained by explanatory risk factors (behavioral, psychosocial, biomedical risk factors and employment) measured at two points in time, as compared to one measurement at baseline. Methods and Findings From the Norwegian total county population-based HUNT Study (years 1984-86 and 1995-1997, respectively) 61 513 men and women aged 25-80 (82.5% of all enrolled) were followed-up for mortality in 25 years until 2009, employing a discrete time survival analysis. Socioeconomic inequalities in mortality were observed. As compared to their highest socioeconomic counterparts, the lowest educated men had an OR (odds ratio) of 1.41 (95% CI 1.29-1.55) and for the lowest income quartile OR = 1.59 (1.48-1.571), for women OR = 1.35 (1.17-1.55), and OR = 1.40 (1.28-1.52), respectively. Baseline explanatory variables attenuated the association between education and income with mortality by 54% and 54% in men, respectively, and by 69% and 18% in women. After entering time-varying variables, this attainment increased to 63% and 59% in men, respectively, and to 25% (income) in women, with no improvement in regard to education in women. Change in biomedical factors and employment did not amend the explanation. Conclusions Addition of a second measurement for risk factors provided only a modest improvement in explaining educational and income inequalities in mortality in Norwegian men and women. Accounting for change in behavior provided the largest improvement in explained inequalities in mortality for both men and women, as compared to measurement at baseline. Psychosocial factors explained the largest share of income inequalities in mortality for men, but repeated measurement of these factors contributed only to modest improvement in explanation. Further comparative research on the relative importance of explanatory pathways assessed over time is needed.	[Skalicka, Vera; Ringdal, Kristen; Witvliet, Margot I.] Norwegian Univ Sci & Technol, Dept Sociol & Polit Sci, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Skalicka, V (corresponding author), Norwegian Univ Sci & Technol, Dept Sociol & Polit Sci, N-7034 Trondheim, Norway.	vera.skalicka@samfunn.ntnu.no			Norwegian University of Science and Technology	Norwegian University of Science and Technology	Norwegian University of Science and Technology (www.ntnu.no) has supported this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; Aldabe B, 2011, J EPIDEMIOL COMMUN H, V65, P1123, DOI 10.1136/jech.2009.102517; Bartley M., 2004, HLTH INEQUALITY INTR; Blom JW, 2013, AGE, V35, P431, DOI 10.1007/s11357-011-9349-7; Crimmins EM, 2009, J GERONTOL A-BIOL, V64, P286, DOI 10.1093/gerona/gln010; Droyvold WB, 2006, INT J OBESITY, V30, P935, DOI 10.1038/sj.ijo.0803178; Eikemo TA, 2008, J EPIDEMIOL COMMUN H, V62, P3, DOI 10.1136/jech.2007.066787; Ernstsen L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-266; Evans GW, 2010, ANN NY ACAD SCI, V1186, P174, DOI 10.1111/j.1749-6632.2009.05336.x; Ferrie JE, 2002, J EPIDEMIOL COMMUN H, V56, P450, DOI 10.1136/jech.56.6.450; Franks P, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-28; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Huisman M, 2013, EPIDEMIOL REV, V35, P84, DOI 10.1093/epirev/mxs010; Institute NPH, 2012, DOD DODS NORG GJENN; Keller HH, 2005, J NUTR HEALTH AGING, V9, P316; Krokstad S, 2004, SOCIOECONOMIC INEQUA; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; Lantz PM, 2005, J HEALTH SOC BEHAV, V46, P274, DOI 10.1177/002214650504600305; Lynch J, 2006, J EPIDEMIOL COMMUN H, V60, P436, DOI 10.1136/jech.2005.041350; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; Mustard CA, 2003, J EPIDEMIOL COMMUN H, V57, P974, DOI 10.1136/jech.57.12.974; NAESS O, 2007, SOSIAL ULIKHET HELSE; NTNU HUNT Research centre, THE HUNT STUD 2014; Pantell M, 2013, AM J PUBLIC HEALTH, V103, P2056, DOI 10.2105/AJPH.2013.301261; Rogers RG, 2010, DEMOGRAPHY, V47, P555, DOI 10.1353/dem.0.0119; Roux AVD, 2002, CIRCULATION, V106, P703, DOI 10.1161/01.CIR.0000025402.84600.CD; Sabia S, 2012, CAN MED ASSOC J, V184, P1985, DOI 10.1503/cmaj.121080; Schrijvers CTM, 1999, AM J PUBLIC HEALTH, V89, P535, DOI 10.2105/AJPH.89.4.535; Siegrist J, 2006, SOCIAL INEQUALITIES, P73; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Skalicka V, 2009, INT J EPIDEMIOL, V38, P1272, DOI 10.1093/ije/dyp262; Steptoe A, 2002, EUR HEART J, V23, P13, DOI 10.1053/euhj.2001.2611; Strand Bjorn Heine, 2003, Tidsskr Nor Laegeforen, V123, P2849; Strand BH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c654; Stringhini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049443; Stringhini S, 2012, AM J EPIDEMIOL, V175, P1275, DOI 10.1093/aje/kwr461; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; van Oort FVA, 2005, J EPIDEMIOL COMMUN H, V59, P214, DOI 10.1136/jech.2003.016493; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P18, DOI 10.1097/EDE.0b013e31818f69ce; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; White EW, 2013, ASTM INT MAN SER, P1, DOI 10.1520/MNL72-EB; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	47	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124690	10.1371/journal.pone.0124690	http://dx.doi.org/10.1371/journal.pone.0124690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853571	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400142
J	Yates, PM; Heupel, MR; Tobin, AJ; Simpfendorfer, CA				Yates, Peter M.; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.			Ecological Drivers of Shark Distributions along a Tropical Coastline	PLOS ONE			English	Article							JUVENILE SANDBAR SHARKS; BULL SHARKS; CARCHARHINUS-LEUCAS; NURSERY AREA; SPHYRNA-LEWINI; SUMMER NURSERY; LEMON SHARKS; HABITAT USE; FLORIDA; BAY	As coastal species experience increasing anthropogenic pressures there is a growing need to characterise the ecological drivers of their abundance and habitat use, and understand how they may respond to changes in their environment. Accordingly, fishery-independent surveys were undertaken to investigate shark abundance along approximately 400 km of the tropical east coast of Australia. Generalised linear models were used to identify ecological drivers of the abundance of immature blacktip Carcharhinus tilstoni/Carcharhinus limbatus, pigeye Carcharhinus amboinensis, and scalloped hammerhead Sphyma lewini sharks. Results indicated general and species-specific patterns in abundance that were characterised by a range of abiotic and biotic variables. Relationships with turbidity and salinity were similar across multiple species, highlighting the importance of these variables in the functioning of communal shark nurseries. In particular, turbid environments were especially important for all species at typical oceanic salinities. Mangrove proximity, depth, and water temperature were also important; however, their influence varied between species. Ecological drivers may promote spatial diversity in habitat use along environmentally heterogeneous coastlines and may therefore have important implications for population resilience.	[Yates, Peter M.; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Yates, Peter M.; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Heupel, Michelle R.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	James Cook University; James Cook University; Australian Institute of Marine Science	Yates, PM (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.	peter.yates2@my.jcu.edu.au	Simpfendorfer, Colin A/G-9681-2011	Simpfendorfer, Colin A/0000-0002-0295-2238; Heupel, Michelle/0000-0002-8245-7332; Yates, Peter/0000-0003-4659-7159	Australian Government's National Environmental Research Program under the Tropical Ecosystems Hub; Australian Postgraduate Award	Australian Government's National Environmental Research Program under the Tropical Ecosystems Hub(Australian Government); Australian Postgraduate Award(Australian Government)	Funding for this research was provided by the Australian Government's National Environmental Research Program under the Tropical Ecosystems Hub (http://www.nerptropical.edu.au/). PMY was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2000, ENVIRON BIOL FISH, V58, P33, DOI 10.1023/A:1007657019696; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barton K., 2013, MUMIN MULTI MODEL IN; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernal D, 2012, CRC MAR BIOL SER, P211; BLABER SJM, 1995, ESTUAR COAST SHELF S, V40, P177, DOI 10.1016/S0272-7714(05)80004-6; BLABER SJM, 1980, J FISH BIOL, V17, P143, DOI 10.1111/j.1095-8649.1980.tb02749.x; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Breheny P, 2013, VISREG VISUALLIZATIO; Breheny P, 2013, VISUALIZATION REGRES; Bureau of Resources and Energy Economics, 2012, AUSTR BULK COMM EXP, P150; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Bush A, 2002, J EXP MAR BIOL ECOL, V278, P157, DOI 10.1016/S0022-0981(02)00332-5; Chin A, 2012, MAR ECOL PROG SER, V460, P115, DOI 10.3354/meps09722; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; CLARKE TA, 1971, PAC SCI, V25, P133; Compagno L.J.V., 1984, FAO Fisheries Synopsis, P251; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; CUI G, 1991, FISH RES, V10, P255, DOI 10.1016/0165-7836(91)90079-U; Curtis TH, 2013, MAR COAST FISH, V5, P28, DOI 10.1080/19425120.2012.756438; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Drymon JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097124; Drymon JM, 2013, FISH B-NOAA, V111, P370, DOI 10.7755/FB.111.4.6; Espinoza M, 2011, J EXP MAR BIOL ECOL, V401, P63, DOI 10.1016/j.jembe.2011.03.001; Fox F, 2011, CAR R COMPANION APPL; Francis MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057021; Froeschke J, 2010, MAR ECOL PROG SER, V407, P279, DOI 10.3354/meps08546; Froeschke JT, 2010, AQUAT BIOL, V11, P65, DOI 10.3354/ab00290; Furnas M, 1993, CATCHMENTS CORALS TE; Gardiner JM, 2012, CRC MAR BIOL SER, P349; Gelsleichter J, 2005, ARCH ENVIRON CON TOX, V48, P474, DOI 10.1007/s00244-003-0275-2; Giraudoux P., 2013, PGIRMESS DATA ANAL E; GOTCEITAS V, 1989, OECOLOGIA, V80, P158, DOI 10.1007/BF00380145; Great Barrier Reef Marine Park Authority, 2011, EXTR WEATH GREAT BAR, P26; Grech A, 2013, MAR POLLUT BULL, V75, P8, DOI 10.1016/j.marpolbul.2013.07.013; Grubbs R. Dean, 2007, V50, P87; Gutteridge AN, 2011, J FISH BIOL, V78, P1405, DOI 10.1111/j.1095-8649.2011.02945.x; Gutteridge AN, 2011, THESIS U QUEENSLAND; Guttridge TL, 2012, MAR ECOL PROG SER, V445, P279, DOI 10.3354/meps09423; Harry AV, 2011, MAR FRESHWATER RES, V62, P710, DOI 10.1071/MF10155; Harry AV, 2011, THESIS J COOK U; Heihaus Michael R., 2007, V50, P3; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heithaus MR, 2004, CRC MAR BIOL SER, P487; Heupel Michelle R., 2007, V50, P265; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; HOLLAND KN, 1993, COPEIA, P495, DOI 10.2307/1447150; Jacoby DMP, 2012, FISH FISH, V13, P399, DOI 10.1111/j.1467-2979.2011.00436.x; Jennings DE, 2008, ENVIRON BIOL FISH, V83, P369, DOI 10.1007/s10641-008-9357-3; Kinney MJ, 2011, MAR ECOL PROG SER, V439, P263, DOI 10.3354/meps09327; Kinney MJ, 2011, THESIS J COOK U; Knip DM, 2011, MAR FRESHWATER RES, V62, P658, DOI 10.1071/MF10136; Knip DM, 2011, MAR ECOL PROG SER, V425, P233, DOI 10.3354/meps09006; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Last P. R., 2009, SHARKS RAYS AUSTR, V2; McCallister M, 2013, MAR COAST FISH, V5, P200, DOI 10.1080/19425120.2013.786002; McCandless Camilla T., 2007, V50, P45; McCandless CT, 2007, S 50 BETH MD AM FISH; McKenzie L, 2012, REEF RESCUE MARINE M, P230; MORGAN MJ, 1985, Z TIERPSYCHOL, V70, P236; MORRISSEY JF, 1993, ENVIRON BIOL FISH, V38, P311, DOI 10.1007/BF00007524; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; Ortega LA, 2009, ENVIRON BIOL FISH, V84, P361, DOI 10.1007/s10641-009-9442-2; PANG PKT, 1977, AM ZOOL, V17, P365; R Core Team, 2021, R LANGUAGE ENV STAT; ROBERTSON AI, 1987, MAR BIOL, V96, P193, DOI 10.1007/BF00427019; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schlaff AM, 2014, REV FISH BIOL FISHER, V24, P1089, DOI 10.1007/s11160-014-9364-8; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V37, P337, DOI 10.1007/BF00005200; Simpfendorfer CA, 2012, CRC MAR BIOL SER, P579; Skaug H, 2012, GLMMADMB GEN LINEAR; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; Taylor S, 2007, THESIS U QUEENSLAND; Torres LG, 2006, HYDROBIOLOGIA, V569, P449, DOI 10.1007/s10750-006-0148-6; Rojas YET, 2014, HYDROBIOLOGIA, V726, P81, DOI 10.1007/s10750-013-1753-9; Ubeda AJ, 2009, ENVIRON BIOL FISH, V84, P293, DOI 10.1007/s10641-008-9436-5; Ulrich Glenn F., 2007, V50, P125; Venables WN., 2002, MODERN APPL STAT S, V4; Ward-Paige CA, 2014, MAR ECOL, V2014, P1; White WT, 2004, MAR BIOL, V145, P1023, DOI 10.1007/s00227-004-1386-7; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Yates PM, 2015, MAR FRESHWATER RES, V66, P399, DOI 10.1071/MF14033; Yates PM, 2012, MAR ECOL PROG SER, V458, P269, DOI 10.3354/meps09759; Zuur A.F, 2012, ZERO INFLATED MODELS; Zuur Alain F., 2009, P1	89	31	31	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121346	10.1371/journal.pone.0121346	http://dx.doi.org/10.1371/journal.pone.0121346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853657	Green Accepted, Green Published, gold			2022-12-27	WOS:000352478400035
J	Guaita, M; Melia, U; Vallverdu, M; Caminal, P; Vilaseca, I; Montserrat, JM; Gaig, C; Salamero, M; Santamaria, J				Guaita, Marc; Melia, Umberto; Vallverdu, Montserrat; Caminal, Pere; Vilaseca, Isabel; Montserrat, Josep M.; Gaig, Carles; Salamero, Manel; Santamaria, Joan			Regularity of Cardiac Rhythm as a Marker of Sleepiness in Sleep Disordered Breathing	PLOS ONE			English	Article							AUTONOMIC INFORMATION-FLOW; HEART-RATE-VARIABILITY; LATENCY TEST; PRACTICE PARAMETERS; DAYTIME SLEEPINESS; WAKEFULNESS TEST; MAINTENANCE; AROUSAL; SCALE; ONSET	Aim The present study aimed to analyse the autonomic nervous system activity using heart rate variability (HRV) to detect sleep disordered breathing (SDB) patients with and without excessive daytime sleepiness (EDS) before sleep onset. Methods Two groups of 20 patients with different levels of daytime sleepiness -sleepy group, SG; alert group, AG-were selected consecutively from a Maintenance of Wakefulness Test (MWT) and Multiple Sleep Latency Test (MSLT) research protocol. The first waking 3-min window of RR signal at the beginning of each nap test was considered for the analysis. HRV was measured with traditional linear measures and with time-frequency representations. Non-linear measures -correntropy, CORR; auto-mutual-information function, AMIF-were used to describe the regularity of the RR rhythm. Statistical analysis was performed with non-parametric tests. Results Non-linear dynamic of the RR rhythm was more regular in the SG than in the AG during the first wakefulness period of MSLT, but not during MWT. AMIF (in high-frequency and in Total band) and CORR (in Total band) yielded sensitivity > 70%, specificity >75% and an area under ROC curve >0.80 in classifying SG and AG patients. Conclusion The regularity of the RR rhythm measured at the beginning of the MSLT could be used to detect SDB patients with and without EDS before the appearance of sleep onset.	[Guaita, Marc; Vilaseca, Isabel; Montserrat, Josep M.; Gaig, Carles; Salamero, Manel; Santamaria, Joan] Hosp Clin Barcelona, Multidisciplinary Unit Sleep Disorders, Barcelona, Spain; [Guaita, Marc; Salamero, Manel; Santamaria, Joan] IDIBAPS, Barcelona, Spain; [Melia, Umberto; Vallverdu, Montserrat; Caminal, Pere] CIBER, BBN, BarcelonaTech, Ctr Biomed Engn Res,Dept ESAII, Barcelona, Spain; [Vilaseca, Isabel] Hosp Clin Barcelona, Dept Otorhinolaryngol, Barcelona, Spain; [Vilaseca, Isabel; Montserrat, Josep M.] CIBERES, Madrid, Spain; [Vilaseca, Isabel; Montserrat, Josep M.; Salamero, Manel; Santamaria, Joan] Univ Barcelona, Sch Med, Barcelona, Spain; [Montserrat, Josep M.] Hosp Clin Barcelona, Dept Pneumol, Barcelona, Spain; [Gaig, Carles; Santamaria, Joan] Hosp Clin Barcelona, Dept Neurol, Barcelona, Spain; [Gaig, Carles; Santamaria, Joan] Ciber Enfermedades Neurol CIBERNED, Barcelona, Spain; [Salamero, Manel] Hosp Clin Barcelona, Dept Psychiat, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona	Guaita, M (corresponding author), Hosp Clin Barcelona, Multidisciplinary Unit Sleep Disorders, Barcelona, Spain.	marcguaita@gmail.com; jsantama@clinic.ub.es	Vilaseca, Isabel/J-1528-2019	Vilaseca, Isabel/0000-0003-4399-5522; MONTSERRAT, Josep Maria/0000-0003-3098-4605; Melia, Umberto/0000-0003-3033-0505	FIS [PI07/0318]; FEDER; CICYT [TEC2013-44666-R]; Spanish Government [FPU AP2009-0858]	FIS(Instituto de Salud Carlos III); FEDER(European Commission); CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Spanish Government(Spanish GovernmentEuropean Commission)	This study was supported by FIS PI07/0318 to MS, cofinanced by FEDER. Barcelona Tech group was supported by the CICYT grant TEC2013-44666-R and the Research Fellowship Grant FPU AP2009-0858 from the Spanish Government.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Baldwin CM, 2001, SLEEP, V24, P96, DOI 10.1093/sleep/24.1.96; Bonnet MH, 2005, SLEEP, V28, P685, DOI 10.1093/sleep/28.6.685; Bonnet MH, 1999, J SLEEP RES, V8, P247, DOI 10.1046/j.1365-2869.1999.00168.x; Bonnet MH, 2001, SLEEP, V24, P441, DOI 10.1093/sleep/24.4.441; Bonnet MH, 2000, PHYSIOL BEHAV, V71, P485, DOI 10.1016/S0031-9384(00)00353-X; Burgess HJ, 1999, PSYCHOPHYSIOLOGY, V36, P298, DOI 10.1017/S0048577299980198; Camm AJ, 1996, EUR HEART J, V17, P354; Carrington MJ, 2005, J APPL PHYSIOL, V98, P468, DOI 10.1152/japplphysiol.00702.2004; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chervin RD, 1999, NEUROLOGY, V52, P125, DOI 10.1212/WNL.52.1.125; Chervin RD, 2000, CHEST, V118, P372, DOI 10.1378/chest.118.2.372; Chua ECP, 2012, SLEEP, V35, P325, DOI 10.5665/sleep.1688; Claria F, 2005, PHYSIOL MEAS, V29, P401; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; De Gennaro L, 2005, J SLEEP RES, V14, P107, DOI 10.1111/j.1365-2869.2005.00444.x; Doghramji K, 1993, ELECTROENCEPHALOGR C, V103, P554; Donadio V, 2007, J SLEEP RES, V16, P327, DOI 10.1111/j.1365-2869.2007.00602.x; Goncalves MA, 2004, CHEST, V125, P2091, DOI 10.1378/chest.125.6.2091; Hoyer D, 2005, IEEE T BIO-MED ENG, V52, P584, DOI 10.1109/TBME.2005.844023; Kendzerska TB, 2014, SLEEP MED REV, V18, P321, DOI 10.1016/j.smrv.2013.08.002; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Lombardi C, 2008, J SLEEP RES, V17, P263, DOI 10.1111/j.1365-2869.2008.00659.x; Macey PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076631; McCullagh P., 1990, GEN LINEAR MODELS, V2nd; Melia U, 2014, PHYSIOL MEAS, V35, P2067, DOI 10.1088/0967-3334/35/10/2067; Palacios M, 2007, PHYSIOL MEAS, V28, P677, DOI 10.1088/0967-3334/28/6/006; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Pivik RT, 1996, J SLEEP RES, V5, P33, DOI 10.1046/j.1365-2869.1996.d01-50.x; Porta A, 2007, AM J PHYSIOL-HEART C, V293, pH702, DOI 10.1152/ajpheart.00006.2007; SANGAL RB, 1992, CHEST, V101, P898, DOI 10.1378/chest.101.4.898; Santamaria I, 2006, IEEE T SIGNAL PROCES, V54, P2187, DOI 10.1109/TSP.2006.872524; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; Shinar Z, 2006, AUTON NEUROSCI-BASIC, V130, P17, DOI 10.1016/j.autneu.2006.04.006	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122645	10.1371/journal.pone.0122645	http://dx.doi.org/10.1371/journal.pone.0122645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860587	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300053
J	Guidetti, L; Buzzachera, CF; Emerenziani, GP; Meucci, M; Saavedra, F; Gallotta, MC; Baldari, C				Guidetti, Laura; Buzzachera, Cosme Franklim; Emerenziani, Gian Pietro; Meucci, Marco; Saavedra, Francisco; Gallotta, Maria Chiara; Baldari, Carlo			Psychophysiological Responses to Salsa Dance	PLOS ONE			English	Article							PREDICTING BODY DENSITY; PHYSICAL-ACTIVITY; PHYSIOLOGICAL-CHARACTERISTICS; GENERALIZED EQUATIONS; EXERCISE; INTENSITY; SCALE; INDIVIDUALS; EXERTION	Speculation exists whether dance provides physiological stimuli adequate to promote health and fitness benefits. Unfortunately, research to date has not addressed the affective and exertional responses to dance. These responses are of interest as positive affective and exertional responses experienced during physical activity may play an important role in predicting adherence. The present study aims to examine the psychophysiological responses of different Salsa dance styles. Ten pairs of dancers performed two different structured lessons of Salsa dance, including Typical Salsa and Rueda de Casino lessons, and a non-structured Salsa dance at a night club. Physiological responses (i.e., percent of heart rate reserve; %HRR) were continuously assessed and perceived exertion and affective valence were rated every 15 min throughout the trials. %HRR responses differed between the Salsa dance styles (%HRR from 41.3 to 51.9%), and participants were dancing at intensities near their ventilatory threshold. Specifically, Typical Salsa lesson elicited lower %HRR responses than Rueda de Casino lesson (p < 0.05), but similar %HRR responses to Salsa dance at a night club condition (p > 0.05). Surprisingly, exertional (from 8 to 11) and affective (from +3 to +5) responses were unaffected by Salsa dance styles (p > 0.05). These data support that different Salsa dance styles provide physiological stimuli adequate to promote health and fitness benefits, and perhaps more importantly, produce pleasurable experiences, which in turn might lead to an increase in adherence to Salsa dancing which likely provides exercise-like health benefits.	[Guidetti, Laura; Emerenziani, Gian Pietro; Gallotta, Maria Chiara; Baldari, Carlo] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy; [Buzzachera, Cosme Franklim] North Univ Parana, Dept Phys Educ, Londrina, Brazil; [Meucci, Marco] Appalachian State Univ, Dept Hlth & Exercise Sci, Boone, NC 28608 USA; [Saavedra, Francisco] Univ Tras Os Monte & Alto Douro, Res Ctr Sport Hlth & Human Dev, Vila Real, Portugal	Foro Italico University of Rome; University of North Carolina; Appalachian State University; University of Tras-os-Montes & Alto Douro	Baldari, C (corresponding author), Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.	carlo.baldari@uniroma4.it	Buzzachera, Cosme Franklim/W-8076-2019; Guidetti, Laura/K-1142-2014; Meucci, Marco/AGO-6524-2022; Emerenziani, Gian Pietro/ABF-1876-2020; Gallotta, Maria Chiara/L-4982-2019; Gallotta, Maria Chiara/K-1762-2019; Baldari, Carlo/N-6756-2014	Buzzachera, Cosme Franklim/0000-0002-7827-4656; Guidetti, Laura/0000-0002-1419-4550; Emerenziani, Gian Pietro/0000-0002-5426-5317; Gallotta, Maria Chiara/0000-0001-5532-6380; Gallotta, Maria Chiara/0000-0001-5532-6380; Saavedra, Francisco/0000-0002-0439-5420; Baldari, Carlo/0000-0001-6227-3571				American College of Sports Medicine, 2009, ACSMS GUID EX TEST P, VV; Angioi Manuela, 2009, J Dance Med Sci, V13, P115; Baldari C, 2002, MED SCI SPORTS EXERC, V32, P1798; Bixby WR, 2001, J SPORT EXERCISE PSY, V23, P171, DOI 10.1123/jsep.23.3.171; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bria S, 2011, J SPORT MED PHYS FIT, V51, P194; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Di Blasio A, 2009, J SPORT MED PHYS FIT, V49, P30; DISHMAN RK, 1994, MED SCI SPORT EXER, V26, P783, DOI 10.1249/00005768-199406000-00019; Dishman RK, 1996, MED SCI SPORT EXER, V28, P706, DOI 10.1097/00005768-199606000-00010; Ekkekakis P, 2005, J SPORT SCI, V23, P477, DOI 10.1080/02640410400021492; Emerenziani GP, 2013, INT J SPORTS MED, V34, P330, DOI 10.1055/s-0032-1323722; Gordon CC, 1988, ANTHROPOMETRIC STAND; HARDY CJ, 1989, J SPORT EXERCISE PSY, V11, P304, DOI 10.1123/jsep.11.3.304; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; KAHNEMAN D, 1993, PSYCHOL SCI, V4, P401, DOI 10.1111/j.1467-9280.1993.tb00589.x; Keogh JWL, 2009, J AGING PHYS ACTIV, V17, P479, DOI 10.1123/japa.17.4.479; Kilpatrick MW, 2009, MED SCI SPORT EXER, V41, P681, DOI 10.1249/MSS.0b013e31818a0f09; Kiviniemi MT, 2007, HEALTH PSYCHOL, V26, P152, DOI 10.1037/0278-6133.26.2.152; Kwan BM, 2010, PSYCHOL SPORT EXERC, V11, P71, DOI 10.1016/j.psychsport.2009.05.010; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Liiv H, 2014, EUR J SPORT SCI, V14, pS429, DOI 10.1080/17461391.2012.711861; Lind E, 2009, SPORTS MED, V39, P743, DOI 10.2165/11315120-000000000-00000; MARGARIA R, 1965, J APPL PHYSIOL, V20, P1070, DOI 10.1152/jappl.1965.20.5.1070; Noble B., 1996, PERCEIVED EXERTION; Parfitt G, 2006, BRIT J HEALTH PSYCH, V11, P39, DOI 10.1348/135910705X43606; Rose EA, 2008, MED SCI SPORT EXER, V40, P1852, DOI 10.1249/MSS.0b013e31817a8aea; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Swain DP, 1998, MED SCI SPORT EXER, V30, P318, DOI 10.1097/00005768-199802000-00022; Van Landuyt LM, 2000, J SPORT EXERCISE PSY, V22, P208, DOI 10.1123/jsep.22.3.208; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002; World Health Organization, 2004, GLOB STRAT DIET PHYS	35	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121465	10.1371/journal.pone.0121465	http://dx.doi.org/10.1371/journal.pone.0121465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25860568	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300025
J	Jelesijevic, T; Zimmerman, SM; Harvey, SB; Mead, DG; Shaffer, TL; Estes, DM; Michel, F; Quinn, FD; Hogan, RJ; Lafontaine, ER				Jelesijevic, Tomislav; Zimmerman, Shawn M.; Harvey, Stephen B.; Mead, Daniel G.; Shaffer, Teresa L.; Estes, D. Mark; Michel, Frank; Quinn, Frederick D.; Hogan, Robert J.; Lafontaine, Eric R.			Use of the Common Marmoset to Study Burkholderia mallei Infection	PLOS ONE			English	Article							GLANDERS; MODEL; MELIOIDOSIS	Burkholderia mallei is a host-adapted bacterium that does not persist outside of its equine reservoir. The organism causes the zoonosis glanders, which is endemic in Asia, Africa, the Middle East and South America. Infection by B. mallei typically occurs via the respiratory or percutaneous route, and the most common manifestations are life-threatening pneumonia and bacteremia. Glanders is difficult to diagnose and requires prolonged antibiotic therapy with low success rates. There is no vaccine to protect against B. malleiand there is concern regarding its use as a biothreat agent. Thus, experiments were performed to establish a non-human primate model of intranasal infection to study the organism and develop countermeasures. Groups of marmosets (Callithrix jacchus) were inoculated intranasally with B. mallei strain ATCC 23344 and monitored for clinical signs of illness for up to 13 days. We discovered that 83% of marmosets inoculated with doses of 2.5 X 10(4) to 2.5 X 10(5) bacteria developed acute lethal infection within 3-4 days. Signs of disease were severe and included lethargy, inappetence, conjunctivitis, mucopurulent and hemorrhagic nasal discharges, and increased respiratory effort with abdominal lifts. Burkholderia mallei was cultured from the lungs, spleen and liver of these animals, and pathologic examination of tissues revealed lesions characteristic of glanders. Challenge experiments also revealed that 91% of animals infected with doses ranging from 25 to 2.5 X 10(3) bacteria exhibited mild non-specific signs of illness and were culture negative. One marmoset inoculated with 2.5 X 10(3) organisms developed moderate signs of disease and reached humane end-points 8 days post-infection. The liver and spleen of this animal were colonized with the agent and pathological analysis of tissues showed nasal, splenic and hepatic lesions. Taken together, these data indicate that the marmoset is a suitable model to study respiratory infection by B. mallei.	[Jelesijevic, Tomislav; Zimmerman, Shawn M.; Estes, D. Mark; Quinn, Frederick D.; Hogan, Robert J.; Lafontaine, Eric R.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Harvey, Stephen B.; Mead, Daniel G.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA USA; [Shaffer, Teresa L.] Univ Georgia, Franklin Coll Arts & Sci, Dept Microbiol, Athens, GA USA; [Jelesijevic, Tomislav; Michel, Frank; Hogan, Robert J.] Univ Georgia, Coll Vet Med, Dept Vet Biosci & Diagnost Imaging, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lafontaine, ER (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	elafon10@uga.edu			NIAID [U01 AI082103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082103] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIAID award U01 AI082103. The funders had no input in the study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Alibek K, 1999, BIOHAZARD CHILLING T; [Anonymous], 1971, IMMUNOBIOLOGII; Arun S, 1999, VET REC, V144, P255, DOI 10.1136/vr.144.10.255; Burtnick MN, 2010, INFECT IMMUN, V78, P88, DOI 10.1128/IAI.00985-09; Carr-Gregory B, 2007, MED ASPECTS BIOL WAR, P121; da Silva KPC, 2013, BRAZ J MICROBIOL, V44, P179, DOI 10.1590/S1517-83822013005000022; Derbyshire JB, 2002, CAN VET J, V43, P722; DeShazer D, 2001, MICROB PATHOGENESIS, V30, P253, DOI 10.1006/mpat.2000.0430; Duval CW, 1907, J EXP MED, V9, P352, DOI 10.1084/jem.9.4.352; Dvorak GD, 2008, JAVMA-J AM VET MED A, V233, P570, DOI 10.2460/javma.233.4.570; FERSTER LN, 1982, ARK PATOL, V44, P24; Fritz DL, 1999, VET PATHOL, V36, P276, DOI 10.1354/vp.36-4-276; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Goodyear A, 2009, INFECT IMMUN, V77, P1579, DOI 10.1128/IAI.01384-08; HOWE C, 1947, ANN INTERN MED, V26, P93, DOI 10.7326/0003-4819-26-1-93; Howe C., 1950, OXFORD MED, P185; Jeddeloh JA, 2003, INFECT IMMUN, V71, P584, DOI 10.1128/IAI.71.1.584-587.2003; Khan I, 2013, TRANSBOUND EMERG DIS, V60, P204, DOI 10.1111/j.1865-1682.2012.01342.x; Khomiakov Iu N, 1998, Zh Mikrobiol Epidemiol Immunobiol, P70; Lafontaine ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076804; Lehavi O, 2002, HAREFUAH, V141, P88; Lever MS, 2003, J MED MICROBIOL, V52, P1109, DOI 10.1099/jmm.0.05180-0; Lipsitz Rebecca, 2012, Emerg Infect Dis, V18, pe2, DOI 10.3201/eid1812.120638; Lopez J, 2003, MICROBES INFECT, V5, P1125, DOI 10.1016/j.micinf.2003.07.004; Manzeniuk IN, 1996, MINISTERSTVO MEDITSI, V41, P13; MILLER WR, 1948, J BACTERIOL, V55, P127, DOI 10.1128/JB.55.1.127-135.1948; Nelson M, 2014, INT J EXP PATHOL, V95, P378, DOI 10.1111/iep.12105; Nelson M, 2011, INT J EXP PATHOL, V92, P428, DOI 10.1111/j.1365-2613.2011.00791.x; Neubauer H., 1997, Revue Internationale des Services de Sante des Forces Armees, V70, P258; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Reed L.J., 1938, AM J HYG, V27, P793; Regis E, 1999, BIOL DOOM; Robins G, 1906, STUDIES ROYAL VICTOR, V1, P1; Saqib M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-214; Scholz HC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003195; SHARRER GT, 1995, AGR HIST, V69, P79; Slater J, 2013, VET REC, V173, P186, DOI 10.1136/vr.f5260; Smart JK, 1997, TXB MILITARY MED, P16; Song H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000922; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Van Zandt KE, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-131; Waag DM., 2004, BIOL WEAPONS DEFENSE, P209; Wernery U, 2011, EMERG INFECT DIS, V17, P1277, DOI 10.3201/eid1707.110222; Wheelis M, 1998, NATURE, V395, P213, DOI 10.1038/26089; Wheelis M., 1999, BIOLOGICAL TOXIN WEA, P35; Woods DE, 2002, TRENDS MICROBIOL, V10, P483, DOI 10.1016/S0966-842X(02)02464-2	47	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124181	10.1371/journal.pone.0124181	http://dx.doi.org/10.1371/journal.pone.0124181			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860021	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300132
J	Knapp, M; Rezac, M				Knapp, Michal; Rezac, Milan			Even the Smallest Non-Crop Habitat Islands Could Be Beneficial: Distribution of Carabid Beetles and Spiders in Agricultural Landscape	PLOS ONE			English	Article							GROUND BEETLES; SPECIES RICHNESS; PATCH SIZE; DIVERSITY; BIODIVERSITY; ASSEMBLAGES; COLEOPTERA; ABUNDANCE; ARANEAE; FIELD	Carabid beetles and ground-dwelling spiders inhabiting agroecosystems are beneficial organisms with a potential to control pest species. Intensification of agricultural management and reduction of areas covered by non-crop vegetation during recent decades in some areas has led to many potentially serious environmental problems including a decline in the diversity and abundance of beneficial arthropods in agricultural landscapes. This study investigated carabid beetle and spider assemblages in non-crop habitat islands of various sizes (50 to 18,000 square metres) within one large field, as well as the arable land within the field, using pitfall traps in two consecutive sampling periods (spring to early summer and peak summer). The non-crop habitat islands situated inside arable land hosted many unique ground-dwelling arthropod species that were not present within the surrounding arable land. Even the smallest non-crop habitat islands with areas of tens of square metres were inhabited by assemblages substantially different from these inhabiting arable land and thus enhanced the biodiversity of agricultural landscapes. The non-crop habitat area substantially affected the activity density, recorded species richness and recorded species composition of carabid and ground-dwelling spider assemblages; however, the effects were weakened when species specialised to non-crop habitats species were analysed separately. Interestingly, recorded species richness of spiders increased with non-crop habitat area, whereas recorded species richness of carabid beetles exhibited an opposite trend. There was substantial temporal variation in the spatial distribution of ground-dwelling arthropods, and contrasting patterns were observed for particular taxa (carabid beetles and spiders). In general, local environmental conditions (i.e., non-crop habitat island tree cover, shrub cover, grass cover and litter depth) were better determinants of arthropod assemblages than non-crop habitat island size, indicating that the creation of quite small but diversified (e.g., differing in vegetation cover) non-crop habitat islands could be the most efficient tool for the maintenance and enhancement of diversity of ground-dwelling carabids and spiders in agricultural landscapes.	[Knapp, Michal] Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic; [Rezac, Milan] Crop Res Inst, Grp Funct Biodivers, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Crop Research Institute (CRI)	Knapp, M (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Dept Ecol, Prague, Czech Republic.	knapp@fzp.czu.cz	Řezáč, Milan/ABE-8186-2020; Knapp, Michal/AAF-4864-2020	Knapp, Michal/0000-0003-4487-7317; Rezac, Milan/0000-0003-4373-7064	grants IGA - Czech University of Life Sciences Prague [42900/1312/3166, 42110/1312/3164]	grants IGA - Czech University of Life Sciences Prague	The study was financially supported by grants IGA #42900/1312/3166 and #42110/1312/3164 awarded by the Czech University of Life Sciences Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, CARABIDAE CZECH SLOV; Aviron S, 2005, AGR ECOSYST ENVIRON, V108, P205, DOI 10.1016/j.agee.2005.02.004; Baines M, 1998, ECOGRAPHY, V21, P74, DOI 10.1111/j.1600-0587.1998.tb00395.x; Batary P, 2012, AGR ECOSYST ENVIRON, V146, P130, DOI 10.1016/j.agee.2011.10.018; Bell JR, 2002, AGR ECOSYST ENVIRON, V93, P295, DOI 10.1016/S0167-8809(01)00343-7; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Cameron KH, 2012, J INSECT CONSERV, V16, P523, DOI 10.1007/s10841-011-9438-z; Campbell RE, 2011, ECOL APPL, V21, P3147, DOI 10.1890/10-2390.1; Carvalheiro LG, 2012, J APPL ECOL, V49, P1373, DOI 10.1111/j.1365-2664.2012.02217.x; Castellazzi MS, 2007, AGR ECOSYST ENVIRON, V118, P339, DOI 10.1016/j.agee.2006.06.003; Crowley MJ, 2012, R BOOK; Davey JS, 2013, J APPL ECOL, V50, P271, DOI 10.1111/1365-2664.12008; Desender K, 2010, BIOL CONSERV, V143, P1549, DOI 10.1016/j.biocon.2010.03.039; Diekotter T, 2013, INSECT CONSERV DIVER, V6, P607, DOI 10.1111/icad.12015; Diekotter T, 2010, AGR ECOSYST ENVIRON, V137, P108, DOI 10.1016/j.agee.2010.01.008; Duelli P, 2003, BASIC APPL ECOL, V4, P129, DOI 10.1078/1439-1791-00140; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fournier E, 2001, LANDSCAPE ECOL, V16, P17, DOI 10.1023/A:1008115516551; Gaublomme E, 2008, BIOL CONSERV, V141, P2585, DOI 10.1016/j.biocon.2008.07.022; Geiger F, 2009, BIOCONTROL, V54, P529, DOI 10.1007/s10526-008-9206-5; Hambler C., 2013, CONSERVATION; Hancock MH, 2012, INSECT CONSERV DIVER, V5, P312, DOI 10.1111/j.1752-4598.2011.00162.x; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Holland JM, 2005, J APPL ECOL, V42, P1140, DOI 10.1111/j.1365-2664.2005.01083.x; Jonsson M, 2009, ECOGRAPHY, V32, P963, DOI 10.1111/j.1600-0587.2009.05784.x; Knapp M, 2012, EUR J ENTOMOL, V109, P419, DOI 10.14411/eje.2012.054; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; Kohler F, 2008, J APPL ECOL, V45, P753, DOI 10.1111/j.1365-2664.2007.01394.x; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lang A, 2003, OECOLOGIA, V134, P144, DOI 10.1007/s00442-002-1091-5; Laura Moreno M, 2013, J INSECT SCI, V13; Leps J, 2014, MULTIVARIATE ANAL EC; Lindborg R, 2014, BIOL CONSERV, V169, P206, DOI 10.1016/j.biocon.2013.11.015; LOBL I., 2003, ARCHOSTEMATA MYXOPHA, V1, P1, DOI DOI 10.1673/031.013.12601; Lovei GL, 2006, GLOBAL ECOL BIOGEOGR, V15, P283, DOI 10.1111/j.1466-8238.2005.00221.x; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; Magura T, 2007, AGR ECOSYST ENVIRON, V119, P396, DOI 10.1016/j.agee.2006.08.014; Marc P, 1999, AGR ECOSYST ENVIRON, V74, P229, DOI 10.1016/S0167-8809(99)00038-9; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; Oberg S, 2007, AGR ECOSYST ENVIRON, V122, P211, DOI 10.1016/j.agee.2006.12.034; Platnick N.I., 2012, WORLD SPIDER CATALOG; Pluess T, 2010, AGR ECOSYST ENVIRON, V137, P68, DOI 10.1016/j.agee.2009.12.020; R Development Core Team, LANG ENV STAT COMP; Ribera I, 2001, ECOLOGY, V82, P1112, DOI 10.1890/0012-9658(2001)082[1112:EOLDAS]2.0.CO;2; Rosch V, 2013, J APPL ECOL, V50, P387, DOI 10.1111/1365-2664.12056; Roume A, 2011, AGR FOREST ENTOMOL, V13, P395, DOI 10.1111/j.1461-9563.2011.00534.x; Rusch A, 2013, J APPL ECOL, V50, P345, DOI 10.1111/1365-2664.12055; Saska P, 2013, J APPL ECOL, V50, P181, DOI 10.1111/1365-2664.12023; Schellhorn NA, 2014, ANNU REV ENTOMOL, V59, P559, DOI 10.1146/annurev-ento-011613-161952; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Sunderland K, 2000, ENTOMOL EXP APPL, V95, P1, DOI 10.1023/A:1003986225443; Thomas CFG, 2001, J APPL ECOL, V38, P100, DOI 10.1046/j.1365-2664.2001.00574.x; THOMAS MB, 1992, J APPL ECOL, V29, P524, DOI 10.2307/2404521; Torma A, 2014, AGR ECOSYST ENVIRON, V196, P42, DOI 10.1016/j.agee.2014.06.021; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.1890/1051-0761(2002)012[0354:COSHFT]2.0.CO;2; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Vieira MV, 2009, BIOL CONSERV, V142, P1191, DOI 10.1016/j.biocon.2009.02.006; Wamser S, 2012, INSECT CONSERV DIVER, V5, P9, DOI 10.1111/j.1752-4598.2010.00110.x; Weibull AC, 2003, BIODIVERS CONSERV, V12, P1335, DOI 10.1023/A:1023617117780; White GC, 1996, ECOLOGY, V77, P2549, DOI 10.2307/2265753; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Woodcock BA, 2014, J APPL ECOL, V51, P142, DOI 10.1111/1365-2664.12171; Zhao ZH, 2013, BASIC APPL ECOL, V14, P472, DOI 10.1016/j.baae.2013.06.002	67	46	54	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123052	10.1371/journal.pone.0123052	http://dx.doi.org/10.1371/journal.pone.0123052			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859850	gold, Green Submitted, Green Published			2022-12-27	WOS:000352590300075
J	Palmer, K; Horn, MA				Palmer, Katharina; Horn, Marcus A.			Denitrification Activity of a Remarkably Diverse Fen Denitrifier Community in Finnish Lapland Is N-Oxide Limited	PLOS ONE			English	Article							NITROUS-OXIDE; MICROBIAL COMMUNITIES; WATER-TABLE; NOSZ GENES; N2O; NITRATE; BACTERIA; METHANE; RESPONSES; FLUXES	Peatlands cover more than 30% of the Finnish land area and impact N2O fluxes. Denitrifiers release N2O as an intermediate or end product. In situ N2O emissions of a near pH neutral pristine fen soil in Finnish Lapland were marginal during gas chamber measurements. However, nitrate and ammonium fertilization significantly stimulated in situ N2O emissions. Stimulation with nitrate was stronger than with ammonium. N2O was produced and subsequently consumed in gas chambers. In unsupplemented anoxic microcosms, fen soil produced N2O only when acetylene was added to block nitrous oxide reductase, suggesting complete denitrification. Nitrate and nitrite stimulated denitrification in fen soil, and maximal reaction velocities (v(max)) of nitrate or nitrite dependent denitrification where 18 and 52 nmol N2O h(-1) g(DW)(-1), respectively. N2O was below 30% of total produced N gases in fen soil when concentrations of nitrate and nitrite were <500 mu M. v(max) for N2O consumption was up to 36 nmol N2O h(-1) gDW(-1). Denitrifier diversity was assessed by analyses of narG, nirK/nirS, and nosZ (encoding nitrate-, nitrite-, and nitrous oxide reductases, respectively) by barcoded amplicon pyrosequencing. Analyses of similar to 14,000 quality filtered sequences indicated up to 25 species-level operational taxonomic units (OTUs), and up to 359 OTUs at 97% sequence similarity, suggesting diverse denitrifiers. Phylogenetic analyses revealed clusters distantly related to publicly available sequences, suggesting hitherto unknown denitrifiers. Representatives of species-level OTUs were affiliated with sequences of unknown soil bacteria and Actinobacterial, Alpha-, Beta-, Gamma-, and Delta-Proteobacterial sequences. Comparison of the 4 gene markers at 97% similarity indicated a higher diversity of narG than for the other gene markers based on Shannon indices and observed number of OTUs. The collective data indicate (i) a high denitrification and N2O consumption potential, and (ii) a highly diverse, nitrate limited denitrifier community associated with potential N2O fluxes in a pH-neutral fen soil.	[Palmer, Katharina; Horn, Marcus A.] Univ Bayreuth, Dept Ecol Microbiol, Bayreuth, Germany	University of Bayreuth	Horn, MA (corresponding author), Univ Bayreuth, Dept Ecol Microbiol, Bayreuth, Germany.	marcus.horn@uni-bayreuth.de	Horn, Marcus A./E-3726-2013	Horn, Marcus A./0000-0001-8510-9651; Kujala, Katharina/0000-0003-3697-8521	German Research Foundation (DFG) [HO 4020/2-2]; German Academic Exchange Service (DAAD); LAPBIAT (part of the 6th EU Framework Program "Infrastructures"); DFG; University of Bayreuth	German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); LAPBIAT (part of the 6th EU Framework Program "Infrastructures"); DFG(German Research Foundation (DFG)); University of Bayreuth	Funding of consumables was provided by the German Research Foundation (DFG), grant HO 4020/2-2. Funding of KP's stay in Finland and infrastructure at the field site were provided by the German Academic Exchange Service (DAAD) and LAPBIAT (part of the 6th EU Framework Program "Infrastructures"), respectively. Publication was funded by DFG and the University of Bayreuth in the funding programme "Open Access Publishing". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA JS, 1995, BIOTECHNOL BIOENG, V46, P476, DOI 10.1002/bit.260460512; Blicher-Mathiesen G, 1999, J ENVIRON QUAL, V28, P257, DOI 10.2134/jeq1999.00472425002800010031x; Braker G, 2011, ADV APPL MICROBIOL, V75, P33, DOI 10.1016/B978-0-12-387046-9.00002-5; Bremner JM, 1997, NUTR CYCL AGROECOSYS, V49, P7, DOI 10.1023/A:1009798022569; Bru D, 2011, ISME J, V5, P532, DOI 10.1038/ismej.2010.130; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chapuis-Lardy L, 2007, GLOBAL CHANGE BIOL, V13, P1, DOI 10.1111/j.1365-2486.2006.01280.x; Christensen TR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016848; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Demaneche S, 2009, APPL ENVIRON MICROB, V75, P534, DOI 10.1128/AEM.01706-08; Eurola S, 1984, EUROPEAN MIRES, P11, DOI [10.1016/b978-0-12-505580-2.50006-4, DOI 10.1016/B978-0-12-505580-2.50006-4]; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Goldberg SD, 2008, ISOT ENVIRON HEALT S, V44, P377, DOI 10.1080/10256010802507433; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jahangir MMR, 2012, AGR ECOSYST ENVIRON, V147, P13, DOI 10.1016/j.agee.2011.04.015; Jones CM, 2013, ISME J, V7, P417, DOI 10.1038/ismej.2012.125; Jones CM, 2011, FEMS MICROBIOL ECOL, V76, P541, DOI 10.1111/j.1574-6941.2011.01071.x; Kirchman DL, 2001, DEEP-SEA RES PT II, V48, P4179, DOI 10.1016/S0967-0645(01)00085-6; Kolb Steffen, 2012, Front Microbiol, V3, P78, DOI 10.3389/fmicb.2012.00078; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Lohila A, 2010, EUR J SOIL SCI, V61, P651, DOI 10.1111/j.1365-2389.2010.01265.x; MAHNE I, 1995, APPL ENVIRON MICROB, V61, P1110, DOI 10.1128/AEM.61.3.1110-1115.1995; Maljanen M, 2010, BIOGEOSCIENCES, V7, P2711, DOI 10.5194/bg-7-2711-2010; Mannisto MK, 2006, SYST APPL MICROBIOL, V29, P229, DOI 10.1016/j.syapm.2005.09.001; MARTIKAINEN PJ, 1993, NATURE, V366, P51, DOI 10.1038/366051a0; Marushchak ME, 2011, GLOBAL CHANGE BIOL, V17, P2601, DOI 10.1111/j.1365-2486.2011.02442.x; Moore TR, 1998, CLIMATIC CHANGE, V40, P229, DOI 10.1023/A:1005408719297; Orellana LH, 2014, MBIO, V5, DOI 10.1128/mBio.01193-14; Palmer K, 2012, APPL ENVIRON MICROB, V78, P5584, DOI 10.1128/AEM.00810-12; Palmer K, 2012, ISME J, V6, P1058, DOI 10.1038/ismej.2011.172; Palmer K, 2010, APPL ENVIRON MICROB, V76, P1125, DOI 10.1128/AEM.02256-09; Palmer K, 2009, APPL ENVIRON MICROB, V75, P5170, DOI 10.1128/AEM.00254-09; Persoh D, 2008, J MICROBIOL METH, V75, P19, DOI 10.1016/j.mimet.2008.04.009; Philippot L, 2002, APPL ENVIRON MICROB, V68, P6121, DOI 10.1128/AEM.68.12.6121-6128.2002; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ratkowsky D., 1983, NONLINEAR REGRESSION; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rich JJ, 2003, APPL ENVIRON MICROB, V69, P5974, DOI 10.1128/AEM.69.10.5974-5982.2003; Roobroeck D, 2010, EUR J SOIL SCI, V61, P662, DOI 10.1111/j.1365-2389.2010.01269.x; ROULET N, 1992, TELLUS B, V44, P100, DOI 10.1034/j.1600-0889.1992.t01-1-00002.x; Sanford RA, 2012, P NATL ACAD SCI USA, V109, P19709, DOI [10.1073/pnas., 10.1073/pnas.1211238109]; Schulze ED, 2009, NAT GEOSCI, V2, P842, DOI 10.1038/ngeo686; Singh BK, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2119-c1; Smith KA, 1997, GLOBAL CHANGE BIOL, V3, P327, DOI 10.1046/j.1365-2486.1997.00100.x; Takakai F, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000521; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; van Cleemput O, 1998, NUTR CYCL AGROECOSYS, V52, P187, DOI 10.1023/A:1009728125678; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; Whitman WB, 2012, BERGEYS MANUAL OF SY; YOSHINARI T, 1976, BIOCHEM BIOPH RES CO, V69, P705, DOI 10.1016/0006-291X(76)90932-3; Zaprasis A, 2010, APPL ENVIRON MICROB, V76, P119, DOI 10.1128/AEM.01727-09; Zenova GM, 2011, EURASIAN SOIL SCI+, V44, P417, DOI 10.1134/S1064229311040132; Zumft WG, 2007, ADV MICROB PHYSIOL, V52, P107, DOI 10.1016/S0065-2911(06)52003-X; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	59	27	27	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123123	10.1371/journal.pone.0123123	http://dx.doi.org/10.1371/journal.pone.0123123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860353	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300079
J	Rausch, JW; Tian, MJ; Li, YJ; Angelova, L; Bagaya, BS; Krebs, KC; Qian, F; Zhu, CW; Arts, EJ; Le Grice, SFJ; Gao, Y				Rausch, Jason W.; Tian, Meijuan; Li, Yuejin; Angelova, Lora; Bagaya, Bernard S.; Krebs, Kendall C.; Qian, Feng; Zhu, Chuanwu; Arts, Eric J.; Le Grice, Stuart F. J.; Gao, Yong			SiRNA-Induced Mutation in HIV-1 Polypurine Tract Region and Its Influence on Viral Fitness	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MURINE LEUKEMIA-VIRUS; STRAND DNA-SYNTHESIS; TYPE-1 REVERSE-TRANSCRIPTASE; SEQUENCE FEATURES IMPORTANT; RIBONUCLEASE-H; SUBSTRATE-SPECIFICITY; RNA/DNA HYBRID; PRIMER; INTEGRASE	Converting single-stranded viral RNA into double stranded DNA for integration is an essential step in HIV-1 replication. Initial polymerization of minus-strand DNA is primed from a host derived tRNA, whereas subsequent plus-strand synthesis requires viral primers derived from the 3' and central polypurine tracts (3' and cPPTs). The 5' and 3' termini of these conserved RNA sequence elements are precisely cleaved by RT-associated RNase H to generate specific primers that are used to initiate plus-strand DNA synthesis. In this study, siRNA wad used to produce a replicative HIV-1 variant contained G(-1) A and T(-16) A substitutions within/adjacent to the 3'PPT sequence. Introducing either or both mutations into the 3'PPT region or only the G(-1) A substitution in the cPPT region of NL4-3 produced infectious virus with decreased fitness relative to the wild-type virus. In contrast, introducing the T(-16) A or both mutations into the cPPT rendered the virus(es) incapable of replication, most likely due to the F185L integrase mutation produced by this nucleotide substitution. Finally, the effects of G(-1) A and T(-16) A mutations on cleavage of the 3'PPT were examined using an in vitro RNase H cleavage assay. Substrate containing both mutations was miscleaved to a greater extent than either wild-type substrate or substrate containing the T(-16) A mutation alone, which is consistent with the observed effects of the equivalent nucleotide substitutions on the replication fitness of NL4-3 virus. In conclusion, siRNA targeting of the HIV-1 3'PPT region can substantially suppress virus replication, and this selective pressure can be used to generate infectious virus containing mutations within or near the HIV-1 PPT. Moreover, in-depth analysis of the resistance mutations demonstrates that although virus containing a G(-1) A mutation within the 3'PPT is capable of replication, this nucleotide substitution shifts the 3'-terminal cleavage site in the 3'PPT by one nucleotide (nt) and significantly reduces viral fitness.	[Rausch, Jason W.; Le Grice, Stuart F. J.] Frederick Natl Lab Canc Res, HIV Drug Resistance Program, Frederick, MD USA; [Tian, Meijuan; Li, Yuejin; Angelova, Lora; Krebs, Kendall C.; Gao, Yong] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; [Bagaya, Bernard S.; Gao, Yong] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Qian, Feng; Zhu, Chuanwu] Suzhou Fifth Peoples Hosp, Suzhou, Jiangsu, Peoples R China; [Arts, Eric J.] Western Univ, Dept Microbiol & Immunol, London, ON, Canada	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University; Case Western Reserve University; Western University (University of Western Ontario)	Gao, Y (corresponding author), Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA.	yong.gao@case.edu	Angelova, Lora/AAG-3211-2020; LI, Yue/GRS-8071-2022	Angelova, Lora/0000-0003-2496-9310; Arts, Eric/0000-0002-4880-7968; Ssentalo Bagaya, Bernard/0000-0002-3847-2615	National Institutes of Health [R01 AI49170, R01 AI84816]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI084816, R01AI049170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by the National Institutes of Health (grant R01 AI49170 and grant R01 AI84816 to YG and EJA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Abraha Awet, 2005, Methods Mol Biol, V304, P355; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Al-Mawsawi LQ, 2008, VIROLOGY, V377, P353, DOI 10.1016/j.virol.2008.04.030; Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Brin E, 2002, J BIOL CHEM, V277, P18357, DOI 10.1074/jbc.M201354200; BUSHMAN FD, 1990, J VIROL, V64, P5645, DOI 10.1128/JVI.64.11.5645-5648.1990; Champoux JJ, 2009, FEBS J, V276, P1506, DOI 10.1111/j.1742-4658.2009.06909.x; CHARNEAU P, 1991, J VIROL, V65, P2415, DOI 10.1128/JVI.65.5.2415-2421.1991; CHARNEAU P, 1992, J VIROL, V66, P2814, DOI 10.1128/JVI.66.5.2814-2820.1992; Dash C, 2004, J BIOL CHEM, V279, P37095, DOI 10.1074/jbc.M403306200; DeStefano JJ, 2006, NUCLEIC ACIDS RES, V34, P130, DOI 10.1093/nar/gkj426; Dicker IB, 2007, J BIOL CHEM, V282, P31186, DOI 10.1074/jbc.M704935200; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Dudley DM, 2009, BIOTECHNIQUES, V46, P458, DOI 10.2144/000113119; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; FURFINE ES, 1991, BIOCHEMISTRY-US, V30, P7041, DOI 10.1021/bi00243a001; FURFINE ES, 1991, J BIOL CHEM, V266, P406; Gao Y, 2004, J VIROL, V78, P5390, DOI 10.1128/JVI.78.10.5390-5401.2004; Gao Y, 2008, J VIROL, V82, P2938, DOI 10.1128/JVI.02126-07; Han GW, 1997, J MOL BIOL, V269, P811, DOI 10.1006/jmbi.1997.1085; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; HUBER HE, 1990, J BIOL CHEM, V265, P10565; HUNGNES O, 1992, VIROLOGY, V190, P440, DOI 10.1016/0042-6822(92)91230-R; Iglesias C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-92; Ilyinskii PO, 1998, EMBO J, V17, P3766, DOI 10.1093/emboj/17.13.3766; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Julias JG, 2003, J VIROL, V77, P8548, DOI 10.1128/JVI.77.15.8548-8554.2003; Kelleher CD, 2000, J BIOL CHEM, V275, P13061, DOI 10.1074/jbc.275.17.13061; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kopka ML, 2003, J MOL BIOL, V334, P653, DOI 10.1016/j.jmb.2003.09.057; Kvaratskhelia M, 2002, J BIOL CHEM, V277, P16689, DOI 10.1074/jbc.M109914200; LAFEMINA RL, 1991, J VIROL, V65, P5624, DOI 10.1128/JVI.65.10.5624-5630.1991; Lankas F, 2002, BIOPHYS J, V82, P2592, DOI 10.1016/S0006-3495(02)75601-4; Lapkouski M, 2013, NAT STRUCT MOL BIOL, V20, P230, DOI 10.1038/nsmb.2485; Lener D, 2003, J BIOL CHEM, V278, P26526, DOI 10.1074/jbc.M302374200; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Lobritz MA, 2007, J VIROL, V81, P8258, DOI 10.1128/JVI.02739-06; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Marozsan AJ, 2003, J VIROL METHODS, V111, P111, DOI 10.1016/S0166-0934(03)00166-6; Masuda T, 1998, J VIROL, V72, P8396, DOI 10.1128/JVI.72.10.8396-8402.1998; McWilliams MJ, 2003, J VIROL, V77, P11150, DOI 10.1128/JVI.77.20.11150-11157.2003; Moore Dawn M, 2005, Methods Mol Biol, V304, P369; PANGANIBAN AT, 1983, NATURE, V306, P155, DOI 10.1038/306155a0; Payne RP, 2010, J VIROL, V84, P10543, DOI 10.1128/JVI.00793-10; Powell MD, 1996, J VIROL, V70, P5288, DOI 10.1128/JVI.70.8.5288-5296.1996; PULLEN KA, 1992, J VIROL, V66, P367, DOI 10.1128/JVI.66.1.367-373.1992; PULLEN KA, 1993, J BIOL CHEM, V268, P6221; RATTRAY AJ, 1989, J MOL BIOL, V208, P445, DOI 10.1016/0022-2836(89)90508-1; Rausch JW, 2007, NUCLEIC ACIDS RES, V35, P256, DOI 10.1093/nar/gkl909; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Rausch JW, 2003, P NATL ACAD SCI USA, V100, P11279, DOI 10.1073/pnas.1932546100; Rausch JW, 2002, BIOCHEMISTRY-US, V41, P4856, DOI 10.1021/bi015970t; REPASKE R, 1989, J VIROL, V63, P1460, DOI 10.1128/JVI.63.3.1460-1464.1989; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; SMITH JS, 1992, J BIOL CHEM, V267, P15071; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; TELESNITSKY A, 1992, J VIROL, V66, P615, DOI 10.1128/JVI.66.2.615-622.1992; Telesnitsky A, 1997, REVERSE TRANSCRIPTAS; TISDALE M, 1991, J GEN VIROL, V72, P59, DOI 10.1099/0022-1317-72-1-59; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; VINK C, 1991, J VIROL, V65, P4636, DOI 10.1128/JVI.65.9.4636-4644.1991; WHITCOMB JM, 1992, ANNU REV CELL BIOL, V8, P275, DOI 10.1146/annurev.cb.08.110192.001423	64	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122953	10.1371/journal.pone.0122953	http://dx.doi.org/10.1371/journal.pone.0122953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860884	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300070
J	Wang, ZG; Martorell, BC; Walchli, T; Vogel, O; Fischer, J; Born, W; Vogel, J				Wang, Zhenghui; Martorell, Belen Canto; Waelchli, Thomas; Vogel, Olga; Fischer, Jan; Born, Walter; Vogel, Johannes			Calcitonin Gene-Related Peptide (CGRP) Receptors Are Important to Maintain Cerebrovascular Reactivity in Chronic Hypertension	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ACTIVITY-MODIFYING PROTEIN-1; ANTIHYPERTENSIVE TREATMENT; TRANSGENIC MICE; ONE-CLIP; AUTOREGULATION; ADRENOMEDULLIN; 2-KIDNEY; INCREASE	Cerebral blood flow autoregulation (CA) shifts to higher blood pressures in chronic hypertensive patients, which increases their risk for brain damage. Although cerebral vascular smooth muscle cells express the potent vasodilatatory peptides calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) and their receptors (calcitonin receptor-like receptor (Calclr), receptor-modifying proteins (RAMP) 1 and 2), their contribution to CA during chronic hypertension is poorly understood. Here we report that chronic (10 weeks) hypertensive (one-kidney-one-clip-method) mice overexpressing the Calclr in smooth muscle cells (CLR-tg), which increases the natural sensitivity of the brain vasculature to CGRP and AM show significantly better blood pressure drop-induced cerebrovascular reactivity than wt controls. Compared to sham mice, this was paralleled by increased cerebral CGRP-binding sites (receptor autoradiography), significantly in CLR-tg but not wt mice. AM-binding sites remained unchanged. Whereas hypertension did not alter RAMP-1 expression (droplet digital (dd) PCR) in either mouse line, RAMP-2 expression dropped significantly in both mouse lines by about 65%. Moreover, in wt only Calclr expression was reduced by about 70% parallel to an increase of smooth muscle actin (Acta2) expression. Thus, chronic hypertension induces a stoichiometric shift between CGRP and AM receptors in favor of the CGRP receptor. However, the parallel reduction of Calclr expression observed in wt mice but not CLR-tg mice appears to be a key mechanism in chronic hypertension impairing cerebrovascular reactivity.	[Wang, Zhenghui; Martorell, Belen Canto; Vogel, Olga; Vogel, Johannes] Univ Zurich, Inst Vet Physiol, Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich, Swiss Ctr Regenerat Med, Grp CNS Angiogenesis & Neurovasc Link, Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich, Swiss Ctr Regenerat Med, Phys Scientist Program, Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich Hosp, Div Neurosurg, CH-8091 Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich Hosp, Div Surg Res, CH-8091 Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich Hosp, Mol Neurooncol Lab, CH-8091 Zurich, Switzerland; [Waelchli, Thomas] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Waelchli, Thomas] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland; [Fischer, Jan; Born, Walter] Univ Zurich, Orthoped Univ Hosp Zurich, Res Lab Calcium Metab, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Vogel, J (corresponding author), Univ Zurich, Inst Vet Physiol, Zurich, Switzerland.	jvogel@vetphys.uzh.ch		Walchli, Thomas/0000-0002-8961-6551; Vogel, Johannes/0000-0003-4181-4521	Swiss National Science Foundation [310000_120321/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (310000_120321/1, to J.V.).	Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Chrissobolis S, 2010, STROKE, V41, P2329, DOI 10.1161/STROKEAHA.110.589648; Deng PY, 2004, REGUL PEPTIDES, V119, P155, DOI 10.1016/j.regpep.2004.01.011; Deng PY, 2003, REGUL PEPTIDES, V114, P175, DOI 10.1016/S0167-0115(03)00124-1; Deschepper CF, 2004, J APPL PHYSIOL, V97, P369, DOI 10.1152/japplphysiol.00073.2004; Dogan A, 1997, J CEREBR BLOOD F MET, V17, P19, DOI 10.1097/00004647-199701000-00004; Edvinsson L, 2014, ACTA PHYSIOL, V210, P811, DOI 10.1111/apha.12213; Edvinsson L, 2010, NEUROTHERAPEUTICS, V7, P164, DOI 10.1016/j.nurt.2010.02.004; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; HARPER SL, 1987, CIRC RES, V60, P229, DOI 10.1161/01.RES.60.2.229; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; HENKE H, 1985, BRAIN RES, V360, P165, DOI 10.1016/0006-8993(85)91232-6; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; HONG KW, 1994, AM J PHYSIOL, V266, pH11, DOI 10.1152/ajpheart.1994.266.1.H11; Immink RV, 2004, CIRCULATION, V110, P2241, DOI 10.1161/01.CIR.0000144472.08647.40; Ittner LM, 2008, CLIN SCI, V114, P49, DOI 10.1042/CS20070163; Kis B, 2002, J NEUROENDOCRINOL, V14, P283, DOI 10.1046/j.1365-2826.2002.00778.x; Kunz TH, 2007, AM J PHYSIOL-HEART C, V293, pH2155, DOI 10.1152/ajpheart.00629.2007; MASUDA A, 1992, J HYPERTENS, V10, P1499, DOI 10.1097/00004872-199210120-00010; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mitchell A, 2005, HERZ, V30, P401, DOI 10.1007/s00059-005-2711-8; Pedersen TF, 2003, AM J PHYSIOL-HEART C, V285, pH1097, DOI 10.1152/ajpheart.00098.2003; Pemu PI, 2008, J CLIN HYPERTENS, V10, P406, DOI 10.1111/j.1751-7176.2008.06552.x; Pondel MD, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-7; PORTALUPPI F, 1992, J HYPERTENS, V10, P1227, DOI 10.1097/00004872-199210000-00017; SCHIFTER S, 1991, AM J HYPERTENS, V4, P565, DOI 10.1093/ajh/4.7.565; Scott D, 2013, AM J PHYSIOL-LUNG C, V304, pL70, DOI 10.1152/ajplung.00342.2012; Shin HK, 2004, CLIN EXP PHARMACOL P, V31, P1, DOI 10.1111/j.1440-1681.2004.03943.x; Stachniak TJE, 2003, J NEUROENDOCRINOL, V15, P840, DOI 10.1046/j.1365-2826.2003.01064.x; STRANDGAARD S, 1976, CIRCULATION, V53, P720, DOI 10.1161/01.CIR.53.4.720; STRANDGAARD S, 1975, CIRC RES, V37, P164, DOI 10.1161/01.RES.37.2.164; Tejada Thor, 2006, Curr Cardiol Rep, V8, P418, DOI 10.1007/s11886-006-0099-6; VORSTRUP S, 1984, STROKE, V15, P312, DOI 10.1161/01.STR.15.2.312; Wang ZH, 2010, EXP BRAIN RES, V207, P249, DOI 10.1007/s00221-010-2447-4; WERBER AH, 1990, CAN J PHYSIOL PHARM, V68, P476, DOI 10.1139/y90-067; Wiesel P, 1997, HYPERTENSION, V29, P1025, DOI 10.1161/01.HYP.29.4.1025; Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40; Zhang ZM, 2007, J NEUROSCI, V27, P2693, DOI 10.1523/JNEUROSCI.4542-06.2007	38	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123697	10.1371/journal.pone.0123697	http://dx.doi.org/10.1371/journal.pone.0123697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860809	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352590300111
J	Yamamichi, N; Shimamoto, T; Takahashi, Y; Sakaguchi, Y; Kakimoto, H; Matsuda, R; Kataoka, Y; Saito, I; Tsuji, Y; Yakabi, S; Takeuchi, C; Minatsuki, C; Niimi, K; Asada-Hirayama, I; Nakayama, C; Ono, S; Kodashima, S; Yamaguchi, D; Fujishiro, M; Yamaji, Y; Wada, R; Mitsushima, T; Koike, K				Yamamichi, Nobutake; Shimamoto, Takeshi; Takahashi, Yu; Sakaguchi, Yoshiki; Kakimoto, Hikaru; Matsuda, Rie; Kataoka, Yosuke; Saito, Itaru; Tsuji, Yosuke; Yakabi, Seiichi; Takeuchi, Chihiro; Minatsuki, Chihiro; Niimi, Keiko; Asada-Hirayama, Itsuko; Nakayama, Chiemi; Ono, Satoshi; Kodashima, Shinya; Yamaguchi, Daisuke; Fujishiro, Mitsuhiro; Yamaji, Yutaka; Wada, Ryoichi; Mitsushima, Toru; Koike, Kazuhiko			Trend and Risk Factors of Diverticulosis in Japan: Age, Gender, and Lifestyle/Metabolic-Related Factors May Cooperatively Affect on the Colorectal Diverticula Formation	PLOS ONE			English	Article							COLONIC DIVERTICULOSIS; REFLUX DISEASE; EPIDEMIOLOGY; ASSOCIATION; CONSUMPTION; PREVALENCE; OBESITY; FIBER; DIET	Background Despite the marked increase of diverticulosis, its risk factors have not been adequately elucidated. We therefore aim to identify significantly associated factors with diverticulosis. We also aim to investigate the present state of diverticulosis in Japan. Methods We reviewed the medical records from 1990 to 2010 that included the data of consecutive 62,503 asymptomatic colonoscopy examinees from the general population in Japan. Most recent 3,327 examinees were analyzed with 16 background factors. Results Among the 62,503 subjects (47,325 men and 15,178 women; 52.1 +/- 9.2 years old), diverticulosis was detected in 11,771 subjects (18.8%; 10,023 men and 1,748 women). The incidences of diverticulosis in 1990-2000 and 2001-2010 were respectively 13.0% (3,771 of 29,071) and 23.9% (8,000 of 33,432): the latter was much higher than the former in all age groups and for both genders. Considering the anatomical locations of colorectal diverticula, left-sided ones have markedly increased with age but not significantly changed with times. Univariate analyses of the 3,327 subjects showed significant association of diverticulosis with four basic factors (age, sex, body mass index, blood pressure), three life style-related factor (smoking, drinking, severe weight increase in adulthood), and two blood test values (triglyceride, HbA1c). The multiple logistic analysis calculating standardized coefficients (beta) and odds ratio (OR) demonstrated that age (beta = 0.217-0.674, OR = 1.24-1.96), male gender (beta = 0.185, OR = 1.20), smoking (beta = 0.142-0.200, OR = 1.15-1.22), severe weight increase in adulthood (beta = 0.153, OR = 1.17), HbA1c (beta = 0.136, OR = 1.15), drinking (beta = 0.109, OR = 1.11), and serum triglyceride (beta = 0.098, OR = 1.10) showed significantly positive association with diverticulosis whereas body mass index and blood pressure did not. Conclusions The large-scale data of asymptomatic colonoscopy examinees from the general population from 1990 to 2010 indicated that the prevalence of diverticulosis is still increasing in Japan. Age, male gender, smoking, severe weight increase in adulthood, serum HbA1c, drinking, and serum triglyceride showed significant positive association with diverticulosis.	[Yamamichi, Nobutake; Shimamoto, Takeshi; Takahashi, Yu; Sakaguchi, Yoshiki; Kakimoto, Hikaru; Matsuda, Rie; Kataoka, Yosuke; Saito, Itaru; Tsuji, Yosuke; Yakabi, Seiichi; Takeuchi, Chihiro; Minatsuki, Chihiro; Niimi, Keiko; Asada-Hirayama, Itsuko; Nakayama, Chiemi; Ono, Satoshi; Kodashima, Shinya; Yamaguchi, Daisuke; Fujishiro, Mitsuhiro; Yamaji, Yutaka; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan; [Shimamoto, Takeshi; Wada, Ryoichi; Mitsushima, Toru] Kameda Med Ctr Makuhari, Mihama Ku, Chiba, Japan	University of Tokyo	Yamamichi, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.	nyamamic-tky@umin.ac.jp	藤城, 光弘/AAN-3131-2020; Yamaguchi, Daisuke/V-1990-2019; Ono, Satoshi/AFP-6208-2022	Yamaguchi, Daisuke/0000-0001-9782-9998; Takeuchi, Chihiro/0000-0002-2746-9189; Sakaguchi, Yoshiki/0000-0001-5078-3750	Japan Society for the Promotion of Science [25460381]; Smoking Research Foundation of Japan; Grants-in-Aid for Scientific Research [25460381] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Smoking Research Foundation of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (Grant number: 25460381), and also partly supported by a grant from the Smoking Research Foundation of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldoori Walid H., 1995, Annals of Epidemiology, V5, P221, DOI 10.1016/1047-2797(94)00109-7; ALDOORI WH, 1994, AM J CLIN NUTR, V60, P757, DOI 10.1093/ajcn/60.5.757; BURKITT DP, 1972, LANCET, V1, P1408; Delvaux M, 2003, ALIMENT PHARM THERAP, V18, P71, DOI 10.1046/j.0953-0673.2003.01720.x; Dobbins C, 2006, COLORECTAL DIS, V8, P37, DOI 10.1111/j.1463-1318.2005.00847.x; Faucheron JL, 2013, COLORECTAL DIS, V15, pE266, DOI 10.1111/codi.12137; GEAR JSS, 1979, LANCET, V1, P511; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074699; Heise CP, 2008, J GASTROINTEST SURG, V12, P1309, DOI 10.1007/s11605-008-0492-0; Higuchi S, 2007, ADDICTION, V102, P1849, DOI 10.1111/j.1360-0443.2007.01902.x; Hirata T, 2008, WORLD J GASTROENTERO, V14, P2411, DOI 10.3748/wjg.14.2411; Hjern F, 2011, BRIT J SURG, V98, P997, DOI 10.1002/bjs.7477; Hjern F, 2012, AM J GASTROENTEROL, V107, P296, DOI 10.1038/ajg.2011.352; Jeyarajah S, 2008, INT J COLORECTAL DIS, V23, P619, DOI 10.1007/s00384-008-0446-8; Jun S, 2002, BEST PRACT RES CL GA, V16, P529, DOI 10.1053/bega.2002.0328; Kawamori R, 2002, DIABETES-METAB RES, V18, pS9, DOI 10.1002/dmrr.296; KUBO A, 1983, JPN J MED, V22, P185; KYLE J, 1975, BRIT J SURG, V62, P537, DOI 10.1002/bjs.1800620709; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Martel J, 2008, J CLIN GASTROENTEROL, V42, P1125, DOI 10.1097/MCG.0b013e3181865f18; Minatsuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069891; Miura S, 2000, DIS COLON RECTUM, V43, P1383, DOI 10.1007/BF02236634; Morimoto A., 2010, JMAJ - Japan Medical Association Journal, V53, P36; Muhammad A, 2014, INT J COLORECTAL DIS, V29, P947, DOI 10.1007/s00384-014-1908-9; Nagata N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081137; NAKADA I, 1995, DIS COLON RECTUM, V38, P755, DOI 10.1007/BF02048036; NARASAKA T, 1975, TOHOKU J EXP MED, V115, P271, DOI 10.1620/tjem.115.271; Niikura R, 2013, WORLD J GASTROENTERO, V19, P2362, DOI 10.3748/wjg.v19.i15.2362; Nukada A, 1973, J Hum Ergol (Tokyo), V1, P29; PAINTER NS, 1971, BMJ-BRIT MED J, V2, P450, DOI 10.1136/bmj.2.5759.450; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; Rosemar A, 2008, DIS COLON RECTUM, V51, P450, DOI 10.1007/s10350-007-9172-5; Sharara AI, 2013, J CLIN GASTROENTEROL, V47, P420, DOI 10.1097/MCG.0b013e31826be847; Sherwin R, 2012, J CLIN ENDOCR METAB, V97, P4293, DOI 10.1210/jc.2012-3487; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Shimamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065996; Sugihara K, 1987, Ann Acad Med Singap, V16, P504; Takahashi Y, 2014, J GASTROENTEROL, V49, P882, DOI 10.1007/s00535-013-0832-z; Tonnesen H, 1999, BRIT J SURG, V86, P1067, DOI 10.1046/j.1365-2168.1999.01171.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamamichi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111359; Yamamichi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088277; Yamamichi N, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-45	43	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123688	10.1371/journal.pone.0123688	http://dx.doi.org/10.1371/journal.pone.0123688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860671	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300110
J	Zhang, Y; Zhao, P; Dong, ZM; Wang, DD; Guo, PC; Guo, XM; Song, QR; Zhang, WW; Xia, QY				Zhang, Yan; Zhao, Ping; Dong, Zhaoming; Wang, Dandan; Guo, Pengchao; Guo, Xiaomeng; Song, Qianru; Zhang, Weiwei; Xia, Qingyou			Comparative Proteome Analysis of Multi-Layer Cocoon of the Silkworm, Bombyx mori	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; PROTEASE INHIBITOR; PROTEINASE K; IDENTIFICATION; PEPTIDES; SEQUENCE	Bombyx mori cocoon has a multi-layer structure that provides optimal protection for silkworm pupa. Research on the mechanical properties of the multi-layer structure revealed structure-property relationships of the cocoon. Here, we investigated the protein components of the B. mori cocoon in terms of its multi-layer structure. Liquid chromatography-tandem mass spectrometry identified 286 proteins from the multiple cocoon layers. In addition to fibroins and sericins, we identified abundant protease inhibitors, seroins and proteins of unknown function. By comparing protein abundance across layers, we found that the outermost layer contained more sericin1 and protease inhibitors and the innermost layer had more seroin1. As many as 36 protease inhibitors were identified in cocoons, showing efficient inhibitory activities against a fungal protease. Thus, we propose that more abundant protease inhibitors in the outer cocoon layers may provide better protection for the cocoon. This study increases our understanding of the multi-layer mechanism of cocoons, and helps clarify the biological characteristics of cocoons. The data have been deposited to the ProteomeXchange with identifier PXD001469.	[Zhang, Yan; Zhao, Ping; Dong, Zhaoming; Wang, Dandan; Guo, Pengchao; Guo, Xiaomeng; Song, Qianru; Zhang, Weiwei; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.	xiaqy@swu.edu.cn	Dong, Zhaoming/AAW-3060-2021; guo, peng/AAG-4052-2019; Dong, Zhaoming/AAK-1802-2021; Guo, Peng/GWC-0572-2022	Dong, Zhaoming/0000-0001-5665-9953; Dong, Zhaoming/0000-0001-5665-9953; 	National Basic Research Program of China [2012CB114600]; National Hi-Tech Research and Development Program of China [2011AA100306]; National Natural Science Foundation of China [31172157]; China Postdoctoral Science Foundation [2013M540695, 2014T70843]; fundamental research funds for the central universities of China [XDJK2014C048]	National Basic Research Program of China(National Basic Research Program of China); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); fundamental research funds for the central universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (2012CB114600), the National Hi-Tech Research and Development Program of China (2011AA100306), the National Natural Science Foundation of China (31172157), the China Postdoctoral Science Foundation (2013M540695, 2014T70843), and the fundamental research funds for the central universities of China (XDJK2014C048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai H., 1997, INT J WILD SILKMOTH, V3, P79; Blossman-Myer B, 2010, COMP BIOCHEM PHYS A, V155, P259, DOI 10.1016/j.cbpa.2009.11.007; Chen FJ, 2013, J EXP BIOL, V216, P2648, DOI 10.1242/jeb.082545; Chen FJ, 2012, J R SOC INTERFACE, V9, P2299, DOI 10.1098/rsif.2011.0887; Chen FJ, 2012, ACTA BIOMATER, V8, P2620, DOI 10.1016/j.actbio.2012.03.043; Chen WQ, 2010, PROTEOMICS, V10, P369, DOI 10.1002/pmic.200900624; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Danks HV, 2004, EUR J ENTOMOL, V101, P433, DOI 10.14411/eje.2004.062; Dong ZM, 2013, J PROTEOME RES, V12, P5213, DOI 10.1021/pr4005772; EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x; EGUCHI M, 1993, COMP BIOCHEM PHYS B, V104, P537, DOI 10.1016/0305-0491(93)90279-E; GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9; Gauthier N, 2004, J INSECT PHYSIOL, V50, P1065, DOI 10.1016/j.jinsphys.2004.09.008; Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012; KELLENBERGER C, 1995, J BIOL CHEM, V270, P25514, DOI 10.1074/jbc.270.43.25514; Kludkiewicz B, 2009, INSECT BIOCHEM MOLEC, V39, P938, DOI 10.1016/j.ibmb.2009.11.005; KRAUS E, 1976, H-S Z PHYSIOL CHEM, V357, P937, DOI 10.1515/bchm2.1976.357.2.937; Kurioka A, 1999, EUR J BIOCHEM, V259, P120, DOI 10.1046/j.1432-1327.1999.00030.x; Kurioka Akira, 1999, Journal of Sericultural Science of Japan, V68, P397; Li YS, 2015, INSECT BIOCHEM MOLEC, V57, P11, DOI 10.1016/j.ibmb.2014.11.006; Li YS, 2012, INSECT BIOCHEM MOLEC, V42, P766, DOI 10.1016/j.ibmb.2012.07.004; Mondal M., 2007, Caspian Journal of Environmental Sciences, V5, P63; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nirmala X, 2001, INSECT MOL BIOL, V10, P437, DOI 10.1046/j.0962-1075.2001.00282.x; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; Palmieri G, 2009, J PROTEOME RES, V8, P327, DOI 10.1021/pr800587t; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pham TN, 1996, J BIOCHEM, V119, P428; Singh CP, 2014, CELL MICROBIOL, V16, P1354, DOI 10.1111/cmi.12294; Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Weisman S, 2008, BIOMACROMOLECULES, V9, P3065, DOI 10.1021/bm8005853; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04428; Zhang J, 2013, MAT SCI ENG C-MATER, V33, P3206, DOI 10.1016/j.msec.2013.03.051; Zhao HP, 2005, POLYMER, V46, P9192, DOI 10.1016/j.polymer.2005.07.004; Zurovec M, 1998, J BIOL CHEM, V273, P15423, DOI 10.1074/jbc.273.25.15423	40	30	39	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123403	10.1371/journal.pone.0123403	http://dx.doi.org/10.1371/journal.pone.0123403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860555	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300095
J	Lee, SY; Kim, M; Jung, S; Lee, SH; Lee, JH				Lee, Sae Young; Kim, Minjoo; Jung, Saem; Lee, Sang-Hyun; Lee, Jong Ho			Altered Plasma Lysophosphatidylcholines and Amides in Non-Obese and Non-Diabetic Subjects with Borderline-To-Moderate Hypertriglyceridemia: A Case-Control Study	PLOS ONE			English	Article							DICARBOXYLIC-ACIDS; OXIDATIVE STRESS; METABOLITES; IDENTIFICATION; BIOSYNTHESIS; PERFORMANCE; DISEASE; ALPHA; OBESE; FAT	Hypertriglyceridemia (HTG) is a risk factor for atherosclerotic cardiovascular disease (CVD). We investigated alterations in plasma metabolites associated with borderline-to-moderate HTG (triglycerides (TG) 150-500 mg/dL). Using UPLC-LTQ-Orbitrap mass spectrometry analysis, the metabolomics profiles of 111 non-diabetic and non-obese individuals with borderline-to-moderate HTG were compared with those of 111 age-and sex-matched controls with normotriglyceridemia (NTG, TG < 150 mg/dL). When compared to the NTG control group, the HTG group exhibited higher plasma levels of lysophosphatidylcholines (lysoPCs), including C14: 0 (q = 0.001) and C16: 0 (q = 1.8E-05), and several amides, including N-ethyldodecanamide (q = 2.9E-05), N-propyldodecanamide (q = 3.5E-05), palmitoleamide (q = 2.9E-06), and palmitic amide (q = 0.019). The metabolomic profiles of the HTG group also exhibited lower plasma levels of cis-4-octenedioic acid (q< 1.0E-9) and docosanamide (q = 0.002) compared with those of the NTG controls. LysoPC 16: 0 and palmitoleamide emerged as the primary metabolites able to discriminate the HTG group from the NTG group in a partial least-squares discriminant analysis and were positively associated with the fasting triglyceride levels. We identified alterations in lysoPCs, amides, and cis-4-octenedioic acid among non-diabetic and non-obese individuals with borderline-to-moderate HTG. These results provide novel insights into the metabolic alterations that occur in the early metabolic stages of HTG. This information may facilitate the design of early interventions to prevent disease progression.	[Lee, Sae Young] Yonsei Univ, Interdisciplinary Course Sci Aging, Seoul 120749, South Korea; [Kim, Minjoo; Lee, Jong Ho] Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul 120749, South Korea; [Jung, Saem; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Natl Leading Res Lab Clin Nutrigenet Nutrigen, Seoul 120749, South Korea; [Jung, Saem; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Brain Korea PLUS Project 21, Dept Food & Nutr, Seoul 120749, South Korea; [Lee, Sang-Hyun] Natl Hlth Insurance Corp Ilsan Hosp, Dept Family Practice, Goyang, South Korea; [Lee, Jong Ho] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System	Lee, JH (corresponding author), Yonsei Univ, Inst Symbiot Life TECH, Res Ctr Silver Sci, Seoul 120749, South Korea.	jhleeb@yonsei.ac.kr			Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2012M3A9C4048762]	Bio-Synergy Research Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation	This work was supported by the Bio-Synergy Research Project (NRF-2012M3A9C4048762) of the Ministry of Science, ICT and Future Planning through the National Research Foundation.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cui Y, 2014, J NEUROPATH EXP NEUR, V73, P954, DOI 10.1097/NEN.0000000000000116; Driscoll WJ, 2007, J BIOL CHEM, V282, P22353, DOI 10.1074/jbc.M610070200; Eisinger K, 2014, EXP MOL PATHOL, V97, P37, DOI 10.1016/j.yexmp.2014.05.002; Eriksson L., 2006, MULTI AND MEGAVARIAT; Farrell EK, 2012, J LIPID RES, V53, P247, DOI 10.1194/jlr.M018606; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Friedrich N, 2012, J ENDOCRINOL, V215, P29, DOI 10.1530/JOE-12-0120; Goncalves I, 2012, ARTERIOSCL THROM VAS, V32, P1505, DOI 10.1161/ATVBAHA.112.249854; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x; HINE DG, 1984, BIOMED MASS SPECTROM, V11, P332, DOI 10.1002/bms.1200110704; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; JIN SJ, 1989, J LIPID RES, V30, P1611; JIN SJ, 1990, BIOCHEMISTRY-US, V29, P8540, DOI 10.1021/bi00489a006; Jung S, 2015, METABOLOMICS, V11, P40, DOI 10.1007/s11306-014-0669-3; Katsuki A, 2003, DIABETES CARE, V26, P2341, DOI 10.2337/diacare.26.8.2341; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096735; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Matsumoto T, 2007, CURR MED CHEM, V14, P3209, DOI 10.2174/092986707782793899; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Merkler DJ, 1996, ARCH BIOCHEM BIOPHYS, V330, P430, DOI 10.1006/abbi.1996.0272; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Qiu YP, 2009, J PROTEOME RES, V8, P4844, DOI 10.1021/pr9004162; Rizzo M, 2005, J ATHEROSCLER THROMB, V12, P237, DOI 10.5551/jat.12.237; Sahebkar A, 2014, PROG LIPID RES, V56, P47, DOI 10.1016/j.plipres.2014.07.002; Sasabe N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-48; Simental-Mendia LE, 2013, DIABETES-METAB RES, V29, P214, DOI 10.1002/dmrr.2379; Skoog T, 2002, EUR HEART J, V23, P376, DOI 10.1053/euhj.2001.2805; TSERNG KY, 1990, J LIPID RES, V31, P763; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Wilcox BJ, 1999, BIOCHEMISTRY-US, V38, P3235, DOI 10.1021/bi982255j; Wold S., 1995, QSAR CHEMOMETRIC MET, V2, P195; Yang L, 2008, CHEM RES TOXICOL, V21, P2280, DOI 10.1021/tx800225q	38	6	7	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123306	10.1371/journal.pone.0123306	http://dx.doi.org/10.1371/journal.pone.0123306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856314	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500086
J	Li, X; Ju, Q; Jie, WC; Li, F; Jiang, XJ; Hu, JJ; Qu, MJ				Li, Xiao; Ju, Qian; Jie, Wencai; Li, Fei; Jiang, Xiaojing; Hu, Jingjing; Qu, Mingjing			Chemosensory Gene Families in Adult Antennae of Anomala corpulenta Motschulsky (Coleoptera: Scarabaeidae: Rutelinae)	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; PHEROMONE DETECTION; RECEPTORS; TRANSCRIPTOME; ANNOTATION; MOTH; IDENTIFICATION; LOCALIZATION; PURIFICATION; EVOLUTION	Background The metallic green beetle, Anomala corpulenta (Coleoptera: Scarabaeidae: Rutelinae), is a destructive pest in agriculture and horticulture throughout Asia, including China. Olfaction plays a crucial role in the survival and reproduction of A. corpulenta. As a non-model species, A. corpulenta is poorly understood, and information regarding the molecular mechanisms underlying olfaction in A. corpulenta and other scarab species is scant. Methodology/Principle Findings We assembled separate antennal transcriptome for male and female A. corpulenta using Illumina sequencing technology. The relative abundance of transcripts with gene ontology annotations, including those related to olfaction in males and females was highly similar. Transcripts encoding 15 putative odorant binding proteins, five chemosensory proteins, one sensory neuron membrane protein, 43 odorant receptors, eight gustatory receptors, and five ionotropic receptors were identified. The sequences of all of these chemosensory-related transcripts were confirmed using reverse transcription polymerase chain reaction (RTPCR), and direct DNA sequencing. The expression patterns of 54 putative chemosensory genes were analyzed using quantitative real time RT-PCR (qRT-PCR). Antenna-specific expression was detected for many of these genes, suggesting that they may have important functions in semiochemical detection. Conclusions The identification of a large number of chemosensory proteins provides a major resource for the study of the molecular mechanism of odorant detection in A. corpulenta and its chemical ecology. The genes identified, especially those that were expressed at high levels in the antennae may represent novel molecular targets for the development of population control strategies based on the manipulation of chemoreception-driven behaviors.	[Li, Xiao; Ju, Qian; Jiang, Xiaojing; Hu, Jingjing; Qu, Mingjing] Shandong Peanut Res Inst, Qingdao 266100, Shandong, Peoples R China; [Jie, Wencai; Li, Fei] Nanjing Agr Univ, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Qu, MJ (corresponding author), Shandong Peanut Res Inst, Fushan Rd 126, Qingdao 266100, Shandong, Peoples R China.	13455277580@163.com		Li, Xiao/0000-0002-0505-1654	China Agriculture Research System [CARS-14]; Shandong Foundation for Outstanding Young Scientists [BS2010NY022]; Agriculture Science Technology Achievement Transformation Fund [2013GB2C620547]; Open Fund Project of the Key Laboratory of Crop Comprehensive Management of Biological Disasters, Ministry of Education, Nanjing Agricultural University [IMCDP201304]	China Agriculture Research System; Shandong Foundation for Outstanding Young Scientists; Agriculture Science Technology Achievement Transformation Fund; Open Fund Project of the Key Laboratory of Crop Comprehensive Management of Biological Disasters, Ministry of Education, Nanjing Agricultural University	This study was supported by awards and grants from the China Agriculture Research System (CARS-14); the Shandong Foundation for Outstanding Young Scientists (BS2010NY022); the Agriculture Science Technology Achievement Transformation Fund (2013GB2C620547); and the Open Fund Project of the Key Laboratory of Crop Comprehensive Management of Biological Disasters, Ministry of Education, Nanjing Agricultural University (IMCDP201304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001319; Andersson MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-198; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Dani FR, 2011, CHEM SENSES, V36, P335, DOI 10.1093/chemse/bjq137; Engsontia P, 2008, INSECT BIOCHEM MOLEC, V38, P387, DOI 10.1016/j.ibmb.2007.10.005; Field LM, 2000, INSECT MOL BIOL, V9, P545, DOI 10.1046/j.1365-2583.2000.00221.x; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gong L, 2012, B ENTOMOL RES, V102, P600, DOI 10.1017/S0007485312000168; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Guo M, 2014, INT J BIOL SCI, V10, P1, DOI 10.7150/ijbs.7624; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Jacquin-Joly E, 2012, INT J BIOL SCI, V8, P1036, DOI 10.7150/ijbs.4469; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; Mitchell RF, 2012, INSECT BIOCHEM MOLEC, V42, P499, DOI 10.1016/j.ibmb.2012.03.007; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; NOMURA A, 1992, INT J DEV BIOL, V36, P391; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poivet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060263; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; WEI XT, 1995, BIOL CONTROL, V5, P290, DOI 10.1006/bcon.1995.1036; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Zhang J, 2014, INSECT SCI IN PRESS, DOI [10.1111/1744-7917.12131, DOI 10.1111/1744-7917.12131]; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JingJiang, 2010, Outlooks on Pest Management, V21, P31, DOI 10.1564/21feb08; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930; Zhu JY, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/491748	62	36	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121504	10.1371/journal.pone.0121504	http://dx.doi.org/10.1371/journal.pone.0121504			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856077	Green Published, gold			2022-12-27	WOS:000352588500021
J	Ali, EAI; Barakat, BM; Hassan, R				Ali, Eman A. I.; Barakat, Bassant M.; Hassan, Ranya			Antioxidant and Angiostatic Effect of Spirulina platensis Suspension in Complete Freund's Adjuvant-Induced Arthritis in Rats	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; OXIDATIVE STRESS; C-PHYCOCYANIN; ANGIOGENESIS; INFLAMMATION; INDOMETHACIN; INTEGRINS; CELECOXIB; DISEASE	Background Currently, natural products have built a well-recognized role in the management of many degenerative diseases, mainly rheumatoid arthritis. Recent studies suggest that Spirulina, a unicellular blue-green alga, may have a variety of health benefits and curative properties and is also competent of acting as an anti-inflammatory, antioxidant and recently anti-angiogenic agent. In the present study, the antioxidant and the immunomodulatory effect of Spirulina platensis as well as its anti-angiogenic effect against complete Freund's adjuvant-induced arthritis (AIA) in rat model were tested. Results We found that the development of arthritis was concealed; moreover it successfully inhibited the development of macroscopic as well as microscopic and histopathological lesions in AIA rats when compared to control. Spirulina treated group showed a higher survival rate and moreover, it reduced the clinical score of RA in a dose dependent manner. Furthermore, Spirulina decreased serum levels of COX-2, TNF-alpha, IL-6, TBARS, VEGF and increased serum levels of GSH compared to the RA non-treated group. Conclusions The present study concluded that Spirulina is able to restrain the changes produced through adjuvant-induced arthritis. The suppressing effect of Spirulina could be attributed, at least in part, to anti-inflammatory, antioxidant and anti-angiogenic properties.	[Ali, Eman A. I.] Suez Canal Univ, Fac Med, Dept Histol & Cell Biol, Ismailia, Egypt; [Barakat, Bassant M.] Al Azhar Univ, Fac Pharm Girls, Dept Pharmacol & Toxicol, Cairo, Egypt; [Hassan, Ranya] Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismailia, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); Suez Canal University	Hassan, R (corresponding author), Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismailia, Egypt.	ranyamoustafa@hotmail.com	Hassan, Ranya Moustafa/R-2421-2018	Hassan, Ranya Moustafa/0000-0001-7178-1965; Barakat, Bassant/0000-0003-1800-5814				Abdel-Daim MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072991; Ahn MY, 2013, TOX RESEARCH, V29, P195, DOI 10.5487/TR.2013.29.3.195; Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; ALBANI S, 1997, ARTHRITIS ALLIED CON, P979; Azab SS, 2013, MED CHEM RES, V22, P4269, DOI 10.1007/s00044-012-0420-4; Barton A, 2009, ARTHRIT CARE RES, V61, P1441, DOI 10.1002/art.24672; Belay A., 2020, J AM NUTRACEUTICAL A, V5, P27; Chen JC, 2012, NUTR NEUROSCI, V15, P252, DOI 10.1179/1476830512Y.0000000020; Cho ML, 2002, ARTHRITIS RHEUM, V46, P1202, DOI 10.1002/art.10215; Clavel G, 2003, JOINT BONE SPINE, V70, P321, DOI 10.1016/S1297-319X(03)00088-5; Datta S, 2014, CLIN RHEUMATOL, V33, P1557, DOI 10.1007/s10067-014-2597-z; Dillon J C, 1995, World Rev Nutr Diet, V77, P32; El-Desoky GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059177; El-Sayed RM, 2014, INFLAMMOPHARMACOLOGY, V22, P305, DOI 10.1007/s10787-014-0200-5; Eldahshan OA, 2014, CYTOTECHNOL IN PRESS; Goldbach-Mansky R, 2003, ANNU REV MED, V54, P197, DOI 10.1146/annurev.med.54.101601.152342; Ibrahim A, 2015, CELL J YAKH IN PRESS, P17; Kavanaugh Arthur, 2007, Am J Orthop (Belle Mead NJ), V36, P4; Kimpel D, 2003, ARTHRITIS RHEUM-US, V48, P3557, DOI 10.1002/art.11424; Koch AE, 2000, ANN RHEUM DIS, V59, P65, DOI 10.1136/ard.59.suppl_1.i65; Koch AE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2187; Kumar Narendra, 2009, Inflammopharmacology, V17, P181, DOI 10.1007/s10787-009-0004-1; Kundu S, 2012, FREE RADICAL RES, V46, P1482, DOI 10.3109/10715762.2012.727991; Lee D, 2011, LANCET, V358, P903; Madkour FF, 2013, INDIAN J PHARM SCI, V75, P642; Majithia V, 2007, AM J MED, V120, P936, DOI 10.1016/j.amjmed.2007.04.005; Mi WL, 2008, BRAIN RES BULL, V77, P98, DOI 10.1016/j.brainresbull.2008.04.008; Muller-Ladner U, 2005, NAT CLIN PRACT RHEUM, V1, P102, DOI 10.1038/ncprheum0047; O'Dell JR, 2001, BEST PRACT RES CL RH, V15, P125, DOI 10.1053/berh.2000.0130; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Piliero S J, 1966, Life Sci, V5, P1057, DOI 10.1016/0024-3205(66)90088-9; Ruegg C, 2003, CELL MOL LIFE SCI, V60, P1135, DOI 10.1007/s00018-003-2297-3; Ruegg C, 2004, BBA-REV CANCER, V1654, P51, DOI 10.1016/j.bbcan.2003.09.003; Schramm C, 2004, ARTHRITIS RES THER, V6, pR114, DOI 10.1186/ar1039; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shih CM, 2009, ANESTH ANALG, V108, P1303, DOI 10.1213/ane.0b013e318193e919; SUN Y, 1990, FREE RADICAL BIO MED, V8, P583, DOI 10.1016/0891-5849(90)90156-D; Taiwo Victor Olusegun, 2008, Veterinarski Arhiv, V78, P167; Ucar A, 1998, INFLAMMATION, V22, P243, DOI 10.1023/A:1022354614385; Vogler GA, 2006, AM COLL LAB, P627, DOI 10.1016/B978-012074903-4/50022-4; Yang LL, 2012, INT J OPHTHALMOL-CHI, V5, P32, DOI 10.3980/j.issn.2222-3959.2012.01.07; Zhang CF, 2014, J ETHNOPHARMACOL, V153, P793, DOI 10.1016/j.jep.2014.03.046	42	40	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121523	10.1371/journal.pone.0121523	http://dx.doi.org/10.1371/journal.pone.0121523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853428	gold, Green Submitted, Green Published			2022-12-27	WOS:000352478400041
J	Bitocchi, E; Bellucci, E; Rau, D; Albertini, E; Rodriguez, M; Veronesi, F; Attene, G; Nanni, L				Bitocchi, Elena; Bellucci, Elisa; Rau, Domenico; Albertini, Emidio; Rodriguez, Monica; Veronesi, Fabio; Attene, Giovanna; Nanni, Laura			European Flint Landraces Grown In Situ Reveal Adaptive Introgression from Modern Maize	PLOS ONE			English	Article							BEAN PHASEOLUS-VULGARIS; ESTIMATING POPULATION-STRUCTURE; GENE FLOW; DIVERGENT SELECTION; AFLP; DIVERSITY; HYBRIDIZATION; DOMESTICATION; POLYMORPHISM; DOMINANT	We have investigated the role of selection in the determination of the detected levels of introgression from modern maize hybrid varieties into maize landraces still cultivated in situ in Italy. We exploited the availability of a historical collection of landraces undertaken before the introduction and widespread use of modern maize, to analyse genomic changes that have occurred in these maize landraces over 50 years of co-existence with hybrid varieties. We have combined a previously published SSR dataset (n=21) with an AFLP loci dataset (n=168) to provide higher resolution power and to obtain a more detailed picture. We show that selection pressures for adaptation have favoured new alleles introduced by migration from hybrids. This shows the potential for analysis of historical introgression even over this short period of 50 years, for an understanding of the evolution of the genome and for the identification of its functionally important regions. Moreover, this demonstrates that landraces grown in situ represent almost unique populations for use for such studies when the focus is on the domesticated plant. This is due to their adaptation, which has arisen from their dynamic evolution under a continuously changing agro-ecological environment, and their capture of new alleles from hybridisation. We have also identified loci for which selection has inhibited introgression from modern germplasm and has enhanced the distinction between landraces and modern maize. These loci indicate that selection acted in the past, during the formation of the flint and dent gene pools. In particular, the locus showing the strongest signals of selection is a Misfit transposable element. Finally, molecular characterisation of the same samples with two different molecular markers has allowed us to compare their performances. Although the genetic-diversity and population-structure analyses provide the same global qualitative pattern, which thus provides the same inferences, there are differences related to their natures and characteristics.	[Bitocchi, Elena; Bellucci, Elisa; Nanni, Laura] Univ Politecn Marche, Dept Agr Food & Environm Sci, Ancona, Italy; [Rau, Domenico; Rodriguez, Monica; Attene, Giovanna] Univ Sassari, Dept Agr, I-07100 Sassari, Italy; [Albertini, Emidio; Veronesi, Fabio] Univ Perugia, Dept Agr Food & Environm Sci, I-06100 Perugia, Italy	Marche Polytechnic University; University of Sassari; University of Perugia	Bitocchi, E (corresponding author), Univ Politecn Marche, Dept Agr Food & Environm Sci, Ancona, Italy.	e.bitocchi@univpm.it	Bitocchi, Elena/J-7996-2019; Nanni, Laura/HDN-7936-2022; Bellucci, Elisa/AAS-9237-2021; Rodriguez, Monica/G-6731-2012; Albertini, Emidio/F-7393-2014	Bitocchi, Elena/0000-0002-2152-4634; Rodriguez, Monica/0000-0001-8926-2987; Veronesi, Fabio/0000-0001-7884-6987; Rau, Domenico/0000-0002-5294-9053; Albertini, Emidio/0000-0003-2585-5649	Universita Politecnica delle Marche	Universita Politecnica delle Marche	This work was funded by Universita Politecnica delle Marche. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON E, 1948, EVOLUTION, V2, P1, DOI 10.2307/2405610; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Anderson E., 1949, INTROGRESSIVE HYBRID; [Anonymous], 1999, POPGENE VERSION 1 3; Arnaud JF, 2003, P ROY SOC B-BIOL SCI, V270, P1565, DOI 10.1098/rspb.2003.2407; Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bellucci E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083891; Bitocchi E, 2009, MOL ECOL, V18, P603, DOI 10.1111/j.1365-294X.2008.04064.x; Bitocchi E, 2009, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.1339, DOI 10.5061/DRYAD.1339]; Bitocchi E, 2013, NEW PHYTOL, V197, P300, DOI 10.1111/j.1469-8137.2012.04377.x; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Campbell D, 2003, MOL ECOL, V12, P1979, DOI 10.1046/j.1365-294X.2003.01856.x; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Chapman MA, 2008, PLANT CELL, V20, P2931, DOI 10.1105/tpc.108.059808; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2010, MOL ECOL, V19, P4638, DOI 10.1111/j.1365-294X.2010.04820.x; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Fujino K, 2010, MOL GENET GENOMICS, V284, P137, DOI 10.1007/s00438-010-0555-2; Garoia F, 2007, MOL ECOL, V16, P1377, DOI 10.1111/j.1365-294X.2007.03247.x; Goettel W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000516; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hufford MB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003477; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; KIMURA M, 1964, GENETICS, V49, P725; Krauss SL, 2000, MOL ECOL, V9, P1241, DOI 10.1046/j.1365-294x.2000.01001.x; Levin DA, 1996, CONSERV BIOL, V10, P10, DOI 10.1046/j.1523-1739.1996.10010010.x; LEWONTIN RC, 1966, EVOLUTION, V20, P315, DOI 10.1111/j.1558-5646.1966.tb03369.x; LEWONTIN RC, 1973, GENETICS, V74, P175; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MANTEL N, 1967, CANCER RES, V27, P209; Mariette S, 2002, SILVAE GENET, V51, P72; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Messing J, 2006, CURR OPIN PLANT BIOL, V9, P157, DOI 10.1016/j.pbi.2006.01.009; Morrell PL, 2005, MOL ECOL, V14, P2143, DOI 10.1111/j.1365-294X.2005.02579.x; NEI M, 1974, GENETICS, V76, P379; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Papa R, 2005, THEOR APPL GENET, V111, P1147, DOI 10.1007/s00122-005-0045-9; Papa R, 2003, THEOR APPL GENET, V106, P239, DOI 10.1007/s00122-002-1085-z; Papa R, 2007, ANN BOT-LONDON, V100, P1039, DOI 10.1093/aob/mcm151; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Figueroa A, 2010, J EVOLUTION BIOL, V23, P2267, DOI 10.1111/j.1420-9101.2010.02093.x; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Pritchard JK, 2000, GENETICS, V155, P945; Pusadee T, 2009, P NATL ACAD SCI USA, V106, P13880, DOI 10.1073/pnas.0906720106; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Roques S, 1999, MOL ECOL, V8, P1703, DOI 10.1046/j.1365-294x.1999.00759.x; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VEKEMANS X, 2002, AFLP SURV VERSION 1; Vigouroux Y, 2002, P NATL ACAD SCI USA, V99, P9650, DOI 10.1073/pnas.112324299; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang QH, 2006, P NATL ACAD SCI USA, V103, P17644, DOI 10.1073/pnas.0603080103; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitney KD, 2010, PERSPECT PLANT ECOL, V12, P175, DOI 10.1016/j.ppees.2010.02.002; Woodhead M, 2005, MOL ECOL, V14, P1681, DOI 10.1111/j.1365-294X.2005.02543.x; Wu YR, 2009, THEOR APPL GENET, V119, P721, DOI 10.1007/s00122-009-1083-5; Xia HB, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016189, 10.1371/journal.pone.0028553]; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	83	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121381	10.1371/journal.pone.0121381	http://dx.doi.org/10.1371/journal.pone.0121381			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853809	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400037
J	Jackson, JA; Linse, K; Whittle, R; Griffiths, HJ				Jackson, Jennifer A.; Linse, Katrin; Whittle, Rowan; Griffiths, Huw J.			The Evolutionary Origins of the Southern Ocean Philobryid Bivalves: Hidden Biodiversity, Ancient Persistence	PLOS ONE			English	Article							PHYLOGENETIC INFERENCE; LIMOPSIS BIVALVIA; HIGH-LATITUDES; MODELS; SEQUENCES; MAXIMUM; SEA; REPRODUCTION; ALIGNMENTS; ANTARCTICA	Philobryids (Bivalvia: Arcoida) are one of the most speciose marine bivalve families in the Southern Ocean and are common throughout the Southern Hemisphere. Considering this diversity and their brooding reproductive mode (limiting long-distance dispersal), this family may have been present in the Southern Ocean since its inception. However Philobrya and Adacnarca appear only in the Quaternary fossil record of the Antarctic, suggesting a much more recent incursion. Molecular dating provides an independent means of measuring the time of origin and radiation of this poorly known group. Here we present the first combined molecular and morphological investigation of the Philobryidae in the Southern Ocean. Two nuclear loci (18S and 28S) were amplified from 35 Southern Ocean Adacnarca and Philobrya specimens, with a combined sequence length of 2,282 base pairs (bp). Adacnarca specimens (A. nitens and A. limopsoides) were resolved as a strongly supported monophyletic group. Genus Philobrya fell into two strongly supported groups ('sublaevis' and 'magellanica/wandelensis'), paraphyletic with Adacnarca. The A. nitens species complex is identified as at least seven morpho-species through morphological and genetic analysis of taxon clustering. Phylogenetic analyses resolve Philobryidae as a strongly supported monophyletic clade and sister taxon to the Limopsidae, as anticipated by their classification into the superfamily Limopsoidea. Bayesian relaxed clock analyses of divergence times suggest that genus Adacnarca radiated in the Southern Ocean from the Early Paleogene, while P. sublaevis and P. wandelensis clades radiated in the late Miocene, following the formation of the Antarctic Circumpolar Current.	[Jackson, Jennifer A.; Linse, Katrin; Whittle, Rowan; Griffiths, Huw J.] British Antarctic Survey, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Jackson, JA (corresponding author), British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England.	jennifer.jackson@bas.ac.uk	Griffiths, Huw J/D-4234-2009	Griffiths, Huw J/0000-0003-1764-223X; Linse, Katrin/0000-0003-3477-3047	Natural Environment Research Council; NERC [bas0100026, bas0100030] Funding Source: UKRI; Natural Environment Research Council [bas0100026, bas0100030] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (http://www.nerc.ac.uk) and is a contribution to British Antarctic Survey core project 'EVOLHIST' under the NERC 'Polar Science for Planet Earth' programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bowden DA, 2005, MAR ECOL PROG SER, V297, P101, DOI 10.3354/meps297101; BREY T, 1992, MAR ECOL PROG SER, V82, P219, DOI 10.3354/meps082219; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke A, 2010, PHILOS T R SOC B, V365, P3655, DOI 10.1098/rstb.2010.0270; Dalziel IWD, 2013, GEOLOGY, V41, P947, DOI 10.1130/G34352.1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dell RK, 1964, DISCOVERY REPORTS, V33; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fujisawa T, 2013, SYST BIOL; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gordillo S, 2005, SCI MAR, V69, P337, DOI 10.3989/scimar.2005.69s2337; Grant RA, 2011, POLAR BIOL, V34, P775, DOI 10.1007/s00300-010-0932-7; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Higgs ND, 2009, MAR BIOL, V156, P1073, DOI 10.1007/s00227-009-1154-9; Janosik AM, 2010, INTEGR COMP BIOL, V50, P981, DOI 10.1093/icb/icq119; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Linse K, 2005, EXPEDITION ANTARKTIS, P74; Linse K, 2003, BER POLARFORSCH, V462, P19; Linse K, 2003, EXPEDITIONS ANTARKTI, P101; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Malchus N, 2005, MAR BIOL RES, V1, P350, DOI 10.1080/17451000500384100; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; NICOL DAVID, 1950, JOUR PALEONTOL, V24, P89; Oliver PG, 2006, ZOOL J LINN SOC-LOND, V148, P237, DOI 10.1111/j.1096-3642.2006.00256.x; OLIVER PG, 1981, MALACOLOGIA, V21, P61; Pearse JS, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P181, DOI 10.5479/si.097884601X.13; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulin E, 2014, GLOBAL PLANET CHANGE; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rambaut A., 2007, TRACE 1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savill NJ, 2001, GENETICS, V157, P399; SCHONIGER M, 1994, MOL PHYLOGENET EVOL, V3, P240, DOI 10.1006/mpev.1994.1026; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Skelton P.W., 1993, P237; Steiner G, 2000, GEOL SOC SPEC PUBL, V177, P11, DOI 10.1144/GSL.SP.2000.177.01.02; Stiller F, 2004, J PALEONTOL, V78, P414, DOI 10.1666/0022-3360(2004)078<0414:ESNGAS>2.0.CO;2; Strugnell JM, 2008, CLADISTICS, V24, P853, DOI 10.1111/j.1096-0031.2008.00234.x; Tevesz MJS, 1977, TAXONOMY ECOLOGY PHI; Van de Putte AP, 2014, ANTARCTIC BIODIVERSI; Whittle RJ, 2011, PALAEONTOLOGY, V54, P935, DOI 10.1111/j.1475-4983.2011.01061.x; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	52	6	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121198	10.1371/journal.pone.0121198	http://dx.doi.org/10.1371/journal.pone.0121198			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853413	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000352478400032
J	Mei, YJ; He, CC; Huang, YC; Liu, Y; Zhang, ZQ; Chen, XD; Shen, P				Mei, Yunjun; He, Congcong; Huang, Yongchi; Liu, Ying; Zhang, Ziqian; Chen, Xiangdong; Shen, Ping			Salinity Regulation of the Interaction of Halovirus SNJ1 with Its Host and Alteration of the Halovirus Replication Strategy to Adapt to the Variable Ecosystem	PLOS ONE			English	Article							BACTERIOPHAGE INFECTING HALOBACTERIUM; NUCLEOTIDE-SEQUENCE; ICOSAHEDRAL VIRUSES; IDENTIFICATION; GLYCOSYLATION; HALOBIUM; ARCHAEA; ENVIRONMENTS; ORGANIZATION; ATTACHMENT	Halovirus is a major force that affects the evolution of extreme halophiles and the biogeochemistry of hypersaline environments. However, until now, the systematic studies on the halovirus ecology and the effects of salt concentration on virus-host systems are lacking. To provide more valuable information for understanding ecological strategies of a virus-host system in the hypersaline ecosystem, we studied the interaction between halovirus SNJ1 and its host Natrinema sp. J7-2 under various NaCl concentrations. We found that the adsorption rate and lytic rate increased with salt concentration, demonstrating that a higher salt concentration promoted viral adsorption and proliferation. Contrary to the lytic rate, the lysogenic rate decreased as the salt concentration increased. Our results also demonstrated that cells incubated at a high salt concentration prior to infection increased the ability of the virus to adsorb and lyse its host cells; therefore, the physiological status of host cells also affected the virus-host interaction. In conclusion, SNJ1 acted as a predator, lysing host cells and releasing progeny viruses in hypersaline environments; in low salt environments, viruses lysogenized host cells to escape the damage from low salinity.	[Mei, Yunjun; He, Congcong] Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Hubei, Peoples R China; [Huang, Yongchi] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China; [Liu, Ying; Zhang, Ziqian; Chen, Xiangdong; Shen, Ping] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China	Wuhan Polytechnic University; Wuhan Polytechnic University; Wuhan University	Mei, YJ (corresponding author), Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Hubei, Peoples R China.	meiyunjun_2000@163.com; xdchen@whu.edu.cn		Huang, Yongchi/0000-0002-3938-529X	Natural Science Foundation of China [31270215]; National Basic Research Program of China (973 Program) [2011CB808800]; Ministry of Science and Technology of the People's Republic of China; Open Research Fund Program of the State Key Laboratory of Virology of China [2014KF003]; Graduate Education Innovation Fund of Wuhan Polytechnic University [2013cx003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Open Research Fund Program of the State Key Laboratory of Virology of China; Graduate Education Innovation Fund of Wuhan Polytechnic University	This work was supported by grants from the Natural Science Foundation of China (no. 31270215, to YM), the National Basic Research Program of China (973 Program, no. 2011CB808800), Ministry of Science and Technology of the People's Republic of China (to XC) Open Research Fund Program of the State Key Laboratory of Virology of China (no. 2014KF003, to YM) and Graduate Education Innovation Fund of Wuhan Polytechnic University (no. 2013cx003, to CH). The	Aalto AP, 2012, P NATL ACAD SCI USA, V109, P7079, DOI 10.1073/pnas.1120174109; Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Atanasova NS, 2012, ENVIRON MICROBIOL, V14, P426, DOI 10.1111/j.1462-2920.2011.02603.x; Bettarel Y, 2006, APPL ENVIRON MICROB, V72, P5274, DOI 10.1128/AEM.00863-06; Calo D, 2011, MOL MICROBIOL, V81, P1166, DOI 10.1111/j.1365-2958.2011.07781.x; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; DANIELS LL, 1990, APPL ENVIRON MICROB, V56, P3605, DOI 10.1128/AEM.56.11.3605-3608.1990; Dyall-Smith M, 2003, RES MICROBIOL, V154, P309, DOI 10.1016/S0923-2508(03)00076-7; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Jaakkola ST, 2012, J VIROL, V86, P4734, DOI 10.1128/JVI.06666-11; Jaalinoja HT, 2008, P NATL ACAD SCI USA, V105, P8008, DOI 10.1073/pnas.0801758105; Jalasvuori M, 2010, J BACTERIOL, V192, P3231, DOI 10.1128/JB.00124-10; Jalasvuori M, 2009, J VIROL, V83, P9388, DOI 10.1128/JVI.00869-09; Jones GM, 2012, J BACTERIOL, V194, P2693, DOI 10.1128/JB.06686-11; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kandiba L, 2013, BBA-BIOMEMBRANES, V1828, P938, DOI 10.1016/j.bbamem.2012.11.023; Kandler O, 1985, BACTERIA TREATISE ST; Klein R, 2002, MOL MICROBIOL, V45, P851, DOI 10.1046/j.1365-2958.2002.03064.x; Kukkaro P, 2009, ENV MICROBIOL REP, V1, P71, DOI 10.1111/j.1758-2229.2008.00007.x; MAGRUM LJ, 1978, J MOL EVOL, V11, P1, DOI 10.1007/BF01768019; Matsushita I, 2009, J BIOCHEM, V146, P775, DOI 10.1093/jb/mvp125; Mei YJ, 2007, CAN J MICROBIOL, V53, P1106, DOI 10.1139/W07-072; Meyer BH, 2011, MOL MICROBIOL, V82, P1150, DOI 10.1111/j.1365-2958.2011.07875.x; Ng SYM, 2008, J BACTERIOL, V190, P6039, DOI 10.1128/JB.00546-08; NUTTALL SD, 1995, J VIROL, V69, P2322, DOI 10.1128/JVI.69.4.2322-2327.1995; Oren A, 1990, MICOBIOL MOL BIOL RE, V63, P334; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; PAULING C, 1982, CAN J MICROBIOL, V28, P916, DOI 10.1139/m82-138; Pietila MK, 2014, TRENDS MICROBIOL, V22, P334, DOI 10.1016/j.tim.2014.02.007; Pina M, 2011, FEMS MICROBIOL REV, V35, P1035, DOI 10.1111/j.1574-6976.2011.00280.x; Porter K, 2007, CURR OPIN MICROBIOL, V10, P418, DOI 10.1016/j.mib.2007.05.017; Porter K, 2013, ARCHAEA, V2013, DOI 10.1155/2013/456318; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; Roine E, 2010, J VIROL, V84, P3682, DOI 10.1128/JVI.01879-09; SCHNABEL H, 1984, P NATL ACAD SCI-BIOL, V81, P1017, DOI 10.1073/pnas.81.4.1017; Sencilo A, 2012, NUCLEIC ACIDS RES, V40, P5523, DOI 10.1093/nar/gks215; Shen P, 1994, Yi Chuan Xue Bao, V21, P409; Sime-Ngando T, 2011, ENVIRON MICROBIOL, V13, P1956, DOI 10.1111/j.1462-2920.2010.02323.x; Srinivasiah S, 2008, RES MICROBIOL, V159, P349, DOI 10.1016/j.resmic.2008.04.010; STOECKENIUS W, 1967, J CELL BIOL, V34, P365, DOI 10.1083/jcb.34.1.365; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; TORSVIK T, 1974, NATURE, V248, P680, DOI 10.1038/248680a0; TORSVIK T, 1980, J GEN VIROL, V47, P29, DOI 10.1099/0022-1317-47-1-29; VanDyke DJ, 2009, MOL MICROBIOL, V72, P633, DOI 10.1111/j.1365-2958.2009.06671.x; WAIS AC, 1975, NATURE, V256, P314, DOI 10.1038/256314a0; WAIS AC, 1985, FEMS MICROBIOL ECOL, V31, P323, DOI 10.1111/j.1574-6968.1985.tb01167.x; Ye XC, 2003, FEMS MICROBIOL LETT, V221, P53, DOI 10.1016/S0378-1097(03)00175-7; Zhang ZQ, 2012, VIROLOGY, V434, P233, DOI 10.1016/j.virol.2012.05.036; Zhang ZQ., 2012, STUDY TEMPERATE HALO, P84	52	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123874	10.1371/journal.pone.0123874	http://dx.doi.org/10.1371/journal.pone.0123874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853566	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400124
J	Moleirinho, A; Lopes, AM; Seixas, S; Morales-Hojas, R; Prata, MJ; Amorim, A				Moleirinho, Ana; Lopes, Alexandra M.; Seixas, Susana; Morales-Hojas, Ramiro; Prata, Maria J.; Amorim, Antonio			Distinctive Patterns of Evolution of the delta-Globin Gene (HBD) in Primates	PLOS ONE			English	Article							FUNCTIONAL DIVERSIFICATION; PURIFYING SELECTION; SUBSTITUTION MODELS; SEQUENCE-ANALYSIS; FETAL-HEMOGLOBIN; MOSAIC STRUCTURE; BETA; CONVERSION; RECOMBINATION; DUPLICATION	In most vertebrates, hemoglobin (Hb) is a heterotetramer composed of two dissimilar globin chains, which change during development according to the patterns of expression of alpha- and beta-globin family members. In placental mammals, the beta-globin cluster includes three early-expressed genes, epsilon(HBE)-gamma(HBG)-psi beta(HBBP1), and the late expressed genes, delta (HBD) and beta (HBB). While HBB encodes the major adult beta-globin chain, HBD is weakly expressed or totally silent. Paradoxically, in human populations HBD shows high levels of conservation typical of genes under strong evolutionary constraints, possibly due to a regulatory role in the fetal-to-adult switch unique of Anthropoid primates. In this study, we have performed a comprehensive phylogenetic and comparative analysis of the two adult beta-like globin genes in a set of diverse mammalian taxa, focusing on the evolution and functional divergence of HBD in primates. Our analysis revealed that anthropoids are an exception to a general pattern of concerted evolution in placental mammals, showing a high level of sequence conservation at HBD, less frequent and shorter gene conversion events. Moreover, this lineage is unique in the retention of a functional GATA-1 motif, known to be involved in the control of the developmental expression of the beta-like globin genes. We further show that not only the mode but also the rate of evolution of the delta-globin gene in higher primates are strictly associated with the fetal/adult beta-cluster developmental switch. To gain further insight into the possible functional constraints that have been shaping the evolutionary history of HBD in primates, we calculated dN/dS (omega) ratios under alternative models of gene evolution. Although our results indicate that HBD might have experienced different selective pressures throughout primate evolution, as shown by different. values between apes and Old World Monkeys + New World Monkeys (0.06 versus 0.43, respectively), these estimates corroborated a constrained evolution for HBD in Anthropoid lineages, which is unlikely to be related to protein function. Collectively, these findings suggest that sequence change at the delta-globin gene has been under strong selective constraints over 65 Myr of primate evolution, likely due to a regulatory role in ontogenic switches of gene expression.	[Moleirinho, Ana; Lopes, Alexandra M.; Seixas, Susana; Prata, Maria J.; Amorim, Antonio] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Porto, Portugal; [Moleirinho, Ana; Lopes, Alexandra M.; Seixas, Susana; Prata, Maria J.; Amorim, Antonio] Univ Porto, Inst Mol Pathol & Immunol IPATIMUP, P-4100 Porto, Portugal; [Moleirinho, Ana; Prata, Maria J.; Amorim, Antonio] Univ Porto, Fac Sci, Dept Biol, P-4100 Porto, Portugal; [Morales-Hojas, Ramiro] Pirbright Inst, Compton Lab, Genet & Genom Grp, Compton, Berkshire, England	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Moleirinho, A (corresponding author), Univ Porto, Inst Invest & Inovacao Saude, Rua Campo Alegre 823, P-4100 Porto, Portugal.	amoleirinho@ipatimup.pt	Amorim, Antonio/A-7938-2008; Prata, Maria João/A-6945-2010; Seixas, Susana/I-5084-2013; Lopes, Alexandra/B-1616-2013	Amorim, Antonio/0000-0002-7518-6247; Prata, Maria João/0000-0002-0583-1028; Seixas, Susana/0000-0002-7035-7422; Lopes, Alexandra/0000-0003-3539-2318	Portuguese Foundation for Science and Technology (FCT) [PTDC/SAU-MET/110323/2009]; FCT [SFRH / BD / 73508 / 2010, SFRH / BPD / 73366 / 2010]; POPH-QREN Promotion of scientific employment; European Social Fund; national funds of the Ministry of Education and Science; FCT	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH-QREN Promotion of scientific employment; European Social Fund(European Social Fund (ESF)); national funds of the Ministry of Education and Science; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) (PTDC/SAU-MET/110323/2009). AM and AML are supported by fellowrships from FCT (SFRH / BD / 73508 / 2010 and SFRH / BPD / 73366 / 2010, respectively). SS is supported by POPH-QREN Promotion of scientific employment, by the European Social Fund, and by national funds of the Ministry of Education and Science. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Education and Science and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2004, J MOL EVOL, V59, P177, DOI 10.1007/s00239-004-2612-0; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; BANK A, 1980, SCIENCE, V207, P486, DOI 10.1126/science.7352255; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Beauchemin H, 2009, MOL CELL BIOL, V29, P1635, DOI 10.1128/MCB.01735-08; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bottardi S, 2009, MOL CELL BIOL, V29, P1526, DOI 10.1128/MCB.01523-08; BOYER SH, 1971, BIOCHEM GENET, V5, P405, DOI 10.1007/BF00487132; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; CHANG LYE, 1984, J MOL BIOL, V180, P767, DOI 10.1016/0022-2836(84)90256-0; CZELUSNIAK J, 1982, NATURE, V298, P297, DOI 10.1038/298297a0; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; DEBRUIN SH, 1973, BIOCHIM BIOPHYS ACTA, V295, P490, DOI 10.1016/0005-2795(73)90044-5; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; Gaudry MJ, 2014, GENOME BIOL EVOL, V6, P1219, DOI 10.1093/gbe/evu097; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gil M, 2013, MOL BIOL EVOL, V30, P1270, DOI 10.1093/molbev/mst034; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; GOODMAN M, 1987, COLD SPRING HARB SYM, V52, P875, DOI 10.1101/SQB.1987.052.01.096; GOODMAN M, 1975, NATURE, V253, P603, DOI 10.1038/253603a0; GOODMAN M, 1984, J MOL BIOL, V180, P803, DOI 10.1016/0022-2836(84)90258-4; HARDIES SC, 1984, J BIOL CHEM, V259, P3748; Hardison R, 1998, J EXP BIOL, V201, P1099; Hardison R, 2001, DISORDERS OF HEMOGLO; HARDISON RC, 1984, MOL BIOL EVOL, V1, P302; HARDISON RC, 1984, MOL BIOL EVOL, V1, P390; Hardison RC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011627; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hoffmann FG, 2008, MOL BIOL EVOL, V25, P2589, DOI 10.1093/molbev/msn200; Hoffmann FG, 2007, MOL BIOL EVOL, V24, P1982, DOI 10.1093/molbev/msm127; Hoffmann FG, 2010, MOL BIOL EVOL, V27, P1126, DOI 10.1093/molbev/msp325; Holwerda Sjoerd, 2012, Frontiers in Genetics, V3, P217, DOI 10.3389/fgene.2012.00217; JEFFREYS AJ, 1982, J MOL BIOL, V156, P487, DOI 10.1016/0022-2836(82)90262-5; Johnson RM, 2002, COMP BIOCHEM PHYS A, V133, P877, DOI 10.1016/S1095-6433(02)00205-2; Keys JR, 2008, BRIT J HAEMATOL, V141, P398, DOI 10.1111/j.1365-2141.2008.07065.x; KOOP BF, 1989, J BIOL CHEM, V264, P68; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; MARTIN SL, 1983, J MOL BIOL, V164, P513, DOI 10.1016/0022-2836(83)90048-7; MARTIN SL, 1980, P NATL ACAD SCI-BIOL, V77, P3563, DOI 10.1073/pnas.77.6.3563; MATSUDA M, 1992, BLOOD, V80, P1347; Miller M.A., 2010, P GAT COMP ENV WORKS; Moleirinho A, 2013, GENOME BIOL EVOL, V5, P559, DOI 10.1093/gbe/evt029; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Opazo JC, 2008, P NATL ACAD SCI USA, V105, P12950, DOI 10.1073/pnas.0804392105; Opazo JC, 2008, P NATL ACAD SCI USA, V105, P1590, DOI 10.1073/pnas.0710531105; Opazo JC, 2009, MOL BIOL EVOL, V26, P1469, DOI 10.1093/molbev/msp064; OTTOLENGHI S, 1979, NATURE, V278, P654, DOI 10.1038/278654a0; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Patel VS, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-34; Petronella N, 2014, GENOMICS, V103, P40, DOI 10.1016/j.ygeno.2013.10.004; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Prychitko T, 2005, MOL PHYLOGENET EVOL, V35, P225, DOI 10.1016/j.ympev.2004.11.002; Rambaut A., 2014, TRACER V1 6; RANNEY HM, 1993, AM J HEMATOL, V42, P107, DOI 10.1002/ajh.2830420121; Ristaldi MS, 1999, BLOOD CELL MOL DIS, V25, P193, DOI 10.1006/bcmd.1999.0245; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sankaran VG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011643; Sankaran VG, 2011, NEW ENGL J MED, V365, P807, DOI 10.1056/NEJMoa1103070; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; SMITH JM, 1992, J MOL EVOL, V34, P126; Song G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-226; SPRITZ RA, 1988, MOL BIOL EVOL, V5, P21; Stamatakis A, 2014, RAXML VERSION 8 A TO; STEINBERG MH, 1991, BLOOD, V78, P2165; Steinberg MH, 2009, DISORDERS OF HEMOGLO; Storz JF, 2013, MOL PHYLOGENET EVOL, V66, P469, DOI 10.1016/j.ympev.2012.07.013; Storz JF, 2011, IUBMB LIFE, V63, P313, DOI 10.1002/iub.482; TAGLE DA, 1991, J BIOL CHEM, V266, P7469; Tang DC, 1997, BLOOD, V90, P421; Tang DC, 1998, BRIT J HAEMATOL, V103, P835, DOI 10.1046/j.1365-2141.1998.01052.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; VINCENT KA, 1989, J MOL BIOL, V207, P465, DOI 10.1016/0022-2836(89)90457-9; Webster MT, 2003, HUM GENET, V113, P123, DOI 10.1007/s00439-003-0954-0; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhao ZM, 1998, J MOL EVOL, V46, P494, DOI 10.1007/PL00013147	92	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123365	10.1371/journal.pone.0123365	http://dx.doi.org/10.1371/journal.pone.0123365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853817	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400100
J	Paulus, A; Chitta, KS; Wallace, PK; Advani, PP; Akhtar, S; Kuranz-Blake, M; Ailawadhi, S; Chanan-Khan, AA				Paulus, Aneel; Chitta, Kasyapa S.; Wallace, Paul K.; Advani, Pooja P.; Akhtar, Sharoon; Kuranz-Blake, Maja; Ailawadhi, Sikander; Chanan-Khan, Asher A.			Immunophenotyping of Waldenstroms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications	PLOS ONE			English	Article							BONE-MARROW; LYMPHOPLASMACYTIC LYMPHOMA; ABERRANT EXPRESSION; IN-VITRO; DIAGNOSIS; THROMBOPOIETIN; ESTABLISHMENT; PROGRESSION; LEUKEMIA; MUTATION	Waldenstroms macroglobulinemia (WM) is a subtype of Non-Hodgkin's lymphoma in which the tumor cell population is markedly heterogeneous, consisting of immunoglobulin-M secreting B-lymphocytes, plasmacytoid lymphocytes and plasma cells. Due to rarity of disease and scarcity of reliable preclinical models, many facets of WM molecular and phenotypic architecture remain incompletely understood. Currently, there are 3 human WM cell lines that are routinely used in experimental studies, namely, BCWM. 1, MWCL-1 and RPCI-WM1. During establishment of RPCI-WM1, we observed loss of the CD19 and CD20 antigens, which are typically present on WM cells. Intrigued by this observation and in an effort to better define the immunophenotypic makeup of this cell line, we conducted a more comprehensive analysis for the presence or absence of other cell surface antigens that are present on the RPCI-WM1 model, as well as those on the two other WM cell lines, BCWM. 1 and MWCL-1. We examined expression of 65 extracellular and 4 intracellular antigens, comprising B-cell, plasma cell, T-cell, NK-cell, myeloid and hematopoietic stem cell surface markers by flow cytometry analysis. RPCI-WM1 cells demonstrated decreased expression of CD19, CD20, and CD23 with enhanced expression of CD28, CD38 and CD184, antigens that were differentially expressed on BCWM. 1 and MWCL-1 cells. Due to increased expression of CD184/CXCR4 and CD38, RPCI-WM1 represents a valuable model in which to study the effects anti-CXCR4 or anti-CD38 targeted therapies that are actively being developed for treatment of hematologic cancers. Overall, differences in surface antigen expression across the 3 cell lines may reflect the tumor clone population predominant in the index patients, from whom the cell lines were developed. Our analysis defines the utility of the most commonly employed WM cell lines as based on their immunophenotype profiles, highlighting unique differences that can be further studied for therapeutic exploit.	[Paulus, Aneel; Chitta, Kasyapa S.; Akhtar, Sharoon; Kuranz-Blake, Maja] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Wallace, Paul K.] Roswell Pk Canc Inst, Dept Flow & Image Cytometry, Buffalo, NY 14263 USA; [Advani, Pooja P.; Ailawadhi, Sikander; Chanan-Khan, Asher A.] Mayo Clin, Dept Internal Med, Div Hematol & Oncol, Jacksonville, FL 32224 USA	Mayo Clinic; Roswell Park Cancer Institute; Mayo Clinic	Chanan-Khan, AA (corresponding author), Mayo Clin, Dept Internal Med, Div Hematol & Oncol, Jacksonville, FL 32224 USA.	chanan-khan.asher@mayo.edu	Wallace, PK/ABB-7704-2022	Wallace, PK/0000-0001-7823-9917; Akhtar, Sharoon/0000-0003-3428-3769; Blake, Maja/0000-0002-2916-846X	Leukemia Lymphoma Society; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Leukemia Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AC-K received support from Leukemia Lymphoma Society (no number assigned). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell SM, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.4; Ansell SM, 2010, MAYO CLIN PROC, V85, P824, DOI 10.4065/mcp.2010.0304; Barakat FH, 2011, AM J CLIN PATHOL, V135, P365, DOI 10.1309/AJCP15YFULCZHZVH; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Belaaloui G, 2003, LEUKEMIA, V17, P1137, DOI 10.1038/sj.leu.2402916; Bergsagel FL, 2008, BLOOD, V112, P917, DOI 10.1182/blood-2008-05-154831; Chitta KS, 2013, LEUKEMIA LYMPHOMA, V54, P387, DOI 10.3109/10428194.2012.713481; Chng WJ, 2006, BLOOD, V108, P2755, DOI 10.1182/blood-2006-02-005488; Craig FE, 2008, BLOOD, V111, P3941, DOI 10.1182/blood-2007-11-120535; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Drexler HG, 2008, LEUKEMIA RES, V32, P1669, DOI 10.1016/j.leukres.2008.04.016; Drexler HG, 2013, LEUKEMIA LYMPHOMA, V54, P224, DOI 10.3109/10428194.2012.727418; Facchetti F., 2008, WHO CLASSIFICATION T, V4th ed; Goteri G, 2006, INT J IMMUNOPATH PH, V19, P421, DOI 10.1177/039463200601900218; Groves FD, 1998, CANCER-AM CANCER SOC, V82, P1078; Hodge LS, 2011, BLOOD, V117, pE190, DOI 10.1182/blood-2010-12-326868; Iijima K, 2000, LEUKEMIA, V14, P1598, DOI 10.1038/sj.leu.2401893; Ishiura Y, 2010, BIOCHEM BIOPH RES CO, V396, P329, DOI 10.1016/j.bbrc.2010.04.092; Jani P, 2007, AM J HEMATOL, V82, P73, DOI 10.1002/ajh.20747; Kaleem Z, 2001, AM J CLIN PATHOL, V115, P396; Kaushansky K, 2009, BEST PRACT RES CL HA, V22, P495, DOI 10.1016/j.beha.2009.08.004; Konoplev S, 2005, AM J CLIN PATHOL, V124, P414, DOI 10.1309/3G1XDX0DVHBNVKB4; Kuhne MR, 2013, CLIN CANCER RES, V19, P357, DOI 10.1158/1078-0432.CCR-12-2333; Kularatne SA, 2014, ANGEW CHEM INT ED EN; Laubach JP, 2014, EXPERT OPIN INV DRUG, V23, P445, DOI 10.1517/13543784.2014.889681; Morice WG, 2009, MODERN PATHOL, V22, P807, DOI 10.1038/modpathol.2009.34; Nakase K, 1996, AM J CLIN PATHOL, V105, P761; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Ngo HT, 2008, BLOOD, V112, P150, DOI 10.1182/blood-2007-12-129395; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Paiva B, 2014, LEUKEMIA, V28, P166, DOI 10.1038/leu.2013.124; Paulus A, 2014, BRIT J HAEMATOL, V164, P352, DOI 10.1111/bjh.12633; Reichert JM, 2014, MABS-AUSTIN, V6, P5, DOI 10.4161/mabs.27333; Robak T, 2002, LEUKEMIA LYMPHOMA, V43, P2343, DOI 10.1080/1042819021000040044; Roccaro AM, 2014, BLOOD, V123, P4120, DOI 10.1182/blood-2014-03-564583; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; SCHMITT C, 1991, CLIN EXP IMMUNOL, V85, P168; Sekhar J, 2012, LEUKEMIA LYMPHOMA, V53, P1625, DOI 10.3109/10428194.2012.656103; THOMAS X, 1995, LEUKEMIA, V9, P249; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Varghese AM, 2009, CLIN LYMPHOMA MYELOM, V9, P53, DOI 10.3816/CLM.2009.n.013; Wotherspoon A, 2000, CURR DIAGN PATHOL, V6, P55; Yuasa H, 2002, BIOCHEM BIOPH RES CO, V298, P731, DOI 10.1016/S0006-291X(02)02524-X	45	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122338	10.1371/journal.pone.0122338	http://dx.doi.org/10.1371/journal.pone.0122338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853860	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400065
J	Rabinowitch, TC; Knafo-Noam, A				Rabinowitch, Tal-Chen; Knafo-Noam, Ariel			Synchronous Rhythmic Interaction Enhances Children's Perceived Similarity and Closeness towards Each Other	PLOS ONE			English	Article							PERCEPTION; BEHAVIOR	Inter-personal synchronization is important for performing many cooperative tasks. Notably, synchrony has also been shown to have considerable positive social influences, possibly mediated by synchrony-induced changes in social attitude such as an increased sense of similarity and affiliation between interacting individuals. This effect has been demonstrated in adults, but it is unknown whether synchrony might have a similar impact on the social attitudes of children. We thus set to directly examine the influence of synchronous rhythmic interaction on perceived similarity and closeness in pairs of 8-9 year old children. We found that children who had participated in a synchronous interaction regarded their interacting partner as more similar and closer to themselves than children who had not interacted at all or who had taken part in an asynchronous interaction. These findings reveal that synchronous interaction can positively alter social attitudes between interacting children, suggesting a potential mechanism by which synchrony may enhance positive social interaction through attitudinal shift.	[Rabinowitch, Tal-Chen; Knafo-Noam, Ariel] Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; [Rabinowitch, Tal-Chen] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	Hebrew University of Jerusalem; University of Washington; University of Washington Seattle	Knafo-Noam, A (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.	msarielk@huji.ac.il	Knafo-Noam, Ariel/E-8067-2011	Knafo-Noam, Ariel/0000-0003-0613-1960; Rabinowitch, Tal-Chen/0000-0003-0112-5350	European Research Council [240994]	European Research Council(European Research Council (ERC)European Commission)	Preparation of this manuscript was supported by Starting Grant no. 240994 from the European Research Council to Ariel Knafo. http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RE, 2001, J ADOLESCENCE, V24, P353, DOI 10.1006/jado.2000.0402; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Avinun R, 2013, TWIN RES HUM GENET, V16, P197, DOI 10.1017/thg.2012.73; Cameron L, 2006, CHILD DEV, V77, P1208, DOI 10.1111/j.1467-8624.2006.00929.x; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cirelli LK, 2014, DEVELOPMENTAL SCI, V17, P1003, DOI 10.1111/desc.12193; CROSBY LA, 1990, J MARKETING, V54, P68, DOI 10.2307/1251817; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Duck SW., 1994, MEANINGFUL RELATIONS; Feldman R, 1999, DEV PSYCHOL, V35, P223, DOI 10.1037/0012-1649.35.1.223; Feldman R, 1997, INF MENTAL HLTH J, V18, P4, DOI 10.1002/(SICI)1097-0355(199721)18:1<4::AID-IMHJ2>3.0.CO;2-R; Feldman R, 2007, CURR DIR PSYCHOL SCI, V16, P340, DOI 10.1111/j.1467-8721.2007.00532.x; Filippetti ML, 2013, CURR BIOL, V23, P2413, DOI 10.1016/j.cub.2013.10.017; Gordon R., 1986, MIND LAN GUAGE, V1, P158, DOI [10.1111/j.1468-0017.1986.tb00324.x, DOI 10.1111/J.1468-0017.1986.TB00324.X]; Grahn JA, 2012, EXP BRAIN RES, V220, P51, DOI 10.1007/s00221-012-3114-8; Gremler Dwayne D., 2000, J SERV RES-US, V3, P82, DOI [10.1177/109467050031006, DOI 10.1177/109467050031006]; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; JONES HAROLD E., 1955, EUGENICS QUART, V2, P98; Kenny D.A., 2006, DYADIC DATA ANAL MET; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kokal I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027272; Konstantoudaki X, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00007; Kreuz T, 2011, J NEUROSCI METH, V195, P92, DOI 10.1016/j.jneumeth.2010.11.020; Liviatan I, 2008, J EXP SOC PSYCHOL, V44, P1256, DOI 10.1016/j.jesp.2008.04.007; Macrae CN, 2008, COGNITION, V109, P152, DOI 10.1016/j.cognition.2008.07.007; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Papoutsi A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00161; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Rabinowitch TC, 2012, KINESTHETIC EMPATHY IN CREATIVE AND CULTURAL PRACTICES, P109; Rabinowitch TC, 2013, PSYCHOL MUSIC, V41, P484, DOI 10.1177/0305735612440609; SCARR S, 1968, EUGEN QUART, V15, P34, DOI 10.1080/19485565.1968.9987750; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Wheatley T, 2012, SOC PERSONAL PSYCHOL, V6, P589, DOI 10.1111/j.1751-9004.2012.00450.x; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	38	70	71	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120878	10.1371/journal.pone.0120878	http://dx.doi.org/10.1371/journal.pone.0120878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853859	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400020
J	Rigaud, S; d'Errico, F; Vanhaeren, M				Rigaud, Solange; d'Errico, Francesco; Vanhaeren, Marian			Ornaments Reveal Resistance of North European Cultures to the Spread of Farming	PLOS ONE			English	Article							HUNTER-GATHERERS; DIVERSITY; MOBILITY; AMBER	The transition to farming is the process by which human groups switched from hunting and gathering wild resources to food production. Understanding how and to what extent the spreading of farming communities from the Near East had an impact on indigenous foraging populations in Europe has been the subject of lively debates for decades. Ethnographic and archaeological studies have shown that population replacement and admixture, trade, and long distance diffusion of cultural traits lead to detectable changes in symbolic codes expressed by associations of ornaments on the human body. Here we use personal ornaments to document changes in cultural geography during the Mesolithic-Neolithic transition. We submitted a binary matrix of 224 bead-types found at 212 European Mesolithic and 222 Early Neolithic stratigraphic units to a series of spatial and multivariate analyses. Our results reveal consistent diachronic and geographical trends in the use of personal ornaments during the Neolithisation. Adoption of novel bead-types combined with selective appropriation of old attires by incoming farmers is identified in Southern and Central Europe while cultural resistance leading to the nearly exclusive persistence of indigenous personal ornaments characterizes Northern Europe. We argue that this pattern reflects two distinct cultural trajectories with different potential for gene flow.	[Rigaud, Solange] NYU, Ctr Int Res Humanities & Social Sci CIRHUS, CNRS, UMI3199, New York, NY 11201 USA; [Rigaud, Solange] Univ Liege, Serv Prehist, Liege, Belgium; [d'Errico, Francesco; Vanhaeren, Marian] Univ Bordeaux, PACEA, CNRS, UMR5199, Talence, France; [d'Errico, Francesco] Univ Bergen, Inst Archaeol Hist Cultural Studies & Relig, Bergen, Norway	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); New York University; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Bergen	Rigaud, S (corresponding author), NYU, Ctr Int Res Humanities & Social Sci CIRHUS, CNRS, UMI3199, New York, NY 11201 USA.	srigaud@nyu.edu	Rigaud, Solange/ABF-4684-2021	Rigaud, Solange/0000-0002-9108-200X	French Ministry of Higher Education and Research; Fyssen Foundation; Marie Curie COFUND Action	French Ministry of Higher Education and Research; Fyssen Foundation; Marie Curie COFUND Action	This research was funded by the French Ministry of Higher Education and Research. The final stage of this study was conducted during a post-doctoral research consecutively granted by the Fyssen Foundation and the Marie Curie COFUND Action. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W.Y., 1991, ARCHAEOLOGICAL TYPOL; Ammerman AJ, 1984, THE NEOLITHIC TRANSI; Arnaud M, 2000, ESTIMATION ET INTERP; Bar-Yosef O, 2004, CURR ANTHROPOL, V45, pS1, DOI 10.1086/423970; BECK CW, 1987, ANTHROPOLOGIE, V91, P259; Benito JLP, 1998, UTILLAJE OSEO ADORNO; Bentley RA, 2009, HUM BIOL, V81, P159, DOI 10.3378/027.081.0304; Bentley RA, 2003, ANTIQUITY, V77, P63, DOI 10.1017/S0003598X00061342; Biehl PE, 2012, ARCHEOL PAP AM ANTHR, P130, DOI 10.1111/j.1551-8248.2012.01041.x; Bocquet-Appel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P35, DOI 10.1007/978-1-4020-8539-0_3; Bonnardin S, 2009, LA PARURE FUNERAIRE; Boric D, 2013, P NATL ACAD SCI USA, V110, P3298, DOI 10.1073/pnas.1211474110; Bowles S, 2011, P NATL ACAD SCI USA, V108, P4760, DOI 10.1073/pnas.1010733108; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Colledge S, 2004, CURR ANTHROPOL, V45, pS35, DOI 10.1086/422086; Crema ER, 2014, J ARCHAEOL SCI, V43, P289, DOI 10.1016/j.jas.2014.01.002; Cymbron T, 2005, P ROY SOC B-BIOL SCI, V272, P1837, DOI 10.1098/rspb.2005.3138; Czebreszuk J, 2007, BETWEEN THE AEGEAN A, P363; DErrico F, 1997, J HUM EVOL, V33, P1, DOI 10.1006/jhev.1997.0141; Desailly L, 1930, BULL SOC PREHIST FR, V27, P360, DOI 10.3406/bspf.1930.6855; du Gardin C, 1986, B SOC PREHISTORIQUE, V83, P546, DOI [10.1016/j.brainresbull.2012.06.011, DOI 10.1016/J.BRAINRESBULL.2012.06.011]; DUNNELL RC, 1978, AM ANTIQUITY, V43, P192, DOI 10.2307/279244; Dupont C., 2011, CONCHEIRO TOLEDO CON, P185; Eriksen B.V., 2002, BAR INT SERIES, V1093, P27; Fernandez EA, 2001, ANTHROPOLOGIE, V105, P547; Fernandez E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004401; Galeta P, 2011, AM J PHYS ANTHROPOL, V146, P104, DOI 10.1002/ajpa.21572; Gorley C.K., 2006, GETTING STARTED PRIM; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Gutierrez-Zugasti I, 2011, QUATERN INT, V239, P70, DOI 10.1016/j.quaint.2011.02.031; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HODDER I, 1979, AM ANTIQUITY, V44, P446, DOI 10.2307/279544; Hoisaeter Tore, 2009, Fauna Norvegica, V28, P5; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jeunesse C., 2004, CAH ASSOC POUR PROMO, V20, P3; Klumpp D, 1993, BEING MAASAI ETHNICI, P195; Larsson M., 2013, NW EUROPE TRANSITION, V2475, P37; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lewis JP, 2011, HOLOCENE ENVIRONMENT; Lipo C, 2000, STYLE FUNCTION CONCE, P91; Lock A., 1999, HDB HUMAN SYMBOLIC E, P204; Mafart B., 2004, BRIT ARCHAEOLOGICAL, P289; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; MANTEL N, 1967, CANCER RES, V27, P209; Martinez-Moreno J., 2010, MUNIBE SOC CIENCIAS, V31, P100; Muller J, 2011, BERICHT ROMISCH GERM, V89, P287; Newell RR, 1990, AN INQUIRY INTO THE; Ozdogan M, 2011, CURR ANTHROPOL, V52, pS415, DOI 10.1086/658895; Paschou P, 2014, P NATL ACAD SCI USA, V111, P9211, DOI 10.1073/pnas.1320811111; Perles C, 2001, THE EARLY NEOLITHIC; Perles C., DOCUMENTA PRAEHISTOR, V30, P99; Perles C, 2005, AUTOUR DE POLANYI VO, P201; Perles C, 2010, REVOLUTION NEOLITHIQ, P263; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Rigaud S, 2014, B SOC PREHISTORIQUE, V111, P21, DOI [10.1016/j.brainresbull.2012.06.011, DOI 10.1016/J.BRAINRESBULL.2012.06.011]; Rigaud S, 2009, J ARCHAEOL SCI, V36, P25, DOI 10.1016/j.jas.2008.07.001; Rogers DS, 2008, P NATL ACAD SCI USA, V105, P3416, DOI 10.1073/pnas.0711802105; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Shennan S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3486; Sidera I., 2000, GALLIA PREHISTOIRE, V42, P107; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Taffinder J., 1998, THE ALLURE OF THE EX; Tresset A., 2007, GOING MESOLITHIC NEO, P189, DOI DOI 10.5871/BACAD/9780197264140.003.0010; Vanhaeren M, 2006, J ARCHAEOL SCI, V33, P1105, DOI 10.1016/j.jas.2005.11.017; Verswijver G, 1986, B ANN MUSEE ETHNOGRA, V29, P25; Vigne JD, 2011, CURR ANTHROPOL, V52, pS255, DOI 10.1086/659306; von Cramon-Taubadel N, 2011, P ROY SOC B-BIOL SCI, V278, P2874, DOI 10.1098/rspb.2010.2678; Whallon R, 1982, ESSAYS ON ARCHAEOLOG; White R, 2007, RETHINKING HUMAN REV, P1; Whittle A., 1996, EUROPE IN THE NEOLIT; Zvelebil M, 2006, J ANTHROPOL ARCHAEOL, V25, P178, DOI 10.1016/j.jaa.2005.11.003	79	36	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121166	10.1371/journal.pone.0121166	http://dx.doi.org/10.1371/journal.pone.0121166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CF3WA	25853888	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400030
J	Cook, DA; Enders, F; Caraballo, PJ; Nishimura, RA; Lloyd, FJ				Cook, David A.; Enders, Felicity; Caraballo, Pedro J.; Nishimura, Rick A.; Lloyd, Farrell J.			An Automated Clinical Alert System for Newly-Diagnosed Atrial Fibrillation	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DECISION-SUPPORT-SYSTEMS; DRUG-INTERACTION ALERTS; ORDER ENTRY SYSTEMS; WARFARIN USE; AMBULATORY-CARE; MEDICATION ALERTS; PREDICTING STROKE; PATIENT OUTCOMES; RISK FACTOR	Objective Clinical decision support systems that notify providers of abnormal test results have produced mixed results. We sought to develop, implement, and evaluate the impact of a computer-based clinical alert system intended to improve atrial fibrillation stroke prophylaxis, and identify reasons providers do not implement a guideline-concordant response. Materials and Methods We conducted a cohort study with historical controls among patients at a tertiary care hospital. We developed a decision rule to identify newly-diagnosed atrial fibrillation, automatically notify providers, and direct them to online evidence-based management guidelines. We tracked all notifications from December 2009 to February 2010 (notification period) and applied the same decision rule to all patients from December 2008 to February 2009 (control period). Primary outcomes were accuracy of notification (confirmed through chart review) and prescription of warfarin within 30 days. Results During the notification period 604 notifications were triggered, of which 268 (44%) were confirmed as newly-diagnosed atrial fibrillation. The notifications not confirmed as newly-diagnosed involved patients with no recent electrocardiogram at our institution. Thirty-four of 125 high-risk patients (27%) received warfarin in the notification period, compared with 34 of 94 (36%) in the control period (odds ratio, 0.66 [95% CI, 0.37-1.17]; p = 0.16). Common reasons to not prescribe warfarin (identified from chart review of 151 patients) included up-coming surgical procedure, choice to use aspirin, and discrepancy between clinical notes and the medication record. Conclusions An automated system to identify newly-diagnosed atrial fibrillation, notify providers, and encourage access to management guidelines did not change provider behaviors.	[Cook, David A.; Enders, Felicity; Caraballo, Pedro J.; Nishimura, Rick A.; Lloyd, Farrell J.] Mayo Clin, Knowledge Delivery Ctr, Rochester, MN 55905 USA; [Cook, David A.; Caraballo, Pedro J.] Mayo Clin, Coll Med, Div Gen Internal Med, Rochester, MN USA; [Cook, David A.] Mayo Clin, Coll Med, Mayo Clin Online Learning, Rochester, MN USA; [Enders, Felicity] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Nishimura, Rick A.] Mayo Clin, Coll Med, Div Cardiovasc Dis, Rochester, MN USA; [Lloyd, Farrell J.] Mayo Clin, Coll Med, Div Hosp Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Cook, DA (corresponding author), Mayo Clin, Knowledge Delivery Ctr, Rochester, MN 55905 USA.	cook.david33@mayo.edu						Agarwal S, 2010, AM J CARDIOVASC DRUG, V10, P37, DOI 10.2165/11318870-000000000-00000; Amer Coll Cardiology Amer Heart, 2006, CIRCULATION, V114, P700, DOI 10.1161/CIRCULATIONAHA.106.177031; Austrian JS, 2011, J AM MED INFORM ASSN, V18, P783, DOI 10.1136/amiajnl-2011-000138; Banzi R, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1288; Cook DA, 2015, ACAD MED, V90, P33, DOI 10.1097/ACM.0000000000000551; Cook DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080318; Cook DA, 2013, JAMA INTERN MED, V173, P1962, DOI 10.1001/jamainternmed.2013.10103; Curran JA, 2011, J CONTIN EDUC HEALTH, V31, P174, DOI 10.1002/chp.20124; Del Fiol G, 2008, J AM MED INFORM ASSN, V15, P752, DOI 10.1197/jamia.M2725; Eva KW, 2007, ACAD MED, V82, pS81, DOI 10.1097/ACM.0b013e31813e6755; Ewen E, 2012, VASC HEALTH RISK MAN, V8, P587, DOI 10.2147/VHRM.S34280; FIHN SD, 1994, J GEN INTERN MED, V9, P131, DOI 10.1007/BF02600026; Fraenkel L, 2012, J AM GERIATR SOC, V60, P1434, DOI 10.1111/j.1532-5415.2012.04080.x; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Gladstone DJ, 2009, STROKE, V40, P235, DOI 10.1161/STROKEAHA.108.516344; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Grimshaw JM, 2012, IMPLEMENT SCI, V7, P1748; Grouin Cyril, 2011, AMIA Annu Symp Proc, V2011, P501; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Haugaa KH, 2013, MAYO CLIN PROC, V88, P315, DOI 10.1016/j.mayocp.2013.01.013; Haynes RB, 2006, JAMA-J AM MED ASSOC, V295, P1801, DOI 10.1001/jama.295.15.1801; Holt TA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-385; Isaac T, 2009, ARCH INTERN MED, V169, P305, DOI 10.1001/archinternmed.2008.551; January CT, 2014, J AM COLL CARDIOL; Kashiouris M, 2013, APPL CLIN INFORM, V4, P212, DOI 10.4338/ACI-2012-12-RA-0053; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kruger Kjell, 2011, ISRN Nurs, V2011, P208142, DOI 10.5402/2011/208142; Langemeijer MM, 2011, STUD HEALTH TECHNOL, V169, P930, DOI 10.3233/978-1-60750-806-9-930; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lobach David, 2012, Evid Rep Technol Assess (Full Rep), P1; Miller AM, 2011, J AM MED INFORM ASSN, V18, pI45, DOI 10.1136/amiajnl-2011-000262; Murphy DR, 2012, AM J MED, V125, P209, DOI 10.1016/j.amjmed.2011.07.029; Nelson JL, 2011, ANN EMERG MED, V57, P500, DOI 10.1016/j.annemergmed.2010.12.008; Nilsson Gunnar H, 2004, BMC Clin Pharmacol, V4, P1, DOI 10.1186/1472-6904-4-1; Partington SL, 2007, THROMB RES, V120, P663, DOI 10.1016/j.thromres.2006.12.019; Paterno MD, 2009, J AM MED INFORM ASSN, V16, P40, DOI 10.1197/jamia.M2808; Reed DA, 2012, J GEN INTERN MED, V27, P917, DOI 10.1007/s11606-012-2017-5; Riedmann D, 2011, J AM MED INFORM ASSN, V18, P760, DOI 10.1136/amiajnl-2010-000006; Rosenman MB, 2012, AM J THER, V19, P330, DOI 10.1097/MJT.0b013e3182546840; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Shojania KG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001096.pub2; Singh H, 2010, AM J MED, V123, P238, DOI 10.1016/j.amjmed.2009.07.027; Sittig DF, 2008, J BIOMED INFORM, V41, P387, DOI 10.1016/j.jbi.2007.09.003; Smithburger PL, 2011, EXPERT OPIN DRUG SAF, V10, P871, DOI 10.1517/14740338.2011.583916; Tulner LR, 2010, DRUG AGING, V27, P39, DOI 10.2165/11319540-000000000-00000; Weingart SN, 2011, DRUG SAFETY, V34, P587, DOI 10.2165/11589360-000000000-00000; Weingart SN, 2009, ARCH INTERN MED, V169, P1465, DOI 10.1001/archinternmed.2009.252; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	52	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122153	10.1371/journal.pone.0122153	http://dx.doi.org/10.1371/journal.pone.0122153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849969	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800105
J	Ding, ZJ; Li, MH; Sun, F; Xi, PG; Sun, LH; Zhang, LH; Jiang, ZD				Ding, Zhaojian; Li, Minhui; Sun, Fei; Xi, Pinggen; Sun, Longhua; Zhang, Lianhui; Jiang, Zide			Mitogen-Activated Protein Kinases Are Associated with the Regulation of Physiological Traits and Virulence in Fusarium oxysporum f. sp cubense	PLOS ONE			English	Article							CELL-WALL INTEGRITY; RICE BLAST FUNGUS; MAP KINASE; OXIDATIVE STRESS; CANDIDA-ALBICANS; CHITIN SYNTHASE; PLANT DEFENSE; BANANA; ACID; MPKA	Fusarium oxysporum f. sp. cubense(FOC) is an important soil-borne fungal pathogen causing devastating vascular wilt disease of banana plants and has become a great concern threatening banana production worldwide. However, little information is known about the molecular mechanisms that govern the expression of virulence determinants of this important fungal pathogen. In this study, we showed that null mutation of three mitogen-activated protein (MAP) kinase genes, designated as FoSlt2, FoMkk2and FoBck1, respectively, led to substantial attenuation in fungal virulence on banana plants. Transcriptional analysis revealed that the MAP kinase signaling pathway plays a key role in regulation of the genes encoding production of chitin, peroxidase, beauvericin and fusaric acid. Biochemical analysis further confirmed the essential role of MAP kinases in modulating the production of fusaric acid, which was a crucial phytotoxin in accelerating development of Fusarium wilt symptoms in banana plants. Additionally, we found that the MAP kinase FoSlt2 was required for siderophore biosynthesis under iron-depletion conditions. Moreover, disruption of the MAP kinase genes resulted in abnormal hypha and increased sensitivity to Congo Red, Calcofluor White and H2O2. Taken together, these results depict the critical roles of MAP kinases in regulation of FOC physiology and virulence.	[Ding, Zhaojian; Li, Minhui; Sun, Fei; Xi, Pinggen; Sun, Longhua; Zhang, Lianhui; Jiang, Zide] South China Agr Univ, Dept Plant Pathol, Guangzhou 510642, Guangdong, Peoples R China; [Ding, Zhaojian; Zhang, Lianhui; Jiang, Zide] South China Agr Univ, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Zhang, LH (corresponding author), South China Agr Univ, Dept Plant Pathol, Guangzhou 510642, Guangdong, Peoples R China.	lhzhang01@scau.edu.cn; zdjiang@scau.edu.cn		Ding, Zhaojian/0000-0003-2974-388X	Council of Agriculture, China [CAR-32-05]; National Natural Science Foundation of China [31200112]	Council of Agriculture, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Council of Agriculture, China. (No. CAR-32-05) and National Natural Science Foundation of China (31200112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown DW, 2012, FUNGAL GENET BIOL, V49, P521, DOI 10.1016/j.fgb.2012.05.010; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Dirr F, 2010, INT J MED MICROBIOL, V300, P496, DOI 10.1016/j.ijmm.2010.03.001; Dong X, 2012, PLANT PHYSIOL BIOCH, V60, P171, DOI 10.1016/j.plaphy.2012.08.004; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; Leng YQ, 2012, MOL PLANT PATHOL, V13, P375, DOI 10.1111/j.1364-3703.2011.00756.x; Li CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070226; Li MH, 2014, FUNGAL GENET BIOL, V65, P1, DOI 10.1016/j.fgb.2014.01.005; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; Logrieco A, 1998, APPL ENVIRON MICROB, V64, P3084; Lopez-Berges MS, 2013, MOL MICROBIOL, V87, P49, DOI 10.1111/mmi.12082; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Muller Sebastian, 2012, BMC Genomics, V13, P519, DOI 10.1186/1471-2164-13-519; Navarro-Garcia F, 1998, MICROBIOL-UK, V144, P411, DOI 10.1099/00221287-144-2-411; Niehaus EM, 2014, APPL MICROBIOL BIOT, V98, P1749, DOI 10.1007/s00253-013-5453-1; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Odenbach D, 2009, MOL PLANT PATHOL, V10, P81, DOI 10.1111/j.1364-3703.2008.00515.x; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Qi XZ, 2013, PHYSIOL MOL PLANT P, V84, P76, DOI 10.1016/j.pmpp.2013.07.007; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Rui O, 2007, MOL PLANT PATHOL, V8, P173, DOI 10.1111/J.1364-3703.2007.00383.X; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Selvaggini S, 2004, MICROBIOL-SGM, V150, P921, DOI 10.1099/mic.0.26661-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Yago JI, 2011, MOL PLANT PATHOL, V12, P653, DOI [10.1111/j.1364-3703.2010.00701.x, 10.1111/J.1364-3703.2010.00701.X]; Zeng FY, 2012, FUNGAL GENET BIOL, V49, P347, DOI 10.1016/j.fgb.2012.02.008; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07	48	19	30	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122634	10.1371/journal.pone.0122634	http://dx.doi.org/10.1371/journal.pone.0122634			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849862	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800152
J	Kim, KR; Sung, CO; Kwon, TJ; Lee, J; Robboy, SJ				Kim, Kyu Rae; Sung, Chang Ohk; Kwon, Tae Jeong; Lee, JungBok; Robboy, Stanley J.			Defective Pericyte Recruitment of Villous Stromal Vessels as the Possible Etiologic Cause of Hydropic Change in Complete Hydatidiform Mole	PLOS ONE			English	Article							EARLY-PREGNANCY; MOLECULAR-MECHANISMS; LUMEN FORMATION; VASCULOGENESIS; P57(KIP2); PATHOLOGY; FLUID	The pathogenetic mechanism underlying the hydropic change in complete hydatidiform moles (CHMs) is poorly understood. A growing body of data suggests that pericytes play a role in vascular maturation. Since maturation of villous stromal vessels in CHMs is markedly impaired at early stages, we postulated that a defect in pericytes around stromal vessels in chorionic villi might cause vascular immaturity and subsequent hydropic change. To investigate this, we examined several markers of pericytes, namely, alpha-smooth muscle actin (alpha-SMA), platelet-derived growth factor receptor-beta (PDGFR-beta), and desmin, in 61 normally developing placentas and 41 CHMs with gestational ages of 4-12 weeks. The ultrastructure of villous stromal vessels was also examined. Mature blood vessels from normal placentas show patent vascular lumens and formed hematopoietic components in the villous stroma. alpha-SMA and PDGFR-beta expression in the villous stroma gradually increased and extended from the chorionic plate to peripheral villous branches. The labeled cells formed a reticular network in the villous stroma and, after week 7, encircled villous stromal vessels. In comparison, alpha-SMA and PDGFR-beta expression in the villous stroma and stromal vessels of CHMs was significantly lower (p<0.05). Ultrastructurally, endothelial cells in villous stromal vessels in normal placentas were consistently attached by pericytes after week 7 when the vessels formed distinct lumen, whereas the villous stromal vessels in CHMs consisted of linear chains of endothelial cells, often disclosing primitive clefts without hematopoietic cells inside, and neither pericytes nor basal lamina surrounded the endothelial cells at any gestational age studied. This suggests that pericytes recruitment around villous stromal vessels is defective in CHMs and links to the persistent vascular immaturity of the villous stroma in CHMs, which in turns leads to hydropic villi.	[Kim, Kyu Rae; Sung, Chang Ohk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Kwon, Tae Jeong] Myong JI Gen Hosp, Dept Pathol, Goyang Si, Gyeongi Do, South Korea; [Lee, JungBok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Robboy, Stanley J.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Duke University	Kim, KR (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	krkim@amc.seoul.kr		Sung, Chang Ohk/0000-0002-8567-456X	National Research Foundation grant from the Ministry of Education and Science Technology, Korea [2011-0026130]	National Research Foundation grant from the Ministry of Education and Science Technology, Korea	This study was supported by a National Research Foundation grant from the Ministry of Education and Science Technology, Korea (No. 2011-0026130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Borriello A, 2011, MOL CANCER RES, V9, P1269, DOI 10.1158/1541-7786.MCR-11-0220; Chen PL, 2010, BIOCHEM BIOPH RES CO, V391, P936, DOI 10.1016/j.bbrc.2009.11.168; Chen Q, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/917168; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Demir R, 1997, MICROSC RES TECHNIQ, V38, P29; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Edelman DA, 2006, J SURG RES, V135, P305, DOI 10.1016/j.jss.2006.06.010; Edgar LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085178; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Fowler DJ, 2007, ULTRASOUND OBST GYN, V29, P76, DOI 10.1002/uog.3880; HAGIWARA K, 1986, PLACENTA, V7, P199, DOI 10.1016/S0143-4004(86)80158-8; Hamilton N.B., 2010, FRONT NEUROENERGETIC, V2, DOI 10.3389/fnene.2010.00005; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hussein MRA, 2010, EXP MOL PATHOL, V89, P343, DOI 10.1016/j.yexmp.2010.07.002; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Jauniaux E, 1998, AM J OBSTET GYNECOL, V178, P765, DOI 10.1016/S0002-9378(98)70489-2; Kabara M, 2014, LAB INVEST; Keep D, 1996, HUM PATHOL, V27, P708, DOI 10.1016/S0046-8177(96)90402-5; Kim KR, 2009, AM J SURG PATHOL, V33, P176, DOI 10.1097/PAS.0b013e31817fada1; Kim MJ, 2006, AM J SURG PATHOL, V30, P362; Kramann R., 2013, CURR PATHOBIOL REP, V1; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Mairet-Coello G, 2012, DEVELOPMENT, V139, P475, DOI 10.1242/dev.067314; Murray IR, 2014, CELL MOL LIFE SCI, V71, P1353, DOI 10.1007/s00018-013-1462-6; Novac L, 2011, ROM J MORPHOL EMBRYO, V52, P61; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Sebire NJ, 2003, PEDIATR DEVEL PATHOL, V6, P69, DOI 10.1007/s10024-002-0079-9; Sebire NJ, 2001, ULTRASOUND OBST GYN, V18, P662, DOI 10.1046/j.0960-7692.2001.00589.x; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a005090; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Tury A, 2012, DEV NEUROBIOL, V72, P821, DOI 10.1002/dneu.20999; Wells M, 2007, PATHOLOGY, V39, P88, DOI 10.1080/00313020601137367; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122266	10.1371/journal.pone.0122266	http://dx.doi.org/10.1371/journal.pone.0122266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849742	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800114
J	Grauso, L; Mariggio, S; Corda, D; Fontana, A; Cutignano, A				Grauso, Laura; Mariggio, Stefania; Corda, Daniela; Fontana, Angelo; Cutignano, Adele			An Improved UPLC-MS/MS Platform for Quantitative Analysis of Glycerophosphoinositol in Mammalian Cells	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; METABOLITES; PHOSPHOINOSITIDES; GROWTH	The glycerophosphoinositols constitute a class of biologically active lipid-derived mediators whose intracellular levels are modulated during physiological and pathological cell processes. Comprehensive assessment of the role of these compounds expands beyond the cellular biology of lipids and includes rapid and unambiguous measurement in cells and tissues. Here we describe a sensitive and simple liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantitative analysis of the most abundant among these phosphoinositide derivatives in mammalian cells, the glycerophosphoinositol (GroPIns). The method has been developed in mouse Raw 264.7 macrophages with limits of quantitation at 3 ng/ml. Validation on the same cell line showed excellent response in terms of linear dynamic range (from 3 to 3,000 ng/ml), intra-day and inter-day precision (coefficient of variation <= 7.10%) and accuracy (between 98.1 and 109.0%) in the range 10-320 ng/ml. As proof of concept, a simplified analytical platform based on this method and external calibration was also tested on four stimulated and unstimulated cell lines, including Raw 264.7 macrophages, Jurkat T-cells, A375MM melanoma cells and rat basophilic leukemia RBL-2H3 cells. The results indicate a wide variation in GroPIns levels among different cell lines and stimulation conditions, although the measurements were always in line with the literature. No significant matrix effects were observed thus indicating that the here proposed method can be of general use for similar determinations in cells of different origin.	[Grauso, Laura; Fontana, Angelo; Cutignano, Adele] CNR, Ist Chim Biomol, I-80078 Naples, Italy; [Mariggio, Stefania; Corda, Daniela] CNR, Ist Biochim Prot, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Cutignano, A (corresponding author), CNR, Ist Chim Biomol, Via Campi Flegrei 34, I-80078 Naples, Italy.	adele.cutignano@icb.cnr.it	Fontana, Angelo/C-3354-2012; Fontana, Angelo/AAO-2741-2021; Mariggio', Stefania/H-5467-2015; Cutignano, Adele/C-3343-2012; Corda, Daniela/K-6385-2016	Fontana, Angelo/0000-0002-5453-461X; Fontana, Angelo/0000-0002-5453-461X; Mariggio', Stefania/0000-0002-6397-3016; Cutignano, Adele/0000-0003-3035-9252; Corda, Daniela/0000-0002-3614-751X; Grauso, Laura/0000-0001-9165-8796	Programma Operativo Nazionale [01/00117, 01/00862]; Italian Association for Cancer Research Grant (Milan, Italy) [IG10341]; FaReBio di Qualita Ministry of Economy and Finance; PRIN project [2012CK5RPF_05];  [FIT DM 24/09/2009];  [Legge 46/82]	Programma Operativo Nazionale; Italian Association for Cancer Research Grant (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); FaReBio di Qualita Ministry of Economy and Finance; PRIN project(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); ; 	This work was supported by Programma Operativo Nazionale 01/00117 (AF), Programma Operativo Nazionale 01/00862 (DC), the Italian Association for Cancer Research Grant IG10341 (Milan, Italy, DC), grant FIT DM 24/09/2009, Legge 46/82 and FaReBio di Qualita Ministry of Economy and Finance (DC), and PRIN project 2012CK5RPF_05 (SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrie CP, 2007, METHOD ENZYMOL, V434, P187, DOI 10.1016/S0076-6879(07)34011-1; Berrie CP, 2002, EUR J CANCER, V38, P2463, DOI 10.1016/S0959-8049(02)00485-9; Corda D, 2002, BBA-MOL CELL BIOL L, V1582, P52, DOI 10.1016/S1388-1981(02)00137-3; Corda D, 2009, CELL MOL LIFE SCI, V66, P3449, DOI 10.1007/s00018-009-0113-4; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Dragani LK, 2004, J CHROMATOGR B, V802, P283, DOI 10.1016/j.jchromb.2003.12.002; Falasca M, 1996, EUR J BIOCHEM, V241, P386, DOI 10.1111/j.1432-1033.1996.00386.x; Kopp F, 2010, CHEM BIOL, V17, P831, DOI 10.1016/j.chembiol.2010.06.009; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Mariggio S, 2007, CANCER RES, V67, P11769, DOI 10.1158/0008-5472.CAN-07-1997; Mariggio S, 2006, FASEB J, V20, P2567, DOI 10.1096/fj.05-5397fje; MAZZOLA G, 1984, ANAL BIOCHEM, V141, P137, DOI 10.1016/0003-2697(84)90436-6; MORSE MJ, 1987, PLANT PHYSIOL, V83, P640, DOI 10.1104/pp.83.3.640; Patrussi L, 2007, CELL SIGNAL, V19, P2351, DOI 10.1016/j.cellsig.2007.07.014; Patrussi L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00213; Sun T, 2012, J CHROMATOGR B, V897, P1, DOI 10.1016/j.jchromb.2012.03.034; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; U.S. FDA, 1998, GUIDANCE IND BIOANAL; VALITUTTI S, 1991, CELL SIGNAL, V3, P321, DOI 10.1016/0898-6568(91)90061-X; Zizza P, 2012, J BIOL CHEM, V287, P16849, DOI 10.1074/jbc.M111.309419	21	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123198	10.1371/journal.pone.0123198	http://dx.doi.org/10.1371/journal.pone.0123198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860666	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300082
J	Kakaire, O; Byamugisha, JK; Tumwesigye, NM; Gamzell-Danielsson, K				Kakaire, Othman; Byamugisha, Josaphat Kayogoza; Tumwesigye, Nazarius Mbona; Gamzell-Danielsson, Kristina			Prevalence and Factors Associated with Sexually Transmitted Infections among HIV Positive Women Opting for Intrauterine Contraception	PLOS ONE			English	Article							KENYAN SEX WORKERS; MALE CIRCUMCISION; YOUNG-ADULTS; SOUTH-AFRICA; RISK-FACTORS; DISEASES; TRANSMISSION; TANZANIA; UGANDA; VULNERABILITY	Background Women living with HIV/AIDS (WLHA) are a high risk group for sexually transmitted infections (STIs). However, the majority of women with STIs are asymptomatic. Data on prevalence of STIs among WLHA in Uganda are limited. The objective of the study was to determine prevalence and factors associated with STIs among WLHA opting for intrauterine contraceptive device (IUD). Methods Three hundred fifty one WLHA deemed free of STIs using a syndromic logarithm were enrolled into the study. Endo-cervical swabs were taken before IUD insertion and PCR test for Nisseria gonorrhea (NG), Trichomonas vaginalis (TV) and Chlamydia trachomatis (CT) infections conducted. Results Participants' mean age was 29.4 +/- 6.2 years, 83% were under 35years, 50% had secondary education and 73% were married. The majority (69%) had disclosed their HIV sero status to their spouses, 82% used Cotrimoxazole prophylaxis, 70% were on antiretroviral therapy, 90% had CD4 count greater than 350, about 60% reported condoms use and 70% were of parity 2-4. Over 50% of the participants' spouses were older than 35 years and 72% had attained secondary education. STIs prevalence was 11.1%, (95% CI 7.8-14.4) and individual prevalence for TV, NG, and CT was 5.9%, 5.4% and 0.9% respectively. Factors independently associated with STI were having primary or less education (OR=2.3, 95% CI: 1.09 - 4.85) having a spouse of primary or less education ( OR=3.3, 95% CI: 1.6 - 6.78) and muslim faith ( OR= 0.2, 95% CI: 0.04 - 0.78). Conclusion STI prevalence was 11.1%. TV and NG were the commonest STIs in this population. Having primary or less education for both participant and spouse was associated with increased risk while being of muslim faith was associated with reduced risk of STI.	[Kakaire, Othman; Byamugisha, Josaphat Kayogoza] Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Kampala, Uganda; [Tumwesigye, Nazarius Mbona] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Gamzell-Danielsson, Kristina] Karolinska Univ Hosp, Karolinska Inst, Div Obstet & Gynecol, Dept Womens & Childrens Hlth, Stockholm, Sweden	Makerere University; Makerere University; Karolinska Institutet; Karolinska University Hospital	Kakaire, O (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Obstet & Gynecol, Mulago Hosp Complex,Old Mulago Hill, Kampala, Uganda.	kakaireothman@hotmail.com	Byamugisha, Josaphat/AAL-5776-2020	Byamugisha, Josaphat/0000-0002-3438-9662; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780	Medical Education for Equitable Services to All Ugandans a Medical Education Partnership Initiative from the Office of Global AIDS Coordinator [5R24TW008886]; U. S. Department of Health and Human Services, Health Resources and Services Administration and National Institutes of Health; Swedish International Development Agency, Swedish Research Council (SIDA/VR); FOGARTY INTERNATIONAL CENTER [R24TW008886] Funding Source: NIH RePORTER	Medical Education for Equitable Services to All Ugandans a Medical Education Partnership Initiative from the Office of Global AIDS Coordinator; U. S. Department of Health and Human Services, Health Resources and Services Administration and National Institutes of Health; Swedish International Development Agency, Swedish Research Council (SIDA/VR); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was made possible by Medical Education for Equitable Services to All Ugandans a Medical Education Partnership Initiative grant number 5R24TW008886 from the Office of Global AIDS Coordinator and the U. S. Department of Health and Human Services, Health Resources and Services Administration and National Institutes of Health. Additional funding was from the Swedish International Development Agency, Swedish Research Council (SIDA/VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel Elizabeth, 2004, Health Care Women Int, V25, P761, DOI 10.1080/07399330490475601; Arbabi Mohsen, 2014, Iran J Reprod Med, V12, P507; Asavapiriyanont S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-373; CDC U. S, 2013, SEL PRACT REC CONTR; Chanakira E, 2014, INT J STD AIDS; Chersich MF, 2008, AIDS, V22, pS27, DOI 10.1097/01.aids.0000341775.94123.75; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Desai VK, 2003, SEX TRANSM INFECT, V79, P111, DOI 10.1136/sti.79.2.111; Djoba Siawaya JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090174, DOI 10.1371/J0URNAL.P0NE.0090174]; Francis SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101221; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Grimes DA, 2000, LANCET, V356, P1013, DOI 10.1016/S0140-6736(00)02699-4; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Harling G, 2013, SEX TRANSM DIS, V40, P575, DOI 10.1097/OLQ.0b013e31829529cf; Hogben M, 2008, SEX TRANSM DIS, V35, pS13, DOI 10.1097/OLQ.0b013e31818d3cad; Hook Er., 1999, SEX TRANSM DIS; Jones R, 2007, AIDS BEHAV, V11, P812, DOI 10.1007/s10461-006-9194-3; JUDSON FN, 1990, MED CLIN N AM, V74, P1353, DOI 10.1016/S0025-7125(16)30485-0; Kapiga SH, 2006, AIDS CARE, V18, P379, DOI 10.1080/09540120500465012; Katz BP, 1990, CHLAMYDIA INFECT, P567; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Kaul R, 1997, SEX TRANSM DIS, V24, P387, DOI 10.1097/00007435-199708000-00001; Kwena ZA, 2014, SEX TRANSM INFECT, V90, P139, DOI 10.1136/sextrans-2013-051168; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; Maughan-Brown B, 2013, SEX HEALTH, V10, P246, DOI 10.1071/SH12148; Mayer KH, 2012, SEX TRANSM DIS, V39, P1, DOI 10.1097/OLQ.0b013e31823b1922; Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298; Mohllajee AP, 2005, AM J PREV MED, V28, P483, DOI 10.1016/j.amepre.2005.02.008; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; Musinguzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085646; Ncube N M, 2012, Ghana Med J, V46, P27; Rassjo EB, 2006, J ADOLESCENT HEALTH, V38, P213, DOI 10.1016/j.jadohealth.2004.10.011; Roberts ST, 2006, ARCH PSYCHIAT NURS, V20, P32, DOI 10.1016/j.apnu.2005.08.008; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Seth P, 2011, WOMEN HEALTH ISS, V21, P130, DOI 10.1016/j.whi.2010.10.005; Sinei S K, 1988, J Obstet Gynaecol East Cent Africa, V7, P71; Singa B, 2013, SEX TRANSM DIS, V40, P148, DOI 10.1097/OLQ.0b013e31827aab89; Stam WE, 1980, SEXUALLY TRANSMITTED, P181; Tenkorang EY, 2012, ARCH SEX BEHAV, V41, P1353, DOI 10.1007/s10508-012-9960-4; Turner AN, 2008, SEX TRANSM DIS, V35, P689, DOI 10.1097/OLQ.0b013e31816b1fcc; Tyndall MW, 1999, SEX TRANSM DIS, V26, P476, DOI 10.1097/00007435-199909000-00010; Ukwuani FA, 2003, JAIDS-J ACQ IMM DEF, V34, P203, DOI 10.1097/00126334-200310010-00011; Vandepitte J, 2011, SEX TRANSM DIS, V38, P316, DOI 10.1097/OLQ.0b013e3182099545; Venkatesh KK, 2011, SEX TRANSM DIS, V38, P562, DOI 10.1097/OLQ.0b013e31820a8c2c; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; World Health Organization, 2012, GLOB PREV INC SEL CU	49	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122400	10.1371/journal.pone.0122400	http://dx.doi.org/10.1371/journal.pone.0122400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25859659	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300046
J	Martinez-Donate, AP; Rangel, MG; Rhoads, N; Zhang, X; Hovell, M; Magis-Rodriguez, C; Gonzalez-Fagoaga, E				Martinez-Donate, Ana P.; Rangel, Maria Gudelia; Rhoads, Natalie; Zhang, Xiao; Hovell, Melbourne; Magis-Rodriguez, Carlos; Gonzalez-Fagoaga, Eduardo			Identifying Opportunities to Increase HIV Testing among Mexican Migrants: A Call to Step Up Efforts in Health Care and Detention Settings	PLOS ONE			English	Article							UNITED-STATES; RISK-FACTORS; INFECTION; PREVENTION; BARRIERS; JAILS	HIV testing and counseling is a critical component of HIV prevention efforts and core element of current "treatment as prevention" strategies. Mobility, low education and income, and limited access to health care put Latino migrants at higher risk for HIV and represent barriers for adequate levels of HIV testing in this population. We examined correlates of, and missed opportunities to increase, HIV testing for circular Mexican migrants in the U.S. We used data from a probability-based survey of returning Mexican migrants ( N=1161) conducted in the border city of Tijuana, Mexico. We estimated last 12-months rates of HIV testing and the percentage of migrants who received other health care services or were detained in an immigration center, jail, or prison for 30 or more days in the U.S., but were not tested for HIV. Twenty-two percent of migrants received HIV testing in the last 12 months. In general, utilization of other health care services or detention for 30 or more days in the U.S. was a significant predictor of last 12-months HIV testing. Despite this association, we found evidence of missed opportunities to promote testing in healthcare and/or correctional or immigration detention centers. About 27.6% of migrants received other health care and/or were detained at least 30 days but not tested for HIV. Health care systems, jails and detention centers play an important role in increasing access to HIV testing among circular migrants, but there is room for improvement. Policies to offer opt-out, confidential HIV testing and counseling to Mexican migrants in these settings on a routine and ethical manner need to be designed and pilot tested. These policies could increase knowledge of HIV status, facilitate engagement in HIV treatment among a highly mobile population, and contribute to decrease incidence of HIV in the host and receiving communities.	[Martinez-Donate, Ana P.; Rhoads, Natalie; Zhang, Xiao] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA; [Rangel, Maria Gudelia; Gonzalez-Fagoaga, Eduardo] El Colegio Frontera Norte, Tijuana, Mexico; [Hovell, Melbourne] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Magis-Rodriguez, Carlos] Ctr Invest Infecc Transmis Sexual, Programa VIH & SIDA Ciudad Mexico, Mexico City, DF, Mexico	University of Wisconsin System; University of Wisconsin Madison; Colegio Frontera Norte; California State University System; San Diego State University	Martinez-Donate, AP (corresponding author), Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA.	martinezdona@wisc.edu		Zhang, Xiao/0000-0001-8043-1721; Magis-Rodriguez, Carlos/0000-0001-5481-1253	National Institutes of Health/National Institute of Child Health and Human Development [1 R01-HD046886-01A2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046886] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by Grant 1 R01-HD046886-01A2 (PI: AMD) from the National Institutes of Health/National Institute of Child Health and Human Development (https://www.nichd.nih.gov/Pages/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuedo-Dorantes C, 2013, DEMOGRAPHY, V50, P1067, DOI 10.1007/s13524-013-0200-x; [Anonymous], 2009, FORC AP BY NUMB NONC; Arya M, 2013, AIDS PATIENT CARE ST, V27, P38, DOI 10.1089/apc.2012.0230; Bernstein N., 2012, NY TIMES; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Branson Bernard M, 2009, Virtual Mentor, V11, P974, DOI 10.1001/virtualmentor.2009.11.12.pfor1-0912; Bronfman M., 1998, MIGRACION SIDA MEXIC; Bureau of Justice Statistics, 2009, HIV PRIS 2007 2008; Centers for Diseases Control and Prevention, 2014, HIV CORR SETT; Chin T, 2013, AIDS PATIENT CARE ST, V27, P392, DOI 10.1089/apc.2013.0099; Cohn D, 2009, MEXICAN IMMIGRANTS M; Crabtree-Ramirez B, 2012, SALUD PUBLICA MEXICO, V54, P506, DOI 10.1590/S0036-36342012000500007; Department of Homeland Security, 2006, TREATM IMM DET HOUS; Ejebe IH, 2015, PREV MED, V71, P57, DOI 10.1016/j.ypmed.2014.12.004; El Colegio de la Frontera Norte, 2013, BAS DAT ENC MIGR FRO; Espinoza L, 2012, JAIDS-J ACQ IMM DEF, V60, P205, DOI 10.1097/QAI.0b013e31824d9a29; Fenton Kevin A, 2007, Top HIV Med, V15, P146; Fish D, 2014, GUIDE HIV AIDS CLIN; Flanigan TP, 2010, JAIDS-J ACQ IMM DEF, V55, pS78, DOI 10.1097/QAI.0b013e3181fbc94f; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Garfield R DA, 2014, COVERAGE GAP UNINSUR; Gayet C, 2000, ENFERM INFEC MICR CL, V20, P134; Rangel MG, 2012, AIDS BEHAV, V16, P1630, DOI 10.1007/s10461-012-0196-z; Hall HI, 2013, AIDS BEHAV, V17, P1632, DOI 10.1007/s10461-013-0426-z; Hirsch JS, 2002, AM J PUBLIC HEALTH, V92, P1227, DOI 10.2105/AJPH.92.8.1227; Hugo G, 2013, MIGRATION POLICY I, V7, P1; Human Rights Watch, 2007, CHRON IND HIV AIDS S; Instituto Nacional de Migracion, 2013, B MENS EST MIGR 2013; Joint United Nations Programme on HIV/AIDS (UNAIDS), 1993, WHO GUID HIV INF AID; Levy Vivian, 2007, J Immigr Minor Health, V9, P49; Lopez-Quintero C, 2005, AIDS PATIENT CARE ST, V19, P672, DOI 10.1089/apc.2005.19.672; Lucas A, 2013, AIDS, V27, P795, DOI 10.1097/QAD.0b013e32835c54f9; Magis-Rodriguez C, 2014, ENGAGEMENT HIV CARE; Martinez-Donate Ana P, 2014, Int J Migr Bord Stud, V1, P57; Martinez-Donate AP, 2015, AM J PUBLIC HEALTH, V105, P497, DOI 10.2105/AJPH.2014.302336; Moyer LB, 2008, DRUG ALCOHOL REV, V27, P39, DOI 10.1080/09595230701710845; *NAT COMM CORR HLT, 2002, HLTH STAT SOON TO BE; National institute of Corrections, 2011, 2011 OP MAN ICE PERF; Organista KC, 2004, JAIDS-J ACQ IMM DEF, V37, pS227, DOI 10.1097/01.qai.0000141250.08475.91; PA/ MidAtlantic AIDS Education Training Center at the Health Federation of Philadelphia, 2013, FREQ ASK QUEST 4 GEN; Painter TM, 2008, AIDS BEHAV, V12, P213, DOI 10.1007/s10461-007-9220-0; Priest D., 2008, WASHINGTON POST; Roser MA, 2012, NOT JOINING MEDICAID; Sanchez MA, 2012, JAIDS-J ACQ IMM DEF, V61, P610, DOI 10.1097/QAI.0b013e318273b651; Sena AC, 2010, AIDS PATIENT CARE ST, V24, P165, DOI 10.1089/apc.2009.0135; Solomon L, 2014, HEALTH AFFAIR, V33, P434, DOI 10.1377/hlthaff.2013.1115; Solorio MR, 2004, JAIDS-J ACQ IMM DEF, V37, pS240, DOI 10.1097/01.qai.0000141251.16099.74; Statewide AIDS Services Delivery Consortium Advisory Group New York State Department of Health and AIDS Institute, 2007, MIGR SEAS FARMW HLTH; Tang JJ, 2011, PUBLIC HEALTH REP, V126, P338, DOI 10.1177/003335491112600306; The Kaiser Family Foundation, 2014, HIV TEST US; Thrun MW, 2014, LGBT HEALTH, V1, P75, DOI 10.1089/lgbt.2014.0007; U.S. Immigration and Customs Enforcement (ICE), 2013, FY 2013 ICE IMM REM; UNAIDS, 2006, KEEP BEST CHANG REST; Venters Homer D, 2009, Health Hum Rights, V11, P89; WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004	56	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123631	10.1371/journal.pone.0123631	http://dx.doi.org/10.1371/journal.pone.0123631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25860261	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300106
J	Benton, G; DeGray, G; Kleinman, HK; George, J; Arnaoutova, I				Benton, Gabriel; DeGray, Gerald; Kleinman, Hynda K.; George, Jay; Arnaoutova, Irina			In Vitro Microtumors Provide a Physiologically Predictive Tool for Breast Cancer Therapeutic Screening	PLOS ONE			English	Article							STROMAL CELLS; TUMOR-GROWTH; STEM-CELLS; HYPOXIA; INVASION; CONTRIBUTES; INVASIVENESS; ANGIOGENESIS; EXPRESSION; PACLITAXEL	Many anti-cancer drugs fail in human trials despite showing efficacy in preclinical models. It is clear that the in vitro assays involving 2D monoculture do not reflect the complex extracellular matrix, chemical, and cellular microenvironment of the tumor tissue, and this may explain the failure of 2D models to predict clinical efficacy. We first optimized an in vitro microtumor model using a tumor-aligned ECM, a tumor-aligned medium, MCF-7 and MDA-MB- 231 breast cancer spheroids, human umbilical vein endothelial cells, and human stromal cells to recapitulate the tissue architecture, chemical environment, and cellular organization of a growing and invading tumor. We assayed the microtumor for cell proliferation and invasion in a tumor-aligned extracellular matrix, exhibiting collagen deposition, acidity, glucose deprivation, and hypoxia. We found maximal proliferation and invasion when the multicellular spheroids were cultured in a tumor-aligned medium, having low pH and low glucose, with 10% fetal bovine serum under hypoxic conditions. In a 7-day assay, varying doses of fluorouracil or paclitaxel had differential effects on proliferation for MCF-7 and MDA-MB-231 tumor spheroids in microtumor compared to 2D and 3D monoculture. The microtumors exhibited a tumor morphology and drug response similar to published xenograft data, thus demonstrating a more physiologically predictive in vitro model.	[Benton, Gabriel; DeGray, Gerald; Kleinman, Hynda K.; George, Jay; Arnaoutova, Irina] Trevigen Inc, Gaithersburg, MD USA		Benton, G (corresponding author), Trevigen Inc, Gaithersburg, MD USA.	gbenton@trevigen.com		Benton, Gabriel/0000-0003-4244-5764	SBIR [HHSN261201300042C]	SBIR	This work was funded by SBIR contract number HHSN261201300042C issued by the National Cancer Institute. Trevigen Inc. provided support in the form of salaries for authors [GB, GD, JG, IA] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, FORBES; Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4; Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Benton G, 2014, ADV DRUG DELIV REV; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Benton G, 2009, FASEB J, V23, P3884, DOI 10.1096/fj.08-128702; Bocci G, 2006, CLIN PHARMACOL THER, V80, P384, DOI 10.1016/j.clpt.2006.06.007; Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121; Dai Y, 2011, INT J RADIAT ONCOL, V81, P521, DOI 10.1016/j.ijrobp.2011.04.027; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dufau I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-15; EISENHAUER EA, 1994, J CLIN ONCOL, V12, P2654, DOI 10.1200/JCO.1994.12.12.2654; Flach EH, 2011, MOL PHARMACEUT, V8, P2039, DOI 10.1021/mp200421k; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Guth U, 2008, CANCER DETECT PREV, V32, P224, DOI 10.1016/j.cdp.2008.04.002; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232; Hotchkiss KA, 2002, MOL CANCER THER, V1, P1191; Huang X, 2014, ONCOL LETT, V8, P1217, DOI 10.3892/ol.2014.2259; Ji F, 2013, INT J ONCOL, V42, P1578, DOI 10.3892/ijo.2013.1878; Kang NH, 2012, CANCER GENE THER, V19, P412, DOI 10.1038/cgt.2012.15; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Lam CRI, 2014, MOL PHARMACEUT, V11, P2016, DOI 10.1021/mp500059q; Lopez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-48; Marconi C., 2013, Experimental Oncology, V35, P187; Nakayama S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2231; Neiva KG, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-99; Nowicka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081859; Olsen C., 2010, BMC CANCER, V10, P1; Otvos L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-90; Parks SK, 2013, J CELL PHYSIOL, V228, P1854, DOI 10.1002/jcp.24346; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Peppicelli S, 2014, CANCER METAST REV, V33, P823, DOI 10.1007/s10555-014-9506-4; Ryu MH, 2010, BIOCHEM BIOPH RES CO, V393, P11, DOI 10.1016/j.bbrc.2010.01.060; Santhanam AN, 2010, ONCOGENE, V29, P3921, DOI 10.1038/onc.2010.158; Sasser AK, 2007, CANCER LETT, V254, P255, DOI 10.1016/j.canlet.2007.03.012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi CY, 2013, CELL PHYSIOL BIOCHEM, V32, P561, DOI 10.1159/000354460; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Suzuki K, 2011, MOL MED, V17, P579, DOI 10.2119/molmed.2010.00157; Szalad A, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-129; Thoma CR, 2014, ADV DRUG DELIVERY RE; VESCIO RA, 1991, P NATL ACAD SCI USA, V88, P5163, DOI 10.1073/pnas.88.12.5163; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Wu WJ, 2010, ONCOL REP, V23, P255, DOI 10.3892/or_00000631; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zeng W, CANC LETT; Zhang B, 2012, J HUAZHONG U SCI-MED, V32, P173, DOI 10.1007/s11596-012-0031-9	52	47	47	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123312	10.1371/journal.pone.0123312	http://dx.doi.org/10.1371/journal.pone.0123312			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856378	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500087
J	Jiang, KZ; Zhang, NW; Zhang, H; Wang, JM; Qian, MR				Jiang, Kezhi; Zhang, Ningwen; Zhang, Hu; Wang, Jianmei; Qian, Mingrong			Investigation on the Gas-Phase Decomposition of Trichlorfon by GC-MS and Theoretical Calculation	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDES; PYROLYSIS; DIPTEREX; NANOPARTICLES	The gas phase pyrolysis of trichlorfon was investigated by the on-line gas chromatography mass spectrometry (GC-MS) pyrolysis and theoretical calculations. Two reaction channels were proposed in the pyrolytic reaction, by analyzing the detected pyrolytic products in the total ion chromatography, including 2,2,2-trichloroacetaldehyde, dimethyl phosphite, and dichlorvos. Theoretical calculations showed that there is an intramolecular hydrogen bond between the hydroxyl group and the phosphate O atom in trichlorfon, through which the hydroxyl H atom can be easily transferred to phosphate O atom to trigger two pyrolytic channels. In path-a, migration of H atom results in direct decomposition of trichlorfon to give 2,2,2-trichloroacetaldehyde and dimethyl phosphite in one step. In path-b, migration of H atom in trichlorfon is combined with formation of the O-P bond to give an intermediate, followed by HCl elimination to afford dichlorvos. Path-a is kinetically more favorable than path-b, which is consistent with the GC-MS results.	[Jiang, Kezhi; Zhang, Ningwen] Hangzhou Normal Univ, Key Lab Organosilicon Chem & Mat Technol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hu; Wang, Jianmei; Qian, Mingrong] Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, MOA Key Lab Pesticide Residue Detect, Hangzhou, Zhejiang, Peoples R China	Hangzhou Normal University; Zhejiang Academy of Agricultural Sciences	Qian, MR (corresponding author), Zhejiang Acad Agr Sci, Inst Qual & Stand Agroprod, MOA Key Lab Pesticide Residue Detect, Hangzhou, Zhejiang, Peoples R China.	qianmr@mail.zaas.ac.cn	Wang, Jianmei/HHZ-0585-2022		National Science Foundation of China [21205025]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work received financial support from the National Science Foundation of China (No. 21205025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Perez-Serradilla JA, 2010, CHROMATOGRAPHIA, V71, P899, DOI 10.1365/s10337-010-1575-0; BLOTNY G, 1980, J CHROMATOGR, V193, P61, DOI 10.1016/S0021-9673(00)81444-2; Chai MK, 2009, FOOD CHEM, V117, P561, DOI 10.1016/j.foodchem.2009.04.034; Fang T, 2012, J ENVIRON SCI-CHINA, V24, P1149, DOI 10.1016/S1001-0742(11)60882-6; Foresman J. B, 1996, EXPLORING CHEM ELECT, V2nd; Frisch M.J., 2009, GAUSSIAN 09 REVIS D0; GAIND VS, 1990, ANALYST, V115, P143, DOI 10.1039/an9901500143; Garcia JL, 2002, J ORG CHEM, V67, P2755, DOI 10.1021/jo016209s; Jiang KZ, 2009, J PHYS CHEM A, V113, P697, DOI 10.1021/jp808273m; Li LQ, 2014, SPECTROSC SPECT ANAL, V34, P122, DOI 10.3964/j.issn.1000-0593(2014)01-0122-06; Li Z, 2014, SENSOR ACTUAT B-CHEM, V193, P205, DOI 10.1016/j.snb.2013.11.096; Liu T, 2011, SENSOR ACTUAT B-CHEM, V160, P1255, DOI 10.1016/j.snb.2011.09.059; Perez-Ruiz T, 2005, ANAL CHIM ACTA, V540, P383, DOI 10.1016/j.aca.2005.03.055; Qi TT, 2013, J PHYS CHEM A, V117, P11115, DOI 10.1021/jp4081096; Sanz CP, 2004, ANAL CHIM ACTA, V524, P265, DOI 10.1016/j.aca.2004.06.024; Singh V, 2003, J CHROMATOGR A, V1010, P243, DOI 10.1016/S0021-9673(03)01123-3; Wang C, 2011, J SEP SCI, V34, P3231, DOI 10.1002/jssc.201100661; YAMASHITA K, 1962, Ind Med Surg, V31, P170; Zhang X, 2013, BIOSENS BIOELECTRON, V41, P669, DOI 10.1016/j.bios.2012.09.047; Zou CY, 2014, J PHYS CHEM B, V118, P6302, DOI 10.1021/jp501925a	20	7	7	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121389	10.1371/journal.pone.0121389	http://dx.doi.org/10.1371/journal.pone.0121389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856549	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500018
J	Luo, XS; Liu, F; Wang, X; Yang, Q; Wang, SB; Zhou, XY; Qian, YL; Yang, J; Levin, LS				Luo, Xusong; Liu, Fei; Wang, Xi; Yang, Qun; Wang, Shoubao; Zhou, Xianyu; Qian, Yunliang; Yang, Jun; Levin, Lawrence Scott			Region-Oriented and Staged Treatment Strategy in Reconstruction of Severe Cervical Contracture	PLOS ONE			English	Article							POSTBURN MENTOSTERNAL CONTRACTURES; NECK RECONSTRUCTION; CERVICOMENTAL-ANGLE; FLAP; CLASSIFICATION; PLATYSMA; HEAD	Introduction Severe cervical contracture after burns causes obvious impairment of neck movement and the aesthetic silhouette. Although various surgical techniques for treatment have been described, there is not a definitive strategy to guide treatment. Over the past 6 years, we have been utilizing a region-oriented and staged treatment strategy to guide reconstruction of severe cervical contracture. Satisfactory results have been achieved with this strategy. Methods The first stage of treatment focuses on the anterior cervical region and submental region. Procedures include cicatrix resection, contracture release, division and elevation of the platysma to form two platysma flaps, and skin grafting. Three to six months later, the second stage treatment is performed, which localize to the mental region. This includes scar resection, correction of the lower lip eversion, and reconstruction with free (para) scapular skin flap. Three subtypes of cervicomental angle that we proposed were measured as quantitative tool for evaluation of the reconstruction. Results 4 patients who completed the treatment were reviewed. By the 3rd postoperative month, their CM angles changed significantly: the soft tissue CM angle was reduced from 135.0 degrees +/- 17.3 degrees to 111.1 degrees +/- 11.3 degrees, the osseous CM angle increased from 67.1 degrees +/- 9.0 degrees to 90.5 degrees +/- 11.6 degrees and the dynamic CM angle increased from 21.9 degrees +/- 8.7 degrees to 67.4 degrees +/- 13.1 degrees. 22 in 24 (91.7%) of these patients gained notable improvement of cervical motion and aesthetic contour. Conclusions Our results suggest that the region-oriented and staged treatment strategy can achieve satisfactory functional and aesthetic results, combining usage of both skin graft and skin flap while minimizing the donor site morbidity.	[Luo, Xusong; Liu, Fei; Wang, Xi; Yang, Qun; Wang, Shoubao; Zhou, Xianyu; Qian, Yunliang; Yang, Jun] Shanghai Jiao Tong Univ, Sch Med, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai 200011, Peoples R China; [Levin, Lawrence Scott] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA	Shanghai Jiao Tong University; University of Pennsylvania; Pennsylvania Medicine	Yang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai 200011, Peoples R China.	yj55569@hotmail.com; scott.levin@uphs.upenn.edu			Guidance Foundation of Science and Technology Committee of Shanghai [10411964200]; National Natural Science Foundation of China [81171833, 81371701]	Guidance Foundation of Science and Technology Committee of Shanghai; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Guidance Foundation of Science and Technology Committee of Shanghai (grant No. 10411964200), National Natural Science Foundation of China (grant No. 81171833, 81371701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung KC, 2009, PLAST RECONSTR SURG, V123, P1385, DOI 10.1097/PRS.0b013e31819f25ff; Dayan SH, 2010, PLAST RECONSTR SURG, V126, p141E, DOI 10.1097/PRS.0b013e3181e3b55b; Grevious MA, 2008, J CRANIOFAC SURG, V19, P1010, DOI 10.1097/SCS.0b013e318175f468; Huang CY, 2013, BURNS, V39, P507, DOI 10.1016/j.burns.2012.07.006; Hyakusoku H, 2010, COLOR ATLAS BURN REC; Imanishi N, 2005, PLAST RECONSTR SURG, V115, P1018, DOI 10.1097/01.PRS.0000154211.52778.71; Kumar B, 2011, ACTA ANAESTH BELG, V62, P95; Matsumine H, 2008, PLAST RECONSTR SURG, V122, P782, DOI 10.1097/PRS.0b013e318180ed43; Motamed S, 2008, BURNS, V34, P878, DOI 10.1016/j.burns.2007.11.018; Olasz L, 2011, J ORAL MAXIL SURG, V69, P1242, DOI 10.1016/j.joms.2010.02.046; Onah II, 2005, ARCH SURG-CHICAGO, V140, P671, DOI 10.1001/archsurg.140.7.671; Ono S, 2012, PLAST RECONSTR SURG, V129, P879, DOI 10.1097/PRS.0b013e318244230b; Pallua N, 1997, PLAST RECONSTR SURG, V99, P1878, DOI 10.1097/00006534-199706000-00011; Parrett BM, 2007, PLAST RECONSTR SURG, V120, P1871, DOI 10.1097/01.prs.0000287272.28417.14; Rebelo M, 2009, J PLAST RECONSTR AES, V62, P137, DOI 10.1016/j.bjps.2008.05.033; Tsai FC, 2006, BURNS, V32, P626, DOI 10.1016/j.burns.2005.12.009; Vu QV, 2009, PLAST RECONSTR SURG, V123, P1471, DOI 10.1097/PRS.0b013e3181a205ba; Walden JL, 2000, ANN PLAS SURG, V45, P162, DOI 10.1097/00000637-200045020-00011; Zhang YX, 2010, ANN PLAS SURG, V65, P528, DOI 10.1097/SAP.0b013e3181cc29e7	19	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122669	10.1371/journal.pone.0122669	http://dx.doi.org/10.1371/journal.pone.0122669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855973	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500048
J	Saint-Macary, ME; Barbisan, C; Gagey, MJ; Frelin, O; Beffa, R; Lebrun, MH; Droux, M				Saint-Macary, Marie Emmanuelle; Barbisan, Crystel; Gagey, Marie Josephe; Frelin, Oceane; Beffa, Roland; Lebrun, Marc Henri; Droux, Michel			Methionine Biosynthesis is Essential for Infection in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							CYSTATHIONINE GAMMA-SYNTHASE; S-ADENOSYLMETHIONINE; ASPERGILLUS-NIDULANS; GENE; METHYLMETHIONINE; HOMOCYSTEINE; GRISEA; ACCUMULATION; PURIFICATION; METABOLISM	Methionine is a sulfur amino acid standing at the crossroads of several biosynthetic pathways. In fungi, the last step of methionine biosynthesis is catalyzed by a cobalamine-independent methionine synthase (Met6, EC 2.1.1.14). In the present work, we studied the role of Met6 in the infection process of the rice blast fungus, Magnaporthe oryzae. To this end MET6 null mutants were obtained by targeted gene replacement. On minimum medium, MET6 null mutants were auxotrophic for methionine. Even when grown in presence of excess methionine, these mutants displayed developmental defects, such as reduced mycelium pigmentation, aerial hypha formation and sporulation. They also displayed characteristic metabolic signatures such as increased levels of cysteine, cystathionine, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine while methionine and glutathione levels remained unchanged. These metabolic perturbations were associated with the over-expression of MgCBS1 involved in the reversed transsulfuration pathway that metabolizes homocysteine into cysteine and MgSAM1 and MgSAHH1 involved in the methyl cycle. This suggests a physiological adaptation of M. oryzae to metabolic defects induced by the loss of Met6, in particular an increase in homocysteine levels. Pathogenicity assays showed that MET6 null mutants were non-pathogenic on both barley and rice leaves. These mutants were defective in appressorium-mediated penetration and invasive infectious growth. These pathogenicity defects were rescued by addition of exogenous methionine and S-methylmethionine. These results show that M. oryzae cannot assimilate sufficient methionine from plant tissues and must synthesize this amino acid de novo to fulfill its sulfur amino acid requirement during infection.	[Saint-Macary, Marie Emmanuelle; Gagey, Marie Josephe; Frelin, Oceane; Lebrun, Marc Henri; Droux, Michel] UCB, INSA, BCS, Bayer CropSci,CNRS,MAP,UMR 5240, F-69263 Lyon, France; [Barbisan, Crystel; Beffa, Roland] Bayer CropSci, Dept Biochem, F-69263 Lyon, France	Bayer AG; Bayer CropScience; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Bayer AG; Bayer CropScience	Lebrun, MH (corresponding author), UCB, INSA, BCS, Bayer CropSci,CNRS,MAP,UMR 5240, F-69263 Lyon, France.	marc-henri.lebrun@versailles.inra.fr		LEBRUN, marc-henri/0000-0003-1562-1902; Droux, Michel/0000-0001-5635-2046	French Ministry of Industry; Bayer CropScience (CIFRE fellowship)	French Ministry of Industry; Bayer CropScience (CIFRE fellowship)	Marie-Emmanuelle Saint-Macary and Oceane Frelin PhD fellowships were funded by the French Ministry of Industry and Bayer CropScience (CIFRE fellowship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balhadere PV, 1999, MOL PLANT MICROBE IN, V12, P129, DOI 10.1094/MPMI.1999.12.2.129; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Bourgis F, 1999, PLANT CELL, V11, P1485, DOI 10.1105/tpc.11.8.1485; Capdevila A, 1998, ANAL BIOCHEM, V264, P180, DOI 10.1006/abio.1998.2839; Clergeot PH, 2001, P NATL ACAD SCI USA, V98, P6963, DOI 10.1073/pnas.111132998; Collemare J, 2008, NEW PHYTOL, V179, P196, DOI 10.1111/j.1469-8137.2008.02459.x; CSAIKL U, 1986, GENE, V46, P207, DOI 10.1016/0378-1119(86)90405-1; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Eggermont K, 1996, PLANT MOL BIOL REP, V14, P273, DOI 10.1007/BF02671663; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; FAHEY RC, 1987, METHOD ENZYMOL, V143, P85; Fernandez J, 2014, ANNU REV PHYTOPATHOL, V52, P81; Ferrer JL, 2004, J BIOL CHEM, V279, P44235, DOI 10.1074/jbc.C400325200; Fischer JA, 2001, FUNGAL GENET BIOL, V34, P21, DOI 10.1006/fgbi.2001.1287; Fu J, 2013, FUNGAL BIOL-UK, V117, P13, DOI 10.1016/j.funbio.2012.11.001; Fujita Y, 2006, MICROBIOL-SGM, V152, P397, DOI 10.1099/mic.0.28398-0; Grynberg M, 2001, BBA-GENE STRUCT EXPR, V1519, P78, DOI 10.1016/S0167-4781(01)00224-X; Kacprzak MM, 2003, BIOCHEM J, V376, P517, DOI 10.1042/BJ20030747; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Lo SCC, 2002, EUKARYOT CELL, V1, P311, DOI 10.1128/EC.1.2.311-314.2002; McCann MP, 2008, FUNGAL GENET BIOL, V45, pS77, DOI 10.1016/j.fgb.2008.05.006; Menegus F, 2004, J PLANT PHYSIOL, V161, P725, DOI 10.1078/0176-1617-01081; Pascon RC, 2004, MICROBIOL-SGM, V150, P3013, DOI 10.1099/mic.0.27235-0; PASZEWSKI A, 1975, J BACTERIOL, V124, P893, DOI 10.1128/JB.124.2.893-904.1975; PERKINS DD, 1982, MICROBIOL REV, V46, P426, DOI 10.1128/MMBR.46.4.426-570.1982; Pieniazek A, 1973, ACTA BIOCHIM POL, V20, P159; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; RAVANEL S, 1995, ARCH BIOCHEM BIOPHYS, V316, P572, DOI 10.1006/abbi.1995.1077; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seong K, 2005, PHYTOPATHOLOGY, V95, P744, DOI 10.1094/PHYTO-95-0744; Sienko M, 2009, CURR GENET, V55, P561, DOI 10.1007/s00294-009-0269-3; Solomon PS, 2003, MOL PLANT PATHOL, V4, P203, DOI 10.1046/j.1364-3703.2003.00161.x; Solomon PS, 2001, PLANTA, V213, P241, DOI 10.1007/s004250000500; Suliman HS, 2005, ARCH BIOCHEM BIOPHYS, V441, P56, DOI 10.1016/j.abb.2005.06.016; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Thomas D, 2000, J BIOL CHEM, V275, P40718, DOI 10.1074/jbc.M005967200; Wilson RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047392; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 2007, ADV GENET, V57, P175, DOI 10.1016/S0065-2660(06)57005-1; Yan X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076914	45	29	30	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0111108	10.1371/journal.pone.0111108	http://dx.doi.org/10.1371/journal.pone.0111108			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856162	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500001
J	Sun, XJ; Yang, AG; Wu, BA; Zhou, LQ; Liu, ZH				Sun, Xiujun; Yang, Aiguo; Wu, Biao; Zhou, Liqing; Liu, Zhihong			Characterization of the Mantle Transcriptome of Yesso Scallop (Patinopecten yessoensis): Identification of Genes Potentially Involved in Biomineralization and Pigmentation	PLOS ONE			English	Article							MOLLUSK SHELL FORMATION; CALMODULIN-LIKE PROTEIN; PEARL OYSTER; NACREOUS LAYER; KEY MACROMOLECULE; MATRIX PROTEIN; RNA-SEQ; LOCALIZATION; TISSUE; SKIN	The Yesso scallop Patinopecten yessoensis is an economically important marine bivalve species in aquaculture and fishery in Asian countries. However, limited genomic resources are available for this scallop, which hampers investigations into molecular mechanisms underlying their unique biological characteristics, such as shell formation and pigmentation. Mantle is the special tissue of P. yessoensis that secretes biomineralization proteins inducing shell deposition as well as pigmentation on the shells. However, a current deficiency of transcriptome information limits insight into mechanisms of shell formation and pigmentation in this species. In this study, the transcriptome of the mantle of P. yessoensis was deeply sequenced and characterized using Illumina RNA-seq technology. A total of 86,521 unique transcripts are assembled from 55,884,122 reads that passed quality filters, and annotated, using Gene Ontology classification. A total of 259 pathways are identified in the mantle transcriptome, including the calcium signaling and melanogenesis pathways. A total of 237 unigenes that are homologous to 102 reported biomineralization genes are identified, and 121 unigenes that are homologous to 93 known proteins related to melanin biosynthesis are found. Twenty-three annotated unigenes, which are mainly homologous to calmodulin and related proteins, Ca2+/calmodulin-dependent protein kinase, adenylate/guanylate cyclase, and tyrosinase family are potentially involved in both biomineralization and melanin biosynthesis. It is suggested that these genes are probably not limited in function to induce shell deposition by calcium metabolism, but may also be involved in pigmentation of the shells of the scallop. This potentially supports the idea that there might be a link between calcium metabolism and melanin biosynthesis, which was previously found in vertebrates. The findings presented here will notably advance the understanding of the sophisticated processes of shell formation as well as shell pigmentation in P. yessoensis and other bivalve species, and also provide new evidence on gene expression for the understanding of pigmentation and biomineralization not only in invertebrates but also probably in vertebrates.	[Sun, Xiujun; Yang, Aiguo; Wu, Biao; Zhou, Liqing; Liu, Zhihong] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Yang, AG (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	yangag@ysfri.ac.cn			Independent Innovation Funds of Shandong Province [2013CXC80202]; Emerging Strategic Industries Project of Qingdao City [13-4-1-60hy]; Key Laboratory of Mariculture (KLM), Ministry of Education, OUC	Independent Innovation Funds of Shandong Province; Emerging Strategic Industries Project of Qingdao City; Key Laboratory of Mariculture (KLM), Ministry of Education, OUC	This work was supported by the grants from Independent Innovation Funds of Shandong Province (2013CXC80202), Emerging Strategic Industries Project of Qingdao City (13-4-1-60hy), and the Key Laboratory of Mariculture (KLM), Ministry of Education, OUC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; [Anonymous], 1983, SHELL FORMATION MO 1; Bai ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053617; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x; Cai Zhongqiang, 2014, International Journal of Biology, V6, P37; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; COBABE EA, 1995, GEOCHIM COSMOCHIM AC, V59, P87, DOI 10.1016/0016-7037(94)00374; Colihueque N, 2010, REV FISH BIOL FISHER, V20, P71, DOI 10.1007/s11160-009-9121-6; COMFORT A, 1951, BIOL REV, V26, P285, DOI 10.1111/j.1469-185X.1951.tb01358.x; Cui ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082156; Eisenhaber B, 2000, TRENDS BIOCHEM SCI, V25, P340, DOI 10.1016/S0968-0004(00)01601-7; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fang D, 2012, J BIOL CHEM, V287, P15776, DOI 10.1074/jbc.M112.341594; Fang Z, 2008, PROG NAT SCI-MATER, V18, P405, DOI 10.1016/j.pnsc.2007.11.011; Freer A, 2014, MAR BIOTECHNOL, V16, P34, DOI 10.1007/s10126-013-9516-1; Gazeau F, 2013, MAR BIOL, V160, P2207, DOI 10.1007/s00227-013-2219-3; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HERMANN A, 1995, COMP BIOCHEM PHYS B, V111, P337, DOI 10.1016/0305-0491(94)00218-J; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang J, 2007, BBA-GEN SUBJECTS, V1770, P1037, DOI 10.1016/j.bbagen.2007.03.006; Ito H., 1991, SCALLOPS BIOL ECOLOG, P1024; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Jones DB, 2013, MAR BIOTECHNOL, V15, P647, DOI 10.1007/s10126-013-9514-3; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Le Roy N, 2012, J EXP ZOOL PART B, V318B, P353, DOI 10.1002/jez.b.22452; Li Q, 2007, AQUACULTURE, V269, P211, DOI 10.1016/j.aquaculture.2007.04.017; Li S, 2005, FEBS J, V272, P4899, DOI 10.1111/j.1742-4658.2005.04899.x; Lin Aiguang, 2010, Journal of the Chinese Ceramic Society, V38, P504; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; Lv JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094055; Mann S., 2002, BIOMINERALIZATION PR; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; McGinty EL, 2012, MAR GENOM, V5, P27, DOI 10.1016/j.margen.2011.08.006; McKinnon JS, 2010, MOL ECOL, V19, P5101, DOI 10.1111/j.1365-294X.2010.04846.x; MEANS AR, 1980, NATURE, V285, P73, DOI 10.1038/285073a0; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Nagai K, 2007, COMP BIOCHEM PHYS B, V146, P207, DOI 10.1016/j.cbpb.2006.10.105; Newman AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-382; Niecke M, 2003, OECOLOGIA, V137, P153, DOI 10.1007/s00442-003-1307-3; Palumbo A, 2003, PIGM CELL RES, V16, P517, DOI 10.1034/j.1600-0749.2003.00080.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roulin A, 2006, NATURWISSENSCHAFTEN, V93, P426, DOI 10.1007/s00114-006-0128-8; Roulin A, 2013, SEMIN CELL DEV BIOL, V24, P594, DOI 10.1016/j.semcdb.2013.05.005; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Schonitzer V, 2011, BIOCHEM BIOPH RES CO, V415, P586, DOI 10.1016/j.bbrc.2011.10.109; Schonitzer V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-71; Shi MJ, 2013, MAR BIOTECHNOL, V15, P706, DOI 10.1007/s10126-013-9517-0; Shi YH, 2013, MAR BIOTECHNOL, V15, P175, DOI 10.1007/s10126-012-9476-x; Simon JD, 2009, PIGM CELL MELANOMA R, V22, P563, DOI 10.1111/j.1755-148X.2009.00610.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Veis A., 1990, SCIENCE, V247, P1129; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Weiss IM, 2006, FEBS LETT, V580, P1846, DOI 10.1016/j.febslet.2006.02.044; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Werner GDA, 2013, MAR BIOTECHNOL, V15, P230, DOI 10.1007/s10126-012-9481-0; Yan ZG, 2007, BBA-GEN SUBJECTS, V1770, P1338, DOI 10.1016/j.bbagen.2007.06.018; [杨爱国 Yang Aiguo], 2004, [海洋水产研究, Marine Fisheries Research], V25, P1; Yang Hui-Ping, 2001, Acta Zoologica Sinica, V47, P459; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Q, 2000, MAR SCI, V24, P14; Zheng HP, 2013, AQUAC RES, V44, P1229, DOI 10.1111/j.1365-2109.2012.03124.x	70	56	63	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122967	10.1371/journal.pone.0122967	http://dx.doi.org/10.1371/journal.pone.0122967			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856556	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500068
J	Uguru, NP; Mbachu, C; Ibe, OP; Uguru, CC; Odukoya, O; Okwuosa, C; Onwujekwe, O				Uguru, Nkoli P.; Mbachu, Chinyere; Ibe, Ogochukwu P.; Uguru, Chibuzo C.; Odukoya, Oluwakemi; Okwuosa, Chinenye; Onwujekwe, Obinna			Investigating Male Tobacco Use and Expenditure Patterns across Socio-Economic Groups in Nigeria	PLOS ONE			English	Article							DETERMINANTS	The magnitude of variation in economic costs of tobacco consumption among socio-economic status (SES) groups in Nigeria is unclear. Understanding the factors that influence tobacco use and expenditure among different socio-economic groups would inform decisions on interventions for tobacco control in Nigeria. Secondary data was obtained from the 2008 National demographic and health survey. Information on tobacco use and expenditure in households and individual males were extracted from the database. A total of 34,070 households and 15,846 individual males were sampled. Analysis was done using descriptive statistics and binary logistic regression analysis. Information on wealth index obtained were categorized into socio-economic quintile groups (Q1 to Q5), representing poorest to richest socio-economic groups. To estimate expenditure on cigarettes, the average cost of a stick of cigarette was obtained and multiplied with the number of sticks smoked per day. The proportion of households that use tobacco in Nigeria is 5.25% with a greater percentage (89.6%) residing in the rural areas. Prevalence of cigarette smoking in individual males is 8.59%, and the poorer SES group smoked more cigarettes (20.9%) and spent more (0.60-1.19USD) than the richest SES group. Low education level, traditional beliefs, literacy levels, SES and employment status all influence cigarette smoking in adult males. Although poor people smoked more and spent more of their income on cigarettes, other factors like educational level and traditional beliefs were found to influence practice of cigarette smoking in men. This implies that tobacco control legislation through increased taxes alone may not effectively reduce the use of tobacco and its products in Nigeria. A consolidated approach that includes behavioral change procedures, enforcing bans on tobacco advertisement and the use of strong graphic anti-tobacco messages targeted at both the poor and rich as well as the educated and uneducated need to be effected to reduce tobacco use.	[Uguru, Nkoli P.] Univ Nigeria, Coll Med, Fac Dent, Dept Prevent Dent, Enugu, Nigeria; [Mbachu, Chinyere] Univ Nigeria, Coll Med, Dept Community Med, Enugu, Nigeria; [Uguru, Nkoli P.; Mbachu, Chinyere; Ibe, Ogochukwu P.; Okwuosa, Chinenye; Onwujekwe, Obinna] Univ Nigeria, Coll Med, Dept Pharmacol & Therapeut, Hlth Policy Res Grp, Enugu, Nigeria; [Uguru, Chibuzo C.] Univ Nigeria, Coll Med, Fac Dent, Dept Oral & Maxillofacial Surg, Enugu, Nigeria; [Odukoya, Oluwakemi] Univ Lagos, Coll Med, Dept Community Med, Lagos, Nigeria; [Onwujekwe, Obinna] Univ Nigeria, Coll Med, Fac Hlth Sci & Technol, Dept Hlth Adm & Management, Enugu, Nigeria	University of Nigeria; University of Nigeria; University of Nigeria; University of Nigeria; University of Lagos; University of Nigeria	Uguru, NP (corresponding author), Univ Nigeria, Coll Med, Fac Dent, Dept Prevent Dent, Enugu Campus, Enugu, Nigeria.	nk_uguru@yahoo.com	Mbachu, Chinyere/AAE-5010-2022; Odukoya, kemi O/G-9875-2015; Onwujekwe, Obinna/O-6232-2014	Odukoya, kemi O/0000-0001-7199-3300; Onwujekwe, Obinna/0000-0002-1214-4285	University of Cape Town (UCT) [15549]; American cancer society; NU [15549]	University of Cape Town (UCT); American cancer society(American Cancer Society); NU	This study was funded by the University of Cape Town (UCT) and NU was a receipient of this fund under the project entitled 'Emerging Tobacco Researchers Project'. UCT received funding from the American cancer society. The funders reviewed the study design, data collection and analysis. They had no role in the preparation of the manuscript. Research agreement number between UCT and NU: 15549.	Action on Smoking and Health (ASH) Tobacco, 2007, ACT SMOK HLTH ASH TO; Ademigbuji A, 2012, MULTIBILLION NAIRA T; Alam AY, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-50; [Anonymous], 2008, WHO REP GLOB TOB EP, P278; ASH (Action on Smoking and Health), 2008, TOB DEV WORLD FACT S; Drope J, 2011, TOBACCO CONTROL AFRI; Gilani SI, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-16; Hosseinpoor AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020331; Kale Y, 2012, GLOBAL ADULT TOBACCO; Liu YL, 2006, SOC SCI MED, V63, P2784, DOI 10.1016/j.socscimed.2006.06.019; Mushtaq N, 2011, TOB CONTROL, V20, P431, DOI 10.1136/tc.2010.040048; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Nura J, 2007, NURUDDEEN, V1, P1; Rani M, 2003, Tob Control, V12, pe4, DOI 10.1136/tc.12.4.e4; Stevens S., 2003, RURAL HLTH PEOPLE 20, V2, P237; van Loon AJM, 2005, EUR J PUBLIC HEALTH, V15, P256, DOI 10.1093/eurpub/cki077; Wikepedia contributors, 2009, NIG COUNTR PROF WIK; World Bank Report, 2008, WORLD BANK REPORT; World Health Organization, FACTS FIG TOB	19	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122021	10.1371/journal.pone.0122021	http://dx.doi.org/10.1371/journal.pone.0122021			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856074	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500028
J	van Breugel, P; Kindt, R; Lilleso, JPB; van Breugel, M				van Breugel, Paulo; Kindt, Roeland; Lilleso, Jens-Peter Barnekow; van Breugel, Michiel			Environmental Gap Analysis to Prioritize Conservation Efforts in Eastern Africa	PLOS ONE			English	Article							PROTECTED AREAS; BIODIVERSITY CONSERVATION; CONSERVING BIODIVERSITY; SPECIES RICHNESS; LAND; DIVERSITY; ECOREGIONS; HOTSPOTS; FOREST; INDICATORS	Countries in eastern Africa have set aside significant proportions of their land for protection. But are these areas representative of the diverse range of species and habitats found in the region? And do conservation efforts include areas where the state of biodiversity is likely to deteriorate without further interventions? Various studies have addressed these questions at global and continental scales. However, meaningful conservation decisions are required at finer geographical scales. To operate more effectively at the national level, finer scale baseline data on species and on higher levels of biological organization such as the eco-regions are required, among other factors. Here we adopted a recently developed high-resolution potential natural vegetation (PNV) map for eastern Africa as a baseline to more effectively identify conservation priorities. We examined how well different potential natural vegetations (PNVs) are represented in the protected area (PA) network of eastern Africa and used a multivariate environmental similarity index to evaluate biases in PA versus PNV coverage. We additionally overlaid data of anthropogenic factors that potentially influence the natural vegetation to assess the level of threat to different PNVs. Our results indicate substantial differences in the conservation status of PNVs. In addition, particular PNVs in which biodiversity protection and ecological functions are at risk due to human influences are revealed. The data and approach presented here provide a step forward in developing more transparent and better informed translation from global priorities to regional or national implementation in eastern Africa, and are valid for other geographic regions.	[van Breugel, Paulo; Lilleso, Jens-Peter Barnekow] Univ Copenhagen, Dept Geosci & Nat Resource Management, Forest Nat & Biomass, DK-1958 Frederiksberg C, Denmark; [van Breugel, Paulo; Kindt, Roeland] World Agroforestry Ctr, Nairobi, Kenya; [van Breugel, Michiel] Natl Univ Singapore, Dept Biol Sci, Yale NUS Coll, Singapore 138614, Singapore; [van Breugel, Michiel] Ciudad Panam, Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Panama City, Panama; [van Breugel, Michiel] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	University of Copenhagen; CGIAR; World Agroforestry (ICRAF); National University of Singapore; Yale NUS College; Smithsonian Institution; Smithsonian Tropical Research Institute; National University of Singapore	van Breugel, P (corresponding author), Univ Copenhagen, Dept Geosci & Nat Resource Management, Forest Nat & Biomass, Rolighedsvej 23, DK-1958 Frederiksberg C, Denmark.	p.vanbreugel@gmail.com	Lillesø, Jens-Peter Barnekow B/F-4455-2015; Kindt, Roeland/AAV-3346-2020	Lillesø, Jens-Peter Barnekow B/0000-0003-1418-3496; Kindt, Roeland/0000-0002-7672-0712; van Breugel, Paulo/0000-0001-9579-0831	Consultative Research Committee for Development Research (FFU) [10-095-LIFE]	Consultative Research Committee for Development Research (FFU)	The research presented was funded by a grant from the Consultative Research Committee for Development Research (FFU) under project 10-095-LIFE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W.M., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; Adams WM, 2001, ORYX, V35, P193, DOI 10.1017/S0030605300031847; Ahmed AGM, 2003, POSTDROUGHT RECOVERY; Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; [Anonymous], 1995, GLOBAL BIODIVERSITY; Araujo MB, 2003, ECOGRAPHY, V26, P380, DOI 10.1034/j.1600-0587.2003.03625.x; Araujo MB, 2001, ECOGRAPHY, V24, P103, DOI 10.1034/j.1600-0587.2001.240112.x; Balletto E, 2010, ITAL J ZOOL, V77, P2, DOI 10.1080/11250000902758923; Beggs PJ, 2013, ATMOS ENVIRON, V68, P112, DOI 10.1016/j.atmosenv.2012.11.044; BELBIN L, 1993, BIOL CONSERV, V66, P223, DOI 10.1016/0006-3207(93)90007-N; Bertzky B., 2012, PROTECTED PLANET REP; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bray DB, 2003, CONSERV BIOL, V17, P672, DOI 10.1046/j.1523-1739.2003.01639.x; Brooks JS, 2006, CONSERV BIOL, V20, P1528, DOI 10.1111/j.1523-1739.2006.00506.x; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Bunce RGH, 2013, ECOL INDIC, V33, P19, DOI 10.1016/j.ecolind.2012.07.014; Burgess N., 2004, Terrestrial ecoregions of Africa and Madagascar: a conservation assessment; Burgess N, 2013, CEE 10 007; Burgess ND, 2006, BIOL CONSERV, V127, P383, DOI 10.1016/j.biocon.2005.08.018; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CGIAR-CSI, 2008, CGIAR CSI SRTM 90M D; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chape S., 2009, BIOSCIENCE, V59, P623; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Cox RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014508; da Fonseca GAB, 2000, NATURE, V405, P393, DOI 10.1038/35013249; Davis S.D., 2013, VERSION 1 0 DIGITAL, P1994; De Leeuw P. N., 1995, World Animal Review (Multilingual Edition), V83, P47; de Wit M, 2006, SCIENCE, V311, P1917, DOI 10.1126/science.1119929; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Duelli P, 2003, AGR ECOSYST ENVIRON, V98, P87, DOI 10.1016/S0167-8809(03)00072-0; Duputie A, 2014, GLOBAL ECOL BIOGEOGR, V23, P457, DOI 10.1111/geb.12118; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; ESA, 2007, GLOBCOVER 2005 06 VE; Faith DP, 2003, ECOGRAPHY, V26, P374, DOI 10.1034/j.1600-0587.2003.03300.x; Ferrier S, 2004, BIOSCIENCE, V54, P1101, DOI 10.1641/0006-3568(2004)054[1101:MMOTBF]2.0.CO;2; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ferrier S, 1997, EVALUATION EFFECTIVE; Forero-Medina G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013210; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Fritz S, 2012, ENVIRON MODELL SOFTW, V31, P110, DOI 10.1016/j.envsoft.2011.11.015; Fritz S, 2009, REMOTE SENS-BASEL, V1, P345, DOI 10.3390/rs1030345; Fuller RA, 2010, NATURE, V466, P365, DOI 10.1038/nature09180; Funk SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008923; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Gordon JE, 2012, P GEOLOGIST ASSOC, V123, P1, DOI 10.1016/j.pgeola.2011.08.002; Gorenflo LJ, 2011, ECOL STUD-ANAL SYNTH, V214, P153, DOI 10.1007/978-3-642-16707-2_9; Gould W, 2000, ECOL APPL, V10, P1861, DOI 10.1890/1051-0761(2000)010[1861:RSOVPS]2.0.CO;2; GRASS Development Team, 2014, GEOGR RES AN SUPP SY; Green JMH, 2013, BIOL CONSERV, V164, P62, DOI 10.1016/j.biocon.2013.04.016; Gryseels G., 1988, CASE STUDY BASO WORE; Hayes TM, 2006, WORLD DEV, V34, P2064, DOI 10.1016/j.worlddev.2006.03.002; Hazen HD, 2004, PHYS GEOGR, V25, P499, DOI 10.2747/0272-3646.25.6.499; Hazen H, 2007, PROF GEOGR, V59, P256, DOI 10.1111/j.1467-9272.2007.00611.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; IUCN and UNEP-WCMC, 2013, WORLD DAT PROT AR WD; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; JRC, 2003, GLOB LAND COV 2000 D; Kier G, 2001, BIODIVERS CONSERV, V10, P1513, DOI 10.1023/A:1011812528849; Kruska RL, 2003, AGR SYST, V77, P39, DOI 10.1016/S0308-521X(02)00085-9; Kuper W, 2004, ANN MO BOT GARD, V91, P525; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Leroux SJ, 2010, BIOL CONSERV, V143, P609, DOI 10.1016/j.biocon.2009.11.018; Leverington F, 2010, MANAGEMENT EFFECTIVE, P87; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Lindenmayer DB, 2009, LANDSCAPE ECOL, V24, P1091, DOI 10.1007/s10980-008-9244-5; Lombard AT, 2003, BIOL CONSERV, V112, P45, DOI 10.1016/S0006-3207(02)00422-6; LP DAAC, 2009, MODIS LAND COV TYP Y; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mascia MB, 2014, BIOL CONSERV, V169, P355, DOI 10.1016/j.biocon.2013.11.021; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Nelson A., 2008, TRAVEL TIME MAJOR CI; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Neumann RP, 2001, AFRICA, V71, P641, DOI 10.2307/1161583; Neumann RP., 1995, ECUMENE, V2, P149, DOI DOI 10.1177/147447409500200203; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Ovaskainen O, 2002, J THEOR BIOL, V218, P419, DOI 10.1006/jtbi.2002.3089; Overton JM, 2001, SCI CONSERVATION, V174, P1; Panitsa M, 2011, J NAT CONSERV, V19, P269, DOI 10.1016/j.jnc.2011.04.001; Rodriguez JP, 2011, CONSERV BIOL, V25, P21, DOI 10.1111/j.1523-1739.2010.01598.x; Peters H, 2015, GLOBAL CHANGE BIOL, V21, P618, DOI 10.1111/gcb.12749; Pfeifer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039337; Powell GVN, 2000, BIOL CONSERV, V93, P35, DOI 10.1016/S0006-3207(99)00115-9; Pressey RL, 1996, FOREST ECOL MANAG, V85, P311, DOI 10.1016/S0378-1127(96)03766-8; Pressey RL, 2001, CONSERV BIOL, V15, P275, DOI 10.1046/j.1523-1739.2001.99541.x; Redford KH, 2003, CONSERV BIOL, V17, P647; Robbins P., 2012, POLITICAL ECOLOGY; Rocchini D, 2010, ECOL INFORM, V5, P318, DOI 10.1016/j.ecoinf.2010.06.001; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez JP, 2007, SCIENCE, V317, P755, DOI 10.1126/science.1145560; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scherr SJ, 2008, PHILOS T R SOC B, V363, P477, DOI 10.1098/rstb.2007.2165; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Somodi I, 2012, J VEG SCI, V23, P590, DOI 10.1111/j.1654-1103.2011.01378.x; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; The World Bank, 2012, WORLDBANK DATA; Thompson M, 2002, HUM ECOL, V30, P107, DOI 10.1023/A:1014519113923; Tikkanen OP, 2007, BIOL CONSERV, V140, P359, DOI 10.1016/j.biocon.2007.08.020; Trabucco A., 2009, GLOBAL ARIDITY INDEX; Trakhtenbrot A, 2005, ECOL APPL, V15, P335, DOI 10.1890/04-0077; UN-Habitat, 2008, STAT AFR CIT FRAM AD; Van Breugel P, 2015, ALTERNATIVE SIMPLIFI; Van Breugel P, 2012, POTENTIAL NATURAL VE; Van Breugel P, 2011, POTENTIAL NATURAL VE, P139; Vistnets I, 2001, GLOBAL METHODOLOGY M; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Watson JEM, 2009, DIVERS DISTRIB, V15, P1028, DOI 10.1111/j.1472-4642.2009.00601.x; White F., 1983, VEGETATION AFRICA DE, P1876; Wikramanayake E, 2002, CONSERV BIOL, V16, P238, DOI 10.1046/j.1523-1739.2002.01403.x; Wild R, 2009, SACRED NATURAL SITES; Wilson KA, 2009, ANN NY ACAD SCI, V1162, P237, DOI 10.1111/j.1749-6632.2009.04149.x; Wint G. R. W., 2007, GRIDDED LIVESTOCK WO, P131; Woodley S., 2012, PARKS, V18, P23, DOI DOI 10.2305/IUCN.CH.2012.PARKS-18-1.SW.EN; Zachos F.E., 2011, BIODIVERSITY HOTSPOT	130	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121444	10.1371/journal.pone.0121444	http://dx.doi.org/10.1371/journal.pone.0121444			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25855968	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500020
J	Xifro, X; Vidal-Sancho, L; Boadas-Vaello, P; Turrado, C; Alberch, J; Puig, T; Verdu, E				Xifro, Xavier; Vidal-Sancho, Laura; Boadas-Vaello, Pere; Turrado, Carlos; Alberch, Jordi; Puig, Teresa; Verdu, Enrique			Novel Epigallocatechin-3-Gallate (EGCG) Derivative as a New Therapeutic Strategy for Reducing Neuropathic Pain after Chronic Constriction Nerve Injury in Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FATTY-ACID SYNTHASE; NF-KAPPA-B; GREEN TEA POLYPHENOLS; SPINAL-CORD; CENTRAL SENSITIZATION; ANTICANCER ACTIVITY; MUTANT HUNTINGTIN; GALLATE; MECHANISMS	Neuropathic pain is common in peripheral nerve injury and often fails to respond to ordinary medication. Here, we investigated whether the two novel epigallocatechin-3-gallate (EGCG) polyphenolic derivatives, compound 23 and 30, reduce the neuropathic pain in mice chronic constriction nerve injury (CCI). First, we performed a dose-response study to evaluate nociceptive sensation after administration of EGCG and its derivatives 23 and 30, using the Hargreaves test at 7 and 21 days after injury (dpi). We daily administered EGCG, 23 and 30 (10 to 100 mg/Kg; i.p.) during the first week post-CCI. None of the doses of compound 23 caused significant pain diminution, whereas 50mg/kg was optimal for both EGCG and 30 to delay the latency of paw withdrawal. With 50 mg/Kg, we showed that EGCC prevented the thermal hyperalgesia from 7 to 21 dpi and compound 30 from 14 to 56 dpi. To evaluate the molecular mechanisms underpinning why EGCG and compound 30 differentially prevented the thermal hyperalgesia, we studied several biochemical parameters in the dorsal horn of the spinal cord at 14 and 56 dpi. We showed that the effect observed with EGCG and compound 30 was related to the inhibition of fatty acid synthase (FASN), a known target of these polyphenolic compounds. Additionally, we observed that EGCG and compound 30 reduced the expression of CCI-mediated inflammatory proteins and the nuclear localization of nuclear factor-kappa B at 14 dpi, but not at 56 dpi. We also strongly detected a decrease of synaptic plasma membrane levels of N-methyl-D-asparte receptor 2B in CCI-mice treated with compound 30 at 56 dpi. Altogether, compound 30 reduced the chronic thermal hyperalgesia induced by CCI better than the natural compound EGCG. Thus, our findings provide a rationale for the preclinical development of compound 30 as an agent to treat neuropathic pain.	[Xifro, Xavier; Vidal-Sancho, Laura; Boadas-Vaello, Pere; Puig, Teresa; Verdu, Enrique] Univ Girona UdG, Fac Med, Dept Ciencias Med, Grp Invest Anat Clin Embriol Neurociencia & Oncol, Girona, Spain; [Xifro, Xavier; Vidal-Sancho, Laura; Alberch, Jordi] Univ Barcelona, Fac Med, Dept Biol Cellular Immunol & Neurociencies, Barcelona 7, Spain; [Xifro, Xavier; Vidal-Sancho, Laura; Alberch, Jordi] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Xifro, Xavier; Vidal-Sancho, Laura; Alberch, Jordi] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Turrado, Carlos] Univ Complutense Madrid, Fac Ciencias Quim, Dept Quim Organ 1, Lab Quim Med, E-28040 Madrid, Spain	Universitat de Girona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; Complutense University of Madrid	Puig, T (corresponding author), Univ Girona UdG, Fac Med, Dept Ciencias Med, Grp Invest Anat Clin Embriol Neurociencia & Oncol, Girona, Spain.	teresa.puig@udg.edu; enric.verdu@udg.edu	Xifro, Xavier/ABH-2365-2020; Alberch, Jordi/K-5702-2014; Boadas-Vaello, Pere/L-1040-2015; Verdú, Enrique/L-1956-2015	Xifro, Xavier/0000-0002-7417-9475; Alberch, Jordi/0000-0002-8684-2721; Boadas-Vaello, Pere/0000-0001-8497-1207; Verdú, Enrique/0000-0002-0816-1146	Spanish Ministerio de Economia y Competitividad [SAF2011-29507]; Accions Singulars de R+D (Sing 12/17) del Vicerrectorat de Recerca de la Universitat de Girona; RecerCaixa, Spain; Spanish Ministerio de Economia y Competitividad (MINECO) [SAF2010-22198-C02-01]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Accions Singulars de R+D (Sing 12/17) del Vicerrectorat de Recerca de la Universitat de Girona; RecerCaixa, Spain; Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government)	This study was supported by grants from RecerCaixa2010 (EV and TP), Spain, from the Spanish Ministerio de Economia y Competitividad (SAF2011-29507, XX and JA) and Accions Singulars de R+D (Sing 12/17) del Vicerrectorat de Recerca de la Universitat de Girona (PBV). CT was a fellow of Spanish Ministerio de Economia y Competitividad (MINECO, SAF2010-22198-C02-01, CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Anglada-Huguet M, 2012, J NEUROCHEM, V121, P639, DOI 10.1111/j.1471-4159.2012.07711.x; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Boyce S, 1999, NEUROPHARMACOLOGY, V38, P611, DOI 10.1016/S0028-3908(98)00218-4; Chen D, 2011, ADV CLIN CHEM, V53, P155, DOI 10.1016/S0065-2423(11)53007-0; Choi JI, 2012, NEUROSCI LETT, V510, P53, DOI 10.1016/j.neulet.2011.12.070; Cohen SP, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7656; Denkers EY, 2004, IMMUNOL REV, V201, P191, DOI 10.1111/j.0105-2896.2004.00180.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Jackson Kenneth C 2nd, 2006, Pain Pract, V6, P27; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Khalatbary Ali Reza, 2011, Iranian Biomedical Journal, V15, P31; Khalatbary AR, 2010, BRAIN RES, V1306, P168, DOI 10.1016/j.brainres.2009.09.109; Kiguchi N, 2012, CURR OPIN PHARMACOL, V12, P55, DOI 10.1016/j.coph.2011.10.007; Ko GD, 2010, CLIN J PAIN, V26, P168, DOI 10.1097/AJP.0b013e3181bb8533; Koh SH, 2006, NEUROSCI LETT, V395, P103, DOI 10.1016/j.neulet.2005.10.056; Kridel SJ, 2007, EXPERT OPIN INV DRUG, V16, P1817, DOI 10.1517/13543784.16.11.1817; Kuang X, 2012, EUR J PHARMACOL, V676, P51, DOI 10.1016/j.ejphar.2011.11.037; Landis-Piwowar K, 2013, EXPERT OPIN THER PAT, V23, P189, DOI 10.1517/13543776.2013.743993; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu Hailan, 2010, Int J Biochem Mol Biol, V1, P69; Lu H, 2003, DRUG METAB DISPOS, V31, P452, DOI 10.1124/dmd.31.4.452; Martin YB, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-8; Muller C, 2010, FREE RADICAL RES, V44, P1425, DOI 10.3109/10715762.2010.512919; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Oberbach A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010882; Pan ZH, 1996, P NATL ACAD SCI USA, V93, P15423, DOI 10.1073/pnas.93.26.15423; Perez J, 2005, ANESTH ANALG, V101, P444, DOI 10.1213/01.ANE.0000158469.11775.52; Puig T, 2008, BREAST CANCER RES TR, V109, P471, DOI 10.1007/s10549-007-9678-5; Puig T, 2009, CLIN CANCER RES, V15, P7608, DOI 10.1158/1078-0432.CCR-09-0856; Qiu S, 2011, SEMIN CELL DEV BIOL, V22, P521, DOI 10.1016/j.semcdb.2011.06.003; Renno WM, 2014, NEUROPHARMACOLOGY, V77, P100, DOI 10.1016/j.neuropharm.2013.09.013; Saini R, 2006, J LEUKOCYTE BIOL, V79, P519, DOI 10.1189/jlb.0605320; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Sun T, 2006, BRIT J ANAESTH, V97, P553, DOI 10.1093/bja/ael209; Sutherland BA, 2006, J NUTR BIOCHEM, V17, P291, DOI 10.1016/j.jnutbio.2005.10.005; Tian W, 2013, NEUROCHEM RES, V38, P772, DOI 10.1007/s11064-013-0976-5; Torres-Peraza JF, 2008, NEUROBIOL DIS, V29, P409, DOI 10.1016/j.nbd.2007.10.003; Tsang MYC, 2004, NITRIC OXIDE-BIOL CH, V10, P11, DOI 10.1016/j.niox.2004.01.005; Turrado C, 2012, J MED CHEM, V55, P5013, DOI 10.1021/jm2016045; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Wei IH, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-52; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Weinreb O, 2004, J NUTR BIOCHEM, V15, P506, DOI 10.1016/j.jnutbio.2004.05.002; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Wu LJ, 2009, NEUROTHERAPEUTICS, V6, P693, DOI 10.1016/j.nurt.2009.07.008; Xifro X, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-74; Xu B, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-15	52	25	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123122	10.1371/journal.pone.0123122	http://dx.doi.org/10.1371/journal.pone.0123122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855977	gold, Green Published			2022-12-27	WOS:000352588500076
J	Ahire, JJ; Neveling, DP; Hattingh, M; Dicks, LMT				Ahire, Jayesh J.; Neveling, Deon P.; Hattingh, Melanie; Dicks, Leon M. T.			Ciprofloxacin-Eluting Nanofibers Inhibits Biofilm Formation by Pseudomonas aeruginosa and a Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							OXIDE) PEO; ELECTROSPUN; COMBINATIONS; INFECTIONS; DRESSINGS; BACTERIA; RELEASE	Pseudomonas aeruginosa and Staphylococcus aureus are commonly associated with hospital-acquired infections and are known to form biofilms. Ciprofloxacin (CIP), which is normally used to treat these infections, is seldom effective in killing cells in a biofilm. This is mostly due to slow or weak penetration of CIP to the core of biofilms. The problem is accentuated by the release of CIP below MIC (minimal inhibitory concentration) levels following a rapid (burst) release. The aim of this study was to develop a drug carrier that would keep CIP above MIC levels for an extended period. Ciprofloxacin was suspended into poly(D, Llactide) (PDLLA) and poly(ethylene oxide) (PEO), and electrospun into nanofibers (CIP-F). All of the CIP was released from the nanofibers within 2 h, which is typical of a burst release. However, 99% of P. aeruginosa PA01 cells and 91% of S. aureus Xen 30 cells (a methicillin-resistant strain) in biofilms were killed when exposed to CIP-F. CIP levels remained above MIC for 5 days, as shown by growth inhibition of the cells in vitro. The nanofibers were smooth in texture with no bead formation, as revealed by scanning electron and atomic force microscopy. A single vibration peak at 1632 cm(-1), recorded with Fourier transform infrared spectroscopy, indicated that CIP remained in crystal form when incorporated into PDLLA: PEO. No abnormalities in the histology of MCF-12A breast epithelial cells were observed when exposed to CIP-F. This is the first report of the inhibition of biofilm formation by CIP released from PDLLA: PEO nanofibers.	[Ahire, Jayesh J.; Neveling, Deon P.; Hattingh, Melanie; Dicks, Leon M. T.] Univ Stellenbosch, Dept Microbiol, Matieland, Stellenbosch, South Africa	Stellenbosch University	Dicks, LMT (corresponding author), Univ Stellenbosch, Dept Microbiol, Matieland, Stellenbosch, South Africa.	LMTD@sun.ac.za	Dicks, Leon/X-6642-2019; Ahire, Jayesh J/Q-1632-2018; Neveling, Deon/AAH-3763-2020	Ahire, Jayesh J/0000-0002-1142-8630; Neveling, Deon/0000-0003-4090-9684; Dicks, Leon/0000-0002-5157-9046	Claude Leon Foundation, Cape Town, South Africa	Claude Leon Foundation, Cape Town, South Africa	This work was supported by Claude Leon Foundation in the form of Postdoctoral Fellowship to JJA, Cape Town, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeid M, 2010, J GENET ENG BIOTECHN, V8, P29; Abrigo M, 2014, MACROMOL BIOSCI, V14, P772, DOI 10.1002/mabi.201300561; Ahire JJ, 2015, PROBIOTICS ANTIMICRO, V7, P52, DOI 10.1007/s12602-014-9171-5; Ahire JJ, 2014, CURR MICROBIOL, V69, P587, DOI 10.1007/s00284-014-0635-3; Ahire JJ, 2014, ANTIMICROB AGENTS CH, V58, P2098, DOI 10.1128/AAC.02397-13; Ahmed Z, 2013, SAUDI J BIOL SCI, V20, P79, DOI 10.1016/j.sjbs.2012.10.005; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Ball C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049792; Bottino MC, 2014, CLIN ORAL INVEST, V18, P2151, DOI 10.1007/s00784-014-1201-x; Cross A., 1983, REV INFECT DIS, V5, P837; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Das RR, 2013, SCI WORLD J, DOI 10.1155/2013/645653; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Demirci S, 2014, POLYM CHEM-UK, V5, P2050, DOI 10.1039/c3py01276j; Hernandez-Borrell J, 2003, INT J PHARMACEUT, V252, P149, DOI 10.1016/S0378-5173(02)00633-6; Heunis TDJ, 2010, J BIOMED BIOTECHNOL, V61, P1; Heunis T, 2011, INT J MOL SCI, V12, P2158, DOI 10.3390/ijms12042158; Heunis TDJ, 2013, ANTIMICROB AGENTS CH, V57, P3928, DOI 10.1128/AAC.00622-13; Hu XL, 2014, J CONTROL RELEASE, V185, P12, DOI 10.1016/j.jconrel.2014.04.018; Jannesari M, 2011, INT J NANOMED, V6, DOI 10.2147/IJN.S17595; Lucena A, 2014, J HOSP INFECT, V87, P234, DOI 10.1016/j.jhin.2014.05.007; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Shawki MM., 2010, ROMANIAN J BIOPHYS, V20, P335; Shive MS, 1997, ADV DRUG DELIV REV, V28, P5; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Toncheva A, 2012, EUR J PHARM SCI, V47, P642, DOI 10.1016/j.ejps.2012.08.006; Tseng BS, 2013, ENVIRON MICROBIOL, V15, P2865, DOI 10.1111/1462-2920.12155; Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983; Yu DG, 2010, AAPS PHARMSCITECH, V11, P809, DOI 10.1208/s12249-010-9438-4; Zhao TM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-140	30	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123648	10.1371/journal.pone.0123648	http://dx.doi.org/10.1371/journal.pone.0123648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853255	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400112
J	Cysique, LA; Hey-Cunningham, WJ; Dermody, N; Chan, P; Brew, BJ; Koelsch, KK				Cysique, Lucette A.; Hey-Cunningham, William J.; Dermody, Nadene; Chan, Phillip; Brew, Bruce J.; Koelsch, Kersten K.			Peripheral Blood Mononuclear Cells HIV DNA Levels Impact Intermittently on Neurocognition	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; IMPAIRMENT; INFECTION; DYNAMICS; THERAPY; PERSIST; COHORT	Objectives To determine the contribution of peripheral blood mononuclear cells' (PBMCs) HIV DNA levels to HIV-associated dementia (HAD) and non-demented HIV-associated neurocognitive disorders (HAND) in chronically HIV-infected adults with long-term viral suppression on combined antiretroviral treatment (cART). Methods Eighty adults with chronic HIV infection on cART (>97% with plasma and CSF HIV RNA <50 copies/mL) were enrolled into a prospective observational cohort and underwent assessments of neurocognition and pre-morbid cognitive ability at two visits 18 months apart. HIV DNA in PBMCs was measured by real-time PCR at the same time-points. Results At baseline, 46% had non-demented HAND; 7.5% had HAD. Neurocognitive decline occurred in 14% and was more likely in those with HAD (p<.03). Low pre-morbid cognitive ability was uniquely associated with HAD (p<.05). Log(10) HIV DNA copies were stable between study visits (2.26 vs. 2.22 per 10(6) PBMC). Baseline HIV DNA levels were higher in those with lower pre-morbid cognitive ability (p<.04), and higher in those with no ART treatment during HIV infection 1st year (p = .03). Baseline HIV DNA was not associated with overall neurocognition. However, % ln HIV DNA change was associated with decline in semantic fluency in unadjusted and adjusted analyses (p = .01-.03), and motor-coordination (p = .02-.12) to a lesser extent. Conclusions PBMC HIV DNA plays a role in HAD pathogenesis, and this is moderated by pre-morbid cognitive ability in the context of long-term viral suppression. While the HIV DNA levels in PBMC are not associated with current non-demented HAND, increasing HIV DNA levels were associated with a decline in neurocognitive functions associated with HAND progression.	[Cysique, Lucette A.; Dermody, Nadene] Neurosci Res Australia, Sydney, NSW, Australia; [Hey-Cunningham, William J.; Koelsch, Kersten K.] UNSW Australia, UNSW Med, Kirby Inst, Sydney, NSW, Australia; [Cysique, Lucette A.; Brew, Bruce J.] St Vincents Ctr Appl Med Res, Peter Duncan Neurosci Unit, Sydney, NSW, Australia; [Chan, Phillip; Brew, Bruce J.; Koelsch, Kersten K.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Chan, Phillip; Brew, Bruce J.; Koelsch, Kersten K.] St Vincents Hosp, Dept HIV, Sydney, NSW 2010, Australia; [Cysique, Lucette A.; Hey-Cunningham, William J.; Brew, Bruce J.; Koelsch, Kersten K.] Univ New S Wales, Sydney, NSW, Australia; [Dermody, Nadene] Macquarie Univ, Sydney, NSW 2109, Australia; [Chan, Phillip] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China	Neuroscience Research Australia; University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Macquarie University	Cysique, LA (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	lcysique@unsw.edu.au	Cysique, Lucette A./U-1357-2017	Cysique, Lucette A./0000-0002-7711-6373; Chan, Phillip/0000-0002-4071-4409; brew, bruce/0000-0003-0622-1392	National Health and Medical Research Council of Australia (Cysique CIA/PI) [ID568746]; post-doctoral Brain Science UNSW fellowship (Cysique); Mercks Sharp Dome (MSD); National Heath and Medical Research Council of Australia Career Development Fellowship (Cysique CIA/PI) [APP1045400]; Peter Duncan Neurosciences Unit	National Health and Medical Research Council of Australia (Cysique CIA/PI)(National Health and Medical Research Council (NHMRC) of Australia); post-doctoral Brain Science UNSW fellowship (Cysique); Mercks Sharp Dome (MSD); National Heath and Medical Research Council of Australia Career Development Fellowship (Cysique CIA/PI)(National Health and Medical Research Council (NHMRC) of Australia); Peter Duncan Neurosciences Unit	This study was supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au) project grant ID568746 (Cysique CIA/PI), the 2009-2012 post-doctoral Brain Science UNSW fellowship (Cysique), 2012 Mercks Sharp Dome (MSD) partial salary support for 2012, the National Heath and Medical Research Council of Australia Career Development Fellowship APP1045400 (Cysique CIA/PI) and the Peter Duncan Neurosciences Unit (Head Prof. Bruce Brew). MSD had no direct participation in the current study design, data analyses and interpretation. Dr. Cysique has otherwise no conflict of interest with the organizations that funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CF, 2010, J VIROL METHODS, V165, P151, DOI 10.1016/j.jviromet.2010.01.012; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Besson GJ, 2014, CLIN INFECT DIS, V59, P1312, DOI 10.1093/cid/ciu585; Brew BJ, 2013, EXPERT OPIN BIOL TH, V13, P403, DOI 10.1517/14712598.2013.748029; Chelune G. J., 1986, ADV CLIN NEUROPSYCHO, V3, P15, DOI DOI 10.1007/978-1-4613-2211-5_4; Cysique LA, 2014, J NEUROVIROL, V20, P258, DOI 10.1007/s13365-014-0242-x; Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504; Dahl V, 2014, AIDS, V28, P2251, DOI 10.1097/QAD.0000000000000400; Desplats P, 2013, NEUROLOGY, V80, P1415, DOI 10.1212/WNL.0b013e31828c2e9e; DUBREUIL RM, 1993, PCR METH APPL, V3, P57; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Hopkins GW, 2014, NEW VIEW STAT; Kamat A, 2012, JAIDS-J ACQ IMM DEF, V60, P234, DOI 10.1097/QAI.0b013e318256f3bc; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; Kusao I, 2012, J NEUROPSYCH CLIN N, V24, P71, DOI 10.1176/appi.neuropsych.11050109; Lane TA, 2012, NEUROPSYCHOLOGY, V26, P713, DOI 10.1037/a0029964; Murray JM, 2014, J VIROL, V88, P3516, DOI 10.1128/JVI.03331-13; Murray JM, 2012, AIDS, V26, P543, DOI 10.1097/QAD.0b013e328350fb3c; Nelson H., 1991, NATL ADULT READING T; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Shiramizu B, 2007, J NEUROPSYCH CLIN N, V19, P157, DOI 10.1176/appi.neuropsych.19.2.157; Shiramizu B, 2009, J NEUROPSYCH CLIN N, V21, P68, DOI 10.1176/appi.neuropsych.21.1.68; Valcour VG, 2009, NEUROLOGY, V72, P992, DOI 10.1212/01.wnl.0000344404.12759.83; Valcour VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070164; Valcour VG, 2010, J LEUKOCYTE BIOL, V87, P621, DOI 10.1189/jlb.0809571	27	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120488	10.1371/journal.pone.0120488	http://dx.doi.org/10.1371/journal.pone.0120488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853424	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400014
J	Dumas, P; Barbut, J; Le Ru, B; Silvain, JF; Clamens, AL; d'Alencon, E; Kergoat, GJ				Dumas, Pascaline; Barbut, Jerome; Le Ru, Bruno; Silvain, Jean-Francois; Clamens, Anne-Laure; d'Alencon, Emmanuelle; Kergoat, Gael J.			Phylogenetic Molecular Species Delimitations Unravel Potential New Species in the Pest Genus Spodoptera Guenee, 1852 (Lepidoptera, Noctuidae)	PLOS ONE			English	Article							FALL ARMYWORM LEPIDOPTERA; REPRODUCTIVE ISOLATION MECHANISMS; PARTITIONED BAYESIAN ANALYSES; BRANCH-LENGTH ESTIMATION; YULE-COALESCENT MODEL; FRUGIPERDA LEPIDOPTERA; HOST STRAINS; INTEGRATIVE TAXONOMY; MITOCHONDRIAL-DNA; CRYPTIC SPECIATION	FNowadays molecular species delimitation methods promote the identification of species boundaries within complex taxonomic groups by adopting innovative species concepts and theories (e.g. branching patterns, coalescence). As some of them can efficiently deal with large single-locus datasets, they could speed up the process of species discovery compared to more time consuming molecular methods, and benefit from the existence of large public datasets; these methods can also particularly favour scientific research and actions dealing with threatened or economically important taxa. In this study we aim to investigate and clarify the status of economically important moths species belonging to the genus Spodoptera (Lepidoptera, Noctuidae), a complex group in which previous phylogenetic analyses and integrative approaches already suggested the possible occurrence of cryptic species and taxonomic ambiguities. In this work, the effectiveness of innovative (and faster) species delimitation approaches to infer putative species boundaries has been successfully tested in Spodoptera, by processing the most comprehensive dataset (in terms of number of species and specimens) ever achieved; results are congruent and reliable, irrespective of the set of parameters and phylogenetic models applied. Our analyses confirm the existence of three potential new species clusters (for S. exigua (Hubner, 1808), S. frugiperda (J.E. Smith, 1797) and S. mauritia (Boisduval, 1833)) and support the synonymy of S. marima (Schaus, 1904) with S. ornithogalli (Guenee, 1852). They also highlight the ambiguity of the status of S. cosmiodes (Walker, 1858) and S. descoinsi Lalanne-Cassou & Silvain, 1994. This case study highlights the interest of molecular species delimitation methods as valuable tools for species discovery and to emphasize taxonomic ambiguities.	[Dumas, Pascaline] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Barbut, Jerome] Museum Natl Hist Nat, Direct Collect, USM 602, F-75231 Paris, France; [Le Ru, Bruno; Silvain, Jean-Francois] CNRS, IRD, Lab Evolut Genomes Speciat, Gif Sur Yvette, France; [Le Ru, Bruno; Silvain, Jean-Francois] Univ Paris 11, Orsay, France; [Le Ru, Bruno] African Insect Sci Food & Hlth icipe, Unite Rech IRD 072, Nairobi, Kenya; [Clamens, Anne-Laure] INRA, IRD, CIRAD, Montpellier SupAgro,UMR CBGP 1062, Montferrier Sur Lez, France; [d'Alencon, Emmanuelle] Univ Montpellier 2, DGIMI, UM2, UMR 1333, Montpellier, France; [d'Alencon, Emmanuelle] Univ Montpellier 2, DGIMI, INRA, UMR 1333, Montpellier, France	University of Amsterdam; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; International Centre of Insect Physiology & Ecology (ICIPE); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Universite de Montpellier	Dumas, P (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	pascalinedumas@gmail.com	LE RU, BRUNO/C-5862-2011; d'Alençon, Emmanuelle/AAD-3069-2020; Le Ru, bruno/K-3480-2016; Kergoat, Gael J./AAW-6505-2020	Le Ru, bruno/0000-0002-4208-3727; Kergoat, Gael J./0000-0002-8284-6215; BARBUT, Jerome/0000-0002-5022-2475	INRA (AAP SPE SPODOPTERA); French National Research Agency [ANR-12-BSV7-0004-01 ADA-SPODO]	INRA (AAP SPE SPODOPTERA); French National Research Agency(French National Research Agency (ANR))	Part of the sequencing was supported by a Genoscope project @-Speed-Id (Accurate SPEciEs Delimitation and Identification of eukaryotic biodiversity using DNA markers) proposed by F-BoL, the French Barcode of life initiative and by the program 'Bibliotheque du Vivant' (Project SPODOBAR) supported by a joint "Centre national de la recherche scientifique", "Institut National de la Recherche Agronomique" and "Museum national d'Histoire naturelle" consortium. The project was also supported by INRA (AAP SPE SPODOPTERA) and a grant from the French National Research Agency (ANR-12-BSV7-0004-01 ADA-SPODO).	Alvarez N, 2005, J ZOOL SYST EVOL RES, V43, P29, DOI 10.1111/j.1439-0469.2004.00286.x; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Astrin JJ, 2012, MOL PHYLOGENET EVOL, V63, P1, DOI 10.1016/j.ympev.2011.11.018; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Barros EM, 2010, ENTOMOL EXP APPL, V137, P237, DOI 10.1111/j.1570-7458.2010.01058.x; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Bond JE, 2002, EVOLUTION, V56, P1123; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; BROWN ES, 1975, B ENTOMOL RES, V65, P221, DOI 10.1017/S0007485300005939; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Butcher BA, 2012, ZOOTAXA, P7; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Collin R, 2003, BIOL J LINN SOC, V78, P541, DOI 10.1046/j.0024-4066.2002.00166.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dumas P, 2015, GENETICA IN PRESS, DOI [10.1007/s10709-015-9829-2, DOI 10.1007/S10709-015-9829-2]; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Ekman S, 2011, SYST BIOL, V60, P541, DOI 10.1093/sysbio/syr022; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Ezard T, 2009, PACKAGE SPLITS SPECI; Fletcher D. S., 1956, Bulletin of Entomological Research London, V47, P215, DOI 10.1017/S0007485300046666; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Frey JE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-106; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gebiola M, 2012, MOL ECOL, V21, P1190, DOI 10.1111/j.1365-294X.2011.05428.x; Gentile G, 2002, GENETICS, V161, P1561; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Gompert Z, 2006, MOL ECOL, V15, P1759, DOI 10.1111/j.1365-294X.2006.02905.x; Greenberg SM, 2001, ANN ENTOMOL SOC AM, V94, P566, DOI 10.1603/0013-8746(2001)094[0566:FALHOS]2.0.CO;2; Groot AT, 2010, ECOL ENTOMOL, V35, P105, DOI 10.1111/j.1365-2311.2009.01138.x; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hamback PA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-92; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huber BA, 2005, ZOOL ANZ, V243, P273, DOI 10.1016/j.jcz.2004.12.001; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Juarez ML, 2014, ENTOMOL EXP APPL, V152, P182, DOI 10.1111/eea.12215; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kergoat GJ, 2008, SYST ENTOMOL, V33, P289, DOI 10.1111/j.1365-3113.2007.00405.x; Kergoat GJ, 2012, MOL PHYLOGENET EVOL, V65, P855, DOI 10.1016/j.ympev.2012.08.006; Kodandaramaiah U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041058; Lalanne-Cassou B, 1999, ANN SOC ENTOMOL FR, V35, P109; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Le Ru BP, 2014, INVERTEBR SYST, V28, P451, DOI 10.1071/IS13062; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Levy HC, 2002, FLA ENTOMOL, V85, P186, DOI 10.1653/0015-4040(2002)085[0186:SIOSFL]2.0.CO;2; Lima ER, 2009, CHEMOECOLOGY, V19, P29, DOI 10.1007/s00049-009-0005-y; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Lu YJ, 1996, FLA ENTOMOL, V79, P48, DOI 10.2307/3495753; Lumley LM, 2010, SYST ENTOMOL, V35, P416, DOI 10.1111/j.1365-3113.2009.00514.x; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Machado V, 2008, ANN ENTOMOL SOC AM, V101, P619, DOI 10.1603/0013-8746(2008)101[619:MCOHSO]2.0.CO;2; Maddison WP, 2010, MESQUITE A MODULAR S; Marshall DC, 2006, SYST BIOL, V55, P993, DOI 10.1080/10635150601087641; Martinelli S, 2006, J ECON ENTOMOL, V99, P519, DOI 10.1603/0022-0493-99.2.519; McMichael M, 1999, ANN ENTOMOL SOC AM, V92, P175, DOI 10.1093/aesa/92.2.175; Meagher RL, 2003, FLA ENTOMOL, V86, P450, DOI 10.1653/0015-4040(2003)086[0450:IHSOFA]2.0.CO;2; Meagher RL, 2011, J INSECT BEHAV, V24, P337, DOI 10.1007/s10905-011-9259-7; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Melville J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101847; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nagoshi RN, 2008, ANN ENTOMOL SOC AM, V101, P1112, DOI 10.1603/0013-8746-101.6.1112; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Nagoshi RN, 2009, ENVIRON ENTOMOL, V38, P1546, DOI 10.1603/022.038.0605; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Meara BC, 2006, EVOLUTION, V60, P922; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; PAIR SD, 1986, FLA ENTOMOL, V69, P468, DOI 10.2307/3495380; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PASHLEY DP, 1987, ANN ENTOMOL SOC AM, V80, P731, DOI 10.1093/aesa/80.6.731; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Phillips MJ, 2009, GENE, V441, P132, DOI 10.1016/j.gene.2008.08.017; Pogue M.G, 2002, WORLD REVISION GENUS, V43, P1; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prado BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027776; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Prowell DP, 2004, ANN ENTOMOL SOC AM, V97, P1034, DOI 10.1603/0013-8746(2004)097[1034:MGAOHU]2.0.CO;2; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; QUISENBERRY SS, 1991, FLA ENTOMOL, V74, P194, DOI 10.2307/3495297; Rannala B, 2003, GENETICS, V164, P1645; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Rougerie R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043920; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Salinas-Hernandez H, 2011, NEOTROP ENTOMOL, V40, P421, DOI 10.1590/S1519-566X2011000400002; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schofl G, 2009, J EVOLUTION BIOL, V22, P1447, DOI 10.1111/j.1420-9101.2009.01759.x; Schofl G, 2011, AM NAT, V177, P470, DOI 10.1086/658904; Silvain Jean-Francois, 1997, Revue Francaise d'Entomologie (Nouvelle Serie), V19, P95; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; TODD EL, 1980, ANN ENTOMOL SOC AM, V73, P722, DOI 10.1093/aesa/73.6.722; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Velasquez-Velez MI, 2011, ANN ENTOMOL SOC AM, V104, P826, DOI 10.1603/AN10164; WHITFORD F, 1988, FLA ENTOMOL, V71, P234, DOI 10.2307/3495426; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Wilson EO, 2004, PHILOS T R SOC B, V359, P739, DOI 10.1098/rstb.2003.1440; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	145	53	54	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122407	10.1371/journal.pone.0122407	http://dx.doi.org/10.1371/journal.pone.0122407			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853412	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400068
J	Harville, EW; Jacobs, M; Boynton-Jarrett, R				Harville, Emily W.; Jacobs, Marni; Boynton-Jarrett, Renee			When Is Exposure to a Natural Disaster Traumatic? Comparison of a Trauma Questionnaire and Disaster Exposure Inventory	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; POSTNATAL DEPRESSION; PTSD PREVALENCE; EPIDEMIOLOGY; VALIDATION; CRITERION; SYMPTOMS; OUTCOMES; ADULTS; HEALTH	Few studies have compared the sensitivity of trauma questionnaires to disaster inventories for assessing the prevalence of exposure to natural disaster or associated risk for post-disaster psychopathology. The objective of this analysis was to compare reporting of disaster exposure on a trauma questionnaire (Brief Trauma Questionnaire [BTQ]) to an inventory of disaster experience. Between 2011 and 2014, a sample of 841 reproductive-aged southern Louisiana women were interviewed using the BTQ and completed a detailed inventory about exposure to hurricanes and flooding. Post-traumatic stress disorder (PTSD) symptomology was measured with the Post-Traumatic Stress Checklist, and depression with the Edinburgh Depression Scale. The single question addressing disaster exposure on the BTQ had a sensitivity of between 65% and 70% relative to the more detailed questions. Reporting disaster exposure on the BTQ was more likely for those who reported illness/injury due to a hurricane or flood (74%-77%) or danger (77-79%), compared to those who reported damage (69-71%) or evacuation (64-68%). Reporting disaster exposure on the BTQ was associated with depression (odds ratio [OR] 2.29, 95% confidence interval [CI] 1.43-3.68). A single question is unlikely to be useful for assessing the degree of exposure to disaster across a broad population, and varies in utility depending on the mental health outcome of interest: the single trauma question is useful for assessing depression risk.	[Harville, Emily W.; Jacobs, Marni] Tulane Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [Boynton-Jarrett, Renee] Boston Univ, Sch Med, Div Gen Pediat, Boston, MA 02118 USA	Tulane University; Boston University	Harville, EW (corresponding author), Tulane Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.	harville@tulane.edu		Harville, Emily/0000-0003-0319-0922; Boynton-Jarrett, Renee/0000-0002-5392-6443	National Institute of Environmental Health Sciences, Risk and Resilience in Environmental Health; Baton Rouge Area Foundation;  [U19 ES020677]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U19ES020677] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, Risk and Resilience in Environmental Health; Baton Rouge Area Foundation; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by U19 ES020677; National Institute of Environmental Health Sciences, Risk and Resilience in Environmental Health, and the Baton Rouge Area Foundation, https://www.facebook.com/BRAreaFoundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Breslau N, 2002, CAN J PSYCHIAT, V47, P923, DOI 10.1177/070674370204701003; Breslau N, 2001, BIOL PSYCHIAT, V50, P699, DOI 10.1016/S0006-3223(01)01167-2; Briere J, 2000, J TRAUMA STRESS, V13, P661, DOI 10.1023/A:1007814301369; Carmassi C, 2014, J AFFECT DISORDERS, V160, P55, DOI 10.1016/j.jad.2014.02.028; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x; Friedman M. J., 2010, DEPRESS ANXIETY, V28, P1; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Gentes EL, 2014, J PSYCHIATR RES, V59, P60, DOI 10.1016/j.jpsychires.2014.08.014; Goodman LA, 1998, J TRAUMA STRESS, V11, P521, DOI 10.1023/A:1024456713321; Hafstad GS, 2014, J AFFECT DISORDERS, V169, P40, DOI 10.1016/j.jad.2014.06.055; Harville EW, 2011, J PSYCHIATR MENT HLT, V18, P288, DOI 10.1111/j.1365-2850.2010.01658.x; Harville EW, 2010, DISASTER MED PUBLIC, V4, pS39, DOI 10.1001/dmp.2010.15; Harville EW, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-21; Koenen KC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-29; Kubzansky LD, 2014, JAMA PSYCHIAT, V71, P44, DOI 10.1001/jamapsychiatry.2013.2798; Lancaster SL, 2009, J ANXIETY DISORD, V23, P711, DOI 10.1016/j.janxdis.2009.02.010; Matijasevich A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0284-x; Morgan CA, 2001, AM J PSYCHIAT, V158, P1239, DOI 10.1176/appi.ajp.158.8.1239; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 2002, PSYCHIATRY, V65, P240, DOI 10.1521/psyc.65.3.240.20169; Norris FH, 1999, ANXIETY STRESS COPIN, V12, P363, DOI 10.1080/10615809908249317; Oyarzo C, 2012, J MATERN-FETAL NEO M, V25, P1868, DOI 10.3109/14767058.2012.678437; Resnick HS, 1996, STRESSFUL LIFE EVENT; Schnurr P, 2002, J CLIN GEROPSYCHOL, V8, P175, DOI [DOI 10.1023/A:1015992110544, 10.1023/A:1015992110544]; Schnurr PP, 2002, J CLIN PSYCHOL, V58, P877, DOI 10.1002/jclp.10064; Weathers FW, 2007, J TRAUMA STRESS, V20, P107, DOI 10.1002/jts.20210; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 1993, ANN CONV INT SOC TRA; Xiong X., 2010, AM J DISASTER MED, V5, P181, DOI DOI 10.5055/AJDM.2010.0016	33	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123632	10.1371/journal.pone.0123632	http://dx.doi.org/10.1371/journal.pone.0123632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853820	gold, Green Published			2022-12-27	WOS:000352478400110
J	Liang, CH; Kelsey, KT; McClean, MD; Christensen, BC; Marsit, CJ; Karagas, MR; Waterboer, T; Pawlita, M; Nelson, HH				Liang, Caihua; Kelsey, Karl T.; McClean, Michael D.; Christensen, Brock C.; Marsit, Carmen J.; Karagas, Margaret R.; Waterboer, Tim; Pawlita, Michael; Nelson, Heather H.			A Coding Variant in TMC8 (EVER2) Is Associated with High Risk HPV Infection and Head and Neck Cancer Risk	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; HUMAN-PAPILLOMAVIRUS; PROTEINS; PATHOGENESIS; SEROLOGY; ELISA	HPV infection is a causal agent in many epithelial cancers, yet our understanding of genetic susceptibility to HPV infection and resultant cancer risk is limited. Epidermodysplasia Verruciformis is a rare condition of extreme susceptibility to cutaneous HPV infection primarily attributable to mutations in TMC6 and TMC8. Genetic variation in the TMC6/TMC8 region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer. Here, we have tested the hypothesis that the common TMC8 SNP rs7208422 is associated with high-risk HPV infection and risk of head and neck squamous cell carcinoma (HNSCC). Seropositivity to the HPV L1 protein (HPV16, 18, 11, 31, 33, 35, 45, 52, 58) was measured in 514 cases and 452 population-based controls. Genotype was significantly associated with seropositivity to HPV18 L1 (OR (TT vs AA) = 0.48, 95% CI = 0.22-0.99) and borderline significantly associated with HPV16 L1 (OR (TT vs AA) = 0.58, 95% CI = 0.22-1.17). There was a consistent inverse association between TMC8 genotype and infection with other HPV types, including statistically significant associations for HPV31 and HPV52. Consistent with these results, the variant T genotype was associated with a reduced risk of HNSCC (ORAT: 0.63, 95% CI 0.45-0.89, ORTT: 0.54, 95% CI 0.36-0.81), even among subjects seronegative for all HPV types (ORAT: 0.71, 95% CI 0.45-1.11, ORTT: 0.54, 95% CI 0.31-0.93). Our data indicate that common genetic variation in TMC8 is associated with high-risk HPV infection and HNSCC etiology.	[Liang, Caihua; Kelsey, Karl T.] Brown Univ, Dept Epidemiol, Div Biol & Med, Providence, RI 02912 USA; [Kelsey, Karl T.] Brown Univ, Dept Pathol & Lab Med, Div Biol & Med, Providence, RI 02912 USA; [McClean, Michael D.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; [Christensen, Brock C.; Karagas, Margaret R.] Dartmouth Med Sch, Dept Epidemiol, Lebanon, NH USA; [Christensen, Brock C.; Marsit, Carmen J.; Karagas, Margaret R.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH USA; [Marsit, Carmen J.] Dartmouth Med Sch, Dept Toxicol, Lebanon, NH USA; [Waterboer, Tim; Pawlita, Michael] German Canc Res Ctr, Deutsch Krebsforschungszentrum, Infect & Canc Program, Heidelberg, Germany; [Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Nelson, Heather H.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Brown University; Brown University; Boston University; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Helmholtz Association; German Cancer Research Center (DKFZ); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Nelson, HH (corresponding author), Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA.	hhnelson@umn.edu	McClean, Michael D/J-2934-2015; Waterboer, Tim/G-1252-2010	Nelson, Heather/0000-0003-1901-9513; Marsit, Carmen/0000-0003-4566-150X; Pawlita, Michael/0000-0002-4720-8306	 [NIH R01CA118443];  [R01CA078609]; NATIONAL CANCER INSTITUTE [R01CA078609, R01CA118443, R01CA057494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104416] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the following grants: NIH R01CA118443, R01CA078609. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro FA, 2012, INT J CANCER, V130, P349, DOI 10.1002/ijc.26016; Clifford GM, 2007, CANCER EPIDEM BIOMAR, V16, P1874, DOI 10.1158/1055-9965.EPI-07-0349; Crequer A, 2013, J CLIN IMMUNOL, V33, P14, DOI 10.1007/s10875-012-9749-1; Gaud G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.27; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Lazarczyk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039995; Lazarczyk M, 2009, MICROBIOL MOL BIOL R, V73, P348, DOI 10.1128/MMBR.00033-08; Michaud DS, 2014, INT J CANCER, V135, P1653, DOI 10.1002/ijc.28811; Patel AS, 2008, J INVEST DERMATOL, V128, P2888, DOI 10.1038/jid.2008.162; Peters ES, 2005, CANCER EPIDEM BIOMAR, V14, P476, DOI 10.1158/1055-9965.EPI-04-0431; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Wang SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008667; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381	16	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123716	10.1371/journal.pone.0123716	http://dx.doi.org/10.1371/journal.pone.0123716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853559	gold, Green Submitted, Green Published			2022-12-27	WOS:000352478400115
J	Abiko, T; Shimamura, R; Ogawa, D; Abiko, Y; Hirosawa, M; Momose, N; Tsuchihashi, W; Suzuki, T; Takei, H				Abiko, Teppei; Shimamura, Ryota; Ogawa, Daisuke; Abiko, Yoko; Hirosawa, Masaki; Momose, Natsumi; Tsuchihashi, Wataru; Suzuki, Takaharu; Takei, Hitoshi			Difference in the Electromyographic Onset of the Deep and Superficial Multifidus during Shoulder Movement while Standing	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; LOW-BACK-PAIN; UPPER-LIMB MOVEMENT; VOLUNTARY ARM MOVEMENTS; TRANSVERSUS ABDOMINIS; MUSCLES; CONTRACTION; ACTIVATION; FLEXION; PEOPLE	Based on the current literature, it remains unclear whether electromyographic onset of the deep fibers of the multifidus (DM) is dependent on the direction of shoulder movement and the position of the center of foot pressure (CFP). In the present study, we re-examined the electromyographic onset of the DM during shoulder flexion and extension and investigated the influence of the CFP position before arm movement. Intramuscular and surface electrodes recorded the electromyographic onset of the DM, superficial fibers of the multifidus (SM), rectus abdominis, and anterior and posterior deltoid. Eleven healthy participants performed rapid, unilateral shoulder flexion and extension in response to audio stimuli at three CFP positions: quiet standing, extreme forward leaning, and extreme backward leaning. It was found that the electromyographic onset of the DM and SM relative to the deltoid was dependent on the direction of arm movement. Additionally, of all electromyographic onsets recorded, only that of the DM occurred earlier in the extreme forward leaning position than in the extreme backward leaning position during shoulder flexion. These results suggest that the electromyographic onset of DM was influenced by the biomechanical disturbance such as shoulder movement and CFP position.	[Abiko, Teppei] Kyoto Tachibana Univ, Fac Hlth Sci, Dept Phys Therapy, Yamashina Ku, Kyoto, Japan; [Abiko, Teppei; Shimamura, Ryota; Ogawa, Daisuke; Hirosawa, Masaki; Takei, Hitoshi] Tokyo Metropolitan Univ, Fac Human Sci Grad Sch Human Hlth Sci, Div Phys Therapy Sci, Arakawa Ku, Tokyo 158, Japan; [Shimamura, Ryota; Hirosawa, Masaki] Tokyo Metropolitan Rehabil Hosp, Div Phys Therapy, Sumida Ku, Tokyo, Japan; [Ogawa, Daisuke] Mejiro Univ, Fac Human Hlth Sci, Dept Phys Therapy, Saitama, Japan; [Abiko, Yoko] Senri Chuo Hosp, Div Phys Therapy, Toyonaka, Osaka, Japan; [Momose, Natsumi; Tsuchihashi, Wataru; Suzuki, Takaharu] Keio Univ, Grad Sch Fundamental Sci & Technol, Ctr Biosci & Informat, Yokohama, Kanagawa 223, Japan	Kyoto Tachibana University; Keio University	Abiko, T (corresponding author), Kyoto Tachibana Univ, Fac Hlth Sci, Dept Phys Therapy, Yamashina Ku, Kyoto, Japan.	abiko@tachibana-u.ac.jp						Alexandrov AV, 2005, BIOL CYBERN, V93, P309, DOI [10.1007/s00422-005-0004-1, 10.1007/s00422-005-0004-l]; Aruin AS, 1998, ELECTROMYOGR MOTOR C, V109, P350, DOI 10.1016/S0924-980X(98)00029-0; ARUIN AS, 1995, EXP BRAIN RES, V103, P323; ARUIN AS, 1995, EXP BRAIN RES, V106, P291; BELEN'KII V. E., 1967, BIOFIZIKA, V12, P135; Benvenuti F, 1997, BRAIN RES, V761, P59, DOI 10.1016/S0006-8993(97)00260-6; Bogduk N, 1997, CLIN J PAIN, V13, P285, DOI 10.1097/00002508-199712000-00003; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; CORDO PJ, 1982, J NEUROPHYSIOL, V47, P287, DOI 10.1152/jn.1982.47.2.287; Dankaerts W, 2006, SPINE, V31, P698, DOI 10.1097/01.brs.0000202532.76925.d2; De Wolf S, 1998, EXP BRAIN RES, V121, P7, DOI 10.1007/s002210050431; FRIEDLI WG, 1984, J NEUROL NEUROSUR PS, V47, P611, DOI 10.1136/jnnp.47.6.611; FRIEDLI WG, 1988, J NEUROL NEUROSUR PS, V51, P232, DOI 10.1136/jnnp.51.2.232; Fujiwara K, 2003, GAIT POSTURE, V17, P254, DOI 10.1016/S0966-6362(02)00100-5; Fujiwara K, 2009, J ELECTROMYOGR KINES, V19, pE187, DOI 10.1016/j.jelekin.2008.01.003; Hodges P, 1999, EXP BRAIN RES, V124, P69, DOI 10.1007/s002210050601; Hodges PW, 1999, ARCH PHYS MED REHAB, V80, P1005, DOI 10.1016/S0003-9993(99)90052-7; Hodges PW, 2000, GAIT POSTURE, V11, P92, DOI 10.1016/S0966-6362(99)00055-7; Hodges PW, 1998, J SPINAL DISORD, V11, P46; Hodges PW, 2000, J APPL PHYSIOL, V89, P967, DOI 10.1152/jappl.2000.89.3.967; Hodges PW, 1997, EXP BRAIN RES, V114, P362, DOI 10.1007/PL00005644; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horak FB, 1996, J NEUROPHYSIOL, V75, P2380, DOI 10.1152/jn.1996.75.6.2380; INGLIN B, 1988, J GERONTOL, V43, pM105, DOI 10.1093/geronj/43.4.M105; Lee LJ, 2009, J ELECTROMYOGR KINES, V19, P46, DOI 10.1016/j.jelekin.2007.06.015; Lee YJ, 2014, CLIN NEUROPHYSIOL, V125, P768, DOI 10.1016/j.clinph.2013.09.036; LIPSHITS M I, 1981, Human Physiology (English Translation of Fiziologiya Cheloveka), V7, P165; MacDonald D, 2009, PAIN, V142, P183, DOI 10.1016/j.pain.2008.12.002; MACPHERSON JM, 1989, EXP BRAIN RES, V78, P557; Maki BE, 1996, CLIN GERIATR MED, V12, P635; MOSELEY GL, 2002, SPINE, V15, P29, DOI DOI 10.1097/00007632-200201150-00013; O'Sullivan PB, 2006, MANUAL THER, V11, P264, DOI 10.1016/j.math.2005.04.004; Shiozawa S, 2013, HUM MOVEMENT SCI, V32, P1239, DOI 10.1016/j.humov.2013.01.009; Solomonow M, 1998, SPINE, V23, P2552, DOI 10.1097/00007632-199812010-00010; Tsao H, 2008, J ELECTROMYOGR KINES, V18, P559, DOI 10.1016/j.jelekin.2006.10.012; Tsao H, 2007, EXP BRAIN RES, V181, P537, DOI 10.1007/s00221-007-0950-z; Williams PL, 1989, GRAYS ANATOMY, P592; WOOLLACOTT MH, 1984, EXP BRAIN RES, V55, P263; ZATTARA M, 1988, J NEUROL NEUROSUR PS, V51, P956, DOI 10.1136/jnnp.51.7.956	39	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122303	10.1371/journal.pone.0122303	http://dx.doi.org/10.1371/journal.pone.0122303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850066	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800117
J	Assinger, A; Volf, I; Schmid, D				Assinger, Alice; Volf, Ivo; Schmid, Diethart			A Novel, Rapid Method to Quantify Intraplatelet Calcium Dynamics by Ratiometric Flow Cytometry	PLOS ONE			English	Article							INDICATORS; GENERATION; PLATELETS; MYOCYTES; FLUO-3; CA-2	Cytosolic free calcium ions represent important second-messengers in platelets. Therefore, quantitative measurement of intraplatelet calcium provides a popular and very sensitive tool to evaluate platelet activation and reactivity. Current protocols for determination of intracellular calcium concentrations in platelets have a number of limitations. Cuvette-based methods do not allow measurement of calcium flux in complex systems, such as whole blood, and therefore require isolation steps that potentially interfere with platelet activation. Flow cytometry has the potential to overcome this limitation, but to date the application of calibrated, quantitative readout of calcium kinetics has only been described for Indo-1. As excitation of Indo-1 requires a laser in the ultraviolet range, such measurements cannot be performed with a standard flow cytometer. Here, we describe a novel, rapid calibration method for ratiometric calcium measurement in platelets using both Ar+-laser excited fluorescence dyes Fluo-4 and Fura Red. We provide appropriate equations that allow rapid quantification of intraplatelet calcium fluxes by measurement of only two standardisation buffers. We demonstrate that this method allows quantitative calcium measurement in platelet rich plasma as well as in whole blood. Further, we show that this method prevents artefacts due to platelet aggregate formation and is therefore an ideal tool to determine basal and agonist induced calcium kinetics.	[Assinger, Alice; Volf, Ivo; Schmid, Diethart] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Physiol, Vienna, Austria	Medical University of Vienna	Schmid, D (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Physiol, Vienna, Austria.	diethart.schmid@meduniwien.ac.at	Schmid, Diethart/C-5049-2009	Schmid, Diethart/0000-0002-2225-9836; Assinger, Alice/0000-0002-5670-5910	Austrian Science Fund [FWF-P24978]; Austrian Science Fund (FWF) [P 24978] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was funded by the Austrian Science Fund issued to AA (grant number FWF-P24978); http://www.fwf.ac.at/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey S, 2006, J IMMUNOL METHODS, V311, P220, DOI 10.1016/j.jim.2006.02.005; Dustin LB, 2000, CLIN APPL IMMUNOL RE, V1, P5, DOI DOI 10.1016/S1529-1049(00)00002-7; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Greimers R, 1996, CYTOMETRY, V23, P205, DOI 10.1002/(SICI)1097-0320(19960301)23:3<205::AID-CYTO4>3.0.CO;2-H; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagen BM, 2012, CELL CALCIUM, V52, P170, DOI 10.1016/j.ceca.2012.05.010; KOLLER E, 1992, METHOD ENZYMOL, V215, P383; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; RAO GHR, 1985, BIOCHEM BIOPH RES CO, V132, P652, DOI 10.1016/0006-291X(85)91182-9; Rinder H M, 1998, Clin Lab Sci, V11, P365; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; WILLIAMS DA, 1990, CELL CALCIUM, V11, P75, DOI 10.1016/0143-4160(90)90061-X	16	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122527	10.1371/journal.pone.0122527	http://dx.doi.org/10.1371/journal.pone.0122527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849642	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800139
J	Chamberlain, S; Stolz, U; Dreifuss, B; Nelson, SW; Hammerstedt, H; Andinda, J; Maling, S; Bisanzo, M				Chamberlain, Stacey; Stolz, Uwe; Dreifuss, Bradley; Nelson, Sara W.; Hammerstedt, Heather; Andinda, Jovita; Maling, Samuel; Bisanzo, Mark			Mortality Related to Acute Illness and Injury in Rural Uganda: Task Shifting to Improve Outcomes	PLOS ONE			English	Article							EMERGENCY CARE; PNEUMONIA; CHILDREN; MALARIA; NEEDS	Background Due to the dual critical shortages of acute care and healthcare workers in resource-limited settings, many people suffer or die from conditions that could be easily treated if existing resources were used in a more timely and effective manner. In order to address this preventable morbidity and mortality, a novel emergency midlevel provider training program was developed in rural Uganda. This is the first study that assesses this unique application of a task-shifting model to acute care by evaluating the outcomes of 10,105 patients. Methods Nurses participated in a two-year training program to become midlevel providers called Emergency Care Practitioners at a rural district hospital. This is a retrospective analysis of the Emergency Department's quality assurance database, including three-day follow-up data. Case fatality rates (CFRs) are reported as the percentage of cases with a specific diagnosis that died within three days of their Emergency Department visit. Findings Overall, three-day mortality was 2.0%. The most common diagnoses of patients who died were malaria (n=60), pneumonia (n=51), malnutrition (n=21), and trauma (n=18). Overall and under-five CFRs were as follows: malaria, 2.0% and 1.9%; pneumonia, 5.5% and 4.1%; and trauma, 1.2% and 1.6%. Malnutrition-related fatality (all cases < 18 years old) was 6.5% overall and 6.8% for under-fives. Interpretation This study describes the outcomes of emergency patients treated by midlevel providers in a resource-limited setting. Our fatality rates are lower than previously published regional rates. These findings suggest this model of task-shifting can be successfully applied to acute care in order to address the shortage of emergency care services in similar settings as part of an integrated approach to health systems strengthening.	[Chamberlain, Stacey; Stolz, Uwe; Dreifuss, Bradley; Nelson, Sara W.; Hammerstedt, Heather; Andinda, Jovita; Bisanzo, Mark] Global Emergency Care Collaborat, Boston, MA 02114 USA; [Chamberlain, Stacey; Stolz, Uwe; Dreifuss, Bradley; Nelson, Sara W.; Hammerstedt, Heather; Andinda, Jovita; Bisanzo, Mark] Global Emergency Care Collaborat, Kampala, Uganda; [Chamberlain, Stacey] Univ Illinois, Dept Emergency Med, Chicago, IL USA; [Chamberlain, Stacey] Univ Illinois, Ctr Global Hlth, Chicago, IL USA; [Stolz, Uwe; Dreifuss, Bradley] Univ Arizona, Dept Emergency Med, Tucson, AZ USA; [Nelson, Sara W.] Maine Med Ctr, Dept Emergency Med, Portland, ME 04102 USA; [Hammerstedt, Heather] Idaho Emergency Phys, Boise, ID USA; [Andinda, Jovita] Karoli Lwanga Hosp, Nyakibale, Uganda; [Maling, Samuel] Mbarara Univ Sci & Technol, Dept Psychiat, Mbarara, Uganda; [Bisanzo, Mark] Univ Massachusetts, Dept Emergency Med, Worcester, MA 01605 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; Maine Medical Center; Mbarara University of Science & Technology; University of Massachusetts System; University of Massachusetts Worcester	Chamberlain, S (corresponding author), Global Emergency Care Collaborat, Boston, MA 02114 USA.	chamberlain.stacey@gmail.com			Global Emergency Care Collaborative (GECC); GECC	Global Emergency Care Collaborative (GECC); GECC	Global Emergency Care Collaborative (GECC) is a non-profit charitable organization registered in the United States and Uganda, which is funded through private non-corporate, non-governmental donations. GECC was responsible for providing partial salary support for the Emergency Care Practitioners who were the health professionals who cared for emergency patients in this study. Additionally, GECC paid stipends for volunteer research assistants and an onsite Program Director. None of the authors of this study have received any financial compensation for activities related to this study.	Africa Health Workforce Observatory, 2009, HUM RES HLTH COUNTR; [Anonymous], UG MAL CONTR STRAT P; [Anonymous], PRES MAL IN UG MAL O; [Anonymous], CAS FAT RAT HO UNPUB; [Anonymous], 2011, DEMOGRAPHIC HLTH SUR; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Caruso N, 2011, AFR J EMERG MED, V1, P108, DOI 10.1016/j.afjem.2011.08.002; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Hammerstedt H, 2014, ANN EMERG MED, DOI [10.1016/j.annemergmed2014.01.035, DOI 10.1016/J.ANNEMERGMED2014.01.035]; Jayaraman S, 2011, WORLD J SURG, V35, P505, DOI 10.1007/s00268-010-0871-z; Kendjo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058686; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Molyneux EM, 2010, ANN TROP PAEDIATR, V30, P165, DOI 10.1179/146532810X12703902516482; Msangeni HA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-256; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Nantanda R, 2008, ANN TROP PAEDIATR, V28, P253, DOI 10.1179/146532808X375404; Opoka RO, 2008, PEDIATR INFECT DIS J, V27, P319, DOI 10.1097/INF.0b013e31815d74dd; Owor G, 2001, E CENTRAL AFR J S, V6, P57; Periyanayagam U, 2012, AFR J EMERG MED, V2, P151, DOI 10.1016/j.afjem.2012.09.002; Reynolds TA, 2012, J PUBLIC HEALTH POL, V33, pS126, DOI 10.1057/jphp.2012.41; Srinivasan MG, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-14; Steen TW, 2001, INT J TUBERC LUNG D, V5, P775; Terry B, 2012, AFR J EMERG MED, V2, P182, DOI 10.1016/j.afjem.2012.06.005; Wang H, 2010, LANCET, V380, p2071 , DOI DOI 10.1016/S0140-6736(12)61719-X; World Health Organisation, 2008, TASK SHIFT GLOB REC; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	28	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122559	10.1371/journal.pone.0122559	http://dx.doi.org/10.1371/journal.pone.0122559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849960	Green Published, gold			2022-12-27	WOS:000352477800141
J	Konno, S; Munakata, M				Konno, Satoshi; Munakata, Masanori			Moderately Increased Albuminuria Is an Independent Risk Factor of Cardiovascular Events in the General Japanese Population under 75 Years of Age: The Watari Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; BLOOD-PRESSURE; MICROALBUMINURIA; ASSOCIATION	Background Moderately increased albuminuria (formerly called microalbuminuria) is widely recognized as a predictor of cardiovascular disease. However, it is not clear whether this observation is applicable to the Asian population, as studies leading to this conclusion were conducted on Western populations. The aim of this study was to examine the hypothesis if moderately increased albuminuria could be an independent predictor of cardiovascular mortality and morbidity in the Japanese population. Methods and Results The study population consisted of 3093 inhabitants of Watari, Miyagi Prefecture, who participated in an annual health check-up in 2009. We examined anthropometry, sitting blood pressure, fasting blood sample, and urine albumin-to-creatinine ratio (UACR). After baseline assessment, subjects were followed prospectively for up to 60 months. The incidence of major cardiovascular events (stroke, myocardial infarction, revascularization, and cardiovascular death) was determined based on death certificate records or medical claims sent to the National Health Insurance of Japan. Follow-up was discontinued for those who reached 75 years of age because they were moved to a different medical insurance system. We observed 57 cardiovascular events during a mean follow-up period of 47.8 months. The cumulative incidence rate for major cardiovascular events was significantly higher in patients with moderately increased albuminuria (UACR 30-299 mg/gCr) than in those with normoalbuminuria (UACR < 30 mg/gCr) (6.4% vs. 2.2%, p = 0.0002 by log-rank test). Multivariate Cox proportional hazards analyses have revealed that moderately increased albuminuria is an independent predictor of cardiovascular events (HR 2.386, 95% CI: 1.120-4.390). Conclusions Moderately increased albuminuria is an independent predictor of cardiovascular events in the general Japanese population under 75 years of age.	[Konno, Satoshi; Munakata, Masanori] Tohoku Rosai Hosp, Div Hypertens, Sendai, Miyagi, Japan; [Konno, Satoshi; Munakata, Masanori] Tohoku Rosai Hosp, Res Ctr Life Style Related Dis, Sendai, Miyagi, Japan		Munakata, M (corresponding author), Tohoku Rosai Hosp, Div Hypertens, Sendai, Miyagi, Japan.	munakata@tohokuh.rofuku.go.jp			Japan Labor, Health, and Welfare Organization	Japan Labor, Health, and Welfare Organization(Ministry of Health, Labour and Welfare, Japan)	The Watari study was made possible by Grants-in-Aid from the Japan Labor, Health, and Welfare Organization. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CLIN EXP NEPHROL, V13, P537, DOI 10.1007/s10157-009-0237-8; Chen YY, 2012, SCAND J CLIN LAB INV, V72, P281, DOI 10.3109/00365513.2012.661071; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Jensen JS, 2000, HYPERTENSION, V35, P898, DOI 10.1161/01.HYP.35.4.898; Konno S, 2013, J HYPERTENS, V31, P798, DOI 10.1097/HJH.0b013e32835e2146; Konta T, 2013, CLIN EXP NEPHROL, V17, P805, DOI 10.1007/s10157-013-0770-3; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Munakata M, 2011, HYPERTENS RES, V34, P1135, DOI 10.1038/hr.2011.98; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Romundstad S, 2003, AM J KIDNEY DIS, V42, P466, DOI 10.1016/S0272-6386(03)00742-X; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; Wang ZQ, 2005, KIDNEY INT, V68, P1289, DOI 10.1111/j.1523-1755.2005.00526.x; WHO MONICA Project, 1999, MONICA MAN 4 1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yuyun MF, 2004, AM J EPIDEMIOL, V159, P284, DOI 10.1093/aje/kwh037	20	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123893	10.1371/journal.pone.0123893	http://dx.doi.org/10.1371/journal.pone.0123893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849735	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800259
J	Braczkowski, AR; Balme, GA; Dickman, A; Macdonald, DW; Fattebert, J; Dickerson, T; Johnson, P; Hunter, L				Braczkowski, Alex Richard; Balme, Guy Andrew; Dickman, Amy; Macdonald, David Whyte; Fattebert, Julien; Dickerson, Tristan; Johnson, Paul; Hunter, Luke			Who Bites the Bullet First? The Susceptibility of Leopards Panthera pardus to Trophy Hunting	PLOS ONE			English	Article							KRUGER-NATIONAL-PARK; LION POPULATION; CONSERVATION; DISPERSAL; SELECTIVITY; IMPACT; TRAP; PREY	Reliable data is fundamentally important for managing large carnivore populations, and vital for informing hunting quota levels if those populations are subject to trophy hunting. Camera-trapping and spoor counts can provide reliable population estimates for many carnivores, but governments typically lack the resources to implement such surveys over the spatial scales required to inform robust quota setting. It may therefore be prudent to shift focus away from estimating population size and instead focus on monitoring population trend. In this paper we assess the susceptibility of African leopards Panthera pardus to trophy hunting. This has management ramifications, particularly if the use of harvest composition is to be explored as a metric of population trend. We explore the susceptibility of different leopard age and sex cohorts to trophy hunting; first by examining their intrinsic susceptibility to encountering trophy hunters using camera-traps as surrogates, and second by assessing their extrinsic susceptibility using photographic questionnaire surveys to determine their attractiveness to hunters. We show that adult male and female leopards share similar incident rates to encountering hunters but adult males are the most susceptible to hunting due to hunter preference for large trophies. In contrast, sub-adult leopards rarely encounter hunters and are the least attractive trophies. We suggest that our findings be used as a foundation for the exploration of a harvest composition scheme in the Kwazulu-Natal and Limpopo provinces where post mortem information is collected from hunted leopards and submitted to the local provincial authorities.	[Braczkowski, Alex Richard; Dickman, Amy; Macdonald, David Whyte; Johnson, Paul] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Oxford, England; [Braczkowski, Alex Richard; Balme, Guy Andrew; Fattebert, Julien; Dickerson, Tristan; Hunter, Luke] Panthera, New York, NY USA; [Balme, Guy Andrew] Univ Cape Town, Dept Biol Sci, ZA-7700 Rondebosch, South Africa; [Dickman, Amy] Ruaha Carnivore Project, Iringa, Tanzania; [Fattebert, Julien; Hunter, Luke] Univ Kwazulu Natal, Sch Life Sci, Durban, South Africa	University of Oxford; University of Cape Town; University of Kwazulu Natal	Braczkowski, AR (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House, Oxford, England.	alexander.braczkowski@gmail.com	Fattebert, Julien/I-8126-2019; Hunter, Luke T.B./H-3324-2019	Fattebert, Julien/0000-0001-5510-6804; Hunter, Luke T.B./0000-0001-9653-6544; Braczkowski, Alexander/0000-0002-0099-7803	Panthera Foundation; Albert and Didi Hartog and the Timbo-Stitching Foundation	Panthera Foundation; Albert and Didi Hartog and the Timbo-Stitching Foundation	This research was funded by the Panthera Foundation, Albert and Didi Hartog and the Timbo-Stitching Foundation. However the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2005, WILDLIFE SOC B, V33, P179, DOI 10.2193/0091-7648(2005)33[179:EEOPTA]2.0.CO;2; Bailey, 1993, AFRICAN LEOPARD ECOL; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme GA, 2010, BIOL CONSERVATION WI; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Balme GA, 2014, CONSERV LETT, V7, P3, DOI 10.1111/conl.12028; Balme GA, 2013, ANIM BEHAV, V86, P791, DOI 10.1016/j.anbehav.2013.07.019; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Barnhurst D, 1986, THESIS UTAH STATE U; Beecham J., 1980, Bear Biology Association Conference Series, P201; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; Booth VR, 2009, COMP PRICES HUNTING; Braczkowski AR, PLOS ONE; Bunnefeld N, 2009, J ANIM ECOL, V78, P485, DOI 10.1111/j.1365-2656.2008.01500.x; Clark T.W., 2005, COEXISTING LARGE CAR; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Crosmary WG, 2013, ANIM CONSERV, V16, P648, DOI 10.1111/acv.12043; Daly B, 2005, P WORKSH CONS BREED; Di Minin E, 2013, ANIM CONSERV, V16, P249, DOI 10.1111/j.1469-1795.2012.00595.x; Dutta T, 2012, CONSERV GENET RESOUR, V4, P665, DOI 10.1007/s12686-012-9618-5; Fattebert J, 2013, THESIS U KWAZULU NAT; Fattebert J, 2013, S AFR J WILDL RES, V43, P61, DOI 10.3957/056.043.0108; Ferreira SM, 2010, WILDLIFE RES, V37, P194, DOI 10.1071/WR09030; Grant TL, 2012, THESIS RHODES U GRAH; Hunter L., 2018, FIELD GUIDE CARNIVOR; Leader-Williams N, 2001, SCIENCE, V293, P2203; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; LITVAITIS JA, 1994, WILDLIFE SOC B, V22, P604; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Maputla NW, 2013, AFR J ECOL, V51, P422, DOI 10.1111/aje.12047; Marker LL, 2005, S AFR J WILDL RES, V35, P105; Martin RB, 1988, SRUVEY STATUS LEOPAR; Martins Q, 2013, AFR J ECOL, V51, P571, DOI 10.1111/aje.12068; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; MITHTHAPALA S, 1989, J ZOOL, V218, P527, DOI 10.1111/j.1469-7998.1989.tb04996.x; Mizutani F, 1998, J ZOOL, V244, P269, DOI 10.1111/j.1469-7998.1998.tb00031.x; Mysterud A, 2011, J APPL ECOL, V48, P827, DOI 10.1111/j.1365-2664.2011.02006.x; Noyce KV, 2001, URSUS-SERIES, V12, P211; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; R Core Team, 2018, R LANG ENV STAT COMP; Spong Goran, 2000, Conservation Genetics, V1, P169, DOI 10.1023/A:1026543308136; SUNQUIST ME, 1983, J MAMMAL, V64, P337, DOI 10.2307/1380574; Venables WN., 2002, MODERN APPL STAT S 4; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; [No title captured]	48	9	9	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123100	10.1371/journal.pone.0123100	http://dx.doi.org/10.1371/journal.pone.0123100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860139	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300077
J	Campbell, CL; Torres-Perez, F; Acuna-Retamar, M; Schountz, T				Campbell, Corey L.; Torres-Perez, Fernando; Acuna-Retamar, Mariana; Schountz, Tony			Transcriptome Markers of Viral Persistence in Naturally-Infected Andes Virus (Bunyaviridae) Seropositive Long-Tailed Pygmy Rice Rats	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HANTAVIRUS PULMONARY SYNDROME; SIN NOMBRE HANTAVIRUS; RETINOID-X-RECEPTOR; CD4 T-CELLS; GENE-EXPRESSION; SEOUL-VIRUS; RIG-I; INTERFERON; RESPONSES	Long-tailed pygmy rice rats (Oligoryzomys longicaudatus) are principal reservoir hosts of Andes virus (ANDV) (Bunyaviridae), which causes most hantavirus cardiopulmonary syndrome cases in the Americas. To develop tools for the study of the ANDV-host interactions, we used RNA-Seq to generate a de novo transcriptome assembly. Splenic RNA from five rice rats captured in Chile, three of which were ANDV-infected, was used to generate an assembly of 66,173 annotated transcripts, including noncoding RNAs. Phylogenetic analysis of selected predicted proteins showed similarities to those of the North American deer mouse (Peromyscus maniculatus), the principal reservoir of Sin Nombre virus (SNV). One of the infected rice rats had about 50-fold more viral burden than the others, suggesting acute infection, whereas the remaining two had levels consistent with persistence. Differential expression analysis revealed distinct signatures among the infected rodents. The differences could be due to 1) variations in viral load, 2) dimorphic or reproductive differences in splenic homing of immune cells, or 3) factors of unknown etiology. In the two persistently infected rice rats, suppression of the JAK-STAT pathway at Stat5b and Ccnot1, elevation of Casp1, RIG-I pathway factors Ppp1cc and Mff, and increased FC receptor-like transcripts occurred. Caspase-1 and Stat5b activation pathways have been shown to stimulate T helper follicular cell (TFH) development in other species. These data are also consistent with reports suggestive of TFH stimulation in deer mice experimentally infected with hantaviruses. In the remaining acutely infected rice rat, the apoptotic pathway marker Cox6a1 was elevated, and putative anti-viral factors Abcb1a, Fam46c, Spp1, Rxra, Rxrb, Trmp2 and Trim58 were modulated. Transcripts for preproenkephalin (Prenk) were reduced, which may be predictive of an increased T cell activation threshold. Taken together, this transcriptome dataset will permit rigorous examination of rice rat-ANDV interactions and may lead to better understanding of virus ecology.	[Campbell, Corey L.; Schountz, Tony] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA; [Torres-Perez, Fernando] Pontificia Univ Catolica Valparaiso, Inst Biol, Valparaiso, Chile; [Acuna-Retamar, Mariana] Univ Chile, Fac Vet & Pecuarias, Santiago, Chile	Colorado State University; Pontificia Universidad Catolica de Valparaiso; Universidad de Chile	Campbell, CL (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.	corey.campbell@colostate.edu	Schountz, Tony/I-2161-2017; Torres-Perez, Fernando/B-5002-2008	Torres-Perez, Fernando/0000-0001-8655-7288; Campbell, Corey L./0000-0002-6384-1259	FONDECYT [1110664]; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [5U19AI045452]; NIH [2U01A1045452]; USA NIH [AI054461]; Department of Microbiology, Immunology and Pathology, CSU; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI054461, U19AI045452] Funding Source: NIH RePORTER	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USA NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology, Immunology and Pathology, CSU; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by FONDECYT 1110664, the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, grant 5U19AI045452, and NIH 2U01A1045452 (FTP), and USA NIH grant AI054461 and startup funds provided by the Department of Microbiology, Immunology and Pathology, CSU (TS).	Alff PJ, 2006, J VIROL, V80, P9676, DOI 10.1128/JVI.00508-06; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Burdette D, 2012, J GEN VIROL, V93, P235, DOI 10.1099/vir.0.034033-0; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cautivo K, 2014, VIRUSES-BASEL, V6, P2028, DOI 10.3390/v6052028; Cheng M, 2013, J VIROL, V87, P9707, DOI 10.1128/JVI.00802-13; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cui HC, 2014, EUR J IMMUNOL, V44, P2085, DOI 10.1002/eji.201344126; De Leon-Nava MA, 2009, J STEROID BIOCHEM, V113, P57, DOI 10.1016/j.jsbmb.2008.11.003; De Windt LJ, 2001, P NATL ACAD SCI USA, V98, P3322, DOI 10.1073/pnas.031371998; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Easterbrook JD, 2007, P NATL ACAD SCI USA, V104, P15502, DOI 10.1073/pnas.0707453104; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gronholm J, 2012, FASEB J, V26, P1239, DOI 10.1096/fj.11-195875; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hammerbeck CD, 2011, J VIROL, V85, P9929, DOI 10.1128/JVI.05356-11; Hannah MF, 2008, BRAIN BEHAV IMMUN, V22, P503, DOI 10.1016/j.bbi.2007.10.005; He S, 2013, BLOOD, V121, P4663, DOI 10.1182/blood-2012-07-441360; Heward JA, 2014, TRENDS IMMUNOL; Hjelle B, 2010, VIRUSES-BASEL, V2, P2559, DOI 10.3390/v2122559; Hook S, 2003, J NEUROIMMUNOL, V140, P61, DOI 10.1016/S0165-5728(03)00168-1; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Huang YP, 2005, WORLD J GASTROENTERO, V11, P5659, DOI 10.3748/wjg.v11.i36.5659; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Ivanova LB, 2014, ENVIRON MICROBIOL, V16, P1069, DOI 10.1111/1462-2920.12310; Jiang L, 2012, INT IMMUNOPHARMACOL, V14, P217, DOI 10.1016/j.intimp.2012.07.003; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kariwa H, 1996, ARCH VIROL, V141, P2327, DOI 10.1007/BF01718634; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim CH, 2004, BLOOD, V104, P1952, DOI 10.1182/blood-2004-03-1206; Kim SJ, 2014, P NATL ACAD SCI USA, V111, P6413, DOI 10.1073/pnas.1321114111; Kleer CG, 2004, BREAST CANCER RES, V6, pR110, DOI 10.1186/bcr755; Kopp A, 2012, BIOMOLECULES, V2, P46, DOI 10.3390/biom2010046; Li AM, 2013, INT J BIOCHEM CELL B, V45, P858, DOI 10.1016/j.biocel.2013.01.008; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; MacNeil A, 2011, VIRUS RES, V162, P138, DOI 10.1016/j.virusres.2011.09.017; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matsuda S, 2000, EMBO REP, V1, P428, DOI 10.1093/embo-reports/kvd090; Medina RA, 2009, J VIROL, V83, P2446, DOI 10.1128/JVI.01057-08; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Mills JN, 2008, INFECT DIS WILD MAMM, P254; Mo R, 2005, J IMMUNOL, V174, P6023, DOI 10.4049/jimmunol.174.10.6023; Montoya-Ruiz C, 2014, VIRUSES-BASEL, V6, P1274, DOI 10.3390/v6031274; Nunez V, 2010, P NATL ACAD SCI USA, V107, P10626, DOI 10.1073/pnas.0913545107; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Prescott J, 2013, IMMUNOLOGY, V140, P168, DOI 10.1111/imm.12116; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; Rosa EST, 2005, VECTOR-BORNE ZOONOT, V5, P11, DOI 10.1089/vbz.2005.5.11; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Samrat SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086567; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schountz T, 2007, EMERG INFECT DIS, V13, P1604, DOI 10.3201/eid1310.070383; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Schountz T, 2014, J VIROL, V88, P8319, DOI 10.1128/JVI.00004-14; Schountz T, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-18; Schountz T, 2012, J VIROL, V86, P10015, DOI 10.1128/JVI.06875-11; Spiropoulou CF, 2013, VIRULENCE, V4, P525, DOI 10.4161/viru.25569; Tam VC, 2013, CELL, V154, P213, DOI 10.1016/j.cell.2013.05.052; Tchivilev I, 2008, J BIOL CHEM, V283, P22193, DOI 10.1074/jbc.M803452200; Torres-Perez F, 2004, AM J TROP MED HYG, V70, P305, DOI 10.4269/ajtmh.2004.70.305; Wahl-Jensen V, 2007, J VIROL, V81, P7449, DOI 10.1128/JVI.00238-07; Wang K, 2012, BRAZ J MED BIOL RES, V45, P1112, DOI 10.1590/S0100-879X2012007500130; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wu XH, 2013, INFLAMM RES, V62, P929, DOI 10.1007/s00011-013-0631-2; Xu DM, 2004, IMMUNOL CELL BIOL, V82, P462, DOI 10.1111/j.0818-9641.2004.01274.x; YANAGIHARA R, 1985, J VIROL, V55, P34, DOI 10.1128/JVI.55.1.34-38.1985; Yang X, 2013, BRIEF BIOINFORM, V14, P56, DOI 10.1093/bib/bbs015; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yilmaz G, 2011, J CLIN VIROL, V50, P209, DOI 10.1016/j.jcv.2010.11.014; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055733	84	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122935	10.1371/journal.pone.0122935	http://dx.doi.org/10.1371/journal.pone.0122935			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856432	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500067
J	Dalton, BR; Sabuda, DM; Bresee, LC; Conly, JM				Dalton, Bruce R.; Sabuda, Deana M.; Bresee, Lauren C.; Conly, John M.			Use of an Electronic Medication Administration Record (eMAR) for Surveillance of Medication Omissions: Results of a One Year Study of Antimicrobials in the Inpatient Setting	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; ERRORS; ADHERENCE	Introduction Medication administration omissions (MAO) are usually considered medication errors but not all MAO are clinically relevant. We determined the frequency of clinically relevant MAO of antimicrobial drugs in adult hospitals in Calgary, Alberta, Canada based on electronic medication administration record (eMAR). Methods We examined 2011 data from eMAR records on medical wards and developed a reproducible assessment scheme to categorize and determine clinical relevance of MAO. We applied this scheme to records from 2012 in a retrospective cohort study to quantify clinically relevant MAO. Significant predictors of clinically relevant MAO were identified. Results A total of 294,718 dose records were assessed of which 10,282 (3.49%) were for doses not administered. Among these 4903 (1.66% of total); 47.68% of MAO were considered clinically relevant. Significant positive predictors of clinically relevant MAO included inhaled (OR 4.90, 95% CI 3.54-6.94) and liquid oral (OR 1.32, 95% CI 1.18-1.47) route of medication compared to solid oral and irregular dose schedules. Evening nursing shift compared to night shift (OR 0.77 95% CI 0.70-0.85) and parenteral (OR 0.50, 95% CI 0.46-0.54) were negative predictors, The commonest reasons for relevant MAO were patient preference, unspecified reason, administration access issues, drug not available or patient condition. Conclusion Assessment of MAO by review of computer records provides a greater scope and sample size than directly observed medication administration assessments without "observer" effect. We found that MAO of antimicrobials in inpatients were uncommon but were seen more frequently with orally administered antimicrobials which may have significance to antimicrobial stewardship initiatives.	[Dalton, Bruce R.; Sabuda, Deana M.; Bresee, Lauren C.] Alberta Hlth Serv, Dept Pharm, Calgary, AB, Canada; [Dalton, Bruce R.; Conly, John M.] Univ Calgary, Cumming Sch Med, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Bresee, Lauren C.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Conly, John M.] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada; [Conly, John M.] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Conly, John M.] Univ Calgary, Cumming Sch Med, Dept Pathol & Lab Med, Calgary, AB, Canada; [Conly, John M.] Univ Calgary, Cumming Sch Med, Synder Inst Chron Dis, Calgary, AB, Canada	Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Dalton, BR (corresponding author), Alberta Hlth Serv, Dept Pharm, Calgary, AB, Canada.	bruce.dalton@albertahealthservices.ca	Bresee, Lauren/ABB-7393-2021	Bresee, Lauren/0000-0002-4387-9612	Alberta Sepsis Network; Pfizer; bioMerieux; National Collaborating Centre for Infectious Diseases	Alberta Sepsis Network; Pfizer(Pfizer); bioMerieux; National Collaborating Centre for Infectious Diseases	BRD, DMS and LCB have no potential conflicts to declare. JMC's potential conflicts are as follows; "Dr. Conly reports grants from Alberta Sepsis Network, personal fees and non-financial support from Pfizer, non-financial support from bioMerieux and from the National Collaborating Centre for Infectious Diseases." This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; Christensen R, 1997, LOG LINEAR MODELS LO; Coleman JJ, 2013, INT J QUAL HEALTH C, V25, P564, DOI 10.1093/intqhc/mzt044; Coleman JJ, 2012, DRUG SAFETY, V35, P677, DOI 10.2165/11630750-000000000-00000; Cutler DM, 2010, NEW ENGL J MED, V362, P1553, DOI 10.1056/NEJMp1002305; Gould E, 2010, GERIATR NURS, V31, P290, DOI 10.1016/j.gerinurse.2010.05.004; Kopp BJ, 2006, CRIT CARE MED, V34, P415, DOI 10.1097/01.CCM.0000198106.54306.D7; Kraemer HC, 2002, STAT MED, V21, P2109, DOI 10.1002/sim.1180; Lesar TS, 1997, ARCH INTERN MED, V157, P1569, DOI 10.1001/archinte.157.14.1569; Lisby M, 2005, INT J QUAL HEALTH C, V17, P15, DOI 10.1093/intqhc/mzi015; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; McGhee J.W., 1985, INTRO STAT; Robert J, 2012, J ANTIMICROB CHEMOTH, V67, P1020, DOI 10.1093/jac/dkr571; Rybak MJ, 2006, AM J INFECT CONTROL, V34, pS38, DOI 10.1016/j.ajic.2006.05.227; Summa-Sorgini Claudia, 2012, Can J Hosp Pharm, V65, P19; Thomas JK, 1998, ANTIMICROB AGENTS CH, V42, P521, DOI 10.1128/AAC.42.3.521; Valentin A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b814	17	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122422	10.1371/journal.pone.0122422	http://dx.doi.org/10.1371/journal.pone.0122422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856373	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500038
J	Jacquez, GM; Shi, C; Meliker, JR				Jacquez, Geoffrey M.; Shi, Chen; Meliker, Jaymie R.			Local Bladder Cancer Clusters in Southeastern Michigan Accounting for Risk Factors, Covariates and Residential Mobility	PLOS ONE			English	Article							BONFERRONI PROCEDURE; LIFETIME EXPOSURE; DRINKING-WATER; MULTIPLE TESTS; BREAST-CANCER; DISEASE; ERROR	Background In case control studies disease risk not explained by the significant risk factors is the unexplained risk. Considering unexplained risk for specific populations, places and times can reveal the signature of unidentified risk factors and risk factors not fully accounted for in the case-control study. This potentially can lead to new hypotheses regarding disease causation. Methods Global, local and focused Q-statistics are applied to data from a population-based case-control study of 11 southeast Michigan counties. Analyses were conducted using both year- and age-based measures of time. The analyses were adjusted for arsenic exposure, education, smoking, family history of bladder cancer, occupational exposure to bladder cancer carcinogens, age, gender, and race. Results Significant global clustering of cases was not found. Such a finding would indicate large-scale clustering of cases relative to controls through time. However, highly significant local clusters were found in Ingham County near Lansing, in Oakland County, and in the City of Jackson, Michigan. The Jackson City cluster was observed in working-ages and is thus consistent with occupational causes. The Ingham County cluster persists over time, suggesting a broad-based geographically defined exposure. Focused clusters were found for 20 industrial sites engaged in manufacturing activities associated with known or suspected bladder cancer carcinogens. Set-based tests that adjusted for multiple testing were not significant, although local clusters persisted through time and temporal trends in probability of local tests were observed. Conclusion Q analyses provide a powerful tool for unpacking unexplained disease risk from case-control studies. This is particularly useful when the effect of risk factors varies spatially, through time, or through both space and time. For bladder cancer in Michigan, the next step is to investigate causal hypotheses that may explain the excess bladder cancer risk localized to areas of Oakland and Ingham counties, and to the City of Jackson.	[Jacquez, Geoffrey M.; Shi, Chen] SUNY Buffalo, Dept Geog, Buffalo, NY 14260 USA; [Jacquez, Geoffrey M.] BioMedware Inc, Ann Arbor, MI USA; [Meliker, Jaymie R.] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Meliker, Jaymie R.] SUNY Stony Brook, Grad Program Publ Hlth, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Jacquez, GM (corresponding author), SUNY Buffalo, Dept Geog, Buffalo, NY 14260 USA.	geoff.jacquez@gmail.com		Meliker, Jaymie/0000-0002-6408-8596	National Cancer Institute [R44CA117171, R44CA135818]; NATIONAL CANCER INSTITUTE [R44CA117171, R44CA135818] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grants from the National Cancer Institute R44CA117171 and R44CA135818. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, TOX REL INV TRI DAT; BioMedware, 2013, SPAC V 3 6, V3. 6; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; CUZICK J, 1990, J ROY STAT SOC B MET, V52, P73; Goldberg D W, 2007, URISA J, V19, P33, DOI DOI 10.1079/9781780640891.0051; Goldberg DW, 2012, SPAT SPATIO-TEMPORAL, V3, P1, DOI 10.1016/j.sste.2012.02.001; Goovaerts P, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-32; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; IARC, 2012, IARC MON EV CARC R C, V100C, P41; Jacquez Geoffrey M, 2005, Environ Health, V4, P4, DOI 10.1186/1476-069X-4-4; Jacquez GM, 2014, INT J ENV RES PUB HE, V11, P271, DOI 10.3390/ijerph110100271; Jacquez GM, 2012, SPAT SPATIO-TEMPORAL, V3, P7, DOI 10.1016/j.sste.2012.02.002; Jacquez GM, 2009, SAGE HDB SPATIAL ANA, P355; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2004, SATSCAN V4 0 SOFTWAR; Lawson AB, 1989, SCORE TESTS DETECTIO; Meliker JR, 2008, ENVIRON RES, V106, P42, DOI 10.1016/j.envres.2007.09.001; Meliker JR, 2007, INT ARCH OCC ENV HEA, V80, P184, DOI 10.1007/s00420-006-0119-2; Meliker JR, 2010, ANN EPIDEMIOL, V20, P750, DOI 10.1016/j.annepidem.2010.06.012; Meliker JR, 2010, CANCER CAUSE CONTROL, V21, P745, DOI 10.1007/s10552-010-9503-z; Meliker JR, 2009, CANCER CAUSE CONTROL, V20, P1061, DOI 10.1007/s10552-009-9312-4; Nordsborg RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060800; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Patil GP, 2006, ENVIRON ECOL STAT, V13, P365, DOI 10.1007/s10651-006-0017-5; Schmiedel S, 2011, CANCER CAUSE CONTROL, V22, P849, DOI 10.1007/s10552-011-9755-2; Silverman DT, 2006, CANC EPIDEMIOLOGY PR, V3, P1101; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Sloan CD, 2013, PLOS ONE IN PRESS; Sloan CD, 2012, SPAT SPATIO-TEMPORAL, V3, P297, DOI 10.1016/j.sste.2012.09.002; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11; WALLER LA, 1995, STAT MED, V14, P3, DOI 10.1002/sim.4780140103; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124516	10.1371/journal.pone.0124516	http://dx.doi.org/10.1371/journal.pone.0124516			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856581	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500117
J	Jodal, A; Pape, F; Becker-Pauly, C; Maas, O; Schibli, R; Behe, M				Jodal, Andreas; Pape, Fabienne; Becker-Pauly, Christoph; Maas, Ole; Schibli, Roger; Behe, Martin			Evaluation of In-111-Labelled Exendin-4 Derivatives Containing Different Meprin beta-Specific Cleavable Linkers	PLOS ONE			English	Article							GLP-1 RECEPTOR; ALPHA-SUBUNIT; SUBSTRATE; LINKAGES	Background Cleavable linkers, which are specifically cleaved by defined conditions or enzymes, are powerful tools that can be used for various purposes. Amongst other things, they have been successfully used to deliver toxic payloads as prodrugs into target tissues. In this work novel linker sequences targeting meprin beta, a metalloprotease expressed in the kidney brush-border membrane, were designed and included in the sequence of three radiolabelled exendin-4 derivatives. As radiolabelled exendin-4 derivatives strongly accumulate in the kidneys, we hypothesised that specific cleavage of the radiolabelled moiety at the kidney brush-border membrane would allow easier excretion of the activity into the urine and therefore improve the pharmacological properties of the peptide. Results The insertion of a cleavable linker did not negatively influence the in vitro properties of the peptides. They showed a good affinity to the GLP-1 receptor expressed in CHL cells, a high internalisation and sufficiently high stability in fresh human blood plasma. In vitro digestion with recombinant meprin beta rapidly metabolised the corresponding linker sequences. After 60 min the majority of the corresponding peptides were digested and at the same time the anticipated fragments were formed. The peptides were also quickly metabolised in CD1 nu/nu mouse kidney homogenates. Immunofluorescence staining of meprin beta in kidney sections confirmed the expression of the protease in the kidney brush-border membrane. Biodistribution in GLP-1 receptor positive tumour-xenograft bearing mice revealed high specific uptake of the In-111-labelled tracers in receptor positive tissue. Accumulation in the kidneys, however, was still high and comparable to the lead compound In-111-Ex4NOD40. Conclusion In conclusion, we show that the concept of cleavable linkers specific for meprin beta is feasible, as the peptides are rapidly cleaved by the enzyme while retaining their biological properties.	[Jodal, Andreas; Pape, Fabienne; Schibli, Roger; Behe, Martin] Paul Scherrer Inst, Ctr Radiopharmaceut Sci ETH PSI USZ, Villigen, Switzerland; [Pape, Fabienne; Schibli, Roger] ETH, Dept Chem & Appl Biosci, Zurich, Switzerland; [Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, Kiel, Germany; [Maas, Ole] Univ Basel Hosp, Div Nucl Med, Dept Radiol & Nucl Med, CH-4031 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kiel; University of Basel	Behe, M (corresponding author), Paul Scherrer Inst, Ctr Radiopharmaceut Sci ETH PSI USZ, Villigen, Switzerland.	martin.behe@psi.ch	Becker-Pauly, Christoph/B-7569-2011	Schibli, Roger/0000-0002-1537-3833	Seventh Framework Programme [222980, 602812]; Juvenile Diabetes Research Foundation International [37-2012-4]; Deutsche Forschungsgemeinschaft [SFB 877/2];  [A9]	Seventh Framework Programme(European Commission); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by the following sources of funding: Seventh Framework Programme (http://ec.europa.eu/research/fp7/index_en.cfm) grant numbers 222980 and 602812; Juvenile Diabetes Research Foundation International (http://jdrf.org/) grant number 37-2012-4; and Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) grant number SFB 877/2 2014; Projekt A9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizawa H, 2013, BIOCONJUGATE CHEM, V24, P291, DOI 10.1021/bc300428b; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Biasin V, 2014, J PATHOL, V233, P7, DOI 10.1002/path.4303; Bodei L, 2008, EUR J NUCL MED MOL I, V35, P1847, DOI 10.1007/s00259-008-0778-1; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Brom M, 2014, DIABETOLOGIA, V57, P950, DOI 10.1007/s00125-014-3166-3; Brom M, 2012, CONTRAST MEDIA MOL I, V7, P160, DOI 10.1002/cmmi.475; Chen YJ, 2014, BIOMATERIALS, V35, P304, DOI 10.1016/j.biomaterials.2013.09.100; Christ E, 2013, LANCET DIABETES ENDO, V1, P115, DOI 10.1016/S2213-8587(13)70049-4; Fujioka Y, 2005, BIOCONJUGATE CHEM, V16, P1610, DOI 10.1021/bc050211z; Gotthardt M, 2007, J NUCL MED, V48, P596, DOI 10.2967/jnumed.106.036020; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jodal A, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0031-9; Leriche G, 2012, BIOORGAN MED CHEM, V20, P571, DOI 10.1016/j.bmc.2011.07.048; Lottaz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026450; Pattou F, 2010, NEW ENGL J MED, V363, P1289, DOI 10.1056/NEJMc1004547; Sloniec J, 2013, J PHYS CHEM B, V117, P14336, DOI 10.1021/jp409388b; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Trejtnar F, 2002, Q J NUCL MED, V46, P181; Uehara T, 2014, BIOCONJUGATE CHEM, V25, P2038, DOI 10.1021/bc5004058; VANEYLL B, 1994, FEBS LETT, V348, P7, DOI 10.1016/0014-5793(94)00553-2; Vegt E, 2011, EUR J NUCL MED MOL I, V38, P623, DOI 10.1007/s00259-010-1685-9; Wessels BW, 2008, J NUCL MED, V49, P1884, DOI 10.2967/jnumed.108.053173; Wild D, 2006, J NUCL MED, V47, P2025; Yim CB, 2013, NUCL MED BIOL, V40, P1006, DOI 10.1016/j.nucmedbio.2013.06.012; Zhang W, 2011, BIOORG MED CHEM LETT, V21, P1452, DOI 10.1016/j.bmcl.2011.01.013	32	16	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123443	10.1371/journal.pone.0123443	http://dx.doi.org/10.1371/journal.pone.0123443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855967	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500090
J	Luo, BL; Chen, XY; Ding, LQ; Huang, YH; Zhou, J; Yang, TT				Luo, Bang-lin; Chen, Xiao-yan; Ding, Lin-qiao; Huang, Yu-han; Zhou, Ji; Yang, Tian-tian			Response Characteristics of Soil Fractal Features to Different Land Uses in Typical Purple Soil Watershed	PLOS ONE			English	Article							PARTICLE-SIZE DISTRIBUTIONS; MULTIFRACTAL CHARACTERIZATION; LASER DIFFRACTION; CHINA; FRAGMENTATION; MODEL; BASIN	As a fundamental characteristic of soil physical properties, the soil Particle Size Distribution (PSD) is important in the research on soil moisture migration, solution transformation, and soil erosion. In this research, the PSD characteristics with distinct methods in different land uses are analyzed. The results show that the upper bound of the volume domain of the clay domain ranges from 5.743 mu m to 5.749 mu m for all land-use types. For the silt domain of purple soil, the value ranges among 286.852 similar to 286.966 mu m. For all purple soil land-use types, the order of the volume domain fractal dimensions is D-clay<D-silt<D-sand. However, the values of D-silt and D-sand in the Pinus massoniana Lamb, Robinia pseudoacacia L and Ipomoea batatas are all higher than the corresponding values in the Citrus reticulate Blanco and Setaria viridis. Moreover, in all the land-use types, all of the parameters in volume domain fractal dimension (D-vi) are higher than the corresponding parameter values from the United States Department of Agriculture (D-vi(U)). The correlation study between the volume domain fractal dimension and the soil properties shows that the intensity of correlation to the soil texture and soil organic matter has the order as: D-silt>D-silt(U)>D-sand(U)>D-sand and D-silt>D-silt(U)>D-sand>D-sand(U), respectively. As it is compared with all D-vi, the D-silt has the most significant correlativity to the soil texture and organic matter in different land uses of the typical purple soil watersheds. Therefore, D-silt will be a potential indictor for evaluating the proportion of fine particles in the PSD, as well as a key measurement in soil quality and productivity studies.	[Luo, Bang-lin; Chen, Xiao-yan; Ding, Lin-qiao; Huang, Yu-han] Southwest Univ, Minist Educ, Coll Resources & Environm, Key Lab Ecoenvironm Three Gorges Reg, Chongqing, Peoples R China; [Zhou, Ji] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Yang, Tian-tian] Univ Calif Irvine, Dept Civil & Environm Engn, Irvine, CA USA	Southwest University - China; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of California System; University of California Irvine	Chen, XY (corresponding author), Southwest Univ, Minist Educ, Coll Resources & Environm, Key Lab Ecoenvironm Three Gorges Reg, Chongqing, Peoples R China.	c400716@126.com	Yang, Tiantian/P-5989-2016; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022	Yang, Tiantian/0000-0002-0148-396X; 	Fundamental Research Funds for the Central Universities [XDJK2011C013]; National Technology Support Program [2011BAD31B03]; Construction Funds for Ecology Key Disciplines for Project 211 Southwest University, National Key Basic Special Foundation Project of China [2010CB95160402]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Technology Support Program; Construction Funds for Ecology Key Disciplines for Project 211 Southwest University, National Key Basic Special Foundation Project of China	This work was funded by Fundamental Research Funds for the Central Universities (XDJK2011C013); National Technology Support Program(2011BAD31B03); Construction Funds for Ecology Key Disciplines for Project 211 Southwest University, National Key Basic Special Foundation Project of China (2010CB95160402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya LM, 2010, SOIL SCI SOC AM J, V74, P33, DOI 10.2136/sssaj2009.0022; Bittelli M, 1999, SOIL SCI SOC AM J, V63, P782, DOI 10.2136/sssaj1999.634782x; Caniego FJ, 2005, ECOL MODEL, V182, P291, DOI 10.1016/j.ecolmodel.2004.04.014; [程先富 Cheng Xianfu], 2003, [地理科学, Scientia Geographica Sinica], V23, P617; Dane JH, 2002, SOIL SCI SOC AM 4; Dumanski J, 2000, AGR ECOSYST ENVIRON, V81, P93, DOI 10.1016/S0167-8809(00)00183-3; Falconer K., 2014, FRACTAL GEOMETRY MAT; Huang GH, 2005, GEODERMA, V127, P52, DOI 10.1016/j.geoderma.2004.11.016; Huang GuanHua, 2002, Acta Pedologica Sinica, V39, P490; Liu X, 2009, GEODERMA, V154, P123, DOI 10.1016/j.geoderma.2009.10.005; MANDELBORT B. B., 1982, FRACTAL GEOMETRY NAT, P45; Mandelort BB, 1977, FRACTALS FORM CHANCE; Martin MA, 2002, SOIL TILL RES, V64, P113, DOI 10.1016/S0167-1987(01)00249-5; Miao CY, 2011, GLOBAL PLANET CHANGE, V76, P196, DOI 10.1016/j.gloplacha.2011.01.008; Miao CY, 2010, PROG PHYS GEOG, V34, P541, DOI 10.1177/0309133310369434; PERFECT E, 1993, SOIL SCI SOC AM J, V57, P896, DOI 10.2136/sssaj1993.03615995005700040003x; Posadas AND, 2003, SOIL SCI SOC AM J, V67, P1361, DOI 10.2136/sssaj2003.1361; Posadas AND, 2001, SOIL SCI SOC AM J, V65, P1361, DOI 10.2136/sssaj2001.6551361x; Prosperini N, 2008, GEODERMA, V145, P185, DOI 10.1016/j.geoderma.2008.03.004; RIEU M, 1991, SOIL SCI SOC AM J, V55, P1231, DOI 10.2136/sssaj1991.03615995005500050006x; Scott WT, 1989, SOIL SCI SOC AM J, V53, P987; Scott WT, 1992, SOIL SCI SOC AM J, V56, P362; Segal E, 2009, SOIL SCI, V174, P639, DOI 10.1097/SS.0b013e3181c2a928; Su YZ, 2004, SOIL TILL RES, V75, P27, DOI 10.1016/S0167-1987(03)00157-0; Sun QH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/015001; Wang D, 2008, CATENA, V72, P29, DOI 10.1016/j.catena.2007.03.019; [王德 WANG De], 2007, [生态学报, Acta Ecologica Sinica], V27, P3081; Wang GL, 2005, ACTA PEDOLOGICA SINI, V42, P546; WU Q, 1993, SOIL SCI SOC AM J, V57, P883, DOI 10.2136/sssaj1993.03615995005700040001x; Yang JingLing, 2008, Acta Pedologica Sinica, V45, P413; Yang P.L, 1993, CHINESE SCI BULL, V38, P1896, DOI DOI 10.1360/csb1993-38-20-1896; [张金池 ZHANG JinChi], 2008, [生态学报, Acta Ecologica Sinica], V28, P2199; Zhang Z, 2008, PARTICUOLOGY, V6, P157, DOI 10.1016/j.partic.2008.03.001; Zhao WenZhi, 2002, Acta Pedologica Sinica, V39, P877	34	5	6	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122842	10.1371/journal.pone.0122842	http://dx.doi.org/10.1371/journal.pone.0122842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856376	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500059
J	Savona, R; Soumare, M; Andersen, JV				Savona, Roberto; Soumare, Maxence; Andersen, Jorgen Vitting			Financial Symmetry and Moods in the Market	PLOS ONE			English	Article							ORDER IMBALANCE; MINORITY GAME; DYNAMICS; BEHAVIOR; RETURNS; AGENTS; MODEL	This paper studies how certain speculative transitions in financial markets can be ascribed to a symmetry break that happens in the collective decision making. Investors are assumed to be bounded rational, using a limited set of information including past price history and expectation on future dividends. Investment strategies are dynamically changed based on realized returns within a game theoretical scheme with Nash equilibria. In such a setting, markets behave as complex systems whose payoff reflect an intrinsic financial symmetry that guarantees equilibrium in price dynamics (fundamentalist state) until the symmetry is broken leading to bubble or anti-bubble scenarios (speculative state). We model such two-phase transition in a micro-to-macro scheme through a Ginzburg-Landau-based power expansion leading to a market temperature parameter which modulates the state transitions in the market. Via simulations we prove that transitions in the market price dynamics can be phenomenologically explained by the number of traders, the number of strategies and amount of information used by agents, all included in our market temperature parameter.	[Savona, Roberto] Univ Brescia, Dept Econ & Management, Brescia, Italy; [Soumare, Maxence] Univ Nice Sophia Antipolis, Lab JA Dieudonne, F-06189 Nice, France; [Andersen, Jorgen Vitting] Univ Paris 01, CNRS, Ctr Econ Sorbonne, Paris, France	University of Brescia; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); heSam Universite; Universite Pantheon-Sorbonne	Andersen, JV (corresponding author), Univ Paris 01, CNRS, Ctr Econ Sorbonne, Paris, France.	jorgen-vitting.andersen@univ-paris1.fr	Chanelian, Serena/ABE-4873-2021; Savona, Roberto/F-4775-2014	Chanelian, Serena/0000-0001-5727-6137; Savona, Roberto/0000-0002-0213-2459	European Union's Seventh Framework Programme (FP7-SSH) [320270-SYRTO]	European Union's Seventh Framework Programme (FP7-SSH)	JVA and RS have received funding from the European Union's Seventh Framework Programme (FP7-SSH/2007-2013) for research, technological development and demonstration under grant agreement no 320270-SYRTO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JV, 2010, J BEHAV FINANC, V11, P129, DOI 10.1080/15427560.2010.483186; Andersen JV, 2003, EUR PHYS J B, V31, P141, DOI 10.1140/epjb/e2003-00017-7; Bornhodtb S, 2001, INT J MOD PHYS C, P667; Brock WA, 1997, ECONOMETRICA, V65, P1059, DOI 10.2307/2171879; Brock WA, 2005, J MATH ECON, V41, P7, DOI 10.1016/j.jmateco.2004.02.002; Challet D, 1999, PHYS REV E, V60, pR6271, DOI 10.1103/PhysRevE.60.R6271; Challet D, 1998, PHYSICA A, V256, P514, DOI 10.1016/S0378-4371(98)00260-X; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; Challet D, 2000, PHYS REV E, V62, P1862, DOI 10.1103/PhysRevE.62.1862; Chiarella C., 2002, COMPUT ECON, V19, P95, DOI DOI 10.1023/A:1014957310778; Chordia T, 2004, J FINANC ECON, V72, P485, DOI 10.1016/S0304-405X(03)00175-2; COPPINGER VM, 1980, ECON INQ, V18, P1, DOI 10.1111/j.1465-7295.1980.tb00556.x; Farmer JD, 2002, IND CORP CHANGE, V11, P895, DOI 10.1093/icc/11.5.895; Foster J, 2005, CAMB J ECON, V29, P873, DOI 10.1093/cje/bei083; Havlin S, 2014, EUROPEAN PHYS J SPEC, V214, P273; HOLTHAUSEN RW, 1987, J FINANC ECON, V19, P237, DOI 10.1016/0304-405X(87)90004-3; Hommes C, 2008, J ECON BEHAV ORGAN, V67, P116, DOI 10.1016/j.jebo.2007.06.006; Johnson NF, 1999, PHYSICA A, V269, P1, DOI 10.1016/S0378-4371(99)00073-4; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kaizoji T, 2002, PHYSICA A, V316, P441, DOI 10.1016/S0378-4371(02)01216-5; Kenett DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019378; Kirman A., 1991, MONEY FINANCIAL MARK, P354; Lamper D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017902; LeBaron B, 1999, J ECON DYN CONTROL, V23, P1487, DOI 10.1016/S0165-1889(98)00081-5; Majdandzic A, 2014, NAT PHYS, V10, P34, DOI [10.1038/nphys2819, 10.1038/NPHYS2819]; Plerou V, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.027104; PLOTT CR, 1978, REV ECON STUD, V45, P133, DOI 10.2307/2297090; Roszczynska-Kurasinska M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050700; Savit R, 1999, PHYS REV LETT, V82, P2203, DOI 10.1103/PhysRevLett.82.2203; SMITH VL, 1965, J POLIT ECON, V73, P387, DOI 10.1086/259041; SMITH VL, 1962, J POLIT ECON, V70, P111, DOI 10.1086/258609; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vitting Andersen J., 2013, INTRO SOCIO FINANCE; Zhang Y-C, 1998, EUROPHYS NEWS, V29, P51, DOI DOI 10.1007/s00770-998-0051-y; [No title captured]	37	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0118224	10.1371/journal.pone.0118224	http://dx.doi.org/10.1371/journal.pone.0118224			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856392	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500004
J	Weatherspoon, DJ; Horowitz, AM; Kleinman, DV; Wang, MQ				Weatherspoon, Darien J.; Horowitz, Alice M.; Kleinman, Dushanka V.; Wang, Min Qi			The Use of Recommended Communication Techniques by Maryland Family Physicians and Pediatricians	PLOS ONE			English	Article							HEALTH LITERACY; CARE; HYPERTENSION; OUTCOMES; IMPACT	Background Health literacy experts and the American Medical Association have developed recommended communication techniques for healthcare providers given that effective communication has been shown to greatly improve health outcomes. The purpose of this study was to determine the number and types of communication techniques routinely used by Maryland physicians. Methods In 2010, a 30-item survey was mailed to a random sample of 1,472 Maryland family physicians and pediatricians, with 294 surveys being returned and usable. The survey contained questions about provider and practice characteristics, and 17 items related to communication techniques, including seven basic communication techniques. Physicians' use of recommended communication techniques was analyzed using descriptive statistics, analysis of variance, and ordinary least squares regression. Results Family physicians routinely used an average of 6.6 of the 17 total techniques and 3.3 of the seven basic techniques, whereas pediatricians routinely used 6.4 and 3.2 techniques, respectively. The use of simple language was the only technique that nearly all physicians routinely utilized (Family physicians, 91%; Pediatricians, 93%). Physicians who had taken a communications course used significantly more techniques than those who had not. Physicians with a low percentage of patients on Medicaid were significantly less likely to use the recommended communication techniques compared to those providers who had high proportion of their patient population on Medicaid. Conclusions Overall, the use of recommended communication techniques was low. Additionally, many physicians were unsure of the effectiveness of several of the recommended techniques, which could suggest that physicians are unaware of valuable skills that could enhance their communication. The findings of this study suggest that communications training should be given a higher priority in the medical training process in the United States.	[Weatherspoon, Darien J.] Univ Illinois, Coll Dent, Dept Pediat Dent, Chicago, IL 60607 USA; [Horowitz, Alice M.; Kleinman, Dushanka V.; Wang, Min Qi] Univ Maryland, Sch Publ Hlth, College Pk, MD 20742 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University System of Maryland; University of Maryland College Park	Weatherspoon, DJ (corresponding author), Univ Illinois, Coll Dent, Dept Pediat Dent, Chicago, IL 60607 USA.	dweath3@uic.edu	Horowitz, Alice/AAU-6750-2020		DentaQuest Foundation	DentaQuest Foundation	This study was supported by the DentaQuest Foundation [http://dentaquestfoundation.org/] (author who received funding: AMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboumatar HJ, 2013, J GEN INTERN MED, V28, P1469, DOI 10.1007/s11606-013-2466-5; Baker DW, 1996, ARCH FAM MED, V5, P329, DOI 10.1001/archfami.5.6.329; Castro CM, 2007, AM J HEALTH BEHAV, V31, pS85; dela Cruz GG, 2004, PEDIATRICS, V114, pE642, DOI 10.1542/peds.2004-1269; Heisler M, 2007, J GERONTOL A-BIOL, V62, P1435, DOI 10.1093/gerona/62.12.1435; Holtzman JS, 2014, COMMUNITY DENT ORAL, V42, P263, DOI 10.1111/cdoe.12089; Horowitz Alice M, 2013, J Dent Hyg, V87, P212; Howard T, 2013, J HEALTH COMMUN, V18, P991, DOI 10.1080/10810730.2012.757398; Institute for Healthcare Improvement, HOW TO GUID CREAT ID; Institute of Medicine, 2004, HLTH LITERACY PRESCR; Kutner M, 2006, HLTH LITERACY AM ADU; Levinson W, 2010, HEALTH AFFAIR, V29, P1310, DOI 10.1377/hlthaff.2009.0450; Maybury C, 2013, J AM DENT ASSOC, V144, P1386, DOI 10.14219/jada.archive.2013.0075; Miller E, 2010, PEDIATRICS, V126, P107, DOI 10.1542/peds.2009-2887; Powell CK, 2005, J GEN INTERN MED, V20, P1042, DOI 10.1007/s11606-005-0246-6; Rozier RG, 2011, J AM DENT ASSOC, V142, P518, DOI 10.14219/jada.archive.2011.0222; Safeer RS, 2005, AM FAM PHYSICIAN, V72, P463; Schwartzberg JG, 2007, AM J HEALTH BEHAV, V31, pS96; US. Department of Health and Human Services Office of Disease Prevention and Health Promotion, 2020, HLTH PEOPL 2020; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Williams MV, 2002, FAM MED, V34, P383; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	23	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0119855	10.1371/journal.pone.0119855	http://dx.doi.org/10.1371/journal.pone.0119855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856371	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500010
J	Nigh, G				Nigh, Gordon			Engelmann Spruce Site Index Models: A Comparison of Model Functions and Parameterizations	PLOS ONE			English	Article							ALGEBRAIC DIFFERENCE APPROACH; VARIABLE ASYMPTOTES; MIXED-MODEL; GROWTH; POLYMORPHISM; DERIVATION; EQUATIONS; DOMINANT; HEIGHT; CURVES	Engelmann spruce (Picea engelmannii Parry ex Engelm.) is a high-elevation species found in western Canada and western USA. As this species becomes increasingly targeted for harvesting, better height growth information is required for good management of this species. This project was initiated to fill this need. The objective of the project was threefold: develop a site index model for Engelmann spruce; compare the fits and modelling and application issues between three model formulations and four parameterizations; and more closely examine the grounded-Generalized Algebraic Difference Approach (g-GADA) model parameterization. The model fitting data consisted of 84 stem analyzed Engelmann spruce site trees sampled across the Engelmann Spruce - Subalpine Fir biogeoclimatic zone. The fitted models were based on the Chapman-Richards function, a modified Hossfeld IV function, and the Schumacher function. The model parameterizations that were tested are indicator variables, mixed-effects, GADA, and g-GADA. Model evaluation was based on the finite-sample corrected version of Akaike's Information Criteria and the estimated variance. Model parameterization had more of an influence on the fit than did model formulation, with the indicator variable method providing the best fit, followed by the mixed-effects modelling (9% increase in the variance for the Chapman-Richards and Schumacher formulations over the indicator variable parameterization), g-GADA (optimal approach) (335% increase in the variance), and the GADA/g-GADA (with the GADA parameterization) (346% increase in the variance). Factors related to the application of the model must be considered when selecting the model for use as the best fitting methods have the most barriers in their application in terms of data and software requirements.	British Columbia Minist Forests Lands & Nat Resou, Forest Anal & Inventory Branch, Victoria, BC, Canada		Nigh, G (corresponding author), British Columbia Minist Forests Lands & Nat Resou, Forest Anal & Inventory Branch, Victoria, BC, Canada.	gordon.nigh@gov.bc.ca			Land Base Investment Strategy (LBIS) of the British Columbia Ministry of Forests, Lands and Natural Resource Operations	Land Base Investment Strategy (LBIS) of the British Columbia Ministry of Forests, Lands and Natural Resource Operations	Funding for the data collection for this project was provided by the Land Base Investment Strategy (LBIS) of the British Columbia Ministry of Forests, Lands and Natural Resource Operations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RR, 1990, USDA FOREST SERVICE, V654; [Anonymous], 1932, FOREST CHRON; BAILEY RL, 1974, FOREST SCI, V20, P155; BEAL SL, 1982, CRIT REV BIOMED ENG, V8, P195; Burnham K. P., 1998, MODEL SELECTION INFE; Carvalho JP, 2005, CAN J FOREST RES, V35, P93, DOI [10.1139/x04-155, 10.1139/X04-155]; Chen Han Y. H., 2000, Western Journal of Applied Forestry, V15, P62; Cieszewski C, 2000, FOREST SCI, V46, P116; Cieszewski CJ, 2008, FOREST SCI, V54, P303; Cieszewski CJ, 2003, FOREST SCI, V49, P539; Davidian M., 1995, NONLINEAR MODELS REP; Feng ZL, 2006, FOREST CHRON, V82, P819, DOI 10.5558/tfc82819-6; Jiang LC, 2010, J COMPUT, V5, P1575, DOI 10.4304/jcp.5.10.1575-1581; Klinka K., 2000, DISTRIBUTION SYNOPSI; Krumland B., 2005, SITE INDEX SYSTEMS M; Liu Zhao-gang, 2003, Journal of Forestry Research (Harbin), V14, P19, DOI 10.1007/BF02856757; Luttmerding HA, 1990, 11 MIN ENV LANDS PAR; Meidinger D., 1991, BC MINISTRY FORESTS; Meng SX, 2009, CAN J FOREST RES, V39, P1148, DOI 10.1139/X09-039; Ministry of Forests and Range, SIT IND EST SIT SER; Nord-Larsen T, 2009, SCAND J FOREST RES, V24, P194, DOI 10.1080/02827580902795036; Panik M. J., 2014, GROWTH CURVE MODELIN; Pinheiro J, 2001, MIXED EFFECTS MODELS; Ratkowsky D.A, 1990, HDB NONLINEAR REGRES; SAS Institute Inc, 2011, SAS ONLINEDOC 9 3; Schumacher F. X., 1939, Journal of Forestry, V37, P819; Sen A., 1990, REGRESSION ANAL THEO; Stewart B, 2011, FOREST SCI, V57, P408; STRAND LARS, 1964, FOREST SCI, V10, P410; Strub M, 2006, FOREST SCI, V52, P182; Strub M, 2003, P S STAT INF TECHN F, P97; Verbeke G, 2000, LINEAR MIXED MODELS; Wang ML, 2008, FOREST ECOL MANAG, V255, P2659, DOI 10.1016/j.foreco.2008.01.030; Wang ML, 2008, FOREST SCI, V54, P625; Yang YQ, 2011, CAN J FOREST RES, V41, P1671, DOI [10.1139/x11-071, 10.1139/X11-071]; ZEIDE B, 1978, J FOREST, V76, P289	36	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124079	10.1371/journal.pone.0124079	http://dx.doi.org/10.1371/journal.pone.0124079			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853472	gold, Green Submitted, Green Published			2022-12-27	WOS:000352478400132
J	Roelle, J; Muller, C; Roelle, D; Berthold, K				Roelle, Julian; Mueller, Claudia; Roelle, Detlev; Berthold, Kirsten			Learning from Instructional Explanations: Effects of Prompts Based on the Active-Constructive-Interactive Framework	PLOS ONE			English	Article							TEXT COMPREHENSION; EXPERTISE; KNOWLEDGE; AIDS	Although instructional explanations are commonly provided when learners are introduced to new content, they often fail because they are not integrated into effective learning activities. The recently introduced active-constructive-interactive framework posits an effectiveness hierarchy in which interactive learning activities are at the top; these are then followed by constructive and active learning activities, respectively. Against this background, we combined instructional explanations with different types of prompts that were designed to elicit these learning activities and tested the central predictions of the active-constructive-interactive framework. In Experiment 1, N = 83 students were randomly assigned to one of four combinations of instructional explanations and prompts. To test the active < constructive learning hypothesis, the learners received either (1) complete explanations and engaging prompts designed to elicit active activities or (2) explanations that were reduced by inferences and inference prompts designed to engage learners in constructing the withheld information. Furthermore, in order to explore how interactive learning activities can be elicited, we gave the learners who had difficulties in constructing the prompted inferences adapted remedial explanations with either (3) unspecific engaging prompts or (4) revision prompts. In support of the active < constructive learning hypothesis, we found that the learners who received reduced explanations and inference prompts outperformed the learners who received complete explanations and engaging prompts. Moreover, revision prompts were more effective in eliciting interactive learning activities than engaging prompts. In Experiment 2, N = 40 students were randomly assigned to either (1) a reduced explanations and inference prompts or (2) a reduced explanations and inference prompts plus adapted remedial explanations and revision prompts condition. In support of the constructive < interactive learning hypothesis, the learners who received adapted remedial explanations and revision prompts as add-ons to reduced explanations and inference prompts acquired more conceptual knowledge.	[Roelle, Julian; Mueller, Claudia; Berthold, Kirsten] Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany; [Roelle, Detlev] Archigymnasium Soest, Soest, Germany	University of Bielefeld	Roelle, J (corresponding author), Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany.	julian.roelle@uni-bielefeld.de	Roelle, Julian/AAH-5241-2019	Roelle, Julian/0000-0001-9581-9120	Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University Library	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University Library	The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna SR, 2011, EUR J PSYCHOL EDUC, V26, P435, DOI 10.1007/s10212-010-0049-y; ANDRE T, 1979, REV EDUC RES, V49, P280, DOI 10.3102/00346543049002280; Bannert M, 2012, INSTR SCI, V40, P193, DOI 10.1007/s11251-011-9167-4; Berthold K, 2011, COMPUT HUM BEHAV, V27, P69, DOI 10.1016/j.chb.2010.05.025; Berthold K, 2010, EDUC PSYCHOL REV, V22, P25, DOI 10.1007/s10648-010-9124-9; Berthold K, 2009, J EDUC PSYCHOL, V101, P70, DOI 10.1037/a0013247; Butler AC, 2013, J EDUC PSYCHOL, V105, P290, DOI 10.1037/a0031026; Chi MTH, 2009, TOP COGN SCI, V1, P73, DOI 10.1111/j.1756-8765.2008.01005.x; Chi MTH, 2000, ADV INSTR P, V5, P161; Chi MTH, 2001, COGNITIVE SCI, V25, P471, DOI 10.1016/S0364-0213(01)00044-1; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; de Koning BB, 2010, COMPUT EDUC, V55, P681, DOI 10.1016/j.compedu.2010.02.027; Devolder A, 2012, J COMPUT ASSIST LEAR, V28, P557, DOI 10.1111/j.1365-2729.2011.00476.x; Fonseca BA, 2011, EDUC PSYCHOL HANDB, P296; Furr R. M., 2003, Understanding Statistics, V2, P45, DOI 10.1207/S15328031US0201_03; Hattie J, 2007, REV EDUC RES, V77, P81, DOI 10.3102/003465430298487; Hausmann RG., 2010, INT J ARTIFICIAL INT, V20, P303, DOI [10.3233/JAI-2010-010, DOI 10.3233/JAI-2010-010]; Kalyuga S, 2006, APPL COGNITIVE PSYCH, V20, P333, DOI 10.1002/acp.1249; Kalyuga S, 2005, ETR&D-EDUC TECH RES, V53, P83, DOI 10.1007/BF02504800; Kalyuga S, 2008, J EDUC PSYCHOL, V100, P603, DOI 10.1037/0022-0663.100.3.603; Karpicke JD, 2012, EDUC PSYCHOL REV, V24, P401, DOI 10.1007/s10648-012-9202-2; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; Kintsch W., 2004, THEORETICAL MODELS P, P1270, DOI [10.1598/0872075028.46, DOI 10.1598/0872075028.46]; Leahy W, 2011, APPL COGNITIVE PSYCH, V25, P943, DOI 10.1002/acp.1787; Leinhardt G., 2001, HDB RES TEACHING, V4th, P333; Leopold C, 2012, LEARN INSTR, V22, P16, DOI 10.1016/j.learninstruc.2011.05.005; Mayer RE, 2009, MULTIMEDIA LEARNING, 2ND EDITION, P1, DOI 10.1017/CBO9780511811678; McNamara D. S, 2007, READING COMPREHENSIO; McNamara DS, 1996, COGNITION INSTRUCT, V14, P1, DOI 10.1207/s1532690xci1401_1; Menekse M, 2013, J ENG EDUC, V102, P346, DOI 10.1002/jee.20021; Nokes TJ, 2011, INSTR SCI, V39, P645, DOI 10.1007/s11251-010-9151-4; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Roelle Julian, 2011, International Journal of Cyber Behavior, Psychology and Learning, V1, P16, DOI 10.4018/ijcbpl.2011040102; Roelle J, 2015, J EDUC PSYCHOL, V107, P705, DOI 10.1037/edu0000010; Roelle J, 2014, INSTR SCI, V42, P207, DOI 10.1007/s11251-013-9277-2; Roelle J, 2013, INSTR SCI, V41, P635, DOI 10.1007/s11251-012-9247-0; Rosenthal R, 2000, CONTRASTS AND EFFECT; Sanchez E, 2013, LEARN INSTR, V26, P1, DOI 10.1016/j.learninstruc.2012.12.003; Sanchez E, 2009, INSTR SCI, V37, P537, DOI 10.1007/s11251-008-9074-5; Shute VJ, 2008, REV EDUC RES, V78, P153, DOI 10.3102/0034654307313795; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; VanLehn K, 2003, COGNITION INSTRUCT, V21, P209, DOI 10.1207/S1532690XCI2103_01; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Wittrock MC, 2010, EDUC PSYCHOL-US, V45, P40, DOI 10.1080/00461520903433554; Wittwer J, 2008, EDUC PSYCHOL-US, V43, P49, DOI 10.1080/00461520701756420; Wittwer J, 2010, J EDUC PSYCHOL, V102, P74, DOI 10.1037/a0016727; Wong A, 2012, LEARN INSTR, V22, P449, DOI 10.1016/j.learninstruc.2012.05.004	48	16	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124115	10.1371/journal.pone.0124115	http://dx.doi.org/10.1371/journal.pone.0124115			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853629	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400134
J	Weerakoon, H; Navaratne, A; Ranasinghe, S; Sivakanesan, R; Galketiya, KB; Rosairo, S				Weerakoon, Harshi; Navaratne, Ayanthi; Ranasinghe, Shirani; Sivakanesan, Ramaiah; Galketiya, Kuda Banda; Rosairo, Shanthini			Chemical Characterization of Gallstones: An Approach to Explore the Aetiopathogenesis of Gallstone Disease in Sri Lanka	PLOS ONE			English	Article							X-RAY DIFFRACTION; PIGMENT GALLSTONES; CHOLESTEROL; BILE; CHOLELITHIASIS; SPECTROSCOPY; EPIDEMIOLOGY; CALCIUM	Introduction Records on gallstones and associated ailments in Sri Lankan community are scarce, despite frequent detection of gallstone disease. Identification of the chemical composition of gallstones in the local setting is important in defining aetiopathogenic factors which in turn are useful in implementing therapeutic and preventive strategies. This study aimed to describe the chemical composition of gallstones and the socio-demographic factors of a cohort of Sri Lankan patients with gallstone disease. Materials and Methods Data on clinical and socio-demographic factors, and gallstones removed at surgery were collected from patients with cholelithiasis admitted to Teaching Hospital, Peradeniya, Sri Lanka from May 2011 to December 2012. External and cross sectional morphological features of gallstones were recorded by naked eye observation. Compositional analysis was carried out by Fourier Transform Infrared Spectroscopy, X - ray Powder Diffraction, and Atomic Absorption Spectrophotometry. Scanning Electron Microscopy was used to identify the microstructure of gallstones. Results Data of 102 patients were analyzed. Of them majority (n = 77, 76%) were females with a female: male ratio of 3:1. Mean age of the study group was 46.1 +/- 11.6 years. All the patients had primary gallbladder stones. According to the physical and chemical analysis, majority (n = 54, 53%) were pigment gallstones followed by mixed cholesterol gallstones (n = 38, 37%). Only 10 (9%) had pure cholesterol gallstones. Calcium bilirubinate, calcium carbonate and calcium phosphate were the commonest calcium salts identified in pigment gallstones and core of mixed cholesterol gallstones. Conclusion Presence of a pigment nidus in gallstones is a common feature in majority of Sri Lankan patients denoting the possible role of elevated unconjugated bilirubin in bile on the pathogenesis of GS. Hence it is imperative to explore this further to understand the aetiopathogenesis of GS among Sri Lankans.	[Weerakoon, Harshi] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Biochem, Saliyapura, Sri Lanka; [Navaratne, Ayanthi] Univ Peradeniya, Fac Sci, Dept Chem, Peradeniya, Sri Lanka; [Ranasinghe, Shirani; Sivakanesan, Ramaiah] Univ Peradeniya, Fac Med, Dept Biochem, Peradeniya, Sri Lanka; [Galketiya, Kuda Banda] Univ Peradeniya, Fac Med, Dept Surg, Peradeniya, Sri Lanka; [Rosairo, Shanthini] Univ Peradeniya, Fac Med, Dept Radiol, Peradeniya, Sri Lanka; [Weerakoon, Harshi; Navaratne, Ayanthi; Ranasinghe, Shirani; Sivakanesan, Ramaiah] Univ Peradeniya, Post Grad Inst Sci, Peradeniya, Sri Lanka	Rajarata University of Sri Lanka; University of Peradeniya; University of Peradeniya; University of Peradeniya; University of Peradeniya; University of Peradeniya	Weerakoon, H (corresponding author), Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Biochem, Saliyapura, Sri Lanka.	harshitw83@yahoo.com	Sivakanesan, Ramiah/AAK-6486-2020; Rosairo, Shanthini/V-5453-2019	Sivakanesan, Ramiah/0000-0001-9401-7337; Weerakoon, Harshi/0000-0002-8699-133X	Rajarata University of Sri Lanka, Mihintale, Sri Lanka [RJT/RP & HDC/2011/Med. Alli./R/07, RJT/RP & HDC/2013/Med. Alli./R/07]	Rajarata University of Sri Lanka, Mihintale, Sri Lanka	HW received a grant from Rajarata University of Sri Lanka, Mihintale, Sri Lanka (http://www.rjt.ac.lk/page.php); grants no: RJT/RP & HDC/2011/Med. & Alli./R/07 and RJT/RP & HDC/2013/Med. & Alli./R/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysuriya V, 2008, HEPATOB PANCREAT DIS, V7, P633; Alatise OI, 2010, BIOL TRACE ELEM RES, V134, P13, DOI 10.1007/s12011-009-8453-3; Athanasiadou D, 2013, J TRACE ELEM MED BIO, V27, P79, DOI 10.1016/j.jtemb.2012.08.004; Berzina-Cimdina L, 2012, INFRARED SPECTROSCOPY - MATERIALS SCIENCE, ENGINEERING AND TECHNOLOGY, P123; CAREY MC, 1978, J CLIN INVEST, V61, P998, DOI 10.1172/JCI109025; Chandran P, 2007, INDIAN J CLIN BIOCHE, V22, P145, DOI 10.1007/BF02913334; CIKRT M, 1972, BRIT J IND MED, V29, P74; HENICHART JP, 1982, CLIN CHIM ACTA, V118, P279, DOI 10.1016/0009-8981(82)90014-6; Jayanthi V, 2005, Indian J Gastroenterol, V24, P97; JUNIPER K, 1956, AM J MED, V20, P383, DOI 10.1016/0002-9343(56)90123-1; Kim IS, 2003, YONSEI MED J, V44, P561, DOI 10.3349/ymj.2003.44.4.561; Kleiner Oleg, 2002, BMC Gastroenterol, V2, P3, DOI 10.1186/1471-230X-2-3; Marth E, 2001, Int J Occup Med Environ Health, V14, P375; Omer LS., 2011, INT J CHEM, V3, P105; Pradhan Sailesh B, 2009, Kathmandu Univ Med J (KUMJ), V7, P268; Qiao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074887; Rautray TR, 2007, NUCL INSTRUM METH B, V255, P409, DOI 10.1016/j.nimb.2006.12.147; Schafmayer C, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-36; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; SUTOR DJ, 1969, GUT, V10, P681, DOI 10.1136/gut.10.8.681; SUTOR DJ, 1973, GUT, V14, P215, DOI 10.1136/gut.14.3.215; SUZUKI N, 1975, TOHOKU J EXP MED, V116, P259, DOI 10.1620/tjem.116.259; Toscano RA, 2004, THERMOCHIM ACTA, V410, P125, DOI 10.1016/j.tca.2003.07.002; TROTMAN BW, 1982, HEPATOLOGY, V2, P879, DOI 10.1002/hep.1840020624; Vitek L, 2012, CLIN RES HEPATOL GAS, V36, P122, DOI 10.1016/j.clinre.2011.08.010; Weerakoon HTW, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-88; WOSIEWITZ U, 1983, SCAN ELECTRON MICROS, P419	29	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121537	10.1371/journal.pone.0121537	http://dx.doi.org/10.1371/journal.pone.0121537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853583	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400043
J	Dong, YJ; Dai, MF; Ye, DD				Dong, Yujuan; Dai, Meifeng; Ye, Dandan			Non-Homogeneous Fractal Hierarchical Weighted Networks	PLOS ONE			English	Article								A model of fractal hierarchical structures that share the property of non-homogeneous weighted networks is introduced. These networks can be completely and analytically characterized in terms of the involved parameters, i.e., the size of the original graph Nk and the non-homogeneous weight scaling factors r(1), r(2),..., r(M). We also study the average weighted shortest path (AWSP), the average degree and the average node strength, taking place on the non-homogeneous hierarchical weighted networks. Moreover the AWSP is scrupulously calculated. We show that the AWSP depends on the number of copies and the sum of all non-homogeneous weight scaling factors in the infinite network order limit.	[Dong, Yujuan; Dai, Meifeng; Ye, Dandan] Jiangsu Univ, Fac Sci, Zhenjiang 212013, Jiangsu, Peoples R China	Jiangsu University	Dai, MF (corresponding author), Jiangsu Univ, Fac Sci, Zhenjiang 212013, Jiangsu, Peoples R China.	daimf@mail.ujs.edu.cn	DAI, M/GPS-8291-2022		National Science Foundation of China [11071224]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research is supported by the National Science Foundation of China (11071224) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barnsley M, 1993, FRACTALS EVERYWHERE; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066149; Barrat A., 2007, LARGE SCALE STRUCTUR; Barthelemy M, 2005, PHYSICA A, V346, P34, DOI 10.1016/j.physa.2004.08.047; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Carletti T, 2010, PHYSICA A, V389, P2134, DOI 10.1016/j.physa.2010.01.019; Dai MF, 2012, PHYSICA A, V391, P6165, DOI 10.1016/j.physa.2012.06.066; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Edgar G. A, 1990, MEASURE TOPOLOGY FRA; Li GL, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045103; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Song CM, 2006, NAT PHYS, V2, P275, DOI 10.1038/nphys266; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Zhang ZZ, 2008, EUR PHYS J B, V65, P141, DOI 10.1140/epjb/e2008-00305-8; Zhang ZZ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051120; Zhang ZZ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061113	18	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121946	10.1371/journal.pone.0121946	http://dx.doi.org/10.1371/journal.pone.0121946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849619	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800090
J	Gonzalez-Blanch, C; Gleeson, JF; Koval, P; Cotton, SM; McGorry, PD; Alvarez-Jimenez, M				Gonzalez-Blanch, Cesar; Gleeson, John F.; Koval, Peter; Cotton, Sue M.; McGorry, Patrick D.; Alvarez-Jimenez, Mario			Social Functioning Trajectories of Young First-Episode Psychosis Patients with and without Cannabis Misuse: A 30-Month Follow-Up Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RELAPSE PREVENTION THERAPY; SCREENING-TEST ASSIST; SUBSTANCE USE; MENTAL-ILLNESS; USE DISORDERS; DRUG-ABUSE; SCHIZOPHRENIA; ALCOHOL; PEOPLE	The aim of the study was to investigate trajectories of social functioning in young people with first-episode psychosis (FEP) with and without cannabis misuse using a secondary analysis of data from the Episode-II trial. Forty-two young people with FEP and comorbid cannabis use disorder were compared with 39 young people with FEP but without a cannabis use disorder. Social functioning was assessed every 6 months during a 30-month follow-up. Multilevel linear growth curve modeling was used to compare the social functioning trajectories over time for those with and without cannabis misuse. Cannabis misuse was not associated with social functioning at baseline assessment. Over a 30-month follow-up, FEP patients without cannabis disorder showed significant improvements in their social functioning, whereas patients with cannabis misuse at baseline displayed no such improvement. Patients with and without cannabis misuse differed significantly in their levels of social functioning after 24 months. Similar results were obtained after adjusting for potential confounders (i.e., age, gender, negative symptoms, premorbid functioning, DSM-IV diagnoses, baseline social functioning and other substance use). In the context of a specialized early intervention service, patients with cannabis misuse at baseline did not attain the improvements in social outcomes observed in their counterparts without cannabis misuse. There is a need to develop effective interventions to reduce cannabis misuse to ultimately improve social outcomes in young people with psychosis.	[Gonzalez-Blanch, Cesar] Univ Hosp Marques de Valdecilla, Mental Hlth Ctr, Santander, Spain; [Gleeson, John F.; Koval, Peter] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia; [Koval, Peter] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Cotton, Sue M.; McGorry, Patrick D.; Alvarez-Jimenez, Mario] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia; [Cotton, Sue M.; McGorry, Patrick D.; Alvarez-Jimenez, Mario] Orygen Youth Hlth Res Ctr, Melbourne, Vic, Australia	Hospital Universitario Marques de Valdecilla (HUMV); Australian Catholic University; KU Leuven; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health	Gonzalez-Blanch, C (corresponding author), Univ Hosp Marques de Valdecilla, Mental Hlth Ctr, Santander, Spain.	cesar.gonzalezblanch@scsalud.es	McGorry, Patrick/O-4115-2019; Alvarez-Jimenez, Mario/G-4691-2013; Gonzalez-Blanch, Cesar/AAA-6065-2019; Gleeson, John F/I-1977-2018; Koval, Peter/ABB-9116-2020	Alvarez-Jimenez, Mario/0000-0002-3535-9086; Gleeson, John F/0000-0001-7969-492X; Koval, Peter/0000-0003-2460-0943; McGorry, Patrick/0000-0002-3789-6168; Gonzalez-Blanch, Cesar/0000-0002-3181-4731; Cotton, Sue/0000-0002-9386-8348	Eli Lilly via the Lilly Melbourne Academic Psychiatry Consortium; Colonial Foundation; National Health and Medical Research Council of Australia [350241]; Alicia Koplowitz Foundation; CR Roper Fellowship, Faculty of Medicine, Dentistry, and Health Science, the University of Melbourne; NHMRC Career Development Fellowship [APP1061998]	Eli Lilly via the Lilly Melbourne Academic Psychiatry Consortium(Eli Lilly); Colonial Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Alicia Koplowitz Foundation; CR Roper Fellowship, Faculty of Medicine, Dentistry, and Health Science, the University of Melbourne; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by an unrestricted grant from Eli Lilly via the Lilly Melbourne Academic Psychiatry Consortium. In addition, the study was supported by the Colonial Foundation and a Program grant from the National Health and Medical Research Council of Australia (350241). This study was further supported by a grant from the Alicia Koplowitz Foundation to Dr. Gonzalez-Blanch. Dr. Alvarez-Jimenez is supported by the CR Roper Fellowship, Faculty of Medicine, Dentistry, and Health Science, the University of Melbourne. A/Prof Sue Cotton is supported by a NHMRC Career Development Fellowship (APP1061998). No funding body had any involvement in any aspect of the study or	Addington J, 2007, ACTA PSYCHIAT SCAND, V115, P304, DOI 10.1111/j.1600-0447.2006.00900.x; Ali R, 2002, ADDICTION, V97, P1183; Alvarez-Jimenez M, 2009, CAN J PSYCHIAT, V54, P710, DOI 10.1177/070674370905401008; Andreasen N.C, 1984, SCALE FOR THE ASSESS; APA APA, 1994, DIAGNOSTIC AND STATI; Bahorik AL, 2013, ADDICTION, V108, P1259, DOI 10.1111/add.12153; Barrowclough C, 2013, SCHIZOPHRENIA BULL, V39, P339, DOI 10.1093/schbul/sbr152; Bellack AS, 2006, ARCH GEN PSYCHIAT, V63, P426, DOI 10.1001/archpsyc.63.4.426; Birchwood M, 1998, BRIT J PSYCHIAT, V172, P53, DOI 10.1192/S0007125000297663; Bolger N, 2013, INTENSIVE LONGITUDIN; CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470; Cassidy CM, 2010, SCHIZOPHRENIA BULL, V36, P1001, DOI 10.1093/schbul/sbp007; Clausen L, 2014, PSYCHOL MED, V44, P117, DOI 10.1017/S0033291713000433; Edwards J, 2006, ACTA PSYCHIAT SCAND, V114, P109, DOI 10.1111/j.1600-0447.2006.00783.x; Faber G, 2012, J CLIN PSYCHIAT, V73, P632, DOI 10.4088/JCP.11m07069; First M., 1997, STRUCTURED CLIN INTE; Foti DJ, 2010, AM J PSYCHIAT, V167, P987, DOI 10.1176/appi.ajp.2010.09020189; Ginsberg J., 2003, APPL NEUROPSYCHOL, V10, P182, DOI DOI 10.1207/S15324826AN1003_08; Gleeson JFM, 2013, SCHIZOPHRENIA BULL, V39, P436, DOI 10.1093/schbul/sbr165; Gleeson JFM, 2010, J CLIN PSYCHIAT, V71, P475, DOI 10.4088/JCP.08m04672yel; Gleeson JFM, 2009, J CLIN PSYCHIAT, V70, P477, DOI 10.4088/JCP.08m04407; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Gonzalez-Blanch C, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.07.002; Gonzalez-Blanch C, 2010, PSYCHOL MED, V40, P935, DOI 10.1017/S0033291709991267; Gonzalez-Pinto A, 2011, SCHIZOPHRENIA BULL, V37, P631, DOI 10.1093/schbul/sbp126; Hides L, 2009, ADDICT BEHAV, V34, P821, DOI 10.1016/j.addbeh.2009.03.001; Hjorthoj CR, 2014, CURR PHARM DESIGN, V20, P2205, DOI 10.2174/13816128113199990431; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Koskinen J, 2010, SCHIZOPHRENIA BULL, V36, P1115, DOI 10.1093/schbul/sbp031; LUKOFF D, 1986, SCHIZOPHRENIA BULL, V12, P578, DOI 10.1093/schbul/12.4.578; Lynskey M, 2000, ADDICTION, V95, P1621, DOI 10.1046/j.1360-0443.2000.951116213.x; MONTGOMERY SM, 1979, PROG NEURO-PSYCHOPHA, V3, P429, DOI 10.1016/0364-7722(79)90058-4; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Nakagami E, 2008, SCHIZOPHR RES, V105, P95, DOI 10.1016/j.schres.2008.06.015; Newcombe DAL, 2005, DRUG ALCOHOL REV, V24, P217, DOI 10.1080/09595230500170266; Pencer A, 2005, PSYCHIAT RES, V133, P35, DOI 10.1016/j.psychres.2004.10.004; Portney L. G., 2000, FOUNDATIONS OF CLINI; Rabin RA, 2011, SCHIZOPHR RES, V128, P111, DOI 10.1016/j.schres.2011.02.017; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rey JM, 2004, J AM ACAD CHILD PSY, V43, P1194, DOI 10.1097/01.chi.0000135623.12843.60; Schimmelmann BG, 2012, EUR PSYCHIAT, V27, P463, DOI 10.1016/j.eurpsy.2011.03.001; United Nations Office on Drugs and Crime, 2013, WORLD DRUG REPORT 20; Wisdom JP, 2011, PSYCHIAT SERV, V62, P1007, DOI 10.1176/appi.ps.62.9.1007; Yucel M, 2012, SCHIZOPHRENIA BULL, V38, P316, DOI 10.1093/schbul/sbq079; Zammit S, 2008, BRIT J PSYCHIAT, V193, P357, DOI 10.1192/bjp.bp.107.046375	45	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122404	10.1371/journal.pone.0122404	http://dx.doi.org/10.1371/journal.pone.0122404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849623	Green Published, gold			2022-12-27	WOS:000352477800127
J	Han, Y; Zhu, QG; Zhang, ZK; Meng, K; Hou, YL; Ban, QY; Suo, JT; Rao, JP				Han, Ye; Zhu, Qinggang; Zhang, Zhengke; Meng, Kun; Hou, Yali; Ban, Qiuyan; Suo, Jiangtao; Rao, Jingping			Analysis of Xyloglucan Endotransglycosylase/Hydrolase (XTH) Genes and Diverse Roles of Isoenzymes during Persimmon Fruit Development and Postharvest Softening	PLOS ONE			English	Article							WALL-MODIFYING ENZYMES; ENDOTRANSGLUCOSYLASE/HYDROLASE XTH; TOMATO FRUIT; CELL-WALLS; ENDO-TRANSGLYCOSYLASES; GIBBERELLIC-ACID; EXPRESSION; ETHYLENE; METABOLISM; CLONING	Xyloglucan endotransglycosylase/hydrolase (XTH) enzymes have played a role in the remodeling of cell wall hemicelluloses. To investigate the function of XTHs in persimmon (Diospyros kaki L.) fruit development and postharvest softening, five cDNAs (DkXTH1 to DkXTH5), whose putative proteins contained the conserved DEIDFEFLG motif of XTH, were cloned. Real time quantitative PCR analysis revealed that DkXTH1, DkXTH4, and DkXTH5 peaked in immature expanding fruit, and their higher expression was observed along with higher fruit firmness in cold-treated fruit or firmer cultivar fruit during storage. The opposite gene expression patterns were observed in DkXTH2 and DkXTH3, which reached maxima concomitance with pronounced fruit softening. Meanwhile, the xyloglucan endotransglycosylase (XET) enzymes play important roles in both the rapid growth and ripening of persimmon fruit. Furthermore, the recombined DkXTH1 and DkXTH2 proteins showed significant XET activity without any detected XEH activity. However, the XET activity of recombined DkXTH2 protein had a higher affinity for small acceptor molecules than that of recombined DkXTH1 protein. The former might prefer to participate in cell wall restructuring, and the latter is more inclined to participate in cell wall assembly. Besides, DKXTH proteins could function by targeting to the cell wall under regulation of a signal peptide. The data suggested that individual DKXTHs could exhibit different patterns of expression, and the encoded products possessed specific enzymatic properties conferring on their respective functions in growth and postharvest softening of persimmon fruit.	[Han, Ye; Zhu, Qinggang; Meng, Kun; Hou, Yali; Ban, Qiuyan; Suo, Jiangtao; Rao, Jingping] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Zhang, Zhengke] Hainan Univ, Coll Food Sci & Technol, Haikou, Peoples R China	Northwest A&F University - China; Hainan University	Rao, JP (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	raojingpingxn@163.com		Zhu, Qinggang/0000-0002-8786-2169				Akaura Kazuyuki, 2008, Horticultural Research (Japan), V7, P111, DOI 10.2503/hrj.7.111; Atkinson RG, 2009, POSTHARVEST BIOL TEC, V51, P149, DOI 10.1016/j.postharvbio.2008.06.014; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Catala C, 2000, PLANT PHYSIOL, V122, P527, DOI 10.1104/pp.122.2.527; Catala C, 2001, PLANT PHYSIOL, V127, P1180, DOI 10.1104/pp.010481; Chanliaud E, 2004, PLANT J, V38, P27, DOI 10.1111/j.1365-313X.2004.02018.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 1997, PLANT CELL, V9, P1031, DOI 10.1105/tpc.9.7.1031; CUTILLASITURRALDE A, 1994, PHYSIOL PLANTARUM, V91, P169, DOI [10.1111/j.1399-3054.1994.tb00415.x, 10.1034/j.1399-3054.1994.910206.x]; DESILVA J, 1994, J EXP BOT, V45, P1693, DOI 10.1093/jxb/45.Special_Issue.1693; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; Figueroa CR, 2008, POSTHARVEST BIOL TEC, V49, P210, DOI 10.1016/j.postharvbio.2008.01.018; Figueroa CR, 2009, POSTHARVEST BIOL TEC, V53, P51, DOI 10.1016/j.postharvbio.2009.02.005; Fonseca S, 2005, J EXP BOT, V56, P2029, DOI 10.1093/jxb/eri201; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Fry SC, 1998, BIOCHEM J, V332, P507, DOI 10.1042/bj3320507; Genovesi V, 2008, J EXP BOT, V59, P875, DOI 10.1093/jxb/ern013; Goulao LF, 2008, POSTHARVEST BIOL TEC, V48, P37, DOI 10.1016/j.postharvbio.2007.09.022; Harada T, 2000, THEOR APPL GENET, V101, P742, DOI 10.1007/s001220051539; Harima S, 2003, POSTHARVEST BIOL TEC, V29, P319, DOI 10.1016/S0925-5214(03)00058-9; Henriksson H, 2003, BIOCHEM J, V375, P61, DOI 10.1042/BJ20030485; Hiwasa K, 2004, J EXP BOT, V55, P2281, DOI 10.1093/jxb/erh250; Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI 10.1016/j.tplants.2005.11.006; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; Kallas AM, 2005, BIOCHEM J, V390, P105, DOI 10.1042/BJ20041749; Li CR, 2009, POSTHARVEST BIOL TEC, V52, P254, DOI 10.1016/j.postharvbio.2008.12.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu W, 2006, PLANT PHYSIOL BIOCH, V44, P707, DOI 10.1016/j.plaphy.2006.09.020; Lv JY, 2014, POSTHARVEST BIOL TEC, V92, P54, DOI 10.1016/j.postharvbio.2014.01.015; MACLACHLAN G, 1994, PLANT PHYSIOL, V105, P965, DOI 10.1104/pp.105.3.965; Mark P, 2009, PROTEINS, V75, P820, DOI 10.1002/prot.22291; Miedes E, 2010, J AGR FOOD CHEM, V58, P5708, DOI 10.1021/jf100242z; Miedes E, 2009, J PLANT PHYSIOL, V166, P489, DOI 10.1016/j.jplph.2008.07.003; Munoz-Bertomeu J, 2013, J PLANT PHYSIOL, V170, P1194, DOI 10.1016/j.jplph.2013.03.015; Mworia EG, 2010, POSTHARVEST BIOL TEC, V55, P108, DOI 10.1016/j.postharvbio.2009.08.007; Nardi CF, 2014, SCI HORTIC-AMSTERDAM, V165, P111, DOI 10.1016/j.scienta.2013.10.035; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; NISHITANI K, 1995, J PLANT RES, V108, P137, DOI 10.1007/BF02344317; Nishiyama K, 2007, J EXP BOT, V58, P1281, DOI 10.1093/jxb/erl283; Ohba T, 2011, PLANT BIOTECHNOL-NAR, V28, P25, DOI 10.5511/plantbiotechnology.10.0922a; Opazo MC, 2013, POSTHARVEST BIOL TEC, V77, P28, DOI 10.1016/j.postharvbio.2012.11.007; Percy AE, 1996, PHYSIOL PLANTARUM, V96, P43, DOI [10.1111/j.1399-3054.1996.tb00181.x, 10.1034/j.1399-3054.1996.960107.x]; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Saladie M, 2006, PLANT J, V47, P282, DOI 10.1111/j.1365-313X.2006.02784.x; Schroder R, 1998, PLANTA, V204, P242, DOI 10.1007/s004250050253; Steele NM, 2000, PHYTOCHEMISTRY, V54, P667, DOI 10.1016/S0031-9422(00)00203-X; Steele NM, 2001, BIOCHEM J, V355, P671, DOI 10.1042/bj3550671; Sulova Z, 2003, PLANT PHYSIOL BIOCH, V41, P431, DOI 10.1016/S0981-9428(03)00050-0; SULOVA Z, 1995, ANAL BIOCHEM, V229, P80, DOI 10.1006/abio.1995.1381; Tabuchi A, 1997, PLANT CELL PHYSIOL, V38, P653, DOI 10.1093/oxfordjournals.pcp.a029217; Thompson JE, 1997, BIOCHEM J, V327, P699; Thompson JE, 2001, PLANT J, V26, P23, DOI 10.1046/j.1365-313x.2001.01005.x; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Zhang ZK, 2012, HORTSCIENCE, V47, P378, DOI 10.21273/HORTSCI.47.3.378; Zhu QG, 2013, FOOD CHEM, V138, P471, DOI 10.1016/j.foodchem.2012.09.141	58	32	36	7	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123668	10.1371/journal.pone.0123668	http://dx.doi.org/10.1371/journal.pone.0123668			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849978	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800249
J	Maruyama, T; Akutsu, Y; Suganami, A; Tamura, Y; Fujito, H; Ouchi, T; Akanuma, N; Isozaki, Y; Takeshita, N; Hoshino, I; Uesato, M; Toyota, T; Hayashi, H; Matsubara, H				Maruyama, Tetsuro; Akutsu, Yasunori; Suganami, Akiko; Tamura, Yutaka; Fujito, Hiromichi; Ouchi, Tomoki; Akanuma, Naoki; Isozaki, Yuka; Takeshita, Nobuyoshi; Hoshino, Isamu; Uesato, Masaya; Toyota, Taro; Hayashi, Hideki; Matsubara, Hisahiro			Treatment of Near-Infrared Photodynamic Therapy Using a Liposomally Formulated Indocyanine Green Derivative for Squamous Cell Carcinoma	PLOS ONE			English	Article							CANCER-CELLS; NANOPARTICLES; MECHANISMS; DRUG	Introduction Photodynamic therapy (PDT) is a less invasive option for cancer treatment that has evolved through recent developments in nanotechnology. We have designed and synthesized a novel liposome system that includes an indocyanine green (ICG) derivative, ICG-C18, in its bilayer. In addition to its use as an optical imager to visualize blood, lymphatic, and bile flow, ICG has also been used as an optical sensitizer. In the present report, we evaluate the use of our novel liposome system, LP-ICG-C18, in PDT for squamous cell carcinoma in an autologous murine model. Materials and Methods An excitation pulse beam (300 mu J/pulse) of a single band (800 nm) was used for sensitization. The cytotoxicity of the photodynamic therapy was evaluated in terms of cellular morphology changes, methyl thiazolyl tetrazolium (MTT) assay results, and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL) staining. We tested the enhanced permeability and retention effect of LP-ICG-C18 in tumor-bearing C3H/He mice using a near-infrared fluorescence imaging system and fluorescence microscopy. We also examined the antitumor effect of PDT by measuring tumor volume in tumor-bearing mice. Results Cell death and apoptosis were only observed in the PDT group receiving LP-ICG-C18. LPICG-C18 itself had no cytotoxic activity and showed good biocompatibility. LP-ICG-C18 accumulated on the tumor 24 hours after injection and was retained for approximately 3 weeks. Tumor cell apoptosis following PDT with LP-ICG-C18 was also observed under optical microscopy, MTT assay, and TUNEL staining. Conclusion These findings suggest that LP-ICG-C18 may be an effective intervening material in PDT for malignant disease.	[Maruyama, Tetsuro; Akutsu, Yasunori; Akanuma, Naoki; Isozaki, Yuka; Takeshita, Nobuyoshi; Hoshino, Isamu; Uesato, Masaya; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan; [Suganami, Akiko; Tamura, Yutaka] Chiba Univ, Grad Sch Med, Dept Bioinformat, Chiba, Japan; [Fujito, Hiromichi] Chiba Univ, Fac Engn, Dept Med Syst Engn, Chiba 260, Japan; [Ouchi, Tomoki] Chiba Univ, Grad Sch Adv Integrat Sci, Div Neurosci, Chiba, Japan; [Toyota, Taro] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo, Japan; [Hayashi, Hideki] Chiba Univ, Ctr Frontier Med Engn, Chiba, Japan	Chiba University; Chiba University; Chiba University; Chiba University; University of Tokyo; Chiba University	Akutsu, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan.	yakutsu@faculty.chiba-u.jp			Nakayama Cancer Research Institute Gastrointestinal Project grant	Nakayama Cancer Research Institute Gastrointestinal Project grant	Nakayama Cancer Research Institute Gastrointestinal Project grant (http://ncri.or.jp/prize/prize.html) TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Barth BM, 2011, ACS NANO, V5, P5325, DOI 10.1021/nn2005766; Baumler W, 1999, BRIT J CANCER, V80, P360, DOI 10.1038/sj.bjc.6690363; Cheng Y, 2011, J AM CHEM SOC, V133, P2583, DOI 10.1021/ja108846h; Cui SS, 2013, ACS NANO, V7, P676, DOI 10.1021/nn304872n; Douillard S, 2013, PHOTODIAGN PHOTODYN, V10, P62, DOI 10.1016/j.pdpdt.2012.05.004; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Fickweiler S, 1997, J PHOTOCH PHOTOBIO B, V38, P178, DOI 10.1016/S1011-1344(96)07453-2; Hirano T, 2007, J JPN SOC LASER SURG, V28, P122, DOI DOI 10.2530/jslsm.28.122; Hocine O, 2010, INT J PHARMACEUT, V402, P221, DOI 10.1016/j.ijpharm.2010.10.004; HOPEROSS M, 1994, OPHTHALMOLOGY, V101, P529; Huang CJ, 2013, NANO LETT, V13, P1611, DOI 10.1021/nl400033h; Hulchanskyy TY, 2007, NANO LETT, V7, P2835, DOI 10.1021/nl0714637; Karakullukcu B, 2013, EUR ARCH OTO-RHINO-L, V270, P1093, DOI 10.1007/s00405-012-2104-6; Lee SJ, 2011, J CONTROL RELEASE, V152, P21, DOI 10.1016/j.jconrel.2011.03.027; Lee YEK, 2011, METHODS MOL BIOL, V726, P151, DOI 10.1007/978-1-61779-052-2_11; MAC E., 2003, PHOTODYNAMIC THERAPY; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Paszko E, 2013, EUR J PHARM SCI, V48, P202, DOI 10.1016/j.ejps.2012.10.018; Proulx ST, 2010, CANCER RES, V70, P7053, DOI 10.1158/0008-5472.CAN-10-0271; Qin M, 2011, PHOTOCH PHOTOBIO SCI, V10, P832, DOI 10.1039/c1pp05022b; Qumseya BJ, 2013, CLIN ENDOSC, V46, P30, DOI 10.5946/ce.2013.46.1.30; Radzi R, 2012, J VET MED SCI, V74, P545, DOI 10.1292/jvms.11-0464; Reddy GR, 2006, CLIN CANCER RES, V12, P6677, DOI 10.1158/1078-0432.CCR-06-0946; Rungta P, 2011, MACROMOL BIOSCI, V11, P927, DOI 10.1002/mabi.201100043; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Sakagami H, 2006, IN VIVO, V20, P499; SHIBAMOTO Y, 1991, CANCER RES, V51, P5134; Suganami A, 2012, BIOORG MED CHEM LETT, V22, P7481, DOI 10.1016/j.bmcl.2012.10.044; Toyota T, 2013, BIOORGANIC MEDICINAL, V22, P721; Urbanska K, 2002, ACTA BIOCHIM POL, V49, P387; Vranic S, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-2; Yano T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-113; Yoon HY, 2012, KOREAN J INTERN MED, V27, P278, DOI 10.3904/kjim.2012.27.3.278; Zhao BZ, 2010, EXPERT REV ANTICANC, V10, P1797, DOI [10.1586/era.10.154, 10.1586/ERA.10.154]	35	11	11	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122849	10.1371/journal.pone.0122849	http://dx.doi.org/10.1371/journal.pone.0122849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850029	Green Submitted, gold, Green Published			2022-12-27	WOS:000352477800165
J	Zhang, L; Fang, Y; Lian, YJ; Chen, Y; Wu, TW; Zheng, YK; Zong, HL; Sun, LM; Zhang, RF; Wang, ZH; Xu, YM				Zhang, Lu; Fang, Yu; Lian, Yajun; Chen, Yuan; Wu, Tianwen; Zheng, Yake; Zong, Huili; Sun, Limin; Zhang, Ruifang; Wang, Zhenhua; Xu, Yuming			Brain-Derived Neurotrophic Factor Ameliorates Learning Deficits in a Rat Model of Alzheimer's Disease Induced by A beta 1-42	PLOS ONE			English	Article							LONG-TERM-POTENTIATION; BDNF MESSENGER-RNA; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; ADULT HIPPOCAMPUS; MEMORY DEFICITS; GENE-EXPRESSION; WORKING-MEMORY; MICE; NEURONS	An emerging body of data suggests that the early onset of Alzheimer's disease (AD) is associated with decreased brain-derived neurotrophic factor (BDNF). Because BDNF plays a critical role in the regulation of high-frequency synaptic transmission and long-term potentiation in the hippocampus, the up-regulation of BDNF may rescue cognitive impairments and learning deficits in AD. In the present study, we investigated the effects of hippocampal BDNF in a rat model of AD produced by a ventricle injection of amyloid-beta 1-42 (A beta 1-42). We found that a ventricle injection of A beta 1-42 caused learning deficits in rats subjected to the Morris water maze and decreased BDNF expression in the hippocampus. Chronic intra-hippocampal BDNF administration rescued learning deficits in the water maze, whereas infusions of NGF and NT-3 did not influence the behavioral performance of rats injected with A beta 1-42. Furthermore, the BDNF-related improvement in learning was ERK-dependent because the inhibition of ERK, but not JNK or p38, blocked the effects of BDNF on cognitive improvement in rats injected with A beta 1-42. Together, our data suggest that the up-regulation of BDNF in the hippocampus via activation of the ERK signaling pathway can ameliorate A beta 1-42-induced learning deficits, thus identifying a novel pathway through which BDNF protects against AD-related cognitive impairments. The results of this research may shed light on a feasible therapeutic approach to control the progression of AD.	[Zhang, Lu; Fang, Yu; Xu, Yuming] Key Disciplines Lab Clin Med Henan, Zhengzhou, Henan, Peoples R China; [Zhang, Lu; Lian, Yajun; Chen, Yuan; Wu, Tianwen; Zheng, Yake; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China; [Fang, Yu; Zong, Huili; Sun, Limin; Zhang, Ruifang; Wang, Zhenhua] Zhengzhou Univ, Affiliated Hosp 1, Dept Intens Care Unit, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Xu, YM (corresponding author), Key Disciplines Lab Clin Med Henan, Zhengzhou, Henan, Peoples R China.	zhangluys@163.com	Zhang, Rui/GXN-3801-2022		Zhengzhou Science & Technology Basic Research Program [340600531794]; Henan Science & Technology Basic Research Program [122300410365]	Zhengzhou Science & Technology Basic Research Program; Henan Science & Technology Basic Research Program	This work was supported by Zhengzhou Science & Technology Basic Research Program (No. 340600531794) and by Henan Science & Technology Basic Research Program (No. 122300410365). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2009, ALZHEIMERS DIS INT W, P1; Aicardi G, 2004, P NATL ACAD SCI USA, V101, P15788, DOI 10.1073/pnas.0406960101; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Bekinschtein P, 2014, NEUROPHARMACOLOGY, V76, P677, DOI 10.1016/j.neuropharm.2013.04.024; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CARLESIMO GA, 1992, NEUROPSYCHOL REV, V3, P119, DOI 10.1007/BF01108841; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Fahnestock M, 2002, J NEURAL TRANSM-SUPP, P241; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Ferri C.P., 2009, ALZHEIMERS DIS INT W; FISCHER W, 1994, P NATL ACAD SCI USA, V91, P8607, DOI 10.1073/pnas.91.18.8607; Gartner AG, 2002, P NATL ACAD SCI USA, V99, P6386, DOI 10.1073/pnas.092129699; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Gil-Bea FJ, 2011, HIPPOCAMPUS, V21, P999, DOI 10.1002/hipo.20812; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu YH, 2008, J NEUROCHEM, V105, P1, DOI 10.1111/j.1471-4159.2008.05237.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jeronimo-Santos A., 2014, CEREB CORTEX; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kinoshita S, 1999, J NEUROSCI, V19, P2122; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Ma YL, 1999, CHINESE J PHYSIOL, V42, P73; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; Miettinen R, 2012, J NEUROSCI METH, V205, P130, DOI 10.1016/j.jneumeth.2011.12.017; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nagahara AH, 2013, J NEUROSCI, V33, P15596, DOI 10.1523/JNEUROSCI.5195-12.2013; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Papaleo F, 2011, LEARN MEMORY, V18, P534, DOI 10.1101/lm.2213711; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Ueyama T, 1997, NEUROSCI RES, V28, P103, DOI 10.1016/S0168-0102(97)00030-8; Xing B, 2012, BEHAV BRAIN RES, V235, P36, DOI 10.1016/j.bbr.2012.06.035; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	50	145	156	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122415	10.1371/journal.pone.0122415	http://dx.doi.org/10.1371/journal.pone.0122415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849905	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800129
J	Pfahler, S; Distl, O				Pfahler, Sophia; Distl, Ottmar			Effective Population Size, Extended Linkage Disequilibrium and Signatures of Selection in the Rare Dog Breed Lundehund	PLOS ONE			English	Article							ARTIFICIAL SELECTION; SYNAPTIC PLASTICITY; HOMOZYGOSITY; GENOME; GENES; RUNS; DOMESTICATION; ASSOCIATION; ADAPTATION; EXPRESSION	The Lundehund is an old dog breed with remarkable anatomical features including polydactyly in all four limbs and extraordinary flexibility of the spine. We genotyped 28 Lundehund using the canine Illumina high density beadchip to estimate the effective population size (N-e) and inbreeding coefficients as well as to identify potential regions of positive selection. The decay of linkage disequilibrium was slow with r(2) = 0.95 in 50 kb distance. The last 7-200 generations ago, Ne was at 10-13. An increase of N-e was noted in the very recent generations with a peak value of 19 for N-e at generation 4. The FROH estimated for 50-, 65- and 358-SNP windows were 0.87, 087 and 0.81, respectively. The most likely estimates for F-ROH after removing identical-by-state segments due to linkage disequilibria were at 0.80-0.81. The extreme loss of heterozygosity has been accumulated through continued inbreeding over 200 generations within a probably closed population with a small effective population size. The mean inbreeding coefficient based on pedigree data for the last 11 generations (F-Ped = 0.10) was strongly biased downwards due to the unknown coancestry of the founders in this pedigree data. The long-range haplotype test identified regions with genes involved in processes of immunity, olfaction, woundhealing and neuronal development as potential targets of selection. The genes QSOX2, BMPR1B and PRRX2 as well as MYOM1 are candidates for selection on the Lundehund characteristics small body size, increased number of digits per paw and extraordinary mobility, respectively.	[Pfahler, Sophia; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, D-30559 Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Bunteweg 17p, D-30559 Hannover, Germany.	ottmar.distl@tiho-hannover.de			University of Veterinary Medicine Hannover	University of Veterinary Medicine Hannover	Funding of this research was by private breeders and internal funds of the University of Veterinary Medicine Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, DEV DYNAM, V218, P280; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Ames JB, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00010, 10.1016/j.bbagen.2011.10.003]; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Berghoff N, 2007, COMP CONT EDUC PRACT, V29, P456; Biesecker LG, 2011, DEV DYNAM, V240, P931, DOI 10.1002/dvdy.22609; Bjelland DW, 2013, J DAIRY SCI, V96, P4697, DOI 10.3168/jds.2012-6435; Bonnefoy A, 2008, CELL MOL LIFE SCI, V65, P713, DOI 10.1007/s00018-007-7487-y; Bosse M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003100; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Choi Y, 2010, HUM MUTAT, V31, P788, DOI 10.1002/humu.21264; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Espelien IS, 2013, J INT SOC PRESERVATI, V35, P37; Ferencakovic M, 2013, J ANIM BREED GENET, V130, P286, DOI 10.1111/jbg.12012; Flower DR, 1996, BIOCHEM J, V318, P1; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Gutierrez JP, 2008, GENET SEL EVOL, V40, P359, DOI 10.1051/gse:2008008; Haass NK, 1996, J CELL BIOL, V134, P731, DOI 10.1083/jcb.134.3.731; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Jin JZ, 2006, DEV DYNAM, V235, P547, DOI 10.1002/dvdy.20642; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; King MDA, 2014, J NEUROCHEM, V128, P391, DOI 10.1111/jnc.12462; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li Y, 2014, MOL BIOL EVOL, V31, P1200, DOI 10.1093/molbev/msu070; Li Y, 2013, MOL BIOL EVOL, V30, P1867, DOI 10.1093/molbev/mst088; Lu MF, 1999, DEV BIOL, V205, P145, DOI 10.1006/dbio.1998.9116; Lv D, 2011, EUR J CANCER, V47, P2068, DOI 10.1016/j.ejca.2011.04.021; Herrero-Medrano JM, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-106; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Melis C, 2013, ANIM GENET, V44, P348, DOI 10.1111/age.12000; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Park K, 2008, GENETICS, V179, P2163, DOI 10.1534/genetics.108.087114; Parker CL, 2002, MOL IMMUNOL, V39, P453, DOI 10.1016/S0161-5890(02)00121-9; Pfahler S, 2014, ANIM GENET, V45, P154, DOI 10.1111/age.12084; Pinotsis N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001261; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Scraggs E, 2014, J ANIM BREED GENET, V131, P3, DOI 10.1111/jbg.12066; Singh B, 2012, CARCINOGENESIS, V33, P2601, DOI 10.1093/carcin/bgs300; Stern JA, 2013, MAMM GENOME, V24, P409, DOI 10.1007/s00335-013-9474-y; SVED J A, 1971, Theoretical Population Biology, V2, P125; Trotter J, 2013, J NEUROSCI, V33, P15652, DOI 10.1523/JNEUROSCI.2010-13.2013; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voorbij AMWY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027940; Wong AK, 2012, ANIM BIOTECHNOL, V23, P241, DOI 10.1080/10495398.2012.717151; Wrede J, 2003, OPTI MATE 3 81 MANAG; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Zhang ZY, 2000, DEV BIOL, V220, P154, DOI 10.1006/dbio.2000.9637	54	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122680	10.1371/journal.pone.0122680	http://dx.doi.org/10.1371/journal.pone.0122680			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860808	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300055
J	Pirone-Davies, C; Hoffmann, M; Roberts, RJ; Muruvanda, T; Timme, RE; Strain, E; Luo, Y; Payne, J; Luong, K; Song, Y; Tsai, YC; Boitano, M; Clark, TA; Korlach, J; Evans, PS; Allard, MW				Pirone-Davies, Cary; Hoffmann, Maria; Roberts, Richard J.; Muruvanda, Tim; Timme, Ruth E.; Strain, Errol; Luo, Yan; Payne, Justin; Luong, Khai; Song, Yi; Tsai, Yu-Chih; Boitano, Matthew; Clark, Tyson A.; Korlach, Jonas; Evans, Peter S.; Allard, Marc W.			Genome-Wide Methylation Patterns in Salmonella enterica Subsp enterica Serovars	PLOS ONE			English	Article							DNA ADENINE METHYLATION; SINGLE-MOLECULE; ESCHERICHIA-COLI; RESTRICTION; METHYLTRANSFERASE; SPECIFICITIES; ENZYMES; GENES	The methylation of DNA bases plays an important role in numerous biological processes including development, gene expression, and DNA replication. Salmonella is an important foodborne pathogen, and methylation in Salmonella is implicated in virulence. Using single molecule real-time (SMRT) DNA-sequencing, we sequenced and assembled the complete genomes of eleven Salmonella enterica isolates from nine different serovars, and analysed the whole-genome methylation patterns of each genome. We describe 16 distinct N-6-methyladenine (m6A) methylated motifs, one N-4-methylcytosine (m4C) motif, and one combined m6A-m4C motif. Eight of these motifs are novel, i.e., they have not been previously described. We also identified the methyltransferases (MTases) associated with 13 of the motifs. Some motifs are conserved across all Salmonella serovars tested, while others were found only in a subset of serovars. Eight of the nine serovars contained a unique methylated motif that was not found in any other serovar (most of these motifs were part of Type I restriction modification systems), indicating the high diversity of methylation patterns present in Salmonella.	[Pirone-Davies, Cary; Hoffmann, Maria; Muruvanda, Tim; Timme, Ruth E.; Payne, Justin; Evans, Peter S.; Allard, Marc W.] US FDA, Ctr Food Safety & Appl Nutr, Off Regulatory Sci, Div Microbiol, College Pk, MD 20993 USA; [Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA; [Strain, Errol; Luo, Yan] US FDA, Ctr Food Safety & Appl Nutr, Off Analyt & Outreach, College Pk, MD USA; [Luong, Khai; Song, Yi; Tsai, Yu-Chih; Boitano, Matthew; Clark, Tyson A.; Korlach, Jonas] Pacific Biosci, Menlo Pk, CA USA	US Food & Drug Administration (FDA); New England Biolabs; US Food & Drug Administration (FDA)	Pirone-Davies, C (corresponding author), US FDA, Ctr Food Safety & Appl Nutr, Off Regulatory Sci, Div Microbiol, College Pk, MD 20993 USA.	cary.pirone@fda.hhs.gov		Roberts, Richard/0000-0002-4348-0169; Timme, Ruth/0000-0002-9705-5897; Song, Yi/0000-0003-0125-6019; Tsai, Yu-Chih/0000-0002-2958-0278; Clark, Tyson/0000-0002-7779-3227	Center for Food Safety and Applied Nutrition at the US Food and Drug Administration; National Institutes of Health [1R44GM105125]; Research Fellowship Program for Center for Food Safety and Applied Nutrition; New England Biolabs; Pacific Biosciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM105125] Funding Source: NIH RePORTER	Center for Food Safety and Applied Nutrition at the US Food and Drug Administration; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Fellowship Program for Center for Food Safety and Applied Nutrition; New England Biolabs; Pacific Biosciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Center for Food Safety and Applied Nutrition at the US Food and Drug Administration, http://www.fda.gov/AboutFDA/CentersOffices/OfficeofFoods/CFSAN/; the National Institutes of Health (grant number 1R44GM105125 to RJR), www.nih.gov; and the Research Fellowship Program for Center for Food Safety and Applied Nutrition, administered by the Oak Ridge Associated Universities to CPD. New England Biolabs and Pacific Biosciences provided support in the form of salaries for authors RJR, KL, YS, YCT, MB, TAC, and JK, but did not have any additional role in the study design, data collection, decision to publish, or preparation of the manuscript. However, they did participate in analysis of some of the data; RJR identified methyltransferases in the genomes sequenced, and KL, YS, YCT, MB, TAC, and JK helped assemble several of the genomes. The specific roles of these authors are articulated in the 'author contributions' section.	Allard MW, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00081-13; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Bendall ML, 2013, J BACTERIOL, V195, P4966, DOI 10.1128/JB.00935-13; Blumenthal RM, 2002, MODERN MICROBIAL GEN, P177, DOI [10.1002/047122197X.ch7, DOI 10.1002/047122197X.CH7]; Broadbent SE, 2010, MOL MICROBIOL, V77, P337, DOI 10.1111/j.1365-2958.2010.07203.x; Broadbent SE, 2007, J BACTERIOL, V189, P4325, DOI 10.1128/JB.01854-06; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Cota I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036863; Davies GP, 1999, J MOL BIOL, V290, P565, DOI 10.1006/jmbi.1999.2908; Davis BM, 2013, CURR OPIN MICROBIOL, V16, P192, DOI 10.1016/j.mib.2013.01.011; Evans PS, 2014, GENOME ANNOUNC, V2; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; HALE WB, 1994, J BACTERIOL, V176, P3438, DOI 10.1128/jb.176.11.3438-3441.1994; He XJ, 2011, CELL RES, V21, P442, DOI 10.1038/cr.2011.23; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Hoffmann M., 2013, GENOME ANNOUNC, V1; Hoffmann M, GENOME ANNO IN PRESS; Huehn S, 2009, APPL ENVIRON MICROB, V75, P1011, DOI 10.1128/AEM.02187-08; Jakomin M, 2008, J BACTERIOL, V190, P7406, DOI 10.1128/JB.01136-08; Jeltsch A, 1996, J MOL EVOL, V42, P91, DOI 10.1007/BF02198833; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Lluch-Senar M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003191; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Loenen W.A., 2013, NUCL ACIDS RES; Morgan RD, 2009, NUCLEIC ACIDS RES, V37, P5222, DOI 10.1093/nar/gkp535; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; Nicholson B, 2000, MOL MICROBIOL, V35, P728, DOI 10.1046/j.1365-2958.2000.01743.x; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schouler C, 1998, MOL MICROBIOL, V28, P169, DOI 10.1046/j.1365-2958.1998.00787.x; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; Ventura M, 2006, APPL ENVIRON MICROB, V72, P3130, DOI 10.1128/AEM.72.5.3130-3146.2006; WOODBURY CP, 1980, J BIOL CHEM, V255, P1526; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	40	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123639	10.1371/journal.pone.0123639	http://dx.doi.org/10.1371/journal.pone.0123639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860355	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300107
J	Pridmore, RW; Melgosa, M				Pridmore, Ralph W.; Melgosa, Manuel			All Effects of Psychophysical Variables on Color Attributes: A Classification System	PLOS ONE			English	Article							BRUCKE HUE-SHIFT; CONSTANT HUE; BRIGHTNESS; LUMINANCE; LIGHTNESS; PREDICTION; SATURATION; SAMPLES; PURITY; LOCI	This paper reports the research and structuring of a classification system for the effects of psychophysical variables on the color attributes. A basic role of color science is to psychophysically specify color appearance. An early stage is to specify the effects of the psychophysical variables (as singles, pairs, etc) on the color attributes (as singles, pairs, etc), for example to model color appearance. Current data on effects are often scarce or conflicting. Few effects are well understood, and the practice of naming effects after their discoverer(s) is inadequate and can be confusing. The number and types of possible effects have never been systematically analyzed and categorized. We propose a simple and rigorous system of classification including nomenclature. The total range of effects is computed from the possible combinations of three psychophysical variables (luminance, dominant wavelength, purity) and six color attributes (lightness, brightness, hue, chroma, colorfulness, saturation) in all modes of appearance. Omitting those effects that are normally impossible to perceive at any one time (such as four-or five-dimensional colors), the total number perceivable is 161 types of effects for all modes of appearance. The type of effect is named after the psychophysical stimulus (or stimuli) and the relevant color attribute(s), e.g., Luminance-on-hue effect (traditionally known as Bezold-Brucke effect). Each type of effect may include slightly different effects with infinite variations depending on experimental parameters.	[Pridmore, Ralph W.] Cent Houses P Ltd, Sydney, NSW 2074, Australia; [Melgosa, Manuel] Univ Granada, Dept Opt, E-18071 Granada, Spain	University of Granada	Pridmore, RW (corresponding author), Cent Houses P Ltd, 8c Rothwell Rd, Sydney, NSW 2074, Australia.	rpridmo@bigpond.net.au			Ministry of Economy and Competitiveness of the Government of Spain; European Regional Development Fund [FIS2013-40661-P]	Ministry of Economy and Competitiveness of the Government of Spain(Spanish Government); European Regional Development Fund(European Commission)	MM received funding from Ministry of Economy and Competitiveness of the Government of Spain, with support from European Regional Development Fund. Project Code: FIS2013-40661-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney WW, 1910, P ROY SOC LOND A MAT, VA83, P120; [Anonymous], 2004, CIE PUBL; AYAMA M, 1987, J OPT SOC AM A, V4, P1136, DOI 10.1364/JOSAA.4.001136; BARTELSO.CJ, 1967, J OPT SOC AM, V57, P953, DOI 10.1364/JOSA.57.000953; Bezold W, 1873, ANN PHYSL CHEM, V226, P221; Bimler DL, 2009, J OPT SOC AM A, V26, P163, DOI 10.1364/JOSAA.26.000163; Bimler DL, 2005, J OPT SOC AM A, V22, P2120, DOI 10.1364/JOSAA.22.002120; BLACKWELL KT, 1988, COLOR RES APPL, V13, P166, DOI 10.1002/col.5080130309; Blunt B, 2004, LINNAEUS COMPLEAT NA, P266; Boynton R. M., 1979, HUMAN COLOR VISION; BOYNTON RM, 1965, J OPT SOC AM, V55, P78, DOI 10.1364/JOSA.55.000078; BRESSAN P, 1993, PERCEPT PSYCHOPHYS, V54, P55, DOI 10.3758/BF03206937; BURNS SA, 1982, J OPT SOC AM, V72, P1225, DOI 10.1364/JOSA.72.001225; Cao R, 2014, J OPT SOC AM A, V31, P1773, DOI 10.1364/JOSAA.31.001773; Chevreul, 1839, PRICIPLES HARMONY CO; CIE, 2001, CIE PUBL; CIE, 2004, CIE PUBL, V15; Cohen JB., 2001, VISUAL COLOR COLOR M; Ekroll V, 2012, PSYCHOL SCI, V23, P1246, DOI 10.1177/0956797612443369; Fairchild M. D., 2005, COLOR APPEARANCE MOD; Helson H, 1938, J EXP PSYCHOL, V23, P439, DOI 10.1037/h0060971; HUNT RWG, 1952, J OPT SOC AM, V42, P190, DOI 10.1364/JOSA.42.000190; HUNT RWG, 1989, COLOR RES APPL, V14, P235, DOI 10.1002/col.5080140506; Hurvich LM., 1981, COLOR VISION; Imhoff SM, 2004, VISION RES, V44, P1891, DOI 10.1016/j.visres.2004.03.006; Kuehni R.G., 2003, COLOR SPACE ITS DIVI; Lee T-H, 2007, P SPIE INT SOC OPTIC, V6493; Lillo J, 2004, PSICOLOGICA, V25, P23; Lillo J, 2006, SPAN J PSYCHOL, V9, P300, DOI 10.1017/S113874160000620X; MACADAM DL, 1950, J OPT SOC AM, V40, P589, DOI 10.1364/JOSA.40.000589; Melgosa M, 1999, COLOR RES APPL, V24, P38, DOI 10.1002/(SICI)1520-6378(199902)24:1<38::AID-COL8>3.0.CO;2-I; Melgosa M, 2000, COLOR RES APPL, V25, P356, DOI 10.1002/1520-6378(200010)25:5<356::AID-COL6>3.0.CO;2-S; Melgosa M, 2013, ADV COLOR IMAGE PROC; Melgosa M, 2007, COLOR RES APPL, V32, P159, DOI 10.1002/col.20300; Mizokami Y, 2006, J VISION, V6, P996, DOI 10.1167/6.9.12; Mori L, 1991, P CIE 22 SESS, P55; NAYATANI Y, 1994, COLOR RES APPL, V19, P246, DOI 10.1002/col.5080190405; O'Neil SF, 2012, J OPT SOC AM A, V29, pA165, DOI 10.1364/JOSAA.29.00A165; Optical Society of America, 1963, SCI COLOR; Pridmore R. W., 2006, Atti della Fondazione Giorgio Ronchi, V61, P61; Pridmore RW, 2007, COLOR RES APPL, V32, P208, DOI 10.1002/col.20312; Pridmore RW, 2007, COLOR RES APPL, V32, P25, DOI 10.1002/col.20286; Pridmore RW, 2005, COLOR RES APPL, V30, P186, DOI 10.1002/col.20107; Pridmore RW, 2004, COLOR RES APPL, V29, P241, DOI 10.1002/col.20011; Pridmore RW, 1999, VISION RES, V39, P3873, DOI 10.1016/S0042-6989(99)00085-1; Purdy DM, 1931, AM J PSYCHOL, V43, P541, DOI 10.2307/1415157; Sanchez JM, 2001, P SOC PHOTO-OPT INS, V4421, P607; SEMMELROTH CC, 1970, J OPT SOC AM, V60, P1685, DOI 10.1364/JOSA.60.001685; STEVENS JC, 1963, J OPT SOC AM, V53, P375, DOI 10.1364/JOSA.53.000375; Wang ZH, 2014, CHIN OPT LETT, V12, DOI 10.3788/COL201412.023301; Withouck M, 2013, J OPT SOC AM A, V30, P1248, DOI 10.1364/JOSAA.30.001248; Wyszecki G., 1973, 2nd Congress of the International Colour Association, Colour '73 (extended abstracts), P21; Wyszecki G, 1982, COLOR SCI, Vsecond; [No title captured]	54	5	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0119024	10.1371/journal.pone.0119024	http://dx.doi.org/10.1371/journal.pone.0119024			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859845	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300005
J	Trujillo-de Santiago, G; Portales-Cabrera, CG; Portillo-Lara, R; Araiz-Hernandez, D; Del Barone, MC; Garcia-Lopez, E; Rojas-de Gante, C; De Santiago-Miramontes, MD; Segoviano-Ramirez, JC; Garcia-Lara, S; Rodriguez-Gonzalez, CA; Alvarez, MM; Di Maio, E; Iannace, S				Trujillo-de Santiago, Grissel; Guadalupe Portales-Cabrera, Cynthia; Portillo-Lara, Roberto; Araiz-Hernandez, Diana; Del Barone, Maria Cristina; Garcia-Lopez, Erika; Rojas-de Gante, Cecilia; de los Angeles De Santiago-Miramontes, Maria; Carlos Segoviano-Ramirez, Juan; Garcia-Lara, Silverio; Angel Rodriguez-Gonzalez, Ciro; Moises Alvarez, Mario; Di Maio, Ernesto; Iannace, Salvatore			Supercritical CO2 Foaming of Thermoplastic Materials Derived from Maize: Proof-of-Concept Use in Mammalian Cell Culture Applications	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BONE REGENERATION; ZEIN FILMS; SCAFFOLDS; BIOCOMPATIBILITY; MICROSTRUCTURE; PCL; BIODEGRADATION; MORPHOLOGY; COMPOSITE	Background Foams are high porosity and low density materials. In nature, they are a common architecture. Some of their relevant technological applications include heat and sound insulation, lightweight materials, and tissue engineering scaffolds. Foams derived from natural polymers are particularly attractive for tissue culture due to their biodegradability and bio-compatibility. Here, the foaming potential of an extensive list of materials was assayed, including slabs elaborated from whole flour, the starch component only, or the protein fraction only of maize seeds. Methodology/Principal Findings We used supercritical CO2 to produce foams from thermoplasticized maize derived materials. Polyethylene-glycol, sorbitol/glycerol, or urea/formamide were used as plasticizers. We report expansion ratios, porosities, average pore sizes, pore morphologies, and pore size distributions for these materials. High porosity foams were obtained from zein thermoplasticized with polyethylene glycol, and from starch thermoplasticized with urea/formamide. Zein foams had a higher porosity than starch foams (88% and 85%, respectively) and a narrower and more evenly distributed pore size. Starch foams exhibited a wider span of pore sizes and a larger average pore size than zein (208.84 vs. 55.43 mu m(2), respectively). Proof-of-concept cell culture experiments confirmed that mouse fibroblasts (NIH 3T3) and two different prostate cancer cell lines (22RV1, DU145) attached to and proliferated on zein foams. Conclusions/Significance We conducted screening and proof-of-concept experiments on the fabrication of foams from cereal-based bioplastics. We propose that a key indicator of foamability is the strain at break of the materials to be foamed (as calculated from stress vs. strain rate curves). Zein foams exhibit attractive properties (average pore size, pore size distribution, and porosity) for cell culture applications; we were able to establish and sustain mammalian cell cultures on zein foams for extended time periods.	[Trujillo-de Santiago, Grissel; Guadalupe Portales-Cabrera, Cynthia; Portillo-Lara, Roberto; Araiz-Hernandez, Diana; Rojas-de Gante, Cecilia; Garcia-Lara, Silverio; Moises Alvarez, Mario] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico; [Trujillo-de Santiago, Grissel; Moises Alvarez, Mario] Harvard MIT Helath Sci & Technol, Brigham & Womens Hosp, Cambridge, MA USA; [Del Barone, Maria Cristina; Iannace, Salvatore] CNR, Inst Polymers Composites & Biomat, I-80125 Naples, Italy; [Garcia-Lopez, Erika; Angel Rodriguez-Gonzalez, Ciro] Tecnol Monterrey, Ctr Innovac Diseno & Tecnol, Monterrey, Nuevo Leon, Mexico; [de los Angeles De Santiago-Miramontes, Maria] Univ Autonoma Agr Antonio Narro, Dept Prod Anim, Torreon, Coahuila, Mexico; [Carlos Segoviano-Ramirez, Juan] Univ Autonoma Nuevo Leon, Unidad Bioimagen Microscopia, Monterrey, Nuevo Leon, Mexico; [Di Maio, Ernesto] Univ Naples Federico II, Dipartimento Ingn Chim Mat & Prod Ind, Naples, Italy	Tecnologico de Monterrey; Harvard University; Brigham & Women's Hospital; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR); Tecnologico de Monterrey; Universidad Autonoma de Nuevo Leon; University of Naples Federico II	Alvarez, MM (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Nuevo Leon, Mexico.	mario.alvarez@itesm.mx; edimaio@unina.it	Di Maio, Ernesto/A-6517-2012; Portillo-Lara, Roberto/AAX-5002-2020; García-Lara, Silverio/D-9687-2012; García-Lara, Silverio/B-5746-2009; Segoviano-Ramírez, Juan-Carlos/AAH-5763-2020	Di Maio, Ernesto/0000-0002-3276-174X; Portillo-Lara, Roberto/0000-0002-1781-3126; García-Lara, Silverio/0000-0002-3463-957X; García-Lara, Silverio/0000-0002-3463-957X; Segoviano-Ramírez, Juan-Carlos/0000-0001-9169-2118	Tecnologico de Monterrey [CAT-122]; FEMSA; CONACYT [45964]	Tecnologico de Monterrey; FEMSA; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The financial support of Tecnologico de Monterrey (through the seed fund CAT-122), and FEMSA (through the seed fund for Nutrigenomics Reseach), and CONACYT (through the doctoral scholarship 45964 provided to GTdS) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh M, 2013, MAT SCI ENG C-MATER, V33, P3958, DOI 10.1016/j.msec.2013.05.039; Barrios M, 2013, CRYOGENICS, V55-56, P12, DOI 10.1016/j.cryogenics.2012.11.004; Bhamidipati M, 2013, TISSUE ENG PART B-RE, V19, P221, DOI 10.1089/ten.teb.2012.0361; Cardoso ECL, 2013, RADIAT PHYS CHEM, V84, P170, DOI 10.1016/j.radphyschem.2012.06.023; Castillejo M, 2012, APPL SURF SCI, V258, P8919, DOI 10.1016/j.apsusc.2012.05.118; Chanvrier H, 2006, CARBOHYD POLYM, V65, P346, DOI 10.1016/j.carbpol.2006.01.027; Chiu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060728; Corradini Elisângela, 2007, Mat. Res., V10, P227, DOI 10.1590/S1516-14392007000300002; Corre YM, 2011, J SUPERCRIT FLUID, V58, P177, DOI 10.1016/j.supflu.2011.03.006; Correlo VM, 2009, J BIOMED MATER RES A, V91A, P489, DOI 10.1002/jbm.a.32221; da Silva A, 2013, J APPL POLYM SCI, V130, P3043, DOI 10.1002/app.39526; DANZER LA, 1976, CAN J BIOCHEM CELL B, V54, P196, DOI 10.1139/o76-030; De Barros MA, 2013, MICROSC RES TECHNIQ, V76, P388, DOI 10.1002/jemt.22178; Di Maio E, 2010, J POLYM ENVIRON, V18, P626, DOI 10.1007/s10924-010-0224-x; Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084; Ferkl P, 2013, CHEM ENG SCI, V97, P50, DOI 10.1016/j.ces.2013.04.018; Gillgren T, 2010, J MATER SCI, V45, P5762, DOI 10.1007/s10853-010-4649-3; Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019; Han YL, 2014, COLLOID SURFACE B, V120, P55, DOI 10.1016/j.colsurfb.2014.04.019; Krogars K, 2003, INT J PHARM, V251, P205, DOI 10.1016/S0378-5173(02)00585-9; Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058; Lawton JW, 2002, CEREAL CHEM, V79, P1, DOI 10.1094/CCHEM.2002.79.1.1; LeBlon CE, 2013, J APPL POLYM SCI, V128, P2701, DOI 10.1002/app.38321; Marrazzo C, 2008, POLYM ENG SCI, V48, P336, DOI 10.1002/pen.20937; Marrazzo C, 2008, J CELL PLAST, V44, P37, DOI 10.1177/0021955X07079147; Moraes C, 2012, ANN BIOMED ENG, V40, P1211, DOI 10.1007/s10439-011-0455-6; Mosanenzadeh SG, 2013, POLYM ENG SCI, V53, P1979, DOI 10.1002/pen.23443; Murua-Pagola B, 2009, J FOOD ENG, V91, P380, DOI 10.1016/j.jfoodeng.2008.09.035; Oh DS, 2013, CERAM INT, V39, P8401, DOI 10.1016/j.ceramint.2013.04.021; Oke MO, 2013, J FOOD PROCESS PRES, V37, P456, DOI 10.1111/j.1745-4549.2011.00661.x; Oliviero M, 2010, J APPL POLYM SCI, V115, P277, DOI 10.1002/app.31116; Peltola P, 2006, POLYM ENG SCI, V46, P995, DOI 10.1002/pen.20586; Peng X, 2013, J CELL PLAST, V49, P147, DOI 10.1177/0021955X13477439; Pushpadass HA, 2008, STARCH-STARKE, V60, P527, DOI 10.1002/star.200800713; Qu ZH, 2008, ACTA BIOMATER, V4, P1360, DOI 10.1016/j.actbio.2008.03.006; Rojas-de Gante C, 2010, Patent application number, Patent No. [PCT/MX2009/000092, 2009000092]; Salerno A, 2007, INT POLYM PROC, V22, P480, DOI 10.3139/217.2065; Salerno A, 2011, J CELL PLAST, V47, P245, DOI 10.1177/0021955X11404832; Salerno A, 2012, J POROUS MAT, V19, P181, DOI 10.1007/s10934-011-9458-9; Salerno A, 2014, EUR POLYM J, V51, P1, DOI 10.1016/j.eurpolymj.2013.11.015; Salerno A, 2010, COMPOS SCI TECHNOL, V70, P1838, DOI 10.1016/j.compscitech.2010.06.014; Salerno A, 2010, J MATER SCI-MATER M, V21, P2569, DOI 10.1007/s10856-010-4119-0; Song SA, 2013, COMPOS SCI TECHNOL, V76, P45, DOI 10.1016/j.compscitech.2012.12.018; Thielen M, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/2/025001; Tillekeratne M, 2000, POLYM INT, V49, P127, DOI 10.1002/(SICI)1097-0126(200001)49:1<127::AID-PI320>3.0.CO;2-B; Trujillo-de Santiago G, 2015, J POLYM ENVIRON, V23, P72, DOI 10.1007/s10924-014-0708-1; Trujillo-de Santiago G, 2014, J POLYM ENVIRON, V22, P508, DOI 10.1007/s10924-014-0685-4; Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017; Wang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056330; White LJ, 2012, ACTA BIOMATER, V8, P61, DOI 10.1016/j.actbio.2011.07.032; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071563; Wysokowski M, 2013, INT J BIOL MACROMOL, V62, P94, DOI 10.1016/j.ijbiomac.2013.08.039; Yamane T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073988; Yang M-Y, 2014, J BIOMED MA IN PRESS; Yu C, 2013, BIOMATERIALS, V34, P3290, DOI 10.1016/j.biomaterials.2013.01.056; Zhang WH, 2013, J APPL POLYM SCI, V130, P3066, DOI 10.1002/app.39523; Zullo R, 2009, CARBOHYD POLYM, V77, P376, DOI 10.1016/j.carbpol.2009.01.007	57	5	5	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122489	10.1371/journal.pone.0122489	http://dx.doi.org/10.1371/journal.pone.0122489			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859853	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300047
J	Chen, YM; Li, WY; Wu, VC; Wang, YC; Hwang, SJ; Lin, SH; Wu, KD				Chen, Yung-Ming; Li, Wen-Yi; Wu, Vin-Cent; Wang, Yi-Cheng; Hwang, Shang-Jyh; Lin, Shih-Hwa; Wu, Kwan-Dun			Impact of Weaning from Acute Dialytic Therapy on Outcomes of Chronic Kidney Disease following Urgent-Start Dialysis	PLOS ONE			English	Article							STAGE RENAL-DISEASE; LONG-TERM PROGNOSIS; REPLACEMENT THERAPY; UNITED-STATES; MORTALITY; INJURY; INITIATION; DEATH; WITHDRAWAL; RATES	Discontinuation of acute, unplanned dialysis is always an important therapeutic goal in dialysis- requiring patients with existing chronic kidney disease. Only a limited proportion of patients could be weaned off dialysis and remained dialysis-free. Here we performed a multicenter, observational study to investigate factors associated with successful weaning from acute dialysis, and to explore the potential impact of weaning itself on outcomes of patients with chronic kidney disease following urgent-start dialysis. We recruited 440 chronic kidney disease patients with a baseline estimated glomerular filtration rate < 45 ml/min per 1/73 m2, and used propensity score-adjusted Cox regression analysis to measure the effect of weaning from acute dialysis on death during the index hospitalization and death or readmission after discharge. Over 2 years, 64 of 421 (15.2%) patients who survived > 1 month died, and 36 (8.6%) were removed from dialysis, with 26 (6.2%) remaining alive and dialysis- free. Logistic regression analysis found that age. 65 years, ischemic acute tubular necrosis, nephrotoxic exposure, urinary obstruction, and higher predialysis estimated glomerular filtration rate and serum hemoglobin were predictors of weaning off dialysis. After adjustment for propensity scores for dialysis weaning, Cox proportional hazards models showed successful weaning from dialysis (adjusted hazard ratio 0.06; 95% confidence interval 0.01 to 0.35), along with a history of hypertension and serum albumin, were independent protectors for early death. Conversely, a history of stroke, peripheral arterial disease and cancer predicted the occurrence of early mortality. In conclusion, this prospective cohort study shows that compared to patients with chronic kidney disease who became end-stage renal disease after acute dialysis, patients who could be weaned off acute dialytic therapy were associated with reduced risk of premature death over a 2-year observation period.	[Chen, Yung-Ming; Li, Wen-Yi] Natl Taiwan Univ Hosp, Dept Internal Med, Div Renal, Yun Lin Branch, Yunlin, Taiwan; [Chen, Yung-Ming; Wu, Vin-Cent; Wang, Yi-Cheng; Wu, Kwan-Dun] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Renal Div,Dept Internal Med, Taipei 10764, Taiwan; [Hwang, Shang-Jyh] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Geriatr & Gerontol, Taipei, Taiwan; [Lin, Shih-Hwa] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Health Research Institutes - Taiwan; National Defense Medical Center; Tri-Service General Hospital	Chen, YM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Renal, Yun Lin Branch, Yunlin, Taiwan.	chenym@ntuh.gov.tw	Li, Wen-Yi/AAM-9668-2021	CHEN, YUNG-MING/0000-0002-9241-1258; WU, VIN-CENT/0000-0001-7935-0991; WU, KWAN-DUN/0000-0002-3339-1509	Department of Health (now the Ministry of Health and Welfare) [DOH97-HP-1102]; Ta-Tung Kidney Foundation; Mrs Hsiu-Chin Lee Kidney Research Fund, Taipei, Taiwan	Department of Health (now the Ministry of Health and Welfare); Ta-Tung Kidney Foundation; Mrs Hsiu-Chin Lee Kidney Research Fund, Taipei, Taiwan	This study was supported by grants from the Department of Health (now the Ministry of Health and Welfare), DOH97-HP-1102, the Ta-Tung Kidney Foundation, and the Mrs Hsiu-Chin Lee Kidney Research Fund, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour SJ, 2010, NEPHROL DIAL TRANSPL, V25, P3663, DOI 10.1093/ndt/gfq189; Cerda J, 2007, NEPHROL DIAL TRANSPL, V22, P2781, DOI 10.1093/ndt/gfm395; Claure-Del Granado R, 2011, SEMIN DIALYSIS, V24, P208, DOI 10.1111/j.1525-139X.2011.00832.x; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Conneen S, 1998, DIALYSIS TRANSPLANT, V27, P200; Derose SF, 2013, AM J KIDNEY DIS, V62, P236, DOI 10.1053/j.ajkd.2013.01.019; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Ellwood AD, 2013, CLIN J AM SOC NEPHRO, V8, P265, DOI 10.2215/CJN.01000112; Foley RN, 2009, J AM SOC NEPHROL, V20, P1432, DOI 10.1681/ASN.2009030282; Gibney N, 2008, CLIN J AM SOC NEPHRO, V3, P876, DOI 10.2215/CJN.04871107; Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Hall YN, 2005, J AM SOC NEPHROL, V16, P3711, DOI 10.1681/ASN.2005060580; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Iseki K, 2000, AM J KIDNEY DIS, V36, P820, DOI 10.1053/ajkd.2000.17676; Iseki K, 2000, NEPHROL DIAL TRANSPL, V15, P1808, DOI 10.1093/ndt/15.11.1808; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309; Koch M, 2012, NEPHROL DIAL TRANSPL, V27, P375, DOI 10.1093/ndt/gfr262; Kovesdy CP, 2009, SEMIN NEPHROL, V29, P3, DOI 10.1016/j.semnephrol.2008.10.002; Lee PH, 2011, AM J NEPHROL, V34, P95, DOI 10.1159/000329082; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Mendelssohn DC, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-22; Metcalfe W, 2000, KIDNEY INT, V57, P2539, DOI 10.1046/j.1523-1755.2000.00113.x; O'Hare A, 2001, J AM SOC NEPHROL, V12, P2838, DOI 10.1681/ASN.V12122838; Steenkamp R, 2013, NEPHRON CLIN PRACT, V123, P93, DOI 10.1159/000353324; Tennankore KK, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-72; Teo BW, 2010, ANN ACAD MED SINGAP, V39, P79; Vanholder R, 2012, J AM SOC NEPHROL, V23, P1291, DOI 10.1681/ASN.2011111094; Wei SY, 2010, NEPHROLOGY, V15, P108, DOI 10.1111/j.1440-1797.2009.01154.x; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; Wu VC, 2008, INTENS CARE MED, V34, P101, DOI 10.1007/s00134-007-0813-x; Wu VC, 2011, KIDNEY INT, V80, P1222, DOI 10.1038/ki.2011.259; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406; Yoshino M, 2006, J AM SOC NEPHROL, V17, P3510, DOI 10.1681/ASN.2006020156	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123386	10.1371/journal.pone.0123386	http://dx.doi.org/10.1371/journal.pone.0123386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856435	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500089
J	Gomez, P; Bennie, J; Gaston, KJ; Buckling, A				Gomez, Pedro; Bennie, Jonathan; Gaston, Kevin J.; Buckling, Angus			The Impact of Resource Availability on Bacterial Resistance to Phages in Soil	PLOS ONE			English	Article							ANTAGONISTIC COEVOLUTION; COMMUNITY; PARASITE; BACTERIOPHAGE; PRODUCTIVITY; ADAPTATION; ENRICHMENT; DIVERSITY; EVOLUTION; DRIVES	Resource availability can affect the coevolutionary dynamics between host and parasites, shaping communities and hence ecosystem function. A key finding from theoretical and in vitro studies is that host resistance evolves to greater levels with increased resources, but the relevance to natural communities is less clear. We took two complementary approaches to investigate the effect of resource availability on the evolution of bacterial resistance to phages in soil. First, we measured the resistance and infectivity of natural communities of soil bacteria and phage in the presence and absence of nutrient-providing plants. Second, we followed the real-time coevolution between defined bacteria and phage populations with resource availability manipulated by the addition or not of an artificial plant root exudate. Increased resource availability resulted in increases in bacterial resistance to phages, but without a concomitant increase in phage infectivity. These results suggest that phages may have a reduced impact on the control of bacterial densities and community composition in stable, high resource environments.	[Gomez, Pedro; Buckling, Angus] Univ Exeter, Biosci, Penryn TR10 9FE, Cornwall, England; [Bennie, Jonathan; Gaston, Kevin J.; Buckling, Angus] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9FE, Cornwall, England	University of Exeter; University of Exeter	Gomez, P (corresponding author), CSIC, CEBAS, Dept Stress Biol & Plant Pathol, Campus Espinardo, Murcia 30100, Spain.	pglopez@cebas.csic.es	Gómez López, Pedro/H-2230-2012; López, Pedro Gómez/M-4712-2019	Gómez López, Pedro/0000-0003-2830-4105; López, Pedro Gómez/0000-0003-2830-4105; Gaston, Kevin J./0000-0002-7235-7928; Buckling, Angus/0000-0003-1170-4604; Bennie, Jonathan/0000-0003-4394-2041	NERC; BBSRC; Royal Society; European Research Council [268504]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission)	The work was supported by NERC, the AXA research fund, BBSRC, the Royal Society (A. B.), and European Research Council funding under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 268504 (K.J.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Bohannan BJM, 1999, EVOLUTION, V53, P292, DOI 10.1111/j.1558-5646.1999.tb05355.x; Bohannan BJM, 1999, AM NAT, V153, P73, DOI 10.1086/303151; Bohannan BJM, 1997, ECOLOGY, V78, P2303; Bohannan BJM, 2000, AM NAT, V156, P329, DOI 10.1086/303393; Boots M, 2011, AM NAT, V178, P214, DOI 10.1086/660833; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P6119, DOI 10.1073/pnas.0502069102; Forde SE, 2008, EVOLUTION, V62, P1830, DOI 10.1111/j.1558-5646.2008.00411.x; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Gomez P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2297; Gomez P, 2011, SCIENCE, V332, P106, DOI 10.1126/science.1198767; Griffiths BS, 1999, SOIL BIOL BIOCHEM, V31, P145, DOI 10.1016/S0038-0717(98)00117-5; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Harrison E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0937; Hochberg ME, 1998, AM NAT, V152, P620, DOI 10.1086/286194; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; Lopez-Pascua LDC, 2010, J EVOLUTION BIOL, V23, P207, DOI 10.1111/j.1420-9101.2009.01877.x; McKean KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-76; Middelboe M, 2009, ENVIRON MICROBIOL, V11, P1971, DOI 10.1111/j.1462-2920.2009.01920.x; Mostowy R, 2011, P ROY SOC B-BIOL SCI, V278, P2283, DOI 10.1098/rspb.2010.2359; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Pascua LL, 2014, ECOL LETT, V17, P1380, DOI 10.1111/ele.12337; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thomson BC, 2010, MICROB ECOL, V59, P335, DOI 10.1007/s00248-009-9575-z; Vos M, 2009, SCIENCE, V325, P833, DOI 10.1126/science.1174173; Zahid MSH, 2008, INFECT IMMUN, V76, P5266, DOI 10.1128/IAI.00578-08	32	22	23	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123752	10.1371/journal.pone.0123752	http://dx.doi.org/10.1371/journal.pone.0123752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856079	Green Submitted, gold, Green Published			2022-12-27	WOS:000352588500105
J	Kypridemos, C; Bandosz, P; Hickey, GL; Guzman-Castillo, M; Allen, K; Buchan, I; Capewell, S; O'Flaherty, M				Kypridemos, Chris; Bandosz, Piotr; Hickey, Graeme L.; Guzman-Castillo, Maria; Allen, Kirk; Buchan, Iain; Capewell, Simon; O'Flaherty, Martin			Quantifying the Contribution of Statins to the Decline in Population Mean Cholesterol by Socioeconomic Group in England 1991-2012: A Modelling Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; SERUM-CHOLESTEROL; UNITED-KINGDOM; TIME TRENDS; ADHERENCE; HEALTH; DIET; INEQUALITIES; METAANALYSIS	Background Serum total cholesterol is one of the major targets for cardiovascular disease prevention. Statins are effective for cholesterol control in individual patients. At the population level, however, their contribution to total cholesterol decline remains unclear. The aim of this study was to quantify the contribution of statins to the observed fall in population mean cholesterol levels in England over the past two decades, and explore any differences between socioeconomic groups. Methods and Findings This is a modelling study based on data from the Health Survey for England. We analysed changes in observed mean total cholesterol levels in the adult England population between 1991-92 (baseline) and 2011-12. We then compared the observed changes with a counterfactual 'no statins' scenario, where the impact of statins on population total cholesterol was estimated and removed. We estimated uncertainty intervals (UI) using Monte Carlo simulation, where confidence intervals (CI) were impractical. In 2011-12, 13.2%(95% CI: 12.5-14.0%) of the English adult population used statins at least once per week, compared with 1991-92 when the proportion was just 0.5% (95% CI: 0.3-1.0%). Between 1991-92 and 2011-12, mean total cholesterol declined from 5.86 mmol/L (95% CI: 5.82-5.90) to 5.17 mmol/L (95% CI: 5.14-5.20). For 2011-12, mean total cholesterol was lower in more deprived groups. In our 'no statins' scenario we predicted a mean total cholesterol of 5.36 mmol/L (95% CI: 5.33-5.40) for 2011-12. Statins were responsible for approximately 33.7% (95% UI: 28.9-38.8%) of the total cholesterol reduction since 1991-92. The statin contribution to cholesterol reduction was greater among the more deprived groups of women, while showing little socio-economic gradient among men. Conclusions Our model suggests that statins explained around a third of the substantial falls in total cholesterol observed in England since 1991. Approximately two thirds of the cholesterol decrease can reasonably be attributed non-pharmacological determinants.	[Kypridemos, Chris; Bandosz, Piotr; Guzman-Castillo, Maria; Allen, Kirk; Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Bandosz, Piotr] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland; [Hickey, Graeme L.] Univ Liverpool, Epidemiol & Populat Hlth Inst Infect & Global Hlt, Liverpool L69 3BX, Merseyside, England; [Allen, Kirk] Univ Lancaster, Lancaster Med Sch, Lancaster, England; [Buchan, Iain] Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester, Lancs, England	University of Liverpool; Fahrenheit Universities; Medical University Gdansk; University of Liverpool; Lancaster University; University of Manchester	Kypridemos, C (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.	c.kypridemos@liverpool.ac.uk	Buchan, Iain E/H-5767-2013; Bandosz, Piotr/E-4964-2017; Kypridemos, Chris/I-4172-2019; Shao, Ruitai/AAU-7642-2021	Buchan, Iain E/0000-0003-3392-1650; Kypridemos, Chris/0000-0002-0746-9229; O'Flaherty, Martin/0000-0001-8944-4131	UK Department of Health; Health and Social Care Information Centre; Medical Research Council Health eResearch Centre [MR/K006665/1]; Medical Research Council [MC_PC_13042, MR/K006665/1, G0900847] Funding Source: researchfish; MRC [MR/K006665/1, G0900847] Funding Source: UKRI	UK Department of Health; Health and Social Care Information Centre; Medical Research Council Health eResearch Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The HSE 1991-92 was funded by the UK Department of Health (https://www.gov.uk/government/organisations/department-of-health). The HSE for 2011 and 2012 was funded by the Health and Social Care Information Centre (http://www.hscic.gov.uk/). This project was supported in part by Medical Research Council Health eResearch Centre grant MR/K006665/1 (http://www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; [Anonymous], 2014, R LANG ENV STAT COMP; Ashworth M, 2007, J PUBLIC HEALTH-UK, V29, P40, DOI 10.1093/pubmed/fdl068; Bajekal M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001237; Blackman T, 2007, BRIT MED J, V334, P902, DOI 10.1136/bmj.39163.563519.55; Boniface S, 2012, HLTH SURVEY ENGLAND; Bouchard MH, 2007, BRIT J CLIN PHARMACO, V63, P698, DOI 10.1111/j.1365-2125.2006.02828.x; Bridges S., 2013, HLTH SURVEY ENGLAND; BRUNNER EJ, 1993, ATHEROSCLEROSIS, V102, P195, DOI 10.1016/0021-9150(93)90162-N; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-641; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Chaudhry HJ, 2008, CURR ATHEROSCLER REP, V10, P19, DOI 10.1007/s11883-008-0004-4; Cifkova R, 2010, ATHEROSCLEROSIS, V211, P676, DOI 10.1016/j.atherosclerosis.2010.04.007; Cochran WG., 1963, SAMPLING TECHNIQUES; Cohen JD, 2010, AM J CARDIOL, V106, P969, DOI 10.1016/j.amjcard.2010.05.030; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Department for Communities and Local Government, 2011, ENGL IND DEPR 2010 P; Department of Health, PHARM PRESCR STAT; Edwards Jayne E, 2003, BMC Fam Pract, V4, P18, DOI 10.1186/1471-2296-4-18; Ekstrom C., 2014, MESS MISCELLANEOUS E; Eliasson M, 2006, J INTERN MED, V260, P551, DOI 10.1111/j.1365-2796.2006.01730.x; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Franks P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-68; GATZ DF, 1995, ATMOS ENVIRON, V29, P1185, DOI 10.1016/1352-2310(94)00210-C; Gazmararian JA, 2006, J GEN INTERN MED, V21, P1215, DOI 10.1111/j.1525-1497.2006.00591.x; Health and Social Care Information Centre, 2013, PRESCR COST AN 2012; Health and Social Care Information Centre, 2011, PRESCR COST AN 2011; Hippisley-Cox J, 2007, HEART, V93, P1256, DOI 10.1136/hrt.2006.110171; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Jones P, 1998, AM J CARDIOL, V81, P582, DOI 10.1016/S0002-9149(97)00965-X; Jorgensen T, 2013, EUR J PREV CARDIOL, V20, P409, DOI 10.1177/2047487312441726; Kong SXD, 1997, CLIN THER, V19, P778, DOI 10.1016/S0149-2918(97)80102-6; Korn E, 1998, SURV METHODOL, V24, P193; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lumley T., 2013, SURVEY ANAL COMPLEX; Morton GM, 1995, J HUM NUTR DIET, V8, P429, DOI 10.1111/j.1365-277X.1995.tb00338.x; NatCen Social Research, 2011, HLTH SURV ENGL; NatCen Social Research University College London Department of Epidemiology and Public Health, 2014, HLTH SURV ENGL; National Clinical Guideline Center, 2014, LIP MOD CARD RISK AS; Office for National Statistics, 2012, STAND OCC CLASS SOC; Office of Population Censuses and Surveys. Social Survey Division, 1997, HLTH SURV ENGL 1991; Ohlsson H, 2010, J EPIDEMIOL COMMUN H, V64, P678, DOI 10.1136/jech.2008.081166; Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Scholes S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-129; SHEKELLE RB, 1981, NEW ENGL J MED, V304, P65, DOI 10.1056/NEJM198101083040201; Stocks NP, 2004, MED J AUSTRALIA, V180, P229, DOI 10.5694/j.1326-5377.2004.tb05891.x; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Sugiyama T, 2014, JAMA INTERN MED, V174, P1038, DOI 10.1001/jamainternmed.2014.1927; The Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group, GLOB BURD MET RISK F; Thompson R, 2014, NICE STATIN LETT LAT; Thomsen RW, 2005, BRIT J CLIN PHARMACO, V60, P534, DOI 10.1111/j.1365-2125.2005.02494.x; Thorsson B, 2013, EUR HEART J, V34, P1778, DOI 10.1093/eurheartj/ehs395; Townsend N, 2012, CORONARY HEART DIS S; UK Data Service, HLTH SURV ENGL 1991; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Valsta LM, 2010, PUBLIC HEALTH NUTR, V13, P932, DOI 10.1017/S1368980010001126; Wallach-Kildemoes H, 2013, EUR J CLIN PHARMACOL, V69, P1553, DOI 10.1007/s00228-013-1488-6; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3937; Wu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067611	63	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123112	10.1371/journal.pone.0123112	http://dx.doi.org/10.1371/journal.pone.0123112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856394	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500074
J	Singh, P; Mohanta, TK; Sinha, AK				Singh, Pallavi; Mohanta, Tapan Kumar; Sinha, Alok Krishna			Unraveling the Intricate Nexus of Molecular Mechanisms Governing Rice Root Development: OsMPK3/6 and Auxin-Cytokinin Interplay	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; VASCULAR DIFFERENTIATION; STOMATAL DEVELOPMENT; PLANT MAPK; ARABIDOPSIS; CELL; EXPRESSION; TRANSPORT; STRESS; MPK6	The root system is an imperative component of a plant, involved in water and nutrient acquisition from the soil. Any subtle change in the root system may lead to drastic changes in plant productivity. Both auxin and cytokinin are implicated in regulating various root developmental aspects. One of the major signaling cascades facilitating various hormonal and developmental allocations is the Mitogen Activated Protein Kinase (MAPK) cascade. Innumerable efforts have been made to unravel the complex nexus involved in rice root development. In spite of a plethora of studies, a comprehensive study aiming to decipher the plausible cross-talk of MAPK signaling module with auxin and cytokinin signaling components in rice is missing. In the present study, extensive phenomics analysis of different stages of rice roots; transcript profiling by qRT-PCR of entire gene family of MAPK, MAPKK and PIN genes; as well as protein level and activity of potential MAPKs was investigated using western and immuno kinase assays both on auxin and cytokinin treatment. The above study led to the identification of various novel rice root specific phenotypic traits by using GiA roots software framework. High expression profile of OsMPK3/6, OsMKK4/5 and OsPIN 1b/9 and their marked transcript level modulation in response to both auxin and cytokinin was observed. Finally, the protein levels and activity assay further substantiated our present findings. Thus, OsMPK3/6-OsMKK4/5 module is elucidated as the putative, key player in auxin-cytokinin interaction augmenting their role by differentially regulating the expression patterns of OsPIN 1b/9 in root development in rice.	[Singh, Pallavi; Mohanta, Tapan Kumar; Sinha, Alok Krishna] Natl Inst Plant Genome Res, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Sinha, AK (corresponding author), Natl Inst Plant Genome Res, Aruna Asaf Ali Marg, New Delhi 110067, India.	alok@nipgr.ac.in	Singh, Pallavi/AAU-2254-2020; Mohanta, Tapan Kumar/F-9907-2018	Singh, Pallavi/0000-0003-3694-6378; Mohanta, Tapan Kumar/0000-0002-3196-7746	Department of Biotechnology (DBT), Govt of India, New Delhi [BT/PR3298/AGR/2/812/2011]	Department of Biotechnology (DBT), Govt of India, New Delhi(Department of Biotechnology (DBT) India)	This study was supported by the Department of Biotechnology (DBT), Govt of India, New Delhi, DBT Sanction Order No.: BT/PR3298/AGR/2/812/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloni R, 2006, ANN BOT-LONDON, V97, P883, DOI 10.1093/aob/mcl027; Aloni R, 2013, PLANTA, V238, P819, DOI 10.1007/s00425-013-1927-8; Bielach A, 2012, PHILOS T R SOC B, V367, P1469, DOI 10.1098/rstb.2011.0233; Bishopp A, 2011, CURR OPIN PLANT BIOL, V14, P10, DOI 10.1016/j.pbi.2010.08.014; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Coudert Y, 2010, TRENDS PLANT SCI, V15, P219, DOI 10.1016/j.tplants.2010.01.008; Dai Y, 2006, PLANT CELL, V18, P308, DOI 10.1105/tpc.105.037846; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Doczi R, 2012, TRENDS PLANT SCI, V17, P518, DOI 10.1016/j.tplants.2012.05.009; Durbak A, 2012, CURR OPIN PLANT BIOL, V15, P92, DOI 10.1016/j.pbi.2011.12.004; Fridman Y, 2014, GENE DEV, V28, P912, DOI 10.1101/gad.239335.114; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Galkovskyi T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-116; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Han S, 2014, J PLANT PHYSIOL, V171, P26, DOI 10.1016/j.jplph.2013.09.023; Hirt H, 2000, P NATL ACAD SCI USA, V97, P2405, DOI 10.1073/pnas.97.6.2405; Hord CLH, 2008, MOL PLANT, V1, P645, DOI 10.1093/mp/ssn029; Jaggi M, 2011, APPL MICROBIOL BIOT, V90, P1005, DOI 10.1007/s00253-011-3131-8; Jones B, 2010, PLANT CELL, V22, P2956, DOI 10.1105/tpc.110.074856; Lau OS, 2012, DEVELOPMENT, V139, P3683, DOI 10.1242/dev.080523; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Bucio JS, 2014, J EXP BOT, V65, P169, DOI 10.1093/jxb/ert368; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Mockaitis K, 2000, PLANT J, V24, P785, DOI 10.1046/j.1365-313x.2000.00921.x; Muller J, 2010, PLANT J, V61, P234, DOI 10.1111/j.1365-313X.2009.04046.x; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Raghuram B, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29804; Raina SK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-134; Rao KP, 2011, ARCH BIOCHEM BIOPHYS, V506, P73, DOI 10.1016/j.abb.2010.11.006; Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; Rebouillat J, 2009, RICE, V2, P15, DOI 10.1007/s12284-008-9016-5; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Saini S, 2013, PLANT CELL REP, V32, P741, DOI 10.1007/s00299-013-1430-5; Samaj J, 2003, CELL BIOL INT, V27, P257, DOI 10.1016/S1065-6995(02)00344-X; Samajova O, 2013, BIOTECHNOL ADV, V31, P118, DOI 10.1016/j.biotechadv.2011.12.002; Sethi V, 2014, PLANT CELL, V26, P3343, DOI 10.1105/tpc.114.128702; Singh R, 2013, PLANT CELL REP, V32, P923, DOI 10.1007/s00299-013-1437-y; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; Smekalova V, 2014, NEW PHYTOL; Su YH, 2011, MOL PLANT, V4, P616, DOI 10.1093/mp/ssr007; Taj G, 2010, PLANT SIGNAL BEHAV, V5, P1370, DOI 10.4161/psb.5.11.13020; Wang HC, 2008, PLANT CELL, V20, P602, DOI 10.1105/tpc.108.058032; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wang JR, 2009, MOL PLANT, V2, P823, DOI 10.1093/mp/ssp023; Wankhede DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065011; Zeng QN, 2011, PLANT SIGNAL BEHAV, V6, P1436, DOI 10.4161/psb.6.10.17089; Zhang XD, 2008, PLANT SIGNAL BEHAV, V3, P272, DOI 10.4161/psb.3.4.5230	50	33	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123620	10.1371/journal.pone.0123620	http://dx.doi.org/10.1371/journal.pone.0123620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856151	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500099
J	Troppan, K; Hofer, S; Wenzl, K; Lassnig, M; Pursche, B; Steinbauer, E; Wiltgen, M; Zulus, B; Renner, W; Beham-Schmid, C; Deutsch, A; Neumeister, P				Troppan, Katharina; Hofer, Sybille; Wenzl, Kerstin; Lassnig, Markus; Pursche, Beata; Steinbauer, Elisabeth; Wiltgen, Marco; Zulus, Barbara; Renner, Wilfried; Beham-Schmid, Christine; Deutsch, Alexander; Neumeister, Peter			Frequent Down Regulation of the Tumor Suppressor Gene A20 in Multiple Myeloma	PLOS ONE			English	Article							NF-KAPPA-B; CELL LYMPHOMA; MARGINAL ZONE; TNFAIP3 A20; MUTATIONS; DISEASE; EXPRESSION; ABNORMALITIES; ACTIVATION; PATHWAYS	Multiple myeloma (MM) is a malignant clonal expansion of plasma cells in the bone marrow and belongs to the mature B-cell neoplams. The pathogenesis of MM is associated with constitutive NF-kappa B activation. However, genetic alterations causing constitutive NF-kappa B activation are still incompletely understood. Since A20 (TNFAIP3) is a suppressor of the NF-kappa B pathway and is frequently inactivated in various lymphoid malignancies, we investigated the genetic and epigenetic properties of A20 in MM. In total, of 46 patient specimens analyzed, 3 single base pair exchanges, 2 synonymous mutations and one missense mutation were detected by direct sequencing. Gene copy number analysis revealed a reduced A20 gene copy number in 8 of 45 (17.7%) patients. Furthermore, immunohistochemical staining confirmed that A20 expression correlates with the reduction of A20 gene copy number. These data suggest that A20 contributes to tumor formation in a significant fraction of myeloma patients.	[Troppan, Katharina; Hofer, Sybille; Wenzl, Kerstin; Lassnig, Markus; Pursche, Beata; Deutsch, Alexander; Neumeister, Peter] Med Univ Graz, Dept Internal Med, Div Hematol, Graz, Austria; [Steinbauer, Elisabeth; Beham-Schmid, Christine] Med Univ Graz, Inst Pathol, Graz, Austria; [Wiltgen, Marco] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Zulus, Barbara; Renner, Wilfried] Med Univ Graz, Div Med & Chem Lab Diagnost, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Deutsch, A (corresponding author), Med Univ Graz, Dept Internal Med, Div Hematol, Graz, Austria.	alexander.deutsch@medunigraz.at	Prochazka, Katharina/F-3639-2017; Deutsch, Alexander AJ/F-2168-2010	Prochazka, Katharina/0000-0002-7201-5987; Deutsch, Alexander AJ/0000-0003-0914-2809	Fellinger Krebsforschung; Land Steiermark; Hygienefond; Jubilaeumsfond der OENB; TART-Funding-Program of the Medical University of Graz	Fellinger Krebsforschung; Land Steiermark; Hygienefond; Jubilaeumsfond der OENB; TART-Funding-Program of the Medical University of Graz	This work was supported by grants from Fellinger Krebsforschung, Land Steiermark, Hygienefond, and Jubilaeumsfond der OENB and by the START-Funding-Program of the Medical University of Graz and the city of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; Braggio E, 2012, MODERN PATHOL, V25, P651, DOI 10.1038/modpathol.2011.213; Braggio E, 2009, CANCER RES, V69, P3579, DOI 10.1158/0008-5472.CAN-08-3701; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Chanudet E, 2010, LEUKEMIA, V24, P483, DOI 10.1038/leu.2009.234; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Crawford LJ, 2012, MULTIPLE MYELOMA OVE, P1; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Deutsch AJA, 2008, J PATHOL, V215, P431, DOI 10.1002/path.2372; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hammer GE, 2011, NAT IMMUNOL, V12, P1184, DOI 10.1038/ni.2135; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Jensen F., 2007, INTRO COMPUTATIONAL; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim WS, 2007, GENE CHROMOSOME CANC, V46, P776, DOI 10.1002/gcc.20463; Kristinsson SY, 2007, J CLIN ONCOL, V25, P1993, DOI 10.1200/JCO.2006.09.0100; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Mohamed AN, 2007, AM J HEMATOL, V82, P1080, DOI 10.1002/ajh.20998; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Ni H, 2001, BRIT J HAEMATOL, V115, P279, DOI 10.1046/j.1365-2141.2001.03102.x; Nocturne G, 2013, BLOOD, V122, P4068, DOI 10.1182/blood-2013-05-503383; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Rinaldi A, 2008, ASH ANNUAL MEETING A, V112, P622; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Thelander EF, 2008, LEUKEMIA LYMPHOMA, V49, P477, DOI 10.1080/10428190701817282; Wiltgen M, 2009, CURR BIOINFORM, V4, P54, DOI 10.2174/157489309787158170	39	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123922	10.1371/journal.pone.0123922	http://dx.doi.org/10.1371/journal.pone.0123922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856582	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500109
J	Guo, AJ				Guo, Aijiang			Comparative Analysis of Cystatin Superfamily in Platyhelminths	PLOS ONE			English	Article							CYSTEINE-PROTEINASE-INHIBITOR; RAY CRYSTAL-STRUCTURE; EGG-WHITE CYSTATIN; TAENIA-SOLIUM; CHICKEN CYSTATIN; WEB SERVER; STEFIN; SEQUENCE; PROTEASE; PAPAIN	The cystatin superfamily is comprised of cysteine proteinase inhibitors and encompasses at least 3 subfamilies: stefins, cystatins and kininogens. In this study, the platyhelminth cystatin superfamily was identified and grouped into stefin and cystatin subfamilies. The conserved domain of stefins (G, QxVxG) was observed in all members of platyhelminth stefins. The three characteristics of cystatins, the cystatin-like domain (G, QxVxG, PW), a signal peptide, and one or two conserved disulfide bonds, were observed in platyhelminths, with the exception of cestodes, which lacked the conserved disulfide bond. However, it is noteworthy that cestode cystatins had two tandem repeated domains, although the second tandem repeated domain did not contain a cystatin-like domain, which has not been previously reported. Tertiary structure analysis of Taenia solium cystatin, one of the cestode cystatins, demonstrated that the N-terminus of T. solium cystatin formed a five turn alpha-helix, a five stranded beta-pleated sheet and a hydrophobic edge, similar to the structure of chicken cystatin. Although no conserved disulfide bond was found in T. solium cystatin, the models of T. solium cystatin and chicken cystatin corresponded at the site of the first disulfide bridge of the chicken cystatin. However, the two models were not similar regarding the location of the second disulfide bridge of chicken cystatin. These results showed that T. solium cystatin and chicken cystatin had similarities and differences, suggesting that the biochemistry of T. solium cystatin could be similar to chicken cystatin in its inhibitory function and that it may have further functional roles. The same results were obtained for other cestode cystatins. Phylogenetic analysis showed that cestode cystatins constituted an independent clade and implied that cestode cystatins should be considered to have formed a new clade during evolution.	[Guo, Aijiang] Chinese Acad Agr Sci, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Guo, Aijiang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Guo, AJ (corresponding author), Chinese Acad Agr Sci, Key Lab Vet Parasitol Gansu Prov, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	guoaijiang@caas.cn						Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Baig S, 2005, PARASITOLOGY, V131, P411, DOI 10.1017/S0031182005007821; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; BODE W, 1990, BIOL CHEM H-S, V371, P111; BRZIN J, 1983, H-S Z PHYSIOL CHEM, V364, P1475, DOI 10.1515/bchm2.1983.364.2.1475; Cuesta-Astroz Y, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00206; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Foth BJ, 2014, NAT GENET, V46, P693, DOI 10.1038/ng.3010; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Hartmann S, 2002, PARASITE IMMUNOL, V24, P253, DOI 10.1046/j.1365-3024.2002.00459.x; Khaznadji E, 2005, INT J PARASITOL, V35, P1115, DOI 10.1016/j.ijpara.2005.05.001; Knox DP, 2007, PARASITE IMMUNOL, V29, P57, DOI 10.1111/j.1365-3024.2006.00913.x; Kordis D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-266; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li AH, 2006, VET PARASITOL, V141, P251, DOI 10.1016/j.vetpar.2006.05.015; LINDAHL P, 1988, BIOCHEMISTRY-US, V27, P5074, DOI 10.1021/bi00414a019; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; MACHLEIDT W, 1989, FEBS LETT, V243, P234, DOI 10.1016/0014-5793(89)80135-8; MACHLEIDT W, 1983, H-S Z PHYSIOL CHEM, V364, P1481, DOI 10.1515/bchm2.1983.364.2.1481; Magister S, 2013, J CANCER, V4, P45, DOI 10.7150/jca.5044; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Martinez M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-198; Molinari JL, 2000, EXP PARASITOL, V94, P133, DOI 10.1006/expr.2000.4490; MULLERESTERL W, 1985, FEBS LETT, V191, P221, DOI 10.1016/0014-5793(85)80012-0; Nagata K, 2000, BIOCHEMISTRY-US, V39, P14753, DOI 10.1021/bi0006971; NYCANDER M, 1990, BIOCHEM J, V271, P281, DOI 10.1042/bj2710281; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rawlings ND, 2004, BIOCHEM J, V378, P705, DOI 10.1042/BJ20031825; RAWLINGS ND, 1990, J MOL EVOL, V30, P60, DOI 10.1007/BF02102453; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rigden DJ, 2002, PROTEIN SCI, V11, P1971, DOI 10.1110/ps.0207202; SALVESEN G, 1986, BIOCHEM J, V234, P429, DOI 10.1042/bj2340429; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siricoon S, 2012, MOL BIOCHEM PARASIT, V186, P126, DOI 10.1016/j.molbiopara.2012.10.003; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; Tarasuk M, 2009, MOL BIOCHEM PARASIT, V167, P60, DOI 10.1016/j.molbiopara.2009.04.010; Trap C, 2000, VET RES, V31, P461, DOI 10.1051/vetres:2000132; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Turk B, 2002, CURR PHARM DESIGN, V8, P1623, DOI 10.2174/1381612023394124; Turk B, 1997, BIOL CHEM, V378, P141; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Vasiljeva O, 2008, BIOCHIMIE, V90, P380, DOI 10.1016/j.biochi.2007.10.004; Wang S, 2014, FEBS J, V281, P877, DOI 10.1111/febs.12655	51	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124683	10.1371/journal.pone.0124683	http://dx.doi.org/10.1371/journal.pone.0124683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853513	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400141
J	Migliori, M; Cantaluppi, V; Mannari, C; Bertelli, AAE; Medica, D; Quercia, AD; Navarro, V; Scatena, A; Giovannini, L; Biancone, L; Panichi, V				Migliori, Massimiliano; Cantaluppi, Vincenzo; Mannari, Claudio; Bertelli, Alberto A. E.; Medica, Davide; Quercia, Alessandro Domenico; Navarro, Victor; Scatena, Alessia; Giovannini, Luca; Biancone, Luigi; Panichi, Vincenzo			Caffeic Acid, a Phenol Found in White Wine, Modulates Endothelial Nitric Oxide Production and Protects from Oxidative Stress-Associated Endothelial Cell Injury	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ISCHEMIA-REPERFUSION INJURY; RED WINE; OLIVE OIL; MEDITERRANEAN DIET; FRENCH PARADOX; BLOOD-FLOW; ATHEROSCLEROSIS; DYSFUNCTION; SURVIVAL	Introduction Several studies demonstrated that endothelium dependent vasodilatation is impaired in cardiovascular and chronic kidney diseases because of oxidant stress-induced nitric oxide availability reduction. The Mediterranean diet, which is characterized by food containing phenols, was correlated with a reduced incidence of cardiovascular diseases and delayed progression toward end stage chronic renal failure. Previous studies demonstrated that both red and white wine exert cardioprotective effects. In particular, wine contains Caffeic acid (CAF), an active component with known antioxidant activities. Aim of the study The aim of the present study was to investigate the protective effect of low doses of CAF on oxidative stress-induced endothelial injury. Results CAF increased basal as well as acetylcholine-induced NO release by a mechanism independent from eNOS expression and phosphorylation. In addition, low doses of CAF (100 nM and 1 mu M) increased proliferation and angiogenesis and inhibited leukocyte adhesion and endothelial cell apoptosis induced by hypoxia or by the uremic toxins ADMA, pcresyl sulfate and indoxyl sulfate. The biological effects exerted by CAF on endothelial cells may be at least in part ascribed to modulation of NO release and by decreased ROS production. In an experimental model of kidney ischemia-reperfusion injury in mice, CAF significantly decreased tubular cell apoptosis, intraluminal cast deposition and leukocyte infiltration. Conclusion The results of the present study suggest that CAF, at very low dosages similar to those observed after moderate white wine consumption, may exert a protective effect on endothelial cell function by modulating NO release independently from eNOS expression and phosphorylation. CAF-induced NO modulation may limit cardiovascular and kidney disease progression associated with oxidative stress-mediated endothelial injury.	[Migliori, Massimiliano; Scatena, Alessia; Panichi, Vincenzo] Versilia Hosp, Nephrol & Dialysis Unit, Lido Di Camaiore, Italy; [Cantaluppi, Vincenzo; Medica, Davide; Quercia, Alessandro Domenico; Navarro, Victor; Biancone, Luigi] Univ Turin, Dept Med Sci, Nephrol Dialysis & Kidney Transplantat Unit, Turin, Italy; [Mannari, Claudio; Giovannini, Luca] Univ Pisa, Dept Translat Res & New Technol Med, Pisa, Italy; [Bertelli, Alberto A. E.] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Ospedale Versilia; University of Turin; University of Pisa; University of Milan	Migliori, M (corresponding author), Versilia Hosp, Nephrol & Dialysis Unit, Lido Di Camaiore, Italy.	m.migliori@usl12.toscana.it	Migliori, Massimiliano/GRF-4854-2022; Cantaluppi, Vincenzo/K-8531-2016; Medica, Davide/AAM-7691-2021	Migliori, Massimiliano/0000-0001-8050-2120; Cantaluppi, Vincenzo/0000-0002-4120-3555; Medica, Davide/0000-0002-6171-8919; BIANCONE, Luigi/0000-0002-7700-6350; Navarro Tableros, Victor Manuel/0000-0001-7629-1199; panichi, vincenzo/0000-0002-5003-3172	Fondazione Cassa di Risparmio di Lucca	Fondazione Cassa di Risparmio di Lucca	This work was supported by a grant of Fondazione Cassa di Risparmio di Lucca (www.fondazionecarilucca.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu U, 2011, CONTRIB NEPHROL, V174, P119, DOI 10.1159/000329249; Altug ME, 2008, BRAIN RES, V1201, P135, DOI 10.1016/j.brainres.2008.01.053; Anselm E, 2007, CARDIOVASC RES, V73, P404, DOI 10.1016/j.cardiores.2006.08.004; Antoniades C, 2011, HYPERTENSION, V58, P93, DOI 10.1161/HYPERTENSIONAHA.110.168245; Barbacanne MA, 2000, FREE RADICAL BIO MED, V29, P388, DOI 10.1016/S0891-5849(00)00336-1; Bertelli A, 2002, DRUG EXP CLIN RES, V28, P11; Bertelli AAE, 2002, ANN NY ACAD SCI, V957, P295, DOI 10.1111/j.1749-6632.2002.tb02929.x; Bertelli AAE, 2007, ATHEROSCLEROSIS, V195, P242, DOI 10.1016/j.atherosclerosis.2007.04.006; Bolati D, 2011, AM J NEPHROL, V34, P318, DOI 10.1159/000330852; Boto-Ordonez M, 2013, J AGR FOOD CHEM, V61, P9166, DOI 10.1021/jf402394c; Brunet P, 2011, KIDNEY BLOOD PRESS R, V34, P284, DOI 10.1159/000327131; Bussolati B, 2002, KIDNEY INT, V62, P1322; Buttiglieri S, 2003, BIOMATERIALS, V24, P2731, DOI 10.1016/S0142-9612(03)00088-7; Cantaluppi V, 2001, AIDS RES HUM RETROV, V17, P965, DOI 10.1089/088922201750290087; Cantaluppi V, 2012, CELL TRANSPLANT, V21, P1305, DOI 10.3727/096368911X627534; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Carrero JJ, 2012, CLIN J AM SOC NEPHRO, V7, P207, DOI 10.2215/CJN.06840711; Cicala C, 2003, LIFE SCI, V73, P73, DOI 10.1016/S0024-3205(03)00235-2; Cui JH, 2002, ANN NY ACAD SCI, V957, P308, DOI 10.1111/j.1749-6632.2002.tb02931.x; Diebolt M, 2001, HYPERTENSION, V38, P159, DOI 10.1161/01.HYP.38.2.159; Dudley JI, 2008, J AGR FOOD CHEM, V56, P9362, DOI 10.1021/jf801791d; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Fito M, 2007, MOL NUTR FOOD RES, V51, P1215, DOI 10.1002/mnfr.200600308; Fliser D, 2010, J NEPHROL, V23, P369; FREIMAN PC, 1986, CIRC RES, V58, P783, DOI 10.1161/01.RES.58.6.783; Furchgott RF, 1996, JAMA-J AM MED ASSOC, V276, P1186, DOI 10.1001/jama.276.14.1186; Ghosh D, 2009, MOL NUTR FOOD RES, V53, P322, DOI 10.1002/mnfr.200800182; GOLINO P, 1991, NEW ENGL J MED, V324, P641, DOI 10.1056/NEJM199103073241001; Huang XY, 2013, CLIN J AM SOC NEPHRO, V8, P1548, DOI 10.2215/CJN.01780213; Ito S, 2010, J BIOL CHEM, V285, P38869, DOI 10.1074/jbc.M110.166686; Jourde-Chiche N, 2011, SEMIN DIALYSIS, V24, P327, DOI 10.1111/j.1525-139X.2011.00925.x; Khan AQ, 2012, FOOD CHEM TOXICOL, V50, P175, DOI 10.1016/j.fct.2011.10.043; Kok FJ, 2004, EUR J NUTR, V43, P2, DOI 10.1007/s00394-004-1102-x; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Leone AM, 1996, BIOCHEM BIOPH RES CO, V221, P37, DOI 10.1006/bbrc.1996.0557; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Malyszko J, 2010, CLIN CHIM ACTA, V411, P1412, DOI 10.1016/j.cca.2010.06.019; Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Moon MK, 2009, BIOL PHARM BULL, V32, P1371, DOI 10.1248/bpb.32.1371; Niwa T, 2010, NAGOYA J MED SCI, V72, P1; Prasad NR, 2009, J PHOTOCH PHOTOBIO B, V95, P196, DOI 10.1016/j.jphotobiol.2009.03.007; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rietjens SJ, 2007, AM J PHYSIOL-HEART C, V292, pH1931, DOI 10.1152/ajpheart.00755.2006; Samuel SM, 2008, J AGR FOOD CHEM, V56, P9692, DOI 10.1021/jf802050h; Schepers E, 2010, BLOOD PURIFICAT, V30, P277, DOI 10.1159/000320765; Shoji K, 2014, CURR OPIN NEPHROL HY, V23, P161, DOI 10.1097/01.mnh.0000441049.98664.6c; Simonetti P, 2001, METHOD ENZYMOL, V335, P122; Simonetti P, 2001, J AGR FOOD CHEM, V49, P5964, DOI 10.1021/jf010546k; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Thirunavukkarasu M, 2008, J AGR FOOD CHEM, V56, P6733, DOI 10.1021/jf801473v; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; van de Wiel A, 2001, Eur J Intern Med, V12, P484, DOI 10.1016/S0953-6205(01)00170-4; Visioli F, 2005, EUR J NUTR, V44, P121, DOI 10.1007/s00394-004-0504-0; Vissers MN, 2004, EUR J CLIN NUTR, V58, P955, DOI 10.1038/sj.ejcn.1601917; Wallerath T, 2005, NITRIC OXIDE-BIOL CH, V12, P97, DOI 10.1016/j.niox.2004.12.004; Wiklund NP, 1999, ACTA PHYSIOL SCAND, V167, P161; Wollin SD, 2001, J NUTR, V131, P1401, DOI 10.1093/jn/131.5.1401; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634; Zhang JL, 2006, MOL NUTR FOOD RES, V50, P996, DOI 10.1002/mnfr.200600072	61	37	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0117530	10.1371/journal.pone.0117530	http://dx.doi.org/10.1371/journal.pone.0117530			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853700	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400001
J	Tung, YC; Chang, CH; Chen, YC; Chu, PH				Tung, Ying-Chang; Chang, Chih-Hsiang; Chen, Yung-Chang; Chu, Pao-Hsien			Combined Biomarker Analysis for Risk of Acute Kidney Injury in Patients with ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							RECEPTOR FAMILY-MEMBER; GELATINASE-ASSOCIATED LIPOCALIN; NATRIURETIC PEPTIDE LEVELS; WORSENING RENAL-FUNCTION; ACUTE CORONARY SYNDROMES; SERUM-SOLUBLE ST2; HEART-FAILURE; CARDIORENAL SYNDROME; CARDIAC-SURGERY; CYSTATIN-C	Background Acute kidney injury (AKI) complicating ST-segment elevation myocardial infarction (STEMI) increases subsequent morbidity and mortality. We combined the biomarkers of heart failure (HF; B-type natriuretic peptide [BNP] and soluble ST2 [sST2]) and renal injury (NGAL [neutrophil gelatinase-associated lipocalin] and cystatin C) in predicting the development of AKI in patients with STEMI undergoing primary percutaneous coronary intervention (PCI). Methods and Results From March 2010 to September 2013, 189 STEMI patients were sequentially enrolled and serum samples were collected at presentation for BNP, sST2, NGAL and cystatin C analysis. 37 patients (19.6%) developed AKI of varying severity within 48 hours of presentation. Univariate analysis showed age, Killip class >= 2, hypertension, white blood cell counts, hemoglobin, estimated glomerular filtration rate, blood urea nitrogen, creatinine, and all the four biomarkers were predictive of AKI. Serum levels of the biomarkers were correlated with risk of AKI and the Acute Kidney Injury Network (AKIN) stage and all significantly discriminated AKI (area under the receiver operating characteristic [ROC] curve: BNP: 0.86, sST2: 0.74, NGAL: 0.75, cystatin C: 0.73; all P < 0.05). Elevation of >= 2 of the biomarkers higher than the cutoff values derived from the ROC analysis improved AKI risk stratification, regardless of the creatine level (creatinine < 1.24 mg/dL: odds ratio [OR] 11.25, 95% confidence interval [CI] 1.63-77.92, P = 0.014; creatinine >= 1.24: OR 15.0, 95% CI 1.23-183.6, P = 0.034). Conclusions In this study of STEMI patients undergoing primary PCI, the biomarkers of heart failure (BNP and sST2) and renal injury (NGAL and cystatin C) at presentation were predictive of AKI. High serum levels of the biomarkers were associated with an elevated risk and more advanced stage of AKI. Regardless of the creatinine level, elevation of >= 2 of the biomarkers higher than the cutoff values indicated a further rise in AKI risk. Combined biomarker approach may assist in risk stratification of AKI in patients with STEMI.	[Tung, Ying-Chang; Chu, Pao-Hsien] Chang Gung Mem Hosp, Dept Cardiol, Taipei 10591, Taiwan; [Chang, Chih-Hsiang; Chen, Yung-Chang; Chu, Pao-Hsien] Chang Gung Mem Hosp, Div Nephrol, Taipei 10591, Taiwan; [Chu, Pao-Hsien] Chang Gung Mem Hosp, Healthcare Ctr, Taipei 10591, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chu, PH (corresponding author), Chang Gung Mem Hosp, Dept Cardiol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	pchu@adm.cgmh.org.tw	Chu, Pao-Hsien/G-3685-2010; Chu, Pao-Hsien/P-5249-2019; Chang, Jason Chih-Hsiang/P-8662-2017	Chu, Pao-Hsien/0000-0003-0361-6348; Chang, Jason Chih-Hsiang/0000-0002-7342-335X	Chang Gung Memorial Hospital, Taiwan [CMRPG391091, CMRPG1B0581, CMRPG 3B0821]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by research grants from Chang Gung Memorial Hospital, Taiwan (CMRPG391091, CMRPG1B0581, and CMRPG 3B0821). The authors declare that no author has any conflicts of financial or non-financial competing interests to disclose.	Aghel A, 2010, J CARD FAIL, V16, P49, DOI 10.1016/j.cardfail.2009.07.003; Akgul O, 2014, HERZ, V39, P507, DOI 10.1007/s00059-013-3853-8; Amin AP, 2010, AM HEART J, V160, P1065, DOI 10.1016/j.ahj.2010.08.007; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Austin WJ, 2006, AM J CLIN PATHOL, V126, P506, DOI 10.1309/M7AAXA0J1THMNCDF; Aviles RJ, 2002, NEW ENGL J MED, V346, P2047, DOI 10.1056/NEJMoa013456; Bayes-Genis A, 2013, J CARD FAIL, V19, P768, DOI 10.1016/j.cardfail.2013.09.005; Broch K, 2012, EUR J HEART FAIL, V14, P268, DOI 10.1093/eurjhf/hfs006; Bruetto RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035496; Chen TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032328; Coglianese EE, 2012, CLIN CHEM, V58, P1673, DOI 10.1373/clinchem.2012.192153; Damman K, 2009, J AM COLL CARDIOL, V53, P582, DOI 10.1016/j.jacc.2008.08.080; De Berardinis B, 2015, CLIN CHEM LAB MED, V53, P613, DOI 10.1515/cclm-2014-0191; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; Dhillon OS, 2011, AM HEART J, V161, P1163, DOI 10.1016/j.ahj.2011.03.025; Eggers KM, 2010, AM HEART J, V159, P788, DOI 10.1016/j.ahj.2010.02.022; Fouad Mohamed, 2013, Arab J Nephrol Transplant, V6, P21; Fox CS, 2012, CIRCULATION, V125, P497, DOI 10.1161/CIRCULATIONAHA.111.039909; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; Gnanaraj JF, 2013, KIDNEY INT, V83, P384, DOI 10.1038/ki.2012.406; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Guerchicoff A, 2015, CATHETER CARDIO INTE, V85, P335, DOI 10.1002/ccd.25620; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Hata N, 2010, EUR J HEART FAIL, V12, P32, DOI 10.1093/eurjhf/hfp169; Hsiao PG, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.05.003; Ismail Y, 2012, SEMIN NEPHROL, V32, P18, DOI 10.1016/j.semnephrol.2011.11.003; Januzzi JL, 2007, J AM COLL CARDIOL, V50, P607, DOI 10.1016/j.jacc.2007.05.014; Januzzi JL, 2013, J CARDIOVASC TRANSL, V6, P493, DOI 10.1007/s12265-013-9459-y; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P2174, DOI 10.1001/jama.290.16.2174; Kiessling AH, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-10; Ko B, 2012, EUR HEART J, V33, P2065, DOI 10.1093/eurheartj/ehr493; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Ky B, 2011, CIRC-HEART FAIL, V4, P180, DOI 10.1161/CIRCHEARTFAILURE.110.958223; LABOVITZ AJ, 1987, J AM COLL CARDIOL, V10, P748, DOI 10.1016/S0735-1097(87)80266-8; Lassus JPE, 2010, EUR HEART J, V31, P2791, DOI 10.1093/eurheartj/ehq293; Latchamsetty R, 2007, AM J CARDIOL, V99, P939, DOI 10.1016/j.amjcard.2006.10.058; Leblanc M, 2005, CURR OPIN CRIT CARE, V11, P533, DOI 10.1097/01.ccx.0000183666.54717.3d; Legrand M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112313; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lindberg S, 2012, J AM COLL CARDIOL, V60, P339, DOI 10.1016/j.jacc.2012.04.017; LJUNGMAN S, 1990, DRUGS, V39, P10, DOI 10.2165/00003495-199000394-00004; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Marenzi G, 2010, CRIT CARE MED, V38, P438, DOI 10.1097/CCM.0b013e3181b9eb3b; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; McCullough PA, 2013, CONTRIB NEPHROL, V182, P82, DOI [10.1159/000349966, 10.1159/000361059]; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Mueller T, 2008, CLIN CHEM, V54, P752, DOI 10.1373/clinchem.2007.096560; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Nigwekar SU, 2009, AM J KIDNEY DIS, V54, P413, DOI 10.1053/j.ajkd.2009.01.267; Palazzuoli A, 2014, HEART FAIL REV, V19, P267, DOI 10.1007/s10741-013-9391-x; Palomba H, 2007, KIDNEY INT, V72, P624, DOI 10.1038/sj.ki.5002419; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Pfister R, 2008, EUR J HEART FAIL, V10, P315, DOI 10.1016/j.ejheart.2008.01.009; Poniatowski B, 2009, KIDNEY BLOOD PRESS R, V32, P77, DOI 10.1159/000208989; Prabhu A, 2010, ANN VASC SURG, V24, P525, DOI 10.1016/j.avsg.2010.01.001; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; Ronco C, 2010, CONTRIB NEPHROL, V165, P54, DOI 10.1159/000313745; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022; Sabatine MS, 2004, J AM COLL CARDIOL, V44, P1988, DOI 10.1016/j.jacc.2004.07.057; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Shah RV, 2009, CIRC-HEART FAIL, V2, P311, DOI 10.1161/CIRCHEARTFAILURE.108.833707; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Silva D, 2012, AM J CARDIOL, V109, P1431, DOI 10.1016/j.amjcard.2012.01.356; Tang WHW, 2010, HEART, V96, P255, DOI 10.1136/hrt.2009.166256; Tsai HS, 2014, ACTA CARDIOL SIN, V30, P93; Tung YC, 2014, ACTA CARDIOL SIN, V30, P501; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Wald R, 2010, CLIN J AM SOC NEPHRO, V5, P1373, DOI 10.2215/CJN.06350909; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Weir RAP, 2010, J AM COLL CARDIOL, V55, P243, DOI 10.1016/j.jacc.2009.08.047; Winton FR, 1931, J PHYSIOL-LONDON, V72, P49, DOI 10.1113/jphysiol.1931.sp002761; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zhu JQ, 2006, CLIN CHIM ACTA, V374, P116, DOI 10.1016/j.cca.2006.06.001	84	25	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0125282	10.1371/journal.pone.0125282	http://dx.doi.org/10.1371/journal.pone.0125282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853556	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400151
J	Conti, HR; Whibley, N; Coleman, BM; Garg, AV; Jaycox, JR; Gaffen, SL				Conti, Heather R.; Whibley, Natasha; Coleman, Bianca M.; Garg, Abhishek V.; Jaycox, Jillian R.; Gaffen, Sarah L.			Signaling through IL-17C/IL-17RE Is Dispensable for Immunity to Systemic, Oral and Cutaneous Candidiasis	PLOS ONE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; INNATE LYMPHOID-CELLS; HOST-DEFENSE; CUTTING EDGE; TH17 CELLS; IL-17 PATHWAY; T-CELLS; INTERLEUKIN-17; RECEPTOR; RESPONSES	Candida albicans is a commensal fungal microbe of the human orogastrointestinal tract and skin. C. albicans causes multiple forms of disease in immunocompromised patients, including oral, vaginal, dermal and disseminated candidiasis. The cytokine IL-17 ( IL-17A) and its receptor subunits, IL-17RA and IL-17RC, are required for protection to most forms of candidiasis. The importance of the IL-17R pathway has been observed not only in knockout mouse models, but also in humans with rare genetic mutations that impact generation of Th17 cells or the IL-17 signaling pathway, including Hyper-IgE Syndrome (STAT3 or TYK2 mutations) or IL17RA or ACT1 gene deficiency. The IL-17 family of cytokines is a distinct subclass of cytokines with unique structural and signaling properties. IL-17A is the bestcharacterized member of the IL-17 family to date, but far less is known about other IL-17related cytokines. In this study, we sought to determine the role of a related IL-17 cytokine, IL-17C, in protection against oral, dermal and disseminated forms of C. albicans infection. IL-17C signals through a heterodimeric receptor composed of the IL-17RA and IL-17RE subunits. We observed that IL-17C mRNA was induced following oral C. albicans infection. However, mice lacking IL-17C or IL-17RE cleared C. albicans infections in the oral mucosa, skin and bloodstream at rates similar to WT littermate controls. Moreover, these mice demonstrated similar gene transcription profiles and recovery kinetics as WT animals. These findings indicate that IL-17C and IL-17RE are dispensable for immunity to the forms of candidiasis evaluated, and illustrate a surprisingly limited specificity of the IL-17 family of cytokines with respect to systemic, oral and cutaneous Candida infections.	[Conti, Heather R.; Whibley, Natasha; Coleman, Bianca M.; Garg, Abhishek V.; Gaffen, Sarah L.] Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA; [Jaycox, Jillian R.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Gaffen, SL (corresponding author), Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA.	sarah.gaffen@pitt.edu			National Institutes of Health [R01-AI107825, R01-DE022550, R01-DE023815];  [F32-E023293]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F32DE023293, R01DE023815, R01DE022550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	SLG was supported the by the National Institutes of Health (R01-AI107825, R01-DE022550, R01-DE023815). HRC was supported by F32-E023293. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bar E, 2012, J IMMUNOL, V188, P5636, DOI 10.4049/jimmunol.1200594; Bishu S, 2014, INFECT IMMUN, V82, P1173, DOI 10.1128/IAI.01335-13; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Conti HR, 2014, CURRENT PROTOCOLS IM, V105, P61; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Ferreira MC, 2014, INFECT IMMUN, V82, P1030, DOI 10.1128/IAI.01389-13; Fidel P L Jr, 2011, Adv Dent Res, V23, P45, DOI 10.1177/0022034511399284; Friedrich M, 2014, INFLAMM BOWEL DIS, V20, P1891, DOI 10.1097/MIB.0000000000000198; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Glocker E, 2010, CURR OPIN ALLERGY CL, V10, P542, DOI 10.1097/ACI.0b013e32833fd74f; Golden JB, 2013, CYTOKINE, V62, P195, DOI 10.1016/j.cyto.2013.03.013; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Huppler AR, 2014, J IMMUNOL, V192, P1745, DOI 10.4049/jimmunol.1302265; Huppler AR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3893; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Kamai Y, 2001, ANTIMICROB AGENTS CH, V45, P3195, DOI 10.1128/AAC.45.11.3195-3197.2001; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; Milner JD, 2013, NAT REV IMMUNOL, V13, P635, DOI 10.1038/nri3493; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Pietrella D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022770; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Reynolds JM, 2012, J IMMUNOL, V189, P4226, DOI 10.4049/jimmunol.1103014; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; van de Veerdonk FL, 2010, SHOCK, V34, P407, DOI 10.1097/SHK.0b013e3181d67041; Whibley N, 2014, EUR J IMMUNOL, V44, P1069, DOI 10.1002/eji.201343604; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yano J, 2012, CYTOKINE, V58, P118, DOI 10.1016/j.cyto.2011.11.021; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	59	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122807	10.1371/journal.pone.0122807	http://dx.doi.org/10.1371/journal.pone.0122807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849644	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000352477800162
J	Rozanov, D; Spellman, P; Savinov, A; Strongin, AY				Rozanov, Dmitri; Spellman, Paul; Savinov, Alexei; Strongin, Alex Y.			A Humanized Leucine Zipper-TRAIL Hybrid Induces Apoptosis of Tumors both In Vitro and In Vivo	PLOS ONE			English	Article							CELL-DEATH; CANCER-CELLS; TNF-FAMILY; LIGAND; INDUCTION; MEMBER; IDENTIFICATION; RECEPTORS; MOLECULES; PATHWAY	Evidence suggests that stimulating apoptosis in malignant cells without inflicting collateral damage to the host's normal tissues is a promising cancer therapy. Chemo-and radiation therapies that, especially if combined, induce apoptosis in tumor cells have been used for treating cancer patients for decades. These treatments, however, are limited in their ability to discriminate between malignant and non-malignant cells and, therefore, produce substantial healthy tissue damage and subsequent toxic side-effects. In addition, as a result of these therapies, many tumor types acquire an apoptosis-resistant phenotype and become more aggressive and metastatic. Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) has been considered a promising and reliable selective inducer of apoptosis in cancerous cells. TRAIL, however, is not uniformly effective in cancer and multiple cancer cell types are considered resistant to natural TRAIL. To overcome this deficiency of TRAIL, we have earlier constructed a yeast-human hybrid leucine zipper-TRAIL in which the yeast GCN4-pII leucine zipper was fused to human TRAIL (GCN4-TRAIL). This construct exhibited a significantly improved anti-tumor apoptotic activity and safety, but is potentially immunogenic in humans. Here, we report a novel, potent, and fully human ATF7 leucine zipperTRAIL (ATF7-TRAIL) fusion construct that is expected to have substantially lower immunogenicity. In solution, ATF7-TRAIL exists solely as a trimer with a Tm of 80 degrees C and is active against cancer cells both in vitro and in vivo, in a mouse tumor xenograft model. Our data suggest that our re-engineered TRAIL is a promising candidate for further evaluation as an antitumor agent.	[Rozanov, Dmitri; Spellman, Paul] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Savinov, Alexei] Sanford Res, Sioux Falls, SD USA; [Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Oregon Health & Science University; Sanford Health; Sanford Burnham Prebys Medical Discovery Institute	Rozanov, D (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.	rozanov@ohsu.edu	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	Department of Defense [W81XWH-09-1-0601]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Department of Defense, Concept award W81XWH-09-1-0601, http://www.usamraa.army.mil/DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroui S, 2009, APOPTOSIS, V14, P1352, DOI 10.1007/s10495-009-0397-8; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Badran A, 2010, INT J ONCOL, V36, P1229, DOI 10.3892/ijo_00000606; Bodmer JL, 2000, J BIOL CHEM, V275, P20632, DOI 10.1074/jbc.M909721199; CHATTON B, 1994, ONCOGENE, V9, P375; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; De Graeve F, 1999, ONCOGENE, V18, P3491, DOI 10.1038/sj.onc.1202723; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Hamard PJ, 2005, ONCOGENE, V24, P3472, DOI 10.1038/sj.onc.1208565; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hartung F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-109; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kandasamy K, 2003, CANCER RES, V63, P1712; Kelley SK, 2001, J PHARMACOL EXP THER, V299, P31; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111; Park C, 2008, ACTA PHARMACOL SIN, V29, P341, DOI 10.1111/j.1745-7254.2008.00761.x; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Prasad S, 2011, J BIOL CHEM, V286, P5546, DOI 10.1074/jbc.M110.183699; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Rozanov DV, 2009, MOL CANCER THER, V8, P1515, DOI 10.1158/1535-7163.MCT-09-0202; Schimmer AD, 2006, CANCER RES, V66, P2367, DOI 10.1158/0008-5472.CAN-05-1061; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Song JH, 2003, BRAIN PATHOL, V13, P539; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang S, 2008, ONCOGENE, V27, P6207, DOI 10.1038/onc.2008.298; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122980	10.1371/journal.pone.0122980	http://dx.doi.org/10.1371/journal.pone.0122980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849628	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800187
J	Dragas, M; Koncar, I; Opacic, D; Ilic, N; Maksimovic, Z; Markovic, M; Ercegovac, M; Simic, T; Pljesa-Ercegovac, M; Davidovic, L				Dragas, Marko; Koncar, Igor; Opacic, Dragan; Ilic, Nikola; Maksimovic, Zivan; Markovic, Miroslav; Ercegovac, Marko; Simic, Tatjana; Pljesa-Ercegovac, Marija; Davidovic, Lazar			Fluctuations of Serum Neuron Specific Enolase and Protein S-100B Concentrations in Relation to the Use of Shunt during Carotid Endarterectomy	PLOS ONE			English	Article							S-100-BETA PROTEIN; ISCHEMIC-STROKE; CARDIAC-ARREST; BRAIN-INJURY; ANESTHESIA; DAMAGE; EXPERIENCE; INFARCTION; RELEASE; SURGERY	Objective To evaluate the changes in serum neuron specific enolase and protein S-100B, after carotid endarterectomy performed using the conventional technique with routine shunting and patch closure, or eversion technique without the use of shunt. Materials and Methods Prospective non-randomized study included 43 patients with severe (> 80%) carotid stenosis undergoing carotid endarterectomy in regional anesthesia. Patients were divided into two groups: conventional endarterectomy with routine use of shunt and Dacron patch (csCEA group) and eversion endarterectomy without the use of shunt (eCEA group). Protein S-100B and NSE concentrations were measured from peripheral blood before carotid clamping, after declamping and 24 hours after surgery. Results Neurologic examination and brain CT findings on the first postoperative day did not differ from preoperative controls in any patients. In csCEA group, NSE concentrations decreased after declamping (P<0.01), and 24 hours after surgery (P<0.01), while in the eCEA group NSE values slightly increased (P=ns), accounting for a significant difference between groups on the first postoperative day (P=0.006). In both groups S-100B concentrations significantly increased after declamping (P<0.05), returning to near pre-clamp values 24 hours after surgery (P=ns). Sub-group analysis revealed significant decline of serum NSE concentrations in asymptomatic patients shunted during surgery after declamping (P<0.05) and 24 hours after surgery (P<0.01), while no significant changes were noted in non-shunted patients (P=ns). Decrease of NSE serum levels was also found in symptomatic patients operated with the use of shunt on the first postoperative day (P<0.05). Significant increase in NSE serum levels was recorded in non-shunted symptomatic patients 24 hours after surgery (P<0.05). Conclusion Variations of NSE concentrations seemed to be influenced by cerebral perfusion alterations, while protein S-100B values were unaffected by shunting strategy. Routine shunting during surgery for symptomatic carotid stenosis may have the potential to prevent postoperative increase of serum NSE levels, a potential marker of brain injury.	[Dragas, Marko; Koncar, Igor; Ilic, Nikola; Maksimovic, Zivan; Markovic, Miroslav; Davidovic, Lazar] Clin Ctr Serbia, Clin Vasc & Endovasc Surg, Belgrade, Serbia; [Dragas, Marko; Koncar, Igor; Ilic, Nikola; Maksimovic, Zivan; Markovic, Miroslav; Ercegovac, Marko; Simic, Tatjana; Pljesa-Ercegovac, Marija; Davidovic, Lazar] Univ Belgrade, Fac Med, Belgrade, Serbia; [Opacic, Dragan] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Physiol, NL-6200 MD Maastricht, Netherlands; [Ercegovac, Marko] Clin Ctr Serbia, Neurol Clin, Belgrade, Serbia; [Simic, Tatjana; Pljesa-Ercegovac, Marija] Univ Belgrade, Fac Med, Inst Med & Clin Biochem, Belgrade, Serbia	Clinical Centre of Serbia; University of Belgrade; Maastricht University; Clinical Centre of Serbia; University of Belgrade	Dragas, M (corresponding author), Clin Ctr Serbia, Clin Vasc & Endovasc Surg, Belgrade, Serbia.	markobmf@gmail.com	Pljesa-Ercegovac, Marija/AFS-8309-2022	Simic, Tatjana/0000-0001-8683-5129; Davidovic, Lazar/0000-0002-0529-2378; Markovic, Miroslav/0000-0003-3810-000X; Opacic, Dragan/0000-0002-0125-7938	Ministry of Education and Science of the Republic of Serbia [OI175008]	Ministry of Education and Science of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	Presented study is a part of a scientific research project (Grant OI175008) supported by the Ministry of Education and Science of the Republic of Serbia, MD NI ZM MM LD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuRahma AF, 2013, J VASC SURG, V58, P666, DOI 10.1016/j.jvs.2013.02.016; AbuRahma AF, 2011, J VASC SURG, V54, P1502, DOI 10.1016/j.jvs.2011.06.020; AbuRahma AF, 2009, J VASC SURG, V50, P921, DOI 10.1016/j.jvs.2009.04.071; Aleksic M, 2007, ANN VASC SURG, V21, P571, DOI 10.1016/j.avsg.2007.04.002; Bellosta R, 2006, ANN VASC SURG, V20, P482, DOI 10.1007/s10016-006-9037-8; Brightwell RE, 2007, EUR J VASC ENDOVASC, V34, P552, DOI 10.1016/j.ejvs.2007.06.016; Capoccia L, 2010, J VASC SURG, V51, P584, DOI 10.1016/j.jvs.2009.10.079; Connolly ES, 2001, NEUROSURGERY, V49, P1076, DOI 10.1097/00006123-200111000-00010; Cooper E. H., 1994, International Journal of Biological Markers, V9, P205; Falkensammer J, 2008, ANN VASC SURG, V22, P497, DOI 10.1016/j.avsg.2008.01.013; Godet G, 2001, J CARDIOTHOR VASC AN, V15, P25, DOI 10.1053/jcan.2001.20213; Goncalves CA, 2008, CLIN BIOCHEM, V41, P755, DOI 10.1016/j.clinbiochem.2008.04.003; Hertzer NR, 1997, J VASC SURG, V26, P1, DOI 10.1016/S0741-5214(97)70139-3; Kalimeris K, 2013, J CARDIOTHOR VASC AN, V27, P1246, DOI 10.1053/j.jvca.2012.12.009; Kilminster S, 1999, STROKE, V30, P1869, DOI 10.1161/01.STR.30.9.1869; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030; Palombo D, 2007, EUR J VASC ENDOVASC, V34, P546, DOI 10.1016/j.ejvs.2007.05.028; Radak D, 2012, ANN VASC SURG, V26, P924, DOI 10.1016/j.avsg.2011.09.011; Rasmussen LS, 2000, J CARDIOTHOR VASC AN, V14, P166, DOI 10.1016/S1053-0770(00)90012-0; Rerkasem K, 2009, COCHRANE DB SYST REV, V7, DOI [10.1002/14651858. CD000190. pub2, DOI 10.1002/14651858.CD000190.PUB2.PMID:19821268]; Rundgren M, 2009, RESUSCITATION, V80, P784, DOI 10.1016/j.resuscitation.2009.03.025; Sahlein DH, 2003, NEUROSURGERY, V53, P1243, DOI 10.1227/01.NEU.0000093493.16850.11; Samson RH, 1998, CARDIOVASC SURG, V6, P475, DOI 10.1016/S0967-2109(98)00018-0; Sandroni C, 2014, RESUSCITATION, V85, P1779, DOI 10.1016/j.resuscitation.2014.08.011; Selakovic V, 2005, J CLIN NEUROSCI, V12, P542, DOI 10.1016/j.jocn.2004.07.019; Singh HV, 2013, CLIN CHIM ACTA, V419, P136, DOI 10.1016/j.cca.2013.02.014; Wijeyaratne SM, 2009, EUR J VASC ENDOVASC, V38, P262, DOI 10.1016/j.ejvs.2009.05.011; Yadav JS, 2003, J AM COLL CARDIOL, V42, P1014, DOI 10.1016/S0735-1097(03)00900-8; Yoshida K, 2014, WORLD NEUROSURG, V82, pE229, DOI 10.1016/j.wneu.2013.06.018	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124067	10.1371/journal.pone.0124067	http://dx.doi.org/10.1371/journal.pone.0124067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859683	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300130
J	Du, YF; Seibenhener, ML; Yan, J; Jiang, J; Wooten, MC				Du, Yifeng; Seibenhener, Michael L.; Yan, Jin; Jiang, Jianxiong; Wooten, Michael C.			aPKC Phosphorylation of HDAC6 Results in Increased Deacetylation Activity	PLOS ONE			English	Article							PROTEIN-KINASE-C; 2 CATALYTIC DOMAINS; ZETA-PKC; P62; GROWTH; ACTIVATION; INHIBITOR; TUBULIN; AURORA; CELLS	The Class II histone deacetylase, HDAC6, has been shown to be involved in cell motility, aggresome formation and mitochondria transport. HDAC6 deacetylase activity regulates alpha-tubulin acetylation levels and thus plays a critical role in these processes. In turn, HDAC6 activity can be regulated by interaction with various proteins including multiple kinases. Kinase mediated phosphorylation of HDAC6 can lead to either increased or reduced activity. Our previous research has shown that sequestosome1/p62 (SQSTM1/p62) interacts with HDAC6 and regulates its activity. As SQSTM1/p62 is a scaffolding protein known to interact directly with the zeta isoform of Protein Kinase C (PKC zeta), we sought to examine if HDAC6 could be a substrate for PKC zeta phosphorylation and if so, how its activity might be regulated. Our data demonstrate that HDAC6 is not only present in a protein complex with PKC. but can also be phosphorylated by PKC zeta. We also show that specific phosphorylation of HDAC6 by PKC. increases HDAC6 deacetylase activity resulting in reduced acetylated tubulin levels. Our findings provide novel insight into the molecular mechanism by which HDAC6, PKC. and SQSTM1/p62 function together in protein aggregate clearance. These results also highlight a new research direction which may prove fruitful for understanding the underlying cause of several neurodegenerative diseases.	[Du, Yifeng; Seibenhener, Michael L.; Wooten, Michael C.] Auburn Univ, Dept Biol Sci, Cellular & Mol Biosci Program, Auburn, AL 36849 USA; [Yan, Jin] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Jiang, Jianxiong] Univ Cincinnati, James L Winkle Coll Pharm, Cincinnati, OH 45267 USA	Auburn University System; Auburn University; University of Kentucky; University System of Ohio; University of Cincinnati	Wooten, MC (corresponding author), Auburn Univ, Dept Biol Sci, Cellular & Mol Biosci Program, Auburn, AL 36849 USA.	wootemc@auburn.edu	Jiang, Jianxiong/A-1987-2010	Jiang, Jianxiong/0000-0003-3955-8928	 [NIH-2RO1NS033661]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033661] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH-2RO1NS033661 (MCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Calderilla-Barbosa L, 2014, J CELL SCI, V127, P4052, DOI 10.1242/jcs.152363; Chattopadhyay S, 2013, MBIO, V4, DOI [10.1128/mBio.00636-12, DOI 10.1128/MBI0.00636-12]; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; He Q, 2014, MOL BIOL CELL, V25, P1715, DOI 10.1091/mbc.E13-12-0730; Hiruma Y, 2009, BLOOD, V113, P4894, DOI 10.1182/blood-2008-08-173948; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Lafarga V, 2012, CELL ADHES MIGR, V6, P495, DOI 10.4161/cam.21585; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sokal R. R., 2012, BIOMETRY; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Watabe M, 2011, J CELL SCI, V124, P1519, DOI 10.1242/jcs.081778; Williams KA, 2013, J BIOL CHEM, V288, P33156, DOI 10.1074/jbc.M113.472506; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Xiao HL, 2013, CELL MOL LIFE SCI, V70, P3057, DOI 10.1007/s00018-012-1192-1; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076016; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2006, J BIOL CHEM, V281, P2401, DOI 10.1074/jbc.C500241200; Zhou J, 2009, J BIOL CHEM, V284, P9648, DOI 10.1074/jbc.M808708200; Zhu JZ, 2011, EMBO J, V30, P4838, DOI 10.1038/emboj.2011.351; Zou H, 2006, BIOCHEM BIOPH RES CO, V341, P45, DOI 10.1016/j.bbrc.2005.12.144	36	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123191	10.1371/journal.pone.0123191	http://dx.doi.org/10.1371/journal.pone.0123191			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860570	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300081
J	Ma, XF; Qiu, YW; Tian, JZ; Wang, JH; Li, SM; Zhan, WF; Wang, TY; Zeng, SQ; Jiang, GH; Xu, YK				Ma, Xiaofen; Qiu, Yingwei; Tian, Junzhang; Wang, Jinhui; Li, Shumei; Zhan, Wenfeng; Wang, Tianyue; Zeng, Shaoqing; Jiang, Guihua; Xu, Yikai			Aberrant Default-Mode Functional and Structural Connectivity in Heroin-Dependent Individuals	PLOS ONE			English	Article							NETWORK CONNECTIVITY; DECISION-MAKING; BRAIN; MEMORY; ARCHITECTURE; IMPULSIVITY; COMPONENTS; ADDICTION; CORTEX; ATLAS	Background Little is known about connectivity within the default mode network (DMN) in heroin-dependent individuals (HDIs). In the current study, diffusion-tensor imaging (DTI) and resting-state functional MRI (rs-fMRI) were combined to investigate both structural and functional connectivity within the DMN in HDIs. Methods Fourteen HDIs and 14 controls participated in the study. Structural (path length, tracts count, (fractional anisotropy) FA and (mean diffusivity) MD derived from DTI tractography) and functional (temporal correlation coefficient derived from rs-fMRI) DMN connectivity changes were examined in HDIs. Pearson correlation analysis was performed to compare the structural/functional indices and duration of heroin use/Iowa gambling task(IGT) performance in HDIs. Results HDIs had lower FA and higher MD in the tract connecting the posterior cingulate cortex/precuneus (PCC/PCUN) to right parahippocampal gyrus (PHG), compared to the controls. HDIs also had decreased FA and track count in the tract connecting the PCC/PCUN and medial prefrontal cortex (MPFC), as well as decreased functional connectivity between the PCC/PCUN and bilateral PHG and MPFC, compared to controls. FA values for the tract connecting PCC/PCUN to the right PHG and connecting PCC/PCUN to the MPFC were negatively correlated to the duration of heroin use. The temporal correlation coefficients between the PCC/PCUN and the MPFC, and the FA values for the tract connecting the PCC/PCUN to the MPFC were positively correlated to IGT performance in HDIs. Conclusions Structural and functional connectivity within the DMN are both disturbed in HDIs. This disturbance progresses as duration of heroin use increases and is related to deficits in decision making in HDIs.	[Ma, Xiaofen; Wang, Tianyue; Xu, Yikai] Southern Medial Univ, Nanfang Hosp, Dept Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Qiu, Yingwei; Tian, Junzhang; Li, Shumei; Zhan, Wenfeng; Wang, Tianyue; Zeng, Shaoqing; Jiang, Guihua] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Wang, Jinhui] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Wang, Jinhui] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China	Southern Medical University - China; Hangzhou Normal University	Jiang, GH (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	jiangguihua177@163.com; mayuqin2004@163.com	Wang, jinhui/AAF-8668-2019	Tian, Junzhang/0000-0002-6212-1882; Qiu, Yingwei/0000-0003-1298-8506	National Natural Science Foundation of China [81471639]; Science and Technology Planning Project of Guangdong Province, China [2011B031800044, 2012B031800170, 2012A030400019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This research was supported by grants from National Natural Science Foundation of China (No. 81471639); The Science and Technology Planning Project of Guangdong Province, China (No. 2011B031800044, 2012B031800170, 2012A030400019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2012, CORTEX, V48, P604, DOI 10.1016/j.cortex.2011.02.011; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bora E, 2012, ADDICT BIOL, V17, P141, DOI 10.1111/j.1369-1600.2010.00266.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chen B, 2008, MAGN RESON IMAGING, V26, P103, DOI 10.1016/j.mri.2007.05.003; Cheng GLF, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.36; Ding JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026596; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fingelkurts AA, 2009, INT J NEUROSCI, V119, P1469, DOI 10.1080/00207450903007985; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Goh JOS, 2011, AGING DIS, V2, P30; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Grant S, 2000, NEUROPSYCHOLOGIA, V38, P1180, DOI 10.1016/S0028-3932(99)00158-X; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hayes SM, 2004, BEHAV NEUROSCI, V118, P885, DOI 10.1037/0735-7044.118.5.885; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; Liao W, 2011, HUM BRAIN MAPP, V32, P883, DOI 10.1002/hbm.21076; Ma LS, 2007, MAGN RESON IMAGING, V25, P47, DOI 10.1016/j.mri.2006.09.032; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Ornstein TJ, 2000, NEUROPSYCHOPHARMACOL, V23, P113, DOI 10.1016/S0893-133X(00)00097-X; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041376; Qiu YW, 2013, NEUROSCI LETT, V538, P43, DOI 10.1016/j.neulet.2013.01.019; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Qiu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063212; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tang YL, 2006, ADDICTION, V101, P657, DOI 10.1111/j.1360-0443.2006.01367.x; Vassileva J, 2007, DRUG ALCOHOL DEPEN, V86, P287, DOI 10.1016/j.drugalcdep.2006.06.015; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang YR, 2011, NEUROSCI LETT, V494, P49, DOI 10.1016/j.neulet.2011.02.053; Watrous AJ, 2013, NAT NEUROSCI, V16, P349, DOI 10.1038/nn.3315; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Zhao LY, 2009, PSYCHOPHARMACOLOGY, V203, P599, DOI 10.1007/s00213-008-1406-2	52	33	36	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120861	10.1371/journal.pone.0120861	http://dx.doi.org/10.1371/journal.pone.0120861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25859661	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300018
J	Schwager, C; Kull, S; Krause, S; Schocker, F; Petersen, A; Becker, WM; Jappe, U				Schwager, Christian; Kull, Skadi; Krause, Susanne; Schocker, Frauke; Petersen, Arnd; Becker, Wolf-Meinhard; Jappe, Uta			Development of a Novel Strategy to Isolate Lipophilic Allergens (Oleosins) from Peanuts	PLOS ONE			English	Article							SEED OIL BODIES; BODY PROTEINS; SOYBEAN OIL; ISOFORMS; IDENTIFICATION; EXTRACTION; SESAME; POLYACRYLAMIDE; STABILIZATION; PURIFICATION	Background Peanut allergy is one of the most severe class I food allergies with increasing prevalence. Especially lipophilic allergens, such as oleosins, were found to be associated with severe symptoms, but are usually underrepresented in diagnostic extracts. Therefore, this study focused on isolation, molecular characterization and assessment of the allergenicity of peanut oleosins. Methods and Results A comprehensive method adapted for the isolation of peanut oil bodies of high purity was developed comprising a stepwise removal of seed storage proteins from oil bodies. Further separation of the oil body constituents, including the allergens Ara h 10, Ara h 11, the presumed allergen oleosin 3 and additional oleosin variants was achieved by a single run on a preparative electrophoresis cell. Protein identification realized by N-terminal sequencing, peptide mass fingerprinting and homology search revealed the presence of oleosins, steroleosins and a caleosin. Immunoblot analysis with sera of peanut-allergic individuals illustrated the IgE-binding capacity of peanut-derived oleosins. Conclusion Our method is a novel way to isolate all known immunologically distinct peanut oleosins simultaneously. Moreover, we were able to provide evidence for the allergenicity of oleosins and thus identified peanut oleosins as probable candidates for component-resolved allergy diagnosis.	[Schwager, Christian; Kull, Skadi; Krause, Susanne; Schocker, Frauke; Petersen, Arnd; Becker, Wolf-Meinhard; Jappe, Uta] German Ctr Lung Res DZL, Airway Res Ctr North, Res Ctr Borstel, Div Clin & Mol Allergol, Borstel, Germany; [Jappe, Uta] Univ Lubeck, Dept Dermatol Allergol & Venereol, Lubeck, Germany	Forschungszentrum Borstel; University of Lubeck	Jappe, U (corresponding author), German Ctr Lung Res DZL, Airway Res Ctr North, Res Ctr Borstel, Div Clin & Mol Allergol, Borstel, Germany.	ujappe@fz-borstel.de			German Research Foundation [JA 1007/2-1]	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation (http://www.dfg.de/) Grant no. JA 1007/2-1. Receiver of funding: UJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GG, 2012, FOOD CHEM, V134, P1919, DOI 10.1016/j.foodchem.2012.03.114; Akkerdaas JH, 2006, MOL NUTR FOOD RES, V50, P18, DOI 10.1002/mnfr.200500147; Alexander LG, 2002, PLANTA, V214, P546, DOI 10.1007/s004250100655; Bhatla SC, 2010, BIOTECHNOL ADV, V28, P293, DOI 10.1016/j.biotechadv.2010.01.001; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Bublin M, 2014, J ALLERGY CLIN IMMUN, V134, P521, DOI 10.1016/j.jaci.2014.04.015; Cabanos C, 2011, PROTEIN J, V30, P457, DOI 10.1007/s10930-011-9351-z; Chang MT, 2013, J AGR FOOD CHEM, V61, P9666, DOI 10.1021/jf4019195; Chen ECF, 1998, PLANT CELL PHYSIOL, V39, P935, DOI 10.1093/oxfordjournals.pcp.a029457; Chen YM, 2010, J AGR FOOD CHEM, V58, P7402, DOI 10.1021/jf1006159; Chiang CJ, 2010, J AGR FOOD CHEM, V58, P11695, DOI 10.1021/jf102944c; DRIESSEN HPC, 1985, CRIT REV BIOCHEM MOL, V18, P281, DOI 10.3109/10409238509086784; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Haider SR, 2010, ANAL BIOANAL CHEM, V397, P655, DOI 10.1007/s00216-010-3588-9; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P7021, DOI 10.1073/pnas.81.22.7021; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Iwanaga D, 2007, J AGR FOOD CHEM, V55, P8711, DOI 10.1021/jf071008w; Jolivet P, 2004, PLANT PHYSIOL BIOCH, V42, P501, DOI 10.1016/j.plaphy.2004.04.006; Jolivet P, 2013, PROTEOMICS, V13, P1836, DOI 10.1002/pmic.201200431; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Kim H, 2007, BIOTECHNOL BIOPROC E, V12, P542, DOI 10.1007/BF02931352; Kobayashi S, 2012, BIOSCI BIOTECH BIOCH, V76, P1182, DOI 10.1271/bbb.120063; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leduc V, 2006, ALLERGY, V61, P349, DOI 10.1111/j.1398-9995.2006.01013.x; LEE K, 1995, PLANT J, V7, P603, DOI 10.1046/j.1365-313X.1995.7040603.x; LI M, 1992, J BIOL CHEM, V267, P8245; Lin LJ, 2005, PLANT PHYSIOL BIOCH, V43, P770, DOI 10.1016/j.plaphy.2005.07.008; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Maurer S, 2013, J PHYS CHEM B, V117, P13872, DOI 10.1021/jp403893n; Millichip M, 1996, BIOCHEM J, V314, P333, DOI 10.1042/bj3140333; Nicolaou N, 2010, J ALLERGY CLIN IMMUN, V125, P191, DOI 10.1016/j.jaci.2009.10.008; Nikiforidis CV, 2009, J AGR FOOD CHEM, V57, P5591, DOI 10.1021/jf900771v; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Olszewski A, 1998, CLIN EXP ALLERGY, V28, P850, DOI 10.1046/j.1365-2222.1998.00325.x; Parthibane V, 2012, J BIOL CHEM, V287, P1946, DOI 10.1074/jbc.M111.309955; Peng CC, 2003, BIOTECHNOL PROGR, V19, P1623, DOI 10.1021/bp034129z; Permyakov SE, 2012, CELL CALCIUM, V52, P366, DOI 10.1016/j.ceca.2012.06.002; Petersen A, 2006, CLIN EXP ALLERGY, V36, P840, DOI 10.1111/j.1365-2222.2006.02505.x; Petersen A, 2006, PROTEOMICS, V6, P6317, DOI 10.1002/pmic.200600173; Pons L, 1998, J CHROMATOGR B, V706, P131, DOI 10.1016/S0378-4347(97)00530-6; Pons L, 2005, PLANT PHYSIOL BIOCH, V43, P659, DOI 10.1016/j.plaphy.2005.06.002; Pons L, 2002, ALLERGY, V57, P88, DOI 10.1034/j.1398-9995.57.s72.16.x; Ring J, 2007, J EUR ACAD DERMATOL, V21, P452, DOI 10.1111/j.1468-3083.2006.02133.x; Rodelas AJD, 2008, PHILIPP AGRIC SCI, V91, P389; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimada TL, 2010, BIOL PHARM BULL, V33, P360, DOI 10.1248/bpb.33.360; SMYTH DG, 1979, NATURE, V279, P252, DOI 10.1038/279252a0; Souci S, 2000, FOOD COMPOSITION NUT, P1014; Strid J, 2005, CLIN EXP ALLERGY, V35, P757, DOI 10.1111/j.1365-2222.2005.02260.x; Tai SSK, 2002, BIOSCI BIOTECH BIOCH, V66, P2146, DOI 10.1271/bbb.66.2146; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; Tzen JTC, 1998, J BIOCHEM-TOKYO, V123, P318, DOI 10.1093/oxfordjournals.jbchem.a021939; TZEN JTC, 1990, PLANT PHYSIOL, V94, P1282, DOI 10.1104/pp.94.3.1282; TZEN JTC, 1992, J BIOL CHEM, V267, P15626; Tzen JTC, 1997, J BIOCHEM-TOKYO, V121, P762, DOI 10.1093/oxfordjournals.jbchem.a021651; Vargo KB, 2014, LANGMUIR, V30, P11292, DOI 10.1021/la502664e; Waschatko G, 2012, J PHYS CHEM B, V116, P10832, DOI 10.1021/jp211871v; White BL, 2013, J AGR FOOD CHEM, V61, P3957, DOI 10.1021/jf400184y; White DA, 2008, FOOD HYDROCOLLOID, V22, P1224, DOI 10.1016/j.foodhyd.2007.07.004; Zuidmeer-Jongejan L, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-4	62	31	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123419	10.1371/journal.pone.0123419	http://dx.doi.org/10.1371/journal.pone.0123419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860789	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300097
J	Szalai, G; Romero, R; Chaiworapongsa, T; Xu, Y; Wang, B; Ahn, H; Xu, ZH; Chiang, PJ; Sundell, B; Wang, R; Jiang, Y; Plazyo, O; Olive, M; Tarca, AL; Dong, Z; Qureshi, F; Papp, Z; Hassan, SS; Hernandez-Andrade, E; Than, NG				Szalai, Gabor; Romero, Roberto; Chaiworapongsa, Tinnakorn; Xu, Yi; Wang, Bing; Ahn, Hyunyoung; Xu, Zhonghui; Chiang, Po Jen; Sundell, Birgitta; Wang, Rona; Jiang, Yang; Plazyo, Olesya; Olive, Mary; Tarca, Adi L.; Dong, Zhong; Qureshi, Faisal; Papp, Zoltan; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor			Full-Length Human Placental sFlt-1-e15a Isoform Induces Distinct Maternal Phenotypes of Preeclampsia in Mice	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; UTERINE PERFUSION-PRESSURE; FOR-GESTATIONAL-AGE; CIRCULATING ANGIOGENIC FACTORS; FACTOR RECEPTOR-1 CONCENTRATION; ELEVATED LIVER-ENZYMES; NITRIC-OXIDE SYNTHESIS; INNATE-IMMUNE-SYSTEM; GOMBE NATIONAL-PARK; BLOOD-PRESSURE	Objective Most anti-angiogenic preeclampsiamodels in rodents utilized the overexpression of a truncated soluble fms-like tyrosine kinase-1 (sFlt-1) not expressed in any species. Other limitations of mouse preeclampsiamodels included stressful blood pressure measurements and the lack of postpartum monitoring. We aimed to 1) develop a mouse model of preeclampsia by administering the most abundant human placental sFlt-1 isoform (hsFlt-1-e15a) in preeclampsia; 2) determine blood pressures in non-stressed conditions; and 3) develop a survival surgery that enables the collection of fetuses and placentas and postpartum (PP) monitoring. Methods Pregnancy status of CD-1 mice was evaluated with high-frequency ultrasound on gestational days (GD) 6 and 7. Telemetry catheters were implanted in the carotid artery on GD7, and their positions were verified by ultrasound on GD13. Mice were injected through tail-vein with adenoviruses expressing hsFlt-1-e15a (n = 11) or green fluorescent protein (GFP; n = 9) on GD8/GD11. Placentas and pups were delivered by cesarean section on GD18 allowing PP monitoring. Urine samples were collected with cystocentesis on GD6/GD7, GD13, GD18, and PPD8, and albumin/creatinine ratios were determined. GFP and hsFlt-1-e15a expression profiles were determined by qRT-PCR. Aortic ring assays were performed to assess the effect of hsFlt-1-e15a on endothelia. Results Ultrasound predicted pregnancy on GD7 in 97% of cases. Cesarean section survival rate was 100%. Mean arterial blood pressure was higher in hsFlt-1-e15a-treated than in GFP-treated mice (. MAP = 13.2 mmHg, p = 0.00107; GD18). Focal glomerular changes were found in hsFlt-1-e15a -treated mice, which had higher urine albumin/creatinine ratios than controls (109.3 +/- 51.7 mu g/mg vs. 19.3 +/- 5.6 mu g/mg, p = 4.4x10(-2); GD18). Aortic ring assays showed a 46% lesser microvessel outgrowth in hsFlt-1-e15a-treated than in GFP-treated mice (p = 1.2x10(-2)). Placental and fetal weights did not differ between the groups. One mouse with liver disease developed early-onset preeclampsia-like symptoms with intrauterine growth restriction (IUGR). Conclusions A mouse model of late-onset preeclampsia was developed with the overexpression of hsFlt-1-e15a, verifying the in vivo pathologic effects of this primate-specific, predominant placental sFlt-1 isoform. HsFlt-1-e15a induced early-onset preeclampsia-like symptoms associated with IUGR in a mouse with a liver disease. Our findings support that hsFlt-1-e15a is central to the terminal pathway of preeclampsia, and it can induce the full spectrum of symptoms in this obstetrical syndrome.	[Szalai, Gabor; Romero, Roberto; Chaiworapongsa, Tinnakorn; Xu, Yi; Wang, Bing; Ahn, Hyunyoung; Xu, Zhonghui; Chiang, Po Jen; Sundell, Birgitta; Wang, Rona; Jiang, Yang; Plazyo, Olesya; Olive, Mary; Tarca, Adi L.; Dong, Zhong; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Olive, Mary] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Tarca, Adi L.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI USA; [Qureshi, Faisal] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Papp, Zoltan; Than, Nandor Gabor] Semmelweis Univ, Kutvolgyi Clin Block, Matern Private Dept, H-1085 Budapest, Hungary; [Than, Nandor Gabor] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary; [Than, Nandor Gabor] Semmelweis Univ, Dept Pathol & Expt Canc 1, H-1085 Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University	Romero, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	romeror@mail.nih.gov; nthan@med.wayne.edu	Than, Nandor G/N-1442-2016; Xu, Zhonghui/F-3353-2018; Romero, Roberto/A-5268-2019	Xu, Zhonghui/0000-0002-6469-9178; Plazyo, Olesya/0000-0002-6859-7590; Romero, Roberto/0000-0002-4448-5121	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); Federal funds from NICHD, NIH [HHSN275201300006C]; NIH Center [P30CA22453]; Perinatology Research Branch (NICHD/NIH); Hungarian Academy of Sciences Momentum [LP2014-7/2014]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); Federal funds from NICHD, NIH; NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch (NICHD/NIH); Hungarian Academy of Sciences Momentum; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HHSN275201300006C. The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center grant P30CA22453 to the Karmanos Cancer Institute, Wayne State University, and the Perinatology Research Branch (NICHD/NIH). Manuscript writing was supported, in part, by the Hungarian Academy of Sciences Momentum Grant "LP2014-7/2014" (to NGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; Agostinis C, 2010, J IMMUNOL, V185, P4420, DOI 10.4049/jimmunol.0903215; Ahmed A, 2011, THROMB RES, V127, pS72, DOI 10.1016/S0049-3848(11)70020-2; Aldinger KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004729; Alfaidy N, 2013, ANTIOXID REDOX SIGN, V18, P400, DOI 10.1089/ars.2012.4637; [Anonymous], 2011, HD X11 DEVICE SURGIC, P32; BAIRD JN, 1981, AM J OBSTET GYNECOL, V141, P345; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Balogh A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.023; Barton JR, 2004, CLIN PERINATOL, V31, P807, DOI 10.1016/j.clp.2004.06.008; Baumwell S, 2007, NEPHRON CLIN PRACT, V106, pC72, DOI 10.1159/000101801; Baxter JSK, 2004, OBSTET GYNECOL SURV, V59, P838, DOI 10.1097/01.ogx.0000146948.19308.c5; Bdolah Y, 2005, CROAT MED J, V46, P728; Bergmann A, 2010, J CELL MOL MED, V14, P1857, DOI 10.1111/j.1582-4934.2009.00820.x; Berkane N, 2007, NEPHROL DIAL TRANSPL, V22, P2753, DOI 10.1093/ndt/gfm429; Bohlender J, 2000, J AM SOC NEPHROL, V11, P2056, DOI 10.1681/ASN.V11112056; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; BROSENS IA, 1977, CLIN OBSTET GYNAECOL, V4, P573; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brosens I, 2010, HUM REPROD, V25, P569, DOI 10.1093/humrep/dep474; Brown SD, 2006, COMPARATIVE MED, V56, P262; Buhimschi CS, 2010, AM J PATHOL, V177, P197, DOI 10.2353/ajpath.2010.091209; Bujold E, 2005, J MATERN-FETAL NEO M, V18, P9, DOI 10.1080/14767050500202493; Burke SD, 2010, AM J REPROD IMMUNOL, V63, P472, DOI 10.1111/j.1600-0897.2010.00818.x; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; Byers BD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.044; Bytautiene E, 2010, AM J PHYSIOL-HEART C, V298, pH189, DOI 10.1152/ajpheart.00792.2009; Cao Junran, 2012, Front Psychiatry, V3, P28, DOI 10.3389/fpsyt.2012.00028; Carlson SH, 2000, HYPERTENSION, V35, pE1, DOI 10.1161/01.HYP.35.2.e1; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Carter AM, 2011, BEST PRACT RES CL OB, V25, P249, DOI 10.1016/j.bpobgyn.2010.10.010; CAVANAGH D, 1977, AM J OBSTET GYNECOL, V128, P75, DOI 10.1016/0002-9378(77)90296-4; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Chaiworapongsa T, 2002, AM J OBSTET GYNECOL, V187, P889, DOI 10.1067/mob.2002.127309; Chaiworapongsa T, 2010, ULTRASOUND OBST GYN, V35, P155, DOI 10.1002/uog.7491; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P41, DOI 10.1080/14767050701831397; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P25, DOI 10.1080/14767050701832833; Chaiworapongsa T, 2011, J MATERN-FETAL NEO M, V24, P1187, DOI 10.3109/14767058.2011.589932; Chaiworapongsa T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.002; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; CLARK KE, 1982, AM J PHYSIOL, V242, pH297, DOI 10.1152/ajpheart.1982.242.2.H297; COMBS CA, 1993, AM J OBSTET GYNECOL, V169, P215; Conway BR, 2012, J AM SOC NEPHROL, V23, P405, DOI 10.1681/ASN.2011060577; Costantine MM, 2010, OBSTET GYNECOL, V116, P114, DOI 10.1097/AOG.0b013e3181e10ebd; Cox B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.37; Davisson RL, 2002, HYPERTENSION, V39, P337, DOI 10.1161/hy02t2.102904; De P, 2009, EXP CELL RES, V315, P248, DOI 10.1016/j.yexcr.2008.10.003; Dekker G, 2007, J REPROD IMMUNOL, V76, P8, DOI 10.1016/j.jri.2007.03.015; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804; Doridot L, 2014, ANTIOXID REDOX SIGN, V21, P819, DOI 10.1089/ars.2013.5661; Dynon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045956; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545; Erez O, 2008, J MATERN-FETAL NEO M, V21, P345, DOI 10.1080/14767050802034859; Erez O, 2007, J MATERN-FETAL NEO M, V20, P661, DOI 10.1080/14767050701495011; Erez O, 2008, J MATERN-FETAL NEO M, V21, P855, DOI 10.1080/14767050802361872; Erez O, 2009, J MATERN-FETAL NEO M, V22, P662, DOI 10.1080/14767050902801751; Eshkoli T, 2013, J MATERN-FETAL NEO M, V26, P116, DOI 10.3109/14767058.2012.722725; Espinoza J, 2006, J PERINAT MED, V34, P447, DOI 10.1515/JPM.2006.089; Falcao S, 2009, HYPERTENSION, V54, P1401, DOI 10.1161/HYPERTENSIONAHA.109.137356; Falcao S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.003; Fan XJ, 2014, J CLIN INVEST, V124, P4941, DOI 10.1172/JCI76864; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Foster FS, 2002, ULTRASOUND MED BIOL, V28, P1165, DOI 10.1016/S0301-5629(02)00567-7; Fox KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.083; GABER LW, 1994, BAILLIERE CLIN OB GY, V8, P443, DOI 10.1016/S0950-3552(05)80330-X; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; GERRETSEN G, 1981, BRIT J OBSTET GYNAEC, V88, P876, DOI 10.1111/j.1471-0528.1981.tb02222.x; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P792, DOI 10.1067/mob.2001.117311; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Gilbert JS, 2007, HYPERTENSION, V50, P1142, DOI 10.1161/HYPERTENSIONAHA.107.096594; Gilbert JS, 2009, HYPERTENSION, V53, P399, DOI 10.1161/HYPERTENSIONAHA.108.123513; Girardi G, 2011, MOL IMMUNOL, V48, P1621, DOI 10.1016/j.molimm.2011.04.011; Girardi G, 2011, THROMB RES, V127, pS43, DOI 10.1016/S0049-3848(11)70012-3; Gotsch F, 2008, J MATERN-FETAL NEO M, V21, P389, DOI 10.1080/14767050802046069; Gotsch F, 2007, J MATERN-FETAL NEO M, V20, P777, DOI 10.1080/14767050701483298; Granger JP, 2006, METH MOLEC MED, V122, P383; Haram K, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-8; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Helske S, 2001, MOL HUM REPROD, V7, P205, DOI 10.1093/molehr/7.2.205; Hernandez-Andrade E, 2014, ULTRASOUND MED BIOL, V40, P351, DOI 10.1016/j.ultrasmedbio.2013.09.026; Hernandez-Andrade E, 2013, CURR OPIN OBSTET GYN, V25, P138, DOI 10.1097/GCO.0b013e32835e0e9c; Hernandez-Andrade E, 2012, PRENATAL DIAG, V32, P103, DOI 10.1002/pd.2913; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; Hertig A, 2008, EUR J OBSTET GYN R B, V140, P138, DOI 10.1016/j.ejogrb.2007.09.007; Hertig A, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.006; Heydarian M, 2009, PLACENTA, V30, P250, DOI 10.1016/j.placenta.2008.12.010; Higgins JR, 1998, AM J OBSTET GYNECOL, V179, P464, DOI 10.1016/S0002-9378(98)70380-1; HODARI AA, 1967, AM J OBSTET GYNECOL, V97, P597, DOI 10.1016/0002-9378(67)90448-6; Hoogstraten-Miller SL, 2008, CURR PROTOC IMMUNOL; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; Irani RA, 2010, HYPERTENSION, V55, P1246, DOI 10.1161/HYPERTENSIONAHA.110.150540; Jebbink J, 2011, HYPERTENSION, V58, P70, DOI 10.1161/HYPERTENSIONAHA.110.164079; Jose Pinheiro DB, 2013, R PACKAGE VERSION 3; Kaidi S, 2007, LAB ANIM-UK, V41, P388, DOI 10.1258/002367707781282839; Kalkunte S, 2010, AM J PATHOL, V177, P2387, DOI 10.2353/ajpath.2010.100475; Kalkunte S, 2009, J REPROD IMMUNOL, V83, P134, DOI 10.1016/j.jri.2009.08.006; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Karumanchi SA, 2007, AM J OBSTET GYNECOL, V196, P287, DOI 10.1016/j.ajog.2007.02.013; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Khalil RA, 2002, AM J PHYSIOL-REG I, V283, pR29, DOI 10.1152/ajpregu.00762.2001; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Kim JS, 2007, PLACENTA, V28, P571, DOI 10.1016/j.placenta.2006.07.007; Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053; Kliman HJ, 2012, REPROD SCI, V19, P16, DOI 10.1177/1933719111424445; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Kondo K, 1998, GENE, V208, P297, DOI 10.1016/S0378-1119(98)00006-7; KRAAYENBRINK AA, 1993, AM J OBSTET GYNECOL, V169, P160, DOI 10.1016/0002-9378(93)90154-B; Kramer K, 2003, PHYSIOL GENOMICS, V13, P197, DOI 10.1152/physiolgenomics.00164.2002; Kramer K, 2000, LAB ANIM, V34, P272, DOI 10.1258/002367700780384663; Krishnamurthy U, 2014, GYNECOL OBSTET INVES, V78, P33, DOI 10.1159/000362552; KRISTAL MB, 1980, NEUROSCI BIOBEHAV R, V4, P141, DOI 10.1016/0149-7634(80)90012-3; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Kurtz TW, 2005, ARTERIOSCL THROM VAS, V25, P478, DOI 10.1161/01.ATV.0000153088.15433.8f; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Kusinski LC, 2012, AM J PHYSIOL-REG I, V303, pR86, DOI 10.1152/ajpregu.00600.2011; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; LaMarca BBD, 2005, HYPERTENSION, V46, P1022, DOI 10.1161/01.HYP.0000175476.26719.36; Leno-Duran E, 2010, PLACENTA, V31, P731, DOI 10.1016/j.placenta.2010.06.002; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2006, AM J OBSTET GYNECOL, V194, P1034, DOI 10.1016/j.ajog.2005.10.192; Levine RJ, 2005, CLIN OBSTET GYNECOL, V48, P372, DOI 10.1097/01.grf.0000160313.82606.d7; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li F, 2012, J AM SOC NEPHROL, V23, P652, DOI 10.1681/ASN.2011040369; Li J, 2012, AM J PHYSIOL-HEART C, V303, pH1, DOI 10.1152/ajpheart.00117.2012; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; LONG PA, 1980, BRIT J OBSTET GYNAEC, V87, P13, DOI 10.1111/j.1471-0528.1980.tb04419.x; LOSONCZY G, 1992, AM J MED SCI, V303, P233, DOI 10.1097/00000441-199204000-00005; Lu FX, 2007, AM J OBSTET GYNECOL, V197, pS141, DOI 10.1016/j.ajog.2007.10.558; Lu F, 2007, AM J OBSTET GYNECOL, V197, pS3, DOI 10.1016/j.ajog.2007.10.008; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Mateus J, 2011, AM J PHYSIOL-HEART C, V301, pH1781, DOI 10.1152/ajpheart.00373.2011; Matthiesen L, 2005, CHEM IMMUNOL ALLERGY, V89, P49, DOI 10.1159/000087912; Matthys LA, 2004, AM J OBSTET GYNECOL, V190, P1464, DOI 10.1016/j.ajog.2004.02.037; Mayhew TM, 2003, PLACENTA, V24, P219, DOI 10.1053/plac.2002.0900; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; McCarthy FP, 2011, PLACENTA, V32, P413, DOI 10.1016/j.placenta.2011.03.010; Mcgowen MR, 2014, INT J DEV BIOL, V58, P155, DOI 10.1387/ijdb.140020dw; Mills PA, 2000, J APPL PHYSIOL, V88, P1537, DOI 10.1152/jappl.2000.88.5.1537; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; MOLNAR M, 1994, AM J OBSTET GYNECOL, V170, P1458; Moore AG, 2012, J MATERN-FETAL NEO M, V25, P2651, DOI 10.3109/14767058.2012.713055; Mu JW, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-34; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Myatt L, 2009, J THROMB HAEMOST, V7, P375, DOI 10.1111/j.1538-7836.2008.03259.x; National Research Council of the National Academies, 2011, GUIDE FOR THE CARE A; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; NICOSIA RF, 1990, LAB INVEST, V63, P115; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P820, DOI 10.3109/14767050903366119; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P476, DOI 10.3109/14767050903216033; Orshal JM, 2004, HYPERTENSION, V43, P434, DOI 10.1161/01.HYP.0000113044.46326.98; PAGE E W, 1948, Obstet Gynecol Surv, V3, P615, DOI 10.1097/00006254-194810000-00002; PAGE ERNEST W., 1949, CALIFORNIA MED, V70, P1; Paidas MJ, 2005, SEMIN PERINATOL, V29, P150, DOI 10.1053/j.semperi.2005.05.008; Pallares P, 2008, THERIOGENOLOGY, V70, P44, DOI 10.1016/j.theriogenology.2008.02.012; Pallares P, 2009, REPROD FERT DEVELOP, V21, P283, DOI 10.1071/RD08124; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Podjarny E, 1998, J AM SOC NEPHROL, V9, P9; Powers RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013263; Preedy, 2012, HDB GROWTH GROWTH MO, P1867; Rajakumar A, 2009, PLACENTA, V30, P25, DOI 10.1016/j.placenta.2008.10.006; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Rasmussen S, 2003, OBSTET GYNECOL, V101, P575, DOI 10.1016/S0029-7844(02)03071-5; Rath W, 2000, J PERINAT MED, V28, P249, DOI 10.1515/JPM.2000.033; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Reimer T, 2012, J MATERN FETAL NEONA; Reuvekamp A, 1999, BRIT J OBSTET GYNAEC, V106, P1019, DOI 10.1111/j.1471-0528.1999.tb08107.x; Rigo J, 2000, HYPERTENS PREGNANCY, V19, P163, DOI 10.1081/PRG-100100132; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Roberts JM, 1999, AM J KIDNEY DIS, V33, P992, DOI 10.1016/S0272-6386(99)70439-7; ROBERTSON WB, 1967, J PATHOL BACTERIOL, V93, P581, DOI 10.1002/path.1700930219; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2011, BEST PRACT RES CL OB, V25, P313, DOI 10.1016/j.bpobgyn.2011.02.006; Romero R, 2009, J MATERN-FETAL NEO M, V22, P636, DOI 10.1080/14767050902784171; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; SALAS SP, 1995, HYPERTENSION, V26, P1019, DOI 10.1161/01.HYP.26.6.1019; Sargent IL, 2003, J REPROD IMMUNOL, V59, P153, DOI 10.1016/S0165-0378(03)00044-5; Sebire N J, 2005, J Obstet Gynaecol, V25, P117; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; Sharma S, 2010, J REPROD IMMUNOL, V85, P112, DOI 10.1016/j.jri.2010.01.002; Shesely EG, 2001, AM J OBSTET GYNECOL, V185, P1198, DOI 10.1067/mob.2001.118142; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; SHIBUYA M, 1990, ONCOGENE, V5, P519; Shibuya M, 2011, P JPN ACAD B-PHYS, V87, P167, DOI 10.2183/pjab.87.167; Shinkai A, 1998, J BIOL CHEM, V273, P31283, DOI 10.1074/jbc.273.47.31283; Sholook MM, 2007, AM J PHYSIOL-HEART C, V293, pH2080, DOI 10.1152/ajpheart.00667.2007; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 2006, SEMIN PERINATOL, V30, P16, DOI 10.1053/j.semperi.2006.01.008; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Siddiqui AH, 2011, AM J HYPERTENS, V24, P606, DOI 10.1038/ajh.2010.247; Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013; Singh H, 2010, PLACENTA, V31, P1085, DOI 10.1016/j.placenta.2010.10.003; Singh H, 2011, HUM REPROD, V26, P748, DOI 10.1093/humrep/der019; Singh J, 2011, HYPERTENSION, V58, P716, DOI 10.1161/HYPERTENSIONAHA.111.175919; Slevin JC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-10; Smith GCS, 2009, CURR OPIN OBSTET GYN, V21, P111, DOI 10.1097/GCO.0b013e328328cf7d; Staff AC, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.036; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stillman IE, 2007, J AM SOC NEPHROL, V18, P2281, DOI 10.1681/ASN.2007020255; STOUT C, 1969, AM J OBSTET GYNECOL, V105, P212, DOI 10.1016/0002-9378(69)90060-X; Sugimoto H, 2003, J BIOL CHEM, V278, P12605, DOI 10.1074/jbc.C300012200; Sunderland N, 2011, AM J REPROD IMMUNOL, V65, P533, DOI 10.1111/j.1600-0897.2010.00929.x; Suzuki H, 2009, HYPERTENSION, V54, P1129, DOI 10.1161/HYPERTENSIONAHA.109.134668; Szalai G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110867; Takimoto E, 1996, SCIENCE, V274, P995, DOI 10.1126/science.274.5289.995; Tal R, 2010, AM J PATHOL, V177, P2950, DOI 10.2353/ajpath.2010.090800; Tanaka K, 1997, JPN J CANCER RES, V88, P867, DOI 10.1111/j.1349-7006.1997.tb00463.x; Taylor RN, 1998, SEMIN REPROD ENDOCR, V16, P17, DOI 10.1055/s-2007-1016249; Terio KA, 2011, J ZOO WILDLIFE MED, V42, P597, DOI 10.1638/2010-0237.1; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Than NG, 2014, PLACENTA, V35, P855, DOI 10.1016/j.placenta.2014.07.015; Than NG, 2008, PLACENTA, V29, pS83, DOI 10.1016/j.placenta.2007.10.008; Than NG, 2008, VIRCHOWS ARCH, V453, P387, DOI 10.1007/s00428-008-0658-x; Than NG, 2008, AM J REPROD IMMUNOL, V60, P333, DOI 10.1111/j.1600-0897.2008.00631.x; Than NG, 2012, REPROD SCI, V19, P14, DOI 10.1177/1933719111431678; Theiler K, 1989, THE HOUSE MOUSE ATLA; Thomas CP, 2009, J CLIN ENDOCR METAB, V94, P2524, DOI 10.1210/jc.2009-0017; Thomas C, 2007, ANIMAL, V1, P1, DOI 10.1017/S1751731107658467; THORNTON JG, 1992, AM J OBSTET GYNECOL, V167, P240, DOI 10.1016/S0002-9378(11)91665-2; Turnbull DH, 1999, COMPUT MED IMAG GRAP, V23, P25, DOI 10.1016/S0895-6111(98)00060-3; Vaisbuch E, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.049; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; Van Vliet BN, 2000, J PHARMACOL TOXICOL, V44, P361, DOI 10.1016/S1056-8719(00)00126-X; Varkonyi T, 2011, PLACENTA, V32, pS21, DOI 10.1016/j.placenta.2010.04.014; Vatten LJ, 2007, AM J OBSTET GYNECOL, V196, P239, DOI 10.1016/j.ajog.2006.10.909; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Verlohren S, 2012, CLIN SCI, V122, P43, DOI 10.1042/CS20110097; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; von Dadelszen P, 2009, SEMIN PERINATOL, V33, P152, DOI 10.1053/j.semperi.2009.02.009; Vuorela P, 2000, OBSTET GYNECOL, V95, P353, DOI 10.1016/S0029-7844(99)00565-7; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang HM, 2003, MOL REPROD DEV, V65, P123, DOI 10.1002/mrd.10308; Webster RR, 2008, PLACENTA, V29, P985, DOI 10.1016/j.placenta.2008.09.003; Weed S, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.003; WEINSTEIN L, 1982, AM J OBSTET GYNECOL, V142, P159, DOI 10.1016/S0002-9378(16)32330-4; Whitehead CL, 2011, BJOG-INT J OBSTET GY, V118, P1268, DOI 10.1111/j.1471-0528.2011.02962.x; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; *WHO, 2005, THE WORLD HEALTH REP; Wildman DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024509; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Woods AK, 2011, HYPERTENSION, V57, P94, DOI 10.1161/HYPERTENSIONAHA.110.160242; Xing AY, 2000, HUM GENE THER, V11, P167, DOI 10.1089/10430340050016247; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zenclussen AC, 2004, EUR J IMMUNOL, V34, P377, DOI 10.1002/eji.200324469; Zhao Xin, 2011, Curr Protoc Mouse Biol, V1, P105; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388; Zhou YQ, 2002, PHYSIOL GENOMICS, V10, P113, DOI 10.1152/physiolgenomics.00119.2001	281	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0119547	10.1371/journal.pone.0119547	http://dx.doi.org/10.1371/journal.pone.0119547			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860260	gold, Green Published, Green Accepted			2022-12-27	WOS:000352590300008
J	Wong, ELY; Coulter, A; Hewitson, P; Cheung, AWL; Yam, CHK; Lui, SF; Tam, WWS; Yeoh, EK				Wong, Eliza L. Y.; Coulter, Angela; Hewitson, Paul; Cheung, Annie W. L.; Yam, Carrie H. K.; Lui, Siu Fai; Tam, Wilson W. S.; Yeoh, Eng-Kiong			Patient Experience and Satisfaction with Inpatient Service: Development of Short Form Survey Instrument Measuring the Core Aspect of Inpatient Experience	PLOS ONE			English	Article							HEALTH-CARE; SAMPLE-SIZE; QUESTIONNAIRE; VALIDATION; GUIDELINES; LONG	Patient experience reflects quality of care from the patients' perspective; therefore, patients' experiences are important data in the evaluation of the quality of health services. The development of an abbreviated, reliable and valid instrument for measuring inpatients' experience would reflect the key aspect of inpatient care from patients' perspective as well as facilitate quality improvement by cultivating patient engagement and allow the trends in patient satisfaction and experience to be measured regularly. The study developed a short-form inpatient instrument and tested its ability to capture a core set of inpatients' experiences. The Hong Kong Inpatient Experience Questionnaire (HKIEQ) was established in 2010; it is an adaptation of the General Inpatient Questionnaire of the Care Quality Commission created by the Picker Institute in United Kingdom. This study used a consensus conference and a cross-sectional validation survey to create and validate a short-form of the Hong Kong Inpatient Experience Questionnaire (SF-HKIEQ). The short-form, the SF-HKIEQ, consisted of 18 items derived from the HKIEQ. The 18 items mainly covered relational aspects of care under four dimensions of the patient's journey: hospital staff, patient care and treatment, information on leaving the hospital, and overall impression. The SF-HKIEQ had a high degree of face validity, construct validity and internal reliability. The validated SF-HKIEQ reflects the relevant core aspects of inpatients' experience in a hospital setting. It provides a quick reference tool for quality improvement purposes and a platform that allows both healthcare staff and patients to monitor the quality of hospital care over time.	[Wong, Eliza L. Y.; Cheung, Annie W. L.; Yam, Carrie H. K.; Lui, Siu Fai; Tam, Wilson W. S.; Yeoh, Eng-Kiong] Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Coulter, Angela; Hewitson, Paul] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England	Chinese University of Hong Kong; University of Oxford	Wong, ELY (corresponding author), Chinese Univ Hong Kong, Fac Med, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China.	lywong@cuhk.edu.hk	Coulter, Angela/N-6998-2019; Wong, Eliza Lai-Yi/ABI-2092-2020; Tam, Wilson/K-1664-2019; TAM, Wilson W.S./H-5890-2019	Coulter, Angela/0000-0002-6308-8375; TAM, Wilson W.S./0000-0003-0641-3060; Wong, Eliza/0000-0001-9983-6219	Hong Kong Hospital Authority [8110001414]	Hong Kong Hospital Authority	This work was supported by Grant numbers: 8110001414 (Hong Kong Hospital Authority); Funder's website: http://www.ha.org.hk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniotti S, 2009, INT J QUAL HEALTH C, V21, P243, DOI 10.1093/intqhc/mzp021; Care Quality Commission (CQC), 2014, INP SURV 2013; Cleary P D, 1992, QRB Qual Rev Bull, V18, P53; Cleary PD, 1998, INT J TECHNOL ASSESS, V14, P35, DOI 10.1017/S0266462300010503; Cleary PD, 1997, JAMA-J AM MED ASSOC, V278, P1608, DOI 10.1001/jama.278.19.1608; Coulter A, 2009, POINT CARE MEASURES; Fan XT, 2001, EDUC PSYCHOL MEAS, V61, P517, DOI 10.1177/00131640121971365; Garratt A., 2008, 072008 NORW I PUBL H; Gerteis M., 1993, PATIENTS EYES UNDERS; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hewitson P, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-33; Horne R, 2001, QUAL HEALTH CARE, V10, P135, DOI 10.1136/qhc.0100135..; Hurst J., 2001, SOC POLICY, V47; Jenkinson C, 2003, J PUBLIC HEALTH MED, V25, P197, DOI 10.1093/pubmed/fdg049; Jenkinson C, 2002, INT J QUAL HEALTH C, V14, P353, DOI 10.1093/intqhc/14.5.353; Jenkinson C, 2002, SCAND J CARING SCI, V16, P329, DOI 10.1046/j.1471-6712.2002.00088.x; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Kline P., 2000, PSYCHOMETRICS PRIMER; Larsson BW, 2002, J CLIN NURS, V11, P681, DOI 10.1046/j.1365-2702.2002.00640.x; Linstone H. A., 1975, DELPHI METHOD TECHNI; Ludwig B., 1997, J EXT, V35, P1; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Marshall GN., 1994, PATIENT SATISFACTION; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Picker Institute Europe, 2012, PAT SERV US EXP SURV; Rouquette A, 2011, INT J METH PSYCH RES, V20, P235, DOI 10.1002/mpr.352; Sjetne IS, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-88; Ware JE, 1994, USER MANUAL SF12; Wong ELY, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-265; Wong ELY, 2013, INT J QUAL HEALTH C, V25, P443, DOI 10.1093/intqhc/mzt034; Wong ELY, 2012, HONG KONG MED J, V18, P371	32	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122299	10.1371/journal.pone.0122299	http://dx.doi.org/10.1371/journal.pone.0122299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5II	25860775	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300040
J	[Anonymous]				[Anonymous]			Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CEREBROSPINAL-FLUID; NEUROFILAMENT LIGHT; UP-REGULATION; CXCL13; NEOPTERIN; IMMUNE; MACROPHAGES; DISEASE; MARKER	Background Expression of soluble CD163 (sCD163), a macrophage/microglia biomarker, is increased in inflammatory conditions, and sCD163 levels in the cerebrospinal fluid (CSF) have recently been shown to be elevated in patients with multiple sclerosis (MS): the sCD163 CSF/serum ratio was elevated in patients with relapsing-remitting MS (RRMS), primary progressive MS (PPMS), and clinically isolated syndrome (CIS) compared with symptomatic controls. Objective To investigate the contributions of the sCD163 CSF/serum ratio to a biomarker panel focusing on inflammation and axonal degeneration in newly diagnosed MS; thus optimising a diagnostic biomarker panel for MS. Methods After a full MS diagnostic work-up, including collection of paired samples of CSF and serum, 125 patients were included in this study. Patients were divided into groups based on their diagnosis, and patients with normal clinical and paraclinical findings were defined as symptomatic controls. Serum and CSF levels, ratios, and indices of sCD163, CXCL13, osteopontin, neopterin, and CSF levels of neurofilament light polypeptide were determined by enzyme-linked immunosorbent assays (ELISAs). For sCD163 the results constitute a post-hoc analysis of already published data. Results All tested biomarkers, notably the sCD163 ratio, the CXCL13 ratio, the NEO ratio, the CSF level of NfL, the IgG index, and the serum level of OPN, were significantly correlated to RRMS, PPMS, and/or CIS. The individual biomarkers in single tests had a lower performance than the IgG index, however, their combined receiver operating characteristic (ROC) curve demonstrated excellent diagnostic discriminatory power. Conclusion The biomarker panel showed distinct profiles for each patient group and could be a valuable tool for clinical differentiation of MS subgroups. The combined ROC analysis showed that sCD163 contributes positively as a diagnostic marker to a panel of established MS biomarkers. Patients with PPMS were demonstrated to have significantly elevated levels of both inflammatory and degenerative markers.						Carstensen, Mikkel/0000-0001-5676-1173; Christensen, Tove/0000-0003-3977-6677; Moller, Holger Jon/0000-0001-7687-5995; Rasmussen, Peter Vestergaard/0000-0001-6417-7743; Petersen, Thor/0000-0001-5633-2600	Danish Multiple Sclerosis Society [8990, 14567]; Riisfort Foundation [15399]; Aase and Einar Danielsen's Foundation [904587]; Jascha Foundation [3099]; Dagmar Marshalls Fond	Danish Multiple Sclerosis Society; Riisfort Foundation; Aase and Einar Danielsen's Foundation; Jascha Foundation; Dagmar Marshalls Fond	This study was funded by The Danish Multiple Sclerosis Society, grant number(s): 8990 and 14567, funder URL: http://scleroseforeningen.dk/, The Riisfort Foundation, grant no. 15399, URL: http://www.riisfort.dk/riisfort-fonden/, the Aase and Einar Danielsen's Foundation; grant no 904587; URL: http://www.danielsensfond.dk/, The Jascha Foundation, grant no. 3099 URL: http://www.jaschafonden.dk/, and the Dagmar Marshalls Fond, grant no. N/A URL: N/A (it is a small Danish Foundation; applications via solicitor Oluf Engell; Bruun & Hjejle; Amagertorv 24; 1160 KobenhavnK). HJM and Aarhus University have received royalties from IQ-products, NL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2013, MULT SCLER J, V19, P1204, DOI 10.1177/1352458512473362; [Anonymous], 2003, STATA TIP 1 THE EFOR; Avsar T, 2012, MULT SCLER J, V18, P1081, DOI 10.1177/1352458511433303; Bartos A, 2007, ACTA NEUROL SCAND, V116, P100, DOI 10.1111/j.1600-0404.2006.00794.x; Bielekova B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048370; BO L, 1994, J NEUROIMMUNOL, V51, P135, DOI 10.1016/0165-5728(94)90075-2; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Carlsen HS, 2004, BLOOD, V104, P3021, DOI 10.1182/blood-2004-02-0701; Centonze D, 2010, CELL DEATH DIFFER, V17, P1083, DOI 10.1038/cdd.2009.179; Christensen JR, 2013, MULT SCLER J, V19, P877, DOI 10.1177/1352458512466929; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Correale J, 2014, MULT SCLER J, V20, P1288, DOI 10.1177/1352458514533230; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Dobson R, 2013, ACTA NEUROL SCAND, V128, P321, DOI 10.1111/ane.12119; Edwards KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081007; Ehling R, 2004, MULT SCLER J, V10, P601, DOI 10.1191/1352458504ms1100oa; Etzerodt A, 2014, J BIOL CHEM, V289, P778, DOI 10.1074/jbc.M113.520213; Fabriek BO, 2005, GLIA, V51, P297, DOI 10.1002/glia.20208; Festa ED, 2009, MULT SCLER J, V15, P1271, DOI 10.1177/1352458509107017; Galea J, 2012, J NEUROCHEM, V121, P785, DOI 10.1111/j.1471-4159.2012.07716.x; Giovannoni G, 1997, BRAIN, V120, P1, DOI 10.1093/brain/120.1.1; Harris VK, 2009, MOL DIAGN THER, V13, P225, DOI 10.2165/11313470-000000000-00000; Hiraoka A, 2005, J GASTROENTEROL, V40, P52, DOI 10.1007/s00535-004-1493-8; Hoffmann G, 2003, INFLAMM RES, V52, P313, DOI 10.1007/s00011-003-1181-9; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; Huizinga R, 2012, GLIA, V60, P422, DOI 10.1002/glia.22276; Katsavos S, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/340508; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P506, DOI 10.2174/187152712801661248; Kivisakk P, 2014, MULT SCLER J, V20, P438, DOI 10.1177/1352458513503052; Kowarik MC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-93; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Lieury A, 2014, GLIA, V62, P1645, DOI 10.1002/glia.22705; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lycke JN, 1998, J NEUROL NEUROSUR PS, V64, P402, DOI 10.1136/jnnp.64.3.402; Malmestrom C, 2003, NEUROLOGY, V61, P1720, DOI 10.1212/01.WNL.0000098880.19793.B6; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Moller HJ, 2004, EUR J HAEMATOL, V72, P135, DOI 10.1046/j.0902-4441.2003.00193.x; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P29, DOI 10.1080/003655102762377466; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P293, DOI 10.1080/003655102760145852; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; OTT M, 1993, J NEUROL, V241, P108, DOI 10.1007/BF00869773; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ragheb S, 2011, MULT SCLER J, V17, P819, DOI 10.1177/1352458511398887; Rittling SR, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001839; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Semra YK, 2002, J NEUROIMMUNOL, V122, P132, DOI 10.1016/S0165-5728(01)00455-6; SHAW CE, 1995, J NEUROL, V242, P53, DOI 10.1007/BF00887815; Sinclair C, 2005, NEUROPATH APPL NEURO, V31, P292, DOI 10.1111/j.1365-2990.2004.00638.x; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Stangel M, 2013, NAT REV NEUROL, V9, P267, DOI 10.1038/nrneurol.2013.41; Stilund M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098588; Teunissen CE, 2011, MULT SCLER J, V17, P838, DOI 10.1177/1352458511399614; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tumani H, 2009, NEUROBIOL DIS, V35, P117, DOI 10.1016/j.nbd.2009.04.010; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; WERNERFELMAYER G, 1990, CANCER RES, V50, P2863; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Zhang Z, 2011, J NEUROIMMUNOL, V237, P73, DOI 10.1016/j.jneuroim.2011.06.006; Ziemann U, 2011, PROG NEUROBIOL, V95, P670, DOI 10.1016/j.pneurobio.2011.04.007	72	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0119681	10.1371/journal.pone.0119681	http://dx.doi.org/10.1371/journal.pone.0119681			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860354	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300009
J	Arai, L; Panca, M; Morris, S; Curtis-Tyler, K; Lucas, PJ; Roberts, HM				Arai, Lisa; Panca, Monica; Morris, Steve; Curtis-Tyler, Katherine; Lucas, Patricia J.; Roberts, Helen M.			Time, Monetary and Other Costs of Participation in Family-Based Child Weight Management Interventions: Qualitative and Systematic Review Evidence	PLOS ONE			English	Review							OVERWEIGHT; OBESITY; TRIAL	Background Childhood overweight and obesity have health and economic impacts on individuals and the wider society. Families participating in weight management programmes may foresee or experience monetary and other costs which deter them from signing up to or completing programmes. This is recognised in the health economics literature, though within this sparse body of work, costs to families are often narrowly defined and not fully accounted for. A societal perspective incorporating a broader array of costs may provide a more accurate picture. This paper brings together a review of the health economics literature on the costs to families attending child weight management programmes with qualitative data from families participating in a programme to manage child overweight and obesity. Methods A search identified economic evaluation studies of lifestyle interventions in childhood obesity. The qualitative work drew on interviews with families who attended a weight management intervention in three UK regions. Results We identified four cost-effectiveness analyses that include information on costs to families. These were categorised as direct (e.g. monetary) and indirect (e.g. time) costs. Our analysis of qualitative data demonstrated that, for families who attended the programme, costs were associated both with participation on the scheme and with maintaining a healthy lifestyle afterwards. Respondents reported three kinds of cost: time-related, social/emotional and monetary. Conclusion Societal approaches to measuring cost-effectiveness provide a framework for assessing the monetary and non-monetary costs borne by participants attending treatment programmes. From this perspective, all costs should be considered in any analysis of cost-effectiveness. Our data suggest that family costs are important, and may act as a barrier to the uptake, completion and maintenance of behaviours to reduce child obesity. These findings have implications for the development and implementation of child weight initiatives in particular, in relation to reducing inequalities in health.	[Arai, Lisa] Univ Teesside, Sch Hlth & Social Care, Middlesbrough, Cleveland, England; [Panca, Monica] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Morris, Steve] UCL, Dept Appl Hlth Res, London, England; [Curtis-Tyler, Katherine] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Lucas, Patricia J.] Univ Bristol, Sch Policy Studies, Bristol, Avon, England; [Roberts, Helen M.] UCL, Inst Child Hlth, London, England	University of Teesside; University of London; University College London; University of London; University College London; City University London; University of Bristol; University of London; University College London	Roberts, HM (corresponding author), UCL, Inst Child Hlth, London, England.	h.roberts@ucl.ac.uk	Lucas, Patricia/P-5349-2017	Roberts, Helen/0000-0002-6319-061X; Lucas, Patricia Jane/0000-0002-0469-8085; Curtis Tyler, Katherine/0000-0002-8212-1134; Morris, Stephen/0000-0002-5828-3563	National Institute for Health Research Public Health Research programme [09-3005-05];  [09300505]; National Institute for Health Research [09/3005/05] Funding Source: researchfish	National Institute for Health Research Public Health Research programme; ; National Institute for Health Research(National Institute for Health Research (NIHR))	The data collection for the qualitative part of this paper, but not the economic review was funded by the National Institute for Health Research Public Health Research programme (project number -09-3005-05). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHRPHR programme of the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HR and SM were co-investigators on the grant. Details of the funding here: http://www.nets.nihr.ac.uk/projects/phr/09300505	Banks Jonathan, 2012, Br J Gen Pract, V62, pe1, DOI 10.3399/bjgp12X616300; Callahan KP, 2012, J COMP EFFECT RES, V1, P299, DOI [10.2217/CER.12.33, 10.2217/cer.12.33]; Drummond MF, 2015, METHODS EC EVALUATIO; Fagg J, 2014, INT J OBESITY, V38, P1343, DOI 10.1038/ijo.2014.103; Greater London Authority, 2011, CHILDH OB LOND; Haycox A, 2009, WHAT IS HLTH EC; Kalra P, 2004, ETHNIC DIS, V14, P497; Law C, 2014, PUBLIC HLTH RES, V2, P5; Lucas PJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-614; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moodie M, 2008, ECON HUM BIOL, V6, P363, DOI 10.1016/j.ehb.2008.06.001; National Collaborative on Childhood Obesity Research (NCCOR), 2009, CHILDH OB US; National Institute for Health and Care Excellence (NICE), 2012, METH DEV NICE PUBL H, VThird; National Obesity Observatory (Public Health England), 2010, EC BURD OB; National Obesity Observatory (Public Health England), CHILD OB OV; National Obesity Observatory (Public Health England), INT COMP; NICE, 2012, OB WORK LOC COMM COS; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Ritchie J., 2003, QUALITATIVE RES PRAC, P219, DOI DOI 10.4135/9781452230108; Robertson W, 2012, CHILD CARE HLTH DEV, V38, P229, DOI 10.1111/j.1365-2214.2011.01237.x; Wake M, 2008, AMBUL PEDIATR, V8, P336, DOI 10.1016/j.ambp.2008.06.006; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; Woodman J, 2008, 1610 U LOND EPPI CTR	23	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123782	10.1371/journal.pone.0123782	http://dx.doi.org/10.1371/journal.pone.0123782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853729	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000352478400117
J	Buric, M; Blahovec, J; Kouril, J				Buric, Milos; Blahovec, Josef; Kouril, Jan			Back to the Roots: The Integration of a Constructed Wetland into a Recirculating Hatchery - A Case Study	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; VEGETATED DRAINAGE DITCHES; SALMON SALMO-SALAR; LOW-GRADE WEIRS; AQUACULTURE SYSTEMS; WATER-QUALITY; WASTE-WATER; FISH PRODUCTION; PERFORMANCE; EFFLUENT	Aquaculture is currently one of the fastest growing food-producing sectors, accounting for around 50% of the world's food fish. Limited resources, together with climatic change, have stimulated the search for solutions to support and sustain the production of fish as a nutritious food. The integration of a constructed wetland (CW) into a recirculating hatchery (RHS) was evaluated with respect to its economic feasibility and environmental impact. The outcome of eight production cycles showed the potential of CW integration for expanded production without increased operation costs or environmental load. Concretely, the use of constructed wetland allows the rearing about 40% more fish biomass, resulting in higher production and profitability. The low requirements for space, fresh water, and energy enable the establishment of such systems almost anywhere. Constructed wetlands could enhance the productivity of existing small scale facilities, as well as larger systems, to address economic and environmental issues in aquaculture. Such systems have potential to be sustainable in the context of possible future climate change and resource limitations.	[Buric, Milos; Kouril, Jan] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic; [Blahovec, Josef] Trout Farm Mlyny, Stachy, Czech Republic	University of South Bohemia Ceske Budejovice	Buric, M (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic.	buric@frov.jcu.cz	Buric, Milos/F-8114-2015	Buric, Milos/0000-0003-2220-5579	Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.05/2.1.00/01.0024, LO1205]; Ministry of Agriculture of the Czech Republic [NAZV QJ1210013]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The study was financially supported by the Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/?lang=2) - projects "CENAKVA" (No. CZ.1.05/2.1.00/01.0024), "CENAKVA II" (No. LO1205 under the NPU I program) and by the Ministry of Agriculture of the Czech Republic (http://eagri.cz/public/web/en/mze/) (project No. NAZV QJ1210013). Trout farm Mlyny provided support in the form of salaries for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adarme-Vega TC, 2014, CURR OPIN BIOTECH, V26, P14, DOI 10.1016/j.copbio.2013.08.003; Arismendi I, 2009, FRESHWATER BIOL, V54, P1135, DOI 10.1111/j.1365-2427.2008.02157.x; Barnes ME, 2013, N AM J AQUACULT, V75, P244, DOI 10.1080/15222055.2013.768573; Blanchet C, 2005, LIPIDS, V40, P529, DOI 10.1007/s11745-005-1414-0; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Boyd CE, 2003, AQUACULTURE, V226, P101, DOI 10.1016/S0044-8486(03)00471-X; Bunting SW, 2009, AQUACULTURE, V294, P43, DOI 10.1016/j.aquaculture.2009.04.017; Buric M., 2014, Journal of Aquaculture Research and Development, V5, P271; Buric M, 2016, AQUAC RES, V47, P1156, DOI 10.1111/are.12572; Cole DW, 2009, INT J HYG ENVIR HEAL, V212, P369, DOI 10.1016/j.ijheh.2008.08.003; d'Orbcastel ER, 2009, AQUACULT ENG, V40, P113, DOI 10.1016/j.aquaeng.2008.12.002; Davidson J, 2014, AQUACULT ENG, V59, P30, DOI 10.1016/j.aquaeng.2014.01.003; Davidson J, 2011, AQUACULT ENG, V44, P80, DOI 10.1016/j.aquaeng.2011.04.001; Dewailly E, 2007, FOOD CHEM TOXICOL, V45, P1343, DOI 10.1016/j.fct.2007.01.010; Endut A, 2009, DESALIN WATER TREAT, V5, P19, DOI 10.5004/dwt.2009.559; Flora C, 2014, AQUACULT ENG, V60, P68, DOI 10.1016/j.aquaeng.2014.04.007; Flora C, 2014, AQUACULT ENG, V60, P56, DOI 10.1016/j.aquaeng.2014.04.006; Food and Agriculture Organization of United Nations, 2013, FAO YB, P105; Godfray HCJ, 2010, PHILOS T R SOC B, V365, P2769, DOI 10.1098/rstb.2010.0180; Good C, 2011, AQUACULT ENG, V44, P97, DOI 10.1016/j.aquaeng.2011.04.003; Graber A, 2009, DESALINATION, V246, P147, DOI 10.1016/j.desal.2008.03.048; Hagopian DS, 1998, AQUACULT ENG, V18, P223, DOI 10.1016/S0144-8609(98)00032-6; Hastein I, 2008, REV SCI TECH OIE, V27, P125, DOI 10.20506/rst.27.1.1798; Idris S, 2012, ENVIRON SCI POLLUT R, V19, P1159, DOI 10.1007/s11356-011-0642-x; Jesus JM, 2014, INT J PHYTOREMEDIAT, V16, P334, DOI 10.1080/15226514.2013.773284; Klinger D, 2012, ANNU REV ENV RESOUR, V37, P247, DOI 10.1146/annurev-environ-021111-161531; Kozak P, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011014; Kroupova H, 2005, VET MED-CZECH, V50, P461, DOI 10.17221/5650-VETMED; Laursen DC, 2013, APPL ANIM BEHAV SCI, V144, P163, DOI 10.1016/j.applanim.2013.01.010; Lin YF, 2003, ENVIRON POLLUT, V123, P107, DOI 10.1016/S0269-7491(02)00338-X; Malone RF, 2000, AQUACULT ENG, V22, P57, DOI 10.1016/S0144-8609(00)00032-7; Manley CB, 2014, AQUACULTURE, V420, P89, DOI 10.1016/j.aquaculture.2013.10.040; Martins CIM, 2010, AQUACULT ENG, V43, P83, DOI 10.1016/j.aquaeng.2010.09.002; Midilli A, 2012, ENVIRON PROG SUSTAIN, V31, P604, DOI 10.1002/ep.10580; Muir J, 2005, PHILOS T R SOC B, V360, P191, DOI 10.1098/rstb.2004.1572; National Intelligence Council, 2012, GLOB TRENDS 2030 ALT, P160; Pedersen LF, 2012, AQUACULTURE, V338, P237, DOI 10.1016/j.aquaculture.2012.01.035; Salama NKG, 2011, AQUACULT ENV INTERAC, V2, P61, DOI 10.3354/aei00030; Sharrer M, 2010, BIORESOURCE TECHNOL, V101, P6630, DOI 10.1016/j.biortech.2010.03.101; Shi YH, 2011, BIORESOURCE TECHNOL, V102, P9416, DOI 10.1016/j.biortech.2011.07.058; Sindilariu PD, 2008, AQUACULTURE, V277, P179, DOI 10.1016/j.aquaculture.2008.02.026; Sindilariu PD, 2009, ECOL ENG, V35, P711, DOI 10.1016/j.ecoleng.2008.11.007; Skaala O, 2014, MAR BIOL RES, V10, P308, DOI 10.1080/17451000.2013.810758; Snow A, 2012, ENVIRON REV, V20, P54, DOI [10.1139/A11-023, 10.1139/a11-023]; Suhr KI, 2010, AQUACULT ENG, V42, P31, DOI 10.1016/j.aquaeng.2009.10.001; Svendsen LM, 2010, FARMING FRESHWATER R; Svobodova Z, 2005, ACTA VET BRNO, V74, P129, DOI 10.2754/avb200574010129; Tello A, 2010, ENVIRON POLLUT, V158, P1147, DOI 10.1016/j.envpol.2009.11.029; Terjesen BF, 2013, AQUACULT ENG, V54, P49, DOI 10.1016/j.aquaeng.2012.11.002; Turcios AE, 2014, SUSTAINABILITY-BASEL, V6, P836, DOI 10.3390/su6020836; van Rijn J, 2013, AQUACULT ENG, V53, P49, DOI 10.1016/j.aquaeng.2012.11.010; Vymazal J, 2011, HYDROBIOLOGIA, V674, P133, DOI 10.1007/s10750-011-0738-9; Wang XX, 2012, AQUACULT ENV INTERAC, V2, P267, DOI 10.3354/aei00044; Weaver KL, 2008, J AM DIET ASSOC, V108, P1178, DOI 10.1016/j.jada.2008.04.023; Webb JA, 2012, AQUACULT ENV INTERAC, V3, P23, DOI 10.3354/aei00048; Wilfart A, 2013, J ENVIRON MANAGE, V121, P96, DOI 10.1016/j.jenvman.2013.01.031; Zachritz WH, 2008, AQUACULT ENG, V39, P16, DOI 10.1016/j.aquaeng.2008.05.001; Zhang SY, 2011, AQUACULT ENG, V45, P93, DOI 10.1016/j.aquaeng.2011.08.001; Zhong F, 2011, J ENVIRON SCI HEAL A, V46, P789, DOI 10.1080/10934529.2011.571974	59	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123577	10.1371/journal.pone.0123577	http://dx.doi.org/10.1371/journal.pone.0123577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853416	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400104
J	Corazzini, L; Filippin, A; Vanin, P				Corazzini, Luca; Filippin, Antonio; Vanin, Paolo			Economic Behavior under the Influence of Alcohol: An Experiment on Time Preferences, Risk-Taking, and Altruism	PLOS ONE			English	Article							FRATERNITY MEMBERSHIP; DRINKING; DELAY; AVERSION; UTILITY; INTOXICATION; IMPULSIVITY; HEALTH	We report results from an incentivized laboratory experiment undertaken with the purpose of providing controlled evidence on the causal effects of alcohol consumption on risk-taking, time preferences and altruism. Our design disentangles the pharmacological effects of alcohol intoxication from those mediated by expectations, as we compare the behavior of three groups of subjects: those who participated in an experiment with no reference to alcohol, those who were exposed to the possibility of consuming alcohol but were given a placebo and those who effectively consumed alcohol. All subjects participated in a series of economic tasks administered in the same sequence across treatments. After controlling for both the willingness to pay for an object and the potential misperception of probabilities as elicited in the experiment, we detect no effect of alcohol in depleting subjects' risk tolerance. However, we find that alcohol intoxication increases impatience and makes subjects less altruistic.	[Corazzini, Luca] Univ Messina, Dept Law Sci, Messina, Italy; [Corazzini, Luca] Univ Messina, Hist Inst, Messina, Italy; [Corazzini, Luca] Bocconi Univ, ISLA, Milan, Italy; [Filippin, Antonio] Univ Milan, Dept Econ, Milan, Italy; [Filippin, Antonio] Inst Study Labor IZA, Bonn, Germany; [Vanin, Paolo] Univ Bologna, Dept Econ, Bologna, Italy	University of Messina; University of Messina; Bocconi University; University of Milan; IZA Institute Labor Economics; University of Bologna	Corazzini, L (corresponding author), Univ Messina, Dept Law Sci, Messina, Italy.	lcorazzini@unime.it	Filippin, Antonio/L-4243-2017	VANIN, PAOLO/0000-0001-8767-8567; FILIPPIN, ANTONIO/0000-0002-3824-9544	Italian Ministry of Research and Education (FIRB, SoNIC) [RBFR084L83]	Italian Ministry of Research and Education (FIRB, SoNIC)	The authors gratefully acknowledge support from the Italian Ministry of Research and Education (FIRB 2008, SoNIC, RBFR084L83). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2006, J STUD ALCOHOL, V67, P628, DOI 10.15288/jsa.2006.67.628; Ainslie G, 1983, ETIOLOGIC ASPECTS AL, V12, P311; Anderhub V, 2001, GER ECON REV, V2, P239, DOI DOI 10.1111/1468-0475.00036; Anderson LR, 2008, J HEALTH ECON, V27, P1260, DOI 10.1016/j.jhealeco.2008.05.011; Barsky RB, 1997, Q J ECON, V112, P537, DOI 10.1162/003355397555280; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Benjamin DJ, 2013, J EUR ECON ASSOC, V11, P1231, DOI 10.1111/jeea.12055; Bernheim BD, 2004, AM ECON REV, V94, P1558, DOI 10.1257/0002828043052222; Bradford WD, 2014, CEP DISCUSSION PAPER, V1255; Breslin FC, 1999, PSYCHOL ADDICT BEHAV, V13, P243, DOI 10.1037/0893-164X.13.3.243; Buonanno P, 2013, EMPIR ECON, V44, P1635, DOI 10.1007/s00181-012-0585-1; Burghart DR, 2013, J RISK UNCERTAINTY, V46, P215, DOI 10.1007/s11166-013-9167-7; Chatterji P, 2006, NBER WORKING PAPERS; Chatterji P, 2005, NBER WORKING PAPERS; Crosetto P, 2013, JENA EC RES PAPERS, V009; CUTTER HSG, 1973, BRIT J SOC CLIN PSYC, V12, P83, DOI 10.1111/j.2044-8260.1973.tb00849.x; Dee TS, 1999, J PUBLIC ECON, V72, P289, DOI 10.1016/S0047-2727(98)00093-0; DeSimone J, 2007, J HEALTH ECON, V26, P950, DOI 10.1016/j.jhealeco.2007.01.003; DeSimone J, 2009, ECON INQ, V47, P337, DOI 10.1111/j.1465-7295.2008.00121.x; Dills AK., 2004, AM LAW ECON REV, V6, P285, DOI DOI 10.1093/ALER/AHH003; Duarte R, 2006, ECON EDUC REV, V25, P179, DOI 10.1016/j.econedurev.2005.01.007; Estle SJ, 2007, PSYCHOL SCI, V18, P58, DOI 10.1111/j.1467-9280.2007.01849.x; Field M, 2007, ADDICTION, V102, P579, DOI 10.1111/j.1360-0443.2007.01743.x; Filippin A, 2014, IZA DISCUSSION PAPER, V8184; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; G Loewenstein, 2007, HEAT MOMENT MODELING; Galizzi MM, 2012, WORKING PAPERS IMPER, V9792; Gonzalez R, 1999, COGNITIVE PSYCHOL, V38, P129, DOI 10.1006/cogp.1998.0710; Green L, 2013, J EXP ANAL BEHAV, V99, P3, DOI 10.1002/jeab.1; Grossman M., 2005, E ECON J, V31, P383; GUSTAFSON R, 1990, PERCEPT MOTOR SKILL, V71, P1367, DOI 10.2466/PMS.71.8.1367-1374; Harrison GW, 2008, RES EXP ECON, V12, P41, DOI 10.1016/S0193-2306(08)00003-3; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Kessler J, 2015, METHODS MOD IN PRESS; Kirby KN, 2004, ADDICTION, V99, P461, DOI 10.1111/j.1360-0443.2003.00669.x; Koch SF, 2005, ECON INQ, V43, P750, DOI 10.1093/ei/cbi052; Kremer M, 2008, J ECON PERSPECT, V22, P189, DOI 10.1257/jep.22.3.189; Lane SD, 2004, PSYCHOPHARMACOLOGY, V172, P68, DOI 10.1007/s00213-003-1628-2; Levitt SD, 2001, J POLIT ECON, V109, P1198, DOI 10.1086/323281; Lundborg P, 2006, J HEALTH ECON, V25, P214, DOI 10.1016/j.jhealeco.2005.02.001; Malani A, 2008, ADV HEALTH ECON HEAL, V20, P311, DOI 10.1016/S0731-2199(08)20013-0; Markowitz S, 2005, INT REV LAW ECON, V25, P20, DOI 10.1016/j.irle.2005.05.003; Markowitz S, 2005, AM ECON REV, V95, P263, DOI 10.1257/000282805774669899; Meier SE, 1996, J STUD ALCOHOL, V57, P85, DOI 10.15288/jsa.1996.57.85; Menon M, 2009, RIV INT SCI SOC, V117, P593; Moore SC, 2010, PSYCHIAT RES, V179, P324, DOI 10.1016/j.psychres.2008.07.024; Ortner CNM, 2003, ALCOHOL ALCOHOLISM, V38, P151, DOI 10.1093/alcalc/agg041; Petry NM, 2001, PSYCHOPHARMACOLOGY, V154, P243, DOI 10.1007/s002130000638; Poulos CX, 1995, BEHAV PHARMACOL, V6, P810; Proestakis A, 2013, J NEUROSCI PSYCHOL E, V6, P115, DOI 10.1037/npe0000004; Rabin M, 2000, ECONOMETRICA, V68, P1281, DOI 10.1111/1468-0262.00158; Reynolds B, 2006, PHARMACOL BIOCHEM BE, V83, P194, DOI 10.1016/j.pbb.2006.01.007; Richards JB, 1999, J EXP ANAL BEHAV, V71, P121, DOI 10.1901/jeab.1999.71-121; SJOBERG L, 1969, PSYCHOPHARMACOLOGIA, V14, P284, DOI 10.1007/BF02190113; Vuchinich RE, 1998, EXP CLIN PSYCHOPHARM, V6, P292, DOI 10.1037/1064-1297.6.3.292	56	14	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121530	10.1371/journal.pone.0121530	http://dx.doi.org/10.1371/journal.pone.0121530			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853520	gold, Green Published			2022-12-27	WOS:000352478400042
J	Frikha, Z; Girerd, N; Huttin, O; Courand, PY; Bozec, E; Olivier, A; Lamiral, Z; Zannad, F; Rossignol, P				Frikha, Zied; Girerd, Nicolas; Huttin, Olivier; Courand, Pierre Yves; Bozec, Erwan; Olivier, Arnaud; Lamiral, Zohra; Zannad, Faiez; Rossignol, Patrick			Reproducibility in Echocardiographic Assessment of Diastolic Function in a Population Based Study (The STANISLAS Cohort Study)	PLOS ONE			English	Article							LEFT-VENTRICULAR DIMENSIONS; HEART-FAILURE; RECOMMENDATIONS; INTEROBSERVER; INTRAOBSERVER; RELAXATION	Introduction There is limited evidence regarding intra-observer and inter-observer variations in echocardiographic measurements of diastolic function. This study aimed to assess this reproducibly within a population-based cohort study. Methods Sixty subjects in sinus rhythm were randomly selected among 4th visit participants of the STANISLAS Cohort (Lorraine region, France). This 4th examination systematically included M-mode, 2-dimensional, DTI and pulsed-wave Doppler echocardiograms. Reproducibility of variables was studied by intra-class correlation coefficients (ICC) and Bland Altman plots. Results Our population was on average middle-aged (50 +/- 14y), overweight (BMI = 26 +/- 6kg/m(2)) and non-smoking (87%) with a quarter of the participants having self-declared hypertension or treated with anti-hypertensive medication(s). Intra-observer ICC were > 0.90 for all analyzed parameters except for left ventricular ejection fraction (LVEF) which was 0.89 (0.81-0.93). The mean relative intra-observer differences were small and limits of agreement of relative differences were narrow for all considered parameters (<5% and <15% respectively). Inter-observer ICC were > 0.90 for all analyzed parameters except for LVEF (ICC = 0.87) and both mitral and pulmonary A wave duration (0.83 and 0.73 respectively). The mean relative inter-observer differences were <5% for all parameters except for pulmonary A wave duration (mean difference = 6.5%). Limits of agreement of relative differences were narrow (<15%), except for mitral A wave duration and velocity (both <20%) as well as left ventricular mass and pulmonary A wave duration (both <30%). Intra-observer agreements with regard to the presence and severity of diastolic dysfunction were excellent (Kappa = 0.93 (0.83-1.00) and 0.88 (0.75-0.99), respectively). Conclusion In this validation study within the STANISLAS cohort, diastolic function echocardiographic parameters were found to be highly reproducible. Diastolic dysfunction consequently appears as a highly effective clinical and research tool.	[Frikha, Zied; Girerd, Nicolas; Bozec, Erwan; Lamiral, Zohra; Zannad, Faiez; Rossignol, Patrick] Univ Lorraine, CHU Nancy, Inst Lorrain Coeur & Vaisseaux, INSERM,Ctr Invest Clin 9501, Nancy, France; [Huttin, Olivier; Lamiral, Zohra] Ctr Hosp Univ Nancy, Inst Lorrain Coeur & Vaisseaux, Serv Cardiol, Nancy, France; [Courand, Pierre Yves] Hosp Civils Lyon, Hop Croix Rousse, European Soc Hypertens Excellence Ctr, Federat Cardiol, F-69004 Lyon, France; [Courand, Pierre Yves] Univ Lyon 1, Genom Fonctionnelle Hypertens Arterielle, EA 4173, F-69100 Villeurbanne, France; [Courand, Pierre Yves] Hop Nord Ouest, F-69400 Villefranche, France	CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Rossignol, P (corresponding author), Univ Lorraine, CHU Nancy, Inst Lorrain Coeur & Vaisseaux, INSERM,Ctr Invest Clin 9501, Nancy, France.	p.rossignol@chu-nancy.fr	Courand, Pierre-Yves/O-1054-2016; HUttin, Olivier/AAW-8052-2020; Zannad, Faiez/K-4649-2019; GIRERD, Nicolas/D-5493-2011	Courand, Pierre-Yves/0000-0003-3199-7977; Girerd, Nicolas/0000-0002-3278-2057	Nancy CHU; Lorraine Region; Programme Hospitalier de Recherche Clinique Interregional (BioSe); 7th EU-FP MEDIA project (FP7) [261409]; HOMAGE (FP7) [305507]; FIBRO-TARGETS project (FP7) [602904]	Nancy CHU; Lorraine Region(Region Grand-Est); Programme Hospitalier de Recherche Clinique Interregional (BioSe); 7th EU-FP MEDIA project (FP7); HOMAGE (FP7); FIBRO-TARGETS project (FP7)	This study was sponsored by Nancy CHU and granted by the Lorraine Region, the Programme Hospitalier de Recherche Clinique Interregional (BioSe), the 7th EU-FP MEDIA project (FP7 #261409), the HOMAGE (FP7 #305507) and the FIBRO-TARGETS project (FP7 #602904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, J CARD FAIL, V12, P10, DOI 10.1016/j.cardfail.2005.12.001; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; GALDERISI M, 1992, AM J CARDIOL, V70, P1341, DOI 10.1016/0002-9149(92)90772-Q; GRANDITS GA, 1994, CONTROL CLIN TRIALS, V15, P395, DOI 10.1016/0197-2456(94)90035-3; Hatle L, 2007, EUR HEART J, V28, P2421, DOI 10.1093/eurheartj/ehm412; Kuecherer H F, 1991, J Am Soc Echocardiogr, V4, P203; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; LADIPO GOA, 1980, BRIT HEART J, V44, P284; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Last JM, DICT EPIDEMIOLOGY; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Otterstad JE, 1997, EUR HEART J, V18, P507; Palmieri V, 1999, J AM COLL CARDIOL, V34, P1625, DOI 10.1016/S0735-1097(99)00396-4; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; SCHIEKEN RM, 1979, AM J EPIDEMIOL, V110, P504, DOI 10.1093/oxfordjournals.aje.a112831; SPIRITO P, 1988, EUR HEART J, V9, P879, DOI 10.1093/oxfordjournals.eurheartj.a062582; Unzek S, 2011, JACC-CARDIOVASC IMAG, V4, P460, DOI 10.1016/j.jcmg.2011.01.016; Valantine H A, 1990, J Am Soc Echocardiogr, V3, P276; VALDEZ RS, 1979, CIRCULATION, V60, P921, DOI 10.1161/01.CIR.60.4.921; Zile MR, 2004, NEW ENGL J MED, V350, P1953, DOI 10.1056/NEJMoa032566	21	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122336	10.1371/journal.pone.0122336	http://dx.doi.org/10.1371/journal.pone.0122336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853818	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400064
J	Hu, ZX; Wan, XB; Hao, R; Zhang, H; Li, L; Li, L; Xie, Q; Wang, P; Gao, YB; Chen, S; Wei, M; Luan, ZD; Zhang, AQ; Huang, N; Chen, L				Hu, Zexi; Wan, Xiaobo; Hao, Rui; Zhang, Heng; Li, Li; Li, Lin; Xie, Qiang; Wang, Peng; Gao, Yibo; Chen, She; Wei, Min; Luan, Zhidong; Zhang, Aiqun; Huang, Niu; Chen, Liang			Phosphorylation of Mutationally Introduced Tyrosine in the Activation Loop of HER2 Confers Gain-of-Function Activity	PLOS ONE			English	Article							KINASE DOMAIN; BREAST-CANCER; ERBB2; RECEPTOR; RESISTANCE; MECHANISM; INHIBITOR; LAPATINIB; FORMS; KIT	Amplification, overexpression, and somatic mutation of the HER2 gene have been reported to play a critical role in tumorigenesis of various cancers. The HER2 H878Y mutation was recently reported in 11% of hepatocellular carcinoma (HCC) patients. However, its functional impact on the HER2 protein and its role in tumorigenesis has not been determined. Here, we show that HER2 H878Y is a gain-of-function mutation. Y878 represents a phosphorylation site, and phospho-Y878 interacts with R898 residue to stabilize the active conformation of HER2, thereby enhancing its kinase activity. H878Y mutant is transforming and the transformed cells are sensitive to HER2 kinase inhibitors. Thus, our study reveals the following novel mechanism underlying the tumorigenic function of the HER2 H878Y mutation: the introduction of a tyrosine residue into the kinase activation loop via mutagenesis modulates the conformation of the kinase, thereby enhancing its activity.	[Hu, Zexi] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Hu, Zexi; Wan, Xiaobo; Li, Li; Li, Lin; Chen, She; Huang, Niu] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Hao, Rui; Wei, Min] BeiGene Beijing Co Ltd, Beijing 102206, Peoples R China; [Zhang, Heng] Cent Hosp Lishui City, Lishui 323000, Zhejiang, Peoples R China; [Xie, Qiang] Fuzhou Pulm Hosp Fujian, Fujian 350008, Peoples R China; [Wang, Peng] Beijing Ditan Hosp, Beijing 100015, Peoples R China; [Gao, Yibo] Inst Canc Res, Dept Thorac Surg, Beijing 100021, Peoples R China; [Gao, Yibo] Hosp Chinese Acad Med Sci, Beijing 100021, Peoples R China; [Luan, Zhidong] Liaoning Med Univ, Jinzhou 121001, Liaoning, Peoples R China; [Zhang, Aiqun] 301 Hosp, Gen Hosp Peoples Liberat Army, Beijing 100853, Peoples R China; [Chen, Liang] Natl Inst Biol Sci, Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China	Beijing Normal University; National Institute of Biological Sciences, Beijing; Capital Medical University; Jinzhou Medical University; National Institute of Biological Sciences, Beijing	Chen, L (corresponding author), Natl Inst Biol Sci, Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China.	chenliang@nibs.ac.cn	Gao, Yi-Bo/AAP-4866-2020; Huang, Niu/J-9656-2012	Gao, Yi-Bo/0000-0002-0501-9814; Huang, Niu/0000-0002-6912-033X; Chen, Liang/0000-0001-7300-6604	Chinese Ministry of Science and Technology [2011CB812401]; National Natural Science Foundation of China [81472606]; National Science and Technology Major Project for Infectious Diseases of China [2012ZX10002-017]; BeiGene (Beijing) Co., Ltd.	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project for Infectious Diseases of China; BeiGene (Beijing) Co., Ltd.	Funding was provided by the Chinese Ministry of Science and Technology grant 2011CB812401 to LC, National Natural Science Foundation of China grant 81472606 to LC, National Science and Technology Major Project for Infectious Diseases of China 2012ZX10002-017 to AZ (http://www.most.gov.cn/eng/). BeiGene (Beijing) Co., Ltd. provided support in the form of salaries for authors RH and MW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Bekaii-Saab T, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-278; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fernandes A, 1999, INT J CANCER, V83, P564, DOI 10.1002/(SICI)1097-0215(19991112)83:4<564::AID-IJC20>3.0.CO;2-Q; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Kancha RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026760; Katterle Y, 2004, BRIT J CANCER, V90, P230, DOI 10.1038/sj.bjc.6601506; Kim SY, 2011, BIOCHEM BIOPH RES CO, V410, P224, DOI 10.1016/j.bbrc.2011.05.111; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; PELES E, 1991, EMBO J, V10, P2077, DOI 10.1002/j.1460-2075.1991.tb07739.x; Richardson CJ, 2009, NUCLEIC ACIDS RES, V37, pD824, DOI 10.1093/nar/gkn832; Riely GJ, 2008, J THORAC ONCOL, V3, pS146, DOI 10.1097/JTO.0b013e318174e96e; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Sendur MAN, 2012, CURR MED RES OPIN, V28, P1709, DOI 10.1185/03007995.2012.728132; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Trowe T, 2008, CLIN CANCER RES, V14, P2465, DOI 10.1158/1078-0432.CCR-07-4367; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Woodman SE, 2010, BIOCHEM PHARMACOL, V80, P568, DOI 10.1016/j.bcp.2010.04.032; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yuan GG, 2008, CELL SIGNAL, V20, P1284, DOI 10.1016/j.cellsig.2008.02.017	29	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123623	10.1371/journal.pone.0123623	http://dx.doi.org/10.1371/journal.pone.0123623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853726	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400109
J	Pereira, L; Choquet, C; Perozziello, A; Wargon, M; Juillien, G; Colosi, L; Hellmann, R; Ranaivoson, M; Casalino, E				Pereira, Laurent; Choquet, Christophe; Perozziello, Anne; Wargon, Mathias; Juillien, Gaelle; Colosi, Luisa; Hellmann, Romain; Ranaivoson, Michel; Casalino, Enrique			Unscheduled-Return-Visits after an Emergency Department (ED) Attendance and Clinical Link between Both Visits in Patients Aged 75 Years and Over: A Prospective Observational Study	PLOS ONE			English	Article							HOSPITAL READMISSIONS; HIGH-RISK; ADMISSIONS; CARE; QUALITY	Background Predictors of unscheduled return visits (URV), best time-frame to evaluate URV rate and clinical relationship between both visits have not yet been determined for the elderly following an ED visit. Methods We conducted a prospective-observational study including 11,521 patients aged >= 75-years and discharged from ED (5,368 patients (53.5%)) or hospitalized after ED visit (6,153 patients). Logistic Regression and time-to-failure analyses including Cox proportional model were performed. Results Mean time to URV was 17 days; 72-hour, 30-day and 90-day URV rates were 1.8%, 6.1% and 10% respectively. Multivariate analysis indicates that care-pathway and final disposition decisions were significantly associated with a 30-day URV. Thus, we evaluated predictors of 30-day URV rates among non-admitted and hospitalized patient groups. By using the Cox model we found that, for non-admitted patients, triage acuity and diagnostic category and, for hospitalized patients, that visit time (day, night) and diagnostic categories were significant predictors (p< 0.001). For URV, we found that 25% were due to closely related-clinical conditions. Time lapses between both visits constituted the strongest predictor of closely related-clinical conditions. Conclusion Our study shows that a decision of non-admission in emergency departments is linked with an accrued risk of URV, and that some diagnostic categories are also related for non- admitted and hospitalized subjects alike. Our study also demonstrates that the best time frame to evaluate the URV rate after an ED visit is 30 days, because this is the time period during which most URVs and cases with close clinical relationships between two visits are concentrated. Our results suggest that URV can be used as an indicator or quality.	[Pereira, Laurent; Choquet, Christophe; Juillien, Gaelle; Colosi, Luisa; Hellmann, Romain; Ranaivoson, Michel; Casalino, Enrique] Univ Hosp Bichat Claude Bernard, AP HP, Emergency Dept, Paris, France; [Pereira, Laurent; Choquet, Christophe; Perozziello, Anne; Wargon, Mathias; Juillien, Gaelle; Colosi, Luisa; Hellmann, Romain; Ranaivoson, Michel; Casalino, Enrique] Study Grp Efficiency & Qual, Emergency Dept, Paris, France; [Pereira, Laurent; Choquet, Christophe; Perozziello, Anne; Wargon, Mathias; Juillien, Gaelle; Colosi, Luisa; Hellmann, Romain; Ranaivoson, Michel; Casalino, Enrique] Nonscheduled Act Dept, Paris, France; [Perozziello, Anne] Univ Hosp Bichat Claude Bernard, Med Informat Syst Program PMSI, Paris, France; [Wargon, Mathias] Hop St Camille, Bry Sur Marne, France; [Casalino, Enrique] Univ Paris Diderot, Sorbonne Paris Cite, REMES, EA 7334, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Casalino, E (corresponding author), Univ Hosp Bichat Claude Bernard, AP HP, Emergency Dept, Paris, France.	enrique.casalino@bch.aphp.fr	Casalino, Enrique/GYU-1974-2022	Casalino, Enrique/0000-0002-4352-6729				[Anonymous], 2008, EMERGENCY READMISSIO; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Bianco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048263; Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; Bottle A, 2006, J ROY SOC MED, V99, P406, DOI 10.1258/jrsm.99.8.406; Carret ML, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-131; de Stampa M, 2010, INT J INTEGR CARE, V10; Department of Health, 2010, A E CLIN QUAL IND IM; Epstein AM, 2009, NEW ENGL J MED, V360, P1457, DOI 10.1056/NEJMe0901006; Fan LJ, 2015, EMERG MED J, V32, P738, DOI 10.1136/emermed-2014-203770; Foo CL, 2012, AUSTRALAS J AGEING, V31, P40, DOI 10.1111/j.1741-6612.2010.00499.x; Friedman B, 2004, MED CARE RES REV, V61, P225, DOI 10.1177/1077558704263799; George G, 2006, EMERG MED J, V23, P379, DOI 10.1136/emj.2005.029793; Gruneir Andrea, 2011, Open Med, V5, pe104; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Hampton T, 2008, JAMA-J AM MED ASSOC, V299, P2613, DOI 10.1001/jama.299.22.2613; Hastings SN, 2011, AM J MANAG CARE, V17, pE215; Huang AR, 2011, CAN GERIATR J, V14, P100, DOI [10.5770/cgj.v14i4.8, 10.57700/cgj.v14i4.8]; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; KEITH KD, 1989, ANN EMERG MED, V18, P964, DOI 10.1016/S0196-0644(89)80461-5; Laniece I, 2008, AGE AGEING, V37, P416, DOI 10.1093/ageing/afn093; Lowthian J, 2013, INTERN MED J, V43, P554, DOI 10.1111/imj.12061; McBride S, 2008, PARAMETERS FOR THE A, P4; McCusker J, 2006, J GERONTOL A-BIOL, V61, P53, DOI 10.1093/gerona/61.1.53; McCusker J, 2007, ACAD EMERG MED, V14, P426, DOI 10.1197/j.aem.2006.11.020; McCusker J, 2012, J AM GERIATR SOC, V60, P1534, DOI 10.1111/j.1532-5415.2012.04058.x; Newnham HH, 2012, MED J AUSTRALIA, V196, P101, DOI 10.5694/mja11.10619; ODWYER F, 1991, ARCH EMERG MED, V8, P196; Roberts C, 2005, STAT METHODS MED RES, V14, P493, DOI 10.1191/0962280205sm413oa; Roland M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6017; Silow-Carroll S, REDUCING HOSPITAL RE; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Trivedy CR, 2015, EMERG MED J, V32, P324, DOI 10.1136/emermed-2013-202719; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Zapatero A, 2012, EUR J INTERN MED, V23, P451, DOI 10.1016/j.ejim.2012.01.005	36	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123803	10.1371/journal.pone.0123803	http://dx.doi.org/10.1371/journal.pone.0123803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853822	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400118
J	Pi, C; Allott, EH; Ren, D; Poulton, S; Lee, SYR; Perkins, S; Everett, ML; Holzknecht, ZE; Lin, SS; Parker, W				Pi, Cinthia; Allott, Emma H.; Ren, Daniel; Poulton, Susan; Lee, S. Y. Ryan; Perkins, Sarah; Everett, Mary Lou; Holzknecht, Zoie E.; Lin, Shu S.; Parker, William			Increased Biodiversity in the Environment Improves the Humoral Response of Rats	PLOS ONE			English	Article							NATURAL ANTIBODIES; HYGIENE HYPOTHESIS; SPECIFICITY; IGG	Previous studies have compared the immune systems of wild and of laboratory rodents in an effort to determine how laboratory rodents differ from their naturally occurring relatives. This comparison serves as an indicator of what sorts of changes might exist between modern humans living in Western culture compared to our hunter-gatherer ancestors. However, immunological experiments on wild-caught animals are difficult and potentially confounded by increased levels of stress in the captive animals. In this study, the humoral immune responses of laboratory rats in a traditional laboratory environment and in an environment with enriched biodiversity were examined following immunization with a panel of antigens. Biodiversity enrichment included colonization of the laboratory animals with helminths and co-housing the laboratory animals with wild-caught rats. Increased biodiversity did not apparently affect the IgE response to peanut antigens following immunization with those antigens. However, animals housed in the enriched biodiversity setting demonstrated an increased mean humoral response to T-independent and T-dependent antigens and increased levels of "natural" antibodies directed at a xenogeneic protein and at an autologous tissue extract that were not used as immunogens.	[Pi, Cinthia; Ren, Daniel; Poulton, Susan; Lee, S. Y. Ryan; Everett, Mary Lou; Holzknecht, Zoie E.; Lin, Shu S.; Parker, William] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Allott, Emma H.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Perkins, Sarah] Cardiff Sch Biosci, Cardiff, S Glam, Wales	Duke University; University of North Carolina; University of North Carolina Chapel Hill; Cardiff University	Parker, W (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	bparker@duke.edu		Parker, William/0000-0003-3644-9152	Coalition for SafeMinds	Coalition for SafeMinds	This work was supported in part by the Coalition for SafeMinds (http://www.safeminds.org/) to WP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolins SR, 2011, MOL ECOL, V20, P881, DOI 10.1111/j.1365-294X.2010.04910.x; AlBalaghi S, 1996, SCAND J IMMUNOL, V44, P470, DOI 10.1046/j.1365-3083.1996.d01-338.x; Arai H. P., 1980, BIOL TAPEWORM HYMENO; Bilbo SD, 2011, MED HYPOTHESES, V77, P494, DOI 10.1016/j.mehy.2011.06.019; Casali P, 1996, CURR TOP MICROBIOL, V210, P167; de Jonge JD, 2007, METHODS, V41, P99, DOI 10.1016/j.ymeth.2006.09.004; Devalapalli AP, 2006, SCAND J IMMUNOL, V64, P125, DOI 10.1111/j.1365-3083.2006.01785.x; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; Leon-Cabrera S, 2014, INT J BIOL SCI, V10, P948, DOI 10.7150/ijbs.9033; Lesher A, 2006, IMMUNOL CELL BIOL, V84, P374, DOI 10.1111/j.1440-1711.2006.01440.x; Lin SS, 2012, J EVOLUTIONARY MED, V1, P1; Mishra PK, 2014, MUCOSAL IMMUNOL, V7, P753, DOI 10.1038/mi.2014.23; Parker W, 1997, J CLIN IMMUNOL, V17, P311, DOI 10.1023/A:1027378716015; Parker W, 2012, CURR MED RES OPIN, V28, P1193, DOI 10.1185/03007995.2012.695731; Parker William, 2002, P87; Rook GAW, 2009, IMMUNOLOGY, V126, P3, DOI 10.1111/j.1365-2567.2008.03007.x; Trama AM, 2012, CELL MOL IMMUNOL, V9, P163, DOI 10.1038/cmi.2011.61; TURMAN MA, 1991, TRANSPLANTATION, V52, P710, DOI 10.1097/00007890-199110000-00024; Vollmers HP, 2007, J AUTOIMMUN, V29, P295, DOI 10.1016/j.jaut.2007.07.013; Vollmers HP, 2009, NEW BIOTECHNOL, V25, P294, DOI 10.1016/j.nbt.2009.03.016	20	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120255	10.1371/journal.pone.0120255	http://dx.doi.org/10.1371/journal.pone.0120255			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853852	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000352478400011
J	Sirot, M; Willemsen, G; Sundar, P; Pitts, SJ; Potluri, S; Prifti, E; Kennedy, S; Ehrlich, SD; Neuteboom, J; Kluft, C; Malone, KE; Cox, DR; de Geus, EJC; Boomsma, DI				Sirot, Marina; Willemsen, Gonneke; Sundar, Purnima; Pitts, Steven J.; Potluri, Shobha; Prifti, Edi; Kennedy, Sean; Ehrlich, S. Dusko; Neuteboom, Jacoline; Kluft, Cornelis; Malone, Karen E.; Cox, David R.; de Geus, Eco J. C.; Boomsma, Dorret I.			Effect of Genome and Environment on Metabolic and Inflammatory Profiles	PLOS ONE			English	Article							NETHERLANDS TWIN REGISTER; BODY-MASS INDEX; BLOOD-PRESSURE; TELOMERE LENGTH; NUCLEAR RECEPTORS; HERITABILITY; METAANALYSIS; PHENOTYPES; MARKERS; INTERLEUKIN-6	Twin and family studies have established the contribution of genetic factors to variation in metabolic, hematologic and immunological parameters. The majority of these studies analyzed single or combined traits into pre-defined syndromes. In the present study, we explore an alternative multivariate approach in which a broad range of metabolic, hematologic, and immunological traits are analyzed simultaneously to determine the resemblance of monozygotic (MZ) twin pairs, twin-spouse pairs and unrelated, non-cohabiting individuals. A total of 517 participants from the Netherlands Twin Register, including 210 MZ twin pairs and 64 twin-spouse pairs, took part in the study. Data were collected on body composition, blood pressure, heart rate, and multiple biomarkers assessed in fasting blood samples, including lipid levels, glucose, insulin, liver enzymes, hematological measurements and cytokine levels. For all 51 measured traits, pair-wise Pearson correlations, correcting for family relatedness, were calculated across all the individuals in the cohort. Hierarchical clustering techniques were applied to group the measured traits into sub-clusters based on similarity. Sub-clusters were observed among metabolic traits and among inflammatory markers. We defined a phenotypic profile as the collection of all the traits measured for a given individual. Average within-pair similarity of phenotypic profiles was determined for the groups of MZ twin pairs, spouse pairs and pairs of unrelated individuals. The average similarity across the full phenotypic profile was higher for MZ twin pairs than for spouse pairs, and lowest for pairs of unrelated individuals. Cohabiting MZ twins were more similar in their phenotypic profile compared to MZ twins who no longer lived together. The correspondence in the phenotypic profile is therefore determined to a large degree by familial, mostly genetic, factors, while household factors contribute to a lesser degree to profile similarity.	[Sirot, Marina; Sundar, Purnima; Pitts, Steven J.; Potluri, Shobha; Cox, David R.] Rinat Pfizer, San Francisco, CA 94080 USA; [Willemsen, Gonneke; de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Prifti, Edi; Kennedy, Sean; Ehrlich, S. Dusko] INRA, Metagenopolis, Jouy En Josas, France; [Neuteboom, Jacoline; Kluft, Cornelis; Malone, Karen E.] Good Biomarker Sci, Leiden, Netherlands	Pfizer; Vrije Universiteit Amsterdam; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Willemsen, G (corresponding author), Rinat Pfizer, San Francisco, CA 94080 USA.	a.h.m.willemsen@vu.nl	Prifti, Edi/F-3967-2019; de Geus, Eco J.C./M-9318-2015; Boomsma, Dorret I/AAX-4470-2020; Ehrlich, S./Y-2423-2019	Prifti, Edi/0000-0001-8861-1305; de Geus, Eco J.C./0000-0001-6022-2666; Ehrlich, S./0000-0002-7563-4046; Sirota, Marina/0000-0002-7246-6083; Willemsen, Gonneke/0000-0003-3755-0236	INRA-Pfizer; Netherlands Organisation for Scientific Research [NWO 911 -09-032, NWO 480-04-004]; EMGO+Institute for Health and Care Research, Neuroscience Campus Amsterdam, BBMRI-NL (Biobanking and Biomolecular Resources Research Infrastructure); European Research Council [230374]	INRA-Pfizer; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EMGO+Institute for Health and Care Research, Neuroscience Campus Amsterdam, BBMRI-NL (Biobanking and Biomolecular Resources Research Infrastructure); European Research Council(European Research Council (ERC)European Commission)	Funding was obtained from INRA-Pfizer, the Netherlands Organisation for Scientific Research (NWO 911 -09-032; NWO 480-04-004), EMGO+Institute for Health and Care Research, Neuroscience Campus Amsterdam, BBMRI-NL (Biobanking and Biomolecular Resources Research Infrastructure), and the European Research Council (Genetics of Mental Illness 230374). Pfizer provided support in the form of salaries for authors PS, SP and SJP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Brito Diaz B, 2013, MED CLIN; Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; DEFAYS D, 1977, COMPUT J, V20, P364, DOI 10.1093/comjnl/20.4.364; Di Castelnuovo A, 2009, AM J EPIDEMIOL, V169, P1, DOI 10.1093/aje/kwn234; Draisma HHM, 2013, TWIN RES HUM GENET, V16, P947, DOI 10.1017/thg.2013.59; Fragoso TM, 2014, GENET EPIDEMIOL, V38, P152, DOI 10.1002/gepi.21784; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hottenga JJ, 2007, HYPERTENSION, V49, P832, DOI 10.1161/01.HYP.0000260092.93964.ed; IL'Yasova D, 2008, BIOMARKERS, V13, P41, DOI 10.1080/13547500701617708; Insel KC, 2012, BIOL RES NURS, V14, P124, DOI 10.1177/1099800411406433; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; KORKEILA M, 1995, INT J OBESITY, V19, P310; MCCARTNEY K, 1990, PSYCHOL BULL, V107, P226, DOI 10.1037/0033-2909.107.2.226; Merline AC, 2008, J STUD ALCOHOL DRUGS, V69, P352, DOI 10.15288/jsad.2008.69.352; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Min J, 2013, OBES REV, V14, P871, DOI 10.1111/obr.12065; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Neijts M, 2013, TWIN RES HUM GENET, V16, P931, DOI 10.1017/thg.2013.58; O'Garra A, 2009, NAT IMMUNOL, V10, P929, DOI 10.1038/ni0909-929; Ohmori Y, 1997, J BIOL CHEM, V272, P14899, DOI 10.1074/jbc.272.23.14899; Patrawalla P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044540; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Raggi P, 2010, AM J NEPHROL, V32, P317, DOI 10.1159/000319449; Ray KK, 2007, INT J CLIN PRACT, V61, P1145, DOI 10.1111/j.1742-1241.2007.01425.x; Schnabel RB, 2009, CIRC-CARDIOVASC GENE, V2, P229, DOI 10.1161/CIRCGENETICS.108.804245; Schousboe K, 2003, TWIN RES, V6, P409, DOI 10.1375/twin.6.5.409; SHANNON MF, 1995, J LEUKOCYTE BIOL, V57, P767, DOI 10.1002/jlb.57.5.767; Silventoinen K, 2003, J BIOSOC SCI, V35, P263, DOI 10.1017/S0021932003002633; Su S, 2008, ATHEROSCLEROSIS, V200, P213, DOI 10.1016/j.atherosclerosis.2007.12.009; TURULA M, 1990, DIABETES RES CLIN PR, V10, pS33, DOI 10.1016/0168-8227(90)90137-I; Valensi P, 2011, DIABETIC MED, V28, P440, DOI 10.1111/j.1464-5491.2010.03222.x; van Dongen J, 2014, BEHAV GENETICS; van Dongen J, 2013, J LIPID RES, V54, P2914, DOI 10.1194/jlr.P041673; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; van Rijn MJE, 2007, J HYPERTENS, V25, P565, DOI 10.1097/HJH.0b013e32801449fb; Willemsen G, 2013, TWIN RES HUM GENET, V16, P271, DOI 10.1017/thg.2012.140; Willemsen G, 2010, TWIN RES HUM GENET, V13, P231, DOI 10.1375/twin.13.3.231; Wu T, 2013, PSYCHOSOM MED, V75, P404, DOI 10.1097/PSY.0b013e31828d3cb6; Xu XJ, 2013, J HYPERTENS, V31, P690, DOI 10.1097/HJH.0b013e32835e2a4a	45	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120898	10.1371/journal.pone.0120898	http://dx.doi.org/10.1371/journal.pone.0120898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853885	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400021
J	Desch, KC; Kretz, C; Yee, A; Gildersleeve, R; Metzger, K; Agrawal, N; Cheng, J; Ginsburg, D				Desch, Karl C.; Kretz, Colin; Yee, Andrew; Gildersleeve, Robert; Metzger, Kristin; Agrawal, Nidhi; Cheng, Jane; Ginsburg, David			Probing ADAMTS13 Substrate Specificity using Phage Display	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-VIII; PLASMINOGEN-ACTIVATOR; SCISSILE BOND; DOMAIN A2; CLEAVAGE; LOCALIZATION; CONSTRUCTION; SUFFICIENT; CONTRIBUTE	Von Willebrand factor (VWF) is a large, multimeric protein that regulates hemostasis by tethering platelets to the subendothelial matrix at sites of vascular damage. The procoagulant activity of plasma VWF correlates with the length of VWF multimers, which is proteolytically controlled by the metalloprotease ADAMTS13. To probe ADAMTS13 substrate specificity, we created phage display libraries containing randomly mutated residues of a minimal ADAMTS13 substrate fragment of VWF, termed VWF73. The libraries were screened for phage particles displaying VWF73 mutant peptides that were resistant to proteolysis by ADAMTS13. These peptides exhibited the greatest mutation frequency near the ADAMTS13 scissile residues. Kinetic assays using mutant and wild-type substrates demonstrated excellent agreement between rates of cleavage for mutant phage particles and the corresponding mutant peptides. Cleavage resistance of selected mutations was tested in vivo using hydrodynamic injection of corresponding full-length expression plasmids into VWF-deficient mice. These studies confirmed the resistance to cleavage resulting from select amino acid substitutions and uncovered evidence of alternate cleavage sites and recognition by other proteases in the circulation of ADAMTS13 deficient mice. Taken together, these studies demonstrate the key role of specific amino acids residues including P3-P2' and P11', for substrate specificity and emphasize the importance in flowing blood of other ADAMTS13-VWF exosite interactions outside of VWF73.	[Desch, Karl C.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Kretz, Colin; Yee, Andrew; Gildersleeve, Robert; Metzger, Kristin; Agrawal, Nidhi; Cheng, Jane] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ginsburg, David] Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med & Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Ginsburg, D (corresponding author), Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu	Kretz, Colin/L-1178-2016	Kretz, Colin/0000-0001-7979-7603; Ginsburg, David/0000-0002-6436-8942	National Institute of Health (US); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL039693] Funding Source: NIH RePORTER	National Institute of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants from the National Institute of Health (US). DG is a Howard Hughes Investigator.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Akiyama M, 2009, ACTA CRYSTALLOGR F, V65, P739, DOI 10.1107/S1744309109023410; Banno F, 2004, J BIOL CHEM, V279, P30896, DOI 10.1074/jbc.M314184200; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; Cao WJ, 2012, J BIOL CHEM, V287, P32459, DOI 10.1074/jbc.M112.390690; Chen JC, 2008, NAT BIOTECHNOL, V26, P114, DOI 10.1038/nbt1373; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; Gao WQ, 2006, P NATL ACAD SCI USA, V103, P19099, DOI 10.1073/pnas.0607264104; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; Ke SH, 1997, J BIOL CHEM, V272, P16603, DOI 10.1074/jbc.272.26.16603; Kokame K, 2004, BLOOD, V103, P607, DOI 10.1182/blood-2003-08-2861; LAWRENCE DA, 1994, J BIOL CHEM, V269, P15223; Levy GG, 2005, BLOOD, V106, P11, DOI 10.1182/blood-2004-10-4097; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; LYONS LB, 1972, VIROLOGY, V49, P45, DOI 10.1016/S0042-6822(72)80006-0; LYONS SE, 1992, J BIOL CHEM, V267, P4424; McKinnon TAJ, 2008, BLOOD, V111, P3042, DOI 10.1182/blood-2007-06-095042; MEISSNER PS, 1987, P NATL ACAD SCI USA, V84, P4171, DOI 10.1073/pnas.84.12.4171; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Muia J, 2014, P NATL ACAD SCI USA, V111, P18584, DOI 10.1073/pnas.1413282112; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; Perkin-Elmer, 2014, ALPHALISA ALPHASCREE; Pruss CM, 2012, J THROMB HAEMOST, V10, P940, DOI 10.1111/j.1538-7836.2012.04675.x; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; TSAI HM, 1994, BLOOD, V83, P2171; Uemura M, 2005, BLOOD, V106, P922, DOI 10.1182/blood-2005-01-0152; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; Xiang YZ, 2011, P NATL ACAD SCI USA, V108, P11602, DOI 10.1073/pnas.1018559108; Xu AJ, 2013, J BIOL CHEM, V288, P6317, DOI 10.1074/jbc.M112.422618; Yee A, 2014, BLOOD, V124, P445, DOI 10.1182/blood-2013-11-540534; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zhou WH, 2007, BLOOD, V110, P886, DOI 10.1182/blood-2007-01-070953; Zhou WH, 2005, LAB INVEST, V85, P780, DOI 10.1038/labinvest.3700275	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122931	10.1371/journal.pone.0122931	http://dx.doi.org/10.1371/journal.pone.0122931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849793	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800176
J	Dopheide, A; Lear, G; He, ZL; Zhou, JZ; Lewis, GD				Dopheide, Andrew; Lear, Gavin; He, Zhili; Zhou, Jizhong; Lewis, Gillian D.			Functional Gene Composition, Diversity and Redundancy in Microbial Stream Biofilm Communities	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BACTERIAL COMMUNITIES; BENTHIC INVERTEBRATES; NUTRIENT-UPTAKE; NEW-ZEALAND; LITTER; GEOCHIP; COPPER; BIOGEOGRAPHY; CONTAMINANTS	We surveyed the functional gene composition and diversity of microbial biofilm communities in 18 New Zealand streams affected by different types of catchment land use, using a comprehensive functional gene array, GeoChip 3.0. A total of 5,371 nutrient cycling and energy metabolism genes within 65 gene families were detected among all samples (342 to 2,666 genes per stream). Carbon cycling genes were most common, followed by nitrogen cycling genes, with smaller proportions of sulphur, phosphorus cycling and energy metabolism genes. Samples from urban and native forest streams had the most similar functional gene composition, while samples from exotic forest and rural streams exhibited the most variation. There were significant differences between nitrogen and sulphur cycling genes detected in native forest and urban samples compared to exotic forest and rural samples, attributed to contrasting proportions of nitrogen fixation, denitrification, and sulphur reduction genes. Most genes were detected only in one or a few samples, with only a small minority occurring in all samples. Nonetheless, 42 of 65 gene families occurred in every sample and overall proportions of gene families were similar among samples from contrasting streams. This suggests the existence of functional gene redundancy among different stream biofilm communities despite contrasting taxonomic composition.	[Dopheide, Andrew; Lear, Gavin; Lewis, Gillian D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [He, Zhili; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	University of Auckland; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Lewis, GD (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	gd.lewis@auckland.ac.nz	Lewis, Gillian/P-5538-2016; He, Zhili/C-2879-2012; Dopheide, Andrew/ABE-4778-2020; 吴, 昊/AAB-1620-2020; Lear, Gavin/AGI-4146-2022; Lear, Gavin/AHD-1751-2022	Lewis, Gillian/0000-0003-2904-7956; He, Zhili/0000-0001-8225-7333; Dopheide, Andrew/0000-0003-1554-9832; Lear, Gavin/0000-0001-5083-4773	New Zealand Foundation for Research, Science and Technology [UOAx306]; Royal Society of New Zealand Marsden Fund [LIU0901]	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This study was supported by the New Zealand Foundation for Research, Science and Technology UOAx306 (GDL) (http://www.msi.govt.nz/) and the Royal Society of New Zealand Marsden Fund LIU0901 (GL) (http://www.royalsociety.org.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Ancion P, 2010, THESIS U AUCKLAND NZ; Ancion PY, 2010, ENVIRON POLLUT, V158, P2738, DOI 10.1016/j.envpol.2010.04.013; [Anonymous], 2010, R LANG ENV STAT COMP; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Bernot MJ, 2006, FRESHWATER BIOL, V51, P499, DOI 10.1111/j.1365-2427.2006.01508.x; De la Iglesia R, 2012, FEMS MICROBIOL ECOL, V79, P720, DOI 10.1111/j.1574-6941.2011.01254.x; Dopheide A, 2009, APPL ENV MICROBIOL, V75; Fierer N, 2007, ECOLOGY, V88, P2162, DOI 10.1890/06-1746.1; Findlay S, 1997, NEW ZEAL J MAR FRESH, V31, P701, DOI 10.1080/00288330.1997.9516800; Findlay S, 2010, J N AM BENTHOL SOC, V29, P170, DOI 10.1899/09-023.1; Frossard A, 2012, ISME J, V6, P680, DOI 10.1038/ismej.2011.134; GEESEY GG, 1978, LIMNOL OCEANOGR, V23, P1214, DOI 10.4319/lo.1978.23.6.1214; Hagen EM, 2010, HYDROBIOLOGIA, V655, P61, DOI 10.1007/s10750-010-0404-7; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Headley JV, 1998, ENVIRON SCI TECHNOL, V32, P3968, DOI 10.1021/es980499l; Hoover TM, 2011, CAN J FOREST RES, V41, P1394, DOI [10.1139/x11-067, 10.1139/X11-067]; JONES SE, 1993, HYDROBIOLOGIA, V257, P1, DOI 10.1007/BF00013991; Kimes NE, 2010, ENVIRON MICROBIOL, V12, P541, DOI 10.1111/j.1462-2920.2009.02113.x; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Langenheder S, 2006, APPL ENVIRON MICROB, V72, P212, DOI 10.1128/AEM.72.1.212-220.2006; Lear G, 2009, ECOL INDIC, V9, P848, DOI 10.1016/j.ecolind.2008.10.001; Lear G, 2009, FRESHWATER BIOL, V54, P1532, DOI 10.1111/j.1365-2427.2009.02190.x; Lear G, 2013, GLOBAL ECOL BIOGEOGR, V22, P544, DOI 10.1111/geb.12046; Lear G, 2011, AQUAT ECOL, V45, P517, DOI 10.1007/s10452-011-9372-x; Lear G, 2009, APPL ENVIRON MICROB, V75, P3455, DOI 10.1128/AEM.00274-09; Magalhaes CM, 2011, FEMS MICROBIOL ECOL, V77, P274, DOI 10.1111/j.1574-6941.2011.01107.x; Neale MW, 2010, 2010016 AUCKL REG CO; Neale MW, 2009, 2009102 AUCKL REG CO; Paerl HW, 1996, MICROB ECOL, V31, P225; Peter H, 2011, ISME J, V5, P351, DOI 10.1038/ismej.2010.119; Quinn JM, 1997, NEW ZEAL J MAR FRESH, V31, P579, DOI 10.1080/00288330.1997.9516791; Quinn JM, 2000, NEW ZEAL J MAR FRESH, V34, P253, DOI 10.1080/00288330.2000.9516931; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Rice D.A., 2010, BIG THOMPSON RIVER W, P80523; Romani AM, 2004, MICROB ECOL, V47, P316, DOI 10.1007/s00248-003-2019-2; Scarsbrook MR, 2001, NEW ZEAL J MAR FRESH, V35, P751, DOI 10.1080/00288330.2001.9517040; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Sweeney BW, 2004, P NATL ACAD SCI USA, V101, P14132, DOI 10.1073/pnas.0405895101; Tu Qichao, 2014, Mol Ecol Resour, V14, P914, DOI 10.1111/1755-0998.12239; VAN HULLEBUSCH E. D., 2003, REV ENVIRON SCI BIO, V2, P9, DOI DOI 10.1023/B:RESB.0000022995.48330.55; Van Nostrand JD, 2009, ENVIRON MICROBIOL, V11, P2611, DOI 10.1111/j.1462-2920.2009.01986.x; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Wang LT, 2007, INT J SYST EVOL MICR, V57, P1846, DOI 10.1099/ijs.0.64685-0; Whiles MR, 1997, HYDROBIOLOGIA, V353, P107, DOI 10.1023/A:1003054827248; WRIGHT AC, 1981, NEW ZEAL J GEOL GEOP, V24, P155, DOI 10.1080/00288306.1981.10422711; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Xie JP, 2011, APPL ENVIRON MICROB, V77, P991, DOI 10.1128/AEM.01798-10; Yin HQ, 2008, ARCH MICROBIOL, V189, P101, DOI 10.1007/s00203-007-0298-6; Zak DR, 2006, TRENDS ECOL EVOL, V21, P288, DOI 10.1016/j.tree.2006.04.003; Zhang GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023059; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	56	36	37	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123179	10.1371/journal.pone.0123179	http://dx.doi.org/10.1371/journal.pone.0123179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849814	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800212
J	Carty, N; Berson, N; Tillack, K; Thiede, C; Scholz, D; Kottig, K; Sedaghat, Y; Gabrysiak, C; Yohrling, G; von der Kammer, H; Ebneth, A; Mack, V; Munoz-Sanjuan, I; Kwak, S				Carty, Nikisha; Berson, Nadege; Tillack, Karsten; Thiede, Christina; Scholz, Diana; Kottig, Karsten; Sedaghat, Yalda; Gabrysiak, Christina; Yohrling, George; von der Kammer, Heinz; Ebneth, Andreas; Mack, Volker; Munoz-Sanjuan, Ignacio; Kwak, Seung			Characterization of HTT Inclusion Size, Location, and Timing in the zQ175 Mouse Model of Huntington's Disease: An In Vivo High-Content Imaging Study	PLOS ONE			English	Article							MUTANT HUNTINGTIN; EARLY MOTOR; CAG REPEAT; MICE; EXPRESSION; LENGTH; ONSET	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the huntingtin gene. Major pathological hallmarks of HD include inclusions of mutant huntingtin (mHTT) protein, loss of neurons predominantly in the caudate nucleus, and atrophy of multiple brain regions. However, the early sequence of histological events that manifest in region-and cell-specific manner has not been well characterized. Here we use a high-content histological approach to precisely monitor changes in HTT expression and characterize deposition dynamics of mHTT protein inclusion bodies in the recently characterized zQ175 knock-in mouse line. We carried out an automated multi-parameter quantitative analysis of individual cortical and striatal cells in tissue slices from mice aged 2-12 months and confirmed biochemical reports of an age-associated increase in mHTT inclusions in this model. We also found distinct regional and subregional dynamics for inclusion number, size and distribution with subcellular resolution. We used viral-mediated suppression of total HTT in the striatum of zQ175 mice as an example of a therapeutically-relevant but heterogeneously transducing strategy to demonstrate successful application of this platform to quantitatively assess target engagement and outcome on a cellular basis.	[Carty, Nikisha; Berson, Nadege; Tillack, Karsten; Thiede, Christina; Scholz, Diana; Kottig, Karsten; Sedaghat, Yalda; Gabrysiak, Christina; von der Kammer, Heinz; Ebneth, Andreas; Mack, Volker] Evotec AG, Hamburg, Germany; [Yohrling, George; Munoz-Sanjuan, Ignacio; Kwak, Seung] CHDI Fdn, CHDI Management, Princeton, NJ 08540 USA	Evotec	Kwak, S (corresponding author), CHDI Fdn, CHDI Management, Princeton, NJ 08540 USA.	Seung.kwak@chdifoundation.org		Carty, Nikisha/0000-0002-0824-3897	CHDI Foundation	CHDI Foundation	This work was supported by CHDI Foundation, a privately-funded nonprofit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, research was conducted at the contract research organization Evotec AG under a fee-for-service agreements. The authors listed all contributed to the conception, planning, and direction of the research, including generation, analysis, and interpretation of the data. The specific roles of these authors are articulated in the author contributions section.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Gagnon KT, 2010, BIOCHEMISTRY-US, V49, P10166, DOI 10.1021/bi101208k; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Grondin R, 2012, BRAIN, V135, P1197, DOI 10.1093/brain/awr333; Gutekunst CA, 1998, J NEUROSCI, V18, P7674, DOI 10.1523/jneurosci.18-19-07674.1998; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Heng MY, 2007, J NEUROSCI, V27, P8989, DOI 10.1523/JNEUROSCI.1830-07.2007; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Menalled L, 2009, SOC NEUR ANN C; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled LB, 2002, J NEUROSCI, V22, P8266; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Minderer M, 2012, J PHYSIOL-LONDON, V590, P99, DOI 10.1113/jphysiol.2011.219014; Munoz-Sanjuan I, 2011, J CLIN INVEST, V121, P476, DOI 10.1172/JCI45364; Nedelec Jean-Francois J, 2004, Dialogues Clin Neurosci, V6, P227; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	28	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123527	10.1371/journal.pone.0123527	http://dx.doi.org/10.1371/journal.pone.0123527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859666	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300102
J	Li, X; Zhou, J; Huang, KC; Tang, FX; Zhou, H; Wang, SS; Jia, Y; Sun, HY; Ma, D; Li, S				Li, Xiong; Zhou, Jin; Huang, Kecheng; Tang, Fangxu; Zhou, Hang; Wang, Shaoshuai; Jia, Yao; Sun, Haiying; Ma, Ding; Li, Shuang			The Predictive Value of Serum Squamous Cell Carcinoma Antigen in Patients with Cervical Cancer Who Receive Neoadjuvant Chemotherapy followed by Radical Surgery: A Single-Institute Study	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; NODAL METASTASIS; SCC ANTIGEN; LEVEL	Objective Neoadjuvant chemotherapy (NACT) could affect the levels of squamous cell carcinoma antigen (SCC-Ag). This study evaluates the predictive value of pre- and posttreatment SCC-Ag levels in patients with cervical cancer who were treated with NACT followed by radical surgery. Methods A total of 286 patients with Stage IB1-IIIB squamous cell carcinoma of the uterine cervix who were treated with NACT followed by radical hysterectomy were analyzed retrospectively. The relationship between SCC-Ag levels, the clinicopathologic parameters, the response to NACT and the three-year survival rate was investigated. Results The levels of SCC-Ag were elevated (>3.5 ng/mL) in 43.8% of patients before NACT, and 13.0% of patients after NACT. Pre- and posttreatment levels of SCC-Ag correlated with the response to NACT (P = 0.010, and P<0.001), deep stromal infiltration (P = 0.041, and P = 0.006), and lymph node status (P<0.001, and P<0.001). In the multivariate analysis, the elevated pretreatment level of SCC-Ag was demonstrated to be an independent risk factor for Lymph node metastases (P<0.001). Patients with both pre- and posttreatment SCC-Ag levels <= 3.5 ng/mL showed the best 3-year disease-free survival (DFS) and 3-year overall survival (OS) compared with patients with either pre- or posttreatment levels >3.5 ng/mL (P<0.001, and P<0.001, respectively). A multivariate analysis showed that posttreatment SCC-Ag levels were a strong independent predictor of OS (P = 0.001) and DFS ( P = 0.012). Conclusion Elevated pretreatment levels of SCC-Ag (>3.5 ng/mL) indicated a poor response to NACT and a higher risk of lymph node metastases. Elevated posttreatment levels of SCC-Ag were correlated with poor DFS and OS.	[Li, Xiong; Zhou, Jin; Huang, Kecheng; Tang, Fangxu; Zhou, Hang; Wang, Shaoshuai; Jia, Yao; Sun, Haiying; Ma, Ding; Li, Shuang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China; [Zhou, Jin] Wuhan Univ, Renmin Hosp, Ctr Canc, Wuhan 430072, Hubei, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Ma, D (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China.	dma@tjh.tjmu.edu.cn; lee5190008@126.com	li, xiong/ABG-2578-2020	li, xiong/0000-0003-0203-2973; Li, Shuang/0000-0002-9193-0320	Key Basic Research and Development Program Foundation of China (973 Program) [2015CB553903, 2009CB521806]; National Natural Science Foundation of China [81230038, 81472783, 81272422, 81172464, 81090414, 81101964]	Key Basic Research and Development Program Foundation of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was endorsed by the Key Basic Research and Development Program Foundation of China (973 Program; No. 2015CB553903, 2009CB521806) and was supported by grants from the National Natural Science Foundation of China (No. 81230038; 81472783; 81272422; 81172464; 81090414; 81101964). No other potential conflict of interest relevant to this article was reported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVALLLUNDQVIST EH, 1992, EUR J CANCER, V28A, P1695, DOI 10.1016/0959-8049(92)90071-9; Bae SN, 1997, GYNECOL ONCOL, V64, P418, DOI 10.1006/gyno.1996.4589; Bolger BS, 1997, GYNECOL ONCOL, V65, P309, DOI 10.1006/gyno.1997.4619; BRIOSCHI PA, 1991, INT J CANCER, V47, P376, DOI 10.1002/ijc.2910470311; CROMBACH G, 1989, DEUT MED WOCHENSCHR, V114, P700, DOI 10.1055/s-2008-1066658; CROMBACH G, 1989, CANCER, V63, P1337, DOI 10.1002/1097-0142(19890401)63:7<1337::AID-CNCR2820630719>3.0.CO;2-J; Duk JM, 1996, J CLIN ONCOL, V14, P111, DOI 10.1200/JCO.1996.14.1.111; Eskander RN, 2014, J GYNECOL ONCOL, V25, P249, DOI 10.3802/jgo.2014.25.3.249; Gaarenstroom KN, 2000, GYNECOL ONCOL, V77, P164, DOI 10.1006/gyno.2000.5732; GAARENSTROOM KN, 1995, CANCER-AM CANCER SOC, V76, P807, DOI 10.1002/1097-0142(19950901)76:5<807::AID-CNCR2820760515>3.0.CO;2-M; Hong JH, 1998, INT J RADIAT ONCOL, V41, P823, DOI 10.1016/S0360-3016(98)00147-3; Hu T, 2012, EUR J CANCER, V48, P2353, DOI 10.1016/j.ejca.2012.03.015; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Kim DY, 2014, BRIT J CANCER, V110, P34, DOI 10.1038/bjc.2013.718; Lin H, 2000, ACTA OBSTET GYN SCAN, V79, P140, DOI 10.1034/j.1600-0412.2000.079002140.x; Massuger LFAG, 1997, GYNECOL ONCOL, V64, P473, DOI 10.1006/gyno.1996.4581; PATSNER B, 1989, OBSTET GYNECOL, V74, P786; SCAMBIA G, 1994, J CLIN ONCOL, V12, P2309, DOI 10.1200/JCO.1994.12.11.2309; Schmidt-Rhode P, 1988, Int J Biol Markers, V3, P87; Sturgeon CM, 2010, CLIN CHEM, V56, pE1, DOI 10.1373/clinchem.2009.133124; Takeshima N, 1998, GYNECOL ONCOL, V68, P263, DOI 10.1006/gyno.1998.4939	22	23	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122361	10.1371/journal.pone.0122361	http://dx.doi.org/10.1371/journal.pone.0122361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860888	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300042
J	Lin, YL; Ma, LT; Lee, YR; Lin, SS; Wang, SY; Chang, TT; Shaw, JF; Li, WH; Chu, FH				Lin, Yan-Liang; Ma, Li-Ting; Lee, Yi-Ru; Lin, Shih-Shun; Wang, Sheng-Yang; Chang, Tun-Tschu; Shaw, Jei-Fu; Li, Wen-Hsiung; Chu, Fang-Hua			MicroRNA-Like Small RNAs Prediction in the Development of Antrodia cinnamomea	PLOS ONE			English	Article							GENOME SEQUENCE; IDENTIFICATION; FUNGUS; ANNOTATION; GENE; RECONSTRUCTION; BIOGENESIS; MECHANISMS; GENERATION; INSIGHTS	Antrodia cinnamomea, a precious, host-specific brown-rot fungus that has been used as a folk medicine in Taiwan for centuries is known to have diverse bioactive compounds with potent pharmaceutical activity. In this study, different fermentation states of A. cinnamomea (wild-type fruiting bodies and liquid cultured mycelium) were sequenced using the next-generation sequencing (NGS) technique. A 45.58 Mb genome encoding 6,522 predicted genes was obtained. High quality reads were assembled into a total of 13,109 unigenes. Using a previously constructed pipeline to search for microRNAs (miRNAs), we then identified 4 predicted conserved miRNA and 63 novel predicted miRNA-like small RNA (milRNA) candidates. Target prediction revealed several interesting proteins involved in tri-terpenoid synthesis, mating type recognition, chemical or physical sensory protein and transporters predicted to be regulated by the miRNAs and milRNAs.	[Lin, Yan-Liang; Ma, Li-Ting; Lee, Yi-Ru; Chu, Fang-Hua] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan; [Lin, Shih-Shun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Wang, Sheng-Yang] Natl Chung Hsing Univ, Dept Forestry, Taichung 40227, Taiwan; [Wang, Sheng-Yang] Acad Sinica, Biotechnol Res Ctr, Agr, Taipei 115, Taiwan; [Wang, Sheng-Yang] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Chang, Tun-Tschu] Taiwan Forestry Res Inst, Div Forest Protect, Taipei, Taiwan; [Shaw, Jei-Fu] I Shou Univ, Dept Biol Sci & Technol, Kaohsiung, Taiwan; [Li, Wen-Hsiung] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Li, Wen-Hsiung] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Chu, Fang-Hua] Natl Taiwan Univ, Expt Forest, Nan Tou, Taiwan	National Taiwan University; National Taiwan University; National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University; I Shou University; Academia Sinica - Taiwan; University of Chicago; National Taiwan University	Chu, FH (corresponding author), Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan.	fhchu@ntu.edu.tw	Wang, Sheng-Yang/M-9656-2019; Lin, Shih-Shun/HCH-9241-2022; Ma, Li-Ting/GQB-3044-2022	Wang, Sheng-Yang/0000-0002-8579-3569; LIN, SHIH-SHUN/0000-0002-7295-5004; CHU, FANG-HUA/0000-0003-2299-5013; Ma, Li-Ting/0000-0001-6028-0831; Li, Wen-Hsiung/0000-0003-1086-1456	National Science Council [NSC-101-2911-I-005-301, NSC-102-2911- I-005-301]; Ministry of Education, Taiwan, under the Development Plan for World Class University and Research Centers of Excellence plan	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, under the Development Plan for World Class University and Research Centers of Excellence plan	This work was supported by the National Science Council (NSC-101-2911-I-005-301, NSC-102-2911- I-005-301), and the Ministry of Education, Taiwan, under the Development Plan for World Class University and Research Centers of Excellence plan.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chang TC, 2012, THESIS NATL TAIWAN U; Chang TT, 2004, BOT BULL ACAD SINICA, V45, P347; Chang YM, 2010, FEBS LETT, V584, P2028, DOI 10.1016/j.febslet.2009.12.035; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104956; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Chu FH, 2008, MYCOL RES, V112, P1421, DOI 10.1016/j.mycres.2008.06.006; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Du YC, 2012, PHYTOMEDICINE, V19, P788, DOI 10.1016/j.phymed.2012.03.014; Fernandez-Aguado M, 2014, METAB ENG, V22, P89, DOI 10.1016/j.ymben.2014.01.004; Geethangili M., 2011, EVID BASED COMPLEMEN; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jiang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052734; Jones SK, 2011, FUNGAL GENET BIOL, V48, P668, DOI 10.1016/j.fgb.2011.04.001; Kang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076288; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; LAI MH, 1994, GENE, V140, P41; Larsen PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009780; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lin YL, 2011, INT J MED MUSHROOMS, V13, P473, DOI 10.1615/IntJMedMushr.v13.i5.70; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu MC, 2013, PHARMACOL THERAPEUT, V139, P124, DOI 10.1016/j.pharmthera.2013.04.001; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Shen YC, 2004, PLANTA MED, V70, P310, DOI 10.1055/s-2004-818941; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu SH, 1997, BOT BULL ACAD SINICA, V38, P273; Wymelenberg A.V., 2006, FUNGAL GENET BIOL, V43, P343, DOI [DOI 10.1016/J.FGB.2006.01.003, 10.1016/J.FGB.2006.01.003]; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8; Zhou Q, 2012, FUNGAL BIOL-UK, V116, P1156, DOI 10.1016/j.funbio.2012.09.001	49	19	20	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123245	10.1371/journal.pone.0123245	http://dx.doi.org/10.1371/journal.pone.0123245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860872	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300084
J	Pant, M; Sopariwala, DH; Bal, NC; Lowe, J; Delfin, DA; Rafael-Fortney, J; Periasamy, M				Pant, Meghna; Sopariwala, Danesh H.; Bal, Naresh C.; Lowe, Jeovanna; Delfin, Dawn A.; Rafael-Fortney, Jill; Periasamy, Muthu			Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; MDX-MOUSE; ENERGY-METABOLISM; OXIDATIVE-PHOSPHORYLATION; SARCOLIPIN; EXPRESSION; MICE; PATHOLOGY; PROTEIN; THERMOGENESIS	The utrophin-dystrophin deficient (DKO) mouse model has been widely used to understand the progression of Duchenne muscular dystrophy (DMD). However, it is unclear as to what extent muscle pathology affects metabolism. Therefore, the present study was focused on understanding energy expenditure in the whole animal and in isolated extensor digitorum longus (EDL) muscle and to determine changes in metabolic enzymes. Our results show that the 8 week-old DKO mice consume higher oxygen relative to activity levels. Interestingly the EDL muscle from DKO mouse consumes higher oxygen per unit integral force, generates less force and performs better in the presence of pyruvate thus mimicking a slow twitch muscle. We also found that the expression of hexokinase 1 and pyruvate kinase M2 was upregulated several fold suggesting increased glycolytic flux. Additionally, there is a dramatic increase in dynamin-related protein 1 (Drp 1) and mitofusin 2 protein levels suggesting increased mitochondrial fission and fusion, a feature associated with increased energy demand and altered mitochondrial dynamics. Collectively our studies point out that the dystrophic disease has caused significant changes in muscle metabolism. To meet the increased energetic demand, upregulation of metabolic enzymes and regulators of mitochondrial fusion and fission is observed in the dystrophic muscle. A better understanding of the metabolic demands and the accompanied alterations in the dystrophic muscle can help us design improved intervention therapies along with existing drug treatments for the DMD patients.	[Pant, Meghna; Sopariwala, Danesh H.; Bal, Naresh C.; Periasamy, Muthu] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Lowe, Jeovanna; Delfin, Dawn A.; Rafael-Fortney, Jill] Ohio State Univ, Coll Med, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Periasamy, M (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.	periasamy.1@osu.edu			National Institutes of Health [R01-HL088555, R01 DK098240-01]; American Diabetes Association for basic science Research Award [7-13-BS-131]; Muscular Dystrophy Association; NIH [R01 NS082868]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001448, UL1TR001449] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association for basic science Research Award; Muscular Dystrophy Association(Muscular Dystrophy Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants to MP R01-HL088555 and R01 DK098240-01, American Diabetes Association for basic science Research Award (7-13-BS-131) to MP; Muscular Dystrophy Association and NIH R01 NS082868 to JRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedov D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00371; Babu GJ, 2007, P NATL ACAD SCI USA, V104, P17867, DOI 10.1073/pnas.0707722104; Baker PE, 2006, NEUROGENETICS, V7, P81, DOI 10.1007/s10048-006-0031-7; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; CHI MMY, 1987, METABOLISM, V36, P761, DOI 10.1016/0026-0495(87)90113-2; CHINET AE, 1994, EXPERIENTIA, V50, P602, DOI 10.1007/BF01921731; Crisp A, 2011, HUM MOL GENET, V20, P413, DOI 10.1093/hmg/ddq477; Crosbie RH, 1998, HUM MOL GENET, V7, P823, DOI 10.1093/hmg/7.5.823; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck N, 1998, NEUROMUSCULAR DISORD, V8, P362, DOI 10.1016/S0960-8966(98)00048-0; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; DUNN JF, 1993, P ROY SOC B-BIOL SCI, V251, P201, DOI 10.1098/rspb.1993.0030; EMERY A, 1995, NEUROMUSCULAR DISORD, V5, P521, DOI 10.1016/0960-8966(95)98952-S; EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649; FELLOWS IW, 1989, CLIN NUTR, V8, P135, DOI 10.1016/0261-5614(89)90062-9; Gehrig SM, 2010, AM J PATHOL, V176, P29, DOI 10.2353/ajpath.2010.090760; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Goyenvalle A, 2012, HUM MOL GENET, V21, P2559, DOI 10.1093/hmg/dds082; Goyenvalle A, 2010, MOL THER, V18, P198, DOI 10.1038/mt.2009.248; Hawley JA, 2006, ESSAYS BIOCHEM, V42, P1, DOI 10.1042/bse0420001; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Koopman R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00032; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Michel RN, 2007, APPL PHYSIOL NUTR ME, V32, P921, DOI 10.1139/H07-093; MILLAR NC, 1992, AM J PHYSIOL, V262, pC1239, DOI 10.1152/ajpcell.1992.262.5.C1239; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; PHILLIPS SK, 1993, J PHYSIOL-LONDON, V462, P135, DOI 10.1113/jphysiol.1993.sp019547; Pich S, 2005, HUM MOL GENET, V14, P1405, DOI 10.1093/hmg/ddi149; Radley-Crabb HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089277; Rafael JA, 2000, HUM MOL GENET, V9, P1357, DOI 10.1093/hmg/9.9.1357; Rafael JA, 2000, MICROSC RES TECHNIQ, V48, P155, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<155::AID-JEMT4>3.0.CO;2-0; Schneider JS, 2013, J MUSCLE RES CELL M, V34, P349, DOI 10.1007/s10974-013-9350-0; Schuh RA, 2012, AM J PHYSIOL-REG I, V302, pR712, DOI 10.1152/ajpregu.00229.2011; Sesaki H, 2014, BBA-MOL BASIS DIS, V1842, P1179, DOI 10.1016/j.bbadis.2013.11.024; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Smith IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068924; Spassov A, 2011, EXP TOXICOL PATHOL, V63, P549, DOI 10.1016/j.etp.2010.04.006; STRICKLAND JM, 1975, NATURE, V253, P464, DOI 10.1038/253464b0; Stump CS, 2006, ANN MED, V38, P389, DOI 10.1080/07853890600888413; Terrill JR, 2013, FEBS J, V280, P4149, DOI 10.1111/febs.12142; Torres CAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063608; van Putten M, 2012, NEUROMUSCULAR DISORD, V22, P406, DOI 10.1016/j.nmd.2011.10.011; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; ZATZ M, 1978, J NEUROL SCI, V36, P349, DOI 10.1016/0022-510X(78)90043-6; Zorzano A, 2010, BBA-BIOENERGETICS, V1797, P1028, DOI 10.1016/j.bbabio.2010.02.017; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004; Zorzano A, 2009, APPL PHYSIOL NUTR ME, V34, P433, DOI 10.1139/H09-049; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857; ZURLO F, 1994, METABOLISM, V43, P481, DOI 10.1016/0026-0495(94)90081-7	64	39	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123875	10.1371/journal.pone.0123875	http://dx.doi.org/10.1371/journal.pone.0123875			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859846	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300117
J	Rochman, Y; Yukawa, M; Kartashov, AV; Barski, A				Rochman, Yrina; Yukawa, Masashi; Kartashov, Andrey V.; Barski, Artem			Functional Characterization of Human T Cell Hyporesponsiveness Induced by CTLA4-Ig	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; MOLECULAR-MECHANISMS; AIRWAY EOSINOPHILIA; CO-STIMULATION; MURINE MODEL; DOUBLE-BLIND; ANERGY; INDUCTION; TOLERANCE; P27(KIP1)	` During activation, T cells integrate multiple signals from APCs and cytokine milieu. The blockade of these signals can have clinical benefits as exemplified by CTLA4-Ig, which blocks interaction of B7 co-stimulatory molecules on APCs with CD28 on T cells. Variants of CTLA4-Ig, abatacept and belatacept are FDA approved as immunosuppressive agents in arthritis and transplantation, yet murine studies suggested that CTLA4-Ig could be beneficial in a number of other diseases. However, detailed analysis of human CD4 cell hyporesponsivness induced by CTLA4-Ig has not been performed. Herein, we established a model to study the effect of CTLA4-Ig on the activation of human naive T cells in a human mixed lymphocytes system. Comparison of human CD4 cells activated in the presence or absence of CTLA4-Ig showed that co-stimulation blockade during TCR activation does not affect NFAT signaling but results in decreased activation of NF-kappa B and AP-1 transcription factors followed by a profound decrease in proliferation and cytokine production. The resulting T cells become hyporesponsive to secondary activation and, although capable of receiving TCR signals, fail to proliferate or produce cytokines, demonstrating properties of anergic cells. However, unlike some models of T cell anergy, these cells did not possess increased levels of the TCR signaling inhibitor CBLB. Rather, the CTLA4-Ig-induced hyporesponsiveness was associated with an elevated level of p27(kip1) cyclin-dependent kinase inhibitor.	[Rochman, Yrina; Yukawa, Masashi; Kartashov, Andrey V.; Barski, Artem] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45220 USA; [Rochman, Yrina; Yukawa, Masashi; Kartashov, Andrey V.; Barski, Artem] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Rochman, Yrina] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH USA; [Barski, Artem] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cincinnati	Barski, A (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45220 USA.	Artem.Barski@cchmc.org		Yukawa, Masashi/0000-0003-1798-2410; Kartashov, Andrey/0000-0001-9102-5681; Barski, Artem/0000-0002-1861-5316	Children's Hospital Research Foundation; National Heart, Lung and Blood Institute; National Institutes of Health career transition award [K22 HL098691]; PHS Grant (Digestive Health Center) [P30 DK078392]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL098691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	Children's Hospital Research Foundation; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health career transition award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS Grant (Digestive Health Center); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported in part by the Children's Hospital Research Foundation, a National Heart, Lung and Blood Institute, National Institutes of Health career transition award to A.B. (K22 HL098691), and the PHS Grant P30 DK078392 (Digestive Health Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barbosa Ramiro S., 2012, J ROBOTICS, V2012, P1; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Caporali R, 2014, AUTOIMMUN REV, V13, P49, DOI 10.1016/j.autrev.2013.06.008; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Choi S, 2007, SEMIN IMMUNOL, V19, P140, DOI 10.1016/j.smim.2007.02.005; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Kartashov AV, 2014, BIORXIV 012799; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; LENSCHOW DJ, 1995, J EXP MED, V181, P1145, DOI 10.1084/jem.181.3.1145; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Mayer L, 2012, GASTROENTEROLOGY, V143, P13, DOI 10.1053/j.gastro.2012.05.015; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Merrill JT, 2010, ARTHRITIS RHEUM-US, V62, P3077, DOI 10.1002/art.27601; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Padrid PA, 1998, AM J RESP CELL MOL, V18, P453, DOI 10.1165/ajrcmb.18.4.3055; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parulekar AD, 2013, AM J RESP CRIT CARE, V187, P494, DOI 10.1164/rccm.201207-1205OC; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Powell JD, 2001, EUR J IMMUNOL, V31, P3737, DOI 10.1002/1521-4141(200112)31:12<3737::AID-IMMU3737>3.0.CO;2-G; Rengarajan J, 2000, IMMUNITY, V12, P293, DOI 10.1016/S1074-7613(00)80182-X; Riella LV, 2012, AM J TRANSPLANT, V12, P846, DOI 10.1111/j.1600-6143.2011.03929.x; Rowell EA, 2005, J IMMUNOL, V174, P3359, DOI 10.4049/jimmunol.174.6.3359; Rowell EA, 2006, J IMMUNOL, V177, P5169, DOI 10.4049/jimmunol.177.8.5169; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sandborn WJ, 2012, GASTROENTEROLOGY, V143, P62, DOI 10.1053/j.gastro.2012.04.010; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; TAN P, 1993, J EXP MED, V177, P165, DOI 10.1084/jem.177.1.165; Thomas RM, 2007, J IMMUNOL, V179, P7305, DOI 10.4049/jimmunol.179.11.7305; VanOosterhout AJM, 1997, AM J RESP CELL MOL, V17, P386, DOI 10.1165/ajrcmb.17.3.2679; Webb LMC, 1996, EUR J IMMUNOL, V26, P2320, DOI 10.1002/eji.1830261008; Wekerle T, 2002, CURR OPIN IMMUNOL, V14, P592, DOI 10.1016/S0952-7915(02)00378-3; Wekerle T, 2012, TRANSPL INT, V25, P139, DOI 10.1111/j.1432-2277.2011.01386.x; Wells AD, 2001, J CLIN INVEST, V108, P895, DOI 10.1172/JCI200113220; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zheng Y, 2008, EMBO REP, V9, P50, DOI 10.1038/sj.embor.7401138; Zheng Y, 2012, J EXP MED, V209, P2157, DOI 10.1084/jem.20120342	45	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122198	10.1371/journal.pone.0122198	http://dx.doi.org/10.1371/journal.pone.0122198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860138	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300035
J	Nielsen, MV; Amemasor, S; Agyekum, A; Loag, W; Marks, F; Sarpong, N; Dekker, D; Adu-Sarkodie, Y; May, J				Nielsen, Maja Verena; Amemasor, Solomon; Agyekum, Alex; Loag, Wibke; Marks, Florian; Sarpong, Nimako; Dekker, Denise; Adu-Sarkodie, Yaw; May, Juergen			Clinical Indicators for Bacterial Co-Infection in Ghanaian Children with P-falciparum Infection	PLOS ONE			English	Article							NON-TYPHOIDAL SALMONELLA; AFRICAN CHILDREN; MALARIA; BACTEREMIA; AREA; IMPACT	Differentiation of infectious causes in severely ill children is essential but challenging in sub-Saharan Africa. The aim of the study was to determine clinical indicators that are able to identify bacterial co-infections in P. falciparum infected children in rural Ghana. In total, 1,915 severely ill children below the age of 15 years were recruited at Agogo Presbyterian Hospital in Ghana between May 2007 and February 2011. In 771 (40%) of the children malaria parasites were detected. This group was analyzed for indicators of bacterial co-infections using bivariate and multivariate regression analyses with 24 socio-economic variables, 16 terms describing medical history and anthropometrical information and 68 variables describing clinical symptoms. The variables were tested for sensitivity, specificity, positive predictive value and negative predictive value. In 46 (6.0%) of the children with malaria infection, bacterial co-infection was detected. The most frequent pathogens were non-typhoid salmonellae (45.7%), followed by Streptococcus spp. (13.0%). Coughing, dehydration, splenomegaly, severe anemia and leukocytosis were positively associated with bacteremia. Domestic hygiene and exclusive breastfeeding is negatively associated with bacteremia. In cases of high parasitemia (>10,000/mu l), a significant association with bacteremia was found for splenomegaly (OR 8.8; CI 1.6-48.9), dehydration (OR 18.2; CI 2.0-166.0) and coughing (OR 9.0; CI 0.7-118.6). In children with low parasitemia, associations with bacteremia were found for vomiting (OR 4.7; CI 1.4-15.8), severe anemia (OR 3.3; CI 1.0-11.1) and leukocytosis (OR 6.8 CI 1.9-24.2). Clinical signs of impaired microcirculation were negatively associated with bacteremia. Ceftriaxone achieved best coverage of isolated pathogens. The results demonstrate the limitation of clinical symptoms to determine bacterial co-infections in P. falciparum infected children. Best clinical indicators are dependent on the parasitemia level. Even with a moderate sensitivity of >60%, only low positive predictive values can be obtained due to low prevalence of bacteremia. Rapid testing for distinguishing parasitemia and bacteremia is essential.	[Nielsen, Maja Verena; Loag, Wibke; Dekker, Denise; May, Juergen] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol, D-20359 Hamburg, Germany; [Amemasor, Solomon; Agyekum, Alex; Loag, Wibke; Sarpong, Nimako] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Kumasi, Ghana; [Marks, Florian] Int Vaccine Inst, Seoul, South Korea; [Sarpong, Nimako; May, Juergen] German Ctr Infect Res DZIF, Partner Site Hamburg Borstel Lubeck, Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; International Vaccine Institute; German Center for Infection Research	Nielsen, MV (corresponding author), Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	maja.v.nielsen@googlemail.com		May, Jurgen/0000-0001-7831-8420; Marks, Florian/0000-0002-6043-7170	Swiss Foundation; International Vaccine Institute, Seoul, South Korea	Swiss Foundation(Swiss National Science Foundation (SNSF)); International Vaccine Institute, Seoul, South Korea	This study was funded by a Swiss Foundation and the International Vaccine Institute, Seoul, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 2009, WORLD MAL REP 2009; Ayoola OO, 2002, J HEALTH POPUL NUTR, V20, P223; Berkley JA, 2005, BMJ-BRIT MED J, V330, P995, DOI 10.1136/bmj.38408.471991.8F; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; Choge JK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-332; Church J, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-31; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Evans JA, 2006, J PEDIATR-US, V149, P676, DOI 10.1016/j.jpeds.2006.07.040; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Ghana. Cities & Urban Localities, 2011, CIT URB LOC CENS DAT; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Kahama-Maro J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-332; Kariuki S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-101; Krefis AC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-201; Krefis AC, 2011, AM J TROP MED HYG, V84, P285, DOI 10.4269/ajtmh.2011.10-0381; Lathia T B, 2004, Indian J Med Sci, V58, P239; Lokken KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004049; Maltha J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089103; Nadjm B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1350; Nankabirwa J, 2013, AM J TROP MED HYG, V88, P1102, DOI 10.4269/ajtmh.12-0633; Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063; Planche T, 2003, CLIN INFECT DIS, V37, P890, DOI 10.1086/377536; Renner LA, 2007, PEDIATR INFECT DIS J, V26, P356, DOI 10.1097/01.inf.0000258693.19247.8e; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Sarpong N, 2010, TROP MED INT HEALTH, V15, P191, DOI 10.1111/j.1365-3156.2009.02439.x; Schwarz NG, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-319; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; WHO Management of the child with a serious infection or severe malnutrition, 2000, WHO MAN CHILD SER IN	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122139	10.1371/journal.pone.0122139	http://dx.doi.org/10.1371/journal.pone.0122139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856341	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500031
J	Nieuwstadt, HA; Kassar, ZAM; van der Lugt, A; Breeuwer, M; van der Steen, AFW; Wentzel, JJ; Gijsen, FJH				Nieuwstadt, Harm A.; Kassar, Zaid A. M.; van der Lugt, Aad; Breeuwer, Marcel; van der Steen, Anton F. W.; Wentzel, Jolanda J.; Gijsen, Frank J. H.			A Computer-Simulation Study on the Effects of MRI Voxel Dimensions on Carotid Plaque Lipid-Core and Fibrous Cap Segmentation and Stress Modeling	PLOS ONE			English	Article							BLACK-BLOOD MRI; ATHEROSCLEROTIC PLAQUE; HIGH-RESOLUTION; SPATIAL-RESOLUTION; REPRODUCIBILITY; COMPONENTS; LESIONS; BURDEN; MOTION	Background The benefits of a decreased slice thickness and/or in-plane voxel size in carotid MRI for atherosclerotic plaque component quantification accuracy and biomechanical peak cap stress analysis have not yet been investigated in detail because of practical limitations. Methods In order to provide a methodology that allows such an investigation in detail, numerical simulations of a T1-weighted, contrast-enhanced, 2D MRI sequence were employed. Both the slice thickness (2 mm, 1 mm, and 0.5 mm) and the in plane acquired voxel size (0.62x0.62 mm(2) and 0.31x0.31 mm(2)) were varied. This virtual MRI approach was applied to 8 histology-based 3D patient carotid atherosclerotic plaque models. Results A decreased slice thickness did not result in major improvements in lumen, vessel wall, and lipid-rich necrotic core size measurements. At 0.62x0.62 mm2 in-plane, only a 0.5 mm slice thickness resulted in improved minimum fibrous cap thickness measurements (a 2-3 fold reduction in measurement error) and only marginally improved peak cap stress computations. Acquiring voxels of 0.31x0.31 mm(2) in-plane, however, led to either similar or significantly larger improvements in plaque component quantification and computed peak cap stress. Conclusions This study provides evidence that for currently-used 2D carotid MRI protocols, a decreased slice thickness might not be more beneficial for plaque measurement accuracy than a decreased in-plane voxel size. The MRI simulations performed indicate that not a reduced slice thickness (i.e. more isotropic imaging), but the acquisition of anisotropic voxels with a relatively smaller in-plane voxel size could improve carotid plaque quantification and computed peak cap stress accuracy.	[Nieuwstadt, Harm A.; Kassar, Zaid A. M.; van der Steen, Anton F. W.; Wentzel, Jolanda J.; Gijsen, Frank J. H.] Erasmus MC, Dept Biomed Engn, Rotterdam, Netherlands; [Kassar, Zaid A. M.; van der Lugt, Aad] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Breeuwer, Marcel] Philips Healthcare, Best, Netherlands; [Breeuwer, Marcel] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [van der Steen, Anton F. W.] Delft Univ Technol, Dept Imaging Sci & Technol, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Philips; Philips Healthcare; Eindhoven University of Technology; Delft University of Technology	Gijsen, FJH (corresponding author), Erasmus MC, Dept Biomed Engn, Rotterdam, Netherlands.	f.gijsen@erasmusmc.nl			Dutch Heart Foundation [01C-202]; Philips Healthcare	Dutch Heart Foundation(Netherlands Heart Foundation); Philips Healthcare	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PARISk (grant 01C-202), and supported by the Dutch Heart Foundation. Philips Healthcare provided partial support in the form of a salary for author MB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Al-Kwifi O, 2004, MAGN RESON MED, V52, P605, DOI 10.1002/mrm.20185; Antiga L, 2008, MAGN RESON MED, V60, P1020, DOI 10.1002/mrm.21758; Balu N, 2008, J MAGN RESON IMAGING, V27, P918, DOI 10.1002/jmri.21282; Balu N, 2007, MAGN RESON MED, V57, P592, DOI 10.1002/mrm.21160; Balu N, 2011, MAGN RESON MED, V65, P627, DOI 10.1002/mrm.22642; Benoit-Cattin H, 2005, J MAGN RESON, V173, P97, DOI 10.1016/j.jmr.2004.09.027; Cai JM, 2005, CIRCULATION, V112, P3437, DOI 10.1161/CIRCULATIONAHA.104.528174; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; CHENG GC, 1993, CIRCULATION, V87, P1179, DOI 10.1161/01.CIR.87.4.1179; Coombs BD, 2001, STROKE, V32, P2516, DOI 10.1161/hs1101.098663; Dong L, 2010, J MAGN RESON IMAGING, V32, P452, DOI 10.1002/jmri.22274; Gao H, 2009, J MAGN RESON IMAGING, V30, P85, DOI 10.1002/jmri.21799; Gonzalez Ballester MA, 2002, MED IMAGE ANAL, V6, P389, DOI 10.1016/S1361-8415(02)00061-0; Groen HC, 2010, J BIOMECH, V43, P2087, DOI 10.1016/j.jbiomech.2010.04.005; Hacklander T, 2005, ACAD RADIOL, V12, P85, DOI 10.1016/j.acra.2004.09.011; Hofman JMA, 2006, MAGN RESON MED, V55, P790, DOI 10.1002/mrm.20828; Holzapfel GA, 2014, J BIOMECH, V47, P859, DOI 10.1016/j.jbiomech.2014.01.011; Klepaczko A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093689; Li B, 2013, MAGN RESON MED, V70, P1347, DOI 10.1002/mrm.24579; Li FY, 2010, J MAGN RESON IMAGING, V31, P168, DOI 10.1002/jmri.22014; Li ZY, 2006, J BIOMECH, V39, P2611, DOI 10.1016/j.jbiomech.2005.08.022; Liu WB, 2012, J MAGN RESON IMAGING, V35, P812, DOI 10.1002/jmri.22886; Luk-Pat GT, 1999, MAGNET RESON MED, V42, P762, DOI 10.1002/(SICI)1522-2594(199910)42:4<762::AID-MRM19>3.0.CO;2-M; Nieuwstadt HA, 2013, J BIOMECH, V46, P689, DOI 10.1016/j.jbiomech.2012.11.042; Nieuwstadt HA, 2014, MAGN RESON MED, V72, P188, DOI 10.1002/mrm.24905; Nieuwstadt HA, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026178; Ronen RR, 2006, MAGN RESON MED, V56, P290, DOI 10.1002/mrm.20956; Schar M, 2003, J MAGN RESON IMAGING, V17, P538, DOI 10.1002/jmri.10287; Speelman L, 2011, J BIOMECH, V44, P2376, DOI 10.1016/j.jbiomech.2011.07.004; Stocker T, 2010, MAGN RESON MED, V64, P186, DOI 10.1002/mrm.22406; Tang DL, 2009, STROKE, V40, P3258, DOI 10.1161/STROKEAHA.109.558676; Toussaint JF, 1996, CIRCULATION, V94, P932, DOI 10.1161/01.CIR.94.5.932; Truijman MTB, 2014, INT J STROKE, V9, P747, DOI 10.1111/ijs.12167; Underhill HR, 2010, NAT REV CARDIOL, V7, P165, DOI 10.1038/nrcardio.2009.246; van Wijk DF, 2014, MAGN RESON MATER PHY, V27, P219, DOI 10.1007/s10334-013-0407-2; Watanabe Y, 2010, NEURORADIOLOGY, V52, P253, DOI 10.1007/s00234-010-0663-z; Xanthis CG, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-48; Yuan C, 2001, RADIOLOGY, V221, P285, DOI 10.1148/radiol.2212001612; Yuan C, 2004, J MAGN RESON IMAGING, V19, P710, DOI 10.1002/jmri.20070	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123031	10.1371/journal.pone.0123031	http://dx.doi.org/10.1371/journal.pone.0123031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856094	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500070
J	Peres, EA; Sobral-Souza, T; Perez, MF; Bonatelli, IAS; Silva, DP; Silva, MJ; Solferini, VN				Peres, Elen A.; Sobral-Souza, Thadeu; Perez, Manolo F.; Bonatelli, Isabel A. S.; Silva, Daniel P.; Silva, Marcio J.; Solferini, Vera N.			Pleistocene Niche Stability and Lineage Diversification in the Subtropical Spider Araneus omnicolor (Araneidae)	PLOS ONE			English	Article							BRAZILIAN ATLANTIC FOREST; SEX-BIASED DISPERSAL; POPULATION-GROWTH; NEOTROPICAL BIODIVERSITY; HISTORICAL BIOGEOGRAPHY; SPECIES DISTRIBUTIONS; DISTRIBUTION MODELS; BAYESIAN-INFERENCE; CLIMATIC CHANGES; PHYLOGEOGRAPHY	The influence of Quaternary climate oscillations on the diversification of the South American fauna is being increasingly explored. However, most of these studies have focused on taxa that are endemic to tropical environments, and relatively few have treated organisms restricted to subtropical biomes. Here we used an integrative phylogeographical framework to investigate the effects of these climate events on the ecological niche and genetic patterns of the subtropical orb-weaver spider Araneus omnicolor (Araneidae). We analyzed the mitochondrial (Cytochrome Oxidase I, COI) and nuclear (Internal Transcribed Subunit II, ITS2) DNA of 130 individuals throughout the species' range, and generated distribution models in three different climate scenarios [present, Last Glacial Maximum (LGM), and Last Interglacial Maximum (LIG)]. Additionally, we used an Approximate Bayesian Computation (ABC) approach to compare possible demographic scenarios and select the hypothesis that better explains the genetic patterns of A. omnicolor. We obtained high haplotype diversity but low nucleotide variation among sequences. The population structure and demographic analyses showed discrepancies between markers, suggesting male-biased dispersal in the species. The time-calibrated COI phylogenetic inference showed a recent diversification of lineages (Middle/Late Pleistocene), while the paleoclimate modeling indicated niche stability since similar to 120 Kya. The ABC results agreed with the niche models, supporting a panmictic population as the most likely historical scenario for the species. These results indicate that A. omnicolor experienced no niche or population reductions during the Late Pleistocene, despite the intense landscape modifications that occurred in the subtropical region, and that other factors beside LGM and LIG climate oscillations might have contributed to the demographic history of this species. This pattern may be related to the high dispersal ability and wide environmental tolerance of A. omnicolor, highlighting the need for more phylogeographical studies with invertebrates and other generalist taxa, in order to understand the effects of Quaternary climate changes on Neotropical biodiversity.	[Peres, Elen A.; Sobral-Souza, Thadeu; Solferini, Vera N.] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil; [Perez, Manolo F.; Bonatelli, Isabel A. S.] Univ Fed Sao Carlos, Dept Biol, Sorocaba, SP, Brazil; [Silva, Daniel P.] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Silva, Marcio J.] Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Sao Carlos; Universidade Federal do Para; Universidade Estadual de Campinas	Solferini, VN (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil.	veras@unicamp.br	Perez, Manolo Fernandez/H-2243-2012; Solferini, Vera/E-9121-2012; Bonatelli, Isabel A. S./D-2361-2015; Peres, Elen Arroyo/A-2253-2014; UNICAMP, CCES -/J-7787-2015; Silva, Daniel Paiva/F-8052-2010; Sobral-Souza, Thadeu/O-1068-2017	Perez, Manolo Fernandez/0000-0002-4642-7793; Solferini, Vera/0000-0001-6582-1449; Peres, Elen Arroyo/0000-0002-2118-2144; Silva, Daniel Paiva/0000-0002-2457-6245; Sobral Souza, Thadeu/0000-0002-2367-2315; da Silva Bonatelli, Isabel Aparecida/0000-0002-0930-1411	FAPESP [2012/02526-7]; CNPq fellowship	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by a grant from FAPESP (2012/02526-7) to VNS. EAP, MFP, and IASB had FAPESP fellowships and TSS had a CNPq fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, J ARACHNOL, V38, P377, DOI 10.1636/B10-01.1; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batalha H, 2012, MOL PHYLOGENET EVOL, V65, P892, DOI 10.1016/j.ympev.2012.08.010; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Behling H, 1998, REV PALAEOBOT PALYNO, V99, P143, DOI 10.1016/S0034-6667(97)00044-4; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; Blum MGB, 2010, STAT COMPUT, V20, P63, DOI 10.1007/s11222-009-9116-0; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bush Mark B., 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000100002; Cabanne GS, 2007, BIOL J LINN SOC, V91, P73, DOI 10.1111/j.1095-8312.2007.00775.x; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval Ana Carolina, 2014, Proc Biol Sci, V281, DOI 10.1098/rspb.2014.1461; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Chang J, 2007, MOL PHYLOGENET EVOL, V42, P104, DOI 10.1016/j.ympev.2006.06.013; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Csillery K, 2012, METHODS ECOL EVOL, V3, P475, DOI 10.1111/j.2041-210X.2011.00179.x; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; De Almeida MC, 2010, INSECT CONSERV DIVER, V3, P252, DOI 10.1111/j.1752-4598.2010.00096.x; De Re FC, 2014, BIOL J LINN SOC, V112, P55, DOI 10.1111/bij.12244; Munoz MED, 2011, GEOINFORMATICA, V15, P111, DOI 10.1007/s10707-009-0090-7; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Flot JF, 2006, MOL ECOL NOTES, V6, P627, DOI 10.1111/j.1471-8286.2006.01355.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Framenau VW, 2010, ARTHROPOD SYST PHYLO, V68, P79; Fu YX, 1997, GENETICS, V147, P915; Garrick RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-118; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hedin MC, 2001, MOL PHYLOGENET EVOL, V18, P238, DOI 10.1006/mpev.2000.0882; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Ledru MP, 2005, QUATERNARY RES, V64, P444, DOI 10.1016/j.yqres.2005.08.006; LEDRU MP, 1993, QUATERNARY RES, V39, P90, DOI 10.1006/qres.1993.1011; Legrand RS, 2000, BIOL J LINN SOC, V71, P643, DOI 10.1006/bijl.2000.0466; LEVI H W, 1991, Bulletin of the Museum of Comparative Zoology, V152, P167; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Uribe MM, 2014, MOL ECOL, V23, P1874, DOI 10.1111/mec.12689; MANTEL N, 1967, CANCER RES, V27, P209; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Martins FD, 2011, BIOL J LINN SOC, V104, P499, DOI 10.1111/j.1095-8312.2011.01745.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Oliveira AT, 2015, J PLANT ECOL, V8, P242, DOI 10.1093/jpe/rtt058; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pinheiro F, 2011, J BIOGEOGR, V38, P1923, DOI 10.1111/j.1365-2699.2011.02539.x; Porto TJ, 2013, DIVERS DISTRIB, V19, P330, DOI 10.1111/j.1472-4642.2012.00944.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Rambaut A., 2007, TRACER V1 4; Rambaut A., 2009, FIGTREE; RAMBO BALDUINO, 1950, AN BOT HERBARIO BARBOSA RODRIGUES", V2, P125; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Rix MG, 2012, MOL PHYLOGENET EVOL, V62, P375, DOI 10.1016/j.ympev.2011.10.009; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tax DMJ, 2004, MACH LEARN, V54, P45, DOI 10.1023/B:MACH.0000008084.60811.49; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Turchetto-Zolet AC, 2013, MOL ECOL, V22, P1193, DOI 10.1111/mec.12164; Vanzolini P.E., 1981, Papeis Avulsos de Zoologia (Sao Paulo), V34, P251; Vollrath F, 1998, TRENDS ECOL EVOL, V13, P159, DOI 10.1016/S0169-5347(97)01283-4; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	90	35	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121543	10.1371/journal.pone.0121543	http://dx.doi.org/10.1371/journal.pone.0121543			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856149	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500022
J	Lekhanont, K; Nonpassopon, M; Wannarosapark, K; Chuckpaiwong, V				Lekhanont, Kaevalin; Nonpassopon, Manachai; Wannarosapark, Khemruetai; Chuckpaiwong, Varintorn			Agreement between Clinical History Method, Orbscan IIz, and Pentacam in Estimating Corneal Power after Myopic Excimer Laser Surgery	PLOS ONE			English	Article							INTRAOCULAR-LENS CALCULATION; REFRACTIVE SURGERY; EYES; REPEATABILITY; ACCURACY; TOPOGRAPHY; REPRODUCIBILITY; KERATOMETRY; CATARACT	The purpose of this study was to investigate the agreement between the clinical history method (CHM), Orbscan IIz, and Pentacam in estimating corneal power after myopic excimer laser surgery. Fifty five patients who had myopic LASIK/ PRK were recruited into this study. One eye of each patient was randomly selected by a computer-generated process. At 6 months after surgery, postoperative corneal power was calculated from the CHM, Orbscan IIz total optical power at the 3.0 and 4.0 mm zones, and Pentacam equivalent keratometric readings (EKRs) at 3.0, 4.0, and 4.5 mm. Statistical analyses included multilevel models, Pearson's correlation test, and Bland-Altman plots. The Orbscan IIz 3.0-mm and 4.0 mm total optical power, and Pentacam 3.0-mm, 4.0-mm, and 4.5-mm EKR values had strong linear positive correlations with the CHM values (r = 0.90-0.94, P = < 0.001, for all comparisons, Pearson's correlation). However, only Pentacam 3.0-mm EKR was not statistically different from CHM (P = 0.17, multilevel models). The mean 3.0-and 4.0-mm total optical powers of the Orbscan IIz were significantly flatter than the values derived from CHM, while the average EKRs of the Pentacam at 4.0 and 4.5 mm were significantly steeper. The mean Orbscan IIz 3.0-mm total optical power was the lowest keratometric reading compared to the other 5 values. Large 95% LoA was observed between each of these values, particularly EKRs, and those obtained with the CHM. The width of the 95% LoA was narrowest for Orbscan IIz 3.0-mm total optical power. In conclusion, the keratometric values extracted from these 3 methods were disparate, either because of a statistically significant difference in the mean values or moderate agreement between them. Therefore, they are not considered equivalent and cannot be used interchangeably.	[Lekhanont, Kaevalin; Nonpassopon, Manachai; Wannarosapark, Khemruetai; Chuckpaiwong, Varintorn] Mahidol Univ, Ramathibodi Hosp, Dept Ophthalmol, Bangkok 10700, Thailand	Mahidol University	Lekhanont, K (corresponding author), Mahidol Univ, Ramathibodi Hosp, Dept Ophthalmol, Bangkok 10700, Thailand.	lekhanont@yahoo.com			Faculty of Medicine, Ramathibodi Hospital, Mahidol University: KL [55058]; Department of Ophthalmology, Ramathibodi Hospital (stationery and office supplies)	Faculty of Medicine, Ramathibodi Hospital, Mahidol University: KL; Department of Ophthalmology, Ramathibodi Hospital (stationery and office supplies)	Supported by 1. A Research Grant number 55058 from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University: KL, 2. Department of Ophthalmology, Ramathibodi Hospital (stationery and office supplies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce CG, 2009, J REFRACT SURG, V25, P1061, DOI 10.3928/1081597X-20091117-05; Argento C, 2003, J CATARACT REFR SURG, V29, P1346, DOI 10.1016/S0886-3350(03)00351-1; Borasio E, 2006, J CATARACT REFR SURG, V32, P2004, DOI 10.1016/j.jcrs.2006.08.037; Cheng ACK, 2005, J REFRACT SURG, V21, P365; Crawford AZ, 2013, AM J OPHTHALMOL, V156, P53, DOI 10.1016/j.ajo.2013.01.029; Falavarjani KG, 2010, CLIN EXP OPHTHALMOL, V38, P341, DOI 10.1111/j.1442-9071.2010.02286.x; Feiz V, 2010, MIDDLE EAST AFR J OP, V17, P63, DOI 10.4103/0974-9233.61219; Geggel HS, 2009, OPHTHALMOLOGY, V116, P1057, DOI 10.1016/j.ophtha.2009.01.017; Gimbel HV, 2001, J CATARACT REFR SURG, V27, P571, DOI 10.1016/S0886-3350(00)00795-1; Holladay JT, 2009, J REFRACT SURG, V25, P862, DOI 10.3928/1081597X-20090917-07; Huang David, 2013, Trans Am Ophthalmol Soc, V111, P34; Jonna G, 2013, CURR OPIN OPHTHALMOL, V24, P275, DOI 10.1097/ICU.0b013e3283622955; Kalyani SD, 2008, CURR OPIN OPHTHALMOL, V19, P357, DOI 10.1097/ICU.0b013e3282fec43e; Kawamorita T, 2009, J CATARACT REFR SURG, V35, P127, DOI 10.1016/j.jcrs.2008.10.019; Kim EC, 2013, J CATARACT REFR SURG, V39, P1640, DOI 10.1016/j.jcrs.2013.04.045; Kim SW, 2009, J REFRACT SURG, V25, P285, DOI 10.3928/1081597X-20090301-08; Lackner B, 2005, OPTOMETRY VISION SCI, V82, P892, DOI 10.1097/01.opx.0000180817.46312.0a; Latkany RA, 2005, J CATARACT REFR SURG, V31, P562, DOI 10.1016/j.jcrs.2004.06.053; Leyland M, 2004, EYE, V18, P357, DOI 10.1038/sj.eye.6700659; Michaels DD, 1985, VISUAL OPTICS REFRAC; Oh JH, 2014, CORNEA, V33, P261, DOI 10.1097/ICO.0000000000000034; Qazi MA, 2007, J CATARACT REFR SURG, V33, P21, DOI 10.1016/j.jcrs.2006.08.026; Quisling S, 2006, OPHTHALMOLOGY, V113, P1629, DOI [10.1016/j.ophtha.2006.03.046, 10.1016/j.ophtha.2006.06.046]; Savini G, 2008, J CATARACT REFR SURG, V34, P809, DOI 10.1016/j.jcrs.2008.01.012; Savini G, 2006, OPHTHALMOLOGY, V113, P1271, DOI 10.1016/j.ophtha.2006.03.024; Savini G, 2013, J CATARACT REFR SURG, V39, P605, DOI 10.1016/j.jcrs.2012.12.031; Savini G, 2011, J CATARACT REFR SURG, V37, P302, DOI 10.1016/j.jcrs.2010.07.039; Seitz B, 2000, J REFRACT SURG, V16, P349; Shetty R, 2011, RECENT ADV OPHTHALMO, V10, P89; Sonego-Krone S, 2004, ARCH OPHTHALMOL-CHIC, V122, P159, DOI 10.1001/archopht.122.2.159; Srivannaboon S, 1999, J CATARACT REFR SURG, V25, P1596, DOI 10.1016/S0886-3350(99)00286-2; Tang QY, 2009, J CATARACT REFR SURG, V35, P1198, DOI 10.1016/j.jcrs.2009.02.030; Tay E, 2011, J CATARACT REFR SURG, V37, P1945, DOI 10.1016/j.jcrs.2011.05.025; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P1716, DOI 10.1167/iovs.09-4982; Wang L, 2010, J CATARACT REFR SURG, V36, P1466, DOI 10.1016/j.jcrs.2010.03.044	35	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123729	10.1371/journal.pone.0123729	http://dx.doi.org/10.1371/journal.pone.0123729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853655	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400116
J	Zhao, JJ; Ji, GH; Qiang, Y; Han, XH; Pei, B; Shi, ZH				Zhao, Juanjuan; Ji, Guohua; Qiang, Yan; Han, Xiaohong; Pei, Bo; Shi, Zhenghao			A New Method of Detecting Pulmonary Nodules with PET/CT Based on an Improved Watershed Algorithm	PLOS ONE			English	Article							MULTIMODALITY IMAGE REGISTRATION; CT	Background Integrated F-18-fluorodeoxyglucose positron emission tomography/ computed tomography (F-18-FDG PET/CT) is widely performed for staging solitary pulmonary nodules (SPNs). However, the diagnostic efficacy of SPNs based on PET/CT is not optimal. Here, we propose a method of detection based on PET/CT that can differentiate malignant and benign SPNs with few false-positives. Method Our proposed method combines the features of positron-emission tomography (PET) and computed tomography (CT). A dynamic threshold segmentation method was used to identify lung parenchyma in CT images and suspicious areas in PET images. Then, an improved watershed method was used to mark suspicious areas on the CT image. Next, the support vector machine (SVM) method was used to classify SPNs based on textural features of CT images and metabolic features of PET images to validate the proposed method. Results Our proposed method was more efficient than traditional methods and methods based on the CT or PET features alone (sensitivity 95.6%; average of 2.9 false positives per scan).	[Zhao, Juanjuan; Ji, Guohua; Qiang, Yan; Han, Xiaohong; Pei, Bo] Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan 030024, Peoples R China; [Shi, Zhenghao] Xian Univ Technol, Coll Comp Sci & Engn, Xian 710048, Peoples R China	Taiyuan University of Technology; Xi'an University of Technology	Qiang, Y (corresponding author), Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan 030024, Peoples R China.	27420265@qq.com	han, xiao/HDN-9782-2022		National Natural Science Foundation of China [61202163, 61373100]; Science and Technique Project of Shanxi Province [20120313032-3]; Natural Science Foundation of Shanxi Province [2012011015-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technique Project of Shanxi Province; Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province)	The work is supported by the fund of National Natural Science Foundation of China (61202163, 61373100), (http://www.nsfc.gov.cn/) the Science and Technique Project of Shanxi Province under Grant (20120313032-3), (http://www.sxinfo.gov.cn/) and the Natural Science Foundation of Shanxi Province (2012011015-1), (http://www.sxinfo.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Choi WJ, 2012, INFORM SCIENCES, V212, P57, DOI 10.1016/j.ins.2012.05.008; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Darmanayagam SE, 2013, J DIGIT IMAGING, V26, P496, DOI 10.1007/s10278-012-9539-6; Dehmeshki J, 2007, COMPUT MED IMAG GRAP, V31, P408, DOI 10.1016/j.compmedimag.2007.03.002; Du XG, 2013, 2013 THIRD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEM DESIGN AND ENGINEERING APPLICATIONS (ISDEA), P274, DOI 10.1109/ISDEA.2012.68; Eichkitz CG, 2013, COMPUT GEOSCI-UK, V60, P176, DOI 10.1016/j.cageo.2013.07.006; FORREST S, 1993, FOUNDATIONS OF GENETIC ALGORITHMS 2, P109; Fraioli F, 2010, RADIOL MED, V115, P385, DOI 10.1007/s11547-010-0507-2; Gao ZY, 2008, IMAGE VISION COMPUT, V26, P164, DOI 10.1016/j.imavis.2006.08.002; Guo YH, 2013, MED PHYS, V40, DOI 10.1118/1.4812679; Suarez-Cuenca JJ, 2009, COMPUT BIOL MED, V39, P921, DOI 10.1016/j.compbiomed.2009.07.005; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Masoumi H, 2012, BIOMED SIGNAL PROCES, V7, P429, DOI 10.1016/j.bspc.2012.01.002; Messay T, 2010, MED IMAGE ANAL, V14, P390, DOI 10.1016/j.media.2010.02.004; Nandan M, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036001; Okada T, 2009, JPN J RADIOL, V27, P91, DOI 10.1007/s11604-008-0306-z; Opfer R, 2007, MED IMAGING INT SOC; Shi ZH, 2013, APPL MATH INFORM SCI, V7, P1165, DOI 10.12785/amis/070339; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takahashi Y, 2013, ACTA RADIOL, V54, P164, DOI 10.1258/ar.2012.120138; VIOLA P, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P16, DOI 10.1109/ICCV.1995.466930; Wei J, 2002, CARS 2002: COMPUTER ASSISTED RADIOLOGY AND SURGERY, PROCEEDINGS, P706; Wei Y, 2013, J APPL MATH, P1, DOI DOI 10.1109/GIT4NDM.2013.8; Yan J, 2009, SPIE MED IMAGING INT; Zhang J, 2010, P 2010 3 INT C BIOM	28	176	177	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123694	10.1371/journal.pone.0123694	http://dx.doi.org/10.1371/journal.pone.0123694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853496	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400114
J	Zhou, CC; Dong, HG; Hu, R; Chen, QH				Zhou, Cancan; Dong, Hongguang; Hu, Rui; Chen, Qinghua			Smarter than Others? Conjectures in Lowest Unique Bid Auctions	PLOS ONE			English	Article							GAME-THEORY; MODEL	Research concerning various types of auctions, such as English auctions, Dutch auctions, highest-price sealed-bid auctions, and second-price sealed-bid auctions, is always a topic of considerable interest in interdisciplinary fields. The type of auction, known as a lowest unique bid auction (LUBA), has also attracted significant attention. Various models have been proposed, but they often fail to explain satisfactorily the real bid-distribution characteristics. This paper discusses LUBA bid-distribution characteristics, including the inverted-J shape and the exponential decrease in the upper region. The authors note that this type of distribution, which initially increases and later decreases, cannot be derived from the symmetric Nash equilibrium framework based on perfect information that has previously been used. A novel optimization model based on non-perfect information is presented. The kernel of this model is the premise that agents make decisions to achieve maximum profit based on imaginary information or assumptions regarding the behavior of others.	[Zhou, Cancan; Hu, Rui; Chen, Qinghua] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Dong, Hongguang] Beijing Higher Educ Press, Beijing, Peoples R China	Beijing Normal University	Chen, QH (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	qinghuachen@bnu.edu.cn			Beijing Higher Education Press	Beijing Higher Education Press	The author(s) received no specific funding for this work. Beijing Higher Education Press provided support in the form of salary for author HD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Anderson SP, 2002, SOUTH ECON J, V69, P21, DOI 10.2307/1061555; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Goeree JK, 1999, P NATL ACAD SCI USA, V96, P10564, DOI 10.1073/pnas.96.19.10564; Houba H, 2011, THEOR DECIS, V71, P269, DOI 10.1007/s11238-010-9196-5; Krishna V, 2009, AUCTION THEORY; Li CG, 2005, J PHYS A-MATH GEN, V38, P9741, DOI 10.1088/0305-4470/38/45/002; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Ostling R, 2011, AM ECON J-MICROECON, V3, P1, DOI 10.1257/mic.3.3.1; Pigolotti S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.088701; Press W. H., 1992, ART SCI COMPUTING; Radicchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029910; Rapoport A, 2007, UNIQUE BID AUCTION E, P4185; Rothkopf MH., 2007, DECIS ANAL, V4, P167, DOI [10.1287/deca.1070.0097, DOI 10.1287/DECA.1070.0097]; Zeng Q, 2007, FLUCT NOISE LETT, V7, pL439, DOI 10.1142/S0219477507004069; Zhao YN, 2013, INT J MOD PHYS C, V25	18	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122923	10.1371/journal.pone.0122923	http://dx.doi.org/10.1371/journal.pone.0122923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849631	Green Published, Green Submitted, gold			2022-12-27	WOS:000352477800175
J	Parra-Rojas, J; Moreno, AA; Mitina, I; Orellana, A				Parra-Rojas, Juan; Moreno, Adrian A.; Mitina, Irina; Orellana, Ariel			The Dynamic of the Splicing of bZIP60 and the Proteins Encoded by the Spliced and Unspliced mRNAs Reveals Some Unique Features during the Activation of UPR in Arabidopsis thaliana	PLOS ONE			English	Article							RETICULUM STRESS-RESPONSE; TRANSCRIPTION FACTOR; ER STRESS; CELL FATE; IRE1; TRANSFORMATION; DISSOCIATION; MECHANISM; LIGASE; SENSOR	The unfolded protein response (UPR) is a signaling pathway that is activated when the workload of the endoplasmic reticulum (ER) is surpassed. IRE1 is a sensor involved in triggering the UPR and plays a key role in the unconventional splicing of an mRNA leading to the formation of a transcription factor that up-regulates the transcription of genes that play a role in restoring the homeostasis in the ER. In plants, bZIP60 is the substrate for IRE1; however, questions such as what is the dynamics of the splicing of bZIP60 and the fate of the proteins encoded by the spliced and unspliced forms of the mRNA, remain unanswered. In the present work, we analyzed the processing of bZIP60 by determining the levels of the spliced form mRNA in plants exposed to different conditions that trigger UPR. The results show that induction of ER stress increases the content of the spliced form of bZIP60 (bZIP60s) reaching a maximum, that depending on the stimuli, varied between 30 min or 2 hrs. In most cases, this was followed by a decrease in the content. In contrast to other eukaryotes, the splicing never occurred to full extent. The content of bZIP60s changed among different organs upon induction of the UPR suggesting that splicing is regulated differentially throughout the plant. In addition, we analyzed the distribution of a GFP-tagged version of bZIP60 when UPR was activated. A good correlation between splicing of bZIP60 and localization of the protein in the nucleus was observed. No fluorescence was observed under basal conditions, but interestingly, the fluorescence was recovered and found to co-localize with an ER marker upon treatment with an inhibitor of the proteasome. Our results indicate that the dynamics of bZIP60, both the mRNA and the protein, are highly dynamic processes which are tissue-specific and stimulus-dependent.	[Parra-Rojas, Juan; Moreno, Adrian A.; Mitina, Irina; Orellana, Ariel] Univ Andres Bello, Fac Ciencias Biol, FONDAP Ctr Genome Regulat, Ctr Biotecnol Vegetal, Santiago, Chile	Universidad Andres Bello	Orellana, A (corresponding author), Univ Andres Bello, Fac Ciencias Biol, FONDAP Ctr Genome Regulat, Ctr Biotecnol Vegetal, Santiago, Chile.	aorellana@unab.cl	Moreno, Adrian/H-4956-2019; Orellana, Ariel/AAE-4866-2021; Orellana, Ariel/E-2166-2014	Orellana, Ariel/0000-0002-9243-808X; Orellana, Ariel/0000-0002-9243-808X; Moreno, Adrian/0000-0001-5125-2927; Parra, Juan/0000-0002-3111-0603	FONDECYT [1110954]; FONDAP Centro de Regulacion del Genoma [15090007]; Fundacion ciencia para la vida [PFB 16]; Iniciativa Cientifica Milenio [P10-062-F]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP Centro de Regulacion del Genoma(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Fundacion ciencia para la vida; Iniciativa Cientifica Milenio	1. FONDECYT 1110954 (http://ri.conicyt.cl/575/article-40406.html) (AO) FONDAP Centro de Regulacion del Genoma 15090007 (http://www.conicyt.cl/fondap/centros-fondap/crg/) (AO) Fundacion ciencia para la vida PFB 16 (http://ri.conicyt.cl/575/article-27894.html) (AO) Iniciativa Cientifica Milenio P10-062-F (http://www.iniciativamilenio.cl/centros/nucleos_det.php?id=29) (AO) 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chawla A, 2011, J CELL BIOL, V193, P41, DOI 10.1083/jcb.201008071; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Deng Y, 2011, P NATL ACAD SCI USA, V108, P7247, DOI 10.1073/pnas.1102117108; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Hollien J, 2013, BBA-MOL CELL RES, V1833, P2458, DOI 10.1016/j.bbamcr.2013.01.016; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Lu SJ, 2012, MOL PLANT, V5, P504, DOI 10.1093/mp/ssr115; Moreno AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031944; Mori T, 2010, MOL BIOL CELL, V21, P3722, DOI 10.1091/mbc.E10-08-0693; Nagashima Y, 2014, PLANT CELL PHYSIOL, V55, P1772, DOI 10.1093/pcp/pcu108; Nagashima Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00029; Oikawa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051290; Oikawa D, 2009, EXP CELL RES, V315, P2496, DOI 10.1016/j.yexcr.2009.06.009; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Ryoo HD, 2007, EMBO J, V26, P242, DOI 10.1038/sj.emboj.7601477; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Weber K, 1972, Methods Enzymol, V26, P3; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	35	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122936	10.1371/journal.pone.0122936	http://dx.doi.org/10.1371/journal.pone.0122936			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860807	Green Published, gold			2022-12-27	WOS:000352590300069
J	Wang, YF; Lv, JP; Cheng, Y; Du, JP; Chen, DG; Li, CT; Zhang, J				Wang, Yufang; Lv, Junping; Cheng, Yao; Du, Jipei; Chen, Degao; Li, Chengtao; Zhang, Ji			Apoptosis Induced by Ginkgo biloba (EGb761) in Melanoma Cells Is Mcl-1-Dependent	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; CANCER-CELLS; OVERCOMING RESISTANCE; CARCINOMA-CELLS; EXTRACT; INHIBITION; BAX; MITOCHONDRIA; MCL-1; ACTIVATION	Melanoma is an aggressive skin cancer. Unfortunately, there is currently no chemotherapeutic agent available to significantly prolong the survival of the most patients with metastatic melanomas. Here we report that the Ginkgo biloba extract (EGb761), one of the most widely sold herbal supplements in the world, potently induces apoptosis in human melanoma cells by disturbing the balance between pro-and anti-apoptosis Bcl-2 family proteins. Treatment with EGb761 induced varying degrees of apoptosis in melanoma cell lines but not in melanocytes. Induction of apoptosis was caspase-dependent and appeared to be mediated by the mitochondrial pathway, in that it was associated with reduction in mitochondrial membrane potential and activation of Bax and Bak. Although EGb761 did not cause significant change in the expression levels of the BH3-only Bcl-2 family proteins Bim, Puma, Noxa, and Bad, it significantly downregulated Mcl-1 in sensitive but not resistant melanoma cells, suggesting a major role of Mcl-1 in regulating apoptosis of melanoma cells induced by EGb761. Indeed, siRNA knockdown of Mcl-1 enhanced EGb761-induced apoptosis, which was associated with increased activation of Bax and Bak. Taken together, these results demonstrate that EGb761 kills melanoma cells through the mitochondrial apoptotic pathway, and that Mcl-1 is a major regulator of sensitivity of melanoma cells to apoptosis induced by EGb761. Therefore, EGb761 with or without in combination with targeting Mcl-1 may be a useful strategy in the treatment of melanoma.	[Wang, Yufang; Cheng, Yao; Du, Jipei; Chen, Degao] Sichuan Univ, Sch Preclin & Forens Med, Dept Pathophysiol, Chengdu 610064, Peoples R China; [Lv, Junping] Beijing Inst Biomed, Dept Pharmacol, Beijing, Peoples R China; [Li, Chengtao] Inst Forens Sci, Shanghai Key Lab Forens Med, Minist Justice, Shanghai, Peoples R China; [Zhang, Ji] Sichuan Univ, Sch Preclin & Forens Med, Dept Forens Genet, Chengdu 610064, Peoples R China	Sichuan University; Institute of Forensic Science Ministry of Justice PRC; Sichuan University	Zhang, J (corresponding author), Sichuan Univ, Sch Preclin & Forens Med, Dept Forens Genet, Chengdu 610064, Peoples R China.	zhangj@scu.edu.cn		Li, Chengtao/0000-0001-6852-9144	National Nature Science Foundation [81201560, 81471551]; priming scientific research foundation for the junior teachers of medicine in Sichuan University [2012SCU11020]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); priming scientific research foundation for the junior teachers of medicine in Sichuan University	This work was supported by research grants from the National Nature Science Foundation (81201560 and 81471551); the priming scientific research foundation for the junior teachers of medicine in Sichuan University (2012SCU11020).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Chaabane W, 2013, ARCH IMMUNOL THER EX, V61, P43, DOI 10.1007/s00005-012-0205-y; Chao JCJ, 2004, WORLD J GASTROENTERO, V10, P37; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; DeFeudis FV, 2003, FUND CLIN PHARMACOL, V17, P405, DOI 10.1046/j.1472-8206.2003.00156.x; DEFEUDIS FV, 1991, LIFE SCI, V49, P689, DOI 10.1016/0024-3205(91)90101-G; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fabrega A, 2012, THERIOGENOLOGY, V78, P867, DOI 10.1016/j.theriogenology.2012.03.039; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gohil K, 2002, CELL MOL BIOL, V48, P625; Hersey P, 2003, J CELL PHYSIOL, V196, P9, DOI 10.1002/jcp.10256; Hersey P, 2001, NAT REV CANCER, V1, P142, DOI 10.1038/35101078; Hersey P, 2008, ADV EXP MED BIOL, V615, P105, DOI 10.1007/978-1-4020-6554-5_6; Hersey P, 2006, INT REV CYTOL, V251, P131, DOI 10.1016/S0074-7696(06)51004-6; Jacobs BP, 2000, AM J MED, V108, P341, DOI 10.1016/S0002-9343(00)00290-4; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Jiang CC, 2011, CLIN CANCER RES, V17, P721, DOI 10.1158/1078-0432.CCR-10-2225; Jung IH, 2012, EXP MOL MED, V44, P311, DOI 10.3858/emm.2012.44.5.035; Kim KS, 2005, ORAL ONCOL, V41, P383, DOI 10.1016/j.oraloncology.2004.09.013; Limberg, 1976, TECHNIQUES CLIN APPL; Liu XP, 2007, LIFE SCI, V80, P1586, DOI 10.1016/j.lfs.2007.01.034; Lu G, 2006, BRAIN RES, V1090, P23, DOI 10.1016/j.brainres.2006.02.138; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Mutoh M, 2000, CARCINOGENESIS, V21, P959, DOI 10.1093/carcin/21.5.959; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Trotter Shannon C, 2013, J Clin Aesthet Dermatol, V6, P18; Uzdensky AB, 2013, CURR CANCER DRUG TAR, V13, P843; Vilar JB, 2009, GENET MOL RES, V8, P328, DOI 10.4238/vol8-1gmr519; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wouters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076550; Xiaodong Liu GY, 1992, J PRACTICAL ONCOLOGY, V3, P2; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Zekanowski C, 2001, J MED SCREEN, V8, P132, DOI 10.1136/jms.8.3.132; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200; Zhang XD, 2006, CLIN CANCER RES, V12, P1355, DOI 10.1158/1078-0432.CCR-05-2084; Zhang XD, 2001, CANCER RES, V61, P7339; Zhuang LQ, 2007, MODERN PATHOL, V20, P416, DOI 10.1038/modpathol.3800750; Zixin Li LW, 1988, CHINESE OBSTETRICS G, V23, P3	50	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124812	10.1371/journal.pone.0124812	http://dx.doi.org/10.1371/journal.pone.0124812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860257	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300148
J	Kollitz, EM; Zhang, GZ; Hawkins, MB; Whitfield, GK; Reif, DM; Kullman, SW				Kollitz, Erin M.; Zhang, Guozhu; Hawkins, Mary Beth; Whitfield, G. Kerr; Reif, David M.; Kullman, Seth W.			Molecular Cloning, Functional Characterization, and Evolutionary Analysis of Vitamin D Receptors Isolated from Basal Vertebrates	PLOS ONE			English	Article							NUCLEAR HORMONE-RECEPTORS; RETINOID-X-RECEPTOR; GENOME DUPLICATION; 1,25-DIHYDROXYVITAMIN D-3; CONFORMATIONAL-CHANGES; TELEOST FISH; GENE; ACID; BINDING; LIGAND	The vertebrate genome is a result of two rapid and successive rounds of whole genome duplication, referred to as 1R and 2R. Furthermore, teleost fish have undergone a third whole genome duplication (3R) specific to their lineage, resulting in the retention of multiple gene paralogs. The more recent 3R event in teleosts provides a unique opportunity to gain insight into how genes evolve through specific evolutionary processes. In this study we compare molecular activities of vitamin D receptors (VDR) from basal species that diverged at key points in vertebrate evolution in order to infer derived and ancestral VDR functions of teleost paralogs. Species include the sea lamprey (Petromyzon marinus), a 1R jawless fish; the little skate (Leucoraja erinacea), a cartilaginous fish that diverged after the 2R event; and the Senegal bichir (Polypterus senegalus), a primitive 2R ray-finned fish. Saturation binding assays and gel mobility shift assays demonstrate high affinity ligand binding and classic DNA binding characteristics of VDR has been conserved across vertebrate evolution. Concentration response curves in transient transfection assays reveal EC50 values in the low nanomolar range, however maximum transactivational efficacy varies significantly between receptor orthologs. Protein-protein interactions were investigated using co-transfection, mammalian 2-hybrid assays, and mutations of coregulator activation domains. We then combined these results with our previous study of VDR paralogs from 3R teleosts into a bioinformatics analysis. Our results suggest that 1, 25D(3) acts as a partial agonist in basal species. Furthermore, our bioinformatics analysis suggests that functional differences between VDR orthologs and paralogs are influenced by differential protein interactions with essential coregulator proteins. We speculate that we may be observing a change in the pharmacodynamics relationship between VDR and 1, 25D(3) throughout vertebrate evolution that may have been driven by changes in protein-protein interactions between VDR and essential coregulators.	[Kollitz, Erin M.; Kullman, Seth W.] N Carolina State Univ, Dept Biol Sci, Program Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Zhang, Guozhu; Reif, David M.] N Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Hawkins, Mary Beth; Reif, David M.] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Whitfield, G. Kerr] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Arizona	Kullman, SW (corresponding author), N Carolina State Univ, Dept Biol Sci, Program Environm & Mol Toxicol, Raleigh, NC 27695 USA.	swkullma@ncsu.edu		Kullmam, Seth/0000-0002-6029-2266; Reif, David/0000-0001-7815-6767; Kollitz, Erin/0000-0003-1769-1496	National Science Foundation [IOS0818799]; Mount Desert Island Biological Laboratory; North Carolina State University; National Institute of Environmental Health Sciences Training Grant [T32-ES007046]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007329, T32ES007046, P30ES025128] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Mount Desert Island Biological Laboratory; North Carolina State University; National Institute of Environmental Health Sciences Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Science Foundation grant IOS0818799 (to SWK); a Stan and Judy Fellowship from the Mount Desert Island Biological Laboratory (to EMK); a Dissertation Completion Grant from North Carolina State University (to EMK); and National Institute of Environmental Health Sciences Training Grant T32-ES007046 (to EMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi R, 2004, MOL ENDOCRINOL, V18, P43, DOI 10.1210/me.2003-0244; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Bettoun DJ, 2003, MOL ENDOCRINOL, V17, P2320, DOI 10.1210/me.2003-0148; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Bouillon Roger, 2014, Bonekey Rep, V3, P480, DOI 10.1038/bonekey.2013.214; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Bury NR, 2003, J MOL ENDOCRINOL, V31, P141, DOI 10.1677/jme.0.0310141; Carlberg C, 2004, J STEROID BIOCHEM, V89-90, P227, DOI 10.1016/j.jsbmb.2004.03.112; Crow KD, 2006, MOL BIOL EVOL, V23, P887, DOI 10.1093/molbev/msj083; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Drocourt L, 2001, DRUG METAB DISPOS, V29, P1325; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Escriva H, 2004, ESSAYS BIOCHEM, V40, P11, DOI 10.1042/bse0400011; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Force A, 1999, GENETICS, V151, P1531; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Hawkins MB, 2004, ENDOCRINOLOGY, V145, P2968, DOI 10.1210/en.2003-0806; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Howarth DL, 2008, ENDOCRINOLOGY, V149, P2411, DOI 10.1210/en.2007-1256; Howarth DL, 2009, THESIS DUKE U DURHAM; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; JONES BB, 1995, MOL CELL BIOL, V15, P5226; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jurutka PW, 2005, J CELL BIOCHEM, V94, P917, DOI 10.1002/jcb.20359; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Kobayashi T, 1991, VITAMIN D GENE REGUL; Kollitz EM, 2014, ENDOCRINOLOGY, V155, P4641, DOI 10.1210/en.2014-1505; Laudet V, 2002, NUCL RECEPTOR FACTSB; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li YC, 1997, ENDOCRINOLOGY, V138, P2347, DOI 10.1210/en.138.6.2347; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045650; Lock EJ, 2010, AQUACULT NUTR, V16, P100, DOI 10.1111/j.1365-2095.2009.00722.x; MACDONALD PN, 1993, MOL CELL BIOL, V13, P5907, DOI 10.1128/MCB.13.9.5907; Maglich JM, 2003, NUCLEIC ACIDS RES, V31, P4051, DOI 10.1093/nar/gkg444; Metpally RPR, 2007, J BIOSCIENCES, V32, P43, DOI 10.1007/s12038-007-0005-4; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Ogino Y, 2009, ENDOCRINOLOGY, V150, P5415, DOI 10.1210/en.2009-0523; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; Ohno S., 1970, P1; PELEG S, 1995, J BIOL CHEM, V270, P10551, DOI 10.1074/jbc.270.18.10551; Pierens SL, 2015, J STEROID BIOCHEM, V145, P58, DOI 10.1016/j.jsbmb.2014.10.005; Ploner A, 2012, HEATPLUS HEATMAPS RO; RCoreTeam, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Reschly EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-222; Robinson-Rechavi M, 2001, TRENDS GENET, V17, P554, DOI 10.1016/S0168-9525(01)02417-9; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Rozen S, 2000, BIOINFORMATICS METHO; Schartl M, 2014, DIS MODEL MECH, V7, P181, DOI 10.1242/dmm.012245; Shaffer PL, 2004, VITAM HORM, V68, P257; Shaffer PL, 2004, J STEROID BIOCHEM, V89-90, P215, DOI 10.1016/j.jsbmb.2004.03.084; Suzuki T, 2000, BIOCHEM BIOPH RES CO, V270, P40, DOI 10.1006/bbrc.2000.2378; Takeuchi A, 1991, VITAMIN D GENE REGUL; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson PD, 1998, J BIOL CHEM, V273, P8483, DOI 10.1074/jbc.273.14.8483; Thompson PD, 2001, J MOL ENDOCRINOL, V27, P211, DOI 10.1677/jme.0.0270211; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Whitfield GK, 2003, ENDOCRINOLOGY, V144, P2704, DOI 10.1210/en.2002-221101	65	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122853	10.1371/journal.pone.0122853	http://dx.doi.org/10.1371/journal.pone.0122853			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855982	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500062
J	Maduna, PH; Dolan, M; Kondlo, L; Mabuza, H; Dlamini, JN; Polis, M; Mnisi, T; Orsega, S; Maja, P; Ledwaba, L; Molefe, T; Sangweni, P; Malan, L; Matchaba, G; Khabo, P; Grandits, G; Neaton, JD				Maduna, Patrick H.; Dolan, Matt; Kondlo, Lwando; Mabuza, Honey; Dlamini, Judith N.; Polis, Mike; Mnisi, Thabo; Orsega, Susan; Maja, Patrick; Ledwaba, Lotty; Molefe, Thuthukile; Sangweni, Phumelele; Malan, Lisette; Matchaba, Gugu; Khabo, Paul; Grandits, Greg; Neaton, James D.			Morbidity and Mortality According to Latest CD4+Cell Count among HIV Positive Individuals in South Africa Who Enrolled in Project Phidisa	PLOS ONE			English	Article							NON-AIDS EVENTS; STARTING ANTIRETROVIRAL THERAPY; CD4 CELL COUNTS; SHORT-TERM RISK; INFECTED ADULTS; FOLLOW-UP; NONFATAL AIDS; ALL-CAUSE; DEATH; SETTINGS	Background Short-term morbidity and mortality rates for HIV positive soldiers in the South African National Defence Force (SANDF) would inform decisions about deployment and HIV disease management. Risks were determined according to the latest CD4+ cell count and use of antiretroviral therapy (ART) for HIV positive individuals in the SANDF and their dependents. Methods and Findings A total of 7,114 participants were enrolled and followed for mortality over a median of 4.7 years (IQR: 1.9, 7.1 years). For a planned subset (5,976), progression of disease (POD) and grade 4, potentially life-threatening events were also ascertained. CD4+ count and viral load were measured every 3 to 6 months. Poisson regression was used to compare event rates by latest CD4+ count (<50, 50-99, 100-199, 200-349, 350-499, 500+) with a focus on upper three strata, and to estimate relative risks (RRs) (ART/no ART). Median entry CD4+ was 207 cells/mm(3). During follow-up over 70% were prescribed ART. Over follow-up 1,226 participants died; rates ranged from 57.6 (<50 cells) to 0.8 (500+ cells) per 100 person years (py). Compared to those with latest CD4+ 200-349 (2.2/100py), death rates were significantly lower (p<0.001), as expected, for those with 350-499 (0.9/100py) and with 500+ cells (0.8/100py). The composite outcome of death, POD or grade 4 events occurred in 2,302 participants (4,045 events); rates were similar in higher CD4+ count strata (9.4 for 350-499 and 7.9 for 500+ cells) and lower than those with counts 200-349 cells (13.5) (p<0.001). For those with latest CD4+ 350+ cells, 63% of the composite outcomes (680 of 1,074) were grade 4 events. Conclusion Rates of morbidity and mortality are lowest among those with CD4+ count of 350 or higher and rates do not differ for those with counts of 350-499 versus 500+ cells. Grade 4 events are the predominant morbidity for participants with CD4+ counts of 350+ cells.	[Maduna, Patrick H.; Mabuza, Honey; Mnisi, Thabo; Malan, Lisette] South African Natl Def Forces, South Africa Mil Hlth Serv, Pretoria, South Africa; [Dolan, Matt] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Kondlo, Lwando; Dlamini, Judith N.; Maja, Patrick; Ledwaba, Lotty; Molefe, Thuthukile; Sangweni, Phumelele; Matchaba, Gugu; Khabo, Paul] Charisma Healthcare Solut, Pretoria, South Africa; [Polis, Mike; Orsega, Susan] NIAID, NIH, Bethesda, MD 20892 USA; [Grandits, Greg; Neaton, James D.] Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities	Neaton, JD (corresponding author), Univ Minnesota, Div Biostat, Minneapolis, MN 55455 USA.	jim@ccbr.umn.edu			Phidisa Project; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; South African National Defence Force; United States National Institutes of Health; United States Department of Defense	Phidisa Project; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); South African National Defence Force; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense)	Funding for the Phidisa Project, the Phidisa I and II studies, and this substudy were provided by the South African National Defence Force, the United States National Institutes of Health and the United States Department of Defense. SAIC-Frederick, Inc. helped fund the study through the employment of Beth Basseler and Xiao Liu who contributed to the study. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Anglaret X, 2012, CLIN INFECT DIS, V54, P714, DOI 10.1093/cid/cir898; Babiker AG, 2013, CLIN TRIALS, V10, pS5, DOI 10.1177/1740774512440342; Badri M, 2006, LANCET, V368, P1254, DOI 10.1016/S0140-6736(06)69117-4; Belloso WH, 2010, HIV MED, V11, P554, DOI 10.1111/j.1468-1293.2010.00824.x; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Borges AH, 2013, AIDS, V27, P1433, DOI 10.1097/QAD.0b013e32835f6b0c; Brennan AT, 2013, TROP MED INT HEALTH, V18, P619, DOI 10.1111/tmi.12079; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014149; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; De Cock KM, 2013, NEW ENGL J MED, V368, P886, DOI 10.1056/NEJMp1300458; Deuffic-Burban S, 2007, EUR J EPIDEMIOL, V22, P737, DOI 10.1007/s10654-007-9175-5; Dunn D, 2008, J INFECT DIS, V197, P398, DOI 10.1086/524686; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Floyd S, 2012, TROP MED INT HEALTH, V17, pe84, DOI 10.1111/j.1365-3156.2012.03032.x; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gabillard D, 2013, JAIDS-J ACQ IMM DEF, V62, P555, DOI 10.1097/QAI.0b013e3182821821; Hassan AS, 2012, TROP MED INT HEALTH, V17, P82, DOI 10.1111/j.1365-3156.2011.02889.x; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Lewden C, 2012, JAIDS-J ACQ IMM DEF, V59, P213, DOI 10.1097/QAI.0b013e31823b837e; Lodwick RK, 2010, LANCET, V376, P340, DOI 10.1016/S0140-6736(10)60932-4; Losina E, 2007, ANTIVIR THER, V12, P543; Lucero C, 2013, AIDS RES HUM RETROV, V29, P1161, DOI [10.1089/aid.2012.0367, 10.1089/AID.2012.0367]; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; National Department of Health, 2010, CLIN GUID MAN HIV AI; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; Phillips AN, 2006, CURR OPIN HIV AIDS, V1, P43, DOI 10.1097/01.COH.0000194106.12816.b1; Phillips AN, 2007, AIDS, V21, P1717; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Preisser JS, 1996, BIOMETRIKA, V83, P551, DOI 10.1093/biomet/83.3.551; Ratsela A, 2010, J INFECT DIS, V202, P1529, DOI 10.1086/656718; Reekie J, 2011, AIDS, V25, P2259, DOI 10.1097/QAD.0b013e32834cdb4b; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Tawfik L, 2006, IMPACT HIV AIDS HLTH; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684; Wester CW, 2011, AIDS, V25, P1471, DOI 10.1097/QAD.0b013e328347f9d4; Young J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001194	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121843	10.1371/journal.pone.0121843	http://dx.doi.org/10.1371/journal.pone.0121843			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856495	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500026
J	McCullagh, BN; Costello, CM; Li, LL; O'Connell, C; Codd, M; Lawrie, A; Morton, A; Kiely, DG; Condliffe, R; Elliot, C; McLoughlin, P; Gaine, S				McCullagh, Brian N.; Costello, Christine M.; Li, Lili; O'Connell, Caroline; Codd, Mary; Lawrie, Allan; Morton, Allison; Kiely, David G.; Condliffe, Robin; Elliot, Charles; McLoughlin, Paul; Gaine, Sean			Elevated Plasma CXCL12 alpha Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; SURVIVAL; HYPOXIA; PATHOGENESIS; ADHESION; CXCR7; CELLS	Rationale Recent work in preclinical models suggests that signalling via the pro-angiogenic and pro-inflammatory cytokine, CXCL12 (SDF-1), plays an important pathogenic role in pulmonary hypertension (PH). The objective of this study was to establish whether circulating concentrations of CXCL12 alpha were elevated in patients with PAH and related to mortality. Methods Plasma samples were collected from patients with idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue diseases (CTD-PAH) attending two pulmonary hypertension referral centres (n = 95) and from age and gender matched healthy controls (n = 44). Patients were subsequently monitored throughout a period of five years. Results CXCL12 alpha concentrations were elevated in PAH groups compared to controls (P<0.05) and receiver-operating-characteristic analysis showed that plasma CXCL12 alpha concentrations discriminated patients from healthy controls (AUC 0.80, 95% confidence interval 0.73-0.88). Kaplan Meier analysis indicated that elevated plasma CXCL12a concentration was associated with reduced survival (P<0.01). Multivariate Cox proportional hazards model showed that elevated CXCL12 alpha independently predicted (P<0.05) earlier death in PAH with a hazard ratio (95% confidence interval) of 2.25 (1.01-5.00). In the largest subset by WHO functional class (Class 3, 65% of patients) elevated CXCL12 alpha independently predicted (P<0.05) earlier death, hazard ratio 2.27 (1.05-4.89). Conclusions Our data show that elevated concentrations of circulating CXCL12 alpha in PAH predicted poorer survival. Furthermore, elevated circulating CXCL12 alpha was an independent risk factor for death that could potentially be included in a prognostic model and guide therapy.	[McCullagh, Brian N.; Costello, Christine M.; Li, Lili; O'Connell, Caroline; McLoughlin, Paul] Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 4, Ireland; [Codd, Mary] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 4, Ireland; [Lawrie, Allan] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Morton, Allison] No Gen Hosp, Dept Cardiol, Sheffield S5 7AU, S Yorkshire, England; [Kiely, David G.; Condliffe, Robin; Elliot, Charles] Royal Hallamshire Hosp, Sheffield Pulm Vasc Dis Unit, Sheffield S10 2JF, S Yorkshire, England; [McCullagh, Brian N.; O'Connell, Caroline; Gaine, Sean] Mater Misericordiae Univ Hosp, Pulm Hypertens Unit, Dublin 7, Ireland	University College Dublin; University College Dublin; University of Sheffield; Northern General Hospital; University of Sheffield; Mater Misericordiae University Hospital; University College Dublin	McLoughlin, P (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 4, Ireland.	paul.mcloughlin@ucd.ie	Lawrie, Allan/A-2708-2012	Lawrie, Allan/0000-0003-4192-9505; Gaine, Sean/0000-0002-5941-684X; McLoughlin, Paul/0000-0001-6200-016X; Condliffe, Robin/0000-0002-3492-4143	Health Research Board; Higher Education Authority (Programme for Research in Third Level Institutions) of Ireland and Science Foundation Ireland; Actelion-Newman Fellowship; Medical Research Council Career Development Award [G0800318]; British Heart Foundation [PG/11/116/29288]; National Institute for Health Research Sheffield Cardiovascular Biomedical Research Unit; MRC [G0800318] Funding Source: UKRI; British Heart Foundation [FS/13/48/30453] Funding Source: researchfish; Medical Research Council [G0800318] Funding Source: researchfish	Health Research Board; Higher Education Authority (Programme for Research in Third Level Institutions) of Ireland and Science Foundation Ireland(Science Foundation Ireland); Actelion-Newman Fellowship; Medical Research Council Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); National Institute for Health Research Sheffield Cardiovascular Biomedical Research Unit; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants from the Health Research Board, the Higher Education Authority (Programme for Research in Third Level Institutions) of Ireland and Science Foundation Ireland, an Actelion-Newman Fellowship (BM), a Medical Research Council Career Development Award (G0800318, AL), a British Heart Foundation clinical project grant (PG/11/116/29288), National Institute for Health Research Sheffield Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the patients and staff at the participating centres in the study.	Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Benza RL, 2012, THROMB HAEMOSTASIS, V108, P1049, DOI 10.1160/TH11-11-0821; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Costello CM, 2008, AM J PHYSIOL-LUNG C, V295, pL272, DOI 10.1152/ajplung.00358.2007; Costello CM, 2012, EUR RESPIR J, V39, P1415, DOI 10.1183/09031936.00044911; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Farha S, 2011, BLOOD, V117, P3485, DOI 10.1182/blood-2010-09-306357; Gambaryan N, 2011, EUR RESPIR J, V37, P1392, DOI 10.1183/09031936.00045710; Hashimoto K, 2004, CIRC J, V68, P227, DOI 10.1253/circj.68.227; Hopkins N, 2002, J ANAT, V201, P335, DOI 10.1046/j.1469-7580.2002.00096.x; Humbert M, 2010, EUR RESPIR J, V36, P549, DOI 10.1183/09031936.00057010; Kiely DG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2028; Kuhn KP, 2003, AM J RESP CRIT CARE, V167, P580, DOI 10.1164/rccm.200204-333OC; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; McLaughlin VV, 2004, CHEST, V126, p78S, DOI 10.1378/chest.126.1_suppl.78S; Montani D, 2011, AM J RESP CRIT CARE, V184, P116, DOI 10.1164/rccm.201006-0905OC; Rabinovitch M, 2012, J CLIN INVEST, V122, P4306, DOI 10.1172/JCI60658; Raychaudhuri B, 2002, J BIOL CHEM, V277, P33344, DOI 10.1074/jbc.M203567200; Rhodes CJ, 2013, AM J RESP CRIT CARE, V187, P294, DOI 10.1164/rccm.201205-0839OC; Rhodes CJ, 2011, HEART, V97, P1054, DOI 10.1136/hrt.2011.224857; Sartina E, 2012, PEDIATR RES, V71, P682, DOI 10.1038/pr.2012.30; Satoh K, 2009, CARDIOVASC RES, V81, P226, DOI 10.1093/cvr/cvn244; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Toshner M, 2009, AM J RESP CRIT CARE, V180, P780, DOI 10.1164/rccm.200810-1662OC; Young KC, 2009, CIRC RES, V104, P1293, DOI 10.1161/CIRCRESAHA.109.197533; Yu LY, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-21	30	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123709	10.1371/journal.pone.0123709	http://dx.doi.org/10.1371/journal.pone.0123709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856504	Green Accepted, gold, Green Published			2022-12-27	WOS:000352588500103
J	Mostafavi, L; Marfori, W; Arellano, C; Tognolini, A; Speier, W; Adibi, A; Ruehm, SG				Mostafavi, Leila; Marfori, Wanda; Arellano, Cesar; Tognolini, Alessia; Speier, William; Adibi, Ali; Ruehm, Stefan G.			Prevalence of Coronary Artery Disease Evaluated by Coronary CT Angiography in Women with Mammographically Detected Breast Arterial Calcifications	PLOS ONE			English	Article							HEART-DISEASE; RISK-FACTORS; CARDIOVASCULAR MORTALITY; ASSOCIATION; MAMMOGRAMS; CALCIUM	To assess the correlation between breast arterial calcifications (BAC) on digital mammography and the extent of coronary artery disease (CAD) diagnosed with dual source coronary computed tomography angiography (CTA) in a population of women both symptomatic and asymptomatic for coronary artery disease. 100 consecutive women (aged 34 - 86 years) who underwent both coronary CTA and digital mammography were included in the study. Health records were reviewed to determine the presence of cardiovascular risk factors such as hypertension, hyperlipidemia, diabetes mellitus, and smoking. Digital mammograms were reviewed for the presence and degree of BAC, graded in terms of severity and extent. Coronary CTAs were reviewed for CAD, graded based on the extent of calcified and non-calcified plaque, and the degree of major vessel stenosis. A four point grading scale was used for both coronary CTA and mammography. The overall prevalence of positive BAC and CAD in the studied population were 12% and 29%, respectively. Ten of the 12 patients with moderate or advanced BAC on mammography demonstrated moderate to severe CAD as determined by coronary CTA. For all women, the positive predictive value of BAC for CAD was 0.83 and the negative predictive value was 0.78. The presence of BAC on mammography appears to correlate with CAD as determined by coronary CTA (Spearman's rank correlation coefficient = 0.48, p<.000001). Using logistic regression, the inclusion of BAC as a feature in CAD predication significantly increased classification results (p=0.04).	[Mostafavi, Leila; Arellano, Cesar; Tognolini, Alessia; Adibi, Ali; Ruehm, Stefan G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Marfori, Wanda] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92717 USA; [Speier, William] Univ Calif Irvine, Dept Radiol Sci, Med Imaging Informat, Irvine, CA 92717 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; University of California System; University of California Irvine	Mostafavi, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA.	Lmostafavi@mednet.ucla.edu	Speier, William/H-9974-2019; Mostafavi, Leila/AAA-3236-2022	Speier, William/0000-0002-0890-8684; Mostafavi, Leila/0000-0002-8383-3678				Adkins JR, 2007, AM SURGEON, V73, P717; BAUM JK, 1980, RADIOLOGY, V136, P61, DOI 10.1148/radiology.136.1.7384525; Braun TM, 2008, BIOSTATISTICS, V9, P364, DOI 10.1093/biostatistics/kxm036; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Cetin M, 2004, CLIN RADIOL, V59, P92, DOI 10.1016/j.crad.2003.09.007; Cox J, 2002, J MED SCREEN, V9, P38, DOI 10.1136/jms.9.1.38; Crystal P, 2000, AM J CARDIOL, V86, P216, DOI 10.1016/S0002-9149(00)00860-2; Crystal P, 2004, J WOMENS HEALTH, V13, P390, DOI 10.1089/154099904323087079; Dale PS, 2008, J SURG RES, V148, P1, DOI 10.1016/j.jss.2007.08.022; EVERHART JE, 1988, DIABETOLOGIA, V31, P16; Ferreira EMPF, 2007, ACAD RADIOL, V14, P144, DOI 10.1016/j.acra.2006.10.017; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Hekimoglu B, 2012, JBR-BTR, V95, P229, DOI 10.5334/jbr-btr.626; Henkin Y, 2003, J MED SCREEN, V10, P139, DOI 10.1258/096914103769011049; Iribarren C, 2004, J WOMENS HEALTH, V13, P381, DOI 10.1089/154099904323087060; Johnson TRC, 2007, INVEST RADIOL, V42, P684, DOI 10.1097/RLI.0b013e31806907d0; Kataoka M, 2006, AM J ROENTGENOL, V187, P73, DOI 10.2214/AJR.05.0365; Kemmeren JM, 1996, RADIOLOGY, V201, P75, DOI 10.1148/radiology.201.1.8816524; Kemmeren JM, 1998, AM J EPIDEMIOL, V147, P333, DOI 10.1093/oxfordjournals.aje.a009455; Kim HJ, 1999, RADIOGRAPHICS, V19, P1401, DOI 10.1148/radiographics.19.5.g99se221401; Kohli P, 2010, CIRCULATION, V122, P2570, DOI 10.1161/CIRCULATIONAHA.109.914754; Lerman A, 2006, J AM COLL CARDIOL, V47, p59S, DOI 10.1016/j.jacc.2004.10.083; Maas AHEM, 2004, AM J CARDIOL, V94, P655, DOI 10.1016/j.amjcard.2004.05.036; Maas AHEM, 2007, EUR J RADIOL, V63, P396, DOI 10.1016/j.ejrad.2007.02.009; Maas AHEM, 2006, RADIOLOGY, V240, P33, DOI 10.1148/radiol.2401050170; Markopoulos C, 2004, ACTA RADIOL, V45, P726, DOI 10.1080/02841850410008261; Metz CNB, 2006, J AM COLL CARDIOL, V47, p21S, DOI 10.1016/j.jacc.2004.12.084; MOSHYEDI AC, 1995, RADIOLOGY, V194, P181, DOI 10.1148/radiology.194.1.7997548; MURABITO JM, 1990, AM J MED, V89, P297, DOI 10.1016/0002-9343(90)90341-A; NIELSEN BB, 1985, ACTA PATH MICRO IM A, V93, P13; Pecchi Annarita, 2003, Radiol Med, V106, P305; Quyyumi AA, 2006, J AM COLL CARDIOL, V47, p66S, DOI 10.1016/j.jacc.2004.11.075; Rafeh NA, 2012, J WOMENS HEALTH, V21, P1053, DOI 10.1089/jwh.2011.3388; Rotter MA, 2008, MENOPAUSE, V15, P276, DOI 10.1097/gme.0b013e3181405d0a; Sarrafzadegann N, 2009, East Mediterr Health J, V15, P1474; Shah N, 2014, CARDIOL REV, V22, P69, DOI 10.1097/CRD.0b013e318295e029; Topal U, 2007, EUR J RADIOL, V63, P391, DOI 10.1016/j.ejrad.2007.01.035; vanNoord PAH, 1996, EUR J CANCER PREV, V5, P483; Zgheib MH, 2010, RADIOLOGY, V254, P367, DOI 10.1148/radiol.09090102	39	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122289	10.1371/journal.pone.0122289	http://dx.doi.org/10.1371/journal.pone.0122289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856075	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500035
J	Zhao, MX; Geekiyanage, N; Xu, JC; Khin, MM; Nurdiana, DR; Paudel, E; Harrison, RD				Zhao, Mingxu; Geekiyanage, Nalaka; Xu, Jianchu; Khin, Myo Myo; Nurdiana, Dian Ridwan; Paudel, Ekananda; Harrison, Rhett Daniel			Structure of the Epiphyte Community in a Tropical Montane Forest in SW China	PLOS ONE			English	Article							VASCULAR EPIPHYTES; DIVERSITY PATTERNS; LOWLAND; NESTEDNESS; ECOLOGY; CANOPY; RICHNESS; GRADIENT; VERACRUZ	Vascular epiphytes are an understudied and particularly important component of tropical forest ecosystems. However, owing to the difficulties of access, little is known about the properties of epiphyte-host tree communities and the factors structuring them, especially in Asia. We investigated factors structuring the vascular epiphyte-host community and its network properties in a tropical montane forest in Xishuangbanna, SW China. Vascular epiphytes were surveyed in six plots located in mature forests. Six host and four micro-site environmental factors were investigated. Epiphyte diversity was strongly correlated with host size (DBH, diameter at breast height), while within hosts the highest epiphyte diversity was in the middle canopy and epiphyte diversity was significantly higher in sites with canopy soil or a moss mat than on bare bark. DBH, elevation and stem height explained 22% of the total variation in the epiphyte species assemblage among hosts, and DBH was the most important factor which alone explained 6% of the variation. Within hosts, 51% of the variation in epiphyte assemblage composition was explained by canopy position and substrate, and the most important single factor was substrate which accounted for 16% of the variation. Analysis of network properties indicated that the epiphyte host community was highly nested, with a low level of epiphyte specialization, and an almost even interaction strength between epiphytes and host trees. Together, these results indicate that large trees harbor a substantial proportion of the epiphyte community in this forest.	[Zhao, Mingxu; Xu, Jianchu; Paudel, Ekananda; Harrison, Rhett Daniel] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Zhao, Mingxu; Paudel, Ekananda] Univ Chinese Acad Sci, Beijing, Peoples R China; [Geekiyanage, Nalaka] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Lab Trop Forest Resources & Environm, Kitashirakawa Oiwake, Kyoto, Japan; [Geekiyanage, Nalaka] Rajarata Univ Sri Lanka, Fac Agr, Dept Plant Sci, Anuradhapura, Sri Lanka; [Zhao, Mingxu; Xu, Jianchu; Paudel, Ekananda; Harrison, Rhett Daniel] World Agroforestry Ctr, East Asia Off, Kunming, Yunnan, Peoples R China; [Khin, Myo Myo] Wildlife Conservat Soc, Yangon, Myanmar; [Nurdiana, Dian Ridwan] Indonesian Inst Sci, Cibodas Bot Garden, Cianjur, West Java, Indonesia	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Kyoto University; Rajarata University of Sri Lanka; Indonesian Institute of Sciences	Harrison, RD (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	r.harrison@cgiar.org	Xu, Jianchu/Y-2890-2019; Geekiyanage, Nalaka/AAB-6171-2021	Geekiyanage, Nalaka/0000-0002-7400-3453; Harrison, Rhett/0000-0001-9055-3546	GTZ/BMZ [08.7860.3-001.00]; GIZ [13.1432.7-001.00]; Centre for Mountain Ecosystem Studies; Advanced Fieldcourse in Ecology and Conservation-Xishuangbanna Tropical Botanic Garden	GTZ/BMZ; GIZ; Centre for Mountain Ecosystem Studies; Advanced Fieldcourse in Ecology and Conservation-Xishuangbanna Tropical Botanic Garden	This research was supported in part by the following grants; GTZ/BMZ (Project No. 08.7860.3-001.00) and GIZ (Project No. 13.1432.7-001.00) both to Jianchu Xu. Funding for Mingxu Zhao and Myo Myo Khin was provided by the Centre for Mountain Ecosystem Studies. Other authors were funded by Advanced Fieldcourse in Ecology and Conservation-Xishuangbanna Tropical Botanic Garden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1981, OIKOS, V37, P199, DOI 10.2307/3544465; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Beckett Stephen J, 2014, F1000Res, V3, P185, DOI 10.12688/f1000research.4831.1; Benzing D., 1990, J TROP ECOL, V8, P55, DOI [10.1017/S0266467400006088, DOI 10.1017/S0266467400006088]; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.2307/3071801; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Brualdi RA, 1999, OECOLOGIA, V119, P256, DOI 10.1007/s004420050784; Burns KC, 2007, J ECOL, V95, P1142, DOI 10.1111/j.1365-2745.2007.01267.x; Burns KC, 2010, ECOLOGY, V91, P377, DOI 10.1890/08-2004.1; Burns KC, 2008, BOTANY, V86, P1252, DOI 10.1139/B08-084; Cardelus CL, 2009, PLANT SOIL, V318, P47, DOI 10.1007/s11104-008-9816-9; Cardelus CL, 2006, J ECOL, V94, P144, DOI 10.1111/j.1365-2745.2005.01052.x; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; CORNELISSEN JHC, 1989, J TROP ECOL, V5, P131, DOI 10.1017/S0266467400003400; Dhanmanonda P., 1996, THAI J FOR, V15, P81; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Flores-Palacios A, 2006, J BIOGEOGR, V33, P323, DOI 10.1111/j.1365-2699.2005.01382.x; Freiberg M, 1996, BIOTROPICA, V28, P345, DOI 10.2307/2389198; Freiberg M, 2000, J TROP ECOL, V16, P673, DOI 10.1017/S0266467400001644; Freiberg Martin, 1997, Selbyana, V18, P77; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Harrison RD, 2003, BIOL J LINN SOC, V78, P439, DOI 10.1046/j.0024-4066.2002.00205.x; HIETZ P, 1995, J VEG SCI, V6, P487, DOI 10.2307/3236347; JOHANSSON D, 1974, Acta Phytogeographica Suecica, V59, P1; Joppa LN, 2010, EVOL ECOL RES, V12, P35; Koster N, 2011, BIOTROPICA, V43, P685, DOI 10.1111/j.1744-7429.2011.00759.x; Kreft H, 2004, J BIOGEOGR, V31, P1463, DOI 10.1111/j.1365-2699.2004.01083.x; Kromer T, 2007, PLANT ECOL, V189, P261, DOI 10.1007/s11258-006-9182-8; Kromer T, 2005, J BIOGEOGR, V32, P1799, DOI 10.1111/j.1365-2699.2005.01318.x; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kuper W, 2004, J BIOGEOGR, V31, P1477, DOI 10.1111/j.1365-2699.2004.01093.x; Laube S, 2006, ANN BOT-LONDON, V97, P1103, DOI 10.1093/aob/mcl067; Mehltreter K, 2005, J TROP ECOL, V21, P651, DOI 10.1017/S0266467405002683; Nadkarni NM, 2002, PEDOBIOLOGIA, V46, P24, DOI 10.1078/0031-4056-00110; Normann F, 2010, ECOL INDIC, V10, P1111, DOI 10.1016/j.ecolind.2010.03.008; Oksanen J., 2007, VEGAN COMMUNITY ECOL; Piazzon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019637; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Girones MA, 2006, J BIOGEOGR, V33, P924, DOI 10.1111/j.1365-2699.2006.01444.x; Rosell JA, 2014, NEW PHYTOL, V201, P486, DOI 10.1111/nph.12541; SANFORD WW, 1968, J ECOL, V56, P697, DOI 10.2307/2258101; Sayago R, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2821; Shaw D.C., 2004, FOREST CANOPIES, P73, DOI DOI 10.1016/B978-012457553-0/50008-3; Sillett SC, 2004, FOREST CANOPIES, P151, DOI [DOI 10.1016/B978-012457553-0/50013-7, 10.1016/B978-012457553-0/50013-7]; Haristoy CT, 2014, SOIL SCI SOC AM J, V78, pS118, DOI 10.2136/sssaj2013.07.0300nafsc; TERSTEEGE H, 1989, BIOTROPICA, V21, P331, DOI 10.2307/2388283; Ulrich W, 2007, ECOLOGY, V88, P1824, DOI 10.1890/06-1208.1; Wang H, 2001, GUIHAIA, V21, P303; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Wu Z, 2014, FLORA CHINA, V1-25; Xu JC, 2009, ECOL SOC, V14; Yang J., 2008, THESIS CHINESE ACAD; Zhang LW, 2010, BIOTROPICA, V42, P464, DOI 10.1111/j.1744-7429.2009.00607.x; Zotz G, 2001, J EXP BOT, V52, P2067, DOI 10.1093/jexbot/52.364.2067; Zotz G, 2008, PLANT ECOL, V195, P131, DOI 10.1007/s11258-007-9310-0; Zotz G, 2013, BOT J LINN SOC, V171, P453, DOI 10.1111/boj.12010	59	33	37	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122210	10.1371/journal.pone.0122210	http://dx.doi.org/10.1371/journal.pone.0122210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856457	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500033
J	Hansen, EL; Sozer, EB; Romeo, S; Frandsen, SK; Vernier, PT; Gehl, J				Hansen, Emilie Louise; Sozer, Esin Bengisu; Romeo, Stefania; Frandsen, Stine Krog; Vernier, P. Thomas; Gehl, Julie			Dose-Dependent ATP Depletion and Cancer Cell Death following Calcium Electroporation, Relative Effect of Calcium Concentration and Electric Field Strength	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; BLADDER-CANCER; IN-VITRO; ELECTROCHEMOTHERAPY; NECROPTOSIS; ABLATION; TUMORS; ELECTROPERMEABILIZATION; CYTOTOXICITY; MITOCHONDRIA	Background Electroporation, a method for increasing the permeability of membranes to ions and small molecules, is used in the clinic with chemotherapeutic drugs for cancer treatment (electrochemotherapy). Electroporation with calcium causes ATP (adenosine triphosphate) depletion and cancer cell death and could be a novel cancer treatment. This study aims at understanding the relationship between applied electric field, calcium concentration, ATP depletion and efficacy. Methods In three human cell lines-H69 (small-cell lung cancer), SW780 (bladder cancer), and U937 (leukaemia), viability was determined after treatment with 1, 3, or 5 mM calcium and eight 99 mu s pulses with 0.8, 1.0, 1.2, 1.4 or 1.6 kV/cm. Fitting analysis was applied to quantify the cell-killing efficacy in presence of calcium. Post-treatment intracellular ATP was measured in H69 and SW780 cells. Post-treatment intracellular ATP was observed with fluorescence confocal microscopy of quinacrine-labelled U937 cells. Results Both H69 and SW780 cells showed dose-dependent (calcium concentration and electric field) decrease in intracellular ATP (p<0.05) and reduced viability. The 50% effective cell kill was found at 3.71 kV/cm (H69) and 3.28 kV/cm (SW780), reduced to 1.40 and 1.15 kV/cm (respectively) with 1 mM calcium (lower EC50 for higher calcium concentrations). Quinacrine fluorescence intensity of calcium-electroporated U937 cells was one third lower than in controls (p<0.0001). Conclusions Calcium electroporation dose-dependently reduced cell survival and intracellular ATP. Increasing extracellular calcium allows the use of a lower electric field. General Significance This study supports the use of calcium electroporation for treatment of cancer and possibly lowering the applied electric field in future trials.	[Hansen, Emilie Louise; Frandsen, Stine Krog; Gehl, Julie] Univ Copenhagen, Herlev Hosp, Ctr Expt Drug & Gene Electrotransfer, Dept Oncol, Copenhagen, Denmark; [Sozer, Esin Bengisu; Vernier, P. Thomas] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA; [Romeo, Stefania] Italian Natl Res Council, Inst Elect Sensing Environm IREA, Naples, Italy	University of Copenhagen; Herlev & Gentofte Hospital; Old Dominion University; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Rilevamento Elettromagnetico Dell'Ambiente (IREA-CNR)	Gehl, J (corresponding author), Univ Copenhagen, Herlev Hosp, Ctr Expt Drug & Gene Electrotransfer, Dept Oncol, Copenhagen, Denmark.	Karen.Julie.Gehl@RegionH.dk	Sozer, Esin B/AAA-5318-2020; Romeo, Stefania/I-6664-2019; Vernier, P. Thomas/D-7926-2016	Romeo, Stefania/0000-0002-9849-3637; Vernier, P. Thomas/0000-0003-2335-1500; Frandsen, Stine/0000-0002-3133-5351; Vissing, Mille/0000-0002-7823-5139; Sozer, Esin/0000-0002-6244-3670; Gehl, Julie/0000-0003-3829-0210	Danish Cancer Society [R81-A5208-13-S7]; COST Action "European Network for the Development of Electroporation-based Technologies and Treatments" [TD1104-010414-042351]; COST Action [TD1104-040514-041263]; Acta Oncologica Foundation; The Danish Cancer Society [R81-A5208, R110-A6996] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); COST Action "European Network for the Development of Electroporation-based Technologies and Treatments"; COST Action(European Cooperation in Science and Technology (COST)); Acta Oncologica Foundation; The Danish Cancer Society(Danish Cancer Society)	ELH was supported by a scholarship from the Danish Cancer Society (R81-A5208-13-S7) and by a grant from the COST Action "European Network for the Development of Electroporation-based Technologies and Treatments" (TD1104-010414-042351). SR was supported by a grant from the COST Action (TD1104-040514-041263). JG was a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Acta Oncologica Foundation (2009-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopova I, 2012, PURINERG SIGNAL, V8, P59, DOI 10.1007/s11302-011-9259-2; BELEHRADEK M, 1993, CANCER-AM CANCER SOC, V72, P3694, DOI 10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2; Bergner A, 2008, ANTI-CANCER AGENT ME, V8, P705, DOI 10.2174/187152008785914734; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bower M, 2011, J SURG ONCOL, V104, P22, DOI 10.1002/jso.21899; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Ellis TL, 2011, J NEUROSURG, V114, P681, DOI 10.3171/2010.5.JNS091448; Frandsen SK, 2014, BBA-GEN SUBJECTS, V1840, P1204, DOI 10.1016/j.bbagen.2013.12.003; Frandsen SK, 2012, CANCER RES, V72, P1336, DOI 10.1158/0008-5472.CAN-11-3782; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; Gehl J, 1998, ANTI-CANCER DRUG, V9, P319, DOI 10.1097/00001813-199804000-00005; Giorgi C, 2008, CURR MOL MED, V8, P119; Gjetting T, 2010, INT J NANOMED, V5, P371; Heller R, 1998, CANCER-AM CANCER SOC, V83, P148, DOI 10.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W; Herbsleb M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-31; Jaroszeski MJ, 2000, ANTI-CANCER DRUG, V11, P201, DOI 10.1097/00001813-200003000-00008; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Kingham TP, 2012, J AM COLL SURGEONS, V215, P379, DOI 10.1016/j.jamcollsurg.2012.04.029; Mahmood F, 2011, BIOELECTROCHEMISTRY, V81, P10, DOI 10.1016/j.bioelechem.2010.12.002; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Matthiessen LW, 2011, ACTA ONCOL, V50, P621, DOI 10.3109/0284186X.2011.573626; Miklavcic D, 2012, MED BIOL ENG COMPUT, V50, P1213, DOI 10.1007/s11517-012-0991-8; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Movahed S, 2011, MICROFLUID NANOFLUID, V10, P703, DOI 10.1007/s10404-010-0716-y; Neal RE, 2014, PROSTATE, V74, P458, DOI 10.1002/pros.22760; Pakhomova ON, 2013, J CELL MOL MED, V17, P154, DOI 10.1111/j.1582-4934.2012.01658.x; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; ROLS MP, 1990, BIOPHYS J, V58, P1089, DOI 10.1016/S0006-3495(90)82451-6; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Tracy CR, 2011, BJU INT, V107, P1982, DOI 10.1111/j.1464-410X.2010.09797.x; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vasquez JL, 2014, J UROL IN PRESS; Vasquez JL, 2012, BIOELECTROCHEMISTRY, V88, P127, DOI 10.1016/j.bioelechem.2012.08.001; Weaver J C, 1995, Methods Mol Biol, V48, P3; WHITE PN, 1995, HEARING RES, V90, P97, DOI 10.1016/0378-5955(95)00151-1; Wu W, 2012, CRIT REV ONCOL HEMAT, V82, P249, DOI 10.1016/j.critrevonc.2011.08.004; Yegutkin GG, 2006, MOL BIOL CELL, V17, P3378, DOI 10.1091/mbc.E05-10-0993	38	44	45	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122973	10.1371/journal.pone.0122973	http://dx.doi.org/10.1371/journal.pone.0122973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853661	gold, Green Published			2022-12-27	WOS:000352478400089
J	Kim, YJ; Kim, JH; Lee, KJ; Choi, MM; Kim, YH; Rhie, GE; Yoo, CK; Cha, K; Shin, NR				Kim, Yun Jeong; Kim, Jeong-Hee; Lee, Kwang-Jun; Choi, Myung-Min; Kim, Yeon Hee; Rhie, Gi-eun; Yoo, Cheon-Kwon; Cha, Kiweon; Shin, Na-Ri			Botulinum Neurotoxin Type A Induces TLR2-Mediated Inflammatory Responses in Macrophages	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; TUMOR-NECROSIS-FACTOR; CELL-WALL COMPONENTS; INNATE IMMUNITY; NEGATIVE REGULATOR; HUMAN-MONOCYTES; HOST-DEFENSE; IFN-GAMMA; TOXIN; LIPOPOLYSACCHARIDE	Botulinum neurotoxin type A (BoNT/A) is the most potent protein toxin and causes fatal flaccid muscle paralysis by blocking neurotransmission. Application of BoNT/A has been extended to the fields of therapeutics and biodefense. Nevertheless, the global response of host immune cells to authentic BoNT/A has not been reported. Employing microarray analysis, we performed global transcriptional profiling of RAW264.7 cells, a murine alveolar macrophage cell line. We identified 70 genes that were modulated following 1 nM BoNT/A treatment. The altered genes were mainly involved in signal transduction, immunity and defense, protein metabolism and modification, neuronal activities, intracellular protein trafficking, and muscle contraction. Microarray data were validated with real-time RT-PCR for seven selected genes including tlr2, tnf, inos, ccl4, slpi, stx11, and irg1. Proinflammatory mediators such as nitric oxide (NO) and tumor necrosis factor alpha (TNF alpha) were induced in a dose-dependent manner in BoNT/A-stimulated RAW264.7 cells. Increased expression of these factors was inhibited by monoclonal anti-Toll-like receptor 2 (TLR2) and inhibitors specific to intracellular proteins such as c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and p38 mitogen-activated protein kinase (MAPK). BoNT/A also suppressed lipopolysaccharide-induced NO and TNFa production from RAW264.7 macrophages at the transcription level by blocking activation of JNK, ERK, and p38 MAPK. As confirmed by TLR2-/- knock out experiments, these results suggest that BoNT/A induces global gene expression changes in host immune cells and that host responses to BoNT/A proceed through a TLR2-dependent pathway, which is modulated by JNK, ERK, and p38 MAPK.	[Kim, Yun Jeong; Kim, Jeong-Hee; Lee, Kwang-Jun; Choi, Myung-Min; Kim, Yeon Hee; Rhie, Gi-eun; Yoo, Cheon-Kwon; Cha, Kiweon; Shin, Na-Ri] Korea Ctr Dis Control & Prevent, Ctr Infect Dis, Korea Natl Inst Hlth, Div High Risk Pathogen Res, Cheongju, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease	Cha, K (corresponding author), Korea Ctr Dis Control & Prevent, Ctr Infect Dis, Korea Natl Inst Hlth, Div High Risk Pathogen Res, Cheongju, South Korea.	kiweoncha@naver.com; shinnari1@hanmail.net			Korea National Institute of Health grant [4840-300-210-13]	Korea National Institute of Health grant	These studies were supported by Korea National Institute of Health grant 4840-300-210-13. The funder had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Adekar SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017491; Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Chan ED, 2001, AM J PHYSIOL-CELL PH, V280, pC441, DOI 10.1152/ajpcell.2001.280.3.C441; Cheng H, 2011, J BIOL CHEM, V286, P18013, DOI 10.1074/jbc.M111.221028; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; DasGupa BR, 1989, BOTULINUM NEUROTOXIN, P53; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Froude JW, 2011, MABS-AUSTIN, V3, P517, DOI 10.4161/mabs.3.6.17621; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Imai K, 2003, FEMS IMMUNOL MED MIC, V39, P173, DOI 10.1016/S0928-8244(03)00231-1; IMAMURA K, 1989, MOL CELL BIOL, V9, P2239, DOI 10.1128/MCB.9.5.2239; Jang J, 2011, INFECT IMMUN, V79, P3846, DOI 10.1128/IAI.01145-10; Jankovic J, 2009, TOXICON, V54, P614, DOI 10.1016/j.toxicon.2008.11.013; Kaisho T, 2000, CRIT REV IMMUNOL, V20, P393; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Katz HR, 2007, IMMUNOL REV, V217, P222, DOI 10.1111/j.1600-065X.2007.00522.x; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lee JC, 2005, MICROBIOL-SGM, V151, P3739, DOI 10.1099/mic.0.28421-0; Lee K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003690; Liang S, 2009, VACCINE, V27, P4302, DOI 10.1016/j.vaccine.2009.05.027; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Malizio CJ, 2000, METH MOL B, V145, P27; McKiernan PJ, 2011, BIOCHEM SOC T, V39, P1421, DOI 10.1042/BST0391421; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Moon SK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-12; Offenhauser C, 2011, TRAFFIC, V12, P762, DOI 10.1111/j.1600-0854.2011.01189.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Riekenberg S, 2009, FEBS J, V276, P649, DOI 10.1111/j.1742-4658.2008.06813.x; Sallenave JM, 2010, AM J RESP CELL MOL, V42, P635, DOI 10.1165/rcmb.2010-0095RT; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Tacket CO MA Rogawski Academic Press Inc., 1989, BOTULINUM NEUROTOXIN, P351; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taysse L, 2005, TOXICOL PATHOL, V33, P336, DOI 10.1080/01926230590922884; Triantafilou M, 2007, CELL MICROBIOL, V9, P2880, DOI 10.1111/j.1462-5822.2007.01003.x; Vinay DS, 2006, J MOL MED, V84, P726, DOI 10.1007/s00109-006-0072-2; Vroling AB, 2011, MOL IMMUNOL, V48, P630, DOI 10.1016/j.molimm.2010.11.002; White GE, 2011, J MOL HISTOL, V42, P137, DOI 10.1007/s10735-011-9317-7; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13	52	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120840	10.1371/journal.pone.0120840	http://dx.doi.org/10.1371/journal.pone.0120840			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853816	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400019
J	Oudejans, MG; Visser, F; Englund, A; Rogan, E; Ingram, SN				Oudejans, Machiel G.; Visser, Fleur; Englund, Anneli; Rogan, Emer; Ingram, Simon N.			Evidence for Distinct Coastal and Offshore Communities of Bottlenose Dolphins in the North East Atlantic	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; POPULATION-STRUCTURE; GENETIC DIFFERENTIATION; BAY; ECOLOGY; SIZE; CONSERVATION; MOVEMENTS; SARASOTA; BYCATCH	Bottlenose dolphin stock structure in the northeast Atlantic remains poorly understood. However, fine scale photo-id data have shown that populations can comprise multiple overlapping social communities. These social communities form structural elements of bottlenose dolphin (Tursiops truncates) populations, reflecting specific ecological and behavioural adaptations to local habitats. We investigated the social structure of bottlenose dolphins in the waters of northwest Ireland and present evidence for distinct inshore and offshore social communities. Individuals of the inshore community had a coastal distribution restricted to waters within 3 km from shore. These animals exhibited a cohesive, fission-fusion social organisation, with repeated resightings within the research area, within a larger coastal home range. The offshore community comprised one or more distinct groups, found significantly further offshore (>4 km) than the inshore animals. In addition, dorsal fin scarring patterns differed significantly between inshore and offshore communities with individuals of the offshore community having more distinctly marked dorsal fins. Specifically, almost half of the individuals in the offshore community (48%) had characteristic stereotyped damage to the tip of the dorsal fin, rarely recorded in the inshore community (7%). We propose that this characteristic is likely due to interactions with pelagic fisheries. Social segregation and scarring differences found here indicate that the distinct communities are likely to be spatially and behaviourally segregated. Together with recent genetic evidence of distinct offshore and coastal population structures, this provides evidence for bottlenose dolphin inshore/offshore community differentiation in the northeast Atlantic. We recommend that social communities should be considered as fundamental units for the management and conservation of bottlenose dolphins and their habitat specialisations.	[Oudejans, Machiel G.] Dulra Res, Heiloo, Netherlands; [Oudejans, Machiel G.; Visser, Fleur] Kelp Marine Res, Hoorn, Netherlands; [Visser, Fleur] Leiden Univ, Behav Biol Grp, Leiden, Netherlands; [Englund, Anneli; Rogan, Emer; Ingram, Simon N.] Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [Ingram, Simon N.] Univ Plymouth, Sch Marine Sci & Engn, Marine Vertebrate Res Grp, Plymouth PL4 8AA, Devon, England	Leiden University; Leiden University - Excl LUMC; University College Cork; University of Plymouth	Oudejans, MG (corresponding author), Dulra Res, Heiloo, Netherlands.	machiel.oudejans@gmail.com		Visser, Fleur/0000-0003-1024-3244	Science Foundation Ireland; National Parks and Wildlife Service; Heritage Council; Fiontar Bellacorick Fund; Dulra Research; Kelp Marine Research	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Parks and Wildlife Service; Heritage Council; Fiontar Bellacorick Fund; Dulra Research; Kelp Marine Research	Data collection was funded from a number of different sources and the authors are grateful to Science Foundation Ireland, The National Parks and Wildlife Service, The Heritage Council and the Fiontar Bellacorick Fund for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dulra Research and Kelp Marine Research provided support in the form of salaries for authors MGO and FV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen SJ, 2010, FINAL REPORT FISHERI; Alves F, 2013, AQUAT CONSERV, V23, P758, DOI 10.1002/aqc.2332; Anderwald P, 2012, J MAR BIOL ASSOC UK, V92, P1757, DOI 10.1017/S0025315412001397; [Anonymous], 2009, ATLAS COMMERCIAL FIS; [Anonymous], 1983, SIERRA CLUB HDB WHAL; Ansmann IC, 2012, MOL ECOL, V21, P4472, DOI 10.1111/j.1365-294X.2012.05722.x; Baird RW, 2015, MAR MAMMAL SCI, V31, P579, DOI 10.1111/mms.12177; Baird RW, 2005, PAC SCI, V59, P593, DOI 10.1353/psc.2005.0042; Bearzi G, 2003, MAMMAL REV, V33, P224, DOI 10.1046/j.1365-2907.2003.00032.x; Bearzi Maddalena, 2005, Journal of Cetacean Research and Management, V7, P75; Bearzi M, 2009, MAR FRESHWATER RES, V60, P584, DOI 10.1071/MF08279; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Caldwell M., 2001, THESIS U MIAMI MIAMI THESIS U MIAMI MIAMI; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; CHU K, 1988, CAN J ZOOL, V66, P416, DOI 10.1139/z88-059; CODA, 2008, CET OFFSH DISTR AB E; Connor RC, 2000, CETACEAN SOCIETIES, P91; Corkeron PJ, 1987, AQUAT MAMM, V13, P11; Couperus A.S., 1997, Journal of Northwest Atlantic Fishery Science, V22, P209; Daura-Jorge FG, 2012, BIOL LETTERS, V8, P702, DOI 10.1098/rsbl.2012.0174; Defran RH, 1999, MAR MAMMAL SCI, V15, P366, DOI 10.1111/j.1748-7692.1999.tb00807.x; Defran RH, 1999, MAR MAMMAL SCI, V15, P381, DOI 10.1111/j.1748-7692.1999.tb00808.x; Heithaus MR, 2001, MAR MAMMAL SCI, V17, P526, DOI 10.1111/j.1748-7692.2001.tb01002.x; Hersh SL., 1990, BOTTLENOSE DOLPHIN, P129, DOI [10.1016/B978-0-12-440280-5.50010-X, DOI 10.1016/B978-0-12-440280-5.50010-X]; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 1998, P ROY SOC B-BIOL SCI, V265, P1177, DOI 10.1098/rspb.1998.0416; Ingram S. N., 2000, THESIS U COLL CORK; Ingram SN, 2002, MAR ECOL PROG SER, V244, P247, DOI 10.3354/meps244247; IRVINE AB, 1981, FISH B-NOAA, V79, P671; Jaiteh VF, 2013, MAR MAMMAL SCI, V29, pE266, DOI 10.1111/j.1748-7692.2012.00620.x; Kenney R.D., 1990, P369; Louis M, 2014, MOL ECOL, V23, P857, DOI 10.1111/mec.12653; Luksenburg JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088988; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Mann J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1983; Mirimin L, 2011, ANIM CONSERV, V14, P342, DOI 10.1111/j.1469-1795.2010.00432.x; Moller LM, 2007, MAR FRESHWATER RES, V58, P640, DOI 10.1071/MF06218; Natoli A, 2004, J EVOLUTION BIOL, V17, P363, DOI 10.1046/j.1420-9101.2003.00672.x; O'Brien Joanne M., 2010, Journal of Cetacean Research and Management, V11, P69; Oudejans Machiel G., 2010, Irish Naturalists' Journal, V31, P46; Perrin WF, 2011, MAR MAMMAL SCI, V27, P769, DOI 10.1111/j.1748-7692.2010.00442.x; Querouil S, 2007, CONSERV GENET, V8, P1405, DOI 10.1007/s10592-007-9291-5; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Robinson Kevin P., 2012, Journal of Cetacean Research and Management, V12, P365; Rogan E, 2007, FISH RES, V86, P6, DOI 10.1016/j.fishres.2007.02.013; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P231, DOI 10.1017/S0025315407055233; Scott M.D., 1990, P235; Silva MA, 2008, MAR BIOL, V156, P179, DOI 10.1007/s00227-008-1075-z; Tezanos-Pinto G, 2009, J HERED, V100, P11, DOI 10.1093/jhered/esn039; Torres LG, 2009, MAR MAMMAL SCI, V25, P797, DOI 10.1111/j.1748-7692.2009.00297.x; Torres LG, 2003, MAR MAMMAL SCI, V19, P502, DOI 10.1111/j.1748-7692.2003.tb01317.x; Urian KW, 2009, MAR MAMMAL SCI, V25, P619, DOI 10.1111/j.1748-7692.2009.00284.x; Wells R, 1987, CURRENT MAMMOLOGY; Wells RS, 2003, ANIMAL SOCIAL COMPLEXITY, P32; Wells RS, 1997, MAR MAMMAL SCI, V13, P475, DOI 10.1111/j.1748-7692.1997.tb00654.x; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Wiszniewski J, 2010, CONSERV GENET, V11, P1405, DOI 10.1007/s10592-009-9968-z; Wiszniewski J, 2009, ANIM BEHAV, V77, P1449, DOI 10.1016/j.anbehav.2009.02.025; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755	64	13	14	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122668	10.1371/journal.pone.0122668	http://dx.doi.org/10.1371/journal.pone.0122668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853823	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400074
J	Papale, E; Gamba, M; Perez-Gil, M; Martin, VM; Giacoma, C				Papale, Elena; Gamba, Marco; Perez-Gil, Monica; Martin, Vidal Martel; Giacoma, Cristina			Dolphins Adjust Species-Specific Frequency Parameters to Compensate for Increasing Background Noise	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; WHALES ORCINUS-ORCA; STENELLA-COERULEOALBA; ACOUSTIC PARAMETERS; SPOTTED DOLPHINS; VESSEL NOISE; WHISTLES; SIGNALS; IDENTIFICATION; COMMUNICATION	An increase in ocean noise levels could interfere with acoustic communication of marine mammals. In this study we explored the effects of anthropogenic and natural noise on the acoustic properties of a dolphin communication signal, the whistle. A towed array with four elements was used to record environmental background noise and whistles of short-beaked common-, Atlantic spotted-and striped-dolphins in the Canaries archipelago. Four frequency parameters were measured from each whistle, while Sound Pressure Levels (SPL) of the background noise were measured at the central frequencies of seven one-third octave bands, from 5 to 20 kHz. Results show that dolphins increase the whistles' frequency parameters with lower variability in the presence of anthropogenic noise, and increase the end frequency of their whistles when confronted with increasing natural noise. This study provides the first evidence that the synergy among SPLs has a role in shaping the whistles' structure of these three species, with respect to both natural and anthropogenic noise.	[Papale, Elena; Gamba, Marco; Giacoma, Cristina] Univ Turin, Life Sci & Syst Biol Dept, Turin, Italy; [Perez-Gil, Monica; Martin, Vidal Martel] Soc Study Cetaceans Canary Archipelago SECAC, Lanzarote, Spain	University of Turin	Papale, E (corresponding author), Univ Turin, Life Sci & Syst Biol Dept, Turin, Italy.	elena.papale@iamc.cnr.it	Gamba, Marco/I-1184-2012; Martin, Vidal/GLR-0396-2022	Gamba, Marco/0000-0001-9545-2242; GIACOMA, Cristina/0000-0002-8429-7723; papale, elena/0000-0002-5150-9240	EU LIFE programme, project LIFE INDEMARES [LIFE 07/NAT/E/000732]; Fundacion Biodiversidad under the Spanish Ministry of Environment, Rural and Marine Affairs (project ZEC-TURSIOPS)	EU LIFE programme, project LIFE INDEMARES; Fundacion Biodiversidad under the Spanish Ministry of Environment, Rural and Marine Affairs (project ZEC-TURSIOPS)	Data collection by SECAC was funded by the EU LIFE programme, project LIFE INDEMARES (LIFE 07/NAT/E/000732), and the Fundacion Biodiversidad under the Spanish Ministry of Environment, Rural and Marine Affairs (project ZEC-TURSIOPS).	Ansmann IC, 2007, J MAR BIOL ASSOC UK, V87, P19, DOI 10.1017/S0025315407054963; AU WWL, 1985, J ACOUST SOC AM, V77, P726, DOI 10.1121/1.392341; Azevedo AF, 2010, J ACOUST SOC AM, V127, P2646, DOI 10.1121/1.3308469; Azzolin M, 2014, J ACOUST SOC AM, V135, P502, DOI 10.1121/1.4845275; Azzolin M, 2013, J ACOUST SOC AM, V134, P694, DOI 10.1121/1.4808329; Baron SC, 2008, MAR MAMMAL SCI, V24, P42, DOI 10.1111/j.1748-7692.2007.00168.x; Bateson M., 2007, INT J COMP PSYCHOL, V20, P169; Boersma P., 2013, PRAAT DOING PHONETIC; Branstetter BK, 2013, J ACOUST SOC AM, V133, P1811, DOI 10.1121/1.4789939; Clark CW, 2009, MAR ECOL PROG SER, V395, P201, DOI 10.3354/meps08402; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Ding Wang, 1995, P299; Dolman SJ, 2006, SC58E22 INT WHAL COM; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Erbe C, 2002, MAR MAMMAL SCI, V18, P394, DOI 10.1111/j.1748-7692.2002.tb01045.x; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Gamba M, 2012, J ETHOL, V30, P191, DOI 10.1007/s10164-011-0291-z; Gelfand S. A., 2004, HEARING INTRO PSYCHO; Hatch LT, 2012, CONSERV BIOL, V26, P983, DOI 10.1111/j.1523-1739.2012.01908.x; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Jensen FH, 2009, MAR ECOL PROG SER, V395, P161, DOI 10.3354/meps08204; KETTEN DR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P717; La Manna G, 2013, AQUAT CONSERV, V23, P745, DOI 10.1002/aqc.2355; Lammers MO, 2003, J ACOUST SOC AM, V114, P1629, DOI 10.1121/1.1596173; Lesage V, 1999, MAR MAMMAL SCI, V15, P65, DOI 10.1111/j.1748-7692.1999.tb00782.x; Luis AR, 2014, MAR MAMMAL SCI, V30, P1417, DOI 10.1111/mms.12125; Maciej P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023015; May-Collado LJ, 2008, J MAMMAL, V89, P1229, DOI 10.1644/07-MAMM-A-310.1; Miksis-Olds JL, 2009, J ACOUST SOC AM, V125, P1806, DOI 10.1121/1.3068455; Morisaka T, 2005, FISHERIES SCI, V71, P568, DOI 10.1111/j.1444-2906.2005.01001.x; Morisaka T, 2005, J MAMMAL, V86, P541, DOI 10.1644/1545-1542(2005)86[541:EOANOT]2.0.CO;2; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Oswald JN, 2003, MAR MAMMAL SCI, V19, P20, DOI 10.1111/j.1748-7692.2003.tb01090.x; Oswald JN, 2007, J ACOUST SOC AM, V122, P587, DOI 10.1121/1.2743157; Papale E, 2014, ETHOL ECOL EVOL, V26, P392, DOI 10.1080/03949370.2013.851122; Papale E, 2013, J ACOUST SOC AM, V133, P1126, DOI 10.1121/1.4774274; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; Petrella V, 2009, THESIS; Rendell LE, 1999, J ZOOL, V249, P403, DOI 10.1017/S0952836999009875; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Smolker R, 1999, ETHOLOGY, V105, P595, DOI 10.1046/j.1439-0310.1999.00441.x; STEINER WW, 1981, BEHAV ECOL SOCIOBIOL, V9, P241, DOI 10.1007/BF00299878; Tyack Peter L., 1997, Bioacoustics, V8, P21	45	42	42	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121711	10.1371/journal.pone.0121711	http://dx.doi.org/10.1371/journal.pone.0121711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853825	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400046
J	Akushevich, I; Arbeev, K; Kravchenko, J; Berry, M				Akushevich, Igor; Arbeev, Konstantin; Kravchenko, Julia; Berry, Mark			Causal Effects of Time-Dependent Treatments in Older Patients with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; GERIATRIC-ONCOLOGY SIOG; END RESULTS DATABASE; ELDERLY-PATIENTS; ADJUVANT RADIOTHERAPY; INTERNATIONAL-SOCIETY; PULMONARY RESECTION; UNITED-STATES; TASK-FORCE; SURVIVAL	Background Treatment selection for elderly patients with lung cancer must balance the benefits of curative/life-prolonging therapy and the risks of increased mortality due to comorbidities. Lung cancer trials generally exclude patients with comorbidities and current treatment guidelines do not specifically consider comorbidities, so treatment decisions are usually made on subjective individual-case basis. Methods Impacts of surgery, radiation, and chemotherapy mono-treatment as well as combined chemo/ radiation on one-year overall survival (compared to no-treatment) are studied for stage-specific lung cancer in 65+ y.o. patients. Methods of causal inference such as propensity score with inverse probability weighting (IPW) for time-independent and marginal structural model (MSM) for time-dependent treatments are applied to SEER-Medicare data considering the presence of comorbid diseases. Results 122,822 patients with stage I (26.8%), II (4.5%), IIIa (11.5%), IIIb (19.9%), and IV (37.4%) lung cancer were selected. Younger age, smaller tumor size, and fewer baseline comorbidities predict better survival. Impacts of radio-and chemotherapy increased and impact of surgery decreased with more advanced cancer stages. The effects of all therapies became weaker after adjustment for selection bias, however, the changes in the effects were minor likely due to the weak selection bias or incompleteness of the list of predictors that impacted treatment choice. MSM provides more realistic estimates of treatment effects than the IPW approach for time-independent treatment. Conclusions Causal inference methods provide substantive results on treatment choice and survival of older lung cancer patients with realistic expectations of potential benefits of specific treatments. Applications of these models to specific subsets of patients can aid in the development of practical guidelines that help optimize lung cancer treatment based on individual patient characteristics.	[Akushevich, Igor; Arbeev, Konstantin] Duke Univ, Ctr Populat Hlth & Aging, Durham, NC 27708 USA; [Kravchenko, Julia] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Berry, Mark] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA	Duke University; Duke University; Stanford University	Akushevich, I (corresponding author), Duke Univ, Ctr Populat Hlth & Aging, Durham, NC 27708 USA.	igor.akushevich@duke.edu	Arbeev, Konstantin/AAJ-4425-2020	Arbeev, Konstantin/0000-0002-4195-7832	National Institute on Aging [R21AG045245, R01AG046860]; NATIONAL INSTITUTE ON AGING [R21AG045245, R01AG046860, RF1AG046860] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research reported in this paper was supported by the National Institute on Aging grants R21AG045245 (PI is IA; covers efforts of all coauthors) and R01AG046860 (covers efforts of IA, KA, and JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akushevich I, 2012, J AM GERIATR SOC, V60, P323, DOI 10.1111/j.1532-5415.2011.03786.x; Berry MF, 2013, J THORAC ONCOL, V8, P744, DOI 10.1097/JTO.0b013e31828916aa; Berry MF, 2011, EUR J CARDIO-THORAC, V39, P989, DOI 10.1016/j.ejcts.2010.09.038; Berry MF, 2009, ANN THORAC SURG, V88, P1093, DOI 10.1016/j.athoracsur.2009.06.012; Carreca I, 2005, CANCER TREAT REV, V31, P380, DOI 10.1016/j.ctrv.2005.04.012; Cerfolio RJ, 2006, ANN THORAC SURG, V82, P424, DOI 10.1016/j.athoracsur.2006.02.085; Cole SR, 2005, AM J EPIDEMIOL, V162, P471, DOI 10.1093/aje/kwi216; Earle CC, 2002, J CLIN ONCOL, V20, P1786, DOI 10.1200/JCO.2002.07.142; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Extermann M, 2005, CRIT REV ONCOL HEMAT, V55, P241, DOI 10.1016/j.critrevonc.2005.06.003; Faries DE., 2010, ANAL OBSERVATIONAL H, V1, P211; Gadgeel SM, 2001, CHEST, V120, P55, DOI 10.1378/chest.120.1.55; Garber AM, 2009, NEW ENGL J MED, V360, P1925, DOI 10.1056/NEJMp0901355; Goldsmith B, 2009, CANCER-AM CANCER SOC, V115, P4865, DOI 10.1002/cncr.24512; Gore E, 2012, SEMIN RADIAT ONCOL, V22, P304, DOI 10.1016/j.semradonc.2012.05.007; Hardy D, 2009, CANCER, V115, P4807, DOI 10.1002/cncr.24521; Hernan MA, 2001, J AM STAT ASSOC, V96, P440, DOI 10.1198/016214501753168154; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Janssen-Heijnen MLG, 2004, THORAX, V59, P602, DOI 10.1136/thx.2003.018044; Kertai MD, 2014, J THORAC CARDIOV SUR, V147, P1368, DOI 10.1016/j.jtcvs.2013.09.067; Kinsey T, 2008, JNCI-J NATL CANCER I, V100, P1003, DOI 10.1093/jnci/djn207; Kravchenko J, 2015, LUNG CANCER, V88, P85, DOI 10.1016/j.lungcan.2015.01.006; Lathan CS, 2008, J CLIN ONCOL, V26, P4347, DOI 10.1200/JCO.2007.15.5291; Lewis JH, 2003, J CLIN ONCOL, V21, P1383, DOI 10.1200/JCO.2003.08.010; McCulloch M, 2011, INTEGR CANCER THER, V10, P260, DOI 10.1177/1534735411406439; McDade TP, 2010, CANCER-AM CANCER SOC, V116, P3257, DOI 10.1002/cncr.25069; McGarry RC, 2005, INT J RADIAT ONCOL, V63, P1010, DOI 10.1016/j.ijrobp.2005.03.073; Mulligan CR, 2006, CANCER EPIDEM BIOMAR, V15, P25, DOI 10.1158/1055-9965.EPI-05-0537; O'Connell JB, 2004, ANN SURG ONCOL, V11, P962, DOI 10.1245/ASO.2004.03.052; Onishi H, 2004, CANCER-AM CANCER SOC, V101, P1623, DOI 10.1002/cncr.20539; Owonikoko TK, 2007, J CLIN ONCOL, V25, P5570, DOI 10.1200/JCO.2007.12.5435; Pagni S, 1998, EUR J CARDIO-THORAC, V14, P40, DOI 10.1016/S1010-7940(98)00145-6; Pallis AG, 2010, ANN ONCOL, V21, P692, DOI 10.1093/annonc/mdp360; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Tammemagi MC, 2000, ANN EPIDEMIOL, V10, P176, DOI 10.1016/S1047-2797(99)00048-4; Toh S, 2010, EPIDEMIOLOGY, V21, P528, DOI 10.1097/EDE.0b013e3181df1b69; Wingo PA, 2003, CANCER-AM CANCER SOC, V97, P3133, DOI 10.1002/cncr.11380; Worni M, 2012, ANN SURG ONCOL, V19, P1316, DOI 10.1245/s10434-011-2088-2; Yashin AI, 2011, MATH POPUL STUD, V18, P207, DOI 10.1080/08898480.2011.614486; Yazgan S, 2005, SURG TODAY, V35, P823, DOI 10.1007/s00595-004-3035-7	41	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121406	10.1371/journal.pone.0121406	http://dx.doi.org/10.1371/journal.pone.0121406			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849715	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800055
J	Lenoir-Wijnkoop, I; Gerlier, L; Bresson, JL; Le Pen, C; Berdeaux, G				Lenoir-Wijnkoop, Irene; Gerlier, Laetitia; Bresson, Jean-Louis; Le Pen, Claude; Berdeaux, Gilles			Public Health and Budget Impact of Probiotics on Common Respiratory Tract Infections: A Modelling Study	PLOS ONE			English	Article							FERMENTED DAIRY PRODUCT; INFLUENZA-LIKE ILLNESS; DOUBLE-BLIND; RISK; CHILDREN; COLDS; CARE; TRANSMISSION; CONSUMPTION; SYMPTOMS	Objectives Two recent meta-analyses by the York Health Economics Consortium (YHEC) and Cochrane demonstrated probiotic efficacy in reducing the duration and number of common respiratory tract infections (CRTI) and associated antibiotic prescriptions. A health-economic analysis was undertaken to estimate the public health and budget consequences of a generalized probiotic consumption in France. Methods A virtual age-and gender-standardized population was generated using a Markov microsimulation model. CRTI risk factors incorporated into this model were age, active/passive smoking and living in a community setting. Incidence rates and resource utilization were based on the 2011-2012 flu season and retrieved from the French GPs Sentinelles network. Results of both meta-analyses were independently applied to the French population to estimate CRTI events, assuming a generalized probiotic use compared to no probiotics during winter months: -0.77 days/CRTI episode (YHEC scenario) or odds-ratio 0.58 for >= 1 CRTI episode (Cochrane scenario) with vs. without probiotics. Economic perspectives were National Health System (NHS), society, family. Outcomes included cost savings related to the reduced numbers of CRTI episodes, days of illness, number of antibiotic courses, sick leave days, medical and indirect costs. Results For France, generalized probiotic use would save 2.4 million CRTI-days, 291,000 antibiotic courses and 581,000 sick leave days, based on YHEC data. Applying the Cochrane data, reductions were 6.6 million CRTI days, 473,000 antibiotic courses and 1.5 million sick days. From the NHS perspective, probiotics' economic impact was about (sic)14.6 million saved according to YHEC and (sic)37.7 million according to Cochrane. Higher savings were observed in children, active smokers and people with more frequent human contacts. Conclusions Public health and budget impact of probiotics are substantial, whether they reduce CRTI episodes frequency or duration. Noteworthy, the 2011-12 winter CRTI incidence was low and this analysis focused on the fraction of CRTI patients consulting a practitioner.	[Lenoir-Wijnkoop, Irene] Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands; [Lenoir-Wijnkoop, Irene] Danone Co, Publ Hlth & Sci Relat, Paris, France; [Gerlier, Laetitia; Berdeaux, Gilles] IMS RWES HEOR, Vilvoorde, Belgium; [Bresson, Jean-Louis] Univ Descartes, Hop Necker Enfants Malad, Paris, France; [Le Pen, Claude] Univ Paris 09, Paris, France	Utrecht University; Danone Nutricia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine	Lenoir-Wijnkoop, I (corresponding author), Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands.	P.I.Lenoir-Wijnkoop@uu.nl		Gerlier, Laetitia/0000-0003-0061-0194	Global Alliance for Probiotics (GAP); Danone; IMS RWES HEOR	Global Alliance for Probiotics (GAP); Danone(Danone Nutricia); IMS RWES HEOR(Health Economics & Outcomes Research Ltd)	This study was funded by an unrestricted grant from the Global Alliance for Probiotics (GAP. URL: http://www.gap-probiotics.org). GAP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ILW is employed by Danone, LG is employed by IMS RWES HEOR and GB was employed by IMS RWES HEOR during the course of the study. Danone and IMS RWES HEOR provided support in the form of salaries for authors ILW, LG and GB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arroll B, 2011, AM FAM PHYSICIAN, V84, P1390; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Bensenor IM, 2001, ANN EPIDEMIOL, V11, P225, DOI 10.1016/S1047-2797(00)00214-3; Berdeaux G, 1998, QUAL LIFE RES, V7, P501, DOI 10.1023/A:1008874324258; Berggren A, 2011, EUR J NUTR, V50, P203, DOI 10.1007/s00394-010-0127-6; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Bramley TJ, 2002, J OCCUP ENVIRON MED, V44, P822, DOI 10.1097/00043764-200209000-00004; Busse PJ, 2010, J ALLERGY CLIN IMMUN, V126, P690, DOI 10.1016/j.jaci.2010.08.011; Caceresa P, 2010, J PEDIAT INFECT DISE, V5, P353, DOI 10.3233/JPI-2010-0267; Cohen JM, 2003, M S-MED SCI, V19, P239; Cohen JM, 2007, 12 JOURNEE NATL GROG, V15; de Vrese M, 2005, CLIN NUTR, V24, P481, DOI 10.1016/j.clnu.2005.02.006; Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; FLEMING DM, 1988, J ROY COLL GEN PRACT, V38, P159; Gueyffier F, 2012, THERAPIE, V67, P367, DOI 10.2515/therapie/2012042; Guillemard E, 2010, BRIT J NUTR, V103, P58, DOI 10.1017/S0007114509991395; Guillemard E, 2010, J AM COLL NUTR, V29, P455, DOI 10.1080/07315724.2010.10719882; Hao QK, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006895.pub2, 10.1002/14651858.CD006895.pub3]; Haute Autorite de Sante, 2011, CHOIX METH EV EC HAS; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hojsak I, 2010, CLIN NUTR, V29, P312, DOI 10.1016/j.clnu.2009.09.008; Hojsak I, 2010, PEDIATRICS, V125, pE1171, DOI 10.1542/peds.2009-2568; JAAKKOLA JJK, 1995, EUR J EPIDEMIOL, V11, P213, DOI 10.1007/BF01719490; Jefferson T, 2011, COCHRANE DB SYST REV, V7; Kang EJ, 2013, KOREAN J FAM MED, V34, P2, DOI 10.4082/kjfm.2013.34.1.2; Kekkonen RA, 2007, INT J SPORT NUTR EXE, V17, P352, DOI 10.1123/ijsnem.17.4.352; Kenealy T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub3; Kim SY, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006362.pub2; King S, 2014, BRIT J NUTR; Lenoir-Wijnkoop I, 2007, NUTR REV, V65, P469, DOI [10.1301/nr.2007.nov.469-489, 10.1111/j.1753-4887.2007.tb00272.x]; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Mosnier A, 2002, 7 JOURNEE NATL GROG; Navarro-Mari JM, 2005, J CLIN EPIDEMIOL, V58, P275, DOI 10.1016/j.jclinepi.2004.08.014; Nichol KL, 2005, CLIN INFECT DIS, V40, P1263, DOI 10.1086/429237; Pitman RJ, 2013, VACCINE, V31, P927, DOI 10.1016/j.vaccine.2012.12.010; Rautava S, 2009, BRIT J NUTR, V101, P1722, DOI 10.1017/S0007114508116282; Sanders ME, 2014, ANN NY ACAD SCI, V1309, P19, DOI 10.1111/nyas.12377; Schlundt J, 2002, REPORT JOINT FAO WHO; Simasek M, 2007, AM FAM PHYSICIAN, V75, P515; Smerud Hilde Kloster, 2008, Microbial Ecology in Health and Disease, V20, P80, DOI 10.1080/08910600801924928; Turchet P, 2003, J Nutr Health Aging, V7, P75; van Cauwenberge P, 1999, CLIN THER, V21, P404, DOI 10.1016/S0149-2918(00)88296-X; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Vingilis E, 1999, CAN FAM PHYSICIAN, V45, P2644	47	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122765	10.1371/journal.pone.0122765	http://dx.doi.org/10.1371/journal.pone.0122765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859849	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300061
J	Brehler, ACE; Hartmann, W; Wiebe, S; Kerkhoff, A; Schliemann, C; Palmes, D; Senninger, N; Lenze, F; Ullerich, H; Berdel, WE; Kessler, T				Brehler, Ann-Christin E.; Hartmann, Wolfgang; Wiebe, Stefanie; Kerkhoff, Andrea; Schliemann, Christoph; Palmes, Daniel; Senninger, Norbert; Lenze, Frank; Ullerich, Hansjoerg; Berdel, Wolfgang E.; Kessler, Torsten			Perioperative Chemotherapy in Gastroesophageal Cancer. A Retrospective Monocenter Evaluation of 42 Cases	PLOS ONE			English	Article							ESMO CLINICAL RECOMMENDATIONS; GASTRIC-CANCER; ESOPHAGEAL; CAPECITABINE; OXALIPLATIN; CHEMORADIOTHERAPY; 5-FLUOROURACIL; MULTICENTER; PANITUMUMAB; EPIRUBICIN	Background Perioperative chemotherapy increases the overall and progression-free survival of patients suffering from resectable adenocarcinomas of the lower esophagus, gastroesophageal junction and stomach (GEC). Comparing different chemotherapy regimens platin-based protocols with 5-fluorouracil (5-FU)/calcium folinate (CF) or oral fluoropyrimidines were favorable in terms of efficacy and side-effects. However, there is no consensus which regimen is the most efficacious. Methods 42 consecutive patients with resectable GEC (UICC II and III) were treated with 3 pre- and postoperative chemotherapy cycles each consisting of epirubicin, oxaliplatin and capecitabine (EOX). We analyzed the overall survival, progression-free survival and toxicity retrospectively in comparison to published data. Results The median overall survival in our cohort was 29 months and the progression-free survival was 17 months. The most frequent grade 3 and 4 toxicities during preoperative chemotherapy were diarrhea (16.7%), leukocytopenia (9.5%) and nausea (9.5%); overall 38.1% of our patients suffered from grade 3 or 4 toxicity. Surgery was carried out in 83% of our patients, 69% of those achieved R0 resection. Conclusion Comparing our data with the results of previously published randomized trials EOX is at least non-inferior with regard to overall survival, progression-free survival and toxicity. In conclusion, EOX is an appropriate perioperative therapy for patients with resectable GEC.	[Brehler, Ann-Christin E.; Wiebe, Stefanie; Kerkhoff, Andrea; Schliemann, Christoph; Berdel, Wolfgang E.; Kessler, Torsten] Univ Munster, Dept Med Hematol & Oncol, D-48149 Munster, Germany; [Hartmann, Wolfgang] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany; [Palmes, Daniel; Senninger, Norbert] Univ Munster, Dept Gen & Visceral Surg, D-48149 Munster, Germany; [Lenze, Frank; Ullerich, Hansjoerg] Univ Munster, Dept Med, Gastroenterol, D-48149 Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Kessler, T (corresponding author), Univ Munster, Dept Med Hematol & Oncol, D-48149 Munster, Germany.	torstenkessler@uni-muenster.de	Hartmann, Wolfgang/G-1893-2017; Kessler, Torsten/S-3319-2016	Hartmann, Wolfgang/0000-0002-7609-5021; Kessler, Torsten/0000-0001-7679-5362				Baldus SE, 2004, PATHOLOGE, V25, P421, DOI 10.1007/s00292-004-0697-2; Cunningham D, 2008, ANN ONCOL, V19, P23, DOI 10.1093/annonc/mdn075; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Faivre J, 1998, EUR J CANCER, V34, P2167, DOI 10.1016/S0959-8049(98)00329-3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferri LE, 2012, ANN ONCOL, V23, P1512, DOI 10.1093/annonc/mdr465; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; Gomez-Martin C, 2012, CLIN TRANSL ONCOL, V14, P689, DOI 10.1007/s12094-012-0858-3; HERMANS J, 1993, J CLIN ONCOL, V11, P1441, DOI 10.1200/JCO.1993.11.8.1441; Homann N, 2012, INT J CANCER, V130, P1706, DOI 10.1002/ijc.26180; Lorenzen S, 2013, BRIT J CANCER, V108, P519, DOI 10.1038/bjc.2012.588; Mariette C, 2011, LANCET ONCOL, V12, P296, DOI 10.1016/S1470-2045(10)70125-X; Norman G, 2010, HEALTH TECHNOL ASSES, V14, P11, DOI 10.3310/hta14suppl2/02; Okines AFC, 2010, J CLIN ONCOL, V28, P3945, DOI 10.1200/JCO.2010.29.2847; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Sehdev A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-66; Stahl M, 2008, ANN ONCOL, V19, P21, DOI 10.1093/annonc/mdn074; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Waddell T, 2013, LANCET ONCOL, V14, P481, DOI 10.1016/S1470-2045(13)70096-2; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597	23	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122974	10.1371/journal.pone.0122974	http://dx.doi.org/10.1371/journal.pone.0122974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855972	Green Published, gold			2022-12-27	WOS:000352588500069
J	Mantel, B; Stoffregen, TA; Campbell, A; Bardy, BG				Mantel, Bruno; Stoffregen, Thomas A.; Campbell, Alain; Bardy, Benoit G.			Exploratory Movement Generates Higher-Order Information That Is Sufficient for Accurate Perception of Scaled Egocentric Distance	PLOS ONE			English	Article							MOTION PARALLAX; PSYCHOMETRIC FUNCTION; SPACE-PERCEPTION; DEPTH; AFFORDANCES; HEAVINESS; SIGNALS; FUSION	Body movement influences the structure of multiple forms of ambient energy, including optics and gravito-inertial force. Some researchers have argued that egocentric distance is derived from inferential integration of visual and non-visual stimulation. We suggest that accurate information about egocentric distance exists in perceptual stimulation as higher-order patterns that extend across optics and inertia. We formalize a pattern that specifies the egocentric distance of a stationary object across higher-order relations between optics and inertia. This higher-order parameter is created by self-generated movement of the perceiver in inertial space relative to the illuminated environment. For this reason, we placed minimal restrictions on the exploratory movements of our participants. We asked whether humans can detect and use the information available in this higher-order pattern. Participants judged whether a virtual object was within reach. We manipulated relations between body movement and the ambient structure of optics and inertia. Judgments were precise and accurate when the higher-order optical-inertial parameter was available. When only optic flow was available, judgments were poor. Our results reveal that participants perceived egocentric distance from the higher-order, optical-inertial consequences of their own exploratory activity. Analysis of participants' movement trajectories revealed that self-selected movements were complex, and tended to optimize availability of the optical-inertial pattern that specifies egocentric distance. We argue that accurate information about egocentric distance exists in higher-order patterns of ambient energy, that self-generated movement can generate these higher-order patterns, and that these patterns can be detected and used to support perception of egocentric distance that is precise and accurate.	[Mantel, Bruno; Bardy, Benoit G.] Univ Montpellier I, EuroMov, Movement Hlth Lab, Montpellier, France; [Mantel, Bruno; Campbell, Alain] Normandie Univ, Caen, France; [Mantel, Bruno] Univ Caen Basse Normandie, Ctr Etudes Sport & Act Motrices, Caen, France; [Stoffregen, Thomas A.] Univ Minnesota, Affordance Percept Act Lab, Minneapolis, MN USA; [Campbell, Alain] Univ Caen Basse Normandie, Lab Math Nicolas Oresme, UMR 6139, Caen, France; [Campbell, Alain] CNRS, Caen, France; [Bardy, Benoit G.] Inst Univ France, Paris, France	Universite de Montpellier; Universite de Caen Normandie; University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France	Bardy, BG (corresponding author), Univ Montpellier I, EuroMov, Movement Hlth Lab, Montpellier, France.	benoit.bardy@univ-montp1.fr	Stoffregen, Thomas/ABC-8710-2021; Bardy, Benoît/AAU-3078-2021	Bardy, Benoit/0000-0001-9272-1734	ENACTIVE, a network of Excellence of the European Union [FP6-IST-022114]	ENACTIVE, a network of Excellence of the European Union	This research was funded by ENACTIVE, a network of Excellence of the European Union (FP6-IST-022114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Amazeen EL, 2011, ECOL PSYCHOL, V23, P1, DOI 10.1080/10407413.2011.539100; BEALL AC, 1995, P SOC PHOTO-OPT INS, V2411, P288, DOI 10.1117/12.207547; BINGHAM GP, 1994, ECOL PSYCHOL, V6, P219, DOI 10.1207/s15326969eco0603_4; Bingham GP, 1998, J EXP PSYCHOL HUMAN, V24, P145, DOI 10.1037/0096-1523.24.1.145; BOOTSMA R J, 1992, Ecological Psychology, V4, P1; CARELLO C, 1992, PERCEPT PSYCHOPHYS, V51, P580, DOI 10.3758/BF03211655; CARELLO C, 1989, Ecological Psychology, V1, P27, DOI 10.1207/s15326969eco0101_3; CLIFF N, 1993, PSYCHOL BULL, V114, P494, DOI 10.1037/0033-2909.114.3.494; Cornus S, 1999, ECOL PSYCHOL, V11, P249, DOI 10.1207/s15326969eco1104_1; Creem-Regehr SH, 2005, PERCEPTION, V34, P191, DOI 10.1068/p5144; CROWELL JA, 1993, PERCEPT PSYCHOPHYS, V53, P325, DOI 10.3758/BF03205187; DURGIN FH, 1995, J EXP PSYCHOL HUMAN, V21, P679, DOI 10.1037/0096-1523.21.3.679; ELLARD CG, 1984, BEHAV BRAIN RES, V14, P29, DOI 10.1016/0166-4328(84)90017-2; ERIKSSON ES, 1974, PERCEPT PSYCHOPHYS, V16, P197, DOI 10.3758/BF03203274; ERIKSSON ES, 1973, PERCEPT PSYCHOPHYS, V13, P379, DOI 10.3758/BF03205789; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FALMAGNE JC, 1986, HDB PERCEPTION HUMAN, V1, P1; FERRIS SH, 1972, J EXP PSYCHOL, V95, P258, DOI 10.1037/h0033605; Fisher N. I., 1987, STAT ANAL SPHERICAL, V343, DOI [10.1017/CBO9780511623059, DOI 10.1017/CB09780511623059, 10. 1017/CBO9780511623059]; Gardner DL, 2001, ECOL PSYCHOL, V13, P245, DOI 10.1207/S15326969ECO1304_01; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; GIBSON J J, 1955, Am J Psychol, V68, P372, DOI 10.2307/1418521; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gibson JJ, 1966, SENSES CONSIDERED PE; GOGEL WC, 1979, VISION RES, V19, P1161, DOI 10.1016/0042-6989(79)90013-0; GOGEL WC, 1973, PERCEPT PSYCHOPHYS, V13, P284, DOI 10.3758/BF03214141; Gomer JA, 2009, PRESENCE-TELEOP VIRT, V18, P304, DOI 10.1162/pres.18.4.304; Guillaud E, 2006, J NEUROPHYSIOL, V95, P1134, DOI 10.1152/jn.00453.2005; HEFT H, 1993, ECOL PSYCHOL, V5, P255, DOI 10.1207/s15326969eco0503_3; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Johansson G, 1973, PERCEPTION, V2, P136; KALNINS IV, 1973, PERCEPTION, V2, P307, DOI 10.1068/p020307; LONGUETHIGGINS HC, 1986, VISION RES, V26, P181, DOI 10.1016/0042-6989(86)90079-9; LOOMIS JM, 1992, J EXP PSYCHOL HUMAN, V18, P906, DOI 10.1037/0096-1523.18.4.906; LOOMIS JM, 2003, VIRTUAL ADAPTIVE ENV, P21; Mantel B, 2007, STUDIES PERCEPTION A, P222; Mantel B, 2010, ECOL PSYCHOL, V22, P192, DOI 10.1080/10407413.2010.496665; Mardia KV, 2000, DIRECTIONAL STAT; Mark LS, 1997, J EXP PSYCHOL HUMAN, V23, P1365, DOI 10.1037/0096-1523.23.5.1365; MARK LS, 1987, J EXP PSYCHOL HUMAN, V13, P361, DOI 10.1037/0096-1523.13.3.361; MAROTTA JJ, 1995, EXP BRAIN RES, V104, P107; Michaels C.F., 1981, DIRECT PERCEPTION; NAKAYAMA K, 1974, PERCEPTION, V3, P63, DOI 10.1068/p030063; Panerai F, 2002, PERCEPT PSYCHOPHYS, V64, P717, DOI 10.3758/BF03194739; Peh CH, 2002, VISION RES, V42, P1991, DOI 10.1016/S0042-6989(02)00120-7; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Poulton E.C., 1989, BIAS QUANTIFYING JUD; RUNESON S, 1988, J EXP PSYCHOL HUMAN, V14, P295, DOI 10.1037/0096-1523.14.2.295; Sedgwick H., 1986, HDB PERCEPTION HUMAN, V1, P1; SMETS GJF, 1987, PERCEPT MOTOR SKILL, V64, P1023, DOI 10.2466/pms.1987.64.3c.1023; SOLOMON HY, 1988, J EXP PSYCHOL HUMAN, V14, P404, DOI 10.1037/0096-1523.14.3.404; Stappers PJ, 1992, THESIS DELFT U; Stoffregen TA, 2004, BEHAV BRAIN SCI, V27, P892, DOI 10.1017/S0140525X04270200; Stoffregen TA, 2001, BEHAV BRAIN SCI, V24, P195, DOI 10.1017/S0140525X01003946; Streit M, 2007, PSYCHON B REV, V14, P1001, DOI 10.3758/BF03194135; Treutwein B, 1999, PERCEPT PSYCHOPHYS, V61, P87, DOI 10.3758/BF03211951; Turvey MT, 2007, HUM MOVEMENT SCI, V26, P657, DOI 10.1016/j.humov.2007.04.002; Turvey MT, 2014, J MOTOR BEHAV, V46, P143, DOI 10.1080/00222895.2013.798252; TURVEY MT, 1981, COGNITION, V9, P237, DOI 10.1016/0010-0277(81)90002-0; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; WALLACE GK, 1959, J EXP BIOL, V36, P512; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; Watt SJ, 2003, J EXP PSYCHOL HUMAN, V29, P404, DOI 10.1037/0096-1523.29.2.404; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wickelgren EA, 2000, PERCEPT PSYCHOPHYS, V62, P1051, DOI 10.3758/BF03212088; YONAS A, 1993, CHILD DEV, V64, P298, DOI 10.1111/j.1467-8624.1993.tb02911.x	68	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0120025	10.1371/journal.pone.0120025	http://dx.doi.org/10.1371/journal.pone.0120025			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856410	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500012
J	Troup, GJ; Navarini, L; Liverani, FS; Drew, SC				Troup, Gordon J.; Navarini, Luciano; Liverani, Furio Suggi; Drew, Simon C.			Stable Radical Content and Anti-Radical Activity of Roasted Arabica Coffee: From In-Tact Bean to Coffee Brew	PLOS ONE			English	Article							ELECTRON-SPIN-RESONANCE; ANTIOXIDANTS; SPECTROSCOPY; VITRO; ACIDS; CHROMATOGRAPHY; MELANOIDINS; STABILITY; DISEASE; HEALTH	The roasting of coffee beans generates stable radicals within melanoidins produced by non-enzymatic browning. Roasting coffee beans has further been suggested to increase the antioxidant (AO) capacity of coffee brews. Herein, we have characterized the radical content and AO capacity of brews prepared from Coffea arabica beans sourced directly from an industrial roasting plant. In-tact beans exhibited electron paramagnetic resonance signals arising from Fe3+, Mn2+ and at least three distinct stable radicals as a function of roasting time, whose intensity changed upon grinding and ageing. In coffee brews, the roasting-induced radicals were harboured within the high molecular weight (> 3 kD) melanoidin-containing fraction at a concentration of 15 nM and was associated with aromatic groups within the melanoidins. The low molecular weight (< 3 kD) fraction exhibited the highest AO capacity using DPPH as an oxidant. The AO activity was not mediated by the stable radicals or by metal complexes within the brew. While other non-AO functions of the roasting-induced radical and metal complexes may be possible in vivo, we confirm that the in vitro antiradical activity of brewed coffee is dominated by low molecular weight phenolic compounds.	[Troup, Gordon J.] Monash Univ, Sch Phys, Clayton, Vic 3800, Australia; [Navarini, Luciano; Liverani, Furio Suggi] Illycaffe Spa, I-34147 Trieste, Italy; [Drew, Simon C.] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia	Monash University; University of Melbourne	Drew, SC (corresponding author), Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia.	sdrew@unimelb.edu.au	Drew, Simon/ABB-8102-2021	Drew, Simon/0000-0002-1459-9865	Future Fellowship [FT110100199]	Future Fellowship(Australian Research Council)	SCD was supported by a Future Fellowship (FT110100199) administered by the Australian Research Council (www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. illycaffe Spa provided support in the form of salaries for authors (LN and FSL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; [Anonymous], 1966, INTRO ELECT PARAMAGN; BAESSO ML, 1990, Z LEBENSM UNTERS FOR, V191, P24, DOI 10.1007/BF01202360; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Bekedam EK, 2008, J AGR FOOD CHEM, V56, P4597, DOI 10.1021/jf8004004; Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006; Brezova V, 2009, FOOD CHEM, V114, P859, DOI 10.1016/j.foodchem.2008.10.025; de Toledo RA, 2009, INT J ENVIRON AN CH, V89, P1099, DOI 10.1080/03067310903094487; del Castillo MD, 2005, EUR FOOD RES TECHNOL, V221, P471, DOI 10.1007/s00217-005-1209-1; GONIS J, 1995, FREE RADICAL RES, V23, P393, DOI 10.1080/1071576042000191790; Goodman BA, 2011, FOOD CHEM, V125, P248, DOI 10.1016/j.foodchem.2010.07.072; Goodman BA, 2015, PROCESSING IMPACT AC, P559; Hanson GR, 2004, J INORG BIOCHEM, V98, P903, DOI 10.1016/j.jinorgbio.2004.02.003; Ionita P, 2005, CHEM PAP, V59, P11; Jaiswal R, 2012, FOOD FUNCT, V3, P976, DOI 10.1039/c2fo10260a; Kenche V, 2013, OXID ANTIOXID MED SC, V2, P255; Komes D, 2014, PROCESSING AND IMPACT ON ANTIOXIDANTS IN BEVERAGES, P87, DOI 10.1016/B978-0-12-404738-9.00010-6; LICHT BH, 1992, FOOD CHEM TOXICOL, V30, P365, DOI 10.1016/0278-6915(92)90062-P; OLSSON L, 1974, J CHROMATOGR, V93, P189, DOI 10.1016/S0021-9673(00)83030-7; Opitz SEW, 2014, FOODS, V3, P586, DOI 10.3390/foods3040586; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Pascual EC, 2002, J AGR FOOD CHEM, V50, P6114, DOI 10.1021/jf020352k; Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x; Pilbrow J. R., 1990, TRANSITION ION ELECT; Polovka M, 2006, J FOOD NUTR RES, V45, P1; POVICH MJ, 1975, ANAL CHEM, V47, P346, DOI 10.1021/ac60352a039; Rufian-Henares JA, 2007, FOOD RES INT, V40, P995, DOI 10.1016/j.foodres.2007.05.002; SMITH RM, 1987, SCI TOTAL ENVIRON, V64, P125, DOI 10.1016/0048-9697(87)90127-6; Smrke S, 2013, FOOD FUNCT, V4, P1082, DOI 10.1039/c3fo30377b; Sulaiman Shaida Fariza, 2011, Journal of Dietary Supplements, V8, P293, DOI 10.3109/19390211.2011.593618; Tai J, 2010, NUTR CANCER, V62, P1044, DOI 10.1080/01635581.2010.492083; Vitaglione P, 2012, FOOD FUNCT, V3, P916, DOI 10.1039/c2fo30037k; Wang HY, 2011, FOOD CHEM, V128, P573, DOI 10.1016/j.foodchem.2011.03.075; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Yeretzian C, 2012, FOOD CHEM, V131, P811, DOI 10.1016/j.foodchem.2011.09.048	35	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122834	10.1371/journal.pone.0122834	http://dx.doi.org/10.1371/journal.pone.0122834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856192	gold, Green Published			2022-12-27	WOS:000352588500057
J	Fortuny, J; Marce-Nogue, J; Heiss, E; Sanchez, M; Gil, L; Galobart, A				Fortuny, Josep; Marce-Nogue, Jordi; Heiss, Egon; Sanchez, Montserrat; Gil, Lluis; Galobart, Angel			3D Bite Modeling and Feeding Mechanics of the Largest Living Amphibian, the Chinese Giant Salamander Andrias davidianus (Amphibia:Urodela)	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; PREY-CAPTURE; IN-VIVO; PERFORMANCE; MORPHOLOGY; SKULL; EVOLUTION; BEHAVIOR; RECONSTRUCTION; BIOMECHANICS	Biting is an integral feature of the feeding mechanism for aquatic and terrestrial salamanders to capture, fix or immobilize elusive or struggling prey. However, little information is available on how it works and the functional implications of this biting system in amphibians although such approaches might be essential to understand feeding systems performed by early tetrapods. Herein, the skull biomechanics of the Chinese giant salamander, Andrias davidianus is investigated using 3D finite element analysis. The results reveal that the prey contact position is crucial for the structural performance of the skull, which is probably related to the lack of a bony bridge between the posterior end of the maxilla and the anterior quadrato-squamosal region. Giant salamanders perform asymmetrical strikes. These strikes are unusual and specialized behavior but might indeed be beneficial in such sit-and-wait or ambush-predators to capture laterally approaching prey. However, once captured by an asymmetrical strike, large, elusive and struggling prey have to be brought to the anterior jaw region to be subdued by a strong bite. Given their basal position within extant salamanders and their "conservative" morphology, cryptobranchids may be useful models to reconstruct the feeding ecology and biomechanics of different members of early tetrapods and amphibians, with similar osteological and myological constraints.	[Fortuny, Josep; Marce-Nogue, Jordi; Galobart, Angel] Inst Catala Paleontol Miquel Crusafont, Sabadell, Spain; [Fortuny, Josep; Marce-Nogue, Jordi; Sanchez, Montserrat; Gil, Lluis] Univ Politecn Cataluna, BarcelonaTech, Terrassa, Spain; [Heiss, Egon] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Heiss, Egon] Univ Jena, Inst Systemat Zool & Evolutionary Biol, Jena, Germany	Institut Catala de Paleontologia Miquel Crusafont (ICP); Universitat Politecnica de Catalunya; University of Vienna; Friedrich Schiller University of Jena	Fortuny, J (corresponding author), Inst Catala Paleontol Miquel Crusafont, Sabadell, Spain.	Josep.Fortuny@icp.cat	Galobart, Àngel À/H-5024-2011; Fortuny, Josep/L-2523-2014; Marcé-Nogué, Jordi/B-3933-2012; Gil, Lluís/K-9157-2013	Galobart, Àngel À/0000-0003-1508-4561; Fortuny, Josep/0000-0003-4282-1619; Marcé-Nogué, Jordi/0000-0001-9852-7027; Gil, Lluís/0000-0002-2007-4846; Heiss, Egon/0000-0002-5257-8889	Spanish Ministry of Economy and Competitiveness [CGL 2011-30069-C02-01]; Austrian Science Fund FWF [J3186-B17]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Austrian Science Fund FWF(Austrian Science Fund (FWF))	This work was supported by the Spanish Ministry of Economy and Competitiveness (Project number: CGL 2011-30069-C02-01. 2012-2014) and the Austrian Science Fund FWF (Project number: J3186-B17). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R., 1992, EXPLORING BIOMECHANI; Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Anderson PSL, 2012, BIOL LETTERS, V8, P119, DOI 10.1098/rsbl.2011.0674; Anderson RA, 2008, BIOL J LINN SOC, V93, P709, DOI 10.1111/j.1095-8312.2007.00905.x; Attard MRG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093088; Bright JA, 2014, J PALEONTOL, V88, P760, DOI 10.1666/13-090; CARROLL RL, 1980, ZOOL J LINN SOC-LOND, V68, P1, DOI 10.1111/j.1096-3642.1980.tb01916.x; Carroll RL, 2009, THE RISE OF AMPHIBIA; CUNDALL D, 1987, EXPERIENTIA, V43, P1229, DOI 10.1007/BF01945537; CURREY JD, 1987, J BIOMECH, V20, P1035, DOI 10.1016/0021-9290(87)90021-2; Curtis N, 2010, J BIOMECH, V43, P2804, DOI 10.1016/j.jbiomech.2010.05.037; Deban SM, 2003, EXPTL BIOL REV, P161; Deban Stephen M., 2000, P65, DOI 10.1016/B978-012632590-4/50004-6; Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003; Duellman WE, 1994, BIOLOGY OF AMPHIBIAN; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Eaton TH, 1936, J MORPHOL, V37, P31, DOI 10.1002/jmor.1050600104; ELWOOD JRL, 1994, J MORPHOL, V220, P47, DOI 10.1002/jmor.1052200106; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Fortuny J, 2011, J EVOLUTION BIOL, V24, P2040, DOI 10.1111/j.1420-9101.2011.02338.x; Fortuny J, 2012, ANAT REC, V295, P1134, DOI 10.1002/ar.22486; Gao KQ, 2003, NATURE, V422, P424, DOI 10.1038/nature01491; Heiss E, 2013, J EXP BIOL, V216, P4426, DOI 10.1242/jeb.091991; Heiss E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1028; Herrel A, 2012, ELS, P1; Hyrtl J, 1865, CRYPTOBRANCHUS JAPON; Kathe W, 1999, ZOOL J LINN SOC-LOND, V126, P1; Kathe W, 1995, GEOBIOS-LYON, V28, P255, DOI DOI 10.1016/S0016-6995(95)80123-5; Lanyon L.E., 1985, P1; LARSEN JH, 1975, J MORPHOL, V147, P137, DOI 10.1002/jmor.1051470203; Lauder G.V., 1985, P210; LAUDER GV, 1986, ZOOL J LINN SOC-LOND, V88, P277, DOI 10.1111/j.1096-3642.1986.tb01191.x; LAUDER GV, 1985, J MORPHOL, V185, P297, DOI 10.1002/jmor.1051850304; Lintner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046344; Marce-Nogue J, 2011, PROC 13TH INT CONF O, P237; Marce-Nogue J, SPANISH JOURNAL OF P; Marce-Nogue J, 2013, PALAEONTOL ELECTRON, V16; Markey MJ, 2007, P NATL ACAD SCI USA, V104, P7134, DOI 10.1073/pnas.0701706104; Mase GE, 1999, CONTINUUM MECHANICS; Meers, 2003, HIST BIOL, V16, P1, DOI DOI 10.1080/0891296021000050755; MILLER BT, 1990, J EXP ZOOL, V256, P135, DOI 10.1002/jez.1402560204; Pardo J, 2013, ANAT REC, V296, P243; Parr WCH, 2012, J THEOR BIOL, V301, P1, DOI 10.1016/j.jtbi.2012.01.030; Rafferty KL, 1999, J MORPHOL, V242, P167, DOI 10.1002/(SICI)1097-4687(199911)242:2<167::AID-JMOR8>3.3.CO;2-T; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; Schoch RR, 2014, J EXP ZOOL PART B, V322, P619, DOI [10.1002/jez.b.22599, 10.1002/.22599]; Schoch RR, 2000, ENCYCLOPEDIA OF PALE; Schumacher G. H., 1958, Anatomischer Anzeiger, V105, P361; Schumacher G. H., 1959, Anatomischer Anzeiger, V107, P266; Schwenk Kurt, 2000, P21, DOI 10.1016/B978-012632590-4/50003-4; Skutschas P, 2011, ZOOL J LINN SOC-LOND, V161, P816, DOI 10.1111/j.1096-3642.2010.00663.x; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Wake David B., 2000, P95, DOI 10.1016/B978-012632590-4/50005-8; Walmsley CW, 2013, PEERJ, V1, DOI 10.7717/peerj.204; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Witzmann F, 2013, J MORPHOL, V274, P525, DOI 10.1002/jmor.20113; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P492, DOI 10.1016/j.ympev.2009.07.010	61	33	33	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121885	10.1371/journal.pone.0121885	http://dx.doi.org/10.1371/journal.pone.0121885			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853557	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400052
J	Hoyt, JR; Cheng, TL; Langwig, KE; Hee, MM; Frick, WF; Kilpatrick, AM				Hoyt, Joseph R.; Cheng, Tina L.; Langwig, Kate E.; Hee, Mallory M.; Frick, Winifred F.; Kilpatrick, A. Marm			Bacteria Isolated from Bats Inhibit the Growth of Pseudogymnoascus destructans, the Causative Agent of White-Nose Syndrome	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS; GEOMYCES-DESTRUCTANS; CUTANEOUS BACTERIA; SKIN; IDENTIFICATION; PATHOGEN; DISEASE; 2,4-DIACETYLPHLOROGLUCINOL; CHYTRIDIOMYCOSIS; PERSISTENCE	Emerging infectious diseases are a key threat to wildlife. Several fungal skin pathogens have recently emerged and caused widespread mortality in several vertebrate groups, including amphibians, bats, rattlesnakes and humans. White-nose syndrome, caused by the fungal skin pathogen Pseudogymnoascus destructans, threatens several hibernating bat species with extinction and there are few effective treatment strategies. The skin microbiome is increasingly understood to play a large role in determining disease outcome. We isolated bacteria from the skin of four bat species, and co-cultured these isolates with P. destructans to identify bacteria that might inhibit or kill P. destructans. We then conducted two reciprocal challenge experiments in vitro with six bacterial isolates (all in the genus Pseudomonas) to quantify the effect of these bacteria on the growth of P. destructans. All six Pseudomonas isolates significantly inhibited growth of P. destructans compared to non-inhibitory control bacteria, and two isolates performed significantly better than others in suppressing P. destructans growth for at least 35 days. In both challenge experiments, the extent of suppression of P. destructans growth was dependent on the initial concentration of P. destructans and the initial concentration of the bacterial isolate. These results show that bacteria found naturally occurring on bats can inhibit the growth of P. destructans in vitro and should be studied further as a possible probiotic to protect bats from white-nose syndrome. In addition, the presence of these bacteria may influence disease outcomes among individuals, populations, and species.	[Hoyt, Joseph R.; Cheng, Tina L.; Langwig, Kate E.; Hee, Mallory M.; Frick, Winifred F.; Kilpatrick, A. Marm] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Hoyt, JR (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	jrhoyt@ucsc.edu	Frick, Winifred/ABA-3519-2020	Frick, Winifred/0000-0002-9469-1839	United States Fish and Wildlife Service [F12AP01081]; National Science Foundation [DEB-1115895]; Bat Conservation International Student Scholarship	United States Fish and Wildlife Service(US Fish & Wildlife Service); National Science Foundation(National Science Foundation (NSF)); Bat Conservation International Student Scholarship	This work was supported by United States Fish and Wildlife Service (F12AP01081) to WFF; National Science Foundation (DEB-1115895) to AMK; and Bat Conservation International Student Scholarship to JRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Bangera MG, 1999, J BACTERIOL, V181, P3155, DOI 10.1128/JB.181.10.3155-3163.1999; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Clinical and Laboratory Standards Institute (CLSI), 2006, PERFORMANCE STANDARD; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Cornelison CT, 2014, MYCOPATHOLOGIA, V177, P1, DOI 10.1007/s11046-013-9716-2; Cryan PM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-47; Culp CE, 2007, HERPETOLOGICA, V63, P66, DOI 10.1655/0018-0831(2007)63[66:IOTNBM]2.0.CO;2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Diby P, 2005, ANN MICROBIOL, V55, P129; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Frick WF, 2015, GLOBAL ECOL BIOGEOGR, V24, P741, DOI 10.1111/geb.12290; Gram L, 1999, APPL ENVIRON MICROB, V65, P969; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hoyt JR, 2015, ECOHEALTH, V12, P330, DOI 10.1007/s10393-014-0981-4; Irianto A., 2002, J FISH DIS, V25, P1, DOI DOI 10.1046/J.1365-2761.2002.00375.X; Johnson KB, 1998, ANNU REV PHYTOPATHOL, V36, P227, DOI 10.1146/annurev.phyto.36.1.227; Kilpatrick AM, 2006, BIOL CONSERV, V128, P475, DOI 10.1016/j.biocon.2005.10.014; Knight SC, 1997, ANNU REV PHYTOPATHOL, V35, P349, DOI 10.1146/annurev.phyto.35.1.349; Langwig KE, 2015, FRONT ECOL ENVIRON, V13, P195, DOI 10.1890/140241; Langwig KE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2335; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lindow SE, 1985, BIOL CONTROL PHYLLOP; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; McCallum H, 2012, PHILOS T R SOC B, V367, P2828, DOI 10.1098/rstb.2012.0224; Meteyer CU, 2011, J WILDLIFE DIS, V47, P618, DOI 10.7589/0090-3558-47.3.618; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Robbins A, 2011, WHITE NOSE SYNDROME, P24; Roelle J, 2006, USGS SCIENTIFIC INVE, P288; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Schrezenmeir J, 2001, AM J CLIN NUTR, V73, p361S, DOI 10.1093/ajcn/73.2.361s; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Storm JJ, 2011, ACTA THERIOL, V56, P123, DOI 10.1007/s13364-010-0018-5; Thomas MB, 1998, TRENDS ECOL EVOL, V13, P325, DOI 10.1016/S0169-5347(98)01417-7; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warmink JA, 2011, SOIL BIOL BIOCHEM, V43, P760, DOI 10.1016/j.soilbio.2010.12.009; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; ZANOWIAK DJ, 1993, SOUTHWEST NAT, V38, P73, DOI 10.2307/3671650	48	92	93	1	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121329	10.1371/journal.pone.0121329	http://dx.doi.org/10.1371/journal.pone.0121329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853558	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400034
J	Li, J; Veltri, RW; Yuan, Z; Christudass, CS; Mandecki, W				Li, Ji; Veltri, Robert W.; Yuan, Zhen; Christudass, Christhunesa S.; Mandecki, Wlodek			Macrophage Inhibitory Cytokine 1 Biomarker Serum Immunoassay in Combination with PSA Is a More Specific Diagnostic Tool for Detection of Prostate Cancer	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; UNITED-STATES; ANTIGEN; EXPRESSION; OVERDIAGNOSIS; FLUORESCENCE; MORTALITY; GROWTH; TISSUE; CHIPS	Background Prostate cancer (PCa) is the most common malignancy among men in the United States. Though highly sensitive, the often-used prostate-specific antigen (PSA) test has low specificity which leads to overdiagnosis and overtreatment of PCa. This paper presents results of a retrospective study that indicates that testing for macrophage inhibitory cytokine 1 (MIC-1) concentration along with the PSA assay could provide much improved specificity to the assay. Methods The MIC-1 serum level was determined by a novel p-Chip-based immunoassay run on 70 retrospective samples. The assay was configured on p-Chips, small integrated circuits (IC) capable of storing in their electronic memories a serial number to identify the molecular probe immobilized on its surface. The distribution of MIC-1 and pre-determined PSA concentrations were displayed in a 2D plot and the predictive power of the dual MIC-1/PSA assay was analyzed. Results MIC-1 concentration in serum was elevated in PCa patients (1.44 ng/ml) compared to normal and biopsy-negative individuals (0.93 ng/ml and 0.88 ng/ml, respectively). In addition, the MIC-1 level was correlated with the progression of PCa. The area under the receiver operator curve (AUC-ROC) was 0.81 providing an assay sensitivity of 83.3% and specificity of 60.7% by using a cutoff of 0.494 for the logistic regression value of MIC-1 and PSA. Another approach, by defining high-frequency PCa zones in a two-dimensional plot, resulted in assay sensitivity of 78.6% and specificity of 89.3%. Conclusions The analysis based on correlation of MIC-1 and PSA concentrations in serum with the patient PCa status improved the specificity of PCa diagnosis without compromising the high sensitivity of the PSA test alone and has potential for PCa prognosis for patient therapy strategies.	[Li, Ji; Yuan, Zhen; Mandecki, Wlodek] PharmaSeq Inc, Monmouth Jct, NJ 08852 USA; [Veltri, Robert W.; Christudass, Christhunesa S.] Johns Hopkins Univ, Sch Med, JHUSOM, Baltimore, MD USA	Johns Hopkins University	Mandecki, W (corresponding author), PharmaSeq Inc, Monmouth Jct, NJ 08852 USA.	mandecki@pharmaseq.com			National Cancer Institute [HSSN261201200069C]; PharmaSeq, Inc.	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PharmaSeq, Inc.	The study design, data collection and analysis were supported by a grant/contract from the National Cancer Institute (HSSN261201200069C to WM) (http://www.cancer.gov). JL, ZY and WM are employed by PharmaSeq, Inc. PharmaSeq, Inc. provided support in the form of salaries for authors JL, ZY and WM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bastian PJ, 2009, EUR UROL, V55, P1321, DOI 10.1016/j.eururo.2009.02.028; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Cheung PK, 2004, CANCER RES, V64, P5929, DOI 10.1158/0008-5472.CAN-04-1216; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Etzioni R, 2002, J NATL CANCER I, V94, P981; Etzioni R, 2008, CANCER CAUSE CONTROL, V19, P175, DOI 10.1007/s10552-007-9083-8; Gruda MC, 2010, J AM ASSOC LAB ANIM, V49, P826; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kakehi Y, 2004, PROSTATE, V59, P351, DOI 10.1002/pros.10365; Karan D, 2003, BIOCHEM BIOPH RES CO, V305, P598, DOI 10.1016/S0006-291X(03)00823-4; Khan MA, 2003, J UROLOGY, V170, P723, DOI 10.1097/01.ju.0000086940.10392.93; Klotz L, 2013, CURR OPIN ENDOCRINOL, V20, P204, DOI 10.1097/MED.0b013e328360332a; Li J, 2010, ANAL BIOANAL CHEM, V398, P1993, DOI 10.1007/s00216-010-4108-7; Lin X, 2007, CLIN CHEM, V53, P1372, DOI 10.1373/clinchem.2006.081810; Mandecki W, 2006, CYTOM PART A, V69A, P1097, DOI 10.1002/cyto.a.20344; Mikolajczyk Stephen D., 2003, Keio Journal of Medicine, V52, P86; Miller MC, 2001, UROLOGY, V57, P1105, DOI 10.1016/S0090-4295(01)00953-0; Nakamura T, 2003, BRIT J CANCER, V88, P1101, DOI 10.1038/sj.bjc.6600869; Partin AW, 2013, J UROLOGY, V190, P427, DOI 10.1016/j.juro.2013.05.030; Presti Joseph C, 2007, Rev Urol, V9, P93; Rasiah KK, 2006, CANCER EPIDEM BIOMAR, V15, P711, DOI 10.1158/1055-9965.EPI-05-0752; Rich R, 2012, ANAL BIOANAL CHEM, V404, P2223, DOI 10.1007/s00216-012-6369-9; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Sokoll LJ, 2010, CANCER EPIDEM BIOMAR, V19, P1193, DOI 10.1158/1055-9965.EPI-10-0007; STENMAN UH, 1991, CANCER RES, V51, P222; Stephan C, 2006, PROSTATE, V66, P651, DOI 10.1002/pros.20381; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Yang MH, 2014, LIFE SCI, V100, P75, DOI 10.1016/j.lfs.2014.01.075	37	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122249	10.1371/journal.pone.0122249	http://dx.doi.org/10.1371/journal.pone.0122249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853582	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400061
J	Lutz, HL; Hochachka, WM; Engel, JI; Bell, JA; Tkach, VV; Bates, JM; Hackett, SJ; Weckstein, JD				Lutz, Holly L.; Hochachka, Wesley M.; Engel, Joshua I.; Bell, Jeffrey A.; Tkach, Vasyl V.; Bates, John M.; Hackett, Shannon J.; Weckstein, Jason D.			Parasite Prevalence Corresponds to Host Life History in a Diverse Assemblage of Afrotropical Birds and Haemosporidian Parasites	PLOS ONE			English	Article							AVIAN MALARIA PARASITES; BLOOD PARASITES; HAEMOPROTEUS HAEMOSPORIDA; NEOTROPICAL SAVANNA; SEXUAL SELECTION; FEEDING SUCCESS; AEDES-AEGYPTI; FOREST BIRDS; PLASMODIUM; HEMATOZOA	Avian host life history traits have been hypothesized to predict rates of infection by haemosporidian parasites. Using molecular techniques, we tested this hypothesis for parasites from three haemosporidian genera (Plasmodium, Haemoproteus, and Leucocytozoon) collected from a diverse sampling of birds in northern Malawi. We found that host life history traits were significantly associated with parasitism rates by all three parasite genera. Nest type and nest location predicted infection probability for all three parasite genera, whereas flocking behavior is an important predictor of Plasmodium and Haemoproteus infection and habitat is an important predictor of Leucocytozoon infection. Parasite prevalence was 79.1% across all individuals sampled, higher than that reported for comparable studies from any other region of the world. Parasite diversity was also exceptionally high, with 248 parasite cytochrome b lineages identified from 152 host species. A large proportion of Plasmodium, Haemoproteus, and Leucocytozoon parasite DNA sequences identified in this study represent new, previously undocumented lineages (n = 201; 81% of total identified) based on BLAST queries against the avian malaria database, MalAvi.	[Lutz, Holly L.] Cornell Univ, Coll Agr & Life Sci, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Lutz, Holly L.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Lutz, Holly L.; Hochachka, Wesley M.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14853 USA; [Engel, Joshua I.; Bates, John M.; Hackett, Shannon J.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Bell, Jeffrey A.; Tkach, Vasyl V.] Univ N Dakota, Dept Biol, Grand Forks, ND 58201 USA; [Weckstein, Jason D.] Drexel Univ, Acad Nat Sci, Dept Ornithol, Philadelphia, PA 19104 USA; [Weckstein, Jason D.] Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Cornell University; Cornell University; Cornell University; Field Museum of Natural History (Chicago); University of North Dakota Grand Forks; Drexel University	Lutz, HL (corresponding author), Cornell Univ, Coll Agr & Life Sci, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	hll47@cornell.edu	Hochachka, Wesley M./J-9768-2012; Bell, Jeffrey Andrew/Q-5057-2019	Hochachka, Wesley M./0000-0002-0595-7827; Bell, Jeffrey Andrew/0000-0001-9146-4318; Weckstein, Jason/0000-0001-7941-5724; Tkach, Vasyl/0000-0001-5084-7566; Lutz, Holly/0000-0001-6454-809X	Field Museum of Natural History's Emerging Pathogens Project - Davee Foundation; Dr. Ralph and Mariam Faulk Medical Research Trust; Division Of Environmental Biology [1120734] Funding Source: National Science Foundation	Field Museum of Natural History's Emerging Pathogens Project - Davee Foundation; Dr. Ralph and Mariam Faulk Medical Research Trust; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Field Museum of Natural History's Emerging Pathogens Project, funded by the Davee Foundation and Dr. Ralph and Mariam Faulk Medical Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Bates D., 2012, IME4 LINEAR MIXED EF; Beadell JS, 2009, INT J PARASITOL, V39, P257, DOI 10.1016/j.ijpara.2008.06.005; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Belo NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017654; BENNETT G. F., 1960, CANADIAN JOUR ZOOL, V38, P261, DOI 10.1139/z60-033; BENNETT GF, 1991, J PARASITOL, V77, P207, DOI 10.2307/3283083; BENNETT GORDON F., 1960, CANADIAN JOUR ZOOL, V38, P377, DOI 10.1139/z60-042; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bernier UR, 1999, ANAL CHEM, V71, P1, DOI 10.1021/ac980990v; BIDLINGMAYER WL, 1994, J AM MOSQUITO CONTR, V10, P272; Bishop AL, 2002, RESPONSE CULICOIDES; Bishop AL, 2008, AUST J ENTOMOL, V47, P121, DOI 10.1111/j.1440-6055.2008.00637.x; BLACKMORE JOHN S., 1958, MOSQUITO NEWS, V18, P15; Brown LH, 1982, BIRDS AFRICA, VI; Burkett-Cadena ND, 2010, AM J TROP MED HYG, V83, P395, DOI 10.4269/ajtmh.2010.10-0048; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caillouet KA, 2013, J MED ENTOMOL, V50, P462, DOI 10.1603/ME12183; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Clark NJ, 2014, INT J PARASITOL, V44, P329, DOI 10.1016/j.ijpara.2014.01.004; Combes C, 1997, INT J PARASITOL, V27, P1, DOI 10.1016/S0020-7519(96)00168-3; Day JF, 1999, J MED ENTOMOL, V36, P614, DOI 10.1093/jmedent/36.5.614; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dowsett-Lemaire F, 2006, THE BIRDS OF MALAWI; Durrant KL, 2006, ORNITHOL MONOGR, P98; EDMAN JD, 1987, INSECT SCI APPL, V8, P617, DOI 10.1017/S1742758400022694; EDMAN JD, 1971, ANN ENTOMOL SOC AM, V64, P513, DOI 10.1093/aesa/64.2.513; Engel Joshua I., 2013, Journal of East African Natural History, V101, P223; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Ewen JG, 2012, ECOL LETT, V15, P1112, DOI 10.1111/j.1461-0248.2012.01833.x; Fallon SM, 2005, AM NAT, V165, P466, DOI 10.1086/428430; Fallon SM, 2004, P ROY SOC B-BIOL SCI, V271, P493, DOI 10.1098/rspb.2003.2621; Fallon SM, 2003, J PARASITOL, V89, P1044, DOI 10.1645/GE-3157; Fecchio A, 2013, PARASITOLOGY, V140, P181, DOI 10.1017/S0031182012001412; Fecchio A, 2011, EMU, V111, P132, DOI 10.1071/MU10063; Freed LA, 2006, CONDOR, V108, P459, DOI 10.1650/0010-5422(2006)108[459:DQAAOA]2.0.CO;2; Fry C.H., 2004, BIRDS AFRICA, V7; Fry C. H., 2002, BIRDS AFRICA, VVI; Fry CH., 1988, BIRDS AFRICA, V3; Garvin MC, 1997, AUK, V114, P179, DOI 10.2307/4089159; Giardina AR, 2000, CAN J ZOOL, V78, P2184, DOI 10.1139/cjz-78-12-2184; Gilbert KL, 2012, THESIS E KENTUCKY U; Gonzalez AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100695; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAYES RO, 1967, AM J TROP MED HYG, V16, P675, DOI 10.4269/ajtmh.1967.16.675; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; Ishtiaq F, 2007, J WILDLIFE DIS, V43, P382, DOI 10.7589/0090-3558-43.3.382; Ishtiaq F, 2012, PARASITOLOGY, V139, P221, DOI 10.1017/S0031182011001831; Janousek WM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-399; Jasinskiene N, 2007, AM J TROP MED HYG, V76, P1072, DOI 10.4269/ajtmh.2007.76.1072; KALE HW, 1972, MOSQ NEWS, V32, P343; Keith S., 1992, BIRDS AFRICA, V4; Khan AA, 1977, CHEM CONTROL INSECT, P91; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kuznetsova Alexandra, 2013, LMERTEST TESTS LINEA; Lacorte GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057770; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Logan JG, 2010, ECOL CONT VECTOR-BOR, V2, P217; Loiseau C, 2012, MOL ECOL, V21, P431, DOI 10.1111/j.1365-294X.2011.05341.x; Loiseau C, 2010, J PARASITOL, V96, P21, DOI 10.1645/GE-2123.1; Londono A, 2007, CARIBB J SCI, V43, P87; Mahmood F, 2004, J MED ENTOMOL, V41, P965, DOI 10.1603/0022-2585-41.5.965; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; Medeiros MCI, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2947; Merino S, 2008, AUSTRAL ECOL, V33, P329, DOI 10.1111/j.1442-9993.2008.01820.x; Mijares A, 2012, AVIAN DIS, V56, P583, DOI 10.1637/10058-011312-ResNote.1; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MUIR LE, 1992, J MED ENTOMOL, V29, P278, DOI 10.1093/jmedent/29.2.278; Muller M, 1991, REPORT BLUETONGUE RE; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Poulin R., 2007, EVOL ECOL, V2; PRUETTJONES SG, 1991, CURR ORNITHOL, V8, P213; READ AF, 1991, AM NAT, V138, P434, DOI 10.1086/285225; READ AF, 1988, TRENDS ECOL EVOL, V3, P97, DOI 10.1016/0169-5347(88)90115-2; Ribeiro SF, 2005, PARASITOLOGY, V130, P261, DOI 10.1017/S0031182004006596; Richard FA, 2002, J PARASITOL, V88, P819, DOI 10.1645/0022-3395(2002)088[0819:ACAOPB]2.0.CO;2; Ricklefs RE, 2005, ECOL MONOGR, V75, P543, DOI 10.1890/04-1820; RICKLEFS RE, 1992, P NATL ACAD SCI USA, V89, P4722, DOI 10.1073/pnas.89.10.4722; Rodríguez Oscar A., 2009, Hornero, V24, P1; Savage AF, 2009, J WILDLIFE DIS, V45, P907, DOI 10.7589/0090-3558-45.4.907; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Scott T.W., 1991, Oxford Ornithology Series, P179; SCOTT TW, 1990, J MED ENTOMOL, V27, P856, DOI 10.1093/jmedent/27.5.856; Sehgal RNM, 2011, P ROY SOC B, V10, P1025; SOUSA OE, 1982, J WILDLIFE DIS, V18, P205, DOI 10.7589/0090-3558-18.2.205; Svensson-Coelho M, 2013, ORNITHOL MONOGR; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; Urban E.K., 1986, BIRDS AFRICA, V2; Urban EK, 1997, BIRDS AFRICA, V5; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2008, PARASITOL RES, V102, P1185, DOI 10.1007/s00436-008-0892-9; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; WICKLER SJ, 1981, PHYSIOL ZOOL, V54, P132, DOI 10.1086/physzool.54.1.30155811; WITHERS PC, 1978, AM NAT, V112, P1101, DOI 10.1086/283349; YOUNG BE, 1993, J WILDLIFE DIS, V29, P555, DOI 10.7589/0090-3558-29.4.555	99	80	81	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121254	10.1371/journal.pone.0121254	http://dx.doi.org/10.1371/journal.pone.0121254			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853491	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400033
J	Pascual-Ezama, D; Dunfield, D; de Liano, BGG; Prelec, D				Pascual-Ezama, David; Dunfield, Derek; Gil-Gomez de Liano, Beatriz; Prelec, Drazen			Peer Effects in Unethical Behavior: Standing or Reputation?	PLOS ONE			English	Article							COMPETITION; MOTIVATION; PRESTIGE	Recent empirical evidence shows that working in an unsupervised, isolated situation under competition, can increase dishonest behavior to achieve prestige. However, could working in a common space, in the presence of colleagues affect cheating? Here, we examine how familiar-peer influence, supervision and social incentives affect worker performance and dishonest behavior. First, we show that working in the presence of peers is an effective mechanism to constrain honest/dishonest behavior compared to an isolated work situation (experiment 1). Second, we demonstrate that the mere suspicion of dishonesty from another peer is not enough to affect individual cheating behavior (experiment 2), suggesting that reputation holds great importance in a worker's self-image acting as a strong social incentives. Third, we show that when the suspicion of dishonesty increases with multiple peers behaving dishonestly, the desire to increase standing is sufficient to nudge individuals' behavior back to cheating at the same levels as isolated situations (experiment 3).	[Pascual-Ezama, David] Univ Complutense Madrid, Dept Financial Econ & Accounting 2, Madrid, Spain; [Dunfield, Derek; Prelec, Drazen] MIT, Sloan Sch Management, Cambridge, MA 02139 USA; [Gil-Gomez de Liano, Beatriz] Univ Autonoma Madrid, Dept Methodol & Social Psychol, Madrid, Spain	Complutense University of Madrid; Massachusetts Institute of Technology (MIT); Autonomous University of Madrid	Pascual-Ezama, D (corresponding author), Univ Complutense Madrid, Dept Financial Econ & Accounting 2, Madrid, Spain.	david.pascual@ccee.ucm.es	de Liaño, Beatriz Gil-Gómez/L-1715-2014	de Liaño, Beatriz Gil-Gómez/0000-0002-7823-4486				Ariely D, 2008, J ECON BEHAV ORGAN, V67, P671, DOI 10.1016/j.jebo.2008.01.004; Ariely D, 2009, REV ECON STUD, V76, P451, DOI 10.1111/j.1467-937X.2009.00534.x; BECKER GS, 1968, J POLIT ECON, V76, P169, DOI 10.1086/259394; Boozer M, 2001, 832 YAL U EC GROWTH; Carrell SE, 2008, J HUM RESOUR, V43, P173, DOI 10.1353/jhr.2008.0013; Cialdini R.B., 1998, HDB SOCIAL PSYCHOL 4, P151; Falk A, 2006, J LABOR ECON, V24, P38; Falk A, 2006, AM ECON REV, V96, P1611, DOI 10.1257/aer.96.5.1611; Foster G, 2006, J PUBLIC ECON, V90, P1455, DOI 10.1016/j.jpubeco.2005.12.001; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Gneezy U, 2000, J LEGAL STUD, V29, P1, DOI 10.1086/468061; Gneezy U, 2004, AM ECON REV, V94, P377, DOI 10.1257/0002828041301821; Graham J., 2005, EC IMPLICATIONS CORP; Lam C, 2012, ESTIMATING VARIOUS K; Lyle DS, 2007, REV ECON STAT, V89, P289, DOI 10.1162/rest.89.2.289; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; McCabe DL, 2001, J HIGH EDUC, V72, P29, DOI 10.2307/2649132; Nagin DS, 2002, AM ECON REV, V92, P850, DOI 10.1257/00028280260344498; Pascual-Ezama D, 2013, J ECON BEHAV ORGAN, V93, P367, DOI 10.1016/j.jebo.2013.03.015; Sacerdote B, 2001, Q J ECON, V116, P681, DOI 10.1162/00335530151144131; Schweitzer ME, 2002, J RISK UNCERTAINTY, V25, P185, DOI 10.1023/A:1020647814263; Schwieren C, 2010, J ECON PSYCHOL, V31, P241, DOI 10.1016/j.joep.2009.02.005; SHARP JM, 1982, BEHAV SCI, V27, P12, DOI 10.1002/bs.3830270103; Shenkar O, 1997, HUM RELAT, V50, P1361, DOI 10.1177/001872679705001102; Vigdor J, 2004, WORKING PAPER; Zimmerman DJ, 2003, REV ECON STAT, V85, P9, DOI 10.1162/003465303762687677	26	14	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122305	10.1371/journal.pone.0122305	http://dx.doi.org/10.1371/journal.pone.0122305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853716	Green Accepted, Green Published, gold			2022-12-27	WOS:000352478400063
J	Veit, TD; Chies, JAB; Switala, M; Wagner, B; Horn, PA; Busatto, M; Brenol, CV; Brenol, JCT; Xavier, RM; Rebmann, V				Veit, Tiago Degani; Bogo Chies, Jose Artur; Switala, Magdalena; Wagner, Bettina; Horn, Peter A.; Busatto, Mauricio; Brenol, Claiton Viegas; Tavares Brenol, Joao Carlos; Xavier, Ricardo Machado; Rebmann, Vera			The Paradox of High Availability and Low Recognition of Soluble HLA-G by LILRB1 Receptor in Rheumatoid Arthritis Patients	PLOS ONE			English	Article							LEUKOCYTE ANTIGEN-G; G MESSENGER-RNA; G EXPRESSION; IN-VITRO; MOLECULES; BLOOD; CELLS; SUSCEPTIBILITY; IDENTIFICATION; POLYMORPHISMS	HLA-G is a regulatory molecule involved in immunologic tolerance. Growing evidence indicates that HLA-G plays a role in the regulation of inflammatory processes and autoimmune diseases. This study aimed at a systematic evaluation of soluble HLA-G (sHLA-G) in plasma of rheumatoid arthritis (RA) patients with long-lasting chronic inflammation. RA patients (n= 68) and healthy controls (n= 26) had their plasmatic sHLA-G measured by ELISA whereas the binding capability of sHLA-G to its cognate LILRB1 receptor was measured by a Luminex-based assay. All subjects were PCR-genotyped for HLA-G 14bp polymorphism (rs66554220). Significantly higher sHLA-G levels were observed in patients (p<0.001), however no significant differences were observed in LILRB1 binding capacity between RA patients and controls. Remarkably, the proportion of patients presenting specific binding of sHLA-G to LILRB1 was significantly decreased as compared to controls (56% vs. 81%, p=0.027). Patients without rheumatoid factor (RF-) were significantly overrepresented in the group of patients positive for LILRB1 binding as compared to patients without LILRB1 binding (31% vs 10%, p= 0.033). Furthermore, methotrexate treated patients (n= 58) revealed significantly lower LILRB1 binding to sHLA-G molecules than non-treated patients (medians: 12.2 vs. 67.7 units/ml, p=0.031). Unlike in controls, no significant differences in sHLA-G levels were observed among patients grouped by 14pb genotype. Thus, in a substantial number of late RA patients, the circulating sHLA-G molecules are impaired regarding LILRB1 recognition, meaning that although increased levels are observed; these molecules are not qualified to exert their protective functions against inflammation. Our findings offer new insights into the immunopathology of RA patients with long-lasting anti-RA-treatment and highlight the importance to also measure the binding capability of sHLA-G to LILRB1.	[Veit, Tiago Degani; Bogo Chies, Jose Artur; Busatto, Mauricio] Univ Fed Rio Grande do Sul, Lab Imunogenet, Porto Alegre, RS, Brazil; [Switala, Magdalena; Wagner, Bettina; Horn, Peter A.; Rebmann, Vera] Univ Hosp Essen, Inst Transfus Med, Essen, Germany; [Brenol, Claiton Viegas; Tavares Brenol, Joao Carlos; Xavier, Ricardo Machado] Hosp Clin Porto Alegre, Serv Reumatol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; University of Duisburg Essen	Rebmann, V (corresponding author), Univ Fed Rio Grande do Sul, Lab Imunogenet, Porto Alegre, RS, Brazil.	Vera.Rebmann@uk-essen.de	Brenol, Claiton V/D-5235-2009; Brenol, João Carlos Tavares/V-7062-2019; Xavier, Ricardo Machado/G-4426-2012; Chies, Jose/K-9664-2015	Brenol, Claiton V/0000-0003-0229-7912; Brenol, João Carlos Tavares/0000-0002-8745-566X; Xavier, Ricardo Machado/0000-0001-6570-4533; Chies, Jose/0000-0001-7025-0660; Veit, Tiago/0000-0002-7390-4583	German Academic Exchange Service (DAAD) [54391617]; German-Brazilian DAAD/CAPES PROBRAL 1 collaboration [382/12]; OPEN Access funding program "Open Access Publizieren" of the "Deutsche Forschungsgemeinschaft (DFG)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German-Brazilian DAAD/CAPES PROBRAL 1 collaboration; OPEN Access funding program "Open Access Publizieren" of the "Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the German Academic Exchange Service (DAAD, grant 54391617), German-Brazilian DAAD/CAPES PROBRAL 1 collaboration (grant 382/12), OPEN Access funding program "Open Access Publizieren" of the "Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2007, EUR J IMMUNOL, V37, P1924, DOI 10.1002/eji.200737089; Apps R, 2011, MOL HUM REPROD, V17, P577, DOI 10.1093/molehr/gar022; Aractingi S, 2001, AM J PATHOL, V159, P71, DOI 10.1016/S0002-9440(10)61675-6; Baricordi Olavio R., 2008, Inflammation & Allergy Drug Targets, V7, P67, DOI 10.2174/187152808785107615; Carosella ED, 2001, TRENDS IMMUNOL, V22, P553, DOI 10.1016/S1471-4906(01)02007-5; Carosella ED, 2011, BLOOD, V118, P6499, DOI 10.1182/blood-2011-07-370742; Chen XY, 2008, TISSUE ANTIGENS, V72, P335, DOI 10.1111/j.1399-0039.2008.01107.x; Cordero EAA, 2009, TISSUE ANTIGENS, V74, P308, DOI 10.1111/j.1399-0039.2009.01331.x; Fainardi E, 2003, J NEUROIMMUNOL, V142, P149, DOI 10.1016/S0165-5728(03)00266-2; Fainardi E, 2011, CELL MOL LIFE SCI, V68, P433, DOI 10.1007/s00018-010-0584-3; FERRAZ MB, 1990, J RHEUMATOL, V17, P813; FUJII T, 1994, J IMMUNOL, V153, P5516; Gonzalez A, 2012, CRIT REV CL LAB SCI, V49, P63, DOI 10.3109/10408363.2012.677947; Gonzalez A, 2011, CLIN CHEM, V57, P1013, DOI 10.1373/clinchem.2010.159673; Hviid TV, 2002, TISSUE ANTIGENS, V60, P122, DOI 10.1034/j.1399-0039.2002.600202.x; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Kanai T, 2001, MOL HUM REPROD, V7, P195, DOI 10.1093/molehr/7.2.195; Kapasi K, 2000, IMMUNOLOGY, V101, P191, DOI 10.1046/j.1365-2567.2000.00109.x; Khosrotehrani K, 2001, J INVEST DERMATOL, V117, P750, DOI 10.1046/j.0022-202x.2001.01487.x; KIRSZENBAUM M, 1994, P NATL ACAD SCI USA, V91, P4209, DOI 10.1073/pnas.91.10.4209; Kuroki K, 2013, HUM IMMUNOL, V74, P433, DOI 10.1016/j.humimm.2012.11.060; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Mitsdoerffer M, 2005, J NEUROIMMUNOL, V159, P155, DOI 10.1016/j.jneuroim.2004.09.016; Naji A, 2012, LEUKEMIA, V26, P1889, DOI 10.1038/leu.2012.62; Paul P, 2000, HUM IMMUNOL, V61, P1138, DOI 10.1016/S0198-8859(00)00197-X; Prigione I, 2011, RHEUMATOLOGY, V50, P966, DOI 10.1093/rheumatology/keq418; Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x; Rebmann V, 2005, HUM IMMUNOL, V66, P853, DOI 10.1016/j.humimm.2005.05.003; Rebmann V, 2007, HUM IMMUNOL, V68, P251, DOI 10.1016/j.humimm.2006.11.003; Rizzo R, 2008, TISSUE ANTIGENS, V71, P520, DOI 10.1111/j.1399-0039.2008.01037.x; Rizzo R, 2013, HUM IMMUNOL; Rizzo R, 2006, PHARMACOGENET GENOM, V16, P615, DOI 10.1097/01.fpc.0000230115.41828.3a; Rosadoab S, 2008, HUM IMMUNOL, V69, P9, DOI 10.1016/j.humimm.2007.11.001; Schutt P, 2010, HUM IMMUNOL, V71, P489, DOI 10.1016/j.humimm.2010.02.015; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; Torres MI, 2004, INT IMMUNOL, V16, P579, DOI 10.1093/intimm/dxh061; Veit Tiago Degani, 2010, Current Immunology Reviews, V6, P1; Verbruggen LA, 2006, HUM IMMUNOL, V67, P561, DOI 10.1016/j.humimm.2006.03.023; Verloes A, 2011, J IMMUNOL, V186, P2663, DOI 10.4049/jimmunol.1001081; Wiendl H, 2000, ANN NEUROL, V48, P679, DOI 10.1002/1531-8249(200010)48:4<679::AID-ANA19>3.3.CO;2-M; Zhang MH, 2009, TRANSPLANTATION, V87, P8, DOI 10.1097/TP.0b013e31818b6141; Zilberman S, 2012, EUR J IMMUNOL, V42, P1599, DOI 10.1002/eji.201141761	42	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123838	10.1371/journal.pone.0123838	http://dx.doi.org/10.1371/journal.pone.0123838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853899	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400120
J	Yokosaka, T; Kuroki, S; Nishida, S; Watanabe, J				Yokosaka, Takumi; Kuroki, Scinob; Nishida, Shin'ya; Watanabe, Junji			Apparent Time Interval of Visual Stimuli Is Compressed during Fast Hand Movement	PLOS ONE			English	Article							VELOCITY-DEPENDENT SUPPRESSION; SACCADIC EYE-MOVEMENTS; PERCEIVED DURATION; VOLUNTARY ACTION; TACTILE STIMULI; ATTENTION; PERCEPTION; INTERFERENCE; LOCALIZATION; REDUCTION	The influence of body movements on visual time perception is receiving increased attention. Past studies showed apparent expansion of visual time before and after the execution of hand movements and apparent compression of visual time during the execution of eye movements. Here we examined whether the estimation of sub-second time intervals between visual events is expanded, compressed, or unaffected during the execution of hand movements. The results show that hand movements, at least the fast ones, reduced the apparent time interval between visual events. A control experiment indicated that the apparent time compression was not produced by the participants' involuntary eye movements during the hand movements. These results, together with earlier findings, suggest hand movement can change apparent visual time either in a compressive way or in an expansive way, depending on the relative timing between the hand movement and visual stimulus.	[Yokosaka, Takumi; Kuroki, Scinob; Nishida, Shin'ya; Watanabe, Junji] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation	Yokosaka, T (corresponding author), NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.	yokosaka.takumi@lab.ntt.co.jp		Yokosaka, Takumi/0000-0003-3429-744X; Kuroki, Scinob/0000-0002-7585-0099	NTT Communication Science Laboratories, Nippon Telegraph and Telephone Corporation	NTT Communication Science Laboratories, Nippon Telegraph and Telephone Corporation	NTT Communication Science Laboratories, Nippon Telegraph and Telephone Corporation, provided support in the form of salaries for authors TY, SK, SN and JW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL RW, 1982, EXP NEUROL, V77, P266, DOI 10.1016/0014-4886(82)90244-8; Ariff G, 2002, J NEUROSCI, V22, P7721; Brown SW, 2006, MEM COGNITION, V34, P1464, DOI 10.3758/BF03195911; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; BROWN SW, 1995, PERCEPT PSYCHOPHYS, V57, P105, DOI 10.3758/BF03211853; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Burr D, 2006, CURR BIOL, V16, pR847, DOI 10.1016/j.cub.2006.08.075; Carlini A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05363; Cicchini GM, 2009, J VISION, V9, DOI 10.1167/9.1.9; DASSONVILLE P, 1995, EXP BRAIN RES, V106, P434; Dewey JA, 2013, CONSCIOUS COGN, V22, P987, DOI 10.1016/j.concog.2013.06.007; Dieter KC, 2014, PSYCHOL SCI, V25, P66, DOI 10.1177/0956797613497968; Efron B., 1993, MONOGRAPHS STAT APPL; Forster B, 2007, NEUROSCI LETT, V419, P142, DOI 10.1016/j.neulet.2007.04.027; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Hagura N, 2012, P ROY SOC B-BIOL SCI, V279, P4399, DOI 10.1098/rspb.2012.1339; Hass J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038092; Ibbotson MR, 2006, CURR BIOL, V16, pR834, DOI 10.1016/j.cub.2006.08.081; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Kaneko S, 2009, J VISION, V9, DOI 10.1167/9.7.14; Maij F, 2013, J NEUROPHYSIOL, V110, P2661, DOI 10.1152/jn.00971.2012; Maij F, 2011, EXP BRAIN RES, V213, P223, DOI 10.1007/s00221-011-2680-5; Mattes S, 1998, PERCEPT PSYCHOPHYS, V60, P1305, DOI 10.3758/BF03207993; MILNE RJ, 1988, EXP BRAIN RES, V70, P569; MITRANI L, 1970, VISION RES, V10, P411, DOI 10.1016/0042-6989(70)90121-5; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; Press C, 2014, J EXP PSYCHOL GEN, V143, P1787, DOI 10.1037/a0037650; RAUCH R, 1985, ELECTROEN CLIN NEURO, V62, P421, DOI 10.1016/0168-5597(85)90051-6; Schutz AC, 2010, VISION RES, V50, P2702, DOI 10.1016/j.visres.2010.07.022; STEVENSON SB, 1986, VISION RES, V26, P1815, DOI 10.1016/0042-6989(86)90133-1; Terao M, 2008, NAT NEUROSCI, V11, P541, DOI 10.1038/nn.2111; Terao M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011214; Tomassini A, 2014, J NEUROSCI, V34, P9164, DOI 10.1523/JNEUROSCI.2782-13.2014; Tomassini A, 2012, J NEUROPHYSIOL, V108, P2092, DOI 10.1152/jn.00238.2012; Tomassini A, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00051; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; Vercher JL, 1997, BIOL CYBERN, V77, P267, DOI 10.1007/s004220050387; Watanabe J, 2009, EXP BRAIN RES, V193, P483, DOI 10.1007/s00221-009-1711-y; Yamamoto K, 2012, J VISION, V12, DOI 10.1167/12.4.1; Yarrow K, 2003, CURR BIOL, V13, P1134, DOI 10.1016/S0960-9822(03)00413-5; Yarrow K, 2001, NATURE, V414, P302, DOI 10.1038/35104551; Yeshurun Y, 2008, VIS COGN, V16, P826, DOI 10.1080/13506280701588022; ZUBER BL, 1966, EXP NEUROL, V16, P65, DOI 10.1016/0014-4886(66)90087-2	45	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124901	10.1371/journal.pone.0124901	http://dx.doi.org/10.1371/journal.pone.0124901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853892	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400147
J	Pan, ZY; Yang, GZ; Wang, YX; He, H; Pang, XC; Gao, Y; Shi, WY; Li, Y; Dong, LH; Song, YY				Pan, Zhenyu; Yang, Guozi; Wang, Yongxiang; He, Hua; Pang, Xiaochuan; Gao, Yan; Shi, Weiyan; Li, Yu; Dong, Lihua; Song, Yuanyuan			Thinprep plus Papanicolaou Stain Method Is More Sensitive than Cytospin-Coupled Wright Giems Stain Method in Cerebrospinal Fluid Cytology for Diagnosis of Leptomeningeal Metastasis from Solid Tumors	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; EXPERIENCE; SPECIMENS	Background The present study was designed to determine whether the Thinprep plus Papanicolaou stain (Thinprep) method is more sensitive than the Cytospin-coupled Wright-Giemsa (WG) stain (Cytospin) method in diagnosis of leptomeningeal metastasis (LM) from malignant solid tumors in cerebrospinal fluid (CSF). We also explored if the Thinprep method could be used in the differential diagnosis of the type of primary tumor cells based on the morphology of tumor cells in CSF samples. Methods The morphological features of tumor cells in fresh CSF samples were analyzed using both methods. The tumor cell detection rates were compared between the two methods. Results Using the Thinprep method, we found that each type of tumor cells in the CSF samples had specific identifiable morphological features linked to their primary cancer origins, such as adenocarcinomas originated from the lungs, breast, and stomach, and lung squamous cell carcinomas, small cell lung cancer, large-cell neuroendocrine lung cancer, hepatocellular carcinoma, and malignant melanoma. In a retrospective study with 88 LM patients, cancer cells were detected in 80 out of the 88 CSF samples. In the comparative study with 45 LM patients, the initial detection rate of the Thinprep method was significantly higher than that of the Cytospin method (73.3% vs. 57.8%, P<0.01). The cell morphology was better preserved and subcellular structures were clearer using the Thinprep method, compared to the Cytospin method. Conclusions The Thinprep method is more sensitive and suitable for LM diagnosis in CSF in patients with malignant solid tumors than the Cytospin method. The Thinprep method may facilitate primary tumor detection and help design early treatment regimens for LM patients with tumors of unknown primary origin.	[Pan, Zhenyu; Yang, Guozi; Gao, Yan; Shi, Weiyan; Li, Yu; Dong, Lihua] Jilin Univ, Hosp 1, Dept Radiat Oncol, Changchun 130023, Peoples R China; [Wang, Yongxiang; Pang, Xiaochuan; Song, Yuanyuan] Jilin Univ, Hosp 1, Dept Clin Lab, Changchun 130023, Peoples R China; [He, Hua] Jilin Univ, Hosp 1, Ctr Canc, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Dong, LH (corresponding author), Jilin Univ, Hosp 1, Dept Radiat Oncol, Changchun 130023, Peoples R China.	dlh@jlu.edu.cn; 13504316235@163.com						Argona A, 2013, ACTA CYTOL, V57, P266, DOI 10.1159/000346716; Bristow R E, 2000, Clin Cornerstone, V3, P12, DOI 10.1016/S1098-3597(00)90018-8; Chamberlain MC, 2005, J CLIN ONCOL, V23, P3605, DOI 10.1200/JCO.2005.01.131; Glantz MJ, 1998, CANCER, V82, P733, DOI 10.1002/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z; Jan Drappatz M, 2009, LEPTOMENINGEAL METAS, P100; Le Rhun Emilie, 2013, Surg Neurol Int, V4, pS265, DOI 10.4103/2152-7806.111304; Michael CW, 2001, DIAGN CYTOPATHOL, V25, P177, DOI 10.1002/dc.2033; Prayson RA, 1998, ARCH PATHOL LAB MED, V122, P47; Salhadar A, 2001, DIAGN CYTOPATHOL, V25, P101, DOI 10.1002/dc.2012; Singh G, 2013, CYTOJOURNAL, V10, DOI 10.4103/1742-6413.114212; Straathof CSM, 1999, J NEUROL, V246, P810, DOI 10.1007/s004150050459; Veneti S, 2003, ACTA CYTOL, V47, P188, DOI 10.1159/000326502; WASSERSTROM WR, 1982, CANCER, V49, P759, DOI 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7; Weston CL, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-14; Ylagan LR, 2005, DIAGN CYTOPATHOL, V32, P137, DOI 10.1002/dc.20200	15	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122016	10.1371/journal.pone.0122016	http://dx.doi.org/10.1371/journal.pone.0122016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850010	gold, Green Submitted, Green Published			2022-12-27	WOS:000352477800093
J	Saengsuwan, J; Nef, T; Laubacher, M; Hunt, KJ				Saengsuwan, Jittima; Nef, Tobias; Laubacher, Marco; Hunt, Kenneth J.			Comparison of Peak Cardiopulmonary Performance Parameters on a Robotics-Assisted Tilt Table, a Cycle and a Treadmill	PLOS ONE			English	Article							MAXIMAL HEART-RATE; OXYGEN-UPTAKE; WORK RATE; EXERCISE; REPRODUCIBILITY; ARM; FEASIBILITY; ERGOMETRY; VALIDITY; PROTOCOL	Robotics-assisted tilt table (RATT) technology provides body support, cyclical stepping movement and physiological loading. This technology can potentially be used to facilitate the estimation of peak cardiopulmonary performance parameters in patients who have neurological or other problems that may preclude testing on a treadmill or cycle ergometer. The aim of the study was to compare the magnitude of peak cardiopulmonary performance parameters including peak oxygen uptake (VO2peak) and peak heart rate (HRpeak) obtained from a robotics-assisted tilt table (RATT), a cycle ergometer and a treadmill. The strength of correlations between the three devices, test-retest reliability and repeatability were also assessed. Eighteen healthy subjects performed six maximal exercise tests, with two tests on each of the three exercise modalities. Data from the second tests were used for the comparative and correlation analyses. For nine subjects, test-retest reliability and repeatability of VO2peak and HRpeak were assessed. Absolute VO2peak from the RATT, the cycle ergometer and the treadmill was (mean (SD)) 2.2 (0.56), 2.8 (0.80) and 3.2 (0.87) L/min, respectively (p < 0.001). HRpeak from the RATT, the cycle ergometer and the treadmill was 168 (9.5), 179 (7.9) and 184 (6.9) beats/min, respectively (p < 0.001). VO2peak and HRpeak from the RATT vs the cycle ergometer and the RATT vs the treadmill showed strong correlations. Test-retest reliability and repeatability were high for VO2peak and HRpeak for all devices. The results demonstrate that the RATT is a valid and reliable device for exercise testing. There is potential for the RATT to be used in severely impaired subjects who cannot use the standard modalities.	[Saengsuwan, Jittima; Laubacher, Marco; Hunt, Kenneth J.] Bern Univ Appl Sci, Dept Engn & Informat Technol, Div Mech Engn, Inst Rehabil & Performance Technol, Burgdorf, Switzerland; [Saengsuwan, Jittima; Nef, Tobias] Univ Bern, Gerontechnol & Rehabil Res Grp, ARTORG Ctr Biomed Engn Res, Bern, Switzerland; [Saengsuwan, Jittima] Khon Kaen Univ, Dept Phys Med & Rehabil, Fac Med, Khon Kaen, Thailand	University of Bern; Khon Kaen University	Saengsuwan, J (corresponding author), Bern Univ Appl Sci, Dept Engn & Informat Technol, Div Mech Engn, Inst Rehabil & Performance Technol, Burgdorf, Switzerland.	jittima.saengsuwan@bfh.ch		Nef, Tobias/0000-0002-8069-9450; Hunt, Kenneth/0000-0002-6521-9455				ASTRAND PO, 1961, J APPL PHYSIOL, V16, P977; Bichsel L, 2011, AT-AUTOM, V59, P622, DOI 10.1524/auto.2011.0953; Billinger SA, 2008, J STRENGTH COND RES, V22, P1556, DOI 10.1519/JSC.0b013e3181739dd7; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Carter H, 2000, J APPL PHYSIOL, V89, P899, DOI 10.1152/jappl.2000.89.3.899; Faff J, 2007, BIOL SPORT, V24, P129; FAIRBARN MS, 1994, CHEST, V105, P1365, DOI 10.1378/chest.105.5.1365; GARRARD CS, 1986, RESPIRATION, V49, P94, DOI 10.1159/000194865; Hunt KJ, 2008, BIOMED SIGNAL PROCES, V3, P278, DOI 10.1016/j.bspc.2008.01.004; Jacobs PL, 2004, SPORTS MED, V34, P727, DOI 10.2165/00007256-200434110-00003; Jurca R, 2005, AM J PREV MED, V29, P185, DOI 10.1016/j.amepre.2005.06.004; Laubacher M, 2015, DISABIL REHABIL-ASSI, V10, P433, DOI 10.3109/17483107.2014.908246; LEE J, 1989, COMPUT BIOL MED, V19, P61, DOI 10.1016/0010-4825(89)90036-X; Marzolini S, 2012, STROKE, V43, P1075, DOI 10.1161/STROKEAHA.111.635128; MYERS J, 1991, J AM COLL CARDIOL, V17, P1334, DOI 10.1016/S0735-1097(10)80144-5; Myers J, 2010, ACSMS RESOURCES CLIN; NORDREHAUG JE, 1991, SCAND J CLIN LAB INV, V51, P655, DOI 10.3109/00365519109104577; Orr JL, 2013, ANAESTHESIA, V68, P497, DOI 10.1111/anae.12195; Pescatello L.S., 2014, ACSMS GUIDELINES EXE, V9; PINA IL, 1995, CIRCULATION, V91, P912, DOI 10.1161/01.CIR.91.3.912; Porszasz J, 2003, MED SCI SPORT EXER, V35, P1596, DOI 10.1249/01.MSS.0000084593.56786.DA; REYBROUCK T, 1975, J APPL PHYSIOL, V38, P774, DOI 10.1152/jappl.1975.38.5.774; Saengsuwan J, 2014, TECHNOL HEALTH CARE, V22, P179, DOI 10.3233/THC-140783; Schrieks IC, 2011, CLIN PHYSIOL FUNCT I, V31, P326, DOI 10.1111/j.1475-097X.2011.01014.x; Simmelink EK, 2009, INT J REHABIL RES, V32, P324, DOI 10.1097/MRR.0b013e328325a8a8; Simonson SR, 2003, BIOL SPORT, V20, P3; Smith AC, 2012, INT J STROKE, V7, P499, DOI 10.1111/j.1747-4949.2012.00791.x; TAMMEMAGI MC, 1995, J CLIN EPIDEMIOL, V48, P1123, DOI 10.1016/0895-4356(94)00243-J; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8	32	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122767	10.1371/journal.pone.0122767	http://dx.doi.org/10.1371/journal.pone.0122767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860019	Green Published, gold			2022-12-27	WOS:000352590300062
J	Wang, XM; Soetaert, K; Peirs, P; Kalai, M; Fontaine, V; Dehaye, JP; Lefevre, P				Wang, Xiao Ming; Soetaert, Karine; Peirs, Priska; Kalai, Michael; Fontaine, Veronique; Dehaye, Jean Paul; Lefevre, Philippe			Biochemical Analysis of the NAD(+)-Dependent Malate Dehydrogenase, a Substrate of Several Serine/Threonine Protein Kinases of Mycobacterium tuberculosis	PLOS ONE			English	Article							STRESS-RESPONSE; METABOLISM; SURVIVAL; PKND; PHOSPHORYLATION; GENOME; DOMAIN; TRANSPORTER; PERSISTENCE; ADAPTATION	PknD is one of the eleven eukaryotic-like serine/threonine protein kinases (STPKs) of Mycobacterium tuberculosis (Mtb). In vitro phosphorylation assays with the active recombinant PknD showed that the intracellular protein NAD(+)-dependent malate dehydrogenase (MDH) is a substrate of this kinase. MDH, an energy-supplying enzyme, catalyzes the interconversion of malate and oxaloacetate and plays crucial roles in several metabolic pathways including the citric acid cycle. The phosphorylation site was identified on threonine residues and the phosphorylation inhibited the MDH activity. In vitro, the recombinant MDH could also be phosphorylated by at least five other STPKs, PknA, PknE, PknH, PknJ, and PknG. Immunoprecipitation analysis revealed that MDH was hyperphosphorylated in the bacteria at the beginning of the stationary and under oxygen-limited conditions by STPKs other than PknD. On the contrary, when PknD-deficient mutant mycobacteria were grown in a phosphate-depleted medium, MDH was not detectably phosphorylated. These results suggest that although the MDH is a substrate of several mycobacterial STPKs, the activity of these kinases can depend on the environment, as we identified PknD as a key element in the MDH phosphorylation assay under phosphate-poor conditions.	[Wang, Xiao Ming; Soetaert, Karine; Peirs, Priska; Kalai, Michael] Sci Inst Publ Hlth, Direct Communicable & Infect Dis, B-1180 Brussels, Belgium; [Fontaine, Veronique; Dehaye, Jean Paul; Lefevre, Philippe] Univ Libre Bruxelles, Fac Pharm, Unite Microbiol Pharmaceut & Hyg, B-1050 Brussels, Belgium	Universite Libre de Bruxelles	Lefevre, P (corresponding author), Univ Libre Bruxelles, Fac Pharm, Unite Microbiol Pharmaceut & Hyg, Blvd Triomphe,CP205-2, B-1050 Brussels, Belgium.	philefev@ulb.ac.be		Fontaine, Veronique/0000-0001-7588-5462	FRSM (Belgian Fund for Medical Scientific Research) [3.4.511.07]	FRSM (Belgian Fund for Medical Scientific Research)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the grant no 3.4.511.07 from the FRSM (Belgian Fund for Medical Scientific Research).	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Baer CE, 2014, J BIOL CHEM, V289, P20422, DOI 10.1074/jbc.M114.559054; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; BIRKTOFT JJ, 1989, BIOCHEM SOC T, V17, P301, DOI 10.1042/bst0170301; Bishai W, 2000, NATURE, V406, P683, DOI 10.1038/35021159; Bloom BR, 1999, NAT MED, V5, P872, DOI 10.1038/11309; BREITER DR, 1994, PROTEIN SCI, V3, P2023, DOI 10.1002/pro.5560031115; CANNATA JJB, 1984, MOL BIOCHEM PARASIT, V11, P37, DOI 10.1016/0166-6851(84)90053-7; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cousin C, 2013, FEMS MICROBIOL LETT, V346, P11, DOI 10.1111/1574-6968.12189; Dalhus B, 2002, J MOL BIOL, V318, P707, DOI 10.1016/S0022-2836(02)00050-5; Daniel J, 2004, J BACTERIOL, V186, P5017, DOI 10.1128/jb.186.15.5017-5030.2004; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Edwards KM, 2001, AM J RESP CRIT CARE, V164, P2213, DOI 10.1164/ajrccm.164.12.2106093; England P, 2009, FEBS LETT, V583, P301, DOI 10.1016/j.febslet.2008.12.036; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Hatzios SK, 2013, P NATL ACAD SCI USA, V110, pE5069, DOI 10.1073/pnas.1321205110; Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x; Jiang X, 2006, MICROB DRUG RESIST, V12, P231, DOI 10.1089/mdr.2006.12.231; Kumar P, 2009, J BIOL CHEM, V284, P11090, DOI 10.1074/jbc.M808705200; Kusebauch U, 2014, P NATL ACAD SCI USA, V111, P9265, DOI 10.1073/pnas.1323894111; Lee JJ, 2014, NEW MICROBIOL, V37, P525; Lefevre P, 1997, J BACTERIOL, V179, P2900, DOI 10.1128/jb.179.9.2900-2906.1997; Li J, 2000, J CELL SCI, V113, P4143; Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033; Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Peirs P, 1997, EUR J BIOCHEM, V244, P604, DOI 10.1111/j.1432-1033.1997.00604.x; Peirs P, 2000, FEMS MICROBIOL LETT, V188, P135; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Perez J, 2006, BIOCHEM BIOPH RES CO, V348, P6, DOI 10.1016/j.bbrc.2006.06.164; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Roumestand C, 2011, STRUCTURE, V19, P1525, DOI 10.1016/j.str.2011.07.011; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Shi LB, 2010, MOL MICROBIOL, V78, P1199, DOI 10.1111/j.1365-2958.2010.07399.x; Smith CV, 2004, TUBERCULOSIS, V84, P45, DOI 10.1016/j.tube.2003.08.019; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Vanzembergh F, 2010, TUBERCULOSIS, V90, P338, DOI 10.1016/j.tube.2010.09.004; Ventura M, 2013, MOL MICROBIOL, V90, P356, DOI 10.1111/mmi.12368; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006	53	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123327	10.1371/journal.pone.0123327	http://dx.doi.org/10.1371/journal.pone.0123327			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860441	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300094
J	Li, YM; Zhou, WM; Zhao, YJ; Wang, YQ; Xie, ZD; Lou, YL; Tan, WJ				Li, Yamin; Zhou, Weimin; Zhao, Yanjie; Wang, Yanqun; Xie, Zhengde; Lou, Yongliang; Tan, Wenjie			Molecular Typing and Epidemiology Profiles of Human Adenovirus Infection among Paediatric Patients with Severe Acute Respiratory Infection in China	PLOS ONE			English	Article							KOREAN CHILDREN; TRACT INFECTION; GENOME SEQUENCE; IDENTIFICATION; RECOMBINATION; DIAGNOSIS; DISEASE	Background Human adenoviruses (HAdVs) have been recognised as pathogens that cause a broad spectrum of diseases. The studies on HAdV infection among children with severe acute respiratory infection (SARI) are limited. Objective To investigate the prevalence, epidemiology, and genotype of HAdV among children with SARI in China. Study Design Nasopharyngeal aspirates (NPAs) or induced sputum (IS) was collected from hospitalised children with SARIs in Beijing (representing Northern China; n = 259) and Zhejiang Province (representing Eastern China; n = 293) from 2007 to 2010. The prevalence of HAdV was screened by polymerase chain reaction (PCR), followed by sequence typing of PCR fragments that targeted the second half of the hexon gene. In addition, co-infection with other human respiratory viruses, related epidemiological profiles and clinical presentations were investigated. Results and Conclusions In total, 76 (13.8%) of 552 SARI patients were positive for HAdV, and the infection rates of HAdV in Northern and Eastern China were 20.1%(n = 52) and 8.2% (n = 24), respectively. HAdV co-infection with other respiratory viruses was frequent (infection rates: Northern China, 90.4%; Eastern China, 70.8%). The peak seasons for HAdV-B infection was winter and spring. Additionally, members of multiple species (Human mastadenovirus B, C, D and E) were circulating among paediatric patients with SARI, of which HAdV-B (34/52; 65.4%) and HAdV-C (20/24, 83.3%) were the most predominant in Northern and Eastern China, respectively. These findings provide a benchmark for future epidemiology and prevention strategies for HAdV.	[Li, Yamin; Zhou, Weimin; Wang, Yanqun; Tan, Wenjie] China CDC, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China; [Zhao, Yanjie; Lou, Yongliang] Wenzhou Med Univ, Inst Med Virol, Wenzhou, Zhejiang, Peoples R China; [Xie, Zhengde] BCH CMU, Beijing Pediat Res Inst, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Wenzhou Medical University	Tan, WJ (corresponding author), China CDC, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China.	tanwj28@163.com	wang, yanqun/AGZ-1821-2022		State Megaproject for Infectious Disease Research of China [2013ZX10004-001, 2013ZX10004601, 2013ZX10004-605]	State Megaproject for Infectious Disease Research of China	This work was supported by grants from the State Megaproject for Infectious Disease Research of China (2013ZX10004-001, 2013ZX10004601 and 2013ZX10004-605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas KZ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-15; Abd-Jamil J, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-46; Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001; Biere B, 2010, J CLIN VIROL, V47, P366, DOI 10.1016/j.jcv.2010.01.005; BOURSNELL MEG, 1981, VIROLOGY, V112, P198, DOI 10.1016/0042-6822(81)90625-5; Ebner K, 2005, J VIROL, V79, P12635, DOI 10.1128/JVI.79.20.12635-12642.2005; Elizabet GR, 2010, PRINCIPLES PRACTICE, P2077; Hage E, 2014, J INFECTION, V69, P490, DOI 10.1016/j.jinf.2014.06.015; Han Guiyuan, 2013, Virologica Sinica, V28, P103, DOI 10.1007/s12250-013-3308-7; Harrach B., 2012, VIRUS TAXONOMY, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; Hong JY, 2001, CLIN INFECT DIS, V32, P1423, DOI 10.1086/320146; Kaneko H, 2009, J GEN VIROL, V90, P1471, DOI 10.1099/vir.0.009225-0; Lee J, 2010, J MED VIROL, V82, P624, DOI 10.1002/jmv.21701; Lu MP, 2013, WORLD J PEDIATR, V9, P346, DOI 10.1007/s12519-013-0431-3; Lukashev AN, 2008, J GEN VIROL, V89, P380, DOI 10.1099/vir.0.83057-0; McLaughlin J., 2010, Morbidity and Mortality Weekly Report, V59, P6; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; SaitohInagawa W, 1996, J CLIN MICROBIOL, V34, P2113, DOI 10.1128/JCM.34.9.2113-2116.1996; Selvaraju SB, 2011, J CLIN VIROL, V51, P126, DOI 10.1016/j.jcv.2011.02.014; Seto D, 2011, J VIROL, V85, P5701, DOI 10.1128/JVI.00354-11; Shimada Y, 2004, J CLIN MICROBIOL, V42, P1577, DOI 10.1128/JCM.42.4.1577-1584.2004; Sun B, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0456-6; Tabain I, 2012, PEDIATR INFECT DIS J, V31, P680, DOI 10.1097/INF.0b013e318256605e; Tang LY, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-23; Walsh MP, 2011, J CLIN MICROBIOL, V49, P3482, DOI 10.1128/JCM.00156-11; Wang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075208; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Woo PCY, 2010, J CLIN VIROL, V47, P282, DOI 10.1016/j.jcv.2009.12.014; Xie L, 2012, J CLIN MICROBIOL, V50, P1879, DOI 10.1128/JCM.06523-11; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072606; Zhou WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079477	32	28	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123234	10.1371/journal.pone.0123234	http://dx.doi.org/10.1371/journal.pone.0123234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856575	Green Published, gold, Green Submitted			2022-12-27	WOS:000352588500081
J	Serth, K; Schuster-Gossler, K; Kremmer, E; Hansen, B; Marohn-Kohn, B; Gossler, A				Serth, Katrin; Schuster-Gossler, Karin; Kremmer, Elisabeth; Hansen, Birte; Marohn-Koehn, Britta; Gossler, Achim			O-Fucosylation of DLL3 Is Required for Its Function during Somitogenesis	PLOS ONE			English	Article							LUNATIC-FRINGE; DROSOPHILA-MELANOGASTER; TRANSMEMBRANE PROTEIN; SIGNAL-TRANSDUCTION; SEGMENTATION CLOCK; NOTCH INHIBITION; NERVOUS-SYSTEM; DELTA-HOMOLOG; GENE; EXPRESSION	Delta-like 3 (DLL3) is a member of the DSL family of Notch ligands in amniotes. In contrast to DLL1 and DLL4, the other Delta-like proteins in the mouse, DLL3 does not bind in trans to Notch and does not activate the receptor, but shows cis-interaction and cis-inhibitory properties on Notch signaling in vitro. Loss of the DSL protein DLL3 in the mouse results in severe somite patterning defects, which are virtually indistinguishable from the defects in mice that lack lunatic fringe (LFNG), a glycosyltransferase involved in modifying Notch signaling. Like LFNG, DLL3 is located within the trans-Golgi, however, its biochemical function is still unclear. Here, we show that i) both proteins interact, ii) epidermal growth factor like repeats 2 and 5 of DLL3 are O-fucosylated at consensus sites for POFUT1, and iii) further modified by FNG proteins in vitro. Embryos double homozygous for null mutations in DII3 and Lfng are phenotypically indistinguishable from the single mutants supporting a potential common function. Mutation of the O-fucosylation sites in DLL3 does not disrupt the interaction of DLL3 with LFNG or full length Notch1or DLL1, and O-fucosylation-deficient DLL3 can still inhibit Notch in cis in vitro. However, in contrast to wild type DLL3, O-fucosylation-deficient DLL3 cannot compensate for the loss of endogenous DLL3 during somitogenesis in the embryo. Together our results suggest that the cis-inhibitory activity of DLL3 observed in cultured cells might not fully reflect its assumed essential physiological property, suggest that DLL3 and LFNG act together, and strongly supports that modification of DLL3 by O-linked fucose is essential for its function during somitogenesis.	[Serth, Katrin; Schuster-Gossler, Karin; Hansen, Birte; Marohn-Koehn, Britta; Gossler, Achim] Hannover Med Sch, Inst Mol Biol OE5250, D-30625 Hannover, Germany; [Kremmer, Elisabeth] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, D-81377 Munich, Germany	Hannover Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Gossler, A (corresponding author), Hannover Med Sch, Inst Mol Biol OE5250, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gossler.achim@mh-hannover.de			German Research Council (DFG) [GO 449/9-3]; Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy"	German Research Council (DFG)(German Research Foundation (DFG)); Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy"	This work was supported by a grant of the German Research Council (DFG; http://www.dfg.de) to AG (GO 449/9-3), and by funding of the Cluster of Excellence "From Regenerative Biology to Reconstructive Therapy" (http://www.mh-hannover.de/rebirth.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alten L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047785; Beckers J, 2000, MECH DEVELOP, V95, P23, DOI 10.1016/S0925-4773(00)00322-1; Ben Abdelkhalek H, 2004, GENE DEV, V18, P1725, DOI 10.1101/gad.303504; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Haltiwanger RS, 2002, CURR OPIN STRUC BIOL, V12, P593, DOI 10.1016/S0959-440X(02)00371-8; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kageyama R, 2007, DEV DYNAM, V236, P1403, DOI 10.1002/dvdy.21114; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Kusumi K, 1998, NAT GENET, V19, P274, DOI 10.1038/961; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Loomes KM, 2007, DEV DYNAM, V236, P2943, DOI 10.1002/dvdy.21296; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Maatman R, 1997, DEVELOPMENT, V124, P4019; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morth JP, 2011, NAT REV MOL CELL BIO, V12, P60, DOI 10.1038/nrm3031; Muller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088571; NAGY A, 1990, DEVELOPMENT, V110, P815; Neidhardt LM, 1997, DEV GENES EVOL, V207, P330, DOI 10.1007/s004270050120; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okubo Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2133; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pourquie O, 2007, Cold Spring Harb Symp Quant Biol, V72, P445, DOI 10.1101/sqb.2007.72.016; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Schuster-Gossler K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-6; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Sewell W, 2009, DEV BIOL, V329, P400, DOI 10.1016/j.ydbio.2009.02.023; Shao L, 2003, J BIOL CHEM, V278, P7775, DOI 10.1074/jbc.M212221200; Shimizu K, 2001, J BIOL CHEM, V276, P25753, DOI 10.1074/jbc.M103473200; Stanley P, 2007, CURR OPIN STRUC BIOL, V17, P530, DOI 10.1016/j.sbi.2007.09.007; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; THOMAS U, 1991, DEVELOPMENT, V111, P749; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; Wang Y, 1996, GLYCOBIOLOGY, V6, P837, DOI 10.1093/glycob/6.8.837; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zhang N, 2002, GENESIS, V33, P21, DOI 10.1002/gene.10081; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	72	37	39	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123776	10.1371/journal.pone.0123776	http://dx.doi.org/10.1371/journal.pone.0123776			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856312	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500106
J	Cue, D; Junecko, JM; Lei, MG; Blevins, JS; Smeltzer, MS; Lee, CY				Cue, David; Junecko, Jennifer M.; Lei, Mei G.; Blevins, Jon S.; Smeltzer, Mark S.; Lee, Chia Y.			SaeRS-Dependent Inhibition of Biofilm Formation in Staphylococcus aureus Newman	PLOS ONE			English	Article							2-COMPONENT SYSTEM SAERS; SENSOR KINASE SAES; REGULATORY SYSTEM; STRAIN NEWMAN; RNA-SEQ; EPIDERMIDIS; VIRULENCE; LOCUS; HOST; PATHOGENESIS	The SaeRS two-component regulatory system of Staphylococcus aureus is known to affect the expression of many genes. The SaeS protein is the histidine kinase responsible for phosphorylation of the response regulator SaeR. In S. aureus Newman, the sae system is constitutively expressed due to a point mutation in saeS, relative to other S. aureus strains, which results in substitution of proline for leucine at amino acid 18. Strain Newman is unable to form a robust biofilm and we report here that the biofilm-deficient phenotype is due to the saeS(P) allele. Replacement of the Newman saeS(P)with saeS(L), or deletion of saeRS, resulted in a biofilm-proficient phenotype. Newman culture supernatants were observed to inhibit biofilm formation by other S. aureusstrains, but did not affect biofilm formation by S. epidermidis. Culture supernatants of Newman saeS(L)or Newman Delta saeRS had no significant effect on biofilm formation. The inhibitory factor was inactivated by incubation with proteinase K, but survived heating, indicating that the inhibitory protein is heat-stable. The inhibitory protein was found to affect the attachment step in biofilm formation, but had no effect on preformed biofilms. Replacement of saeS(L) with saeS(P) in the biofilm-proficient S. aureus USA300 FPR3757 resulted in the loss of biofilm formation. Culture supernatants of USA300 FPR3757 saeS(P), did not inhibit biofilm formation by other staphylococci, suggesting that the inhibitory factor is produced but not secreted in the mutant strain. A number of biochemical methods were utilized to isolate the inhibitory protein. Although a number of candidate proteins were identified, none were found to be the actual inhibitor. In an effort to reduce the number of potential inhibitory genes, RNA-Seq analyses were done with wild-type strain Newman and the saeS(L) and Delta saeRS mutants. RNA-Seq results indicated that sae regulates many genes that may affect biofilm formation by Newman.	[Cue, David; Junecko, Jennifer M.; Lei, Mei G.; Blevins, Jon S.; Smeltzer, Mark S.; Lee, Chia Y.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Lee, CY (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	clee2@uams.edu	Smeltzer, Mark/M-2009-2018	Smeltzer, Mark/0000-0002-0878-0692	National Institute of Allergy and Infectious Diseases [AI113766, AI067857, AI087678, AI074935]; National Institutes of Health [P20GM103429, P30GM103450, P20GM103625]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087678, R01AI113766, R56AI074935, R01AI074935, R01AI067857, R56AI113766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429, P20GM103625, P30GM103450] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institute of Allergy and Infectious Diseases (AI113766 and AI067857 to CL, AI087678 to JB, AI074935 to MS). The authors also acknowledge the UAMS proteomic core and sequencing core, which are supported in part by National Institutes of Health grants P20GM103429, P30GM103450, and P20GM103625, for proteomic and sequencing analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2012, J MED MICROBIOL, V61, P1062, DOI 10.1099/jmm.0.040758-0; Adhikari RP, 2008, MICROBIOL-SGM, V154, P949, DOI 10.1099/mic.0.2007/012245-0; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Beenken KE, 2014, MOL MICROBIOL, V92, P1299, DOI 10.1111/mmi.12629; Beenken KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010790; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Bose JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042244; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Flack CE, 2014, P NATL ACAD SCI USA, V111, pE2037, DOI 10.1073/pnas.1322125111; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hirschhausen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040353; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Jeong DW, 2012, MOL MICROBIOL, V86, P331, DOI 10.1111/j.1365-2958.2012.08198.x; Jeong DW, 2011, J BACTERIOL, V193, P4672, DOI 10.1128/JB.00353-11; Kiedrowski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026714; Lei MG, 2011, J BACTERIOL, V193, P5231, DOI 10.1128/JB.05454-11; Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004; Luong TT, 2011, J BACTERIOL, V193, P686, DOI 10.1128/JB.00987-10; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Mainiero M, 2010, J BACTERIOL, V192, P613, DOI 10.1128/JB.01242-09; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; McKenney D, 1998, INFECT IMMUN, V66, P4711, DOI 10.1128/IAI.66.10.4711-4720.1998; Memmi G, 2012, J BACTERIOL, V194, P759, DOI 10.1128/JB.06261-11; Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453; Novick RP, 2003, MICROBIOL-SGM, V149, P2709, DOI 10.1099/mic.0.26575-0; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2014, METHODS MOL BIOL, V1106, P17, DOI 10.1007/978-1-62703-736-5_2; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Quiles-Puchalt N, 2014, P NATL ACAD SCI USA, V111, P6016, DOI 10.1073/pnas.1320538111; Ranjit DK, 2011, J BACTERIOL, V193, P2468, DOI 10.1128/JB.01545-10; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Rice KC, 2008, MICROBIOL MOL BIOL R, V72, P85, DOI 10.1128/MMBR.00030-07; Rogasch K, 2006, J BACTERIOL, V188, P7742, DOI 10.1128/JB.00555-06; Sharma-Kuinkel BK, 2009, J BACTERIOL, V191, P4767, DOI 10.1128/JB.00348-09; SUGAI M, 1990, J BACTERIOL, V172, P6494, DOI 10.1128/jb.172.11.6494-6498.1990; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852	51	37	37	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123027	10.1371/journal.pone.0123027	http://dx.doi.org/10.1371/journal.pone.0123027			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853849	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400092
J	Hein, SJ; Lehmann, LH; Kossack, M; Juergensen, L; Fuchs, D; Katus, HA; Hassel, D				Hein, Selina J.; Lehmann, Lorenz H.; Kossack, Mandy; Juergensen, Lonny; Fuchs, Dieter; Katus, Hugo A.; Hassel, David			Advanced Echocardiography in Adult Zebrafish Reveals Delayed Recovery of Heart Function after Myocardial Cryoinjury	PLOS ONE			English	Article							SPECKLE TRACKING; REGENERATION; MODEL; CONDUCTION; FAILURE; SYSTEM; STRAIN; TIME	Translucent zebrafish larvae represent an established model to analyze genetics of cardiac development and human cardiac disease. More recently adult zebrafish are utilized to evaluate mechanisms of cardiac regeneration and by benefiting from recent genome editing technologies, including TALEN and CRISPR, adult zebrafish are emerging as a valuable in vivo model to evaluate novel disease genes and specifically validate disease causing mutations and their underlying pathomechanisms. However, methods to sensitively and noninvasively assess cardiac morphology and performance in adult zebrafish are still limited. We here present a standardized examination protocol to broadly assess cardiac performance in adult zebrafish by advancing conventional echocardiography with modern speckle-tracking analyses. This allows accurate detection of changes in cardiac performance and further enables highly sensitive assessment of regional myocardial motion and deformation in high spatio-temporal resolution. Combining conventional echocardiography measurements with radial and longitudinal velocity, displacement, strain, strain rate and myocardial wall delay rates after myocardial cryoinjury permitted to non-invasively determine injury dimensions and to longitudinally follow functional recovery during cardiac regeneration. We show that functional recovery of cryoinjured hearts occurs in three distinct phases. Importantly, the regeneration process after cryoinjury extends far beyond the proposed 45 days described for ventricular resection with reconstitution of myocardial performance up to 180 days post-injury (dpi). The imaging modalities evaluated here allow sensitive cardiac phenotyping and contribute to further establish adult zebrafish as valuable cardiac disease model beyond the larval developmental stage.	[Hein, Selina J.; Lehmann, Lorenz H.; Kossack, Mandy; Juergensen, Lonny; Katus, Hugo A.; Hassel, David] Univ Heidelberg Hosp, Dept Med 3, Cardiol, D-69120 Heidelberg, Germany; [Hein, Selina J.; Lehmann, Lorenz H.; Kossack, Mandy; Juergensen, Lonny; Katus, Hugo A.; Hassel, David] DZHK German Ctr Cardiovasc Res, Partner Site Heidelberg, Heidelberg, Germany; [Fuchs, Dieter] FUJIFILM VisualSonics Inc, Amsterdam, Netherlands	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Fujifilm Corporation	Hassel, D (corresponding author), Univ Heidelberg Hosp, Dept Med 3, Cardiol, D-69120 Heidelberg, Germany.	david.hassel@med.uni-heidelberg.de	Lehmann, Lorenz/AAP-9161-2021; Hein, Selina/AAA-5673-2022	Lehmann, Lorenz/0000-0001-5077-8580; Hein, Selina/0000-0003-0139-4200; Fuchs, Dieter/0000-0002-9516-2875	Heidelberg Medical School; Molecular Medicine Partnership Unit (MMPU) of the University of Heidelberg; German Center for Cardiovascular Diseases (DZHK); BMBF (German Ministry of Education and Research); Deutsche Forschungsgemeinschaft (DFG) [HA 52819/4-1]; Ministry for Science, Research and Arts of Baden-Wuerttemberg (MWK); Deutsche Stiftung fur Herzforschung (DSHF); Federal Ministry of Education and Research (BMBF) [01ZX1409A]; Klaus-Tschira and Dietmar-Hopp Stiftung	Heidelberg Medical School; Molecular Medicine Partnership Unit (MMPU) of the University of Heidelberg; German Center for Cardiovascular Diseases (DZHK); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry for Science, Research and Arts of Baden-Wuerttemberg (MWK); Deutsche Stiftung fur Herzforschung (DSHF); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Klaus-Tschira and Dietmar-Hopp Stiftung	SH was supported by the Rahel-Goitein-Straus research fellowship of Heidelberg Medical School. LHL was supported by a fellowship of the Molecular Medicine Partnership Unit (MMPU) of the University of Heidelberg. DH, MK, LHL and HAK was supported by the German Center for Cardiovascular Diseases (DZHK, Partnersite Heidelberg/Mannheim) and by the BMBF (German Ministry of Education and Research). DH was supported by the Deutsche Forschungsgemeinschaft (DFG; HA 52819/4-1), the Ministry for Science, Research and Arts of Baden-Wuerttemberg (MWK), the Deutsche Stiftung fur Herzforschung (DSHF) and the Federal Ministry of Education and Research (BMBF; 01ZX1409A). This work was supported by generous donations from the Klaus-Tschira and Dietmar-Hopp Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Bakkers J, 2011, CARDIOVASC RES, V91, P279, DOI 10.1093/cvr/cvr098; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Blessberger H, 2010, HEART, V96, P2032, DOI 10.1136/hrt.2010.199885; Blessberger H, 2010, HEART, V96, P716, DOI 10.1136/hrt.2007.141002; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Chablais F, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-21; Chi NC, 2010, P NATL ACAD SCI USA, V107, P14662, DOI 10.1073/pnas.0909432107; D'hooge J, 2000, Eur J Echocardiogr, V1, P154, DOI 10.1053/euje.2000.0031; Dandel M, 2009, CURR CARDIOL REV, V5, P133, DOI 10.2174/157340309788166642; Ding YH, 2012, AUTOPHAGY, V8, P142, DOI 10.4161/auto.8.1.18536; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Foster FS, 2009, ULTRASOUND MED BIOL, V35, P1700, DOI 10.1016/j.ultrasmedbio.2009.04.012; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Goertz DE, 2000, ULTRASOUND MED BIOL, V26, P63, DOI 10.1016/S0301-5629(99)00101-5; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Ho YL, 2002, ULTRASOUND MED BIOL, V28, P1137, DOI 10.1016/S0301-5629(02)00564-1; Hoage T, 2012, METHODS MOL BIOL, V843, P11, DOI 10.1007/978-1-61779-523-7_2; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; Huttner IG, 2013, J MOL CELL CARDIOL, V61, P123, DOI 10.1016/j.yjmcc.2013.06.005; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kabli S, 2006, ZEBRAFISH, V3, P431, DOI 10.1089/zeb.2006.3.431; Kalogirou S, 2014, CARDIOVASC RES, V104, P49, DOI 10.1093/cvr/cvu186; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Lee SC, 2014, MOL GENET METAB, V112, P218, DOI 10.1016/j.ymgme.2014.04.005; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Liu JD, 2012, CIRC RES, V110, P870, DOI 10.1161/CIRCRESAHA.111.246504; Mahmoud AM, 2013, ULTRASONICS, V53, P727, DOI 10.1016/j.ultras.2012.10.017; Gonzalez-Rosa JM, 2011, DEVELOPMENT, V138, P1663, DOI 10.1242/dev.060897; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Nanna M, 2014, CURR OPIN CARDIOL, V29, P417, DOI 10.1097/HCO.0000000000000095; Parente V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053748; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Poss KD, 2007, SEMIN CELL DEV BIOL, V18, P36, DOI 10.1016/j.semcdb.2006.11.009; Rao KD, 2009, J BIOPHOTONICS, V2, P288, DOI 10.1002/jbio.200910032; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; Schnabel K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018503; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; Sun L, 2008, ULTRASOUND MED BIOL, V34, P31, DOI 10.1016/j.ultrasmedbio.2007.07.002; Sun L, 2008, ULTRASON, P1738, DOI 10.1109/ULTSYM.2008.0426; Sun XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006596; Swillens A, 2010, IEEE T ULTRASON FERR, V57, P327, DOI 10.1109/TUFFC.2010.1413; Teske Arco J, 2007, Cardiovasc Ultrasound, V5, P27; Thorstensen A, 2011, EUR J ECHOCARDIOGR, V12, P924, DOI 10.1093/ejechocard/jer178; Volkers M, 2012, J CELL SCI, V125, P287, DOI 10.1242/jcs.090464; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385; Xiong JW, 2013, BIRTH DEFECTS RES C, V99, P160, DOI 10.1002/bdrc.21039; Yin VP, 2012, DEV BIOL, V365, P319, DOI 10.1016/j.ydbio.2012.02.018; Zhang KW, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000550; Zhou XW, 2013, IEEE T ULTRASON FERR, V60, P718, DOI 10.1109/TUFFC.2013.2620	57	48	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122665	10.1371/journal.pone.0122665	http://dx.doi.org/10.1371/journal.pone.0122665			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853735	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400073
J	Li, RWS; Yang, C; Chan, SW; Hoi, MPM; Lee, SMY; Kwan, YW; Leung, GPH				Li, Rachel Wai Sum; Yang, Cui; Chan, Shun Wan; Hoi, Maggie Pui Man; Lee, Simon Ming Yuen; Kwan, Yiu Wa; Leung, George Pak Heng			Relaxation Effect of Abacavir on Rat Basilar Arteries	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EQUILIBRATIVE NUCLEOSIDE TRANSPORTERS; REVERSE-TRANSCRIPTASE INHIBITORS; ADENOSINE-INDUCED DILATION; DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; HIV-INFECTED PATIENTS; MYOCARDIAL-INFARCTION; ANTIRETROVIRAL THERAPY; SMOOTH-MUSCLE	Background The use of abacavir has been linked with increased cardiovascular risk in patients with human immunodeficiency virus infection; however, the mechanism involved remains unclear. We hypothesize that abacavir may impair endothelial function. In addition, based on the structural similarity between abacavir and adenosine, we propose that abacavir may affect vascular contractility through endogenous adenosine release or adenosine receptors in blood vessels. Methods The relaxation effect of abacavir on rat basilar arteries was studied using the myograph technique. Cyclic GMP and AMP levels were measured by immunoassay. The effects of abacavir on nucleoside transporters were studied using radiolabeled nucleoside uptake experiments. Ecto-50 nucleotidase activity was determined by measuring the generation of inorganic phosphate using adenosine monophosphate as the substrate. Results Abacavir induced the relaxation of rat basilar arteries in a concentration-dependent manner. This relaxation was abolished when endothelium was removed. In addition, the relaxation was diminished by the nitric oxide synthase inhibitor, L-NAME, the guanylyl cyclase inhibitor, ODQ, and the protein kinase G inhibitor, KT5820. Abacavir also increased the cGMP level in rat basilar arteries. Abacavir-induced relaxation was also abolished by adenosine A2 receptor blockers. However, abacavir had no effect on ecto-5' nucleotidase and nucleoside transporters. Short-term and long-term treatment of abacavir did not affect acetylcholine- induced relaxation in rat basilar arteries. Conclusion Abacavir induces acute endothelium-dependent relaxation of rat basilar arteries, probably through the activation of adenosine A2 receptors in endothelial cells, which subsequently leads to the release of nitric oxide, resulting in activation of the cyclic guanosine monophosphate/protein kinase G-dependent pathway in vascular smooth muscle cells. It is speculated that abacavir-induced cardiovascular risk may not be related to endothelial dysfunction as abacavir does not impair relaxation of blood vessels. The most likely explanation of increased cardiovascular risk may be increased platelet aggregation as suggested by other studies.	[Li, Rachel Wai Sum; Leung, George Pak Heng] Univ Hong Kong, Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Yang, Cui] Yunnan Univ Nationalities, Sch Chem & Biotechnol, Key Lab Ethn Med Resource Chem, State Ethn Affairs Commiss & Minist Educ, Kunming, Peoples R China; [Chan, Shun Wan] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, State Key Lab Chinese Med & Mol Pharmacol, Hong Kong, Hong Kong, Peoples R China; [Hoi, Maggie Pui Man; Lee, Simon Ming Yuen] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China; [Kwan, Yiu Wa] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Yunnan Minzu University; Hong Kong Polytechnic University; University of Macau; Chinese University of Hong Kong	Leung, GPH (corresponding author), Univ Hong Kong, Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.	gphleung@hku.hk	Hoi, Maggie Pui Man/AAY-5962-2021; Kwan, Yiu Wa/R-6468-2018; Chan, Shun-Wan/K-9363-2013; Leung, George Pak Heng/B-4529-2009	Kwan, Yiu Wa/0000-0002-9024-1275; Chan, Shun-Wan/0000-0001-8238-798X; Leung, George Pak Heng/0000-0003-3529-9367; Hoi, Maggie Pui Man/0000-0003-2630-3707	RGC General Research Grant of Hong Kong [770109]; University of Hong Kong; GPHL	RGC General Research Grant of Hong Kong; University of Hong Kong(University of Hong Kong); GPHL	This work is financially supported by RGC General Research Grant of Hong Kong (project number: 770109). The University of Hong Kong and GPHL are the organization/person who receive the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari HR, 2007, AM J PHYSIOL-HEART C, V292, pH719, DOI 10.1152/ajpheart.00593.2006; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baum PD, 2011, AIDS, V25, P2243, DOI 10.1097/QAD.0b013e32834d3cc3; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Bienstock RJ, 2004, MITOCHONDRION, V4, P203, DOI 10.1016/j.mito.2004.05.018; Bo J, 2006, JAIDS-J ACQ IMM DEF, V42, P391, DOI 10.1097/01.qai.0000228790.40235.0c; Brothers CH, 2009, JAIDS-J ACQ IMM DEF, V51, P20, DOI 10.1097/QAI.0b013e31819ff0e6; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Conklin BS, 2004, CARDIOVASC RES, V63, P168, DOI 10.1016/j.cardiores.2004.03.020; CUSHING DJ, 1991, AM J PHYSIOL, V261, pH343, DOI 10.1152/ajpheart.1991.261.2.H343; Daluge SM, 1997, ANTIMICROB AGENTS CH, V41, P1082, DOI 10.1128/AAC.41.5.1082; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Falcinelli E, 2013, THROMB HAEMOSTASIS, V110, P349, DOI 10.1160/TH12-07-0504; FARACI FM, 1990, AM J PHYSIOL, V259, pH1216, DOI 10.1152/ajpheart.1990.259.4.H1216; Ferre S, 2008, CURR PHARM DESIGN, V14, P1468, DOI 10.2174/138161208784480108; FISCUS RR, 1985, BIOCHIM BIOPHYS ACTA, V846, P179, DOI 10.1016/0167-4889(85)90124-7; FISCUS RR, 1984, BIOCHIM BIOPHYS ACTA, V805, P382, DOI 10.1016/0167-4889(84)90022-3; FISCUS RR, 1984, J CYCLIC NUCL PROT, V9, P415; Foster RH, 1998, DRUGS, V55, P729, DOI 10.2165/00003495-199855050-00018; Goicoechea M, 2008, LANCET, V372, P803, DOI 10.1016/S0140-6736(08)61331-8; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammond E, 2008, AIDS, V22, P2540, DOI 10.1097/QAD.0b013e328319807f; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; Hino A, 1996, NEUROSURGERY, V39, P562, DOI 10.1097/00006123-199609000-00026; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; KASUYA H, 1995, J NEUROSURG, V82, P250, DOI 10.3171/jns.1995.82.2.0250; Kim C, 2011, ANTIVIR THER, V16, P1335, DOI 10.3851/IMP1891; Kline MW, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e47; Kristoffersen US, 2009, HIV MED, V10, P627, DOI 10.1111/j.1468-1293.2009.00733.x; Lasley RD, 2007, AM J PHYSIOL-HEART C, V292, pH426, DOI 10.1152/ajpheart.00675.2006; Li RWS, 2008, AM J PHYSIOL-HEART C, V295, pH1177, DOI 10.1152/ajpheart.91513.2007; Li RWS, 2007, EUR J PHARMACOL, V568, P75, DOI 10.1016/j.ejphar.2007.04.033; Marchetti G, 2008, CLIN INFECT DIS, V47, P1495, DOI 10.1086/593110; Martin A, 2010, AIDS, V24, P2657, DOI 10.1097/QAD.0b013e32833f147f; Martinez E, 2010, AIDS, V24, pF1, DOI 10.1097/QAD.0b013e32833562c5; Minuesa G, 2008, J PHARMACOL EXP THER, V324, P558, DOI 10.1124/jpet.107.131482; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; Murphy K, 2003, MOL PHARMACOL, V64, P640, DOI 10.1124/mol.64.3.640; Ngai AC, 2001, AM J PHYSIOL-HEART C, V280, pH2329, DOI 10.1152/ajpheart.2001.280.5.H2329; Nunes H, 2003, AM J RESP CRIT CARE, V167, P1433, DOI 10.1164/rccm.200204-330OC; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Oxhorn B C, 2000, AACN Clin Issues, V11, P241, DOI 10.1097/00044067-200005000-00007; Padilla S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-40; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pellicelli AM, 1998, ANGIOLOGY, V49, P1005, DOI 10.1177/000331979804901206; Pelligrino DA, 1998, PROG NEUROBIOL, V56, P1, DOI 10.1016/S0301-0082(98)00009-4; Phillis John W., 2004, Critical Reviews in Neurobiology, V16, P237, DOI 10.1615/CritRevNeurobiol.v16.i4.20; POUCHER SM, 1995, BRIT J PHARMACOL, V115, P1096, DOI 10.1111/j.1476-5381.1995.tb15923.x; Ralevic V, 1998, PHARMACOL REV, V50, P413; RAPOPORT RM, 1983, J CYCLIC NUCL PROT, V9, P281; Rasmussen LD, 2011, AIDS, V25, P1637, DOI 10.1097/QAD.0b013e3283493fb0; Ribaudo HJ, 2011, CLIN INFECT DIS, V52, P929, DOI 10.1093/cid/ciq244; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sands WA, 2005, IMMUNOL LETT, V101, P1, DOI 10.1016/j.imlet.2005.04.005; Schafer JJ, 2010, PHARMACOTHERAPY, V30, P1072, DOI 10.1592/phco.30.10.1072; Schinazi RF, 2011, ANTIMICROB AGENTS CH, V55, P2054, DOI 10.1128/AAC.01700-10; Shimokawa H, 2001, DIALOG CARDIOVASC ME, V6, P235; Sobey CG, 1998, STROKE, V29, P1439, DOI 10.1161/01.STR.29.7.1439; Sutliff RL, 2002, AM J PHYSIOL-HEART C, V283, pH2363, DOI 10.1152/ajpheart.00151.2002; Tabrizchi R, 2001, PHARMACOL THERAPEUT, V91, P133, DOI 10.1016/S0163-7258(01)00152-8; Teixeira CE, 2006, HYPERTENSION, V47, P596, DOI 10.1161/01.HYP.0000199914.36936.1b; Thomas SA, 2004, CURR PHARM DESIGN, V10, P1313, DOI 10.2174/1381612043384835; Wang XW, 2009, AM J PATHOL, V174, P771, DOI 10.2353/ajpath.2009.080157; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; West GA, 2003, J CARDIOVASC PHARM, V41, P444, DOI 10.1097/00005344-200303000-00013	66	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123043	10.1371/journal.pone.0123043	http://dx.doi.org/10.1371/journal.pone.0123043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853881	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400093
J	Ozcan, B; Negi, P; Laezza, F; Papadakis, M; Labate, D				Ozcan, Burcin; Negi, Pooran; Laezza, Fernanda; Papadakis, Manos; Labate, Demetrio			Automated Detection of Soma Location and Morphology in Neuronal Network Cultures	PLOS ONE			English	Article							IMAGE; ALGORITHM; GPU	Automated identification of the primary components of a neuron and extraction of its subcellular features are essential steps in many quantitative studies of neuronal networks. The focus of this paper is the development of an algorithm for the automated detection of the location and morphology of somas in confocal images of neuronal network cultures. This problem is motivated by applications in high-content screenings (HCS), where the extraction of multiple morphological features of neurons on large data sets is required. Existing algorithms are not very efficient when applied to the analysis of confocal image stacks of neuronal cultures. In addition to the usual difficulties associated with the processing of fluorescent images, these types of stacks contain a small number of images so that only a small number of pixels are available along the z-direction and it is challenging to apply conventional 3D filters. The algorithm we present in this paper applies a number of innovative ideas from the theory of directional multiscale representations and involves the following steps: (i) image segmentation based on support vector machines with specially designed multiscale filters; (ii) soma extraction and separation of contiguous somas, using a combination of level set method and directional multiscale filters. We also present an approach to extract the soma's surface morphology using the 3D shearlet transform. Extensive numerical experiments show that our algorithms are computationally efficient and highly accurate in segmenting the somas and separating contiguous ones. The algorithms presented in this paper will facilitate the development of a high-throughput quantitative platform for the study of neuronal networks for HCS applications.	[Ozcan, Burcin; Negi, Pooran; Papadakis, Manos; Labate, Demetrio] Univ Houston, Dept Math, Houston, TX 77204 USA; [Laezza, Fernanda] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	University of Houston System; University of Houston; University of Texas System; University of Texas Medical Branch Galveston	Labate, D (corresponding author), Univ Houston, Dept Math, Houston, TX 77204 USA.	dlabate@math.uh.edu	Laezza, Fernanda/X-4076-2019; Laezza, Fernanda/L-6019-2016; Negi, Pooran/O-2750-2019	Laezza, Fernanda/0000-0003-1141-1852; Laezza, Fernanda/0000-0003-1141-1852; 	National Science Foundation [DMS 1320910, DMS 1008900]; National Institutes of Health [R01 MH095995]; Division Of Mathematical Sciences [1320910] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095995] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding provided by National Science Foundation (http://www.nsf.gov) GRANTS: DMS 1320910 (MP,DL) and DMS 1008900 (DL) and National Institutes of Health (http://www.nih.gov/) grant: R01 MH095995 (FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOU IE, 1979, P IEEE, V67, P753, DOI 10.1109/PROC.1979.11325; Al-Kofahi KA, 2002, IEEE T INF TECHNOL B, V6, P171, DOI 10.1109/TITB.2002.1006304; Al-Kofahi Y, 2008, CYTOM PART A, V73A, P36, DOI 10.1002/cyto.a.20499; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055037; Cates JE, 2004, MED IMAGE ANAL, V8, P217, DOI 10.1016/j.media.2004.06.022; Cornelissen F, 2013, J BIOMOL SCREEN, V18, P807, DOI 10.1177/1087057113486518; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Easley G, 2008, APPL COMPUT HARMON A, V25, P25, DOI 10.1016/j.acha.2007.09.003; Easley GR, 2012, APPL NUMER HARMON AN, P283, DOI 10.1007/978-0-8176-8316-0_8; El-Laithy K, 2012, J NEUROSCI METH, V210, P206, DOI 10.1016/j.jneumeth.2012.07.007; Gibert X, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-64; Gonzalez R. C., 2013, DIGITAL IMAGE PROCES, V2nd; Gough AH, 2007, METH MOL B, V356, P41; Guo KH, 2012, J FOURIER ANAL APPL, V18, P488, DOI 10.1007/s00041-011-9209-y; Guo K, 2011, APPL COMPUT HARMON A, V30, P231, DOI 10.1016/j.acha.2010.08.004; Guo KH, 2009, SIAM J IMAGING SCI, V2, P959, DOI 10.1137/080741537; He W, 2003, MICROSC MICROANAL, V9, P296, DOI 10.1017/S143192760303040X; Huang Y, 2010, J NEUROSCI METH, V190, P299, DOI 10.1016/j.jneumeth.2010.05.012; Jimenez D, 2015, APPL COMPUT HARMON A, P1; Jimenez D, 2015, NEUROINFORMATICS, V13, P227, DOI 10.1007/s12021-014-9256-z; Jimenez D, 2013, I S BIOMED IMAGING, P1050; Kutyniok G, 2012, APPL NUMER HARMON AN, P1, DOI 10.1007/978-0-8176-8316-0; Labate D, 2014, MATH MODEL NAT PHENO, V9, P177, DOI 10.1051/mmnp/20149512; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Negi PS, 2012, IEEE T IMAGE PROCESS, V21, P2944, DOI 10.1109/TIP.2012.2183883; Nieland TJF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091744; Osher S., 2003, LEVEL SET METHODS DY, P17; Ozcan B, 2013, SPIE P, V8858, P1050; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Schug DA, 2011, PROC SPIE 8058, V8058; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; Sharma K, 2013, CELL REP, V5, P1330, DOI 10.1016/j.celrep.2013.11.008; Shavkunov AS, 2013, J BIOL CHEM, V288, P19370, DOI 10.1074/jbc.M112.445924; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Svoboda K, 2011, NEUROINFORMATICS, V9, P97, DOI 10.1007/s12021-011-9097-y; Vallotton P, 2007, CYTOM PART A, V71A, P889, DOI 10.1002/cyto.a.20462; Weaver CM, 2003, J NEUROSCI METH, V124, P197, DOI 10.1016/S0165-0270(03)00017-7; Yi S, 2009, IEEE T IMAGE PROCESS, V18, P929, DOI 10.1109/TIP.2009.2013082	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121886	10.1371/journal.pone.0121886	http://dx.doi.org/10.1371/journal.pone.0121886			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853656	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400053
J	Shen, T; Tang, LQ; Luo, DH; Chen, QY; Li, PJ; Mai, DM; Guo, SS; Liu, LT; Qian, CN; Guo, X; Zeng, MS; Mo, HY; Mai, HQ				Shen, Ting; Tang, Lin-Quan; Luo, Dong-Hua; Chen, Qiu-Yan; Li, Pei-Jing; Mai, Dong-Mei; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mo, Hao-Yuan; Mai, Hai-Qiang			Different Prognostic Values of Plasma Epstein-Barr Virus DNA and Maximal Standardized Uptake Value of F-18-FDG PET/CT for Nasopharyngeal Carcinoma Patients with Recurrence	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; QUANTITATIVE-ANALYSIS; EBV DNA; TUMOR VOLUME; FDG-PET; PREDICTION; RADIOTHERAPY; CANCER; MARKER; GLUT1	Purpose To evaluate and compare the prognostic value of Epstein-Barr virus (EBV) DNA and maximal standard uptake values (SUVmax) of F-18-fluoro-2-deoxy-D-glucose positron emission tomography (F-18-FDG-PET) in subgroups of nasopharyngeal carcinoma (NPC) patients with locoregional or distant recurrence. Patients and Methods A total of 194 patients with recurrent NPC (locoregional recurrence: 107, distant recurrence: 87) were enrolled. Patients took evidence of recurrence performed with F-18-FDG-PET and an EBV DNA test before salvage treatment. Clinical parameters, the status of EBV DNA and the value of SUVmax were used for survival analysis using the Kaplan-Meier method and the Cox proportional hazards regression model. Results In the subgroup of patients with locoregional recurrence, patients with SUVmax<8.65 had significantly better overall survival (OS) (P=0.005) compared with the patients with SUVmax >= 8.65. However, both elevated EBV DNA load (>= 21,100 copies/ml) and distant SUVmax (>= 13.55) were significantly associated with worse OS compared with the patients with EBV DNA < 21,100 copies/ml or distant SUVmax < 13.55 for the subgroup with distant recurrence (P=0.015 and P=0.006, respectively). The predictive ability of EBV DNA was superior to that of SUVmax (P=0.062). Multivariate analysis showed that SUVmax was only an independent prognostic factor for OS in patients with locoregional recurrence (P=0.042), whereas EBV DNA independently predicted OS for the patients with distant recurrence (P=0.007). For those patients with undetectable EBV DNA, SUVmax<8.65 was still an independent favorable prognostic factor (P=0.038). Conclusions SUVmax is a useful biomarker for predicting OS in nasopharyngeal carcinoma patients with locoregional recurrence or with undetectable EBV DNA. Both distant SUVmax and EBV DNA appear to be independent predictors of OS in patients with distant recurrence; however, the predictive ability of EBV DNA was superior to that of SUVmax.	[Shen, Ting; Tang, Lin-Quan; Luo, Dong-Hua; Chen, Qiu-Yan; Li, Pei-Jing; Mai, Dong-Mei; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mo, Hao-Yuan; Mai, Hai-Qiang] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Shen, Ting; Tang, Lin-Quan; Luo, Dong-Hua; Chen, Qiu-Yan; Li, Pei-Jing; Mai, Dong-Mei; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Mo, Hao-Yuan; Mai, Hai-Qiang] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Mo, HY (corresponding author), Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	mohy@mail.sysu.edu.cn; maihq@mail.sysu.edu.cn	Li, Peijing/AAU-9696-2021		Ministry of Science and Technology of China [2011CB504300]; National Natural Science Foundation of China [81201629, 81072226]; 863 Project [2012AA02A501]; National Key Basic Research Program of China [2013CB910304]; Sci-Tech Project Foundation of Guangdong Province [2011B080701034, 2011B031800161, 2011B031800314]; Sci-Tech Project Foundation of Guangzhou City [2011J4300100]; Sun Yat-sen University Clinical Research 5010 Program; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Sci-Tech Project Foundation of Guangdong Province; Sci-Tech Project Foundation of Guangzhou City; Sun Yat-sen University Clinical Research 5010 Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was partially supported by the Ministry of Science and Technology of China (No. 2011CB504300), the National Natural Science Foundation of China (81201629 and 81072226), the 863 Project (No: 2012AA02A501), the National Key Basic Research Program of China (No: 2013CB910304), the Sci-Tech Project Foundation of Guangdong Province (No: 2011B080701034, 2011B031800161 and 2011B031800314), the Sci-Tech Project Foundation of Guangzhou City (No: 2011J4300100), the Sun Yat-sen University Clinical Research 5010 Program and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Allal AS, 2004, INT J RADIAT ONCOL, V59, P1295, DOI 10.1016/j.ijrobp.2003.12.039; An X, 2011, CANCER-AM CANCER SOC, V117, P3750, DOI 10.1002/cncr.25932; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Chan JYW, 2014, LARYNGOSCOPE, V124, P126, DOI 10.1002/lary.24193; Chan JYW, 2012, HEAD NECK-J SCI SPEC, V34, P541, DOI 10.1002/hed.21768; Chan SC, 2013, ORAL ONCOL, V49, P71, DOI 10.1016/j.oraloncology.2012.07.016; Chan SC, 2009, ORAL ONCOL, V45, P52, DOI 10.1016/j.oraloncology.2008.03.010; Chang KP, 2012, J NUCL MED, V53, P21, DOI 10.2967/jnumed.111.090696; Delbeke D, 2006, J NUCL MED, V47, P885; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fleming ID, 1997, AJCC CANC STAGING MA, P31; Haber RS, 1998, CANCER, V83, P34, DOI 10.1002/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E; Higashi K, 2002, J NUCL MED, V43, P39; Ho J H, 1978, IARC Sci Publ, P99; Hua YJ, 2012, EUR J CANCER, V48, P3422, DOI 10.1016/j.ejca.2012.06.016; Kaira K, 2010, J CLIN ONCOL, V28, P3746, DOI 10.1200/JCO.2009.27.4662; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Kitagawa Y, 2003, EUR J NUCL MED MOL I, V30, P63, DOI 10.1007/s00259-002-0978-z; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Lee SW, 2008, RADIOTHER ONCOL, V87, P211, DOI 10.1016/j.radonc.2008.01.009; Leung SF, 2003, CLIN CANCER RES, V9, P3431; Leung SF, 2006, J CLIN ONCOL, V24, P5414, DOI 10.1200/JCO.2006.07.7982; Lin JC, 2007, INT J RADIAT ONCOL, V68, P1342, DOI 10.1016/j.ijrobp.2007.02.012; Liu SF, 2013, CARCINOGENESIS, V34, P627, DOI 10.1093/carcin/bgs364; Liu T, 2007, RADIOTHER ONCOL, V85, P327, DOI 10.1016/j.radonc.2007.11.002; Lo YMD, 1999, CANCER RES, V59, P1188; Lo YMD, 1999, CANCER RES, V59, P5452; MIN HQ, 1994, INT J RADIAT ONCOL, V30, P1037; Minn H, 1997, J NUCL MED, V38, P1907; Le QT, 2013, CLIN CANCER RES, V19, P2208, DOI 10.1158/1078-0432.CCR-12-3702; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Ayala FRR, 2010, MOLECULES, V15, P2374, DOI 10.3390/molecules15042374; Seol YM, 2010, ACTA ONCOL, V49, P201, DOI 10.3109/02841860903440270; Shao JY, 2004, CANCER, V100, P1162, DOI 10.1002/cncr.20099; Shotelersuk K, 2000, CLIN CANCER RES, V6, P1046; Wang WY, 2010, CLIN CANCER RES, V16, P1016, DOI 10.1158/1078-0432.CCR-09-2796; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wei WI, 2004, HEAD NECK-J SCI SPEC, V26, P878, DOI 10.1002/hed.20066; Wildeman MA, 2012, CLIN CANCER RES, V18, P5061, DOI 10.1158/1078-0432.CCR-12-0574; Yang XS, 2015, INT J CANCER, V136, pE127, DOI 10.1002/ijc.29192; Yen TC, 2006, INT J RADIAT ONCOL, V65, P1307, DOI 10.1016/j.ijrobp.2006.02.031; Yip TTC, 2014, ORAL ONCOL, V50, P527, DOI 10.1016/j.oraloncology.2013.12.011; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	46	25	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122756	10.1371/journal.pone.0122756	http://dx.doi.org/10.1371/journal.pone.0122756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853677	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400080
J	Cinget, B; Gerardi, S; Beaulieu, J; Bousquet, J				Cinget, Benjamin; Gerardi, Sebastien; Beaulieu, Jean; Bousquet, Jean			Less Pollen-Mediated Gene Flow for More Signatures of Glacial Lineages: Congruent Evidence from Balsam Fir cpDNA and mtDNA for Multiple Refugia in Eastern and Central North America	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MINISATELLITE; PINE PINUS-BANKSIANA; TAGGED-SITE MARKERS; SPRUCE BUDWORM; ABIES PINACEAE; CHLOROPLAST MICROSATELLITES; BLACK SPRUCE; WHITE SPRUCE; PHYLOGEOGRAPHIC STRUCTURE; POSTGLACIAL COLONIZATION	The phylogeographic structure and postglacial history of balsam fir (Abies balsamea), a transcontinental North American boreal conifer, was inferred using mitochondrial DNA (mtDNA) and chloroplast DNA (cpDNA) markers. Genetic structure among 107 populations (mtDNA data) and 75 populations (cpDNA data) was analyzed using Bayesian and genetic distance approaches. Population differentiation was high for mtDNA (dispersed by seeds only), but also for cpDNA (dispersed by seeds and pollen), indicating that pollen gene flow is more restricted in balsam fir than in other boreal conifers. Low cpDNA gene flow in balsam fir may relate to low pollen production due to the inherent biology of the species and populations being decimated by recurrent spruce budworm epidemics, and/or to low dispersal of pollen grains due to their peculiar structural properties. Accordingly, a phylogeographic structure was detected using both mtDNA and cpDNA markers and population structure analyses supported the existence of at least five genetically distinct glacial lineages in central and eastern North America. Four of these would originate from glacial refugia located south of the Laurentide ice sheet, while the last one would have persisted in the northern Labrador region. As expected due to reduced pollen-mediated gene flow, congruence between the geographic distribution of mtDNA and cpDNA lineages was higher than in other North American conifers. However, concordance was not complete, reflecting that restricted but nonetheless detectable cpDNA gene flow among glacial lineages occurred during the Holocene. As a result, new cpDNA and mtDNA genome combinations indicative of cytoplasmic genome capture were observed.	[Cinget, Benjamin; Gerardi, Sebastien; Beaulieu, Jean; Bousquet, Jean] Univ Laval, Canada Res Chair Forest & Environm Genom, Ctr Forest Res, Quebec City, PQ, Canada; [Cinget, Benjamin; Gerardi, Sebastien; Beaulieu, Jean; Bousquet, Jean] Univ Laval, Inst Syst & Integrat Biol, Quebec City, PQ, Canada; [Beaulieu, Jean] Nat Resources Canada, Canadian Wood Fibre Ctr, Quebec City, PQ, Canada	Laval University; Laval University; Natural Resources Canada	Bousquet, J (corresponding author), Univ Laval, Canada Res Chair Forest & Environm Genom, Ctr Forest Res, Quebec City, PQ, Canada.	jean.bousquet@sbf.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [46273]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by Natural Sciences and Engineering Research Council of Canada, grant number 46273, http://www.nserc-crsng.gc.ca/index_eng.asp, to J. Bousquet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Planter E, 2012, MOL PHYLOGENET EVOL, V62, P263, DOI 10.1016/j.ympev.2011.09.021; [Anonymous], 1971, ATLAS US TREES; BAGNELL CR, 1975, REV PALAEOBOT PALYNO, V19, P203, DOI 10.1016/0034-6667(75)90041-X; Bagnell CRJ, 1974, POLLEN MORPHOLOGY AB; Bagnoli F., 2011, Genetics, genomics and breeding of conifers, P141; BAKUZIS EV, 1965, BALSAM FIR MONOGRAPH; Bartlein PJ, 1998, QUATERNARY SCI REV, V17, P549, DOI 10.1016/S0277-3791(98)00012-2; Baskerville GL, 1979, DEP ENV CAN FOR SERV; BENNETT KD, 1985, J BIOGEOGR, V12, P147, DOI 10.2307/2844838; BIRKS HJB, 1981, QUATERNARY RES, V16, P322, DOI 10.1016/0033-5894(81)90015-6; Blais J.R., 1985, P49; BLAIS J. R., 1952, CANADIAN JOUR ZOOL, V30, P1, DOI 10.1139/z52-001; BLAIS JR, 1981, CAN J FOREST RES, V11, P620, DOI 10.1139/x81-085; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chapco W, 2002, GENOME, V45, P313, DOI 10.1139/G01-156; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Clark CM, 2000, AM J BOT, V87, P774, DOI 10.2307/2656885; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colbeck GJ, 2008, J HERED, V99, P453, DOI 10.1093/jhered/esn025; Corander J., 2009, BAPS BAYESIAN ANAL P; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Cutler PI, 2001, GEOLOGY, V29, P1039, DOI 10.1130/0091-7613(2001)029<1039:IOTGLO>2.0.CO;2; de Lafontaine G, 2010, ECOSYSTEMS, V13, P932, DOI 10.1007/s10021-010-9366-x; de Lafontaine G, 2010, J BIOGEOGR, V37, P741, DOI 10.1111/j.1365-2699.2009.02241.x; DiGiovanni F, 1996, FOREST ECOL MANAG, V83, P87, DOI 10.1016/0378-1127(95)03691-1; Du FK, 2009, MOL ECOL, V18, P1396, DOI 10.1111/j.1365-294X.2009.04107.x; DUPONT A, 1991, CAN J FOREST RES, V21, P1752, DOI 10.1139/x91-242; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; Eisenhut G, 1961, UNTERSUCHUNGEN MORPH; Ennos RA, 1999, SYST ASSOC SPEC VOL, V57, P1; Excoffier L, 2006, ANNU REV ECOL EVOL S, V40, P481; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farrar J, 1996, NATURAL RESOURCES; Frank R.M., 1990, ABIES BALSAMEA, VVolume 1; Frank RM, 1973, SILVICULTURAL GUIDE; Gerardi S, 2010, MOL ECOL, V19, P5265, DOI 10.1111/j.1365-294X.2010.04881.x; Godbout J, 2005, MOL ECOL, V14, P3497, DOI 10.1111/j.1365-294X.2005.02674.x; Godbout J, 2008, MOL ECOL, V17, P2463, DOI 10.1111/j.1365-294X.2008.03761.x; Godbout J, 2012, ECOL EVOL, V2, P1853, DOI 10.1002/ece3.294; Godbout J, 2010, AM J BOT, V97, P1903, DOI 10.3732/ajb.1000148; Gugger PF, 2008, J BIOGEOGR, V35, P1665, DOI 10.1111/j.1365-2699.2008.01915.x; Hansen OK, 2005, TREE GENET GENOMES, V1, P116, DOI 10.1007/s11295-005-0016-y; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heilveil JS, 2006, MOL ECOL, V15, P1627, DOI 10.1111/j.1365-294X.2006.02876.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Isoda K, 2000, SILVAE GENET, V49, P161; Ives W.G.H., 1995, FOREST INSECT PESTS, P95; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Jackson ST, 1997, QUATERNARY SCI REV, V16, P1, DOI 10.1016/S0277-3791(96)00047-9; Jaramillo-Correa JP, 2003, THEOR APPL GENET, V106, P1353, DOI 10.1007/s00122-002-1174-z; Jaramillo-Correa JP, 2004, MOL ECOL, V13, P2735, DOI 10.1111/j.1365-294X.2004.02258.x; Jaramillo-Correa JP, 2008, MOL ECOL, V17, P2476, DOI 10.1111/j.1365-294X.2008.03762.x; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Kleman J, 1999, NATURE, V402, P63, DOI 10.1038/47005; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Laroche J, 1997, P NATL ACAD SCI USA, V94, P5722, DOI 10.1073/pnas.94.11.5722; Lemieux MJ, 2008, CAN J FOREST RES, V41, P1047; MACLEAN DA, 1984, FOREST CHRON, V60, P273, DOI 10.5558/tfc60273-5; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Nagylaki T, 1998, GENETICS, V148, P1325; Neale D, 1998, GENETIC MANIPULATION, P251; NIKLAS KJ, 1984, AM J BOT, V71, P356, DOI 10.2307/2443495; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Parducci L, 2001, THEOR APPL GENET, V102, P733, DOI 10.1007/s001220051704; Perron M, 2000, P NATL ACAD SCI USA, V97, P11331, DOI 10.1073/pnas.200417097; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Potter KM, 2008, CAN J FOREST RES, V38, P2128, DOI 10.1139/X08-064; Potter KM, 2010, CONSERV GENET, V11, P1499, DOI 10.1007/s10592-009-9980-3; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Prunier J, 2012, MOL ECOL, V21, P4270, DOI 10.1111/j.1365-294X.2012.05691.x; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Searcy J.L., 1984, AGR HDB USDA, V620, P83; Semerikova SA, 2011, J BIOGEOGR, V38, P326, DOI 10.1111/j.1365-2699.2010.02394.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Shaw J, 2006, QUATERNARY SCI REV, V25, P2059, DOI 10.1016/j.quascirev.2006.03.002; Simard I, 2006, HOLOCENE, V16, P31, DOI 10.1191/0959683606hl904rp; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Su Q, 1996, CAN J FOREST RES, V26, P1620, DOI 10.1139/x26-182; TAKAHATA N, 1985, GENETICS, V109, P441; Tremblay NO, 1999, MOL ECOL, V8, P1187, DOI 10.1046/j.1365-294x.1999.00680.x; Tsumura Y, 1998, EVOLUTION, V52, P1031, DOI [10.1111/j.1558-5646.1998.tb01831.x, 10.2307/2411234]; VANZANT K, 1979, QUATERNARY RES, V12, P358, DOI 10.1016/0033-5894(79)90034-6; Vendramin GG, 1997, GENOME, V40, P857, DOI 10.1139/g97-811; Vendramin GG, 1999, MOL ECOL, V8, P1117, DOI 10.1046/j.1365-294x.1999.00666.x; Vendramin GG, 1996, MOL ECOL, V5, P595, DOI 10.1111/j.1365-294X.1996.tb00353.x; Verity R, 2014, MOL ECOL, V23, P4216, DOI 10.1111/mec.12856; Walter R, 2001, MOL ECOL, V10, P103, DOI 10.1046/j.1365-294X.2001.01177.x; Wei XX, 2011, TREE GENET GENOMES, V7, P1025, DOI 10.1007/s11295-011-0392-4; Weir B. S., 1996, GENETIC DATA ANAL; Weir G.H., 1977, PALYNOL, V1, P157; Williams CG, 2009, CONIFER REPRODUCTIVE BIOLOGY, P3; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; WINKLER MG, 1986, QUATERNARY RES, V25, P235, DOI 10.1016/0033-5894(86)90060-8; Wu JY, 1998, GENETICS, V150, P1605; Xiang QP, 2009, TAXON, V58, P141, DOI 10.1002/tax.581015	104	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122815	10.1371/journal.pone.0122815	http://dx.doi.org/10.1371/journal.pone.0122815			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849816	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800163
J	Maguire, CP; Lize, A; Price, TAR				Maguire, Chris P.; Lize, Anne; Price, Tom A. R.			Assessment of Rival Males through the Use of Multiple Sensory Cues in the Fruitfly Drosophila pseudoobscura	PLOS ONE			English	Article							MATING RIVALS; COPULATION; PERCEPTION; EVOLUTION; COURTSHIP; RESPONSES; SYSTEMS	Environments vary stochastically, and animals need to behave in ways that best fit the conditions in which they find themselves. The social environment is particularly variable, and responding appropriately to it can be vital for an animal's success. However, cues of social environment are not always reliable, and animals may need to balance accuracy against the risk of failing to respond if local conditions or interfering signals prevent them detecting a cue. Recent work has shown that many male Drosophila fruit flies respond to the presence of rival males, and that these responses increase their success in acquiring mates and fathering offspring. In Drosophila melanogaster males detect rivals using auditory, tactile and olfactory cues. However, males fail to respond to rivals if any two of these senses are not functioning: a single cue is not enough to produce a response. Here we examined cue use in the detection of rival males in a distantly related Drosophila species, D. pseudoobscura, where auditory, olfactory, tactile and visual cues were manipulated to assess the importance of each sensory cue singly and in combination. In contrast to D. melanogaster, male D. pseudoobscura require intact olfactory and tactile cues to respond to rivals. Visual cues were not important for detecting rival D. pseudoobscura, while results on auditory cues appeared puzzling. This difference in cue use in two species in the same genus suggests that cue use is evolutionarily labile, and may evolve in response to ecological or life history differences between species.	[Maguire, Chris P.; Price, Tom A. R.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Lize, Anne] Univ Rennes 1, UMR ECOBIO 6553, Rennes, France	University of Liverpool; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes	Price, TAR (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	Tom.Price@liverpool.ac.uk	Lizé, Anne/B-9897-2011	Lizé, Anne/0000-0002-7289-4205; Price, Thomas/0000-0002-4394-6301	Natural Environment Research Council [NE/H015604/1]; NERC [NE/H015604/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (www.nerc.ac.uk), which was not directly involved in the work in any way (grant NE/H015604/1 to TP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1990, ETHOL SOCIOBIOL, V11, P241, DOI 10.1016/0162-3095(90)90012-U; Andersson Malte, 1994; ARMSTRONG DP, 1991, BEHAV ECOL SOCIOBIOL, V29, P103, DOI 10.1007/BF00166484; Billeter JC, 2013, CURR OPIN NEUROBIOL, V23, P17, DOI 10.1016/j.conb.2012.08.009; Bourdeau PE, 2013, ECOLOGY, V94, P1449, DOI 10.1890/12-2116.1; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bretman A, 2013, EVOLUTION, V67, P2413, DOI 10.1111/evo.12125; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Bretman A, 2011, CURR BIOL, V21, P617, DOI 10.1016/j.cub.2011.03.008; Bretman A, 2009, P ROY SOC B-BIOL SCI, V276, P1705, DOI 10.1098/rspb.2008.1878; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; David JR, 2005, HEREDITY, V94, P3, DOI 10.1038/sj.hdy.6800562; delBarco-Trillo J, 2004, NATURE, V431, P446, DOI 10.1038/nature02845; Fernandez MP, 2013, J COMP PHYSIOL A, V199, P1065, DOI 10.1007/s00359-013-0851-5; Garbaczewska M, 2012, J INSECT PHYSIOL, V59, P306; Gray SJ, 2002, ANIM BEHAV, V63, P531, DOI 10.1006/anbe.2001.1932; Grether GF, 2011, INTEGR COMP BIOL, V51, P807, DOI 10.1093/icb/icr060; Huijbers CM, 2012, ECOLOGY, V93, P46, DOI 10.1890/10-2236.1; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jukema J, 2006, BIOL LETTERS, V2, P161, DOI 10.1098/rsbl.2005.0416; Karlsson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012755; Kim WJ, 2012, NAT NEUROSCI, V15, P876, DOI 10.1038/nn.3104; Lize A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0631; Lize A, 2012, PHYSIOL ENTOMOL, V37, P227, DOI 10.1111/j.1365-3032.2012.00836.x; Lize A, 2012, BIOL LETTERS, V8, P35, DOI 10.1098/rsbl.2011.0544; Markow T.A., 2005, DROSOPHILA GUIDE SPE; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Paaby AB, 2009, FLY, V3, P29, DOI 10.4161/fly.3.1.7771; Panhuis TM, 1999, BEHAV ECOL SOCIOBIOL, V46, P221, DOI 10.1007/s002650050613; Pitnick S, 1997, EVOLUTION, V51, P833, DOI [10.2307/2411158, 10.1111/j.1558-5646.1997.tb03665.x]; Popov A V, 2004, Zh Evol Biokhim Fiziol, V40, P521; Price TAR, 2012, BEHAV ECOL SOCIOBIOL, V66, P561, DOI 10.1007/s00265-011-1304-1; Price TAR, 2012, J INSECT PHYSIOL, V58, P1669, DOI 10.1016/j.jinsphys.2012.10.008; Rypstra AL, 2009, ANIM BEHAV, V77, P937, DOI 10.1016/j.anbehav.2008.12.026; Santangelo N, 2002, BEHAV ECOL, V13, P676, DOI 10.1093/beheco/13.5.676; Seetharam AS, 2013, PEERJ, V1, DOI 10.7717/peerj.226; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Spottiswoode CN, 2012, AM NAT, V179, P633, DOI 10.1086/665031; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Thibert-Plante X, 2013, ECOL LETT, V16, P1004, DOI 10.1111/ele.12131; Turner TL, 2012, GENETICS, V191, P633, DOI 10.1534/genetics.112.139337; WALDMAN B, 1987, J THEOR BIOL, V128, P159, DOI 10.1016/S0022-5193(87)80167-4; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Zuk M, 2014, ANNU REV ENTOMOL, V59, P321, DOI 10.1146/annurev-ento-011613-162014	45	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123058	10.1371/journal.pone.0123058	http://dx.doi.org/10.1371/journal.pone.0123058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849643	Green Published, gold, Green Submitted			2022-12-27	WOS:000352477800199
J	Mi, G; Di, YM				Mi, Gu; Di, Yanming			The Level of Residual Dispersion Variation and the Power of Differential Expression Tests for RNA-Seq Data	PLOS ONE			English	Article							BIOCONDUCTOR	RNA-Sequencing (RNA-Seq) has been widely adopted for quantifying gene expression changes in comparative transcriptome analysis. For detecting differentially expressed genes, a variety of statistical methods based on the negative binomial (NB) distribution have been proposed. These methods differ in the ways they handle the NB nuisance parameters (i.e., the dispersion parameters associated with each gene) to save power, such as by using a dispersion model to exploit an apparent relationship between the dispersion parameter and the NB mean. Presumably, dispersion models with fewer parameters will result in greater power if the models are correct, but will produce misleading conclusions if not. This paper investigates this power and robustness trade-off by assessing rates of identifying true differential expression using the various methods under realistic assumptions about NB dispersion parameters. Our results indicate that the relative performances of the different methods are closely related to the level of dispersion variation unexplained by the dispersion model. We propose a simple statistic to quantify the level of residual dispersion variation from a fitted dispersion model and show that the magnitude of this statistic gives hints about whether and how much we can gain statistical power by a dispersion-modeling approach.	[Mi, Gu; Di, Yanming] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA; [Di, Yanming] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Mi, G (corresponding author), Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA.	neo.migu@gmail.com	Mi, Gu/M-6559-2015	Mi, Gu/0000-0001-8778-954X	National Institute of General Medical Sciences of the National Institutes of Health [R01GM104977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104977] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	YD and GM were supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM104977. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, R LANG ENV STAT COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Chen YS, 2014, FRONT PROBAB STAT SC, P51, DOI 10.1007/978-3-319-07212-8_3; Di Y, 2014, STAT ITS IN IN PRESS; Di YM, 2013, STAT APPL GENET MOL, V12, DOI 10.1515/sagmb-2012-0071; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hsu PY, 2013, ELIFE, V2, DOI 10.7554/eLife.00473; Huber W, 2011, GENOME RES; Landau WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081415; Laplace PS, 1986, STAT SCI, V1, P621, DOI DOI 10.1214/SS/1177013621; Li SYS, 2005, STAT MED, V24, P2267, DOI 10.1002/sim.2119; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lund SP, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1826; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McCullagh P, 1989, GEN LINEAR MODELS; Mi G, 2015, PLOS ONE, V10; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ramsey F., 2012, STAT SLEUTH COURSE M; Risso D, 2014, FRONT PROBAB STAT SC, P169, DOI 10.1007/978-3-319-07212-8_9; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Veneman WJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-255; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu H, 2013, BIOSTATISTICS, V14, P232, DOI 10.1093/biostatistics/kxs033; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310	38	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120117	10.1371/journal.pone.0120117	http://dx.doi.org/10.1371/journal.pone.0120117			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849826	gold, Green Published, Green Submitted			2022-12-27	WOS:000352477800020
J	Aybek, S; Nicholson, TR; O'Daly, O; Zelaya, F; Kanaan, RA; David, AS				Aybek, Selma; Nicholson, Timothy R.; O'Daly, Owen; Zelaya, Fernando; Kanaan, Richard A.; David, Anthony S.			Emotion-Motion Interactions in Conversion Disorder: An fMRI Study	PLOS ONE			English	Article							MOTOR INHIBITION; LIFE EVENTS; PAIN; PROJECTIONS; FEAR	Objectives To evaluate the neural correlates of implicit processing of negative emotions in motor conversion disorder (CD) patients. Methods An event related fMRI task was completed by 12 motor CD patients and 14 matched healthy controls using standardised stimuli of faces with fearful and sad emotional expressions in comparison to faces with neutral expressions. Temporal changes in the sensitivity to stimuli were also modelled and tested in the two groups. Results We found increased amygdala activation to negative emotions in CD compared to healthy controls in region of interest analyses, which persisted over time consistent with previous findings using emotional paradigms. Furthermore during whole brain analyses we found significantly increased activation in CD patients in areas involved in the 'freeze response' to fear (periaqueductal grey matter), and areas involved in self-awareness and motor control (cingulate gyrus and supplementary motor area). Conclusions In contrast to healthy controls, CD patients exhibited increased response amplitude to fearful stimuli over time, suggesting abnormal emotional regulation (failure of habituation / sensitization). Patients with CD also activated midbrain and frontal structures that could reflect an abnormal behavioral-motor response to negative including threatening stimuli. This suggests a mechanism linking emotions to motor dysfunction in CD.	[Aybek, Selma; Nicholson, Timothy R.; David, Anthony S.] Kings Coll London, Inst Psychiat, Sect Cognit Neuropsychiat, London SE5 8AF, England; [Aybek, Selma] Univ Geneva, Lab Behav Neurol & Imaging Cognit Fundamental Neu, Geneva, Switzerland; [O'Daly, Owen; Zelaya, Fernando] Kings Coll London, Inst Psychiat, Dept Neuroimaging, London SE5 8AF, England; [Kanaan, Richard A.] Univ Melbourne, Austin Hlth, Dept Psychiat, Heidelberg, Vic 3084, Australia	University of London; King's College London; University of Geneva; University of London; King's College London; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Aybek, S (corresponding author), Kings Coll London, Inst Psychiat, Sect Cognit Neuropsychiat, London SE5 8AF, England.	selma.aybek@unige.ch	; David, Anthony/C-1315-2011; aybek, selma/G-7836-2016	Nicholson, Timothy/0000-0002-2350-2332; David, Anthony/0000-0003-0967-774X; Edwards, Anthony David/0000-0003-4801-7066; aybek, selma/0000-0002-7877-6760; Zelaya, Fernando/0000-0002-9525-1560	UK Medical Research Council Milstein Grant; Boursiere d'Excellence grant (University of Geneva); National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at the South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; NIHR; MRC; Medical Research Council [MR/J004162/1, G0701055] Funding Source: researchfish; National Institute for Health Research [CL-2009-17-006] Funding Source: researchfish; MRC [G0701055, MR/J004162/1] Funding Source: UKRI	UK Medical Research Council Milstein Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boursiere d'Excellence grant (University of Geneva); National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at the South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by a UK Medical Research Council Milstein Grant. S.A. was supported by the Boursiere d'Excellence grant (University of Geneva). T.R.N. and A.S.D. were supported by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and the Institute of Psychiatry, King's College London. F.Z. received funding support from NIHR and the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPHS R, 1995, J NEUROSCI, V15, P5879; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; An X, 1998, J COMP NEUROL, V401, P455; Aybek S, 2010, J PSYCHOSOM RES, V68, P606; Aybek S, 2014, JAMA PSYCHIAT, V71, P52, DOI 10.1001/jamapsychiatry.2013.2842; Bakvis P, 2010, EPILEPSIA, V51, P752, DOI 10.1111/j.1528-1167.2009.02394.x; Bakvis P, 2009, EPILEPSY BEHAV, V16, P558, DOI 10.1016/j.yebeh.2009.09.006; Brown G., 1978, SOCIAL ORIGINS DEPRE; Bryant RA, 2011, J ABNORM PSYCHOL, P1, DOI [10. 1037/ a0020797, DOI 10.1037/A0020797]; Bushnell MC, 2013, NAT REV NEUROSCI, V14, P502, DOI 10.1038/nrn3516; Bzdok D, 2013, HUM BRAIN MAPP, V34, P3247, DOI 10.1002/hbm.22138; Cojan Y, 2009, NEUROIMAGE, V47, P1026, DOI 10.1016/j.neuroimage.2009.05.023; Demenescu LR, 2011, PSYCHOL MED, V41, P2253, DOI 10.1017/S0033291711000596; Diedrichsen J, 2005, NEUROIMAGE, V27, P624, DOI 10.1016/j.neuroimage.2005.04.039; Edwards MJ, 2012, BRAIN, V135, P3495, DOI 10.1093/brain/aws129; Hermans EJ, 2013, NEUROIMAGE, V66, P278, DOI 10.1016/j.neuroimage.2012.10.063; HORVATH T, 1980, AM J PSYCHIAT, V137, P217; Kanaan RAA, 2007, PSYCHOSOM MED, V69, P202, DOI 10.1097/PSY.0b013e31802e4297; Kozlowska K, 2013, PSYCHOSOM MED, V75, P272, DOI 10.1097/PSY.0b013e318286be43; Kozlowska Kasia, 2007, Clin Child Psychol Psychiatry, V12, P487, DOI 10.1177/1359104507080977; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Mailis-Gagnon A, 2003, NEUROLOGY, V60, P1501, DOI 10.1212/WNL.60.9.1501; Maizels M, 2012, HEADACHE, V52, P1553, DOI 10.1111/j.1526-4610.2012.02209.x; Marshall JC, 1997, COGNITION, V64, pB1, DOI 10.1016/S0010-0277(97)00020-6; Mattavelli G., 2013, SOCIAL COGNITIVE AFF; Miquel TT, 2006, BRAIN RES, V1076, P42, DOI 10.1016/j.brainres.2005.12.095; Nelson H., 1991, NATL ADULT READING T; Sagaspe P, 2011, NEUROIMAGE, V55, P1825, DOI 10.1016/j.neuroimage.2011.01.027; Saj A, 2009, JAMA-J AM MED ASSOC, V302, P2552, DOI 10.1001/jama.2009.1834; Stone J, 2011, MOVEMENT DISORD, V26, P1787, DOI 10.1002/mds.23882; Surguladze SA, 2003, NEUROIMAGE, V19, P1317, DOI 10.1016/S1053-8119(03)00085-5; van Beilen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025918; van der Kruijs SJM, 2012, J NEUROL NEUROSUR PS, V83, P239, DOI 10.1136/jnnp-2011-300776; Voon V, 2010, NEUROLOGY, V74, P223, DOI 10.1212/WNL.0b013e3181ca00e9; Voon V, 2011, MOVEMENT DISORD, V26, P2396, DOI 10.1002/mds.23890; Voon V, 2010, BRAIN, V133, P1526, DOI 10.1093/brain/awq054; Werring DJ, 2004, PSYCHOL MED, V34, P583, DOI 10.1017/S0033291703008985; Worsley KJ, 2001, FUNCTIONAL MRI INTRO; Young AW, 2002, FACIAL EXPRESSIONS E; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	98	98	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123273	10.1371/journal.pone.0123273	http://dx.doi.org/10.1371/journal.pone.0123273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859660	gold, Green Published			2022-12-27	WOS:000352590300088
J	Ghosh, M; Dwyer-Nield, LD; Kwon, JB; Barthel, L; Janssen, WJ; Merrick, DT; Keith, RL				Ghosh, Moumita; Dwyer-Nield, Lori D.; Kwon, Jennifer B.; Barthel, Lea; Janssen, William J.; Merrick, Daniel T.; Keith, Robert L.			Tracheal Dysplasia Precedes Bronchial Dysplasia in Mouse Model of N-Nitroso Trischloroethylurea Induced Squamous Cell Lung Cancer	PLOS ONE			English	Article							AIRWAY STEM-CELLS; BASAL-CELLS; IN-VITRO; QUANTITATIVE ASSESSMENT; LESIONS; DIFFERENTIATION; EXPRESSION; CHEMOPREVENTION; MAINTENANCE; GROWTH	Squamous cell lung cancer (SCC) is the second leading cause of lung cancer death in the US and has a 5-year survival rate of only 16%. Histological changes in the bronchial epithelium termed dysplasia are precursors to invasive SCC. However, the cellular mechanisms that cause dysplasia are unknown. To fill this knowledge gap, we used topical application of N-nitroso-tris chloroethylurea (NTCU) for 32 weeks to induce squamous dysplasia and SCC in mice. At 32 weeks the predominant cell type in the dysplastic airways was Keratin (K) 5 and K14 expressing basal cells. Notably, basal cells are extremely rare in the normal mouse bronchial epithelium but are abundant in the trachea. We therefore evaluated time-dependent changes in tracheal and bronchial histopathology after NTCU exposure (4, 8, 12, 16, 25 and 32 weeks). We show that tracheal dysplasia occurs significantly earlier than that of the bronchial epithelium (12 weeks vs. 25 weeks). This was associated with increased numbers of K5(+)/K14(+) tracheal basal cells and a complete loss of secretory (Club cell secretory protein expressing CCSP+) and ciliated cells. TUNEL staining of NTCU treated tissues confirmed that the loss of CCSP+ and ciliated cells was not due to apoptosis. However, mitotic index (measured by bromodeoxyuridine incorporation) showed that NTCU treatment increased proliferation of K5(+) basal cells in the trachea, and altered bronchial mitotic population from CCSP+ to K5(+) basal cells. Thus, we demonstrate that NTCU-induced lung epithelial dysplasia starts in the tracheal epithelium, and is followed by basal cell metaplasia of the bronchial epithelium. This analysis extends our knowledge of the NTCU-SCC model by defining the early changes in epithelial cell phenotypes in distinct airway locations, and this may assist in identifying new targets for future chemoprevention studies.	[Ghosh, Moumita; Kwon, Jennifer B.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Dwyer-Nield, Lori D.] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Barthel, Lea; Janssen, William J.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Keith, Robert L.] Denver Veteran Affairs Med Ctr, Div Pulm Sci & Crit Care Med, Dept Med, Denver, CO USA; [Merrick, Daniel T.] Univ Colorado, Dept Pathol, Aurora, CO USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Ghosh, M (corresponding author), Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA.	ghoshm@njhealth.org			FAMRI [YCSA 113259]; NCI [R01 CA132552-05]; NIH [P50-CA058187]; Lung cancer prevention award [AWD 120560]; Department of Veterans Affairs;  [HL107686]; NATIONAL CANCER INSTITUTE [P50CA058187, R01CA132552] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109517, K18HL107686] Funding Source: NIH RePORTER	FAMRI; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lung cancer prevention award; Department of Veterans Affairs(US Department of Veterans Affairs); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the following funding: (HL107686, MG), FAMRI (YCSA 113259, MG), NCI R01 CA132552-05 (LDD), NIH SPORE in lung cancer (P50-CA058187, RLK, DTM), Lung cancer prevention award (AWD 120560, DTM) and Department of Veterans Affairs Merit Review program (RLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Banerjee AK, 2009, J THORAC ONCOL, V4, P545, DOI 10.1097/JTO.0b013e31819667bd; Brechbuhl HM, 2011, AM J PATHOL, V179, P367, DOI 10.1016/j.ajpath.2011.03.016; Cole BB, 2010, AM J PATHOL, V177, P362, DOI 10.2353/ajpath.2010.090870; Dakir ELH, 2008, CARCINOGENESIS, V29, P2377, DOI 10.1093/carcin/bgn190; Evans MJ, 2004, CLIN EXP ALLERGY, V34, P1131, DOI 10.1111/j.1365-2222.2004.02004.x; Ghosh M, 2013, STEM CELLS, V31, P2767, DOI 10.1002/stem.1440; Ghosh M, 2013, AM J RESP CELL MOL, V49, P1127, DOI 10.1165/rcmb.2013-0049OC; Ghosh M, 2011, AM J RESP CELL MOL, V45, P459, DOI 10.1165/rcmb.2010-0314OC; Ghosh M, 2011, AM J RESP CELL MOL, V45, P403, DOI 10.1165/rcmb.2010-0283OC; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Hudish TM, 2011, CANCER PREV RES, V5, P283; Ishida-Yamamoto A, 1998, EXP DERMATOL, V7, P1, DOI 10.1111/j.1600-0625.1998.tb00295.x; JETTEN AM, 1989, ENVIRON HEALTH PERSP, V80, P149, DOI 10.2307/3430740; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kelly K, 2009, CANCER PREV RES, V2, P440, DOI 10.1158/1940-6207.CAPR-08-0136; Khojasteh M, 2012, ANAL QUANT CYTOL, V34, P120; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lam S, 2006, CANCER EPIDEM BIOMAR, V15, P1526, DOI 10.1158/1055-9965.EPI-06-0128; Merrick DT, 2006, CLIN CANCER RES, V12, P2281, DOI 10.1158/1078-0432.CCR-05-2291; Miller YE, 2007, CANCER EPIDEM BIOMAR, V16, P2425, DOI 10.1158/1055-9965.EPI-07-0220; Nicholson AG, 2001, HISTOPATHOLOGY, V38, P202, DOI 10.1046/j.1365-2559.2001.01078.x; Ooi AT, 2010, CANCER RES, V70, P6639, DOI 10.1158/0008-5472.CAN-10-0455; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; REHM S, 1991, AM J PATHOL, V139, P413; Reynolds SD, 2010, INT J BIOCHEM CELL B, V42, P1, DOI 10.1016/j.biocel.2009.09.002; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Van Winkle LS, 2004, J APPL PHYSIOL, V97, P2355, DOI 10.1152/japplphysiol.00470.2004; Wang Y, 2004, CANCER RES, V64, P1647, DOI 10.1158/0008-5472.CAN-03-3273; Xiao ZX, 2013, CANCER CELL, V23, P527, DOI 10.1016/j.ccr.2013.03.009; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122823	10.1371/journal.pone.0122823	http://dx.doi.org/10.1371/journal.pone.0122823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860262	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300064
J	Han, XP; Wang, XW; Yan, XY; Wang, BH				Han, Xiao-Pu; Wang, Xiang-Wen; Yan, Xiao-Yong; Wang, Bing-Hong			Cascading Walks Model for Human Mobility Patterns	PLOS ONE			English	Article							SCALING LAWS; HEAVY TAILS; PREDICTABILITY	Background Uncovering the mechanism behind the scaling laws and series of anomalies in human trajectories is of fundamental significance in understanding many spatio-temporal phenomena. Recently, several models, e.g. the explorations-returns model (Song et al., 2010) and the radiation model for intercity travels (Simini et al., 2012), have been proposed to study the origin of these anomalies and the prediction of human movements. However, an agent-based model that could reproduce most of empirical observations without priori is still lacking. Methodology/Principal Findings In this paper, considering the empirical findings on the correlations of move-lengths and staying time in human trips, we propose a simple model which is mainly based on the cascading processes to capture the human mobility patterns. In this model, each long-range movement activates series of shorter movements that are organized by the law of localized explorations and preferential returns in prescribed region. Conclusions/Significance Based on the numerical simulations and analytical studies, we show more than five statistical characters that are well consistent with the empirical observations, including several types of scaling anomalies and the ultraslow diffusion properties, implying the cascading processes associated with the localized exploration and preferential returns are indeed a key in the understanding of human mobility activities. Moreover, the model shows both of the diverse individual mobility and aggregated scaling displacements, bridging the micro and macro patterns in human mobility. In summary, our model successfully explains most of empirical findings and provides deeper understandings on the emergence of human mobility patterns.	[Han, Xiao-Pu] Hangzhou Normal Univ, Inst Informat Econ, Hangzhou 311121, Zhejiang, Peoples R China; [Han, Xiao-Pu; Yan, Xiao-Yong] Hangzhou Normal Univ, Alibaba Res Ctr Complex Sci, Hangzhou 311121, Zhejiang, Peoples R China; [Wang, Xiang-Wen] Virginia Polytech Inst & State Univ, Dept Phys, Blacksburg, VA 24061 USA; [Wang, Xiang-Wen; Wang, Bing-Hong] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Yan, Xiao-Yong] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China; [Yan, Xiao-Yong] Shijiazhuang Tiedao Univ, Dept Transportat Engn, Shijiazhuang 050043, Peoples R China; [Yan, Xiao-Yong] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610051, Peoples R China	Hangzhou Normal University; Hangzhou Normal University; Virginia Polytechnic Institute & State University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing Normal University; Shijiazhuang Tiedao University; University of Electronic Science & Technology of China	Han, XP (corresponding author), Hangzhou Normal Univ, Inst Informat Econ, Hangzhou 311121, Zhejiang, Peoples R China.	xp@hznu.edu.cn	Yan, Xiao-Yong/P-6027-2018; Wang, Xiangwen/AAR-6326-2021; Han, Xiao-Pu/E-8401-2010	Yan, Xiao-Yong/0000-0003-2091-6967; Wang, Xiangwen/0000-0002-4755-4639	National Natural Science Foundation of China [11205040, 11105024, 61304177, 11305043, 11275186]; Zhejiang Provincial Natural Science Foundation of China [LY12A05003]; Hangzhou Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Hangzhou Normal University	This work is supported by the National Natural Science Foundation of China (11205040, 11105024, 61304177, 11305043, 11275186), and the Zhejiang Provincial Natural Science Foundation of China under the grant No. LY12A05003, and the research startup fund of Hangzhou Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; De Domenico M, 2013, PERVASIVE MOB COMPUT, V9, P798, DOI 10.1016/j.pmcj.2013.07.008; Gallotti R, 2013, INT J MOD PHYS C, V24, DOI 10.1142/S0129183113920010; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Grabowicz PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092196; Han XP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036117; Horner MW., 2001, J TRANSP GEOGR, V9, P255, DOI DOI 10.1016/S0966-6923(01)00019-9; Jia T, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11024; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Lee K, 2009, IEEE INFOCOM SER, P855, DOI 10.1109/INFCOM.2009.5061995; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Ni SJ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016111; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Peng CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034487; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Rhe I., 2008, P IEEE INFOCOM, P924; Rybski D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00560; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sinatra R, 2014, ENTROPY-SWITZ, V16, P543, DOI 10.3390/e16010543; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Veneziano D, ARXIV11013719; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021197; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Wang XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084954; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678; Yan XY, 2011, CHINESE PHYS LETT, V28, DOI 10.1088/0256-307X/28/12/120506; Zhao ZD, 2012, CHAOS, V22, DOI 10.1063/1.4730750; Zheng Y., 2009, P 18 INT C WORLD WID, P791, DOI DOI 10.1145/1526709.1526816; Zheng Y, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P312, DOI 10.1145/1409635.1409677	43	1	2	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0124800	10.1371/journal.pone.0124800	http://dx.doi.org/10.1371/journal.pone.0124800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860140	gold, Green Published, Green Submitted			2022-12-27	WOS:000352590300147
J	Lambert, D; Carrillo, CD; Koziol, AG; Manninger, P; Blais, BW				Lambert, Dominic; Carrillo, Catherine D.; Koziol, Adam G.; Manninger, Paul; Blais, Burton W.			GeneSippr: A Rapid Whole-Genome Approach for the Identification and Characterization of Foodborne Pathogens such as Priority Shiga Toxigenic Escherichia coli	PLOS ONE			English	Article							VIRULENCE; SEQUENCE; SURVEILLANCE; OUTBREAK; SYSTEM; O26	The timely identification and characterization of foodborne bacteria for risk assessment purposes is a key operation in outbreak investigations. Current methods require several days and/or provide low-resolution characterization. Here we describe a whole-genome-sequencing (WGS) approach (GeneSippr) enabling same-day identification of colony isolates recovered from investigative food samples. The identification of colonies of priority Shiga-toxigenic Escherichia coli (STEC) (i.e., serogroups O26, O45, O103, O111, O121, O145 and O157) served as a proof of concept. Genomic DNA was isolated from single colonies and sequencing was conducted on the Illumina MiSeq instrument with raw data sampling from the instrument following 4.5 hrs of sequencing. Modeling experiments indicated that datasets comprised of 21-nt reads representing approximately 4-fold coverage of the genome were sufficient to avoid significant gaps in sequence data. A novel bioinformatic pipeline was used to identify the presence of specific marker genes based on mapping of the short reads to reference sequence libraries, along with the detection of dispersed conserved genomic markers as a quality control metric to assure the validity of the analysis. STEC virulence markers were correctly identified in all isolates tested, and single colonies were identified within 9 hrs. This method has the potential to produce high-resolution characterization of STEC isolates, and whole-genome sequence data generated following the GeneSippr analysis could be used for isolate identification in place of lengthy biochemical characterization and typing methodologies. Significant advantages of this procedure include ease of adaptation to the detection of any gene marker of interest, as well as to the identification of other foodborne pathogens for which genomic markers have been defined.	[Lambert, Dominic; Carrillo, Catherine D.; Koziol, Adam G.; Manninger, Paul; Blais, Burton W.] Canadian Food Inspect Agcy, Sci Branch, Ottawa Lab Carling, Res & Dev, Ottawa, ON, Canada	Canadian Food Inspection Agency	Blais, BW (corresponding author), Canadian Food Inspect Agcy, Sci Branch, Ottawa Lab Carling, Res & Dev, Ottawa, ON, Canada.	Burton.Blais@inspection.gc.ca	Carrillo, Catherine/X-2714-2019	Carrillo, Catherine/0000-0002-2334-8718	Canadian Safety and Security Program [CSSP-2013-TI-1145]	Canadian Safety and Security Program	The sequencing instrument was purchased through funding provided by the Canadian Safety and Security Program (CSSP-2013-TI-1145). Budget for materials and reagents was provided by the Canadian Food Inspection Agency, technology development funds.	Aurass P, 2011, ENVIRON MICROBIOL, V13, P3139, DOI 10.1111/j.1462-2920.2011.02604.x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bielaszewska M, 2013, CLIN INFECT DIS, V56, P1373, DOI 10.1093/cid/cit055; Blais BW, 2012, J FOOD PROTECT, V75, P1691, DOI 10.4315/0362-028X.JFP-12-116; Deer DM, 2010, LETT APPL MICROBIOL, V50, P366, DOI 10.1111/j.1472-765X.2010.02804.x; Delannoy S, 2013, J CLIN MICROBIOL, V51, P1083, DOI 10.1128/JCM.02864-12; den Bakker HC, 2014, EMERG INFECT DIS, V20, P1306, DOI 10.3201/eid2008.131399; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Eklund M, 2002, J CLIN MICROBIOL, V40, P4585, DOI 10.1128/JCM.40.12.4585-4593.2002; Eppinger M, 2015, GUT MICROBES, V6, P194, DOI 10.4161/19490976.2014.969979; Evans PS, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01154-13; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Franz E, 2014, INT J FOOD MICROBIOL, V187, P57, DOI 10.1016/j.ijfoodmicro.2014.07.002; Gill A, 2012, J FOOD PROTECT, V75, P827, DOI 10.4315/0362-028X.JFP-11-395; Gilmour MW, 2006, J CLIN MICROBIOL, V44, P449, DOI 10.1128/JCM.44.2.449-458.2006; Gordon A, 2010, FASTX TOOLKIT FASTQA; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Huszczynski G, 2013, J FOOD PROTECT, V76, P1689, DOI 10.4315/0362-028X.JFP-13-059; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Lamble S, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-104; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leekitcharoenphon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087991; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Martinez-Perez A, 2010, FOOD CONTROL, V21, P1354, DOI 10.1016/j.foodcont.2010.04.009; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Postingl H., SEQUENCE MAPPING ALI; Prager R, 2005, INT J MED MICROBIOL, V295, P29, DOI 10.1016/j.ijmm.2004.12.009; Prager R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095379; Schmid D, 2014, CLIN MICROBIOL INFEC, V20, P431, DOI 10.1111/1469-0691.12638; Shringi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051572; Shringi S, 2012, INFECT IMMUN, V80, P369, DOI 10.1128/IAI.05470-11; Trees E, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00718-14; U.S. Department of Agriculture F.S. and I.S. (USDA-FSIS), 2011, FED REGISTER, V76, P58157; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	37	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122928	10.1371/journal.pone.0122928	http://dx.doi.org/10.1371/journal.pone.0122928			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860693	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300068
J	Lee, JS; Kim, DH; Lee, HJ; Kim, HJ; Koo, JW; Choi, HG; Park, B; Hong, SK				Lee, Joong Seob; Kim, Dong Hyun; Lee, Hyo Jeong; Kim, Hyung Jong; Koo, Ja Won; Choi, Hyo Geun; Park, Bumjung; Hong, Sung Kwang			Lipid Profiles and Obesity as Potential Risk Factors of Sudden Sensorineural Hearing Loss	PLOS ONE			English	Article							CARDIOVASCULAR RISK; MEDICAL LITERATURE; CRITICAL-APPRAISAL; BLOOD-VISCOSITY	Objectives The objective of our study was to establish whether increased lipid profiles and obesity affect the prevalence and prognosis of sudden sensorineural hearing loss (SSNHL). Methods This was a case-controlled study with a longitudinal design. According to our criteria, 324 patients with SSNHL were included in this study. To manage potential covariates, 972 subjects with normal hearing from the Korean National Health and Nutrition Examination Survey were matched as control group according to their propensity scores. Age, level of total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), and body mass index (BMI) were obtained from the clinical data. Multivariate logistic regression analysis was used to investigate the association between SSNHL and lipid profiles or obesity in the 1296 subjects. Multivariate Cox regression analysis was used to determine whether lipid profiles and obesity are prognostic factors in patients with SSNHL. Results Mean body weight, BMI, TC, and TG were significantly higher in patients with SSNHL compared with control subjects (p<0.05). However, LDL-C values did not differ significantly between the two groups. Subjects with elevated TC and TG levels had a 2.20-(95% CI 1.50-3.24) and 1.50-fold (95% CI 1.08-2.08) increased odds, respectively, of SSNHL compared with subjects with normal TC and TG levels. Subjects with grade III BMI had a 1.59-fold (95% CI 1.17-2.16) increased odds of SSNHL. Multivariate Cox regression analyses revealed that BMI was an independent risk factor of treatment outcome, as patients with BMI >= 27.5 were less likely to achieve complete recovery than those with BMI <27.5 (p<0.05). Conclusions The results of this study revealed that elevated TC and TG levels and increased BMI are significantly associated with the prevalence of SSNHL and its prognosis, indicating that vascular compromise may play an important role in the pathogenesis of SSNHL.	[Lee, Joong Seob; Kim, Dong Hyun; Lee, Hyo Jeong; Kim, Hyung Jong; Choi, Hyo Geun; Park, Bumjung; Hong, Sung Kwang] Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Koo, Ja Won] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Songnam, South Korea	Hallym University; Seoul National University (SNU)	Hong, SK (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	skhong96@hallym.ac.kr	Choi, Hyo Geun/K-4461-2019; Lee, Hyo-Jeong/AAK-7973-2020	Choi, Hyo Geun/0000-0003-1655-9549; Lee, Hyo-Jeong/0000-0003-2258-0803	Hallym University Research Fund [HURF-2014-27]; National Research Foundation (NRF) of Korea grants - Korean Government [NRF-2014R1A1A2A16054791]	Hallym University Research Fund; National Research Foundation (NRF) of Korea grants - Korean Government	The corresponding author, SKH, received the funds, Hallym University Research Fund 2014 (HURF-2014-27) and National Research Foundation (NRF) of Korea grants funded by Korean Government (NRF-2014R1A1A2A16054791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimoni C, 2010, AUDIOL NEURO-OTOL, V15, P111, DOI 10.1159/000231636; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Ballesteros F, 2012, AUDIOL NEURO-OTOL, V17, P400, DOI 10.1159/000341989; Ballesteros F, 2009, AUDIOL NEURO-OTOL, V14, P139, DOI 10.1159/000171475; Cadoni G, 2007, OTOL NEUROTOL, V28, P878; Cadoni G, 2010, ANN OTO RHINOL LARYN, V119, P82, DOI 10.1177/000348941011900203; Ciccone MM, 2012, ATHEROSCLEROSIS, V225, P511, DOI 10.1016/j.atherosclerosis.2012.10.024; GATEHOUSE S, 1989, ARCH OTOLARYNGOL, V115, P1227; Hansen BB, 2008, STAT MED, V27, P2050, DOI 10.1002/sim.3208; Jellinger PS, 2012, ENDOCR PRACT, V18, P270, DOI 10.4158/EP.18.2.269; Kim DR, 2011, OTOL NEUROTOL, V32, P1596, DOI 10.1097/MAO.0b013e31823558a0; Marcucci R, 2005, J THROMB HAEMOST, V3, P929, DOI 10.1111/j.1538-7836.2005.01310.x; MILLER JM, 1988, AM J OTOLARYNG, V9, P302, DOI 10.1016/S0196-0709(88)80038-3; Mosnier I, 2011, AUDIOL NEURO-OTOL, V16, P55, DOI 10.1159/000312640; OHINATA Y, 1994, ACTA OTO-LARYNGOL, V114, P601, DOI 10.3109/00016489409126112; Rudack C, 2006, THROMB HAEMOSTASIS, V95, P454, DOI 10.1160/TH05-08-0554; Shamai L, 2011, OBES SURG, V21, P42, DOI 10.1007/s11695-010-0170-7; Shiwaku K, 2004, LANCET, V363, P1077, DOI 10.1016/S0140-6736(04)15856-X; SIEGEL LG, 1975, OTOLARYNG CLIN N AM, V8, P467; Skeggs JW, 2002, J LIPID RES, V43, P1264, DOI 10.1194/jlr.M100431-JLR200; Stachler RJ, 2012, OTOLARYNG HEAD NECK, V146, pS1, DOI 10.1177/0194599812436449; ULLRICH D, 1992, EUR ARCH OTO-RHINO-L, V249, P273, DOI 10.1007/BF00714491; Westreich D, 2011, PHARMACOEPIDEM DR S, V20, P317, DOI 10.1002/pds.2074; Yavuz E, 2005, J NEUROSCI METH, V147, P55, DOI 10.1016/j.jneumeth.2005.03.004	24	26	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0122496	10.1371/journal.pone.0122496	http://dx.doi.org/10.1371/journal.pone.0122496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860024	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300048
J	Clark, DB; Hurtado, J; Saatchi, SS				Clark, David B.; Hurtado, Johanna; Saatchi, Sassan S.			Tropical Rain Forest Structure, Tree Growth and Dynamics along a 2700-m Elevational Transect in Costa Rica	PLOS ONE			English	Article							MOUNT-KINABALU; RANGE SHIFTS; BIOMASS; CLIMATE; GRADIENTS; MORTALITY	Rapid biological changes are expected to occur on tropical elevational gradients as species migrate upslope or go extinct in the face of global warming. We established a series of 9 1-ha plots in old-growth tropical rainforest in Costa Rica along a 2700 m relief elevational gradient to carry out long-term monitoring of tropical rain forest structure, dynamics and tree growth. Within each plot we mapped, identified, and annually measured diameter for all woody individuals with stem diameters >10 cm for periods of 3-10 years. Wood species diversity peaked at 400-600 m and decreased substantially at higher elevations. Basal area and stem number varied by less than two-fold, with the exception of the 2800 m cloud forest summit, where basal area and stem number were approximately double that of lower sites. Canopy gaps extending to the forest floor accounted for <3% of microsites at all elevations. Height of highest crowns and the coefficient of variation of crown height both decreased with increasing elevation. Rates of turnover of individuals and of stand basal area decreased with elevation, but rates of diameter growth and stand basal area showed no simple relation to elevation. We discuss issues encountered in the design and implementation of this network of plots, including biased sampling, missing key meteorological and biomass data, and strategies for improving species-level research. Taking full advantage of the major research potential of tropical forest elevational transects will require sustaining and extending ground based studies, incorporation of new remotely-sensed data and data-acquisition platforms, and new funding models to support decadal research on these rapidly-changing systems.	[Clark, David B.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Hurtado, Johanna] Org Trop Studies, La Selva Biol Stn, Puerto Viejo de Sarapiqui, Heredia, Costa Rica; [Saatchi, Sassan S.] CALTECH, Jet Prop Lab, Pasadena, CA USA	University of Missouri System; University of Missouri Saint Louis; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Clark, DB (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	dbclark50@yahoo.com	Saatchi, Sassan/AAQ-2649-2021		Tropical Ecology Assessment and Monitoring program (TEAM) of Conservational International; NASA Terrestrial Ecology grant [11-TE11-0100]	Tropical Ecology Assessment and Monitoring program (TEAM) of Conservational International; NASA Terrestrial Ecology grant	JH and DBC received funding from the Tropical Ecology Assessment and Monitoring program (TEAM) of Conservational International (http://www.teamnetwork.org/). DBC and SSS were funded by NASA Terrestrial Ecology grant 11-TE11-0100 (http://cce.nasa.gov/cce/terrestrial.htm). The funders had no role in study design, data collection	Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Beck E., 2008, V198, P1; BROKAW NVL, 1982, BIOTROPICA, V14, P158, DOI 10.2307/2387750; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Clark DB, 2012, J VEG SCI, V23, P1191, DOI 10.1111/j.1654-1103.2012.01471.x; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Clark DB, 2004, ECOL LETT, V7, P52, DOI 10.1046/j.1461-0248.2003.00547.x; Clark DB, 1990, REPROD ECOLOGY TROPI, P291; Clark DB, 2002, ECOLOGIA CONSERVACIO, P193, DOI [10.1016/j.watres.2013.08.031, DOI 10.1016/J.WATRES.2013.08.031]; Clark DA, 2007, BIOTROPICA, V39, P4, DOI 10.1111/j.1744-7429.2006.00227.x; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Clark DA, 2011, BIOTROPICA, V43, P31, DOI 10.1111/j.1744-7429.2010.00654.x; Clark ML, 2005, REMOTE SENS ENVIRON, V96, P375, DOI 10.1016/j.rse.2005.03.009; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Feeley KJ, 2013, GLOBAL CHANGE BIOL, V19, P3472, DOI 10.1111/gcb.12300; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V38, P783, DOI [10.1111/j.1365-2699.2010.02444.x, DOI 10.1111/J.1365-2699.2010.02444.X]; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Fisher JB, 2013, OECOLOGIA, V172, P889, DOI 10.1007/s00442-012-2522-6; Girardin CAJ, 2014, PLANT ECOL DIVERS, V7, P161, DOI 10.1080/17550874.2013.820806; Gotelli N. J., 2004, PRIMER ECOLOGICAL ST; Gradstein RS, 2010, TROPICAL MOUNTAIN FO; Hartshorn GS, 1988, TROPICAL RAINFORESTS, P281; HEANEY A, 1990, J TROP ECOL, V6, P307, DOI 10.1017/S0266467400004557; Hemp A, 2006, PLANT ECOL, V184, P27, DOI 10.1007/s11258-005-9049-4; Holdridge L. R., 1971, Forest environments in tropical life zones: a pilot study.; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; KITAYAMA K, 1992, VEGETATIO, V102, P149, DOI 10.1007/BF00044731; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lieberman D, 1996, J ECOL, V84, P137, DOI 10.2307/2261350; Lloyd J, 2009, ECOL LETT, V12, pE19, DOI 10.1111/j.1461-0248.2009.01326.x; Losos L, 2004, TROPICAL FOREST DIVE, P645; Malhi Y, 2010, GLOBAL CHANGE BIOL, V16, P3171, DOI 10.1111/j.1365-2486.2010.02323.x; Marvin DC, 2014, P NATL ACAD SCI USA, V111, pE5224, DOI 10.1073/pnas.1412999111; Richards PW, 1996, TROPICAL RAIN FOREST, P575; Scatena FN, 2011, TROPICAL MONTANE CLO, P3, DOI DOI 10.1017/CBO9780511778384.003; Silva CE, 2013, GLOBAL CHANGE BIOL, V19, P3423, DOI 10.1111/gcb.12312; Spracklen DV, 2014, BIOGEOSCIENCES, V11, P2741, DOI 10.5194/bg-11-2741-2014; Stocker T., 2013, COMPUTATIONAL GEOMET, DOI 10.1017/ CBO9781107415324; TERBORGH J, 1971, Ecology (Washington D C), V52, P23, DOI 10.2307/1934735; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009	43	39	43	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122905	10.1371/journal.pone.0122905	http://dx.doi.org/10.1371/journal.pone.0122905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856163	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500064
J	Djomehri, SI; Candell, S; Case, T; Browning, A; Marshall, GW; Yun, WB; Lau, SH; Webb, S; Ho, SP				Djomehri, Sabra I.; Candell, Susan; Case, Thomas; Browning, Alyssa; Marshall, Grayson W.; Yun, Wenbing; Lau, S. H.; Webb, Samuel; Ho, Sunita P.			Mineral Density Volume Gradients in Normal and Diseased Human Tissues	PLOS ONE			English	Article							X-RAY-FLUORESCENCE; HUMAN CEMENTUM; HUMAN TEETH; QUANTITATIVE-EVALUATION; MECHANICAL-PROPERTIES; DENTAL CALCULUS; TRACE-ELEMENTS; CARIES; ZINC; MICROANALYSIS	Clinical computed tomography provides a single mineral density (MD) value for heterogeneous calcified tissues containing early and late stage pathologic formations. The novel aspect of this study is that, it extends current quantitative methods of mapping mineral density gradients to three dimensions, discretizes early and late mineralized stages, identifies elemental distribution in discretized volumes, and correlates measured MD with respective calcium (Ca) to phosphorus (P) and Ca to zinc (Zn) elemental ratios. To accomplish this, MD variations identified using polychromatic radiation from a high resolution micro-computed tomography (micro-CT) benchtop unit were correlated with elemental mapping obtained from a microprobe X-ray fluorescence (XRF) using synchrotron monochromatic radiation. Digital segmentation of tomograms from normal and diseased tissues (N=5 per group; 40-60 year old males) contained significant mineral density variations (enamel: 2820-3095mg/cc, bone: 570-1415mg/cc, cementum: 1240-1340mg/cc, dentin: 1480-1590mg/cc, cementum affected by periodontitis: 1100-1220mg/cc, hypomineralized carious dentin: 345-1450mg/cc, hypermineralized carious dentin: 1815-2740mg/cc, and dental calculus: 1290-1770mg/cc). A plausible linear correlation between segmented MD volumes and elemental ratios within these volumes was established, and Ca/P ratios for dentin (1.49), hypomineralized dentin (0.32-0.46), cementum (1.51), and bone (1.68) were observed. Furthermore, varying Ca/Zn ratios were distinguished in adapted compared to normal tissues, such as in bone (855-2765) and in cementum (595-990), highlighting Zn as an influential element in prompting observed adaptive properties. Hence, results provide insights on mineral density gradients with elemental concentrations and elemental footprints that in turn could aid in elucidating mechanistic processes for pathologic formations.	[Djomehri, Sabra I.; Marshall, Grayson W.; Ho, Sunita P.] Univ San Francisco, Div Biomat & Bioengn, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94117 USA; [Candell, Susan; Case, Thomas; Browning, Alyssa; Yun, Wenbing; Lau, S. H.] Xradia Inc, Pleasanton, CA USA; [Webb, Samuel] Stanford Linear Accelerator Ctr, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA	University of San Francisco; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Ho, SP (corresponding author), Univ San Francisco, Div Biomat & Bioengn, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94117 USA.	sunita.ho@ucsf.edu	Webb, Samuel M/D-4778-2009; Ho, Sunita P/B-1084-2008	Webb, Samuel M/0000-0003-1188-0464; Marshall, Grayson W/0000-0001-8921-3253	National Institute of Health (NIH)-National Institute of Dental and Craniofacial Research (NIDCR) [R00DE018212, S10RR026645]; NIH/NIDCR [R01DE022032, R01DE016849]; Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, University of California San Francisco (UCSF); U.S. Department of Energy [DE-AC02-76SF00515]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016849, R01DE022032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R00DE018212, R01DE011526] Funding Source: NIH RePORTER	National Institute of Health (NIH)-National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, University of California San Francisco (UCSF); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	National Institute of Health (NIH)-National Institute of Dental and Craniofacial Research (NIDCR) R00DE018212 (SPH); S10RR026645 (SPH); NIH/NIDCR R01DE022032 (SPH); NIH/NIDCR R01DE016849 (GWM); Departments of Preventive and Restorative Dental Sciences and Orofacial Sciences, University of California San Francisco (UCSF). Work at SSRL was supported by the U.S. Department of Energy under contract number DE-AC02-76SF00515. Xradia Inc., provided support in the form of salaries for authors SC, TC, AB, WYand SHL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aaseth J, 2012, J TRACE ELEM MED BIO, V26, P149, DOI 10.1016/j.jtemb.2012.03.017; Abraham J, 2005, J BIOMED MATER RES A, V75A, P623, DOI 10.1002/jbm.a.30484; Abraham J, 2002, ANAL CHEM, V74, P324, DOI 10.1021/ac0106389; Alvarez-Perez MA, 2005, MICROSC MICROANAL, V11, P313, DOI 10.1017/S1431927605050221; Andrews JC, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012081; Andrews JC, 2011, MICROSC RES TECHNIQ, V74, P671, DOI 10.1002/jemt.20907; Andrews JC, 2010, MICROSC MICROANAL, V16, P327, DOI 10.1017/S1431927610000231; Arnold WH, 2001, CALCIFIED TISSUE INT, V69, P268, DOI 10.1007/s002230020023; Arola D, 2005, BIOMATERIALS, V26, P4051, DOI 10.1016/j.biomaterials.2004.10.029; Arzate H, 2000, J DENT RES, V79, P28, DOI 10.1177/00220345000790010301; ATTRAMADAL A, 1976, ACTA ODONTOL SCAND, V34, P127, DOI 10.3109/00016357609002559; Bazin D, 2008, J SYNCHROTRON RADIAT, V15, P506, DOI 10.1107/S0909049508014556; Bjorndal L, 2002, ENDOD TOPICS, V2, P2, DOI [10.1034/j.1601-1546.2002.30124.x, DOI 10.1034/J.1601-1546.2002.30124.X, 10.1034/j.1601-1546.2002.20102.x, DOI 10.1034/J.1601-1546.2002.20102.X]; Boskey AL, 1996, CONNECT TISSUE RES, V35, P357, DOI 10.3109/03008209609029212; Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007; Bosshardt DD, 1997, PERIODONTOL 2000, V13, P41, DOI 10.1111/j.1600-0757.1997.tb00095.x; Burghardt AJ, 2008, CALCIFIED TISSUE INT, V83, P129, DOI 10.1007/s00223-008-9158-x; Burwell AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038852; Carter Y, 2013, J STRUCT BIOL, V183, P519, DOI 10.1016/j.jsb.2013.07.004; Clementino-Luedemann TNR, 2006, DENT MATER J, V25, P113, DOI 10.4012/dmj.25.113; Davis GR, 1996, PHYSIOL MEAS, V17, P121, DOI 10.1088/0967-3334/17/3/001; Digabel H, 1978, P 2 EUR S QUANT AN M, V19, P8; Dowker SEP, 2003, CARIES RES, V37, P237, DOI 10.1159/000070865; Drzazga Z, 2007, BIOFACTORS, V30, P243, DOI 10.1002/biof.5520300405; Elam WT, 2002, RADIAT PHYS CHEM, V63, P121, DOI 10.1016/S0969-806X(01)00227-4; Entezari V, 2012, BONE, V50, P611, DOI 10.1016/j.bone.2011.10.004; Farah RA, 2010, J DENT, V38, P50, DOI 10.1016/j.jdent.2009.09.002; Frost HM, 1964, BONE BIODYN, V315, P1; FURSETH R, 1968, ARCH ORAL BIOL, V13, P1197, DOI 10.1016/0003-9969(68)90075-7; FUSAYAMA T, 1979, OPER DENT, V4, P63; GlenHaduch E, 1997, AM J PHYS ANTHROPOL, V103, P201, DOI 10.1002/(SICI)1096-8644(199706)103:2<201::AID-AJPA5>3.0.CO;2-W; GRON P, 1967, HELV ODONTOL ACTA, V11, P71; Hayashizaki J, 2008, ARCH ORAL BIOL, V53, P168, DOI 10.1016/j.archoralbio.2007.09.003; Ho SP, 2004, J BIOMED MATER RES A, V68A, P343, DOI 10.1002/jbm.a.20061; Ho SP, 2013, BONE, V57, P455, DOI 10.1016/j.bone.2013.09.007; Ho SP, 2009, DENT MATER, V25, P1195, DOI 10.1016/j.dental.2009.04.005; HOUNSFIELD GN, 1980, SCIENCE, V210, P22, DOI 10.1126/science.6997993; Hurng JM, 2011, BIOMATERIALS, V32, P7106, DOI 10.1016/j.biomaterials.2011.06.021; Jang AT, 2014, J MECH BEHAV BIOMED, V39, P184, DOI 10.1016/j.jmbbm.2014.07.015; Jin Y, 2002, CRIT REV ORAL BIOL M, V13, P426, DOI 10.1177/154411130201300506; Kazakia GJ, 2008, MED PHYS, V35, P3170, DOI 10.1118/1.2924210; Khan A, 2012, SELTZER AND BENDER'S DENTAL PULP, SECOND EDITION, P185; Kim I, 2007, CLIN ANAT, V20, P27, DOI 10.1002/ca.20265; Kinney J, 1993, SCANNING MICROSCOPY, V8, P204; Kinney JH, 2005, BIOMATERIALS, V26, P3363, DOI 10.1016/j.biomaterials.2004.09.004; Kinney JH, 2003, J DENT RES, V82, P957, DOI 10.1177/154405910308201204; KINNEY JH, 1995, J DENT RES, V74, P1179, DOI 10.1177/00220345950740050601; KINNEY JH, 1994, SCANNING MICROSCOPY, V8, P197; KNUUTTILA M, 1980, SCAND J DENT RES, V88, P513; KNUUTTILA M, 1979, SCAND J DENT RES, V87, P192; Kukacka Jiri, 2005, Biomedical Papers (Olomouc), V149, P225; Kyriazis Vassilios, 2004, ScientificWorldJournal, V4, P1027; LIEBERMAN DE, 1994, J ARCHAEOL SCI, V21, P525, DOI 10.1006/jasc.1994.1052; Lin JD, 2013, ACTA BIOMATER, V9, P4787, DOI 10.1016/j.actbio.2012.08.021; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; Liu KZ, 2006, BBA-MOL BASIS DIS, V1762, P775, DOI 10.1016/j.bbadis.2006.05.014; Magloire H, 2001, Adv Dent Res, V15, P46; Martin RR, 2007, J ARCHAEOL SCI, V34, P936, DOI 10.1016/j.jas.2006.09.018; Martin RR, 2010, J SYNCHROTRON RADIAT, V17, P263, DOI 10.1107/S0909049509052807; Martin RR, 2004, J ENVIRON MONITOR, V6, P783, DOI 10.1039/b408525f; McMaster W., 1969, UCRL50174 LAWR RAD L; Moon PC, 2010, OPEN DENT J, V4, P147, DOI 10.2174/1874210601004010147; Nagase H, 1992, Matrix Suppl, V1, P237; NALBANDIAN JOHN, 1960, JOUR DENTAL RES, V39, P598, DOI 10.1177/00220345600390032101; Nemeth JA, 2002, J NATL CANCER I, V94, P17; Neves AD, 2010, DENT MATER, V26, P579, DOI 10.1016/j.dental.2010.01.012; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OGAWA K, 1983, J DENT RES, V62, P7, DOI 10.1177/00220345830620011701; Omae M, 2009, DENT MATER J, V28, P471, DOI 10.4012/dmj.28.471; Oprea C, 2009, APPL RADIAT ISOTOPES, V67, P2142, DOI 10.1016/j.apradiso.2009.04.017; Pemmer B, 2013, BONE, V57, P184, DOI 10.1016/j.bone.2013.07.038; Pugach MK, 2009, J DENT RES, V88, P71, DOI 10.1177/0022034508327552; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Roerdink J. B. T. M., 2000, Fundamenta Informaticae, V41, P187; Rossi M, 2004, NUCL INSTRUM METH B, V213, P747, DOI 10.1016/S0168-583X(03)01697-5; SCHUPBACH P, 1992, CARIES RES, V26, P153, DOI 10.1159/000261436; Schwass DR, 2009, CARIES RES, V43, P314, DOI 10.1159/000226230; SMITH AJ, 1995, INT J DEV BIOL, V39, P273; Sulkala M, 2001, J DENT RES, V80, P1545, DOI 10.1177/00220345010800061301; Swain MV, 2009, INT J ORAL SCI, V1, P177, DOI 10.4248/IJOS09031; Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043; Ten Cate A, 1998, OR HIST DEV STRUCT F, P497; Thompson A, 2009, LBNLPUB490; Webb SM, 2011, AIP CONF PROC, V1365, P196, DOI 10.1063/1.3625338; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; WEINMANN J P, 1955, Oral Surg Oral Med Oral Pathol, V8, P1074, DOI 10.1016/0030-4220(55)90058-X; ZANDER H. A., 1958, JOUR DENTAL RES, V37, P1035; Zheng L, 2003, EUR J ORAL SCI, V111, P243, DOI 10.1034/j.1600-0722.2003.00038.x	89	42	43	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0121611	10.1371/journal.pone.0121611	http://dx.doi.org/10.1371/journal.pone.0121611			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF5HQ	25856386	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500024
J	Funchal, GA; Jaeger, N; Czepielewski, RS; Machado, MS; Muraro, SP; Stein, RT; Bonorino, CBC; Porto, BN				Funchal, Giselle A.; Jaeger, Natalia; Czepielewski, Rafael S.; Machado, Mileni S.; Muraro, Stefanie P.; Stein, Renato T.; Bonorino, Cristina B. C.; Porto, Barbara N.			Respiratory Syncytial Virus Fusion Protein Promotes TLR-4-Dependent Neutrophil Extracellular Trap Formation by Human Neutrophils	PLOS ONE			English	Article							NADPH OXIDASE; SUBGROUP-B; IN-VITRO; KAPPA-B; MEDIATE; MYELOPEROXIDASE; INFECTION; ELASTASE; GLYCOPROTEINS; INFLAMMATION	Acute viral bronchiolitis by Respiratory Syncytial Virus (RSV) is the most common respiratory illness in children in the first year of life. RSV bronchiolitis generates large numbers of hospitalizations and an important burden to health systems. Neutrophils and their products are present in the airways of RSV-infected patients who developed increased lung disease. Neutrophil Extracellular Traps (NETs) are formed by the release of granular and nuclear contents of neutrophils in the extracellular space in response to different stimuli and recent studies have proposed a role for NETs in viral infections. In this study, we show that RSV particles and RSV Fusion protein were both capable of inducing NET formation by human neutrophils. Moreover, we analyzed the mechanisms involved in RSV Fusion protein-induced NET formation. RSV F protein was able to induce NET release in a concentration-dependent fashion with both neutrophil elastase and myeloperoxidase expressed on DNA fibers and F protein-induced NETs was dismantled by DNase treatment, confirming that their backbone is chromatin. This viral protein caused the release of extracellular DNA dependent on TLR-4 activation, NADPH Oxidase-derived ROS production and ERK and p38 MAPK phosphorylation. Together, these results demonstrate a coordinated signaling pathway activated by F protein that led to NET production. The massive production of NETs in RSV infection could aggravate the inflammatory symptoms of the infection in young children and babies. We propose that targeting the binding of TLR-4 by F protein could potentially lead to novel therapeutic approaches to help control RSV-induced inflammatory consequences and pathology of viral bronchiolitis.	[Funchal, Giselle A.; Machado, Mileni S.; Muraro, Stefanie P.; Porto, Barbara N.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Clin & Expt Immunol Lab, Porto Alegre, RS, Brazil; [Funchal, Giselle A.; Jaeger, Natalia; Czepielewski, Rafael S.; Bonorino, Cristina B. C.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Cellular & Mol Immunol Lab, Porto Alegre, RS, Brazil; [Stein, Renato T.; Porto, Barbara N.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Infant Ctr, Porto Alegre, RS, Brazil; [Funchal, Giselle A.; Jaeger, Natalia; Czepielewski, Rafael S.; Machado, Mileni S.; Muraro, Stefanie P.; Stein, Renato T.; Bonorino, Cristina B. C.; Porto, Barbara N.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Inst Biomed Res, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Porto, BN (corresponding author), Pontificia Univ Catolica Rio Grande Sul PUCRS, Clin & Expt Immunol Lab, Porto Alegre, RS, Brazil.	barbara.porto@pucrs.br	Czepielewski, Rafael/ABB-7858-2021; Muraro, Stefanie P/AAM-2017-2021; Muraro, Stefanie P/M-6705-2013; Stein, Renato Tetelbom/K-2568-2014; Bonorino, Cristina/U-2780-2019	Czepielewski, Rafael/0000-0002-2475-3838; Muraro, Stefanie P/0000-0002-5105-6659; Muraro, Stefanie P/0000-0002-5105-6659; Jaeger, Natalia/0000-0003-2875-8297; STEIN, RENATO/0000-0003-0269-0757	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472406/2010-8]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [11/1904-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) grant nr. 472406/2010-8, and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) grant nr. 11/1904-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Bueno SM, 2008, INT IMMUNOPHARMACOL, V8, P1320, DOI 10.1016/j.intimp.2008.03.012; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Emboriadou M, 2007, ANN CLIN LAB SCI, V37, P79; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fujie K, 1999, EUR J PHARMACOL, V374, P117, DOI 10.1016/S0014-2999(99)00268-X; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Jaovisidha P, 1999, J IMMUNOL, V163, P2816; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Kahn JS, 1999, VIROLOGY, V254, P81, DOI 10.1006/viro.1998.9535; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Keshari RS, 2013, J CELL BIOCHEM, V114, P532, DOI 10.1002/jcb.24391; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lindemans CA, 2006, J IMMUNOL, V176, P5529, DOI 10.4049/jimmunol.176.9.5529; Logters T, 2009, MED MICROBIOL IMMUN, V198, P211, DOI 10.1007/s00430-009-0121-x; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; McCormick A, 2010, MICROBES INFECT, V12, P928, DOI 10.1016/j.micinf.2010.06.009; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Mejias Asuncion, 2005, Pediatr Infect Dis J, V24, pS189, DOI 10.1097/01.inf.0000188196.87969.9a; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Parker H, 2012, J LEUKOCYTE BIOL, V92, P841, DOI 10.1189/jlb.1211601; Rallabhandi P, 2012, MBIO, V3, DOI 10.1128/mBio.00218-12; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; Schwarze J, 1997, J CLIN INVEST, V100, P226, DOI 10.1172/JCI119516; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Stokes KL, 2013, J VIROL, V87, P10070, DOI 10.1128/JVI.01347-13; Stoppelenburg AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078461; STOTT EJ, 1985, ARCH VIROL, V84, P1, DOI 10.1007/BF01310552; Tadie JM, 2013, AM J PHYSIOL-LUNG C, V304, pL342, DOI 10.1152/ajplung.00151.2012; Teran LM, 1997, AM J RESP CRIT CARE, V155, P1362, DOI 10.1164/ajrccm.155.4.9105080; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Tsuzuki H, 2001, J SURG RES, V100, P127, DOI 10.1006/jsre.2001.6227; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; van Schaik SM, 1998, J INFECT DIS, V177, P269, DOI 10.1086/514208; Wang S Z, 2000, Respirology, V5, P1, DOI 10.1046/j.1440-1843.2000.00219.x; Wang SZ, 1998, EUR RESPIR J, V12, P612, DOI 10.1183/09031936.98.12030612; Wardini AB, 2010, J GEN VIROL, V91, P259, DOI 10.1099/vir.0.014613-0; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Zhao X, 2000, P NATL ACAD SCI USA, V97, P14172, DOI 10.1073/pnas.260499197	53	96	104	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0124082	10.1371/journal.pone.0124082	http://dx.doi.org/10.1371/journal.pone.0124082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856628	gold, Green Submitted, Green Published			2022-12-27	WOS:000352588500110
J	Lv, XH; Wang, CH; Xie, Y; Yan, ZP				Lv, Xiuhe; Wang, Chunhui; Xie, Yan; Yan, Zhaoping			Diagnostic Efficacy of Magnifying Endoscopy with Narrow-Band Imaging for Gastric Neoplasms: A Meta-Analysis	PLOS ONE			English	Article							PILOT FEASIBILITY TRIAL; WHITE-LIGHT ENDOSCOPY; DIFFERENTIAL-DIAGNOSIS; CANCER; LESIONS; HISTOPATHOLOGY; EPIDEMIOLOGY; CARCINOMA; PATTERN; ADENOMA	Background Magnifying endoscopy with narrow-band imaging (ME-NBI) is a novel, image-enhanced endoscopic technique for differentiating gastrointestinal neoplasms and potentially enabling pathological diagnosis. Objectives The aim of this analysis was to assess the diagnostic performance of ME-NBI for gastric neoplasms. Methods We performed a systematic search of the PubMed, EMbase, Web of Science, and Cochrane Library databases for relevant studies. Meta-DiSc (version 1.4) and STATA (version 11.0) software were used for the data analysis. Random effects models were used to assess diagnostic efficacy. Heterogeneity was tested by the Q statistic and I-2 statistic. Meta-regression was used to analyze the sources of heterogeneity. Results A total of 10 studies, with 2151 lesions, were included. The pooled characteristics of these studies were as follows: sensitivity 0.85 (95% confidence interval [CI]: 0.81-0.89), specificity 0.96 (95% confidence interval [CI]: 0.95-0.97), and area under the curve (AUC) 0.9647. In the subgroup analysis, which compared the diagnostic efficacy of ME-NBI and white light imaging (WLI), the pooled sensitivity and specificity of ME-NBI were 0.87 (95% CI: 0.80-0.92) and 0.93 (95% CI: 0.90-0.95), respectively, and the area under the curve (AUC) was 0.9556. In contrast, the pooled sensitivity and specificity of WLI were 0.61 (95% CI: 0.53-0.69) and 0.65 (95% CI: 0.60-0.69), respectively, and the area under the curve (AUC) was 0.6772. Conclusions ME-NBI presents a high diagnostic value for gastric neoplasms and has a high specificity.	[Lv, Xiuhe; Wang, Chunhui; Xie, Yan; Yan, Zhaoping] Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Xie, Y (corresponding author), Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Sichuan, Peoples R China.	xier917@126.com	Lv, Xiu-He/ABI-3552-2020	Lv, Xiu-He/0000-0002-7188-1824	National Natural Science Foundation of China [81200333]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is supported by National Natural Science Foundation of China (Grant No. 81200333) URL:www.nsfc.gov.cn/publish/portal1/. The author YX received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal A, 2008, GASTROINTEST ENDOSC, V67, P210, DOI 10.1016/j.gie.2007.06.009; Cho WY, 2011, CLIN ENDOSC, V44, P65, DOI 10.5946/ce.2011.44.2.65; CORREA P, 1992, CANCER RES, V52, P6735; Ezoe Y, 2011, GASTROENTEROLOGY, V141, P2017, DOI 10.1053/j.gastro.2011.08.007; Ezoe Y, 2010, GASTROINTEST ENDOSC, V71, P477, DOI 10.1016/j.gie.2009.10.036; Fujiwara S, 2015, GASTRIC CANCER, V18, P590, DOI 10.1007/s10120-014-0399-2; Goh LY, 2014, J DIGEST DIS, V15, P463, DOI 10.1111/1751-2980.12164; Guo T, 2014, GASTRIC CANCER, V17, P122, DOI 10.1007/s10120-013-0250-1; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horiuchi H, 2013, SCAND J GASTROENTERO, V48, P626, DOI 10.3109/00365521.2013.773460; Iwashita, 2002, DIGEST ENDOSC, V14, pS83, DOI DOI 10.1046/J.1443-1661.14.S1.16.X; Kaise M, 2009, ENDOSCOPY, V41, P310, DOI 10.1055/s-0028-1119639; Kaise M, 2010, GASTROENTEROL CLIN N, V39, P771, DOI 10.1016/j.gtc.2010.08.028; Kato M, 2007, ENDOSCOPY, V39, P937, DOI 10.1055/s-2007-966857; Kato M, 2010, GASTROINTEST ENDOSC, V72, P523, DOI 10.1016/j.gie.2010.04.041; Kikuchi D, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/217695; Kiyotoki S, 2010, J GASTROEN HEPATOL, V25, P1636, DOI 10.1111/j.1440-1746.2010.06379.x; Kobara H, 2012, ONCOL REP, V28, P841, DOI 10.3892/or.2012.1889; Li HY, 2012, GASTROINTEST ENDOSC, V76, P1124, DOI 10.1016/j.gie.2012.08.015; Liu H, 2014, DIGEST DIS SCI, V59, P1513, DOI 10.1007/s10620-014-3027-4; Maki S, 2013, GASTRIC CANCER, V16, P140, DOI 10.1007/s10120-012-0160-7; Miwa K, 2012, GASTROINTEST ENDOSC, V54, P1117; Mochizuki Y, 2012, J GASTROINTEST LIVER, V21, P383; Nakamura M, 2010, GASTROINTEST ENDOSC, V71, P1070, DOI 10.1016/j.gie.2009.12.032; Nakayoshi T, 2004, ENDOSCOPY, V36, P1080, DOI 10.1055/s-2004-825961; Nelson DB, 2000, GASTROINTEST ENDOSC, V52, P864, DOI 10.1016/S0016-5107(00)70225-2; Omori T, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-17; Song M., 2014, GASTROINTEST INTERVE, V3, P1, DOI DOI 10.1016/J.GII.2014.02.005]; Sumie H, 2014, MOL CLIN ONCOL, V2, P129, DOI 10.3892/mco.2013.213; Tahara T, 2010, GASTROINTEST ENDOSC, V71, P429, DOI 10.1016/j.gie.2009.05.034; Tsuji Y, 2012, GASTRIC CANCER, V15, P414, DOI 10.1007/s10120-011-0133-2; Uedo N, 2013, GASTROENTEROL CLIN N, V42, P317, DOI 10.1016/j.gtc.2013.01.007; Venerito M, 2014, HELICOBACTER, V19, P32, DOI 10.1111/hel.12164; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yagi K, 2008, DIGEST ENDOSC, V20, P115, DOI 10.1111/j.1443-1661.2008.00788.x; Yao K, 2009, ENDOSCOPY, V41, P462, DOI 10.1055/s-0029-1214594; Yao Kenshi, 2005, Clin Gastroenterol Hepatol, V3, pS23, DOI 10.1016/S1542-3565(05)00255-7; Yokoyama A, 2010, DIGEST LIVER DIS, V42, P704, DOI 10.1016/j.dld.2010.03.013; Zhang J, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-135	39	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123832	10.1371/journal.pone.0123832	http://dx.doi.org/10.1371/journal.pone.0123832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856544	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500108
J	Nicoli, E; Syga, MI; Bosetti, M; Shastri, VP				Nicoli, Elena; Syga, Marie Isabel; Bosetti, Michela; Shastri, V. Prasad			Enhanced Gene Silencing through Human Serum Albumin-Mediated Delivery of Polyethylenimine-siRNA Polyplexes	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; IN-VIVO; NANOPARTICLES; MECHANISM; EXPRESSION; CAVEOLAE; CANCER; SIZE; ENDOCYTOSIS; STRATEGIES	Small interfering RNA (siRNA) targeted therapeutics (STT) offers a compelling alternative to tradition medications for treatment of genetic diseases by providing a means to silence the expression of specific aberrant proteins, through interference at the expression level. The perceived advantage of siRNA therapy is its ability to target, through synthetic antisense oligonucleotides, any part of the genome. Although STT provides a high level of specificity, it is also hindered by poor intracellular uptake, limited blood stability, high degradability and nonspecific immune stimulation. Since serum proteins has been considered as useful vehicles for targeting tumors, in this study we investigated the effect of incorporation of human serum albumin (HSA) in branched polyethylenimine (bPEI)-siRNA polyplexes in their internalization in epithelial and endothelial cells. We observed that introduction of HSA preserves the capacity of bPEI to complex with siRNA and protect it against extracellular endonucleases, while affording significantly improved internalization and silencing efficiency, compared to bPEI-siRNA polyplexes in endothelial and metastatic breast cancer epithelial cells. Furthermore, the uptake of the HSA-bPEI-siRNA ternary polyplexes occurred primarily through a caveolae-mediated endocytosis, thus providing evidence for a clear role for HSA in polyplex internalization. These results provide further impetus to explore the role of serum proteins in delivery of siRNA.	[Nicoli, Elena; Bosetti, Michela] Univ Piemonte Orientale, Dipartimento Sci Farmaco, Novara, Italy; [Nicoli, Elena; Syga, Marie Isabel; Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, Freiburg, Germany; [Syga, Marie Isabel] Univ Freiburg, BIOSS, Ctr Biol Signalling Studies, Freiburg, Germany	University of Eastern Piedmont Amedeo Avogadro; University of Freiburg; University of Freiburg	Shastri, VP (corresponding author), Univ Freiburg, Inst Macromol Chem, Freiburg, Germany.	prasad.shastri@gmail.com	Bosetti, Michela/AAR-9556-2021	Bosetti, Michela/0000-0002-3682-8702	5th INTERREG Upper Rhine Program (Project A21: NANO@MATRIX); German Federal Government; State Government (Centre for Biological Signalling Studies, BIOSS); State Government [EXC 294]	5th INTERREG Upper Rhine Program (Project A21: NANO@MATRIX); German Federal Government; State Government (Centre for Biological Signalling Studies, BIOSS); State Government	This work was funded by the 5th INTERREG Upper Rhine Program (Project A21: NANO@MATRIX), the excellence initiative of the German Federal and State Governments (grant EXC 294; Centre for Biological Signalling Studies, BIOSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi S, 2011, CELL BIOCHEM BIOPHYS, V61, P277, DOI 10.1007/s12013-011-9201-9; Aigner A, 2006, J BIOTECHNOL, V124, P12, DOI 10.1016/j.jbiotec.2005.12.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carrabino S, 2005, J GENE MED, V7, P1555, DOI 10.1002/jgm.799; Desai N, 2009, TRANSL ONCOL, V2, P59, DOI 10.1593/tlo.09109; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Han JF, 2014, SMALL, V10, P524, DOI 10.1002/smll.201301992; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kanasty RL, 2012, MOL THER, V20, P513, DOI 10.1038/mt.2011.294; Kang JH, 2012, J CONTROL RELEASE, V163, P119, DOI 10.1016/j.jconrel.2012.08.030; Kim JA, 2012, NAT NANOTECHNOL, V7, P62, DOI [10.1038/nnano.2011.191, 10.1038/NNANO.2011.191]; Kim SI, 2009, J HEPATOL, V50, P479, DOI 10.1016/j.jhep.2008.10.029; Kratz F, 1998, DRUG DELIV, V5, P281, DOI 10.3109/10717549809065759; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Kwok A, 2011, NANOMED-NANOTECHNOL, V7, P210, DOI 10.1016/j.nano.2010.07.005; Lavie Y, 2001, ADV DRUG DELIVER REV, V49, P317, DOI 10.1016/S0169-409X(01)00144-2; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Malek A, 2009, TOXICOL APPL PHARM, V236, P97, DOI 10.1016/j.taap.2009.01.014; Malik AB, 2009, J MED SCI, V2, P13; McDaneld TG, 2009, J ANIM SCI, V87, pE21, DOI 10.2527/jas.2008-1303; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; O'Connor TP, 2006, NAT REV GENET, V7, P261, DOI 10.1038/nrg1829; Ogris M, 2001, AAPS PHARMSCI, V3, part. no.; Pan T, 2009, J LUMIN, V129, P741, DOI 10.1016/j.jlumin.2009.02.006; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Rhaese S, 2003, J CONTROL RELEASE, V92, P199, DOI 10.1016/S0168-3659(03)00302-X; SCHNITZER JE, 1992, AM J PHYSIOL, V263, pH1872, DOI 10.1152/ajpheart.1992.263.6.H1872; Singh HD, 2010, ACTA BIOMATER, V6, P4277, DOI 10.1016/j.actbio.2010.06.017; Son S, 2013, BIOMATERIALS, V34, P9475, DOI 10.1016/j.biomaterials.2013.08.085; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Voigt J, 2014, P NATL ACAD SCI USA, V111, P2942, DOI 10.1073/pnas.1322356111; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Zuckerman JE, 2014, P NATL ACAD SCI USA, V111, P11449, DOI 10.1073/pnas.1411393111	36	31	32	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122581	10.1371/journal.pone.0122581	http://dx.doi.org/10.1371/journal.pone.0122581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856158	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500043
J	Alam, MT; Weppelmann, TA; Longini, I; De Rochars, VMB; Morris, JG; Ali, A				Alam, Meer T.; Weppelmann, Thomas A.; Longini, Ira; De Rochars, Valery Madsen Beau; Morris, John Glenn, Jr.; Ali, Afsar			Increased Isolation Frequency of Toxigenic Vibrio cholerae O1 from Environmental Monitoring Sites in Haiti	PLOS ONE			English	Article								Since the identification of the first cholera case in 2010, the disease has spread in epidemic form throughout the island nation of Haiti; as of 2014, about 700,000 cholera cases have been reported, with over 8,000 deaths. While case numbers have declined, the more fundamental question of whether the causative bacterium, Vibrio cholerae has established an environmental reservoir in the surface waters of Haiti remains to be elucidated. In a previous study conducted between April 2012 and March 2013, we reported the isolation of toxigenic V. cholerae O1 from surface waters in the Ouest Department. After a second year of surveillance (April 2013 to March 2014) using identical methodology, we observed a more than five-fold increase in the number of water samples containing culturable V. cholerae O1 compared to the previous year (1.7% vs 8.6%), with double the number of sites having at least one positive sample (58% vs 20%). Both seasonal water temperatures and precipitation were significantly related to the frequency of isolation. Our data suggest that toxigenic V. cholerae O1 are becoming more common in surface waters in Haiti; while the basis for this increase is uncertain, our findings raise concerns that environmental reservoirs are being established.	[Alam, Meer T.; Weppelmann, Thomas A.; Ali, Afsar] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32611 USA; [Alam, Meer T.; Weppelmann, Thomas A.; De Rochars, Valery Madsen Beau; Morris, John Glenn, Jr.; Ali, Afsar] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Longini, Ira] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL USA; [Longini, Ira] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [De Rochars, Valery Madsen Beau] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA; [Morris, John Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ali, A (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32611 USA.	aali@epi.ufl.edu	alam, Meer Taifur/AAQ-1435-2020	alam, Meer Taifur/0000-0002-0703-740X	National Institute of Health (NIH) [RO1 AI097405]; Department of Defense grant [C0654_12_UN]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097405] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense grant(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a National Institute of Health (NIH) grant RO1 AI097405 awarded to J. G. M, and a Department of Defense grant (C0654_12_UN) awarded to A. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoachere JF, 2013, BMC INFECT DIS, V13, P1471; Alam M, 2006, APPL ENVIRON MICROB, V72, P2849, DOI 10.1128/AEM.72.4.2849-2855.2006; Alam MT, 2014, EMERG INFECT DIS, V20, P356, DOI 10.3201/eid2003.131293; Ali A, 2011, EMERG INFECT DIS, V17, P699, DOI 10.3201/eid1704.101973; Aliabad NH, 2012, LETT APPL MICROBIOL, V55, P27, DOI 10.1111/j.1472-765X.2012.03253.x; Barzilay EJ, 2013, NEW ENGL J MED, V368, P599, DOI 10.1056/NEJMoa1204927; Clesceri LS, 1998, STANDARD METHODS FOR; Colwell RR, 1994, VIBRIO CHOLERAE AND; Franco AA, 1997, AM J EPIDEMIOL, V146, P1067, DOI 10.1093/oxfordjournals.aje.a009235; Haitian Ministry of Public Health and Population (MSPP), 2014, DAILY REPORTS OF CHO; Haitian Misintry of Public Health and Population (MSPP), 2014, NATIONAL PLAN FOR TH; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; Huq Anwar, 2012, Curr Protoc Microbiol, VChapter 6, DOI 10.1002/9780471729259.mc06a05s26; Morita M, 2008, MICROBIOL IMMUNOL, V52, P314, DOI 10.1111/j.1348-0421.2008.00041.x; Morris JG, 2011, EMERG INFECT DIS, V17, P2099, DOI 10.3201/eid1711.111109; NASA, 2014, NASA EARTH DATA DAIL; Pan American Health Organization, 2014, INTERACTIVE ATLAS OF; Rinaldo A, 2012, P NATL ACAD SCI USA, V109, P6602, DOI 10.1073/pnas.1203333109; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17, P2151, DOI 10.3201/eid1711.110720	19	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124098	10.1371/journal.pone.0124098	http://dx.doi.org/10.1371/journal.pone.0124098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853552	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400133
J	Hughes, JM; Schmidt, DJ; Huey, JA; Real, KM; Espinoza, T; McDougall, A; Kind, PK; Brooks, S; Roberts, DT				Hughes, Jane M.; Schmidt, Daniel J.; Huey, Joel A.; Real, Kathryn M.; Espinoza, Thomas; McDougall, Andrew; Kind, Peter K.; Brooks, Steven; Roberts, David T.			Extremely Low Microsatellite Diversity but Distinct Population Structure in a Long-Lived Threatened Species, the Australian Lungfish Neoceratodus forsteri (Dipnoi)	PLOS ONE			English	Article							LOW GENETIC-VARIATION; COMPUTER-PROGRAM; SIZE; BOTTLENECK; SOFTWARE; TESTS; LOCI; COD	The Australian lungfish is a unique living representative of an ancient dipnoan lineage, listed as 'vulnerable' to extinction under Australia's Environment Protection and Biodiversity Conservation Act 1999. Historical accounts indicate this species occurred naturally in two adjacent river systems in Australia, the Burnett and Mary. Current day populations in other rivers are thought to have arisen by translocation from these source populations. Early genetic work detected very little variation and so had limited power to answer questions relevant for management including how genetic variation is partitioned within and among sub-populations. In this study, we use newly developed microsatellite markers to examine samples from the Burnett and Mary Rivers, as well as from two populations thought to be of translocated origin, Brisbane and North Pine. We test whether there is significant genetic structure among and within river drainages; assign putatively translocated populations to potential source populations; and estimate effective population sizes. Eleven polymorphic microsatellite loci genotyped in 218 individuals gave an average within-population heterozygosity of 0.39 which is low relative to other threatened taxa and for freshwater fishes in general. Based on F-ST values (average over loci = 0.11) and STRUCTURE analyses, we identify three distinct populations in the natural range, one in the Burnett and two distinct populations in the Mary. These analyses also support the hypothesis that the Mary River is the likely source of translocated populations in the Brisbane and North Pine rivers, which agrees with historical published records of a translocation event giving rise to these populations. We were unable to obtain bounded estimates of effective population size, as we have too few genotype combinations, although point estimates were low, ranging from 29 - 129. We recommend that, in order to preserve any local adaptation in the three distinct populations that they be managed separately.	[Hughes, Jane M.; Schmidt, Daniel J.; Huey, Joel A.; Real, Kathryn M.] Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia; [Huey, Joel A.] Western Australian Museum, Terr Zool & Mol Systemat Unit, Welshpool, WA, Australia; [Espinoza, Thomas; McDougall, Andrew] Dept Nat Resources & Mines, Bundaberg, Qld, Australia; [Kind, Peter K.; Brooks, Steven] Queensland Dept Agr Fisheries & Forestry, Brisbane, Qld, Australia; [Roberts, David T.] Seqwater, Ipswich, Qld, Australia	Griffith University; Western Australian Museum; Queensland Department of Agriculture & Fisheries	Hughes, JM (corresponding author), Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia.	Jane.hughes@griffith.edu.au	Roberts, David/W-3004-2019; Roberts, David/AGK-0029-2022; hughes, jane m/C-5321-2008; McDougall, Andrew/AAA-8657-2019	Roberts, David/0000-0002-9768-6314; McDougall, Andrew/0000-0003-3304-984X; Huey, Joel/0000-0001-7108-0552	Australian Research Council Linkage grant [LP13010018]; South East Queensland Water; Queensland Department of Natural Resources and Mines; Queensland Department of Agriculture, Fisheries and Forestry	Australian Research Council Linkage grant(Australian Research Council); South East Queensland Water; Queensland Department of Natural Resources and Mines; Queensland Department of Agriculture, Fisheries and Forestry	Funding for this study was provided by an Australian Research Council Linkage grant LP13010018 to JMH with the support of South East Queensland Water, Queensland Department of Natural Resources and Mines, Queensland Department of Agriculture, Fisheries and Forestry.	Allendorf F. W., 2012, CONSERV GENET; Araripe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054470; Arthington AH, 2009, ENVIRON BIOL FISH, V84, P211, DOI 10.1007/s10641-008-9414-y; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bentley AI, 2010, FRESHWATER BIOL, V55, P1861, DOI 10.1111/j.1365-2427.2010.02420.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Carvalho GR, 1996, BIOL J LINN SOC, V57, P219, DOI 10.1111/j.1095-8312.1996.tb00310.x; Cornuet JM, 1996, GENETICS, V144, P2001; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dudu A., 2014, Scientific Papers: Animal Science and Biotechnologies, V47, P64; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frentiu FD, 2001, CONSERV GENET, V2, P63, DOI 10.1023/A:1011576116472; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Hawley DM, 2005, BIOL LETTERS, V1, P326, DOI 10.1098/rsbl.2005.0303; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huey JA, 2013, CONSERV GENET, V14, P997, DOI 10.1007/s10592-013-0490-y; Huey JA, 2013, CONSERV GENET RESOUR, V5, P737, DOI 10.1007/s12686-013-9894-8; Illidge T, 1893, P ROYAL SOC QUEENSLA, V10, P40; Ingvarsson PK, 2001, TRENDS ECOL EVOL, V16, P62, DOI 10.1016/S0169-5347(00)02065-6; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; James KM, 2010, RADIOCARBON, V52, P1084, DOI 10.1017/S0033822200046166; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KEMP A, 1986, J MORPHOL, P181; Kemp A, 1997, J PALEONTOL, V71, P713, DOI 10.1017/S0022336000040166; KEMP A, 1981, J PALEONTOL, V55, P211; Kemp A, 2012, WORLD LUNGFISH PERSO; Kemp A, 2014, J ARCHAEOL SCI, V52, P184, DOI 10.1016/j.jas.2014.08.021; Kemp A, 2014, AUST J ZOOL, V62, P63, DOI 10.1071/ZO13038; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Lee L, 2013, MULTISCALE GENETIC S; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Lissone I, 2003, THESIS U SUNSHINE CO; McCusker MR, 2010, MOL ECOL, V19, P4852, DOI 10.1111/j.1365-294X.2010.04822.x; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; O'CONNOR D., 1897, P Soc Queensland, Vxii, P102; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Perez T, 1998, MOL ECOL, V7, P1347, DOI 10.1046/j.1365-294x.1998.00484.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Pujolar JM, 2011, PLOS ONE, V6; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Real KM, 2009, CONSERV GENET RESOUR, V1, P411, DOI 10.1007/s12686-009-9095-7; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rourke ML, 2010, MAR FRESHWATER RES, V61, P918, DOI 10.1071/MF10037; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schoebel CN, 2013, J EVOLUTION BIOL, V26, P600, DOI 10.1111/jeb.12077; Schultz JK, 2009, J HERED, V100, P25, DOI 10.1093/jhered/esn077; Tallmon DA, 2004, TRENDS ECOL EVOL, V19, P489, DOI 10.1016/j.tree.2004.07.003; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x	56	15	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121858	10.1371/journal.pone.0121858	http://dx.doi.org/10.1371/journal.pone.0121858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853492	gold, Green Submitted, Green Published			2022-12-27	WOS:000352478400051
J	Trtikova, M; Wikmark, OG; Zemp, N; Widmer, A; Hilbeck, A				Trtikova, Miluse; Wikmark, Odd Gunnar; Zemp, Niklaus; Widmer, Alex; Hilbeck, Angelika			Transgene Expression and Bt Protein Content in Transgenic Bt Maize (MON810) under Optimal and Stressful Environmental Conditions	PLOS ONE			English	Article							MESSENGER-RNA; CRY1AB; COTTON; RESISTANCE; ABUNDANCE; ENDOTOXIN; LESSONS; TOXIN; GENE	Bt protein content in transgenic insect resistant (Bt) maize may vary between tissues within plants and between plants growing under different environmental conditions. However, it is unknown whether and how Bt protein content correlates with transgene expression, and whether this relationship is influenced by stressful environmental conditions. Two Bt maize varieties containing the same transgene cassette (MON 810) were grown under optimal and stressful conditions. Before and during stress exposure, the upper leaves were analysed for transgene expression using quantitative RT-PCR and for Bt content using ELISA. Under optimal conditions there was no significant difference in the transgene expression between the two investigated Bt maize varieties whereas Bt protein content differed significantly. Transgene expression was correlated with Bt protein content in only one of the varieties. Under stressful environmental conditions we found similar transgene expressions as under optimal conditions but Bt content responded differently. These results suggest that Bt content is not only controlled by the transgene expression but is also dependent on the genetic background of the maize variety. Under stressful conditions the concentration of Bt protein is even more difficult to predict.	[Trtikova, Miluse; Zemp, Niklaus; Widmer, Alex; Hilbeck, Angelika] ETH, IBZ, Plant Ecol Genet, CH-8092 Zurich, Switzerland; [Wikmark, Odd Gunnar; Hilbeck, Angelika] Genok Ctr Biosafety, N-9294 Tromso, Norway	Swiss Federal Institutes of Technology Domain; ETH Zurich	Trtikova, M (corresponding author), ETH, IBZ, Plant Ecol Genet, Univ Str 16, CH-8092 Zurich, Switzerland.	miluse.trtikova@env.ethz.ch	Zemp, Niklaus/K-7467-2012; Widmer, Alex/B-6841-2009	Zemp, Niklaus/0000-0002-0991-5130; Widmer, Alex/0000-0001-8253-5137; Wikmark, Odd-Gunnar/0000-0002-8005-138X	ETH Zurich; Genok; Manfred-Hermsen-Stiftung fur Natur und Umwelt; Testbiotech	ETH Zurich(ETH Zurich); Genok; Manfred-Hermsen-Stiftung fur Natur und Umwelt; Testbiotech	This research was funded by ETH Zurich, Genok, Manfred-Hermsen-Stiftung fur Natur und Umwelt and Testbiotech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk JJ, 2009, TRANSGENIC RES, V18, P143, DOI 10.1007/s11248-008-9198-z; Bruns HA, 2003, AGRON J, V95, P207, DOI 10.2134/agronj2003.0207; Coll A, 2008, PLANT MOL BIOL, V68, P105, DOI 10.1007/s11103-008-9355-z; Coll A, 2010, PLANT MOL BIOL, V73, P349, DOI 10.1007/s11103-010-9624-5; Coll A, 2009, TRANSGENIC RES, V18, P801, DOI 10.1007/s11248-009-9266-z; Corrado G, 2009, BIOTECHNOL ADV, V27, P733, DOI 10.1016/j.biotechadv.2009.05.006; Dong HZ, 2007, J AGRON CROP SCI, V193, P21, DOI 10.1111/j.1439-037X.2006.00240.x; FAOSTAT, 2012, FOOD AGR COMM PROD; Gould F, 2000, NAT BIOTECHNOL, V18, P266, DOI 10.1038/73693; Griffiths BS, 2006, J ENVIRON QUAL, V35, P734, DOI 10.2134/jeq2005.0344; Li MY, 2013, J INTEGR AGR, V12, P436, DOI [10.1016/S2095-3119(13)60244-0, 10.1016/s2095-3119(13)60244-0]; La Paz JL, 2010, PLANT MOL BIOL, V74, P563, DOI 10.1007/s11103-010-9696-2; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; MEYER P, 1992, MOL GEN GENET, V231, P345, DOI 10.1007/BF00292701; Nguyen HT, 2007, J PLANT DIS PROTECT, V114, P82, DOI 10.1007/BF03356208; Olsen KM, 2005, J ECON ENTOMOL, V98, P1382, DOI 10.1603/0022-0493-98.4.1382; Olsen KM, 2005, J ECON ENTOMOL, V98, P1007, DOI 10.1603/0022-0493-98.3.1007; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Szekacs A, 2010, ENVIRON TOXICOL CHEM, V29, P182, DOI 10.1002/etc.5; Szekacs A, 2010, ANAL BIOANAL CHEM, V396, P2203, DOI 10.1007/s00216-009-3384-6; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Van den Berg J, 2013, CROP PROT, V54, P154, DOI 10.1016/j.cropro.2013.08.010; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185	26	41	43	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123011	10.1371/journal.pone.0123011	http://dx.doi.org/10.1371/journal.pone.0123011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853814	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400091
J	Saunders, F; Sweeney, B; Antoniou, MN; Stephens, P; Cain, K				Saunders, Fay; Sweeney, Berni; Antoniou, Michael N.; Stephens, Paul; Cain, Katharine			Chromatin Function Modifying Elements in an Industrial Antibody Production Platform - Comparison of UCOE, MAR, STAR and cHS4 Elements	PLOS ONE			English	Article							MATRIX-ATTACHMENT REGION; STRINGENCY SELECTION SYSTEM; DNA METHYLATION; GENE-EXPRESSION; CHO-CELLS; HISTONE MODIFICATIONS; TRANSGENE EXPRESSION; PROTEIN-PRODUCTION; MAMMALIAN-CELLS; INSULATOR	The isolation of stably transfected cell lines suitable for the manufacture of biotherapeutic protein products can be an arduous process relying on the identification of a high expressing clone; this frequently involves transgene amplification and maintenance of the clones' expression over at least 60 generations. Maintenance of expression, or cell line stability, is highly dependent upon the nature of the genomic environment at the site of transgene integration, where epigenetic mechanisms lead to variable expression and silencing in the vast majority of cases. We have assessed four chromatin function modifying elements (A2UCOE, MARX_S29, STAR40 and cHS4) for their ability to negate chromatin insertion site position effects and their ability to express and maintain monoclonal antibody expression. Each element was analysed by insertion into different positions within a vector, either flanking or between heavy chain (HC) and light chain (LC) antibody expression cassettes. Our results clearly show that the A2UCOE is the most beneficial element in this system, with stable cell pools and clones increasing antibody yields 6.5-fold and 6.75-fold respectively. Stability analysis demonstrated that the reduction in antibody expression, seen with cells transfected with the control vector over 120 generations, was mitigated in the clones containing A2UCOE-augmented transgenes. Analysis also showed that the A2UCOE reduced the amount of transgene promoter DNA methylation, which contributed to the maintenance of starting levels of expression.	[Saunders, Fay; Sweeney, Berni; Stephens, Paul; Cain, Katharine] UCB, Prot Express & Purificat Grp, Slough, Berks, England; [Antoniou, Michael N.] Kings Coll London, Guys Hosp, Sch Med, Gene Express & Therapy Grp,Dept Mol Genet, London, England	UCB Pharma SA; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Cain, K (corresponding author), UCB, Prot Express & Purificat Grp, Slough, Berks, England.	Katharine.Cain@UCB.com			UCB Pharma	UCB Pharma(UCB Pharma SA)	Funding was provided by UCB Pharma. Katharine Cain, Bernie Sweeney and Paul Stephens are full time employees of UCB Pharma. Fay Saunders contributed to this work whilst an employee of UCB Pharma. UCB Pharma had a role in study design, data collection and analysis, and the decision to publish, and preparation of the manuscript.	Allen ML, 2007, EPIGENETICS-US, V2, P227, DOI 10.4161/epi.2.4.5231; Antoniou M, 2003, GENOMICS, V82, P269, DOI 10.1016/S0888-7543(03)00107-1; Antoniou MN, 2013, HUM GENE THER, V24, P363, DOI 10.1089/hum.2013.062; Barnes LM, 2003, BIOTECHNOL BIOENG, V81, P631, DOI 10.1002/bit.10517; Benton T, 2002, CYTOTECHNOLOGY, V38, P43, DOI 10.1023/A:1021141712344; Bode J, 1996, CRIT REV EUKAR GENE, V6, P115, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.20; Boscolo S, 2012, NEW BIOTECHNOL, V29, P477, DOI 10.1016/j.nbt.2011.12.005; Brendel C, 2012, GENE THER, V19, P1018, DOI 10.1038/gt.2011.167; BROWN ME, 1992, CYTOTECHNOLOGY, V9, P231, DOI 10.1007/BF02521750; Cacciatore JJ, 2013, J BIOTECHNOL, V164, P346, DOI 10.1016/j.jbiotec.2013.01.016; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Emery DW, 2000, P NATL ACAD SCI USA, V97, P9150, DOI 10.1073/pnas.160159597; Girod PA, 2005, BIOTECHNOL BIOENG, V91, P1, DOI 10.1002/bit.20563; Girod PA, 2007, NAT METHODS, V4, P747, DOI 10.1038/NMETH1076; Gorman C, 2000, CURR OPIN BIOTECH, V11, P455, DOI 10.1016/S0958-1669(00)00127-0; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Hoeksema F, 2011, MOL BIOTECHNOL, V48, P19, DOI 10.1007/s12033-010-9344-8; Izumi M, 2000, J CELL BIOCHEM, V76, P280, DOI 10.1002/(SICI)1097-4644(20000201)76:2<280::AID-JCB11>3.0.CO;2-0; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Kim JM, 2004, J BIOTECHNOL, V107, P95, DOI 10.1016/j.jbiotec.2003.09.015; Kim SJ, 1998, BIOTECHNOL BIOENG, V58, P73, DOI 10.1002/(SICI)1097-0290(19980405)58:1<73::AID-BIT8>3.0.CO;2-R; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; Lattenmayer C, 2006, CYTOTECHNOLOGY, V51, P171, DOI 10.1007/s10616-006-9029-0; Majocchi S, 2014, NUCLEIC ACIDS RES, V42, P193, DOI 10.1093/nar/gkt880; MIELKE C, 1990, BIOCHEMISTRY-US, V29, P7475, DOI 10.1021/bi00484a017; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Otte AP, 2007, BIOTECHNOL PROGR, V23, P801, DOI 10.1021/bp070107r; Pfaff N, 2013, STEM CELLS, V31, P488, DOI 10.1002/stem.1316; Pikaart MI, 1998, GENE DEV, V12, P2852, DOI 10.1101/gad.12.18.2852; Potts W, 2000, BIOCHEM BIOPH RES CO, V273, P1015, DOI 10.1006/bbrc.2000.3013; REITMAN M, 1990, MOL CELL BIOL, V10, P2774, DOI 10.1128/MCB.10.6.2774; STIEF A, 1989, NATURE, V341, P343, DOI 10.1038/341343a0; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; van Blokland HJM, 2007, J BIOTECHNOL, V128, P237, DOI 10.1016/j.jbiotec.2006.09.023; Villemure JF, 2001, J MOL BIOL, V312, P963, DOI 10.1006/jmbi.2001.5015; Walters MC, 1999, MOL CELL BIOL, V19, P3714; Wang TY, 2010, CELL BIOL INT, V34, P141, DOI 10.1042/CBI20090017; Williams S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-17; Yang YS, 2010, J BIOTECHNOL, V147, P180, DOI 10.1016/j.jbiotec.2010.04.004; YU JH, 1994, GENE, V139, P139, DOI 10.1016/0378-1119(94)90747-1; Zahn-Zabal M, 2001, J BIOTECHNOL, V87, P29, DOI 10.1016/S0168-1656(00)00423-5; Zhang F, 2010, MOL THER, V18, P1640, DOI 10.1038/mt.2010.132	44	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120096	10.1371/journal.pone.0120096	http://dx.doi.org/10.1371/journal.pone.0120096			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849659	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800019
J	Sinha, P; Singh, VK; Suryanarayana, V; Krishnamurthy, L; Saxena, RK; Varshney, RK				Sinha, Pallavi; Singh, Vikas K.; Suryanarayana, V.; Krishnamurthy, L.; Saxena, Rachit K.; Varshney, Rajeev K.			Evaluation and Validation of Housekeeping Genes as Reference for Gene Expression Studies in Pigeonpea (Cajanus cajan) Under Drought Stress Conditions	PLOS ONE			English	Article							REAL-TIME PCR; INTERNAL CONTROL; QRT-PCR; NORMALIZATION; SELECTION; POTATO	Gene expression analysis using quantitative real-time PCR (qRT-PCR) is a very sensitive technique and its sensitivity depends on the stable performance of reference gene(s) used in the study. A number of housekeeping genes have been used in various expression studies in many crops however, their expression were found to be inconsistent under different stress conditions. As a result, species specific housekeeping genes have been recommended for different expression studies in several crop species. However, such specific housekeeping genes have not been reported in the case of pigeonpea (Cajanus cajan) despite the fact that genome sequence has become available for the crop. To identify the stable housekeeping genes in pigeonpea for expression analysis under drought stress conditions, the relative expression variations of 10 commonly used housekeeping genes (EF1 alpha, UBQ10, GAPDH, 18SrRNA, 25SrRNA, TUB6, ACT1, IF4 alpha, UBC and HSP90) were studied on root, stem and leaves tissues of Asha (ICPL 87119). Three statistical algorithms geNorm, NormFinder and BestKeeper were used to define the stability of candidate genes. geNorm analysis identified IF4 alpha and TUB6 as the most stable housekeeping genes however, NormFinder analysis determined IF4 alpha and HSP90 as the most stable housekeeping genes under drought stress conditions. Subsequently validation of the identified candidate genes was undertaken in qRT-PCR based gene expression analysis of uspA gene which plays an important role for drought stress conditions in pigeonpea. The relative quantification of the uspA gene varied according to the internal controls (stable and least stable genes), thus highlighting the importance of the choice of as well as validation of internal controls in such experiments. The identified stable and validated housekeeping genes will facilitate gene expression studies in pigeonpea especially under drought stress conditions.	[Sinha, Pallavi; Singh, Vikas K.; Suryanarayana, V.; Krishnamurthy, L.; Saxena, Rachit K.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad 502324, Andhra Pradesh, India; [Varshney, Rajeev K.] Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia; [Varshney, Rajeev K.] Univ Western Australia, Inst Agr, Crawley, WA 6009, Australia	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Western Australia; University of Western Australia	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad 502324, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014	Varshney, Rajeev K/0000-0002-4562-9131; sinha, Pallavi/0000-0003-0810-0711; Singh, Vikas Kumar/0000-0002-1560-1648	CGIAR Generation Challenge Programme (GCP); United States Agency for International Development (USAID)	CGIAR Generation Challenge Programme (GCP); United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The authors thank the CGIAR Generation Challenge Programme (GCP) and United States Agency for International Development (USAID) for financial support for the research work. This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Bohra A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-56; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Dubey A, 2011, DNA RES, V18, P153, DOI 10.1093/dnares/dsr007; Duhoux A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063576; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Gonzalez MC, 2002, PLANT SCI, V162, P233, DOI 10.1016/S0168-9452(01)00548-9; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Krishnamurthy L, 2012, J AGR SCI-CAMBRIDGE, V150, P357, DOI 10.1017/S0021859611000682; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Liu CL, 2012, EXTREMOPHILES, V16, P419, DOI 10.1007/s00792-012-0441-4; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Lopez-Pardo R, 2013, MOL BREEDING, V31, P39, DOI 10.1007/s11032-012-9766-z; Ma SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003840; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Maksup S, 2013, CHINESE SCI BULL, V58, P1919, DOI 10.1007/s11434-013-5726-1; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Nagaraja Deeplanaik, 2013, Journal of Crop Science and Biotechnology, V16, P243, DOI 10.1007/s12892-013-0069-7; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Priyanka B, 2010, MOL GENET GENOMICS, V283, P273, DOI 10.1007/s00438-010-0516-9; Raju NL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-45; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Saxena K. B., 2008, Tropical Plant Biology, V1, P159, DOI 10.1007/s12042-008-9014-1; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Varshney RK, 2010, MOL BREEDING, V26, P393, DOI 10.1007/s11032-009-9327-2; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	49	59	60	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122847	10.1371/journal.pone.0122847	http://dx.doi.org/10.1371/journal.pone.0122847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849964	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000352477800164
J	Zhang, Y; Wang, H; Cui, LJ; Zhang, YY; Liu, Y; Chu, X; Liu, ZY; Zhang, JP; Chu, L				Zhang, Ying; Wang, Hao; Cui, Lijing; Zhang, Yuanyuan; Liu, Yang; Chu, Xi; Liu, Zhenyi; Zhang, Jianping; Chu, Li			Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKER; THALASSEMIA MAJOR; OXIDATIVE STRESS; COMPOUND ASTRAGALUS; COLLAGEN-SYNTHESIS; DANSHEN INJECTION; HEPATIC-FIBROSIS; CARDIAC FIBROSIS; CA2+ CHANNELS; EXTRACT	Iron overload cardiomyopathy results from iron accumulation in the myocardium that is closely linked to iron-mediated myocardial fibrosis. Salvia miltiorrhiza (SM, also known as Danshen), a traditional Chinese medicinal herb, has been widely used for hundreds of years to treat cardiovascular diseases. Here, we investigated the effect and potential mechanism of SM on myocardial fibrosis induced by chronic iron overload (CIO) in mice. Kunming male mice (8 weeks old) were randomized to six groups of 10 animals each: control (CONT), CIO, low-dose SM (L-SM), high-dose SM (H-SM), verapamil (VRP) and deferoxamine (DFO) groups. Normal saline was injected in the CONT group. Mice in the other five groups were treated with iron dextran at 50 mg/kg per day intraperitoneally for 7 weeks, and those in the latter four groups also received corresponding daily treatments, including 3 g/kg or 6 g/kg of SM, 100 mg/kg of VRP, or 100 mg/kg of DFO. The iron deposition was estimated histologically using Prussian blue staining. Myocardial fibrosis was determined by Masson's trichrome staining and hydroxyproline (Hyp) quantitative assay. Superoxide dismutase (SOD) activity, malondialdehyde (MDA) content and protein expression levels of type I collagen (COL I), type I collagen (COL III), transforming growth factor-beta(1) (TGF-beta(1)) and matrix metalloproteinase-9 (MMP-9) were analyzed to investigate the mechanisms underlying the effects of SM against iron-overloaded fibrosis. Treatment of chronic iron-overloaded mice with SM dose-dependently reduced iron deposition levels, fibrotic area percentage, Hyp content, expression levels of COL I and COL III, as well as upregulated the expression of TGF-beta(1) and MMP-9 proteins in the heart. Moreover, SM treatment decreased MDA content and increased SOD activity. In conclusion, SM exerted activities against cardiac fibrosis induced by CIO, which may be attributed to its inhibition of iron deposition, as well as collagen metabolism and oxidative stress.	[Zhang, Ying; Cui, Lijing; Liu, Yang; Zhang, Jianping; Chu, Li] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China; [Wang, Hao] Hebei Med Univ, Dept Chinese Mat Med, Shijiazhuang, Peoples R China; [Zhang, Yuanyuan; Liu, Zhenyi] Hebei Univ Chinese Med, Dept Pharmaceut, Shijiazhuang, Peoples R China; [Chu, Xi] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei University of Chinese Medicine; Hebei Medical University	Chu, L (corresponding author), Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China.	chuli0614@126.com	zhang, yuanyuan/GYA-4428-2022		Nature Fund of Hebei Province, China [C2011206025, H2014206244]; Fund of Hebei Science and Technology Bureau [10276105D-2]	Nature Fund of Hebei Province, China; Fund of Hebei Science and Technology Bureau	This study was supported by the Nature Fund of Hebei Province, China http://hensf.hebstd.gov.cn/(No. C2011206025 and H2014206244) and the Fund of Hebei Science and Technology Bureau http://www.hebstd.gov.cn/(No. 10276105D-2). In this study, the funder conceived and designed the experiments, and wrote the paper.	Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Arezzini B, 2003, INT J BIOCHEM CELL B, V35, P486, DOI 10.1016/S1357-2725(02)00298-4; Barton JC, 1996, NAT MED, V2, P394, DOI 10.1038/nm0496-394; Berdoukas V, 2012, J BLOOD MED, V3, P119, DOI 10.2147/JBM.S27400; Boin F, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0123-7; Borgna-Pignatti C, 2005, ANN NY ACAD SCI, V1054, P40, DOI 10.1196/annals.1345.006; Borgna-Pignatti C, 2006, BLOOD, V107, P3733, DOI 10.1182/blood-2005-07-2933; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Cao CM, 2003, LIFE SCI, V72, P2451, DOI 10.1016/S0024-3205(03)00142-5; Cappellini Maria D, 2009, Hemoglobin, V33 Suppl 1, pS58, DOI 10.3109/03630260903346924; Chang WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097455; Chen L, 2009, PLANTA MED, V75, P1573, DOI 10.1055/s-0029-1185905; Chern JPS, 2007, PEDIATR BLOOD CANCER, V48, P550, DOI 10.1002/pbc.21028; Ding M, 2006, J ALTERN COMPLEM MED, V12, P5, DOI 10.1089/acm.2006.12.5; Fernandes JL, 2013, AM J MED, V126, P834, DOI 10.1016/j.amjmed.2013.05.002; Fraga CG, 2002, TOXICOLOGY, V180, P23, DOI 10.1016/S0300-483X(02)00379-7; Franchini M, 2004, HEMATOL J, V5, P287, DOI 10.1038/sj.thj.6200407; FRIDOVICH I, 1989, FREE RADICAL BIO MED, V7, P557, DOI 10.1016/0891-5849(89)90032-4; Galey JB, 2000, J MED CHEM, V43, P1418, DOI 10.1021/jm9911635; Gao YG, 2014, J ETHNOPHARMACOL, V158, P397, DOI 10.1016/j.jep.2014.10.049; Gao YG, 2013, J ETHNOPHARMACOL, V145, P254, DOI 10.1016/j.jep.2012.10.060; Ge GH, 2014, GENE, V546, P97, DOI 10.1016/j.gene.2014.05.021; Guan SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074318; Gujja P, 2010, J AM COLL CARDIOL, V56, P1001, DOI 10.1016/j.jacc.2010.03.083; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; He S, 2012, BRIT J DERMATOL, V166, P564, DOI 10.1111/j.1365-2133.2011.10674.x; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HOU J, 1999, CHINESE J TUBERCULOS, V22, P43; Hsu YC, 2005, J BIOMED SCI, V12, P185, DOI 10.1007/s11373-004-8167-7; IKEDA H, 1992, HEPATOLOGY, V15, P282, DOI 10.1002/hep.1840150218; Jesmin S, 2002, DIABETOLOGIA, V45, P402, DOI 10.1007/s00125-001-0765-6; Karwinski W, 1996, J SURG RES, V64, P150, DOI 10.1006/jsre.1996.0321; Kudo H, 2008, TOXICOLOGY, V246, P143, DOI 10.1016/j.tox.2008.01.004; Kumfu S, 2011, EUR J HAEMATOL, V86, P156, DOI 10.1111/j.1600-0609.2010.01549.x; Lam FFY, 2006, EUR J PHARMACOL, V553, P240, DOI 10.1016/j.ejphar.2006.09.030; Lee SH, 2011, J ETHNOPHARMACOL, V137, P1409, DOI 10.1016/j.jep.2011.08.007; Lee TY, 2006, J PHARM PHARMACOL, V58, P659, DOI 10.1211/jpp.58.5.0011; Lian WS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-26; Lin H, 2013, MOL PHARMACOL, V84, P275, DOI 10.1124/mol.112.083964; Liu L, 2012, MOL MED REP, V6, P1231, DOI 10.3892/mmr.2012.1076; Lu HY, 2014, BIOL PHARM BULL, V37, P961, DOI 10.1248/bpb.b13-00921; Matsui T, 2010, BIOCHEM BIOPH RES CO, V396, P566, DOI 10.1016/j.bbrc.2010.04.149; Murphy CJ, 2010, J CARD FAIL, V16, P888, DOI 10.1016/j.cardfail.2010.05.009; Nan JX, 2001, J PHARM PHARMACOL, V53, P197, DOI 10.1211/0022357011775406; Oudit GY, 2006, J MOL MED, V84, P349, DOI 10.1007/s00109-005-0029-x; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Patel R, 2006, J VASC SURG, V43, P364, DOI 10.1016/j.jvs.2005.10.032; Pepe A, 2009, HEART, V95, P1688, DOI 10.1136/hrt.2008.156497; Poggiali E, 2012, BLOOD TRANSFUS-ITALY, V10, P411, DOI 10.2450/2012.0008-12; Psaltis PJ, 2011, INT J CARDIOVAS IMAG, V27, P25, DOI 10.1007/s10554-010-9657-5; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reed AL, 2011, AM J PHYSIOL-HEART C, V301, pH824, DOI 10.1152/ajpheart.00407.2010; Reeder BJ, 2008, FREE RADICAL BIO MED, V44, P264, DOI 10.1016/j.freeradbiomed.2007.08.006; Rui WJ, 2014, J ETHNOPHARMACOL, V151, P198, DOI 10.1016/j.jep.2013.10.022; Saewong T, 2010, MED CHEM, V6, P57, DOI 10.2174/157340610791321479; Santos MM, 2000, AM J PATHOL, V157, P1883, DOI 10.1016/S0002-9440(10)64827-4; Selim M, 2010, TRANSL STROKE RES, V1, P35, DOI 10.1007/s12975-009-0001-0; Sugishita K, 2009, INT HEART J, V50, P829, DOI 10.1536/ihj.50.829; Tian Xiao-hui, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P404; Usunier B, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/340257; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang M, 2012, J ETHNOPHARMACOL, V141, P96, DOI 10.1016/j.jep.2012.02.005; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Wasser S, 1998, J HEPATOL, V29, P760, DOI 10.1016/S0168-8278(98)80257-2; Weatherall DJ, 1996, NAT MED, V2, P847, DOI 10.1038/nm0896-847; Wu WY, 2012, ACTA PHARMACOL SIN, V33, P1119, DOI 10.1038/aps.2012.126; Yang Y, 2008, J ETHNOPHARMACOL, V118, P264, DOI 10.1016/j.jep.2008.04.012; Yu QL, 2014, MYCOPATHOLOGIA, V177, P167, DOI 10.1007/s11046-014-9735-7; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang JP, 2013, PLANTA MED, V79, P744, DOI 10.1055/s-0032-1328588; Zhang Y, 2012, EUR J PHARMACOL, V680, P95, DOI 10.1016/j.ejphar.2012.01.010; Zhang Y, 2013, J ETHNOPHARMACOL, V148, P671, DOI 10.1016/j.jep.2013.05.028; Zhou XL, 2012, PHYTOMEDICINE, V19, P1263, DOI 10.1016/j.phymed.2012.08.011; Zou CB, 2013, ENDOCRINE, V44, P666, DOI 10.1007/s12020-013-9907-0	74	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0124061	10.1371/journal.pone.0124061	http://dx.doi.org/10.1371/journal.pone.0124061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850001	Green Submitted, Green Published, gold			2022-12-27	WOS:000352477800261
J	Cacciatore, I; Di Giulio, M; Fornasari, E; Di Stefano, A; Cerasa, LS; Marinelli, L; Turkez, H; Di Campli, E; Di Bartolomeo, S; Robuffo, I; Cellini, L				Cacciatore, Ivana; Di Giulio, Mara; Fornasari, Erika; Di Stefano, Antonio; Cerasa, Laura Serafina; Marinelli, Lisa; Turkez, Hasan; Di Campli, Emanuela; Di Bartolomeo, Soraya; Robuffo, Iole; Cellini, Luigina			Carvacrol Codrugs: A New Approach in the Antimicrobial Plan	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESSENTIAL OILS; PRODRUG; BACTERIA; BIOFILM; OREGANO; THYMOL; AGENTS; ACID	Objective The increasing prevalence of antibiotic-resistant bacterial infections led to identify alternative strategies for a novel therapeutic approach. In this study, we synthesized ten carvacrol codrugs - obtained linking the carvacrol hydroxyl group to the carboxyl moiety of sulphur-containing amino acids via an ester bond - to develop novel compounds with improved antimicrobial and antibiofilm activities and reduced toxicity respect to carvacrol alone. Method All carvacrol codrugs were screened against a representative panel of Gram positive (S. aureus and S. epidermidis), Gram negative (E. coli and P. aeruginosa) bacterial strains and C. albicans, using broth microdilution assays. Findings Results showed that carvacrol codrug 4 possesses the most notable enhancement in the anti-bacterial activity displaying MIC and MBC values equal to 2.5 mg/mL for all bacterial strains, except for P. aeruginosa ATCC 9027 (MIC and MBC values equal to 5 mg/mL and 10 mg/mL, respectively). All carvacrol codrugs 1-10 revealed good antifungal activity against C. albicans ATCC 10231. The cytotoxicity assay showed that the novel carvacrol codrugs did not produce human blood hemolysis at their MIC values except for codrugs 8 and 9. In particular, deepened experiments performed on carvacrol codrug 4 showed an interesting antimicrobial effect on the mature biofilm produced by E. coli ATCC 8739, respect to the carvacrol alone. The antimicrobial effects of carvacrol codrug 4 were also analyzed by TEM evidencing morphological modifications in S. aureus, E. coli, and C. albicans. Conclusion The current study presents an insight into the use of codrug strategy for developing carvacrol derivatives with antibacterial and antibiofilm potentials, and reduced cytotoxicity.	[Cacciatore, Ivana; Di Giulio, Mara; Fornasari, Erika; Di Stefano, Antonio; Cerasa, Laura Serafina; Marinelli, Lisa; Turkez, Hasan; Di Campli, Emanuela; Di Bartolomeo, Soraya; Cellini, Luigina] Univ G dAnnunzio, Dept Pharm, Chieti, Italy; [Turkez, Hasan] Erzurum Tech Univ, Dept Mol Biol & Genet, Fac Sci, Erzurum, Turkey; [Robuffo, Iole] CNR, Inst Mol Genet, Sect Chieti, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; Erzurum Technical University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	Cacciatore, I (corresponding author), Univ G dAnnunzio, Dept Pharm, Chieti, Italy.	cacciatore@unich.it	Türkez, Hasan/AAQ-4905-2020; Robuffo, Iole/O-2918-2015	Robuffo, Iole/0000-0001-5883-4225; cacciatore, ivana/0000-0001-6253-0443; DI CAMPLI, Emanuela/0000-0001-5311-2848; DI STEFANO, Antonio/0000-0002-3042-2234; DI GIULIO, MARA/0000-0002-8375-9404; MARINELLI, LISA/0000-0001-8611-6538; Cellini, Luigina/0000-0003-4068-9124	Foundation Carichieti, Abruzzo-Italy	Foundation Carichieti, Abruzzo-Italy	Support was provided by Foundation Carichieti, Abruzzo-Italy.	Ahmad A, 2011, EUR J CLIN MICROBIOL, V30, P41, DOI 10.1007/s10096-010-1050-8; Ait-Ouazzou A, 2013, J APPL MICROBIOL, V114, P173, DOI 10.1111/jam.12028; Arabaci T, 2013, ACTA ODONTOL SCAND, V71, P1255, DOI 10.3109/00016357.2012.757646; Arendrup MC, 2012, CLIN MICROBIOL INFEC, V18, pE246, DOI 10.1111/j.1469-0691.2012.03880.x; Aslam S, 2011, INT J ARTIF ORGANS, V34, P752, DOI 10.5301/ijao.5000024; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Baldassarre L, 2012, J PEPT SCI, V18, P567, DOI 10.1002/psc.2435; Belley A, 2009, ANTIMICROB AGENTS CH, V53, P800, DOI 10.1128/AAC.00603-08; BERGERON RJ, 1980, J MED CHEM, V23, P1130, DOI 10.1021/jm00184a013; Bertling A, 2010, THROMB HAEMOSTASIS, V104, P270, DOI 10.1160/TH09-11-0769; Borde AS, 2012, EUR J PHARM BIOPHARM, V80, P630, DOI 10.1016/j.ejpb.2011.11.011; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Burt SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093414; Cacciatore I., 2003, Farmaco (Lausanne), V58, P787, DOI 10.1016/S0014-827X(03)00135-6; Cacciatore I, 2005, AMINO ACIDS, V28, P77, DOI 10.1007/s00726-004-0142-0; Cacciatore I, 2013, PHARMACEUTICALS, V6, P54, DOI 10.3390/ph6010054; Cacciatore I, 2013, CHEMMEDCHEM, V8, P1818, DOI 10.1002/cmdc.201300295; Cacciatore I, 2012, CHEMMEDCHEM, V7, P2021, DOI 10.1002/cmdc.201200320; Cingolani GM, 2000, BIOORG MED CHEM LETT, V10, P1385, DOI 10.1016/S0960-894X(00)00249-3; Cirioni O, 2013, PEPTIDES, V40, P77, DOI 10.1016/j.peptides.2012.12.002; Das N, 2010, EUR J PHARM SCI, V41, P571, DOI 10.1016/j.ejps.2010.09.014; Di Stefano A, 2009, MICROB BIOTECHNOL, V2, P634, DOI 10.1111/j.1751-7915.2009.00120.x; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Fujisawa H, 2009, BIOSCI BIOTECH BIOCH, V73, P1948, DOI 10.1271/bbb.90096; Giesbrecht P, 1998, MICROBIOL MOL BIOL R, V62, P1371, DOI 10.1128/MMBR.62.4.1371-1414.1998; Goto M, 2001, J PHARM PHARMACOL, V53, P1711, DOI 10.1211/0022357011778115; Hansen T, 2011, J MED CHEM, V54, P858, DOI 10.1021/jm101327d; Harris JC, 2001, APPL MICROBIOL BIOT, V57, P282, DOI 10.1007/s002530100722; Hasselmann C, 2003, CLIN MICROBIOL INFEC, V9; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Iannitelli A, 2011, INT J MOL SCI, V12, P5039, DOI 10.3390/ijms12085039; Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005; Johnson SA, 2002, J APPL MICROBIOL, V93, P336, DOI 10.1046/j.1365-2672.2002.01691.x; Karkabounas S., 2006, Experimental Oncology, V28, P121; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Minelli A, 2012, AMINO ACIDS, V43, P1359, DOI 10.1007/s00726-011-1210-x; NISHINO T, 1975, JPN J MICROBIOL, V19, P53, DOI 10.1111/j.1348-0421.1975.tb00847.x; Nostro A., 2012, DRUG DISCOVERY, V7, P28, DOI DOI 10.2174/157489112799829684; Nostro A, 2007, J MED MICROBIOL, V56, P519, DOI 10.1099/jmm.0.46804-0; Nostro A, 2009, J MED MICROBIOL, V58, P791, DOI 10.1099/jmm.0.009274-0; Patruno A, 2015, MOL PHARMACEUT, V12, P66, DOI 10.1021/mp500431r; PerezGiraldo C, 1997, J ANTIMICROB CHEMOTH, V39, P643, DOI 10.1093/jac/39.5.643; Sozio P, 2013, MOLECULES, V18, P10747, DOI 10.3390/molecules180910747; Sozio P, 2013, EUR J PHARM SCI, V49, P187, DOI 10.1016/j.ejps.2013.02.013; Tran CD, 2010, SCAND J GASTROENTERO, V45, P1424, DOI 10.3109/00365521.2010.506245; Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002; Veldhuizen EJA, 2006, J AGR FOOD CHEM, V54, P1874, DOI 10.1021/jf052564y; Zhao TM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-140; Zotti M, 2013, MOLECULES, V18, P6161, DOI 10.3390/molecules18066161	49	42	44	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0120937	10.1371/journal.pone.0120937	http://dx.doi.org/10.1371/journal.pone.0120937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25859852	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300019
J	Ding, YN; Gu, DF; Zhang, YX; Han, WJ; Liu, HL; Qu, Q				Ding, Yanan; Gu, Dongfeng; Zhang, Yanxuan; Han, Wenjie; Liu, Hengliang; Qu, Qingshan			Significantly Increased Visceral Adiposity Index in Prehypertension	PLOS ONE			English	Article							METABOLIC-SYNDROME; CARDIOMETABOLIC RISK; NONHYPERTENSIVE PARTICIPANTS; CARDIOVASCULAR RISK; KIDNEY-DISEASE; BLOOD-PRESSURE; HYPERTENSION; PROGRESSION; OBESITY; BURDEN	Background The prevalence of prehypertension has increased in China, and prehypertension frequently progress to hypertension over a short time period; both have become public health problems. Therefore, this study was conducted to determine the relationship between the Visceral Adiposity Index (VAI) and blood pressure (BP) in China. Methods A cross-sectional epidemiological survey was conducted in China using a stratified random cluster sampling method. Sex-specific VAI quartile cut-off points were used as follows: 0.88, 1.41, 2.45 in males and 0.85, 1.33, 2.22 in females. Prehypertension and hypertension were each defined according to The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines. A multivariate logistic analysis was conducted to analyze the relationship among VAI, prehypertension and hypertension. Results The ORs for prehypertension and hypertension in the upper quartiles of the VAI were 1.514 (1.074-2.133), P=0.018 and 1.660 (1.084-2.542), P=0.020, in males, after adjusting for age, education, smoking habits, alcohol consumption, physical activity, serum creatinine, fasting glucose, and plasma insulin. Following further adjustments for the above confounders, chronic kidney disease, and diabetes, the ORs for prehypertension and hypertension in the upper quartile of the VAI were 1.660 1.533 (1.086-2.165), P=0.015, and 1.743 (1.133-2.680), P=0.011, in males. The ORs for prehypertension and hypertension in the upper quartile of the VAI were 1.691 (1.223-2.338), P=0.001, and 1.682 (1.162-2.435), P=0.006, in females, after adjusting for age, education, smoking habits, alcohol consumption, physical activity, serum creatinine, fasting glucose, and plasma insulin. Following further adjustments for the above confounders, chronic kidney disease, and diabetes, the ORs for prehypertension and hypertension in the upper quartile of the VAI were 1.688 (1.220-2.334), P=0.002, and 1.657 (1.141-2.406), P=0.008, in females. Conclusions A higher VAI was positively associated with both prehypertension and hypertension in both males and females. It is both essential and urgent that clinicians take steps to control and prevent visceral adiposity.	[Ding, Yanan; Han, Wenjie; Liu, Hengliang] Southeast Med Univ, Peoples Hosp Zhengzhou, Div Cardiovasc Med, Zhengzhou, Peoples R China; [Gu, Dongfeng; Zhang, Yanxuan; Qu, Qingshan] Southeast Med Univ, Peoples Hosp Zhengzhou, Dept Nephrol, Zhengzhou, Peoples R China; [Gu, Dongfeng; Zhang, Yanxuan; Qu, Qingshan] Southeast Med Univ, Peoples Hosp Zhengzhou, Transplantat Ctr, Zhengzhou, Peoples R China		Qu, Q (corresponding author), Southeast Med Univ, Peoples Hosp Zhengzhou, Dept Nephrol, Zhengzhou, Peoples R China.	13703717386@163.com			Diagnosis and Treatment of Atherosclerosis and Related Diseases [096SYJH33114]; Zhengzhou Municipal Science and Technology Research and Development Commission	Diagnosis and Treatment of Atherosclerosis and Related Diseases; Zhengzhou Municipal Science and Technology Research and Development Commission	This study was supported by the following science foundations and grants as the Diagnosis and Treatment of Atherosclerosis and Related Diseases (No.: 096SYJH33114), which was supported by Zhengzhou Municipal Science and Technology Research and Development Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-183; Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Amato MC, 2011, HUM REPROD, V26, P1486, DOI 10.1093/humrep/der088; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Chen C, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-108; Chen HF, 2014, ADVANCED CERAMICS FOR DENTISTRY, P5, DOI 10.1016/B978-0-12-394619-5.00002-X; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chong EW, 2009, ARCH OPHTHALMOL-CHIC, V127, P1640, DOI 10.1001/archophthalmol.2009.298; Demerath EW, 2008, AM J CLIN NUTR, V88, P1263, DOI 10.3945/ajcn.2008.26546; DeNino WF, 2001, DIABETES CARE, V24, P925, DOI 10.2337/diacare.24.5.925; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Du T, 2015, NUTR METAB CARDIOVAS, V25, P100, DOI 10.1016/j.numecd.2014.07.006; Eknoyan G, 2004, KIDNEY INT, V66, P1310, DOI 10.1111/j.1523-1755.2004.00894.x; Eknoyan G, 2001, AM J KIDNEY DIS, V37, pS5, DOI 10.1016/S0272-6386(01)70004-2; Elisha B, 2013, APPL PHYSIOL NUTR ME, V38, P892, DOI 10.1139/apnm-2012-0307; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kim MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-960; Kishida K, 2012, ANN MED, V44, P233, DOI 10.3109/07853890.2011.564202; Knowles KM, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/931402; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mannisto T, 2013, CIRCULATION, V127, P681, DOI 10.1161/CIRCULATIONAHA.112.128751; Mazzuca E, 2014, J SLEEP RES, V23, P13, DOI 10.1111/jsr.12088; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pickhardt PJ, 2012, AM J ROENTGENOL, V198, P1100, DOI 10.2214/AJR.11.7361; Pierdomenico SD, 2011, AM J HYPERTENS, V24, P1245, DOI 10.1038/ajh.2011.134; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Russo GT, 2015, J ENDOCRINOL INVEST, V38, P81, DOI 10.1007/s40618-014-0163-9; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Stepien M, 2014, ANGIOLOGY, V65, P333, DOI 10.1177/0003319713485807; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104365; Zhang HF, 2006, J HYPERTENS, V24, P1719, DOI 10.1097/01.hjh.0000242395.07473.92; Zoccali C, 2002, CURR HYPERTENS REP, V4, P381, DOI 10.1007/s11906-002-0068-4	38	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123414	10.1371/journal.pone.0123414	http://dx.doi.org/10.1371/journal.pone.0123414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860643	Green Published, gold, Green Submitted			2022-12-27	WOS:000352590300096
J	Iizuka-Kogo, A; Senda, T; Akiyama, T; Shimomura, A; Nomura, R; Hasegawa, Y; Yamamura, K; Kogo, H; Sawai, N; Matsuzaki, T				Iizuka-Kogo, Akiko; Senda, Takao; Akiyama, Tetsu; Shimomura, Atsushi; Nomura, Ryuji; Hasegawa, Yoshimi; Yamamura, Ken-ichi; Kogo, Hiroshi; Sawai, Nobuhiko; Matsuzaki, Toshiyuki			Requirement of DLG1 for Cardiovascular Development and Tissue Elongation during Cochlear, Enteric, and Skeletal Development: Possible Role in Convergent Extension	PLOS ONE			English	Article							PLANAR CELL POLARITY; CARDIAC OUTFLOW TRACT; SECONDARY HEART FIELD; NEURAL-TUBE CLOSURE; MAMMALIAN INNER-EAR; VENTRICULAR SEPTUM; CREST CELLS; FRIZZLED 2; MICE; MOUSE	The Dlg1 gene encodes a member of the MAGUK protein family involved in the polarization of epithelial cells. Null mutant mice for the Dlg1 gene (Dlg1(-/-) mice) exhibit respiratory failure and cyanosis, and die soon after birth. However, the cause of this neonatal lethality has not been determined. In the present study, we further examined Dlg1(-/-) mice and found severe defects in the cardiovascular system, including ventricular septal defect, persistent truncus arteriosus, and double outlet right ventricle, which would cause the neonatal lethality. These cardiovascular phenotypes resemble those of mutant mice lacking planar cell polarity (PCP) genes and support a recent notion that DLG1 is involved in the PCP pathway. We assessed the degree of involvement of DLG1 in the development of other organs, as the cochlea, intestine, and skeleton, in which PCP signaling has been suggested to play a role. In the organ of Corti, tissue elongation was inhibited accompanied by disorganized arrangement of the hair cell rows, while the orientation of the stereocilia bundle was normal. In the sternum, cleft sternum, abnormal calcification pattern of cartilage, and disorganization of chondrocytes were observed. Furthermore, shortening of the intestine, sternum, and long bones of the limbs was observed. These phenotypes of Dlg1(-/-) mice involving cellular disorganization and insufficient tissue elongation strongly suggest a defect in the convergent extension movements in these mice. Thus, our present results provide a possibility that DLG1 is particularly required for convergent extension among PCP signaling-dependent processes.	[Iizuka-Kogo, Akiko; Senda, Takao; Shimomura, Atsushi; Nomura, Ryuji; Hasegawa, Yoshimi] Fujita Hlth Univ, Sch Med, Dept Anat 1, Aichi, Japan; [Iizuka-Kogo, Akiko; Kogo, Hiroshi; Sawai, Nobuhiko; Matsuzaki, Toshiyuki] Gunma Univ, Grad Sch Med, Dept Anat & Cell Biol, Gunma, Japan; [Senda, Takao] Gifu Univ, Grad Sch Med, Dept Anat, Gifu, Japan; [Akiyama, Tetsu] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo, Japan; [Shimomura, Atsushi] Hlth Sci Univ Hokkaido, Sch Psychol Sci, Dept Commun Disorders, Sapporo, Hokkaido, Japan; [Yamamura, Ken-ichi] Kumamoto Univ, Div Dev Genet, Inst Resource Dev, Kumamoto, Japan	Fujita Health University; Gunma University; Gifu University; University of Tokyo; Health Sciences University of Hokkaido; Kumamoto University	Iizuka-Kogo, A (corresponding author), Fujita Hlth Univ, Sch Med, Dept Anat 1, Aichi, Japan.	akogo@gunma-u.ac.jp	Kogo, Hiroshi/AAB-8467-2019	Kogo, Hiroshi/0000-0003-0584-7158	Japan Society for the Promotion of Science [19790158, 22790193, 25460240]; Grants-in-Aid for Scientific Research [25460240, 24592567] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Grants-in-Aid for Young Scientists (B) (19790158 and 22790193) and a Grant-in-Aid for Scientific Research (C) (25460240) to AIK from Japan Society for the Promotion of Science (www.jsps.go.jp). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens MJ, 2009, DEVELOPMENT, V136, P3463, DOI 10.1242/dev.040592; Antic D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008999; Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Cervantes S, 2009, DEV BIOL, V326, P285, DOI 10.1016/j.ydbio.2008.11.020; Chacon-Heszele MF, 2012, DEVELOPMENT, V139, P968, DOI 10.1242/dev.065326; Chen P, 1999, DEVELOPMENT, V126, P1581; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Farlie Peter G, 2004, Birth Defects Res C Embryo Today, V72, P173, DOI 10.1002/bdrc.20013; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Henderson DJ, 2001, CIRC RES, V89, P6, DOI 10.1161/hh1301.092497; Humbert PO, 2006, TRENDS CELL BIOL, V16, P622, DOI 10.1016/j.tcb.2006.10.005; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Iizuka-Kogo A, 2005, HISTOCHEM CELL BIOL, V123, P67, DOI 10.1007/s00418-004-0729-2; Iizuka-Kogo A, 2007, DEVELOPMENT, V134, P1799, DOI 10.1242/dev.02830; Iizuka-Kogo A, 2013, ANAT REC, V296, P1936, DOI 10.1002/ar.22814; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; Kawakami M, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-68; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; Lin CJ, 2012, DEVELOPMENT, V139, P3277, DOI 10.1242/dev.063495; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Mahoney ZX, 2006, P NATL ACAD SCI USA, V103, P19872, DOI 10.1073/pnas.0609326103; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Mauser JF, 2012, PLOS ONE, V7, P118, DOI 10.1371/journal.pone.0029611; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; Naim E, 2005, KIDNEY INT, V68, P955, DOI 10.1111/j.1523-1755.2005.00489.x; Parker M, 2010, J VISUALIZED EXPT; Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406; Phillips HM, 2005, CIRC RES, V96, P292, DOI 10.1161/01.RES.0000154912.08695.88; Rivera C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054410; Sakai Kazuyoshi, 2004, Okajimas Folia Anatomica Japonica, V81, P25, DOI 10.2535/ofaj.81.25; Scherptong RWC, 2012, DEV DYNAM, V241, P1413, DOI 10.1002/dvdy.23833; Schleiffarth JR, 2007, PEDIATR RES, V61, P386, DOI 10.1203/pdr.0b013e3180323810; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Sinha T, 2012, DEV BIOL, V370, P135, DOI 10.1016/j.ydbio.2012.07.023; Walck-Shannon E, 2014, NAT REV MOL CELL BIO, V15, P34, DOI 10.1038/nrm3723; Waldo K, 1998, DEV BIOL, V196, P129, DOI 10.1006/dbio.1998.8860; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212; Yamauchi Y, 1999, DEV BIOL, V212, P191, DOI 10.1006/dbio.1999.9323; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001	54	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123965	10.1371/journal.pone.0123965	http://dx.doi.org/10.1371/journal.pone.0123965			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860837	Green Published, Green Submitted, gold			2022-12-27	WOS:000352590300126
J	Liu, ZL; Tao, XX; Chen, YX; Fan, ZJ; Li, YJ				Liu, Zhenlei; Tao, Xixi; Chen, Yuexin; Fan, Zhongjie; Li, Yongjun			Bed Rest versus Early Ambulation with Standard Anticoagulation in The Management of Deep Vein Thrombosis: A Meta-Analysis	PLOS ONE			English	Article							VENOUS THROMBOSIS; PULMONARY-EMBOLISM; EARLY MOBILIZATION; INCREASE; RISK; COMPRESSION; EXERCISE	Introduction Bed rest has been considered as the cornerstone of management of deep vein thrombosis (DVT) for a long time, though it is not evidence-base, and there is growing evidence favoring early ambulation. Methods Electronic databases including Medline, PubMed, Cochrane Library and three Chinese databases were searched with key words of "deep vein thrombosis", "pulmonary embolism", "venous thrombosis", "bed rest", "immobilization", "mobilization" and "ambulation". We considered randomized controlled trials, prospective or retrospective cohort studies that compared the outcomes of acute DVT patients managed with early ambulation versus bed rest, in addition to standard anticoagulation. Meta-analysis pertaining to the incidence of new pulmonary embolism (PE), progression of DVT, and DVT related deaths were conducted, as well as the extent of remission of pain and edema. Results 13 studies were included with a total of 3269 patients. Compared to bed rest, early ambulation was not associated with a higher incidence of new PE, progression of DVT, or DVT related deaths (RD -0.03, 95% CI -0.05 similar to -0.02; Z = 1.24, p = 0.22; random effect model, Tau(2) = 0.01). Moreover, if the patients suffered moderate or severe pain initially, early ambulation was related to a better outcome, with respect to remission of acute pain in the affected limb (SMD 0.42, 95%CI 0.09 similar to 0.74; Z = 2.52, p = 0.01; random effect model, Tau(2) = 0.04). Meta-analysis of alleviation of edema cannot elicit a solid conclusion because of significant heterogeneity among the few studies. Conclusions Compared to bed rest, early ambulation of acute DVT patients with anticoagulation was not associated with a higher incidence of new PE, progression of DVT, and DVT related deaths. Furthermore, for the patients suffered moderate or severe pain initially, a better outcome can be seen in early ambulation group, regarding to the remission of acute pain in the affected limb.	[Liu, Zhenlei] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Surg, Beijing 100021, Peoples R China; [Liu, Zhenlei; Tao, Xixi; Chen, Yuexin; Fan, Zhongjie; Li, Yongjun] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Tao, Xixi] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Med, Beijing 100021, Peoples R China; [Chen, Yuexin; Li, Yongjun] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Vasc Surg, Beijing 100021, Peoples R China; [Fan, Zhongjie] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Li, YJ (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Surg, Beijing 100021, Peoples R China.	yongj_93@hotmail.com						Aissaoui N, 2009, INT J CARDIOL, V137, P37, DOI 10.1016/j.ijcard.2008.06.020; Anderson CM, 2009, PHYSIOTHER CAN, V61, P133, DOI 10.3138/physio.61.3.133; [Anonymous], 2011, GEMS HLTH; Aschwanden M, 2001, THROMB HAEMOSTASIS, V85, P42, DOI 10.1055/s-0037-1612901; Blattler W, 2003, INT ANGIOL, V22, P393; Galanaud JP, 2013, J THROMB HAEMOST, V11, P402, DOI 10.1111/jth.12127; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; [黄志军 Huang Zhijun], 2010, [中华普通外科杂志, Chinese Journal of General Surgery], V25, P737; Isma N, 2007, J THROMB THROMBOLYS, V23, P25, DOI 10.1007/s11239-006-9010-y; Jiang P, 2012, CHIN J BASES CLIN GE, V19, P1179; Junger M, 2006, CURR MED RES OPIN, V22, P593, DOI 10.1185/030079906X89838; Kahn SR, 2003, CHEST, V123, P399, DOI 10.1378/chest.123.2.399; Kahn SR, 2008, THROMB RES, V122, P763, DOI 10.1016/j.thromres.2007.10.011; Kearon C, 2012, CHEST, V141, pE419S, DOI 10.1378/chest.11-2301; Kiser TS, 1997, ARCH PHYS MED REHAB, V78, P942, DOI 10.1016/S0003-9993(97)90054-X; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Liu J, 2013, CHIN J REHABIL, V28, P117; Lozano F, 2014, J VASC SURG, V59, P1362, DOI 10.1016/j.jvs.2013.11.091; Manganaro A, 2008, ANGIOLOGY, V59, P599, DOI 10.1177/0003319707309655; Partsch H, 2004, INT ANGIOL, V23, P206; Partsch H, 2000, J VASC SURG, V32, P861, DOI 10.1067/mva.2000.110352; Partsch Hugo, 2005, Semin Vasc Surg, V18, P148, DOI 10.1053/j.semvascsurg.2005.05.006; Rahman A, 2009, MED SCI MONITOR, V15, pCR588; Ratiu A, 2009, Rev Med Chir Soc Med Nat Iasi, V113, P795; Romera A, 2006, ANGIOLOGIA, V58, P127, DOI 10.1016/S0003-3170(06)74960-4; Romera-Villegas A, 2008, INT ANGIOL, V27, P494; Schellong Sebastian M., 1999, Thrombosis and Haemostasis, V82, P127; Sterne J, 2011, COCHRANE HDB SYSTEMA, P10; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753; Trujillo-Santos J, 2005, CHEST, V127, P1631, DOI 10.1378/chest.127.5.1631; Vascular Surgery Group of Chineses Medical Association, 2013, CHINESE J SURG, V50, P611; 齐浩山, 2012, [中华外科杂志, Chinese Journal of Surgery], V50, P688	33	31	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0121388	10.1371/journal.pone.0121388	http://dx.doi.org/10.1371/journal.pone.0121388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860350	Green Submitted, Green Published, gold			2022-12-27	WOS:000352590300023
J	Valley, CC; Liu, S; Lidke, DS; Lidke, KA				Valley, Christopher C.; Liu, Sheng; Lidke, Diane S.; Lidke, Keith A.			Sequential Superresolution Imaging of Multiple Targets Using a Single Fluorophore	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; MOLECULE LOCALIZATION; DIFFRACTION-LIMIT; RESOLUTION LIMIT; FLUORESCENCE; DEPLETION; ENDOCYTOSIS; ACCURACY; BLINKING; BINDING	Fluorescence superresolution (SR) microscopy, or fluorescence nanoscopy, provides nanometer scale detail of cellular structures and allows for imaging of biological processes at the molecular level. Specific SR imaging methods, such as localization-based imaging, rely on stochastic transitions between on (fluorescent) and off (dark) states of fluorophores. Imaging multiple cellular structures using multi-color imaging is complicated and limited by the differing properties of various organic dyes including their fluorescent state duty cycle, photons per switching event, number of fluorescent cycles before irreversible photobleaching, and overall sensitivity to buffer conditions. In addition, multiple color imaging requires consideration of multiple optical paths or chromatic aberration that can lead to differential aberrations that are important at the nanometer scale. Here, we report a method for sequential labeling and imaging that allows for SR imaging of multiple targets using a single fluorophore with negligible cross-talk between images. Using brightfield image correlation to register and overlay multiple image acquisitions with similar to 10 nm overlay precision in the x-y imaging plane, we have exploited the optimal properties of AlexaFluor647 for dSTORM to image four distinct cellular proteins. We also visualize the changes in co-localization of the epidermal growth factor (EGF) receptor and clathrin upon EGF addition that are consistent with clathrin-mediated endocytosis. These results are the first to demonstrate sequential SR (s-SR) imaging using direct stochastic reconstruction microscopy (dSTORM), and this method for sequential imaging can be applied to any superresolution technique.	[Valley, Christopher C.; Lidke, Diane S.] Univ New Mexico, Dept Pathol, Albuquerque, NM 87131 USA; [Valley, Christopher C.; Lidke, Diane S.] Univ New Mexico, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Liu, Sheng; Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Lidke, KA (corresponding author), Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA.	klidke@unm.edu			National Science Foundation, U.S. [NSF 0954836, NSF MCB-0845062]; Human Frontiers Science Program [HFSP RGP0027/2012]; New Mexico Spatiotemporal Modeling Center via the National Institutes of Health, U.S. [NIH P50GM085273]; Division Of Physics [0954836] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0845062] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273] Funding Source: NIH RePORTER	National Science Foundation, U.S.(National Science Foundation (NSF)); Human Frontiers Science Program(Human Frontier Science Program); New Mexico Spatiotemporal Modeling Center via the National Institutes of Health, U.S.; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by the National Science Foundation, U.S., NSF 0954836 (KAL) and NSF MCB-0845062 (DSL) and the Human Frontiers Science Program, HFSP RGP0027/2012 (DSL). Additional support was provided to the New Mexico Spatiotemporal Modeling Center via the National Institutes of Health, U.S., NIH P50GM085273 (CCV, SL, DSL, KAL).	Altman RB, 2012, NAT METHODS, V9, P428, DOI 10.1038/nmeth.1988; Altman RB, 2012, NAT METHODS, V9, P68, DOI [10.1038/nmeth.1774, 10.1038/NMETH.1774]; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Cordes T, 2010, J AM CHEM SOC, V132, P2404, DOI 10.1021/ja9099714; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Ehmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5650; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lidke DS, 2012, J CELL SCI, V125, P2571, DOI 10.1242/jcs.090027; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Liu S, 2014, CHEMPHYSCHEM, V15, P696, DOI 10.1002/cphc.201300758; Liu S, 2013, OPT EXPRESS, V21, P29462, DOI 10.1364/OE.21.029462; McGorty Ryan, 2013, Opt Nanoscopy, V2, DOI 10.1186/2192-2853-2-3; Mlodzianoski MJ, 2009, OPT EXPRESS, V17, P8264, DOI 10.1364/OE.17.008264; Muller CB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.198101; Nanguneri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038098; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Ober RJ, 2004, BIOPHYS J, V86, P1185, DOI 10.1016/S0006-3495(04)74193-4; Olivier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069004; Olivier N, 2013, BIOMED OPT EXPRESS, V4, P885, DOI 10.1364/BOE.4.000885; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Quan TW, 2011, OPT EXPRESS, V19, P16963, DOI 10.1364/OE.19.016963; Quirin S, 2012, P NATL ACAD SCI USA, V109, P675, DOI 10.1073/pnas.1109011108; Ram S, 2009, OPT EXPRESS, V17, P6881, DOI 10.1364/OE.17.006881; Ries J, 2012, NAT METHODS, V9, P582, DOI [10.1038/NMETH.1991, 10.1038/nmeth.1991]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schafer P, 2013, ANAL CHEM, V85, P3393, DOI 10.1021/ac400035k; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Shelby SA, 2013, BIOPHYS J, V105, P2343, DOI 10.1016/j.bpj.2013.09.049; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Tam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115512; Tam J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101772; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; Vaughan JC, 2012, NAT METHODS, V9, P1181, DOI [10.1038/NMETH.2214, 10.1038/nmeth.2214]; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Vogelsang J, 2010, CHEMPHYSCHEM, V11, P2475, DOI 10.1002/cphc.201000189; Vogelsang J, 2009, P NATL ACAD SCI USA, V106, P8107, DOI 10.1073/pnas.0811875106; Yan Q, 2014, CHEMPHYSCHEM, V15, P687, DOI 10.1002/cphc.201300757; Zheng QS, 2012, J PHYS CHEM LETT, V3, P2200, DOI 10.1021/jz300670p; Zhu L, 2012, NAT METHODS, V9, P721, DOI [10.1038/NMETH.1978, 10.1038/nmeth.1978]	59	58	60	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2015	10	4							e0123941	10.1371/journal.pone.0123941	http://dx.doi.org/10.1371/journal.pone.0123941			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5II	25860558	Green Submitted, gold, Green Published			2022-12-27	WOS:000352590300123
J	Berenstein, AJ; Pinero, J; Furlong, LI; Chernomoretz, A				Jose Berenstein, Ariel; Pinero, Janet; Ines Furlong, Laura; Chernomoretz, Ariel			Mining the Modular Structure of Protein Interaction Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; CARTOGRAPHY; CENTRALITY; DYNAMICS; MEDICINE; DISEASES; CANCER; GENES; SET	Background Cluster-based descriptions of biological networks have received much attention in recent years fostered by accumulated evidence of the existence of meaningful correlations between topological network clusters and biological functional modules. Several well-performing clustering algorithms exist to infer topological network partitions. However, due to respective technical idiosyncrasies they might produce dissimilar modular decompositions of a given network. In this contribution, we aimed to analyze how alternative modular descriptions could condition the outcome of follow-up network biology analysis. Methodology We considered a human protein interaction network and two paradigmatic cluster recognition algorithms, namely: the Clauset-Newman-Moore and the infomap procedures. We analyzed to what extent both methodologies yielded different results in terms of granularity and biological congruency. In addition, taking into account Guimera's cartographic role characterization of network nodes, we explored how the adoption of a given clustering methodology impinged on the ability to highlight relevant network meso-scale connectivity patterns. Results As a case study we considered a set of aging related proteins and showed that only the high-resolution modular description provided by infomap, could unveil statistically significant associations between them and inter/intra modular cartographic features. Besides reporting novel biological insights that could be gained from the discovered associations, our contribution warns against possible technical concerns that might affect the tools used to mine for interaction patterns in network biology studies. In particular our results suggested that sub-optimal partitions from the strict point of view of their modularity levels might still be worth being analyzed when meso-scale features were to be explored in connection with external source of biological knowledge.	[Jose Berenstein, Ariel; Chernomoretz, Ariel] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina; [Jose Berenstein, Ariel; Chernomoretz, Ariel] Consejo Nacl Invest Cient & Tecn, Inst Fis Buenos Aires, Buenos Aires, DF, Argentina; [Pinero, Janet; Ines Furlong, Laura] Univ Pompeu Fabra, Hosp Mar Med Res Inst IMIM, Res Programme Biomed Informat GRIB, Barcelona 08003, Spain; [Chernomoretz, Ariel] Fdn Inst Leloir, Lab Biol Sistemas Integrat, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; Leloir Institute	Chernomoretz, A (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Pabellon 1,Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.	achernomoretz@leloir.org.ar	Piñero, Janet/O-6583-2016; Gasull, Martina/J-4076-2019; Furlong, Laura I./AAX-1376-2020	Piñero, Janet/0000-0003-1244-7654; Furlong, Laura I./0000-0002-9383-528X	CONICET [PIP0087]; UBACyT [20020110200314]; ISCIII-FEDER [PI13/00082, CP10/00524]; IMI JU [115002, 115191]; IMI JU (EU); IMI JU (EFPIA company)	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACyT; ISCIII-FEDER(Spanish Government); IMI JU; IMI JU (EU); IMI JU (EFPIA company)	CONICET (grant PIP0087), UBACyT (grant 20020110200314), ISCIII-FEDER (PI13/00082 and CP10/00524), IMI JU (grant agreements no [115002] (eTOX) and no [115191] (Open PHACTS)], resources of which are composed of financial contribution from the EU's FP7 (FP7/2007-2013) and EFPIA companies' in kind contribution). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Aldecoa R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02216; Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Arenas A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053039; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyd-Kirkup JD, 2013, EPIGENOMICS-UK, V5, P205, DOI [10.2217/EPI.13.5, 10.2217/epi.13.5]; Budovsky A, 2009, MECH AGEING DEV, V130, P33, DOI 10.1016/j.mad.2008.04.002; Carter H, 2013, CURR OPIN GENET DEV, V23, P611, DOI 10.1016/j.gde.2013.10.003; Chang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep01691; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Datta S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-397; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; del Sol A, 2010, CURR OPIN BIOTECH, V21, P566, DOI 10.1016/j.copbio.2010.07.010; Ferrarini L, 2005, BIOINFORMATICS, V21, P338, DOI 10.1093/bioinformatics/bti004; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hwang W, 2006, P 12 ACM SIGKDD INT, P20; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Lambiotte R., 2010, MOD OPT MOB AD HOC W; Lancichinetti A., 2009, PHYS REV E; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Pritykin Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003243; Promislow DEL, 2004, P ROY SOC B-BIOL SCI, V271, P1225, DOI 10.1098/rspb.2004.2732; R Core Team, 2021, R LANGUAGE ENV STAT; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; Song J, 2013, PLOS COMPUT BIOL, V9; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Viger F, 2005, LECT NOTES COMPUT SC, V3595, P440, DOI 10.1007/11533719_45; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West J, 2013, P NATL ACAD SCI USA, V110, P14138, DOI 10.1073/pnas.1307242110; Witten TM, 2007, CHEM BIODIVERS, V4, P2639, DOI 10.1002/cbdv.200790216; Wolfson M, 2009, INT J BIOCHEM CELL B, V41, P516, DOI 10.1016/j.biocel.2008.08.026; Xiang J, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30301-2; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zotenko E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000140	63	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0122477	10.1371/journal.pone.0122477	http://dx.doi.org/10.1371/journal.pone.0122477			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856434	Green Submitted, Green Published, gold			2022-12-27	WOS:000352588500039
J	Roach, DR; Garrett, WM; Welch, G; Caperna, TJ; Talbot, NC; Shapiro, EM				Roach, Dwayne R.; Garrett, Wesley M.; Welch, Glenn; Caperna, Thomas J.; Talbot, Neil C.; Shapiro, Erik M.			Magnetic Cell Labeling of Primary and Stem Cell-Derived Pig Hepatocytes for MRI-Based Cell Tracking of Hepatocyte Transplantation	PLOS ONE			English	Article							IRON-OXIDE PARTICLES; ACUTE LIVER-FAILURE; PORCINE HEPATOCYTES; CONTINUOUS-CULTURE; SINGLE CELLS; LINE; MPIOS; SURVIVAL; MODEL; POLY(LACTIDE-CO-GLYCOLIDE)	Pig hepatocytes are an important investigational tool for optimizing hepatocyte transplantation schemes in both allogeneic and xenogeneic transplant scenarios. MRI can be used to serially monitor the transplanted cells, but only if the hepatocytes can be labeled with a magnetic particle. In this work, we describe culture conditions for magnetic cell labeling of cells from two different pig hepatocyte cell sources; primary pig hepatocytes (ppHEP) and stem cell-derived hepatocytes (PICM-19FF). The magnetic particle is a micron-sized iron oxide particle (MPIO) that has been extensively studied for magnetic cell labeling for MRI-based cell tracking. ppHEP could endocytose MPIO with labeling percentages as high as 70%, achieving iron content as high as similar to 55 pg/cell, with > 75% viability. PICM-19FF had labeling > 97%, achieving iron content similar to 38 pg/cell, with viability > 99%. Extensive morphological and functional assays indicated that magnetic cell labeling was benign to the cells. The results encourage the use of MRI-based cell tracking for the development and clinical use of hepatocyte transplantation methodologies. Further, these results generally highlight the importance of functional cell assays in the evaluation of contrast agent biocompatibility.	[Roach, Dwayne R.; Shapiro, Erik M.] Michigan State Univ, Dept Radiol, Mol & Cellular Imaging Lab, E Lansing, MI 48824 USA; [Roach, Dwayne R.; Garrett, Wesley M.; Welch, Glenn; Caperna, Thomas J.; Talbot, Neil C.] USDA, Beltsville Agr Res Ctr, ARS, Anim Biosci & Biotechnol Lab, Beltsville, MD USA	Michigan State University; United States Department of Agriculture (USDA)	Shapiro, EM (corresponding author), Michigan State Univ, Dept Radiol, Mol & Cellular Imaging Lab, E Lansing, MI 48824 USA.	erik.shapiro@rad.msu.edu	Roach, Dwayne R./AAK-1307-2020	Roach, Dwayne R./0000-0002-2069-8915				Arbab AS, 2005, NMR BIOMED, V18, P383, DOI 10.1002/nbm.970; Bennewitz MF, 2012, MOL IMAGING BIOL, V14, P676, DOI 10.1007/s11307-012-0553-3; Benoist S, 2001, J HEPATOL, V35, P208, DOI 10.1016/S0168-8278(01)00085-X; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Caperna TJ, 2013, DOMEST ANIM ENDOCRIN, V45, P154, DOI 10.1016/j.domaniend.2013.08.003; CAPERNA TJ, 1985, J ANIM SCI, V61, P1576, DOI 10.2527/jas1985.6161576x; Castell JV, 2006, EXPERT OPIN DRUG MET, V2, P183, DOI 10.1517/17425255.2.2.183; Chouhan M, 2012, INT J ARTIF ORGANS, V35, P450, DOI 10.5301/ijao.5000096; Ciria R, 2012, LIVER TRANSPLANT, V18, P1324, DOI 10.1002/lt.23532; Cooper DKC, 2013, J BIOMED RES, V27, P249, DOI 10.7555/JBR.27.20130063; Cormode DP, 2011, BIOCONJUGATE CHEM, V22, P353, DOI 10.1021/bc1003179; Dhawan A, 2010, METHODS MOL BIOL, V640, P525, DOI 10.1007/978-1-60761-688-7_29; Ekser B, 2012, LANCET, V379, P672, DOI 10.1016/S0140-6736(11)61091-X; Fox IJ, 2004, AM J TRANSPLANT, V4, P7, DOI 10.1111/j.1600-6135.2004.0340.x; Granot D, 2014, MAGN RESON MED, V71, P1238, DOI 10.1002/mrm.24741; Heyn C, 2006, MAGNET RESON MED, V55, P23, DOI 10.1002/mrm.20747; Hickey RD, 2014, LIVER TRANSPL; Huebert RC, 2014, MAYO CLIN PROC, V89, P414, DOI 10.1016/j.mayocp.2013.10.023; Hughes RD, 2012, TRANSPLANTATION, V93, P342, DOI 10.1097/TP.0b013e31823b72d6; Ito M, 2009, J HEPATO-BILIARY-PAN, V16, P97, DOI 10.1007/s00534-008-0023-0; Katsuda Takeshi, 2012, J Stem Cells, V7, P1; Ketkar-Atre A, 2014, BIOMATERIALS, V35, P1015, DOI 10.1016/j.biomaterials.2013.10.029; Kircher MF, 2003, CANCER RES, V63, P6838; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Landis CS, 2006, HEPATOLOGY, V44, P1250, DOI 10.1002/hep.21382; Liu W, 2009, MAGN RESON MED, V61, P761, DOI 10.1002/mrm.21923; Maruyama M, 2003, CELL TRANSPLANT, V12, P593, DOI 10.3727/000000003108747190; Meier RPH, 2013, STEM CELL RES, V11, P1348, DOI 10.1016/j.scr.2013.08.011; Meyburg J, 2009, CLIN TRANSPLANT, V23, P75, DOI 10.1111/j.1399-0012.2009.01113.x; Nagata H, 2003, TRANSPLANTATION, V76, P732, DOI 10.1097/01.TP.0000081560.16039.67; Nagata H, 2007, GASTROENTEROLOGY, V132, P321, DOI 10.1053/j.gastro.2006.10.013; Nkansah MK, 2011, MAGN RESON MED, V65, P1776, DOI 10.1002/mrm.22765; Puppi J, 2014, CELL TRANSPLANT, V23, P329, DOI 10.3727/096368913X663596; Raschzok N, 2012, AM J ROENTGENOL, V198, P1417, DOI 10.2214/AJR.11.7742; Raschzok N, 2011, MOL IMAGING BIOL, V13, P613, DOI 10.1007/s11307-010-0405-y; Raschzok N, 2009, TISSUE ENG PART C-ME, V15, P681, DOI 10.1089/ten.tec.2008.0675; RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shapiro EM, 2007, CONTRAST MEDIA MOL I, V2, P147, DOI 10.1002/cmmi.134; Shapiro EM, 2008, FUND BIOMED TECHNOL, V3, P141; Slotkin JR, 2007, NEUROTHERAPEUTICS, V4, P428, DOI 10.1016/j.nurt.2007.05.010; Soenen SJH, 2011, BIOMATERIALS, V32, P1748, DOI 10.1016/j.biomaterials.2010.11.005; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Struecker B, 2014, NAT REV GASTRO HEPAT, V11, P166, DOI 10.1038/nrgastro.2013.204; Talbot NC, 2013, J ANIM SCI, V91, P66, DOI 10.2527/jas.2012-5748; TALBOT NC, 1994, IN VITRO CELL DEV-AN, V30A, P851; TALBOT NC, 1994, IN VITRO CELL DEV-AN, V30A, P843; Talbot NC, 1996, EXP CELL RES, V225, P22, DOI 10.1006/excr.1996.0153; Talbot NC, 2007, IN VITRO CELL DEV-AN, V43, P72, DOI 10.1007/s11626-007-9014-8; Talbot NC, 2014, CYTOTECHNOLOGY, V66, P1, DOI 10.1007/s10616-013-9541-y; Talbot NC, 2010, IN VITRO CELL DEV-AN, V46, P746, DOI 10.1007/s11626-010-9336-9; Talbot NC, 2010, INT J ARTIF ORGANS, V33, P348, DOI 10.1177/039139881003300603; Tang KS, 2011, MOL IMAGING BIOL, V13, P819, DOI 10.1007/s11307-010-0437-3; Tang KS, 2011, MAGN RESON MED, V65, P1564, DOI 10.1002/mrm.22843; Than N.N., 2014, QJM; Willard RR, 2010, IN VITRO CELL DEV-AN, V46, P11, DOI 10.1007/s11626-009-9244-z; Wu YL, 2006, P NATL ACAD SCI USA, V103, P1852, DOI 10.1073/pnas.0507198103; WYBENGA DR, 1971, CLIN CHEM, V17, P891	61	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0123282	10.1371/journal.pone.0123282	http://dx.doi.org/10.1371/journal.pone.0123282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25856627	Green Published, Green Submitted, gold			2022-12-27	WOS:000352588500082
J	Conde, J; Scotece, M; Abella, V; Gomez, R; Lopez, V; Villar, R; Hermida, M; Pino, J; Gomez-Reino, JJ; Gualillo, O				Conde, Javier; Scotece, Morena; Abella, Vanessa; Gomez, Rodolfo; Lopez, Veronica; Villar, Rosa; Hermida, Miguel; Pino, Jesus; Jesus Gomez-Reino, Juan; Gualillo, Oreste			Identification of Novel Adipokines in the Joint. Differential Expression in Healthy and Osteoarthritis Tissues	PLOS ONE			English	Article							INFRAPATELLAR FAT PAD; KNEE OSTEOARTHRITIS; SYNOVIAL-FLUID; INHIBITOR; MATRIX; WISP2; SERUM	Objectives Emerging data suggest that several metabolic factors, released mainly by white adipose tissue (WAT) and joint tissues, and collectively named adipokines, might have a role in the pathophysiology of OA. Recently, novel adipokines such as SERPINE2, WISP2, GPNMB and ITIH5 have been identified in WAT. The main goal of this study was to analyse the expression of these novel adipokines in synovium, infrapatellar fat pad and chondrocytes and to compare the expression of these molecules in healthy and OA tissues. Methods Synovial tissues, infrapatellar fat pad and chondrocytes were obtained from 36 OA patients (age 52-85; mean BMI 28.9) who underwent total knee replacement surgery. Healthy synovial tissues and infrapatellar fat pad were obtained from 15 traumatic knee patients (age 23-53; mean BMI 23.5). mRNA and protein expression were determined by qRT-PCR and western blot analysis respectively. Results All the novel adipokines, matter of our study, are expressed in OA synovium, infrapatellar fat pad and chondrocytes. Moreover, we detected a differential expression of SERPINE2 and ITIH5 in OA synovial tissues as compared to healthy samples. Finally, we also observed an increased expression of WISP2 in OA infrapatellar fat pad in comparison to healthy controls. Conclusions In this study we demonstrated for the first time the expression of four novel adipokines in different joint tissues and how these molecules are differentially expressed in healthy and OA joint tissues.	[Conde, Javier; Scotece, Morena; Abella, Vanessa; Gomez, Rodolfo; Lopez, Veronica; Villar, Rosa; Jesus Gomez-Reino, Juan; Gualillo, Oreste] Univ Santiago, Clin Hosp, SERGAS Serv Galego Saude, Santiago De Compostela, Spain; [Conde, Javier; Scotece, Morena; Abella, Vanessa; Gomez, Rodolfo; Lopez, Veronica; Villar, Rosa; Gualillo, Oreste] Univ Santiago, Clin Hosp, IDIS Inst Investi Sanitaria Santiago, NEIRID Lab,Res Lab 9, Santiago De Compostela, Spain; [Abella, Vanessa] Univ Coruna UDC, Dept Mol & Cellular Biol, La Coruna, Spain; [Hermida, Miguel; Pino, Jesus] Univ Santiago, Clin Hosp, SERGAS Serv Galego Saude, Div Orthopaed Surg & Traumatol, Santiago De Compostela, Spain; [Jesus Gomez-Reino, Juan] Univ Santiago Compostela, Dept Med, Santiago De Compostela, Spain; [Jesus Gomez-Reino, Juan] Univ Santiago, Clin Hosp, IDIS Inst Invest Sanitaria Santiago, Div Rheumatol, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade da Coruna; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Gualillo, O (corresponding author), Univ Santiago, Clin Hosp, SERGAS Serv Galego Saude, Santiago De Compostela, Spain.	oreste.gualillo@sergas.es	Gomez-Reino, Juan/ABI-2853-2020; Gualillo, Oreste/B-8223-2008; Aranda, Javier Conde/P-5537-2015; Gomez, Rodolfo/B-4642-2012; Scotece, Morena/ABI-6561-2020	Gualillo, Oreste/0000-0002-7154-1328; Aranda, Javier Conde/0000-0002-2187-479X; Gomez, Rodolfo/0000-0002-1309-1023; Scotece, Morena/0000-0002-1150-2933; Abella Cajigal, Vanessa/0000-0002-3658-7208; Pino, Jesus/0000-0002-1847-1199; Gomez-Reino, Juan/0000-0001-5229-6294	Instituto de Salud Carlos III [PI11/01073]; "FPU" programme of the Spanish Ministry of Education; predoctoral program of Fundacion Ramon Dominguez; Xunta de Galicia; ISCIII	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); "FPU" programme of the Spanish Ministry of Education(German Research Foundation (DFG)); predoctoral program of Fundacion Ramon Dominguez; Xunta de Galicia(Xunta de GaliciaEuropean Commission); ISCIII(Instituto de Salud Carlos III)	OG is Staff Personnel of Xunta de Galicia (SERGAS) through a research-staff stabilization contract (ISCIII/SERGAS). OG is supported by Instituto de Salud Carlos III (PI11/01073) Oreste Gualillo is a member of RETICS Programme, RD12/0009/0008 (RIER: Red de Investigacion en Inflamacion y Enfermedades Reumaticas) via Instituto de Salud Carlos III (ISCIII). Morena Scotece is a recipient of the "FPU" programme of the Spanish Ministry of Education. Javier Conde is a recipient of a predoctoral program of Fundacion Ramon Dominguez. Vanessa Abella is a predoctoral recipient of Xunta de Galicia. Veronica Lopez is a recipient of a grant from ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; CHEN L, 1992, J BIOL CHEM, V267, P12380; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; Clockaerts S, 2012, ANN RHEUM DIS, V71, P1012, DOI 10.1136/annrheumdis-2011-200688; Conde J, 2014, ANN RHEUM DIS, V73, P631, DOI 10.1136/annrheumdis-2013-204189; Conde J, 2013, DISCOV MED, V15, P73; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; Dahlman I, 2012, ARCH PHYSIOL BIOCHEM, V118, P84, DOI 10.3109/13813455.2012.685745; Distel E, 2009, ARTHRITIS RHEUM-US, V60, P3374, DOI 10.1002/art.24881; Gabriel TL, 2014, DIABETES, V63, P3310, DOI 10.2337/db13-1720; Gandhi R, 2011, J RHEUMATOL, V38, P1966, DOI 10.3899/jrheum.101302; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Huang K, 2012, BIOMARKERS, V17, P16, DOI 10.3109/1354750X.2011.634028; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Klein-Wieringa IR, 2011, ANN RHEUM DIS, V70, P851, DOI 10.1136/ard.2010.140046; Ku JH, 2009, CLIN RHEUMATOL, V28, P1431, DOI 10.1007/s10067-009-1242-8; Lee Mel S, 2009, Chang Gung Med J, V32, P42; Lehr S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010504; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Pagliara V, 2014, BBA-MOL CELL RES, V1843, P2631, DOI 10.1016/j.bbamcr.2014.07.008; Presle N, 2006, OSTEOARTHR CARTILAGE, V14, P690, DOI 10.1016/j.joca.2006.01.009; RAO JS, 1989, MUSCLE NERVE, V12, P640, DOI 10.1002/mus.880120805; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Sen M, 2000, P NATL ACAD SCI USA, V97, P2791, DOI 10.1073/pnas.050574297; Tanaka I, 2005, BIOCHEM BIOPH RES CO, V334, P973, DOI 10.1016/j.bbrc.2005.06.196	25	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123601	10.1371/journal.pone.0123601	http://dx.doi.org/10.1371/journal.pone.0123601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853553	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400106
J	Guthe, HJT; Indrebo, M; Nedrebo, T; Norgard, G; Wiig, H; Berg, A				Guthe, Hans Jorgen Timm; Indrebo, Marianne; Nedrebo, Torbjorn; Norgard, Gunnar; Wiig, Helge; Berg, Ansgar			Interstitial Fluid Colloid Osmotic Pressure in Healthy Children	PLOS ONE			English	Article							SUBCUTANEOUS TISSUE; PROTEIN CONCENTRATION; PREMATURE-INFANTS; ALBUMIN; MECHANISMS; EXCHANGE; SAMPLES; WOMEN; WICKS	Objective The colloid osmotic pressure (COP) of plasma and interstitial fluid play important roles in transvascular fluid exchange. COP values for monitoring fluid balance in healthy and sick children have not been established. This study set out to determine reference values of COP in healthy children. Materials and Methods COP in plasma and interstitial fluid harvested from nylon wicks was measured in 99 healthy children from 2 to 10 years of age. Nylon wicks were implanted subcutaneously in arm and leg while patients were sedated and intubated during a minor surgical procedure. COP was analyzed in a colloid osmometer designed for small fluid samples. Results The mean plasma COP in all children was 25.6 +/- 3.3 mmHg. Arbitrary division of children in four different age groups, showed no significant difference in plasma or interstitial fluid COP values for patients less than 8 years, whereas patients of 8-10 years had significant higher COP both in plasma and interstitial fluid. There were no gender difference or correlation between COP in interstitial fluid sampled from arm and leg and no significant effect on interstitial COP of gravity. Prolonged implantation time did not affect interstitial COP. Conclusion Plasma and interstitial COP in healthy children are comparable to adults and COP seems to increase with age in children. Knowledge of the interaction between colloid osmotic forces can be helpful in diseases associated with fluid imbalance and may be crucial in deciding different fluid treatment options.	[Guthe, Hans Jorgen Timm; Berg, Ansgar] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Guthe, Hans Jorgen Timm] Univ Bergen, Dept Clin Med, Bergen, Norway; [Indrebo, Marianne] Univ Oslo, Fac Med, Dept Clin Med, Oslo, Norway; [Nedrebo, Torbjorn; Wiig, Helge] Univ Bergen, Dept Biomed, Bergen, Norway; [Nedrebo, Torbjorn] Haukeland Hosp, Dept Occupat Med, Hyperbar Med Unit, N-5021 Bergen, Norway; [Norgard, Gunnar] Univ Oslo, Fac Med, Dept Clin Med, Sect Pediat Heart Lung & Allerg Dis, Oslo, Norway; [Berg, Ansgar] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Bergen	Guthe, HJT (corresponding author), Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway.	hjgu@helse-bergen.no		Wiig, Helge/0000-0002-7740-8210	West Norway Regional Health Authority [911441]	West Norway Regional Health Authority	This work was supported by research grants (HJTG received funding) from West Norway Regional Health Authority, grant number 911441 (http://www.helse-vest.no/no/FagOgSamarbeid/forsking/Sider/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2004, J PHYSIOL-LONDON, V557, P889, DOI 10.1113/jphysiol.2003.058255; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; AUKLAND K, 1987, SCAND J CLIN LAB INV, V47, P331; AUKLAND K, 1973, ACTA PHYSIOL SCAND, V88, P350, DOI 10.1111/j.1748-1716.1973.tb05464.x; Aukland K, 1997, LYMPHOLOGY, V30, P111; AUKLAND K, 1974, ACTA PHYSIOL SCAND, V90, P485, DOI 10.1111/j.1748-1716.1974.tb05611.x; BHAT R, 1981, CRIT CARE MED, V9, P563, DOI 10.1097/00003246-198108000-00001; Blunt MC, 1998, ANAESTHESIA, V53, P755, DOI 10.1046/j.1365-2044.1998.00488.x; Brekke HK, 2013, ANESTHESIOLOGY, V119, P861, DOI 10.1097/ALN.0b013e31829ab018; FADNES HO, 1977, MICROVASC RES, V14, P11, DOI 10.1016/0026-2862(77)90137-6; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Ghoshal AK, 2003, CLIN CHIM ACTA, V331, P135, DOI 10.1016/S0009-8981(03)00114-1; Golab HD, 2011, EUR J CARDIO-THORAC, V39, P886, DOI 10.1016/j.ejcts.2010.09.040; Golab Hanna D, 2009, Interact Cardiovasc Thorac Surg, V8, P512, DOI 10.1510/icvts.2008.198283; Guthe HJT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031332; Iacobelli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062210; Juliusson PB, 2013, ANN HUM BIOL, V40, P220, DOI 10.3109/03014460.2012.759276; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Nichols DG, 2008, MULTIPLE TRAUMA, P384; NODDELAND H, 1982, SCAND J CLIN LAB INV, V42, P131; NODDELAND H, 1982, SCAND J CLIN LAB INV, V42, P139; NODDELAND H, 1981, ACTA PHYSIOL SCAND, V113, P447, DOI 10.1111/j.1748-1716.1981.tb06921.x; NODDELAND H, 1982, SCAND J CLIN LAB INV, V42, P123; OIAN P, 1985, BRIT J OBSTET GYNAEC, V92, P1113; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Riley AA, 2010, ASAIO J, V56, P260, DOI 10.1097/MAT.0b013e3181d0c28d; SOLA A, 1981, CRIT CARE MED, V9, P568, DOI 10.1097/00003246-198108000-00002; Starling E H, 1896, J Physiol, V19, P312; Sussmane JB, 2001, CRIT CARE, V5, P261, DOI 10.1186/cc1043; TOLLAN A, 1993, ACTA OBSTET GYN SCAN, V72, P238, DOI 10.3109/00016349309068030; Toye JM, 2012, PAED CHILD HEALT-CAN, V17, pE20, DOI 10.1093/pch/17.6.e20; Weil M H, 1974, Crit Care Med, V2, P229, DOI 10.1097/00003246-197409000-00001; WEIL MH, 1979, CRIT CARE MED, V7, P113, DOI 10.1097/00003246-197903000-00006; WIIG H, 1988, ACTA PHYSIOL SCAND, V132, P445, DOI 10.1111/j.1748-1716.1988.tb08351.x; Wiig H, 2012, PHYSIOL REV, V92, P1005, DOI 10.1152/physrev.00037.2011; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; Zimmerman B, 1997, ARCH PEDIATRIE, V4, P952, DOI 10.1016/S0929-693X(97)86090-3; ZLOTKIN SH, 1987, CLIN CHEM, V33, P411	38	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122779	10.1371/journal.pone.0122779	http://dx.doi.org/10.1371/journal.pone.0122779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853713	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400081
J	Mayer, J; Reichart, G; Tokay, T; Lange, F; Baltrusch, S; Junghanss, C; Wolkenhauer, O; Jaster, R; Kunz, M; Tiedge, M; Ibrahim, S; Fuellen, G; Kohling, R				Mayer, Johannes; Reichart, Gesine; Tokay, Tursonjan; Lange, Falko; Baltrusch, Simone; Junghanss, Christian; Wolkenhauer, Olaf; Jaster, Robert; Kunz, Manfred; Tiedge, Markus; Ibrahim, Saleh; Fuellen, Georg; Koehling, Ruediger			Reduced Adolescent-Age Spatial Learning Ability Associated with Elevated Juvenile-Age Superoxide Levels in Complex I Mouse Mutants	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MITOCHONDRIAL-DNA MUTATIONS; OXIDATIVE STRESS; SYNAPTIC PLASTICITY; NADH-DEHYDROGENASE; FREE-RADICALS; MEMORY; DISEASE; MICE; HIPPOCAMPUS	Large-scale, heteroplasmic and generally pathogenic mtDNA defects (as induced by defective mitochondrial DNA polymerase, clonal mutations or DNA deletions) are known to negatively impact on life span and can result in apoptosis and tissue loss in, e.g., skeletal muscle or reduce learning abilities. The functional impact of homoplasmic specific mtDNA point mutations, e.g., in genes coding for the electron transport chain, however, remains a matter of debate. The present study contributes to this discussion and provides evidence that a single point mutation in complex I of the respiratory chain is associated with impairment of spatial navigation in adolescent (6-month-old) mice, i.e., reduced performance in the Morris Water Maze, which goes along with increased production of reactive oxygen species (ROS) in juvenile mice (3 months) but not at the age of phenotype expression. A point mutation in complex III goes along with only a mild and non-significant negative effect on cognitive performance and no significant changes in ROS production. These findings suggest to also consider the ontogenetic development of phenotypes when studying mtDNA mutations and highlights a possible impact of complex I dysfunction on the emergence of neurological deficits.	[Mayer, Johannes; Reichart, Gesine; Tokay, Tursonjan; Lange, Falko; Koehling, Ruediger] Univ Rostock, Med Ctr, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany; [Baltrusch, Simone; Tiedge, Markus] Univ Rostock, Med Ctr, Inst Med Biochem & Mol Biol, D-18055 Rostock, Germany; [Junghanss, Christian] Univ Rostock, Med Ctr, Dept Hematol Oncol Palliat Med, D-18055 Rostock, Germany; [Wolkenhauer, Olaf] Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany; [Jaster, Robert] Univ Rostock, Med Ctr, Dept Med 2, Div Gastroenterol, D-18055 Rostock, Germany; [Kunz, Manfred] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04109 Leipzig, Germany; [Ibrahim, Saleh] Lubeck Univ, Med Ctr, Dept Dermatol, Lubeck, Germany; [Fuellen, Georg] Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Fuellen, Georg; Koehling, Ruediger] Univ Rostock, Interdisciplinary Fac, D-18055 Rostock, Germany; [Tokay, Tursonjan] Nazarbayev Univ, Ctr Life Sci, Astana, Kazakhstan	University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock; Leipzig University; University of Lubeck; University of Rostock; Nazarbayev University	Mayer, J (corresponding author), Univ Rostock, Med Ctr, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany.	johannes.mayer@uni-rostock.de; ruediger.koehling@uni-rostock.de	Köhling, Rüdiger/K-8647-2013; Ibrahim, Saleh/AAO-9541-2020; tokay, tursonjan/D-2457-2016	Köhling, Rüdiger/0000-0003-3330-4898; Ibrahim, Saleh/0000-0001-7827-2290; Lange, Falko/0000-0001-8782-5205	Bundesministerium fur Bildung und Forschung (BMBF) [ROSAge 31P6662]; Rostock University Medical Center FORUN programme [889062]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Rostock University Medical Center FORUN programme	This work was supported by Bundesministerium fur Bildung und Forschung (BMBF) grant ROSAge 31P6662, http://www.bmbf.de/, and Rostock University Medical Center FORUN programme funding no. 889062, https://www.med.uni-rostock.de/. The funders had no role in study design,	ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392; Fukui K, 2001, ANN NY ACAD SCI, V928, P168; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; HRUSZKEWYCZ AM, 1992, MUTAT RES, V275, P243, DOI 10.1016/0921-8734(92)90028-N; Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003; Huang H, 2004, FRONT BIOSCI-LANDMRK, V9, P1100, DOI 10.2741/1298; Huang Y, 2013, NEUROSCIENCE, V231, P432, DOI 10.1016/j.neuroscience.2012.11.010; Ishihara K, 1997, BEHAV BRAIN RES, V83, P235, DOI 10.1016/S0166-4328(97)86077-9; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kamsler A, 2003, J NEUROSCI, V23, P269; Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kumar A, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00007; Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055; Lauritzen KH, 2010, MOL CELL BIOL, V30, P1357, DOI 10.1128/MCB.01149-09; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; LOMO T, 1966, ACTA PHYSIOL SCAND, VS 68, P128; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nicolle MM, 2001, NEUROSCIENCE, V107, P415, DOI 10.1016/S0306-4522(01)00374-8; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olsen RHJ, 2013, J NEUROCHEM, V125, P303, DOI 10.1111/jnc.12187; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Schauer M, 2014, EXP DERMATOL, V23, pE6; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Tanaka D., 2008, MOL BRAIN, V16, P1, DOI DOI 10.1186/1756-6606-1-21; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wei Yau-Huei, 2009, Chang Gung Med J, V32, P113; Weiss H, 2013, DIABETOLOGIA, V56, pS87; Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108	55	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123863	10.1371/journal.pone.0123863	http://dx.doi.org/10.1371/journal.pone.0123863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853418	gold, Green Published, Green Submitted			2022-12-27	WOS:000352478400122
J	Palta, P; Kaplinski, L; Nagirnaja, L; Veidenberg, A; Mols, M; Nelis, M; Esko, T; Metspalu, A; Laan, M; Remm, M				Palta, Priit; Kaplinski, Lauris; Nagirnaja, Liina; Veidenberg, Andres; Moels, Maert; Nelis, Mari; Esko, Tonu; Metspalu, Andres; Laan, Maris; Remm, Maido			Haplotype Phasing and Inheritance of Copy Number Variants in Nuclear Families	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HIDDEN-MARKOV MODEL; LINKAGE DISEQUILIBRIUM; POPULATION-GENETICS; GENOTYPE; POLYMORPHISM; INFERENCE; EVOLUTION; MAP; REARRANGEMENTS	DNA copy number variants (CNVs) that alter the copy number of a particular DNA segment in the genome play an important role in human phenotypic variability and disease susceptibility. A number of CNVs overlapping with genes have been shown to confer risk to a variety of human diseases thus highlighting the relevance of addressing the variability of CNVs at a higher resolution. So far, it has not been possible to deterministically infer the allelic composition of different haplotypes present within the CNV regions. We have developed a novel computational method, called PiCNV, which enables to resolve the haplotype sequence composition within CNV regions in nuclear families based on SNP genotyping microarray data. The algorithm allows to i) phase normal and CNV-carrying haplotypes in the copy number variable regions, ii) resolve the allelic copies of rearranged DNA sequence within the haplotypes and iii) infer the heritability of identified haplotypes in trios or larger nuclear families. To our knowledge this is the first program available that can deterministically phase null, mono-, di-, tri- and tetraploid genotypes in CNV loci. We applied our method to study the composition and inheritance of haplotypes in CNV regions of 30 HapMap Yoruban trios and 34 Estonian families. For 93.6% of the CNV loci, PiCNV enabled to unambiguously phase normal and CNV-carrying haplotypes and follow their transmission in the corresponding families. Furthermore, allelic composition analysis identified the co-occurrence of alternative allelic copies within 66.7% of haplotypes carrying copy number gains. We also observed less frequent transmission of CNV-carrying haplotypes from parents to children compared to normal haplotypes and identified an emergence of several de novo deletions and duplications in the offspring.	[Palta, Priit; Kaplinski, Lauris; Remm, Maido] Univ Tartu, Inst Mol & Cell Biol, Dept Bioinformat, EE-50090 Tartu, Estonia; [Palta, Priit] Univ Helsinki, FIMM, Helsinki, Finland; [Kaplinski, Lauris; Moels, Maert; Metspalu, Andres; Remm, Maido] Estonian Bioctr, Tartu, Estonia; [Nagirnaja, Liina; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, Human Mol Genet Res Grp, EE-50090 Tartu, Estonia; [Veidenberg, Andres] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Moels, Maert] Univ Tartu, Inst Stat Math, Chair Math Stat, EE-50090 Tartu, Estonia; [Nelis, Mari; Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, EE-50090 Tartu, Estonia; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Esko, Tonu] Broad Inst, Cambridge, MA USA	University of Tartu; University of Helsinki; Estonian Biocentre; University of Tartu; University of Helsinki; University of Tartu; University of Tartu; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Palta, P (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Bioinformat, Ulikooli 18, EE-50090 Tartu, Estonia.	priit.palta@gmail.com	Nelis, Mari/ABG-7775-2020; Laan, Maris/A-4100-2011; Remm, Maido/L-9072-2019; Palta, Priit/W-2477-2019	Nelis, Mari/0000-0001-9748-1020; Laan, Maris/0000-0002-8519-243X; Remm, Maido/0000-0003-3966-8422; Palta, Priit/0000-0001-9320-7008; Nagirnaja, Liina/0000-0003-1948-2495; Esko, Tonu/0000-0003-1982-6569; Veidenberg, Andres/0000-0001-7451-0626	Estonian Ministry of Education and Research [SF0180026s09]; European Union grant through the European Regional Development Fund through the Estonian Centre of Excellence in Genomics; Finnish Cultural Foundation; Estonian Ministry of Education and Research Core Grants [SF0180022s12]; European Union through the European Regional Development Fund (project HAPPY PREGNANCY) [3.2.0701.12-0047]; Estonian Science Foundation Grant [ETF9030]; FP7 program (ENGAGE); FP7 program (OPENGENE); Estonian Government [SF0180142s08]; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics (EXCEGEN); University of Tartu [SP1GVARENG]; Estonian Research Council [IUT2-2]; European Regional Development Fund	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union grant through the European Regional Development Fund through the Estonian Centre of Excellence in Genomics; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Estonian Ministry of Education and Research Core Grants; European Union through the European Regional Development Fund (project HAPPY PREGNANCY); Estonian Science Foundation Grant; FP7 program (ENGAGE); FP7 program (OPENGENE); Estonian Government; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics (EXCEGEN); University of Tartu; Estonian Research Council(Estonian Research Council); European Regional Development Fund(European Commission)	This work was funded by workgroup grant SF0180026s09 from the Estonian Ministry of Education and Research and by the European Union grant through the European Regional Development Fund through the Estonian Centre of Excellence in Genomics (to MR). PP was also supported by personal research grant from the Finnish Cultural Foundation. Human Molecular Genetics Research Group was supported from the Estonian Ministry of Education and Research Core Grants (SF0180022s12); European Union through the European Regional Development Fund (project HAPPY PREGNANCY, 3.2.0701.12-0047) and Estonian Science Foundation Grant ETF9030 (to ML). The Estonian Genome Center of University of Tartu received financing from FP7 programs (ENGAGE, OPENGENE), targeted financing from Estonian Government (SF0180142s08), and also from Estonian Research Roadmap through Estonian Ministry of Education and Research, Center of Excellence in Genomics (EXCEGEN) and University of Tartu (SP1GVARENG), Estonian Research Council IUT2-2 and European Regional Development Fund (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Brahmachary M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004418; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Clark AG, 2004, LECT N BIOINFORMAT, V2983, P1; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Eleftherohorinou H, 2011, BIOINFORMATICS, V27, P1873, DOI 10.1093/bioinformatics/btr264; Ezawa K, 2013, HEREDITY, V111, P364, DOI 10.1038/hdy.2013.59; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gamazon ER, 2014, AM J HUM GENET; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Hannibal RL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004290; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Iliadis A, 2014, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2014-7; Ionita-Laza I, 2008, GENET EPIDEMIOL, V32, P273, DOI 10.1002/gepi.20302; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Kato M, 2008, AM J HUM GENET, V83, P157, DOI 10.1016/j.ajhg.2008.06.021; Kato M, 2008, BIOINFORMATICS, V24, P1645, DOI 10.1093/bioinformatics/btn242; Kato M, 2011, G3-GENES GENOM GENET, V1, P35, DOI 10.1534/g3.111.000174; Kato M, 2010, HUM MOL GENET, V19, P761, DOI 10.1093/hmg/ddp541; Kim Soon-Young, 2012, Genomics & Informatics, V10, P194, DOI 10.5808/GI.2012.10.3.194; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2014, BIOL PSYCHIAT, V75, P378, DOI 10.1016/j.biopsych.2013.07.022; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Lin YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096841; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MacConaill LE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-211; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Perreault LPL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-226; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schaaf CP, 2011, ANNU REV GENOM HUM G, V12, P25, DOI 10.1146/annurev-genom-092010-110715; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Su SY, 2010, BIOINFORMATICS, V26, P1437, DOI 10.1093/bioinformatics/btq157; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn641; Williams AL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r108; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	79	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122713	10.1371/journal.pone.0122713	http://dx.doi.org/10.1371/journal.pone.0122713			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853576	Green Published, gold, Green Submitted			2022-12-27	WOS:000352478400079
J	Rego, FD; Rugani, JMN; Shimabukuro, PHF; Tonelli, GB; Quaresma, PF; Gontijo, CMF				Rego, Felipe Dutra; Nunes Rugani, Jeronimo Marteleto; Fernandes Shimabukuro, Paloma Helena; Tonelli, Gabriel Barbosa; Quaresma, Patricia Flavia; Ferreira Gontijo, Celia Maria			Molecular Detection of Leishmania in Phlebotomine Sand Flies (Diptera: Psychodidae) from a Cutaneous Leishmaniasis Focus at Xakriaba Indigenous Reserve, Brazil	PLOS ONE			English	Article							LUTZOMYIA-LONGIPALPIS LUTZ; RIO-DOCE VALLEY; MINAS-GERAIS; VISCERAL LEISHMANIASIS; ENDEMIC AREA; FLAGELLATE INFECTIONS; SANDFLIES DIPTERA; MATO-GROSSO; SUL STATE; IDENTIFICATION	Autochthonous cases of American cutaneous leishmaniasis (ACL) have been reported since 2001 in the Xakriaba Indigenous Reserve located in the municipality of Sao Joao das Missoes in northern Minas Gerais state, Brazil. In order to study the presence of Leishmania DNA in phlebotomine sand flies, six entomological collections were carried out from July 2008 through July 2009, using 40 light traps placed in peridomicile areas of 20 randomly selected houses. From October 2011 through August 2012, another six collections were carried out with 20 light traps distributed among four trails (five traps per trail) selected for a previous study of wild and synanthropic hosts of Leishmania. A total of 4,760 phlebotomine specimens were collected belonging to ten genera and twenty-three species. Single female specimens or pools with up to ten specimens of the same locality, species and date, for Leishmania detection by molecular methods. Species identification of parasites was performed with ITS1 PCR-RFLP using HaeIII enzyme and genetic sequencing for SSU rRNA target. The presence of Leishmania DNA was detected in eleven samples from peridomicile areas: Lu. longipalpis (two), Nyssomyia intermedia (four), Lu. renei (two), Lu. ischnacantha, Micropygomyia goiana and Evandromyia lenti (one pool of each specie). The presence of Leishmania DNA was detected in twelve samples from among the trails: Martinsmyia minasensis (six), Ny. intermedia (three), Mi. peresi (two) and Ev. lenti (one). The presence of Leishmania infantum DNA in Lu. longipalpis and Leishmania braziliensis DNA in Ny. inter-mediasupport the epidemiological importance of these species of sand flies in the cycle of visceral and cutaneous leishmaniasis, respectively. The results also found other species associated with Leishmania DNA, such as Mt. minasensis and Ev. lenti, which may participate in a wild and/or synanthropic cycle of Leishmania transmission in the studied area.	[Rego, Felipe Dutra; Nunes Rugani, Jeronimo Marteleto; Fernandes Shimabukuro, Paloma Helena; Tonelli, Gabriel Barbosa; Quaresma, Patricia Flavia; Ferreira Gontijo, Celia Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Grp Estudos Leishmanioses, BR-30190002 Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Rego, FD (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Grp Estudos Leishmanioses, Av Augusto Lima,1715 Barro Preto, BR-30190002 Belo Horizonte, MG, Brazil.	felipedutra@cpqrr.fiocruz.br	Gontijo, Célia/K-6120-2016; Rego, Felipe Dutra/V-4646-2019; Rêgo, Felipe Dutra/S-6013-2017; Shimabukuro, Paloma Helena Fernandes/AAC-8695-2022; Gontijo, Celia MF/AAU-7736-2020; Rugani, Jeronimo/ABE-4235-2020; Quaresma, Patricia/W-3876-2019	Rego, Felipe Dutra/0000-0002-2799-8267; Rêgo, Felipe Dutra/0000-0002-2799-8267; Shimabukuro, Paloma Helena Fernandes/0000-0002-5114-953X; Gontijo, Celia MF/0000-0002-7034-535X; Quaresma, Patricia Flavia/0000-0001-8274-4166; Barbosa Tonelli, Gabriel/0000-0002-8415-3199	National Council for Scientific and Technological Development; Minas Gerais Research Foundation; Oswaldo Cruz Foundation	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Oswaldo Cruz Foundation	This study was funded by the National Council for Scientific and Technological Development, Minas Gerais Research Foundation, and Oswaldo Cruz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR C M, 1984, Memorias do Instituto Oswaldo Cruz, V79, P181, DOI 10.1590/S0074-02761984000200005; Andrade JD, 2009, NEOTROP ENTOMOL, V38, P688, DOI 10.1590/S1519-566X2009000500022; Andrade JD, 2007, MEM I OSWALDO CRUZ, V102, P481, DOI 10.1590/S0074-02762007005000035; ANEZ N, 1994, ANN TROP MED PARASIT, V88, P279, DOI 10.1080/00034983.1994.11812868; Aransay AM, 2000, APPL ENVIRON MICROB, V66, P1933, DOI 10.1128/AEM.66.5.1933-1938.2000; ARIAS JR, 1985, AM J TROP MED HYG, V34, P1098, DOI 10.4269/ajtmh.1985.34.1098; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Barbosa AF, 2006, MEM I OSWALDO CRUZ, V101, P851, DOI 10.1590/S0074-02762006000800005; Brazil Reginaldo P., 1997, Anais da Sociedade Entomologica do Brasil, V26, P191, DOI 10.1590/S0301-80591997000100026; Carvalho GML, 2008, VECTOR-BORNE ZOONOT, V8, P407, DOI 10.1089/vbz.2007.0180; CHAGAS A. W., 1940, Memorias do Instituto Oswaldo Cruz, V35, P327, DOI 10.1590/S0074-02761940000200005; Coelho M V, 1965, Rev Bras Malariol Doencas Trop, V17, P143; CRONIN T M, 1987, Paleontological Society Memoir, P1; Cruz I., 2002, T R SOC TROP MED HYG, V96, pS185, DOI DOI 10.1016/S0035-9203(02)90074-X; Cruz I, 2006, J CLIN MICROBIOL, V44, P2343, DOI 10.1128/JCM.02297-05; da Silva OS, 1999, MEM I OSWALDO CRUZ, V94, P579, DOI 10.1590/S0074-02761999000500002; DASILVA ALFF, 1990, MEM I OSWALDO CRUZ, V85, P453, DOI 10.1590/S0074-02761990000400010; de Oliveira Alessandra Gutierrez, 2003, Cad Saude Publica, V19, P933; de Paiva BR, 2007, CAD SAUDE PUBLICA, V23, P87, DOI 10.1590/S0102-311X2007000100010; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; DEANE L. M., 1957, REV BRASIL MALARIOL E DOENCAS TROP, V9, P225; Deane L.M., 1978, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V18, P231; Deane LM, 1956, THESIS U SAO PAULO; Dias ES, 2007, REV SOC BRAS MED TRO, V40, P49, DOI 10.1590/S0037-86822007000100009; Nascimento João Cezar do, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P119, DOI 10.1590/S0036-46652007000200011; Dorval MEMC, 2006, REV SOC BRAS MED TRO, V39, P43, DOI 10.1590/S0037-86822006000100008; El Tai NO, 2000, T R SOC TROP MED HYG, V94, P1; Perez JE, 2007, MEM I OSWALDO CRUZ, V102, P655, DOI 10.1590/S0074-02762007005000077; FELICIANGELI M D, 1987, Memorias do Instituto Oswaldo Cruz, V82, P167, DOI 10.1590/S0074-02761987000200003; Freitas RA, 2002, MEM I OSWALDO CRUZ, V97, P53, DOI 10.1590/S0074-02762002000100008; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 1996, REV SAUDE PUBL, V30, P115, DOI 10.1590/S0034-89101996000200002; Gontijo CMF, 2002, ACTA TROP, V81, P143, DOI 10.1016/S0001-706X(01)00205-4; GONTIJO CMF, 1995, MEM I OSWALDO CRUZ, V90, P367, DOI 10.1590/S0074-02761995000300011; GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Grisard EC, 2000, ACTA TROP, V74, P89, DOI 10.1016/S0001-706X(99)00054-6; HERMETO MV, 1994, MEM I OSWALDO CRUZ, V89, P519, DOI 10.1590/S0074-02761994000400005; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; KILLICKKENDRICK R, 1981, PARASITOLOGY, V82, P143; LAINSON R, 1968, T ROY SOC TROP MED H, V62, P385, DOI 10.1016/0035-9203(68)90090-4; Lainson R., 1998, Topley & Wilson's microbiology & microbial infections Volume 5: Parasitology., P241; Lainson R., 1979, P1; LAINSON R, 1985, T ROY SOC TROP MED H, V79, P223, DOI 10.1016/0035-9203(85)90340-2; Luz ZMP, 2001, REV SOC BRAS MED TRO, V34, P249, DOI DOI 10.1590/S0037-86822001000300004; Margonari C, 2010, J MED ENTOMOL, V47, P1212, DOI 10.1603/ME09248; Savani ESMM, 2009, VET PARASITOL, V160, P18, DOI 10.1016/j.vetpar.2008.10.090; Martins Flavia, 2002, Revista de Patologia Tropical, V31, P211; Marzochi M C, 1994, Cad Saude Publica, V10 Suppl 2, P359, DOI 10.1590/S0102-311X1994000800014; MAYRINK W, 1979, ANN TROP MED PARASIT, V73, P123, DOI 10.1080/00034983.1979.11687239; Michalsky Érika Monteiro, 2011, Rev. Soc. Bras. Med. Trop., V44, P58, DOI 10.1590/S0037-86822011000100014; Miranda JC, 2002, MEM I OSWALDO CRUZ, V97, P185, DOI 10.1590/S0074-02762002000200006; Missawa Nanci Akemi, 2011, Rev. Soc. Bras. Med. Trop., V44, P76, DOI 10.1590/S0037-86822011000100017; Monteiro EM, 2005, REV SOC BRAS MED TRO, V38, P147, DOI 10.1590/S0037-86822005000200004; OLIVEIRA AC, 1959, HOSPITAL-RIO DE JAN, V56, P625; Paiva BR, 2010, ACTA TROP, V115, P126, DOI 10.1016/j.actatropica.2010.02.013; Paraense L., 1940, Brasil-Medico, V54, P179; PASSOS VMA, 1993, MEM I OSWALDO CRUZ, V88, P103, DOI 10.1590/S0074-02761993000100016; Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4; PEREZ JE, 1994, T ROY SOC TROP MED H, V88, P161, DOI 10.1016/0035-9203(94)90276-3; Pinto ID, 2012, J VECTOR ECOL, V37, P90, DOI 10.1111/j.1948-7134.2012.00204.x; Pita-Pereira D, 2005, ACTA TROP, V99, P905; Quaresma PF, 2011, T ROY SOC TROP MED H, V105, P579, DOI 10.1016/j.trstmh.2011.07.005; Quaresma PF, 2012, MEM I OSWALDO CRUZ, V107, P480, DOI 10.1590/S0074-02762012000400007; RANGEL E F, 1985, Memorias do Instituto Oswaldo Cruz, V80, P373, DOI 10.1590/S0074-02761985000300017; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Rego FD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-220; Rocha LS, 2010, T ROY SOC TROP MED H, V104, P461, DOI 10.1016/j.trstmh.2010.02.005; Ryan L, 1984, Mem Inst Oswaldo Cruz, V79, P383, DOI 10.1590/S0074-02761984000300016; Ryan L, 1987, I EVANDRO CHAGAS 50, V1, P307; Saraiva L, 2006, REV SOC BRAS MED TRO, V39, P56, DOI 10.1590/S0037-86822006000100011; Saraiva L, 2010, MEM I OSWALDO CRUZ, V105, P1033, DOI 10.1590/S0074-02762010000800013; Saraiva L, 2008, MEM I OSWALDO CRUZ, V103, P843, DOI 10.1590/S0074-02762008000800018; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; SHERLOCK I. A., 1957, REV BRASIL BIOL, V17, P77; Sherlock IA, 1992, LEISHMANIASIS CONTRO, p[54, 54]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2; WARD RD, 1973, T ROY SOC TROP MED H, V67, P174, DOI 10.1016/0035-9203(73)90142-9; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	80	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122038	10.1371/journal.pone.0122038	http://dx.doi.org/10.1371/journal.pone.0122038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853254	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400058
J	Scofield, HN; Mattila, HR				Scofield, Hailey N.; Mattila, Heather R.			Honey Bee Workers That Are Pollen Stressed as Larvae Become Poor Foragers and Waggle Dancers as Adults	PLOS ONE			English	Article							DIVISION-OF-LABOR; APIS-MELLIFERA HYMENOPTERA; AMINO-ACID-COMPOSITION; WINTER COLONY LOSSES; NUTRITIONAL STRESS; PROTEIN-CONTENT; BRAIN-DEVELOPMENT; OVARY DEVELOPMENT; FOOD-DEPRIVATION; GENE-EXPRESSION	The negative effects on adult behavior of juvenile undernourishment are well documented in vertebrates, but relatively poorly understood in invertebrates. We examined the effects of larval nutritional stress on the foraging and recruitment behavior of an economically important model invertebrate, the honey bee (Apis mellifera). Pollen, which supplies essential nutrients to developing workers, can become limited in colonies because of seasonal dearths, loss of foraging habitat, or intensive management. However, the functional consequences of being reared by pollen-stressed nestmates remain unclear, despite growing concern that poor nutrition interacts with other stressors to exacerbate colony decline. We manipulated nurse bees' access to pollen and then assessed differences in weight, longevity, foraging activity, and waggle-dance behavior of the workers that they reared (who were co-fostered as adults). Pollen stress during larval development had far-reaching physical and behavioral effects on adult workers. Workers reared in pollen-stressed colonies were lighter and shorter lived than nestmates reared with adequate access to pollen. Proportionally fewer stressed workers were observed foraging and those who did forage started foraging sooner, foraged for fewer days, and were more likely to die after only a single day of foraging. Pollen- stressed workers were also less likely to waggle dance than their unstressed counterparts and, if they danced, the information they conveyed about the location of food was less precise. These performance deficits may escalate if long-term pollen limitation prevents stressed foragers from providing sufficiently for developing workers. Furthermore, the effects of brief pollen shortages reported here mirror the effects of other environmental stressors that limit worker access to nutrients, suggesting the likelihood of their synergistic interaction. Honey bees often experience the level of stress that we created, thus our findings underscore the importance of adequate nutrition for supporting worker performance and their potential contribution to colony productivity and quality pollination services.	[Scofield, Hailey N.; Mattila, Heather R.] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA	Wellesley College	Mattila, HR (corresponding author), Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA.	hmattila@wellesley.edu			Essex County Beekeepers Association Grants Committee (Massachusetts, USA); Wellesley College; Knafel Endowed Chair in the Natural Sciences (Wellesley College); Wellesley's Summer Research Awards; Amabel Boyce James '74 Fund for Summer Research in the Sciences; Janina A. Longtine '76 Endowed Fund for Summer Research in the Natural Sciences; Sherman Fairchild Fund; Susan Todd Horton Class of 1910 Trust	Essex County Beekeepers Association Grants Committee (Massachusetts, USA); Wellesley College; Knafel Endowed Chair in the Natural Sciences (Wellesley College); Wellesley's Summer Research Awards; Amabel Boyce James '74 Fund for Summer Research in the Sciences; Janina A. Longtine '76 Endowed Fund for Summer Research in the Natural Sciences; Sherman Fairchild Fund; Susan Todd Horton Class of 1910 Trust	Research support was provided by the Essex County Beekeepers Association Grants Committee (Massachusetts, USA) and a Fiske Award from Wellesley College. Student support was provided by sponsors of Wellesley's Summer Research Awards, including the Amabel Boyce James '74 Fund for Summer Research in the Sciences, the Janina A. Longtine '76 Endowed Fund for Summer Research in the Natural Sciences, the Sherman Fairchild Fund, and the Susan Todd Horton Class of 1910 Trust. HRM was supported by a Knafel Endowed Chair in the Natural Sciences (Wellesley College). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamy M, 2012, NEUROSCI BIOBEHAV R, V36, P1463, DOI 10.1016/j.neubiorev.2012.03.009; Barrett ELB, 2009, P ROY SOC B-BIOL SCI, V276, P3257, DOI 10.1098/rspb.2009.0725; Bauerfeind SS, 2005, OIKOS, V111, P514, DOI 10.1111/j.0030-1299.2005.13888.x; Blanchard GB, 2000, ANIM BEHAV, V59, P723, DOI 10.1006/anbe.1999.1374; Blaschon B, 1999, ENTOMOL GEN, V24, P49; Brodschneider R, 2009, APIDOLOGIE, V40, P441, DOI 10.1051/apido/2009006; Burns JG, 2012, P NATL ACAD SCI USA, V109, P17239, DOI 10.1073/pnas.1121265109; Carey JR, 2008, AGING CELL, V7, P470, DOI 10.1111/j.1474-9726.2008.00389.x; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; Crespi EJ, 2013, INTEGR COMP BIOL, V53, P989, DOI 10.1093/icb/ict087; Daugherty THF, 2011, MOL ECOL, V20, P5337, DOI 10.1111/j.1365-294X.2011.05344.x; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; de Souza AS, 2011, NUTR REV, V69, P132, DOI 10.1111/j.1753-4887.2011.00374.x; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2010, APIDOLOGIE, V41, P264, DOI 10.1051/apido/2010024; Dmitriew C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017399; Dornhaus A, 2004, BEHAV ECOL SOCIOBIOL, V55, P395, DOI 10.1007/s00265-003-0726-9; DOULL K M, 1973, Apidologie, V4, P285, DOI 10.1051/apido:19730401; DUKAS R, 1994, ANIM BEHAV, V48, P1007, DOI 10.1006/anbe.1994.1333; DUSTMANN JH, 1988, APIDOLOGIE, V19, P245, DOI 10.1051/apido:19880304; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; EISCHEN FA, 1983, J APICULT RES, V22, P163, DOI 10.1080/00218839.1983.11100582; EISHCHEN FA, 1982, J APICULT RES, V21, P19, DOI 10.1080/00218839.1982.11100511; Farrar C. L., 1934, GLEAN BEE CULT, V62, P276; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fischer J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091364; Foley K, 2012, J INVERTEBR PATHOL, V111, P68, DOI 10.1016/j.jip.2012.06.006; Forkpah C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091180; FYG. W., 1959, BEE WORLD, V40, P57; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garedew A, 2004, APIDOLOGIE, V35, P419, DOI 10.1051/apido:2004032; GOODWIN RM, 1994, NEW ZEAL J CROP HORT, V22, P459, DOI 10.1080/01140671.1994.9513858; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; HASSANEIN MH, 1953, ANN APPL BIOL, V40, P418, DOI 10.1111/j.1744-7348.1953.tb01093.x; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Haydak MH, 1935, J ECON ENTOMOL, V28, P657, DOI 10.1093/jee/28.4.657; HELLMICH RL, 1986, APIDOLOGIE, V17, P13, DOI 10.1051/apido:19860102; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hodges F.E.D., 1950, BEE WORLD, V31, DOI [10.1080/0005772X.1950.11094617, DOI 10.1080/0005772X.1950.11094617, https://doi.org/10.1080/0005772X.1950.11094617]; Hoover SER, 2006, J COMP PHYSIOL B, V176, P55, DOI 10.1007/s00360-005-0032-0; Huang Zachary, 2012, Terrestrial Arthropod Reviews, V5, P175, DOI 10.1163/187498312X639568; Iqbal J, 2007, P R SOC B, V274, P1517, DOI 10.1098/rspb.2007.0022; Janmaat AF, 2000, INSECT SOC, V47, P177, DOI 10.1007/PL00001698; JAY SC, 1993, APIDOLOGIE, V24, P557, DOI 10.1051/apido:19930603; JAY SC, 1964, CAN J ZOOLOG, V42, P455, DOI 10.1139/z64-039; JEFFREE EP, 1957, J ECON ENTOMOL, V50, P211, DOI 10.1093/jee/50.2.211; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; Kalev H, 2002, AM BEE J, V142, P675; Keller I, 2005, BEE WORLD, V86, P27, DOI 10.1080/0005772X.2005.11099650; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein BA, 2010, P NATL ACAD SCI USA, V107, P22705, DOI 10.1073/pnas.1009439108; Koletzko B, 2011, AM J CLIN NUTR, V94, p2036S, DOI 10.3945/ajcn.111.018903; Kolss M, 2009, EVOLUTION, V63, P2389, DOI 10.1111/j.1558-5646.2009.00718.x; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Kralj J, 2006, APIDOLOGIE, V37, P577, DOI 10.1051/apido:2006040; Kralj J, 2010, APIDOLOGIE, V41, P21, DOI 10.1051/apido/2009046; KUNERT K, 1988, J APICULT RES, V27, P13, DOI 10.1080/00218839.1988.11100775; Laus MF, 2011, INT J ENV RES PUB HE, V8, P590, DOI 10.3390/ijerph8020590; Li CC, 2014, ENTOMOL EXP APPL, V151, P19, DOI 10.1111/eea.12167; Li ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077354; Lummaa V, 2003, AM J HUM BIOL, V15, P370, DOI 10.1002/ajhb.10155; Lummaa V, 2002, TRENDS ECOL EVOL, V17, P141, DOI 10.1016/S0169-5347(01)02414-4; MacDougall-Shackleton SA, 2012, J ORNITHOL, V153, pS105, DOI 10.1007/s10336-011-0807-x; Malone LA, 2001, J INVERTEBR PATHOL, V77, P258, DOI 10.1006/jipa.2001.5028; Marques AH, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00120; Mattila HR, 2006, ENVIRON ENTOMOL, V35, P708, DOI 10.1603/0046-225X-35.3.708; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MORGANE PJ, 1993, NEUROSCI BIOBEHAV R, V17, P91, DOI 10.1016/S0149-7634(05)80234-9; Morgane PJ, 2002, NEUROSCI BIOBEHAV R, V26, P471, DOI 10.1016/S0149-7634(02)00012-X; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nguyen BK, 2010, J APICULT RES, V49, P337, DOI 10.3896/IBRA.1.49.4.07; Nowicki S, 2002, J COMP PHYSIOL A, V188, P1003, DOI 10.1007/s00359-002-0361-3; Ozanne SE, 1999, P NUTR SOC, V58, P615, DOI 10.1017/S0029665199000804; Phoofolo MW, 2008, ENVIRON ENTOMOL, V37, P315, DOI 10.1603/0046-225X(2008)37[315:LLHRTF]2.0.CO;2; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Pravosudov VV, 2005, BEHAV NEUROSCI, V119, P1368, DOI 10.1037/0735-7044.119.5.1368; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Riessberger U, 1997, APIDOLOGIE, V28, P411, DOI 10.1051/apido:19970608; RINDERER TE, 1977, J ECON ENTOMOL, V70, P431, DOI 10.1093/jee/70.4.431; RINDERER TE, 1974, J INVERTEBR PATHOL, V23, P347, DOI 10.1016/0022-2011(74)90100-1; Saastamoinen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081289; Schmehl DR, 2014, J INSECT PHYSIOL, V71, P177, DOI 10.1016/j.jinsphys.2014.10.002; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; SCHMIDT LS, 1995, J ECON ENTOMOL, V88, P1591, DOI 10.1093/jee/88.6.1591; Sherman G, 2002, NATURE, V419, P920, DOI 10.1038/nature01127; Somerville DC, 2006, AUST J EXP AGR, V46, P141, DOI 10.1071/EA03188; SPIVAK M, 1992, J APPL ECOL, V29, P150, DOI 10.2307/2404358; Spleen AM, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.2.07; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinsphys.2004.05.001; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; van Dooremalen C, 2013, J INSECT PHYSIOL, V59, P487, DOI 10.1016/j.jinsphys.2013.02.006; Vande Velde L, 2013, EVOL ECOL, V27, P221, DOI 10.1007/s10682-012-9580-4; Vanengelsdorp D, 2007, AM BEE J, V147, P599; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2011, J APICULT RES, V50, P1, DOI 10.3896/IBRA.1.50.1.01; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; WANG DER-I, 1965, J APICULT RES, V4, P3; WANG DI, 1970, J INVERTEBR PATHOL, V15, P202, DOI 10.1016/0022-2011(70)90235-1; WEBSTER TC, 1987, PHYSIOL ENTOMOL, V12, P225, DOI 10.1111/j.1365-3032.1987.tb00745.x; Winston M.L., 1991, BIOL HONEY BEE; WINSTON ML, 1992, AM SCI, V80, P374; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Xia SZ, 1997, PHYSIOL BEHAV, V62, P263, DOI 10.1016/S0031-9384(97)00113-3; Zhang YG, 2010, TOXICOL LETT, V193, P167, DOI 10.1016/j.toxlet.2010.01.002	115	64	64	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121731	10.1371/journal.pone.0121731	http://dx.doi.org/10.1371/journal.pone.0121731			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853902	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400048
J	Sharma, SR; Giri, S; Timalsina, U; Bhandari, SS; Basyal, B; Wagle, K; Shrestha, L				Sharma, Sudesh Raj; Giri, Smith; Timalsina, Utsav; Bhandari, Sanjiv Sudarshan; Basyal, Bikash; Wagle, Kusum; Shrestha, Laxman			Low Birth Weight at Term and Its Determinants in a Tertiary Hospital of Nepal: A Case-Control Study	PLOS ONE			English	Article							RISK-FACTORS; GROWTH-RETARDATION; MATERNAL NUTRITION; MORBIDITY; MORTALITY; PRETERM; INFANTS; EPIDEMIOLOGY; PREMATURITY; DIARRHEA	Birth weight of a child is an important indicator of its vulnerability for childhood illness and chances of survival. A large number of infant deaths can be averted by appropriate management of low birth weight babies and prevention of factors associated with low birth weight. The prevalence of low birth weight babies in Nepal is estimated to be about 12-32%. Our study aimed at identifying major determinants of low birth weight among term babies in Nepal. A hospital-based retrospective case control study was conducted in maternity ward of Tribhuvan University Teaching Hospital from February to July 2011. A total of 155 LBW babies and 310 controls were included in the study. Mothers admitted to maternity ward during the study period were interviewed, medical records were assessed and anthropometric measurements were done. Risk factors, broadly classified into proximal and distal factors, were assessed for any association with birth of low-birth weight babies. Regression analysis revealed that a history of premature delivery (adjusted odds ratio; aOR5.24, CI 1.05-26.28), hard physical work during pregnancy (aOR1.48, CI 0.97-2.26), younger age of mother (aOR1.98, CI 1.15-3.41), mothers with haemoglobin level less than 11gm/dl (aOR0.51, CI0.24-1.07) and lack of consumption of nutritious food during pregnancy (aOR1.99, CI 1.28-3.10) were significantly associated with the birth of LBW babies. These factors should be addressed with appropriate measures so as to decrease the prevalence of low birth weight among term babies in Nepal.	[Sharma, Sudesh Raj; Timalsina, Utsav; Bhandari, Sanjiv Sudarshan; Basyal, Bikash; Shrestha, Laxman] Inst Med, Kathmandu, Nepal; [Giri, Smith] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Wagle, Kusum] Om Hlth Campus, Kathmandu, Nepal	University of Tennessee System; University of Tennessee Health Science Center	Sharma, SR (corresponding author), Inst Med, Maharajgunj Med Campus, Kathmandu, Nepal.	yoursudesh@gmail.com		Basyal, Bikash/0000-0002-4217-0396; Sharma, Sudesh Raj/0000-0002-7880-5517				Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Acharya Pratima Poudel, 2004, Health Care Women Int, V25, P40, DOI 10.1080/07399330490253210; Agarwal A, 2011, PREVALENCE AND DETER, P48; Agarwal S, 2001, Indian Pediatr, V38, P1017; Ahmad Muhammad Owais, 2011, J Ayub Med Coll Abbottabad, V23, P77; ALBERTSSONWIKLAND K, 1994, ACTA PAEDIATR, V83, P64, DOI 10.1111/j.1651-2227.1994.tb13292.x; Amin Nurul, 1993, Indian Journal of Pediatrics, V60, P269, DOI 10.1007/BF02822189; Ashworth A, 1998, EUR J CLIN NUTR, V52, pS34; AYLWARD GP, 1989, J PEDIATR-US, V115, P515, DOI 10.1016/S0022-3476(89)80273-2; Badshah S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-197; Bennett L, 2008, CASTE ETHNIC AND REG; Bhandari R, 2012, INT J CHRONIC OBSTR, V7, P253, DOI 10.2147/COPD.S28602; CASEY PH, 1991, J PEDIATR-US, V119, P599, DOI 10.1016/S0022-3476(05)82414-X; Choudhary A K, 2013, Indian J Public Health, V57, P20, DOI 10.4103/0019-557X.111362; Christian P, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-58; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; de Moraes AB, 2012, CAD SAUDE PUBLICA, V28, P2293, DOI 10.1590/S0102-311X2012001400008; Deshmukh J S, 1998, Indian Pediatr, V35, P33; Dickute Jolanta, 2002, Medicina (Kaunas), V38, P321; Dim Cyril C, 2007, MedGenMed, V9, P11; Elhassan Elhassan M, 2010, BMC Res Notes, V3, P181, DOI 10.1186/1756-0500-3-181; Fall CHD, 2003, J NUTR, V133, p1747S, DOI 10.1093/jn/133.5.1747S; Fourn L, 1999, Sante, V9, P7; Gresham E, 2014, AM J CLIN NUTR, V100, P1298, DOI 10.3945/ajcn.113.080655; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; Karkee R, 2015, MATERN CHILD HLTH J, V19, P1, DOI 10.1007/s10995-014-1489-9; Kayastha S, 2007, Nepal Med Coll J, V9, P266; Khanal V, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-4; Khanal V, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-32; Khatun Selina, 2008, Bangladesh Med Res Counc Bull, V34, P81; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lang JM, 1996, EPIDEMIOLOGY, V7, P369, DOI 10.1097/00001648-199607000-00006; Levy A, EUROPEAN JOURNAL OF, V122, P182; Lira PIC, 1996, J PEDIATR-US, V128, P497, DOI 10.1016/S0022-3476(96)70360-8; Mahajan SD, 2004, ENDOCR RES, V30, P189, DOI 10.1081/ERC-200027380; MAVALANKAR DV, 1992, INT J EPIDEMIOL, V21, P263, DOI 10.1093/ije/21.2.263; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Ministry of Health and Population (MoHP) [Nepal] New ERA ICF International Inc., 2011, NEPAL DEMOGRAPHIC AN; MIRA/UNICEF Nepal, 2000, LOW BIRTH WEIGHT PRE; Phung H, 2003, EUR J EPIDEMIOL, V18, P235, DOI 10.1023/A:1023384213536; Rasmussen KM, 2001, J NUTR, V131, p590S, DOI 10.1093/jn/131.2.590S; READ JS, 1995, PAEDIATR PERINAT EP, V9, P351, DOI 10.1111/j.1365-3016.1995.tb00152.x; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Reichman NE, 1997, FAM PLANN PERSPECT, V29, P268, DOI 10.2307/2953415; Sekhavat L, 2011, HEMATOLOGY, V16, P373, DOI 10.1179/102453311X13085644680186; Singh S, 2011, INCIDENCE AND RISK F; Sreeramareddy CT, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-16; SUSSER M, 1975, LANCET, V2, P1145; UNICEF, 2009, THE STATE OF THE WOR; VICTORA CG, 1989, AM J EPIDEMIOL, V129, P1032, DOI 10.1093/oxfordjournals.aje.a115207; VILLAR J, 1986, EARLY HUM DEV, V14, P307, DOI 10.1016/0378-3782(86)90193-3; VILLAR J, 1982, AM J OBSTET GYNECOL, V143, P793, DOI 10.1016/0002-9378(82)90012-6; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; World Health Organization, 1993, INTERNATIONAL STATIS, P129; World Health Organization, 2000, MULTICENTRE STUDY ON; Yadav Hematram, 2013, Med J Malaysia, V68, P44	57	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123962	10.1371/journal.pone.0123962	http://dx.doi.org/10.1371/journal.pone.0123962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853813	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400127
J	Sun, LL; Xie, SB; Peng, GY; Wang, J; Li, YY; Qin, J; Zhong, DS				Sun, Linlin; Xie, Songbo; Peng, Guoyuan; Wang, Jian; Li, Yuanyuan; Qin, Juan; Zhong, Diansheng			Lonafarnib Is a Potential Inhibitor for Neovascularization	PLOS ONE			English	Article							FARNESYLTRANSFERASE INHIBITOR; PROTEIN FARNESYLTRANSFERASE; CELL-MIGRATION; ANGIOGENESIS; ATHEROSCLEROSIS; DISEASE	Atherosclerosis is a common cardiovascular disease that involves the build-up of plaque on the inner walls of the arteries. Intraplaque neovacularization has been shown to be essential in the pathogenesis of atherosclerosis. Previous studies showed that small-molecule compounds targeting farnesyl transferase have the ability to prevent atherosclerosis in apolipoprotein E-deficient mice, but the underlying mechanism remains to be elucidated. In this study, we found that lonafarnib, a specific inhibitor of farnesyl transferase, elicits inhibitory effect on vascular endothelial capillary assembly in vitro in a dose-dependent manner. In addition, we showed that lonafarnib treatment led to a dose-dependent decrease in scratch wound closure in vitro, whereas it had little effect on endothelial cell proliferation. These data indicate that lonafarnib inhibits neovascularization via directly targeting endothelial cells and disturbing their motility. Moreover, we demonstrated that pharmacological inhibition of farnesyl transferase by lonafarnib significantly impaired centrosome reorientation toward the leading edge of endothelial cells. Mechanistically, we found that the catalytic beta subunit of farnesyl transferase associated with a cytoskeletal protein important for the establishment and maintenance of cell polarity. Additionally, we showed that lonafarnib remarkably inhibited the expression of the cytoskeletal protein and interrupted its interaction with farnesyl transferase. Our findings thus offer novel mechanistic insight into the protective effect of farnesyl transferase inhibitors on atherosclerosis and provide encouraging evidence for the potential use of this group of agents in inhibiting plaque neovascularization.	[Sun, Linlin; Zhong, Diansheng] Tianjin Med Univ, Gen Hosp, Lung Canc Inst, Tianjin, Peoples R China; [Zhong, Diansheng] Tianjin Med Univ, Gen Hosp, Dept Med Oncol, Tianjin, Peoples R China; [Xie, Songbo; Peng, Guoyuan; Wang, Jian; Li, Yuanyuan; Qin, Juan] Nankai Univ, Coll Life Sci, Dept Genet & Cell Biol, Tianjin 300071, Peoples R China	Tianjin Medical University; Tianjin Medical University; Nankai University	Zhong, DS (corresponding author), Tianjin Med Univ, Gen Hosp, Lung Canc Inst, Tianjin, Peoples R China.	Zhongdsh@hotmail.com	li, yuanyuan/GZA-4435-2022; Qin, Juan/GQZ-4875-2022; Xie, Songbo/AAD-9850-2020; Qin, Juan/GNH-2502-2022	Qin, Juan/0000-0002-0821-6290; Qin, Juan/0000-0002-0821-6290	National Natural Science Foundation of China [31301160]; Tianjin Municipal Health Bureau [2011KZ107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Health Bureau	This work was supported by grants from National Natural Science Foundation of China (31301160) and Tianjin Municipal Health Bureau (2011KZ107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Al Sabti H, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-49; Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cheng C, 2013, TRENDS CARDIOVAS MED, V23, P153, DOI 10.1016/j.tcm.2012.10.004; Cook KM, 2010, CA-CANCER J CLIN, V60, P222, DOI 10.3322/caac.20075; Etienne-Manneville S, 2013, ANNU REV CELL DEV BI, V29, P471, DOI 10.1146/annurev-cellbio-101011-155711; Gu WZ, 1999, EUR J CANCER, V35, P1394, DOI 10.1016/S0959-8049(99)00132-X; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Moulton KS, 2006, CURR OPIN LIPIDOL, V17, P548, DOI 10.1097/01.mol.0000245261.71129.f0; Scott AN, 2008, ANGIOGENESIS, V11, P337, DOI 10.1007/s10456-008-9115-3; Strickland C L, 1999, Curr Opin Drug Discov Devel, V2, P475; Sugita M, 2007, ARTERIOSCL THROM VAS, V27, P1390, DOI 10.1161/ATVBAHA.107.140673; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Zhou J, 2009, J BIOL CHEM, V284, P9648, DOI 10.1074/jbc.M808708200	18	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122830	10.1371/journal.pone.0122830	http://dx.doi.org/10.1371/journal.pone.0122830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853815	Green Submitted, Green Published, gold			2022-12-27	WOS:000352478400082
J	Xiao, Y; Liu, YY; Huang, SH; Sun, XM; Tang, Y; Cheng, JR; Wang, T; Li, F; Kuang, YX; Luo, R; Zhao, XS				Xiao, Ya; Liu, Yanyan; Huang, Shaohui; Sun, Xiaomin; Tang, Yang; Cheng, Jingru; Wang, Tian; Li, Fei; Kuang, Yuxiang; Luo, Ren; Zhao, Xiaoshan			The Efficacy of Shugan Jianpi Zhixie Therapy for Diarrhea-Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials	PLOS ONE			English	Article							CHINESE HERBAL MEDICINE; QUALITY-OF-LIFE; ALTERNATIVE MEDICINE; RESPONSE RATE; RISK-FACTORS; COMPLEMENTARY	Background Shugan Jianpi Zhixie therapy (SJZT) has been widely used to treat diarrhea-predominant irritable bowel syndrome (IBS-D), but the results are still controversial. A meta-analysis of randomized, double-blind, placebo-controlled trials was performed to assess the efficacy and tolerability of SJZT for IBS-D. Methods The MEDLINE, EMBASE, Cochrane Library, the China National Knowledge Infrastructure database, the Chinese Biomedical Literature database and the Wanfang database were searched up to June 2014 with no language restrictions. Summary estimates, including 95% confidence intervals (CI), were calculated for global symptom improvement, abdominal pain improvement, and Symptom Severity Scale (BSS) score. Results Seven trials (N=954) were included. The overall risk of bias assessment was low. SJZT showed significant improvement for global symptom compared to placebo (RR 1.61; 95% CI 1.24, 2.10; P = 0.0004; therapeutic gain = 33.0%; number needed to treat (NNT) = 3.0). SJZT was significantly more likely to reduce overall BSS score (SMD-0.67; 95% CI 0.94, -0.40; P < 0.00001) and improve abdominal pain (RR 4.34; 95% CI 2.64, 7.14; P < 0.00001) than placebo. The adverse events of SJZT were no different from those of placebo. Conclusions This meta-analysis suggests that SJZT is an effective and safe therapy option for patients with IBS-D. However, due to the high clinical heterogeneity and small sample size of the included trials, further standardized preparation, large-scale and rigorously designed trials are needed.	[Xiao, Ya; Tang, Yang; Cheng, Jingru; Wang, Tian; Li, Fei; Luo, Ren] Southern Med Univ, Nanfang Hosp, Dept Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China; [Xiao, Ya; Huang, Shaohui; Sun, Xiaomin; Tang, Yang; Cheng, Jingru; Wang, Tian; Li, Fei; Luo, Ren; Zhao, Xiaoshan] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China; [Liu, Yanyan] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Dept Rheumat Dis, Guangzhou 510405, Guangdong, Peoples R China; [Kuang, Yuxiang] Guangdong Prov Hosp TCM, Digest Dept, Guangzhou 510120, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Zhao, XS (corresponding author), Southern Med Univ, Sch Tradit Chinese Med, Guangzhou 510515, Guangdong, Peoples R China.	zhaoxs0609@163.com	Zhao, Xiaoshan/GPF-7929-2022; liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022		NSFC-Guangdong joint fund [U1132001]; National Science Foundation of China [81173146, 81373707, 81403447]; State Administration of Traditional Chinese Medicine [JDZX2012013]; Major State Basic Research Development Program of China (973 Program) [2013CB531700]; Guangdong Provincial Department of Science and Technology and Guangdong Provincial Academy of Traditional Chinese Medicine joint fund [2011B032200004, 2012A032500004]; Guangdong Provincial Department of Science and Technology fund [2011B031700018]; China Postdoctoral Science Foundation [2014M552187]; Administration of Traditional Chinese Medicine of Guangdong Province, China [2012KT1145]	NSFC-Guangdong joint fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Administration of Traditional Chinese Medicine; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Guangdong Provincial Department of Science and Technology and Guangdong Provincial Academy of Traditional Chinese Medicine joint fund; Guangdong Provincial Department of Science and Technology fund; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Administration of Traditional Chinese Medicine of Guangdong Province, China	This work was supported by the NSFC-Guangdong joint fund (Nos. U1132001), the National Science Foundation of China (Nos. 81173146, 81373707 and 81403447), the State Administration of Traditional Chinese Medicine (Nos. JDZX2012013), the Major State Basic Research Development Program of China (973 Program Nos. 2013CB531700), the Guangdong Provincial Department of Science and Technology and Guangdong Provincial Academy of Traditional Chinese Medicine joint fund (Nos. 2011B032200004 and 2012A032500004), the Guangdong Provincial Department of Science and Technology fund (Nos. 2011B031700018), China Postdoctoral Science Foundation (Nos. 2014M552187), and Administration of Traditional Chinese Medicine of Guangdong Province, China (Nos. 2012KT1145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Coello P, 2006, BRIT J SURG, V93, P909, DOI 10.1002/bjs.5378; [Anonymous], 2010, CHINA J TRAD CHIN ME, V25, P1062; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bensoussan A, 1998, JAMA-J AM MED ASSOC, V280, P1585, DOI 10.1001/jama.280.18.1585; Bian ZX, 2006, J ALTERN COMPLEM MED, V12, P401, DOI 10.1089/acm.2006.12.401; Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Cai LJ, 2013, CHIN ARCH TRAD CHIN, V5, P1097; Chang JY, 2010, TRENDS PHARMACOL SCI, V31, P326, DOI 10.1016/j.tips.2010.04.008; Chen DF, 2010, CHIN J DIG, V30, P327; Chitkara DK, 2008, AM J GASTROENTEROL, V103, P765, DOI 10.1111/j.1572-0241.2007.01722.x; Cong J, 2013, WORLD CHIN J DIGEST, V21, P1234; Dean BB, 2005, AM J MANAG CARE, V11, pS17; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dorn SD, 2007, NEUROGASTROENT MOTIL, V19, P630, DOI 10.1111/j.1365-2982.2007.00937.x; El-Serag HB, 2002, ALIMENT PHARM THER, V16, P1171, DOI 10.1046/j.1365-2036.2002.01290.x; Ford AC, 2010, ALIMENT PHARM THER, V32, P144, DOI 10.1111/j.1365-2036.2010.04328.x; Ford AC, 2009, AM J GASTROENTEROL, V104, P1831, DOI 10.1038/ajg.2009.223; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hussain Z, 2006, ALIMENT PHARM THER, V23, P465, DOI 10.1111/j.1365-2036.2006.02776.x; Karantanos T, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-3; Leung WK, 2006, AM J GASTROENTEROL, V101, P1574, DOI 10.1111/j.1572-0241.2006.00576.x; Li YM, 2014, CHIN J INTEGR TRAD W, V22, P1; Li YM, 2010, SHANGHAI J TRAD CHIN, V44, P33; Lin JZ, 2010, CHINESE J CHEM ENG, V18, P1, DOI 10.1016/S1004-9541(08)60315-8; Lin M, 2012, SHANGHAI J TCM, V46, P82; Liu JP, 2006, COCHRANE DB SYST REV, VJ 25; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Pogue JM, 1997, CONTROL CLIN TRIALS, V18, P580, DOI 10.1016/S0197-2456(97)00051-2; Rapps N, 2008, J PSYCHOSOM RES, V64, P599, DOI 10.1016/j.jpsychores.2008.02.018; Ringel Y, 2013, AM J PHYSIOL-GASTR L, V305, pG529, DOI 10.1152/ajpgi.00207.2012; Saito YA, 2002, AM J GASTROENTEROL, V97, P1910; Sands BE, 2009, DIGEST DIS, V27, P68, DOI 10.1159/000268123; Shi J, 2008, WORLD J GASTROENTERO, V14, P454, DOI 10.3748/wjg.14.454; Sung JJY, 2004, ALIMENT PHARM THER, V20, P1205, DOI 10.1111/j.1365-2036.2004.02242.x; TALLEY NJ, 1995, GASTROENTEROLOGY, V109, P1736, DOI 10.1016/0016-5085(95)90738-6; Tang X. D., 2011, P OFC, P1; Tornblom H, 2002, GASTROENTEROLOGY, V123, P1972, DOI 10.1053/gast.2002.37059; Xiao HT, 2015, AM J CHINESE MED, V43, P1, DOI 10.1142/S0192415X15500019	38	15	16	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122397	10.1371/journal.pone.0122397	http://dx.doi.org/10.1371/journal.pone.0122397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853241	Green Published, Green Submitted, gold			2022-12-27	WOS:000352478400067
J	Abebe, AS; Mikko, S; Johansson, AM				Abebe, Abiye Shenkut; Mikko, Sofia; Johansson, Anna M.			Genetic Diversity of Five Local Swedish Chicken Breeds Detected by Microsatellite Markers	PLOS ONE			English	Article							POPULATION-STRUCTURE; COMPUTER-PROGRAM; MANAGEMENT; SOFTWARE; CLUSTERS; DISTANCE; NUMBER	This study aimed at investigating the genetic diversity, relationship and population structure of 110 local Swedish chickens derived from five breeds (Gotlandshona, Hedemorahona, Olandsk dvarghona, Skansk blommehona, and Bohuslan-Dals svarthona, in the rest of the paper the shorter name Svarthona is used) using 24 microsatellite markers. In total, one hundred thirteen alleles were detected in all populations, with a mean of 4.7 alleles per locus. For the five chicken breeds, the observed and expected heterozygosity ranged from 0.225 to 0.408 and from 0.231 to 0.515, with the lowest scores for the Svarthona and the highest scores for the Skansk blommehona breeds, respectively. Similarly, the average within breed molecular kinship varied from 0.496 to 0.745, showing high coancestry, with Skansk blommehona having the lowest and Svarthona the highest coancestry. Furthermore, all breeds showed significant deviations from Hardy-Weinberg expectations. Across the five breeds, the global heterozygosity deficit (FIT) was 0.545, population differentiation index (F-ST) was 0.440, and the global inbreeding of individuals within breed (F-IS) was 0.187. The phylogenetic relationships of chickens were examined using neighbor-joining trees constructed at the level of breeds and individual samples. The neighbor-joining tree constructed at breed level revealed two main clusters, with Hedemorahona and Olandsk dvarghona breeds in one cluster, and Gotlandshona and Svarthona breeds in the second cluster leaving the Skansk blommehona in the middle. Based on the results of the STRUCTURE analysis, the most likely number of clustering of the five breeds was at K = 4, with Hedemorahona, Gotlandshona and Svarthona breeds forming their own distinct clusters, while Olandsk dvarghona and Skansk blommehona breeds clustered together. Losses in the overall genetic diversity of local Swedish chickens due to breeds extinction varied from -1.46% to -6.723%. The results of the current study can be used as baseline genetic information for genetic conservation program, for instance, to control inbreeding and to implement further genetic studies in local Swedish chickens.	[Abebe, Abiye Shenkut; Mikko, Sofia; Johansson, Anna M.] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden	Swedish University of Agricultural Sciences	Johansson, AM (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	Anna.Johansson@slu.se	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	Erik PhilipSorensen foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	Erik PhilipSorensen foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	AMJ received funding for the collection of blood samples and genotyping from the Erik PhilipSorensen foundation (www.epss.se). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anmarkrud JA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-138; [Anonymous], 2000, GENETICS DEMOGRAPHY, DOI [DOI 10.1017/CBO9780511623448, 10.1017/CBO9780511623448.008]; Barker JSF, 2001, CAN J FOREST RES, V31, P588, DOI 10.1139/cjfr-31-4-588; Blackburn HD, 2006, POULTRY SCI, V85, P210, DOI 10.1093/ps/85.2.210; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; Chen GH, 2008, ASIAN AUSTRAL J ANIM, V21, P331, DOI 10.5713/ajas.2008.70125; Cuc NTK, 2010, ANIM GENET, V41, P545, DOI 10.1111/j.1365-2052.2010.02039.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Englund T, 2014, HEREDITAS, V151, P229, DOI 10.1111/hrd2.00064; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2011, AN PROD HLTH GUID, V9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Food and Agriculture Organization, 2007, SUB REG REP AN GEN R; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Granevitze Z, 2007, ANIM GENET, V38, P576, DOI 10.1111/j.1365-2052.2007.01650.x; Guo XQ, 1999, HUM HERED, V49, P112, DOI 10.1159/000022855; Gutierrez JP, 2005, J HERED, V96, P718, DOI 10.1093/jhered/esi118; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaya M, 2008, BIOCHEM GENET, V46, P480, DOI 10.1007/s10528-008-9164-8; Meuwissen THE, 1997, J ANIM SCI, V75, P934; Muchadeyi FC, 2007, ANIM GENET, V38, P332, DOI 10.1111/j.1365-2052.2007.01606.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1974, GENETICS, V76, P379; Nei M., 1987, MOL EVOLUTIONARY GEN; Pritchard JK, 2000, GENETICS, V155, P945; Rajkumar U., 2007, Indian Journal of Animal Sciences, V77, P1194; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenberg NA, 2001, GENETICS, V159, P699; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Tadano R, 2008, ANIM GENET, V39, P71, DOI 10.1111/j.1365-2052.2007.01690.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkinson S, 2012, ANIM GENET, V43, P552, DOI 10.1111/j.1365-2052.2011.02296.x; Zanetti E, 2010, POULTRY SCI, V89, P420, DOI 10.3382/ps.2009-00324	40	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0120580	10.1371/journal.pone.0120580	http://dx.doi.org/10.1371/journal.pone.0120580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855978	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500013
J	Rana, Y; Haberer, J; Huang, HJ; Kambugu, A; Mukasa, B; Thirumurthy, H; Wabukala, P; Wagner, GJ; Linnemayr, S				Rana, Yashodhara; Haberer, Jessica; Huang, Haijing; Kambugu, Andrew; Mukasa, Barbara; Thirumurthy, Harsha; Wabukala, Peter; Wagner, Glenn J.; Linnemayr, Sebastian			Short Message Service (SMS)-Based Intervention to Improve Treatment Adherence among HIV-Positive Youth in Uganda: Focus Group Findings	PLOS ONE			English	Article							BEHAVIORAL SKILLS MODEL; ANTIRETROVIRAL THERAPY; ADOLESCENTS; INFORMATION; MOTIVATION	This paper presents one of the first qualitative studies to discuss programmatic barriers to SMS-based interventions for HIV-positive youth and discusses pathways through which youth perceive them to work. We conducted six focus groups with 20 male and 19 female HIV-positive youths in two clinics in Kampala, Uganda. We find that youth commonly use SMS as over 90% of this study's youths knew how to read, write and send messages and almost three-fourths of them had phones. Youth strongly felt that the success of this intervention hinged on ensuring confidentiality about their HIV-positive status. Key programmatic challenges discussed where restrictions on phone use and phone sharing that could exclude some youth. Participants felt that the intervention would improve their adherence by providing them with needed reminders and social support. Youths' suggestions about intervention logistics related to content, frequency, timing and two-way messages will be helpful to practitioners in the field.	[Rana, Yashodhara; Huang, Haijing; Wagner, Glenn J.; Linnemayr, Sebastian] RAND Corp, RAND Hlth, Santa Monica, CA 90401 USA; [Haberer, Jessica] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Kambugu, Andrew] Infect Dis Inst, Kampala, Uganda; [Mukasa, Barbara; Wabukala, Peter] Mildmay Uganda, Kampala, Uganda; [Thirumurthy, Harsha] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA	RAND Corporation; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill	Rana, Y (corresponding author), RAND Corp, RAND Hlth, Santa Monica, CA 90401 USA.	yrana@rand.org	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	National Institute of Child Health and Human Development [R01HD074925]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was sponsored by Grant R01HD074925 from The National Institute of Child Health and Human Development (PI Sebastian Linnemayr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2005, AIDS CARE, V17, P661, DOI 10.1080/09540120500038058; [Anonymous], PUTT YOUNG PEOPL CTR; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; CRAMER J, 1995, EPILEPSIA, V36, P1111, DOI 10.1111/j.1528-1157.1995.tb00469.x; Curioso Walter H, 2009, AMIA Annu Symp Proc, V2009, P129; DellaVigna S, 2009, J ECON LIT, V47, P315, DOI 10.1257/jel.47.2.315; Dowshen N, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2015; Ferrer-Roca O, 2004, J TELEMED TELECARE, V10, P282, DOI 10.1258/1357633042026341; Finitsis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088166; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Gray WN, 2011, J HEALTH PSYCHOL, V16, P828, DOI 10.1177/1359105310394230; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kitara D L, 2012, Afr J Infect Dis, V6, P12; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; Mitchell KJ, 2011, HEALTH EDUC RES, V26, P770, DOI 10.1093/her/cyr022; Mohammed S, 2012, J TELEMED TELECARE, V18, P404, DOI 10.1258/jtt.2012.120311; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Strandbygaard U, 2010, RESP MED, V104, P166, DOI 10.1016/j.rmed.2009.10.003; Thaler R.H., 2021, NUDGE FINAL EDITION	25	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0125187	10.1371/journal.pone.0125187	http://dx.doi.org/10.1371/journal.pone.0125187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25855978	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500115
J	Lodwick, RK; Nakagawa, F; van Sighem, A; Sabin, CA; Phillips, AN				Lodwick, Rebecca K.; Nakagawa, Fumiyo; van Sighem, Ard; Sabin, Caroline A.; Phillips, Andrew N.			Use of Surveillance Data on HIV Diagnoses with HIV-Related Symptoms to Estimate the Number of People Living with Undiagnosed HIV in Need of Antiretroviral Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROGRESSION; PREVALENCE; INFECTION; DISEASE; SIZE	Background It is important to have methods available to estimate the number of people who have undiagnosed HIV and are in need of antiretroviral therapy (ART). Methods The method uses the concept that a predictable level of occurrence of AIDS or other HIV-related clinical symptoms which lead to presentation for care, and hence diagnosis of HIV, arises in undiagnosed people with a given CD4 count. The method requires surveillance data on numbers of new HIV diagnoses with HIV-related symptoms, and the CD4 count at diagnosis. The CD4 count-specific rate at which HIV-related symptoms develop are estimated from cohort data. 95% confidence intervals can be constructed using a simple simulation method. Results For example, if there were 13 HIV diagnoses with HIV-related symptoms made in one year with CD4 count at diagnosis between 150-199 cells/mm(3), then since the CD4 count-specific rate of HIV-related symptoms is estimated as 0.216 per person-year, the estimated number of person years lived in people with undiagnosed HIV with CD4 count 150-199 cells/mm3 is 13/0.216 = 60 (95% confidence interval: 29-100), which is considered an estimate of the number of people living with undiagnosed HIV in this CD4 count stratum. Conclusions The method is straightforward to implement within a short period once a surveillance system of all new HIV diagnoses, collecting data on HIV-related symptoms at diagnosis, is in place and is most suitable for estimating the number of undiagnosed people with CD4 count <200 cells/mm3 due to the low rate of developing HIV-related symptoms at higher CD4 counts. A potential source of bias is under-diagnosis and under-reporting of diagnoses with HIV-related symptoms. Although this method has limitations as with all approaches, it is important for prompting increased efforts to identify undiagnosed people, particularly those with low CD4 count, and for informing levels of unmet need for ART.	[Lodwick, Rebecca K.] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Nakagawa, Fumiyo; Sabin, Caroline A.; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [van Sighem, Ard] Stichting HIV Monitoring, Amsterdam, Netherlands	University of London; University College London; University of London; University College London	Nakagawa, F (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	f.nakagawa@ucl.ac.uk	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	HIV in Europe; European Centre for Disease Prevention and Control (ECDC) [FWC/ECDC/012/050]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	HIV in Europe; European Centre for Disease Prevention and Control (ECDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: The authors acknowledge funding from HIV in Europe and European Centre for Disease Prevention and Control (ECDC) framework contract FWC/ECDC/012/050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR-MORBID MORTAL W, V41; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; British HIV Association Audit & Standards Sub-Committee, 2010 11 SURV HIV TES; BROOKMEYER R, 1986, LANCET, V2, P1320; BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; European AIDS Clinical Society, 2011, EACS GUID VERS 6 1; FLEGG PJ, 1994, J INFECTION, V29, P311, DOI 10.1016/S0163-4453(94)91266-1; Goubar A, 2008, J R STAT SOC A STAT, V171, P541, DOI 10.1111/j.1467-985X.2007.00537.x; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; LEE CA, 1991, BMJ-BRIT MED J, V303, P1093, DOI 10.1136/bmj.303.6810.1093; Lyerla R, 2006, SEX TRANSM INFECT, V82, pIII41, DOI 10.1136/sti.2006.020198; Morgan D, 2002, BRIT MED J, V324, P193, DOI 10.1136/bmj.324.7331.193; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; Porter K., 2011, COMMUNICATION; Sommen C, 2009, STAT MED, V28, P1554, DOI 10.1002/sim.3570; Sweeting MJ, 2005, STAT MED, V24, P3991, DOI 10.1002/sim.2432; Van Sighem A, 2014, C RETR OPP INF CROI; Wand H, 2010, HIV MED, V11, P395, DOI 10.1111/j.1468-1293.2009.00804.x; Working Group on Estimation of HIV Prevalence in Europe, 2011, AIDS, V25, P1017, DOI 10.1097/QAD.0b013e3283467087	22	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121992	10.1371/journal.pone.0121992	http://dx.doi.org/10.1371/journal.pone.0121992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25855978	Green Published, gold			2022-12-27	WOS:000351277500146
